PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, L; Brown, JW; Mok, YF; Hatters, DM; McKnight, CJ				Chen, Lin; Brown, Jeffrey W.; Mok, Yee-Foong; Hatters, Danny M.; McKnight, C. James			The Allosteric Mechanism Induced by Protein Kinase A (PKA) Phosphorylation of Dematin (Band 4.9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNA HEREDITARY HYPOTRICHOSIS; HUMAN ERYTHROID DEMATIN; ACTIN-BINDING; F-ACTIN; HEADPIECE DOMAIN; MEMBRANE; REVEALS; VILLIN; VISUALIZATION; PURIFICATION	Dematin (band 4.9) is an F-actin binding and bundling protein best known for its role within red blood cells, where it both stabilizes as well as attaches the spectrin/actin cytoskeleton to the erythrocytic membrane. Here, we investigate the structural consequences of phosphorylating serine 381, a covalent modification that turns off F-actin bundling activity. In contrast to the canonical doctrine, in which phosphorylation of an intrinsically disordered region/protein confers affinity for another domain/protein, we found the converse to be true of dematin: phosphorylation of the well folded C-terminal villin-type headpiece confers affinity for its intrinsically disordered N-terminal core domain. We employed analytical ultracentrifugation to demonstrate that dematin is monomeric, in contrast to the prevailing view that it is trimeric. Next, using a series of truncation mutants, we verified that dematin has two F-actin binding sites, one in the core domain and the other in the headpiece domain. Although the phosphorylation-mimicking mutant, S381E, was incapable of bundling microfilaments, it retains the ability to bind F-actin. We found that a phosphorylation-mimicking mutant, S381E, eliminated the ability to bundle, but not bind F-actin filaments. Lastly, we show that the S381E point mutant caused the headpiece domain to associate with the core domain, leading us to the mechanism for cAMP-dependent kinase control of dematin's F-actin bundling activity: when unphosphorylated, dematin's two F-actin binding domains move independent of one another permitting them to bind different F-actin filaments. Phosphorylation causes these two domains to associate, forming a compact structure, and sterically eliminating one of these F-actin binding sites.	[Chen, Lin; Brown, Jeffrey W.; McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Mok, Yee-Foong; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 2010, Australia; [Mok, Yee-Foong; Hatters, Danny M.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 2010, Australia	Boston University; University of Melbourne; University of Melbourne	McKnight, CJ (corresponding author), 700 Albany St,W302, Boston, MA 02118 USA.	cjmck@bu.edu	Brown, Jeffrey Wade/ABA-7141-2021	Brown, Jeffrey Wade/0000-0002-3992-9613; Hatters, Danny/0000-0002-9965-2847; McKnight, Christopher/0000-0002-3237-0896	National Institutes of Health [GM62886]; Boston University graduate student research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University graduate student research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62886 (to C. J. M.). This work was also supported by a Boston University graduate student research fellowship (to J. W. B.).	[Anonymous], 2004, PERS VIS RAYTR VERS; AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; Brown JW, 2010, ANAL BIOCHEM, V398, P117, DOI 10.1016/j.ab.2009.11.023; Brown JW, 2009, J MOL BIOL, V393, P608, DOI 10.1016/j.jmb.2009.08.018; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chen L, 2009, PROTEIN SCI, V18, P629, DOI 10.1002/pro.59; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FAQUIN WC, 1988, EUR J CELL BIOL, V46, P168; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Frank BS, 2004, J BIOL CHEM, V279, P7909, DOI 10.1074/jbc.M310524200; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Jiang ZHG, 2006, STRUCTURE, V14, P379, DOI 10.1016/j.str.2005.11.007; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Koshino I, 2012, J BIOL CHEM, V287, P35244, DOI 10.1074/jbc.M111.305441; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; Lutchman M, 1999, CANCER GENET CYTOGEN, V115, P65, DOI 10.1016/S0165-4608(99)00081-3; Lutchman M, 2002, EUR J BIOCHEM, V269, P638, DOI 10.1046/j.0014-2956.2001.02694.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mohseni M, 2008, MOL CELL BIOL, V28, P4712, DOI 10.1128/MCB.00237-08; Mohseni M, 2008, AM J HEMATOL, V83, P430, DOI 10.1002/ajh.21153; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SIEGEL DL, 1985, J CELL BIOL, V100, P775, DOI 10.1083/jcb.100.3.775; Sreekumar GP, 2000, J INVEST DERMATOL, V114, P595, DOI 10.1046/j.1523-1747.2000.114003595.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vardar D, 2002, CELL MOTIL CYTOSKEL, V52, P9, DOI 10.1002/cm.10027; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vocke CD, 1996, CANCER RES, V56, P2411; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	44	13	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8313	8320		10.1074/jbc.M112.438861	http://dx.doi.org/10.1074/jbc.M112.438861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355471	hybrid, Green Published			2022-12-25	WOS:000316564500031
J	Bowers, PM; Neben, TY; Tomlinson, GL; Dalton, JL; Altobell, L; Zhang, X; Macomber, JL; Wu, BF; Toobian, RM; McConnell, AD; Verdino, P; Chau, B; Horlick, RA; King, DJ				Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Dalton, Jennifer L.; Altobell, Larry; Zhang, Xue; Macomber, John L.; Wu, Betty F.; Toobian, Rachelle M.; McConnell, Audrey D.; Verdino, Petra; Chau, Betty; Horlick, Robert A.; King, David J.			Humanization of Antibodies Using Heavy Chain Complementarity-determining Region 3 Grafting Coupled with in Vitro Somatic Hypermutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AFFINITY MATURATION; COMPUTATIONAL DESIGN; SURFACE DISPLAY; MOUSE; CELLS; GENERATION; SEQUENCES; SELECTION; PROTEINS	A method for simultaneous humanization and affinity maturation of monoclonal antibodies has been developed using heavy chain complementarity-determining region (CDR) 3 grafting combined with somatic hypermutation in vitro. To minimize the amount of murine antibody-derived antibody sequence used during humanization, only the CDR3 region from a murine antibody that recognizes the cytokine h beta NGF was grafted into a nonhomologous human germ line V region. The resulting CDR3-grafted HC was paired with a CDR-grafted light chain, displayed on the surface of HEK293 cells, and matured using in vitro somatic hypermutation. A high affinity humanized antibody was derived that was considerably more potent than the parental antibody, possessed a low pM dissociation constant, and demonstrated potent inhibition of h beta NGF activity in vitro. The resulting antibody contained half the heavy chain murine donor sequence compared with the same antibody humanized using traditional methods.	[Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Dalton, Jennifer L.; Altobell, Larry; Zhang, Xue; Macomber, John L.; Wu, Betty F.; Toobian, Rachelle M.; McConnell, Audrey D.; Verdino, Petra; Chau, Betty; Horlick, Robert A.; King, David J.] Anaptysbio Inc, San Diego, CA 92131 USA		Bowers, PM (corresponding author), AnaptysBio Inc, Prot Engn & Computat Biol, 10421 Pacific Ctr Ct,Ste 200, San Diego, CA 92121 USA.	pbowers@anaptysbio.com			Anaptysbio Inc.	Anaptysbio Inc.	All authors associated with this manuscript work for Anaptysbio Inc. and receive a salary, stock, and/or stock options as part of their employment. The scientific work presented in this paper is one part of the Anaptysbio platform and technology.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Baca M, 1997, J BIOL CHEM, V272, P10678; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; Cattaneo A, 2005, Patent, Patent No. [WO/2005/061540, 2005061540]; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Covaceuszach S, 2008, J MOL BIOL, V381, P881, DOI 10.1016/j.jmb.2008.06.008; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; McConnell AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049458; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; ROGERS J, 1981, CELL, V26, P19, DOI 10.1016/0092-8674(81)90029-5; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483	33	16	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7688	7696		10.1074/jbc.M112.445502	http://dx.doi.org/10.1074/jbc.M112.445502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355464	hybrid, Green Published			2022-12-25	WOS:000316455300025
J	Lolis, AA; Londhe, P; Beggs, BC; Byrum, SD; Tackett, AJ; Davie, JK				Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Byrum, Stephanie D.; Tackett, Alan J.; Davie, Judith K.			Myogenin Recruits the Histone Chaperone Facilitates Chromatin Transcription (FACT) to Promote Nucleosome Disassembly at Muscle-specific Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GROUP BOX PROTEIN; MYOD; DNA; EXPRESSION; COMPLEX; BINDING; DIFFERENTIATION; ACTIVATION; SPT16	Facilitates chromatin transcription (FACT) functions to reorganize nucleosomes by acting as a histone chaperone that destabilizes and restores nucleosomal structure. The FACT complex is composed of two subunits: SSRP1 and SPT16. We have discovered that myogenin interacts with the FACT complex. Transfection of FACT subunits with myogenin is highly stimulatory for endogenous muscle gene expression in 10T1/2 cells. We have also found that FACT subunits do not associate with differentiation-specific genes while C2C12 cells are proliferating but are recruited to muscle-specific genes as differentiation initiates and then dissociate as differentiation proceeds. The recruitment is dependent on myogenin, as knockdowns of myogenin show no recruitment of the FACT complex. These data suggest that FACT is involved in the early steps of gene activation through its histone chaperone activities that serve to open the chromatin structure and facilitate transcription. Consistent with this hypothesis, we find that nucleosomes are depleted at muscle-specific promoters upon differentiation and that this activity is dependent on the presence of FACT. Our results show that the FACT complex promotes myogenin-dependent transcription and suggest that FACT plays an important role in the establishment of the appropriate transcription profile in a differentiated muscle cell.	[Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Davie, Judith K.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Lolis, Alexandra A.; Londhe, Priya; Beggs, Benjamin C.; Davie, Judith K.] So Illinois Univ, Sch Med, Simmons Canc Inst, Carbondale, IL 62901 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Arkansas System; University of Arkansas Medical Sciences	Davie, JK (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu			National Institute of Health [R01DA025755, F32GM093614, UL1RR029884, P30GM103450, P20GM103429]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR060017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450, F32GM093614, P20GM103429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025755] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute of Health Grants R01DA025755, F32GM093614, UL1RR029884, P30GM103450, and P20GM103429.	Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Byrum S, 2012, METHODS MOL BIOL, V833, P143, DOI 10.1007/978-1-61779-477-3_10; Byrum S, 2011, J CUTAN PATHOL, V38, P933, DOI 10.1111/j.1600-0560.2011.01761.x; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Garcia H, 2011, ONCOTARGET, V2, P783; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kihara T, 2008, EXP CELL RES, V314, P629, DOI 10.1016/j.yexcr.2007.10.004; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pollard JW, 1997, BASIC CELL CULTURE P; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200	50	22	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7676	7687		10.1074/jbc.M112.426718	http://dx.doi.org/10.1074/jbc.M112.426718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23364797	hybrid, Green Published			2022-12-25	WOS:000316455300024
J	Li, GC; Zhang, Z; Ma, XJ; Zhu, J; Cai, G				Li, Guichao; Zhang, Zhen; Ma, Xuejun; Zhu, Ji; Cai, Gang			Postoperative Chemoradiotherapy Combined with Epirubicin-Based Triplet Chemotherapy for Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction	PLOS ONE			English	Article							PHASE-III TRIAL; RESECTABLE GASTRIC-CANCER; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; PERIOPERATIVE CHEMOTHERAPY; COMPARING CAPECITABINE; D2 GASTRECTOMY; ASIAN PATIENTS; UNITED-STATES; SURGERY	Background: Due to low tolerance to chemotherapy, the maximum number of cycles of postoperative adjuvant chemotherapy is 4 in adjuvant gastric clinical trials. The aim of this study is to retrospectively evaluate the safety and efficacy of adjuvant epirubicin-based triplet chemotherapy and radiotherapy in the treatment of resected locally advanced stomach or gastroesophageal junction adenocarcinoma. Methodology/Principal Findings: From January 2004 to July 2008, ninety-seven consecutive gastric or gastroesophageal junction adenocarcinoma patients in stages T3-4/N+ were treated with postoperative radiotherapy and chemotherapy. The recommended treatment plan was radical resection followed by 1-2 cycles of adjuvant chemotherapy (ACT), postoperative chemoradiotherapy (CRT), and, finally, 4-5 cycles of ACT. The patients were classified into two groups depending on the number of cycles of ACT: group 1 received 4-6 cycles (n = 59), and group 2 received 0-3 cycles (n = 38). The detailed grouping is as follows: RT alone, 2; RT and CT, 18; concurrent RTCT and CT, 41; and CRT, 36. Of the 97 patients, 77 patients received concurrent therapy (CRT, (5-fluorouracil or capecitabine), and 20 received radiotherapy alone because of patient refusal (n = 15) or treatment toxicity (n = 5). After a median follow-up of 44 months, the 3-year disease free survival(DFS) and overall survival (OS) were 66.5% and 69.5% for group 1 and 45.5% and 50% for group 2, respectively (p = 0.005 and p = 0.024). Multivariate analysis revealed that 4-6 cycles of ACT, lymphovascular invasion, or peritoneal metastasis were independent prognostic factors for disease-free survival or overall survival (p < 0.05). Conclusions/Significance: This study demonstrates that concurrent chemoradiation with adjuvant epirubicin-based triplet chemotherapy is feasible and tolerable for gastric or gastroesophageal junction carcinoma patients. Patients can benefit from more cycles of ACT.	[Zhang, Zhen] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Radiat Oncol, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Radiat Oncol, Shanghai 200433, Peoples R China.	zhenzhang6@163.com	zhu, ji/HDM-1538-2022	Zhu, Ji/0000-0001-7134-9419				Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Gill R D, 1992, Math Popul Stud, V3, P259; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; HALLISSEY MT, 1994, LANCET, V343, P1309, DOI 10.1016/S0140-6736(94)92464-3; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Janunger KG, 2001, ACTA ONCOL, V40, P309, DOI 10.1080/02841860151116385; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Leong T, 2011, INT J RADIAT ONCOL, V79, P690, DOI 10.1016/j.ijrobp.2009.11.042; Lim DH, 2004, BRIT J CANCER, V91, P11, DOI 10.1038/sj.bjc.6601896; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; Noguchi Y, 2000, CANCER-AM CANCER SOC, V89, P2237, DOI 10.1002/1097-0142(20001201)89:11<2237::AID-CNCR12>3.3.CO;2-0; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Quero L, 2012, INT J RADIAT ONCOL, V83, P574, DOI 10.1016/j.ijrobp.2011.07.031; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Sumpter K, 2005, BRIT J CANCER, V92, P1976, DOI 10.1038/sj.bjc.6602572; Tepper JE, 2002, SEMIN RADIAT ONCOL, V12, P187, DOI 10.1053/srao.2002.30827; Theuer CP, 2000, CANCER, V89, P1883, DOI 10.1002/1097-0142(20001101)89:9<1883::AID-CNCR3>3.3.CO;2-8; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van de Velde CJH, 1998, ANN CHIR GYNAECOL FE, V87, P89; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54233	10.1371/journal.pone.0054233	http://dx.doi.org/10.1371/journal.pone.0054233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372688	gold, Green Submitted, Green Published			2022-12-25	WOS:000315210400009
J	Arredondo, C; Orellana, M; Vecchiola, A; Pereira, LA; Galdames, L; Andres, ME				Arredondo, Cristian; Orellana, Marcelo; Vecchiola, Andrea; Alberto Pereira, Luis; Galdames, Leopoldo; Estela Andres, Maria			PIAS gamma Enhanced SUMO-2 Modification of Nurr1 Activation-Function-1 Domain Limits Nurr1 Transcriptional Synergy	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; DOPAMINE NEURONS; SUMOYLATION; PATHWAY; MOTIF; RECOGNITION; MECHANISMS; REPRESSES; PROMOTER	Nurr1 (NR4A2) is a transcription factor that belongs to the orphan NR4A group of the nuclear receptor superfamily. Nurr1 plays key roles in the origin and maintenance of midbrain dopamine neurons, and peripheral inflammatory processes. PIAS gamma, a SUMO-E3 ligase, represses Nurr1 transcriptional activity. We report that Nurr1 is SUMOylated by SUMO-2 in the lysine 91 located in the transcriptional activation function 1 domain of Nurr1. Nurr1 SUMOylation by SUMO-2 is markedly facilitated by overexpressing wild type PIAS gamma, but not by a mutant form of PIAS gamma lacking its first LXXLL motif (PIAS gamma mut1). This PIAS gamma mut1 is also unable to interact with Nurr1 and to repress Nurr1 transcriptional activity. Interestingly, the mutant PIAS gamma C342A that lacks SUMO ligase activity is still able to significantly repress Nurr1-dependent transcriptional activity, but not to enhance Nurr1 SUMOylation. A SUMOylation-deficient Nurr1 mutant displays higher transcriptional activity than the wild type Nurr1 only in promoters harboring more than one Nurr1 response element. Furthermore, lysine 91, the major target of Nurr1 SUMOylation is contained in a canonical synergy control motif, indicating that SUMO-2 posttranslational modification of Nurr1 regulates its transcriptional synergy in complex promoters. In conclusion, PIAS gamma can exert two types of negative regulations over Nurr1. On one hand, PIAS gamma limits Nurr1 transactivation in complex promoters by SUMOylating its lysine 91. On the other hand, PIAS gamma fully represses Nurr1 transactivation through a direct interaction, independently of its E3-ligase activity.	[Arredondo, Cristian; Orellana, Marcelo; Vecchiola, Andrea; Alberto Pereira, Luis; Galdames, Leopoldo; Estela Andres, Maria] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile	Andres, ME (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Alameda 340, Santiago, Chile.	mandres@bio.puc.cl			Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110352]; Millennium Scientific Initiative [P10/063-F]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	This work was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.fondecyt.cl) grant No 1110352 and Millennium Scientific Initiative (http://www.iniciativamilenio.cl) grant No P10/063-F. LAP is recipient of a doctoral fellowship of the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (www.conicyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035717; Blanco EH, 2011, NEUROPEPTIDES, V45, P273, DOI 10.1016/j.npep.2011.05.002; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Georges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025463; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Maruyama K, 1998, INT J ONCOL, V12, P1237; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mukherjee S, 2012, J BIOL CHEM, V287, P31195, DOI 10.1074/jbc.M112.395210; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Sacchetti P, 1999, MOL BRAIN RES, V74, P167, DOI 10.1016/S0169-328X(99)00275-2; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	35	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55035	10.1371/journal.pone.0055035	http://dx.doi.org/10.1371/journal.pone.0055035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358114	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600145
J	Bi, SD; Meng, J; McLean, S; Wu, WY; Ni, XJ; Ye, J				Bi, Shundong; Meng, Jin; McLean, Sarah; Wu, Wenyu; Ni, Xijun; Ye, Jie			A New Genus of Aplodontid Rodent (Mammalia, Rodentia) from the Late Oligocene of Northern Junggar Basin, China	PLOS ONE			English	Article							PHYLOGENY; MIOCENE	A new genus and species of aplodontid rodent, Proansomys dureensis, from the late Oligocene of the northern Junggar Basin of China is described. The new genus is referred to as Ansomyinae because the ectoloph on the upper cheek teeth, although not fully crested, has attained the same characteristic bucket-handle-shaped configuration as other members of the subfamily. It represents the earliest record of the subfamily yet discovered in Asia and is more plesiomorphic than species of the genus Ansomys in having a partly crested ectoloph, a lower degree of lophodonty, and less complex tooth basins (lacking accessory lophules). Proansomys has transitional features between Prosciurus and Ansomys, suggesting that the Ansomyinae derived from a group of aplodontids related to Prosciurus, as did other advanced aplodontid rodents. This provides new light on the paleobiogeography of the Ansomyinae.	[Bi, Shundong; Wu, Wenyu; Ni, Xijun; Ye, Jie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Bi, Shundong; McLean, Sarah] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; American Museum of Natural History (AMNH)	Bi, SD (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	sbi@iup.edu			Chinese Academy of Sciences (CAS) Key Project [XDB03020500]; National Nature Science Foundation of China [KA212201]; CAS 100-Talent Project; CAS Fossil Excavation and Preparation Fund; American Museum of Natural History	Chinese Academy of Sciences (CAS) Key Project; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS 100-Talent Project; CAS Fossil Excavation and Preparation Fund; American Museum of Natural History	This research has been funded by the Chinese Academy of Sciences (CAS) Key Project (XDB03020500), the National Nature Science Foundation of China (KA212201), the CAS 100-Talent Project, and the CAS Fossil Excavation and Preparation Fund. Meng is also supported by funds from the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hopkins SSB, 2008, ZOOL J LINN SOC-LOND, V153, P769, DOI 10.1111/j.1096-3642.2008.00399.x; Hopkins SSB, 2004, J PALEONTOL, V78, P731, DOI 10.1666/0022-3360(2004)078<0731:PABOTG>2.0.CO;2; Jie Y, 2003, B AM MUS NAT HIST, P568, DOI 10.1206/0003-0090(2003)279<0568:C>2.0.CO;2; Kelly Thomas S., 2005, Paludicola, V5, P85; KORTH W.W, 1989, J VERTEBR PALEONTOL, V9, P400; Korth WW, 2007, J VERTEBR PALEONTOL, V27, P740, DOI 10.1671/0272-4634(2007)27[740:ANSOAR]2.0.CO;2; Lopatin A. V., 1997, PALAEONTOLOGICAL J, V31, P667; Meng Jin, 2006, Vertebrata Palasiatica, V44, P205; QIU ZD, 1988, VERTEBRAT PALASIATIC, V26, P50; QIU ZD, 1987, VERTEBRAT PALASIATIC, V25, P283; RENSBERGER JM, 1986, J PALEONTOL, V60, P763, DOI 10.1017/S0022336000022289; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Tong Yongsheng, 1990, Vertebrata Palasiatica, V28, P59; Wang Ban-Yue, 2005, Vertebrata Palasiatica, V43, P85; Ye Jie, 2001, Journal of Stratigraphy, V25, P283; Ye Jie, 2001, Journal of Stratigraphy, V25, P193	16	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52625	10.1371/journal.pone.0052625	http://dx.doi.org/10.1371/journal.pone.0052625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359629	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600007
J	Corina, DP; Lawyer, LA; Hauser, P; Hirshorn, E				Corina, David P.; Lawyer, Laurel A.; Hauser, Peter; Hirshorn, Elizabeth			Lexical Processing in Deaf Readers: An fMRI Investigation of Reading Proficiency	PLOS ONE			English	Article							WORD FORM AREA; ANTERIOR CINGULATE CORTEX; CEREBRAL ORGANIZATION; CHINESE CHARACTERS; PREFRONTAL CORTEX; RHYMING SKILLS; SIGN-LANGUAGE; BROCAS REGION; DUAL-ROUTE; ACTIVATION	Individuals with significant hearing loss often fail to attain competency in reading orthographic scripts which encode the sound properties of spoken language. Nevertheless, some profoundly deaf individuals do learn to read at age-appropriate levels. The question of what differentiates proficient deaf readers from less-proficient readers is poorly understood but topical, as efforts to develop appropriate and effective interventions are needed. This study uses functional magnetic resonance imaging (fMRI) to examine brain activation in deaf readers (N = 21), comparing proficient (N = 11) and less proficient (N = 10) readers' performance in a widely used test of implicit reading. Proficient deaf readers activated left inferior frontal gyrus and left middle and superior temporal gyrus in a pattern that is consistent with regions reported in hearing readers. In contrast, the less-proficient readers exhibited a pattern of response characterized by inferior and middle frontal lobe activation (right. left) which bears some similarity to areas reported in studies of logographic reading, raising the possibility that these individuals are using a qualitatively different mode of orthographic processing than is traditionally observed in hearing individuals reading sound-based scripts. The evaluation of proficient and less-proficient readers points to different modes of processing printed English words. Importantly, these preliminary findings allow us to begin to establish the impact of linguistic and educational factors on the neural systems that underlie reading achievement in profoundly deaf individuals.	[Corina, David P.; Lawyer, Laurel A.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Hauser, Peter] Rochester Inst Technol, Natl Tech Inst Deaf, Dept Res & Teacher Educ, Rochester, NY 14623 USA; [Hirshorn, Elizabeth] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	University of California System; University of California Davis; Rochester Institute of Technology; University of Rochester	Corina, DP (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.	dpcorina@ucdavis.edu			NSF Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2) [SBE-0541953]	NSF Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2)	This work was supported by NSF SBE-0541953 Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2).	Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Allen TE, 2009, AM ANN DEAF, V154, P338, DOI 10.1353/aad.0.0109; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; [Anonymous], 1998, PEAB IND ACH TEST RE; Aparicio M, 2007, NEUROIMAGE, V35, P1303, DOI 10.1016/j.neuroimage.2006.12.046; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; CAMPBELL R, 1988, Q J EXP PSYCHOL-A, V40, P771, DOI 10.1080/14640748808402298; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chamberlain C, 2000, LANGUAGE ACQUISITION BY EYE, P221; Chamberlain C., 2008, APPL PSYCHOLINGUIST, V28, P537; Charlier BL, 2000, Q J EXP PSYCHOL-A, V53, P349, DOI 10.1080/027249800390529; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Coltheart M, 2000, BRAIN LANG, V71, P299, DOI 10.1006/brln.1999.2183; Coltheart M, 1980, DEEP DYSLEXIA, P326; Corina D, 1998, APHASIA IN ATYPICAL POPULATIONS, P261; Corina D, 2007, BRAIN RES, V1152, P111, DOI 10.1016/j.brainres.2007.03.054; Corina DP, 1999, BRAIN LANG, V69, P230, DOI 10.1006/brln.1999.2062; De Carli D, 2007, MAGN RESON IMAGING, V25, P933, DOI 10.1016/j.mri.2007.03.031; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dyer Annabella, 2003, J Deaf Stud Deaf Educ, V8, P215, DOI 10.1093/deafed/eng012; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Gizewski ER, 2005, NEUROREPORT, V16, P1913, DOI 10.1097/01.wnr.0000186592.41587.3e; Goldin-Meadow S., 2001, LEARN DISABIL RES PR, V16, P222, DOI [DOI 10.1111/0938-8982.00022, 10.1111/0938-8982.00022]; Goodman K, 1982, LANGUAGE LIT LEARNIN; HANSON VL, 1989, J SPEECH HEAR RES, V32, P2, DOI 10.1044/jshr.3201.02; HANSON VL, 1987, MEM COGNITION, V15, P199, DOI 10.3758/BF03197717; Harris M, 1998, J Deaf Stud Deaf Educ, V3, P205; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Heim S, 2008, NEUROIMAGE, V40, P1362, DOI 10.1016/j.neuroimage.2008.01.009; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hoffmeister RJ, 2000, LANGUAGE ACQUISITION BY EYE, P143; Horwitz B, 2003, NEUROPSYCHOLOGIA, V41, P1868, DOI 10.1016/S0028-3932(03)00125-8; Jones PO, 2011, CEREB CORTEX; KELLY LP, 1995, EXCEPT CHILDREN, V61, P318, DOI 10.1177/001440299506100402; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kuntze M, 1998, TOP LANG DISORD, V18, P1; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacSweeney M, 2009, BRAIN, V132, P1928, DOI 10.1093/brain/awp129; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Meschyan G, 2006, NEUROIMAGE, V29, P1135, DOI 10.1016/j.neuroimage.2005.08.055; Miller P, 1997, J SPEECH LANG HEAR R, V40, P1151, DOI 10.1044/jslhr.4005.1151; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; National Reading Panel, 2000, REP SUBG; Nelson JR, 2009, HUM BRAIN MAPP, V30, P810, DOI 10.1002/hbm.20551; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; NOLAN KA, 1983, BRAIN LANG, V20, P305, DOI 10.1016/0093-934X(83)90047-0; Olson AC, 2004, Q J EXP PSYCHOL-A, V57, P385, DOI 10.1080/02724980343000396; Padden C, 1988, DEAF AM VOICES CULTU; Patterson K. E., 1982, NORMALITY PATHOLOGY, P77; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Smith Frank, 1994, UNDERSTANDING READIN; Sterne A, 2000, J CHILD PSYCHOL PSYC, V41, P609, DOI 10.1111/1469-7610.00648; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tham WWP, 2005, NEUROIMAGE, V28, P579, DOI 10.1016/j.neuroimage.2005.06.057; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Torgesen JK, 1999, J EDUC PSYCHOL, V91, P579, DOI 10.1037/0022-0663.91.4.579; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner RK, 2006, HDB PSYCHOLINGUISTIC; Wang Y, 2008, AM ANN DEAF, V153, P396; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	86	23	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54696	10.1371/journal.pone.0054696	http://dx.doi.org/10.1371/journal.pone.0054696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359269	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600095
J	Dalko, E; Gaudreault, V; Dardon, JS; Moreau, R; Scorza, T				Dalko, Esther; Gaudreault, Veronique; Dardon, Jaime Sanchez; Moreau, Robert; Scorza, Tatiana			Preconditioning with Hemin Decreases Plasmodium chabaudi adami Parasitemia and Inhibits Erythropoiesis in BALB/c Mice	PLOS ONE			English	Article							SEVERE MALARIAL ANEMIA; IFN-GAMMA RESPONSES; T-CELL SUBSETS; BLOOD-STAGE; IN-VITRO; IMMUNE-RESPONSES; OXIDATIVE STRESS; PATHOGENESIS; OXYGENASE-1; MACROPHAGES	Increased susceptibility to bacterial and viral infections and dysfunctional erythropoiesis are characteristic of malaria and other hemolytic hemoglobinopathies. High concentrations of free heme are common in these conditions but little is known about the effect of heme on adaptive immunity and erythropoiesis. Herein, we investigated the impact of heme (hemin) administration on immune parameters and steady state erythropoiesis in BALB/c mice, and on parasitemia and anemia during Plasmodium chabaudi adami infection. Intra-peritoneal injection of hemin (5 mg/Kg body weight) over three consecutive days decreased the numbers of splenic and bone marrow macrophages, IFN-gamma responses to CD3 stimulation and T(h)1 differentiation. Our results show that the numbers of erythroid progenitors decreased in the bone marrow and spleen of mice treated with hemin, which correlated with reduced numbers of circulating reticulocytes, without affecting hemoglobin concentrations. Although blunted IFN-gamma responses were measured in hemin-preconditioned mice, the mice developed lower parasitemia following P.c. adami infection. Importantly, anemia was exacerbated in hemin-preconditioned mice with malaria despite the reduced parasitemia. Altogether, our data indicate that free heme has dual effects on malaria pathology.	[Dalko, Esther] Inst Pasteur, Basic & Clin Immunol Parasit Dis Grp, Ctr Infect & Immun Lille, F-59019 Lille, France; [Dalko, Esther] Inst Pasteur, INSERM, U547, F-59019 Lille, France; [Dalko, Esther; Gaudreault, Veronique; Dardon, Jaime Sanchez; Moreau, Robert; Scorza, Tatiana] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Quebec; University of Quebec Montreal	Scorza, T (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	scorza.tatiana@uqam.ca	Scorza, Tatiana/AAM-8992-2020	Dalko, Esther/0000-0001-7166-7417	Discovery Grant (Natural Sciences and Engineering Research Council); Bone Catalyst Grant (Canadian Institutes of Health Research)	Discovery Grant (Natural Sciences and Engineering Research Council); Bone Catalyst Grant (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	This study was partially funded by a Discovery Grant (Natural Sciences and Engineering Research Council) and a Bone Catalyst Grant (Canadian Institutes of Health Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 1996, T ROY SOC TROP MED H, V90, P147, DOI 10.1016/S0035-9203(96)90118-2; Barcellini W, 2000, BRIT J HAEMATOL, V111, P452, DOI 10.1046/j.1365-2141.2000.02380.x; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bisol GD, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P203; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P362, DOI 10.1128/CDLI.10.3.362-366.2003; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dang TN, 2011, GLIA, V59, P1540, DOI 10.1002/glia.21198; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; Elghazali G, 1997, CLIN EXP IMMUNOL, V109, P84, DOI 10.1046/j.1365-2249.1997.4401337.x; ERSLEV AJ, 1980, BRIT J HAEMATOL, V45, P65, DOI 10.1111/j.1365-2141.1980.tb03811.x; Fagiolo E, 2003, AUTOIMMUNITY, V36, P199, DOI 10.1080/0891693031000151238; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gadsby N, 2009, INT J PARASITOL, V39, P347, DOI 10.1016/j.ijpara.2008.07.005; Gatidis S, 2009, ANN HEMATOL, V88, P721, DOI 10.1007/s00277-009-0697-7; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gharagozloo M, 2009, ANN HEMATOL, V88, P21, DOI 10.1007/s00277-008-0564-y; Giuliani AL, 2001, EUR J HAEMATOL, V66, P221, DOI 10.1034/j.1600-0609.2001.066004221.x; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Malu DT, 2011, J IMMUNOL, V186, P6271, DOI 10.4049/jimmunol.1003355; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; Mohan K, 1998, BRIT J HAEMATOL, V103, P942, DOI 10.1046/j.1365-2141.1998.01126.x; Moreau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046101; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; Omodeo-Sale F, 2005, EUR J HAEMATOL, V74, P324, DOI 10.1111/j.1600-0609.2004.00352.x; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Perlmann Peter, 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P55; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Roussilhon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009309; SANCHEZMEDAL L, 1968, ANN NY ACAD SCI, V149, P377, DOI 10.1111/j.1749-6632.1968.tb15171.x; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; SUTHERLAND RM, 1995, INT IMMUNOL, V7, P771, DOI 10.1093/intimm/7.5.771; Toriani-Terenzi C, 2005, ANN NY ACAD SCI, V1051, P29, DOI 10.1196/annals.1361.044; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Wanachiwanawin W, 1996, EUR J HAEMATOL, V56, P153; Yin XJ, 2004, TOXICOL SCI, V82, P143, DOI 10.1093/toxsci/kfh255	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54744	10.1371/journal.pone.0054744	http://dx.doi.org/10.1371/journal.pone.0054744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358441	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600103
J	Gallet, M; Saidi, S; Hay, E; Photsavang, J; Marty, C; Sailland, J; Carnesecchi, J; Tribollet, V; Barenton, B; Forcet, C; Birling, MC; Sorg, T; Chassande, O; Cohen-Solal, M; Vanacker, JM				Gallet, Marlene; Saidi, Soraya; Hay, Eric; Photsavang, Johann; Marty, Caroline; Sailland, Juliette; Carnesecchi, Julie; Tribollet, Violaine; Barenton, Bruno; Forcet, Christelle; Birling, Marie-Christine; Sorg, Tania; Chassande, Olivier; Cohen-Solal, Martine; Vanacker, Jean-Marc			Repression of Osteoblast Maturation by ERR alpha Accounts for Bone Loss Induced by Estrogen Deficiency	PLOS ONE			English	Article							BREAST-CANCER CELLS; RECEPTOR-ALPHA; DIFFERENTIATION; ORPHAN; EXPRESSION; RISK; PROLIFERATION; OSTEOPOROSIS; ACTIVATION; PROMOTER	ERR alpha is an orphan member of the nuclear receptor family, the complete inactivation of which confers resistance to bone loss induced by ageing and estrogen withdrawal to female mice in correlation with increased bone formation in vivo. Furthermore ERR alpha negatively regulates the commitment of mesenchymal cells to the osteoblast lineage ex vivo as well as later steps of osteoblast maturation. We searched to determine whether the activities of ERR alpha on osteoblast maturation are responsible for one or both types of in vivo induced bone loss. To this end we have generated conditional knock out mice in which the receptor is normally present during early osteoblast differentiation but inactivated upon osteoblast maturation. Bone ageing in these animals was similar to that observed for control animals. In contrast conditional ERR alpha KO mice were completely resistant to bone loss induced by ovariectomy. We conclude that the late (maturation), but not early (commitment), negative effects of ERR alpha on the osteoblast lineage contribute to the reduced bone mineral density observed upon estrogen deficiency.	[Gallet, Marlene; Sailland, Juliette; Carnesecchi, Julie; Tribollet, Violaine; Barenton, Bruno; Forcet, Christelle; Vanacker, Jean-Marc] Univ Lyon, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, Lyon, France; [Saidi, Soraya; Hay, Eric; Marty, Caroline; Cohen-Solal, Martine] Hop Lariboisiere, INSERM, U606, F-75475 Paris, France; [Photsavang, Johann; Chassande, Olivier] INSERM, U1026, Bordeaux, France; [Birling, Marie-Christine; Sorg, Tania] Inst Clin Souris, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanacker, JM (corresponding author), Univ Lyon, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Chassande, Olivier/J-3582-2015; Cohen-Solal, Martine/P-7808-2017	Hay, Eric/0000-0002-0131-9983; Birling, Marie-Christine/0000-0002-3372-8108; Cohen-Solal, Martine/0000-0002-8582-8258; Carnesecchi, Julie/0000-0002-3872-2215	Agence Nationale de la Recherche [ANR-GENOPAT-012]; Ligue contre le Cancer (comite Rhone); Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer (comite Rhone)(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de la Recherche (grant ANR-GENOPAT-012), Ligue contre le Cancer (comite Rhone) and Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Auld KL, 2012, J MOL ENDOCRINOL, V48, P177, DOI 10.1530/JME-11-0140; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; Collins JA, 2005, HUM REPROD UPDATE, V11, P545, DOI 10.1093/humupd/dmi028; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Gallet M, 2010, TRENDS ENDOCRIN MET, V21, P637, DOI 10.1016/j.tem.2010.06.008; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horwitz KB, 2008, MOL ENDOCRINOL, V22, P2743, DOI 10.1210/me.2008-0291; Ijichi N, 2007, BIOCHEM BIOPH RES CO, V358, P813, DOI 10.1016/j.bbrc.2007.04.209; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Macari C, 2010, MOL CELL ENDOCRINOL, V330, P33, DOI 10.1016/j.mce.2010.08.003; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Vico L, 2010, OSTEOPOROSIS INT, V21, P365, DOI 10.1007/s00198-009-0963-5; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	36	16	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54837	10.1371/journal.pone.0054837	http://dx.doi.org/10.1371/journal.pone.0054837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359549	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600119
J	Jain, S; Chodisetti, SB; Agrewala, JN				Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.			Combinatorial Signaling through TLR-2 and CD86 Augments Activation and Differentiation of Resting B Cells	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; ANTIGEN RECEPTOR; DENDRITIC CELLS; CUTTING EDGE; T-CELLS; STIMULATION; PROLIFERATION; B7-2; CD40	B cells are an integral component in mounting humoral immune responses and they are also crucial in programming T cell mediated immunity. Usually, B cell activation is initiated by recognition of antigen through B cell receptor (BCR), followed by its processing and presentation to T cells. But very little is known about BCR independent activation of B cells. Now, there is an increasing body of evidence indicating the combinatorial effect of innate and adaptive immune components in modulating the functions of B cells. In this study, we demonstrate the activation of resting B cells (RB) by simultaneous involvement of Toll like Receptor-2 (TLR-2) and costimulatory molecule, CD86. Interestingly, these B cells exhibited significant level of activation and proliferation. Furthermore, this process of activation leads to the differentiation of RB cells, preferably into marginal zone precursors (CD19(+)IgD(hi)IgM(hi)CD21/35(hi)CD23(hi)) in a shorter time window and showed increased secretion of IgG isotype. These RB cells also showed enhanced antigen uptake capacity. These observations were also substantiated by microarray gene expression results, which strengthen the notion that combinatorial signaling through innate and adaptive immune components enhances B cell mediated immune response. Thus, the present study elucidates a novel BCR independent B cell activation mechanism that links TLR-2 and CD86. Hence signaling of TLRs in conjunction with costimulatory molecules will substantially help in bolstering humoral immune response, which can be extrapolated to formulate vaccination strategies for diseases involving B cell-mediated immunity.	[Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.] Council Sci & Ind Research Inst Microbial Technol, Immunol Lab, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Agrewala, JN (corresponding author), Council Sci & Ind Research Inst Microbial Technol, Immunol Lab, Chandigarh, India.	javed@imtech.res.in	Jain, Shweta/I-4139-2019; Chodisetti, Sathi Babu/H-3239-2018; Agrewala, Javed Naim/AAS-8449-2021	Jain, Shweta/0000-0001-6297-0078; Chodisetti, Sathi Babu/0000-0001-7473-9420; 	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This project was supported by Council of Scientific and Industrial Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank K Ganesan for useful discussions concerning microarray experiments. We acknowledge Uthaman Gowthaman and Nargis Khan for helping in the preparation of the manuscript. We are also thankful to animal house facilities of National Institute of Immunology, New Delhi; National Institute of Pharmaceutical Education and Research, Mohali and National Institute of Nutrition, Hyderabad, India for providing the experimental mice. SJ and SBC are recipients of research fellowships from Council of Scientific and Industrial Research (CSIR), New Delhi, India	Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Fillatreau S, 2006, EUR J IMMUNOL, V36, P798, DOI 10.1002/eji.200636040; HAN SH, 1995, J IMMUNOL, V155, P556; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Haxhinasto SA, 2004, J BIOL CHEM, V279, P2575, DOI 10.1074/jbc.M310628200; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020651; Jeannin P, 1997, J BIOL CHEM, V272, P15613, DOI 10.1074/jbc.272.25.15613; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Kasprowicz DJ, 2000, J IMMUNOL, V165, P680, DOI 10.4049/jimmunol.165.2.680; Kin NW, 2007, J IMMUNOL, V179, P1516, DOI 10.4049/jimmunol.179.3.1516; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Manjarrez-Orduno N, 2007, EUR J IMMUNOL, V37, P358, DOI 10.1002/eji.200636453; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Podojil JR, 2005, TRENDS IMMUNOL, V26, P180, DOI 10.1016/j.it.2005.02.005; Podojil JR, 2004, J BIOL CHEM, V279, P23394, DOI 10.1074/jbc.M313096200; Podojil JR, 2003, J IMMUNOL, V170, P5143, DOI 10.4049/jimmunol.170.10.5143; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Ray A, 2004, MOL IMMUNOL, V41, P1167, DOI 10.1016/j.molimm.2004.06.007; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; SNAPPER CM, 1995, J IMMUNOL, V155, P5582; Sperling AI, 1996, J IMMUNOL, V157, P3909; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Vasilevsky S, 2008, EUR J IMMUNOL, V38, P3316, DOI 10.1002/eji.200838484; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54392	10.1371/journal.pone.0054392	http://dx.doi.org/10.1371/journal.pone.0054392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365665	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600053
J	Mangoni, AA; Zinellu, A; Carru, C; Attia, JR; McEvoy, M				Mangoni, Arduino A.; Zinellu, Angelo; Carru, Ciriaco; Attia, John R.; McEvoy, Mark			Transsulfuration Pathway Thiols and Methylated Arginines: The Hunter Community Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL CYCLE; ASYMMETRIC DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; CAPILLARY-ELECTROPHORESIS; MYOCARDIAL-INFARCTION; CORONARY-ANGIOGRAPHY; OBESE INDIVIDUALS; EMERGING ROLE	Background: Serum homocysteine, when studied singly, has been reported to be positively associated both with the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine [ADMA, via inhibition of dimethylarginine dimethylaminohydrolase (DDAH) activity] and with symmetric dimethylarginine (SDMA). We investigated combined associations between transsulfuration pathway thiols, including homocysteine, and serum ADMA and SDMA concentrations at population level. Methods: Data on clinical and demographic characteristics, medication exposure, C-reactive protein, serum ADMA and SDMA (LC-MS/MS), and thiols (homocysteine, cysteine, taurine, glutamylcysteine, total glutathione, and cysteinylglycine; capillary electrophoresis) were collected from a sample of the Hunter Community Study on human ageing [n = 498, median age (IQR) = 64 (60-70) years]. Results: Regression analysis showed that: a) age (P = 0.001), gender (P = 0.03), lower estimated glomerular filtration rate (eGFR, P = 0.08), body mass index (P = 0.008), treatment with beta-blockers (P = 0.03), homocysteine (P = 0.02), and glutamylcysteine (P = 0.003) were independently associated with higher ADMA concentrations; and b) age (P = 0.001), absence of diabetes (P = 0.001), lower body mass index (P = 0.01), lower eGFR (P < 0.001), cysteine (P = 0.007), and glutamylcysteine (P < 0.001) were independently associated with higher SDMA concentrations. No significant associations were observed between methylated arginines and either glutathione or taurine concentrations. Conclusions: After adjusting for clinical, demographic, biochemical, and pharmacological confounders the combined assessment of transsulfuration pathway thiols shows that glutamylcysteine has the strongest and positive independent associations with ADMA and SDMA. Whether this reflects a direct effect of glutamylcysteine on DDAH activity (for ADMA) and/or cationic amino acid transport requires further investigations.	[Mangoni, Arduino A.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Zinellu, Angelo; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Attia, John R.; McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of Aberdeen; University of Sassari; University of Newcastle	Mangoni, AA (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	a.a.mangoni@abdn.ac.uk	Mangoni, Arduino Aleksander/I-5109-2019; Attia, John R/F-5376-2013; Carru, Ciriaco/AAI-9996-2021	Mangoni, Arduino Aleksander/0000-0001-8699-1412; Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557; Zinellu, Angelo/0000-0002-8396-0968; Carru, Ciriaco/0000-0002-6985-4907	University of Newcastle from Strategic Initiatives Fund; University of Newcastle from Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust	University of Newcastle from Strategic Initiatives Fund; University of Newcastle from Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust	The University of Newcastle provided $300,000 from its Strategic Initiatives Fund, and $600,000 from the Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust, provided $195,000; The Hunter Medical Research Institute provided media support during the initial recruitment of participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEAS STAT, P103; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Can A, 2011, DIABETES RES CLIN PR, V94, pE61, DOI 10.1016/j.diabres.2011.08.008; Cavusoglu E, 2010, ATHEROSCLEROSIS, V210, P226, DOI 10.1016/j.atherosclerosis.2009.10.034; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; Deneva-Koycheva Tanya I, 2011, Folia Med (Plovdiv), V53, P28; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Finkelstein JD, 2000, INT J BIOCHEM CELL B, V32, P385, DOI 10.1016/S1357-2725(99)00138-7; Fratta Pasini A, 2008, AM J HYPERTENS, V21, P1251, DOI 10.1038/ajh.2008.260; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Kandavar R, 2011, J AM SOC HYPERTENS, V5, P161, DOI 10.1016/j.jash.2010.11.003; Kelly AS, 2012, J CLIN HYPERTENS, V14, P85, DOI 10.1111/j.1751-7176.2011.00569.x; Koc F, 2010, MED SCI MONITOR, V16, pCR536; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Korandji C, 2007, CLIN BIOCHEM, V40, P66, DOI 10.1016/j.clinbiochem.2006.08.004; Krzyzanowska K, 2006, ATHEROSCLEROSIS, V189, P236, DOI 10.1016/j.atherosclerosis.2005.12.007; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mamatha SN, 2011, CLIN CHIM ACTA, V412, P139, DOI 10.1016/j.cca.2010.09.026; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Mangoni AA, 2011, J AM COLL CARDIOL, V58, P1034, DOI 10.1016/j.jacc.2011.05.029; Mangoni AA, 2009, ADV CLIN CHEM, V48, P73, DOI 10.1016/S0065-2423(09)48003-X; Mao DW, 2010, ARCH GYNECOL OBSTET, V282, P371, DOI 10.1007/s00404-009-1234-6; Marliss EB, 2006, DIABETOLOGIA, V49, P351, DOI 10.1007/s00125-005-0066-6; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; MEISTER A, 1974, LIFE SCI, V15, P177, DOI 10.1016/0024-3205(74)90206-9; MILLER DE, 1973, MEAS EVAL GUID, V6, P157, DOI 10.1080/00256307.1973.12022590; Nakamura YK, 2012, LIFE SCI, V90, P116, DOI 10.1016/j.lfs.2011.10.016; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Perna M, 2010, ARTHRITIS RHEUM-US, V62, P1718, DOI 10.1002/art.27392; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schutte AE, 2010, EUR J ENDOCRINOL, V162, P525, DOI 10.1530/EJE-09-0865; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Schwedhelm E, 2011, CLIN CHEM LAB MED, V49, P1907, DOI 10.1515/CCLM.2011.679; Serg M, 2011, BLOOD PRESSURE, V20, P111, DOI 10.3109/08037051.2010.533821; Simmons WW, 1996, J BIOL CHEM, V271, P11694, DOI 10.1074/jbc.271.20.11694; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Tan B, 2007, VASC PHARMACOL, V46, P338, DOI 10.1016/j.vph.2006.11.006; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Varela-Moreiras G, 2001, BIOMED PHARMACOTHER, V55, P448, DOI 10.1016/S0753-3322(01)00126-3; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Yoo JH, 2001, ATHEROSCLEROSIS, V158, P425, DOI 10.1016/S0021-9150(01)00444-0; Zinellu A, 2003, ELECTROPHORESIS, V24, P2796, DOI 10.1002/elps.200305570; Zinellu A, 2009, AMINO ACIDS, V36, P35, DOI 10.1007/s00726-007-0022-5; Zinellu A, 2011, CLIN CHEM LAB MED, V49, P897, DOI 10.1515/CCLM.2011.121; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zsuga J, 2007, METABOLISM, V56, P394, DOI 10.1016/j.metabol.2006.10.023	59	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54870	10.1371/journal.pone.0054870	http://dx.doi.org/10.1371/journal.pone.0054870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365680	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600125
J	Tang, XQ; Fang, HR; Zhou, CF; Zhuang, YY; Zhang, P; Gu, HF; Hu, B				Tang, Xiao-Qing; Fang, Heng-Rong; Zhou, Cheng-Fang; Zhuang, Yuan-Yuan; Zhang, Ping; Gu, Hong-Feng; Hu, Bi			A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; CYSTATHIONINE-BETA-SYNTHASE; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; INHALED FORMALDEHYDE; PREFRONTAL CORTEX; PROTECTS NEURONS; PC12 CELLS; VITAMIN-E; HOMOCYSTEINE	Background: Formaldehyde (FA) induces neurotoxicity by overproduction of intracellular reactive oxygen species (ROS). Increasing studies have shown that hydrogen sulfide (H2S), an endogenous gastransmitter, protects nerve cells against oxidative stress by its antioxidant effect. It has been shown that overproduction of nitric oxide (NO) inhibits the activity of cystathionine-beta-synthase (CBS), the predominant H2S-generating enzyme in the central nervous system. Objective: We hypothesize that FA-caused neurotoxicity involves the deficiency of this endogenous protective antioxidant gas, which results from excessive generation of NO. The aim of this study is to evaluate whether FA disturbs H2S synthesis in PC12 cells, and whether this disturbance is associated with overproduction of NO. Principal Findings: We showed that exposure of PC12 cells to FA causes reduction of viability, inhibition of CBS expression, decrease of endogenous H2S production, and NO production. CBS silencing deteriorates FA-induced decreases in endogenous H2S generation, neurotoxicity, and intracellular ROS accumulation in PC12 cells; while ADMA, a specific inhibitor of NOS significantly attenuates FA-induced decreases in endogenous H2S generation, neurotoxicity, and intracellular ROS accumulation in PC12 cells. Conclusion/Significance: Our data indicate that FA induces neurotoxicity by inhibiting the generation of H2S through excess of NO and suggest that strategies to manipulate endogenous H2S could open a suitable novel therapeutic avenue for FA-induced neurotoxicity.	[Tang, Xiao-Qing; Fang, Heng-Rong; Zhou, Cheng-Fang; Zhuang, Yuan-Yuan; Gu, Hong-Feng; Hu, Bi] Univ S China, Dept Physiol, Coll Med, Hengyang, Hunan, Peoples R China; [Fang, Heng-Rong] Hengyang Cent Hosp, Dept Pharm, Hengyang, Hunan, Peoples R China; [Zhang, Ping] Univ S China, Dept Neurol, Nanhua Affiliated Hosp, Hengyang, Hunan, Peoples R China	University of South China; University of South China	Tang, XQ (corresponding author), Univ S China, Dept Physiol, Coll Med, Hengyang, Hunan, Peoples R China.	txq01001@gmail.com; bridgeman1025@yahoo.com.cn			National Natural Science Foundation of China [81071005, 81200985]; Natural Science Foundation of Hunan Province, China [11JJ3117]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by National Natural Science Foundation of China (81071005 and 81200985), Natural Science Foundation of Hunan Province, China (11JJ3117) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2010] 508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahmed S, 2007, J NEUROIMMUNOL, V186, P104, DOI 10.1016/j.jneuroim.2007.03.010; Aslan H, 2006, BRAIN RES, V1122, P191, DOI 10.1016/j.brainres.2006.09.005; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Dwyer BE, 2004, FREE RADICAL BIO MED, V36, P1471, DOI 10.1016/j.freeradbiomed.2004.03.009; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; GRIEVE A, 1992, J NEUROSCI RES, V32, P60, DOI 10.1002/jnr.490320108; Gurel A, 2005, J CHEM NEUROANAT, V29, P173, DOI 10.1016/j.jchemneu.2005.01.001; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Jiang ZJ, 2008, NEUROPATH APPL NEURO, V34, P194, DOI 10.1111/j.1365-2990.2007.00886.x; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; Kamoun P, 2003, AM J MED GENET A, V116A, P310, DOI 10.1002/ajmg.a.10847; KILBURN KH, 1987, ARCH ENVIRON HEALTH, V42, P117, DOI 10.1080/00039896.1987.9935806; KILBURN KH, 1994, ARCH ENVIRON HEALTH, V49, P37, DOI 10.1080/00039896.1994.9934412; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kovacic P, 2010, REV ENVIRON CONTAM T, V203, P119, DOI 10.1007/978-1-4419-1352-4_4; Kubo A, 2007, TOXICOLOGY, V241, P92, DOI 10.1016/j.tox.2007.08.087; Liu Y, 2010, NEUROSCIENCE, V169, P1248, DOI 10.1016/j.neuroscience.2010.05.061; Lowicka E, 2007, PHARMACOL REP, V59, P4; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; Maiese K, 2010, EXP GERONTOL, V45, P217, DOI 10.1016/j.exger.2010.01.004; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Nilsson JA, 1998, J DENT RES, V77, P1896, DOI 10.1177/00220345980770110601; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Pitten FA, 2000, PATHOL RES PRACT, V196, P193, DOI 10.1016/S0344-0338(00)80100-4; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; Songur A, 2008, TOXICOL MECH METHOD, V18, P569, DOI 10.1080/15376510701555288; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Tang XQ, 2012, NEUROCHEM INT, V61, P16, DOI 10.1016/j.neuint.2012.04.011; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; Tang XQ, 2011, NEUROTOX RES, V19, P403, DOI 10.1007/s12640-010-9180-4; Tang XQ, 2011, J MOL NEUROSCI, V45, P60, DOI 10.1007/s12031-010-9477-z; Tang XQ, 2010, NEUROSCI RES, V68, P241, DOI 10.1016/j.neures.2010.07.2039; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Unzeta M, 2007, J NEURAL TRANSM, V114, P857, DOI 10.1007/s00702-007-0701-0; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yin WL, 2009, LIFE SCI, V85, P269, DOI 10.1016/j.lfs.2009.05.023; Yu PH, 2001, MED HYPOTHESES, V57, P175, DOI 10.1054/mehy.2001.1329; Zararsiz I, 2007, CELL BIOCHEM FUNCT, V25, P413, DOI 10.1002/cbf.1315; Zararsiz I, 2006, CELL BIOCHEM FUNCT, V24, P237, DOI 10.1002/cbf.1204; Zhou DX, 2006, ASIAN J ANDROL, V8, P584, DOI 10.1111/j.1745-7262.2006.00198.x	55	26	29	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54829	10.1371/journal.pone.0054829	http://dx.doi.org/10.1371/journal.pone.0054829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359814	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600118
J	Tay, Z; Eng, RJ; Sajiki, K; Lim, KK; Tang, MY; Yanagida, M; Chen, ES				Tay, Zoey; Eng, Ru Jun; Sajiki, Kenichi; Lim, Kim Kiat; Tang, Ming Yi; Yanagida, Mitsuhiro; Chen, Ee Sin			Cellular Robustness Conferred by Genetic Crosstalk Underlies Resistance against Chemotherapeutic Drug Doxorubicin in Fission Yeast	PLOS ONE			English	Article							STRAND BREAK REPAIR; MULTIDRUG-RESISTANCE; DNA TOPOISOMERASES; COENZYME Q(10); INCREASE; ROLES; ANTICANCER; PROTECTION; COMPLEXES; POMBE	Doxorubicin is an anthracycline antibiotic that is among one of the most commonly used chemotherapeutic agents in the clinical setting. The usage of doxorubicin is faced with many problems including severe side effects and chemoresistance. To overcome these challenges, it is important to gain an understanding of the underlying molecular mechanisms with regards to the mode of action of doxorubicin. To facilitate this aim, we identified the genes that are required for doxorubicin resistance in the fission yeast Schizosaccharomyces pombe. We further demonstrated interplay between factors controlling various aspects of chromosome metabolism, mitochondrial respiration and membrane transport. In the nucleus we observed that the subunits of the Ino80, RSC, and SAGA complexes function in the similar epistatic group that shares significant overlap with the homologous recombination genes. However, these factors generally act in synergistic manner with the chromosome segregation regulator DASH complex proteins, possibly forming two major arms for regulating doxorubicin resistance in the nucleus. Simultaneous disruption of genes function in membrane efflux transport or the mitochondrial respiratory chain integrity in the mutants defective in either Ino80 or HR function resulted in cumulative upregulation of drug-specific growth defects, suggesting a rewiring of pathways that synergize only when the cells is exposed to the cytotoxic stress. Taken together, our work not only identified factors that are required for survival of the cells in the presence of doxorubicin but has further demonstrated that an extensive molecular crosstalk exists between these factors to robustly confer doxorubicin resistance.	[Tay, Zoey; Eng, Ru Jun; Lim, Kim Kiat; Tang, Ming Yi; Chen, Ee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Tay, Zoey; Eng, Ru Jun; Lim, Kim Kiat; Tang, Ming Yi; Chen, Ee Sin] Natl Univ Hlth Syst, Singapore, Singapore; [Sajiki, Kenichi; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan	National University of Singapore; National University of Singapore; Okinawa Institute of Science & Technology Graduate University	Chen, ES (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchces@nus.edu.sg		Tang, Richard Ming Yi/0000-0001-8038-1189; Tay, Zoey/0000-0002-6660-5980; Lim, Kim Kiat/0000-0003-0340-5903	National University of Singapore; Ministry of Education, Tier I	National University of Singapore(National University of Singapore); Ministry of Education, Tier I	Start up grant awarded to ESC from National University of Singapore. Ministry of Education, Tier I fund awarded to ESC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2013, MED RES REV, V33, P33, DOI 10.1002/med.20244; Baguley BC, 2010, METHODS MOL BIOL, V596, P1, DOI 10.1007/978-1-60761-416-6_1; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bilardi RA, 2012, BIOCHEM PHARMACOL, V83, P1241, DOI 10.1016/j.bcp.2012.01.029; Brea-Calvo G, 2006, FREE RADICAL BIO MED, V40, P1293, DOI 10.1016/j.freeradbiomed.2005.11.014; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Cavero S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001138; Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Hanusova V, 2011, DRUG METAB REV, V43, P540, DOI 10.3109/03602532.2011.609174; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Khasanov FK, 1999, GENETICS, V152, P1557; Kitano H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.40; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Raji H, 2006, YEAST, V23, P963, DOI 10.1002/yea.1414; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szalay MS, 2007, FEBS LETT, V581, P3675, DOI 10.1016/j.febslet.2007.03.083; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399	33	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55041	10.1371/journal.pone.0055041	http://dx.doi.org/10.1371/journal.pone.0055041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365689	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600146
J	Wang, L; Hu, XB; Zhang, W; Di Wu, L; Liu, YS; Hu, B; Bi, CL; Chen, YF; Liu, XX; Ge, C; Zhang, Y; Zhang, M				Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei			Dickkopf-1 as a Novel Predictor Is Associated with Risk Stratification by GRACE Risk Scores for Predictive Value in Patients with Acute Coronary Syndrome: A Retrospective Research	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GLOBAL REGISTRY; FOLLOW-UP; ATHEROSCLEROSIS; INFLAMMATION; EVENTS; BIOMARKERS; MORTALITY; DEATH; PERFORMANCE	Objective: Dickkopf-1 (DKK-1), a major regulator of the Wnt pathway, plays an important role in cardiovascular disease. However, no study has evaluated the association of DKK-1 and acute coronary syndrome (ACS). We investigated this association and whether the Global Registry of Acute Coronary Events (GRACE) hospital-discharge risk score predicting major adverse cardiac events (MACE) can be improved by adding the DKK-1 value. Methods: We enrolled 291 patients (46 with ST-segment elevation myocardial infarction [STEMI] and 245 with non-ST elevated ACS [NSTE-ACS]) who were divided into groups by tertiles of baseline plasma DKK-1 level measured by ELISA. The GRACE risk score was calculated and predictive value alone and together with DKK-1 and/or high-sensitivity C-reactive protein (hs-CRP) level were assessed, respectively. Results: Compared with patients with NSTE-ACS, those with STEMI had higher plasma DKK-1 level at baseline (P = 0.006). Plasma DKK-1 level was correlated with hs-CRP level (r = 0.295, P < 0.001) and was greater with high than intermediate or low GRACE scores (P = 0.002 and P < 0.001, respectively). We found 44 (15.1%) MACEs during a median 2-year follow-up. DKK-1 levels were higher for patients with than without events (P < 0.001). The rate of MACE increased with increasing DKK-1 level (P < 0.001). The area under the receiver operating characteristic curve for GRACE score with MACE was 0.524 and improved to 0.791 with the addition of hs-CRP level, 0.775 with the addition of DKK-1 level and 0.847 with both values added. Conclusions: DKK-1 is an independent predictor of long-term MACE of patients with ACS. The long-term predictive ability of post-discharge GRACE score may be enhanced by adding DKK-1 level.	[Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Hu, Xiao Bo; Hu, Bo] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Liu, Yu Sheng] Shandong Univ, Hosp 2, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China.	daixh@vip.sina.com			National 973 Basic Research Program [2010CB732605, 2011CB503906]; Natural Science Foundation of China [30970709]; National 863 Hi-Tech Research and Development Program [2007AA02Z448]; Key Projects in the National Science and Technology Pillar Program from the Ministry of Science and Technology, China [2006BAI01A02]	National 973 Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program from the Ministry of Science and Technology, China	The work was supported by grants from the National 973 Basic Research Program (2010CB732605 and 2011CB503906), the Natural Science Foundation of China (30970709), National 863 Hi-Tech Research and Development Program (2007AA02Z448) and Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period (2006BAI01A02) from the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Assi E, 2010, REV ESP CARDIOL, V63, P640, DOI 10.1016/S0300-8932(10)70156-1; Beygui F, 2010, AM J CARDIOL, V106, P650, DOI 10.1016/j.amjcard.2010.04.019; D'Ascenzo F, 2012, CONTEMP CLIN TRIALS, V33, P507, DOI 10.1016/j.cct.2012.01.001; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Eggers KM, 2010, AM HEART J, V160, P88, DOI 10.1016/j.ahj.2010.05.002; Goliasch G, 2012, ATHEROSCLEROSIS, V222, P251, DOI 10.1016/j.atherosclerosis.2012.02.017; Gomceli I, 2012, HEPATO-GASTROENTEROL, V59, P1661, DOI 10.5754/hge11516; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hamm CW, 2011, J AM COLL CARDIOL, V57, P1465, DOI 10.1016/j.jacc.2010.10.044; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meune C, 2011, HEART, V97, P1479, DOI 10.1136/hrt.2010.220988; Mohlenkamp S, 2011, J AM COLL CARDIOL, V57, P1455, DOI 10.1016/j.jacc.2010.10.043; Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909; Nakamura M, 2010, J CARDIOL, V55, P69, DOI 10.1016/j.jjcc.2009.08.007; Schiele F, 2010, EUR HEART J, V31, P290, DOI 10.1093/eurheartj/ehp273; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P131, DOI 10.1007/s11883-004-0102-x; Siasos G, 2012, CURR TOP MED CHEM, V12, P1132, DOI 10.2174/1568026611208011132; Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004; Trepels T, 2004, HERZ, V29, P769, DOI 10.1007/s00059-004-2637-6; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Wang SY, 2011, J RHEUMATOL, V38, P821, DOI 10.3899/jrheum.100089; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6	28	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54731	10.1371/journal.pone.0054731	http://dx.doi.org/10.1371/journal.pone.0054731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359112	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600098
J	Weigel, KM; Jones, KL; Do, JS; Witt, JM; Chung, JH; Valcke, C; Cangelosi, GA				Weigel, Kris M.; Jones, Kelly L.; Do, Julie S.; Witt, Jody Melton; Chung, Jae-Hyun; Valcke, Christian; Cangelosi, Gerard A.			Molecular Viability Testing of Bacterial Pathogens from a Complex Human Sample Matrix	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TUBERCULOSIS MESSENGER-RNA; BLOOD-STREAM INFECTIONS; REAL-TIME PCR; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; WASTE-WATER; LISTERIA-MONOCYTOGENES; PROPIDIUM MONOAZIDE; QUANTITATIVE PCR	Assays for bacterial ribosomal RNA precursors (pre-rRNA) have been shown to distinguish viable from inactivated bacterial cells in drinking water samples. Because the synthesis of pre-rRNA is rapidly induced by nutritional stimulation, viable bacteria can be distinguished from inactivated cells and free nucleic acids by measuring the production of species-specific pre-rRNA in samples that have been briefly stimulated with nutrients. Here, pre-rRNA analysis was applied to bacteria from serum, a human sample matrix. In contrast to drinking water, serum is rich in nutrients that might be expected to mask the effects of nutritional stimulation. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assays were used to detect pre-rRNA of four bacterial species: Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and the Mycobacterium tuberculosis complex. These species were chosen for their clinical significance and phylogenetic diversity (Proteobacteria, Firmicutes, and Actinobacteria). To maximize resolving power, pre-rRNA was normalized to genomic DNA of each pathogen. When viable cells were shifted from serum to bacteriological culture medium, rapid replenishment of pre-rRNA was always observed. Cells of P. aeruginosa that were inactivated in the presence of serum exhibited no pre-rRNA response to nutritional stimulation, despite strong genomic DNA signals in these samples. When semi-automated methods were used, pre-rRNA analysis detected viable A. baumannii cells in serum at densities of <= 100 CFU/mL in <5.5 hours. Originally developed for rapid microbiological analysis of drinking water, ratiometric pre-rRNA analysis can also assess the viability of bacterial cells derived from human specimens, without requiring bacteriological culture.	[Weigel, Kris M.; Jones, Kelly L.; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Do, Julie S.] AttoDx Inc, Seattle, WA USA; [Witt, Jody Melton; Valcke, Christian] Novartis Diagnost, Emeryville, CA USA; [Chung, Jae-Hyun] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Novartis; University of Washington; University of Washington Seattle	Cangelosi, GA (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gcang@uw.edu		Domesle, Kelly/0000-0003-1873-5091; Weigel, Kris/0000-0003-3199-2148	Novartis Vaccines and Diagnostics; AttoDx, Inc.; Catalysis Foundation for Health; NIDCR [R21DE021510]; NIAID [R01AI093418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021510] Funding Source: NIH RePORTER	Novartis Vaccines and Diagnostics; AttoDx, Inc.; Catalysis Foundation for Health; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by Novartis Vaccines and Diagnostics, AttoDx, Inc., the Catalysis Foundation for Health, NIDCR grant # R21DE021510, and NIAID grant # R01AI093418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Cangelosi GA, 1997, J BACTERIOL, V179, P4457, DOI 10.1128/jb.179.14.4457-4463.1997; Cangelosi GA, 2010, APPL ENVIRON MICROB, V76, P960, DOI 10.1128/AEM.01810-09; Condon C, 2001, RNA, V7, P242, DOI 10.1017/S1355838201002163; Flekna G, 2007, RES MICROBIOL, V158, P405, DOI 10.1016/j.resmic.2007.02.008; Gedalanga PB, 2009, APPL MICROBIOL BIOT, V82, P587, DOI 10.1007/s00253-008-1846-y; Gonzalez-Escalona N, 2009, APPL ENVIRON MICROB, V75, P3714, DOI 10.1128/AEM.02686-08; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kobayashi H, 2009, LETT APPL MICROBIOL, V48, P633, DOI 10.1111/j.1472-765X.2009.02585.x; Kobayashi H, 2010, J ORTHOP RES, V28, P1245, DOI 10.1002/jor.21108; Kobayashi H, 2009, DIAGN MICR INFEC DIS, V64, P445, DOI 10.1016/j.diagmicrobio.2009.04.004; Li L, 2010, J CLIN MICROBIOL, V48, P46, DOI 10.1128/JCM.01526-09; Liu YM, 2010, ANAL CHEM, V82, P2612, DOI 10.1021/ac1003272; Lu T, 2009, APPL ENVIRON MICROB, V75, P4589, DOI 10.1128/AEM.02970-08; MACKOW ER, 1985, FEBS LETT, V182, P407, DOI 10.1016/0014-5793(85)80343-4; Mdivani N, 2009, CLIN CHEM, V55, P1694, DOI 10.1373/clinchem.2009.124396; Milner MG, 2001, MICROBIOL-SGM, V147, P2689, DOI 10.1099/00221287-147-10-2689; Nanassy OZ, 2011, J CLIN MICROBIOL, V49, P1010, DOI 10.1128/JCM.01132-10; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Oerther DB, 2002, WATER SCI TECHNOL, V46, P443, DOI 10.2166/wst.2002.0514; Oerther DB, 2000, APPL ENVIRON MICROB, V66, P2154, DOI 10.1128/AEM.66.5.2154-2165.2000; Pai SR, 2000, MICROB PATHOGENESIS, V28, P335, DOI 10.1006/mpat.2000.0353; PATEL BKR, 1993, J INFECT DIS, V168, P799, DOI 10.1093/infdis/168.3.799; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354, DOI 10.1128/AEM.59.5.1354-1360.1993; Redko Y, 2008, MOL MICROBIOL, V68, P1096, DOI 10.1111/j.1365-2958.2008.06207.x; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; Stroot PG, 2003, WATER SCI TECHNOL, V47, P241, DOI 10.2166/wst.2003.0611	29	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54886	10.1371/journal.pone.0054886	http://dx.doi.org/10.1371/journal.pone.0054886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365682	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600128
J	Xu, XD; Chen, YR; Zhao, Y; Liu, XF; Dong, BT; Jones, IM; Chen, HY				Xu, Xiaodong; Chen, Yuanrong; Zhao, Yu; Liu, Xiaofen; Dong, Beitao; Jones, Ian M.; Chen, Hongying			Baculovirus Superinfection: A Probable Restriction Factor on the Surface Display of Proteins for Library Screening	PLOS ONE			English	Article							INFECTED INSECT CELLS; BINDING; GP64; INTERFERON; RECEPTORS; MIMOTOPES; DYNAMICS; KINETICS; DELIVERY; VECTORS	In addition to the expression of recombinant proteins, baculoviruses have been developed as a platform for the display of complex eukaryotic proteins on the surface of virus particles or infected insect cells. Surface display has been used extensively for antigen presentation and targeted gene delivery but is also a candidate for the display of protein libraries for molecular screening. However, although baculovirus gene libraries can be efficiently expressed and displayed on the surface of insect cells, target gene selection is inefficient probably due to super-infection which gives rise to cells expressing more than one protein. In this report baculovirus superinfection of Sf9 cells has been investigated by the use of two recombinant multiple nucleopolyhedrovirus carrying green or red fluorescent proteins under the control of both early and late promoters (vAcBacGFP and vAcBacDsRed). The reporter gene expression was detected 8 hours after the infection of vAcBacGFP and cells in early and late phases of infection could be distinguished by the fluorescence intensity of the expressed protein. Simultaneous infection with vAcBacGFP and vAcBacDsRed viruses each at 0.5 MOI resulted in 80% of infected cells co-expressing the two fluorescent proteins at 48 hours post infection (hpi), and subsequent infection with the two viruses resulted in similar co-infection rate. Most Sf9 cells were re-infectable within the first several hours post infection, but the reinfection rate then decreased to a very low level by 16 hpi. Our data demonstrate that Sf9 cells were easily super-infectable during baculovirus infection, and super-infection could occur simultaneously at the time of the primary infection or subsequently during secondary infection by progeny viruses. The efficiency of super-infection may explain the difficulties of baculovirus display library screening but would benefit the production of complex proteins requiring co-expression of multiple polypeptides.	[Xu, Xiaodong; Chen, Yuanrong; Zhao, Yu; Liu, Xiaofen; Dong, Beitao; Chen, Hongying] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Hongying] Univ Reading, Sch Biol Sci, Reading, Berks, England	Northwest A&F University - China; University of Reading	Chen, HY (corresponding author), NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	chenhy@nwsuaf.edu.cn		Chen, Hongying/0000-0001-8258-0683; Jones, Ian/0000-0002-7738-2516	Program for New Century Excellent Talents in University [NCET-09-0652]; Northwest A F University; MRC [G1000769] Funding Source: UKRI; Medical Research Council [G1000769] Funding Source: researchfish	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Northwest A F University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project is supported by Program for New Century Excellent Talents in University (NCET-09-0652), and starting research fund from Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Dee KU, 1997, BIOTECHNOL BIOENG, V54, P468, DOI 10.1002/(SICI)1097-0290(19970605)54:5<468::AID-BIT7>3.0.CO;2-C; Enden G, 2005, J THEOR BIOL, V237, P257, DOI 10.1016/j.jtbi.2005.04.013; Ernst W, 1998, NUCLEIC ACIDS RES, V26, P1718, DOI 10.1093/nar/26.7.1718; Gotoh T, 2008, J CHEM ENG JPN, V41, P804, DOI 10.1252/jcej.08we032; Grabherr R, 2001, TRENDS BIOTECHNOL, V19, P231, DOI 10.1016/S0167-7799(01)01610-9; Harel HYM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-64; Hericourt F, 2000, BIOCHEM J, V349, P417, DOI 10.1042/0264-6021:3490417; Hitchman Richard B, 2009, Recent Pat Biotechnol, V3, P46; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hu YC, 2008, EXPERT REV VACCINES, V7, P363, DOI 10.1586/14760584.7.3.363; JAMES DC, 1995, BIO-TECHNOL, V13, P592, DOI 10.1038/nbt0695-592; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; LICARI P, 1992, BIOTECHNOL BIOENG, V39, P432, DOI 10.1002/bit.260390409; Makela AR, 2008, COMB CHEM HIGH T SCR, V11, P86, DOI 10.2174/138620708783744525; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Mena JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-39; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Sokolenko S, 2012, BIOTECHNOL ADV, V30, P766, DOI 10.1016/j.biotechadv.2012.01.009; VOLKMAN L.E., 1990, SEMIN VIROL, V1, P249; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Westenberg M, 2008, J GEN VIROL, V89, P424, DOI 10.1099/vir.0.83342-0; Westenberg M, 2007, J GEN VIROL, V88, P3302, DOI 10.1099/vir.0.83240-0; WICKHAM TJ, 1990, BIOPHYS J, V58, P1501, DOI 10.1016/S0006-3495(90)82495-4; WU SC, 1994, BIOTECHNOL PROGR, V10, P55, DOI 10.1021/bp00025a006; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	29	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54631	10.1371/journal.pone.0054631	http://dx.doi.org/10.1371/journal.pone.0054631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365677	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000314023600082
J	Bommarius, B; Anyanful, A; Izrayelit, Y; Bhatt, S; Cartwright, E; Wang, W; Swimm, AI; Benian, GM; Schroeder, FC; Kalman, D				Bommarius, Bettina; Anyanful, Akwasi; Izrayelit, Yevgeniy; Bhatt, Shantanu; Cartwright, Emily; Wang, Wei; Swimm, Alyson I.; Benian, Guy M.; Schroeder, Frank C.; Kalman, Daniel			A Family of Indoles Regulate Virulence and Shiga Toxin Production in Pathogenic E. coli	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; FORM ACTIN PEDESTALS; III SECRETION SYSTEM; CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; CITROBACTER-RODENTIUM; INNATE IMMUNITY; EXPRESSION; SIGNAL; 2,3-DIOXYGENASE	Enteropathogenic Escherichia coli (EPEC), enterohemorrhagic E. coli (EHEC) and enteroaggregative E. coli (EAEC) are intestinal pathogens that cause food and water-borne disease in humans. Using biochemical methods and NMR-based comparative metabolomics in conjunction with the nematode Caenorhabditis elegans, we developed a bioassay to identify secreted small molecules produced by these pathogens. We identified indole, indole-3-carboxaldehyde (ICA), and indole-3-acetic acid (IAA), as factors that only in combination are sufficient to kill C. elegans. Importantly, although lethal to C. elegans, these molecules downregulate several bacterial processes important for pathogenesis in mammals. These include motility, biofilm formation and production of Shiga toxins. Some pathogenic E. coli strains are known to contain a Locus of Enterocyte Effacement (LEE), which encodes virulence factors that cause "attaching and effacing" (A/E) lesions in mammals, including formation of actin pedestals. We found that these indole derivatives also downregulate production of LEE virulence factors and inhibit pedestal formation on mammalian cells. Finally, upon oral administration, ICA inhibited virulence and promoted survival in a lethal mouse infection model. In summary, the C. elegans model in conjunction with metabolomics has facilitated identification of a family of indole derivatives that broadly regulate physiology in E. coli, and virulence in pathogenic strains. These molecules may enable development of new therapeutics that interfere with bacterial small-molecule signaling.	[Bommarius, Bettina; Anyanful, Akwasi; Wang, Wei; Swimm, Alyson I.; Benian, Guy M.; Kalman, Daniel] Emory Univ, Dept Lab Med & Pathol, Atlanta, GA 30322 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Bhatt, Shantanu] Emory Univ, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Cartwright, Emily] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	Emory University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Emory University; Emory University	Kalman, D (corresponding author), Emory Univ, Dept Lab Med & Pathol, Atlanta, GA 30322 USA.	dkalman@emory.edu	Bhatt, Shantanu/AAB-9405-2020; Swimm, Alyson/D-1025-2013	Swimm, Alyson/0000-0001-9975-0247; Bommarius, Bettina/0000-0002-1283-0218; Schroeder, Frank/0000-0002-4420-0237	National Institutes of Health [R01-A107246201, R01-AI056067, R01-GM088290, T32GM008500]; Vassar College Mary Landon Sague Fellowship; Bio-Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vassar College Mary Landon Sague Fellowship; Bio-Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01-A107246201 and R01-AI056067 to D. K., R01-GM088290 to F. S., and T32GM008500 to Y. I.), Vassar College Mary Landon Sague Fellowship (to Y. I.), and a grant from the Bio-Merieux Foundation (to D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bhatt S, 2011, J BACTERIOL, V193, P4516, DOI 10.1128/JB.05197-11; Bhatt S, 2009, INFECT IMMUN, V77, P3552, DOI 10.1128/IAI.00418-09; BRENNER S, 1974, GENETICS, V77, P71; Clarke SC, 2002, BRIT J BIOMED SCI, V59, P123, DOI 10.1080/09674845.2002.11783647; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Denamur E, 2011, CLIN MICROBIOL INFEC, V17, P1124, DOI 10.1111/j.1469-0691.2011.03620.x; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Feng P, 2001, J CLIN MICROBIOL, V39, P24, DOI 10.1128/JCM.39.1.24-28.2001; Forseth RR, 2011, CURR OPIN CHEM BIOL, V15, P38, DOI 10.1016/j.cbpa.2010.10.010; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kuczynska-Wisnik D, 2010, RES MICROBIOL, V161, P847, DOI 10.1016/j.resmic.2010.09.012; Kuczynska-Wisnik D, 2010, MICROBIOL-SGM, V156, P148, DOI 10.1099/mic.0.032334-0; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lambrecht M, 2000, TRENDS MICROBIOL, V8, P298, DOI 10.1016/S0966-842X(00)01732-7; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Mattmann ME, 2010, J ORG CHEM, V75, P6737, DOI 10.1021/jo101237e; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; Mellies JL, 2010, TRENDS MICROBIOL, V18, P448, DOI 10.1016/j.tim.2010.07.002; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Partridge FA, 2010, DEV DYNAM, V239, P1330, DOI 10.1002/dvdy.22232; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wei OL, 2005, INFECT IMMUN, V73, P1978, DOI 10.1128/IAI.73.4.1978-1985.2005; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	53	61	64	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54456	10.1371/journal.pone.0054456	http://dx.doi.org/10.1371/journal.pone.0054456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372726	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500073
J	Kim, HS; Hwang, YC; Koo, SH; Park, KS; Lee, MS; Kim, KW; Lee, MK				Kim, Hyo-Sup; Hwang, You-Cheol; Koo, Seung-Hoi; Park, Kyong Soo; Lee, Myung-Shik; Kim, Kwang-Won; Lee, Moon-Kyu			PPAR-gamma Activation Increases Insulin Secretion through the Up-regulation of the Free Fatty Acid Receptor GPR40 in Pancreatic beta-Cells	PLOS ONE			English	Article							PEROXISOME-PROLIFERATOR; METABOLIC DISEASE; RESPONSE ELEMENT; GENE-EXPRESSION; PROTEIN-KINASE; DIABETIC MICE; IN-VIVO; ROSIGLITAZONE; TROGLITAZONE; RELEASE	Background: It has been reported that peroxisome proliferator-activated receptor (PPAR)-gamma and their synthetic ligands have direct effects on pancreatic beta-cells. We investigated whether PPAR-gamma activation stimulates insulin secretion through the up-regulation of GPR40 in pancreatic beta-cells. Methods: Rat insulinoma INS-1 cells and primary rat islets were treated with rosiglitazone (RGZ) and/or adenoviral PPAR-gamma overexpression. OLETF rats were treated with RGZ. Results: PPAR-gamma activation with RGZ and/or adenoviral PPAR-gamma overexpression increased free fatty acid (FFA) receptor GPR40 expression, and increased insulin secretion and intracellular calcium mobilization, and was blocked by the PLC inhibitors, GPR40 RNA interference, and GLUT2 RNA interference. As a downstream signaling pathway of intracellular calcium mobilization, the phosphorylated levels of CaMKII and CREB, and the downstream IRS-2 and phospho-Akt were significantly increased. Despite of insulin receptor RNA interference, the levels of IRS-2 and phospho-Akt was still maintained with PPAR-gamma activation. In addition, the beta-cell specific gene expression, including Pdx-1 and FoxA2, increased in a GPR40- and GLUT2-dependent manner. The levels of GPR40, phosphorylated CaMKII and CREB, and beta-cell specific genes induced by RGZ were blocked by GW9662, a PPAR-gamma antagonist. Finally, PPAR-gamma activation up-regulated beta-cell gene expressions through FoxO1 nuclear exclusion, independent of the insulin signaling pathway. Based on immunohistochemical staining, the GLUT2, IRS-2, Pdx-1, and GPR40 were more strongly expressed in islets from RGZ-treated OLETF rats compared to control islets. Conclusion: These observations suggest that PPAR-gamma activation with RGZ and/or adenoviral overexpression increased intracellular calcium mobilization, insulin secretion, and beta-cell gene expression through GPR40 and GLUT2 gene up-regulation.	[Kim, Hyo-Sup] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Endocrinol & Metab, Seoul, South Korea; [Hwang, You-Cheol] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Myung-Shik; Kim, Kwang-Won; Lee, Moon-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Sungkyunkwan University (SKKU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, MK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	leemk@skku.edu	Hwang, You-Cheol/AAA-4616-2022; Koo, Seung-Hoi/E-2763-2015; Lee, Myung Shik/C-9606-2011; Park, Kyong Soo/C-2265-2008	Koo, Seung-Hoi/0000-0001-8769-2879; Park, Kyong Soo/0000-0003-3597-342X; Hwang, You-Cheol/0000-0003-4033-7874	Ministry of Health and Welfare, Republic of Korea [A080513]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by funds from the Ministry of Health and Welfare, Republic of Korea (A080513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; Bollheimer LC, 2003, J MOL ENDOCRINOL, V31, P61, DOI 10.1677/jme.0.0310061; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Gromada J, 2006, ENDOCRINOLOGY, V147, P672, DOI 10.1210/en.2005-1388; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235; Ito E, 2004, BIOCHEM BIOPH RES CO, V324, P810, DOI 10.1016/j.bbrc.2004.08.238; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim EK, 2007, INT J BIOCHEM CELL B, V39, P1260, DOI 10.1016/j.biocel.2007.04.005; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2008, BIOCHEM BIOPH RES CO, V367, P623, DOI 10.1016/j.bbrc.2007.12.192; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Nakamichi Y, 2003, BIOCHEM BIOPH RES CO, V306, P832, DOI 10.1016/S0006-291X(03)01045-3; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Richardson H, 2006, DIABETOLOGIA, V49, P685, DOI 10.1007/s00125-006-0155-1; Santini E, 2004, DIABETES, V53, pS79, DOI 10.2337/diabetes.53.suppl_3.S79; Schinner S, 2009, BRIT J PHARMACOL, V157, P736, DOI 10.1111/j.1476-5381.2009.00208.x; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tomita T, 2006, DIABETOLOGIA, V49, P962, DOI 10.1007/s00125-006-0193-8; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Wang X, 2007, LIFE SCI, V81, P160, DOI 10.1016/j.lfs.2007.04.034; Wu PW, 2010, BIOCHEM BIOPH RES CO, V403, P36, DOI 10.1016/j.bbrc.2010.10.105; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Zhao YF, 2008, J ENDOCRINOL, V198, P533, DOI 10.1677/JOE-08-0105	51	71	72	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50128	10.1371/journal.pone.0050128	http://dx.doi.org/10.1371/journal.pone.0050128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372643	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500003
J	Neal, ML; Trister, AD; Cloke, T; Sodt, R; Ahn, S; Baldock, AL; Bridge, CA; Lai, A; Cloughesy, TF; Mrugala, MM; Rockhill, JK; Rockne, RC; Swanson, KR				Neal, Maxwell Lewis; Trister, Andrew D.; Cloke, Tyler; Sodt, Rita; Ahn, Sunyoung; Baldock, Anne L.; Bridge, Carly A.; Lai, Albert; Cloughesy, Timothy F.; Mrugala, Maciej M.; Rockhill, Jason K.; Rockne, Russell C.; Swanson, Kristin R.			Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric	PLOS ONE			English	Article							INDIVIDUAL PATIENTS; GLIOMA GROWTH; CRITERIA; PSEUDOPROGRESSION; PSEUDORESPONSE; PROLIFERATION; RADIOTHERAPY; INVASION; QUANTIFY; TUMORS	Accurate clinical assessment of a patient's response to treatment for glioblastoma multiforme (GBM), the most malignant type of primary brain tumor, is undermined by the wide patient-to-patient variability in GBM dynamics and responsiveness to therapy. Using computational models that account for the unique geometry and kinetics of individual patients' tumors, we developed a method for assessing treatment response that discriminates progression-free and overall survival following therapy for GBM. Applying these models as untreated virtual controls, we generate a patient-specific "Days Gained'' response metric that estimates the number of days a therapy delayed imageable tumor progression. We assessed treatment response in terms of Days Gained scores for 33 patients at the time of their first MRI scan following first-line radiation therapy. Based on Kaplan-Meier analyses, patients with Days Gained scores of 100 or more had improved progression-free survival, and patients with scores of 117 or more had improved overall survival. Our results demonstrate that the Days Gained response metric calculated at the routinely acquired first post-radiation treatment time point provides prognostic information regarding progression and survival outcomes. Applied prospectively, our model-based approach has the potential to improve GBM treatment by accounting for patient-to-patient heterogeneity in GBM dynamics and responses to therapy.	[Neal, Maxwell Lewis; Cloke, Tyler; Sodt, Rita; Ahn, Sunyoung; Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Trister, Andrew D.; Rockhill, Jason K.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA; [Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] NW Brain Tumor Inst, Chicago, IL USA; [Lai, Albert; Cloughesy, Timothy F.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mrugala, Maciej M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Swanson, Kristin R.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Swanson, Kristin R.] Univ Washington, Nancy & Buster Alvord Brain Tumor Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Northwestern University; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Neal, ML (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	mneal@uw.edu; Kristin.swanson@northwestern.edu	Rockne, Russell/T-1549-2017; Cloughesy, Timothy Francis/AGV-1013-2022	Rockne, Russell/0000-0002-1557-159X; Trister, Andrew/0000-0002-7070-0139; Neal, Maxwell/0000-0002-2390-6572	McDonnell Foundation; Brain Tumor Funders Collaborative; National Institutes of Health [R01 CA164371, R01 NS 060752, U54 CA143970]; James D. Murray Endowed Chair; University of Washington Academic Pathology Fund; NATIONAL CANCER INSTITUTE [U54CA143970, R01CA164371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060752] Funding Source: NIH RePORTER	McDonnell Foundation; Brain Tumor Funders Collaborative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. Murray Endowed Chair; University of Washington Academic Pathology Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the McDonnell Foundation, the Brain Tumor Funders Collaborative, the National Institutes of Health (R01 CA164371, R01 NS 060752, U54 CA143970), the James D. Murray Endowed Chair and the University of Washington Academic Pathology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVORD EC, 1995, AM J NEURORADIOL, V16, P1013; Alvord Jr E.C., 1991, PATHOLOGY AGING HUMA, P210; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gu SL, 2012, MATH MED BIOL, V29, P31, DOI 10.1093/imammb/dqr002; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Neal ML, 2011, NEURO-ONCOLOGY, V13, P83; Neal ML, 2010, BRIEF BIOINFORM, V11, P111, DOI 10.1093/bib/bbp049; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Rockne Russell, 2008, Biophysical Reviews and Letters, V3, P111, DOI 10.1142/S1793048008000642; Shaw E. G., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS135, DOI 10.1016/S0360-3016(03)00843-5; Sodt R, COMPUTATION IN PRESS, V2; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Swanson K., 1999, THESIS U WASHINGTON; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson K R, 2002, NEURO-ONCOLOGY, P4340, DOI DOI 10.1093/NEUONC/4.4.308; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson K, 2007, NEURO-ONCOLOGY, V9, P575; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	29	61	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51951	10.1371/journal.pone.0051951	http://dx.doi.org/10.1371/journal.pone.0051951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372647	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500007
J	Nistico, R; Mango, D; Mandolesi, G; Piccinin, S; Berretta, N; Pignatelli, M; Feligioni, M; Musella, A; Gentile, A; Mori, F; Bernardi, G; Nicoletti, F; Mercuri, NB; Centonze, D				Nistico, Robert; Mango, Dalila; Mandolesi, Georgia; Piccinin, Sonia; Berretta, Nicola; Pignatelli, Marco; Feligioni, Marco; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Nicoletti, Ferdinando; Mercuri, Nicola B.; Centonze, Diego			Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VITRO; GAMMA-OSCILLATIONS; NETWORK OSCILLATIONS; GABAERGIC INHIBITION; PYRAMIDAL CELLS; VISUAL-CORTEX; MOTOR CORTEX; RAT	Abnormal use-dependent synaptic plasticity is universally accepted as the main physiological correlate of memory deficits in neurodegenerative disorders. It is unclear whether synaptic plasticity deficits take place during neuroinflammatory diseases, such as multiple sclerosis (MS) and its mouse model, experimental autoimmune encephalomyelitis (EAE). In EAE mice, we found significant alterations of synaptic plasticity rules in the hippocampus. When compared to control mice, in fact, hippocampal long-term potentiation (LTP) induction was favored over long-term depression (LTD) in EAE, as shown by a significant rightward shift in the frequency-synaptic response function. Notably, LTP induction was also enhanced in hippocampal slices from control mice following interleukin-1 beta (IL-1 beta) perfusion, and both EAE and IL-1 beta inhibited GABAergic spontaneous inhibitory postsynaptic currents (sIPSC) without affecting glutamatergic transmission and AMPA/NMDA ratio. EAE was also associated with selective loss of GABAergic interneurons and with reduced gamma-frequency oscillations in the CA1 region of the hippocampus. Finally, we provided evidence that microglial activation in the EAE hippocampus was associated with IL-1 beta expression, and hippocampal slices from control mice incubated with activated microglia displayed alterations of GABAergic transmission similar to those seen in EAE brains, through a mechanism dependent on enhanced IL-1 beta signaling. These data may yield novel insights into the basis of cognitive deficits in EAE and possibly of MS.	[Nistico, Robert; Mango, Dalila; Mandolesi, Georgia; Berretta, Nicola; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Mercuri, Nicola B.; Centonze, Diego] IRCSS Fdn Santa Lucia, Rome, Italy; [Nistico, Robert; Piccinin, Sonia; Pignatelli, Marco; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, Rome, Italy; [Mango, Dalila; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Mercuri, Nicola B.; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Piccinin, Sonia; Pignatelli, Marco; Feligioni, Marco] EBRI, Lab Farmacol Plast Sinapt, Rome, Italy; [Nicoletti, Ferdinando] IRCCS Neuromed, Pozzilli, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata; IRCCS Neuromed	Nistico, R (corresponding author), IRCSS Fdn Santa Lucia, Rome, Italy.	robert.nistico@uniroma1.it; centonze@uniroma2.it	Mango, Dalila/Z-2190-2019; Centonze, Diego/J-7767-2016; musella, alessandra/K-6372-2016; Berretta, Nicola/K-5667-2016; Mercuri, Nicola Biagio/K-5348-2016; Gentile, Antonietta/P-5638-2019; Gentile, Antonietta/I-5765-2018; Mandolesi, Georgia/G-6595-2011; Nicoletti, Ferdinando/K-4410-2016; Nicoletti, Ferdinando/T-4898-2019; Mori, Francesco/AGX-1659-2022; Nicoletti, Ferdinando/A-2446-2010	Centonze, Diego/0000-0002-8390-8545; musella, alessandra/0000-0001-7889-9253; Berretta, Nicola/0000-0001-8097-6238; Mercuri, Nicola Biagio/0000-0001-6700-7491; Gentile, Antonietta/0000-0003-2456-0769; Gentile, Antonietta/0000-0003-2456-0769; Mori, Francesco/0000-0002-4761-6174; Nicoletti, Ferdinando/0000-0003-0917-443X; Mandolesi, Georgia/0000-0003-3612-6820; Mango, Dalila/0000-0003-3358-4068; piccinin, sonia/0000-0001-7363-2699; Nistico, Robert/0000-0003-3433-9232; NICOLETTI, Ferdinando/0000-0003-3366-7269	Ministero della Salute	Ministero della Salute(Ministry of Health, Italy)	This investigation was supported by a grant from Ministero della Salute to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2003, CURR PHARM DESIGN, V9, P245, DOI 10.2174/1381612033392152; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Caramia AD, 2004, CLIN NEUROPHYSIOL, V115, P956, DOI 10.1016/j.clinph.2003.11.024; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Clements RJ, 2008, EXP BRAIN RES, V187, P459, DOI 10.1007/s00221-008-1317-9; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Foong J, 1998, J NEUROL NEUROSUR PS, V64, P529, DOI 10.1136/jnnp.64.4.529; Gambrill AC, 2011, J NEUROPHYSIOL, V105, P162, DOI 10.1152/jn.00457.2010; Gong N, 2009, J NEUROSCI, V29, P15836, DOI 10.1523/JNEUROSCI.4643-09.2009; Grover LM, 1999, J NEUROPHYSIOL, V81, P2814, DOI 10.1152/jn.1999.81.6.2814; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Jansen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026586; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Komaki A, 2007, NEUROSCI LETT, V422, P181, DOI 10.1016/j.neulet.2007.06.017; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Levkovitz Y, 1999, J NEUROSCI, V19, P10977, DOI 10.1523/JNEUROSCI.19-24-10977.1999; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Mandolesi G, 2012, NEUROBIOL DIS, V46, P414, DOI 10.1016/j.nbd.2012.02.005; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mori F, 2011, NEUROPSYCHOPHARMACOL, V36, P559, DOI 10.1038/npp.2010.187; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Rossi S, 2012, MULT SCLER J, V18, P1633, DOI 10.1177/1352458512440207; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Rossi S, 2010, BRAIN BEHAV IMMUN, V24, P1379, DOI 10.1016/j.bbi.2010.07.241; Rossi S, 2009, NEUROBIOL DIS, V36, P51, DOI 10.1016/j.nbd.2009.06.013; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Sederberg PB, 2003, J NEUROSCI, V23, P10809; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Stanton PK, 1996, HIPPOCAMPUS, V6, P35, DOI 10.1002/(SICI)1098-1063(1996)6:1<35::AID-HIPO7>3.0.CO;2-6; Staubli U, 1999, J NEUROSCI, V19, P4609; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Trepel C, 2000, SYNAPSE, V35, P120, DOI 10.1002/(SICI)1098-2396(200002)35:2<120::AID-SYN4>3.0.CO;2-6; WIGSTROM H, 1983, ACTA PHYSIOL SCAND, V119, P455, DOI 10.1111/j.1748-1716.1983.tb07362.x; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Ziehn MO, 2012, J NEUROSCI, V32, P12312, DOI 10.1523/JNEUROSCI.2796-12.2012; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6	58	108	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54666	10.1371/journal.pone.0054666	http://dx.doi.org/10.1371/journal.pone.0054666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355887	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500102
J	Ruusuvirta, T; Lipponen, A; Pellinen, E; Penttonen, M; Astikainen, P				Ruusuvirta, Timo; Lipponen, Arto; Pellinen, Eeva; Penttonen, Markku; Astikainen, Piia			Auditory Cortical and Hippocampal-System Mismatch Responses to Duration Deviants in Urethane-Anesthetized Rats	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS-SPECIFIC ADAPTATION; NEGATIVITY MMN; ODDBALL SITUATION; NEURAL MECHANISM; PITCH DEVIANCES; CORTEX; DISCRIMINATION; ATTENTION; MEMORY	Any change in the invariant aspects of the auditory environment is of potential importance. The human brain preattentively or automatically detects such changes. The mismatch negativity (MMN) of event-related potentials (ERPs) reflects this initial stage of auditory change detection. The origin of MMN is held to be cortical. The hippocampus is associated with a later generated P3a of ERPs reflecting involuntarily attention switches towards auditory changes that are high in magnitude. The evidence for this cortico-hippocampal dichotomy is scarce, however. To shed further light on this issue, auditory cortical and hippocampal-system (CA1, dentate gyrus, subiculum) local-field potentials were recorded in urethane-anesthetized rats. A rare tone in duration (deviant) was interspersed with a repeated tone (standard). Two standard-to-standard (SSI) and standard-to-deviant (SDI) intervals (200 ms vs. 500 ms) were applied in different combinations to vary the observability of responses resembling MMN (mismatch responses). Mismatch responses were observed at 51.5-89 ms with the 500-ms SSI coupled with the 200-ms SDI but not with the three remaining combinations. Most importantly, the responses appeared in both the auditory-cortical and hippocampal locations. The findings suggest that the hippocampus may play a role in (cortical) manifestation of MMN.	[Ruusuvirta, Timo] Univ Turku, Dept Psychol, Turku, Finland; [Ruusuvirta, Timo] Univ Turku, Ctr Learning Res, Turku, Finland; [Lipponen, Arto] Univ Eastern Finland, Fac Hlth Sci, AIV Inst, Dept Neurobiol, Kuopio, Finland; [Pellinen, Eeva; Penttonen, Markku; Astikainen, Piia] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Jyvaskyla	Ruusuvirta, T (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	timo.ruusuvirta@utu.fi	Penttonen, Markku/B-8348-2013; Astikainen, Piia/ABE-4699-2020	Penttonen, Markku/0000-0002-1033-7286; Astikainen, Piia/0000-0003-4842-7460; Lipponen, Arto/0000-0001-6201-6647	Academy of Finland [127595, 139767]	Academy of Finland(Academy of Finland)	The study was supported by the Academy of Finland (project number 127595 for PA and 139767 for MP). The supporter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00283; ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; [Anonymous], 2006, FDN PERCEPTION; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Aubie B, 2012, J NEUROSCI, V32, P6373, DOI 10.1523/JNEUROSCI.5624-11.2012; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; Dolan RJ, 2003, NEUROPSYCHOLOGY MEMO, P204; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; FORD JM, 1981, PSYCHOPHYSIOLOGY, V18, P322, DOI 10.1111/j.1469-8986.1981.tb03043.x; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Grimm S, 2010, PSYCHOPHYSIOLOGY, DOI 10.1111.j.1469-8986.2010.01073.x; IMADA T, 1993, ELECTROEN CLIN NEURO, V87, P144, DOI 10.1016/0013-4694(93)90120-K; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jaaskelainen IP, 1999, NEUROREPORT, V10, P1305; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KROPOTOV JD, 1995, PSYCHOPHYSIOLOGY, V32, P418, DOI 10.1111/j.1469-8986.1995.tb01226.x; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; MAY PJC, 2009, PSYCHOPHYSIOLOGY, V46, P1; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R., 1987, EVOKED POTENTIAL, P392; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Roger C, 2009, PSYCHOPHYSIOLOGY, V46, P1028, DOI 10.1111/j.1469-8986.2009.00840.x; Rosburg T, 2007, NEUROIMAGE, V37, P274, DOI 10.1016/j.neuroimage.2007.05.002; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 2010, NEUROSCIENCE, V170, P232, DOI 10.1016/j.neuroscience.2010.06.062; RUUSUVIRTA T, 1995, INT J PSYCHOPHYSIOL, V20, P33, DOI 10.1016/0167-8760(95)00024-M; Ruusuvirta T, 2009, EUR J NEUROSCI, V30, P1620, DOI 10.1111/j.1460-9568.2009.06938.x; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Takegata R, 2001, NEUROREPORT, V12, P1783, DOI 10.1097/00001756-200106130-00053; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Vinogradova O.S., 1975, HIPPOCAMPUS, V2, P3; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; YAMAGUCHI S, 1993, ELECTROEN CLIN NEURO, V88, P151, DOI 10.1016/0168-5597(93)90066-X; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060	53	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54624	10.1371/journal.pone.0054624	http://dx.doi.org/10.1371/journal.pone.0054624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355884	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500098
J	Musselman, LP; Fink, JL; Ramachandran, PV; Patterson, BW; Okunade, AL; Maier, E; Brent, MR; Turk, J; Baranski, TJ				Musselman, Laura Palanker; Fink, Jill L.; Ramachandran, Prasanna Venkatesh; Patterson, Bruce W.; Okunade, Adewole L.; Maier, Ezekiel; Brent, Michael R.; Turk, John; Baranski, Thomas J.			Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; LITHIATED ADDUCTS; MASS-SPECTROMETRY; ACID ELONGASE; OBESITY; GENE; IDENTIFICATION; HOMEOSTASIS	The Drosophila fat body is a liver- and adipose-like tissue that stores fat and serves as a detoxifying and immune responsive organ. We have previously shown that a high sugar diet leads to elevated hemolymph glucose and systemic insulin resistance in developing larvae and adults. Here, we used stable isotope tracer feeding to demonstrate that rearing larvae on high sugar diets impaired the synthesis of esterified fatty acids from dietary glucose. Fat body lipid profiling revealed changes in both carbon chain length and degree of unsaturation of fatty acid substituents, particularly in stored triglycerides. We tested the role of the fat body in larval tolerance of caloric excess. Our experiments demonstrated that lipogenesis was necessary for animals to tolerate high sugar feeding as tissue-specific loss of orthologs of carbohydrate response element-binding protein or stearoyl-CoA desaturase 1 resulted in lethality on high sugar diets. By contrast, increasing the fat content of the fat body by knockdown of king-tubby was associated with reduced hyperglycemia and improved growth and tolerance of high sugar diets. Our work supports a critical role for the fat body and the Drosophila carbohydrate response element-binding protein ortholog in metabolic homeostasis in Drosophila.	[Musselman, Laura Palanker; Fink, Jill L.; Ramachandran, Prasanna Venkatesh; Turk, John; Baranski, Thomas J.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Patterson, Bruce W.; Okunade, Adewole L.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Maier, Ezekiel; Brent, Michael R.] Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; [Maier, Ezekiel; Brent, Michael R.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baranski, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	tbaransk@dom.wustl.edu	Ramachandran, Prasanna/AAD-9824-2021; Brent, Michael/AAK-3702-2020; Musselman, Laura/K-4697-2019	Ramachandran, Prasanna/0000-0002-3439-6125; Brent, Michael/0000-0002-8689-0299; Musselman, Laura/0000-0002-8478-2526; Maier, Ezekiel/0000-0003-1216-6537; Patterson, Bruce W/0000-0001-9261-0233	National Institutes of Health through the Washington University Diabetes Research and Training Center [T32 GM007464, 5K12HD001459-12, P60 DK20579]; National Institutes of Health through the Nutrition Obesity Research Center [P20 RR020643, P30 DK56341]; National Institutes of Health through Biomedical Mass Spectrometry Resource [P41-RR00954]; Small Business Technology Transfer grant [1R41DK76338]; Children's Discovery Institute [MD-II-2010-41]; Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, P20RR020643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R41DK076338, P30DK056341, P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	National Institutes of Health through the Washington University Diabetes Research and Training Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the Nutrition Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through Biomedical Mass Spectrometry Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Small Business Technology Transfer grant; Children's Discovery Institute; Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007464 (to L.P.M.), 5K12HD001459-12 (to L.P.M.), P60 DK20579 through the Washington University Diabetes Research and Training Center (to J.T. and T.J.B.), P20 RR020643 (to T.J.B.), P30 DK56341 through the Nutrition Obesity Research Center (to A.L.O., B.W.P., and J.T.), P41-RR00954 through the Biomedical Mass Spectrometry Resource (to J.T.), and 1R41DK76338, a Small Business Technology Transfer grant (to Medros, Inc.). This work was also supported by Children's Discovery Institute Grant MD-II-2010-41 (to M.R.B. and T.J.B.) and Washington University (to T.J.B.). T.J.B. is a co-founder of Medros, Inc.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohlin K, 2005, J LIPID RES, V46, P1257, DOI 10.1194/jlr.M400481-JLR200; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Ceriello Antonio, 2006, Curr Atheroscler Rep, V8, P472, DOI 10.1007/s11883-006-0022-z; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chinkes DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE373, DOI 10.1152/ajpendo.1996.271.2.E373; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clifton PM, 2008, NAT CLIN PRACT GASTR, V5, P672, DOI 10.1038/ncpgasthep1283; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166; Fukuchi S, 2004, EXP BIOL MED, V229, P486, DOI 10.1177/153537020422900606; Gagliardi L, 2007, CURR DIABETES REV, V3, P95, DOI 10.2174/157339907780598207; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Knight JA, 2011, ANN CLIN LAB SCI, V41, P107; KRITCHEVSKY D, 1995, EUR J CANCER PREV, V4, P445, DOI 10.1097/00008469-199512000-00002; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Leclercq IA, 2008, CURR OPIN CLIN NUTR, V11, P766, DOI 10.1097/MCO.0b013e328312c353; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Magkos F, 2009, ANNU REV NUTR, V29, P223, DOI 10.1146/annurev-nutr-080508-141200; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Neuschwander-Tetri Brent A, 2010, Curr Gastroenterol Rep, V12, P49, DOI 10.1007/s11894-009-0083-6; Niswender K, 2010, DIABETES OBES METAB, V12, P267, DOI 10.1111/j.1463-1326.2009.01175.x; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Patterson BW, 1999, J LIPID RES, V40, P2118; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; Sullivan S, 2010, CURR OPIN GASTROEN, V26, P160, DOI 10.1097/MOG.0b013e3283358a58; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; van Vliet-Ostaptchouk JV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001405; Wang Y, 2006, PHYSIOL GENOMICS, V27, P131, DOI 10.1152/physiolgenomics.00239.2005; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200	72	78	79	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8028	8042		10.1074/jbc.M112.371047	http://dx.doi.org/10.1074/jbc.M112.371047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355467	Green Published, hybrid			2022-12-25	WOS:000316564500004
J	Van Laer, K; Dziewulska, AM; Fislage, M; Wahni, K; Hbeddou, A; Collet, JF; Versees, W; Mateos, LM; Dufe, VT; Messens, J				Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Collet, Jean-Francois; Versees, Wim; Mateos, Luis M.; Dufe, Veronica Tamu; Messens, Joris			NrdH-redoxin of Mycobacterium tuberculosis and Corynebacterium glutamicum Dimerizes at High Protein Concentration and Exclusively Receives Electrons from Thioredoxin Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RIBONUCLEOTIDE REDUCTASE; STRUCTURAL BASIS; MECHANISM; ELECTROSTATICS; EXPRESSION; CATALYSIS; SYSTEM; GENES	NrdH-redoxins are small reductases with a high amino acid sequence similarity with glutaredoxins and mycoredoxins but with a thioredoxin-like activity. They function as the electron donor for class Ib ribonucleotide reductases, which convert ribonucleotides into deoxyribonucleotides. We solved the x-ray structure of oxidized NrdH-redoxin from Corynebacterium glutamicum (Cg) at 1.5 angstrom resolution. Based on this monomeric structure, we built a homology model of NrdH-redoxin from Mycobacterium tuberculosis (Mt). Both NrdH-redoxins have a typical thioredoxin fold with the active site CXXC motif located at the N terminus of the first alpha-helix. With size exclusion chromatography and small angle x-ray scattering, we show that Mt_NrdH-redoxin is a monomer in solution that has the tendency to form a non-swapped dimer at high protein concentration. Further, Cg_NrdH-redoxin and Mt_NrdH-redoxin catalytically reduce a disulfide with a specificity constant 1.9 x 10(6) and 5.6 x 10(6) M-1 min(-1), respectively. They use a thiol-disulfide exchange mechanism with an N-terminal cysteine pK(a) lower than 6.5 for nucleophilic attack, whereas the pK(a) of the C-terminal cysteine is similar to 10. They exclusively receive electrons from thioredoxin reductase (TrxR) and not from mycothiol, the low molecular weight thiol of actinomycetes. This specificity is shown in the structural model of the complex between NrdH-redoxin and TrxR, where the two surface-exposed phenylalanines of TrxR perfectly fit into the conserved hydrophobic pocket of the NrdH-redoxin. Moreover, nrdh gene deletion and disruption experiments seem to indicate that NrdH-redoxin is essential in C. glutamicum.	[Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Versees, Wim; Dufe, Veronica Tamu; Messens, Joris] Vlaams Inst Biotechnol, Dept Biol Struct, B-1050 Brussels, Belgium; [Van Laer, Koen; Dziewulska, Aleksandra M.; Fislage, Marcus; Wahni, Khadija; Hbeddou, Abderahim; Versees, Wim; Dufe, Veronica Tamu; Messens, Joris] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Van Laer, Koen; Dziewulska, Aleksandra M.; Wahni, Khadija; Hbeddou, Abderahim; Collet, Jean-Francois; Dufe, Veronica Tamu; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Mateos, Luis M.] Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain; [Collet, Jean-Francois] Welbio, B-1200 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain; Universidad de Leon; WELBIO	Messens, J (corresponding author), Vrije Univ Brussel, Vlaams Inst Biotechnol, Redox Biol Lab, Dept Biol Struct, Pleinlaan 2, B-1050 Brussels, Belgium.	joris.messens@vib-vub.be	Versées, Wim/H-5518-2015; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Messens, Joris/AAH-3008-2020	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Messens, Joris/0000-0002-2128-8264; Fislage, Marcus/0000-0002-2527-2657; Collet, Jean-Francois/0000-0001-8069-7036; Versees, Wim/0000-0002-4695-696X	Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel; IWT Ph.D. fellowship	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel; IWT Ph.D. fellowship	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie (IWT), the Vlaams Instituut voor Biotechnologie (VIB), and the HOA-project of the Onderzoeksraad of Vrije Universiteit Brussel.; Supported by an IWT Ph.D. fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akif M, 2005, ACTA CRYSTALLOGR D, V61, P1603, DOI 10.1107/S0907444905030519; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; EKLUND H, 1992, J MOL BIOL, V228, P596, DOI 10.1016/0022-2836(92)90844-A; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; Garcia-Pino A, 2009, J MOL BIOL, V385, P1590, DOI 10.1016/j.jmb.2008.11.040; Guinier A., 1955, SMALL ANGLE SCATTERI; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JAGER W, 1992, J BACTERIOL, V174, P5462; Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Leiting WU, 2010, MICROB PATHOGENESIS, V48, P97, DOI 10.1016/j.micpath.2010.01.004; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Newcomer ME, 2001, NAT STRUCT BIOL, V8, P282, DOI 10.1038/86134; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; NILSSON O, 1988, BIOCHEM SOC T, V16, P91, DOI 10.1042/bst0160091; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; REICHARD P, 1983, SCIENCE, V221, P514, DOI 10.1126/science.6306767; Roos G, 2006, J PHYS CHEM B, V110, P557, DOI 10.1021/jp0549780; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	60	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7942	7955		10.1074/jbc.M112.392688	http://dx.doi.org/10.1074/jbc.M112.392688			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362277	Green Published, hybrid			2022-12-25	WOS:000316455300047
J	Deloron, P; Milet, J; Badaut, C				Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril			Plasmodium falciparum Variability and Immune Evasion Proceed from Antigenicity of Consensus Sequences from DBL6 epsilon; Generalization to All DBL from VAR2CSA	PLOS ONE			English	Article							LOW-COMPLEXITY REGIONS; B-CELL EPITOPES; MALARIA VACCINE; T-CELL; CHONDROITIN SULFATE; VAR GENE; PLACENTAL MALARIA; ANTIBODIES; BINDING; RECOMBINATION	We studied all consensus sequences within the four least 'variable blocks' (VB) present in the DBL6 epsilon domain of VAR2CSA, the protein involved in the adhesion of infected red blood cells by Plasmodium falciparum that causes the Pregnancy-Associated Malaria (PAM). Characterising consensus sequences with respect to recognition of antibodies and percentage of responders among pregnant women living in areas where P. falciparum is endemic allows the identification of the most antigenic sequences within each VB. When combining these consensus sequences among four serotypes from VB1 or VB5, the most often recognized ones are expected to induce pan-reactive antibodies recognizing VAR2CSA from all plasmodial strains. These sequences are of main interest in the design of an immunogenic molecule. Using a similar approach than for DBL6e, we studied the five other DBL and the CIDRpam from VAR2CSA, and again identified VB segments with highly conserved consensus sequences. In addition, we identified consensus sequences in other var genes expressed by non-PAM parasites. This finding paves the way for vaccine design against other pathologies caused by P. falciparum.	[Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril] Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France; [Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France; [Milet, Jacqueline] Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Badaut, C (corresponding author), Inst Rech Biomed Armees, Dept Expertise, Bretigny Sur Orge, France.	cbadaut@gmail.com	Deloron, Philippe/G-6305-2010	Deloron, Philippe/0000-0003-4705-2484; Badaut, Cyril/0000-0002-0064-6384; MILET, Jacqueline/0000-0003-2710-1517	Institut de Medecine et d'Epidemiologie Appliquee [IMEA-0801]; European 7th Framework Programme (STOPPAM programme) [200889]; French National Agency for Research [ANR-05-MIME-009-01]; Institute of Research for Development (IRD)	Institut de Medecine et d'Epidemiologie Appliquee; European 7th Framework Programme (STOPPAM programme); French National Agency for Research(French National Research Agency (ANR)); Institute of Research for Development (IRD)	This study received financial support from the Institut de Medecine et d'Epidemiologie Appliquee (grant IMEA-0801), from the European 7th Framework Programme (STOPPAM programme, grant 200889), and from the French National Agency for Research (grant ANR-05-MIME-009-01). C. Badaut was supported by the Institute of Research for Development (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Baumann A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-46; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; Brabin BJ, 1999, ANN TROP MED PARASIT, V93, pS43, DOI 10.1080/00034983.1999.11813503; Brolin KJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009230; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DEOLIVEIRA GA, 1994, VACCINE, V12, P1012, DOI 10.1016/0264-410X(94)90337-9; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105; Golnitz U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-14; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Kelly-Cirino CD, 2009, INFECT IMMUN, V77, P4859, DOI 10.1128/IAI.00117-09; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; KUMAR A, 1992, J IMMUNOL, V148, P1499; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; LEW AM, 1989, P NATL ACAD SCI USA, V86, P3768, DOI 10.1073/pnas.86.10.3768; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Sanni Latifu A, 2002, Malar J, V1, P7, DOI 10.1186/1475-2875-1-7; Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SNIJDERS A, 1991, J GEN VIROL, V72, P557, DOI 10.1099/0022-1317-72-3-557; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Talundzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031565; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; Vasconcelos NM, 2004, VACCINE, V23, P343, DOI 10.1016/j.vaccine.2004.06.003; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54882	10.1371/journal.pone.0054882	http://dx.doi.org/10.1371/journal.pone.0054882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372786	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400039
J	Francini, RB; Coni, EOC; Meirelles, PM; Amado, GM; Thompson, FL; Pereira, GH; Bastos, AC; Abrantes, DP; Ferreira, CM; Gibran, FZ; Guth, AZ; Sumida, PYG; Oliveira, NL; Kaufman, L; Minte-Vera, CV; Moura, RL				Francini-Filho, Ronaldo B.; Coni, Ericka O. C.; Meirelles, Pedro M.; Amado-Filho, Gilberto M.; Thompson, Fabiano L.; Pereira-Filho, Guilherme H.; Bastos, Alex C.; Abrantes, Douglas P.; Ferreira, Camilo M.; Gibran, Fernando Z.; Gueth, Arthur Z.; Sumida, Paulo Y. G.; Oliveira, Nara L.; Kaufman, Les; Minte-Vera, Carolina V.; Moura, Rodrigo L.			Dynamics of Coral Reef Benthic Assemblages of the Abrolhos Bank, Eastern Brazil: Inferences on Natural and Anthropogenic Drivers	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHASE-SHIFTS; STABLE STATES; LONG-TERM; COMPETITION; SCARIDAE; DECLINE; COVER; FISH; SEDIMENTATION	The Abrolhos Bank (eastern Brazil) encompasses the largest and richest coral reefs of the South Atlantic. Coral reef benthic assemblages of the region were monitored from 2003 to 2008. Two habitats (pinnacles' tops and walls) were sampled per site with 3-10 sites sampled within different reef areas. Different methodologies were applied in two distinct sampling periods: 2003-2005 and 2006-2008. Spatial coverage and taxonomic resolution were lower in the former than in the latter period. Benthic assemblages differed markedly in the smallest spatial scale, with greater differences recorded between habitats. Management regimes and biomass of fish functional groups (roving and territorial herbivores) had minor influences on benthic assemblages. These results suggest that local environmental factors such as light, depth and substrate inclination exert a stronger influence on the structure of benthic assemblages than protection from fishing. Reef walls of unprotected coastal reefs showed highest coral cover values, with a major contribution of Montastraea cavernosa (a sediment resistant species that may benefit from low light levels). An overall negative relationship between fleshy macroalgae and slow-growing reef-building organisms (i.e. scleractinians and crustose calcareous algae) was recorded, suggesting competition between these organisms. The opposite trend (i.e. positive relationships) was recorded for turf algae and the two reef-building organisms, suggesting beneficial interactions and/or co-occurrence mediated by unexplored factors. Turf algae cover increased across the region between 2006 and 2008, while scleractinian cover showed no change. The need of a continued and standardized monitoring program, aimed at understanding drivers of change in community patterns, as well as to subsidize sound adaptive conservation and management measures, is highlighted.	[Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil; [Coni, Ericka O. C.; Ferreira, Camilo M.] Univ Estadual Paraiba, Dept Biol, Campina Grande, Paraiba, Brazil; [Meirelles, Pedro M.; Thompson, Fabiano L.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Dept Biol Marinha, Rio De Janeiro, Brazil; [Amado-Filho, Gilberto M.; Abrantes, Douglas P.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Rural Rio de Janeiro, Dept Bot, Rio De Janeiro, Brazil; [Bastos, Alex C.] Univ Fed Espirito Santo, Dept Oceanog, Vitoria, ES, Brazil; [Gibran, Fernando Z.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Gueth, Arthur Z.; Sumida, Paulo Y. G.] Univ Sao Paulo, Dept Oceanog Biol, Sao Paulo, Brazil; [Oliveira, Nara L.; Moura, Rodrigo L.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Kaufman, Les] Boston Univ, Marine Program, Boston, MA 02215 USA; [Minte-Vera, Carolina V.] Univ Estadual Maringa, Ctr Ciencias Biol, Maringa, Parana, Brazil	Universidade Federal da Paraiba; Universidade Estadual da Paraiba; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Espirito Santo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Estadual de Santa Cruz; Boston University; Universidade Estadual de Maringa	Francini, RB (corresponding author), Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil.	rofilho@yahoo.com	Francini-Filho, Ronaldo/I-5708-2012; Meirelles, Pedro/AAK-5942-2021; Güth, Arthur Z/F-2559-2011; Ferreira, Camilo M/M-9427-2015; Meirelles, Pedro/AAL-4542-2020; Ferreira, Camilo Moitinho/ABA-4883-2021; de Moura, Rodrigo Leao/AAL-5781-2020; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Gibran, Fernando Z/G-5844-2012; Sumida, Paulo Y G/F-2561-2011; Minte-Vera, Carolina/D-6326-2013; Minte-Vera, Carolina V/A-5461-2017; FILHO, GILBERTO M AMADO/I-1324-2012; Bastos, Alex/H-3674-2014	Francini-Filho, Ronaldo/0000-0002-7678-6797; Meirelles, Pedro/0000-0002-1306-0331; Güth, Arthur Z/0000-0001-8388-4187; Ferreira, Camilo M/0000-0001-9022-1963; Ferreira, Camilo Moitinho/0000-0001-9022-1963; de Moura, Rodrigo Leao/0000-0002-5597-6196; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Gibran, Fernando Z/0000-0002-2812-8976; Sumida, Paulo Y G/0000-0001-7549-4541; Minte-Vera, Carolina V/0000-0002-0537-1519; Bastos, Alex/0000-0002-1272-1134; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project [420219/2005-6]; Conservation International (CI); CNPq; FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation International (CI); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project (#420219/2005-6) and Conservation International (CI). This is a contribution of the CI's Marine Management Areas Science Program, Brazil Node, and Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES). RLM, FLT and GMAF acknowledge individual grants from CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Castro CBE, 2012, BRAZ J OCEANOGR, V60, P49, DOI 10.1590/S1679-87592012000100006; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CASTRO C.B., 2006, RAP BULL BIOL ASSESM, V38, P19; Castro CB, 2001, B MAR SCI, V69, P357; Ceccarelli DM, 2007, CORAL REEFS, V26, P853, DOI 10.1007/s00338-007-0275-1; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; Clarke KR, 1994, CHANGE MARINE COMMUN; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Coutinho R., 1993, ACTA BIOL LEOPOLDENS, V15, P133; De Moura RL, 2009, COAST MANAGE, V37, P617, DOI 10.1080/08920750903194165; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Edmunds PJ, 1999, CORAL REEFS, V18, P133, DOI 10.1007/s003380050167; Ferrari R, 2012, MAR ECOL PROG SER, V467, P77, DOI 10.3354/meps09953; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini RB, 2008, NEOTROP ICHTHYOL, V6, P191, DOI 10.1590/S1679-62252008000200006; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Francini RB, 2010, BRAZ J OCEANOGR, V58, P77, DOI 10.1590/S1679-87592010000100008; Freitas MO, 2011, SCI MAR, V75, P135, DOI 10.3989/scimar.2011.75n1135; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; HOEKSEMA BW, 1989, NETH J SEA RES, V23, P149, DOI 10.1016/0077-7579(89)90009-4; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kikuchi RKP, 2004, ATOLL RES B, V496, P172; Kikuchi RKP, 2010, REV BIOL TROP, V58, P1; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; LEAO ZMA, 2003, LATIN AM CORAL REEFS; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leao ZMAN, 2001, ECOL STU AN, V144, P83; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moura R.L., 2002, P917; Moura RL, 2011, ESTUAR COAST SHELF S, V95, P274, DOI 10.1016/j.ecss.2011.08.010; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Neves EG, 2008, GENETICA, V132, P243, DOI 10.1007/s10709-007-9168-z; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Niendonca-Neto JP, 2008, AN ACAD BRAS CIENC, V80, P495, DOI 10.1590/S0001-37652008000300010; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pawlowski-Glahn V, 2012, COMPOSITIONAL DATA A; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pires DO, 2011, J MAR BIOL ASSOC UK, V91, P1613, DOI 10.1017/S0025315410000767; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rosenberg E, 2004, CORAL HLTH DIS; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; SEBENS KP, 1982, B MAR SCI, V32, P316; Segal B, 2001, B MAR SCI, V69, P487; Segal B, 2008, CONT SHELF RES, V28, P533, DOI 10.1016/j.csr.2007.11.003; Segal B, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000200001; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Suchanek T.H., 1982, Proceedings of the International Coral Reef Symposium, P679; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Suzuki G, 2011, J MAR BIOL ASSOC UK, V91, P677, DOI 10.1017/S0025315410000573; Sweatman H, 2011, CORAL REEFS, V30, P661, DOI 10.1007/s00338-011-0794-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; ter Braak, 1996, UNIMODAL MODELS RELA; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Wilkinson C, 2008, STATUS CORAL REEFS W; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	85	110	110	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54260	10.1371/journal.pone.0054260	http://dx.doi.org/10.1371/journal.pone.0054260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365655	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600043
J	Jacobson, AL; Booth, W; Vargo, EL; Kennedy, GG				Jacobson, Alana L.; Booth, Warren; Vargo, Edward L.; Kennedy, George G.			Thrips tabaci Population Genetic Structure and Polyploidy in Relation to Competency as a Vector of Tomato Spotted Wilt Virus	PLOS ONE			English	Article							EVOLUTIONARY GENETICS; BEMISIA-TABACI; THYSANOPTERA; TRANSMISSION; TOSPOVIRUS; CONSEQUENCES; SPECIFICITY; SEQUENCES; EPIDEMIC; FORMS	Knowledge of population-level genetic differences can help explain variation among populations of insect vectors in their role in the epidemiology of specific viruses. Variation in competency to transmit Tomato spotted wilt virus (TSWV) that exists among populations of Thrips tabaci has been associated with the presence of cryptic species that exhibit different modes of reproduction and host ranges. However, recent findings suggest that vector competency of T. tabaci at any given location depends on the thrips and virus populations that are present. This study characterizes the population genetic structure of T. tabaci collected from four locations in North Carolina and examines the relationship between population genetic structure and variation in TSWV transmission by T. tabaci. Mitochondrial COI sequence analysis revealed the presence of two genetically distinct groups with one characterized by thelytokous, parthenogenetic reproduction and the other by arrhenotokous, sexual reproduction. Using a set of 11 microsatellite markers that we developed to investigate T. tabaci population genetic structure, we identified 17 clonal groups and found significant genetic structuring among the four NC populations that corresponded to the geographic locations where the populations were collected. Application of microsatellite markers also led to the discovery of polyploidy in this species. All four populations contained tetraploid individuals, and three contained both diploid and tetraploid individuals. Analysis of variation in transmission ofTSWV among isofemale lines initiated with individuals used in this study revealed that 'clone assignment,' 'virus isolate' and their interaction significantly influenced vector competency. These results highlight the importance of interactions between specific T. tabaci clonal types and specific TSWV isolates underlying transmission of TSWV by T. tabaci.	[Jacobson, Alana L.; Booth, Warren; Vargo, Edward L.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Kennedy, GG (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	george_kennedy@ncsu.edu	Buckman, Rebecca/F-4960-2013		North Carolina Tobacco Commission	North Carolina Tobacco Commission	The sources of funding for this work were provided by the North Carolina Tobacco Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Beatty R. A., 1957, PARTHENOGENESIS POLY; BIRD J, 1978, ADV VIRUS RES, V22, P55, DOI 10.1016/S0065-3527(08)60772-1; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chatzivassiliou EK, 2008, PLANT DIS, V92, P1012, DOI 10.1094/PDIS-92-7-1012; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Copren KA, 2005, MOL PHYLOGENET EVOL, V35, P689, DOI 10.1016/j.ympev.2005.03.002; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dunham R. A., 2004, Aquaculture and fisheries biotechnology: genetic approaches, DOI 10.1079/9780851995960.0000; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jacobson AL, 2013, PLOS ONE IN PRESS; Jenser G, 2003, J APPL ENTOMOL, V127, P7, DOI 10.1046/j.1439-0418.2003.00704.x; LEMMETTY A, 1993, AGR SCI FINLAND, V2, P189, DOI 10.23986/afsci.72648; Lewis Trevor, 1997, P1; Lundmark M, 2006, HEREDITAS, V143, P23, DOI 10.1111/j.2006.0018-0661.01935.x; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mound LA, 2005, THYSANOPTERA THRIPS; Nagata T, 2004, PLANT PATHOL, V53, P136, DOI 10.1111/j.0032-0862.2004.00984.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; PALIWAL YC, 1974, CAN J BOT, V52, P1177, DOI 10.1139/b74-151; PALIWAL YC, 1976, CAN J BOT, V54, P402, DOI 10.1139/b76-038; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terradot L, 1999, B ENTOMOL RES, V89, P355, DOI 10.1017/S0007485399000498; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; van de Wetering F, 1999, B ENTOMOL RES, V89, P579, DOI 10.1017/S0007485399000735; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wilson CR, 1998, PLANT PATHOL, V47, P171, DOI 10.1046/j.1365-3059.1998.00227.x; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	53	27	29	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54484	10.1371/journal.pone.0054484	http://dx.doi.org/10.1371/journal.pone.0054484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365671	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600059
J	Manikkam, M; Tracey, R; Guerrero-Bosagna, C; Skinner, MK				Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.			Plastics Derived Endocrine Disruptors (BPA, DEHP and DBP) Induce Epigenetic Transgenerational Inheritance of Obesity, Reproductive Disease and Sperm Epimutations	PLOS ONE			English	Article							BISPHENOL-A EXPOSURE; DI-(2-ETHYLHEXYL) PHTHALATE DEHP; POLYCYSTIC-OVARY-SYNDROME; SPRAGUE-DAWLEY RATS; ADULT-ONSET DISEASE; ALTERS SEXUAL-DIFFERENTIATION; MALE OFFSPRING RATS; IN-UTERO EXPOSURE; LACTATIONAL EXPOSURE; PERINATAL EXPOSURE	Environmental compounds are known to promote epigenetic transgenerational inheritance of adult onset disease in subsequent generations (F1-F3) following ancestral exposure during fetal gonadal sex determination. The current study was designed to determine if a mixture of plastic derived endocrine disruptor compounds bisphenol-A (BPA), bis(2-ethylhexyl) phthalate (DEHP) and dibutyl phthalate (DBP) at two different doses promoted epigenetic transgenerational inheritance of adult onset disease and associated DNA methylation epimutations in sperm. Gestating F0 generation females were exposed to either the "plastics" or "lower dose plastics" mixture during embryonic days 8 to 14 of gonadal sex determination and the incidence of adult onset disease was evaluated in F1 and F3 generation rats. There were significant increases in the incidence of total disease/abnormalities in F1 and F3 generation male and female animals from plastics lineages. Pubertal abnormalities, testis disease, obesity, and ovarian disease (primary ovarian insufficiency and polycystic ovaries) were increased in the F3 generation animals. Kidney and prostate disease were only observed in the direct fetally exposed F1 generation plastic lineage animals. Analysis of the plastics lineage F3 generation sperm epigenome previously identified 197 differential DNA methylation regions (DMR) in gene promoters, termed epimutations. A number of these transgenerational DMR form a unique direct connection gene network and have previously been shown to correlate with the pathologies identified. Observations demonstrate that a mixture of plastic derived compounds, BPA and phthalates, can promote epigenetic transgenerational inheritance of adult onset disease. The sperm DMR provide potential epigenetic biomarkers for transgenerational disease and/or ancestral environmental exposures.	[Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	Department of Defense (DOD); National Institues of Health (NIH)	Department of Defense (DOD)(United States Department of Defense); National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Department of Defense (DOD), and National Institues of Health (NIH) grants to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewale HB, 2011, NEUROTOXICOLOGY, V32, P38, DOI 10.1016/j.neuro.2010.07.008; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020; Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093; Astill BD, 1996, FUND APPL TOXICOL, V31, P29, DOI 10.1006/faat.1996.0073; Baudry C, 2012, J PHYSIOL-LONDON, V590, P533, DOI 10.1113/jphysiol.2011.219717; Motta AB, 2012, CURR PHARM DESIGN, V18, P2482, DOI 10.2174/13816128112092482; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Campos KE, 2008, BRAZ J MED BIOL RES, V41, P122, DOI 10.1590/S0100-879X2008005000001; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7; Dunaif A, 2012, NAT REV ENDOCRINOL, V8, P72, DOI 10.1038/nrendo.2011.227; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Fiege H., 2002, ULLMANNS ENCY IND CH; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387; Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005; Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035; GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Ishido M, 2004, J NEUROSCI RES, V76, P423, DOI 10.1002/jnr.20050; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Kawai K, 2003, ENVIRON HEALTH PERSP, V111, P175, DOI 10.1289/ehp.5440; Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014; KHALIQ MA, 1993, TOXICOL LETT, V66, P317, DOI 10.1016/0378-4274(93)90013-N; Khurana S, 2000, ENDOCRINOLOGY, V141, P4512, DOI 10.1210/en.141.12.4512; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Koo HJ, 2007, J TOXICOL ENV HEAL A, V70, P383, DOI 10.1080/15287390600882150; Kostka G, 2010, TOXICOL IND HEALTH, V26, P407, DOI 10.1177/0748233710369124; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Linne Y, 2004, Obes Rev, V5, P137, DOI 10.1111/j.1467-789X.2004.00147.x; LORZ PM, 2002, ULLMANNS ENCY IND CH; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Martino-Andrade AJ, 2009, INT J ANDROL, V32, P704, DOI 10.1111/j.1365-2605.2008.00939.x; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Mizuo K, 2004, NEUROSCI LETT, V356, P95, DOI 10.1016/j.neulet.2003.11.027; Monje L, 2010, REPROD TOXICOL, V30, P625, DOI 10.1016/j.reprotox.2010.08.004; Monje L, 2007, J ENDOCRINOL, V194, P201, DOI 10.1677/JOE-07-0014; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1006/toxs.1998.2436; Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Patisaul HB, 2006, NEUROTOXICOL TERATOL, V28, P111, DOI 10.1016/j.ntt.2005.11.004; Patisaul HB, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.010.2009; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Ramos JG, 2003, ENDOCRINOLOGY, V144, P3206, DOI 10.1210/en.2002-0198; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Ryu JY, 2007, TOXICOLOGY, V234, P103, DOI 10.1016/j.tox.2007.02.003; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Simoneau C, 2012, FOOD ADDIT CONTAM A, V29, P469, DOI 10.1080/19440049.2011.644588; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Slocum N., 2012, EXP TOXICOL PATHOL; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Tian YH, 2011, SYNAPSE, V65, P1032, DOI 10.1002/syn.20934; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Van Camp JK, 2012, MOL GENET METAB, V105, P489, DOI 10.1016/j.ymgme.2011.11.197; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Vogel Sarah A, 2009, Am J Public Health, V99 Suppl 3, pS559, DOI 10.2105/AJPH.2008.159228; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Zanni MV, 2010, CLIN ENDOCRINOL, V73, P48, DOI 10.1111/j.1365-2265.2009.03741.x	125	542	569	4	280	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55387	10.1371/journal.pone.0055387	http://dx.doi.org/10.1371/journal.pone.0055387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359474	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600164
J	Mohazab, AR; Plotkin, SS				Mohazab, Ali R.; Plotkin, Steven S.			Polymer Uncrossing and Knotting in Protein Folding, and Their Role in Minimal Folding Pathways	PLOS ONE			English	Article							TRANSITION-STATE ENSEMBLE; ENERGY LANDSCAPE THEORY; RELATE 2 SETS; CONTACT ORDER; CONFORMATIONAL TRANSITIONS; ROTATIONAL SUPERPOSITION; MOLECULAR-DYNAMICS; REACTION PATHS; CHAIN-LENGTH; KNOTS	We introduce a method for calculating the extent to which chain non-crossing is important in the most efficient, optimal trajectories or pathways for a protein to fold. This involves recording all unphysical crossing events of a ghost chain, and calculating the minimal uncrossing cost that would have been required to avoid such events. A depth-first tree search algorithm is applied to find minimal transformations to fold alpha, beta, alpha/beta, and knotted proteins. In all cases, the extra uncrossing/non-crossing distance is a small fraction of the total distance travelled by a ghost chain. Different structural classes may be distinguished by the amount of extra uncrossing distance, and the effectiveness of such discrimination is compared with other order parameters. It was seen that non-crossing distance over chain length provided the best discrimination between structural and kinetic classes. The scaling of non-crossing distance with chain length implies an inevitable crossover to entanglement-dominated folding mechanisms for sufficiently long chains. We further quantify the minimal folding pathways by collecting the sequence of uncrossing moves, which generally involve leg, loop, and elbow-like uncrossing moves, and rendering the collection of these moves over the unfolded ensemble as a multiple-transformation "alignment". The consensus minimal pathway is constructed and shown schematically for representative cases of an alpha, beta, and knotted protein. An overlap parameter is defined between pathways; we find that alpha proteins have minimal overlap indicating diverse folding pathways, knotted proteins are highly constrained to follow a dominant pathway, and beta proteins are somewhere in between. Thus we have shown how topological chain constraints can induce dominant pathway mechanisms in protein folding.	[Mohazab, Ali R.; Plotkin, Steven S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Plotkin, SS (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	steve@physics.ubc.ca	Plotkin, Steven/AAO-3257-2020	Plotkin, Steven/0000-0001-8998-877X	Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver; Natural Sciences and Engineering Council	Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge funding from the Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver, and the Natural Sciences and Engineering Council for providing funding to defray publication page fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Adams CC, 1994, THE KNOT BOOK; ANDERSEN KV, 1993, J BIOMOL NMR, V3, P271, DOI 10.1007/BF00212514; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Banavar JR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940059; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Bodenreider C, 2005, J MOL BIOL, V351, P393, DOI 10.1016/j.jmb.2005.05.062; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Byeon IJL, 1998, MOL CELL, V1, P421, DOI 10.1016/S1097-2765(00)80042-8; Cavagnero S, 1999, J MOL BIOL, V285, P269, DOI 10.1006/jmbi.1998.2273; CERJAN CJ, 1981, J CHEM PHYS, V75, P2800, DOI 10.1063/1.442352; CHAN HS, 1990, J CHEM PHYS, V92, P3118, DOI 10.1063/1.458605; CHAN HS, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881371; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Clementi C, 2003, J MOL BIOL, V326, P933, DOI 10.1016/S0022-2836(02)01379-7; CONNOLLY ML, 1980, BIOPOLYMERS, V19, P1167, DOI 10.1002/bip.1980.360190606; Coutsias EA, 2005, J COMPUT CHEM, V26, P1663, DOI 10.1002/jcc.20316; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; Das A, 2012, PROC NATL ACAD SCI U; Dellago C, 1998, J CHEM PHYS, V108, P1964, DOI 10.1063/1.475562; Ding F, 2005, J MOL BIOL, V350, P1035, DOI 10.1016/j.jmb.2005.05.017; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; ELBER R, 1987, CHEM PHYS LETT, V139, P375, DOI 10.1016/0009-2614(87)80576-6; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Favrin G, 2003, BIOPHYS J, V85, P1457, DOI 10.1016/S0006-3495(03)74578-0; Ferguson A, 2009, J MOL BIOL, V389, P619, DOI 10.1016/j.jmb.2009.04.011; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2000, STRUCTURE AND MECHAN; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Flower DR, 1999, J MOL GRAPH MODEL, V17, P238; Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343; Galzitskaya OV, 2001, FEBS LETT, V489, P113, DOI 10.1016/S0014-5793(01)02092-0; Garel T, 1996, NEW DEV THEORETICAL, P197; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Grosberg AY, 2004, COMPUTATIONAL SOFT M, V23, P375; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hummer G, 2003, J CHEM PHYS, V118, P10762, DOI 10.1063/1.1574777; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Istomin AY, 2007, PROTEIN SCI, V16, P2564, DOI 10.1110/ps.073124507; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Kneller G. R., 1991, MOL SIMULAT, V7, P113; Koczyk G, 2008, NUCLEIC ACIDS RES, V36, pW239, DOI 10.1093/nar/gkn326; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Komatsuzaki T, 2003, CHEMICAL REACTION DY, P79; KONIARIS K, 1991, J CHEM PHYS, V95, P2873, DOI 10.1063/1.460889; KONIARIS K, 1991, PHYS REV LETT, V66, P2211, DOI 10.1103/PhysRevLett.66.2211; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LAL M, 1969, MOL PHYS, V17, P57, DOI 10.1080/00268976900100781; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lua RC, 2006, PLOS COMPUT BIOL, V2, P350, DOI 10.1371/journal.pcbi.0020045; MADRAS N, 1988, J STAT PHYS, V50, P109, DOI 10.1007/BF01022990; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Mansfield ML, 1997, NAT STRUCT BIOL, V4, P166, DOI 10.1038/nsb0397-166; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Mezard M, 1986, WORLD SCI LECT NOTES, V9; Mohazab AR, 2009, INT J QUANTUM CHEM, V109, P3217, DOI 10.1002/qua.22347; Mohazab AR, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/24/244133; Mohazab AR, 2008, BIOPHYS J, V95, P5496, DOI 10.1529/biophysj.108.135046; Nechaev SK, 1996, STATISTICS OF KNOTS; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Norcross TS, 2006, J MOL BIOL, V362, P605, DOI 10.1016/j.jmb.2006.07.054; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Nymeyer H, 2000, P NATL ACAD SCI US; Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Oztop B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.208105; Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Plotkin SS, 1998, PHYS REV LETT, V80, P5015, DOI 10.1103/PhysRevLett.80.5015; Plotkin SS, 2002, Q REV BIOPHYS, V35, P205, DOI 10.1017/S0033583502003785; Plotkin SS, 2002, J CHEM PHYS, V116, P5263, DOI 10.1063/1.1449866; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Plotkin SS, 2007, P NATL ACAD SCI USA, V104, P14899, DOI 10.1073/pnas.0607833104; Potestio R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000864; Prentiss MC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000835; Schuyler AD, 2009, PROTEINS, V74, P760, DOI 10.1002/prot.22200; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Sosnick TR, 2006, CHEM REV, V106, P1862, DOI 10.1021/cr040431q; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Thiruv B, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-12; van der Vaart A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2719697; van Roon AMM, 2008, P NATL ACAD SCI USA, V105, P9621, DOI 10.1073/pnas.0802494105; Virnau P, 2005, J AM CHEM SOC, V127, P15102, DOI 10.1021/ja052438a; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; Wales DJ, 2001, SCIENCE, V293, P2067, DOI 10.1126/science.1062565; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Weinkam P, 2005, P NATL ACAD SCI USA, V102, P12401, DOI 10.1073/pnas.0505274102; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; Wiegel FW, 1986, INTRODUCTION TO PATH; Wolynes P.G., 1992, SPIN GLASSES BIOL, P225; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yang HJ, 2007, J CHEM THEORY COMPUT, V3, P17, DOI 10.1021/ct0502054; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou H, 2009, PROTEIN SCI, V16, P947; Zhou YQ, 1999, J MOL BIOL, V293, P917, DOI 10.1006/jmbi.1999.2936	143	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53642	10.1371/journal.pone.0053642	http://dx.doi.org/10.1371/journal.pone.0053642			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365638	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600017
J	Sasayama, D; Hori, H; Nakamura, S; Miyata, R; Teraishi, T; Hattori, K; Ota, M; Yamamoto, N; Higuchi, T; Amano, N; Kunugi, H				Sasayama, Daimei; Hori, Hiroaki; Nakamura, Seiji; Miyata, Ryo; Teraishi, Toshiya; Hattori, Kotaro; Ota, Miho; Yamamoto, Noriko; Higuchi, Teruhiko; Amano, Naoji; Kunugi, Hiroshi			Identification of Single Nucleotide Polymorphisms Regulating Peripheral Blood mRNA Expression with Genome-Wide Significance: An eQTL Study in the Japanese Population	PLOS ONE			English	Article							GENE-EXPRESSION; TOOL; HAPMAP	Several recent studies have reported that expression quantitative trait loci (eQTLs) may affect gene expression in a cell-dependent manner. In the current study, a genome-wide eQTL analysis was performed in whole blood samples collected from 76 Japanese subjects. RNA microarray analysis was performed for 3 independent sample groups that were genotyped in a genome-wide scan. The correlations between the genotypes of 534,404 autosomal single nucleotide polymorphisms (SNPs) and the expression levels of 30,465 probes were examined for each sample group. The SNP-probe pairs with combined correlation coefficients of all 3 sample groups corresponding to P<3.1x10(-12) (i.e., Bonferroni-corrected P<0.05) were considered significant. SNP-probe pairs with a high likelihood of cross-hybridization and SNP-in-probe effects were excluded to avoid false positive results. We identified 102 cis-acting and 5 trans-acting eQTL regions. The cis-eQTL regions were widely distributed both upstream and downstream of the gene, as well as within the gene. The eQTL SNPs identified were examined for their influence on the expression levels in lymphoblastoid cell lines by using a public database. The results showed that genetic variants affecting expression levels in whole blood may have different effects on gene expression in lymphoblastoid cell lines. Further studies are required to clarify how SNPs function in affecting the expression levels in whole blood as well as in other tissues.	[Sasayama, Daimei; Hori, Hiroaki; Teraishi, Toshiya; Hattori, Kotaro; Ota, Miho; Yamamoto, Noriko; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan; [Sasayama, Daimei; Amano, Naoji] Shinshu Univ, Sch Med, Dept Psychiat, Matsumoto, Nagano 390, Japan; [Nakamura, Seiji; Miyata, Ryo] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Kunugi, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Shinshu University; DNA Chip Research Inc.; Japan Science & Technology Agency (JST)	Kunugi, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan.	hkunugi@ncnp.go.jp	Kunugi, Hiroshi/ABC-5260-2021; Miyata, Ryo/J-8804-2012	Miyata, Ryo/0000-0002-7032-994X; Kunugi, Hiroshi/0000-0002-7209-3790; Hori, Hiroaki/0000-0002-4548-7110	Health and Labor Sciences Research Grants; Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry	This study was supported by Health and Labor Sciences Research Grants, the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Understanding of molecular and environmental bases for brain health), Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency, and an Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dobrin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023480; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; FALLER AJ, 1981, J APPL METEOROL, V20, P203, DOI 10.1175/1520-0450(1981)020<0203:AACC>2.0.CO;2; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Mehta D, 2012, EUR J HUM GENET; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Taurines R, 2011, WORLD J BIOL PSYCHIA, V12, P104, DOI 10.3109/15622975.2011.600297; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	23	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54967	10.1371/journal.pone.0054967	http://dx.doi.org/10.1371/journal.pone.0054967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359819	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600139
J	Euler, Z; van Gils, MJ; Boeser-Nunnink, BD; Schuitemaker, H; van Manen, D				Euler, Zelda; van Gils, Marit J.; Boeser-Nunnink, Brigitte D.; Schuitemaker, Hanneke; van Manen, Danielle			Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals	PLOS ONE			English	Article							HIV-1 INFECTION; DISEASE PROGRESSION; CLINICAL-COURSE; T-CELLS; VIRUS; NK; DETERMINANTS; EXPRESSION; ANTIGENS; BROAD	Broadly neutralizing antibodies may protect against HIV-1 acquisition. In natural infection, only 10-30% of patients have cross-reactive neutralizing humoral immunity which may relate to viral and or host factors. To explore the role of host genetic markers in the formation of cross-reactive neutralizing activity (CrNA) in HIV-1 infected individuals, we performed a genome-wide association study (GWAS), in participants of the Amsterdam Cohort Studies with known CrNA in their sera. Single-nucleotide polymorphisms (SNPs) with the strongest P-values are located in the major histocompatibility complex (MHC) region, close to MICA (P = 7.68 x 10(-7)), HLA-B (P = 6.96 x 10(-6)) and in the coding region of HCP5 (P = 1.34 x 10(-5)). However, none of the signals reached genome-wide significance. Our findings underline the potential involvement of genes close or within the MHC region with the development of CrNA.	Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Schuitemaker, H (corresponding author), Crucell Holland BV, Leiden, Netherlands.	h.schuitemaker@amc.uva.nl	van Gils, Marit J./H-4791-2019	van Gils, Marit J./0000-0003-3422-8161	Netherlands Organization for Scientific Research [918.66.628, 912.06.046]; European Community [037611, 201433]; Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment	This study was financially supported by The Netherlands Organization for Scientific Research (grant 918.66.628 and 912.06.046), the European Community's Six Framework Program European HIV Enterprise (EUROPRISE; FP6/2007-2012) under grant agreement 037611 and the European Community's Seventh Framework Program Next Generation HIV-1 Immunogens inducing broadly reactive Neutralizing antibodies (NGIN) (FP7/2007-2013) under grant agreement 201433. The ACS are financially supported by the Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR RECOMM REP, V41, P1; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Maloy KJ, 1998, P NATL ACAD SCI USA, V95, P1160, DOI 10.1073/pnas.95.3.1160; Mbow ML, 2001, INFECT IMMUN, V69, P2407, DOI 10.1128/IAI.69.4.2407-2415.2001; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Nolting A, 2010, VIROLOGY, V406, P12, DOI 10.1016/j.virol.2010.05.014; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Paul P, 2011, CELL IN PRESS; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218	35	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54684	10.1371/journal.pone.0054684	http://dx.doi.org/10.1371/journal.pone.0054684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372753	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500106
J	Mo, WC; Zhang, ZJ; Liu, Y; Bartlett, PF; He, RQ				Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; Bartlett, Perry F.; He, Rong-qiao			Magnetic Shielding Accelerates the Proliferation of Human Neuroblastoma Cell by Promoting G1-Phase Progression	PLOS ONE			English	Article							STRESS-INDUCED ANALGESIA; HYPOMAGNETIC FIELD; MODEL; EXPOSURE; EMBRYOS; GROWTH	Organisms have been exposed to the geomagnetic field (GMF) throughout evolutionary history. Exposure to the hypomagnetic field (HMF) by deep magnetic shielding has recently been suggested to have a negative effect on the structure and function of the central nervous system, particularly during early development. Although changes in cell growth and differentiation have been observed in the HMF, the effects of the HMF on cell cycle progression still remain unclear. Here we show that continuous HMF exposure significantly increases the proliferation of human neuroblastoma (SH-SY5Y) cells. The acceleration of proliferation results from a forward shift of the cell cycle in G1-phase. The G2/M-phase progression is not affected in the HMF. Our data is the first to demonstrate that the HMF can stimulate the proliferation of SH-SY5Y cells by promoting cell cycle progression in the G1-phase. This provides a novel way to study the mechanism of cells in response to changes of environmental magnetic field including the GMF.	[Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; He, Rong-qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; He, Rong-qiao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mo, Wei-chuan; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Queensland	Liu, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	liuy@moon.ibp.ac.cn; herq@sun5.ibp.ac.cn	Zhang, Zijian/H-6190-2016; Bartlett, Perry/F-3813-2012; Liu, Ying/D-8933-2013	Liu, Ying/0000-0003-0802-3832; Mo, Weichuan/0000-0002-8529-4399	Queensland-Chinese Academy of Sciences Biotechnology Fund [GJHZ1131]; Chinese Academy of Sciences [YZ201148]; National Nature Science Foundation of China [31200628]	Queensland-Chinese Academy of Sciences Biotechnology Fund; Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Queensland-Chinese Academy of Sciences Biotechnology Fund (Grant No. GJHZ1131), the project of Chinese Academy of Sciences for the development of major scientific research equipment (Grant No. YZ201148), and the National Nature Science Foundation of China (Grant No. 31200628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Beischer DE, 1962, NASACR127721, P1; Belyaev IY, 1997, BBA-GEN SUBJECTS, V1336, P465, DOI 10.1016/S0304-4165(97)00059-7; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Berguig MS, 2011, ARAB J GEOSCI, P1; Binhi VN, 2009, ELECTROMAGN BIOL MED, V28, P310, DOI [10.1080/15368370903167246, 10.3109/15368370903167246]; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Borodin Iu I, 1990, Biull Eksp Biol Med, V109, P191; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Choleris E, 2002, P ROY SOC B-BIOL SCI, V269, P193, DOI 10.1098/rspb.2001.1866; Del Seppia C, 2000, LIFE SCI, V66, P1299, DOI 10.1016/S0024-3205(00)00437-9; Dubrov AP, 1989, GEOMAGNETIC FIELD LI; Eldashev I. S., 2010, Biofizika, V55, P868; Gopalakrishnan Kalpana, 2010, Genome Integr, V1, P16, DOI 10.1186/2041-9414-1-16; [贾斌 JIA Bin], 2009, [航天医学与医学工程, Space Medicine & Medical Engineering], V22, P308; Jiang JC, 1998, ACTA SEISMOL SIN, V20, P421; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kolmakov V. M., 2002, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P68; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P649, DOI 10.1002/bem.20606; Mo WC, 2012, PROG BIOCHEM BIOPHYS, V39, P835, DOI 10.3724/SP.J.1206.2011.00597; Mo WC, 2012, BIOELECTROMAGNETICS, V33, P238, DOI 10.1002/bem.20699; Mo WC, 2011, ADV SPACE RES, V47, P1616, DOI 10.1016/j.asr.2010.12.024; Nepomniashchikh L M, 1997, Biull Eksp Biol Med, V124, P455; Nicolini G, 1998, ANTICANCER RES, V18, P2477; Osipenko M. A., 2008, Biofizika, V53, P705; Owens KM, 2012, FREE RADICAL BIO MED, V52, P160, DOI 10.1016/j.freeradbiomed.2011.10.435; Prato FS, 2005, BIOELECTROMAGNETICS, V26, P109, DOI 10.1002/bem.20056; Quah BJC, 2010, JOVE-J VIS EXP, V44, P2259, DOI [10. 3791/2259, DOI 10.3791/2259]; Sandodze V, 2000, RAD STUDIES, V5, P188; Steinhilber F, 2010, J GEOPHYS RES, V115, P1; TrulA Z, 2005, ROMANIAN J BIOPHYS, V15, P73; Wang DL, 2008, BIOCHEM BIOPH RES CO, V376, P363, DOI 10.1016/j.bbrc.2008.08.156; Wang XB, 2003, CHINESE SCI BULL, V48, P2454; Wang XK, 2008, GEOMICROBIOL J, V25, P296, DOI 10.1080/01490450802258295; Watters TR, 2007, ANNU REV EARTH PL SC, V35, P621, DOI 10.1146/annurev.earth.35.031306.140220; Wever R, 1970, Life Sci Space Res, V8, P177; Xiao Y, 2009, ADV SPACE RES, V44, P226, DOI 10.1016/j.asr.2009.04.013; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zhang B, 2004, NEUROSCI LETT, V371, P190, DOI 10.1016/j.neulet.2004.08.072; Zhang X, 2007, BIOELECTROMAGNETICS, V28, P155, DOI 10.1002/bem.20290; 肖颖, 2009, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V39, P392	45	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54775	10.1371/journal.pone.0054775	http://dx.doi.org/10.1371/journal.pone.0054775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355897	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500123
J	Bennett, VA; Doerr, VAJ; Doerr, ED; Manning, AD; Lindenmayer, DB; Yoon, HJ				Bennett, Victoria A.; Doerr, Veronica A. J.; Doerr, Erik D.; Manning, Adrian D.; Lindenmayer, David B.; Yoon, Hwan-Jin			Habitat Selection and Behaviour of a Reintroduced Passerine: Linking Experimental Restoration, Behaviour and Habitat Ecology	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; BROWN TREECREEPER; TEMPERATE WOODLANDS; FORAGING BEHAVIOR; EXPERIMENTAL MANIPULATION; EUCALYPT WOODLANDS; ANIMAL BEHAVIOR; MULLIGANS FLAT; BIRDS; TRANSLOCATION	Habitat restoration can play an important role in recovering functioning ecosystems and improving biodiversity. Restoration may be particularly important in improving habitat prior to species reintroductions. We reintroduced seven brown treecreeper (Climacteris picumnus) social groups into two nature reserves in the Australian Capital Territory in south-eastern Australia. This study provided a unique opportunity to understand the interactions between restoration ecology, behavioural ecology and habitat ecology. We examined how experimental restoration treatments (addition of coarse woody debris, variations in ground vegetation cover and nest box installation) influenced the behaviour and microhabitat use of radio-tracked individuals to evaluate the success of restoration treatments. The addition of coarse woody debris benefited the brown treecreeper through increasing the probability of foraging on a log or on the ground. This demonstrated the value of using behaviour as a bio-indicator for restoration success. Based on previous research, we predicted that variations in levels of ground vegetation cover would influence behaviour and substrate use, particularly that brown treecreepers would choose sites with sparse ground cover because this allows better access to food and better vigilance for predators. However, there was little effect of this treatment, which was likely influenced by the limited overall use of the ground layer. There was also little effect of nest boxes on behaviour or substrate use. These results somewhat confound our understanding of the species based on research from extant populations. Our results also have a significant impact regarding using existing knowledge on a species to inform how it will respond to reintroduction and habitat restoration. This study also places great emphasis on the value of applying an experimental framework to ecological restoration, particularly when reintroductions produce unexpected outcomes.	[Bennett, Victoria A.; Manning, Adrian D.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & soc, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Yoon, Hwan-Jin] Australian Natl Univ, Sch Math Sci, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University	Bennett, VA (corresponding author), Australian Natl Univ, Fenner Sch Environm & soc, Canberra, ACT, Australia.	victoria.bennett325@gmail.com	Manning, Adrian/AAG-2949-2019; Manning, Adrian/AAX-7288-2021; Lindenmayer, David B/P-7183-2017; Doerr, Erik/A-9797-2011; Doerr, Veronica/A-2150-2011	Manning, Adrian/0000-0003-0989-9203; Lindenmayer, David B/0000-0002-4766-4088; Doerr, Erik/0000-0003-4511-9972; Doerr, Veronica/0000-0003-4330-4576; Yoon, Hwan-Jin/0000-0003-1772-7911	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group, Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC) [LP0561817]; Norman Wettenhall Foundation [20108002]; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group, Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC); Norman Wettenhall Foundation; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment	The project has been made possible by funding from Birding NSW (www.birdingnsw.org.au), Birdlife Australia - Stuart Leslie Bird Research Award (www.birdlife.org.au), Canberra Ornithologists Group, Canberra Birds Conservation Fund (www.canberrabirds.org.au), the Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University (http://fennerschool-research.anu.edu.au/cle/), the Fenner School of Environment and Society at The Australian National University (http://fennerschool.anu.edu.au/), the Foundation for National Parks and Wildlife (www.fnpw.org.au), Gould League of NSW 2010 Centenary Year Cayley Memorial Scholarship (www.gould.edu.au), the Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project LP0561817) (http://www.mfgowoodlandexperiment.org.au/), and the Norman Wettenhall Foundation (reference 20108002) (www.nwf.org.au). In-kind contribution was greatly appreciated from CSIRO Ecosystem Sciences (http://www.csiro.au/Organisation-Structure/Divisions/Ecosystem-Sciences.aspx) and The Parks and Conservation Service within the Australian Capital Territory Government Department of Territory and Municipal Services (http://www.tams.act.gov.au/parks-recreation). One field assistant was employed (Jenny Newport) using funds from Conservation and Landscape Ecology Group and the Mulligans Flat-Goorooyarroo Woodland Experiment to assist in collecting data obtained through radio-tracking reintroduced brown treecreepers. Otherwise, individuals that were employed or contracted by the funders (other than the named authors) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos MJ, 2008, EMU, V108, P201, DOI 10.1071/MU08005; Antos MJ, 2006, EMU, V106, P29, DOI 10.1071/MU05039; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Bennett VA, AUSTRAL ECO IN PRESS; Bennett VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050612; Bennett VA, 2012, EMU, V112, P298, DOI 10.1071/MU11048; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler H, 2005, WILDLIFE RES, V32, P157, DOI 10.1071/WR04027; Butler SJ, 2005, ANIM BEHAV, V69, P337, DOI 10.1016/j.anbehav.2004.06.006; Cabezas S, 2011, ANIMAL CONSERVATION; Cooper CB, 2002, ECOL APPL, V12, P1576, DOI 10.1890/1051-0761(2002)012[1576:LPADSS]2.0.CO;2; Cooper CB, 2002, BIOL CONSERV, V105, P1, DOI 10.1016/S0006-3207(01)00172-0; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; Doerr ED, 2007, J ANIM ECOL, V76, P966, DOI 10.1111/j.1365-2656.2007.01280.x; Doerr ED, 2006, ANIM BEHAV, V72, P147, DOI 10.1016/j.anbehav.2005.10.017; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Doerr Veronica A. J., 2002, Corella, V26, P19; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Evans AM, 2003, FOREST ECOL MANAG, V184, P251, DOI 10.1016/S0378-1127(03)00158-0; Ewen JG, 2007, ECOSCIENCE, V14, P401, DOI 10.2980/1195-6860(2007)14[401:SMORIE]2.0.CO;2; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Gilroy JJ, 2008, BIOL CONSERV, V141, P3116, DOI 10.1016/j.biocon.2008.09.019; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Holl KD, 2003, BIOSCIENCE, V53, P491, DOI 10.1641/0006-3568(2003)053[0491:LRMFGT]2.0.CO;2; IUCN, 1998, IUCN GUID REINTR; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Lindell CA, 2008, RESTOR ECOL, V16, P197, DOI 10.1111/j.1526-100X.2008.00389.x; Lindenmayer David, 2010, Ecological Management & Restoration, V11, P201, DOI 10.1111/j.1442-8903.2010.00550.x; Luck GW, 2002, AUSTRAL ECOL, V27, P229, DOI 10.1046/j.1442-9993.2002.01173.x; Mac Nally R, 2006, FOREST ECOL MANAG, V229, P155, DOI 10.1016/j.foreco.2006.03.024; Mac Nally R, 2007, J ANIM ECOL, V76, P643, DOI 10.1111/j.1365-2656.2007.01247.x; Manning A.D., 2011, Australian Zoologist, V35, P633; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McIntyre S., 2010, Cunninghamia, V11, P319; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Morris AJ, 2001, BIOL CONSERV, V101, P197, DOI 10.1016/S0006-3207(01)00067-2; Morrison EB, 2010, J APPL ECOL, V47, P130, DOI 10.1111/j.1365-2664.2009.01743.x; NOSKE RA, 1991, EMU, V91, P73, DOI 10.1071/MU9910073; Noske RA, 1982, COMP BEHAV ECOLOGY S; Ortega-Alvarez Ruben, 2012, Ecological Restoration, V30, P116, DOI 10.3368/er.30.2.116; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinter-Wollman N, 2009, BIOL CONSERV, V142, P1116, DOI 10.1016/j.biocon.2009.01.027; Pomara LY, 2003, AUK, V120, P1000, DOI 10.1642/0004-8038(2003)120[1000:MFAFBO]2.0.CO;2; Prober SM, 2002, AUST J BOT, V50, P687, DOI 10.1071/BT02043; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Richards JD, 2003, BIOL CONSERV, V109, P181, DOI 10.1016/S0006-3207(02)00140-4; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; SCANLAN JC, 1990, AUST J ECOL, V15, P191, DOI 10.1111/j.1442-9993.1990.tb01527.x; Sheean VA, 2012, AUSTRAL ECOL, V37, P204, DOI 10.1111/j.1442-9993.2011.02264.x; Shorthouse David J., 2012, Ecological Management & Restoration, V13, P112, DOI 10.1111/j.1442-8903.2012.00654.x; SPECHT RL, 1981, AUST J ECOL, V6, P193, DOI 10.1111/j.1442-9993.1981.tb01290.x; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stokes VL, 2004, BIOL CONSERV, V117, P331, DOI 10.1016/j.biocon.2003.12.012; Unck CE, 2009, ANIM BEHAV, V78, P625, DOI 10.1016/j.anbehav.2009.05.028; Van Zant JL, 2003, BIOL CONSERV, V112, P405, DOI 10.1016/S0006-3207(02)00338-5; WALKER J, 1986, AUST J ECOL, V11, P135, DOI 10.1111/j.1442-9993.1986.tb01384.x; Walters JR, 1999, BIOL CONSERV, V90, P13, DOI 10.1016/S0006-3207(99)00016-6; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Whittingham MJ, 2008, BASIC APPL ECOL, V9, P779, DOI 10.1016/j.baae.2007.08.002; Yates CJ, 1997, AUST J BOT, V45, P949, DOI 10.1071/BT96091	71	10	11	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54539	10.1371/journal.pone.0054539	http://dx.doi.org/10.1371/journal.pone.0054539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349923	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800062
J	Guardia, D; Carey, A; Cottencin, O; Thomas, P; Luyat, M				Guardia, Dewi; Carey, Aurelie; Cottencin, Olivier; Thomas, Pierre; Luyat, Marion			Disruption of Spatial Task Performance in Anorexia Nervosa	PLOS ONE			English	Article							BODY-IMAGE; HAPTIC PERCEPTION; EATING-DISORDERS; ORIENTATION; TILT; REPRESENTATIONS; LOCALIZATION; INFORMATION; AWARENESS; TACTILE	In anorexia nervosa (AN), body distortions have been associated with parietal cortex (PC) dysfunction. The PC is the anatomical substrate for a supramodal reference framework involved in spatial orientation constancy. Here, we sought to evaluate spatial orientation constancy and the perception of body orientation in AN patients. In the present study, we investigated the effect of passive lateral body inclination on the visual and tactile subjective vertical (SV) and body Z-axis in 25 AN patients and 25 healthy controls. Subjects performed visual-and tactile-spatial judgments of axis orientations in an upright position and tilted 90 degrees clockwise or counterclockwise. We observed a significant deviation of the tactile and visual SV towards the body (an A-effect) under tilted conditions, suggesting a multisensory impairment in spatial orientation. Deviation of the Z-axis in the direction of the tilt was also observed in the AN group. The greater A-effect in AN patients may reflect reduced interoceptive awareness and thus inadequate consideration of gravitational inflow. Furthermore, marked body weight loss could decrease the somatosensory inputs required for spatial orientation. Our study results suggest that spatial references are impaired in AN. This may be due to particular integration of visual, tactile and gravitational information (e. g. vestibular and proprioceptive cues) in the PC.	[Guardia, Dewi; Cottencin, Olivier; Thomas, Pierre; Luyat, Marion] Univ Lille N France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France; [Guardia, Dewi; Carey, Aurelie; Cottencin, Olivier; Luyat, Marion] CHRU Lille, Hop Calmette, Serv Addictol, Lille, France; [Thomas, Pierre] CHRU Lille, Hop Fontan, Serv Psychiat, Lille, France; [Luyat, Marion] Univ Lille 3, UFR Psychol, Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Guardia, D (corresponding author), Univ Lille N France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France.	dewi.guardia@chru-lille.fr	COTTENCIN, Olivier OC/I-4024-2015	COTTENCIN, Olivier OC/0000-0003-3663-1405; Luyat, Marion/0000-0002-5640-5002				Adenzato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044414; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anastasopoulos D, 1999, ANN NY ACAD SCI, V871, P379, DOI 10.1111/j.1749-6632.1999.tb09199.x; Barra J, 2012, NEUROPSYCHOLOGIA, V50, P2492, DOI 10.1016/j.neuropsychologia.2012.06.021; BAUERMEISTER M, 1964, J EXP PSYCHOL, V67, P142, DOI 10.1037/h0046424; BAUERMEISTER M, 1964, AM J PSYCHOL, V77, P451, DOI 10.2307/1421016; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Ceyte H, 2007, EXP BRAIN RES, V176, P504, DOI 10.1007/s00221-006-0764-4; Ceyte H, 2009, NEUROSCI LETT, V462, P85, DOI 10.1016/j.neulet.2009.06.048; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Daprati E, 2010, NEUROPSYCHOLOGIA, V48, P756, DOI 10.1016/j.neuropsychologia.2009.10.008; de Vignemont F, 2008, Q J EXP PSYCHOL, V61, P90, DOI 10.1080/17470210701508764; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Exterkate CC, 2009, EAT BEHAV, V10, P16, DOI 10.1016/j.eatbeh.2008.10.002; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Franko DL, 2002, J PSYCHOSOM RES, V53, P975, DOI 10.1016/S0022-3999(02)00490-7; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Funk J, 2010, NEUROPSYCHOLOGIA, V48, P1616, DOI 10.1016/j.neuropsychologia.2010.01.029; Gallagher S., 2005, BODY SHAPES MIND; Garner D. M., 1991, EDI 2 EATING DISORDE; Gentaz E, 2008, EXP BRAIN RES, V187, P331, DOI 10.1007/s00221-008-1382-0; Graziano Michael S. A., 1995, P1021; Grunwald M, 2004, J CLIN EXP NEUROPSYC, V26, P608, DOI 10.1080/13803390490504407; Grunwald M, 2002, ARCH CLIN NEUROPSYCH, V17, P485, DOI 10.1016/S0887-6177(01)00131-7; Grunwald M, 2001, J CLIN EXP NEUROPSYC, V23, P520, DOI 10.1076/jcen.23.4.520.1229; Guardia D, 2012, PLOS ONE IN PRESS; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; HEILBRUN AB, 1990, J CLIN PSYCHOL, V46, P398, DOI 10.1002/1097-4679(199007)46:4<398::AID-JCLP2270460404>3.0.CO;2-5; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kerkhoff G, 1999, NEUROPSYCHOLOGIA, V37, P1387, DOI 10.1016/S0028-3932(99)00031-7; Kinsbourne M., 1984, PSYCHOBIOLOGY AFFECT, P259; Luyat M, 2001, PERCEPT PSYCHOPHYS, V63, P541, DOI 10.3758/BF03194419; Luyat M, 2002, J EXP PSYCHOL HUMAN, V28, P1002, DOI 10.1037//0096-1523.28.4.1002; Luyat M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-28; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mittelstaedt H, 1997, J VESTIBUL RES-EQUIL, V7, P283, DOI 10.1016/S0957-4271(97)00027-X; Nico D, 2010, PSYCHOL MED, V40, P1531, DOI 10.1017/S0033291709991851; Nico D, 2009, BRAIN COGNITION, V69, P227, DOI 10.1016/j.bandc.2008.07.011; Oldershaw A, 2010, PSYCHOSOM MED, V72, P73, DOI 10.1097/PSY.0b013e3181c6c7ca; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J., 1999, MOTOR CONTROL TODAY, P197, DOI DOI 10.1016/J.NEUROPSYCHOLOGIA.2009.09.022; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Russell TA, 2009, PSYCHIAT RES, V168, P181, DOI 10.1016/j.psychres.2008.10.028; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Santonastaso P, 2009, INT J EAT DISORDER, V42, P464, DOI 10.1002/eat.20706; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Tchanturia K, 2004, J INT NEUROPSYCH SOC, V10, P513, DOI 10.1017/S1355617704104086; Tchanturia K, 2001, J BEHAV THER EXP PSY, V32, P107, DOI 10.1016/S0005-7916(01)00025-8; Tomasino SJ, 1996, J NERV MENT DIS, V184, P758, DOI 10.1097/00005053-199612000-00007; Trousselard M, 2004, COGNITIVE BRAIN RES, V20, P355, DOI 10.1016/j.cogbrainres.2004.03.008; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012	66	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54928	10.1371/journal.pone.0054928	http://dx.doi.org/10.1371/journal.pone.0054928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349990	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800080
J	Ling, H; Roux, E; Hempel, D; Tao, JZ; Smith, M; Lonning, S; Zuk, A; Arbeeny, C; Ledbetter, S				Ling, Hong; Roux, Eric; Hempel, Donna; Tao, Jingzang; Smith, Mandy; Lonning, Scott; Zuk, Anna; Arbeeny, Cynthia; Ledbetter, Steve			Transforming Growth Factor beta Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BILE-DUCT LIGATION; TGF-BETA; LIVER FIBROSIS; STELLATE CELL; II RECEPTOR; CIRRHOSIS; INJURY; REVERSIBILITY; PATHWAYS	Considerable evidence has demonstrated that transforming growth factor beta (TGF-beta) plays a key role in hepatic fibrosis, the final common pathway for a variety of chronic liver diseases leading to liver insufficiency. Although a few studies have reported that blocking TGF-beta with soluble receptors or siRNA can prevent the progression of hepatic fibrosis, as yet no evidence has been provided that TGF-beta antagonism can improve pre-existing hepatic fibrosis. The aim of this study was to examine the effects of a murine neutralizing TGF-beta monoclonal antibody (1D11), in a rat model of thioacetamide (TAA)-induced hepatic fibrosis. TAA administration for 8 weeks induced extensive hepatic fibrosis, whereupon 1D11 dosing was initiated and maintained for 8 additional weeks. Comparing the extent of fibrosis at two time points, pre- and post-1D11 dosing, we observed a profound regression of tissue injury and fibrosis upon treatment, as reflected by a reduction of collagen deposition to a level significantly less than that observed before 1D11 dosing. Hepatic TGF-beta 1 mRNA, tissue hydroxyproline, and plasminogen activator inhibitor 1 (PAI-1) levels were significantly elevated at the end of the 8 week TAA treatment. Vehicle and antibody control groups demonstrated progressive injury through 16 weeks, whereas those animals treated for 8 weeks with 1D11 showed striking improvement in histologic and molecular endpoints. During the course of tissue injury, TAA also induced cholangiocarcinomas. At the end of study, the number and area of cholangiocarcinomas were significantly diminished in rats receiving 1D11 as compared to control groups, presumably by the marked reduction of supporting fibrosis/stroma. The present study demonstrates that 1D11 can reverse pre- existing hepatic fibrosis induced by extended dosing of TAA. The regression of fibrosis was accompanied by a marked reduction in concomitantly developed cholangiocarcinomas. These data provide evidence that therapeutic dosing of a TGF-beta antagonist can diminish and potentially reverse hepatic fibrosis and also reduce the number and size of attendant cholangiocarcinomas.	[Ling, Hong; Roux, Eric; Hempel, Donna; Tao, Jingzang; Smith, Mandy; Lonning, Scott; Zuk, Anna; Arbeeny, Cynthia; Ledbetter, Steve] Sanofi Genzyme R&D Ctr, Framingham, MA USA	Sanofi-Aventis; Genzyme Corporation	Ling, H (corresponding author), Sanofi Genzyme R&D Ctr, Framingham, MA USA.	Hong.ling@genzyme.com						Al-Bader A, 2000, MOL CELL BIOCHEM, V208, P1, DOI 10.1023/A:1007082515548; Arteel GE, 2008, J GASTROEN HEPATOL, V23, pS54, DOI 10.1111/j.1440-1746.2007.05285.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Farazi PA, 2006, CANCER RES, V66, P6622, DOI 10.1158/0008-5472.CAN-05-4609; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2007, NAT CLIN PRACT GASTR, V4, P236, DOI 10.1038/ncpgasthep0813; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Guerra R. R., 2010, Brazilian Journal of Veterinary Pathology, V3, P9; Hu PF, 2009, J HEPATOL, V51, P102, DOI 10.1016/j.jhep.2009.02.025; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Marquez-Aguirre A, 2009, J GENE MED, V11, P207, DOI 10.1002/jgm.1303; Martinez-Rizo A, 2010, LIVER INT, V30, P298, DOI 10.1111/j.1478-3231.2009.02155.x; Matsuzaki K, 2006, J GASTROENTEROL, V41, P295, DOI 10.1007/s00535-006-1795-0; Roldan FP, 2010, GASTROENT HEPAT-BARC, V33, P498, DOI 10.1016/j.gastrohep.2010.04.007; Pilette C, 1998, J HEPATOL, V28, P439, DOI 10.1016/S0168-8278(98)80318-8; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Stroescu Cezar, 2006, J Gastrointestin Liver Dis, V15, P9; Tangkijvanich P, 2002, EUR J SURG, V168, P100; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Wang H, 2007, FEBS LETT, V581, P3098, DOI 10.1016/j.febslet.2007.05.049; Wang HT, 2005, HEPATOLOGY, V42, P1099, DOI 10.1002/hep.20903; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xu W, 2009, HEPATOB PANCREAT DIS, V8, P300; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673; Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037	35	62	65	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54499	10.1371/journal.pone.0054499	http://dx.doi.org/10.1371/journal.pone.0054499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349909	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900073
J	Fu, XB; Koller, S; Abd Alla, J; Quitterer, U				Fu, Xuebin; Koller, Samuel; Abd Alla, Joshua; Quitterer, Ursula			Inhibition of G-protein-coupled Receptor Kinase 2 (GRK2) Triggers the Growth-promoting Mitogen-activated Protein Kinase (MAPK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CARDIAC DYSFUNCTION; BETA; HEART; ERK1/2; RAF; G-PROTEIN-COUPLED-RECEPTOR-KINASE-2; PHOSPHORYLATION; OVEREXPRESSION; SELECTIVITY	Inhibition of G-protein-coupled receptor kinase 2 (GRK2) is an emerging treatment option for heart failure. Because GRK2 is also indispensable for growth and development, we analyzed the impact of GRK2 inhibition on cell growth and proliferation. Inhibition of GRK2 by the dominant-negative GRK2-K220R did not affect the proliferation of cultured cells. In contrast, upon xenograft transplantation of cells into immunodeficient mice, the dominant-negative GRK2-K220R or a GRK2-specific peptide inhibitor increased tumor mass. The enhanced tumor growth upon GRK2 inhibition was attributed to the growth-promoting MAPK pathway because dual inhibition of the GRK2 and RAF-MAPK axis by the Raf kinase inhibitor protein (RKIP) did not increase tumor mass. The MAPK cascade contributed to the cardioprotective profile of GRK2 inhibition by preventing cardiomyocyte death, whereas dual inhibition of RAF/MAPK and GRK2 by RKIP induced cardiomyocyte apoptosis, cardiac dysfunction, and signs of heart failure. Thus, cardioprotective signaling induced by GRK2 inhibition is overlapping with tumor growth promotion.	[Fu, Xuebin; Koller, Samuel; Abd Alla, Joshua; Quitterer, Ursula] Swiss Fed Inst Technol ETH Zuerich, Dept Chem & Appl Biosci, Mol Pharmacol Unit, CH-8057 Zurich, Switzerland; [Quitterer, Ursula] Univ Zurich, Dept Med, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Quitterer, U (corresponding author), Swiss Fed Inst Technol ETH Zuerich, Dept Chem & Appl Biosci, Mol Pharmacol Unit, Rm Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch	Fu, Xuebin/B-6591-2018; Fu, Xuebin/AAH-9622-2019	Fu, Xuebin/0000-0002-7232-3576; Koller, Samuel/0000-0003-0965-0539; Fu, Xuebin/0000-0002-1281-2466	Swiss National Science Foundation [31-140679]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by Swiss National Science Foundation Grant 31-140679 (to U. Q.).	Abd Alla J, 2010, J BIOL CHEM, V285, P23494, DOI 10.1074/jbc.M110.117481; Abd Alla J, 2010, INTEGR BIOL-UK, V2, P209, DOI 10.1039/b922592g; AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla Said, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P190; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Agwa S. H., 2011, FORUM IMMUNOPATHOL D, V2, P71; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Conner DA, 1997, CIRC RES, V81, P1021; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; GULICK J, 1991, J BIOL CHEM, V266, P9180; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KONG GH, 1994, J BIOL CHEM, V269, P13084; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nagy A., 2003, MANIPULATING MOUSE E; Oka Y., 2010, REGEN MED, V6, P149; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Volkers M, 2011, CIRC RES, V108, P27, DOI 10.1161/CIRCRESAHA.110.225201; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Winstel R, 2005, BIOCHEM PHARMACOL, V70, P1001, DOI 10.1016/j.bcp.2005.06.015; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109	52	33	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7738	7755		10.1074/jbc.M112.428078	http://dx.doi.org/10.1074/jbc.M112.428078			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362259	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000316455300030
J	Meitzler, JL; Hinde, S; Banfi, B; Nauseef, WM; de Montellano, PRO				Meitzler, Jennifer L.; Hinde, Sara; Banfi, Botond; Nauseef, William M.; de Montellano, Paul R. Ortiz			Conserved Cysteine Residues Provide a Protein-Protein Interaction Surface in Dual Oxidase (DUOX) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; CONGENITAL GOITER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MYELOPEROXIDASE; PEROXIDASE; ACTIVATION; STABILITY; DOMAIN; MODEL	Intramolecular disulfide bond formation is promoted in oxidizing extracellular and endoplasmic reticulum compartments and often contributes to protein stability and function. DUOX1 and DUOX2 are distinguished from other members of the NOX protein family by the presence of a unique extracellular N-terminal region. These peroxidase-like domains lack the conserved cysteines that confer structural stability to mammalian peroxidases. Sequence-based structure predictions suggest that the thiol groups present are solvent-exposed on a single protein surface and are too distant to support intramolecular disulfide bond formation. To investigate the role of these thiol residues, we introduced four individual cysteine to glycine mutations in the peroxidase-like domains of both human DUOXs and purified the recombinant proteins. The mutations caused little change in the stabilities of the monomeric proteins, supporting the hypothesis that the thiol residues are solvent-exposed and not involved in disulfide bonds that are critical for structural integrity. However, the ability of the isolated hDUOX1 peroxidase-like domain to dimerize was altered, suggesting a role for these cysteines in protein-protein interactions that could facilitate homodimerization of the peroxidase-like domain or, in the full-length protein, heterodimeric interactions with a maturation protein. When full-length hDUOX1 was expressed in HEK293 cells, the mutations resulted in decreased H2O2 production that correlated with a decreased amount of the enzyme localized to the membrane surface rather than with a loss of activity or with a failure to synthesize the mutant proteins. These results support a role for the cysteine residues in intermolecular disulfide bond formation with the DUOX maturation factor DUOXA1.	[Meitzler, Jennifer L.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hinde, Sara; Banfi, Botond; Nauseef, William M.] Univ Iowa, Inflammat Program, Dept Med, Iowa City, IA 52240 USA; [Banfi, Botond] Univ Iowa, Dept Anat & Cell Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52240 USA; [Banfi, Botond] Vet Adm Med Ctr, Iowa City, IA 52240 USA; [de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Genentech Hall GH N572D,600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		Banfi, Botond/0000-0001-9273-1318; Nauseef, William/0000-0003-4032-757X	National Institutes of Health [DK 30297, HL 090830, AI 70958, AI 044642]; National Center for Research Resources Grant [P41RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070958, P01AI044642, R56AI070958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK 30297 (to P. R. O. M.), HL 090830 (to B. B.), and AI 70958 and AI 044642 (to W. M. N.). This work was also supported by the resources and use of facilities at the Iowa City Department of Veterans Affairs Medical Center, Iowa City, IA (to W. M. N.).; We thank Karine Reiter and the Narum laboratory for the use of their JASCO J-815 spectropolarimeter. Mass spectrometric proteomic analyses were carried out by Bio-Organic Bio-medical Mass Spectrometry Resource at the University of California (director, A. L. Burlingame) supported by National Center for Research Resources Grant P41RR001614.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DeLeo FR, 1998, J CLIN INVEST, V101, P2900, DOI 10.1172/JCI2649; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fortunato RS, 2010, J CLIN ENDOCR METAB, V95, P5403, DOI 10.1210/jc.2010-1085; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Hanggi E, 2006, MOL PHARMACOL, V70, P806, DOI 10.1124/mol.105.019547; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Kang DC, 2011, BIOCHEMISTRY-US, V50, P8445, DOI 10.1021/bi201175y; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koo BH, 2012, J BIOL CHEM, V287, P22643, DOI 10.1074/jbc.M111.337949; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Loughran NB, 2012, MOL BIOL EVOL, V29, P2039, DOI 10.1093/molbev/mss073; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meitzler JL, 2011, ARCH BIOCHEM BIOPHYS, V512, P197, DOI 10.1016/j.abb.2011.05.021; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2004, J BIOL CHEM, V279, P30244, DOI 10.1074/jbc.M405406200; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Singh M, 2011, J STRUCT BIOL, V174, P374, DOI 10.1016/j.jsb.2011.01.013; Song Y, 2010, J CLIN ENDOCR METAB, V95, P375, DOI 10.1210/jc.2009-1727; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; Tiedge M, 1997, BBA-PROTEIN STRUCT M, V1337, P175, DOI 10.1016/S0167-4838(96)00162-8; Tiedge M, 2000, ARCH BIOCHEM BIOPHYS, V375, P251, DOI 10.1006/abbi.1999.1666; Wolf SM, 2000, J MASS SPECTROM, V35, P210, DOI 10.1002/(SICI)1096-9888(200002)35:2<210::AID-JMS931>3.0.CO;2-Z; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	42	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7147	7157		10.1074/jbc.M112.414797	http://dx.doi.org/10.1074/jbc.M112.414797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362256	Green Published, hybrid			2022-12-25	WOS:000316002400036
J	Alexandru, N; Popov, D; Dragan, E; Andrei, E; Georgescu, A				Alexandru, Nicoleta; Popov, Doina; Dragan, Emanuel; Andrei, Eugen; Georgescu, Adriana			Circulating Endothelial Progenitor Cell and Platelet Microparticle Impact on Platelet Activation in Hypertension Associated with Hypercholesterolemia	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCE DIFFERENTIATION; POTENTIAL ROLE; ATHEROSCLEROSIS; INFLAMMATION; STENT; CAPACITY; RECRUIT; CAPTURE; DISEASE	Aim: The purpose of this project was to evaluate the influence of circulating endothelial progenitor cells (EPCs) and platelet microparticles (PMPs) on blood platelet function in experimental hypertension associated with hypercholesterolemia. Methods: Golden Syrian hamsters were divided in six groups: (i) control, C; (ii) hypertensive-hypercholesterolemic, HH; (iii) 'prevention', HHin-EPCs, HH animals fed a HH diet and treated with EPCs; (iv) 'regression', HHfin-EPCs, HH treated with EPCs after HH feeding; (v) HH treated with PMPs, HH-PMPs, and (vi) HH treated with EPCs and PMPs, HH-EPCs-PMPs. Results: Compared to HH group, the platelets from HHin-EPCs and HHfin-EPCs groups showed a reduction of: (i) activation, reflected by decreased integrin 3b, FAK, PI3K, src protein expression; (ii) secreted molecules as: SDF-1, MCP-1, RANTES, VEGF, PF4, PDGF and (iii) expression of pro-inflammatory molecules as: SDF-1, MCP-1, RANTES, IL-6, IL-1 beta; TFPI secretion was increased. Compared to HH group, platelets of HH-PMPs group showed increased activation, molecules release and proteins expression. Compared to HH-PMPs group the combination EPCs with PMPs treatment induced a decrease of all investigated platelet molecules, however not comparable with that recorded when EPC individual treatment was applied. Conclusion: EPCs have the ability to reduce platelet activation and to modulate their pro-inflammatory and anti-thrombogenic properties in hypertension associated with hypercholesterolemia. Although, PMPs have several beneficial effects in combination with EPCs, these did not improve the EPC effects. These findings reveal a new biological role of circulating EPCs in platelet function regulation, and may contribute to understand their cross talk, and the mechanisms of atherosclerosis.	[Alexandru, Nicoleta; Georgescu, Adriana] Petru Poni Inst Macromol Chem, R-6600 Iasi, Romania; [Alexandru, Nicoleta; Popov, Doina; Dragan, Emanuel; Andrei, Eugen; Georgescu, Adriana] Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Bucharest, Romania	Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology	Alexandru, N (corresponding author), Petru Poni Inst Macromol Chem, R-6600 Iasi, Romania.	nicoleta.alexandru@icbp.ro; adriana.georgescu@icbp.ro	Georgescu, Adriana/B-9185-2011; L, Popov Doina/AAY-5640-2020; Alexandru, Nicoleta/E-5689-2011	Georgescu, Adriana/0000-0003-4945-1745; 	Romanian National Authority for Scientific Research; CNCS - UEFISCDI, project [PNII-CT-ERC-2012-1, PN-II-RU-TE-2012-3-0020, PN-II-ID-PCE-2012-4-0124]; European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme [POSDRU/89/1.5/S/55216]; Sectoral Operational Programme Human Resources Development; Romanian Academy	Romanian National Authority for Scientific Research; CNCS - UEFISCDI, project(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme; Sectoral Operational Programme Human Resources Development; Romanian Academy(Romanian Academy of Sciences)	This research was financially supported by grants of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project ID PNII-CT-ERC-2012-1 (6ERC-like/July 18, 2012), project ID PN-II-RU-TE-2012-3-0020, project ID PN-II-ID-PCE-2012-4-0124 and by European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme (ID POSDRU/89/1.5/S/55216), Sectoral Operational Programme Human Resources Development 2007-2013, and by Romanian Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Saleh H, 2009, CIRCULATION, V120, P2230, DOI 10.1161/CIRCULATIONAHA.109.894642; Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Alexandru N, 2011, J THROMB HAEMOST, V9, P173, DOI 10.1111/j.1538-7836.2010.04122.x; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Boulanger CM, 2005, CARDIOVASC RES, V67, P1, DOI 10.1016/j.cardiores.2005.05.001; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Co M, 2008, AM HEART J, V155, P128, DOI 10.1016/j.ahj.2007.08.031; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Fadini GP, 2010, CARDIOVASC RES, V87, P12, DOI 10.1093/cvr/cvq119; Flaumenhaft R, 2006, BLOOD CELL MOL DIS, V36, P182, DOI 10.1016/j.bcmd.2005.12.019; Foteinos G, 2008, CIRCULATION, V117, P1856, DOI 10.1161/CIRCULATIONAHA.107.746008; Gawaz M, 2008, J THROMB HAEMOST, V6, P235, DOI 10.1111/j.1538-7836.2007.02867.x; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Georgescu A, 2012, J THROMB HAEMOST, V10, P680, DOI 10.1111/j.1538-7836.2012.04650.x; Georgescu A, 2009, J THROMB HAEMOST, V7, P1566, DOI 10.1111/j.1538-7836.2009.03525.x; Georgescu A, 2011, WORLD J DIABETES, V2, P92, DOI 10.4239/wjd.v2.i6.92; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Leshem-Lev D, 2010, J THROMB THROMBOLYS, V30, P398, DOI 10.1007/s11239-010-0514-0; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Lievens D, 2011, THROMB HAEMOSTASIS, V106, P827, DOI 10.1160/TH11-08-0592; Lindemann S, 2007, CURR OPIN LIPIDOL, V18, P566, DOI 10.1097/MOL.0b013e3282ef7c1e; LUPU C, 1993, THROMB HAEMOSTASIS, V70, P579; Maroney SA, 2011, ARTERIOSCL THROM VAS, V31, P821, DOI 10.1161/ATVBAHA.110.220293; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Miglionico M, 2008, CATHETER CARDIO INTE, V71, P600, DOI 10.1002/ccd.21437; Nagy B, 2012, CURR MED CHEM, V19, P518, DOI 10.2174/092986712798918770; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2007, THROMB HAEMOSTASIS, V98, P922, DOI 10.1160/TH07-02-0147; Theiss HD, 2007, EUR HEART J, V28, P1258, DOI 10.1093/eurheartj/ehm011; Tsoumani ME, 2012, CURR VASC PHARMACOL, V10, P539; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Xu QB, 2003, CIRC RES, V93, pE76, DOI 10.1161/01.RES.0000097864.24725.60; Xu QB, 2007, CURR OPIN LIPIDOL, V18, P534, DOI 10.1097/MOL.0b013e3282a66082; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	54	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52058	10.1371/journal.pone.0052058	http://dx.doi.org/10.1371/journal.pone.0052058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372649	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400002
J	Chung, KY; Day, PW; Velez-Ruiz, G; Sunahara, RK; Kobilka, BK				Chung, Ka Young; Day, Peter W.; Velez-Ruiz, Gisselle; Sunahara, Roger K.; Kobilka, Brian K.			Identification of GPCR-Interacting Cytosolic Proteins Using HDL Particles and Mass Spectrometry-Based Proteomic Approach	PLOS ONE			English	Article							COUPLED-RECEPTORS; 5-HT2C RECEPTORS; COMPLEXES; PURIFICATION; TRANSDUCTION; ARRESTINS; HEART	G protein-coupled receptors (GPCRs) have critical roles in various physiological and pathophysiological processes, and more than 40% of marketed drugs target GPCRs. Although the canonical downstream target of an agonist-activated GPCR is a G protein heterotrimer; there is a growing body of evidence suggesting that other signaling molecules interact, directly or indirectly, with GPCRs. However, due to the low abundance in the intact cell system and poor solubility of GPCRs, identification of these GPCR-interacting molecules remains challenging. Here, we establish a strategy to overcome these difficulties by using high-density lipoprotein (HDL) particles. We used the beta(2)-adrenergic receptor (beta(2)AR), a GPCR involved in regulating cardiovascular physiology, as a model system. We reconstituted purified beta(2)AR in HDL particles, to mimic the plasma membrane environment, and used the reconstituted receptor as bait to pull-down binding partners from rat heart cytosol. A total of 293 proteins were identified in the full agonist-activated beta(2)AR pull-down, 242 proteins in the inverse agonist-activated beta(2)AR pull-down, and 210 proteins were commonly identified in both pull-downs. A small subset of the beta(2)AR-interacting proteins isolated was confirmed by Western blot; three known beta(2)AR-interacting proteins (Gs alpha, NHERF-2, and Grb2) and 3 newly identified known beta(2)AR-interacting proteins (AMPK alpha, acetyl-CoA carboxylase, and UBC-13). Profiling of the identified proteins showed a clear bias toward intracellular signal transduction pathways, which is consistent with the role of beta(2)AR as a cell signaling molecule. This study suggests that HDL particle-reconstituted GPCRs can provide an effective platform method for the identification of GPCR binding partners coupled with a mass spectrometry-based proteomic analysis.	[Chung, Ka Young; Day, Peter W.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Day, Peter W.] Genentech Inc, Roche Grp, Biol Technol, San Francisco, CA USA; [Velez-Ruiz, Gisselle; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; Sungkyunkwan University (SKKU); Roche Holding; Genentech; University of Michigan System; University of Michigan	Chung, KY (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kychung2@skku.edu; kobilka@stanford.edu	Sunahara, Roger/AAJ-8667-2020; Chung, Ka Young/AAO-7984-2020	Kobilka, Brian/0000-0001-5958-3990; Chung, Ka Young/0000-0001-9038-9571	NIH [R01 HL071078, GM083118]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A1039220]; National Center For Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R01GM083118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants R01 HL071078 and GM083118 and National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1039220). The mass spectrometry described in this publication was supported by Award Number S10RR027425 from the National Center For Research Resources. KYC is supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1039220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Capelo JL, 2009, ANAL CHIM ACTA, V650, P151, DOI 10.1016/j.aca.2009.07.034; Daaka Y, 2012, BBA-GEN SUBJECTS, V1820, P743, DOI 10.1016/j.bbagen.2011.03.007; Daulat AM, 2009, TRENDS PHARMACOL SCI, V30, P72, DOI 10.1016/j.tips.2008.10.009; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Farr CD, 2004, J NEUROCHEM, V91, P438, DOI 10.1111/j.1471-4159.2004.02735.x; Free R Benjamin, 2009, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0528s46; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Helbig AO, 2010, J PROTEOMICS, V73, P868, DOI 10.1016/j.jprot.2010.01.005; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Kabbani N, 2007, EUR J PHARMACOL, V572, P83, DOI 10.1016/j.ejphar.2007.06.059; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Maurice P, 2008, MOL CELL PROTEOMICS, V7, P1556, DOI 10.1074/mcp.M700435-MCP200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pluder F, 2006, PHARMACOL THERAPEUT, V112, P1, DOI 10.1016/j.pharmthera.2006.03.001; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206	31	19	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54942	10.1371/journal.pone.0054942	http://dx.doi.org/10.1371/journal.pone.0054942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372797	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400043
J	Reale, ME; Webb, IC; Wang, X; Baltazar, RM; Coolen, LM; Lehman, MN				Reale, Meghan E.; Webb, Ian C.; Wang, Xu; Baltazar, Ricardo M.; Coolen, Lique M.; Lehman, Michael N.			The Transcription Factor Runx2 Is under Circadian Control in the Suprachiasmatic Nucleus and Functions in the Control of Rhythmic Behavior	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EFFERENT PROJECTIONS; OSTEOCALCIN GENE; BONE-DEVELOPMENT; OLFACTORY-BULB; TGF-BETA; IN-VIVO; PERIOD	Runx2, a member of the family of runt-related transcription factors, is rhythmically expressed in bone and may be involved in circadian rhythms in bone homeostasis and osteogenesis. Runx2 is also expressed in the brain, but its function is unknown. We tested the hypothesis that in the brain, Runx2 may interact with clock-controlled genes to regulate circadian rhythms in behavior. First, we demonstrated diurnal and circadian rhythms in the expression of Runx2 in the mouse brain. Expression of Runx2 mRNA and protein mirrored that of the core clock genes, Period1 and Period2, in the suprachiasmatic nucleus (SCN), the paraventricular nucleus and the olfactory bulb. The rhythm of Runx2 expression was eliminated in the SCN of Bmal1(-/-) mice. Moreover, by crossbreeding mPer2(Luc) mice with Runx2(+/-) mice and recording bioluminescence rhythms, a significant lengthening of the period of rhythms was detected in cultured SCN of Runx2(-/-) animals compared to either Runx2(+/-) or Runx2(+/+) mice. Behavioral analyses of Runx2 mutant mice revealed that Runx2(+/-) animals displayed a significantly lengthened free-running period of running wheel activity compared to Runx2(+/+) littermates. Taken together, these findings provide evidence for clock gene-mediated rhythmic expression of Runx2, and its functional role in regulating circadian period at the level of the SCN and behavior.	[Reale, Meghan E.; Wang, Xu; Baltazar, Ricardo M.; Coolen, Lique M.; Lehman, Michael N.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA	Western University (University of Western Ontario); University of Mississippi; University of Mississippi Medical Center	Lehman, MN (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	mlehman@umc.edu	Lehman, Michael/ABC-9076-2020	Lehman, Michael/0000-0002-9076-5108; Coolen, Lique/0000-0003-2920-1116	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada to MNL and MER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Barski A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh097; BERK ML, 1981, BRAIN RES, V226, P1, DOI 10.1016/0006-8993(81)91079-9; Beynon AL, 2009, NEUROIMMUNOMODULAT, V16, P392, DOI 10.1159/000228914; Breen KM, 2010, ENDOCRINOLOGY, V151, P2669, DOI 10.1210/en.2009-0949; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Dai JP, 1997, J COMP NEUROL, V383, P397, DOI 10.1002/(SICI)1096-9861(19970714)383:4<397::AID-CNE1>3.0.CO;2-Y; DUCY P, 1995, MOL CELL BIOL, V15, P1858; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; GERGEN JP, 1986, CELL, V45, P289, DOI 10.1016/0092-8674(86)90393-4; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Gutierrez S, 2004, J BIOL CHEM, V279, P43581, DOI 10.1074/jbc.M408335200; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Luppen CA, 2003, J BIOL CHEM, V278, P44995, DOI 10.1074/jbc.M306730200; Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mickman CT, 2008, AM J PHYSIOL-REG I, V295, pR1688, DOI 10.1152/ajpregu.90510.2008; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NIELSEN HK, 1994, DAN MED BULL, V41, P216; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Smith BJ, 2011, OSTEOPOROSIS INT, V22, P1633, DOI 10.1007/s00198-010-1325-z; Stock M, 2005, J CELL BIOCHEM, V95, P506, DOI 10.1002/jcb.20471; Takarada T, 2009, NEUROSCI LETT, V451, P99, DOI 10.1016/j.neulet.2008.12.037; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; VRANG N, 1995, J COMP NEUROL, V353, P585, DOI 10.1002/cne.903530409; Wang CH, 2006, MOL CELL BIOCHEM, V292, P79, DOI 10.1007/s11010-006-9220-9; Ward SM, 2010, J BIOL CHEM, V285, P38987, DOI 10.1074/jbc.M110.175182; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2003, BLOOD CELL MOL DIS, V30, P184, DOI 10.1016/S1079-9796(03)00020-2; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	68	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54317	10.1371/journal.pone.0054317	http://dx.doi.org/10.1371/journal.pone.0054317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372705	gold, Green Submitted, Green Published			2022-12-25	WOS:000315210400011
J	Thompson, ER; Rowley, SM; Sawyer, S; Eccles, DM; Trainer, AH; Mitchell, G; James, PA; Campbell, IG				Thompson, Ella R.; Rowley, Simone M.; Sawyer, Sarah; Eccles, Diana M.; Trainer, Alison H.; Mitchell, Gillian; James, Paul A.; Campbell, Ian G.		KConFab	Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer	PLOS ONE			English	Article							GERMLINE MUTATIONS; DISEASE; GENE; SUSCEPTIBILITY; TOOL	Mutations in RAD51D have been associated with an increased risk of hereditary ovarian cancer and although they have been observed in the context of breast and ovarian cancer families, the association with breast cancer is unclear. The aim of this current study was to validate the reported association of RAD51D with ovarian cancer and assess for an association with breast cancer. We screened for RAD51D mutations in BRCA1/2 mutation-negative index cases from 1,060 familial breast and/or ovarian cancer families (including 741 affected by breast cancer only) and in 245 unselected ovarian cancer cases. Exons containing novel non-synonymous variants were screened in 466 controls. Two overtly deleterious RAD51D mutations were identified among the unselected ovarian cancers cases (0.82%) but none were detected among the 1,060 families. Our data provide additional evidence that RAD51D mutations are enriched among ovarian cancer patients, but are extremely rare among familial breast cancer patients.	[Thompson, Ella R.; Rowley, Simone M.; Trainer, Alison H.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia; [Sawyer, Sarah; Trainer, Alison H.; Mitchell, Gillian; James, Paul A.] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia; [KConFab] Kathleen Cuningham Fdn Res Familial Breast Canc K, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Eccles, Diana M.] Univ Southampton, Fac Med, Princess Anne Hosp, Canc Sci Div, Southampton SO9 5NH, Hants, England; [Trainer, Alison H.; Mitchell, Gillian; James, Paul A.; Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Campbell, Ian G.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Southampton; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Thompson, ER (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia.	ella.thompson@petermac.org	James, Paul/G-2943-2014; campbell, Ian G/F-6006-2011; Eccles, Diana/K-6327-2019	Eccles, Diana/0000-0002-9935-3169; Thompson, Ella/0000-0001-5206-5111; Campbell, Ian/0000-0002-7773-4155; Thorne, Heather/0000-0003-3610-2511; James, Paul/0000-0002-4361-4657; Rowley, Simone/0000-0002-5897-7979	National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; Cancer Australia (NBCF) [628333]; Victorian Cancer Agency; Cancer Australia; NBCF (Priority-driven Collaborative Cancer Research Scheme grant) [628610]; Wessex Cancer Trust; National Breast Cancer Foundation [IF-12-06, PF-13-10] Funding Source: researchfish	National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Australia (NBCF); Victorian Cancer Agency; Cancer Australia; NBCF (Priority-driven Collaborative Cancer Research Scheme grant); Wessex Cancer Trust; National Breast Cancer Foundation	kConFab is supported by grants from the National Breast Cancer Foundation and the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund; the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia; and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up study was funded between 2001-2009 by NHMRC and currently by the National Breast Cancer Foundation and Cancer Australia (NBCF) (ID 628333). This study was supported by the Victorian Cancer Agency, Cancer Australia, and the NBCF (Priority-driven Collaborative Cancer Research Scheme grant, ID 628610), and the Wessex Cancer Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alsop K, 2012, J CLIN ONCOLOGY; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; Bryan EJ, 1996, CANCER RES, V56, P719; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Osher DJ, 2012, BRIT J CANCER, V106, P1460, DOI 10.1038/bjc.2012.87; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Pelttari LM, 2012, J MED GENET; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; Thompson ER, 2012, HUM MUTAT, V33, P95, DOI 10.1002/humu.21625; Wickramanyake A, 2012, GYNECOL ONCOL, V127, P552, DOI 10.1016/j.ygyno.2012.09.009; Zhang SY, 2011, GYNECOL ONCOL, V121, P353, DOI 10.1016/j.ygyno.2011.01.020	22	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54772	10.1371/journal.pone.0054772	http://dx.doi.org/10.1371/journal.pone.0054772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372765	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000315210400028
J	Bell, JR; Aralimarad, P; Lim, KS; Chapman, JW				Bell, James R.; Aralimarad, Prabhuraj; Lim, Ka-Sing; Chapman, Jason W.			Predicting Insect Migration Density and Speed in the Daytime Convective Boundary Layer	PLOS ONE			English	Article							VERTICAL-LOOKING RADAR; HIGH-ALTITUDE; BALLOONING DISPERSAL; AERIAL MIGRATION; FLIGHT; DISTRIBUTIONS; COMPLEXITY; ABUNDANCE; SPECIFICITY; POPULATIONS	Insect migration needs to be quantified if spatial and temporal patterns in populations are to be resolved. Yet so little ecology is understood above the flight boundary layer (i.e. > 10 m) where in north-west Europe an estimated 3 billion insects km(-1) month(-1) comprising pests, beneficial insects and other species that contribute to biodiversity use the atmosphere to migrate. Consequently, we elucidate meteorological mechanisms principally related to wind speed and temperature that drive variation in daytime aerial density and insect displacements speeds with increasing altitude (150-1200 m above ground level). We derived average aerial densities and displacement speeds of 1.7 million insects in the daytime convective atmospheric boundary layer using vertical-looking entomological radars. We first studied patterns of insect aerial densities and displacements speeds over a decade and linked these with average temperatures and wind velocities from a numerical weather prediction model. Generalized linear mixed models showed that average insect densities decline with increasing wind speed and increase with increasing temperatures and that the relationship between displacement speed and density was negative. We then sought to derive how general these patterns were over space using a paired site approach in which the relationship between sites was examined using simple linear regression. Both average speeds and densities were predicted remotely from a site over 100 km away, although insect densities were much noisier due to local 'spiking'. By late morning and afternoon when insects are migrating in a well-developed convective atmosphere at high altitude, they become much more difficult to predict remotely than during the early morning and at lower altitudes. Overall, our findings suggest that predicting migrating insects at altitude at distances of approximate to 100 km is promising, but additional radars are needed to parameterise spatial covariance.	[Bell, James R.; Lim, Ka-Sing; Chapman, Jason W.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England; [Aralimarad, Prabhuraj] Univ Agr Sci, Dept Entomol, Raichur, Karnataka, India; [Chapman, Jason W.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Bell, JR (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	james.bell@rothamsted.ac.uk	Lim, Ka Sing/B-4480-2012; Bell, James/C-2247-2009	Lim, Ka Sing/0000-0002-9166-2928; Bell, James/0000-0003-1640-6120; Aralimarad, Prabhuraj/0000-0001-7703-4266; Chapman, Jason/0000-0002-7475-4441	UK Biotechnology and Biological Sciences Research Council (BBSRC); University of Agricultural Sciences, Raichur; BBSRC [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: UKRI; NERC [cfaarr010001, NE/I011471/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00005191, BBS/E/C/00005195] Funding Source: researchfish; Natural Environment Research Council [cfaarr010001, NE/I011471/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Agricultural Sciences, Raichur; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). PA's sabbatical at Rothamsted was funded by the University of Agricultural Sciences, Raichur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTEMEIER GL, 1991, J ATMOS OCEAN TECH, V8, P746, DOI 10.1175/1520-0426(1991)008<0746:TUOIAT>2.0.CO;2; Ahrens CD, 2000, METEOROLOGY TODAY; BASCOMPTE J, 1995, TRENDS ECOL EVOL, V10, P361, DOI 10.1016/S0169-5347(00)89134-X; Bell JR, 2012, GLOBAL ECOL BIOGEOGR, V21, P405, DOI 10.1111/j.1466-8238.2011.00685.x; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Betts AK, 1996, J GEOPHYS RES-ATMOS, V101, P7209, DOI 10.1029/95JD02135; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Byers JA, 2011, ENVIRON ENTOMOL, V40, P1210, DOI 10.1603/EN11043; Chandra AS, 2010, J CLIMATE, V23, P5699, DOI 10.1175/2010JCLI3395.1; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2005, ECOL ENTOMOL, V30, P264, DOI 10.1111/j.0307-6946.2005.00702.x; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, COMPUT ELECTRON AGR, V35, P95, DOI 10.1016/S0168-1699(02)00013-3; Cleugh HA, 2001, BOUND-LAY METEOROL, V98, P1, DOI 10.1023/A:1018798928158; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; DeAngelis DL, 2011, AM NAT, V178, P15, DOI 10.1086/660280; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; DRAKE VA, 1984, BOUND-LAY METEOROL, V28, P353, DOI 10.1007/BF00121314; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geerts B, 2005, ENVIRON ENTOMOL, V34, P361, DOI 10.1603/0046-225X-34.2.361; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Johnson C.G., 1969, MIGRATION DISPERSAL; KITCHEN M, 1981, Q J ROY METEOR SOC, V107, P853, DOI 10.1256/smsqj.45406; Letzel MO, 2003, J ATMOS SCI, V60, P2328, DOI 10.1175/1520-0469(2003)060<2328:LESOTI>2.0.CO;2; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; MOORES WH, 1979, Q J ROY METEOR SOC, V105, P397, DOI 10.1002/qj.49710544406; Nathan R, 2005, DIVERS DISTRIB, V11, P131, DOI 10.1111/j.1366-9516.2005.00146.x; Palutikof J, 1997, CLIMATES BRIT ISLES, P220; Reynolds AM, 2007, BIOL LETTERS, V3, P237, DOI 10.1098/rsbl.2007.0109; Reynolds AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015758; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; Reynolds AM, 2009, P R SOC B, V276, P137, DOI 10.1098/rspb.2008.0880; Reynolds DR, 2008, B ENTOMOL RES, V98, P35, DOI 10.1017/S0007485307005470; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Rotach MW, 1996, Q J ROY METEOR SOC, V122, P367, DOI 10.1002/qj; SCHALL R, 1991, BIOMETRIKA, V78, P719; Shortall CR, 2009, INSECT CONSERV DIVER, V2, P251, DOI 10.1111/j.1752-4598.2009.00062.x; Smith AD, 2000, B ENTOMOL RES, V90, P265, DOI 10.1017/S0007485300000389; SMITH AD, 1993, PHILOS T R SOC B, V340, P393, DOI 10.1098/rstb.1993.0081; Storch D, 2004, BASIC APPL ECOL, V5, P389, DOI 10.1016/j.baae.2004.08.001; TAYLOR LR, 1960, J ANIM ECOL, V29, P45, DOI 10.2307/2270; TAYLOR LR, 1980, J ANIM ECOL, V49, P831, DOI 10.2307/4230; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1988, NATURE, V332, P721, DOI 10.1038/332721a0; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Ward SA, 1998, J ANIM ECOL, V67, P763, DOI 10.1046/j.1365-2656.1998.00238.x; Weaver CP, 2001, B AM METEOROL SOC, V82, P269, DOI 10.1175/1520-0477(2001)082<0269:ADCBHM>2.3.CO;2; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2009, METEOROL APPL, V16, P491, DOI 10.1002/met.146; Zuur Alain F., 2009, P1	58	15	16	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54202	10.1371/journal.pone.0054202	http://dx.doi.org/10.1371/journal.pone.0054202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359799	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600038
J	Wu, JJ; Meng, ZF; Xu, JQ; Lei, YH; Jin, L; Zhong, P; Han, RZ; Su, B				Wu, Jianjun; Meng, Zhefeng; Xu, Jianqing; Lei, Yanhua; Jin, Lin; Zhong, Ping; Han, Renzhi; Su, Bin			New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; SUBTYPES; MEN; SEX; PROVINCE; DONORS	In recent years, the population of men who have sex with men (MSM) have become the most significant increasing group of HIV-1 transmission in China. To identify new recombinant strains and transmission patterns of HIV-1 in Chinese MSM population, a cross-sectional investigation of MSM in Anhui Province (in south-eastern China) was performed in 2011. The diagnosed AIDS case rate, CD4 T-cell counts, HIV subtypes, and origin of the recombinant strains were investigated in 138 collected samples. The phylogenetic and bootscan analyses demonstrated that, apart from three previously reported circulating strains (CRF07_BC, CRF01_AE, subtype B), various recombinant strains among subtype B, subtype C, CRF01_AE, and CRF07_BC were simultaneously identified in Chinese MSM for the first time. The introducing time of B subtype in Chinese MSM populations was estimated in 1985, CRF01_AE in 2000, and CRF07_ BC in 2003; the latter two account for more than 85% of MSM infections. Notably, in comparison with B subtype infections in Anhui MSM, CRF01_AE, with the highest prevalence rate, may accelerate AIDS progression. Over half of patients (56%) infected with new recombinant strains infection are diagnosed as progression into AIDS. Both Bayes and phylogenetic analyses indicated that there was active HIV transmission among MSM nationwide, which may facilitate the transmission of the new 01B recombinant strains in MSM. In conclusion, new recombinant strains and active transmission were identified in the Chinese MSM population, which may lead to a new alarming HIV pandemic in this population due to the increased pathogenesis of the newly emerging strains.	[Wu, Jianjun; Jin, Lin; Su, Bin] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Meng, Zhefeng; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS STD, Shanghai, Peoples R China; [Lei, Yanhua] Hefei Ctr Dis Control & Prevent, Hefei, Peoples R China; [Han, Renzhi] Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA	Fudan University; Shanghai Center for Disease Control & Prevention; Loyola University Chicago	Meng, ZF (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhefengm@hotmail.com; sub@ahcdc.com.cn	YANHUA, LEI/AAW-7873-2021; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Han, Renzhi/0000-0002-8202-9186; Wu, Jian/0000-0002-3394-1507; meng, zhefeng/0000-0001-9396-0673	Anhui provincial Program of Prevent medicinePublic Health [2011Y0102]; China Ministry of Health & China ministry of Science and Technology [2012ZX10001-002-001-002, 2012ZX10001-006]	Anhui provincial Program of Prevent medicinePublic Health; China Ministry of Health & China ministry of Science and Technology	This work was supported by Anhui provincial Program of Prevent medicine&Public Health (Grant#2011Y0102) and National Grand Program on Key Infectious Disease Control (Grant#2012ZX10001-002-001-002, 2012ZX10001-006), China Ministry of Health & China ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Ministry of Health Joint United Nations Programme on HIV/AIDS World Health Organization, 2008, 2007 UPDATE ON THE H, V2008, P6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Lau KA, 2007, AIDS REV, V9, P218; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Li L, 2012, AIDS RES HUM RETROV, V201, P27; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li N, 2010, JAIDS-J ACQ IMM DEF, V53, pS41, DOI 10.1097/QAI.0b013e3181c7d717; Liu J, 2011, PLOS ONE, V8; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Meng ZF, 2011, CHINESE MED J-PEKING, V124, P304, DOI 10.3760/cma.j.issn.0366-6999.2011.02.028; Meng ZF, 2007, AIDS RES HUM RETROV, V23, P1049, DOI 10.1089/aid.2007.0058; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Sanchez-Merino V, 2003, AIDS RES HUM RETROV, V19, P49, DOI 10.1089/08892220360473961; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Wang W, 2011, AIDS RES HUM RETROV, V27, P1089; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; WENIGER BG, 1994, AIDS, V8, pS13; WHO, 2000, AIDS EPIDEMIC UPDATE; World Health Organization, 2012, 2012 JOINT MON PROGR, P1; Xin Ruo-lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P876; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	26	47	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54322	10.1371/journal.pone.0054322	http://dx.doi.org/10.1371/journal.pone.0054322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372706	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500057
J	Sato, S; Kamada, H; Watanabe, T; Tsuji, I; Fan, JH				Sato, Shuji; Kamada, Hiroko; Watanabe, Takahiro; Tsuji, Isamu; Fan, Jinhong			Identification of the Cancer Cell Proliferation and Survival Functions of proHB-EGF by Using an Anti-HB-EGF Antibody	PLOS ONE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; GROWTH-FACTOR ACTIVITY; TERMINAL FRAGMENT; EPITHELIAL-CELLS; BINDING; MEMBRANE; PROTEIN; EXPRESSION; FORM; ACTIVATION	Purpose: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family. The membrane-bound proHB-EGF is known to be a precursor of the soluble form of HB-EGF (sHB-EGF), which promotes cell proliferation and survival. While the functions of sHB-EGF have been extensively studied, it is not yet fully understood if proHB-EGF is also involved in cellular signaling events. In this study, we utilized the anti-HB-EGF monoclonal antibodies Y-142 and Y-073, which have differential specificities toward proHB-EGF, in order to elucidate proHB-EGF functions in cancer cells. Experimental Design: The biological activities of proHB-EGF were assessed in cell proliferation, caspase activation, and juxtacrine activity assays by using a 3D spheroid culture of NUGC-3 cells. Results: Y-142 and Y-073 exhibited similar binding and neutralizing activities for sHB-EGF. However, only Y-142 bound to proHB-EGF. We could detect the function of endogenously expressed proHB-EGF in a 3D spheroid culture. Blocking proHB-EGF with Y-142 reduced spheroid formation, suppressed cell proliferation, and increased caspase activation in the 3D spheroid culture of NUGC-3 cells. Conclusions: Our results show that proHB-EGF acts as a cell proliferation and cell survival factor in cancer cells. The results suggest that proHB-EGF may play an important role in tumor progression.	[Sato, Shuji; Fan, Jinhong] Takeda San Francisco Inc, San Francisco, CA USA; [Sato, Shuji; Kamada, Hiroko; Watanabe, Takahiro; Tsuji, Isamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Sato, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shuji.sato@takeda.com		Sato, Shuji/0000-0002-8423-9750				Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hirata M, 2001, BIOCHEM BIOPH RES CO, V283, P915, DOI 10.1006/bbrc.2001.4879; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Miyoshi E, 1997, J BIOL CHEM, V272, P14349, DOI 10.1074/jbc.272.22.14349; Mort JS, 1999, J CLIN PATHOL-MOL PA, V52, P11, DOI 10.1136/mp.52.1.11; Naef M, 1996, INT J CANCER, V66, P315; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nakagawa T, 1996, J BIOL CHEM, V271, P30858, DOI 10.1074/jbc.271.48.30858; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Raab G, 1996, DEVELOPMENT, V122, P637; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Sato S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051964; Shimura T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-205; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Suo ZH, 2002, INT J SURG PATHOL, V10, P91, DOI 10.1177/106689690201000202; Takemura T, 1997, J BIOL CHEM, V272, P31036, DOI 10.1074/jbc.272.49.31036; Takemura T, 1999, KIDNEY INT, V55, P71, DOI 10.1046/j.1523-1755.1999.00259.x; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Thogersen VB, 2001, CANCER RES, V61, P6227; Tsuji I, 2012, MABS-AUSTIN, V4, P732, DOI 10.4161/mabs.21929; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035	39	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54509	10.1371/journal.pone.0054509	http://dx.doi.org/10.1371/journal.pone.0054509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349913	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000041
J	Ribeiro, JF; dos Anjos, EHM; Mello, MLS; Vidal, BD				Ribeiro, Juliana Fulan; Martins dos Anjos, Eli Heber; Mello, Maria Luiza S.; Vidal, Benedicto de Campos			Skin Collagen Fiber Molecular Order: A Pattern of Distributional Fiber Orientation as Assessed by Optical Anisotropy and Image Analysis	PLOS ONE			English	Article							FORM BIREFRINGENCE; MACROMOLECULAR ORIENTATION; CHORDAE TENDINEAE; TISSUE; PROTEOGLYCANS; SCATTERING; REPAIR; AGE	Background: Birefringence can reveal much of the morphology, molecular order, heterogeneity of fiber orientation, and nonlinear optical properties of biopolymers such as collagen. However, the detailed characterization of skin collagen fibers using optical anisotropy methods remains elusive. A clear understanding of collagen fiber organization in skin tissues may be important in the interpretation of their structural-functional relationships under normal and pathological conditions. In this study, fiber orientation in collagen bundles (CBs) and their supramolecular organization were examined in rat skin using polarization microscopy and image analysis. Methodology/Principal Findings: Image variations with rotation of the microscope stage and selection of the in-depth focus plane were investigated in unstained sections of varying thicknesses from rat skin fragments. Total birefringence (image analysis) and form and intrinsic birefringence (Senarmont's method) were estimated. Based on the birefringent images, CBs were found to contain intercrossing points with a twisted helical distribution of collagen fibers (chiral elements) and frequently presented circular structures. Collagen fibers were observed to extend from the surface level to deeper planes, creating a 3D-network of oriented intertwined CBs. At least three levels of birefringent brilliance intensity were revealed by image analysis, indicating a heterogeneous spatial organization of the CBs. Slight differences in optical retardations were found for CBs immersed in some of the fluids used in a comparison of 170- and 240-day old rats. Conclusion/Significance: Polarization microscopy studies provide detailed high-quality structural information on rat skin CBs. A 3D-network structure based on image analysis and birefringence compensation for collagen fibers is suggested for CBs. Form and intrinsic birefringence evaluation can reveal differences in the rat skin associated with age at the levels of collagen fiber crystallinity and macromolecular organization. These findings may inspire future studies of the feedback mechanisms by which spatial, bioelectrical and biomechanical information is transmitted from CBs to skin cells.	[Ribeiro, Juliana Fulan; Martins dos Anjos, Eli Heber; Mello, Maria Luiza S.; Vidal, Benedicto de Campos] Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Vidal, BD (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil.	camposvi@unicamp.br	Mello, Maria Luiza Silveira/D-9158-2012; de Campos Vidal, Benedicto/ABH-6617-2020; Anjos, Eli Heber/ABH-6793-2020; Vidal, Benedicto/I-3227-2012	Mello, Maria Luiza Silveira/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653; Anjos, Eli Heber/0000-0002-9181-715X; Vidal, Benedicto/0000-0003-1629-5619	Sao Paulo State Research Foundation (FAPESP) [2003/04597-0]; Brazilian National Council for Research and Development (CNPq) [501011/2010-2]; CNPq [371286/2011-5]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant no. 2003/04597-0 from the Sao Paulo State Research Foundation (FAPESP) and grant no. 501011/2010-2 from the Brazilian National Council for Research and Development (CNPq). JFR received a Technical Fellowship from CNPq (371286/2011-5). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aharon O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3609003; Aldrovani M, 2007, VISION RES, V47, P3229, DOI 10.1016/j.visres.2007.02.011; Aldrovani M, 2007, PROGR BIOPOLYMER RES, P225; Alenin AS, 2011, PROC SPIE, V8160, DOI 10.1117/12.895552; Basil-Jones MM, 2011, J AGR FOOD CHEM, V59, P9972, DOI 10.1021/jf202579b; Beche B, 2003, OPT COMMUN, V219, P15, DOI 10.1016/S0030-4018(03)01291-4; BENNETT HS, 1967, MCCLUNGS HDB MICROSC, P591; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; CASSIM JY, 1968, BIOCHIM BIOPHYS ACTA, V168, P463, DOI 10.1016/0005-2795(68)90180-3; da Cunha A, 2001, ULTRASOUND MED BIOL, V27, P1691, DOI 10.1016/S0301-5629(01)00477-X; GIBSON T, 1965, BRIT J SURG, V52, P764, DOI 10.1002/bjs.1800521017; HASKELL RC, 1989, BIOPHYS J, V56, P401, DOI 10.1016/S0006-3495(89)82686-4; Jor JWY, 2011, BIOMECH MODEL MECHAN, V10, P767, DOI 10.1007/s10237-010-0272-0; Liu B, 2006, APPL OPTICS, V45, P4464, DOI 10.1364/AO.45.004464; MELLO MLS, 1973, ANN HISTOCHIM, V18, P103; MELLO MLS, 1979, GERONTOLOGY, V25, P2, DOI 10.1159/000212314; MELLO MLS, 1975, ANN HISTOCHIM, V20, P145; Okamoto N, 2010, J BONE JOINT SURG AM, V92A, P2776, DOI 10.2106/JBJS.I.01325; Park J, 2009, OPT EXPRESS, V17, P13402, DOI 10.1364/OE.17.013402; ROTH S, 1981, BIOPOLYMERS, V20, P1271, DOI 10.1002/bip.1981.360200613; ROTH S, 1982, J APPL CRYSTALLOGR, V15, P72, DOI 10.1107/S0021889882011376; Sakai S, 2008, J INVEST DERMATOL, V128, P1641, DOI 10.1038/jid.2008.8; Sakai S, 2011, PROC SPIE, V7883, DOI 10.1117/12.873501; Verhaegen PDHM, 2010, SKIN RES TECHNOL, V16, P325, DOI 10.1111/j.1600-0846.2010.00436.x; Vidal BC, 2010, BIOTECH HISTOCHEM, V85, P365, DOI 10.3109/10520290903430496; Vidal BD, 2003, MICRON, V34, P423, DOI 10.1016/S0968-4328(03)00039-8; VIDAL BD, 1980, CELL MOL BIOL, V26, P415; VIDAL BD, 1988, ACTA HISTOCHEM, V83, P189; VIDAL BD, 1986, CELL MOL BIOL, V32, P527; VIDAL BD, 1965, PROTOPLASMA, V59, P472, DOI 10.1007/BF01252450; VIDAL BDC, 1977, CELL MOL BIOL, V22, P45; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Vidal BD, 2009, J STRUCT BIOL, V167, P166, DOI 10.1016/j.jsb.2009.05.004; VILARTA R, 1989, MATRIX, V9, P55, DOI 10.1016/S0934-8832(89)80019-8; WHITTAKER P, 1987, BRIT HEART J, V57, P264; Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523	36	39	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54724	10.1371/journal.pone.0054724	http://dx.doi.org/10.1371/journal.pone.0054724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349957	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800072
J	Reichmann, F; Painsipp, E; Holzer, P				Reichmann, Florian; Painsipp, Evelin; Holzer, Peter			Environmental Enrichment and Gut Inflammation Modify Stress-Induced c-Fos Expression in the Mouse Corticolimbic System	PLOS ONE			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; WATER-AVOIDANCE STRESS; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; MUCOSAL PERMEABILITY; NEUROTROPHIN LEVELS; RESTRAINT STRESS; INDUCED COLITIS; BRAIN	Environmental enrichment (EE) has a beneficial effect on rodent behaviour, neuronal plasticity and brain function. Although it may also improve stress coping, it is not known whether EE influences the brain response to an external (psychological) stressor such as water avoidance stress (WAS) or an internal (systemic) stressor such as gastrointestinal inflammation. This study hence explored whether EE modifies WAS-induced activation of the mouse corticolimbic system and whether this stress response is altered by gastritis or colitis. Male C67BL/6N mice were housed under standard or enriched environment for 9 weeks, after which they were subjected to a 1-week treatment with oral iodoacetamide to induce gastritis or oral dextran sulfate sodium to induce colitis. Following exposure to WAS the expression of c-Fos, a marker of neuronal activation, was measured by immunocytochemistry. EE aggravated experimentally induced colitis, but not gastritis, as shown by an increase in the disease activity score and the colonic myeloperoxidase content. In the brain, EE enhanced the WAS-induced activation of the dentate gyrus and unmasked an inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression within this part of the hippocampus. Conversely, EE inhibited the WAS-evoked activation of the central amygdala and prevented the inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression in this region. EE, in addition, blunted the WAS-induced activation of the infralimbic cortex and attenuated the inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression in this area. These data reveal that EE has a region-specific effect on stress-induced c-Fos expression in the corticolimbic system, which is likely to improve stress resilience. The response of the prefrontal cortex - amygdala - hippocampus circuitry to psychological stress is also modified by the systemic stress of gut inflammation, and this interaction between external and internal stressors is modulated by the housing environment.	[Reichmann, Florian; Painsipp, Evelin; Holzer, Peter] Med Univ Graz, Res Unit Translat Neurogastroenterol, Inst Expt & Clin Pharmacol, Graz, Austria	Medical University of Graz	Reichmann, F (corresponding author), Med Univ Graz, Res Unit Translat Neurogastroenterol, Inst Expt & Clin Pharmacol, Graz, Austria.	florian.reichmann@medunigraz.at	Holzer, Peter/F-7578-2011; Reichmann, Florian/Q-1279-2019	Holzer, Peter/0000-0002-5754-395X; Reichmann, Florian/0000-0002-5833-3698	Federal Ministry of Science and Research of the Republic of Austria [GZ 80.104/2-BrGT/2007]; Zukunftsfonds Steiermark [262]	Federal Ministry of Science and Research of the Republic of Austria; Zukunftsfonds Steiermark	This study was supported by the Federal Ministry of Science and Research of the Republic of Austria (URL: http://www.bmwf.gv.at/home/, grant GZ 80.104/2-BrGT/2007) and the Zukunftsfonds Steiermark (URL:http://www.zukunftsfonds.steiermark.at/, grant 262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Cakir B, 2004, PEPTIDES, V25, P95, DOI 10.1016/j.peptides.2003.11.005; Cetinel S, 2010, REGUL PEPTIDES, V160, P146, DOI 10.1016/j.regpep.2009.11.011; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; DAVIS S, 1992, J NEUROSCI, V12, P21; de Sousa AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015597; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gabriel AF, 2010, BEHAV BRAIN RES, V208, P90, DOI 10.1016/j.bbr.2009.11.015; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Harbuz MS, 1999, BRAIN BEHAV IMMUN, V13, P335, DOI 10.1006/brbi.1998.0536; Hays W., 2007, STATISTICS; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Ibeakanma C, 2011, GASTROENTEROLOGY, V141, P2098, DOI 10.1053/j.gastro.2011.08.006; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Iwaya H, 2012, EXP BIOL MED, V237, P451, DOI 10.1258/ebm.2011.011269; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kirk RE, 1995, EXPT DESIGN; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kresse AE, 2001, AM J PHYSIOL-GASTR L, V281, pG1203, DOI 10.1152/ajpgi.2001.281.5.G1203; Lamb K, 2003, GASTROENTEROLOGY, V125, P1410, DOI 10.1016/j.gastro.2003.07.010; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Larsson M H, 2009, Stress, V12, P434, DOI 10.1080/10253890802626603; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; LUCKMAN SM, 1994, J NEUROSCI, V14, P4825; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mitrovic M, 2010, BRIT J PHARMACOL, V160, P1430, DOI 10.1111/j.1476-5381.2010.00794.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Painsipp E, 2007, NEUROSCIENCE, V150, P522, DOI 10.1016/j.neuroscience.2007.09.024; Painsipp E, 2011, BRIT J PHARMACOL, V163, P1302, DOI 10.1111/j.1476-5381.2011.01326.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Segovia G, 2008, NEUROCHEM INT, V52, P1198, DOI 10.1016/j.neuint.2007.12.007; Segovia G, 2008, BEHAV BRAIN RES, V187, P304, DOI 10.1016/j.bbr.2007.09.024; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Snoek SA, 2010, EXPERT REV GASTROENT, V4, P637, DOI [10.1586/egh.10.51, 10.1586/EGH.10.51]; Spannuth BM, 2011, NEUROSCIENCE, V179, P104, DOI 10.1016/j.neuroscience.2011.01.042; Sundquist SJ, 2005, J NEUROSCI METH, V141, P9, DOI 10.1016/j.jneumeth.2004.05.007; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tall JM, 2009, BEHAV BRAIN RES, V197, P230, DOI 10.1016/j.bbr.2008.08.010; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Velin AK, 2004, GUT, V53, P494, DOI 10.1136/gut.2003.028506; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; Winer B.J., 1991, STAT PRINCIPLES EXPT; Wultsch T, 2008, PAIN, V134, P245, DOI 10.1016/j.pain.2007.04.025; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	101	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54811	10.1371/journal.pone.0054811	http://dx.doi.org/10.1371/journal.pone.0054811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349972	gold, Green Published, Green Submitted			2022-12-25	WOS:000313738900084
J	Wall, EH; Hewitt, SC; Liu, LW; del Rio, R; Case, LK; Lin, CY; Korach, KS; Teuscher, C				Wall, Emma H.; Hewitt, Sylvia C.; Liu, Liwen; del Rio, Roxana; Case, Laure K.; Lin, Chin-Yo; Korach, Kenneth S.; Teuscher, Cory			Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus	FASEB JOURNAL			English	Article						microarray; uterotropic response; phenotypic variation; inheritance; microarray	QUANTITATIVE TRAIT LOCI; RECEPTOR-ALPHA; BONE LOSS; MICE; MECHANISMS; EXPRESSION; MODEL; OSTEOPOROSIS; OVARIECTOMY; DISCOVERY	The uterotropic response of the uterus to 17 beta-estradiol (E-2) is genetically controlled, with marked variation observed depending on the mouse strain studied. Previous genetic studies from our laboratory using inbred mice that are high [C57BL/6J (B6)] or low [C3H/HeJ (C3H)] responders to E-2 led to the identification of quantitative trait (QT) loci associated with phenotypic variation in uterine growth and leukocyte infiltration. The mechanisms underlying differential responsiveness to E-2, and the genes involved, are unknown. Therefore, we used a microarray approach to show association of distinct E-2-regulated transcriptional signatures with genetically controlled high and low responses to E-2 and their segregation in (C57BL/6J x C3H/HeJ) F-1 hybrids. Among the 6664 E-2-regulated transcripts, analysis of cellular functions of those that were strain specific indicated C3H-selective enrichment of apoptosis, consistent with a 7-fold increase in the apoptosis indicator CASP3, and a 2.4-fold decrease in the apoptosis inhibitor Naip1 (Birc1a) in C3H vs. B6 following treatment with E-2. In addition, several differentially expressed transcripts reside within our previously identified QT loci, including the ER alpha-tethering factor Runx1, demonstrated to enhance E-2-mediated transcript regulation. The level of RUNX1 in uterine epithelial cells was shown to be 3.5-fold greater in B6 compared to C3H. Our novel insights into the mechanisms underlying the genetic control of tissue sensitivity to estrogen have great potential to advance understanding of individualized effects in physiological and disease states.-Wall, E. H., Hewitt, S. C., Liu, L., del Rio, R., Case, L. K., Lin, C.-Y., Korach, K. S., Teuscher, C. Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus. FASEB J. 27, 1874-1886 (2013). www.fasebj.org	[Wall, Emma H.; del Rio, Roxana; Case, Laure K.; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.] NIEHS, Receptor Biol Grp, NIH, Res Triangle Pk, NC 27709 USA; [Liu, Liwen] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Lin, Chin-Yo; Teuscher, Cory] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Houston System; University of Houston	Teuscher, C (corresponding author), Univ Vermont, Immunobiol Program, C331 Given Med Bldg, Burlington, VT 05405 USA.	c.teuscher@uvm.edu	Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Korach, Kenneth/0000-0002-7765-418X; del Rio-Guerra, Roxana/0000-0001-6871-3259; Lin, Chin-Yo/0000-0002-4461-6216	National Center for Research Resources [1S10RR019246]; U.S. National Institutes of Health (NIH) Intramural Research Project [Z01ES70065]; NIH [R01NS36526, R01NS061014, R01NS060901, R01NS069628, R01AI41747]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019246, P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES070065, Z01ES070065, ZICES102546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060901, R01NS061014, R01NS069628, R01NS036526] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. National Institutes of Health (NIH) Intramural Research Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Stephen Grubb (Jackson Laboratory, Bar Harbor, ME, USA) for assistance with the SNP analysis, the U.S. National Institute of Environmental Health Sciences (NIEHS) Microarray Core for microarray analysis of uterine RNA samples, the NIEHS Histology Laboratory for embedding uterine samples, and the NIEHS Comparative Medicine Branch for surgeries. The staff at the Microscopy Imaging Center at the University of Vermont, funded, in part, by the National Center for Research Resources (1S10RR019246), performed staining and imaging of Runx1 and CC3. S.C.H. and K.S.K. were supported by U.S. National Institutes of Health (NIH) Intramural Research Project Z01ES70065. C.T. was supported by NIH Research Projects R01NS36526, R01NS061014, R01NS060901, R01NS069628, and R01AI41747. The authors declare no conflicts of interest.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Andrew Toby, 2004, Curr Osteoporos Rep, V2, P79, DOI 10.1007/s11914-004-0015-1; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLAIR SM, 1957, ENDOCRINOLOGY, V61, P643, DOI 10.1210/endo-61-6-643; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; CLARINGBOLD PJ, 1955, J ENDOCRINOL, V12, P9, DOI 10.1677/joe.0.0120009; CLARK JH, 1994, PHYSL REPROD, V1, P1011; Doll A, 2009, INT J CANCER, V125, P257, DOI 10.1002/ijc.24330; Drasher ML, 1952, J HERED, V46, P190; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Figtree Gemma A, 2009, Recent Pat DNA Gene Seq, V3, P164; Griffith JS, 1997, AM J PATHOL, V150, P2223; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Hewitt SC, 2011, ENVIRON HEALTH PERSP, V119, P63, DOI 10.1289/ehp.1002347; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Li CY, 2005, J BONE MINER RES, V20, P2150, DOI 10.1359/JBMR.050819; Loutradis D, 2012, CURR PHARM BIOTECHNO, V13, P417, DOI 10.2174/138920112799361954; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Mather K, 1943, BIOL REV CAMB PHILOS, V18, P32, DOI 10.1111/j.1469-185X.1943.tb00287.x; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; NAGAI JIRO, 1957, ENDOCRINOL JAPON, V4, P12; Nakai M, 1999, J ANDROL, V20, P626; Nilsen-Hamilton M, 2003, ANN NY ACAD SCI, V995, P94, DOI 10.1111/j.1749-6632.2003.tb03213.x; Padilla-Banks E, 2001, ENVIRON HEALTH PERSP, V109, P821, DOI 10.2307/3454825; Perez MC, 1996, BIOL REPROD, V54, P249, DOI 10.1095/biolreprod54.1.249; Planaguma J, 2005, J PATHOL, V207, P422, DOI 10.1002/path.1853; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Reel JR, 1996, FUND APPL TOXICOL, V34, P288, DOI 10.1006/faat.1996.0198; Richard C, 2003, ENDOCRINOLOGY, V144, P1533, DOI 10.1210/en.2002-0033; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Roper RJ, 1999, ENDOCRINOLOGY, V140, P556, DOI 10.1210/en.140.2.556; SILBERBERG M, 1951, P SOC EXP BIOL MED, V76, P161, DOI 10.3181/00379727-76-18423; Simpson E R, 2006, Ernst Schering Found Symp Proc, P45; Spearow JL, 1999, SCIENCE, V285, P1259, DOI 10.1126/science.285.5431.1259; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; TRENTIN JJ, 1950, CANCER RES, V10, P580; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yin Y, 2008, MOL ENDOCRINOL, V22, P113, DOI 10.1210/me.2007-0295	47	14	14	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2013	27	5					1874	1886		10.1096/fj.12-213462	http://dx.doi.org/10.1096/fj.12-213462			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23371066	Green Published			2022-12-25	WOS:000318226100008
J	Nihei, Y; Ito, D; Okada, Y; Akamatsu, W; Yagi, T; Yoshizaki, T; Okano, H; Suzuki, N				Nihei, Yoshihiro; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Yagi, Takuya; Yoshizaki, Takahito; Okano, Hideyuki; Suzuki, Norihiro			Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; MOTOR-NEURONS; GLUTAMINE REPEATS; DISEASE; EXPRESSION; GENE; INSTABILITY; PATHOGENESIS; PHENOTYPES; 17-AAG	Spinal and bulbar muscular atrophy (SBMA) is an X-linked motor neuron disease caused by a CAG repeat expansion in the androgen receptor (AR) gene. Ligand-dependent nuclear accumulation of mutant AR protein is a critical characteristic of the pathogenesis of SBMA. SBMA has been modeled in AR-overexpressing animals, but precisely how the polyglutamine (polyQ) expansion leads to neurodegeneration is unclear. Induced pluripotent stem cells (iPSCs) are a new technology that can be used to model human diseases, study pathogenic mechanisms, and develop novel drugs. We established SBMA patient-derived iPSCs, investigated their cellular biochemical characteristics, and found that SBMA-iPSCs can differentiate into motor neurons. The CAG repeat numbers in the AR gene of SBMA-iPSCs and also in the atrophin-1 gene of iPSCs derived from another polyQ disease, dentato-rubro-pallido-luysian atrophy (DRPLA), remain unchanged during reprogramming, long term passage, and differentiation, indicating that polyQ disease-associated CAG repeats are stable during maintenance of iPSCs. The level of AR expression is up-regulated by neuronal differentiation and treatment with the AR ligand dihydrotestosterone. Filter retardation assays indicated that aggregation of ARs following dihydrotestosterone treatment in neurons derived from SBMA-iPSCs increases significantly compared with neurological control iPSCs, easily recapitulating the pathological feature of mutant ARs in SBMA-iPSCs. This phenomenon was not observed in iPSCs and fibroblasts, thereby showing the neuron-dominant phenotype of this disease. Furthermore, the HSP90 inhibitor 17-allylaminogeldanamycin sharply decreased the level of aggregated AR in neurons derived from SBMA-iPSCs, indicating a potential for discovery and validation of candidate drugs. We found that SBMA-iPSCs possess disease-specific biochemical features and could thus open new avenues of research into not only SBMA, but also other polyglutamine diseases.	[Nihei, Yoshihiro; Ito, Daisuke; Yagi, Takuya; Yoshizaki, Takahito; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei; Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University	Ito, D (corresponding author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	d-ito@jk9.so-net.ne.jp	Suzuki, Norihiro/J-5125-2013; Ito, Daisuke/GXF-1648-2022; Okada, Yohei/L-1662-2013; Akamatsu, Wado/L-1214-2013; Ito, Daisuke/M-3608-2013; Okano, Hideyuki/I-7584-2019	Suzuki, Norihiro/0000-0002-0399-6590; Ito, Daisuke/0000-0002-4740-1675; 	Eisai Co., Ltd.; ALS Foundation; Japan ALS Association; Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25640038] Funding Source: KAKEN	Eisai Co., Ltd.(Eisai Co Ltd); ALS Foundation; Japan ALS Association; Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Eisai Co., Ltd. (to D.I. and N.S.), the ALS Foundation, the Japan ALS Association (to Y.N.), the Nakabayashi Trust for ALS Research (to Y.N.), and a grant from the Project for the Realization of Regenerative Medicine of the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.O.).	Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Burnstein KL, 1995, MOL CELL ENDOCRINOL, V115, P177, DOI 10.1016/0303-7207(95)03688-1; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chang CY, 2006, FERTIL STERIL, V85, P1195, DOI 10.1016/j.fertnstert.2005.11.031; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ito D, 2012, ANN NEUROL, V72, P167, DOI 10.1002/ana.23596; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lu SF, 1999, J NEUROBIOL, V41, P505, DOI 10.1002/(SICI)1097-4695(199912)41:4<505::AID-NEU6>3.0.CO;2-N; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Martorell L, 2007, PRENATAL DIAG, V27, P68, DOI 10.1002/pd.1627; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Neckers L, 2002, CLIN CANCER RES, V8, P962; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Rusmini P, 2011, NEUROBIOL DIS, V41, P83, DOI 10.1016/j.nbd.2010.08.023; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Takiyama Y, 1999, HUM MOL GENET, V8, P453, DOI 10.1093/hmg/8.3.453; Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yagi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041572; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	55	40	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8043	8052		10.1074/jbc.M112.408211	http://dx.doi.org/10.1074/jbc.M112.408211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364790	Green Published, hybrid			2022-12-25	WOS:000316564500005
J	Sanematsu, F; Nishikimi, A; Watanabe, M; Hongu, T; Tanaka, Y; Kanaho, Y; Cote, JF; Fukui, Y				Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Hongu, Tsunaki; Tanaka, Yoshihiko; Kanaho, Yasunori; Cote, Jean-Francois; Fukui, Yoshinori			Phosphatidic Acid-dependent Recruitment and Function of the Rac Activator DOCK1 during Dorsal Ruffle Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE D1; EXCHANGE FACTORS; PLASMA-MEMBRANE; PROTEIN; BINDING; FAMILY; DOMAIN; ROLES; DIFFERENTIATION; REORGANIZATION	Activation of receptor tyrosine kinases leads to the formation of two different types of plasma membrane structures: peripheral ruffles and dorsal ruffles. Although the formation of both ruffle types requires activation of the small GTPase Rac, the difference in kinetics suggests that a distinct regulatory mechanism operates for their ruffle formation. DOCK1 and DOCK5 are atypical Rac activators and are both expressed in mouse embryonic fibroblasts (MEFs). We found that although PDGF-induced Rac activation and peripheral ruffle formation were coordinately regulated by DOCK1 and DOCK5 in MEFs, DOCK1 deficiency alone impaired dorsal ruffle formation in MEFs. Unlike DOCK5, DOCK1 bound to phosphatidic acid (PA) through the C-terminal polybasic amino acid cluster and was localized to dorsal ruffles. When this interaction was blocked, PDGF-induced dorsal ruffle formation was severely impaired. In addition, we show that phospholipase D, an enzyme that catalyzes PA synthesis, is required for PDGF-induced dorsal, but not peripheral, ruffle formation. These results indicate that the phospholipase D-PA axis selectively controls dorsal ruffle formation by regulating DOCK1 localization.	[Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Sanematsu, Fumiyuki; Nishikimi, Akihiko; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Sanematsu, Fumiyuki; Nishikimi, Akihiko; Watanabe, Mayuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); University of Tsukuba; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Fukui, Y (corresponding author), Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Nishikimi, Akihiko/I-4692-2018	Nishikimi, Akihiko/0000-0001-9497-7557; Fukui, Yoshinori/0000-0003-2335-8745	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Canadian Cancer Society [019104]; Japan Society for the Promotion of Science; Fonds de Recherche en Sante du Quebec; Grants-in-Aid for Scientific Research [24590586] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency (to Y.F.), the Project for Development of Innovative Research for Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science and Technology (to Y.F.), Canadian Cancer Society Grant 019104 (to J.-F.C.), and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to Y.F. and F.S.).; Recipient of a Junior Investigator award from the Fonds de Recherche en Sante du Quebec.	Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Haga Y, 2009, EMBO J, V28, P1197, DOI 10.1038/emboj.2009.78; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; OKADA T, 1994, J BIOL CHEM, V269, P3563; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Patel Manishha, 2011, Small GTPases, V2, P268; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sato T, 2013, MOL CELL BIOL, V33, P136, DOI 10.1128/MCB.00869-12; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Tu YZ, 2001, FEBS LETT, V491, P193, DOI 10.1016/S0014-5793(01)02195-0; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	47	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8092	8100		10.1074/jbc.M112.410423	http://dx.doi.org/10.1074/jbc.M112.410423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362269	hybrid, Green Published			2022-12-25	WOS:000316564500010
J	Basso, D; Fogar, P; Falconi, M; Fadi, E; Sperti, C; Frasson, C; Greco, E; Tamburrino, D; Teolato, S; Moz, S; Bozzato, D; Pelloso, M; Padoan, A; De Franchis, G; Gnatta, E; Facco, M; Zambon, CF; Navaglia, F; Pasquali, C; Basso, G; Semenzato, G; Pedrazzoli, S; Pederzoli, P; Plebani, M				Basso, Daniela; Fogar, Paola; Falconi, Massimo; Fadi, Elisa; Sperti, Cosimo; Frasson, Chiara; Greco, Eliana; Tamburrino, Domenico; Teolato, Sara; Moz, Stefania; Bozzato, Dania; Pelloso, Michela; Padoan, Andrea; De Franchis, Giuseppe; Gnatta, Elisa; Facco, Monica; Zambon, Carlo-Federico; Navaglia, Filippo; Pasquali, Claudio; Basso, Giuseppe; Semenzato, Gianpietro; Pedrazzoli, Sergio; Pederzoli, Paolo; Plebani, Mario			Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study	PLOS ONE			English	Article							REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE EVASION; CLINICAL-SIGNIFICANCE; CANCER; CARCINOMA; DIFFERENTIATION; EXPRESSION; ACCUMULATION	Background: Blood and spleen expansion of immature myeloid cells (IMCs) might compromise the immune response to cancer. We studied in vivo circulating and splenic T lymphocyte and IMC subsets in patients with benign and malignant pancreatic diseases. We ascertained in vitro whether pancreatic adenocarcinoma (PDAC)-associated IMC subsets are induced by tumor-derived soluble factors and whether they are immunosuppressive focusing on the inhibitory co-stimulatory molecules PDL1 and CTLA4. Methodology and Principal Findings: 103 pancreatic and/or splenic surgical patients were enrolled including 52 PDAC, 10 borderline and 10 neuroendocrine tumors (NETs). Lymphocytes and IMCs were analysed by flow cytometry in blood, in spleen and in three PDAC cell conditioned (CM) or non conditioned PBMC. PDL1 and CTLA4 were studied in 30 splenic samples, in control and conditioned PBMC. IMCs were FACS sorted and co-coltured with allogenic T lymphocytes. In PDAC a reduction was found in circulating CD8(+) lymphocytes (p = 0.004) and dendritic cells (p = 0.01), which were reduced in vitro by one PDAC CM (Capan1; p = 0.03). Blood myeloid derived suppressive cells (MDSCs) CD33(+) CD14(-) HLA-DR- were increased in PDAC (p = 0.022) and were induced in vitro by BxPC3 CM. Splenic dendritic cells had a higher PDL1 expression (p = 0.007), while CD33(+) CD14(+) HLA-DR- IMCs had a lower CTLA4 expression (p = 0.029) in PDAC patients. In vitro S100A8/A9 complex, one of the possible inflammatory mediators of immune suppression in PDAC, induced PDL1 (p = 0.018) and reduced CTLA4 expression (p = 0.028) among IMCs. IMCs not expressing CTLA4 were demonstrated to be immune suppressive. Conclusion: In PDAC circulating dendritic and cytotoxic T cells are reduced, while MDSCs are increased and this might favour tumoral growth and progression. The reduced CTLA4 expression found among splenic IMCs of PDAC patients was demonstrated to characterize an immune suppressive phenotype and to be consequent to the direct exposure of myeloid cells to pancreatic cancer derived products, S100A8/A9 complex in particular.	[Basso, Daniela; Fogar, Paola; Fadi, Elisa; Greco, Eliana; Teolato, Sara; Moz, Stefania; Bozzato, Dania; Pelloso, Michela; Padoan, Andrea; De Franchis, Giuseppe; Gnatta, Elisa; Facco, Monica; Zambon, Carlo-Federico; Navaglia, Filippo; Semenzato, Gianpietro; Plebani, Mario] Univ Padua, Dept Med, Padua, Italy; [Falconi, Massimo; Tamburrino, Domenico; Pederzoli, Paolo] Univ Verona, Dept Surg, I-37100 Verona, Italy; [Sperti, Cosimo; Pasquali, Claudio; Pedrazzoli, Sergio] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Womens & Childrens Hlth, Lab Pediat Hematooncol, Padua, Italy	University of Padua; University of Verona; University of Padua; University of Padua	Basso, D (corresponding author), Univ Padua, Dept Med, Padua, Italy.	daniela.basso@sanita.padova.it	Basso, Daniela/J-7855-2016; Facco, Monica/F-7732-2017; Teolato, Sara/J-8642-2016; pelloso, michela/K-5615-2018; Tamburrino, Domenico/AAA-6894-2019; Plebani, Mario/AAF-4953-2020; SEMENZATO, GIANPIETRO C/J-7727-2016; Zambon, Carlo Federico/J-8187-2016; Bozzato, Dania/AAA-5142-2019; Falconi, Massimo/K-2194-2016; Padoan, Andrea/J-7869-2016	Basso, Daniela/0000-0001-8745-6171; Facco, Monica/0000-0003-0100-5789; Teolato, Sara/0000-0002-0327-9858; Tamburrino, Domenico/0000-0003-1435-3651; SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; Zambon, Carlo Federico/0000-0002-4244-879X; Falconi, Massimo/0000-0001-9654-7243; Padoan, Andrea/0000-0003-1284-7885; Pelloso, Michela/0000-0002-2853-4499; BASSO, GIUSEPPE/0000-0002-2634-9302; moz, stefania/0000-0002-7485-520X	"Associazione Wirsung-Onlus," Padova, Italy	"Associazione Wirsung-Onlus," Padova, Italy	Supported in part by "Associazione Wirsung-Onlus," Via Giustiniani 2, 35128 Padova, Italy. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Almog N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044001; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Basso D, 2011, J CELL PHYSIOL, V226, P456, DOI 10.1002/jcp.22355; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clark CE, 2009, CANCER LETT, V279, P1, DOI 10.1016/j.canlet.2008.09.037; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Durgan K, 2011, CANCER IMMUNOL IMMUN, V60, P547, DOI 10.1007/s00262-010-0963-5; Fogar P, 2011, PANCREAS, V40, P1131, DOI 10.1097/MPA.0b013e31822077b8; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Ishizaki H, 2011, CANCER IMMUNOL IMMUN, V60, P99, DOI 10.1007/s00262-010-0923-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Kim MS, 2012, J PROTEOME RES, V11, P5556, DOI 10.1021/pr300483r; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Loos M, 2008, CANCER LETT, V268, P98, DOI 10.1016/j.canlet.2008.03.056; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Ryschich E, 2005, CLIN CANCER RES, V11, P498; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Sheikh AA, 2007, PROTEOMICS, V7, P1929, DOI 10.1002/pmic.200700072; Shevach EM, 2008, SCIENCE, V322, P202, DOI 10.1126/science.1164872; Takahashi K, 2006, CANCER IMMUNOL IMMUN, V55, P775, DOI 10.1007/s00262-005-0079-5; Tjomsland V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013441; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Wang XB, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-21; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	63	35	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54824	10.1371/journal.pone.0054824	http://dx.doi.org/10.1371/journal.pone.0054824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359812	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600116
J	Delacote, F; Perez, C; Guyot, V; Duhamel, M; Rochon, C; Ollivier, N; Macmaster, R; Silva, GH; Paques, F; Daboussi, F; Duchateau, P				Delacote, Fabien; Perez, Christophe; Guyot, Valerie; Duhamel, Marianne; Rochon, Christelle; Ollivier, Nathalie; Macmaster, Rachel; Silva, George H.; Paques, Frederic; Daboussi, Fayza; Duchateau, Philippe			High Frequency Targeted Mutagenesis Using Engineered Endonucleases and DNA-End Processing Enzymes	PLOS ONE			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; HOMING ENDONUCLEASE; GENE DISRUPTION; KNOCKOUT RATS; BINDING; GENERATION; CLEAVAGE; SEQUENCES; REPAIR	Targeting DNA double-strand breaks is a powerful strategy for gene inactivation applications. Without the use of a repair plasmid, targeted mutagenesis can be achieved through Non-Homologous End joining (NHEJ) pathways. However, many of the DNA breaks produced by engineered nucleases may be subject to precise re-ligation without loss of genetic information and thus are likely to be unproductive. In this study, we combined engineered endonucleases and DNA-end processing enzymes to increase the efficiency of targeted mutagenesis, providing a robust and efficient method to (i) greatly improve targeted mutagenesis frequency up to 30-fold, and; (ii) control the nature of mutagenic events using meganucleases in conjunction with DNA-end processing enzymes in human primary cells.	[Delacote, Fabien; Perez, Christophe; Guyot, Valerie; Macmaster, Rachel; Silva, George H.; Paques, Frederic; Daboussi, Fayza; Duchateau, Philippe] Cellectis SA, Paris, France; [Duhamel, Marianne; Rochon, Christelle; Ollivier, Nathalie] Genopole, Cellectis Stem Cells, Evry, France	Genopole; UDICE-French Research Universities; Universite Paris Saclay	Duchateau, P (corresponding author), Cellectis SA, Paris, France.	duchateau@cellectis.com		Daboussi, Fayza/0000-0001-7689-7975				Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Baxter S, 2012, NUCL ACIDS RES; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Daboussi F, 2012, NUCL ACIDS RES; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Grabarz A, 2012, AM J CANCER RES, V2, P249; Grizot S, 2011, NUCL ACIDS RES; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Grosse S, 2011, MOL THER, V19, P694, DOI 10.1038/mt.2010.302; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Komori K, 1999, NUCLEIC ACIDS RES, V27, P4175, DOI 10.1093/nar/27.21.4175; Liu Y, 2010, METHODS MOL BIOL, V584, P229, DOI 10.1007/978-1-60761-369-5_13; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sandor Z, 2004, NUCLEIC ACIDS RES, V32, P1866, DOI 10.1093/nar/gkh502; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Volna P, 2007, NUCLEIC ACIDS RES, V35, P2748, DOI 10.1093/nar/gkm182; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53217	10.1371/journal.pone.0053217	http://dx.doi.org/10.1371/journal.pone.0053217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359797	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600012
J	Voorberg-van der Wel, A; Zeeman, AM; van Amsterdam, SM; van den Berg, A; Klooster, EJ; Iwanaga, S; Janse, CJ; van Gemert, GJ; Sauerwein, R; Beenhakker, N; Koopman, G; Thomas, AW; Kocken, CHM				Voorberg-van der Wel, Annemarie; Zeeman, Anne-Marie; van Amsterdam, Sandra M.; van den Berg, Alexander; Klooster, Els J.; Iwanaga, Shiroh; Janse, Chris J.; van Gemert, Geert-Jan; Sauerwein, Robert; Beenhakker, Niels; Koopman, Gerrit; Thomas, Alan W.; Kocken, Clemens H. M.			Transgenic Fluorescent Plasmodium cynomolgi Liver Stages Enable Live Imaging and Purification of Malaria Hypnozoite-Forms	PLOS ONE			English	Article							MAMMALIAN HOST; LIFE-CYCLE; PARASITES; VIVAX; FALCIPARUM; BERGHEI; TRANSFECTION; PROTEIN; SEGREGATION; EXPRESSION	A major challenge for strategies to combat the human malaria parasite Plasmodium vivax is the presence of hypnozoites in the liver. These dormant forms can cause renewed clinical disease after reactivation through unknown mechanisms. The closely related non-human primate malaria P. cynomolgi is a frequently used model for studying hypnozoite-induced relapses. Here we report the generation of the first transgenic P. cynomolgi parasites that stably express fluorescent markers in liver stages by transfection with novel DNA-constructs containing a P. cynomolgi centromere. Analysis of fluorescent liver stages in culture identified, in addition to developing liver-schizonts, uninucleate persisting parasites that were atovaquone resistant but primaquine sensitive, features associated with hypnozoites. We demonstrate that these hypnozoite-forms could be isolated by fluorescence-activated cell sorting. The fluorescently-tagged parasites in combination with FACS-purification open new avenues for a wide range of studies for analysing hypnozoite biology and reactivation.	[Voorberg-van der Wel, Annemarie; Zeeman, Anne-Marie; van Amsterdam, Sandra M.; van den Berg, Alexander; Klooster, Els J.; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Iwanaga, Shiroh] Mie Univ, Sch Med, Tsu, Mie 514, Japan; [Janse, Chris J.] Leiden Univ Med, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands; [van Gemert, Geert-Jan; Sauerwein, Robert] Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Beenhakker, Niels; Koopman, Gerrit] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	Mie University; Radboud University Nijmegen	Kocken, CHM (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	kocken@bprc.nl	Sauerwein, Robert/C-8519-2013	Iwanaga, Shiroh/0000-0002-4394-7267; Janse, Chris J/0000-0002-6410-6205; Zeeman, Anne-Marie/0000-0002-0157-4669; Voorberg - van der Wel, Annemarie/0000-0001-9403-0515; Kocken, Clemens/0000-0002-4784-1734	Medicines for Malaria Venture; Wellcome Trust [WT078285]; EU [223044]; EVIMALAR [242095]	Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); EVIMALAR	This work was supported by a grant from the Medicines for Malaria Venture, a translational research grant (WT078285) from the Wellcome Trust, and FP7 EU grants MALSIG (contract number 223044) and EVIMALAR (contract number 242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bassat Q, 2011, NAT MED, V17, P48, DOI 10.1038/nm0111-48; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; CLYDE DF, 1981, B WORLD HEALTH ORGAN, V59, P391; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Gueirard P, 2010, P NATL ACAD SCI USA, V107, P18640, DOI 10.1073/pnas.1009346107; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Iwanaga S, 2012, GENOME RES; Iwanaga S, 2010, CELL HOST MICROBE, V7, P245, DOI 10.1016/j.chom.2010.02.010; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kocken CHM, 1999, EXP PARASITOL, V93, P58, DOI 10.1006/expr.1999.4430; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Kocken CHM, 2009, TRENDS PARASITOL, V25, P370, DOI 10.1016/j.pt.2009.05.009; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; MAL ERA, 2011, PLOS MED, V8; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; O'Donnell RA, 2001, NUCLEIC ACIDS RES, V29, P716, DOI 10.1093/nar/29.3.716; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Prudencio M, 2011, TRENDS PARASITOL, V27, P565, DOI 10.1016/j.pt.2011.09.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; vanDijk MR, 1997, MOL BIOCHEM PARASIT, V86, P155, DOI 10.1016/S0166-6851(97)02843-0; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	46	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54888	10.1371/journal.pone.0054888	http://dx.doi.org/10.1371/journal.pone.0054888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359816	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600129
J	Wells, JW; Evans, CH; Scott, MC; Rutgen, BC; O'Brien, TD; Modiano, JF; Cvetkovic, G; Tepic, S				Wells, James W.; Evans, Christopher H.; Scott, Milcah C.; Ruetgen, Barbara C.; O'Brien, Timothy D.; Modiano, Jaime F.; Cvetkovic, Goran; Tepic, Slobodan			Arginase Treatment Prevents the Recovery of Canine Lymphoma and Osteosarcoma Cells Resistant to the Toxic Effects of Prolonged Arginine Deprivation	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RECOMBINANT HUMAN ARGINASE; L-ASPARAGINASE THERAPY; AMINO-ACID; B-CELL; MALIGNANT-LYMPHOMA; GROWTH-INHIBITION; IN-VITRO; LINE; ESTABLISHMENT	Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast, become quiescent and remain viable under arginine restriction, displaying full recovery upon return to arginine-rich conditions. The use of arginase therapy to restrict available arginine for selectively targeting malignant cells is currently under investigation in human clinical trials. However, the suitability of this approach for veterinary uses is unexplored. As a prelude to in vivo studies in canine malignancies, we examined the in vitro effects of arginine-deprivation on canine lymphoid and osteosarcoma cell lines. Two lymphoid and 2 osteosarcoma cell lines were unable to recover following 6 days of arginine deprivation, but all remaining cell lines displayed full recovery upon return to arginine-rich culture conditions. These remaining cell lines all proved susceptible to cell death following the addition of arginase to the cultures. The lymphoid lines were particularly sensitive to arginase, becoming unrecoverable after just 3 days of treatment. Two of the osteosarcoma lines were also susceptible over this time-frame; however the other 3 lines required 6-8 days of arginase treatment to prevent recovery. In contrast, adult progenitor cells from the bone marrow of a healthy dog were able to recover fully following 9 days of culture in arginase. Over 3 days in culture, arginase was more effective than asparaginase in inducing the death of lymphoid lines. These results strongly suggest that short-term arginase treatment warrants further investigation as a therapy for lymphoid malignancies and osteosarcomas in dogs.	[Wells, James W.; Evans, Christopher H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Sch Med, Boston, MA 02215 USA; [Scott, Milcah C.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Ruetgen, Barbara C.] Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria; [O'Brien, Timothy D.] Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA; [O'Brien, Timothy D.] Univ Minnesota, Stem Cell Inst, St Paul, MN 55108 USA; [Cvetkovic, Goran; Tepic, Slobodan] Kyon AG, Zurich, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Veterinary Medicine Vienna; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wells, JW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Sch Med, Boston, MA 02215 USA.	j.wells3@uq.edu.au	MODIANO, JAIME/K-3583-2019; Rütgen, Barbara/ADM-6510-2022; Wells, James W./C-7480-2011	MODIANO, JAIME/0000-0001-6398-7648; Wells, James W./0000-0002-9618-6940; O'Brien, Timothy/0000-0001-9742-0930	Kyon AG	Kyon AG	This study was funded by Kyon AG. The funders were involved in study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Bobak YP, 2010, CELL BIOL INT, V34, P1085, DOI 10.1042/CBI20100451; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Garrett LD, 2002, J VET INTERN MED, V16, P704, DOI 10.1111/j.1939-1676.2002.tb02411.x; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Hsueh EC, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-17; Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120; Jorck C, 2011, PEDIATR HEMAT ONCOL, V28, P3, DOI 10.3109/08880018.2010.484852; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; Lam TL, 2011, PIGM CELL MELANOMA R, V24, P366, DOI 10.1111/j.1755-148X.2010.00798.x; Lamb J, 2000, EXP CELL RES, V255, P238, DOI 10.1006/excr.1999.4779; Modiano JF, 2006, GENE THER MOL BIOL, V10A, P31; Modiano JF, 2006, COLD SPRING HARB MON, V44, P439; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Momoi Y, 1997, VET IMMUNOL IMMUNOP, V59, P11, DOI 10.1016/S0165-2427(97)00053-6; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; MORRIS JG, 1978, J NUTR, V108, P1944, DOI 10.1093/jn/108.12.1944; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; ONIONS DE, 1984, JNCI-J NATL CANCER I, V72, P909; Philip R, 2003, BRIT J CANCER, V88, P613, DOI 10.1038/sj.bjc.6600681; Phillips JC, 2007, GENOMICS, V90, P354, DOI 10.1016/j.ygeno.2007.05.001; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Priester W A, 1980, Natl Cancer Inst Monogr, P1; Raetz EA, 2010, J PEDIAT HEMATOL ONC, V32, P554, DOI 10.1097/MPH.0b013e3181e6f003; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; STEPLEWSKI Z, 1987, CANCER IMMUNOL IMMUN, V24, P197; TESKE E, 1994, VET QUART, V16, P134, DOI 10.1080/01652176.1994.9694435; Wheatley Denys N., 2002, Pathology and Oncology Research, V8, P18; Wheatley DN, 2005, SEMIN CANCER BIOL, V15, P247, DOI 10.1016/j.semcancer.2005.04.002; Wheatley DN, 2003, BRIT J CANCER, V89, P573, DOI 10.1038/sj.bjc.6601134; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; Yau T, 2012, INVESTIGATIONAL NEW	35	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54464	10.1371/journal.pone.0054464	http://dx.doi.org/10.1371/journal.pone.0054464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365669	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600057
J	Zhao, J; Wang, SY; Bao, JQ; Sun, XJ; Zhang, XC; Zhang, XL; Ye, DX; Wei, J; Liu, CS; Jiang, XQ; Shen, G; Zhang, ZY				Zhao, Jun; Wang, Shaoyi; Bao, Jianqiang; Sun, Xiaojuan; Zhang, Xiaochen; Zhang, Xiuli; Ye, Dongxia; Wei, Jie; Liu, Changsheng; Jiang, Xinquan; Shen, Gang; Zhang, Zhiyuan			Trehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENTS; BETA-TRICALCIUM PHOSPHATE; GROWTH-FACTOR RELEASE; BONE MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY SYSTEMS; GELATIN MICROPARTICLES; DEFECT MODEL; RHBMP-2; ANHYDROBIOSIS; BIOMATERIALS	Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25 degrees C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% +/- 5.32%) and area (40.71% +/- 7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% +/- 0.44%, calcein: 6.08% +/- 1.37%) and mineral apposition rate (4.13 +/- 0.62 mu m/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17 +/- 15.02 Mpa) and load of fracture (144.67 +/- 16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.	[Zhao, Jun; Shen, Gang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthodont,Coll Stomatol, Shanghai 200030, Peoples R China; [Wang, Shaoyi; Zhang, Xiaochen; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg,Coll Stomatol, Shanghai 200030, Peoples R China; [Zhang, Xiuli; Ye, Dongxia; Jiang, Xinquan; Shen, Gang; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Bao, Jianqiang] Univ Nevada, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Sun, Xiaojuan] Ningxia Med Univ, Gen Hosp, Dept Oral & Maxillofacial Surg, Ningxia, Peoples R China; [Wei, Jie; Liu, Changsheng] E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Ningxia Medical University; East China University of Science & Technology	Shen, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthodont,Coll Stomatol, Shanghai 200030, Peoples R China.	gangshen@orthosh.com; zhzhy@omschina.org.cn	zhang, zhiyuan/GRS-2141-2022; Ye, Dongxia/AAF-2877-2019; Bao, Jianqiang/G-9184-2016; Ye, Dongxia/S-4804-2018; Bao, Jianqiang/T-7299-2019	Bao, Jianqiang/0000-0003-1248-2687; Ye, Dongxia/0000-0001-8260-4569; 	National Natural Science Foundation of China [81200815, 81271182, 30973363, 81000420]; Science and technology fund, Shanghai Jiao Tong University, School of Medicine [11XJ21024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology fund, Shanghai Jiao Tong University, School of Medicine	This work is supported by the National Natural Science Foundation of China (81200815, 81271182, 30973363, 81000420), Science and technology fund, Shanghai Jiao Tong University, School of Medicine 11XJ21024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229; Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Arakawa T, 2001, ADV DRUG DELIVER REV, V46, P307, DOI 10.1016/S0169-409X(00)00144-7; Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830; Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11; Choi S, 2011, J VET MED SCI, V73, P1547, DOI 10.1292/jvms.11-0016; Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; de Castro AG, 2000, NAT BIOTECHNOL, V18, P473, DOI 10.1038/75237; Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026; Dohzono S, 2009, CLIN ORTHOP RELAT R, V467, P3206, DOI 10.1007/s11999-009-0960-1; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007; GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969; Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018; Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263; Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008; Hertz A, 2007, NANOMEDICINE-UK, V2, P899, DOI 10.2217/17435889.2.6.899; Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940; Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005; Kasper JC, 2011, J CONTROL RELEASE, V151, P246, DOI 10.1016/j.jconrel.2011.01.003; Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kim JW, 2011, ORAL SURG ORAL MED O, V112, P298, DOI 10.1016/j.tripleo.2010.10.025; Klijn RJ, 2012, TISSUE ENG PT A, V18, P1171, DOI [10.1089/ten.tea.2011.0444, 10.1089/ten.TEA.2011.0444]; Le Nihouannen D, 2008, EUR J PHARM BIOPHARM, V70, P813, DOI 10.1016/j.ejpb.2008.07.018; Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038; Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9; Lins RD, 2004, PROTEINS, V55, P177, DOI 10.1002/prot.10632; Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076; Magazu S, 2007, EUR BIOPHYS J BIOPHY, V36, P163, DOI 10.1007/s00249-006-0108-0; Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081; Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H; MOZHAEV VV, 1993, TRENDS BIOTECHNOL, V11, P88, DOI 10.1016/0167-7799(93)90057-G; Niemeyer P, 2010, ACTA BIOMATER, V6, P900, DOI 10.1016/j.actbio.2009.09.007; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1; PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2; Randall R, 1990, ANAL BIOCHEM, V191, P31; Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z; Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007; Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75; Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Sciadini MF, 2000, J ORTHOP RES, V18, P289, DOI 10.1002/jor.1100180218; Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467; Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003; Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0; Xu LL, 2010, TISSUE ENG A, V16, P2927; Zhao J, 2010, ORAL DIS, V16, P46, DOI 10.1111/j.1601-0825.2009.01602.x; Zhao J, 2012, TISSUE ENG PT A, V18, P185, DOI [10.1089/ten.tea.2011.0297, 10.1089/ten.TEA.2011.0297]; Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026; Zhao L, 2011, TISSUE ENG PT A, V17, P969, DOI [10.1089/ten.tea.2010.0521, 10.1089/ten.TEA.2010.0521]; Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]	61	22	24	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54645	10.1371/journal.pone.0054645	http://dx.doi.org/10.1371/journal.pone.0054645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359400	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600084
J	Bansal, A; Lee, IH; Hong, X; Mathur, SC; Tawfik, O; Rastogi, A; Buttar, N; Visvanathan, M; Sharma, P; Christenson, LK				Bansal, Ajay; Lee, In-Hee; Hong, Xiaoman; Mathur, Sharad C.; Tawfik, Ossama; Rastogi, Amit; Buttar, Navtej; Visvanathan, Mahesh; Sharma, Prateek; Christenson, Lane K.			Discovery and Validation of Barrett's Esophagus MicroRNA Transcriptome by Next Generation Sequencing	PLOS ONE			English	Article							EXPRESSION PROFILES; SMALL RNAS; ADENOCARCINOMA; IDENTIFICATION; LIMITATIONS; PROGRESSION; METAPLASIA; DYSPLASIA; PHENOTYPE; TARGETS	Objective: Barrett's esophagus (BE) is transition from squamous to columnar mucosa as a result of gastroesophageal reflux disease (GERD). The role of microRNA during this transition has not been systematically studied. Design: For initial screening, total RNA from 5 GERD and 6 BE patients was size fractionated. RNA <70 nucleotides was subjected to SOLiD 3 library preparation and next generation sequencing (NGS). Bioinformatics analysis was performed using R package "DEseq". A p value <0.05 adjusted for a false discovery rate of 5% was considered significant. NGS-identified miRNA were validated using qRT-PCR in an independent group of 40 GERD and 27 BE patients. MicroRNA expression of human BE tissues was also compared with three BE cell lines. Results: NGS detected 19.6 million raw reads per sample. 53.1% of filtered reads mapped to miRBase version 18. NGS analysis followed by qRT-PCR validation found 10 differentially expressed miRNA; several are novel (-708-5p, -944, -224-5p and -3065-5p). Up-or down-regulation predicted by NGS was matched by qRT-PCR in every case. Human BE tissues and BE cell lines showed a high degree of concordance (70-80%) in miRNA expression. Prediction analysis identified targets that mapped to developmental signaling pathways such as TGF beta and Notch and inflammatory pathways such as toll-like receptor signaling and TGF beta. Cluster analysis found similarly regulated (up or down) miRNA to share common targets suggesting coordination between miRNA. Conclusion: Using highly sensitive next-generation sequencing, we have performed a comprehensive genome wide analysis of microRNA in BE and GERD patients. Differentially expressed miRNA between BE and GERD have been further validated. Expression of miRNA between BE human tissues and BE cell lines are highly correlated. These miRNA should be studied in biological models to further understand BE development.	[Bansal, Ajay; Rastogi, Amit; Sharma, Prateek] Vet Affairs Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS USA; [Bansal, Ajay; Tawfik, Ossama; Rastogi, Amit; Sharma, Prateek; Christenson, Lane K.] Univ Kansas, Med Ctr, Kansas Canc Inst, Kansas City, KS 66103 USA; [Lee, In-Hee; Visvanathan, Mahesh] Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA; [Hong, Xiaoman; Christenson, Lane K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Mathur, Sharad C.] Vet Affairs Med Ctr, Dept Pathol, Kansas City, KS USA; [Buttar, Navtej] Mayo Clin, Dept Gastroenterol, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Mayo Clinic	Bansal, A (corresponding author), Vet Affairs Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS USA.	abansal@kumc.edu	Christenson, Lane K/G-6435-2013	Lee, In-Hee/0000-0002-8857-1355	American Cancer Society; American College of Gastroenterology; VISN 15 Research Award; Hall Family Foundation;  [K-INBRE P20 RR016475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American College of Gastroenterology(General Electric); VISN 15 Research Award; Hall Family Foundation; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a pilot grant from the American Cancer Society (A. B.) and Junior Faculty Development Award from the American College of Gastroenterology (A. B.), VISN 15 Research Award (A. B.), K-INBRE P20 RR016475 (L. K. C., A. B. and M. V.) and Hall Family Foundation (L. K. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bansal A, 2011, AM J GASTROENTEROL; Barrett MT, 2003, CANCER RES, V63, P4211; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Buermans HPJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-716; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; di Pietro M, 2012, P NATL ACAD SCI US; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Fassan M, 2010, INT J CANC; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Fiedler SD, 2010, METHODS MOL BIOL, V630, P49, DOI 10.1007/978-1-60761-629-0_4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2012, CARCINOGENESIS; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kawaji H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040022; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koshiol J, 2010, CANCER EPIDEM BIOMAR, V19, P907, DOI 10.1158/1055-9965.EPI-10-0071; Kosoff RE, 2012, J CELL PHYSIOL, V227, P2654, DOI 10.1002/jcp.23007; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krishnadath KK, 2007, CURR OPIN GASTROEN, V23, P440, DOI 10.1097/MOG.0b013e32814e6b4f; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Ness-Jensen E, 2011, GUT; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Shu M, 2011, MOL PHARM; Souza RF, 2008, AM J PHYSIOL-GASTR L, V295, pG211, DOI 10.1152/ajpgi.90250.2008; Souza RF, 2011, ANN NY ACAD SCI, V1232, P18, DOI 10.1111/j.1749-6632.2011.06043.x; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; van Baal JW, 2012, GUT; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wijnhoven BPL, 2010, BRIT J SURG, V97, P853, DOI 10.1002/bjs.7000; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385	61	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54240	10.1371/journal.pone.0054240	http://dx.doi.org/10.1371/journal.pone.0054240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372692	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500045
J	Crnogorac-Jurcevic, T; Chelala, C; Barry, S; Harada, T; Bhakta, V; Lattimore, S; Jurcevic, S; Bronner, M; Lemoine, NR; Brentnall, TA				Crnogorac-Jurcevic, Tatjana; Chelala, Claude; Barry, Sayka; Harada, Tomohiko; Bhakta, Vipul; Lattimore, Sam; Jurcevic, Stipo; Bronner, Mary; Lemoine, Nicholas R.; Brentnall, Teresa A.			Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; TRANSCRIPTOME ANALYSIS; STELLATE CELLS; MAST-CELLS; EXPRESSION; INFLAMMATION; PROGRESSION; CARCINOMA; PROMOTES; GENES	Background: With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In order to make a significant impact on survival of patients with this malignancy, it is necessary to diagnose the disease early, when curative surgery is still possible. Detailed knowledge of the natural history of the disease and molecular events leading to its progression is therefore critical. Methods and Findings: We have analysed the precursor lesions, PanINs, from prophylactic pancreatectomy specimens of patients from four different kindreds with high risk of familial pancreatic cancer who were treated for histologically proven PanIN-2/3. Thus, the material was procured before pancreatic cancer has developed, rather than from PanINs in a tissue field that already contains cancer. Genome-wide transcriptional profiling using such unique specimens was performed. Bulk frozen sections displaying the most extensive but not microdissected PanIN-2/3 lesions were used in order to obtain the holistic view of both the precursor lesions and their microenvironment. A panel of 76 commonly dysregulated genes that underlie neoplastic progression from normal pancreas to PanINs and PDAC were identified. In addition to shared genes some differences between the PanINs of individual families as well as between the PanINs and PDACs were also seen. This was particularly pronounced in the stromal and immune responses. Conclusions: Our comprehensive analysis of precursor lesions without the invasive component provides the definitive molecular proof that PanIN lesions beget cancer from a molecular standpoint. We demonstrate the need for accumulation of transcriptomic changes during the progression of PanIN to PDAC, both in the epithelium and in the surrounding stroma. An identified 76-gene signature of PDAC progression presents a rich candidate pool for the development of early diagnostic and/or surveillance markers as well as potential novel preventive/therapeutic targets for both familial and sporadic pancreatic adenocarcinoma.	[Crnogorac-Jurcevic, Tatjana; Chelala, Claude; Barry, Sayka; Harada, Tomohiko; Bhakta, Vipul; Lattimore, Sam; Lemoine, Nicholas R.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Jurcevic, Stipo] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England; [Bronner, Mary] Univ Utah, Dept Anat Pathol, Salt Lake City, UT USA; [Brentnall, Teresa A.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA USA	University of London; Queen Mary University London; University of London; King's College London; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle	Crnogorac-Jurcevic, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England.	T.C.Jurcevic@qmul.ac.uk		Lemoine, Nick/0000-0001-8675-058X; chelala, claude/0000-0002-2488-0669	CRUK; Higher Education Funding Council for England (HEFCE); Cancer Research UK [12008] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	CRUK(Cancer Research UK); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by CRUK (http://www.cancerresearchuk.org/). TCJ is funded by Higher Education Funding Council for England (HEFCE); http://www.hefce.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Arumugam T, 2011, PANCREAS, V40, P815, DOI 10.1097/MPA.0b013e31821f6927; Bartsch DK, 2012, NAT REV GASTRO HEPAT, V9, P445, DOI 10.1038/nrgastro.2012.111; Baumgart M, 2010, PANCREAS, V39, P1093, DOI 10.1097/MPA.0b013e3181dc62f6; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Buchholz M, 2005, J MOL MED, V83, P795, DOI 10.1007/s00109-005-0680-2; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Chung HW, 2012, CANCER SCI, V103, P1714, DOI 10.1111/j.1349-7006.2012.02358.x; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; CUBILLA AL, 1976, CANCER RES, V36, P2690; Cutts RJ, 2011, NUCLEIC ACIDS RES, V39, pD1023, DOI 10.1093/nar/gkq937; Dowen SE, 2005, AM J PATHOL, V166, P81, DOI 10.1016/S0002-9440(10)62234-1; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; EVANS JP, 1995, J MED GENET, V32, P330, DOI 10.1136/jmg.32.5.330; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lynch HT, 1996, SEMIN ONCOL, V23, P251; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Meckler KA, 2001, AM J SURG PATHOL, V25, P1047, DOI 10.1097/00000478-200108000-00009; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Pan S, 2009, ELECTROPHORESIS, V30, P1132, DOI 10.1002/elps.200800752; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Real FX, 2008, GASTROENTEROLOGY, V135, P724, DOI 10.1053/j.gastro.2008.07.033; Rulyak SJ, 2004, INT J BIOCHEM CELL B, V36, P1386, DOI 10.1016/j.biocel.2004.02.010; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwartz AM, 2007, AM J SURG PATHOL, V31, P645, DOI 10.1097/PAS.0b013e31802d6d42; Shi CJ, 2009, CLIN CANCER RES, V15, P7737, DOI 10.1158/1078-0432.CCR-09-0004; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Shioya M, 2008, PANCREAS, V36, P197, DOI 10.1097/MPA.0b013e3181594258; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sitek B, 2005, PROTEOMICS, V5, P2665, DOI 10.1002/pmic.200401298; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SOMMERS SC, 1954, GASTROENTEROLOGY, V27, P629, DOI 10.1016/S0016-5085(19)36105-0; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; TAKEUCHI Y, 1993, AM J GASTROENTEROL, V88, P1928; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Theoharides TC, 2008, NEW ENGL J MED, V358, P1860, DOI 10.1056/NEJMcibr0801519; Tobita K, 2002, INT J ONCOL, V21, P1189; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Zhang LZ, 2007, AM J SURG PATHOL, V31, P1191, DOI 10.1097/PAS.0b013e31806841e1; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	61	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54830	10.1371/journal.pone.0054830	http://dx.doi.org/10.1371/journal.pone.0054830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372777	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500134
J	Manevski, N; Troberg, J; Svaluto-Moreolo, P; Dziedzic, K; Yli-Kauhaluoma, J; Finel, M				Manevski, Nenad; Troberg, Johanna; Svaluto-Moreolo, Paolo; Dziedzic, Klaudyna; Yli-Kauhaluoma, Jari; Finel, Moshe			Albumin Stimulates the Activity of the Human UDP-Glucuronosyltransferases 1A7, 1A8, 1A10, 2A1 and 2B15, but the Effects Are Enzyme and Substrate Dependent	PLOS ONE			English	Article							IN VIVO EXTRAPOLATION; HUMAN LIVER-MICROSOMES; BOVINE SERUM-ALBUMIN; UNSATURATED FATTY-ACIDS; ZIDOVUDINE GLUCURONIDATION; DRUG CLEARANCE; VITRO DATA; UGT 1A4; ALAMETHICIN; BINDING	Human UDP-glucuronosyltransferases (UGTs) are important enzymes in metabolic elimination of endo-and xenobiotics. It was recently shown that addition of fatty acid free bovine serum albumin (BSA) significantly enhances in vitro activities of UGTs, a limiting factor in in vitro-in vivo extrapolation. Nevertheless, since only few human UGT enzymes were tested for this phenomenon, we have now performed detailed enzyme kinetic analysis on the BSA effects in six previously untested UGTs, using 2-4 suitable substrates for each enzyme. We also examined some of the previously tested UGTs, but using additional substrates and a lower BSA concentration, only 0.1%. The latter concentration allows the use of important but more lipophilic substrates, such as estradiol and 17-epiestradiol. In five newly tested UGTs, 1A7, 1A8, 1A10, 2A1, and 2B15, the addition of BSA enhanced, to a different degree, the in vitro activity by either decreasing reaction's K-m, increasing its V-max, or both. In contrast, the activities of UGT2B17, another previously untested enzyme, were almost unaffected. The results of the assays with the previously tested UGTs, 1A1, 1A6, 2B4, and 2B7, were similar to the published BSA only as far as the BSA effects on the reactions' K-m are concerned. In the cases of V-max values, however, our results differ significantly from the previously published ones, at least with some of the substrates. Hence, the magnitude of the BSA effects appears to be substrate dependent, especially with respect to V-max increases. Additionally, the BSA effects may be UGT subfamily dependent since K-m decreases were observed in members of subfamilies 1A, 2A and 2B, whereas large V-max increases were only found in several UGT1A members. The results shed new light on the complexity of the BSA effects on the activity and enzyme kinetics of the human UGTs.	[Manevski, Nenad; Troberg, Johanna; Svaluto-Moreolo, Paolo; Dziedzic, Klaudyna; Finel, Moshe] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Manevski, Nenad; Troberg, Johanna; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland	University of Helsinki; University of Helsinki	Finel, M (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland.	Moshe.Finel@helsinki.fi		Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Troberg, Johanna Maaria/0000-0003-3886-4771	Sigrid Juselius Foundation; Graduate School in Pharmaceutical Research; Academy of Finland [120975, 1260010]; University of Helsinki Research Foundation; European Erasmus programme	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Graduate School in Pharmaceutical Research; Academy of Finland(Academy of Finland); University of Helsinki Research Foundation; European Erasmus programme	This study was supported by the Sigrid Juselius Foundation, the Graduate School in Pharmaceutical Research, the Academy of Finland (project numbers 120975 and 1260010), the University of Helsinki Research Foundation grant for young researchers, and the European Erasmus programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Guillemette C, 2010, DRUG METAB REV, V42, P24, DOI 10.3109/03602530903210682; Houston JB, 2000, DRUG METAB DISPOS, V28, P246; Itaaho K, 2008, DRUG METAB DISPOS, V36, P2307, DOI 10.1124/dmd.108.022731; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Kaivosaari S, 2008, DRUG METAB DISPOS, V36, P1529, DOI 10.1124/dmd.108.021709; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Knights KM, 2010, DRUG METAB DISPOS, V38, P1011, DOI 10.1124/dmd.110.032870; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Kurkela M, 2004, BIOCHEM PHARMACOL, V68, P2443, DOI 10.1016/j.bcp.2004.08.019; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; Lautala P, 2000, DRUG METAB DISPOS, V28, P1385; Little JM, 1997, DRUG METAB DISPOS, V25, P5; Loureiro AI, 2011, DRUG METAB DISPOS, V39, P1486, DOI 10.1124/dmd.111.038620; Luukkanen L, 1999, BIOCONJUGATE CHEM, V10, P150, DOI 10.1021/bc980064n; Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093; Manevski N, 2012, DRUG METAB DISPOS, V40, P2192, DOI 10.1124/dmd.112.047746; Manevski N, 2011, DRUG METAB DISPOS, V39, P2117, DOI 10.1124/dmd.111.041418; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Miners JO, 2010, DRUG METAB REV, V42, P189; Miners JO, 2011, DRUG METAB DISPOS, V39, P644, DOI 10.1124/dmd.110.037036; Raungrut P, 2010, J PHARMACOL EXP THER, V334, P609, DOI 10.1124/jpet.110.167916; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Rowland A, 2008, DRUG METAB DISPOS, V36, P870, DOI 10.1124/dmd.107.019885; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1124/jpet.106.118216; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Rowland A, 2009, DRUG METAB DISPOS, V37, P1395, DOI 10.1124/dmd.109.027656; Shareef A, 2006, J CHEM ENG DATA, V51, P879, DOI 10.1021/je050318c; Shiraga T, 2012, DRUG METAB DISPOS, V40, P276, DOI 10.1124/dmd.111.042614; Sneitz N, 2009, PHARMACOGENET GENOM, V19, P923, DOI 10.1097/FPC.0b013e3283330767; Taylor J., 1996, INTRO ERROR ANAL STU; Tsoutsikos P, 2004, BIOCHEM PHARMACOL, V67, P191, DOI 10.1016/j.bcp.2003.08.025; Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200; Uchaipichat V, 2006, BRIT J CLIN PHARMACO, V61, P427, DOI 10.1111/j.1365-2125.2006.02588.x; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; Uchaipichat V, 2008, MOL PHARMACOL, V74, P1152, DOI 10.1124/mol.108.048645; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1051, DOI 10.1124/dmd.111.043117; Wattanachai N, 2012, DRUG METAB DISPOS, V40, P982, DOI 10.1124/dmd.111.044057; Zhang HB, 2011, DRUG METAB DISPOS, V39, P456, DOI 10.1124/dmd.110.036582; Zhou J, 2011, DRUG METAB DISPOS, V39, P322, DOI 10.1124/dmd.110.035030; Zhou J, 2010, DRUG METAB DISPOS, V38, P431, DOI 10.1124/dmd.109.028712	43	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54767	10.1371/journal.pone.0054767	http://dx.doi.org/10.1371/journal.pone.0054767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372764	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500122
J	Shain, AH; Pollack, JR				Shain, A. Hunter; Pollack, Jonathan R.			The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers	PLOS ONE			English	Article							IDENTIFIES FREQUENT MUTATION; SQUAMOUS-CELL CARCINOMA; REMODELING GENE ARID1A; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; INACTIVATING MUTATIONS; COMPLEX; EXPRESSION; LYMPHOMA; MELANOMA	SWI/SNF is a multi-subunit chromatin remodeling complex that uses the energy of ATP hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating evidence suggests that SWI/SNF functions as a tumor suppressor in some cancers. However, the spectrum of SWI/SNF mutations across human cancers has not been systematically investigated. Here, we mined whole-exome sequencing data from 24 published studies representing 669 cases from 18 neoplastic diagnoses. SWI/SNF mutations were widespread across diverse human cancers, with an excess of deleterious mutations, and an overall frequency approaching TP53 mutation. Mutations occurred most commonly in the SMARCA4 enzymatic subunit, and in subunits thought to confer functional specificity ( ARID1A, ARID1B, PBRM1, and ARID2). SWI/SNF mutations were not mutually-exclusive of other mutated cancer genes, including TP53 and EZH2 ( both previously linked to SWI/SNF). Our findings implicate SWI/SNF as an important but under-recognized tumor suppressor in diverse human cancers, and provide a key resource to guide future investigations.	[Shain, A. Hunter; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	pollack1@stanford.edu			NCI [R01CA112016]; NSF, Stanford Graduate Fellowship program; NSF, Cancer Biology program; NATIONAL CANCER INSTITUTE [R01CA112016] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF, Stanford Graduate Fellowship program; NSF, Cancer Biology program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by grants from the NCI: R01CA112016 (J.R.P.). A. H. S. was supported by fellowships from the NSF, Stanford Graduate Fellowship program, and Cancer Biology program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Dal Molin M, 2012, HUM PATHOL, V43, P585, DOI 10.1016/j.humpath.2011.06.009; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; NEIGEBORN L, 1984, GENETICS, V108, P845; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nissenblatt M, 2011, NEW ENGL J MED, V364, P482, DOI 10.1056/NEJMc1012780; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	50	350	365	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55119	10.1371/journal.pone.0055119	http://dx.doi.org/10.1371/journal.pone.0055119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355908	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500156
J	Yang, L; O'Neill, P; Martin, K; Maass, JC; Vassilev, V; Ladher, R; Groves, AK				Yang, Lu; O'Neill, Paul; Martin, Kareen; Maass, Juan C.; Vassilev, Vassil; Ladher, Raj; Groves, Andrew K.			Analysis of FGF-Dependent and FGF-Independent Pathways in Otic Placode Induction	PLOS ONE			English	Article							INNER-EAR; CHICK-EMBRYO; GENE-EXPRESSION; NEURAL CREST; MOUSE; GROWTH; CELL; WNT; IDENTIFICATION; SIGNALS	The inner ear develops from a patch of thickened cranial ectoderm adjacent to the hindbrain called the otic placode. Studies in a number of vertebrate species suggest that the initial steps in induction of the otic placode are regulated by members of the Fibroblast Growth Factor (FGF) family, and that inhibition of FGF signaling can prevent otic placode formation. To better understand the genetic pathways activated by FGF signaling during otic placode induction, we performed microarray experiments to estimate the proportion of chicken otic placode genes that can be up-regulated by the FGF pathway in a simple culture model of otic placode induction. Surprisingly, we find that FGF is only sufficient to induce about 15% of chick otic placode-specific genes in our experimental system. However, pharmacological blockade of the FGF pathway in cultured chick embryos showed that although FGF signaling was not sufficient to induce the majority of otic placode-specific genes, it was still necessary for their expression in vivo. These inhibitor experiments further suggest that the early steps in otic placode induction regulated by FGF signaling occur through the MAP kinase pathway. Although our work suggests that FGF signaling is necessary for otic placode induction, it demonstrates that other unidentified signaling pathways are required to co-operate with FGF signaling to induce the full otic placode program.	[Yang, Lu; Maass, Juan C.; Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yang, Lu; Maass, Juan C.; Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Martin, Kareen] House Res Inst, Div Cell Biol & Genet, Los Angeles, CA USA; [O'Neill, Paul; Vassilev, Vassil; Ladher, Raj] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Maass, Juan C.] Univ Chile, Hosp Clin, Dept Otolaryngol, Santiago, Chile; [Maass, Juan C.] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Dept Otolaryngol, Santiago, Chile	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; RIKEN; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo	Ladher, R (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan.	raj-ladher@cdb.riken.jp; akgroves@bcm.edu		Yang, Lu/0000-0001-7965-2674; Maass, Juan/0000-0002-1586-4608; Groves, Andrew/0000-0002-0784-7998; Ladher, Raj/0000-0002-3613-9456	National Institutes of Health (NIH) [DC004675]; NIH [DC008692]; RIKEN FPR fellowship; RIKEN; MECESUP (Ministerio de Educacion, Gobierno de Chile) [UCH0603]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004675, R03DC008692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN FPR fellowship; RIKEN; MECESUP (Ministerio de Educacion, Gobierno de Chile); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is funded by National Institutes of Health (NIH) DC004675 (A. K. G.), NIH DC008692 (K. M.), RIKEN FPR fellowship (P.O.), RIKEN intramural funding (P.O. and R.L.) and a fellowship from MECESUP (UCH0603, Ministerio de Educacion, Gobierno de Chile, J.C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Adamska M, 2001, MECH DEVELOP, V109, P303, DOI 10.1016/S0925-4773(01)00550-0; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2005, SPR HDB AUD, V26, P10; Groves AK, 2000, DEVELOPMENT, V127, P3489; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harduf H, 2005, DEV DYNAM, V233, P301, DOI 10.1002/dvdy.20364; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Herbrand H, 1998, DEVELOPMENT, V125, P645; Hidalgo-Sanchez M, 2000, MECH DEVELOP, V95, P225, DOI 10.1016/S0925-4773(00)00332-4; Ishihara T, 2008, GENE EXPR PATTERNS, V8, P357, DOI 10.1016/j.gep.2008.01.003; JACOBSON AG, 1966, SCIENCE, V152, P25, DOI 10.1126/science.152.3718.25; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Kil SH, 2005, DEV BIOL, V285, P252, DOI 10.1016/j.ydbio.2005.05.044; Kurose H, 2004, GENE EXPR PATTERNS, V4, P687, DOI 10.1016/j.modgep.2004.04.005; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maroon H, 2002, DEVELOPMENT, V129, P2099; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Matsumata M, 2005, DEV BIOL, V286, P601, DOI 10.1016/j.ydbio.2005.08.005; McKeown SJ, 2005, DEV DYNAM, V233, P430, DOI 10.1002/dvdy.20341; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Niss K, 1998, MECH DEVELOP, V76, P151, DOI 10.1016/S0925-4773(98)00103-8; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Paxton CN, 2010, GENE EXPR PATTERNS, V10, P31, DOI 10.1016/j.gep.2009.11.002; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Riley BB, 2003, DEV BIOL, V261, P289, DOI 10.1016/S0012-1606(03)00245-8; Rogers AAM, 2011, DEV BIOL, V353, P94, DOI 10.1016/j.ydbio.2011.02.022; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Sato S, 2010, DEV BIOL, V344, P158, DOI 10.1016/j.ydbio.2010.04.029; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Sinkkonen ST, 2011, JARO-J ASSOC RES OTO, V12, P697, DOI 10.1007/s10162-011-0286-z; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Urness LD, 2008, DEV DYNAM, V237, P163, DOI 10.1002/dvdy.21380; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Xu H, 2008, DEV BIOL, V317, P174, DOI 10.1016/j.ydbio.2008.02.012; YAN MH, 1994, J BIOL CHEM, V269, P19067	69	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55011	10.1371/journal.pone.0055011	http://dx.doi.org/10.1371/journal.pone.0055011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355906	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500153
J	Zhang, CL; Zhang, CS; Chen, SP; Yin, XY; Pan, XY; Lin, G; Tan, YQ; Tan, K; Xu, ZF; Hu, P; Li, XC; Chen, F; Xu, X; Li, YR; Zhang, XQ; Jiang, H; Wang, W				Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Lin, Ge; Tan, Yueqiu; Tan, Ke; Xu, Zhengfeng; Hu, Ping; Li, Xuchao; Chen, Fang; Xu, Xun; Li, Yingrui; Zhang, Xiuqing; Jiang, Hui; Wang, Wei			A Single Cell Level Based Method for Copy Number Variation Analysis by Low Coverage Massively Parallel Sequencing	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; CHROMOSOME; EVOLUTION; DELETION; MAPS; DNA	Copy number variations (CNVs), a common genomic mutation associated with various diseases, are important in research and clinical applications. Whole genome amplification (WGA) and massively parallel sequencing have been applied to single cell CNVs analysis, which provides new insight for the fields of biology and medicine. However, the WGA-induced bias significantly limits sensitivity and specificity for CNVs detection. Addressing these limitations, we developed a practical bioinformatic methodology for CNVs detection at the single cell level using low coverage massively parallel sequencing. This method consists of GC correction for WGA-induced bias removal, binary segmentation algorithm for locating CNVs breakpoints, and dynamic threshold determination for final signals filtering. Afterwards, we evaluated our method with seven test samples using low coverage sequencing (4 similar to 9.5%). Four single-cell samples from peripheral blood, whose karyotypes were confirmed by whole genome sequencing analysis, were acquired. Three other test samples derived from blastocysts whose karyotypes were confirmed by SNP-array analysis were also recruited. The detection results for CNVs of larger than 1 Mb were highly consistent with confirmed results reaching 99.63% sensitivity and 97.71% specificity at base-pair level. Our study demonstrates the potential to overcome WGA-bias and to detect CNVs (>1 Mb) at the single cell level through low coverage massively parallel sequencing. It highlights the potential for CNVs research on single cells or limited DNA samples and may prove as a promising tool for research and clinical applications, such as pre-implantation genetic diagnosis/screening, fetal nucleated red blood cells research and cancer heterogeneity analysis.	[Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Xu, Xun; Li, Yingrui; Zhang, Xiuqing; Jiang, Hui; Wang, Wei] BGI Shenzhen, Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Lin, Ge; Tan, Yueqiu] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Xu, Zhengfeng; Hu, Ping] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Ctr Prenatal Diag, Nanjing, Peoples R China; [Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Jiang, Hui; Wang, Wei] BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen, Guangdong, Peoples R China; [Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Zhang, Xiuqing; Jiang, Hui] BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen, Guangdong, Peoples R China; [Lin, Ge; Tan, Ke] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Lin, Ge; Tan, Yueqiu] Minist Hlth, Key Lab Stem Cell & Reprod Engn, Changsha, Hunan, Peoples R China; [Chen, Shengpei] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Pan, Xiaoyu] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Chen, Fang; Jiang, Hui] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Central South University; Nanjing Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Central South University; Southeast University - China; South China University of Technology; University of Copenhagen	Jiang, H (corresponding author), BGI Shenzhen, Sci & Technol, Shenzhen, Guangdong, Peoples R China.	jianghui@genomics.cn; wangw@genomics.cn	Pan, Xiaoyu/AAT-9002-2021; Li, Yingrui/K-1064-2015; Xu, Xun/AAI-6763-2020	Pan, Xiaoyu/0000-0002-0282-6047; Xu, Xun/0000-0002-5338-5173	Key Laboratory Project in Guangdong Province [2011A060906007]; Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform [861]	Key Laboratory Project in Guangdong Province; Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform	This project is supported by Key Laboratory Project in Guangdong Province, (2011A060906007) and Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform [2011] No. 861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Bredel M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Corneveaux JJ, 2007, BIOTECHNIQUES, V42, P77, DOI 10.2144/000112308; Dan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027835; DOKRAS A, 1990, HUM REPROD, V5, P821, DOI 10.1093/oxfordjournals.humrep.a137191; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; GRIFFIN DK, 1991, HUM REPROD, V6, P101, DOI 10.1093/oxfordjournals.humrep.a137241; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang R, 2008, PRENATAL DIAG, V28, P892, DOI 10.1002/pd.2079; Krumm N, 2012, GENOME RES; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; STROM CM, 1990, LANCET, V336, P306, DOI 10.1016/0140-6736(90)91835-X; Uum van CMJ, 2010, HUMAN REPROD, V25, pi61; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	30	20	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54236	10.1371/journal.pone.0054236	http://dx.doi.org/10.1371/journal.pone.0054236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372689	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500042
J	Li, X; Florez, S; Wang, JB; Cao, HJ; Amendt, BA				Li, Xiao; Florez, Sergio; Wang, Jianbo; Cao, Huojun; Amendt, Brad A.			Dact2 Represses PITX2 Transcriptional Activation and Cell Proliferation through Wnt/beta-Catenin Signaling during Odontogenesis	PLOS ONE			English	Article							BETA-CATENIN; TOOTH DEVELOPMENT; GENE-EXPRESSION; WNT SIGNALS; CYCLIN D1; PROTEIN; MICE; HOMEODOMAIN; PATHWAY; MOUSE	Dact proteins belong to the Dapper/Frodo protein family and function as cytoplasmic attenuators in Wnt and TGF beta signaling. Previous studies show that Dact1 is a potent Wnt signaling inhibitor by promoting degradation of beta-catenin. We report a new mechanism for Dact2 function as an inhibitor of the canonical Wnt signaling pathway by interacting with PITX2. PITX2 is a downstream transcription factor in Wnt/beta-catenin signaling, and PITX2 synergizes with Lef-1 to activate downstream genes. Immunohistochemistry verified the expression of Dact2 in the tooth epithelium, which correlated with Pitx2 epithelial expression. Dact2 loss of function and PITX2 gain of function studies reveal a feedback mechanism for controlling Dact2 expression. Pitx2 endogenously activates Dact2 expression and Dact2 feeds back to repress Pitx2 transcriptional activity. A Topflash reporter system was employed showing PITX2 activation of Wnt signaling, which is attenuated by Dact2. Transient transfections demonstrate the inhibitory effect of Dact2 on critical dental epithelial differentiation factors during tooth development. Dact2 significantly inhibits PITX2 activation of the Dlx2 and amelogenin promoters. Multiple lines of evidence conclude the inhibition is achieved by the physical interaction between Dact2 and Pitx2 proteins. The loss of function of Dact2 also reveals increased cell proliferation due to up-regulated Wnt downstream genes, cyclinD1 and cyclinD2. In summary, we have identified a novel role for Dact2 as an inhibitor of the canonical Wnt pathway in embryonic tooth development through its regulation of cell proliferation and differentiation.	[Li, Xiao; Florez, Sergio; Wang, Jianbo; Cao, Huojun; Amendt, Brad A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa	Amendt, BA (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Cao, Huojun/0000-0003-4428-8686; Amendt, Brad A./0000-0001-6524-1006	National Institutes of Health grant [DE13941, DE18885]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants DE13941 and DE18885 to B.A.A. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Huang Y, 2010, CELL CYCLE, P9; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Kettunen P, 2010, GENE EXPR PATTERNS, V10, P140, DOI 10.1016/j.gep.2010.02.002; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Lee WC, 2010, AM J PHYSIOL-RENAL, V299, pF740, DOI 10.1152/ajprenal.00148.2010; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Teran E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005522; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]	44	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54868	10.1371/journal.pone.0054868	http://dx.doi.org/10.1371/journal.pone.0054868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349981	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100104
J	Li, ZJ; Zhang, LL; Wang, AX; Xu, XY; Li, JF				Li, Zhenjun; Zhang, Lili; Wang, Aoxue; Xu, Xiangyang; Li, Jingfu			Ectopic Overexpression of SlHsfA3, a Heat Stress Transcription Factor from Tomato, Confers Increased Thermotolerance and Salt Hypersensitivity in Germination in Transgenic Arabidopsis	PLOS ONE			English	Article							FALSE DISCOVERY RATE; OXYGEN GENE NETWORK; SEED-GERMINATION; SHOCK PROTEINS; LOW-TEMPERATURE; DEVELOPMENTAL REGULATION; MOLECULAR CHAPERONES; ENDOTHELIAL-CELLS; ABIOTIC STRESS; THIONIN THI2.1	Plant heat stress transcription factors (Hsfs) are the critical components involved in mediating responses to various environmental stressors. However, the detailed roles of many plant Hsfs are far from fully understood. In this study, an Hsf (SlHsfA3) was isolated from the cultivated tomato (Solanum lycopersicum, Sl) and functionally characterized at the genetic and developmental levels. The nucleus-localized SlHsfA3 was basally and ubiquitously expressed in different plant organs. The expression of SlHsfA3 was induced dramatically by heat stress, moderately by high salinity, and slightly by drought, but was not induced by abscisic acid (ABA). The ectopic overexpression of SlHsfA3 conferred increased thermotolerance and late flowering phenotype to transgenic Arabidopsis plants. Moreover, SlHsfA3 played a negative role in controlling seed germination under salt stress. RNA-sequencing data demonstrated that a number of heat shock proteins (Hsps) and stress-associated genes were induced in Arabidopsis plants overexpressing SlHsfA3. A gel shift experiment and transient expression assays in Nicotiana benthamiana leaves demonstrated that SlHsfA3 directly activates the expression of SlHsp26.1-P and SlHsp21.5-ER. Taken together, our results suggest that SlHsfA3 behaves as a typical Hsf to contribute to plant thermotolerance. The late flowering and seed germination phenotypes and the RNA-seq data derived from SlHsfA3 overexpression lines lend more credence to the hypothesis that plant Hsfs participate in diverse physiological and biochemical processes related to adverse conditions.	[Li, Zhenjun; Zhang, Lili; Wang, Aoxue; Xu, Xiangyang; Li, Jingfu] NE Agr Univ, Coll Hort, Harbin, Heilongjiang, Peoples R China; [Zhang, Lili] NE Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Xu, Xiangyang; Li, Jingfu] Minist Agr, Key Lab Biol & Genet Improvement Hort Crops NE Re, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Northeast Forestry University - China; Ministry of Agriculture & Rural Affairs	Xu, XY (corresponding author), NE Agr Univ, Coll Hort, Harbin, Heilongjiang, Peoples R China.	xuxiangyang_neau@yahoo.com.cn; jfli_neau@yahoo.com.cn			National High Technology Research and Development Program of China [2007AA10Z178]; National Science and Technology Supporting Plan [2012BAD02B02]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science and Technology Supporting Plan	This research was supported by grants from the National High Technology Research and Development Program of China (No. 2007AA10Z178) and National Science and Technology Supporting Plan (No. No. 2012BAD02B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; BARROS MD, 1992, PLANT MOL BIOL, V19, P665, DOI 10.1007/BF00026792; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharti K, 2000, PLANT J, V22, P355, DOI 10.1046/j.1365-313x.2000.00746.x; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Birkenmeier GF, 1998, PLANT PHYSIOL, V117, P687, DOI 10.1104/pp.117.2.687; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen H, 2010, BIOCHEM BIOPH RES CO, V401, P238, DOI 10.1016/j.bbrc.2010.09.038; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Czarnecka-Verner E, 2004, PLANT MOL BIOL, V56, P57, DOI 10.1007/s11103-004-2307-3; Czarnecka-Verner E, 2000, PLANT MOL BIOL, V43, P459, DOI 10.1023/A:1006448607740; Daszkowska-Golec A, 2011, OMICS, V15, P763, DOI 10.1089/omi.2011.0082; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Giorno F, 2010, J EXP BOT, V61, P453, DOI 10.1093/jxb/erp316; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; JAKOB U, 1993, J BIOL CHEM, V268, P1517; JEFFERSON RA, 1987, EMBO J, V6, P3901; KAHN TL, 1993, PLANT PHYSIOL, V103, P597, DOI 10.1104/pp.103.2.597; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kim DH, 2010, P NATL ACAD SCI USA, V107, P17029, DOI 10.1073/pnas.1010834107; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Loeza-Angeles H, 2008, BIOTECHNOL LETT, V30, P1713, DOI 10.1007/s10529-008-9756-8; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; NOVER L, 1987, ENZYME MICROB TECH, V9, P130, DOI 10.1016/0141-0229(87)90066-4; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ochoa-Zarzosa A, 2008, VET MICROBIOL, V127, P425, DOI 10.1016/j.vetmic.2007.08.031; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Rojas A, 1999, PLANT J, V20, P601, DOI 10.1046/j.1365-313X.1999.00635.x; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schmidt R, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls011; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Yoshida T, 2008, BIOCHEM BIOPH RES CO, V368, P515, DOI 10.1016/j.bbrc.2008.01.134; Yuan K, 2011, ACTA PHYSIOL PLANT, V33, P261, DOI 10.1007/s11738-010-0542-6; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhu Y, 2009, PLANT MOL BIOL, V71, P451, DOI 10.1007/s11103-009-9538-2	96	64	74	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54880	10.1371/journal.pone.0054880	http://dx.doi.org/10.1371/journal.pone.0054880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349984	Green Submitted, gold, Green Published			2022-12-25	WOS:000314019100107
J	Egan, SP; Hood, GR; DeVela, G; Ott, JR				Egan, Scott P.; Hood, Glen R.; DeVela, Gabriel; Ott, James R.			Parallel Patterns of Morphological and Behavioral Variation among Host-Associated Populations of Two Gall Wasp Species	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; NATURAL-SELECTION; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; POSTMATING ISOLATION; PLANT ADAPTATION; SYMPATRIC RACES; BODY-SIZE; EVOLUTION; PREFERENCE	A powerful approach to address the general factors contributing to ecological speciation is to compare distantly related taxa that inhabit the same selective environments. In this design, similarities among taxa can elucidate general mechanisms of the process whereas differences may uncover specific factors important to the process for individual taxa. Herein, we present evidence of parallel patterns of morphological and behavioral variation among host-associated populations of two species of cynipid gall wasps, Belonocnema treatae and Disholcaspis quercusvirens, that each exhibit a life cycle intimately tied to the same two host plant environments, Quercus geminata and Q. virginiana. Across both gall-former species we find consistent differences in body size and gall morphology associated with host plant use, as well as strong differences in host plant preference, a measure of habitat isolation among populations. These consistent differences among taxa highlight the important role of host plant use in promoting reproductive isolation and morphological variation among herbivorous insect populations-a prerequisite for ecological speciation.	[Egan, Scott P.; Hood, Glen R.; DeVela, Gabriel] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Egan, Scott P.] Univ Notre Dame, Adv Diagnost & Therapeut Initiat, Notre Dame, IN 46556 USA; [Ott, James R.] Texas State Univ San Marcos, Populat & Conservat Biol Program, Dept Biol, San Marcos, TX USA	University of Notre Dame; University of Notre Dame; Texas State University System; Texas State University San Marcos	Egan, SP (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	scott.p.egan@nd.edu			University of Notre Dame - FRSP Initiation Grant	University of Notre Dame - FRSP Initiation Grant	The research was partially funded by a University of Notre Dame - FRSP Initiation Grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson, 1997, EVOL ECOL, V29; Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Ashmead J. M., 1896, Proceedings United States Museum, Vxix, P113; Ashmead W. H., 1881, TRANSACTION AM ENTOM, V9, P9; Ashmead WH, 1885, T AM ENTOMOLOGICAL S, V12, P5; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Bolnick DI, 2009, EVOLUTION, V63, P2004, DOI 10.1111/j.1558-5646.2009.00699.x; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Coyne JA, 2004, SPECIATION, V37; Craig TP, 2001, EVOLUTION, V55, P773, DOI 10.1554/0014-3820(2001)055[0773:GEAHPP]2.0.CO;2; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dickey AM, 2010, J EVOLUTION BIOL, V23, P945, DOI 10.1111/j.1420-9101.2010.01962.x; Dobzhansky T., 1951, COPEIA; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Egan SP, 2011, J EVOLUTION BIOL, V24, P2217, DOI 10.1111/j.1420-9101.2011.02350.x; Egan S.P., 2012, INT J ECOL, V2012, DOI DOI 10.1155/2012/809897; Egan SP, 2012, BIOL LETTERS, V8, P605, DOI 10.1098/rsbl.2011.1205; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Fitzpatrick BM, 2012, INT J ECOL, V2012, P1, DOI [rg/10.1155/2012/256017, DOI 10.1155/2012/256017]; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hall MC, 2001, THESIS TEXAS STATE U; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; Heard Stephen B., 2012, International Journal of Ecology, P1; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hood GR, 2010, OECOLOGIA, V162, P673, DOI 10.1007/s00442-009-1492-9; Horner JD, 2008, ENTOMOL EXP APPL, V128, P274, DOI 10.1111/j.1570-7458.2008.00728.x; Janz N, 2009, ECOL ENTOMOL, V34, P50, DOI 10.1111/j.1365-2311.2008.01041.x; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.1111/j.1558-5646.1989.tb02549.x; KV Krombein, 1979, CATALOG HYMENOPTERA, VI; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Lund JN, 1998, P ENTOMOL SOC WASH, V100, P755; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Mayr G., 1881, JAHRESBERICHTE COMMU, V20, P1; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; Melika George, 2002, P150; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2006, J EVOLUTION BIOL, V19, P929, DOI 10.1111/j.1420-9101.2005.01035.x; Nosil P, 2006, P ROY SOC B-BIOL SCI, V273, P991, DOI 10.1098/rspb.2005.3359; Nosil P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001907; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Platt JE, 2009, THESIS U FLORIDA US; Price PW, 2004, CONSERV BIOL, V18, P1405, DOI 10.1111/j.1523-1739.2004.00547.x; Rolan-Alvarez E, 1997, EVOLUTION, V51, P1838, DOI 10.1111/j.1558-5646.1997.tb05107.x; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sandoval CP, 2005, EVOLUTION, V59, P2405; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SMITH MA, 1979, ANIM BEHAV, V27, P365, DOI 10.1016/0003-3472(79)90170-2; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; vanEmden HF, 1996, PHYSIOL ENTOMOL, V21, P325, DOI 10.1111/j.1365-3032.1996.tb00873.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vines TH, 2005, P R SOC B, V273, P911; WOOD TK, 1990, EVOLUTION, V44, P619, DOI 10.1111/j.1558-5646.1990.tb05942.x	68	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54690	10.1371/journal.pone.0054690	http://dx.doi.org/10.1371/journal.pone.0054690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349952	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000046
J	Kong, W; He, L; Richards, EJ; Challa, S; Xu, CX; Permuth-Wey, J; Lancaster, JM; Coppola, D; Sellers, TA; Djeu, JY; Cheng, JQ				Kong, W.; He, L.; Richards, E. J.; Challa, S.; Xu, C-X; Permuth-Wey, J.; Lancaster, J. M.; Coppola, D.; Sellers, T. A.; Djeu, J. Y.; Cheng, J. Q.			Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer	ONCOGENE			English	Article						miR-155; angiogenesis; VHL; breast cancer; inflammation	B-CELL LYMPHOMAS; TNF-ALPHA; MICRORNA-155; GROWTH; MIR-155; GENE; INFLAMMATION; EXPRESSION; TUMORIGENESIS; MACROPHAGES	MicroRNA-155 (miR-155) is frequently upregulated in various types of human cancer; however, its role in cancer angiogenesis remains unknown. Here, we demonstrate the role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer. Ectopic expression of miR-155 induced whereas knockdown of miR-155 inhibited human umbilical vein endothelial cell network formation, proliferation, invasion and migration. Furthermore, mammary fat pad xenotransplantation of ectopically expressed miR-155 resulted in extensive angiogenesis, proliferation, tumour necrosis and recruitment of pro-inflammatory cells such as tumour-associated macrophages. Expression of VHL abrogated these miR-155 effects. Moreover, miR-155 expression inversely correlates with VHL expression level and is associated with late-stage, lymph node metastasis and poor prognosis, as well as triple-negative tumour in breast cancer. These findings indicate that miR-155 has a pivotal role in tumour angiogenesis by downregulation of VHL, and provide a basis for miR-155-expressing tumours to embody an aggressive malignant phenotype, and therefore miR-155 is an important therapeutic target in breast cancer.	[Kong, W.; He, L.; Richards, E. J.; Challa, S.; Xu, C-X; Cheng, J. Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Permuth-Wey, J.; Sellers, T. A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Lancaster, J. M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Coppola, D.] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Djeu, J. Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12909 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	Jin.Cheng@moffitt.org	Xu, Cheng-Xiong/ACD-3271-2022; Xu, Cheng-Xiong/AAV-7733-2021	Xu, Cheng-Xiong/0000-0001-5714-8207; CHALLA, SRIDEVI/0000-0002-5308-9243	National Institute of Health [CA114343, CA115308, CA137041]; Florida Bankhead-Coley Cancer Research Program [2BB01]; NATIONAL CANCER INSTITUTE [T32CA115308, R01CA137041, P30CA076292, R01CA160455, R01CA114343] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institute of Health (CA114343 to TAS, CA115308 to JYD, and CA137041 to JQC) and Florida Bankhead-Coley Cancer Research Program (2BB01 to JQC).	Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Li MQ, 2011, J CELL MOL MED, V15, P187, DOI 10.1111/j.1582-4934.2010.01238.x; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tili E, 2011, P NATL ACAD SCI USA, V108, P4908, DOI 10.1073/pnas.1101795108; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zia MK, 2007, INT J MOL MED, V20, P605	53	288	300	5	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					679	689		10.1038/onc.2012.636	http://dx.doi.org/10.1038/onc.2012.636			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23353819	Green Accepted			2022-12-25	WOS:000331129200003
J	Manna, PR; Cohen-Tannoudji, J; Counis, R; Garner, CW; Huhtaniemi, I; Kraemer, FB; Stocco, DM				Manna, Pulak R.; Cohen-Tannoudji, Joelle; Counis, Raymond; Garner, Charles W.; Huhtaniemi, Ilpo; Kraemer, Fredric B.; Stocco, Douglas M.			Mechanisms of Action of Hormone-sensitive Lipase in Mouse Leydig Cells ITS ROLE IN THE REGULATION OF THE STEROIDOGENIC ACUTE REGULATORY PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; HIGH-DENSITY-LIPOPROTEIN; B TYPE-I; SCAVENGER RECEPTOR; TUMOR-CELLS; MOLECULAR-MECHANISMS; MEDIATED REGULATION; DIFFERENTIAL REGULATION; CHOLESTEROL ESTER; NUCLEAR RECEPTORS	Hormone-sensitive lipase (HSL) catalyzes the hydrolysis of cholesteryl esters in steroidogenic tissues and, thus, facilitates cholesterol availability for steroidogenesis. The steroidogenic acute regulatory protein (StAR) controls the rate-limiting step in steroid biosynthesis. However, the modes of action of HSL in the regulation of StAR expression remain obscure. We demonstrate in MA-10 mouse Leydig cells that activation of the protein kinase A (PKA) pathway, by a cAMP analog Bt(2)cAMP, enhanced expression of HSL and its phosphorylation (P) at Ser-660 and Ser-563, but not at Ser-565, concomitant with increased HSL activity. Phosphorylation and activation of HSL coincided with increases in StAR, P-StAR (Ser-194), and progesterone levels. Inhibition of HSL activity by CAY10499 effectively suppressed Bt(2)cAMP-induced StAR expression and progesterone synthesis. Targeted silencing of endogenous HSL, with siRNAs, resulted in increased cholesteryl ester levels and decreased cholesterol content in MA-10 cells. Depletion of HSL affected lipoprotein-derived cellular cholesterol influx, diminished the supply of cholesterol to the mitochondria, and resulted in the repression of StAR and P-StAR levels. Cells overexpressing HSL increased the efficacy of liver X receptor (LXR) ligands on StAR expression and steroid synthesis, suggesting HSL-mediated steroidogenesis entails enhanced oxysterol production. Conversely, cells deficient in LXRs exhibited decreased HSL responsiveness. Furthermore, an increase in HSL was correlated with the LXR target genes, steroid receptor element-binding protein 1c and ATP binding cassette transporter A1, demonstrating HSL-dependent regulation of steroidogenesis predominantly involves LXR signaling. LXRs interact/cooperate with RXRs and result in the activation of StAR gene transcription. These findings provide novel insight and demonstrate the molecular events by which HSL acts to drive cAMP/PKA-mediated regulation of StAR expression and steroidogenesis in mouse Leydig cells.	[Stocco, Douglas M.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Cohen-Tannoudji, Joelle; Counis, Raymond] Univ Paris Diderot, EAC CNRS 4413, Paris, France; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Kraemer, Fredric B.] Vet Affairs Palo Alto Heath Care Syst, Dept Med, Palo Alto, CA 94304 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Stocco, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	doug.stocco@ttuhsc.edu	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807	National Institutes of Health [HD-17481]; Robert A. Welch Foundation [B1-0028]; Universite Paris Diderot-Paris 7; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017481, R01HD017481] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Universite Paris Diderot-Paris 7; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HD-17481 (to D. M. S.), Robert A. Welch Foundation Grant B1-0028 (to D. M. S.), and the Universite Paris Diderot-Paris 7.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; BARTKE A, 1973, PROSTAGLANDINS, V3, P97, DOI 10.1016/0090-6980(73)90141-X; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Christenson LK, 1998, J BIOL CHEM, V273, P30729, DOI 10.1074/jbc.273.46.30729; Chung SR, 2001, ENDOCRINOLOGY, V142, P4272, DOI 10.1210/en.142.10.4272; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dyson MT, 2009, MOL CELL ENDOCRINOL, V300, P94, DOI 10.1016/j.mce.2008.11.029; Fredrikson G, 1981, Methods Enzymol, V71 Pt C, P636; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Holst LS, 1996, GENOMICS, V35, P441, DOI 10.1006/geno.1996.0383; Kabbaj O, 2003, BIOL REPROD, V68, P722, DOI 10.1095/biolreprod.102.008169; King SR, 2004, J MOL ENDOCRINOL, V32, P507, DOI 10.1677/jme.0.0320507; Kolmakova A, 2010, ENDOCRINOLOGY, V151, P5519, DOI 10.1210/en.2010-0347; Kraemer FB, 2004, MOL ENDOCRINOL, V18, P549, DOI 10.1210/me.2003-0179; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Lee YS, 2003, NUCLEIC ACIDS RES, V31, P7165, DOI 10.1093/nar/gkg934; Li H, 2002, ENDOCRINOLOGY, V143, P3333, DOI 10.1210/en.2002-220341; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Mairal A, 2002, BIOCHEM BIOPH RES CO, V291, P286, DOI 10.1006/bbrc.2002.6427; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Manna PR, 1999, J BIOL CHEM, V274, P5909, DOI 10.1074/jbc.274.9.5909; Manna PR, 2004, MOL ENDOCRINOL, V18, P558, DOI 10.1210/me.2003-0223; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Manna PR, 2011, ENDOCRINOLOGY, V152, P313, DOI 10.1210/en.2010-0874; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Manna PR, 2009, ENDOCRINOLOGY, V150, P187, DOI 10.1210/en.2008-0368; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x; Osuga J, 1997, BIOCHEM BIOPH RES CO, V233, P655, DOI 10.1006/bbrc.1997.6518; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; Reaven E, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-43; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413; Savinainen JR, 2010, ANAL BIOCHEM, V399, P132, DOI 10.1016/j.ab.2009.12.009; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Shen WJ, 2003, J BIOL CHEM, V278, P43870, DOI 10.1074/jbc.M303934200; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; SZTALRYD C, 1995, J CLIN INVEST, V95, P2652, DOI 10.1172/JCI117967; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tazoe F, 2008, BIOCHEM BIOPH RES CO, V376, P111, DOI 10.1016/j.bbrc.2008.08.101; Volle DH, 2007, MOL CELL ENDOCRINOL, V265, P183, DOI 10.1016/j.mce.2006.12.018; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Wang SP, 2004, ENDOCRINOLOGY, V145, P5688, DOI 10.1210/en.2004-0919; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu Q, 2003, ENDOCRINOLOGY, V144, P2437, DOI 10.1210/en.2002-221110; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	61	54	58	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8505	8518		10.1074/jbc.M112.417873	http://dx.doi.org/10.1074/jbc.M112.417873			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362264	Green Published, hybrid			2022-12-25	WOS:000316564500047
J	Nguyen, AD; Nguyen, TA; Cenik, B; Yu, G; Herz, J; Walther, TC; Davidson, WS; Farese, RV				Nguyen, Andrew D.; Nguyen, Thi A.; Cenik, Basar; Yu, Gang; Herz, Joachim; Walther, Tobias C.; Davidson, W. Sean; Farese, Robert V., Jr.			Secreted Progranulin Is a Homodimer and Is Not a Component of High Density Lipoproteins (HDL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HOST-DEFENSE; A-I; PLASMA; PROTEIN; INFLAMMATION; GROWTH; SERUM; MICE; CONVERSION	Progranulin is a secreted glycoprotein, and the GRN gene is mutated in some cases of frontotemporal dementia. Progranulin has also been implicated in cell growth, wound healing, inflammation, and cancer. We investigated the molecular nature of secreted progranulin and provide evidence that progranulin exists as a homodimer. Although recombinant progranulin has a molecular mass of similar to 85 kDa by SDS-PAGE, it elutes in fractions corresponding to similar to 170-180 kDa by gel-filtration chromatography. Additionally, recombinant progranulin can be intermolecularly cross-linked, yielding a complex corresponding to a dimer (similar to 180 kDa), and progranulins containing different epitope tags physically interact. In plasma, progranulin similarly forms complexes of similar to 180-190 kDa. Although progranulin partially co-fractionated with high density lipoproteins (HDL) by gel-filtration chromatography, we found no evidence that progranulin in mouse or human plasma is a component of HDL either by ultracentrifugation or by lipid binding assays. We conclude that circulating progranulin exists as a dimer and is not likely a component of HDL.	[Nguyen, Andrew D.; Nguyen, Thi A.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Cenik, Basar; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cenik, Basar; Yu, Gang; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Walther, Tobias C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Davidson, W. Sean] Univ Cincinnati, Ctr Lipid & Arteriosclerosis Sci, Cincinnati, OH 45237 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu		Davidson, William/0000-0003-2756-2989; Nguyen, Andrew/0000-0002-9492-9472; Walther, Tobias/0000-0003-1442-1327	National Institutes of Health [P50 AG023501, GMO100909, R01 AG029547, R01 HL63762, R01 GM097194, F32 HL116197]; Consortium for Frontotemporal Dementia Research; Alzheimer's Disease Research Center; American Diabetes Association; Alzheimer's Association; Welch Foundation; American Health Assistance Foundation; Murchison Foundation; Ted Nash Longlife Foundation; Gladstone Institutes; National Center for Research Resources [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, F32HL116197, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Alzheimer's Disease Research Center; American Diabetes Association(American Diabetes Association); Alzheimer's Association(Alzheimer's Association); Welch Foundation(The Welch Foundation); American Health Assistance Foundation(BrightFocus Foundation); Murchison Foundation; Ted Nash Longlife Foundation; Gladstone Institutes(University of California System); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 AG023501 (to R. V. F.), GMO100909 (to R. V. F.), R01 AG029547 (to G. Y.), R01 HL63762 (to J. H.), R01 GM097194 (to T. C. W.), and F32 HL116197 (to A. D. N.). This work was also supported by Consortium for Frontotemporal Dementia Research (to R. V. F., G. Y., and J. H.), the Alzheimer's Disease Research Center (to R. V. F.), the American Diabetes Association (to R. V. F.), the Alzheimer's Association (to G. Y.), the Welch Foundation (to G. Y.), the American Health Assistance Foundation (to J. H.), the Murchison Foundation (to J. H.), the Ted Nash Longlife Foundation (to J. H.), and the Gladstone Institutes.; We thank Karl Weisgraber and Stephen Young for antibodies, the UCSF Memory and Aging Center for blood samples, Robert Mahley, Yadong Huang, Jay Heinecke, and Daniel Rader for advice, Laura Mitic and members of the Farese laboratory for helpful discussions, Anna Lisa Lucido, and Gary Howard for editorial assistance, John Carroll for assistance with graphics, and Walter Brecht, Grisell Diaz-Ramirez, and Michael Ward for technical assistance. The Gladstone Institutes received support from National Center for Research Resources Grant RR18928.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Carecchio M, 2009, J NEUROL SCI, V287, P291, DOI 10.1016/j.jns.2009.07.011; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; CHAM BE, 1976, J LIPID RES, V17, P176; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2006, AM J PHYSIOL-REG I, V291, pR1602, DOI 10.1152/ajpregu.00616.2005; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tolkatchev D, 2000, BIOCHEMISTRY-US, V39, P2878, DOI 10.1021/bi992130u; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vranken WF, 1999, J PEPT RES, V53, P590, DOI 10.1034/j.1399-3011.1999.00048.x; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	34	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8627	8635		10.1074/jbc.M112.441949	http://dx.doi.org/10.1074/jbc.M112.441949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364791	Green Published, hybrid			2022-12-25	WOS:000316564500063
J	Lopez-Huertas, MR; Mateos, E; del Cojo, MS; Gomez-Esquer, F; Diaz-Gil, G; Rodriguez-Mora, S; Lopez, JA; Calvo, E; Lopez-Campos, G; Alcami, J; Coiras, M				Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Gomez-Esquer, Francisco; Diaz-Gil, Gema; Rodriguez-Mora, Sara; Antonio Lopez, Juan; Calvo, Enrique; Lopez-Campos, Guillermo; Alcami, Jose; Coiras, Mayte			The Presence of HIV-1 Tat Protein Second Exon Delays Fas Protein-mediated Apoptosis in CD4(+) T Lymphocytes A POTENTIAL MECHANISM FOR PERSISTENT VIRAL PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; CYTOCHROME-C RELEASE; CELL-DEATH; CODING EXON; INTERACTING PROTEIN; GENE-EXPRESSION; DOWN-REGULATION; ACTIVATION; BCL-2	HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-kappa B-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-kappa B-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.	[Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Rodriguez-Mora, Sara; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inmunopatol SIDA, Majadahonda 28220, Spain; [Gomez-Esquer, Francisco; Diaz-Gil, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid 28922, Spain; [Antonio Lopez, Juan; Calvo, Enrique] Ctr Nacl Invest Cardiovasc, Unidad Prote, Madrid 28029, Spain; [Lopez-Campos, Guillermo] Melbourne Med Sch, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Rey Juan Carlos; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Coiras, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathol Unit, Ctra Majadahonda Pozuelo Km2, Madrid 28220, Spain.	mcoiras@isciii.es	Campos, Guillermo H Lopez/G-2883-2015; Coiras, Mayte/R-9530-2019; Alcami, Pepe/T-2242-2018; Diaz-Gil, Gema/ABG-6454-2020; Lopez, Juan Antonio/G-7750-2015; Esquer, Francisco Gomez/K-8236-2017; Lopez-Campos, Guillermo/O-4349-2017; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Lopez, Juan Antonio/0000-0002-9097-6060; Lopez-Campos, Guillermo/0000-0003-3011-0940; Lopez Huertas, Maria Rosa/0000-0002-4183-2773; Diaz Gil, Gema/0000-0003-3480-1490; Coiras, Mayte/0000-0001-6464-5770; Rodriguez Mora, Sara/0000-0003-2467-116X; Gomez-Esquer, Francisco/0000-0002-5426-4349	Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant [360924/10]; Spanish Ministry of Economy and Competitiveness [SAF2010-18388]; Spanish Ministry of Health [EC11-285]; AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant [RD06/0006]; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias [PI080752]; Network of Excellence EUROPRISE; European Union; Fondo de Investigaciones Sanitarias [FI09/00347]	Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant; Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias; Network of Excellence EUROPRISE; European Union(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Fundacion para la Investigacion y la Prevencion del Sida en Espana Grant 360924/10, Spanish Ministry of Economy and Competitiveness Grant SAF2010-18388), Spanish Ministry of Health Grant EC11-285, AIDS Network Instituto del Salud Carlos III-Redes Tematicas de Investigacion Cooperativa Grant RD06/0006, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness Grant Fondo de Investigaciones Sanitarias PI080752, and the Network of Excellence EUROPRISE.; Supported by a fellowship from the European Union Programme Health 2009 (Combined Highly Active Anti-Retroviral Microbicides).; Supported by Fellowship FI09/00347 from the Fondo de Investigaciones Sanitarias.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Alekseev OM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-45; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Brenner C, 2003, J CLIN INVEST, V111, P1455, DOI 10.1172/JCI200318609; CARROLL R, 1991, J VIROL, V65, P3460, DOI 10.1128/JVI.65.7.3460-3467.1991; Casula M, 2005, J INFECT DIS, V191, P1468, DOI 10.1086/429412; Chiang CW, 2008, METHOD ENZYMOL, V446, P237, DOI 10.1016/S0076-6879(08)01614-5; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Coiras M, 2006, PROTEOMICS, V6, pS63, DOI 10.1002/pmic.200500437; Conti L, 1998, J EXP MED, V187, P403, DOI 10.1084/jem.187.3.403; Corallini A, 2002, VIROLOGY, V299, P1, DOI 10.1006/viro.2002.1459; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Dandekar DH, 2004, NUCLEIC ACIDS RES, V32, P1270, DOI 10.1093/nar/gkh289; de Lera TL, 1999, ONCOGENE, V18, P1581, DOI 10.1038/sj.onc.1202455; Deniaud A, 2004, MITOCHONDRION, V4, P223, DOI 10.1016/j.mito.2004.06.012; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Gadad SS, 2011, J MOL BIOL, V410, P997, DOI 10.1016/j.jmb.2011.04.009; Gatignol A, 2000, Adv Pharmacol, V48, P209; GIBELLINI D, 1995, BRIT J HAEMATOL, V89, P24, DOI 10.1111/j.1365-2141.1995.tb08915.x; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golstein P, 1998, SCIENCE, V281, P1283, DOI 10.1126/science.281.5381.1283; Gougeon ML, 2005, CELL DEATH DIFFER, V12, P845, DOI 10.1038/sj.cdd.4401616; Hyer ML, 2006, CLIN CANCER RES, V12, P5929, DOI 10.1158/1078-0432.CCR-06-2098; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KURKI P, 1987, J IMMUNOL, V138, P4114; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; Lelievre JD, 2004, CELL DEATH DIFFER, V11, P1017, DOI 10.1038/sj.cdd.4401441; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mahlknecht U, 2008, J LEUKOCYTE BIOL, V83, P718, DOI 10.1189/jlb.0607405; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; McCloskey TW, 1997, J IMMUNOL, V158, P1014; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Moon HS, 2006, MOL CELLS, V21, P7; NARDELLI B, 1995, P NATL ACAD SCI USA, V92, P7312, DOI 10.1073/pnas.92.16.7312; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Paulo Joao A., 2012, Yale Journal of Biology and Medicine, V85, P59; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; PINCUS SH, 1994, J CLIN INVEST, V93, P2505, DOI 10.1172/JCI117260; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; Richard A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.18; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Schories B, 2004, CELL DEATH DIFFER, V11, P940, DOI 10.1038/sj.cdd.4401411; Schwab BL, 1998, EXP CELL RES, V238, P415, DOI 10.1006/excr.1997.3850; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Smith SM, 2003, J BIOL CHEM, V278, P44816, DOI 10.1074/jbc.M307546200; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Szebeni A, 1999, PROTEIN SCI, V8, P905; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Varbanov M, 2006, AIDS REV, V8, P221; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WEISS A, 1984, J IMMUNOL, V133, P123; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xiao H, 1998, BIOCHEM BIOPH RES CO, V244, P384, DOI 10.1006/bbrc.1998.8274; Yang LP, 1997, VIROLOGY, V235, P48, DOI 10.1006/viro.1997.8672; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zachos G, 2001, J VIROL, V75, P2710, DOI 10.1128/JVI.75.6.2710-2728.2001; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045	113	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7626	7644		10.1074/jbc.M112.408294	http://dx.doi.org/10.1074/jbc.M112.408294			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23364796	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000316455300020
J	Li, XM; Yuan, DJ; Zhang, JF; Lin, ZX; Zhang, XL				Li, Ximei; Yuan, Daojun; Zhang, Jinfa; Lin, Zhongxu; Zhang, Xianlong			Genetic Mapping and Characteristics of Genes Specifically or Preferentially Expressed during Fiber Development in Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; BC1 POPULATION; EST-SSRS; BIOSYNTHESIS; ANNOTATION; ELONGATION; BLAST2GO; CLONING; GROWTH	Cotton fiber is an ideal model to study cell elongation and cell wall construction in plants. During fiber development, some genes and proteins have been reported to be specifically or preferentially expressed. Mapping of them will reveal the genomic distribution of these genes, and will facilitate selection in cotton breeding. Based on previous reports, we designed 331 gene primers and 164 protein primers, and used single-strand conformation polymorphism (SSCP) to map and integrate them into our interspecific BC1 linkage map. This resulted in the mapping of 57 loci representing 51 genes or proteins on 22 chromosomes. For those three markers which were tightly linked with quantitative trait loci (QTLs), the QTL functions obtained in this study and gene functions reported in previous reports were consistent. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of 52 polymorphic functional primers showed that 21 gene primers and 17 protein primers had differential expression between Emian22 (Gossypium hirsutum) and 3-79 (G. barbadense). Both RT-PCR and quantitative real-time PCR (qRT-PCR) analyses of the three markers tightly linked with QTLs were consistent with QTL analysis and field experiments. Gene Ontology (GO) categorization revealed that almost all 51 mapped genes belonged to multiple categories that contribute to fiber development, indicating that fiber development is a complex process regulated by various genes. These 51 genes were all specifically or preferentially expressed during fiber cell elongation and secondary wall biosynthesis. Therefore, these functional gene-related markers would be beneficial for the genetic improvement of cotton fiber length and strength.	[Li, Ximei; Yuan, Daojun; Lin, Zhongxu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hubei, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Huazhong Agricultural University; New Mexico State University	Lin, ZX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hubei, Peoples R China.	linzhongxu@mail.hzau.edu.cn	Yuan, Daojun/D-5555-2011; Yuan, Daojun/R-6048-2016	Yuan, Daojun/0000-0001-6007-5571	National Basic Research Program [2010CB126001]; Fundamental Research Funds for the Central Universities [2012MBDX007]	National Basic Research Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Basic Research Program (No. 2010CB126001) and the Fundamental Research Funds for the Central Universities (Program No. 2012MBDX007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fan L, 2006, PLANT PHYSIOL, V140, P603, DOI 10.1104/pp.105.073130; Fan L, 2009, J INTEGR PLANT BIOL, V51, P626, DOI 10.1111/j.1744-7909.2009.00840.x; Fang Dong, 2008, Acta Agronomica Sinica, V34, P207, DOI 10.3724/SP.J.1006.2008.00207; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabber JH, 2004, CR BIOL, V327, P455, DOI 10.1016/j.crvi.2004.02.009; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Han ZhiGuo, 2006, Journal of Agricultural Biotechnology, V14, P360; He YJ, 2008, PLANTA, V228, P473, DOI 10.1007/s00425-008-0751-z; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; Ju Ming, 2009, Acta Agronomica Sinica, V35, P1217, DOI 10.3724/SP.J.1006.2009.01217; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Li XM, 2012, GENOME, V55, P459, DOI [10.1139/G2012-032, 10.1139/g2012-032]; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu CX, 2012, PLANT CELL TISS ORG, V108, P529, DOI 10.1007/s11240-011-0059-8; Lu YZ, 2009, CROP SCI, V49, P1695, DOI 10.2135/cropsci2008.12.0693; Luo M, 2007, PLANT J, V51, P419, DOI 10.1111/j.1365-313X.2007.03144.x; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Varshney RK, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P119, DOI 10.1007/978-90-481-2967-6_5; Wang XQ, 2012, PLANT MOL BIOL REP, V30, P605, DOI 10.1007/s11105-011-0369-3; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang YanJie, 2008, Scientia Agricultura Sinica, V41, P2581; Zhang YX, 2008, GENOME, V51, P534, DOI 10.1139/G08-033; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	40	17	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54444	10.1371/journal.pone.0054444	http://dx.doi.org/10.1371/journal.pone.0054444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372723	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400015
J	Argyropoulos, C; Wang, K; McClarty, S; Huang, D; Bernardo, J; Ellis, D; Orchard, T; Galas, D; Johnson, J				Argyropoulos, Christos; Wang, Kai; McClarty, Sara; Huang, David; Bernardo, Jose; Ellis, Demetrius; Orchard, Trevor; Galas, David; Johnson, John			Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes	PLOS ONE			English	Article							GROWTH-FACTOR NGF; HIGH GLUCOSE; TGF-BETA; EXPRESSION; KIDNEY; TARGETS; MIR-17; CELLS; MICROALBUMINURIA; QUANTIFICATION	Background: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. Methods and Findings: We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. Conclusions: Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes.	[Argyropoulos, Christos; Bernardo, Jose; Johnson, John] Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15260 USA; [Wang, Kai; McClarty, Sara; Huang, David] Inst Syst Biol, Seattle, WA USA; [Huang, David; Galas, David] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Orchard, Trevor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Ellis, Demetrius; Galas, David] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Galas, David] Pacific NW Diabet Res Inst, Seattle, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institute for Systems Biology (ISB); University of Luxembourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pacific Northwest Diabetes Research Institute (PNDRI)	Johnson, J (corresponding author), Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15260 USA.	johnsonj@pitt.edu	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805; orchard, trevor/0000-0001-9552-3215	NIH [DK34818]; ISB University of Luxemburg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034818, R37DK034818, R01DK047874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISB University of Luxemburg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grant #DK34818 and the ISB University of Luxemburg program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bonofiglio R, 2007, J NEPHROL, V20, P186; Box GEP, 1973, NATURE BAYESIAN INFE, P1; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chamorro-Jorganes A, 2011, ARTERIOSCLEROSIS THR; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Heese K, 2003, BIOCHEM PHARMACOL, V65, P293, DOI 10.1016/S0006-2952(02)01487-9; Held L, 2004, J COMPUT GRAPH STAT, V13, P20, DOI 10.1198/1061860043083; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Lorenzen JM, 2011, AM J TRANSPLANTATION; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Neal CS, 2011, NEPHROLOGY DIALYSIS; Ostendorf T, 2011, PEDIAT NEPHROL; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips AO, 1997, KIDNEY INT, V52, P973, DOI 10.1038/ki.1997.419; Roweis S, 1998, ADV NEUR IN, V10, P626; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Scian MJ, 2011, AM J TRANSPLANTATION; Shan D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006800.pub2; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; The Case for Objective Bayesian Analysis, 2006, BAYESIAN ANAL, V1, P385, DOI [10.1214/06-BA115, DOI 10.1214/06-BA115]; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Togliatto G, 2011, DIABETOLOGIA, V54, P1930, DOI 10.1007/s00125-011-2125-5; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang G, 2010, DIS MARKERS, V28, P79, DOI [10.1155/2010/396328, 10.3233/DMA-2010-0687]; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367	64	128	135	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54662	10.1371/journal.pone.0054662	http://dx.doi.org/10.1371/journal.pone.0054662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358711	gold, Green Published			2022-12-25	WOS:000314023600088
J	Bay-Jensen, AC; Wichuk, S; Byrjalsen, I; Leeming, DJ; Morency, N; Christiansen, C; Karsdal, MA; Maksymowych, WP				Bay-Jensen, Anne C.; Wichuk, Stephanie; Byrjalsen, Inger; Leeming, Diana J.; Morency, Nathalie; Christiansen, Claus; Karsdal, Morten A.; Maksymowych, Walter P.			Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; C-REACTIVE PROTEIN; DAMAGE END-POINTS; PSORIATIC-ARTHRITIS; DISEASE-ACTIVITY; VALIDATION; SPONDYLOARTHRITIS; PATHOPHYSIOLOGY; PATHOGENESIS; INFLAMMATION	Inflammation driven connective tissue turnover is key in rheumatic diseases, such as ankylosing spondylitis (AS). Few biomarkers are available for measuring disease prognosis or the efficacy of interventions applied in these tissue-related conditions. Type II collagen is the primary structural protein of cartilage and type III collagen of connective tissues, and obvious targets for the collagenalytic, which increase during tissue inflammation. The objective of the study was to investigate the diagnostic and prognostic utility of cartilage, C2M, and synovial, C3M, turnover biomarkers in AS. Serum samples were retrieved from patients suffering from AS (n = 103), RA (n = 47) and healthy controls (n = 56). AS progressors were defined as having new vertebral syndesmophytes or more that 3 unit change in mSASSS over a two-year period. Type II collagen degradation markers in serum were measured by the C2M ELISA, and type III collagen degradation by the C3M ELISA. Logistic regression and dichotomized decision tree were used to analyze the prognostic value of the markers individually or in combination. Both C2M and C3M levels were significantly higher in RA patients than in healthy controls (p<0.0001). Diagnostic utility was analyzed by ROC and areas under the curve (AUCs) were 72% and 89% for C2M and C3M, respectively. Both C2M and C3M, were significantly higher in serum samples from AS patient than from healthy controls (p<0.0001). The AUCs of C2M and C3M, respectively, were 70% and 81% for AS. A combination of C2M and C3M, dichotomized according to best cut-offs for individual markers, could correctly identify 80% of the progressors and 61% of the non-progressors. The present study is the first to show that specific biomarkers of cartilage and connective tissue degradation facilitate both diagnosis and prediction of progression of RA and AS.	[Bay-Jensen, Anne C.; Byrjalsen, Inger; Leeming, Diana J.; Christiansen, Claus; Karsdal, Morten A.] Nord Biosci, Rheumatol, Herlev, Denmark; [Wichuk, Stephanie; Morency, Nathalie; Maksymowych, Walter P.] Univ Alberta, Div Rheumatol, Edmonton, AB, Canada	Nordic Bioscience; University of Alberta	Bay-Jensen, AC (corresponding author), Nord Biosci, Rheumatol, Herlev, Denmark.	acbj@nordicbioscience.com	Bay-Jensen, Anne-Christine/AEQ-7281-2022	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Karsdal, Morten/0000-0001-5026-8740; Maksymowych, Walter/0000-0002-1291-1755	Danish Research Foundation; department of ACBJ at Nordic Bioscience; University of Alberta; department of WP at Nordic Bioscience	Danish Research Foundation; department of ACBJ at Nordic Bioscience; University of Alberta(University of Alberta); department of WP at Nordic Bioscience	The study was partly supported by the Danish Research Foundation and partly by the research budgets of the departments of ACBJ and WP at Nordic Bioscience and University of Alberta, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ACBJ, IB, DJL and MK are full time employees at, and CC and MK hold stocks in, Nordic Bioscience. This study was partly funded by Nordic Bioscience. Nordic Bioscience is a privately-owned; small-medium size enterprise partly focused the development of biomarkers for rheumatic and fibrotic diseases. The two biomarkers described in the manuscript are patented by Nordic Bioscience (C2M, "ASSAY FOR A TYPE II COLLAGEN BIOMARKER" Patent Application WO/2012/038331; C3M, "FIBROSIS BIOMARKER ASSAY" Patent Application WO/2010/115749 & United States Patent Application 20100209940). Further research on the markers will be conducted which may lead to commercialization. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. WP, SW and NM have no financial or competing interest to declare. WP is a Medical Scientist of the Alberta Heritage Foundation for Medical Research.	Barascuk N, 2010, CLIN BIOCH IN PRESS; Bay-Jensen AC, 2011, RHEUMATOL INT; Bay-Jensen AC, 2011, CLIN BIOCHEM, V44, P423, DOI 10.1016/j.clinbiochem.2011.01.001; Braun J, 2002, CLIN EXP RHEUMATOL, V20, pS16; Colbert Robert A, 2009, J Rheumatol, V36, P1527, DOI 10.3899/jrheum.090122; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; de Vlam K, 2010, BEST PRACT RES CL RH, V24, P671, DOI 10.1016/j.berh.2010.05.009; de Vries MK, 2009, ARTHRIT RHEUM-ARTHR, V61, P1484, DOI 10.1002/art.24838; Garnero P, 2005, ARTHRITIS RHEUM-US, V52, pS56; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Karsdal MA, 2009, BIOMARKERS, V14, P181, DOI 10.1080/13547500902777608; Lories RJ, 2009, CLIN EXP RHEUMATOL, V27, pS10; Lukas C, 2007, J RHEUMATOL, V34, P862; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Maksymowych WP, 2007, ARTHRIT RHEUM-ARTHR, V57, P501, DOI 10.1002/art.22627; Maksymowych WP, 2009, J RHEUMATOL, V36, P1792, DOI 10.3899/jrheum090347; Maksymowych WP, 2009, J RHEUMATOL, V36, P1785, DOI 10.3899/jrheum.090346; Ruof J, 1999, J RHEUMATOL, V26, P966; Schaller S, 2005, ASSAY DRUG DEV TECHN, V3, P553, DOI 10.1089/adt.2005.3.553; Schett G, 2009, CLIN EXP RHEUMATOL, V27, pS33; Schett G, 2007, ANN RHEUM DIS, V66, P42, DOI 10.1136/ard.2007.078972; Segovia-Silvestre Toni, 2011, BMC Res Notes, V4, P407, DOI 10.1186/1756-0500-4-407; Spoorenberg A, 1999, J RHEUMATOL, V26, P980; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vassiliadis E, 2011, BIOMARKERS; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Wanders AJB, 2004, ARTHRIT RHEUM-ARTHR, V51, P1, DOI 10.1002/art.20075	31	57	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54504	10.1371/journal.pone.0054504	http://dx.doi.org/10.1371/journal.pone.0054504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365672	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600062
J	Colacino, JA; Dolinoy, DC; Duffy, SA; Sartor, MA; Chepeha, DB; Bradford, CR; McHugh, JB; Patel, DA; Virani, S; Walline, HM; Bellile, E; Terrell, JE; Stoerker, JA; Taylor, JMG; Carey, TE; Wolf, GT; Rozek, LS				Colacino, Justin A.; Dolinoy, Dana C.; Duffy, Sonia A.; Sartor, Maureen A.; Chepeha, Douglas B.; Bradford, Carol R.; McHugh, Jonathan B.; Patel, Divya A.; Virani, Shama; Walline, Heather M.; Bellile, Emily; Terrell, Jeffrey E.; Stoerker, Jay A.; Taylor, Jeremy M. G.; Carey, Thomas E.; Wolf, Gregory T.; Rozek, Laura S.			Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PAPILLOMAVIRUS-POSITIVE HEAD; ADVANCED OROPHARYNX CANCER; TUMOR-SUPPRESSOR GENE; EPIGENETIC INACTIVATION; GLOBAL HYPOMETHYLATION; COPY-NUMBER; P53; EXPRESSION; REVEALS	Head and neck squamous cell carcinoma (HNSCC) is the eighth most commonly diagnosed cancer in the United States. The risk of developing HNSCC increases with exposure to tobacco, alcohol and infection with human papilloma virus (HPV). HPV-associated HNSCCs have a distinct risk profile and improved prognosis compared to cancers associated with tobacco and alcohol exposure. Epigenetic changes are an important mechanism in carcinogenic progression, but how these changes differ between viral-and chemical-induced cancers remains unknown. CpG methylation at 1505 CpG sites across 807 genes in 68 well-annotated HNSCC tumor samples from the University of Michigan Head and Neck SPORE patient population were quantified using the Illumina Goldengate Methylation Cancer Panel. Unsupervised hierarchical clustering based on methylation identified 6 distinct tumor clusters, which significantly differed by age, HPV status, and three year survival. Weighted linear modeling was used to identify differentially methylated genes based on epidemiological characteristics. Consistent with previous in vitro findings by our group, methylation of sites in the CCNA1 promoter was found to be higher in HPV(+) tumors, which was validated in an additional sample set of 128 tumors. After adjusting for cancer site, stage, age, gender, alcohol consumption, and smoking status, HPV status was found to be a significant predictor for DNA methylation at an additional 11 genes, including CASP8 and SYBL1. These findings provide insight into the epigenetic regulation of viral vs. chemical carcinogenesis and could provide novel targets for development of individualized therapeutic and prevention regimens based on environmental exposures.	[Colacino, Justin A.; Dolinoy, Dana C.; Virani, Shama; Rozek, Laura S.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Duffy, Sonia A.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Duffy, Sonia A.; Chepeha, Douglas B.; Bradford, Carol R.; Walline, Heather M.; Terrell, Jeffrey E.; Carey, Thomas E.; Wolf, Gregory T.; Rozek, Laura S.] Univ Michigan, Sch Med, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [McHugh, Jonathan B.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Patel, Divya A.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Bellile, Emily] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Stoerker, Jay A.] Sequenom Ctr Mol Med, San Diego, CA USA; [Taylor, Jeremy M. G.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; University of Michigan System; University of Michigan; Sequenom; University of Michigan System; University of Michigan	Rozek, LS (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	rozekl@umich.edu	Virani, Shama/AAX-3943-2020; Sartor, Maureen/L-2902-2019	Virani, Shama/0000-0002-1163-432X; Carey, Thomas/0000-0002-5202-7518; Chepeha, Douglas/0000-0001-9062-3719	University of Michigan Head and Neck Specialized Program of Research Excellence [NIH/NCI CA097248, NIH/NCI R01CA158286]; National Institute of Environmental Health Sciences (NIEHS) [T32 ES007062]; National Human Genome Research Institute (NHGRI) [T32 HG00040]; NATIONAL CANCER INSTITUTE [P50CA097248, T32CA009676, R01CA158286] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062, P30ES017885] Funding Source: NIH RePORTER	University of Michigan Head and Neck Specialized Program of Research Excellence; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded as a part of the University of Michigan Head and Neck Specialized Program of Research Excellence, NIH/NCI CA097248, as well as through NIH/NCI R01CA158286. Support for JAC was provided by Institutional Training Grants from the National Institute of Environmental Health Sciences (NIEHS) (T32 ES007062) and the National Human Genome Research Institute (NHGRI) (T32 HG00040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arthur AE, 2011, NUTR CANCER, V63, P734, DOI 10.1080/01635581.2011.570894; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boyer SN, 1996, CANCER RES, V56, P4620; Califano J, 1996, CANCER RES, V56, P2488; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Duffy SA, 2009, J CLIN ONCOL, V27, P1969, DOI 10.1200/JCO.2008.18.2188; ElNaggar AK, 1997, AM J PATHOL, V151, P1767; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lee SH, 2011, OTOLARYNG HEAD NECK, V145, P64, DOI 10.1177/0194599811401327; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Maxwell JH, 2010, HEAD NECK-J SCI SPEC, V32, P562, DOI 10.1002/hed.21216; Monk D, 2008, GENOME RES, V18, P1270, DOI 10.1101/gr.077115.108; Paluszczak J, 2011, ORAL ONCOL, V47, P104, DOI 10.1016/j.oraloncology.2010.11.006; Poage GM, 2011, CLIN CANCER RES, V17, P3579, DOI 10.1158/1078-0432.CCR-11-0044; Ribarska Teodora, 2010, Cancer Genomics & Proteomics, V7, P51; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Sartor MA, 2011, EPIGENETICS-US, V6, P777, DOI 10.4161/epi.6.6.16216; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SOMERS KD, 1992, CANCER RES, V52, P5997; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Tang AL, 2012, HEAD NECK-J SCI SPEC, V34, P1480, DOI 10.1002/hed.21962; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsunematsu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005892; Uesugi H, 2005, INT J MOL MED, V15, P597; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Wang SJ, 2008, BIOMETRICS, V64, P440, DOI 10.1111/j.1541-0420.2007.00922.x; Weiss D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-259; Weiss D, 2011, MOL CARCINOGEN, V50, P680, DOI 10.1002/mc.20798; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Wilop S, 2011, BRIT J HAEMATOL, V155, P65, DOI 10.1111/j.1365-2141.2011.08801.x; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597	52	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54742	10.1371/journal.pone.0054742	http://dx.doi.org/10.1371/journal.pone.0054742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358896	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600102
J	Harboe, ZB; Valentiner-Branth, P; Ingels, H; Rasmussen, JN; Andersen, PHS; Bjerre, CC; Goldblatt, D; Ashton, L; Haston, M; Konradsen, HB; Lambertsen, L				Harboe, Zitta B.; Valentiner-Branth, Palle; Ingels, Helene; Rasmussen, Jeppe N.; Andersen, Peter H. S.; Bjerre, Catherine C.; Goldblatt, David; Ashton, Lindsey; Haston, Mitch; Konradsen, Helle B.; Lambertsen, Lotte		Danish Pneumococcal Surveillance	Pediatric Invasive Pneumococcal Disease Caused by Vaccine Serotypes following the Introduction of Conjugate Vaccination in Denmark	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IMMUNOGENICITY; MENINGITIS; ANTIBODIES; SCHEDULE; CHILDREN; INFANTS; PROGRAM; SAFETY; ERA	A seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the Danish childhood immunization program (2+1 schedule) in October 2007, followed by PCV13 starting from April 2010. The nationwide incidence of IPD among children younger than 5 years nearly halved after the introduction of PCV7 in the program, mainly due to a decline in IPD caused by PCV7-serotypes. We report the results from a nationwide population-based cohort study of laboratory confirmed IPD cases in children younger than 5 years during October 1, 2007 to December 31, 2010 and describe the characteristics of children suspected to present with a vaccine failure. The period between April 19 and December 31, 2010 was considered a PCV7/PCV13 transitional period, where both vaccines were offered. We identified 45 episodes of IPD caused by a PCV7 serotype (23% of the total number) and 105 (55%) caused by one of the 6 additional serotypes in PCV13. Ten children had received at least one PCV7 dose before the onset of IPD caused by a PCV7 serotype. Seven children were considered to be incompletely vaccinated before IPD, but only three cases fulfilled the criteria of vaccine failure (caused by serotypes 14, 19F and 23F). One case of vaccine failure was observed in a severely immunosuppressed child following three PCV7 doses, and two cases were observed in immunocompetent children following two infant doses before they were eligible for their booster. None of the IPD cases caused by the additional PCV13 serotypes had been vaccinated by PCV13 and there were therefore no PCV13-vaccine failures in the first 8-months after PCV13 introduction in Denmark.	[Harboe, Zitta B.; Ingels, Helene; Konradsen, Helle B.; Lambertsen, Lotte] Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Ctr, DK-2300 Copenhagen, Denmark; [Valentiner-Branth, Palle; Rasmussen, Jeppe N.; Andersen, Peter H. S.; Bjerre, Catherine C.] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Goldblatt, David; Ashton, Lindsey; Haston, Mitch] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Statens Serum Institut; Statens Serum Institut; University of London; University College London	Harboe, ZB (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Ctr, DK-2300 Copenhagen, Denmark.	zit@ssi.dk	Harboe, Zitta Barrella/AAZ-2569-2020; Skov, Robert/ABB-3105-2020; Goldblatt, David/C-5972-2008	Harboe, Zitta Barrella/0000-0001-5552-0095; Skov, Robert/0000-0002-6079-5381; Goldblatt, David/0000-0002-0769-5242; Christensen, Jens Jorgen/0000-0001-6721-4917; Lambertsen, Lotte/0000-0001-6409-6337; Dessau, Ram/0000-0002-1497-6309	Statens Serum Institut; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Statens Serum Institut; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by Statens Serum Institut, since data were collected routinely for national surveillance purposes through funding allocated to national surveillance. The funding entity did not have any influence in the study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Angoulvant FO, 2005, CLIN INFECT DIS, V40, P494; [Anonymous], 2007, BEK NR 1102 AF 20 09, V20; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Changed Pneumococcal Vaccine for Children, 2010, EPI NEWS, V2010, P15; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; De Carvalho GH, 2009, EURO SURVEILL, V14, P19159; Deceuninck G, 2010, PEDIATR INFECT DIS J, V29, P546, DOI 10.1097/INF.0b013e3181cffa2a; DTaP-IPV/Hib vaccination coverage, 2011, EPI NEWS, V2011, P20; Ekstrom N, 2005, INFECT IMMUN, V73, P369, DOI 10.1128/IAI.73.1.369-377.2005; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; Harboe ZB, 2008, VACCINE, V26, P3765, DOI 10.1016/j.vaccine.2008.04.040; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hsu K, 2005, PEDIATR INFECT DIS J, V24, P17, DOI 10.1097/01.inf.0000148891.32134.36; Isapof A, 2009, ARCH PEDIATRIE, V16, P1133, DOI 10.1016/j.arcped.2009.04.014; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Lambertsen L, 2010, ABSTRACT PRESENTED A; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; O'Brien KL, 2009, VACCINE, V27, P1863, DOI 10.1016/j.vaccine.2008.12.060; Park SY, 2010, J PEDIATR-US, V156, P478, DOI 10.1016/j.jpeds.2009.10.008; PCV 7 coverage & Invasive Pneumococcal Disease (IPD), 2010, EPI NEWS, V2010, P7; Pneumokokvaccine i det Danske Bornevaccinationsprgram, 2008, EPI NEWS, V2008, P38; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Rose CE, 2011, CLIN VACCINE IMMUNOL, V18, P135, DOI 10.1128/CVI.00370-10; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	35	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e51460	10.1371/journal.pone.0051460	http://dx.doi.org/10.1371/journal.pone.0051460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365635	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600002
J	Ju, RT; Gao, L; Zhou, XH; Li, B				Ju, Rui-Ting; Gao, Lei; Zhou, Xu-Hui; Li, Bo			Tolerance to High Temperature Extremes in an Invasive Lace Bug, Corythucha ciliata (Hemiptera: Tingidae), in Subtropical China	PLOS ONE			English	Article							SIMULATED CLIMATE-CHANGE; LIFE-HISTORY RESPONSES; GREEN STINK BUG; NEZARA-VIRIDULA; HEAT-SHOCK; PHENOTYPIC PLASTICITY; HYMENOPTERA; EXPOSURE; EVENTS; ADULTS	Biological invasions are predicted to be more frequent as climate change is increasing its positive impact on the prevalence of invasive exotic species. Success of insect invaders in different temperature zones is closely related to their tolerance to temperature extremes. In this study, we used an exotic lace bug (Corythucha ciliata) as the study organism to address the hypotheses that an insect species invading a subtropical zone from temperate regions has a high capacity to survive and adapt to high temperatures, and that its thermal tolerance plays an important role in determining its seasonal abundance and geographic distribution. To test these hypotheses, the effects of heat shock on the survival and reproduction of C. ciliata adults were assessed in the laboratory. Adults were exposed to 26 (control), 35, 37, 39, 41, 43, and 45 degrees C for 2 h, and then were transferred to 26 degrees C. Heat-shock temperatures ranging from 35 to 41 degrees C did not significantly affect survival pattern, longevity, and fecundity of adults, but heat shock at 43 and 45 degrees C significantly reduced these traits. Exposing parent females to heat-shock treatments from 35 to 41 degrees C did not significantly affect the hatching rate of their eggs, survival of the nymphs, and the proportion of female F-1 progeny, while no progeny were produced with treatments of 43 and 45 degrees C. The results indicate that C. ciliata can tolerate high temperatures less than 41 degrees C, which may contribute to its expansion into the lower latitudes in China where its hosts (Platanus trees) are widely planted. Our findings have important implications for predicting seasonal abundance and understanding invasion mechanisms of this important urban invader under climate change.	[Ju, Rui-Ting; Gao, Lei] Shanghai Inst Landscape Gardening Sci, Dept Plant Protect, Shanghai, Peoples R China; [Ju, Rui-Ting; Zhou, Xu-Hui; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China	Fudan University	Li, B (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China.	bool@fudan.edu.cn	Zhou, Xuhui/H-4332-2011; Ju, Rui-Ting/E-7538-2016; Li, Bo/AAA-8968-2020; Ju, Rui-Ting/AAD-2444-2019; Zhou, Xuhui/O-5727-2019; Li, Bo/B-8016-2010	Li, Bo/0000-0002-7294-6888; Ju, Rui-Ting/0000-0001-9265-8245; Zhou, Xuhui/0000-0002-2038-9901; Li, Bo/0000-0002-0439-5666	National Basic Research Program of China [2009CB119200]; Shanghai Key Project of Science and Technology [10JC1414100]; Shanghai Rising-Star Program (A type) [11QA1406000]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Key Project of Science and Technology; Shanghai Rising-Star Program (A type)	This research was financially supported by the National Basic Research Program of China (No. 2009CB119200), the Shanghai Key Project of Science and Technology (No. 10JC1414100), and the Shanghai Rising-Star Program (A type) (No. 11QA1406000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam HR, 2009, ANN ENTOMOL SOC AM, V102, P233, DOI 10.1603/008.102.0205; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barthell JF, 2002, PAN-PAC ENTOMOL, V78, P235; Benoit JB, 2010, J INSECT PHYSIOL, V56, P1366, DOI 10.1016/j.jinsphys.2010.02.014; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Carlton James T., 2000, P31; Chihrane J, 1997, CAN J ZOOL, V75, P484, DOI 10.1139/z97-059; CHIHRANE J, 1994, ENTOMOPHAGA, V39, P11, DOI 10.1007/BF02373490; Chown SL, 2008, J EXP BIOL, V211, P3353, DOI 10.1242/jeb.019349; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Cui XH, 2008, J INSECT SCI, V8; Cui YD, 2011, J THERM BIOL, V36, P292, DOI 10.1016/j.jtherbio.2011.04.003; Denlinger D. L., 1998, TEMPERATURE SENSITIV, P6; Donat MG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052459; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Halbert S. E., 1998, ENTOMOL CIRCULAR, V387, P1; HOROWITZ AR, 1992, ENVIRON ENTOMOL, V21, P556, DOI 10.1093/ee/21.3.556; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, P9; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Ju RT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0116; Ju RT, 2011, ENTOMOL EXP APPL, V141, P168, DOI 10.1111/j.1570-7458.2011.01180.x; Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012; Ju RT, 2010, CRYOLETTERS, V31, P445; Ju RT, 2009, ENTOMOL NEWS, V120, P409, DOI 10.3157/021.120.0410; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Knop E, 2012, P ROY SOC B-BIOL SCI, V279, P4668, DOI 10.1098/rspb.2012.1564; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Liu Ya-Jun, 2009, Chinese Bulletin of Entomology, V46, P898; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; Mitchell KA, 2011, FUNCT ECOL, V25, P661, DOI 10.1111/j.1365-2435.2010.01821.x; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Musolin DL, 2010, GLOBAL CHANGE BIOL, V16, P73, DOI 10.1111/j.1365-2486.2009.01914.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scott M, 1997, ENTOMOL EXP APPL, V85, P211, DOI 10.1023/A:1003173612155; [史军 SHI Jun], 2009, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V18, P1143; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Speight R. M., 1999, ECOLOGY INSECTS CONC; SPSS, 2006, SPSS BAS 15 0 ED WIN; Takeda K, 2010, PHYSIOL ENTOMOL, V35, P343, DOI 10.1111/j.1365-3032.2010.00748.x; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tougou D, 2009, ENTOMOL EXP APPL, V130, P249, DOI 10.1111/j.1570-7458.2008.00818.x; Wan FH, 2009, RES BIOL INVASIONS C; West-Eberhard Mary Jane, 2003, pi; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Xie Q, 2008, J ECON ENTOMOL, V101, P736, DOI 10.1603/0022-0493(2008)101[736:TROOFF]2.0.CO;2; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	60	28	33	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54372	10.1371/journal.pone.0054372	http://dx.doi.org/10.1371/journal.pone.0054372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365664	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600052
J	Sun, YP; Wang, FW; Wang, N; Dong, YY; Liu, Q; Zhao, L; Chen, H; Liu, WC; Yin, HL; Zhang, XM; Yuan, YX; Li, HY				Sun, Yepeng; Wang, Fawei; Wang, Nan; Dong, Yuanyuan; Liu, Qi; Zhao, Lei; Chen, Huan; Liu, Weican; Yin, Hailong; Zhang, Xiaomei; Yuan, Yanxi; Li, Haiyan			Transcriptome Exploration in Leymus chinensis under Saline-Alkaline Treatment Using 454 Pyrosequencing	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL DISPLAY; LIPID-PEROXIDATION; INNER-MONGOLIA; MESSENGER-RNA; CALCIUM; HYBRIDIZATION; GENOTYPES; PROTEINS; GENOME	Background: Leymus chinensis (Trin.) Tzvel. is a high saline-alkaline tolerant forage grass genus of the tribe Gramineae family, which also plays an important role in protection of natural environment. To date, little is known about the saline-alkaline tolerance of L. chinensis on the molecular level. To better understand the molecular mechanism of saline-alkaline tolerance in L. chinensis, 454 pyrosequencing was used for the transcriptome study. Results: We used Roche-454 massive parallel pyrosequencing technology to sequence two different cDNA libraries that were built from the two samples of control and under saline-alkaline treatment (optimal stress concentration-Hoagland solution with 100 mM NaCl and 200 mM NaHCO3). A total of 363,734 reads in control group and 526,267 reads in treatment group with an average length of 489 bp and 493 bp were obtained, respectively. The reads were assembled into 104,105 unigenes with MIRA sequence assemable software, among which, 73,665 unigenes were in control group, 88,016 unigenes in treatment group and 57,576 unigenes in both groups. According to the comparative expression analysis between the two groups with the threshold of "log2 Ratio >= 1", there were 36,497 up-regulated unegenes and 18,218 down-regulated unigenes predicted to be the differentially expressed genes. After gene annotation and pathway enrichment analysis, most of them were involved in stress and tolerant function, signal transduction, energy production and conversion, and inorganic ion transport. Furthermore, 16 of these differentially expressed genes were selected for real-time PCR validation, and they were successfully confirmed with the results of 454 pyrosequencing. Conclusions: This work is the first time to study the transcriptome of L. chinensis under saline-alkaline treatment based on the 454-FLX massively parallel DNA sequencing platform. It also deepened studies on molecular mechanisms of saline-alkaline in L. chinensis, and constituted a database for future studies.	[Sun, Yepeng; Wang, Fawei; Wang, Nan; Dong, Yuanyuan; Chen, Huan; Liu, Weican; Yin, Hailong; Li, Haiyan] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Sun, Yepeng; Chen, Huan; Liu, Weican; Yin, Hailong; Zhang, Xiaomei; Yuan, Yanxi; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Liu, Qi] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Zhao, Lei] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species GBOWS, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Wenzhou Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, HY (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	hyli99@163.com			Program for New Century Excellent Talents in University [NCET-08-0693]; Special Program for Research of Transgenic Plants [2011ZX08010-002]; National Natural Science Foundation of China [30971804]; State Key Laboratory of Crop Biology at Shandong Agricultural University, China [2010KF02]; Program for Young Scientific and Technological Talents and Outstanding Innovation Team [20111815]; National High Technology Research and Development Program of China (863 Program) [2010AA1000691008]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Program for Research of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Biology at Shandong Agricultural University, China; Program for Young Scientific and Technological Talents and Outstanding Innovation Team; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for New Century Excellent Talents in University (grant number NCET-08-0693), the Special Program for Research of Transgenic Plants (2011ZX08010-002), the National Natural Science Foundation of China (grant number 30971804), the State Key Laboratory of Crop Biology at Shandong Agricultural University, China (grant number 2010KF02), the Program for Young Scientific and Technological Talents and Outstanding Innovation Team (grant number 20111815) and the National High Technology Research and Development Program of China (863 Program) (grant number 2010AA1000691008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1995, NATURE, V377, P3; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALLEN GJ, 1995, PLANT CELL ENVIRON, V18, P105, DOI 10.1111/j.1365-3040.1995.tb00344.x; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Chen M., 1988, RES GRASSLAND ECOSYS, V2, P193; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Christensen CM, 1997, INNOVATORS DILEMMA N; Clayton WD, 1999, KEW B ADDITIONAL SER, V13; DEBOUCK C, 1995, CURR OPIN BIOTECH, V6, P597, DOI 10.1016/0958-1669(95)80098-0; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Leopold A.C., 1983, PLANT IMPROVEMENT IR, P678; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MENNEN H, 1990, J PLANT PHYSIOL, V137, P180, DOI 10.1016/S0176-1617(11)80078-7; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi De-Cheng, 1992, Acta Botanica Sinica, V34, P386; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; SUSSMAN MR, 1994, ANNU REV PLANT PHYS, V45, P211, DOI 10.1146/annurev.pp.45.060194.001235; Valentina M, 2000, PLANT PHYSIOL, V123, P65; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang KP, 1984, GRASSLAND CHINA, V6, P32; WATAD AEA, 1986, PLANT PHYSIOL, V81, P454, DOI 10.1104/pp.81.2.454; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wu FB, 2003, ENVIRON EXP BOT, V50, P67, DOI 10.1016/S0098-8472(02)00113-2; Xia GM, 1996, PLANT SCI, V120, P197, DOI 10.1016/S0168-9452(96)04492-5; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Yan H., 2006, ACTA PRATACULT SIN, V15, P19; Yin Li-Juan, 1993, Acta Botanica Sinica, V35, P619; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379	46	36	39	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53632	10.1371/journal.pone.0053632	http://dx.doi.org/10.1371/journal.pone.0053632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365637	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600016
J	Barutchu, A; Freestone, DR; Innes-Brown, H; Crewther, DP; Crewther, SG				Barutchu, Ayla; Freestone, Dean R.; Innes-Brown, Hamish; Crewther, David P.; Crewther, Sheila G.			Evidence for Enhanced Multisensory Facilitation with Stimulus Relevance: An Electrophysiological Investigation	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; AUDITORY-VISUAL INTERACTIONS; FINGER MOVEMENTS; MOTOR CORTEX; HUMAN BRAIN; NEURONAL OSCILLATIONS; SELECTIVE ATTENTION; OBJECT RECOGNITION; SPECTRAL DYNAMICS; SPATIAL ATTENTION	Currently debate exists relating to the interplay between multisensory processes and bottom-up and top-down influences. However, few studies have looked at neural responses to newly paired audiovisual stimuli that differ in their prescribed relevance. For such newly associated audiovisual stimuli, optimal facilitation of motor actions was observed only when both components of the audiovisual stimuli were targets. Relevant auditory stimuli were found to significantly increase the amplitudes of the event-related potentials at the occipital pole during the first 100 ms post-stimulus onset, though this early integration was not predictive of multisensory facilitation. Activity related to multisensory behavioral facilitation was observed approximately 166 ms post-stimulus, at left central and occipital sites. Furthermore, optimal multisensory facilitation was found to be associated with a latency shift of induced oscillations in the beta range (14-30 Hz) at right hemisphere parietal scalp regions. These findings demonstrate the importance of stimulus relevance to multisensory processing by providing the first evidence that the neural processes underlying multisensory integration are modulated by the relevance of the stimuli being combined. We also provide evidence that such facilitation may be mediated by changes in neural synchronization in occipital and centro-parietal neural populations at early and late stages of neural processing that coincided with stimulus selection, and the preparation and initiation of motor action.	[Barutchu, Ayla; Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Barutchu, Ayla; Freestone, Dean R.; Innes-Brown, Hamish] Bion Inst, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ, Brain Sci Inst, Melbourne, Vic, Australia; [Freestone, Dean R.] Univ Melbourne, NeuroEngn Lab, Melbourne, Vic, Australia; [Barutchu, Ayla] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	La Trobe University; Bionics Institute; Swinburne University of Technology; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Barutchu, A (corresponding author), La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	aylab@unimelb.edu.au	Crewther, Sheila G/A-2165-2008; Innes-Brown, Hamish/H-3298-2019	Innes-Brown, Hamish/0000-0002-1512-2823; Freestone, Dean/0000-0003-2411-5358	School of Psychological Science, La Trobe University; Victorian Government	School of Psychological Science, La Trobe University; Victorian Government	This study was financially supported by the School of Psychological Science, La Trobe University. The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANIBAR A, 1978, ELECTROEN CLIN NEURO, V44, P307, DOI 10.1016/0013-4694(78)90306-1; Baraldi P, 1999, NEUROSCI LETT, V269, P95, DOI 10.1016/S0304-3940(99)00433-4; Barutchu A, 2003, J VISION, V3, p775a; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Bolognini N, 2011, NEUROPSYCHOLOGIA, V49, P231, DOI 10.1016/j.neuropsychologia.2010.11.015; Cacace AT, 2003, HEARING RES, V176, P25, DOI 10.1016/S0378-5955(02)00715-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Corbetta S, 2000, CLIN ENDOCRINOL, V52, P339, DOI 10.1046/j.1365-2265.2000.00933.x; Czigler I, 2001, NEUROREPORT, V12, P223, DOI 10.1097/00001756-200102120-00009; DERAMBURE P, 1993, ELECTROEN CLIN NEURO, V89, P197, DOI 10.1016/0168-5597(93)90133-A; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Efron B., 1994, INTRO BOOTSTRAP; Eimer M, 1998, PSYCHOPHYSIOLOGY, V35, P313, DOI 10.1017/S004857729897086X; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; Graimann B, 2002, CLIN NEUROPHYSIOL, V113, P43, DOI 10.1016/S1388-2457(01)00697-6; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hoshiyama M, 1997, EXP BRAIN RES, V115, P6, DOI 10.1007/PL00005685; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Kanayama N, 2011, NEUROIMAGE; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; Knosche TR, 2002, CLIN NEUROPHYSIOL, V113, P754, DOI 10.1016/S1388-2457(02)00055-X; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Lebib R, 2003, NEUROSCI LETT, V341, P185, DOI 10.1016/S0304-3940(03)00131-9; Mazaheri A, 2005, COGNITIVE BRAIN RES, V24, P81, DOI 10.1016/j.cogbrainres.2004.12.013; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Puce A, 2007, NEUROPSYCHOLOGIA, V45, P93, DOI 10.1016/j.neuropsychologia.2006.04.017; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Sakowitz OW, 2001, COGNITIVE BRAIN RES, V11, P267, DOI 10.1016/S0926-6410(00)00081-1; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Senkowski D, 2005, EXP BRAIN RES, V166, P411, DOI 10.1007/s00221-005-2381-z; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Sinnett S, 2008, ACTA PSYCHOL, V128, P153, DOI 10.1016/j.actpsy.2007.12.002; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vidal J, 2008, CLIN NEUROPHYSIOL, V119, P763, DOI 10.1016/j.clinph.2007.11.178; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079	69	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e52978	10.1371/journal.pone.0052978	http://dx.doi.org/10.1371/journal.pone.0052978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372652	Green Published, gold			2022-12-25	WOS:000314021500009
J	Cetz-Navarro, NP; Espinoza-Avalos, J; Hernandez-Arana, HA; Carricart-Ganivet, JP				Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio; Hernandez-Arana, Hector A.; Carricart-Ganivet, Juan P.			Biological Responses of the Coral Montastraea annularis to the Removal of Filamentous Turf Algae	PLOS ONE			English	Article							REGION-WIDE DECLINES; REEF CORALS; ZOOXANTHELLAE DENSITY; SCLERACTINIAN CORALS; ANTILLARUM PHILIPPI; HERMATYPIC CORALS; BENTHIC ALGAE; WATER-QUALITY; COMPETITION; MACROALGAE	Coral reef degradation increases coral interactions with filamentous turf algae (FTA) and macroalgae, which may result in chronic stress for the corals. We evaluated the effects of short (2.5 month) and long (10 month) periods of FTA removal on tissue thickness (TT), zooxanthellae density (ZD), mitotic index (MI), and concentration of chlorophyll a (Chl a) in Montastraea annularis at the beginning and end of gametogenesis. Ramets (individual lobes within a colony) consistently surrounded by FTA and ramets surrounded by crustose coralline algae (CCA) were used as controls. FTA removal reduced coral stress, indicated by increased TT and ZD and lower MI. The measured effects were similar in magnitude for the short and long periods of algal removal. Ramets were more stressed at the end of gametogenesis compared with the beginning, with lower ZD and Chl a cm(-2), and higher MI. However, it was not possible to distinguish the stress caused by the presence of FTA from that caused by seasonal changes in seawater temperature. Ramets surrounded by CCA showed less stress in comparison with ramets surrounded by FTA: with higher TT, Chl a cm(-2) and ZD, and lower MI values. Coral responses indicated that ramets with FTA suffered the most deleterious effects and contrasted with those measured in ramets surrounded by CCA. According to published studies and our observations, there could be at least six mechanisms associated to FTA in the stress caused to M. annularis by FTA. Owing to the high cover of FTA (in contrast to macroalgae and CCA) in the Caribbean, the chronic stress, the overgrowth and mortality that this functional algal group can cause on M. annularis species complex, a further decline of this important reef-building coral in the Caribbean is expected.	[Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio; Hernandez-Arana, Hector A.] Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico; [Carricart-Ganivet, Juan P.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Nacional Autonoma de Mexico	Espinoza-Avalos, J (corresponding author), Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico.	jespino@ecosur.mx	Espinoza-Avalos, Julio/H-9189-2013; Hernandez-Arana, Hector A./AAL-2400-2020	Espinoza-Avalos, Julio/0000-0001-5697-446X; Hernandez-Arana, Hector A./0000-0001-9769-3349	PADI Foundation [64]; federal funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [32985]; EU	PADI Foundation; federal funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EU(European Commission)	Funding for this study was provided by PADI Foundation (Req. number 64, 2009; NPCN) and federal funds given to ECOSUR (JEA). NPCN was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) through Graduate Research Scholarship (32985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff at Parque Nacional Arrecifes de Xcalak for providing facilities; H. Bahena-Basave for taking most of the photos for this study; J.A. Batun Catzin, R. Herrera-Pavon and D. I. de la Cruz-Gaitan for their field assistance; A. Zavala-Mendoza and A. U. Beltran-Torres for laboratory training; D. I. de la Cruz-Gaitan for assistance in the laboratory; Mark Eakin (NOAA) for providing the temperature data of the EU-funded FORCE Project; and P. Ramsay for correcting the English. Special thanks to the academic editor, S. C. A. Ferse, and two anonymous reviewers for their valuable comments that greatly improved the final version of the manuscript.	Alvarado JJ, 2009, B MAR SCI, V84, P137; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andersen SB, 2010, AQUAT BIOL, V10, P99, DOI 10.3354/ab00270; Barnes DJ, 1999, CORAL REEFS, V18, P213, DOI 10.1007/s003380050185; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; CARPENTER RC, 1981, J MAR RES, V39, P749; Cervino JM, 2003, MAR POLLUT BULL, V46, P573, DOI 10.1016/S0025-326X(03)00071-7; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; CORTES J, 1985, B MAR SCI, V36, P339; Cruz-Pinon G, 2003, MAR BIOL, V143, P491, DOI 10.1007/s00227-003-1127-3; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; Edmunds PJ, 2011, CORAL REEFS, V30, P123, DOI 10.1007/s00338-010-0676-4; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Jorgensen P, 2008, HIDROBIOLOGICA, V18, P257; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kramarsky-Winter E, 2000, MAR BIOL, V137, P867, DOI 10.1007/s002270000416; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; McClanahan TR, 2011, MAR ECOL PROG SER, V437, P89, DOI 10.3354/meps09285; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mumby PJ, 2005, CORAL REEFS, V24, P681, DOI 10.1007/s00338-005-0058-5; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Obura DO, 2009, MAR POLLUT BULL, V58, P206, DOI 10.1016/j.marpolbul.2008.10.002; Okubo N, 2007, MAR BIOL, V151, P353, DOI 10.1007/s00227-006-0490-2; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Ravindran J, 2006, MAR BIOL, V149, P347, DOI 10.1007/s00227-005-0192-1; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; Rogers CS, 2008, P 11 INT COR REEF S, V7, P226; Roy RE, 2004, REV BIOL TROP, V52, P869; Ruiz-Zarate Miguel A., 2003, Atoll Research Bulletin, V496, P318; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Strychar KB, 2005, J EXP MAR BIOL ECOL, V320, P159, DOI 10.1016/j.jembe.2004.12.039; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Titlyanov E, 2006, P 10 INT COR REEF S, V1, P1931; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P229, DOI 10.3354/meps109229; Venera-Ponton DE, 2011, MAR ECOL PROG SER, V421, P109, DOI 10.3354/meps08869; Vermeij MJA, 2011, MAR ECOL PROG SER, V422, P1, DOI 10.3354/meps08964; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103	76	6	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54810	10.1371/journal.pone.0054810	http://dx.doi.org/10.1371/journal.pone.0054810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372774	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500132
J	Ehrentraut, S; Nagel, S; Scherr, ME; Schneider, B; Quentmeier, H; Geffers, R; Kaufmann, M; Meyer, C; Prochorec-Sobieszek, M; Ketterling, RP; Knudson, RA; Feldman, AL; Kadin, ME; Drexler, HG; MacLeod, RAF				Ehrentraut, Stefan; Nagel, Stefan; Scherr, Michaela E.; Schneider, Bjoern; Quentmeier, Hilmar; Geffers, Robert; Kaufmann, Maren; Meyer, Corinna; Prochorec-Sobieszek, Monika; Ketterling, Rhett P.; Knudson, Ryan A.; Feldman, Andrew L.; Kadin, Marshall E.; Drexler, Hans G.; MacLeod, Roderick A. F.			t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5	PLOS ONE			English	Article							T-CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; KINASE-ACTIVITY; IN-VITRO; JAK2; EXPRESSION; FUSION; INHIBITION; SUPPRESSOR; LEUKEMIA	Fusions of the tyrosine kinase domain of JAK2 with multiple partners occur in leukemia/lymphoma where they reportedly promote JAK2-oligomerization and autonomous signalling, Affected entities are promising candidates for therapy with JAK2 signalling inhibitors. While JAK2-translocations occur in myeloid, B-cell and T-cell lymphoid neoplasms, our findings suggest their incidence among the last group is low. Here we describe the genomic, transcriptional and signalling characteristics of PCM1-JAK2 formed by t(8;9)(p22;p24) in a trio of cell lines established at indolent (MAC-1) and aggressive (MAC-2A/2B) phases of a cutaneous T-cell lymphoma (CTCL). To investigate signalling, PCM1-JAK2 was subjected to lentiviral knockdown which inhibited 7 top upregulated genes in t(8;9) cells, notably SOCS2/3. SOCS3, but not SOCS2, was also upregulated in a chronic eosinophilic leukemia bearing PCM1-JAK2, highlighting its role as a central signalling target of JAK2 translocation neoplasia. Conversely, expression of GATA3, a key T-cell developmental gene silenced in aggressive lymphoma cells, was partially restored by PCM1-JAK2 knockdown. Treatment with a selective JAK2 inhibitor (TG101348) to which MAC-1/2A/2B cells were conspicuously sensitive confirmed knockdown results and highlighted JAK2 as the active moiety. PCM1-JAK2 signalling required pSTAT5, supporting a general paradigm of STAT5 activation by JAK2 alterations in lymphoid malignancies. MAC-1/2A/2B - the first JAK2-translocation leukemia/lymphoma cell lines described - display conspicuous JAK/STAT signalling accompanied by T-cell developmental and autoimmune disease gene expression signatures, confirming their fitness as CTCL disease models. Our data support further investigation of SOCS2/3 as signalling effectors, prognostic indicators and potential therapeutic targets in cancers with JAK2 rearrangements.	[Ehrentraut, Stefan; Nagel, Stefan; Quentmeier, Hilmar; Kaufmann, Maren; Meyer, Corinna; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst, DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Scherr, Michaela E.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Schneider, Bjoern] Univ Rostock, Inst Pathol & Mol Pathol, D-18055 Rostock, Germany; [Geffers, Robert] HZI Helmholtz Ctr Infect Res, Dept Genome Anal, Braunschweig, Germany; [Prochorec-Sobieszek, Monika] Inst Hematol & Transfus Med, Dept Diagnost Hematol, Warsaw, Poland; [Ketterling, Rhett P.; Knudson, Ryan A.; Feldman, Andrew L.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Kadin, Marshall E.] Boston Univ, Sch Med, Dept Dermatol & Skin Surg, Roger Williams Med Ctr, Providence, RI USA	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Hannover Medical School; University of Rostock; Helmholtz Association; Helmholtz-Center for Infection Research; Mayo Clinic; Boston University; Roger Williams Medical Center	MacLeod, RAF (corresponding author), Leibniz Inst, DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Cultures, Braunschweig, Germany.	rml@dsmz.de	Prochorec-Sobieszek, Monika/AAD-5065-2020	Prochorec-Sobieszek, Monika/0000-0002-8109-9553; Feldman, Andrew/0000-0001-5009-4808; Ketterling, Rhett/0000-0001-6479-7897	National Institutes of Health [P20GM103414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grant P20GM103414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RM, 2011, CANC BIOL THER, V12; Adelaide J, 2006, LEUKEMIA, V20, P536, DOI 10.1038/sj.leu.2404104; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Bochtler T, 2012, LEUKEMIA, V26, P728, DOI 10.1038/leu.2011.283; Brender C, 2005, LEUKEMIA, V19, P209, DOI 10.1038/sj.leu.2403610; Brender C, 2001, BLOOD, V97, P1056, DOI 10.1182/blood.V97.4.1056; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; DAVIS TH, 1992, NEW ENGL J MED, V326, P1115, DOI 10.1056/NEJM199204233261704; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Drexler HG, 2000, LEUKEMIA LYMPHOMA CE; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Fridman JS, 2011, J INVEST DERMATOL, V131, P1838, DOI 10.1038/jid.2011.140; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hansen N, 2012, LEUKEMIA IN PRESS; Harrison C, 2012, BRIT J HAEMATOL, V157, P426, DOI 10.1111/j.1365-2141.2012.09108.x; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hoeller S, 2011, EXPERT OPIN THER TAR, V15, P53, DOI 10.1517/14728222.2011.538683; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Irino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022148; KADIN ME, 1994, P NATL ACAD SCI USA, V91, P6002, DOI 10.1073/pnas.91.13.6002; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Krejsgaard T, 2011, J INVEST DERMATOL, V131, P1331, DOI 10.1038/jid.2011.27; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lejeune D, 2001, BIOCHEM J, V353, P109, DOI 10.1042/bj3530109; Lierman E, 2012, BLOOD, V120, P1529, DOI 10.1182/blood-2012-06-433821; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Prochorec-Sobieszek M, 2012, LEUKEMIA LYMPHOMA, V53; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quentmeier H, 2008, LEUKEMIA, V22, P2169, DOI 10.1038/leu.2008.226; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Scherr M, 2002, BLOOD, V99, P709, DOI 10.1182/blood.V99.2.709; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096	50	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53767	10.1371/journal.pone.0053767	http://dx.doi.org/10.1371/journal.pone.0053767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372669	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500024
J	Hirose, N; Shimazu, A; Watanabe, M; Tanimoto, K; Koyota, S; Sugiyama, T; Uchida, T; Tanne, K				Hirose, Naoto; Shimazu, Atsushi; Watanabe, Mineo; Tanimoto, Kotaro; Koyota, Souichi; Sugiyama, Toshihiro; Uchida, Takashi; Tanne, Kazuo			Ameloblastin in Hertwig's Epithelial Root Sheath Regulates Tooth Root Formation and Development	PLOS ONE			English	Article							ENAMEL; DIFFERENTIATION; EXPRESSION; PROTEINS; STAGE; CELLS	Tooth root formation begins after the completion of crown morphogenesis. At the end edge of the tooth crown, inner and outer enamel epithelia form Hertwig's epithelial root sheath (HERS). HERS extends along with dental follicular tissue for root formation. Ameloblastin (AMBN) is an enamel matrix protein secreted by ameloblasts and HERS derived cells. A number of enamel proteins are eliminated in root formation, except for AMBN. AMBN may be related to tooth root formation; however, its role in this process remains unclear. In this study, we found AMBN in the basal portion of HERS of lower first molar in mice, but not at the tip. We designed and synthesized small interfering RNA (siRNA) targeting AMBN based on the mouse sequence. When AMBN siRNA was injected into a prospective mandibular first molar of postnatal day 10 mice, the root became shorter 10 days later. Furthermore, HERS in these mice revealed a multilayered appearance and 5-bromo-2'-deoxyuridine (BrdU) positive cells increased in the outer layers. In vitro experiments, when cells were compared with and without transiently expressing AMBN mRNA, expression of growth suppressor genes such as p21(Cip1) and p27(Kip1) was enhanced without AMBN and BrdU incorporation increased. Thus, AMBN may regulate differentiation state of HERS derived cells. Moreover, our results suggest that the expression of AMBN in HERS functions as a trigger for normal root formation.	[Hirose, Naoto; Tanimoto, Kotaro; Tanne, Kazuo] Hiroshima Univ, Dept Orthodont, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Shimazu, Atsushi] Hiroshima Univ, Dept Publ Oral Hlth, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Watanabe, Mineo; Uchida, Takashi] Hiroshima Univ, Dept Oral Biol, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Koyota, Souichi; Sugiyama, Toshihiro] Akita Univ, Grad Sch Med, Dept Biochem, Akita 010, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Akita University	Hirose, N (corresponding author), Hiroshima Univ, Dept Orthodont, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	hirose@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science [24792286]	Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science, grant number 24792286 (elucidation of promoted mechanism of root dentin formation by ameloblastin and application to treatment of root resorption) (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Broderick KE, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.1; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; DenBesten PK, 2005, ARCH ORAL BIOL, V50, P689, DOI 10.1016/j.archoralbio.2004.12.008; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Hao JJ, 2005, BONE, V37, P578, DOI 10.1016/j.bone.2005.05.013; Hatakeyama J, 2009, J DENT RES, V88, P318, DOI 10.1177/0022034509334749; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Huang XF, 2009, DEV BIOL, V334, P22, DOI 10.1016/j.ydbio.2009.06.034; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kitagawa M, 2011, ARCH ORAL BIOL, V56, P374, DOI 10.1016/j.archoralbio.2010.10.012; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nakata A, 2003, BIOCHEM BIOPH RES CO, V308, P834, DOI 10.1016/S0006-291X(03)01467-0; Nguyen T, 2008, CURR OPIN MOL THER, V10, P158; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Spahr A, 2006, EUR J ORAL SCI, V114, P504, DOI 10.1111/j.1600-0722.2006.00403.x; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; Torres-Quintana Maria Angelica, 2005, J Oral Sci, V47, P27, DOI 10.2334/josnusd.47.27; Turchinovich A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-25; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404	27	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54449	10.1371/journal.pone.0054449	http://dx.doi.org/10.1371/journal.pone.0054449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372724	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500071
J	Juengel, E; Makarevic, J; Tsaur, I; Bartsch, G; Nelson, K; Haferkamp, A; Blaheta, RA				Juengel, Eva; Makarevic, Jasmina; Tsaur, Igor; Bartsch, Georg; Nelson, Karen; Haferkamp, Axel; Blaheta, Roman A.			Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PHASE-II; THERAPY; ACETYLATION; COMBINATION; VORINOSTAT; EXPRESSION; PATHWAY; TARGET; TRIAL	Targeted drugs have significantly improved the therapeutic options for advanced renal cell carcinoma (RCC). However, resistance often develops, negating the benefit of these agents. In the present study, the molecular mechanisms of acquired resistance towards the histone deacetylase (HDAC) inhibitor valproic acid (VPA) in a RCC in vivo model were investigated. NMRI:nu/nu mice were transplanted with Caki-1 RCC cells and then treated with VPA (200 mg/kg/day). Controls remained untreated. Based on tumor growth dynamics, the mice were divided into "responders'' and "non-responders'' to VPA. Histone H3 and H4 acetylation and expression of cell signaling and cell cycle regulating proteins in the RCC mouse tumors were evaluated by Western blotting. Tumor growth of VPA responders was significantly diminished, whereas that of VPA non-responders even exceeded control values. Cdk1, 2 and 4 proteins were strongly enhanced in the non-responders. Importantly, Akt expression and activity were massively up-regulated in the tumors of the VPA non-responders. Chronic application (12 weeks) of VPA to Caki-1 cells in vitro evoked a distinct elevation of Akt activity and cancer cells no longer responded with cell growth reduction, compared to the short 2 week treatment. We assume that chronic use of an HDAC-inhibitor is associated with (re)-activation of Akt, which may be involved in resistance development. Consequently, combined blockade of both HDAC and Akt may delay or prevent drug resistance in RCC.	[Juengel, Eva; Makarevic, Jasmina; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany; [Nelson, Karen] Goethe Univ Frankfurt, Dept Vasc & Endovasc Surg, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Blaheta, RA (corresponding author), Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523	Gisela Stadelmann-Stiftung; Ellinore and Herbert Vogel-Stiftung	Gisela Stadelmann-Stiftung; Ellinore and Herbert Vogel-Stiftung	This work was supported by the Gisela Stadelmann-Stiftung and the Ellinore and Herbert Vogel-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins DJ, 2005, VIRCHOWS ARCH, V447, P634, DOI 10.1007/s00428-005-1262-y; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Coronel J, 2011, MED ONCOL, V28, pS540, DOI 10.1007/s12032-010-9700-3; Fedier A, 2007, INT J ONCOL, V31, P633; Hainsworth JD, 2011, CANCER INVEST, V29, P451, DOI 10.3109/07357907.2011.590568; Ikuerowo SO, 2006, INT J CANCER, V119, P867, DOI 10.1002/ijc.21869; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones J, 2009, J CELL MOL MED, V13, P2342, DOI 10.1111/j.1582-4934.2008.00603.x; Jones J, 2009, J CELL MOL MED, V13, P2376, DOI 10.1111/j.1582-4934.2008.00436.x; Juengel E, 2012, CANC LETT IN PRESS; Kanao K, 2008, J UROLOGY, V180, P1131, DOI 10.1016/j.juro.2008.04.136; Kato Y, 2007, CLIN CANCER RES, V13, P4538, DOI 10.1158/1078-0432.CCR-07-0014; Kodani M, 2005, ONCOL REP, V13, P477; Migita T, 2002, CANCER-AM CANCER SOC, V94, P973, DOI 10.1002/cncr.10338.abs; Mosashvilli D, 2010, CANCER SCI, V101, P2664, DOI 10.1111/j.1349-7006.2010.01717.x; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Pertia A, 2009, INT UROL NEPHROL, V41, P243, DOI 10.1007/s11255-008-9442-8; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Porta C, 2009, J UROLOGY, V182, P2569, DOI 10.1016/j.juro.2009.08.085; Qian C, 2012, CLIN CANC R IN PRESS; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stadler WM, 2006, CLIN GENITOURIN CANC, V5, P57, DOI 10.3816/CGC.2006.n.018; Strickler JH, 2012, CANC CHEMOT IN PRESS	24	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53100	10.1371/journal.pone.0053100	http://dx.doi.org/10.1371/journal.pone.0053100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372654	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500011
J	Larson, DW; Currie, PJ				Larson, Derek W.; Currie, Philip J.			Multivariate Analyses of Small Theropod Dinosaur Teeth and Implications for Paleoecological Turnover through Time	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; HELL CREEK FORMATION; DENTAL MORPHOLOGY; NORTH-DAKOTA; BIG-BEND; DIVERSITY; ALBERTA; TOOTH; DROMAEOSAURIDAE; IDENTIFICATION	Isolated small theropod teeth are abundant in vertebrate microfossil assemblages, and are frequently used in studies of species diversity in ancient ecosystems. However, determining the taxonomic affinities of these teeth is problematic due to an absence of associated diagnostic skeletal material. Species such as Dromaeosaurus albertensis, Richardoestesia gilmorei, and Saurornitholestes langstoni are known from skeletal remains that have been recovered exclusively from the Dinosaur Park Formation (Campanian). It is therefore likely that teeth from different formations widely disparate in age or geographic position are not referable to these species. Tooth taxa without any associated skeletal material, such as Paronychodon lacustris and Richardoestesia isosceles, have also been identified from multiple localities of disparate ages throughout the Late Cretaceous. To address this problem, a dataset of measurements of 1183 small theropod teeth (the most specimen-rich theropod tooth dataset ever constructed) from North America ranging in age from Santonian through Maastrichtian were analyzed using multivariate statistical methods: canonical variate analysis, pairwise discriminant function analysis, and multivariate analysis of variance. The results indicate that teeth referred to the same taxon from different formations are often quantitatively distinct. In contrast, isolated teeth found in time equivalent formations are not quantitatively distinguishable from each other. These results support the hypothesis that small theropod taxa, like other dinosaurs in the Late Cretaceous, tend to be exclusive to discrete host formations. The methods outlined have great potential for future studies of isolated teeth worldwide, and may be the most useful non-destructive technique known of extracting the most data possible from isolated and fragmentary specimens. The ability to accurately assess species diversity and turnover through time based on isolated teeth will help illuminate patterns of evolution and extinction in these groups and potentially others in greater detail than has previously been thought possible without more complete skeletal material.	[Larson, Derek W.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Larson, DW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	derek.larson@mail.utoronto.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Dinosaur Research Institute; Queen Elizabeth II Scholarship; Natural Sciences and Engineering Research Council of Canada [203091-06, 203091-2011]	Dinosaur Research Institute; Queen Elizabeth II Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this study included a student research grant from the Dinosaur Research Institute (www.dinosaurresearch.com) and a Queen Elizabeth II Scholarship to DWL. Also, Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) Grants #203091-06 and # 203091-2011 were provided to PJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Archibald JD, 1997, ENCY DINOSAURS, P221; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Brinkman DB, 2001, PALAEOGEOGR PALAEOCL, V213, P295; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E., 1986, Revue de Paleobiologie, V5, P217; Burnham DA, 2004, LIFE O PAST, P67; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Candeiro CRA, 2004, J S AM EARTH SCI, V18, P1, DOI 10.1016/j.jsames.2004.08.004; CARPENTER K, 1982, Contributions to Geology University of Wyoming, V20, P123; Christiansen P, 2003, NEUES JAHRB GEOL P-A, V227, P287; Cope E.D., 1876, P ACAD NAT SCI PHILA, V28, P340; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; De Valais S, 2001, AMEGHINIANA, V38, P6; Eaton JG, 2006, J VERTEBR PALEONTOL, V26, P446, DOI 10.1671/0272-4634(2006)26[446:SLCMFT]2.0.CO;2; Estes R., 1964, University of California Publications in Geological Sciences, V49, P1; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Fanti F, 2009, PALAEOGEOGR PALAEOCL, V275, P37, DOI 10.1016/j.palaeo.2009.02.007; Farlow J.O., 1991, Modern Geology, V16, P161; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Godefroit P, 2008, J VERTEBR PALEONTOL, V28, P432, DOI 10.1671/0272-4634(2008)28[432:ANSOVD]2.0.CO;2; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Han FL, 2011, J VERTEBR PALEONTOL, V31, P111, DOI 10.1080/02724634.2011.546291; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; HUTCHISON JH, 1986, PALAEOGEOGR PALAEOCL, V55, P1, DOI 10.1016/0031-0182(86)90133-1; JMP, 2002, JMP VERS 5; Larson DW, 2010, CAN J EARTH SCI, V47, P1159, DOI 10.1139/E10-005; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Lehman Thomas M., 2001, P310; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P72; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Lloyd GT, 2012, BIOL LETTERS, V8, P123, DOI 10.1098/rsbl.2011.0210; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Longrich Nick, 2008, P135; Lyson TR, 2010, J VERTEBR PALEONTOL, V30, P394, DOI 10.1080/02724631003618389; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Park EJ, 2000, THESIS KYUNGPOOK NAT; Pearson DA, 2002, GEOL S AM S, P145; Poblete F, 2003, 19 JORN ARG PAL VERT, P24; Prieto-Marquez A, 2000, ECLOGAE GEOL HELV, V93, P497; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; Rauhut OWM, 2002, CRETACEOUS RES, V23, P255, DOI 10.1006/cres.2002.1003; Ruiz-Omenaca J.I., 1996, MAS MATAS, V15, P59; Russell DA, 2002, GEOL S AM S, P169; Ryan MJ, 2005, LIFE O PAST, P312; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; Sankey JT, 2005, LIFE O PAST, P127; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Sankey Julia T., 2008, P117; SANZ J L, 1987, Estudios Geologicos (Madrid), P45; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Sweetman SC, 2004, CRETACEOUS RES, V25, P353, DOI 10.1016/j.cretres.2004.01.004; Telles Antunes M., 1991, Comptes Rendus de l'Academie des Sciences Serie II Mecanique-Physique-Chimie Sciences de l'Univers Sciences de la Terre, V313, P113; Torices A., 2004, GEOTEMAS, V6, P71; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vilas Boas I., 1999, AN ACAD BRAS CIENC, V71, P846; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Weigert Andrea, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V9, P562; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	73	66	67	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54329	10.1371/journal.pone.0054329	http://dx.doi.org/10.1371/journal.pone.0054329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372708	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500059
J	Lopez-Lopez, P; Benavent-Corai, J; Garcia-Ripolles, C; Urios, V				Lopez-Lopez, Pascual; Benavent-Corai, Jose; Garcia-Ripolles, Clara; Urios, Vicente			Scavengers on the Move: Behavioural Changes in Foraging Search Patterns during the Annual Cycle	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; LEVY WALKS EVOLVE; SCALING LAWS; FLIGHT; MOVEMENTS; SANITARY; TRACKING; ECOLOGY; SUCCESS; CONTEXT	Background: Optimal foraging theory predicts that animals will tend to maximize foraging success by optimizing search strategies. However, how organisms detect sparsely distributed food resources remains an open question. When targets are sparse and unpredictably distributed, a Levy strategy should maximize foraging success. By contrast, when resources are abundant and regularly distributed, simple Brownian random movement should be sufficient. Although very different groups of organisms exhibit Levy motion, the shift from a Levy to a Brownian search strategy has been suggested to depend on internal and external factors such as sex, prey density, or environmental context. However, animal response at the individual level has received little attention. Methodology/Principal Findings: We used GPS satellite-telemetry data of Egyptian vultures Neophron percnopterus to examine movement patterns at the individual level during consecutive years, with particular interest in the variations in foraging search patterns during the different periods of the annual cycle (i.e. breeding vs. non-breeding). Our results show that vultures followed a Brownian search strategy in their wintering sojourn in Africa, whereas they exhibited a more complex foraging search pattern at breeding grounds in Europe, including Levy motion. Interestingly, our results showed that individuals shifted between search strategies within the same period of the annual cycle in successive years. Conclusions/Significance: Results could be primarily explained by the different environmental conditions in which foraging activities occur. However, the high degree of behavioural flexibility exhibited during the breeding period in contrast to the non-breeding period is challenging, suggesting that not only environmental conditions explain individuals' behaviour but also individuals' cognitive abilities (e. g., memory effects) could play an important role. Our results support the growing awareness about the role of behavioural flexibility at the individual level, adding new empirical evidence about how animals in general, and particularly scavengers, solve the problem of efficiently finding food resources.	[Lopez-Lopez, Pascual; Garcia-Ripolles, Clara; Urios, Vicente] Univ Alicante, Vertebrates Zool Res Grp, CIBIO Res Inst, E-03080 Alicante, Spain; [Benavent-Corai, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain	Universitat d'Alacant; University of Valencia	Lopez-Lopez, P (corresponding author), Univ Alicante, Vertebrates Zool Res Grp, CIBIO Res Inst, E-03080 Alicante, Spain.	Pascual.Lopez@uv.es	Urios, Vicente/AAD-4800-2022; López-López, Pascual/C-1039-2011	López-López, Pascual/0000-0001-5269-652X	Terra Natura Foundation (Spain); Spanish Regional Administration (Generalitat Valenciana ); Spanish Regional Administration (Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]	Terra Natura Foundation (Spain); Spanish Regional Administration (Generalitat Valenciana )(Center for Forestry Research & Experimentation (CIEF)); Spanish Regional Administration (Junta de Comunidades de Castilla-La Mancha)(Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Satellite tracking devices were supported by the Terra Natura Foundation (Spain) and two Spanish Regional Administrations (Generalitat Valenciana and Junta de Comunidades de Castilla-La Mancha). PLL is supported by a "Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadon JD, 2010, ANIM CONSERV, V13, P495, DOI 10.1111/j.1469-1795.2010.00369.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; [Anonymous], 2008, MATLAB 2008 VERS 7 7; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; BirdLife International, 2012, SPEC FACTSH NEOPHR P; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CEBALLOS O, 1990, Journal of Raptor Research, V24, P19; Christie D ., 2001, RAPTORS BIRDS PREY W; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Cortes-Avizanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021016; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; de Jager M, 2012, SCIENCE, V335, DOI 10.1126/science.1215903; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Garcia-Ripolles C, 2010, BIRD STUDY, V57, P261, DOI 10.1080/00063650903505762; Gotelli NJ, 2013, ECOSIMR 1 00; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jasen VAA, 2012, SCIENCE, V335, P918; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kenward RE., 2000, MANUAL WILDLIFE RADI; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Margalida A, 2012, SCIENCE, V335, P284, DOI 10.1126/science.335.6066.284-a; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; Mundy P., 1992, VULTURES AFRICA; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; SOKAL RR, 1994, BIOMETRY; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zwarts L., 2009, LIVING EDGE WETLANDS	65	41	41	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54352	10.1371/journal.pone.0054352	http://dx.doi.org/10.1371/journal.pone.0054352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372712	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500063
J	Lyra, C; Sinkko, H; Rantanen, M; Paulin, L; Kotilainen, A				Lyra, Christina; Sinkko, Hanna; Rantanen, Matias; Paulin, Lars; Kotilainen, Aarno			Sediment Bacterial Communities Reflect the History of a Sea Basin	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BALTIC SEA; MARINE-SEDIMENTS; MICROBIAL COMMUNITIES; ENVIRONMENTAL-CHANGE; HOLOCENE HISTORY; GOTLAND BASIN; HUMAN IMPACT; METHANE; DIVERSITY	How entire microbial communities are structured across stratified sediments from the historical standpoint is unknown. The Baltic Sea is an ideal research object for historical reconstruction, since it has experienced many fresh-and brackish water periods and is depleted of dissolved oxygen, which increases the sediment's preservation potential. We investigated the bacterial communities, chemical elements (e. g. Cr, Pb Na, P, Sr and U) and sediment composition in a stratified sediment core dated by radiocarbon and spanning 8000 years of Baltic Sea history, using up-to-date multivariate statistics. The communities were analysed by 16S rRNA gene terminal restriction fragment length polymorphism. The communities of the deep Early Litorina and surface Late Litorina Sea laminae were separated from the communities of the middle Litorina Sea laminae, which were associated with elevated concentrations of U and Sr trace elements, palaeo-oxygen and palaeosalinity proxies. Thus, the Litorina Sea laminae were characterized by past oxygen deficiency and salinity increase. The communities of the laminae, bioturbated and homogeneous sediments were differentiated, based on the same historical sea phases, with correct classifications of 90%. Palaeosalinity was one of the major parameters that separated the bacterial communities of the stratified sediments. A discontinuous spatial structure with a surprising increase in community heterogeneity was detected in Litorina Sea sediments from 388 to 422 cm deep, which suggests that a salinity maximum occurred in the central Gulf of Finland app. 6200-6600 years ago. The community heterogeneity decreased from the surface down to 306 cm, which reflected downcore mineralization. The plateau of the decrease was in the app. 2000-year-old sediment layers. Bacterial community data may be used as an additional tool in ocean-drilling projects, in which it is important to detect mineralization plateaus both to determine historically comparable portions of sediment samples and historical events, such as sea-level rise culminations.	[Lyra, Christina; Sinkko, Hanna] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kotilainen, Aarno] Geol Survey Finland, FIN-02150 Espoo, Finland	University of Helsinki; University of Helsinki; Geological Survey of Finland (GTK)	Lyra, C (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	christina.lyra@helsinki.fi		Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling foundation; Centre of Excellence [53305, 118637]; Academy of Finland [214457, 115400]	Maj and Tor Nessling foundation; Centre of Excellence; Academy of Finland(Academy of Finland)	The authors' work was supported by Maj and Tor Nessling foundation, the Centre of Excellence (53305, 118637), and the grants of the Academy of Finland (214457, 115400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Andren E, 2000, HOLOCENE, V10, P687, DOI 10.1191/09596830094944; Aquilina A, 2010, ORG GEOCHEM, V41, P414, DOI 10.1016/j.orggeochem.2009.09.009; Berglund BE, 2005, QUATERN INT, V130, P111, DOI 10.1016/j.quaint.2004.04.036; Bocard D., 1992, ECOLOGY, V73, P1045, DOI DOI 10.2307/1940179; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Brenner WW, 2005, PALAEOGEOGR PALAEOCL, V220, P227, DOI 10.1016/j.palaeo.2004.12.010; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coolen MJL, 2008, ENVIRON MICROBIOL, V10, P1783, DOI 10.1111/j.1462-2920.2008.01601.x; Coolen MJL, 2009, EARTH PLANET SC LETT, V284, P610, DOI 10.1016/j.epsl.2009.05.029; Coolen MJL, 2004, ORG GEOCHEM, V35, P1151, DOI 10.1016/j.orggeochem.2004.06.009; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Emeis KC, 2003, HOLOCENE, V13, P411, DOI 10.1191/0959683603hl634rp; Eronen M, 1988, GEOLOGICAL SURVEY FI, V6, P11; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Kemp A.E.S, 1996, GEOLOGICAL SOC SPECI, V116, P258; Kindt R., 2005, WORLD; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Legendre P., 2012, NUMERICAL ECOLOGY; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lopez-Buendia AM, 1999, CHEM GEOL, V157, P235, DOI 10.1016/S0009-2541(98)00207-1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Miettinen A, 2004, QUATERN INT, V120, P91, DOI 10.1016/j.quaint.2004.01.009; MILLER U, 1986, P 8 INT DIAT S PAR 1, P601; Nath BN, 1997, GEOCHIM COSMOCHIM AC, V61, P2375; Oksanen J., 2008, VEGAN COMMUNITY ECOL; R Development Core Team, 2007, R LANG ENV STAT COMP; Sandgren P, 2004, GFF, V126, P363, DOI 10.1080/11035890401264363; Sohlenius G, 1998, BOREAS, V27, P101; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westman P, 2003, ESTUARIES, V26, P680, DOI 10.1007/BF02711979; Widerlund A, 2011, GEOLOGY, V39, P187, DOI 10.1130/G31524.1; Wu L, 2008, APPL ENVIRON MICROB, V74, P4516, DOI 10.1128/AEM.02751-07; Zheng Y, 2003, APPL GEOCHEM, V18, P539, DOI 10.1016/S0883-2927(02)00119-1; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001	51	18	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54326	10.1371/journal.pone.0054326	http://dx.doi.org/10.1371/journal.pone.0054326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372707	gold, Green Submitted, Green Published			2022-12-25	WOS:000314021500058
J	Puiffe, ML; Lachaise, I; Molinier-Frenkel, V; Castellano, F				Puiffe, Marie-Line; Lachaise, Isabelle; Molinier-Frenkel, Valerie; Castellano, Flavia			Antibacterial Properties of the Mammalian L-Amino Acid Oxidase IL4I1	PLOS ONE			English	Article							DENDRITIC CELLS; SNAKE-VENOM; PROTEIN; PURIFICATION; MACROPHAGES	L-amino acid oxidases (LAAO) are flavoproteins that catalyze the oxidative deamination of L-amino acids to a keto-acid along with the production of H2O2 and ammonia. Interleukin 4 induced gene 1 (IL4I1) is a secreted LAAO expressed by macrophages and dendritic cells stimulated by microbial derived products or interferons, which is endowed with immunoregulatory properties. It is the first LAAO described in mammalian innate immune cells. In this work, we show that this enzyme blocks the in vitro and in vivo growth of Gram negative and Gram positive bacteria. This antibiotic effect is primarily mediated by H2O2 production but is amplified by basification of the medium due to the accumulation of ammonia. The depletion of phenylalanine (the primary amino acid catabolized by IL4I1) may also participate in the in vivo inhibition of staphylococci growth. Thus, IL4I1 plays a distinct role compared to other antibacterial enzymes produced by mononuclear phagocytes.	[Puiffe, Marie-Line; Molinier-Frenkel, Valerie; Castellano, Flavia] Hop Henri Mondor, INSERM, U955, IMRB,Equipe 09, F-94010 Creteil, France; [Puiffe, Marie-Line; Molinier-Frenkel, Valerie; Castellano, Flavia] Univ Paris Est, Fac Med, Creteil, France; [Molinier-Frenkel, Valerie; Castellano, Flavia] Hop H Mondor A Chenevier, AP HP, Serv Immunol Biol, Creteil, France; [Lachaise, Isabelle] ICMPE, Thiais, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Molinier-Frenkel, V (corresponding author), Hop Henri Mondor, INSERM, U955, IMRB,Equipe 09, F-94010 Creteil, France.	valerie.frenkel@inserm.fr; flavia.castellano@inserm.fr	Castellano, Flavia/Q-2847-2018; Molinier-Frenkel, Valérie/Q-2852-2018	Molinier-Frenkel, Valerie/0000-0002-7250-7295; Castellano, Flavia/0000-0001-9389-6704	Institut National de la Sante et de la Recherche Medicale (INSERM) [A1L9-SE]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grant A1L9-SE from Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Carbonnelle-Puscian A, 2009, LEUKEMIA, V23, P952, DOI 10.1038/leu.2008.380; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Jung SK, 2000, J IMMUNOL, V165, P1491, DOI 10.4049/jimmunol.165.3.1491; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Riemann M, 2005, J IMMUNOL, V175, P3560, DOI 10.4049/jimmunol.175.6.3560; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004	16	34	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54589	10.1371/journal.pone.0054589	http://dx.doi.org/10.1371/journal.pone.0054589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355881	Green Published, gold			2022-12-25	WOS:000314021500091
J	Reinius, LE; Gref, A; Saaf, A; Acevedo, N; Joerink, M; Kupczyk, M; D'Amato, M; Bergstrom, A; Melen, E; Scheynius, A; Dahlen, SE; Pershagen, G; Soderhall, C; Kere, J				Reinius, Lovisa E.; Gref, Anna; Saaf, Annika; Acevedo, Nathalie; Joerink, Maaike; Kupczyk, Maciej; D'Amato, Mauro; Bergstroem, Anna; Melen, Erik; Scheynius, Annika; Dahlen, Sven-Erik; Pershagen, Goran; Soderhall, Cilla; Kere, Juha		BIOAIR Study Grp	DNA Methylation in the Neuropeptide S Receptor 1 (NPSR1) Promoter in Relation to Asthma and Environmental Factors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR-154; AIR-POLLUTION; SUSCEPTIBILITY LOCUS; GENE POLYMORPHISM; CHILDHOOD ASTHMA; SMOKE EXPOSURE; TOBACCO-SMOKE; BIRTH COHORT; DISEASE; POPULATION	Asthma and allergy are complex disorders influenced by both inheritance and environment, a relationship that might be further clarified by epigenetics. Neuropeptide S Receptor 1 (NPSR1) has been associated with asthma and allergy and a study suggested modulation of the genetic risk by environmental factors. We aimed to study DNA methylation in the promoter region of NPSR1 in relation to asthma and environmental exposures. Electrophoretic Mobility Shift Assay (EMSA) was used to investigate potential functional roles of both genotypes and methylation status in the NPSR1 promoter. DNA methylation was analysed using EpiTYPER in blood samples from two well-characterized cohorts; the BIOAIR study of severe asthma in adults and the Swedish birth cohort BAMSE. We observed that DNA methylation and genetic variants in the promoter influenced the binding of nuclear proteins to DNA, suggesting functional relevance. Significant, although small, differences in methylation were related to both adult severe asthma (p = 0.0001) and childhood allergic asthma (p = 0.01). Furthermore, DNA methylation was associated with exposures such as current smoking in adults for two CpG sites (p = 0.005 and 0.04), parental smoking during infancy in the children (p = 0.02) and in which month the sample was taken (p = 0.01). In summary, DNA methylation levels in the promoter of NPSR1 showed small but significant associations with asthma, both in adults and in children, and to related traits such as allergy and certain environmental exposures. Both genetic variation and the methylated state of CpG sites seem to have an effect on the binding of nuclear proteins in the regulatory region of NPSR1 suggesting complex regulation of this gene in asthma and allergy.	[Reinius, Lovisa E.; D'Amato, Mauro; Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gref, Anna; Saaf, Annika; Kupczyk, Maciej; Bergstroem, Anna; Melen, Erik; Dahlen, Sven-Erik; Pershagen, Goran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Acevedo, Nathalie; Joerink, Maaike; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Translat Immunol Unit, Stockholm, Sweden; [Melen, Erik] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Biomedicum, Res Programs Unit, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Reinius, Lovisa E.; Gref, Anna; Saaf, Annika; Acevedo, Nathalie; Joerink, Maaike; Kupczyk, Maciej; D'Amato, Mauro; Bergstroem, Anna; Melen, Erik; Scheynius, Annika; Dahlen, Sven-Erik; Pershagen, Goran; Soderhall, Cilla; Kere, Juha] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	juha.kere@ki.se	Kere, Juha/A-9179-2008; D'Amato, Mauro/B-5050-2019; Reinius, Lovisa/C-4555-2014; Vachier, Isabelle/AAV-5731-2020; D'Amato, Mauro/F-2450-2010; Söderhäll, Cilla/E-3940-2012; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Reinius, Lovisa/0000-0001-5029-0120; Vachier, Isabelle/0000-0003-2730-5165; D'Amato, Mauro/0000-0003-2743-5197; Söderhäll, Cilla/0000-0002-8397-3080; Kere, Juha/0000-0003-1974-0271; Johnston, Sebastian/0000-0003-3009-9200; Acevedo, Nathalie/0000-0002-5154-2964; PAPI, ALBERTO/0000-0002-6924-4500; chanez, pascal/0000-0003-4059-0917; Gaga, Mina/0000-0002-9949-6012; Pershagen, Goran/0000-0002-9701-1130	Swedish Foundation for Strategic Research (the Epigene study); Swedish Research Council; Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet; Marie Curie Intra-European Fellowship; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Stockholm County Council; Swedish Foundation for Health Care Sciences and Allergy Research; European Union [QLG1-CT-2000-01185, FOOD-CT-2004-506378]; Sweden: Heart-Lung Foundation; Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education	Swedish Foundation for Strategic Research (the Epigene study)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet(Karolinska Institutet); Marie Curie Intra-European Fellowship(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Swedish Foundation for Health Care Sciences and Allergy Research; European Union(European Commission); Sweden: Heart-Lung Foundation; Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education	The study was supported by grants from the Swedish Foundation for Strategic Research (the Epigene study) and the Swedish Research Council. LER and MK were supported by the Osher Initiative for Research on Severe Asthma at Karolinska Institutet, AG and NA were supported by a PhD grant from Karolinska Institutet, and MJ was supported by a Marie Curie Intra-European Fellowship. The BAMSE birth cohort was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council, Swedish Heart-Lung Foundation, the Stockholm County Council and the Swedish Foundation for Health Care Sciences and Allergy Research, and the European Union. The BIOAIR study was supported by the Fifth and Sixth Framework Programs of the European Union, contract numbers: QLG1-CT-2000-01185 (BIOAIR) and FOOD-CT-2004-506378 (GA2LEN), and several national funding bodies (Sweden: Heart-Lung Foundation and Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Bruce S, 2009, J MED GENET, V46, P159, DOI 10.1136/jmg.2007.055137; Castro-Giner F, 2010, THORAX, V65, P124, DOI 10.1136/thx.2009.119628; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Flom JD, 2011, CANCER EPIDEM BIOMAR, V20, P2518, DOI 10.1158/1055-9965.EPI-11-0553; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Melen E, 2008, ENVIRON HEALTH PERSP, V116, P1077, DOI 10.1289/ehp.11117; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Neuman A, 2011, ALLERGY, V66, P643; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sood A, 2012, CHEST, V142, P425, DOI 10.1378/chest.11-2519; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, P79, DOI 10.1111/j.1365-2982.2009.01366.x; Suter M, 2011, EPIGENETICS, V6; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhu HY, 2011, PEPTIDES, V32, P818, DOI 10.1016/j.peptides.2010.12.002	53	31	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53877	10.1371/journal.pone.0053877	http://dx.doi.org/10.1371/journal.pone.0053877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372674	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500028
J	Santl-Temkiv, T; Finster, K; Dittmar, T; Hansen, BM; Thyrhaug, R; Nielsen, NW; Karlson, UG				Santl-Temkiv, Tina; Finster, Kai; Dittmar, Thorsten; Hansen, Bjarne Munk; Thyrhaug, Runar; Nielsen, Niels Woetmann; Karlson, Ulrich Gosewinkel			Hailstones: A Window into the Microbial and Chemical Inventory of a Storm Cloud	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; MOLECULAR CHARACTERIZATION; WATER; MASS; CARBON; ENUMERATION; CHEMISTRY; BACTERIA; COMMUNITIES; VARIABILITY	Storm clouds frequently form in the summer period in temperate climate zones. Studies on these inaccessible and short-lived atmospheric habitats have been scarce. We report here on the first comprehensive biogeochemical investigation of a storm cloud using hailstones as a natural stochastic sampling tool. A detailed molecular analysis of the dissolved organic matter in individual hailstones via ultra-high resolution mass spectrometry revealed the molecular formulae of almost 3000 different compounds. Only a small fraction of these compounds were rapidly biodegradable carbohydrates and lipids, suitable for microbial consumption during the lifetime of cloud droplets. However, as the cloud environment was characterized by a low bacterial density (Me = 1973 cells/ml) as well as high concentrations of both dissolved organic carbon (Me = 179 mu M) and total dissolved nitrogen (Me = 30 mu M), already trace amounts of easily degradable organic compounds suffice to support bacterial growth. The molecular fingerprints revealed a mainly soil origin of dissolved organic matter and a minor contribution of plant-surface compounds. In contrast, both the total and the cultivable bacterial community were skewed by bacterial groups (gamma-Proteobacteria, Sphingobacteriales and Methylobacterium) that indicated the dominance of plant-surface bacteria. The enrichment of plant-associated bacterial groups points at a selection process of microbial genera in the course of cloud formation, which could affect the long-distance transport and spatial distribution of bacteria on Earth. Based on our results we hypothesize that plant-associated bacteria were more likely than soil bacteria (i) to survive the airborne state due to adaptations to life in the phyllosphere, which in many respects matches the demands encountered in the atmosphere and (ii) to grow on the suitable fraction of dissolved organic matter in clouds due to their ecological strategy. We conclude that storm clouds are among the most extreme habitats on Earth, where microbial life exists.	[Santl-Temkiv, Tina; Hansen, Bjarne Munk; Karlson, Ulrich Gosewinkel] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Santl-Temkiv, Tina; Finster, Kai] Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark; [Santl-Temkiv, Tina; Finster, Kai] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, Aarhus, Denmark; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Max Planck Res Grp Marine Geochem, D-26111 Oldenburg, Germany; [Thyrhaug, Runar] Univ Bergen, Dept Biol, Bergen, Norway; [Nielsen, Niels Woetmann] Danish Meteorol Inst, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Bergen; Danish Meteorological Institute DMI	Karlson, UG (corresponding author), Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.	uka@dmu.dk	Finster, Kai W/I-7475-2013; Dittmar, Thorsten/L-7796-2013	Finster, Kai W/0000-0002-9132-5542; Dittmar, Thorsten/0000-0002-3462-0107; Santl-Temkiv, Tina/0000-0002-3446-5813	Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen); Danish National Research Foundation; ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council [267864]	Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council(European Research Council (ERC)European Commission)	TST was supported by a Ph.D. fellowship granted by the Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen). Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation. The research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (Grant agreement no.: 267864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C.D., 2009, METEOROLOGY TODAY IN; Amato P, 2007, ATMOS CHEM PHYS, V7, P4159, DOI 10.5194/acp-7-4159-2007; Amato P, 2005, ATMOS ENVIRON, V39, P4143, DOI 10.1016/j.atmosenv.2005.04.002; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Burrows S.M., 2009, ATMOS CHEM PHYS DISC, V9, P10777, DOI DOI 10.5194/ACPD-9-10829-2009; Cornell SE, 2003, ATMOS ENVIRON, V37, P2173, DOI 10.1016/S1352-2310(03)00133-X; Delort AM, 2010, ATMOS RES, V98, P249, DOI 10.1016/j.atmosres.2010.07.004; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Garland JL, 2001, MICROBIAL ECOL, V42, P150; GOVINDARAJAN AG, 1988, P NATL ACAD SCI USA, V85, P1334, DOI 10.1073/pnas.85.5.1334; HERLIHY LJ, 1987, ATMOS ENVIRON, V21, P2397, DOI 10.1016/0004-6981(87)90374-X; Hill KA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008002; Jacob JL, 2004, MICROB ECOL, V49, P104; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Kourtev PS, 2011, ATMOS ENVIRON, V45, P5399, DOI 10.1016/j.atmosenv.2011.06.041; MAITA Y, 1990, GEOCHEM J, V24, P245, DOI 10.2343/geochemj.24.245; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marinoni A, 2004, ATMOS CHEM PHYS, V4, P715, DOI 10.5194/acp-4-715-2004; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Niwa R, 2011, CAN J MICROBIOL, V57, P62, DOI [10.1139/W10-101, 10.1139/w10-101]; Oliver JD, 2005, J MICROBIOL, V43, P93; PERDUE EM, 1984, GEOCHIM COSMOCHIM AC, V48, P1435, DOI 10.1016/0016-7037(84)90400-9; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Stenson AC, 2003, ANAL CHEM, V75, P1275, DOI 10.1021/ac026106p; Stubbins A, 2012, LIMNOL OCEANOGR-METH, V10, P347, DOI 10.4319/lom.2012.10.347; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Sun JM, 2006, ATMOS ENVIRON, V40, P795, DOI 10.1016/j.atmosenv.2005.05.052; Temkiv TS, 2012, FEMS MICROBIOL ECOL, V81, P684, DOI 10.1111/j.1574-6941.2012.01402.x; Tremblay LB, 2007, MAR CHEM, V105, P15, DOI 10.1016/j.marchem.2006.12.015; Vaitilingom M, 2010, APPL ENVIRON MICROB, V76, P23, DOI 10.1128/AEM.01127-09; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willey JD, 2000, GLOBAL BIOGEOCHEM CY, V14, P139, DOI 10.1029/1999GB900036; Wozniak AS, 2008, ATMOS CHEM PHYS, V8, P5099, DOI 10.5194/acp-8-5099-2008	38	136	139	18	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53550	10.1371/journal.pone.0053550	http://dx.doi.org/10.1371/journal.pone.0053550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372660	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500016
J	Willett, BJ; Kraase, M; Logan, N; McMonagle, E; Varela, M; Hosie, MJ				Willett, Brian J.; Kraase, Martin; Logan, Nicola; McMonagle, Elizabeth; Varela, Mariana; Hosie, Margaret J.			Selective Expansion of Viral Variants following Experimental Transmission of a Reconstituted Feline Immunodeficiency Virus Quasispecies	PLOS ONE			English	Article							BROAD NEUTRALIZATION RESISTANCE; EXPERIMENTAL VACCINE PROTECTION; IN-VIVO; T-CELLS; FUNCTIONAL RECEPTOR; IMMUNE-RESPONSES; V5 LOOP; INFECTION; CD134; CATS	Following long-term infection with virus derived from the pathogenic GL8 molecular clone of feline immunodeficiency virus (FIV), a range of viral variants emerged with distinct modes of interaction with the viral receptors CD134 and CXCR4, and sensitivities to neutralizing antibodies. In order to assess whether this viral diversity would be maintained following subsequent transmission, a synthetic quasispecies was reconstituted comprising molecular clones bearing envs from six viral variants and its replicative capacity compared in vivo with a clonal preparation of the parent virus. Infection with either clonal (Group 1) or diverse (Group 2) challenge viruses, resulted in a reduction in CD4+ lymphocytes and an increase in CD8+ lymphocytes. Proviral loads were similar in both study groups, peaking by 10 weeks post-infection, a higher plateau (set-point) being achieved and maintained in study Group 1. Marked differences in the ability of individual viral variants to replicate were noted in Group 2; those most similar to GL8 achieved higher viral loads while variants such as the chimaeras bearing the B14 and B28 Envs grew less well. The defective replication of these variants was not due to suppression by the humoral immune response as virus neutralising antibodies were not elicited within the study period. Similarly, although potent cellular immune responses were detected against determinants in Env, no qualitative differences were revealed between animals infected with either the clonal or the diverse inocula. However, in vitro studies indicated that the reduced replicative capacity of variants B14 and B28 in vivo was associated with altered interactions between the viruses and the viral receptor and co-receptor. The data suggest that viral variants with GL8-like characteristics have an early, replicative advantage and should provide the focus for future vaccine development.	[Willett, Brian J.; Logan, Nicola; McMonagle, Elizabeth; Varela, Mariana; Hosie, Margaret J.] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [Kraase, Martin] Vet Med Univ Wien, Inst Virol, Vienna, Austria	University of Glasgow; University of Veterinary Medicine Vienna	Willett, BJ (corresponding author), Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.	brian.willett@glasgow.ac.uk	Willett, Brian J/F-3396-2011		Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/D008425/1] Funding Source: UKRI; MRC [G0300387, G0801822] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D008425/1] Funding Source: researchfish; Medical Research Council [G0801822, G0300387] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and The Wellcome Trust (www.wellcome.ac.uk) to MJH and BJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmal M, 2011, PLOS ONE, P6; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bendinelli M, 2001, J VIROL, V75, P4584, DOI 10.1128/JVI.75.10.4584-4593.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; CALLANAN JJ, 1992, VET REC, V130, P293, DOI 10.1136/vr.130.14.293; CALLANAN JJ, 1992, VET IMMUNOL IMMUNOP, V35, P3, DOI 10.1016/0165-2427(92)90116-8; Callanan JJ, 1996, VET PATHOL, V33, P264, DOI 10.1177/030098589603300302; Callanan John J., 1993, P115; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; Dean GA, 1999, J VIROL, V73, P2596, DOI 10.1128/JVI.73.4.2596-2603.1999; Dean GA, 2004, VET IMMUNOL IMMUNOP, V100, P49, DOI 10.1016/j.vetimm.2004.03.001; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Dunham SP, 2006, VET REC, V158, P561, DOI 10.1136/vr.158.16.561; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; FLYNN JN, 1994, IMMUNOLOGY, V81, P626; Giannecchini S, 2001, J VIROL, V75, P8868, DOI 10.1128/JVI.75.18.8868-8873.2001; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Hosie MJ, 2011, VIRUSES-BASEL, V3, P1870, DOI 10.3390/v3101870; Hosie MJ, 2002, J VIROL, V76, P6062, DOI 10.1128/JVI.76.12.6062-6072.2002; HOSIE MJ, 1995, J VIROL, V69, P1253, DOI 10.1128/JVI.69.2.1253-1255.1995; Inoshima Y, 1996, J VIROL, V70, P8518, DOI 10.1128/JVI.70.12.8518-8526.1996; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kraase M, 2010, VET IMMUNOL IMMUNOP, V134, P96, DOI 10.1016/j.vetimm.2009.10.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CE, 1995, IMMUNOLOGY, V85, P568; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marozsan AJ, 2005, J VIROL, V79, P7121, DOI 10.1128/JVI.79.11.7121-7134.2005; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Nishimura Y, 2004, J GEN VIROL, V85, P2585, DOI 10.1099/vir.0.80102-0; Paillot R, 2005, VET IMMUNOL IMMUNOP, V106, P1, DOI 10.1016/j.vetimm.2004.12.023; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Pistello M, 2002, VIROLOGY, V298, P84, DOI 10.1006/viro.2002.1442; Pu RY, 2005, J FELINE MED SURG, V7, P65, DOI 10.1016/j.jfms.2004.08.005; Pu RY, 2001, AIDS, V15, P1225, DOI 10.1097/00002030-200107060-00004; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; Ryan G, 2003, J VIROL, V77, P7477, DOI 10.1128/JVI.77.13.7477-7485.2003; Samman A, 2010, J GEN VIROL, V91, P242, DOI 10.1099/vir.0.015404-0; Shimojima M, 2003, MICROBES INFECT, V5, P1171, DOI 10.1016/j.micinf.2003.08.004; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; SIEBELINK KHJ, 1995, VET IMMUNOL IMMUNOP, V46, P51, DOI 10.1016/0165-2427(94)07005-R; SIEBELINK KHJ, 1995, J VIROL, V69, P5124, DOI 10.1128/JVI.69.8.5124-5127.1995; Willett BJ, 2006, J VIROL, V80, P3386, DOI 10.1128/JVI.80.7.3386-3394.2006; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; WILLETT BJ, 1993, IMMUNOLOGY, V78, P1; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Willett BJ, 2008, VET IMMUNOL IMMUNOP, V123, P56, DOI 10.1016/j.vetimm.2008.01.012; Willett BJ, 2007, J VIROL, V81, P9665, DOI 10.1128/JVI.01020-07; Willett BJ, 2006, J VIROL, V80, P7744, DOI 10.1128/JVI.00722-06; Willett BJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-38; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; YAMAMOTO JK, 1991, AIDS RES HUM RETROV, V7, P911, DOI 10.1089/aid.1991.7.911; YAMAMOTO JK, 1993, J VIROL, V67, P601, DOI 10.1128/JVI.67.1.601-605.1993	55	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54871	10.1371/journal.pone.0054871	http://dx.doi.org/10.1371/journal.pone.0054871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372784	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000314021500138
J	Armbrecht, AS; Gibbons, H; Stahl, J				Armbrecht, Anne-Simone; Gibbons, Henning; Stahl, Jutta			Effects of Response Force Parameters on Medial-Frontal Negativity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; MOTOR CONTROL; PRODUCTION TASK; COGNITIVE CONTROL; BRAIN POTENTIALS; CORRECT TRIALS; ERP COMPONENTS; NEURAL SYSTEM; PEAK FORCE	The response-related medial-frontal activity (MFN) is often supposed to reflect action-monitoring and error-processing activity. The present force-production task was designed to investigate the effects of two response parameters (i.e., peak response force and time-to-peak, TTP) on the MFN separately. In a 2 x 2 design (high vs. low target force and short vs. long TTP), 22 participants had to produce isometric force pulses to match one of four conditions (e.g., a high target force with a long TTP). Significant main effects of both target force and target TTP were revealed. As previously shown, the MFN amplitude was higher in the high target-force condition than in the low target-force condition. Contrary to the initial expectations, a long TTP had the effect of reducing the MFN amplitude. There was no error-specific effect on the MFN. The force-unit monitoring model (FUMM) is suggested to account for the force-and TTP-specific variations of MFN amplitude, latency and slope.	[Armbrecht, Anne-Simone; Stahl, Jutta] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Gibbons, Henning] Univ Bonn, Inst Psychol, Bonn, Germany	University of Cologne; University of Bonn	Stahl, J (corresponding author), Univ Cologne, Dept Psychol, D-50931 Cologne, Germany.	jutta.stahl@uni-koeln.de		Stahl, Jutta/0000-0002-3252-180X	Deutsche Forschungsgemeinschaft (German Research Foundation) [STA 1035/2]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (German Research Foundation; STA 1035/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; Allain S, 2004, PSYCHOPHYSIOLOGY, V41, P113, DOI 10.1111/j.1469-8986.2003.00136.x; Armbrecht AS, 2012, PSYCHOPHYSIOLOGY, V49, P56, DOI 10.1111/j.1469-8986.2011.01282.x; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Botzel K, 1997, EXP BRAIN RES, V114, P352, DOI 10.1007/PL00005643; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; de Bruijn ERA, 2003, PSYCHOPHYSIOLOGY, V40, P786, DOI 10.1111/1469-8986.00079; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Gallea C, 2008, BEHAV BRAIN RES, V193, P117, DOI 10.1016/j.bbr.2008.05.014; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; KANTOWITZ BH, 1973, J EXP PSYCHOL, V100, P302, DOI 10.1037/h0035780; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kristeva R, 1980, PROGR BRAIN RES, V54, P177; Maier M, 2008, J COGNITIVE NEUROSCI, V20, P2263, DOI 10.1162/jocn.2008.20159; Masaki H, 1998, EVOKED POTENTIAL, V108, P390, DOI 10.1016/S0168-5597(98)00019-7; Mattes S, 1997, PERCEPT PSYCHOPHYS, V59, P1089, DOI 10.3758/BF03205523; Mattes S, 1997, Q J EXP PSYCHOL-A, V50, P405, DOI 10.1080/027249897392152; NEWELL KM, 1985, J MOTOR BEHAV, V17, P230; NEWELL KM, 1988, J EXP PSYCHOL HUMAN, V14, P37; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinkenauer G, 2001, J EXP PSYCHOL HUMAN, V27, P1485, DOI 10.1037/0096-1523.27.6.1485; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Slobounov SM, 1998, PSYCHOPHYSIOLOGY, V35, P537, DOI 10.1017/S0048577298970342; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Stahl J, 2005, ACTA PSYCHOL, V120, P1, DOI 10.1016/j.actpsy.2005.02.003; Stahl J, 2010, INT J PSYCHOPHYSIOL, V77, P43, DOI 10.1016/j.ijpsycho.2010.04.005; Stahl J, 2010, PSYCHOPHYSIOLOGY, V47, P43, DOI 10.1111/j.1469-8986.2009.00878.x; Suzuki K, 2011, NEUROREPORT, V22, P902, DOI 10.1097/WNR.0b013e32834cd736; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; ULRICH R, 1991, PSYCHOL REV, V98, P268, DOI 10.1037/0033-295X.98.2.268; ULRICH R, 1995, J EXP PSYCHOL HUMAN, V21, P1457, DOI 10.1037/0096-1523.21.6.1457; VANGALEN GP, 1995, HUM MOVEMENT SCI, V14, P539, DOI 10.1016/0167-9457(95)00027-3; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54681	10.1371/journal.pone.0054681	http://dx.doi.org/10.1371/journal.pone.0054681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349950	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100090
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Activate to Eradicate: Inhibition of Clostridium difficile Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION DEVICE; SUPERDORMANT SPORES; GERMINATING SPORES; VEGETATIVE CELLS; EFFICACY; DIARRHEA; DECONTAMINATION; DISINFECTION; INITIATION; MECHANISM	Background: Germination is the irreversible loss of spore-specific properties prior to outgrowth. Because germinating spores become more susceptible to killing by stressors, induction of germination has been proposed as a spore control strategy. However, this strategy is limited by superdormant spores that remain unaffected by germinants. Harsh chemicals and heat activation are effective for stimulating germination of superdormant spores but are impractical for use in a hospital setting, where Clostridium difficile spores present a challenge. Here, we tested whether osmotic activation solutes will provide a mild alternative for stimulation of superdormant C. difficile spores in the presence of germinants as previously demonstrated in several species of Bacillus. In addition, we tested the hypothesis that the limitations of superdormancy can be circumvented with a combined approach using nisin, a FDA-approved safe bacteriocin, to inhibit outgrowth of germinated spores and osmotic activation solutes to enhance outgrowth inhibition by stimulating superdormant spores. Principal Findings: Exposure to germination solutiontriggered similar to 1 log(10) colony forming units (CFU) of spores to germinate, and heat activation increased the spores that germinated to >2.5 log(10)CFU. Germinating spores, in contrast to dormant spores, became susceptible to inhibition by nisin. The presence of osmotic activation solutes did not stimulate germination of superdormant C. difficile spores exposed to germination solution. But, in the absence of germination solution, osmotic activation solutes enhanced nisin inhibition of superdormant spores to >3.5 log(10)CFU. The synergistic effects of osmotic activation solutes and nisin were associated with loss of membrane integrity. Conclusions: These findings suggest that the synergistic effects of osmotic activation and nisin bypass the limitations of germination as a spore control strategy, and might be a novel method to safely and effectively reduce the burden of C. difficile spores on skin and environmental surfaces.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA.	michellenerandzi@aim.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This research was funded by a Merit Review grant from the Department of Veterans Affairs to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, FOOD MICROBIOL, V26, P272, DOI 10.1016/j.fm.2008.12.011; Alfa MJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-64; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; Bartoloni A, 2004, J CHEMOTHERAPY, V16, P119, DOI 10.1179/joc.2004.16.2.119; Brandes Ammann Andrea, 2011, Int J Microbiol, V2011, P435281, DOI 10.1155/2011/435281; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; DURBAN E, 1970, J BACTERIOL, V102, P590, DOI 10.1128/JB.102.2.590-592.1970; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Garde S, 2011, INT J FOOD MICROBIOL, V150, P59, DOI 10.1016/j.ijfoodmicro.2011.07.018; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Ghosh S, 2010, J APPL MICROBIOL, V108, P582, DOI 10.1111/j.1365-2672.2009.04442.x; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; GOULD GW, 1968, J APPL BACTERIOL, V31, P357, DOI 10.1111/j.1365-2672.1968.tb00378.x; GOULD GW, 1970, J APPL BACTERIOL, V33, P34, DOI 10.1111/j.1365-2672.1970.tb05232.x; Gould GW, 1978, SPORES, P21; Gut IM, 2008, ANTIMICROB AGENTS CH, V52, P4281, DOI 10.1128/AAC.00625-08; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Jury LA, 2011, INFECT CONT HOSP EP, V32, P181, DOI 10.1086/657911; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MUNAKATA N, 1974, J BACTERIOL, V120, P59, DOI 10.1128/JB.120.1.59-65.1974; Nerandzic MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-120; Nerandzic MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012285; Nerandzic MM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-197; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Pol IE, 2001, APPL ENVIRON MICROB, V67, P1693, DOI 10.1128/AEM.67.4.1693-1699.2001; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; PRESTON RA, 1984, J GEN MICROBIOL, V130, P1041; RAYMAN MK, 1981, APPL ENVIRON MICROB, V41, P375, DOI 10.1128/AEM.41.2.375-380.1981; Rutala WA, 2001, EMERG INFECT DIS, V7, P348, DOI 10.3201/eid0702.010241; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; STUY J. H., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P337, DOI 10.1007/BF02538347; STUY JH, 1956, BIOCHIM BIOPHYS ACTA, V22, P241, DOI 10.1016/0006-3002(56)90146-9; Wei J, 2010, J BACTERIOL, V192, P1455, DOI 10.1128/JB.01497-09; Wheeldon LJ, 2008, J ANTIMICROB CHEMOTH, V62, P522, DOI 10.1093/jac/dkn219; Wheeldon LJ, 2011, J APPL MICROBIOL, V110, P987, DOI 10.1111/j.1365-2672.2011.04953.x; Wijnker JJ, 2011, FOOD MICROBIOL, V28, P974, DOI 10.1016/j.fm.2011.01.009; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	43	32	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54740	10.1371/journal.pone.0054740	http://dx.doi.org/10.1371/journal.pone.0054740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349961	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100094
J	Patel, JC; Oberstaller, J; Xayavong, M; Narayanan, J; DeBarry, JD; Srinivasamoorthy, G; Villegas, L; Escalante, AA; DaSilva, A; Peterson, DS; Barnwell, JW; Kissinger, JC; Udhayakumar, V; Lucchi, NW				Patel, Jaymin C.; Oberstaller, Jenna; Xayavong, Maniphet; Narayanan, Jothikumar; DeBarry, Jeremy D.; Srinivasamoorthy, Ganesh; Villegas, Leopoldo; Escalante, Ananias A.; DaSilva, Alexandre; Peterson, David S.; Barnwell, John W.; Kissinger, Jessica C.; Udhayakumar, Venkatachalam; Lucchi, Naomi W.			Real-Time Loop-Mediated Isothermal Amplification (RealAmp) for the Species-Specific Identification of Plasmodium vivax	PLOS ONE			English	Article							MALARIA INFECTIONS; DIAGNOSIS; LAMP; MICROSCOPY; GENOMICS; TARGETS; TESTS; BLOOD; PCR	Plasmodium vivax infections remain a major source of malaria-related morbidity and mortality. Early and accurate diagnosis is an integral component of effective malaria control programs. Conventional molecular diagnostic methods provide accurate results but are often resource-intensive, expensive, have a long turnaround time and are beyond the capacity of most malaria-endemic countries. Our laboratory has recently developed a new platform called RealAmp, which combines loop-mediated isothermal amplification (LAMP) with a portable tube scanner real-time isothermal instrument for the rapid detection of malaria parasites. Here we describe new primers for the detection of P. vivax using the RealAmp method. Three pairs of amplification primers required for this method were derived from a conserved DNA sequence unique to the P. vivax genome. The amplification was carried out at 64 degrees C using SYBR Green or SYTO-9 intercalating dyes for 90 minutes with the tube scanner set to collect fluorescence signals at 1-minute intervals. Clinical samples of P. vivax and other human-infecting malaria parasite species were used to determine the sensitivity and specificity of the primers by comparing with an 18S ribosomal RNA-based nested PCR as the gold standard. The new set of primers consistently detected laboratory-maintained isolates of P. vivax from different parts of the world. The primers detected P. vivax in the clinical samples with 94.59% sensitivity (95% CI: 87.48-98.26%) and 100% specificity (95% CI: 90.40-100%) compared to the gold standard nested-PCR method. The new primers also proved to be more sensitive than the published species-specific primers specifically developed for the LAMP method in detecting P. vivax.	[Patel, Jaymin C.; Xayavong, Maniphet; DaSilva, Alexandre; Barnwell, John W.; Udhayakumar, Venkatachalam; Lucchi, Naomi W.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Oberstaller, Jenna; Peterson, David S.; Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Oberstaller, Jenna; DeBarry, Jeremy D.; Srinivasamoorthy, Ganesh; Peterson, David S.; Kissinger, Jessica C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Narayanan, Jothikumar; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Villegas, Leopoldo] Asociac Civil Impacto Social, Tumeremo, Venezuela; [Escalante, Ananias A.] Arizona State Univ, Tempe, AZ USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe; University System of Georgia; University of Georgia	Patel, JC (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	jaymin86@gmail.com	Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019	Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101; Peterson, David/0000-0003-4394-6181; DeBarry, Jeremy/0000-0001-5718-2675; Escalante, Ananias/0000-0002-1532-3430; Lucchi, Naomi/0000-0001-8789-8041; Oberstaller, Jenna/0000-0002-3033-2212	CDC-UGA (OPHR) [8212]	CDC-UGA (OPHR)	This work was supported by a CDC-UGA seed grant (OPHR #8212) awarded to JCK and VU. This study was supported in part by resources and technical expertise from the University of Georgia Research Computing Center, a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer and CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, ACTA TROP, V113, P61, DOI 10.1016/j.actatropica.2009.09.007; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lau YL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-197; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paris DH, 2007, AM J TROP MED HYG, V77, P972, DOI 10.4269/ajtmh.2007.77.972; Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Tao ZY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-115; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2020, TOP 10 CAUS DEATH	29	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54986	10.1371/journal.pone.0054986	http://dx.doi.org/10.1371/journal.pone.0054986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349994	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100115
J	Shatz, LF; De Groot, T				Shatz, Lisa F.; De Groot, Theodorus			The Frequency Response of the Vibrissae of Harp Seal, Pagophilus Groenlandicus, to Sound in Air and Water	PLOS ONE			English	Article							RAT VIBRISSAE; DISCRIMINATION; SIZE; WHISKERS; SHAPE	The motion of isolated seal vibrissae due to low frequency sound in air has been measured using a microscope with a video camera and modeled using an FEM method with good agreement between the measurements and the model; the model has also been used to predict the motion of seal vibrissae in water. The shape of the seal vibrissae is that of a tapered right rectangular prism, unlike that of the previously studied rat vibrissae which are conical in shape. Moreover, unlike rat vibrissae which oscillate in the direction of the sound stimulus, two different modes of vibration of seal vibrissae were observed - one corresponding to the wider side being stimulated and one with the narrow side stimulated. The tuning of the seal vibrissae was much sharper than those of rat vibrissae, with quality factors about three times as large as those of rat vibrissae. As shown by the model, this increased sharpness is caused by the larger cross-sectional areas (by more than a factor of ten) of the seal vibrissae. This increased sharpness may be necessary for seal vibrissae so that they can have tuning in water, where the drag more heavily dampens the tuning than in air. The results suggest that vibrissae tuning may be important in the seal's ability to track the wake of its prey.	[Shatz, Lisa F.] Suffolk Univ, Dept Elect & Comp Engn, Boston, MA 02114 USA; [De Groot, Theodorus] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	Suffolk University; University of Wisconsin System; University of Wisconsin Madison	Shatz, LF (corresponding author), Suffolk Univ, Dept Elect & Comp Engn, Boston, MA 02114 USA.	lshatz@suffolk.edu						BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEHNHARDT G, 1994, J COMP PHYSIOL A, V175, P791; Dehnhardt G, 1996, ANIM LEARN BEHAV, V24, P366, DOI 10.3758/BF03199008; Dehnhardt G, 1995, J EXP BIOL, V201, P3023; Hanke W, 2010, J EXP BIOL, V213, P2665, DOI 10.1242/jeb.043216; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; HUMPHREY JAC, 1993, PHILOS T R SOC B, V340, P423, DOI 10.1098/rstb.1993.0083; Miersch L, 2011, PHILOS T R SOC B, V366, P3077, DOI 10.1098/rstb.2011.0155; Neimark MA, 2003, J NEUROSCI, V23, P6499; Schulte-Pelkum N, 2007, J EXP BIOL, V210, P781, DOI 10.1242/jeb.02708; Shatz LF, 2008, J ACOUST SOC AM, V123, P2918, DOI 10.1121/1.2902181; Shimozawa T, 1998, J COMP PHYSIOL A, V183, P171, DOI 10.1007/s003590050245; Stokes G. G., 1851, T CAMBRIDGE PHILOS S, DOI DOI 10.1017/CBO9780511702266.002; Weaver W., 1990, VIBRATION PROBLEMS E; Wieskotten S, 2011, J EXP BIOL, V214, P1922, DOI 10.1242/jeb.053926	17	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54876	10.1371/journal.pone.0054876	http://dx.doi.org/10.1371/journal.pone.0054876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349983	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100106
J	Tokarz, J; Norton, W; Moller, G; de Angelis, MH; Adamski, J				Tokarz, Janina; Norton, William; Moeller, Gabriele; de Angelis, Martin Hrabe; Adamski, Jerzy			Zebrafish 20 beta-Hydroxysteroid Dehydrogenase Type 2 Is Important for Glucocorticoid Catabolism in Stress Response	PLOS ONE			English	Article							DANIO-RERIO; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; MINERALOCORTICOID RECEPTOR; DISEASE RESISTANCE; FISH EMBRYOS; TELEOST FISH; CORTISOL; TISSUE; TARGET	Stress, the physiological reaction to a stressor, is initiated in teleost fish by hormone cascades along the hypothalamuspituitary-interrenal (HPI) axis. Cortisol is the major stress hormone and contributes to the appropriate stress response by regulating gene expression after binding to the glucocorticoid receptor. Cortisol is inactivated when 11 beta-hydroxysteroid dehydrogenase (HSD) type 2 catalyzes its oxidation to cortisone. In zebrafish, Danio rerio, cortisone can be further reduced to 20 beta-hydroxycortisone. This reaction is catalyzed by 20 beta-HSD type 2, recently discovered by us. Here, we substantiate the hypothesis that 20 beta-HSD type 2 is involved in cortisol catabolism and stress response. We found that hsd11b2 and hsd20b2 transcripts were up-regulated upon cortisol treatment. Moreover, a cortisol-independent, short-term physical stressor led to the up-regulation of hsd11b2 and hsd20b2 along with several HPI axis genes. The morpholino-induced knock down of hsd20b2 in zebrafish embryos revealed no developmental phenotype under normal culture conditions, but prominent effects were observed after a cortisol challenge. Reporter gene experiments demonstrated that 20 beta-hydroxycortisone was not a physiological ligand for the zebrafish glucocorticoid or mineralocorticoid receptor but was excreted into the fish holding water. Our experiments show that 20 beta-HSD type 2, together with 11 beta-HSD type 2, represents a short pathway in zebrafish to rapidly inactivate and excrete cortisol. Therefore, 20 beta-HSD type 2 is an important enzyme in stress response.	[Tokarz, Janina; Moeller, Gabriele; de Angelis, Martin Hrabe; Adamski, Jerzy] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany; [Norton, William] CNRS, Gif Sur Yvette, France; [de Angelis, Martin Hrabe; Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich	Adamski, J (corresponding author), German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany.	Adamski@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Tokarz, Janina/AAT-6675-2020	de Angelis, Martin Hrabe/0000-0002-7898-2353; Norton, William/0000-0002-3244-0145; Tokarz, Janina/0000-0003-4344-4149; Moller, Gabriele/0000-0002-2730-1351; Adamski, Jerzy/0000-0001-9259-0199	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft [AD 127/10-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.) and by a Deutsche Forschungsgemeinschaft grant to J.A. (AD 127/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Alsop D, 2009, GEN COMP ENDOCR, V161, P62, DOI 10.1016/j.ygcen.2008.09.011; Baker ME, 2004, FEBS LETT, V574, P167, DOI 10.1016/j.febslet.2004.08.023; Baker ME, 2010, BIOCHEM BIOPH RES CO, V399, P215, DOI 10.1016/j.bbrc.2010.07.057; Baker ME, 2010, FEBS LETT, V584, P2279, DOI 10.1016/j.febslet.2010.03.036; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Edwards CRW, 1996, STEROIDS, V61, P263, DOI 10.1016/0039-128X(96)00033-5; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Hagedorn M, 1997, CRYOBIOLOGY, V34, P335, DOI 10.1006/cryo.1997.2014; HARVEY B, 1983, CRYOBIOLOGY, V20, P432, DOI 10.1016/0011-2240(83)90033-0; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumai Y, 2012, MOL CELL ENDOCRINOL, V364, P113, DOI 10.1016/j.mce.2012.08.017; MAULE AG, 1989, J ENDOCRINOL, V120, P135, DOI 10.1677/joe.0.1200135; McCormick MI, 2002, J EXP ZOOL, V293, P456, DOI 10.1002/jez.10138; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Meyer A, 2012, TOXICOLOGY, V301, P72, DOI 10.1016/j.tox.2012.07.001; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Nesan D, 2012, MOL CELL ENDOCRINOL, V363, P85, DOI 10.1016/j.mce.2012.07.010; Nesan D, 2012, ENDOCRINOLOGY, V153, P1288, DOI 10.1210/en.2011-1559; OLIVEREAU M, 1988, PEPTIDES, V9, P13, DOI 10.1016/0196-9781(88)90004-6; PAYNE DW, 1989, J STEROID BIOCHEM, V33, P289, DOI 10.1016/0022-4731(89)90307-5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKERING AD, 1992, AQUACULTURE, V100, P125, DOI 10.1016/0044-8486(92)90354-N; PICKERING AD, 1989, FISH PHYSIOL BIOCHEM, V7, P253, DOI 10.1007/BF00004714; Pikulkaew S, 2011, DEV DYNAM, V240, P874, DOI 10.1002/dvdy.22586; Pippal JB, 2011, MOL CELL ENDOCRINOL, V332, P58, DOI 10.1016/j.mce.2010.09.014; POTTINGER TG, 1992, FISH PHYSIOL BIOCHEM, V10, P55, DOI 10.1007/BF00004654; R Core Team, 2012, R LANG ENV STAT COMP; Rinaman L, 2007, FRONT NEUROENDOCRIN, V28, P50, DOI 10.1016/j.yfrne.2007.02.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Shimojo M, 1997, ENDOCRINOLOGY, V138, P1305, DOI 10.1210/en.138.3.1305; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Tokarz J, 2012, MOL CELL ENDOCRINOL, V349, P202, DOI 10.1016/j.mce.2011.10.022; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; TRUSCOTT B, 1979, GEN COMP ENDOCR, V38, P196, DOI 10.1016/0016-6480(79)90207-7; Vermeirssen ELM, 1996, GEN COMP ENDOCR, V101, P180, DOI 10.1006/gcen.1996.0020; Vijayan MM, 1997, COMP BIOCHEM PHYS C, V116, P89, DOI 10.1016/S0742-8413(96)00124-7; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	51	37	39	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54851	10.1371/journal.pone.0054851	http://dx.doi.org/10.1371/journal.pone.0054851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349977	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100101
J	Zhang, C; Bai, DS; Huang, XY; Shi, GM; Ke, AW; Yang, LX; Yang, XR; Zhou, J; Fan, J				Zhang, Chi; Bai, Dou-Sheng; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia			Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							CALPAIN PROTEASES; SMALL-SUBUNIT; CELL; ADHESION; PROTEOLYSIS; CD151	Background: Calpain small subunit 1 (Capn4) has been shown to correlate with the metastasis/invasion of hepatocellular carcinoma. This study aimed to investigate the role of Capn4 in intrahepatic cholangiocarcinoma (ICC). Methods: Capn4 expression was measured in 33 ICC tissues by quantitative real-time polymerase chain reaction and western blot. The role of Capn4 in the migration, invasion and proliferation of ICC cells and matrix metalloproteinase 2 (MMP2) expression were assessed after Capn4 depletion by specific small interfering RNA. Capn4 expression was further examined by immunohistochemistry in a tissue microarray consisting of 140 ICC patients and 13 normal liver tissues, and the prognostic role of Capn4 in ICC was evaluated by Kaplan-Meier and Cox regression analyses. Results: Capn4 expression was significantly higher in the ICC tissues compared to the peritumor tissues. Capn4 down-regulation impaired the migration/invasion ability of HCCC-9810 and QBC939 cells in vitro and decreased MMP2 expression. Capn4 overexpression significantly correlated with the presence of lymphatic metastasis of ICC (p = 0.026) and the tumor-node-metastasis (TNM) stage (p = 0.009). The postoperative 2- and 5-year overall survivals in patients with Capn4(low) were higher than those in the Capn4(high) group. The cumulative recurrence rate in patients with Capn4(low) was much lower than in the Capn4(high) group. Multivariate analysis showed that Capn4 overexpression was an independent prognostic marker in ICC. Conclusions: Capn4 overexpression was implicated in ICC metastasis/invasion, and Capn4 overexpression may be used as a molecular therapeutic target for ICC.	[Zhang, Chi; Bai, Dou-Sheng] Yangzhou Univ, Clin Med Coll, Dept Hepatobiliary Surg, Yangzhou, Peoples R China; [Zhang, Chi; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Zhang, Chi; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Fan, Jia] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	Yangzhou University; Fudan University; Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	jiafan99@yahoo.com	Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540; Ke, Ai-Wu/0000-0002-7964-6909	Major Program of National Natural Science Foundation of China [81030038]; National Natural Science Foundation of China [81071741, 81172023]; National Natural Science Foundation of Jiangsu Province [BK2010300]; Ph.D. Programs Foundation of the Ministry of Education of China [20090071120025, 20110072120050]; Shanghai Municipal Natural Science Foundation [11ZR1428300, 114119a5000]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Natural Science Foundation	This work was supported by the Major Program of National Natural Science Foundation of China (81030038), the National Natural Science Foundation of China (81071741 and 81172023,), the National Natural Science Foundation of Jiangsu Province (BK2010300), the Ph.D. Programs Foundation of the Ministry of Education of China (20090071120025, 20110072120050) and the Shanghai Municipal Natural Science Foundation (11ZR1428300, 114119a5000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032775; Huang XY, 2010, CANCER-AM CANCER SOC, V116, P5440, DOI 10.1002/cncr.25485; Ishak KG, 1994, NONEPITHELIAL TUMORS; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Li SR, 2003, EUR SURG RES, V35, P327, DOI 10.1159/000070603; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Morise Z, 2010, WORLD J HEPATOL, V2, P58, DOI 10.4254/wjh.v2.i2.58; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; Okabayashi T, 2001, CANCER-AM CANCER SOC, V92, P2374, DOI 10.1002/1097-0142(20011101)92:9<2374::AID-CNCR1585>3.0.CO;2-L; Rosenberger G, 2005, J BIOL CHEM, V280, P6879, DOI 10.1074/jbc.M412119200; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Shi RY, 2013, CANCER-AM CANCER SOC, V119, P993, DOI 10.1002/cncr.27788; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Wittekind C, 2006, PATHOLOGE, V27, P289, DOI 10.1007/s00292-006-0834-1; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	30	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54619	10.1371/journal.pone.0054619	http://dx.doi.org/10.1371/journal.pone.0054619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349941	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100085
J	Mussulini, BM; Leite, CE; Zenki, KC; Moro, L; Baggio, S; Rico, EP; Rosemberg, DB; Dias, RD; Souza, TM; Calcagnotto, ME; Campos, MM; Battastini, AM; de Oliveira, DL				Mussulini, Ben Hur M.; Leite, Carlos E.; Zenki, Kamila C.; Moro, Luana; Baggio, Suelen; Rico, Eduardo P.; Rosemberg, Denis B.; Dias, Renato D.; Souza, Tadeu M.; Calcagnotto, Maria E.; Campos, Maria M.; Battastini, Ana M.; de Oliveira, Diogo L.			Seizures Induced by Pentylenetetrazole in the Adult Zebrafish: A Detailed Behavioral Characterization	PLOS ONE			English	Article							CURRENT ANIMAL-MODELS; BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; DRUG-TREATMENT; EPILEPSY; ILAE; DISEASE; IDENTIFY; SCREEN; SERUM	Pentylenetetrazole (PTZ) is a common convulsant agent used in animal models to investigate the mechanisms of seizures. Although adult zebrafish have been recently used to study epileptic seizures, a thorough characterization of the PTZ-induced seizures in this animal model is missing. The goal of this study was to perform a detailed temporal behavior profile characterization of PTZ-induced seizure in adult zebrafish. The behavioral profile during 20 min of PTZ immersion (5, 7.5, 10, and 15 mM) was characterized by stages defined as scores: (0) short swim, (1) increased swimming activity and high frequency of opercular movement, (2) erratic movements, (3) circular movements, (4) clonic seizure-like behavior, (5) fall to the bottom of the tank and tonic seizure-like behavior, (6) death. Animals exposed to distinct PTZ concentrations presented different seizure profiles, intensities and latencies to reach all scores. Only animals immersed into 15 mM PTZ showed an increased time to return to the normal behavior (score 0), after exposure. Total mortality rate at 10 and 15 mM were 33% and 50%, respectively. Considering all behavioral parameters, 5, 7.5, 10, and 15 mM PTZ, induced seizures with low, intermediate, and high severity, respectively. Pretreatment with diazepam (DZP) significantly attenuated seizure severity. Finally, the brain PTZ levels in adult zebrafish immersed into the chemoconvulsant solution at 5 and 10 mM were comparable to those described for the rodent model, with a peak after a 20-min of exposure. The PTZ brain levels observed after 2.5-min PTZ exposure and after 60-min removal from exposure were similar. Altogether, our results showed a detailed temporal behavioral characterization of a PTZ epileptic seizure model in adult zebrafish. These behavioral analyses and the simple method for PTZ quantification could be considered as important tools for future investigations and translational research.	[Mussulini, Ben Hur M.; Zenki, Kamila C.; Moro, Luana; Baggio, Suelen; Rico, Eduardo P.; Rosemberg, Denis B.; Dias, Renato D.; Souza, Tadeu M.; Calcagnotto, Maria E.; Battastini, Ana M.; de Oliveira, Diogo L.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil; [Leite, Carlos E.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Mussulini, BM (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.	ben_hurmussulini@yahoo.com.br; losch@ufrgs.br	calcagnotto, maria elisa/B-1645-2013; Rosemberg, Denis B/E-5971-2016; Battastini, Ana M/E-2809-2012; Campos, Maria Martha M/J-8829-2015; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; Leite, Carlos Eduardo/U-4395-2017	calcagnotto, maria elisa/0000-0001-8196-0596; Battastini, Ana M/0000-0001-6068-3278; Campos, Maria Martha M/0000-0002-1153-3633; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Losch de Oliveira, Diogo/0000-0002-9028-6959; Rosemberg, Denis/0000-0003-2538-8761; Marins Mussulini, Ben Hur/0000-0003-4321-5709; Campos, Maria/0000-0001-7738-9892; Leite, Carlos Eduardo/0000-0002-6845-1612	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); INCT para Excitotoxicidade e Neuroprotecao; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP [01.06.0842-00, 01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT para Excitotoxicidade e Neuroprotecao; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), INCT para Excitotoxicidade e Neuroprotecao, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and by FINEP research grants: "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00 and "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) # 01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JM, 2011, EUR J NEUROSCI, V33, P1252, DOI 10.1111/j.1460-9568.2011.07622.x; Bachiega JC, 2008, EPILEPSY BEHAV, V13, P70, DOI 10.1016/j.yebeh.2008.02.010; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Desmond D, 2012, ASSESSING EPILEPSY R; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Eliceiri BP, 2011, METHODS MOL BIOL, V686, P371, DOI 10.1007/978-1-60761-938-3_18; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; GOODMAN LS, 1953, J PHARMACOL EXP THER, V108, P168; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lee Y, 2010, EUR J PHARMACOL, V643, P225, DOI 10.1016/j.ejphar.2010.06.041; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; LOSCHER W, 1984, METHOD FIND EXP CLIN, V6, P531; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Penberthy WT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1439, DOI 10.2741/penber; Pineda R, 2012, DIS MODEL MECH; Pineda R, 2011, J NEUROSCI METH, V200, P20, DOI 10.1016/j.jneumeth.2011.06.001; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAMZAN IM, 1985, J PHARMACOL EXP THER, V234, P624; Rico EP, 2007, TOXICOL LETT, V174, P25, DOI 10.1016/j.toxlet.2007.08.005; Rico EP, 2010, BRAIN RES BULL, V81, P517, DOI 10.1016/j.brainresbull.2009.11.011; Rosemberg DB, 2012, NEUROPHARMACOLOGY, V63, P613, DOI 10.1016/j.neuropharm.2012.05.009; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Rosemberg DB, 2008, COMP BIOCHEM PHYS B, V151, P96, DOI 10.1016/j.cbpb.2008.06.001; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; Shorvon SD, 2009, EPILEPSIA, V50, P93, DOI 10.1111/j.1528-1167.2009.02042.x; Shorvon SD, 2009, EPILEPSIA, V50, P69, DOI 10.1111/j.1528-1167.2009.02041.x; Siebel AM, 2011, BRAIN RES BULL, V86, P385, DOI 10.1016/j.brainresbull.2011.08.017; Sierra S, 2012, BRAIN RES BULL, V88, P467, DOI 10.1016/j.brainresbull.2012.04.007; SOTOOTERO R, 1987, ANAL BIOCHEM, V165, P331, DOI 10.1016/0003-2697(87)90277-6; Stewart AM, 2012, BRAIN RES BULL, V87, P135, DOI 10.1016/j.brainresbull.2011.11.020; Teng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024596; Teng Y, 2010, HUM MOL GENET, V19, P4409, DOI 10.1093/hmg/ddq364; Vermoesen K, 2011, EPILEPSY BEHAV, V22, P450, DOI 10.1016/j.yebeh.2011.08.016; Wong K, 2010, BRAIN RES, V1348, P209, DOI 10.1016/j.brainres.2010.06.012; YONEKAWA WD, 1980, J PHARMACOL EXP THER, V214, P589	49	76	77	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54515	10.1371/journal.pone.0054515	http://dx.doi.org/10.1371/journal.pone.0054515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349914	Green Published, Green Submitted, gold			2022-12-25	WOS:000313943000042
J	Singh, R				Singh, Raghvendra			Signal Oscillation Is Another Reason for Variability in Microarray-Based Gene Expression Quantification	PLOS ONE			English	Article							MOLECULAR CLASSIFICATION; ALZHEIMERS-DISEASE; CDNA MICROARRAY; MASTER-SWITCH; HYBRIDIZATION; REPRODUCIBILITY; CANCER; MODEL; DISCOVERY; DIFFUSION	Microarrays have been widely used for various biological applications, such as, gene expression profiling, determination of SNPs, and disease profiling. However, quantification and analysis of microarray data have been a challenge. Previously, by taking into account translational and rotational diffusion of the target DNA, we have shown that the rate of hybridization depends on its size. Here, by mathematical modeling of surface diffusion of transcript, we show that the dynamics of hybridization on DNA microarray surface is inherently oscillatory and the amplitude of oscillation depends on fluid velocity. We found that high fluid velocity enhances the signal without affecting the background, and reduces the oscillation, thereby reducing likelihood of inter-and intra-experiment variability. We further show that a strong probe reduces dependence of signal-to-noise ratio on probe strength, decreasing inter-microarray variability. On the other hand, weaker probes are required for SNP detection. Therefore, we recommend high fluid velocity and strong probes for all microarray applications except determination of SNPs. For SNP detection, we recommend high fluid velocity with weak probe on the spot. We also recommend a surface with high adsorption and desorption rates of transcripts.	Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Singh, R (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur [IITK/CHE/20090282]	Indian Institute of Technology Kanpur	This work was supported by the Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey NB, 2002, ANAL CHEM, V74, P6413, DOI 10.1021/ac026082m; Amundson SA, 2002, CANCER BIOL THER, V1, P145, DOI 10.4161/cbt.59; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bryant PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019556; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Chan V, 1997, LANGMUIR, V13, P5514; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Gadgil C, 2004, J BIOTECHNOL, V114, P31, DOI 10.1016/j.jbiotec.2004.05.008; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Han T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S17; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Klevecz Robert R., 2000, Functional and Integrative Genomics, V1, P186, DOI 10.1007/s101420000027; Lawrence ND, 2004, BIOINFORMATICS, V20, P518, DOI 10.1093/bioinformatics/btg438; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Ptitsyn AA, 2007, PLOS COMPUT BIOL, V3, P1108, DOI 10.1371/journal.pcbi.0030120; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schaupp CJ, 2005, BIOTECHNIQUES, V38, P117, DOI 10.2144/05381MT01; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Singh R, 2009, ANN BIOMED ENG, V37, P255, DOI 10.1007/s10439-008-9584-y; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spruill SE, 2002, BIOTECHNIQUES, V33, P916, DOI 10.2144/02334mt05; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tan JC, 2009, GENOMICS, V93, P543, DOI 10.1016/j.ygeno.2009.02.007; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang X, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e75; Wong JSS, 2011, MACROMOLECULES, V44, P3073, DOI 10.1021/ma1024939; Workman C, 2002, GENOME BIOL, V3; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168	54	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54753	10.1371/journal.pone.0054753	http://dx.doi.org/10.1371/journal.pone.0054753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349963	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000049
J	Bythell-Douglas, R; Waters, MT; Scaffidi, A; Flematti, GR; Smith, SM; Bond, CS				Bythell-Douglas, Rohan; Waters, Mark T.; Scaffidi, Adrian; Flematti, Gavin R.; Smith, Steven M.; Bond, Charles S.			The Structure of the Karrikin-Insensitive Protein (KAI2) in Arabidopsis thaliana	PLOS ONE			English	Article							F-BOX PROTEIN; GERMINATION STIMULANT; SEED-GERMINATION; STRIGOLACTONES; INHIBITION; MECHANISM; RESPONSES; BOND	KARRIKIN INSENSITIVE 2 (KAI2) is an alpha/beta hydrolase involved in seed germination and seedling development. It is essential for plant responses to karrikins, a class of butenolide compounds derived from burnt plant material that are structurally similar to strigolactone plant hormones. The mechanistic basis for the function of KAI2 in plant development remains unclear. We have determined the crystal structure of Arabidopsis thaliana KAI2 in space groups P2(1) 2(1) 2(1) (a = 63.57 angstrom, b = 66.26 angstrom, c = 78.25 angstrom) and P2(1) (a = 50.20 angstrom, b = 56.04 angstrom, c = 52.43 angstrom, beta = 116.12 degrees) to 1.55 and 2.11 A respectively. The catalytic residues are positioned within a large hydrophobic pocket similar to that of DAD2, a protein required for strigolactone response in Petunia hybrida. KAI2 possesses a second solvent-accessible pocket, adjacent to the active site cavity, which offers the possibility of allosteric regulation. The structure of KAI2 is consistent with its designation as a serine hydrolase, as well as previous data implicating the protein in karrikin and strigolactone signalling.	[Bythell-Douglas, Rohan; Scaffidi, Adrian; Flematti, Gavin R.; Smith, Steven M.; Bond, Charles S.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Waters, Mark T.; Smith, Steven M.] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Bond, CS (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	Charles.Bond@uwa.edu.au	Bond, Charles S/B-4094-2011; Smith, Steven M/G-7183-2015; Bond, Charles/AAF-9608-2020; Flematti, Gavin R/J-2018-2012; Smith, Steven/HDM-9496-2022; Waters, Mark T/H-6054-2014	Bond, Charles S/0000-0002-9584-6783; Smith, Steven M/0000-0001-5661-9994; Bond, Charles/0000-0002-9584-6783; Waters, Mark T/0000-0001-5657-9005; Flematti, Gavin/0000-0003-2545-6939; Bythell-Douglas, Rohan/0000-0002-3823-8749	Australian Research Council [DP1096717, LP0882775, FT110100304]	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the Australian Research Council (http://www.arc.gov.au/) for funding ( DP1096717, LP0882775, FT110100304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bricogne G, 2011, BUSTER VERSION 1 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Cummins I, 2006, J MOL BIOL, V359, P422, DOI 10.1016/j.jmb.2006.03.048; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard-Borger ED, 2007, EUR J ORG CHEM, V2007, P3925, DOI [10.1002/ejoe.200700334, 10.1002/ejoc.200700334]; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nelson DC, 2012, ANNU REV PLANT BIOL, V63, P107, DOI 10.1146/annurev-arplant-042811-105545; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Peng Q, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-95; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Scaffidi A, 2012, BIOORG MED CHEM LETT, V22, P3743, DOI 10.1016/j.bmcl.2012.04.016; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waters MT, 2012, PLANT SIGNAL BEHAV, V7, P969, DOI 10.4161/psb.20977; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida S, 2012, NEW PHYTOL, V196, P1208, DOI 10.1111/j.1469-8137.2012.04339.x	38	42	42	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54758	10.1371/journal.pone.0054758	http://dx.doi.org/10.1371/journal.pone.0054758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349965	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800075
J	Missirlis, D; Teesalu, T; Black, M; Tirrell, M				Missirlis, Dimitris; Teesalu, Tambet; Black, Matthew; Tirrell, Matthew			The Non-Peptidic Part Determines the Internalization Mechanism and Intracellular Trafficking of Peptide Amphiphiles	PLOS ONE			English	Article							ANCHORED PROTEINS; PLASMA-MEMBRANE; CHOLERA-TOXIN; MICELLES; CELL; NANOPARTICLES; TUMORS; ENDOCYTOSIS; STABILITY; ALBUMIN	Background: Peptide amphiphiles (PAs) are a class of amphiphilic molecules able to self-assemble into nanomaterials that have shown efficient in vivo targeted delivery. Understanding the interactions of PAs with cells and the mechanisms of their internalization and intracellular trafficking is critical in their further development for therapeutic delivery applications. Methodology/Principal Findings: PAs of a novel, cell- and tissue-penetrating peptide were synthesized possessing two different lipophilic tail architectures and their interactions with prostate cancer cells were studied in vitro. Cell uptake of peptides was greatly enhanced post-modification. Internalization occurred via lipid-raft mediated endocytosis and was common for the two analogs studied. On the contrary, we identified the non-peptidic part as the determining factor of differences between intracellular trafficking and retention of PAs. PAs composed of di-stearyl lipid tails linked through poly(ethylene glycol) to the peptide exhibited higher exocytosis rates and employed different recycling pathways compared to ones consisting of di-palmitic-coupled peptides. As a result, cell association of the former PAs decreased with time. Conclusions/Significance: Control over peptide intracellular localization and retention is possible by appropriate modification with synthetic hydrophobic tails. We propose this as a strategy to design improved peptide-based delivery systems.	[Missirlis, Dimitris; Black, Matthew; Tirrell, Matthew] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Missirlis, Dimitris] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, Heidelberg, Germany; [Missirlis, Dimitris] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Teesalu, Tambet] Univ Tartu, Canc Biol Lab, Inst Biomed, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Teesalu, Tambet] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Tirrell, Matthew] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	University of California System; University of California Berkeley; Ruprecht Karls University Heidelberg; Max Planck Society; University of Tartu; Sanford Burnham Prebys Medical Discovery Institute; University of Chicago	Missirlis, D (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	missirlis@uni-heidelberg.de	Missirlis, Dimitris/S-3798-2019; Teesalu, Tambet/J-1802-2015	Missirlis, Dimitris/0000-0003-1874-676X; 	College of Engineering at the University of California, Berkeley; Marie Curie International Incoming Fellowship; CellNetworks Postdoctoral fellowship; S. Komen for Cure Career Development Award; European Regional Development Fund; European Research Council	College of Engineering at the University of California, Berkeley; Marie Curie International Incoming Fellowship(European Commission); CellNetworks Postdoctoral fellowship; S. Komen for Cure Career Development Award; European Regional Development Fund(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the College of Engineering at the University of California, Berkeley (DM, MT), a Marie Curie International Incoming Fellowship to DM, a CellNetworks Postdoctoral fellowship to DM, the S. Komen for Cure Career Development Award to TT, the European Regional Development Fund grant to TT, the European Research Council starting grant to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019; Bhagatji P, 2009, J CELL BIOL, V186, P615, DOI 10.1083/jcb.200903102; Braun GB, 2009, ACS NANO, V3, P2007, DOI 10.1021/nn900469q; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kastantin M, 2010, J PHYS CHEM B, V114, P12632, DOI 10.1021/jp1001786; Kastantin M, 2009, LANGMUIR, V25, P7279, DOI 10.1021/la900310k; Lin BF, 2011, NANO LETT, V11, P3946, DOI 10.1021/nl202220q; Missirlis D, 2010, MOL PHARMACEUT, V7, P2173, DOI 10.1021/mp100193h; Missirlis D, 2009, BIOCHEMISTRY-US, V48, P3304, DOI 10.1021/bi802356k; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Roth L, 2012, ONCOGENE, V31, P3754, DOI 10.1038/onc.2011.537; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P3153, DOI 10.1021/bi00063a030; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Torgersen ML, 2001, J CELL SCI, V114, P3737; Trent A, 2011, SOFT MATTER, V7, P9572, DOI 10.1039/c1sm05862b; Wang TY, 2005, J BIOL CHEM, V280, P22839, DOI 10.1074/jbc.M502920200; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	33	20	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54611	10.1371/journal.pone.0054611	http://dx.doi.org/10.1371/journal.pone.0054611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349939	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900081
J	Zhang, DC; Xiang, JB; Wang, LY; Xu, ZB; Sun, LD; Zhou, F; Zha, XL; Cai, D				Zhang, Diancai; Xiang, Jianbin; Wang, Liying; Xu, Zhibin; Sun, Lidong; Zhou, Feng; Zha, Xiliang; Cai, Duan			Comparative Proteomic Analysis of Gallbladder Bile Proteins Related to Cholesterol Gallstones	PLOS ONE			English	Article							SUPERSATURATED MODEL BILE; BILIARY PROTEINS; ELECTROPHORETIC ANALYSIS; ACCURATE SEPARATION; MICELLAR CARRIERS; CRYSTAL-FORMATION; GLYCATED ALBUMIN; CRYSTALLIZATION; ULTRACENTRIFUGATION; DISEASE	Background: Nucleation of cholesterol monohydrate crystals following the aggregation and fusion of cholesterol-enriched vesicles is a critical procedure in the formation of cholesterol gallstone. Biliary proteins play important roles in the process. It is inefficient to screen pro-nucleating or anti-nucleating proteins with routine physiochemical techniques, by which we discovered several pro-nucleating proteins. Methodology/Principal Findings: Based on comparative proteomic technologies, we investigated the differentially expressed proteins between the cholesterol gallstone and control groups, and between the vesicular phase and micellar phase. There are 401 +/- 75 spots detected on the cholesterol gallstone group and 389 +/- 94 spots on the control group gels, 120 +/- 24 spots detected on vesicular phase and 198 +/- 37 on micellar phase gels, and accordingly 22 and 8 differentially expressed proteins were identified successfully, respectively. Three of them, HSA, Profilin and Retinol Binding Protein, were validated by Western blot. Conclusion/Significance: Some of the identified proteins are in good agreement with proteins reported to be involved in the gallstone formation before. The information from this study might provide some important clues to uncover the key proteins involved in the formation of cholesterol gallstone.	[Zhang, Diancai] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Xiang, Jianbin; Cai, Duan] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Xiang, Jianbin; Cai, Duan] Fudan Univ, Shanghai Med Coll, Dept Surg, Shanghai 200433, Peoples R China; [Wang, Liying; Xu, Zhibin; Sun, Lidong; Zhou, Feng; Zha, Xiliang] Fudan Univ, Dept Biochem & Mol Biol, Minist Hlth, Key Lab Glycoconjugate Res, Shanghai 200433, Peoples R China	Nanjing Medical University; Fudan University; Fudan University; Fudan University	Xiang, JB (corresponding author), Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	tease@sohu.com; aroony@gmail.com			National Natural Science Foundation of China [30901443, 30772111]; 'Star of Century' Foundation of Fudan University; Opening Project of Institutes of Biomedical Sciences Fudan University; Opening Project of medical key disciplines in Jiangsu province [XK200703, XK03 200904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Star of Century' Foundation of Fudan University; Opening Project of Institutes of Biomedical Sciences Fudan University; Opening Project of medical key disciplines in Jiangsu province	This work was supported by grants from National Natural Science Foundation of China (30901443, 30772111), a grant from 'Star of Century' Foundation of Fudan University, a grant from Opening Project of Institutes of Biomedical Sciences Fudan University, and a grant from Opening Project of medical key disciplines(XK200703) in Jiangsu province(XK03 200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEI M, 1993, J LIPID RES, V34, P1141; AMIGO L, 1990, J LIPID RES, V31, P341; BURNSTEIN MJ, 1983, GASTROENTEROLOGY, V85, P801; Cohen MP, 2003, ARCH BIOCHEM BIOPHYS, V419, P25, DOI 10.1016/j.abb.2003.08.012; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Donovan JM, 1998, HEPATOLOGY, V27, P641, DOI 10.1002/hep.510270301; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grattagliano I, 2009, EUR J CLIN INVEST, V39, P986, DOI 10.1111/j.1365-2362.2009.02187.x; HARVEY PRC, 1991, J BIOL CHEM, V266, P13996; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; He C, 1997, J CHROMATOGR A, V776, P109, DOI 10.1016/S0021-9673(97)00560-8; He C, 1996, ELECTROPHORESIS, V17, P617, DOI 10.1002/elps.1150170334; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jirsa M, 2001, FRONT BIOSCI-LANDMRK, V6, pE154, DOI 10.2741/Jirsa; Keulemans YCA, 1998, HEPATOLOGY, V28, P11, DOI 10.1002/hep.510280103; KIBE A, 1984, SCIENCE, V225, P514, DOI 10.1126/science.6429856; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Maurer KJ, 2009, GASTROENTEROLOGY, V136, P425, DOI 10.1053/j.gastro.2008.12.031; Miquel JF, 2001, HEPATOLOGY, V33, P328, DOI 10.1053/jhep.2001.21550; MIQUEL JF, 1992, CLIN SCI, V82, P175, DOI 10.1042/cs0820175; Miquel JF, 1998, GASTROENTEROLOGY, V114, P1016, DOI 10.1016/S0016-5085(98)70322-1; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Moschetta A, 2001, BBA-MOL CELL BIOL L, V1532, P15, DOI 10.1016/S1388-1981(01)00110-X; OLEARY DP, 1995, J HEPATOL, V22, P239, DOI 10.1016/0168-8278(95)80435-8; Portincasa P, 2002, J LIPID RES, V43, P604; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SOMJEN GJ, 1985, J LIPID RES, V26, P699; STRASBERG SM, 1990, HEPATOLOGY, V12, pS176; Venneman NG, 2004, EUR J CLIN INVEST, V34, P656, DOI 10.1111/j.1365-2362.2004.01409.x; Wang DQH, 1999, J LIPID RES, V40, P415; Wang HH, 2010, BBA-MOL CELL BIOL L, V1801, P138, DOI 10.1016/j.bbalip.2009.10.003; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Xu ZB, 2007, PROTEOMICS, V7, P2358, DOI 10.1002/pmic.200600041; YAMASHITA G, 1995, J LIPID RES, V36, P1325; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yuet PK, 1996, HEPATOLOGY, V23, P896, DOI 10.1053/jhep.1996.v23.pm0008666347; Zhou H, 2005, RAPID COMMUN MASS SP, V19, P3569, DOI [10.1002/rcm.2207, 10.1007/rcm.2207]	39	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54489	10.1371/journal.pone.0054489	http://dx.doi.org/10.1371/journal.pone.0054489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349907	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900071
J	Gorski, PA; Glaves, JP; Vangheluwe, P; Young, HS				Gorski, Przemek A.; Glaves, John Paul; Vangheluwe, Peter; Young, Howard S.			Sarco(endo)plasmic Reticulum Calcium ATPase (SERCA) Inhibition by Sarcolipin Is Encoded in Its Luminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SOLID-STATE NMR; SKELETAL-MUSCLE; CA2+ PUMP; FUNCTIONAL INTERACTIONS; PEPTIDE INHIBITORS; TWITCH SKELETAL; PHOSPHOLAMBAN; PHOSPHORYLATION; CA2+-ATPASE	The sarco(endo)plasmic reticulum calcium ATPase (SERCA) is regulated in a tissue-dependent manner via interaction with the short integral membrane proteins phospholamban (PLN) and sarcolipin (SLN). Although defects in SERCA activity are known to cause heart failure, the regulatory mechanisms imposed by PLN and SLN could have clinical implications for both heart and skeletal muscle diseases. PLN and SLN have significant sequence homology in their transmembrane regions, suggesting a similar mode of binding to SERCA. However, unlike PLN, SLN has a conserved C-terminal luminal tail composed of five amino acids ((27)RSYQY), which may contribute to a distinct SERCA regulatory mechanism. We have functionally characterized alanine mutants of the C-terminal tail of SLN using co-reconstituted proteoliposomes of SERCA and SLN. We found that Arg(27) and Tyr(31) are essential for SLN function. We also tested the effect of a truncated variant of SLN (Arg(27)stop) and extended chimeras of PLN with the five luminal residues of SLN added to its C terminus. The Arg(27)stop form of SLN resulted in loss of function, whereas the PLN chimeras resulted in superinhibition with characteristics of both PLN and SLN. Based on our results, we propose that the C-terminal tail of SLN is a distinct, essential domain in the regulation of SERCA and that the functional properties of the SLN tail can be transferred to PLN.	[Gorski, Przemek A.; Glaves, John Paul; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Glaves, John Paul; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; [Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	University of Alberta; National Research Council Canada; University of Alberta; KU Leuven	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Young, Howard/0000-0002-5990-8422	Canadian Institutes of Health Research [MOP53306]; Alberta Innovates Technology Futures	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures	This work was supported in part by Canadian Institutes of Health Research Grant MOP53306.; Supported by doctoral awards from the Canadian Institutes of Health Research and Alberta Innovates Technology Futures.	Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Becucci L, 2009, BIOPHYS J, V97, P2693, DOI 10.1016/j.bpj.2009.08.035; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FOWLER C, 1989, BIOCHIM BIOPHYS ACTA, V980, P348, DOI 10.1016/0005-2736(89)90323-4; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; INESI G, 1988, METHOD ENZYMOL, V157, P154; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Karim CB, 2000, BIOCHEMISTRY-US, V39, P10892, DOI 10.1021/bi0003543; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Lockwood NA, 2003, BIOPOLYMERS, V69, P283, DOI 10.1002/bip.10365; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Negash S, 1996, BIOCHEMISTRY-US, V35, P11247, DOI 10.1021/bi960864q; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; SASAKI T, 1992, J BIOL CHEM, V267, P1674; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Waggoner JR, 2007, BIOCHEMISTRY-US, V46, P1999, DOI 10.1021/bi061365k; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	61	53	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8456	8467		10.1074/jbc.M112.446161	http://dx.doi.org/10.1074/jbc.M112.446161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362265	hybrid, Green Published			2022-12-25	WOS:000316564500043
J	Renga, B; Mencarelli, A; Cipriani, S; D'Amore, C; Carino, A; Bruno, A; Francisci, D; Zampella, A; Distrutti, E; Fiorucci, S				Renga, Barbara; Mencarelli, Andrea; Cipriani, Sabrina; D'Amore, Claudio; Carino, Adriana; Bruno, Angela; Francisci, Daniela; Zampella, Angela; Distrutti, Eleonora; Fiorucci, Stefano			The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; TOLL-LIKE RECEPTORS; NUCLEAR HORMONE-RECEPTORS; INNATE IMMUNITY; PPAR-GAMMA; COLITIS; IRF-7; LIVER; MACROPHAGES; METABOLISM	Background: Toll like receptors (TLRs) sense the intestinal microbiota and regulate the innate immune response. A dysregulation of TLRs function participates into intestinal inflammation. Farnesoid X Receptor (FXR) is a nuclear receptor and bile acid sensor highly expressed in entero-hepatic tissues. FXR regulates lipid metabolism and innate immunity. Methodology/Principal Findings: In this study we have investigated whether FXR gene expression/function in the intestine is modulated by TLRs. We found that in human monocytes activation of membrane TLRs (i.e. TLR2, 4, 5 and 6) downregulates, while activation of intracellular TLRs (i.e. TLR3, 7, 8 and 9) upregulates the expression of FXR and its target gene SHP, small heterodimer partner. This effect was TLR9-dependent and TNF alpha independent. Intestinal inflammation induced in mice by TNBS downregulates the intestinal expression of FXR in a TLR9-dependent manner. Protection against TNBS colitis by CpG, a TLR-9 ligand, was lost in FXR-/- mice. In contrast, activation of FXR rescued TLR9(-/-) and MyD88(-/-) mice from colitis. A putative IRF7 response element was detected in the FXR promoter and its functional characterization revealed that IRF7 is recruited on the FXR promoter under TLR9 stimulation. Conclusions/Significance: Intestinal expression of FXR is selectively modulated by TLR9. In addition to its role in regulating type-I interferons and innate antiviral immunity, IRF-7 a TLR9-dependent factor, regulates the expression of FXR, linking microbiota-sensing receptors to host's immune and metabolic signaling.	[Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Carino, Adriana; Bruno, Angela; Fiorucci, Stefano] Univ Perugia, Dipartimento Med & Clin Sperimentale, I-06100 Perugia, Italy; [Cipriani, Sabrina; Francisci, Daniela] Univ Perugia, Dipartimento Med Clin & Sci Biochim, I-06100 Perugia, Italy; [Zampella, Angela] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, Naples, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Osped Santa Maria della Misericordia, Perugia, Italy	University of Perugia; University of Perugia; University of Naples Federico II; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Dipartimento Med & Clin Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it		Carino, Adriana/0000-0003-2341-9528; Zampella, Angela/0000-0002-6170-279X; D'Amore, Claudio/0000-0001-9217-9404				Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guarner F, 2006, J NUTR, V136, P2269, DOI 10.1093/jn/136.8.2269; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim MS, 2003, J BIOL CHEM, V278, P8988, DOI 10.1074/jbc.M212633200; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Renga B, 2012, FASEB J, V26, P3021, DOI 10.1096/fj.11-195701; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; SANTUCCI L, 1995, GASTROENTEROLOGY, V108, P393, DOI 10.1016/0016-5085(95)90065-9; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sepe V, 2012, J MED CHEM, V55, P84, DOI 10.1021/jm201004p; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Szanto A, 2008, FEBS LETT, V582, P106, DOI 10.1016/j.febslet.2007.11.020; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wildenberg ME, 2011, GUT, V60, P432, DOI 10.1136/gut.2010.233304; Wu GD, 2007, GASTROENTEROLOGY, V133, P1068, DOI 10.1053/j.gastro.2007.08.052; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	35	64	69	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54472	10.1371/journal.pone.0054472	http://dx.doi.org/10.1371/journal.pone.0054472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372731	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400017
J	Gao, XR; Huang, ML; Liu, LM; He, Y; Yu, Q; Zhao, H; Zhou, CX; Zhang, JK; Zhu, ZS; Wan, J; Jiang, XH; Gao, YZ				Gao, Xueren; Huang, Moli; Liu, Limin; He, Yan; Yu, Qiang; Zhao, Hua; Zhou, Chunxiao; Zhang, Jinkun; Zhu, Zhansheng; Wan, Jiao; Jiang, Xinghong; Gao, Yuzhen			Insertion/Deletion Polymorphisms in the Promoter Region of BRM Contribute to Risk of Hepatocellular Carcinoma in Chinese Populations	PLOS ONE			English	Article							CHROMATIN-REMODELING FACTORS; CANCER CELL-LINES; LUNG-CANCER; LINKAGE DISEQUILIBRIUM; SWI/SNF COMPLEX; BREAST-CANCER; HEPATITIS-B; EXPRESSION; CARCINOGENESIS; GENOME	Background: BRM (Brahma homologue) is well known for its critical role in tumor suppression and cancer development. Genetic variations in the promoter region of BRM have been suggested to be associated with loss of BRM expression and lung cancer risk. To the authors' knowledge, no study on the role of BRM genetic polymorphisms in hepatocellular carcinoma (HCC) risk has been performed. Methodology/Principal Findings: In two independent case-control studies containing 796 HCC cases and 806 cancer-free individuals, we genotyped two putative functional insertion/deletion (indel) polymorphisms [BRM-1321 (rs3832613) and BRM-741 (rs34480940)] within promoter region of BRM in Chinese populations using a PCR-based method. Real-time RT-PCR analysis was used to explore the genotype-phenotype correlation between these polymorphisms and BRM expression in both tissue samples and HCC cell lines. Logistic regression analysis showed that compared to BRM-1321del/del genotype, the ins/del and ins/ins variant genotypes had an increased HCC risk [adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.19-1.82; adjusted OR = 2.55, 95% CI = 1.75-3.72, respectively]. No significant association between BRM-741 and HCC incidence was observed. However, stratification analysis revealed a significant association between ins/ins genotype of BRM-741 and increased HCC susceptibility in smokers (adjusted OR = 2.07, 95% CI = 1.33-3.22). Quantitative PCR analyses demonstrated that the genotypes of BRM-1321 and the corresponding haplotypes were significantly correlated with BRM expression in vivo. Compared with ins/ins genotype, subjects carrying ins/del and del/del genotype had 2.30 and 4.99 fold higher BRM expression in HCC tissue samples, respectively. Similar trends were observed in western blot analysis at protein level. Conclusions/Significance: Our findings suggest that BRM promoter polymorphism (BRM-1321) could regulate BRM expression and may serve as a potential marker for genetic susceptibility to HCC.	[Gao, Xueren; He, Yan; Zhu, Zhansheng; Wan, Jiao; Gao, Yuzhen] Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China; [Huang, Moli] Soochow Univ, Coll Med, Dept Bioinformat, Suzhou, Jiangsu, Peoples R China; [Liu, Limin] Soochow Univ, Coll Med, Dept Pathophysiol, Suzhou, Jiangsu, Peoples R China; [Yu, Qiang; Zhou, Chunxiao; Zhang, Jinkun] Nanjing Med Univ, Affiliated Hosp, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Zhao, Hua] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Jiangsu, Peoples R China; [Jiang, Xinghong] Soochow Univ, Coll Med, Dept Neurobiol & Psychol, Key Lab Pain Res & Therapy, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Soochow University - China; Soochow University - China	Gao, YZ (corresponding author), Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China.	yuzhengao@suda.edu.cn	liu, li/HGC-0900-2022	Huang, Moli/0000-0001-5543-9334	National Natural Science Foundation of China [81171893, 81201574, 31000630, 11101300]; Natural Science Foundation of Jiangsu Province [BK2011290]; Natural Science Foundation for Colleges and Universities of Jiangsu Province [09KJB180007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Colleges and Universities of Jiangsu Province	This study is supported by grants from National Natural Science Foundation of China (No. 81171893, No. 81201574, No. 31000630 and No. 11101300), Natural Science Foundation of Jiangsu Province (No. BK2011290) and Natural Science Foundation for Colleges and Universities of Jiangsu Province (09KJB180007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Casper Markus, 2011, Hepatology, V53, P1390, DOI 10.1002/hep.24241; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; McClune AC, 2010, CLIN LIVER DIS, V14, P461, DOI 10.1016/j.cld.2010.05.009; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Momi N, 2012, CARCINOGENESIS, V33, P1617, DOI 10.1093/carcin/bgs186; Okabe H, 2001, CANCER RES, V61, P2129; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yu Q, 2012, WORLD J GASTROENTERO, V18, P383, DOI 10.3748/wjg.v18.i4.383	33	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55169	10.1371/journal.pone.0055169	http://dx.doi.org/10.1371/journal.pone.0055169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359823	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600158
J	Li, BD; Zaveri, T; Ziegler, GR; Hayes, JE				Li, Bangde; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.			User Preferences in a Carrageenan-Based Vaginal Drug Delivery System	PLOS ONE			English	Article							MICROBICIDE ACCEPTABILITY; WOMEN; HIV; CHALLENGES; CARRAGUARD; ATTITUDES; TRIALS; CONDOM	Topical microbicides are a promising solution to address the global threat of HIV and other sexually transmitted infections. To be successful, a microbicide not only needs to be biologically functional but also highly acceptable to users. User acceptability of microbicides can be incorporated early in the product formulation and design process. Previous qualitative research revealed women had strong preferences regarding product shape, while preferences related to size and firmness were less clear. Here, we explored the effect of size and firmness on the acceptability of semisolid ovoid microbicide prototypes intended for vaginal use. Sexually active women (n = 74) were randomized to one of two conditions: with and without applicator. Nine different prototypes were evaluated; they were formulated to low, medium and high firmness using mixtures of kappa and iota carrageenan and potassium chloride. Three sizes were produced at each firmness level. Women manipulated all nine prototypes, rating them for perceived effectiveness, imagined ease-of-insertion and willingness-to-try on visual analog scales. The influence of size and firmness on these three outcome measures were assessed using ANOVA and response surface models. Results indicated size and firmness both influenced the outcome measures, but firmess was more influential than size. Also, the specific effects of size and firmness depended strongly on presence or absence of an applicator. Generally, women in the without applicator condition wanted a larger, firmer product. Collectively, these data suggest efforts to rationally design of microbicides for enhanced user acceptability must consider factors like size and firmness. Also, the decision to include or forego an applicator should be addressed early in the design process, as it strongly influences other design decisions.	[Li, Bangde; Zaveri, Toral; Hayes, John E.] Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA; [Li, Bangde; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.] Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayes, JE (corresponding author), Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA.	jeh40@psu.edu	Hayes, John E/A-5893-2008	Hayes, John E/0000-0001-9065-6326; Ziegler, Gregory/0000-0002-3881-649X; Zaveri, Toral/0000-0003-0059-9212	National Institutes of Health from the National Institute Of Allergy And Infectious Diseases [R21AI094514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094514, R33AI094514] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute Of Allergy And Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant number R21AI094514 from the National Institute Of Allergy And Infectious Diseases to JEH and GRZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMD, 2009, MICR PIP SUMM REP; Beksinska ME, 2001, S AFR MED J, V91, P672; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; CDC, 1993, SEXUALLY TRANSMITTED; Centers for Disease Control, 2012, HIV US GLANC; Coggins C, 2000, REPROD HEALTH MATTER, V8, P132, DOI 10.1016/S0968-8080(00)90015-6; Darroch JE, 1999, FAM PLANN PERSPECT, V31, P16, DOI 10.2307/2991552; Elias C, 2001, J WOMEN HEALTH GEN-B, V10, P163, DOI 10.1089/152460901300039502; FRANK ML, 1995, WOMEN HEALTH, V23, P31, DOI 10.1300/J013v23n02_03; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Han L, 2009, J WOMENS HEALTH, V18, P1377, DOI 10.1089/jwh.2008.1239; Hardy E, 2003, CONTRACEPTION, V67, P391, DOI 10.1016/S0010-7824(03)00026-X; HIRA SK, 1995, AM J PUBLIC HEALTH, V85, P1098, DOI 10.2105/AJPH.85.8_Pt_1.1098; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Mahan ED, 2011, CONTRACEPTION, V84, P184, DOI 10.1016/j.contraception.2010.11.012; Mantell JE, 2005, SOC SCI MED, V60, P319, DOI 10.1016/j.socscimed.2004.05.011; Mason TH, 2003, AIDS BEHAV, V7, P339, DOI 10.1023/B:AIBE.0000004726.61630.96; Menon S, 2007, J WOMENS HEALTH, V16, P703, DOI 10.1089/jwh.2006.0163; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Morrow KM, 2007, HEALTH PSYCHOL, V26, P777, DOI 10.1037/0278-6133.26.6.777; Morrow KM, 2010, ANTIVIR RES, V88, pS40, DOI 10.1016/j.antiviral.2010.09.008; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Nnorom J, 2008, W AFRICA HIV AIDS EP; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Piot P, 2001, J Am Med Womens Assoc (1972), V56, P90; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Tasoglu S, 2011, J NON-NEWTON FLUID, V166, P1116, DOI 10.1016/j.jnnfm.2011.06.007; Tolley EE, 2006, AM J PUBLIC HEALTH, V96, P79, DOI 10.2105/AJPH.2004.043471; UNAIDS, 2011, EP UPD HLTH SECT PRO; UNAIDS, 2007, JOINT ASS HIV AIDS P; van de Wijgert Janneke, 2002, BETA, V15, P23; Verguet S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015501; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Whitehead SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014831; Zaveri T, 2012, 19 INT AIDS C JUL 22	39	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54975	10.1371/journal.pone.0054975	http://dx.doi.org/10.1371/journal.pone.0054975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23358688	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600140
J	Mai, ZX; Liu, HY				Mai, Zhongxing; Liu, Haiyan			Random Parameter Sampling of a Generic Three-Tier MAPK Cascade Model Reveals Major Factors Affecting Its Versatile Dynamics	PLOS ONE			English	Article							PROTEIN-KINASE CASCADES; KINETIC-MODELS; REGULATORY NETWORKS; NEGATIVE FEEDBACK; SIGNALING CASCADE; CELL FATE; BISTABILITY; ULTRASENSITIVITY; PHOSPHORYLATION; IDENTIFICATION	The mitogen-activated protein kinase (MAPK) pathway is considered to be a central block in many biological signaling networks. Despite the common core cascade structure, the activation of MAPK in different biological systems can exhibit different types of dynamic behaviors. Computer modeling may help to reveal the mechanisms underlying such variations. However, so far most computational models of the MAPK cascade have been system-specific, or to reflect a particular type among the wide spectrum of possible dynamics. To obtain a general and integrated view of the relationship between the dynamics of MAPK activation and the structures and parameters of the MAPK cascade, we constructed a generic model by comparing previous models covering different specific biological systems. We assumed that reliable qualitative results could be predicted through a qualitative model with pseudo parameters. We used randomly sampled parameters instead of a specific set of "best-fit" parameters to avoid biases towards any particular systems. A range of dynamics behaviors for MAPK activation, including ultrasensitivity, bistability, transient activation and oscillation, were successfully predicted by the generic model. The results indicated that the steady state dynamics (ultrasensitivity and bistability) was jointly determined by the three-tiered structure of the MAPK cascade and the competitive substrate binding in the dual-phosphorylation processes of the central components, while the temporal dynamics (transient activation and oscillation) was mainly affected by the upstream signaling pathway and feedbacks. Moreover, MAPK kinase (MAPKK) played more important roles than the other two components in determining the dynamics of MAPK activation. We hypothesize that this is an important and advantageous property for the regulation and for the functional diversity of MAPK pathways in real cells. Finally, to assist developing generic models for signaling motifs through model comparisons, we proposed a reaction-based database to make the model data more flexible and interoperable.	[Liu, Haiyan] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liu, HY (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	hyliu@ustc.edu.cn	Liu, Haiyan/O-9637-2014	Liu, Haiyan/0000-0002-5926-820X	Chinese Ministry of Science and Technology [2011CBA00801]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work is financially supported by the Chinese Ministry of Science and Technology (grant number 2011CBA00801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Campagne Fabien, 2004, Sci STKE, V2004, ppl11; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; HarshaRani GV, 2005, J BIOCHEM, V137, P653, DOI 10.1093/jb/mvi083; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Nakakuki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001782; Nikolaev EV, 2007, J THEOR BIOL, V247, P442, DOI 10.1016/j.jtbi.2007.02.013; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sivakumaran S, 2003, BIOINFORMATICS, V19, P408, DOI 10.1093/bioinformatics/btf860; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	34	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54441	10.1371/journal.pone.0054441	http://dx.doi.org/10.1371/journal.pone.0054441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365667	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600055
J	Knoll, F; Ridgely, RC; Ortega, F; Sanz, JL; Witmer, LM				Knoll, Fabien; Ridgely, Ryan C.; Ortega, Francisco; Luis Sanz, Jose; Witmer, Lawrence M.			Neurocranial Osteology and Neuroanatomy of a Late Cretaceous Titanosaurian Sauropod from Spain (Ampelosaurus sp.)	PLOS ONE			English	Article							SEMICIRCULAR CANALS; DINOSAUR BRAINCASE; SAURISCHIA; AGILITY; ANATOMY; SKULL	Titanosaurians were a flourishing group of sauropod dinosaurs during Cretaceous times. Fossils of titanosaurians have been found on all continents and their remains are abundant in a number of Late Cretaceous sites. Nonetheless, the cranial anatomy of titanosaurians is still very poorly known. The Spanish latest Cretaceous locality of "Lo Hueco'' yielded a relatively well preserved, titanosaurian braincase, which shares a number of phylogenetically restricted characters with Ampelosaurus atacis from France such as a flat occipital region. However, it appears to differ from A. atacis in some traits such as the greater degree of dorsoventral compression and the presence of proatlas facets. The specimen is, therefore, provisionally identified as Ampelosaurus sp. It was CT scanned, and 3D renderings of the cranial endocast and inner-ear system were generated. Our investigation highlights that, although titanosaurs were derived sauropods with a successful evolutionary history, they present a remarkably modest level of paleoneurological organization. Compared with the condition in the basal titanosauriform Giraffatitan brancai, the labyrinth of Ampelosaurus sp. shows a reduced morphology. The latter feature is possibly related to a restricted range of head-turning movements.	[Knoll, Fabien] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Ortega, Francisco] Univ Nacl Educ Distancia, Dept Fis Matemat & Fluidos, Fac Ciencias, E-28040 Madrid, Spain; [Luis Sanz, Jose] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University System of Ohio; Ohio University; Universidad Nacional de Educacion a Distancia (UNED); Autonomous University of Madrid	Knoll, F (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	knoll@mncn.csic.es	Ortega, Francisco/B-5760-2009; Knoll, Fabien/D-3812-2014; Sanz, Jose Luis/O-1421-2019; Ortega, Francisco/K-3255-2015	Ortega, Francisco/0000-0002-7431-354X; Knoll, Fabien/0000-0001-7822-8740; Ortega, Francisco/0000-0002-7431-354X; Sanz, Jose Luis/0000-0002-5214-5725; Witmer, Lawrence/0000-0002-7610-0118	Ministerio de Economia y Competitividad, Madrid [CGL2009-12143]; Ramon y Cajal Program; United States National Science Foundation [IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1050154] Funding Source: National Science Foundation	Ministerio de Economia y Competitividad, Madrid; Ramon y Cajal Program(Spanish Government); United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This is a contribution to the research project CGL2009-12143 (Ministerio de Economia y Competitividad, Madrid), of which FK, who is currently supported by the Ramon y Cajal Program, is Principal Investigator. LMW and RCR acknowledge funding support from the United States National Science Foundation (IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154) and the Ohio University Heritage College of Osteopathic Medicine. The Ohio Supercomputing Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 1998, THESIS U SCI TECHNIQ; Balanoff AM, 2010, AM MUS NOVIT, P1, DOI 10.1206/591.1; Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P405; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carpenter Kenneth, 1998, Modern Geology, V23, P69; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Cordier R., 1954, TRAITE ZOOLOGIE, V12, P202; Cox PG, 2010, J ANAT, V216, P37, DOI 10.1111/j.1469-7580.2009.01172.x; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Diaz VD, 2011, ACTA PALAEONTOL POL, V56, P521, DOI 10.4202/app.2010.0043; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Galton PM, 2006, GEOL MAG, V143, P905, DOI 10.1017/S0016756806002561; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Gray AA, 1907, LABYRINTH ANIMALS IN, V1; HADZISELIMOVIC H, 1964, ACTA ANAT, V57, P306; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Jeffery N, 2010, J ANAT, V216, P496, DOI 10.1111/j.1469-7580.2010.01211.x; Knoll F, 2006, GEOBIOS-LYON, V39, P215, DOI 10.1016/j.geobios.2004.11.005; Knoll F, 1999, B SOC GEOL FR, V170, P103; Knoll F, 1997, THESIS U SCI TECHNIQ; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; KURZANOV SM, 1983, PALEONTOL ZH, P90; Le Loeuff J, 2005, LIFE O PAST, P115; LELOEUFF J, 1989, CR ACAD SCI II, V309, P851; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Mohabey DM, 2005, GONDWANA GEOLOGICAL, P101; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Paulina Carabajal A, 2007, AMEGHINIANA, V44, P109; Philip J., 2000, ATLAS PERITETHYS PAL; PLESKOT G., 1940, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL TIERE, V60, P13; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Retzius G., 1881, GEHORORGAN WIRBELTHI, V1; RETZIUS G, 1884, GEHORORGAN WIRBELTHI, V2; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado L, 2005, ACTA PALAEONTOL POL, V50, P79; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Tidwell V, 2003, J VERTEBR PALEONTOL, V23, P176, DOI 10.1671/0272-4634(2003)23[176:BOAECT]2.0.CO;2; Weishampel DB, 2011, TRANSYLVANIAN DINOSAURS, P1; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; Werner C., 1960, GEHORORGAN WIRBELTIE; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	54	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54991	10.1371/journal.pone.0054991	http://dx.doi.org/10.1371/journal.pone.0054991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355905	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500152
J	Ohsawa, M; Kobayashi, T; Okura, H; Igarashi, T; Mizuguchi, M; Hino, O				Ohsawa, Maki; Kobayashi, Toshiyuki; Okura, Hidehiro; Igarashi, Takashi; Mizuguchi, Masashi; Hino, Okio			TSC1 Controls Distribution of Actin Fibers through Its Effect on Function of Rho Family of Small GTPases and Regulates Cell Migration and Polarity	PLOS ONE			English	Article							GENE-PRODUCT; MAMMALIAN TARGET; COMPLEX 2; ACTIVATION; HAMARTIN; TUBERIN; ADHESION; JUNCTIONS; ADHERENS; SUPPRESSION	The tumor-suppressor genes TSC1 and TSC2 are mutated in tuberous sclerosis, an autosomal dominant multisystem disorder. The gene products of TSC1 and TSC2 form a protein complex that inhibits the signaling of the mammalian target of rapamycin complex1 (mTORC1) pathway. mTORC1 is a crucial molecule in the regulation of cell growth, proliferation and survival. When the TSC1/TSC2 complex is not functional, uncontrolled mTORC1 activity accelerates the cell cycle and triggers tumorigenesis. Recent studies have suggested that TSC1 and TSC2 also regulate the activities of Rac1 and Rho, members of the Rho family of small GTPases, and thereby influence the ensuing actin cytoskeletal organization at focal adhesions. However, how TSC1 contributes to the establishment of cell polarity is not well understood. Here, the relationship between TSC1 and the formation of the actin cytoskeleton was analyzed in stable TSC1-expressing cell lines originally established from a Tsc1-deficient mouse renal tumor cell line. Our analyses showed that cell proliferation and migration were suppressed when TSC1 was expressed. Rac1 activity in these cells was also decreased as was formation of lamellipodia and filopodia. Furthermore, the number of basal actin stress fibers was reduced; by contrast, apical actin fibers, originating at the level of the tight junction formed a network in TSC1-expressing cells. Treatment with Rho-kinase (ROCK) inhibitor diminished the number of apical actin fibers, but rapamycin had no effect. Thus, the actin fibers were regulated by the Rho-ROCK pathway independently of mTOR. In addition, apical actin fibers appeared in TSC1-deficient cells after inhibition of Rac1 activity. These results suggest that TSC1 regulates cell polarity-associated formation of actin fibers through the spatial regulation of Rho family of small GTPases.	[Ohsawa, Maki; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Grad Sch Med, Tokyo, Japan; [Ohsawa, Maki; Kobayashi, Toshiyuki; Okura, Hidehiro; Hino, Okio] Juntendo Univ Sch Med, Dept Pathol & Oncol, Tokyo, Japan; [Okura, Hidehiro] Juntendo Univ Sch Med, Dept Neurosurg, Tokyo, Japan; [Ohsawa, Maki; Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan	University of Tokyo; Juntendo University; Juntendo University; University of Tokyo	Kobayashi, T (corresponding author), Juntendo Univ Sch Med, Dept Pathol & Oncol, Tokyo, Japan.	koba396@juntendo.ac.jp; ohino@juntendo.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan; Institute for Environmental and Gender-Specific Medicine; Juntendo University	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Institute for Environmental and Gender-Specific Medicine; Juntendo University	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan, and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and the Ministry of Health, Labour and Welfare, Japan. This work was also supported by the Institute for Environmental and Gender-Specific Medicine and a research project of Juntendo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukuda T, 2000, ANAL BIOCHEM, V285, P274, DOI 10.1006/abio.2000.4787; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Haddad LA, 2002, J BIOL CHEM, V277, P44180, DOI 10.1074/jbc.M207211200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jin F, 1996, P NATL ACAD SCI USA, V93, P9154, DOI 10.1073/pnas.93.17.9154; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Kleymenova E, 2001, MOL CELL, V7, P823, DOI 10.1016/S1097-2765(01)00226-X; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Larson Y, 2010, J BIOL CHEM, V285, P24987, DOI 10.1074/jbc.M109.096917; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Orimoto K, 1996, BIOCHEM BIOPH RES CO, V219, P70, DOI 10.1006/bbrc.1996.0183; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Satake N, 1999, CANCER RES, V59, P849; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiono M, 2008, ONCOGENE, V27, P6690, DOI 10.1038/onc.2008.283; Soucek T, 1998, ONCOGENE, V16, P2197, DOI 10.1038/sj.onc.1201743; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tsuchiya H, 1996, CANCER RES, V56, P429; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; YONEMURA S, 1995, J CELL SCI, V108, P127; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211	55	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54503	10.1371/journal.pone.0054503	http://dx.doi.org/10.1371/journal.pone.0054503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355874	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500081
J	Salomonnson, E; Stacer, AC; Ehrlich, A; Luker, KE; Luker, GD				Salomonnson, Emma; Stacer, Amanda C.; Ehrlich, Anna; Luker, Kathryn E.; Luker, Gary D.			Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy	PLOS ONE			English	Article							CHEMOKINE CXCL12; CXCR4; CELLS; EXPRESSION; MICROENVIRONMENT; CHEMOTHERAPY; INHIBITION; ARRESTINS; SURVIVAL; LEUKEMIA	Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer, a disease that continues to have a dismal prognosis. CXCL12-CXCR4 signaling drives proliferation, survival, and invasion of ovarian cancer cells, leading to tumor growth and metastasis. Pleiotropic effects of CXCR4 in multiple key steps in ovarian cancer suggest that blocking this pathway will improve outcomes for patients with this disease. To quantify CXCL12-CXCR4 signaling in cell-based assays and living mouse models of ovarian cancer, we developed a click beetle red luciferase complementation reporter that detects activation of CXCR4 based on recruitment of the cytosolic adapter protein beta-arrestin 2. Both in two-dimensional and three-dimensional cell cultures, we established that bioluminescence from this reporter measures CXCL12-dependent activation of CXCR4 and inhibition of this pathway with AMD3100, a clinically-approved small molecule that blocks CXCL12-CXCR4 binding. We used this imaging system to quantify CXCL12-CXCR4 signaling in a mouse model of metastatic ovarian cancer and showed that treatment with AMD3100 interrupted this pathway in vivo. Combination therapy with AMD3100 and cisplatin significantly decreased tumor burden in mice, although differences in overall survival were not significantly greater than treatment with either agent as monotherapy. These studies establish a molecular imaging reporter system for analyzing CXCL12-CXCR4 signaling in ovarian cancer, which can be used to investigate biology and therapeutic targeting of this pathway in cell-based assays and living mice.	[Salomonnson, Emma; Stacer, Amanda C.; Ehrlich, Anna; Luker, Kathryn E.; Luker, Gary D.] Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Biomed Engn, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	gluker@umich.edu		luker, gary/0000-0001-6832-2581; Luker, Kathryn/0000-0001-8314-3370	National Institutes of Health [NIH R01CA136553, NIH R01CA136829, NIH P50CA093990]; Department of Defense [W81XWH-09-1-0128]; NATIONAL CANCER INSTITUTE [R01CA136553, P50CA093990, R01CA136829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grants from the National Institutes of Health (NIH R01CA136553, R01CA136829, and P50CA093990) and the Department of Defense (W81XWH-09-1-0128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald K, 2012, ONCOGENE, DOI [10.1038/onc.2011.1653, DOI 10.1038/ONC.2011.1653]; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Barbieri F, 2010, J ONCOL, V2010, DOI 10.1155/2010/426956; Barbolina MV, 2010, MOL CANCER RES, V8, P653, DOI 10.1158/1541-7786.MCR-09-0463; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; D'Alterio C, 2012, CANC IMMUNOL IMMUNOT; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dillmann F, 2009, LEUKEMIA LYMPHOMA, V50, P1676, DOI 10.1080/10428190903150847; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kryczek I, 2005, CANCER RES, V65, P465; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lau BW, 2010, ANTICANCER RES, V30, P2153; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; Mehta G, 2012, J CONTROL RELEASE; Moore DH, 1997, GYNECOL ONCOL, V65, P78, DOI 10.1006/gyno.1997.4628; National Cancer Institute, 2012, SEER STAT FACT SHEET; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Scotton C, 2001, CANCER RES, V61, P3; Scotton CJ, 2002, CANCER RES, V62, P5930; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Yu LF, 2010, LAB CHIP, V10, P2424, DOI 10.1039/c004590j; Yu M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.13; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	42	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51500	10.1371/journal.pone.0051500	http://dx.doi.org/10.1371/journal.pone.0051500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372646	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500006
J	Yuen, HF; McCrudden, CM; Huang, YH; Tham, JM; Zhang, XQ; Zeng, Q; Zhang, SD; Hong, WJ				Yuen, Hiu-Fung; McCrudden, Cian M.; Huang, Yu-Han; Tham, Jill M.; Zhang, Xiaoqian; Zeng, Qi; Zhang, Shu-Dong; Hong, WanJin			TAZ Expression as a Prognostic Indicator in Colorectal Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; YES-ASSOCIATED PROTEIN; TEAD TRANSCRIPTION FACTORS; SQUAMOUS-CELL CARCINOMA; HIPPO PATHWAY; GENE-EXPRESSION; RETINOIC ACID; ONCOGENIC TRANSFORMATION; ACTIN CYTOSKELETON; CANDIDATE ONCOGENE	The Hippo pathway restricts the activity of transcriptional coactivators TAZ (WWTR1) and YAP. TAZ and YAP are reported to be overexpressed in various cancers, however, their prognostic significance in colorectal cancers remains unstudied. The expression levels of TAZ and YAP, and their downstream transcriptional targets, AXL and CTGF, were extracted from two independent colon cancer patient datasets available in the Gene Expression Omnibus database, totaling 522 patients. We found that mRNA expressions of both TAZ and YAP were positively correlated with those of AXL and CTGF (p<0.05). High level mRNA expression of TAZ, AXL or CTGF significantly correlated with shorter survival. Importantly, patients co-overexpressing all 3 genes had a significantly shorter survival time, and combinatorial expression of these 3 genes was an independent predictor for survival. The downstream target genes for TAZ-AXL-CTGF overexpression were identified by Java application MyStats. Interestingly, genes that are associated with colon cancer progression (ANTXR1, EFEMP2, SULF1, TAGLN, VCAN, ZEB1 and ZEB2) were upregulated in patients co-overexpressing TAZ-AXL-CTGF. This TAZ-AXL-CTGF gene expression signature (GES) was then applied to Connectivity Map to identify small molecules that could potentially be utilized to reverse this GES. Of the top 20 small molecules identified by connectivity map, amiloride (a potassium sparing diuretic,) and tretinoin (all-trans retinoic acid) have shown therapeutic promise in inhibition of colon cancer cell growth. Using MyStats, we found that low level expression of either ANO1 or SQLE were associated with a better prognosis in patients who co-overexpressed TAZ-AXL-CTGF, and that ANO1 was an independent predictor of survival together with TAZ-AXL-CTGF. Finally, we confirmed that TAZ regulates Axl, and plays an important role in clonogenicity and non-adherent growth in vitro and tumor formation in vivo. These data suggest that TAZ could be a therapeutic target for the treatment of colon cancer.	[Yuen, Hiu-Fung; Huang, Yu-Han; Tham, Jill M.; Zhang, Xiaoqian; Zeng, Qi; Hong, WanJin] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [McCrudden, Cian M.; Zhang, Shu-Dong] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland; [Zeng, Qi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Hong, WanJin] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Queens University Belfast; National University of Singapore; Xiamen University	Zhang, SD (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk; mcbhwj@imcb.a-star.edu.sg	Zhang, Shu-Dong/G-1269-2010; HONG, Wanjin/E-9927-2010	Zhang, Shu-Dong/0000-0002-7721-0167; 	Agency of Science, Technology, and Research (A*STAR), Singapore	Agency of Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This study is funded by The Agency of Science, Technology, and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus L, 2012, ONCOGENE, V31, P238, DOI 10.1038/onc.2011.224; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Babel I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001784; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; Duvvuri U, 2012, CANC RES; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Farzaneh-Far A, 2000, BIOCHEM BIOPH RES CO, V277, P736, DOI 10.1006/bbrc.2000.3747; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Helias-Rodzewicz Z, 2010, GENE CHROMOSOME CANC, V49, P1161, DOI 10.1002/gcc.20825; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOOSEIN NM, 1988, CANCER LETT, V40, P219, DOI 10.1016/0304-3835(88)90014-6; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Kim EJ, 2002, J CELL PHYSIOL, V190, P92, DOI 10.1002/jcp.10045; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; Matusiewicz M, 2008, INT J COLORECTAL DIS, V23, P383, DOI 10.1007/s00384-007-0434-4; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Narahara H, 2000, INT J CANCER, V88, P157, DOI 10.1002/1097-0215(20001015)88:2<157::AID-IJC2>3.0.CO;2-B; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pannocchia A, 1996, CELL BIOCHEM FUNCT, V14, P11, DOI 10.1002/cbf.641; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; SZOLGAYDANIEL E, 1991, CANCER RES, V51, P1039; TATSUTA M, 1995, CARCINOGENESIS, V16, P941, DOI 10.1093/carcin/16.4.941; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Xie M, 2012, J THORAC ONCOL; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yao L, 2012, J PROTEOME RES; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao H, 2010, PROSTATE CANCER P D, V13, P252, DOI 10.1038/pcan.2010.9; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	89	111	122	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54211	10.1371/journal.pone.0054211	http://dx.doi.org/10.1371/journal.pone.0054211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372686	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500040
J	Hillert, L; Jovanovic, H; Ahs, F; Savic, I				Hillert, Lena; Jovanovic, Hristina; Ahs, Fredrik; Savic, Ivanka			Women with Multiple Chemical Sensitivity Have Increased Harm Avoidance and Reduced 5-HT1A Receptor Binding Potential in the Anterior Cingulate and Amygdala	PLOS ONE			English	Article							TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; EMISSION COMPUTED-TOMOGRAPHY; CHRONIC-FATIGUE-SYNDROME; SEROTONIN(2A) RECEPTORS; SUBJECTIVE HEALTH; PYRAMIDAL NEURONS; ALLELIC VARIATION; ODOR INTOLERANCE; NORMATIVE DATA; IN-VIVO	Multiple chemical sensitivity (MCS) is a common condition, characterized by somatic distress upon exposure to odors. As in other idiopathic environmental intolerances, the underlying mechanisms are unknown. Contrary to the expectations it was recently found that persons with MCS activate the odor-processing brain regions less than controls, while their activation of the anterior cingulate cortex (ACC) is increased. The present follow-up study was designed to test the hypotheses that MCS subjects have increased harm avoidance and deviations in the serotonin system, which could render them intolerant to environmental odors. Twelve MCS and 11 control subjects, age 22-44, all working or studying females, were included in a PET study where 5-HT1A receptor binding potential (BP) was assessed after bolus injection of [C-11]WAY100635. Psychological profiles were assessed by the Temperament and Character Inventory and the Swedish universities Scales of Personality. All MCS and 12 control subjects were also tested for emotional startle modulation in an acoustic startle test. MCS subjects exhibited significantly increased harm avoidance, and anxiety compared to controls. They also had a reduced 5-HT1A receptor BP in amygdala (p = 0.029), ACC (p = 0.005) (planned comparisons, significance level 0.05), and insular cortex (p = 0.003; significance level p<0.005 with Bonferroni correction), and showed an inverse correlation between degree of anxiety and the BP in the amygdala (planned comparison). No group by emotional category difference was found in the startle test. Increased harm avoidance and the observed changes in the 5-HT1A receptor BP in the regions processing harm avoidance provides a plausible pathophysiological ground for the symptoms described in MCS, and yields valuable information for our general understanding of idiopathic environmental intolerances.	[Hillert, Lena] Karolinska Inst, Dept Publ Hlth Sci, Div Occupat & Environm Med, Stockholm, Sweden; [Jovanovic, Hristina; Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ahs, Fredrik] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Karolinska Institutet; Karolinska Institutet; Duke University	Hillert, L (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Occupat & Environm Med, Stockholm, Sweden.	lena.hillert@ki.se		Ahs, Fredrik/0000-0002-6355-660X; Hillert, Lena/0000-0002-3459-9782	Swedish Council for Working Life and Social Research [2004-0674]; Swedish Research Council [2009-4925]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Contract Grant Sponsor: Swedish Council for Working Life and Social Research, Contract grant number: 2004-0674, http://www.fas.se/and Swedish Research Council, Contract grant number 2009-4925, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Andine P, 1997, ACTA PSYCHIAT SCAND, V96, P82, DOI 10.1111/j.1600-0447.1997.tb09910.x; Aupperle Robin L, 2010, Dialogues Clin Neurosci, V12, P517; Bartha L, 1999, ARCH ENVIRON HEALTH, V54, P147; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Bergdahl J, 2005, CLIN ORAL INVEST, V9, P251, DOI 10.1007/s00784-005-0015-2; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brandstrom S, 1998, COMPR PSYCHIAT, V39, P122, DOI 10.1016/S0010-440X(98)90070-0; Carlsson F, 2005, PUBLIC HEALTH, V119, P568, DOI 10.1016/j.puhe.2004.07.011; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Cleare AJ, 2005, BIOL PSYCHIAT, V57, P239, DOI 10.1016/j.biopsych.2004.10.031; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1987, J PSYCHIAT RES, V21, P457, DOI 10.1016/0022-3956(87)90094-X; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Conrad R, 2007, PAIN, V133, P197, DOI 10.1016/j.pain.2007.07.024; CULLEN MR, 1987, OCCUP MED, V2, P655; Dalton P, 1996, CHEM SENSES, V21, P447, DOI 10.1093/chemse/21.4.447; Enge S, 2011, BEHAV BRAIN RES, V216, P122, DOI 10.1016/j.bbr.2010.07.021; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; HAMON M, 1990, NEUROPSYCHOPHARMACOL, V3, P349; Hansenne M, 1997, BIOL PSYCHIAT, V42, P959, DOI 10.1016/S0006-3223(97)00325-9; Hausteiner C, 2003, J NERV MENT DIS, V191, P50, DOI 10.1097/00005053-200301000-00009; HEUSER G, 1994, TOXICOL IND HEALTH, V10, P561; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Jacob CP, 2004, AM J PSYCHIAT, V161, P569, DOI 10.1176/appi.ajp.161.3.569; Johansson A, 2005, INT ARCH OCC ENV HEA, V78, P559, DOI 10.1007/s00420-005-0616-8; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Kim HJ, 2009, NEUROSCI LETT, V464, P103, DOI 10.1016/j.neulet.2009.07.087; Kreutzer R, 1999, AM J EPIDEMIOL, V150, P1; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; Lavergne MR, 2010, CAN FAM PHYSICIAN, V56, pE57; Machado CJ, 2010, BEHAV NEUROSCI, V124, P761, DOI 10.1037/a0021560; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; Mohr C, 2008, PAIN, V139, P416, DOI 10.1016/j.pain.2008.05.020; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Osterberg K, 2007, HUM EXP TOXICOL, V26, P231, DOI 10.1177/0960327107070575; Peirson AR, 1999, PSYCHIAT RES, V89, P29, DOI 10.1016/S0165-1781(99)00079-7; Pissiota A, 2003, EUR J NEUROSCI, V18, P1325, DOI 10.1046/j.1460-9568.2003.02855.x; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rabiner EA, 2002, NEUROIMAGE, V15, P620, DOI 10.1006/nimg.2001.0984; Ross GH, 1999, TOXICOL IND HEALTH, V15, P415, DOI 10.1191/074823399678846853; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Savic I, 2004, NEUROLOGY, V62, P1343, DOI 10.1212/01.WNL.0000123696.98166.AF; SIMON TR, 1994, TOXICOL IND HEALTH, V10, P573; Skovbjerg S, 2009, SCAND J PUBLIC HEALT, V37, P621, DOI 10.1177/1403494809105430; Slater P, 1998, J NEURAL TRANSM, V105, P305, DOI 10.1007/s007020050060; Stenn P, 1998, PSYCHOSOMATICS, V39, P547, DOI 10.1016/S0033-3182(98)71289-7; Strobel A, 2003, J NEURAL TRANSM, V110, P1445, DOI 10.1007/s00702-003-0072-0; Szarek MJ, 1997, J ENVIRON PSYCHOL, V17, P345, DOI 10.1006/jevp.1997.0071; Wiesbeck GA, 2004, WORLD J BIOL PSYCHIA, V5, P45, DOI 10.1080/15622970410029907; Yang TT, 2009, NEUROREPORT, V20, P19, DOI 10.1097/WNR.0b013e328317f3cb	66	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54781	10.1371/journal.pone.0054781	http://dx.doi.org/10.1371/journal.pone.0054781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349968	Green Published, gold			2022-12-25	WOS:000314019100096
J	Barben, J; Strippoli, MPF; Trachsel, D; Schiller, B; Hammer, J; Kuehni, CE				Barben, Juerg; Strippoli, Marie-Pierre F.; Trachsel, Daniel; Schiller, Barbara; Hammer, Juerg; Kuehni, Claudia E.			Effect of Mannitol Dry Powder Challenge on Exhaled Nitric Oxide in Children	PLOS ONE			English	Article							ASTHMA; METHACHOLINE; TESTS	Background: Fractional exhaled nitric oxide (FENO), a non-invasive marker of eosinophilic airway inflammation, is increasingly used for diagnostic and therapeutic decisions in adult and paediatric asthma. Standardized guidelines for the measurement of FENO recommend performing FENO measurements before rather than after bronchial provocation tests. Objective: To investigate whether FENO levels decrease after a Mannitol dry powder (MDP) challenge in a clinical setting, and whether the extent of the decrease is influenced by number of MDP manoeuvres, baseline FENO, atopy and doctor diagnosed asthma. Methods: Children aged 6-16 years, referred for possible reactive airway disease to a respiratory outpatient clinic, performed an MDP challenge (Aridol((R)), Pharmaxis, Australia). FENO was measured in doublets immediately before and after the challenge test using the portable NIOX MINO (R) device (Aerocrine, Stockholm, Sweden). We analysed the data using Kruskal-Wallis rank tests, Wilcoxon signed rank tests and multivariable linear regressions. Results: One hundred and seven children completed both tests (mean +/- SD age 11.5 +/- 2.8 years). Overall, median (interquartile range) FENO decreased slightly by -2.5 ppb (-7.0, -0.5), from 18.5 ppb (10.5, 45.5) before the MDP challenge to 16.5 ppb thereafter (8.5, 40.5;p < 0.001). In all participants, the change in FENO was smaller than one standard deviation of the baseline mean. The % fall in FENO was smaller in children with less MDP manoeuvres (e. g. higher bronchial responsiveness; p = 0.08) but was not influenced by levels of baseline FENO (p = 0.68), atopy (p = 0.84) or doctor diagnosed asthma (p = 0.93). Conclusion: MDP challenge test influences FENO values but differences are small and clinically barely relevant.	[Barben, Juerg; Schiller, Barbara] Childrens Hosp, Dept Paediat Pulmonol & Allergol, St Gallen, Switzerland; [Strippoli, Marie-Pierre F.; Kuehni, Claudia E.] Univ Bern, ISPM, Bern, Switzerland; [Trachsel, Daniel; Hammer, Juerg] Univ Childrens Hosp Basel, Dept Pulmonol & Intens Care, Basel, Switzerland	University of Bern; University of Basel	Barben, J (corresponding author), Childrens Hosp, Dept Paediat Pulmonol & Allergol, St Gallen, Switzerland.	juerg.barben@kispisg.ch	Strippoli, Marie-Pierre F/K-8164-2013	Strippoli, Marie-Pierre F/0000-0003-3053-484X; Hammer, Jurg/0000-0001-7404-2383; Kuehni, Claudia E./0000-0001-8957-2002	AstraZeneca (Switzerland); Lung Association St. Gallen; Schmidheiny Foundation (Heerbrugg, St. Gallen); Swiss National Science Foundation [3200B0-122341]	AstraZeneca (Switzerland)(AstraZeneca); Lung Association St. Gallen; Schmidheiny Foundation (Heerbrugg, St. Gallen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by AstraZeneca (Switzerland), the Lung Association St. Gallen and the Schmidheiny Foundation (Heerbrugg, St. Gallen). Mannitol dry powder challenge tests were provided by Pharmaxis (New South Wales, Australia). MPS was supported by the Swiss National Science Foundation (grant 3200B0-122341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; AVITAL A, 1995, THORAX, V50, P511, DOI 10.1136/thx.50.5.511; Barben J, 2003, PEDIATR PULM, V36, P490, DOI 10.1002/ppul.10378; Barben J, 2011, PEDIATR PULM, V46, P842, DOI 10.1002/ppul.21453; Barreto M, 2006, PEDIATR PULM, V41, P141, DOI 10.1002/ppul.20358; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Brannan JD, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-144; Braun-Fahrlander C, 1999, ALLERGOLOGIE, V22, P54; Decimo F, 2011, INT J IMMUNOPATH PH, V24, P1069, DOI 10.1177/039463201102400424; Gabriele C, 2005, PEDIAT ALLERG IMM-UK, V16, P243, DOI 10.1111/j.1399-3038.2005.00255.x; Kersten ETG, 2009, PEDIATR PULM, V44, P655, DOI 10.1002/ppul.21034; Menzies D, 2007, CHEST, V131, P410, DOI 10.1378/chest.06-1335; Schiller B, 2009, PEDIAT ALLERG IMM-UK, V20, P679, DOI 10.1111/j.1399-3038.2009.00853.x; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P882, DOI 10.1136/adc.47.256.882; Subbarao P, 2000, PEDIATR PULM, V29, P291, DOI 10.1002/(SICI)1099-0496(200004)29:4<291::AID-PPUL9>3.0.CO;2-A; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54521	10.1371/journal.pone.0054521	http://dx.doi.org/10.1371/journal.pone.0054521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349918	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800060
J	Feng, YF; Liu, Y; Wang, L; Cai, XQ; Wang, DX; Wu, KM; Chen, HL; Li, J; Lei, W				Feng, Yafei; Liu, Yi; Wang, Lin; Cai, Xiaoqing; Wang, Dexin; Wu, Kaimin; Chen, Hongli; Li, Jia; Lei, Wei			Sustained Oxidative Stress Causes Late Acute Renal Failure via Duplex Regulation on p38 MAPK and Akt Phosphorylation in Severely Burned Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE KIDNEY INJURY; INDUCED APOPTOSIS; DYSFUNCTION; INHIBITION; ALPHA; GENERATION; MORTALITY; NECROSIS; DAMAGE	Background: Clinical evidence indicates that late acute renal failure (ARF) predicts high mortality in severely burned patients but the pathophysiology of late ARF remains undefined. This study was designed to test the hypothesis that sustained reactive oxygen species (ROS) induced late ARF in a severely burned rat model and to investigate the signaling mechanisms involved. Materials and Methods: Rats were exposed to 100 degrees C bath for 15 s to induce severe burn injury (40% of total body surface area). Renal function, ROS generation, tubular necrosis and apoptosis, and phosphorylation of MAPK and Akt were measured during 72 hours after burn. Results: Renal function as assessed by serum creatinine and blood urea nitrogen deteriorated significantly at 3 h after burn, alleviated at 6 h but worsened at 48 h and 72 h, indicating a late ARF was induced. Apoptotic cells and cleavage caspase-3 in the kidney went up slowly and turned into significant at 48 h and 72 h. Tubular cell ROS production shot up at 6 h and continuously rose during the 72-h experiment. Scavenging ROS with tempol markedly attenuated tubular apoptosis and renal dysfunction at 72 h after burn. Interestingly, renal p38 MAPK phosphorylation elevated in a time dependent manner whereas Akt phosphorylation increased during the first 24 h but decreased at 48 h after burn. The p38 MAPK specific inhibitor SB203580 alleviated whereas Akt inhibitor exacerbated burn-induced tubular apoptosis and renal dysfunction. Furthermore, tempol treatment exerted a duplex regulation through inhibiting p38 MAPK phosphorylation but further increasing Akt phosphorylation at 72 h postburn. Conclusions: These results demonstrate that sustained renal ROS overproduction induces continuous tubular cell apoptosis and thus a late ARF at 72 h after burn in severely burned rats, which may result from ROS-mediated activation of p38 MAPK but a late inhibition of Akt phosphorylation.	[Feng, Yafei; Wang, Lin; Lei, Wei] Fourth Mil Med Univ, Dept Orthoped Surg, Xijing Hosp, Xian 710032, Peoples R China; [Liu, Yi] Fourth Mil Med Univ, Dept Oral Implantol, Sch Stomatol, Xian 710032, Peoples R China; [Feng, Yafei; Liu, Yi; Cai, Xiaoqing; Li, Jia] Fourth Mil Med Univ, Dept Physiol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Dexin; Wu, Kaimin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Chen, Hongli] Fourth Mil Med Univ, Dept Toxicol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, J (corresponding author), Fourth Mil Med Univ, Dept Physiol, Sch Basic Med Sci, Xian 710032, Peoples R China.	jiali816@hotmail.com; leiwei@fmmu.edu.cn	; Wang, Lin/J-8805-2018	Lei, Wei/0000-0002-7346-6915; Wang, Lin/0000-0001-5937-6318	Research Fund for the National Natural Science Foundation of China [31170913/C1002]; XIJING ZHUTUI Foundation [XJZT10M07]	Research Fund for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); XIJING ZHUTUI Foundation	This work was supported by the Research Fund for the National Natural Science Foundation of China (No.31170913/C1002) and the Contract Grant Sponsor: XIJING ZHUTUI Foundation (XJZT10M07). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2006, REV MED CHILE, V134, P649; Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386; Brusselaers N, 2010, INTENS CARE MED, V36, P915, DOI 10.1007/s00134-010-1861-1; Calegari VC, 2011, J APPL PHYSL; Cao W, 2011, BASIC RES CARDIOL, V106, P1207, DOI 10.1007/s00395-011-0199-3; Chrysopoulo MT, 1999, J TRAUMA, V46, P141, DOI 10.1097/00005373-199901000-00024; Coca SG, 2007, AM J KIDNEY DIS, V49, P517, DOI 10.1053/j.ajkd.2006.12.018; Dagher PC, 2012, AM J PHYSIOL-RENAL, V302, pF284, DOI 10.1152/ajprenal.00317.2011; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Gao CJ, 2009, BURNS, V35, P547, DOI 10.1016/j.burns.2008.10.006; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gravante G, 2007, APOPTOSIS, V12, P259, DOI 10.1007/s10495-006-0621-8; Guo R, 2005, PHARMACOL RES, V52, P192, DOI 10.1016/j.phrs.2005.03.001; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Holm C, 1999, BURNS, V25, P171, DOI 10.1016/S0305-4179(98)00144-2; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Huang TT, 1999, ANN NY ACAD SCI, V893, P95, DOI 10.1111/j.1749-6632.1999.tb07820.x; Kalia S, 2008, CHEM-BIOL INTERACT, V174, P193, DOI 10.1016/j.cbi.2008.06.004; Kim GH, 2003, AM J NEPHROL, V23, P55, DOI 10.1159/000066299; Kita T, 2004, SHOCK, V21, P535, DOI 10.1097/00024382-200406000-00007; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kou X, 2011, PHYTOTHER RES; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu CM, 2012, TOXICOL APPL PHARM, V258, P330, DOI 10.1016/j.taap.2011.11.015; Lv GF, 2011, J BURN CARE RES, V32, P591, DOI 10.1097/BCR.0b013e31822dc3f2; Mariano F, 2008, CRIT CARE, V12, DOI 10.1186/cc6848; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mustonen KM, 2008, J BURN CARE RES, V29, P227, DOI 10.1097/BCR.0b013e31815f3196; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Palma SA, 2011, ANASTH INTENSIV NOTF, V46, P12, DOI 10.1055/s-0030-1270554; Parajuli N, 2011, FREE RADICAL BIO MED, V51, P406, DOI 10.1016/j.freeradbiomed.2011.04.024; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sener G, 2004, BURNS, V30, P557, DOI 10.1016/j.burns.2004.02.008; Shah SV, 2001, AM J KIDNEY DIS, V37, pS30, DOI 10.1053/ajkd.2001.20736; Shanu A, 2010, FREE RADICAL RES, V44, P843, DOI 10.3109/10715762.2010.485993; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; VERTEL RM, 1967, J AMER MED ASSOC, V200, P598, DOI 10.1001/jama.200.7.598; Wagener FADTG, 2009, APOPTOSIS, V14, P1451, DOI 10.1007/s10495-009-0359-1; Wen XY, 2011, CONTRIB NEPHROL, V174, P129, DOI 10.1159/000329382; Yang HY, 2011, TOXICOLOGY, V287, P38, DOI 10.1016/j.tox.2011.05.014; Yano T, 2007, APOPTOSIS, V12, P1901, DOI 10.1007/s10495-007-0110-8; Yuan L, 2011, AM J PHYSIOL-RENAL, V300, pF207, DOI 10.1152/ajprenal.00073.2010; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025811; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006	58	19	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54593	10.1371/journal.pone.0054593	http://dx.doi.org/10.1371/journal.pone.0054593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349934	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900080
J	Leikam, C; Hufnagel, A; Walz, S; Kneitz, S; Fekete, A; Muller, MJ; Eilers, M; Schartl, M; Meierjohann, S				Leikam, C.; Hufnagel, A.; Walz, S.; Kneitz, S.; Fekete, A.; Mueller, M. J.; Eilers, M.; Schartl, M.; Meierjohann, S.			Cystathionase mediates senescence evasion in melanocytes and melanoma cells	ONCOGENE			English	Article						ROS; melanoma; melanocyte; transsulfuration	MYC DOWN-REGULATION; EPIDERMAL-GROWTH-FACTOR; C-MYC; REACTIVE OXYGEN; GAMMA-LYASE; TRANSSULFURATION PATHWAY; UVEAL MELANOMA; BETA-SYNTHASE; EXPRESSION; PHOSPHORYLATION	The development of malignant melanoma is a highly complex process, which is still poorly understood. A majority of human melanomas are found to express a few oncogenic proteins, such as mutant RAS and BRAF variants. However, these oncogenes are also found in nevi, and it is now a well-accepted fact that their expression alone leads to senescence. This renders the understanding of senescence escape mechanisms an important point to understand tumor development. Here, we approached the question of senescence evasion by expressing the transcription factor v-myc myelocytomatosis viral oncogene homolog (c-MYC), which is known to act synergistically with many oncogenes, in melanocytes. We observed that MYC drives the evasion of reactive-oxygen stress-induced melanocyte senescence, caused by activated receptor tyrosine kinase signaling. Conversely, MIZ1, the growth suppressing interaction partner of MYC, is involved in mediating melanocyte senescence. Both, MYC overexpression and Miz1 knockdown led to a strong reduction of endogenous reactive-oxygen species (ROS), DNA damage and senescence. We identified the cystathionase (CTH) gene product as mediator of the ROS-related MYC and MIZ1 effects. Blocking CTH enzymatic activity in MYC-overexpressing and Miz1 knockdown cells increased intracellular stress and senescence. Importantly, pharmacological inhibition of CTH in human melanoma cells also reconstituted senescence in the majority of cell lines, and CTH knockdown reduced tumorigenic effects such as proliferation, H2O2 resistance and soft agar growth. Thus, we identified CTH as new MYC target gene with an important function in senescence evasion.	[Leikam, C.; Hufnagel, A.; Kneitz, S.; Schartl, M.; Meierjohann, S.] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany; [Walz, S.; Eilers, M.] Univ Wurzburg, Dept Biochem & Mol Biol, Bioctr, D-97074 Wurzburg, Germany; [Fekete, A.; Mueller, M. J.] Univ Wurzburg, Dept Pharmaceut Biol, Julius von Sachs Inst Biol Sci, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Meierjohann, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany.	svenja.meierjohann@biozentrum.uni-wuerzburg.de	Fekete, Agnes/C-8048-2019; mueller, martin j/C-7616-2019	Fekete, Agnes/0000-0003-3058-7570; Eilers, Martin/0000-0002-0376-6533; Schartl, Manfred/0000-0001-9882-5948	Deutsche Forschungsgesellschaft, Transregio 17 ('RAS-dependent pathways in human cancer'); German Excellence Initiative	Deutsche Forschungsgesellschaft, Transregio 17 ('RAS-dependent pathways in human cancer'); German Excellence Initiative	We thank Dorothy Bennett, St George's, University of London (Wellcome Trust Functional Genomics Cell Bank) for providing the cell lines Hermes 3a and melan-a sut. This work was supported by the Deutsche Forschungsgesellschaft, Transregio 17 ('RAS-dependent pathways in human cancer'). CL was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Aziz N, 1999, MOL CELL BIOL, V19, P1101; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Benassi B, 2007, MOL PHARMACOL, V72, P1015, DOI 10.1124/mol.107.038687; Biroccio A, 2001, MOL PHARMACOL, V60, P174, DOI 10.1124/mol.60.1.174; Biroccio A, 2003, J BIOL CHEM, V278, P35693, DOI 10.1074/jbc.M304597200; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Bucci B, 2005, CLIN CANCER RES, V11, P2756, DOI 10.1158/1078-0432.CCR-04-1582; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Huang SF, 2010, J MOL BIOL, V396, P708, DOI 10.1016/j.jmb.2009.11.058; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Kandil S, 2010, NEUROCHEM INT, V56, P611, DOI 10.1016/j.neuint.2010.01.004; KOST DP, 1990, J CELL PHYSIOL, V144, P122, DOI 10.1002/jcp.1041440116; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Mallette FA, 2007, J BIOL CHEM, V282, P34938, DOI 10.1074/jbc.M707074200; Meierjohann S, 2006, CANCER RES, V66, P3145, DOI 10.1158/0008-5472.CAN-05-2667; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Park J, 2007, BIOCHEM BIOPH RES CO, V360, P447, DOI 10.1016/j.bbrc.2007.06.077; Parrella P, 2001, INVEST OPHTH VIS SCI, V42, P1679; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; RAO AM, 1990, J NUTR, V120, P837, DOI 10.1093/jn/120.8.837; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rosado JO, 2007, MOL CELL BIOCHEM, V301, P1, DOI 10.1007/s11010-006-9389-y; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Sankar N, 2009, J BIOL CHEM, V284, P15193, DOI 10.1074/jbc.M900776200; Schlagbauer-Wadl H, 1999, J INVEST DERMATOL, V112, P332, DOI 10.1046/j.1523-1747.1999.00506.x; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tulley PN, 2004, BRIT J OPHTHALMOL, V88, P1563, DOI 10.1136/bjo.2003.033498; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vene R, 2011, ANTIOXID REDOX SIGN, V15, P2439, DOI 10.1089/ars.2010.3830; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Whitwam T, 2007, ONCOGENE, V26, P4563, DOI 10.1038/sj.onc.1210239; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; YAMAMOTO N, 1995, J NUTR SCI VITAMINOL, V41, P197, DOI 10.3177/jnsv.41.197; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	64	25	25	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					771	782		10.1038/onc.2012.641	http://dx.doi.org/10.1038/onc.2012.641			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23353821				2022-12-25	WOS:000331129200011
J	Zhu, QS; Liu, WX; Kao, LY; Azimov, R; Newman, D; Abuladze, N; Kurtz, I				Zhu, Quansheng; Liu, Weixin; Kao, Liyo; Azimov, Rustam; Newman, Debra; Abuladze, Natalia; Kurtz, Ira			Topology of NBCe1 Protein Transmembrane Segment 1 and Structural Effect of Proximal Renal Tubular Acidosis (pRTA) S427L Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; CYTOPLASMIC DOMAIN; CYSTEINE; SODIUM; ACCESSIBILITY; TRAFFICKING; MECHANISM; TRANSPORT; MUTANTS	In the kidney proximal tubule, NBCe1-A plays a critical role in absorbing HCO3- from cell to blood. NBCe1-A transmembrane segment 1 (TM1) is involved in forming part of the ion permeation pathway, and a missense mutation S427L in TM1 impairs ion transport, causing proximal renal tubular acidosis. In the present study, we examined the topology of NBCe1-A-TM1 in detail and its structural perturbation induced by S427L. We analyzed the N-terminal cytoplasmic region (Cys-389-Gln-424) of NBCe1-A-TM1 using the substituted cysteine scanning accessibility method combined with extensive chemical stripping, in situ chemical probing, and functional transport assays. NBCe1-A-TM1 was previously modeled on the anion exchanger 1 TM1 (AE1-TM1); however, our data demonstrated that the topology of AE1-TM1 differs significantly from NBCe1-A-TM1. Our findings revealed that NBCe1-A-TM1 is unusually long, consisting of 31 membrane-embedded amino acids (Phe-412 to Thr-442). The linker region (Arg-394-Pro-411) between the N terminus of TM1 and the cytoplasmic domain is minimally exposed to aqueous and is potentially folded in a helical structure that intimately interacts with the NBCe1-A cytoplasmic domain. In contrast, AE1-TM1 contains 25 amino acids connected to an aqueous-exposed cytoplasmic region. Based on our new NBCe1-A-TM1 model, Ser-427 resides in the middle of TM1. Leucine substitution at Ser-427 blocks the normal aqueous access to Thr-442, Ala-435, and Lys-404, implying a significant alteration of NBCe1-TM1 orientation. Our study provides novel structural insights into the pathogenic mechanism of S427L in mediating proximal renal tubular acidosis.	[Zhu, Quansheng; Liu, Weixin; Kao, Liyo; Azimov, Rustam; Newman, Debra; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90024 USA.	quzhu@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; Coplon grant; UCLA Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coplon grant; UCLA Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563 (to I. K.). This work was also supported in part by a Coplon grant and the UCLA Department of Medicine (to Q. Z.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Cheung JC, 2005, BIOCHEM J, V390, P137, DOI 10.1042/BJ20050315; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; Lo YF, 2011, KIDNEY INT, V79, P730, DOI 10.1038/ki.2010.523; MOHANDAS N, 1992, J CLIN INVEST, V89, P686, DOI 10.1172/JCI115636; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; STECK TL, 1976, BIOCHEMISTRY-US, V15, P1154, DOI 10.1021/bi00650a030; Suzuki M, 2008, PFLUG ARCH EUR J PHY, V455, P583, DOI 10.1007/s00424-007-0319-y; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhang DC, 2000, BLOOD, V96, P2925; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	28	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7894	7906		10.1074/jbc.M112.404533	http://dx.doi.org/10.1074/jbc.M112.404533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362273	hybrid, Green Published			2022-12-25	WOS:000316455300043
J	Li, D; Long, Y; Wang, TC; Xiao, D; Zhang, JX; Guo, ZW; Wang, B; Yan, YP				Li, Duan; Long, Yong; Wang, Tingcai; Xiao, Dan; Zhang, Jingxia; Guo, Zhiwen; Wang, Bo; Yan, Yongping			Epidemiology of Hepatitis C Virus Infection in Highly Endemic HBV Areas in China	PLOS ONE			English	Article							DRUG-USERS; METAANALYSIS; INSIGHTS; DONORS	Background: Wuwei City has the highest prevalence of hepatitis B virus (HBV) in China. From 2007 to 2011, the average reported incidence rate of hepatitis B was 634.56/100,000 people. However, studies assessing the epidemic features and risk factors of HCV in the general population of Wuwei City are limited. Methods: A total of 7189 people were interviewed and screened for HCV antibodies. HCV RNA and HCV genotypes were analyzed by PCR. Relevant information was obtained from the general population using a standardized questionnaire, and association and logistic regression analyses were conducted. Results: The anti-HCV prevalence was 1.64% (118/7189), and HCV-RNA was detected in 37.29% (44/118) of the anti-HCV positive samples. The current HCV infection rate was 0.61% (44/7189) in the Wuwei general population. Hepatitis C infection rate was generally higher in the plains regions (chi(2)=27.54, P<0.05), and the most predominant HCV genotypes were 2a (59.1%) and 1b (34.1%). The concurrent HCV and HBV infection rate was 1.37%, and a history of blood transfusion (OR=17.9, 95% CI: 6.1 to 52.6, p, 0.001) was an independent risk factor for HCV positivity. Conclusions: Although Wuwei is a highly endemic area for HBV, the anti-HCV positive rate in the general population is low. More than one-third of HCV-infected people were unaware of their infection; this may become an important risk factor for hepatitis C prevalence in the general population. Maintaining blood safety is important in order to help reduce the burden of HCV infection in developing regions of China.	[Li, Duan; Long, Yong; Xiao, Dan; Zhang, Jingxia; Wang, Bo; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Li, Duan; Long, Yong; Xiao, Dan; Zhang, Jingxia; Wang, Bo; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Wang, Tingcai; Guo, Zhiwen] Wuwei Municipal Ctr Dis Control & Prevent, Wuwei City, Gansu, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yangyping@fmmu.edu.cn	Yan, Yongping/K-9634-2019		Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); China Special Grant for the Prevention and Control of Infectious Diseases [2012ZX10004907]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Special Grant for the Prevention and Control of Infectious Diseases	This study was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) and the China Special Grant for the Prevention and Control of Infectious Diseases (2012ZX10004907): Infectious disease prevention and control in demonstration areas and the field epidemiological study of viral hepatitis B in Wuwei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadalla HI, 2011, CENT EUR J PUBL HEAL, V19, P217, DOI 10.21101/cejph.a3628; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P131, DOI 10.1111/j.1440-1746.2010.06544.x; Cheng KC, 2011, J PHARM PHARMACOL, V63, P883, DOI 10.1111/j.2042-7158.2011.01267.x; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Forrester JE, 2009, HIV MED, V10, P555, DOI 10.1111/j.1468-1293.2009.00722.x; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Julia U, 2012, J HEPATOL, V54, P736; Li J., 2012, CHIN HEPATOL, V17, P2, DOI [10.3969/j.issn.1672-5069.2012.05.002, DOI 10.3969/J.ISSN.1672-5069.2012.05.002]; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Shi S, 2011, J CLIN VIROL, V51, P110, DOI 10.1016/j.jcv.2011.03.005; Sun JH, 2009, RENAL FAILURE, V31, P610, DOI 10.1080/08860220903003446; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; 刘志英, 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P148	17	17	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54815	10.1371/journal.pone.0054815	http://dx.doi.org/10.1371/journal.pone.0054815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372775	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400032
J	Accordino, SR; Fris, JAR; Appignanesi, GA				Accordino, Sebastian R.; Rodriguez Fris, J. Ariel; Appignanesi, Gustavo A.			Wrapping Effects within a Proposed Function-Rescue Strategy for the Y220C Oncogenic Mutation of Protein p53	PLOS ONE			English	Article							GENERALIZED BORN; CORE DOMAIN; MUTANT; AGGREGATION; MECHANISM; ENERGIES; SURFACE	Soluble proteins must protect their structural integrity from water attack by wrapping interactions which imply the clustering of nonpolar residues around the backbone hydrogen bonds. Thus, poorly wrapped hydrogen bonds constitute defects which have been identified as promoters of protein associations since they favor the removal of hydrating molecules. More specifically, a recent study of our group has shown that wrapping interactions allow the successful identification of protein binding hot spots. Additionally, we have also shown that drugs disruptive of protein-protein interfaces tend to mimic the wrapping behavior of the protein they replace. Within this context, in this work we study wrapping three body interactions related to the oncogenic Y220C mutation of the tumor suppressor protein p53. Our computational results rationalize the oncogenic nature of the Y220C mutation, explain the binding of a drug-like molecule already designed to restore the function of p53 and provide clues to help improve this function-rescue strategy and to apply in other drug design or re-engineering techniques.	[Appignanesi, Gustavo A.] Univ Nacl Sur, Secc Fisicoquim, INQUISUR UNS CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina; Univ Nacl Sur, Dept Quim, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Appignanesi, GA (corresponding author), Univ Nacl Sur, Secc Fisicoquim, INQUISUR UNS CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	appignan@criba.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PME 2006-1581]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support from Agencia Nacional de Promocion Cientifica y Tecnologica (PME 2006-1581) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) is gratefully acknowledged. GAA and JAR-F are research fellows of CONICET. SRA thanks CONICET for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordino SR, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12059-0; Accordino SR, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031503; Accordino SR, 2012, PROTEINS, V80, P1755, DOI 10.1002/prot.24069; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case D.A., 2022, AMBER 2020; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fernandez A, 2004, NAT BIOTECHNOL, V22, P1081, DOI 10.1038/nbt0904-1081; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2010, TRANSFORMATIVE CONCEPTS FOR DRUG DESIGN: TARGET WRAPPING, P1, DOI 10.1007/978-3-642-11792-3_1; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Lee MR, 2000, PROTEINS, V39, P309, DOI 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Schulz E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012844; Wang GZ, 2012, P NATL ACAD SCI USA, V109, P13590, DOI 10.1073/pnas.1211557109; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a	26	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55123	10.1371/journal.pone.0055123	http://dx.doi.org/10.1371/journal.pone.0055123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365691	Green Published, gold			2022-12-25	WOS:000314023600155
J	Baum, P; Petroff, D; Classen, J; Kiess, W; Bluher, S				Baum, Petra; Petroff, David; Classen, Joseph; Kiess, Wieland; Blueher, Susann			Dysfunction of Autonomic Nervous System in Childhood Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; IMPAIRED GLUCOSE-TOLERANCE; SYMPATHETIC SKIN-RESPONSE; PERIOD VARIABILITY; CHILDREN; ADOLESCENTS; PREVALENCE; MODULATION; PUPIL; BODY	Objective: To assess the distribution of autonomic nervous system (ANS) dysfunction in overweight and obese children. Methods: Parasympathetic and sympathetic ANS function was assessed in children and adolescents with no evidence of impaired glucose metabolism by analysis of heart rate variability (low frequency power ln(LF), high frequency power, ln(HF); ln(LF/HF) ratio, ratio of longest RR interval during expiration to shortest interval during inspiration (E/I ratio), root mean square of successive differences (RMSSD); sympathetic skin response (SSR); and quantitative pupillography (pupil diameter in darkness, light reflex amplitude, latency, constriction velocity, re-dilation velocity). The relationship of each ANS variable to the standard deviation score of body mass index (BMI-SDS) was assessed in a linear model considering age, gender and pubertal stage as co-variates and employing an F-statistic to compare the fit of nested models. Group comparisons between normal weight and obese children as well as an analysis of dependence on insulin resistance (as indexed by the Homeostasis Model Assessment of Insulin Resistance, HOMA-IR) were performed for parameters shown to correlate with BMI-SDS. Statistical significance was set at 5%. Results: Measurements were performed in 149 individuals (mean age 12.0 y; 90 obese 45 boys; 59 normal weight, 34 boys). E/I ratio (p = 0.003), ln(HF) (p = 0.03), pupil diameter in darkness (p = 0.01) were negatively correlated with BMI-SDS, whereas ln(LF/HF) was positively correlated (p = 0.05). Early re-dilation velocity was in trend negatively correlated to BMI-SDS (p = 0.08). None of the parameters that depended significantly on BMI-SDS was found to be significantly correlated with HOMA-IR. Conclusion: These findings demonstrate extended ANS dysfunction in obese children and adolescents, affecting several organ systems. Both parasympathetic activity and sympathetic activity are reduced. The conspicuous pattern of ANS dysfunction raises the possibility that obesity may give rise to dysfunction of the peripheral autonomic nerves resembling that observed in normal-weight diabetic children and adolescents.	[Baum, Petra; Classen, Joseph] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Petroff, David] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany; [Petroff, David; Kiess, Wieland; Blueher, Susann] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Kiess, Wieland; Blueher, Susann] Univ Hosp Children & Adolescents, Dept Women & Child Hlth, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Bluher, S (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany.	susann.blueher@medizin.uni-leipzig.de		Weihrauch-Bluher, Susann/0000-0001-7399-223X; Classen, Joseph/0000-0001-7182-6967	German Diabetes Association; Federal Ministry of Education and Research, Germany [FKZ: 01E01001]; Saxonian Ministry of Social Affairs, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany; Nationales Aktionsforum Diabetes Mellitus	German Diabetes Association; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Saxonian Ministry of Social Affairs, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany; Nationales Aktionsforum Diabetes Mellitus	This work was supported by a grant from the German Diabetes Association (to SB and PB), by the Federal Ministry of Education and Research, Germany (Integrated Research and Treatment Center IFB "Adiposity Diseases'', FKZ: 01E01001; to SB, DP, WK), the Saxonian Ministry of Social Affairs, Germany (to SB), the Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany (to SB) and the 'Nationales Aktionsforum Diabetes Mellitus' (to SB and WK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUNODAYA GR, 1995, J NEUROL SCI, V129, P81, DOI 10.1016/0022-510X(94)00265-P; Beijers HJBH, 2009, DIABETES CARE, V32, P1698, DOI 10.2337/dc08-1544; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Boutcher SH, 1998, PSYCHOPHYSIOLOGY, V35, P16, DOI 10.1017/S0048577298951435; Camm AJ, 1996, CIRCULATION, V93, P1043; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dutsch M, 2004, J NEUROL SCI, V222, P75, DOI 10.1016/j.jns.2004.04.008; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Guizar JM, 2005, INDIAN PEDIATR, V42, P464; Gutin B, 1997, J PEDIATR-US, V130, P938, DOI 10.1016/S0022-3476(97)70280-4; Gutin B, 2000, OBES RES, V8, P12, DOI 10.1038/oby.2000.3; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; HELLER PH, 1990, INVEST OPHTH VIS SCI, V31, P156; HOLM S, 1979, SCAND J STAT, V6, P65; Karachaliou F, 1997, DIABETIC MED, V14, P849, DOI 10.1002/(SICI)1096-9136(199710)14:10<849::AID-DIA470>3.0.CO;2-W; KARAVANAKI K, 1994, ARCH DIS CHILD, V71, P511, DOI 10.1136/adc.71.6.511; KARLSEN RL, 1979, ACTA OPHTHALMOL, V57, P41; Kaufman CL, 2007, OBESITY, V15, P1164, DOI 10.1038/oby.2007.619; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lambert E, 2010, HYPERTENSION, V56, P351, DOI 10.1161/HYPERTENSIONAHA.110.155663; LEVY DM, 1992, J NEUROL NEUROSUR PS, V55, P902, DOI 10.1136/jnnp.55.10.902; Lucini D, 2002, AM HEART J, V143, P977, DOI 10.1067/mhj.2002.123117; Vanderlei LCM, 2010, CLINICS, V65, P789, DOI 10.1590/S1807-59322010000800008; Vanderlei LCM, 2010, ARQ BRAS CARDIOL, V95, P35, DOI 10.1590/S0066-782X2010005000082; Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagai N, 2004, INT J OBESITY, V28, P27, DOI 10.1038/sj.ijo.0802470; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; O'Rahilly S, 2005, THE GENETICS OF OBES; Paschoal MA, 2009, ARQ BRAS CARDIOL, V93, P239, DOI 10.1590/S0066-782X2009000900007; PETERSON H R, 1988, New England Journal of Medicine, V318, P1077, DOI 10.1056/NEJM198804283181701; PFEIFER MA, 1984, DIABETES CARE, V7, P447, DOI 10.2337/diacare.7.5.447; Priano L, 2009, EUR J PAIN, V13, P829, DOI 10.1016/j.ejpain.2008.09.011; Rabbia F, 2003, OBES RES, V11, P541, DOI 10.1038/oby.2003.76; Rabbone Ivana, 2009, Acta Biomed, V80, P29; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; SMITH SA, 1983, BRIT J OPHTHALMOL, V67, P89, DOI 10.1136/bjo.67.2.89; Soares-Miranda L, 2011, PEDIATR CARDIOL, V32, P924, DOI 10.1007/s00246-011-0015-8; Straub RH, 1996, DIABETES CARE, V19, P960, DOI 10.2337/diacare.19.9.960; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tascilar ME, 2011, J CLIN RES PEDIATR E, V3, P60, DOI [10.4274/jcrpe.v3i2.131, 10.4274/jcrpe.v3i2.13]; Team RDC, 2010, R A LANGUAGE AND ENV; Tonhajzerova I, 2008, J PHYSIOL PHARMACOL, V59, P709; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; World Health Organization, 2011, OB OV FACT SHEET 311	46	59	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54546	10.1371/journal.pone.0054546	http://dx.doi.org/10.1371/journal.pone.0054546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358101	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600067
J	Huijskens, EGW; Reimerink, J; Mulder, PGH; van Beek, J; Meijer, A; de Bruin, E; Friesema, I; de Jong, MD; Rimmelzwaan, GF; Peeters, MF; Rossen, JWA; Koopmans, M				Huijskens, Elisabeth G. W.; Reimerink, Johan; Mulder, Paul G. H.; van Beek, Janko; Meijer, Adam; de Bruin, Erwin; Friesema, Ingrid; de Jong, Menno D.; Rimmelzwaan, Guus F.; Peeters, Marcel F.; Rossen, John W. A.; Koopmans, Marion			Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; PANDEMIC H1N1 INFLUENZA; A VIRUS; AVIAN INFLUENZA; ANTIBODY; SEVERITY; AGE	Background: The influence of prior seasonal influenza vaccination on the antibody response produced by natural infection or vaccination is not well understood. Methods: We compared the profiles of antibody responses of 32 naturally infected subjects and 98 subjects vaccinated with a 2009 influenza A(H1N1) monovalent MF59-adjuvanted vaccine (Focetria (R), Novartis), with and without a history of seasonal influenza vaccination. Antibodies were measured by hemagglutination inhibition (HI) assay for influenza A(H1N1)pdm09 and by protein microarray (PA) using the HA1 subunit for seven recent and historic H1, H2 and H3 influenza viruses, and three avian influenza viruses. Serum samples for the infection group were taken at the moment of collection of the diagnostic sample, 10 days and 30 days after onset of influenza symptoms. For the vaccination group, samples were drawn at baseline, 3 weeks after the first vaccination and 5 weeks after the second vaccination. Results: We showed that subjects with a history of seasonal vaccination generally exhibited higher baseline titers for the various HA1 antigens than subjects without a seasonal vaccination history. Infection and pandemic influenza vaccination responses in persons with a history of seasonal vaccination were skewed towards historic antigens. Conclusions: Seasonal vaccination is of significant influence on the antibody response to subsequent infection and vaccination, and further research is needed to understand the effect of annual vaccination on protective immunity.	[Huijskens, Elisabeth G. W.; Peeters, Marcel F.; Rossen, John W. A.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Reimerink, Johan; van Beek, Janko; Meijer, Adam; de Bruin, Erwin; Friesema, Ingrid; Koopmans, Marion] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Mulder, Paul G. H.] Amphia Hosp, Amphia Acad, Breda, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Rimmelzwaan, Guus F.; Koopmans, Marion] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands National Institute for Public Health & the Environment; Amphia Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Huijskens, EGW (corresponding author), St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	i.huijskens@gmail.com	Rossen, John W/G-7564-2011; Friesema, Ingrid HM/H-6601-2019; Koopmans, Marion/Y-9170-2019	Rossen, John W/0000-0002-7167-8623; Friesema, Ingrid HM/0000-0001-9943-0518; Koopmans, Marion/0000-0002-5204-2312				Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2011, J VIROL, V85, P11995, DOI 10.1128/JVI.05213-11; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Couch RB, 2012, CLIN INFECT DIS, V54, P311, DOI 10.1093/cid/cir809; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017821; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fange Y, 2012, J VIROL, V86, P2229, DOI 10.1128/JVI.05540-11; Friesema IHM, 2012, INFLUENZA OTHER RESP, V6, pe16, DOI 10.1111/j.1750-2659.2012.00347.x; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Jefferies S, 2011, EURO SURVEILL, V16; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; RUSSELL RJ, 1979, J IMMUNOL, V123, P825; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	30	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54890	10.1371/journal.pone.0054890	http://dx.doi.org/10.1371/journal.pone.0054890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365683	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600130
J	Kang, HW; Crawford, M; Fabbri, M; Nuovo, G; Garofalo, M; Nana-Sinkam, SP; Friedman, A				Kang, Hye-Won; Crawford, Melissa; Fabbri, Muller; Nuovo, Gerard; Garofalo, Michela; Nana-Sinkam, S. Patrick; Friedman, Avner			A Mathematical Model for MicroRNA in Lung Cancer	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; C-MYC; MESSENGER-RNA; CELL; PROTEIN; METASTASIS; MMP-9; AMPLIFICATION; MUTATIONS; INDUCTION	Lung cancer is the leading cause of cancer-related deaths worldwide. Lack of early detection and limited options for targeted therapies are both contributing factors to the dismal statistics observed in lung cancer. Thus, advances in both of these areas are likely to lead to improved outcomes. MicroRNAs (miRs or miRNAs) represent a class of non-coding RNAs that have the capacity for gene regulation and may serve as both diagnostic and prognostic biomarkers in lung cancer. Abnormal expression patterns for several miRNAs have been identified in lung cancers. Specifically, let-7 and miR-9 are deregulated in both lung cancers and other solid malignancies. In this paper, we construct a mathematical model that integrates let-7 and miR-9 expression into a signaling pathway to generate an in silico model for the process of epithelial mesenchymal transition (EMT). Simulations of the model demonstrate that EGFR and Ras mutations in non-small cell lung cancers (NSCLC), which lead to the process of EMT, result in miR-9 upregulation and let-7 suppression, and this process is somewhat robust against random input into miR-9 and more strongly robust against random input into let-7. We elected to validate our model in vitro by testing the effects of EGFR inhibition on downstream MYC, miR-9 and let-7a expression. Interestingly, in an EGFR mutated lung cancer cell line, treatment with an EGFR inhibitor (Gefitinib) resulted in a concentration specific reduction in c-MYC and miR-9 expression while not changing let-7a expression. Our mathematical model explains the signaling link among EGFR, MYC, and miR-9, but not let-7. However, very little is presently known about factors that regulate let-7. It is quite possible that when such regulating factors become known and integrated into our model, they will further support our mathematical model.	[Kang, Hye-Won; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Crawford, Melissa; Nuovo, Gerard; Nana-Sinkam, S. Patrick] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Fabbri, Muller; Garofalo, Michela] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Nana-Sinkam, SP (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Patrick.Nana-Sinkam@osumc.edu		Garofalo, Michela/0000-0002-1741-0415	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; National Cancer Institute [CA 150297]; NATIONAL CANCER INSTITUTE [R21CA150297] Funding Source: NIH RePORTER	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 0931642 and by the National Cancer Institute under grant CA 150297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Chaplain MAJ, 2011, IMA J APPL MATH, V76, P371, DOI 10.1093/imamat/hxr025; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Mitselou A, 2010, HISTOL HISTOPATHOL, V25, P1257, DOI 10.14670/HH-25.1257; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Orton RJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-100; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Saad AG, 2008, CANCER-AM CANCER SOC, V113, P2129, DOI 10.1002/cncr.23826; Safranek J, 2009, ANTICANCER RES, V29, P2513; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Siegel R, 2012, CANCER STATISTICS 20; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Sulzer MA, 1998, AM J RESP CRIT CARE, V157, P1319, DOI 10.1164/ajrccm.157.4.9703099; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vosa U, 2011, GENES CHROMOSOMES AN; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; YOKOTA J, 1988, ONCOGENE, V2, P607; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zheng SQ, 2010, ANTICANCER RES, V30, P713	51	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53663	10.1371/journal.pone.0053663	http://dx.doi.org/10.1371/journal.pone.0053663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365639	Green Published, gold			2022-12-25	WOS:000314023600018
J	Vu, AA; Nadaraja, GS; Huth, ME; Luk, L; Kim, J; Chai, RJ; Ricci, AJ; Cheng, AG				Vu, Andrew A.; Nadaraja, Garani S.; Huth, Markus E.; Luk, Lauren; Kim, John; Chai, Renjie; Ricci, Anthony J.; Cheng, Alan G.			Integrity and Regeneration of Mechanotransduction Machinery Regulate Aminoglycoside Entry and Sensory Cell Death	PLOS ONE			English	Article							OUTER HAIR-CELLS; TIP-LINK INTEGRITY; MECHANICAL TRANSDUCTION; FUNCTIONAL INTERACTION; LATERAL-LINE; MYOSIN VIIA; CADHERIN-23; STEREOCILIA; PROTOCADHERIN-15; EXPOSURE	Sound perception requires functional hair cell mechanotransduction (MET) machinery, including the MET channels and tip-link proteins. Prior work showed that uptake of ototoxic aminoglycosides (AG) into hair cells requires functional MET channels. In this study, we examined whether tip-link proteins, including Cadherin 23 (Cdh23), regulate AG entry into hair cells. Using time-lapse microscopy on cochlear explants, we found rapid uptake of gentamicin-conjugated Texas Red (GTTR) into hair cells from three-day-old Cdh23(+/+) and Cdh23(v2J/+) mice, but failed to detect GTTR uptake in Cdh23(v2J/v2J) hair cells. Pre-treatment of wildtype cochleae with the calcium chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (BAPTA) to disrupt tip-links also effectively reduced GTTR uptake into hair cells. Both Cdh23(v2J/v2J) and BAPTA-treated hair cells were protected from degeneration caused by gentamicin. Six hours after BAPTA treatment, GTTR uptake remained reduced in comparison to controls; by 24 hours, drug uptake was comparable between untreated and BAPTA-treated hair cells, which again became susceptible to cell death induced by gentamicin. Together, these results provide genetic and pharmacologic evidence that tip-links are required for AG uptake and toxicity in hair cells. Because tip-links can spontaneously regenerate, their temporary breakage offers a limited time window when hair cells are protected from AG toxicity.	[Vu, Andrew A.; Nadaraja, Garani S.; Huth, Markus E.; Luk, Lauren; Kim, John; Chai, Renjie; Ricci, Anthony J.; Cheng, Alan G.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Ricci, Anthony J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Ricci, AJ (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	aricci@stanford.edu; aglcheng@stanford.edu		Cheng, Alan/0000-0002-4702-8401; ricci, anthony/0000-0002-1706-8904	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [P30 DC010363]; American Society of Pediatric Otolaryngology Grant; Swiss National Science Foundation [PBSKP3_130635/1]; Stanford Dean's fellowship; Stanford SPARK program [R21 DC012183, RO1 DC003896]; Herbert Silverstein Award [K08 DC011043]; Akiko Yamazaki and Jerry Yang Faculty Scholar Fund; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010363, R01DC003896, K08DC011043, R21DC012183] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Society of Pediatric Otolaryngology Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stanford Dean's fellowship; Stanford SPARK program; Herbert Silverstein Award; Akiko Yamazaki and Jerry Yang Faculty Scholar Fund; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders P30 DC010363, American Society of Pediatric Otolaryngology Grant (G.S.N.), Swiss National Science Foundation PBSKP3_130635/1 (M.E.H.), Stanford Dean's fellowship, Hearing Health Foundation (R.C.), Stanford SPARK program, R21 DC012183 (A.J.R. and A.G.C.), RO1 DC003896 (A.J.R.), Herbert Silverstein Award, K08 DC011043, and Akiko Yamazaki and Jerry Yang Faculty Scholar Fund (A.G.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; HIEL H, 1992, HEARING RES, V57, P157, DOI 10.1016/0378-5955(92)90148-G; Husbands JM, 1999, HEARING RES, V135, P135, DOI 10.1016/S0378-5955(99)00101-X; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kurian R, 2003, HEARING RES, V181, P40, DOI 10.1016/S0378-5955(03)00165-5; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; OSBORNE MP, 1984, CELL TISSUE RES, V237, P43; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Richardson GP, 1997, J NEUROSCI, V17, P9506; RICHARDSON GP, 1991, HEARING RES, V53, P293, DOI 10.1016/0378-5955(91)90062-E; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; RYAN AF, 1982, AM J OTOLARYNG, V3, P264, DOI 10.1016/S0196-0709(82)80065-3; Rzadzinska AK, 2009, NEUROSCIENCE, V158, P365, DOI 10.1016/j.neuroscience.2008.10.012; Rzadzinska AK, 2005, HEARING RES, V208, P114, DOI 10.1016/j.heares.2005.05.008; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Suzuki M, 2002, HEARING RES, V164, P12, DOI 10.1016/S0378-5955(01)00397-5; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	46	44	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54794	10.1371/journal.pone.0054794	http://dx.doi.org/10.1371/journal.pone.0054794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359017	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600111
J	Zhang, DL; Liu, B; Chen, J; Peng, XL; Liu, X; Fan, YY; Liu, M; Huang, RW				Zhang, Delong; Liu, Bo; Chen, Jun; Peng, Xiaoling; Liu, Xian; Fan, Yuanyuan; Liu, Ming; Huang, Ruiwang			Determination of Vascular Dementia Brain in Distinct Frequency Bands with Whole Brain Functional Connectivity Patterns	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; MILD COGNITIVE IMPAIRMENT; VISUAL WORKING-MEMORY; MEDIAL TEMPORAL-LOBE; AGE-RELATED-CHANGES; RESTING STATE FMRI; ALZHEIMERS-DISEASE; RECOGNITION MEMORY; TOPOLOGICAL PATTERNS; MAGNETIC-RESONANCE	Recent studies have shown that multivariate pattern analysis (MVPA) can be useful for distinguishing brain disorders into categories. Such analyses can substantially enrich and facilitate clinical diagnoses. Using MPVA methods, whole brain functional networks, especially those derived using different frequency windows, can be applied to detect brain states. We constructed whole brain functional networks for groups of vascular dementia (VaD) patients and controls using resting state BOLD-fMRI (rsfMRI) data from three frequency bands - slow-5 (0.01 similar to 0.027 Hz), slow-4 (0.027 similar to 0.073 Hz), and whole-band (0.01 similar to 0.073 Hz). Then we used the support vector machine (SVM), a type of MVPA classifier, to determine the patterns of functional connectivity. Our results showed that the brain functional networks derived from rsfMRI data (19 VaD patients and 20 controls) in these three frequency bands appear to reflect neurobiological changes in VaD patients. Such differences could be used to differentiate the brain states of VaD patients from those of healthy individuals. We also found that the functional connectivity patterns of the human brain in the three frequency bands differed, as did their ability to differentiate brain states. Specifically, the ability of the functional connectivity pattern to differentiate VaD brains from healthy ones was more efficient in the slow-5 (0.01 similar to 0.027 Hz) band than in the other two frequency bands. Our findings suggest that the MVPA approach could be used to detect abnormalities in the functional connectivity of VaD patients in distinct frequency bands. Identifying such abnormalities may contribute to our understanding of the pathogenesis of VaD.	[Zhang, Delong; Peng, Xiaoling; Fan, Yuanyuan; Liu, Ming; Huang, Ruiwang] S China Normal Univ, Ctr Studies Psychol Applicat, Guangdong Key Lab Mental Hlth & Cognit Sci, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Liu, Bo; Chen, Jun; Liu, Xian] Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China	South China Normal University; Guangzhou University of Chinese Medicine	Liu, B (corresponding author), Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	lbgdhtcm@163.com; lium@scnu.edu.cn; ruiwang.hang@gmail.com	Chen, Jun/AAD-7667-2020	CHEN, JUN/0000-0001-5049-5759	Guangdong Province Hospital of Traditional Chinese; National Natural Science Foundation of China [81071149, 31140052, 81271548]	Guangdong Province Hospital of Traditional Chinese; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data collection was supported by the Guangdong Province Hospital of Traditional Chinese. The study design, data analysis, decision to publish, or preparation of the manuscript was supported by the funding of National Natural Science Foundation of China under Grant numbers: 81071149, 31140052, and 81271548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Cui Y, 2012, NEUROIMAGE, V60, P894, DOI 10.1016/j.neuroimage.2012.01.084; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P2494, DOI 10.1016/j.clinph.2008.08.010; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gainotti G, 2004, NEUROL SCI, V25, P192, DOI 10.1007/s10072-004-0321-5; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Grinberg LT, 2010, J NEUROL SCI, V299, P136, DOI 10.1016/j.jns.2010.08.055; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jellinger KA, 2008, J NEUROL SCI, V270, P1, DOI 10.1016/j.jns.2008.03.006; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li LL, 2010, MAGN RESON IMAGING, V28, P380, DOI 10.1016/j.mri.2009.11.009; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 2003, BRAIN, V126, P1511, DOI 10.1093/brain/awg157; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Meppelink AM, 2010, J NEUROL NEUROSUR PS, V81, P1295, DOI 10.1136/jnnp.2009.183087; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tak S, 2011, NEUROIMAGE, V55, P176, DOI 10.1016/j.neuroimage.2010.11.046; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Wang J., 2012, BIOL PSYCHIAT; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54512	10.1371/journal.pone.0054512	http://dx.doi.org/10.1371/journal.pone.0054512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359801	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600063
J	Stone, K; Woods, E; Szmania, SM; Stephens, OW; Garg, TK; Barlogie, B; Shaughnessy, JD; Hall, B; Reddy, M; Hoering, A; Hansen, E; van Rhee, F				Stone, Katie; Woods, Emily; Szmania, Susann M.; Stephens, Owen W.; Garg, Tarun K.; Barlogie, Bart; Shaughnessy, John D., Jr.; Hall, Brett; Reddy, Manjula; Hoering, Antje; Hansen, Emily; van Rhee, Frits			Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels	PLOS ONE			English	Article							MULTIPLE-MYELOMA; IL-6 RECEPTOR; GROWTH-FACTOR; SERUM-LEVELS; GENE; ARTHRITIS; GENOTYPES; PROMOTER; ANTIBODY; CANCER	Multicentric Castleman Disease is largely driven by increased signaling in the pathway for the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 receptor/gp130 polymorphisms contribute to increased interleukin-6 and/or other components of the interleukin-6 signaling pathway in HIV-negative Castleman Disease patients. The study group was composed of 58 patients and 50 healthy donors of a similar racial/ethnic profile. Of seven polymorphisms chosen for analysis, we observed an increased frequency between patients and controls of the minor allele of interleukin-6 receptor polymorphism rs4537545, which is in linkage disequilibrium with interleukin-6 receptor polymorphism rs2228145. Further, individuals possessing at least one copy of the minor allele of either polymorphism expressed higher levels of soluble interleukin-6 receptor. These elevated interleukin-6 receptor levels may contribute to increased interleukin-6 activity through the trans-signaling pathway. These data suggest that interleukin-6 receptor polymorphism may be a contributing factor in Castleman Disease, and further research is warranted.	[Stone, Katie; Woods, Emily; Szmania, Susann M.; Stephens, Owen W.; Garg, Tarun K.; Barlogie, Bart; van Rhee, Frits] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; [Shaughnessy, John D., Jr.] Signal Genet LLC, New York, NY USA; [Hall, Brett; Reddy, Manjula] Janssen Res & Dev, Radnor, PA USA; [Hoering, Antje; Hansen, Emily] Canc Res & Biostat, Seattle, WA USA	University of Arkansas System; University of Arkansas Medical Sciences; Cancer Research & Biostatistics	van Rhee, F (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA.	vanrheefrits@uams.edu	Garg, Tarun K/C-8613-2009		Janssen Research and Development, a Johnson and Johnson Company	Janssen Research and Development, a Johnson and Johnson Company	This work was supported by Janssen Research and Development, a Johnson and Johnson Company. The funders developed the panoptic interleukin-6 assay and performed this testing. The funders had no role in study design, decision to publish, or preparation of the manuscript.	BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; CASTLEMAN B, 1954, N Engl J Med, V251, P396; CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4; Cozen W, 2006, CANCER EPIDEM BIOMAR, V15, P2285, DOI 10.1158/1055-9965.EPI-06-0446; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Galicia JC, 2004, GENES IMMUN, V5, P513, DOI 10.1038/sj.gene.6364120; Guerreiro CS, 2009, AM J GASTROENTEROL, V104, P2241, DOI 10.1038/ajg.2009.313; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Krakauer T, 1998, J IMMUNOL METHODS, V219, P161, DOI 10.1016/S0022-1759(98)00138-0; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; LEDUR A, 1995, J IMMUNOL METHODS, V186, P171, DOI 10.1016/0022-1759(95)00184-C; MAY LT, 1991, J BIOL CHEM, V266, P9950; Mazur G, 2005, IMMUNOL LETT, V96, P241, DOI 10.1016/j.imlet.2004.08.015; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Peake NJ, 2006, RHEUMATOLOGY, V45, P1485, DOI 10.1093/rheumatology/kel154; PETERSON BA, 1993, SEMIN ONCOL, V20, P636; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Sehgal PB, 1996, P SOC EXP BIOL MED, V213, P238; Slattery ML, 2007, CANCER CAUSE CONTROL, V18, P1095, DOI 10.1007/s10552-007-9049-x; Stephens OW, 2012, BLOOD, V119, P503, DOI 10.1182/blood-2011-07-367052; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377	27	35	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54610	10.1371/journal.pone.0054610	http://dx.doi.org/10.1371/journal.pone.0054610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372742	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500096
J	Toro, N; Martinez-Abarca, F				Toro, Nicolas; Martinez-Abarca, Francisco			Comprehensive Phylogenetic Analysis of Bacterial Group II Intron-Encoded ORFs Lacking the DNA Endonuclease Domain Reveals New Varieties	PLOS ONE			English	Article							RNA; MATURASE; ARCHAEA; REGION; LESS	Group II introns are self-splicing RNAs that act as mobile retroelements in the organelles of plants, fungi and protists. They are also widely distributed in bacteria, and are generally assumed to be the ancestors of nuclear spliceosomal introns. Most bacterial group II introns have a multifunctional intron-encoded protein (IEP) ORF within the ribozyme domain IV (DIV). This ORF encodes an N-terminal reverse transcriptase (RT) domain, followed by a putative RNA-binding domain with RNA splicing or maturase activity and, in some cases, a C-terminal DNA-binding (D) region followed by a DNA endonuclease (En) domain. In this study, we focused on bacterial group II intron ORF phylogenetic classes containing only reverse transcriptase/maturase open reading frames, with no recognizable D/En region (classes A, C, D, E, F and unclassified introns). On the basis of phylogenetic analyses of the maturase domain and its C-terminal extension, which appears to be a signature characteristic of ORF phylogenetic class, with support from the phylogeny inferred from the RT domain, we have revised the proposed new class F, defining new intron ORF varieties. Our results increase knowledge of the lineage of group II introns encoding proteins lacking the En-domain.	[Toro, Nicolas; Martinez-Abarca, Francisco] CSIC, Estn Expt Zaidin, Grp Ecol Genet, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Estn Expt Zaidin, Grp Ecol Genet, Granada, Spain.	nicolas.toro@eez.csic.es	Toro, Nicolas/K-4909-2014; Martinez-Abarca, Francisco/K-9263-2014	Toro, Nicolas/0000-0002-3614-807X; Martinez-Abarca, Francisco/0000-0003-0417-6217	Spanish Ministerio de Ciencia e Innovacion [BIO2011-24401]; Consolider-Ingenio programme [CSD 2009-0006]; ERDF (European Regional Development Funds)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Ingenio programme(Spanish Government); ERDF (European Regional Development Funds)(European Commission)	This work was supported by research grants BIO2011-24401 from the Spanish Ministerio de Ciencia e Innovacion, and CSD 2009-0006 of the Consolider-Ingenio programme including ERDF (European Regional Development Funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Drummond A, 2010, GENEIOUS V5 1; Eickbush Thomas H., 1994, P121; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Molina-Sanchez MD, 2010, FEBS J, V277, P244, DOI 10.1111/j.1742-4658.2009.07478.x; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Simon DM, 2008, RNA, V14, P1704, DOI 10.1261/rna.1056108; Simon DM, 2009, MOL BIOL EVOL, V26, P2795, DOI 10.1093/molbev/msp193; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55102	10.1371/journal.pone.0055102	http://dx.doi.org/10.1371/journal.pone.0055102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355907	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500155
J	Zha, WB; Wang, GJ; Xu, WR; Liu, XY; Wang, Y; Zha, BS; Shi, J; Zhao, QJ; Gerk, PM; Studer, E; Hylemon, PB; Pandak, WM; Zhou, HP				Zha, Weibin; Wang, Guangji; Xu, Weiren; Liu, Xuyuan; Wang, Yun; Zha, Beth S.; Shi, Jian; Zhao, Qijin; Gerk, Phillip M.; Studer, Elaine; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping			Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages	PLOS ONE			English	Article							CACO-2 CELL MONOLAYERS; IN-VITRO; SIGNALING PATHWAYS; MEDIATED TRANSPORT; ENDOTHELIAL-CELLS; ABC TRANSPORTERS; TNF-ALPHA; EXPRESSION; MODULATION; ABSORPTION	Background: HIV protease inhibitor (PI)-induced inflammatory response in macrophages is a major risk factor for cardiovascular diseases. We have previously reported that berberine (BBR), a traditional herbal medicine, prevents HIV PI-induced inflammatory response through inhibiting endoplasmic reticulum (ER) stress in macrophages. We also found that HIV PIs significantly increased the intracellular concentrations of BBR in macrophages. However, the underlying mechanisms of HIV PI-induced BBR accumulation are unknown. This study examined the role of P-glycoprotein (P-gp) in HIV PI-mediated accumulation of BBR in macrophages. Methodology and Principal Findings: Cultured mouse RAW264.7 macrophages, human THP-1-derived macrophages, Wild type MDCK (MDCK/WT) and human P-gp transfected (MDCK/P-gp) cells were used in this study. The intracellular concentration of BBR was determined by HPLC. The activity of P-gp was assessed by measuring digoxin and rhodamine 123 (Rh123) efflux. The interaction between P-gp and BBR or HIV PIs was predicated by Glide docking using Schrodinger program. The results indicate that P-gp contributed to the efflux of BBR in macrophages. HIV PIs significantly increased BBR concentrations in macrophages; however, BBR did not alter cellular HIV PI concentrations. Although HIV PIs did not affect P-gp expression, P-gp transport activities were significantly inhibited in HIV PI-treated macrophages. Furthermore, the molecular docking study suggests that both HIV PIs and BBR fit the binding pocket of P-gp, and HIV PIs may compete with BBR to bind P-gp. Conclusion and Significance: HIV PIs increase the concentration of BBR by modulating the transport activity of P-gp in macrophages. Understanding the cellular mechanisms of potential drug-drug interactions is critical prior to applying successful combinational therapy in the clinic.	[Zha, Weibin; Wang, Yun; Zha, Beth S.; Studer, Elaine; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zha, Weibin; Wang, Guangji; Shi, Jian; Zhao, Qijin] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Xu, Weiren; Liu, Xuyuan] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin, Peoples R China; [Liu, Xuyuan] Tianjin Med Univ, Basic Med Coll, Tianjin, Peoples R China; [Gerk, Phillip M.] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zhou, Huiping] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China	Virginia Commonwealth University; China Pharmaceutical University; Tianjin Medical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Wenzhou Medical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/J-3639-2015; Shi, Jian/Q-1667-2018; Zhou, Huiping/H-6875-2019; Shi, Jian/Y-9055-2019	Shi, Jian/0000-0003-2609-0094; Zhou, Huiping/0000-0002-0050-372X; Shi, Jian/0000-0003-2609-0094; Gerk, Phillip M./0000-0001-9861-1018	National Institutes of Health (NIH) [R01AT004148, R21AI068432]; VA Merit Award [1I01BX001390]; VCU Presidential Research Incentive Program Award; Merck Research Grant, School of Medicine; VCU Bridge funding; National Science Foundation of China [81070245]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); VCU Presidential Research Incentive Program Award; Merck Research Grant, School of Medicine; VCU Bridge funding; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants R01AT004148 (H.Z.), R21AI068432 (H.Z.), VA Merit Award 1I01BX001390 (H.Z.), The VCU Presidential Research Incentive Program Award (H.Z.), Merck Research Grant, School of Medicine, VCU Bridge funding (H.Z.), and National Science Foundation of China (Grant 81070245 to H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Bierman WFW, 2010, J ANTIMICROB CHEMOTH, V65, P1672, DOI 10.1093/jac/dkq209; Bousquet L, 2008, AIDS RES HUM RETROV, V24, P1147, DOI 10.1089/aid.2007.0022; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Duggan J, 2001, AIDS PATIENT CARE ST, V15, P159, DOI 10.1089/108729101750123661; Fujimoto H, 2009, BIOL PHARM BULL, V32, P1588, DOI 10.1248/bpb.32.1588; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; He SM, 2010, CURR MED CHEM, V17, P4072, DOI 10.2174/092986710793205336; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lei BK, 2010, MOL PHARMACEUT, V7, P844, DOI 10.1021/mp100003r; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Maeng HJ, 2002, J PHARM SCI, V91, P2614, DOI 10.1002/jps.10268; Moreau A, 2011, FUNDAM CLIN PHARM, DOI 0.1111/j.1472-8206.2010.00913.x; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Patel Jignesh, 2004, Am J Ther, V11, P262, DOI 10.1097/01.mjt.0000101827.94820.22; Penzak SR, 2004, THER DRUG MONIT, V26, P322, DOI 10.1097/00007691-200406000-00018; Perloff ES, 2005, DRUG METAB DISPOS, V33, P764, DOI 10.1124/dmd.104.002931; Perloff MD, 2000, AIDS, V14, P1287, DOI 10.1097/00002030-200006160-00034; Perloff MD, 2007, J PHARM PHARMACOL, V59, P947, DOI 10.1211/jpp.59.7.0006; Polli JW, 1999, PHARM RES-DORDR, V16, P1206, DOI 10.1023/A:1018941328702; Profit L, 1999, AIDS, V13, P1623, DOI 10.1097/00002030-199909100-00004; Richter M, 2004, PHARM RES-DORDR, V21, P1862, DOI 10.1023/B:PHAM.0000045240.81664.be; Roy KR, 2007, ARCH BIOCHEM BIOPHYS, V459, P169, DOI 10.1016/j.abb.2007.01.006; Shen Z F, 1993, Yao Xue Xue Bao, V28, P532; Shitan N, 2007, BIOSCI BIOTECH BIOCH, V71, P242, DOI 10.1271/bbb.60441; Storch CH, 2007, BIOCHEM PHARMACOL, V73, P1573, DOI 10.1016/j.bcp.2007.01.027; van Heeswijk RPG, 2006, J CLIN PHARMACOL, V46, P758, DOI 10.1177/0091270006288733; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025436; Wang Y, 2011, J MED CHEM, V54, P3768, DOI 10.1021/jm200017g; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898; Zha W, 2012, CURR DRUG METAB; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793; Zhang YC, 1998, PHARMACEUT RES, V15, P1520, DOI 10.1023/A:1011990730230; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhu XZ, 2004, EUR J PHARMACOL, V500, P221, DOI 10.1016/j.ejphar.2004.07.027	48	25	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54349	10.1371/journal.pone.0054349	http://dx.doi.org/10.1371/journal.pone.0054349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372711	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500062
J	Zhao, DX; Chen, DS; Ge, C; Gotoh, T; Hong, XY				Zhao, Dong-Xiao; Chen, Da-Song; Ge, Cheng; Gotoh, Tetsuo; Hong, Xiao-Yue			Multiple Infections with Cardinium and Two Strains of Wolbachia in The Spider Mite Tetranychus phaselus Ehara: Revealing New Forces Driving the Spread of Wolbachia	PLOS ONE			English	Article							CALLOSOBRUCHUS-CHINENSIS COLEOPTERA; INDUCED CYTOPLASMIC INCOMPATIBILITY; AEDES-ALBOPICTUS; ENDOSYMBIOTIC BACTERIUM; DROSOPHILA-SIMULANS; POPULATION-DYNAMICS; HOST GENOTYPE; RAPID SPREAD; ACARI; PHYLOGENY	Cytoplasmic incompatibility (CI) has been proposed as a major mechanism by which certain strains of Wolbachia to invade and persist in host populations. However, mechanisms that underlie the invasion and persistence of non-CI strains are less well understood. Here, we established a spider mite Tetranychus phaselus population multiply infected by Cardinium as well as two distinct lineages of Wolbachia, designated wCon and wOri, to study the forces driving the spread of the non-CI strain of Wolbachia wOri. Interestingly, we found that wOri provided a longevity advantage to its female hosts under ideal conditions, making wOri stay longer in this population, and then being transmitted to more offspring. Furthermore, the lifespan of uninfected females was reduced when mated with multiple-infected males. As a result, the uninfected population is attenuated by the multiple-infected males. Thus, we infer that the host age effects of multiple infection may represent sufficient forces driving the spread of wOri through the host population.	[Zhao, Dong-Xiao; Chen, Da-Song; Ge, Cheng; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ami, Ibaraki 30003, Japan	Nanjing Agricultural University; Ibaraki University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020	Ge, Cheng/0000-0002-0740-5428	Science and Technology Program of the National Public Welfare Professional Fund [201103020]; Ministry of Agriculture of China; National Basic Science Program of China (973 Program) [2009CB119202]; National Natural Science Foundation of China [31172131]	Science and Technology Program of the National Public Welfare Professional Fund; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Basic Science Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (201103020) from the Ministry of Agriculture of China (www.moa.gov.cn), a Grant-in-Aid from the National Basic Science Program of China (973 Program, number 2009CB119202)(www.most.gov.cn), and a Grant-in-Aid for Scientific Research (number 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bordenstein SR, 1998, GENETICS, V148, P1833; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Gotoh T, 2003, HEREDITY, V91, P208, DOI 10.1038/sj.hdy.6800329; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Gotoh T, 2007, EXP APPL ACAROL, V42, P1, DOI 10.1007/s10493-007-9072-3; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1990, GENETICS, V126, P933; Hong XY, 2002, HEREDITY, V88, P190, DOI 10.1038/sj.hdy.6800026; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P97, DOI 10.1098/rspb.1996.0016; Ijichi N, 2002, APPL ENVIRON MICROB, V68, P4074, DOI 10.1128/AEM.68.8.4074-4080.2002; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Liu Y, 2006, J APPL ENTOMOL, V130, P523, DOI 10.1111/j.1439-0418.2006.01112.x; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; MERCOT H, 1995, GENETICS, V141, P1015; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; PerrotMinnot MJ, 1996, GENETICS, V143, P961; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; Rousset F, 1999, HEREDITY, V82, P620, DOI 10.1046/j.1365-2540.1999.00501.x; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2009, J HERED, V100, P192, DOI 10.1093/jhered/esn079; Watanabe M, 2011, HEREDITY, V106, P642, DOI 10.1038/hdy.2010.100; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zhang H, 2010, ENVIRON ENTOMOL, V39, P1801, DOI 10.1603/EN10051; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	48	26	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54964	10.1371/journal.pone.0054964	http://dx.doi.org/10.1371/journal.pone.0054964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355904	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500151
J	Zhao, ZJ; Zhu, QX; Chen, KX; Wang, YK; Cao, J				Zhao, Zhi-Jun; Zhu, Qiao-Xia; Chen, Ke-Xin; Wang, Yu-Kun; Cao, Jing			Energy Budget, Behavior and Leptin in Striped Hamsters Subjected to Food Restriction and Refeeding	PLOS ONE			English	Article							DEPRIVATION-INDUCED INCREASES; BODY-WEIGHT; SHORT PHOTOPERIOD; CALORIC RESTRICTION; ACOMYS-RUSSATUS; OBESE; THERMOGENESIS; METABOLISM; RATS; MASS	Food restriction induces a loss of body mass that is often followed by rapid regaining of the lost weight when the restriction ends, consequently increasing a risk of development of obesity. To determine the physiological and behavioral mechanisms underlining the regaining, striped hamsters were restricted to 85% of initial food intake for 4 weeks and refed ad libitum for another 4 weeks. Changes in body mass, energy budget, activity, body composition and serum leptin level were measured. Body mass, body fat mass and serum leptin level significantly decreased in food-restricted hamsters, and increased when the restriction ended, showing a short "compensatory growth" rather than over-weight or obesity compared with ad libitum controls. During restriction, the time spent on activity increased significantly, which was opposite to the changes in serum leptin level. Food intake increased shortly during refeeding, which perhaps contributed to the rapid regaining of body mass. No correlation was observed between serum leptin and energy intake, while negative correlations were found in hamsters that were refed for 7 and 28 days. Exogenous leptin significantly decreased the time spent on activity during food restriction and attenuated the increase in food intake during refeeding. This suggests that low leptin in restricted animals may function as a starvation signal to induce an increase in activity behavior, and high leptin likely serves as a satiety signal to prevent activity during refeeding. Leptin may play a crucial role in controlling food intake when the restriction ends, and consequently preventing overweight.	[Zhao, Zhi-Jun; Cao, Jing] Wenzhou Univ, Sch Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Zhao, Zhi-Jun; Zhu, Qiao-Xia; Chen, Ke-Xin; Wang, Yu-Kun; Cao, Jing] Liaocheng Univ, Sch Agr Sci, Liaocheng, Shandong, Peoples R China	Wenzhou University; Liaocheng University	Zhao, ZJ (corresponding author), Wenzhou Univ, Sch Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China.	zhaozj73@yahoo.com.cn			National Natural Science Foundation of China [30800130, 31070367]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was supported by grants (no. 30800130 and 31070367) from the National Natural Science Foundation of China to ZJZ, and was also funded by The State Key Laboratory of Integrated Management of Pest Insects and Rodents (no. ChineseIPM1209) to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda M, 2003, J THERM BIOL, V28, P525, DOI 10.1016/S0306-4565(03)00053-6; Ahima RS, 2005, TRENDS ENDOCRIN MET, V16, P307, DOI 10.1016/j.tem.2005.07.010; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Alvarenga TAF, 2005, BRAIN RES, V1057, P49, DOI 10.1016/j.brainres.2005.07.024; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; BARTNESS TJ, 1994, AM J PHYSIOL, V266, pR1111, DOI 10.1152/ajpregu.1994.266.4.R1111; Bartness TJ, 1997, AM J PHYSIOL-REG I, V272, pR118, DOI 10.1152/ajpregu.1997.272.1.R118; BLANK JL, 1985, AM J PHYSIOL, V248, pR181, DOI 10.1152/ajpregu.1985.248.2.R181; Cameron KM, 2011, J NUTR, V141, P182, DOI 10.3945/jn.110.129056; Cao J, 2009, J THERM BIOL, V34, P290, DOI 10.1016/j.jtherbio.2009.03.006; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; CLEARY MP, 1986, J NUTR, V116, P290, DOI 10.1093/jn/116.2.290; CLEARY MP, 1986, J NUTR, V116, P1489, DOI 10.1093/jn/116.8.1489; CORNISH ER, 1965, ANIM BEHAV, V13, P242, DOI 10.1016/0003-3472(65)90042-4; Day DE, 2003, PHYSIOL BEHAV, V78, P655, DOI 10.1016/S0031-9384(03)00052-0; Ehrhardt N, 2005, J COMP PHYSIOL B, V175, P193, DOI 10.1007/s00360-005-0475-3; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; Fernandez-Galaz C, 2002, DIABETOLOGIA, V45, P997, DOI 10.1007/s00125-002-0851-4; Forbes G, 1987, HUMAN BODY COMPOSITI; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GRAY DS, 1988, AM J CLIN NUTR, V47, P393, DOI 10.1093/ajcn/47.3.393; Grodzinski W., 1975, International biol Progm, V5, P173; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Gutman R, 2007, PHYSIOL BEHAV, V90, P95, DOI 10.1016/j.physbeh.2006.08.033; Hambly C, 2005, OBES RES, V13, P1548, DOI 10.1038/oby.2005.190; Hambly C, 2012, DIS MODEL MECH, V5, P83, DOI 10.1242/dmm.007781; HARRIS RBS, 1984, J NUTR, V114, P1143, DOI 10.1093/jn/114.6.1143; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; HILL JO, 1985, AM J PHYSIOL, V248, pR549, DOI 10.1152/ajpregu.1985.248.5.R549; Kastin AJ, 2000, REGUL PEPTIDES, V92, P37, DOI 10.1016/S0167-0115(00)00147-6; Keen-Rhinehart E, 2008, AM J PHYSIOL-REG I, V295, pR1737, DOI 10.1152/ajpregu.90512.2008; Klingenspor M, 2000, J COMP PHYSIOL B, V170, P37, DOI 10.1007/s003600050005; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; Li XS, 2005, J COMP PHYSIOL B, V175, P593, DOI 10.1007/s00360-005-0022-2; Liu H, 2003, J MAMMAL, V84, P1410, DOI 10.1644/BRG-030; LU H, 1987, Acta Theriologica Sinica, V7, P28; Mercer JG, 1998, COMP BIOCHEM PHYS C, V119, P295, DOI 10.1016/S0742-8413(98)00018-8; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; ROZEN R, 1994, AM J CLIN NUTR, V59, P560, DOI 10.1093/ajcn/59.3.560; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Song ZG, 2003, J THERM BIOL, V28, P509, DOI 10.1016/S0306-4565(03)00051-2; Song ZG, 2002, ACTA THERIOL, V47, P417, DOI 10.1007/BF03192466; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Speakman JR, 2001, J EXP BIOL, V204, P1957; Speakman JR, 1999, FUNCT ECOL, V13, P373, DOI 10.1046/j.1365-2435.1999.00322.x; SZEPESI B, 1977, AM J CLIN NUTR, V30, P1692, DOI 10.1093/ajcn/30.10.1692; VANITALLIE TB, 1985, AM J CLIN NUTR, V42, P914, DOI 10.1093/ajcn/42.5.914; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P274, DOI 10.1016/j.euroneuro.2010.11.006; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Wisse BE, 1999, AM J CLIN NUTR, V70, P321; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wood AD, 1996, PHYSIOL BEHAV, V60, P1137, DOI 10.1016/0031-9384(96)00173-4; Yang H, 2007, PEPTIDES, V28, P1931, DOI 10.1016/j.peptides.2007.07.030; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao ZJ, 2007, COMP BIOCHEM PHYS A, V148, P168, DOI 10.1016/j.cbpa.2007.04.001; Zhao ZJ, 2011, ACTA THERIOL, V56, P129, DOI 10.1007/s13364-010-0004-y; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008; Zhao ZJ, 2009, COMP BIOCHEM PHYS A, V154, P84, DOI 10.1016/j.cbpa.2009.05.004; Zhao ZJ, 2006, HORM BEHAV, V49, P463, DOI 10.1016/j.yhbeh.2005.10.003	64	9	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54244	10.1371/journal.pone.0054244	http://dx.doi.org/10.1371/journal.pone.0054244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372694	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500047
J	Boissiere, A; Gimonneau, G; Tchioffo, MT; Abate, L; Bayibeki, A; Awono-Ambene, PH; Nsango, SE; Morlais, I				Boissiere, Anne; Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Bayibeki, Albert; Awono-Ambene, Parfait H.; Nsango, Sandrine E.; Morlais, Isabelle			Application of a qPCR Assay in the Investigation of Susceptibility to Malaria Infection of the M and S Molecular Forms of An. gambiae s.s. in Cameroon	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SEQUENCE-BASED AMPLIFICATION; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; INSECTICIDE-RESISTANCE; CHROMOSOMAL FORMS; IMPORTED MALARIA; IDENTIFICATION; SPECIATION	Plasmodium falciparum is the causative agent of malaria, a disease that kills almost one million persons each year, mainly in sub-Saharan Africa. P. falciparum is transmitted to the human host by the bite of an Anopheles female mosquito, and Anopheles gambiae sensus stricto is the most tremendous malaria vector in Africa, widespread throughout the afro-tropical belt. An. gambiae s.s. is subdivided into two distinct molecular forms, namely M and S forms. The two molecular forms are morphologically identical but they are distinct genetically, and differ by their distribution and their ecological preferences. The epidemiological importance of the two molecular forms in malaria transmission has been poorly investigated so far and gave distinct results in different areas. We have developed a real-time quantitative PCR (qPCR) assay, and used it to detect P. falciparum at the oocyst stage in wild An. gambiae s.s. mosquitoes experimentally infected with natural isolates of parasites. Mosquitoes were collected at immature stages in sympatric and allopatric breeding sites and further infected at the adult stage. We next measured the infection prevalence and intensity in female mosquitoes using the qPCR assay and correlated the infection success with the mosquito molecular forms. Our results revealed different prevalence of infection between the M and S molecular forms of An. gambiae s.s. in Cameroon, for both sympatric and allopatric populations of mosquitoes. However, no difference in the infection intensity was observed. Thus, the distribution of the molecular forms of An. gambiae s.s. may impact on the malaria epidemiology, and it will be important to monitor the efficiency of malaria control interventions on the two M and S forms.	[Boissiere, Anne; Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Nsango, Sandrine E.; Morlais, Isabelle] Inst Rech Dev, Unite Mixte Rech MIVEGEC IRD CNRS UM1 UM2 224 529, Montpellier, France; [Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Bayibeki, Albert; Awono-Ambene, Parfait H.; Nsango, Sandrine E.; Morlais, Isabelle] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon	Institut de Recherche pour le Developpement (IRD)	Morlais, I (corresponding author), Inst Rech Dev, Unite Mixte Rech MIVEGEC IRD CNRS UM1 UM2 224 529, Montpellier, France.	isabelle.morlais@ird.fr	TSAPI, Majoline TCHIOFFO/S-3007-2019; Morlais, Isabelle/F-5078-2014; Gimonneau, Geoffrey/C-1681-2013; Morlais, Isabelle/Q-2171-2019; BOISSIERE, Anne/ABB-5669-2020	TSAPI, Majoline TCHIOFFO/0000-0001-9517-3665; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; BOISSIERE, Anne/0000-0003-3958-2602; Gimonneau, Geoffrey/0000-0002-0613-841X; abate, luc/0000-0003-3973-3036	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche [ANR-11-BSV7-009-01]; European Community [242095, 223601]	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission)	This work was supported by funds from the Institut de Recherche pour le Developpement (IRD), the Agence Nationale de la Recherche (grant awarded to IM, ANR-11-BSV7-009-01) and the European Community's Seventh Framework Programme (FP7) (grant agreements No 242095, EviMalaR, and No 223601, MALVECBLOK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Arez AP, 2000, EXP PARASITOL, V94, P269, DOI 10.1006/expr.2000.4496; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Berry A, 2008, PARASITE, V15, P484, DOI 10.1051/parasite/2008153484; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Borenstein M, 2009, INTRO META ANAL; Boudin C, 2004, PARASITE IMMUNOL, V26, P105, DOI 10.1111/j.0141-9838.2004.00689.x; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Elsayed S, 2006, J CLIN MICROBIOL, V44, P622, DOI 10.1128/JCM.44.2.622-624.2006; Fabre R, 2004, PARASITOLOGY, V128, P15, DOI 10.1017/S0031182003004219; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fryxell RTT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-133; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Kamdem C, 2012, PLOS ONE, V9; Krungkrai J, 2004, PARASITOLOGY, V129, P511, DOI 10.1017/S0031182004005888; Kudom AA, 2012, J VECTOR ECOL, V37, P77, DOI 10.1111/j.1948-7134.2012.00202.x; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Levashina EA, 2004, INSECT BIOCHEM MOLEC, V34, P673, DOI 10.1016/j.ibmb.2004.03.020; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Mitri C, 2012, CURR OPIN MICROBIOL; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-269; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rao RU, 2009, T ROY SOC TROP MED H, V103, P365, DOI 10.1016/j.trstmh.2008.07.012; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Schwarzer G, 2012, META META ANALYSIS W; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Sinden RE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-70; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Stump AD, 2005, GENETICS, V169, P1509, DOI 10.1534/genetics.104.035303; Team RC, 2012, R LANG ENV STAT COMP; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	71	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54820	10.1371/journal.pone.0054820	http://dx.doi.org/10.1371/journal.pone.0054820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349974	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100099
J	de la Ossa, DHP; Lorente, M; Gil-Alegre, ME; Torres, S; Garcia-Taboada, E; Aberturas, MD; Molpeceres, J; Velasco, G; Torres-Suarez, AI				Hernan Perez de la Ossa, Dolores; Lorente, Mar; Esther Gil-Alegre, Maria; Torres, Sofia; Garcia-Taboada, Elena; del Rosario Aberturas, Maria; Molpeceres, Jesus; Velasco, Guillermo; Isabel Torres-Suarez, Ana			Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; DRUG-DELIVERY; IN-VITRO; HEPATOCELLULAR-CARCINOMA; ANTITUMOR-ACTIVITY; SUSTAINED-RELEASE; MICROSPHERES; CANNABIDIOL; CANCER; DOXORUBICIN	Cannabinoids, the active components of marijuana and their derivatives, are currently investigated due to their potential therapeutic application for the management of many different diseases, including cancer. Specifically, Delta(9)- Tetrahydrocannabinol (THC) and Cannabidiol (CBD) - the two major ingredients of marijuana - have been shown to inhibit tumor growth in a number of animal models of cancer, including glioma. Although there are several pharmaceutical preparations that permit the oral administration of THC or its analogue nabilone or the oromucosal delivery of a THC- and CBD- enriched cannabis extract, the systemic administration of cannabinoids has several limitations in part derived from the high lipophilicity exhibited by these compounds. In this work we analyzed CBD- and THC-loaded poly-epsilon- caprolactone microparticles as an alternative delivery system for long-term cannabinoid administration in a murine xenograft model of glioma. In vitro characterization of THC- and CBD-loaded microparticles showed that this method of microencapsulation facilitates a sustained release of the two cannabinoids for several days. Local administration of THC-, CBD- or a mixture (1:1 w:w) of THC- and CBD- loaded microparticles every 5 days to mice bearing glioma xenografts reduced tumour growth with the same efficacy than a daily local administration of the equivalent amount of those cannabinoids in solution. Moreover, treatment with cannabinoid-loaded microparticles enhanced apoptosis and decreased cell proliferation and angiogenesis in these tumours. Our findings support that THC- and CBD- loaded microparticles could be used as an alternative method of cannabinoid delivery in anticancer therapies.	[Hernan Perez de la Ossa, Dolores; Esther Gil-Alegre, Maria; Isabel Torres-Suarez, Ana] Univ Complutense, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-28040 Madrid, Spain; [Lorente, Mar; Torres, Sofia; Garcia-Taboada, Elena; Velasco, Guillermo] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Lorente, Mar; Velasco, Guillermo] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [del Rosario Aberturas, Maria; Molpeceres, Jesus] Alcala Univ, Sch Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain; [Esther Gil-Alegre, Maria; Isabel Torres-Suarez, Ana] Univ Complutense, Inst Farm Ind, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Universidad de Alcala; Complutense University of Madrid	Velasco, G (corresponding author), Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.	gvd@bbm1.ucm.es	Torres-Suárez, Ana I/N-4666-2013; Velasco, Guillermo/H-5260-2012; del Rosario Aberturas, María/AAA-9014-2019; Lorente, Mar/O-5106-2017; Torres-SuÃrez, Ana Isabel/AAR-9320-2020; /Y-9512-2019; Velasco, Guillermo/AAU-9189-2020; Lorente, Mar/K-2401-2014	Torres-Suárez, Ana I/0000-0003-2468-6177; Velasco, Guillermo/0000-0002-1994-2386; del Rosario Aberturas, María/0000-0001-7875-6009; Lorente, Mar/0000-0003-0982-0956; Torres-SuÃrez, Ana Isabel/0000-0003-2468-6177; /0000-0003-4201-0795; Velasco, Guillermo/0000-0002-1994-2386; GIL-ALEGRE, MARIA ESTHER/0000-0002-8313-8261; Torres, Sofia/0000-0002-9007-8105	Spanish Ministry of Science and Innovation (MICINN) [PS09/01401]; Comunidad Autonoma de Madrid [PR1/06-14474-B]; Complutense University [CCG07-UCM/BIO-2824]; Juan de la Cierva; Spanish Ministry of Education and Science; Comunidad de Madrid; GW Pharmaceuticals	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Complutense University; Juan de la Cierva(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); GW Pharmaceuticals	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN) (PS09/01401 to GV), Comunidad Autonoma de Madrid (PR1/06-14474-B to AITS) and Complutense University (CCG07-UCM/BIO-2824 to AITS). DH was recipient of a FPU fellowship from MICINN. ML was sequentially recipient of a "Juan de la Cierva'' contract, a postdoctoral contract from Spanish Ministry of Education and Science and a postdoctoral contract from Comunidad de Madrid. ST was recipient of a research training contract from Comunidad de Madrid. GW Pharmaceuticals funded part of the research that was performed in GV's laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateh DD, 2011, BIOMATERIALS, V32, P8538, DOI 10.1016/j.biomaterials.2011.07.060; Benny O, 2009, CLIN CANCER RES, V15, P1222, DOI 10.1158/1078-0432.CCR-08-1316; Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Chakravarthi SS, 2011, INT J PHARMACEUT, V409, P111, DOI 10.1016/j.ijpharm.2011.02.034; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dubernet C, 2011, B CANCER, V98, P1363, DOI 10.1684/bdc.2011.1468; Gil-Alegre ME, 2008, J MICROENCAPSUL, V25, P561, DOI [10.1080/02652040802075799, 10.1080/02652040802075799 ]; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GARRETT ER, 1974, J PHARM SCI-US, V63, P1056, DOI 10.1002/jps.2600630705; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Hillegass JM, 2011, INT J CANCER, V129, P233, DOI 10.1002/ijc.25666; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Kim I, 2012, BIOMATERIALS, V33, P5574, DOI 10.1016/j.biomaterials.2012.04.018; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Lin RY, 2005, BIOMATERIALS, V26, P4476, DOI 10.1016/j.biomaterials.2004.11.014; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; McAllister SD, 2011, BREAST CANCER RES TR, V129, P37, DOI 10.1007/s10549-010-1177-4; Menei Philippe, 2005, Expert Opin Drug Deliv, V2, P363, DOI 10.1517/17425247.2.2.363; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Nguyen TLU, 2007, J POLYM SCI POL CHEM, V45, P3256, DOI 10.1002/pola.22074; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; de la Ossa DHP, 2012, J CONTROL RELEASE, V161, P927, DOI 10.1016/j.jconrel.2012.05.003; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Sastre RL, 2004, DRUG DEVELOP RES, V63, P41, DOI 10.1002/ddr.10396; Soma CE, 2000, J CONTROL RELEASE, V68, P283, DOI 10.1016/S0168-3659(00)00269-8; Soma CE, 2000, BIOMATERIALS, V21, P1; Torelli-Souza RR, 2012, J APPL POLYM SCI, V126, pE408, DOI 10.1002/app.36928; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247	41	58	61	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54795	10.1371/journal.pone.0054795	http://dx.doi.org/10.1371/journal.pone.0054795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349970	Green Published, gold			2022-12-25	WOS:000314019100098
J	Ke, PY; Chen, SSL				Ke, Po-Yuan; Chen, Steve S-L			Active RNA Replication of Hepatitis C Virus Downregulates CD81 Expression	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; INFECTION IN-VITRO; RECEPTOR SR-BI; SCAVENGER RECEPTOR; SUPERINFECTION EXCLUSION; HEPATOMA-CELLS; ENTRY FACTOR; PROTEIN; LIVER; HOST	So far how hepatitis C virus (HCV) replication modulates subsequent virus growth and propagation still remains largely unknown. Here we determine the impact of HCV replication status on the consequential virus growth by comparing normal and high levels of HCV RNA expression. We first engineered a full-length, HCV genotype 2a JFH1 genome containing a blasticidin-resistant cassette inserted at amino acid residue of 420 in nonstructural (NS) protein 5A, which allowed selection of human hepatoma Huh7 cells stably-expressing HCV. Short-term establishment of HCV stable cells attained a highly-replicating status, judged by higher expressions of viral RNA and protein as well as higher titer of viral infectivity as opposed to cells harboring the same genome without selection. Interestingly, maintenance of highly-replicating HCV stable cells led to decreased susceptibility to HCV pseudotyped particle (HCVpp) infection and downregulated cell surface level of CD81, a critical HCV entry (co) receptor. The decreased CD81 cell surface expression occurred through reduced total expression and cytoplasmic retention of CD81 within an endoplasmic reticulum -associated compartment. Moreover, productive viral RNA replication in cells harboring a JFH1 subgenomic replicon containing a similar blasticidin resistance gene cassette in NS5A and in cells robustly replicating full-length infectious genome also reduced permissiveness to HCVpp infection through decreasing the surface expression of CD81. The downregulation of CD81 surface level in HCV RNA highly-replicating cells thus interfered with reinfection and led to attenuated viral amplification. These findings together indicate that the HCV RNA replication status plays a crucial determinant in HCV growth by modulating the expression and intracellular localization of CD81.	[Ke, Po-Yuan; Chen, Steve S-L] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Ke, Po-Yuan] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Ke, Po-Yuan] Chang Gung Univ, Coll Med, Mol Med Res Ctr, Tao Yuan, Taiwan	Academia Sinica - Taiwan; Chang Gung University; Chang Gung University	Chen, SSL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	schen@ibms.sinica.edu.tw	Ke, Po-Yuan/AAQ-6324-2021	Ke, Po-Yuan/0000-0002-0471-0806	National Health of Research Institute [NHRI-EX100-10051SI, NHRI-EX101-10051SI]; National Science Council [NSC99-2320-B-001-003-MY3, NSC101-2320-B-001-022-MY3]; Ministry of Education [EMRPD1B0161]; Chang Gung University [NMRPD1B12, CMRPD1B0461]; Foresight Research Grant [AS97FP-L15-1, AS98FP-L15-1, AS99FP-L15-1]; Academia Sinica; Liver Disease Prevention & Treatment Research Foundation	National Health of Research Institute; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chang Gung University; Foresight Research Grant; Academia Sinica(Academia Sinica - Taiwan); Liver Disease Prevention & Treatment Research Foundation	This study was supported by research grants from the National Health of Research Institute (NHRI-EX100-10051SI and NHRI-EX101-10051SI), the National Science Council (NSC99-2320-B-001-003-MY3 and NSC101-2320-B-001-022-MY3), the Ministry of Education (EMRPD1B0161), Chang Gung University (NMRPD1B12 and CMRPD1B0461), and by Foresight Research Grants (AS97FP-L15-1, AS98FP-L15-1, and AS99FP-L15-1), Summit Project III from Academia Sinica, and the Liver Disease Prevention & Treatment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Li HF, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-89; Lin KYK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001148; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lopez D, 1999, ENDOCRINOLOGY, V140, P5669, DOI 10.1210/en.140.12.5669; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2010, J VIROL, V84, P5824, DOI 10.1128/JVI.02397-09; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Wood P, 2011, J BIOL CHEM, V286, P23077, DOI 10.1074/jbc.M111.236398; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	46	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54866	10.1371/journal.pone.0054866	http://dx.doi.org/10.1371/journal.pone.0054866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349980	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100103
J	Banerjee, S; Isaacman-Beck, J; Schneider, VA; Granato, M				Banerjee, Santanu; Isaacman-Beck, Jesse; Schneider, Valerie A.; Granato, Michael			A Novel Role for Lh3 Dependent ECM Modifications during Neural Crest Cell Migration in Zebrafish	PLOS ONE			English	Article							GROWTH CONE MIGRATION; XVIII COLLAGEN; LYSYL-HYDROXYLASE-3 LH3; AXON GUIDANCE; IN-VIVO; TRUNK; EMBRYO; EXPRESSION; PATTERN; SOMITE	During vertebrate development, trunk neural crest cells delaminate along the entire length of the dorsal neural tube and initially migrate as a non-segmented sheet. As they enter the somites, neural crest cells rearrange into spatially restricted segmental streams. Extracellular matrix components are likely to play critical roles in this transition from a sheet-like to a stream-like mode of migration, yet the extracellular matrix components and their modifying enzymes critical for this transition are largely unknown. Here, we identified the glycosyltransferase Lh3, known to modify extracellular matrix components, and its presumptive substrate Collagen18A1, to provide extrinsic signals critical for neural crest cells to transition from a sheet-like migration behavior to migrating as a segmental stream. Using live cell imaging we show that in lh3 null mutants, neural crest cells fail to transition from a sheet to a stream, and that they consequently enter the somites as multiple streams, or stall shortly after entering the somites. Moreover, we demonstrate that transgenic expression of lh3 in a small subset of somitic cells adjacent to where neural crest cells switch from sheet to stream migration restores segmental neural crest cell migration. Finally, we show that knockdown of the presumptive Lh3 substrate Collagen18A1 recapitulates the neural crest cell migration defects observed in lh3 mutants, consistent with the notion that Lh3 exerts its effect on neural crest cell migration by regulating post-translational modifications of Collagen18A1. Together these data suggest that Lh3-Collagen18A1 dependent ECM modifications regulate the transition of trunk neural crest cells from a non-segmental sheet like migration mode to a segmental stream migration mode.	[Banerjee, Santanu; Isaacman-Beck, Jesse; Schneider, Valerie A.; Granato, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu		Isaacman-Beck, Jesse/0000-0002-0932-0962; Schneider, Valerie/0000-0002-3442-1888	United States National Institutes of Health [HD037975]; NSF [0920336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by United States National Institutes of Health grant HD037975 and by NSF grant 0920336 to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; ERICKSON CA, 1983, J EMBRYOL EXP MORPH, V74, P97; ERICKSON CA, 1985, DEV BIOL, V111, P138, DOI 10.1016/0012-1606(85)90442-7; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Halloran MC, 2003, DEV DYNAM, V228, P497, DOI 10.1002/dvdy.10374; Honjo Y, 2005, DEVELOPMENT, V132, P4461, DOI 10.1242/dev.02026; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; KALCHEIM C, 1989, DEVELOPMENT, V106, P85; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Krull CE, 2010, CELL ADH MIGR, V4; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; McLennan R, 2002, GENE EXPRESSION, V10, P295, DOI 10.3727/000000002783992389; Meyer F, 2009, DEV GROWTH DIFFER, V51, P483, DOI 10.1111/j.1440-169X.2009.01111.x; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; PIKE SH, 1992, DEVELOPMENT, V114, P825; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Roffers-Agarwal J, 2009, DEVELOPMENT, V136, P1879, DOI 10.1242/dev.032920; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Schwarz Q, 2009, DEVELOPMENT, V136, P1785, DOI 10.1242/dev.034322; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tucker RP, 1999, DEV DYNAM, V214, P312, DOI 10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54609	10.1371/journal.pone.0054609	http://dx.doi.org/10.1371/journal.pone.0054609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349938	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800066
J	Boldrin, L; Morgan, JE				Boldrin, Luisa; Morgan, Jennifer E.			Grafting of a Single Donor Myofibre Promotes Hypertrophy in Dystrophic Mouse Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SATELLITE CELLS; MYOSTATIN; MDX; GROWTH; REGENERATION; EXPRESSION; MUTATION; PATHWAY; MICE	Skeletal muscle has a remarkable capability of regeneration following injury. Satellite cells, the principal muscle stem cells, are responsible for this process. However, this regenerative capacity is reduced in muscular dystrophies or in old age: in both these situations, there is a net loss of muscle fibres. Promoting skeletal muscle muscle hypertrophy could therefore have potential applications for treating muscular dystrophies or sarcopenia. Here, we observed that muscles of dystrophic mdx nude host mice that had been acutely injured by myotoxin and grafted with a single myofibre derived from a normal donor mouse exhibited increased muscle area. Transplantation experiments revealed that the hypertrophic effect is mediated by the grafted fibre and does not require either an imposed injury to the host muscle, or the contribution of donor cells to the host muscle. These results suggest the presence of a crucial cross-talk between the donor fibre and the host muscle environment.	[Boldrin, Luisa; Morgan, Jennifer E.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of London; University College London	Boldrin, L (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	l.boldrin@ucl.ac.uk			Wellcome Trust University Award [08241/Z/07/Z]; Muscular Dystrophy Campaign [RA3/776]; Association Francaise contre les Myopathies [13948]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Wellcome Trust University Award(Wellcome Trust); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Wellcome Trust University Award grant number: 08241/Z/07/Z (http://www.wellcome.ac.uk/); Muscular Dystrophy Campaign grant number: RA3/776 (http://www.muscular-dystrophy.org/); Association Francaise contre les Myopathies grant number: 13948 (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Boldrin L, 2012, STEM CELLS; Boldrin L, 2012, STEM CELLS, V30, P1971, DOI 10.1002/stem.1158; Boldrin L, 2009, STEM CELLS, V27, P2478, DOI 10.1002/stem.162; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; KLEINOGUS C, 1983, CELL TISSUE RES, V230, P671, DOI 10.1007/BF00216210; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Malerba A, 2009, HUM GENE THER, V20, P955, DOI 10.1089/hum.2008.157; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Morel BG, 2009, REGEN MED, V4, P293, DOI 10.2217/17460751.4.2.293; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Stupka N, 2008, AM J PHYSIOL-REG I, V294, pR983, DOI 10.1152/ajpregu.00375.2007; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	60	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54599	10.1371/journal.pone.0054599	http://dx.doi.org/10.1371/journal.pone.0054599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349935	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800065
J	Galea, GL; Meakin, LB; Sugiyama, T; Zebda, N; Sunters, A; Taipaleenmaki, H; Stein, GS; van Wijnen, AJ; Lanyon, LE; Price, JS				Galea, Gabriel L.; Meakin, Lee B.; Sugiyama, Toshihiro; Zebda, Noureddine; Sunters, Andrew; Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.; Lanyon, Lance E.; Price, Joanna S.			Estrogen Receptor alpha Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt Antagonist Sost Is Mediated by Estrogen Receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INHIBITS ADIPOCYTE DIFFERENTIATION; MESENCHYMAL STEM-CELLS; ER-ALPHA; GENE-EXPRESSION; CORTICAL BONE; IN-VIVO; OSTEOGENIC RESPONSE; POSTMENOPAUSAL WOMEN; SIGNALING PATHWAYS	Mechanical strain and estrogens both stimulate osteoblast proliferation through estrogen receptor (ER)-mediated effects, and both down-regulate the Wnt antagonist Sost/sclerostin. Here, we investigate the differential effects of ER alpha and -beta in these processes in mouse long bone-derived osteoblastic cells and human Saos-2 cells. Recruitment to the cell cycle following strain or 17 beta-estradiol occurs within 30 min, as determined by Ki-67 staining, and is prevented by the ER alpha antagonist 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride. ER beta inhibition with 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-beta]pyrimidin-3-yl]phenol (PTHPP) increases basal proliferation similarly to strain or estradiol. Both strain and estradiol down-regulate Sost expression, as does in vitro inhibition or in vivo deletion of ER alpha. The ER beta agonists 2,3-bis(4-hydroxyphenyl)-propionitrile and ERB041 also down-regulated Sost expression in vitro, whereas the ER alpha agonist 4,4',4 ''-[4-propyl-(1H)-pyrazol-1,3,5-triyl]tris-phenol or the ER beta antagonist PTHPP has no effect. Tamoxifen, a nongenomic ER beta agonist, down-regulates Sost expression in vitro and in bones in vivo. Inhibition of both ERs with fulvestrant or selective antagonism of ER beta, but not ER alpha, prevents Sost down-regulation by strain or estradiol. Sost down-regulation by strain or ER beta activation is prevented by MEK/ERK blockade. Exogenous sclerostin has no effect on estradiol-induced proliferation but prevents that following strain. Thus, in osteoblastic cells the acute proliferative effects of both estradiol and strain are ER alpha-mediated. Basal Sost down-regulation follows decreased activity of ER alpha and increased activity of ER beta. Sost down-regulation by strain or increased estrogens is mediated by ER beta, not ER alpha. ER-targeting therapy may facilitate structurally appropriate bone formation by enhancing the distinct ligand-independent, strain-related contributions to proliferation of both ER alpha and ER beta.	[Galea, Gabriel L.; Meakin, Lee B.; Sugiyama, Toshihiro; Zebda, Noureddine; Lanyon, Lance E.; Price, Joanna S.] Univ Bristol, Sch Vet Sci, Bristol BS40 5DU, Avon, England; [Sunters, Andrew] Univ London, Royal Vet Coll, London NW1 0TU, England; [Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Taipaleenmaki, Hanna; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University of Bristol; University of London; University of London Royal Veterinary College; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Galea, GL (corresponding author), Univ Bristol, Sch Vet Sci, Southwell St, Bristol BS2 8EJ, Avon, England.	gabriel.galea@bristol.ac.uk	Meakin, Lee/H-7726-2019; Taipaleennmäki, Hanna/GRX-7143-2022; Galea, Gabriel/I-9374-2019; van Wijnen, Andre J./AAG-3578-2019	Meakin, Lee/0000-0002-2161-9414; Galea, Gabriel/0000-0003-2515-1342; van Wijnen, Andre J./0000-0002-4458-0946; Sugiyama, Toshihiro/0000-0001-5551-1340	Wellcome Trust; National Institutes of Health Grant [R01AR049069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Wellcome Trust. This work was also supported in part by National Institutes of Health Grant R01AR049069 (to A. v. W.).; Recipients of veterinary integrated training fellowships from the Wellcome Trust.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P1789, DOI 10.1007/s00198-011-1806-8; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Barou O, 1998, AM J PHYSIOL-ENDOC M, V274, pE108, DOI 10.1152/ajpendo.1998.274.1.E108; Bartella V, 2012, BREAST CANCER RES TR, V134, P569, DOI 10.1007/s10549-012-2090-9; Becker K. A., 2005, CELL BIOL HDB LAB MA, P103; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bradford PG, 2010, PHYSIOL BEHAV, V99, P181, DOI 10.1016/j.physbeh.2009.04.025; Braidman IP, 2001, J BONE MINER RES, V16, P214, DOI 10.1359/jbmr.2001.16.2.214; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Cao LH, 2003, J CELL BIOCHEM, V89, P152, DOI 10.1002/jcb.10486; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Chung CJ, 2007, AM J ORTHOD DENTOFAC, V132, pU13, DOI 10.1016/j.ajodo.2007.02.049; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Cooke AL, 2008, J CLIN ONCOL, V26, P5227, DOI 10.1200/JCO.2007.15.7123; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Dupont S, 2000, DEVELOPMENT, V127, P4277; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hagino H, 2005, BONE, V36, P444, DOI 10.1016/j.bone.2004.12.013; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Hong L, 2011, STEM CELLS DEV, V20, P925, DOI 10.1089/scd.2010.0125; Hong L, 2009, J STEROID BIOCHEM, V114, P180, DOI 10.1016/j.jsbmb.2009.02.001; Il Modder U, 2011, J BONE MINER RES, V26, P27, DOI 10.1002/jbmr.128; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Jin WJ, 2012, OSTEOPOROSIS INT, V23, P2469, DOI 10.1007/s00198-011-1859-8; Kallio A, 2008, MOL CELL ENDOCRINOL, V289, P38, DOI 10.1016/j.mce.2008.03.005; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Khalid O, 2008, ENDOCRINOLOGY, V149, P5984, DOI 10.1210/en.2008-0680; Kietz S, 2004, BIOCHEM BIOPH RES CO, V320, P76, DOI 10.1016/j.bbrc.2004.05.132; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kudwa AE, 2003, J NEUROENDOCRINOL, V15, P978, DOI 10.1046/j.1365-2826.2003.01089.x; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Lanyon LE, 2007, CLIN REV BONE MINER, V5, P234, DOI 10.1007/s12018-008-9011-9; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Leskela HV, 2006, BONE, V39, P1026, DOI 10.1016/j.bone.2006.05.003; Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574; Lindberg K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2865; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Maran A, 2006, BONE, V39, P523, DOI 10.1016/j.bone.2006.03.006; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; McCarthy TL, 2011, GENE, V479, P16, DOI 10.1016/j.gene.2011.02.002; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Niziolek PJ, 2012, BONE, V51, P459, DOI 10.1016/j.bone.2012.05.023; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Quaedackers ME, 2001, ENDOCRINOLOGY, V142, P1156, DOI 10.1210/en.142.3.1156; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rozen S, 2000, Methods Mol Biol, V132, P365; Saika M, 2001, ENDOCRINOLOGY, V142, P2205, DOI 10.1210/en.142.6.2205; Sakai D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024847; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE484, DOI 10.1152/ajpendo.00189.2007; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Somjen D, 2011, J STEROID BIOCHEM, V125, P226, DOI 10.1016/j.jsbmb.2011.03.006; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Taku K, 2011, MATURITAS, V70, P333, DOI 10.1016/j.maturitas.2011.09.001; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; van der Eerden BCJ, 2004, J ENDOCRINOL, V180, P457, DOI 10.1677/joe.0.1800457; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Windahl SH, 2001, J BONE MINER RES, V16, P1388, DOI 10.1359/jbmr.2001.16.8.1388; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xie H, 2011, J BONE MINER RES, V26, P156, DOI 10.1002/jbmr.169; Yu LC, 2011, BONE, V49, P1131, DOI 10.1016/j.bone.2011.08.016; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035736; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhao YY, 2009, EXP MOL MED, V41, P478, DOI 10.3858/emm.2009.41.7.053	119	79	89	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9035	9048		10.1074/jbc.M112.405456	http://dx.doi.org/10.1074/jbc.M112.405456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23362266	Green Published, hybrid			2022-12-25	WOS:000316862200023
J	Klein, G; Muller-Loennies, S; Lindner, B; Kobylak, N; Brade, H; Raina, S				Klein, Gracjana; Mueller-Loennies, Sven; Lindner, Buko; Kobylak, Natalia; Brade, Helmut; Raina, Satish			Molecular and Structural Basis of Inner Core Lipopolysaccharide Alterations in Escherichia coli INCORPORATION OF GLUCURONIC ACID AND PHOSPHOETHANOLAMINE IN THE HEPTOSE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; GENE; OLIGOSACCHARIDE; TRANSFERASE; O157-H7; TYPHIMURIUM; REGIONS; CLONING; PROTEIN; OPERON	It is well established that lipopolysaccharide (LPS) often carries nonstoichiometric substitutions in lipid A and in the inner core. In this work, the molecular basis of inner core alterations and their physiological significance are addressed. A new inner core modification of LPS is described, which arises due to the addition of glucuronic acid on the third heptose with a concomitant loss of phosphate on the second heptose. This was shown by chemical and structural analyses. Furthermore, the gene whose product is responsible for the addition of this sugar was identified in all Escherichia coli core types and in Salmonella and was designated waaH. Its deduced amino acid sequence exhibits homology to glycosyltransferase family 2. The transcription of the waaH gene is positively regulated by the PhoB/R two-component system in a growth phase-dependent manner, which is coordinated with the transcription of the ugd gene explaining the genetic basis of this modification. Glucuronic acid modification was observed in E. coli B, K12, R2, and R4 core types and in Salmonella. We also show that the phosphoethanolamine (P-EtN) addition on heptose I in E. coli K12 requires the product of the ORF yijP, a new gene designated as eptC. Incorporation of P-EtN is also positively regulated by PhoB/R, although it can occur at a basal level without a requirement for any regulatory inducible systems. This P-EtN modification is essential for resistance to a variety of factors, which destabilize the outer membrane like the addition of SDS or challenge to sublethal concentrations of Zn2+.	[Klein, Gracjana; Mueller-Loennies, Sven; Lindner, Buko; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Klein, Gracjana; Kobylak, Natalia; Raina, Satish] Gdansk Univ Technol, Dept Microbiol, PL-80233 Gdansk, Poland	Forschungszentrum Borstel; Fahrenheit Universities; Gdansk University of Technology	Raina, S (corresponding author), Gdansk Univ Technol, Dept Microbiol, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065; Kobylak, Natalia/0000-0002-7908-2613	National Science Centre [2011/03/B/NZ1/02825]	National Science Centre(National Science Centre, Poland)	This work was supported by National Science Centre Grant 2011/03/B/NZ1/02825 (to S.R.).	Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; ARONSON BD, 1989, J BIOL CHEM, V264, P5226; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; BOCK K, 1992, CARBOHYD RES, V229, P213, DOI 10.1016/S0008-6215(00)90571-8; Currie CG, 1999, FEMS IMMUNOL MED MIC, V24, P57, DOI 10.1016/S0928-8244(99)00007-3; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Fresno S, 2007, J BACTERIOL, V189, P1128, DOI 10.1128/JB.01489-06; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow Sabine, 2009, Innate Immun, V15, P13, DOI 10.1177/1753425908099765; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LUDERITZ O, 1966, ANN NY ACAD SCI, V133, P349, DOI 10.1111/j.1749-6632.1966.tb52376.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Muller-Loennies S, 2002, EUR J BIOCHEM, V269, P5982, DOI 10.1046/j.1432-1033.2002.03322.x; Muller-Loennies S, 1999, EUR J BIOCHEM, V260, P235, DOI 10.1046/j.1432-1327.1999.00134.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1991, J BACTERIOL, V173, P5999, DOI 10.1128/jb.173.19.5999-6008.1991; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMIDT G, 1969, EUR J BIOCHEM, V10, P501, DOI 10.1111/j.1432-1033.1969.tb00717.x; SCHMIDT G, 1974, EUR J BIOCHEM, V42, P303, DOI 10.1111/j.1432-1033.1974.tb03340.x; SCHMIDT G, 1970, EUR J BIOCHEM, V14, P357, DOI 10.1111/j.1432-1033.1970.tb00297.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tamayo R, 2002, INFECT IMMUN, V70, P6770, DOI 10.1128/IAI.70.12.6770-6778.2002; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Vinogradov EV, 1999, EUR J BIOCHEM, V261, P629, DOI 10.1046/j.1432-1327.1999.00280.x; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yoon JW, 2004, MOL MICROBIOL, V51, P419, DOI 10.1046/j.1365-2958.2003.03827.x; Yoshida Y, 2011, J MICROBIOL, V49, P285, DOI 10.1007/s12275-011-0360-6; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	48	36	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8111	8127		10.1074/jbc.M112.445981	http://dx.doi.org/10.1074/jbc.M112.445981			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372159	Green Published, hybrid			2022-12-25	WOS:000316564500012
J	Ain, QU; Seemab, U; Rashid, S; Nawaz, MS; Kamal, MA				Ain, Qurrat U.; Seemab, Umair; Rashid, Sajid; Nawaz, Muhammad Sulaman; Kamal, Mohammad A.			Prediction of Structure of Human WNT-CRD (FZD) Complex for Computational Drug Repurposing	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; CATENIN PATHWAY; DOCKING; RECEPTOR; REFINEMENT; EXPRESSION; MUTATIONS; ACTIVATE; BINDING; DOMAIN	The observed genetic alterations of various extracellular and intracellular WNT (Wingless, Int-1 proto-oncogene) signaling components can result in an increase or decrease in gene expression, and hence can be obstructed proficiently. These genetics target sites may include the prevention of WNT-FZD (Frizzled) binding, destruction of beta-catenin and formation of Axin, APC and GSK-3 beta complex. Hence, the localized targeting of these interacting partners can help in devising novel inhibitors against WNT signaling. Our present study is an extension of our previous work, in which we proposed the coregulated expression pattern of the WNT gene cluster (WNT-1, WNT-6, WNT-10A and WNT-10B) in human breast carcinoma. We present here the computationally modeled three dimensional structure of human WNT-1 in complex with the FZD-1 CRD (Cysteine Rich Domain) receptor. The dimeric cysteine-rich domain was found to fit into the evolutionarily conserved U-shaped groove of WNT protein. The two ends of the U-shaped cleft contain N-terminal and C-terminal hydrophobic residues, thus providing a strong hydrophobic moiety for the frizzled receptor and serving as the largest binding pocket for WNT-FZD interaction. Detailed structural analysis of this cleft revealed a maximum atomic distance of similar to 28 angstrom at the surface, narrowing down to similar to 17 angstrom and again increasing up to similar to 27 angstrom at the bottom. Altogether, structural prediction analysis of WNT proteins was performed to reveal newer details about post-translational modification sites and to map the novel pharmacophore models for potent WNT inhibitors.	[Ain, Qurrat U.; Nawaz, Muhammad Sulaman] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Seemab, Umair] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan; [Kamal, Mohammad A.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Ain, Qurrat U.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Informat, Cambridge CB2 1EW, England	COMSATS University Islamabad (CUI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Quaid I Azam University; King Abdulaziz University; University of Cambridge	Kamal, MA (corresponding author), King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.	meu.fabg@hotmail.com	Kamal, Mohammad Amjad/J-2918-2014; Kamal, Mohammad A/J-4622-2013; Rashid, Sajid/K-8640-2019	Kamal, Mohammad Amjad/0000-0003-0088-0565; 				AIN Q, 2011, BIOINFORMATION, V7, P339; Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; [Anonymous], 2002, CURR PROTOC BIOINFOR; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bienz M, 2012, SCIENCE, V337, P44, DOI 10.1126/science.1224468; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gopalakrishnan K, 2007, PROTEIN PEPTIDE LETT, V14, P669; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IOZZO RV, 1995, CANCER RES, V55, P3495; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036770; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malinauskas T, 2008, LIPIDS, V43, P227, DOI 10.1007/s11745-007-3144-3; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Millar JBA, 2002, GENOME BIOL, V3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Voronkov AE, 2008, DOKL BIOCHEM BIOPHYS, V419, P75, DOI 10.1134/S1607672908020087	35	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54630	10.1371/journal.pone.0054630	http://dx.doi.org/10.1371/journal.pone.0054630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372744	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400019
J	Amar, J; Lange, C; Payros, G; Garret, C; Chabo, C; Lantieri, O; Courtney, M; Marre, M; Charles, MA; Balkau, B; Burcelin, R				Amar, Jacques; Lange, Celine; Payros, Gaelle; Garret, Celine; Chabo, Chantal; Lantieri, Olivier; Courtney, Michael; Marre, Michel; Charles, Marie Aline; Balkau, Beverley; Burcelin, Remy		DESIR Study Grp	Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The DESIR Study	PLOS ONE			English	Article							GUT MICROBIOME; MYOCARDIAL-INFARCTION; DISEASE; RISK; BACTERIA; INFLAMMATION; ENDOTOXEMIA; STIFFNESS; OUTCOMES; ENOLASE	Aim: We recently described a human blood microbiome and a connection between this microbiome and the onset of diabetes. The aim of the current study was to assess the association between blood microbiota and incident cardiovascular disease. Methods and Results: D. E. S. I. R. is a longitudinal study with the primary aim of describing the natural history of the metabolic syndrome and its complications. Participants were evaluated at inclusion and at 3-, 6-, and 9-yearly follow-up visits. The 16S ribosomal DNA bacterial gene sequence, that is common to the vast majority of bacteria (Eubac) and a sequence that mostly represents Proteobacteria (Pbac), were measured in blood collected at baseline from 3936 participants. 73 incident cases of acute cardiovascular events, including 30 myocardial infarctions were recorded. Eubac was positively correlated with Pbac (r = 0.59; P<0.0001). In those destined to have cardiovascular complications, Eubac was lower (0.14 +/- 0.26 vs 0.12 +/- 0.29 ng/mu l; P = 0.02) whereas a non significant increase in Pbac was observed. In multivariate Cox analysis, Eubac was inversely correlated with the onset of cardiovascular complications, (hazards ratio 0.50 95% CI 0.35-0.70) whereas Pbac (1.56, 95% CI 1.12-2.15) was directly correlated. Conclusion: Pbac and Eubac were shown to be independent markers of the risk of cardiovascular disease. This finding is evidence for the new concept of the role played by blood microbiota dysbiosis on atherothrombotic disease. This concept may help to elucidate the relation between bacteria and cardiovascular disease.	[Amar, Jacques; Chabo, Chantal; Burcelin, Remy] CHU Toulouse, Inst Res Metab & Cardiovasc Dis, INSERM U1048, Toulouse, France; [Lange, Celine; Charles, Marie Aline; Balkau, Beverley] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, U1018, Villejuif, France; [Lange, Celine; Charles, Marie Aline; Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Payros, Gaelle; Garret, Celine; Chabo, Chantal; Burcelin, Remy] Biomed Res Federat Inst Toulouse, Toulouse, France; [Lantieri, Olivier; DESIR Study Grp] IRSA, La Riche, France; [Courtney, Michael] VAIOMER SAS, Toulouse, France; [Marre, Michel] Grp Hosp Bichat Claude Bernard, AP HP, Serv Endocrinol Diabet Nutr, Paris, France; [Marre, Michel] Univ Paris 07, INSERM U695, Paris, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Amar, J (corresponding author), CHU Toulouse, Inst Res Metab & Cardiovasc Dis, INSERM U1048, Toulouse, France.	amar.j@chu-toulouse.fr	Fumeron, Frederic/AAC-6882-2019; burcelin, remy/M-6013-2014; Charles, Marie Aline/S-1866-2019; FROGUEL, Philippe/O-6799-2017; Charles, Marie Aline/F-8567-2017; Alhenc-Gelas, Francois/F-9511-2017	Fumeron, Frederic/0000-0002-7916-4619; Charles, Marie Aline/0000-0003-4025-4390; FROGUEL, Philippe/0000-0003-2972-0784; Charles, Marie Aline/0000-0003-4025-4390; Marre, Michel/0000-0002-3071-1837; Chabo, Chantal/0000-0002-5131-0880	INSERM; CNAMTS; Lilly; Novartis; Pharma; Sanofi-Aventis; INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; Novartis Pharma	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis(Novartis); Pharma; Sanofi-Aventis(Sanofi-Aventis); INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; Novartis Pharma	The D.E.S.I.R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis; by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR 2008), the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Societe Francophone du Diabete, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from commercial sources: Lilly, Novartis Pharma and Sanofi-Aventis, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon. The authors also declare that Remy Burcelin, Chantal Chabo, Beverley Balkau and Jacques Amar are listed as coinventors on patents held by the National Institute for Health and Medical Research (INSERM) that relate to the use of bacterial DNA in metabolic diseases. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2003, J HYPERTENS, V21, P1869, DOI 10.1097/00004872-200310000-00014; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Blacher J, 2004, J HYPERTENS, V22, P415, DOI 10.1097/00004872-200402000-00028; Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Espinola-Klein C, 2002, CIRCULATION, V105, P15, DOI 10.1161/hc0102.101362; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gilbert A., 1889, C R HEBD SEANCES SOC, V41, P583; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Katz JT, 2006, CIRCULATION, V113, P920, DOI 10.1161/CIRCULATIONAHA.105.607358; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maass M, 1998, J AM COLL CARDIOL, V31, P827, DOI 10.1016/S0735-1097(98)00016-3; Madjid M, 2003, CIRCULATION, V108, P2730, DOI 10.1161/01.CIR.0000102380.47012.92; Marcadet A, 1987, HISTOCOMPATIBILITY T, V1, P553; Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhu JH, 2001, CIRCULATION, V103, P45	44	123	130	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54461	10.1371/journal.pone.0054461	http://dx.doi.org/10.1371/journal.pone.0054461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372728	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400016
J	Zhang, WZ; Wang, RJ; Yang, FK; Zhang, LX; Cao, JP; Zhang, XL; Ling, H; Liu, AQ; Shen, YJ				Zhang, Weizhe; Wang, Rongjun; Yang, Fengkun; Zhang, Longxian; Cao, Jianping; Zhang, Xiaoli; Ling, Hong; Liu, Aiqin; Shen, Yujuan			Distribution and Genetic Characterizations of Cryptosporidium spp. in Pre-Weaned Dairy Calves in Northeastern China's Heilongjiang Province	PLOS ONE			English	Article							DEER-LIKE GENOTYPE; MOLECULAR CHARACTERIZATION; SUBTYPE ANALYSIS; BOVINE CRYPTOSPORIDIUM; PARVUM SUBTYPES; CATTLE; PREVALENCE; HUMANS; GIARDIA; WATER	Background: Cryptosporidium spp. are common parasites of humans and animals. Farm animals, especially pre-weaned calves, are considered to be one of main animal reservoir hosts of Cryptosporidium in the transmission of human cryptosporidiosis. The aim of this study was to determine the distribution and genotypes of Cryptosporidium spp. in pre-weaned calves using molecular tools and to assess zoonotic transmission and elucidate the public health significance in northeastern China. Methodology/Principal Findings: A total of 151 fecal specimens from pre-weaned calves were collected in Heilongjiang Province and were screened for Cryptosporidium by PCR. The average prevalence of Cryptosporidium was 47.68% (72/151). Cryptosporidium spp. were characterized by DNA sequencing of the small subunit (SSU) rRNA gene and the 60-kDa glycoprotein (gp60) gene. Based on the SSU rRNA gene, five Cryptosporidium spp. were identified, including C. bovis (n=34), C. andersoni (n=26), C. ryanae (n=5), C. meleagridis (n=5) and C. parvum (n=2). The SSU rRNA nucleotide sequences were identical to each other, respectively, within C. ryanae, C. parvum, C. meleagridis and C. andersoni. Four types of C. bovis were found in the SSU rRNA gene, with two novel types. The gp60 gene was successfully sequenced in one C. parvum isolate and three C. meleagridis isolates, with IIdA19G1 for C. parvum and IIIeA22G2R1 for C. meleagridis. Conclusion/Significance: Molecular analysis indicates that Cryptosporidium spp. are endemic in pre-weaned calves in Heilongjiang Province. The findings of C. parvum and C. meleagridis suggested the possibility of zoonotic transmission and public health significance. The transmission dynamics of C. parvum and C. meleagridis needed to be clarified by further molecular epidemiologic studies from humans and animals. Whether calves could act as the natural reservoirs of C. meleagridis needed to be confirmed by more systematic experimental infection studies.	[Zhang, Weizhe; Yang, Fengkun; Zhang, Xiaoli; Ling, Hong; Liu, Aiqin] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Cao, Jianping; Shen, Yujuan] WHO Collaborating Ctr Malaria Schistosomiasis & F, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China	Harbin Medical University; Henan Agricultural University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Liu, AQ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; shyj12@yahoo.com.cn	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242	Natural Science Foundation of Heilongjiang Province, China [D200628]; Chinese Special Program for Scientific Research of Public Health [200802012]	Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Chinese Special Program for Scientific Research of Public Health	AL was supported by the Natural Science Foundation of Heilongjiang Province, China (No. D200628) and YS was supported by the Chinese Special Program for Scientific Research of Public Health (No. 200802012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2007, ANN TROP MED PARASIT, V101, P539, DOI 10.1179/136485907X193798; Akiyoshi DE, 2003, INFECT IMMUN, V71, P1828, DOI 10.1128/IAI.71.4.1828-1832.2003; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Amer Said, 2010, Journal of the Egyptian Society of Parasitology, V40, P349; Blackburn BG, 2006, EMERG INFECT DIS, V12, P684, DOI 10.3201/eid1204.050796; Broglia A, 2008, VET PARASITOL, V154, P8, DOI 10.1016/j.vetpar.2008.02.029; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Darabus Gh., 2003, Polish Journal of Veterinary Sciences, V6, P225; Diaz P, 2010, PARASITOLOGY, V137, P1187, DOI 10.1017/S0031182010000181; Elwin K, 2012, EPIDEMIOL INFECT, V140, P673, DOI 10.1017/S0950268811000860; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2010, VET PARASITOL, V170, P187, DOI 10.1016/j.vetpar.2010.02.040; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2012, VET PARASITOL, V185, P309, DOI 10.1016/j.vetpar.2011.09.025; Feng YY, 2012, EMERG INFECT DIS, V18, P312, DOI 10.3201/eid1802.110666; Feng YY, 2011, APPL ENVIRON MICROB, V77, P3609, DOI 10.1128/AEM.00146-11; Feng YY, 2009, J CLIN MICROBIOL, V47, P153, DOI 10.1128/JCM.01777-08; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2006, VET PARASITOL, V138, P217, DOI 10.1016/j.vetpar.2006.02.009; Glaberman S, 2001, J EUKARYOT MICROBIOL, p19S; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Halim NA, 2008, VET PARASITOL, V152, P325, DOI 10.1016/j.vetpar.2007.12.035; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Jex AR, 2007, ELECTROPHORESIS, V28, P2818, DOI 10.1002/elps.200600772; Karanis P, 2010, VET PARASITOL, V169, P387, DOI 10.1016/j.vetpar.2010.01.014; Keshavarz A, 2009, VET PARASITOL, V160, P316, DOI 10.1016/j.vetpar.2008.11.008; Kvac M, 2006, VET PARASITOL, V137, P202, DOI 10.1016/j.vetpar.2006.01.027; Kvac M, 2011, VET PARASITOL, V177, P378, DOI 10.1016/j.vetpar.2010.11.048; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Meamar AR, 2007, APPL ENVIRON MICROB, V73, P1033, DOI 10.1128/AEM.00964-06; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Muhid A, 2011, EXP PARASITOL, V127, P534, DOI 10.1016/j.exppara.2010.10.015; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Ng J, 2011, VET PARASITOL, V176, P145, DOI 10.1016/j.vetpar.2010.10.056; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Paul S, 2008, VET PARASITOL, V153, P143, DOI 10.1016/j.vetpar.2008.01.044; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Qi M, 2011, EXP PARASITOL, V128, P336, DOI 10.1016/j.exppara.2011.04.003; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Reed C, 2002, APPL ENVIRON MICROB, V68, P427, DOI 10.1128/AEM.68.1.427-429.2002; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Wang RJ, 2012, VET PARASITOL, V187, P534, DOI 10.1016/j.vetpar.2012.02.002; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang RJ, 2010, AVIAN PATHOL, V39, P447, DOI 10.1080/03079457.2010.518314; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2009, VET PARASITOL, V161, P19, DOI 10.1016/j.vetpar.2008.12.021; Zhou RQ, 2007, PARASITOL RES, V100, P1135, DOI 10.1007/s00436-006-0358-x; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	67	64	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54857	10.1371/journal.pone.0054857	http://dx.doi.org/10.1371/journal.pone.0054857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372782	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400035
J	Currao, M; Balduini, CL; Balduini, A				Currao, Manuela; Balduini, Carlo L.; Balduini, Alessandra			High Doses of Romiplostim Induce Proliferation and Reduce Proplatelet Formation by Human Megakaryocytes	PLOS ONE			English	Article							CHRONIC ITP; IN-VITRO; THROMBOPOIETIN; PLATELETS; EFFICACY; PROTEINS; THROMBOCYTOPENIA; DIFFERENTIATION; RECEPTORS; BIOLOGY	Background: Romiplostim (AMG531) is a Thrombopoietin (TPO) receptor agonist with no homology with the endogenous TPO that has been used to treat patients affected by immune thrombocytopenia (ITP). Despite the use of TPO mimetics in the clinical practice, the mechanisms underlying their impact on megakaryocyte function is still unknown. Methodology/Principal Findings: In this project we took advantage of an in vitro human model, that we have established in our laboratory for long time to study megakaryocyte development from human cord blood-derived progenitor cells, and we demonstrated that increasing doses of AMG531 (100 to 2000 ng/mL) determine a progressive increase of megakaryocyte proliferation with a parallel decrease in megakaryocyte ploidy and capacity of extending proplatelets. Most importantly, these differences in megakaryocyte function seemed to be correlated to modulation of AKT phosphorylation. Conclusions/Significance: Overall our results shed new light on the mechanisms and on the relevance of dosage related to AMG531 impact on megakaryocyte function.	[Currao, Manuela; Balduini, Alessandra] IRCCS Policlin San Matteo Fdn, Dept Mol Med, Biotechnol Labs, Pavia, Italy; [Currao, Manuela; Balduini, Carlo L.; Balduini, Alessandra] Univ Pavia, I-27100 Pavia, Italy; [Balduini, Carlo L.] IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA USA	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Tufts University	Balduini, A (corresponding author), IRCCS Policlin San Matteo Fdn, Dept Mol Med, Biotechnol Labs, Pavia, Italy.	alessandra.balduini@unipv.it	Balduini, Carlo L/D-9299-2015; Balduini, Alessandra/K-6802-2016; BALDUINI, ALESSANDRA/AAC-3363-2022	Balduini, Carlo L/0000-0001-6121-9311; Balduini, Alessandra/0000-0003-3145-1245; BALDUINI, ALESSANDRA/0000-0003-3145-1245	PRIN [A.0MC62.PRIN110]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by PRIN 2008 (A.0MC62.PRIN110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2012, HAEMATOLOGI IN PRESS; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Broudy VC, 2004, CYTOKINE, V25, P52, DOI 10.1016/j.cyto.2003.05.001; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Bussel JB, 2009, BLOOD, V113, P2161, DOI 10.1182/blood-2008-04-150078; Dusheiko G, 2009, CLIN LIVER DIS, V13, P487, DOI 10.1016/j.cld.2009.05.012; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2010, SEMIN HEMATOL, V47, P243, DOI 10.1053/j.seminhematol.2010.02.005; Majka M, 2002, EXP HEMATOL, V30, P751, DOI 10.1016/S0301-472X(02)00810-X; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x	21	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54723	10.1371/journal.pone.0054723	http://dx.doi.org/10.1371/journal.pone.0054723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359807	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600097
J	Glas, J; Seiderer, J; Bues, S; Stallhofer, J; Fries, C; Olszak, T; Tsekeri, E; Wetzke, M; Beigel, F; Steib, C; Friedrich, M; Goke, B; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Bues, Stephanie; Stallhofer, Johannes; Fries, Christoph; Olszak, Torsten; Tsekeri, Eleni; Wetzke, Martin; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Goeke, Burkhard; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTOPHAGY GENE ATG16L1; CROHNS-DISEASE; ULCERATIVE-COLITIS; LOCI; RISK; IL23R; CARD15; PATHOGENESIS; EXPRESSION	Background & Aims: Genome-wide association studies identified the autophagy gene IRGM to be strongly associated with Crohn's disease (CD) but its impact in ulcerative colitis (UC), its phenotypic effects and potential epistatic interactions with other IBD susceptibility genes are less clear which we therefore analyzed in this study. Methodology/Principal Findings: Genomic DNA from 2060 individuals including 817 CD patients, 283 UC patients, and 961 healthy, unrelated controls (all of Caucasian origin) was analyzed for six IRGM single nucleotide polymorphisms (SNPs) (rs13371189, rs10065172 = p.Leu105Leu, rs4958847, rs1000113, rs11747270, rs931058). In all patients, a detailed genotype-phenotype analysis and testing for epistasis with the three major CD susceptibility genes NOD2, IL23R and ATG16L1 were performed. Our analysis revealed an association of the IRGM SNPs rs13371189 (p = 0.02, OR 1.31 [95% CI 1.05-1.65]), rs10065172 = p.Leu105Leu (p = 0.016, OR 1.33 [95% CI 1.06-1.66]) and rs1000113 (p = 0.047, OR 1.27 [95% CI 1.01-1.61]) with CD susceptibility. There was linkage disequilibrium between these three IRGM SNPs. In UC, several IRGM haplotypes were weakly associated with UC susceptibility (p<0.05). Genotype-phenotype analysis revealed no significant associations with a specific IBD phenotype or ileal CD involvement. There was evidence for weak gene-gene-interaction between several SNPs of the autophagy genes IRGM and ATG16L1 (p<0.05), which, however, did not remain significant after Bonferroni correction. Conclusions/Significance: Our results confirm IRGM as susceptibility gene for CD in the German population, supporting a role for the autophagy genes IRGM and ATG16L1 in the pathogenesis of CD.	[Glas, Juergen; Seiderer, Julia; Bues, Stephanie; Stallhofer, Johannes; Fries, Christoph; Olszak, Torsten; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Fries, Christoph; Tsekeri, Eleni; Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, Hannover, Germany; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Hannover Medical School; Max Planck Society	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Wetzke, Martin/HDM-2614-2022	Stallhofer, Johannes/0000-0001-8698-6103	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich (FoFoLe) [422]; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01]; German Research Foundation [BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds)	Broad Medical Foundation; Ludwig-Maximilians-University Munich (FoFoLe); Else Kroner-Fresenius-Stiftung; German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds)	JG was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and JD were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J. Seiderer and Promotionsstipendium to JD); J. Seiderer was also supported by the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the German Research Foundation (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, INFLAMM BOWEL DIS, V17, P1917, DOI 10.1002/ibd.21562; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Huett A, 2009, AUTOPHAGY, V5, P96, DOI 10.4161/auto.5.1.7263; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roberts RL, 2008, GENES IMMUN, V9, P561, DOI 10.1038/gene.2008.49; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Van Limbergen J, 2009, GUT, V58, P610, DOI 10.1136/gut.2008.160721; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	47	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54338	10.1371/journal.pone.0054338	http://dx.doi.org/10.1371/journal.pone.0054338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365659	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600047
J	Kanan, C				Kanan, Christopher			Recognizing Sights, Smells, and Sounds with Gnostic Fields	PLOS ONE			English	Article							TEMPORAL CORTEX; SINGLE NEURONS; SPARSE; REPRESENTATION; RESPONSES; CELLS	Mammals rely on vision, audition, and olfaction to remotely sense stimuli in their environment. Determining how the mammalian brain uses this sensory information to recognize objects has been one of the major goals of psychology and neuroscience. Likewise, researchers in computer vision, machine audition, and machine olfaction have endeavored to discover good algorithms for stimulus classification. Almost 50 years ago, the neuroscientist Jerzy Konorski proposed a theoretical model in his final monograph in which competing sets of "gnostic'' neurons sitting atop sensory processing hierarchies enabled stimuli to be robustly categorized, despite variations in their presentation. Much of what Konorski hypothesized has been remarkably accurate, and neurons with gnostic-like properties have been discovered in visual, aural, and olfactory brain regions. Surprisingly, there have not been any attempts to directly transform his theoretical model into a computational one. Here, I describe the first computational implementation of Konorski's theory. The model is not domain specific, and it surpasses the best machine learning algorithms on challenging image, music, and olfactory classification tasks, while also being simpler. My results suggest that criticisms of exemplar-based models of object recognition as being computationally intractable due to limited neural resources are unfounded.	Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kanan, C (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	ckanan@ucsd.edu			National Science Foundation (NSF) [SBE 0542013, SMA 1041755]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported in part by National Science Foundation (NSF) grant SBE 0542013 and SMA 1041755 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Averbeck BB, 2006, J NEUROSCI, V26, P11023, DOI 10.1523/JNEUROSCI.3466-06.2006; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bowers JS, 2009, PSYCHOL REV, V116, P220, DOI 10.1037/a0014462; Bowman NE, 2012, NEURON, V75, P916, DOI 10.1016/j.neuron.2012.06.035; BROWN GJ, 1994, COMPUT SPEECH LANG, V8, P297, DOI 10.1006/csla.1994.1016; Chai YN, 2011, IEEE I CONF COMP VIS, P2579, DOI 10.1109/ICCV.2011.6126546; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Dhillon IS, 2001, MACH LEARN, V42, P143, DOI 10.1023/A:1007612920971; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Ellis DPW., 2007, ISMIR, V7, P339; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Frisby JP, 2010, SEEING COMPUTATIONAL; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Griffin G., 2007, CNSTR2007001 CALT; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; Grove AJ, 2001, MACH LEARN, V43, P173, DOI 10.1023/A:1010844028087; Haddad R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000740; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Kanan C, 2012, PLOS ONE, V7, P133, DOI 10.1371/journal.pone.0029740; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; Khan F.S., 2011, ADV NEURAL INFORM PR, P1323; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; Ma N., 2008, COCHLEAGRAM REPRESEN; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; MUSAVI MT, 1992, NEURAL NETWORKS, V5, P595, DOI 10.1016/S0893-6080(05)80038-3; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; O'Connor KN, 2005, J NEUROPHYSIOL, V94, P4051, DOI 10.1152/jn.00046.2005; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Raina R, 2007, 24 ANN INT C MACH LE, V227, P759, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rolls ET, 2003, J NEUROSCI, V23, P339; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Shirali-Shahreza S, 2009, IEEE T CONSUM ELECTR, V55, P1731, DOI 10.1109/TCE.2009.5278049; Trincavelli M, 2010, IEEE T BIO-MED ENG, V57, P2884, DOI 10.1109/TBME.2010.2049492; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493	52	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54088	10.1371/journal.pone.0054088	http://dx.doi.org/10.1371/journal.pone.0054088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365648	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600030
J	Roy, S; Bonfield, T; Tartakoff, AM				Roy, Sanhita; Bonfield, Tracey; Tartakoff, Alan M.			Non-Apoptotic Toxicity of Pseudomonas aeruginosa toward Murine Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RESPIRATORY EPITHELIAL-CELLS; PROTEIN SECRETION SYSTEMS; TOLL-LIKE RECEPTORS; CYSTIC-FIBROSIS; LIPOPOLYSACCHARIDE LPS; GAMMA-INTERFERON; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; INNATE IMMUNITY	Although P. aeruginosa is especially dangerous in cystic fibrosis (CF), there is no consensus as to how it kills representative cell types that are of key importance in the lung. This study concerns the acute toxicity of the sequenced strain, PAO1, toward a murine macrophage cell line (RAW 264.7). Toxicity requires brief contact with the target cell, but is then delayed for more than 12 h. None of the classical toxic effectors of this organism is required and cell death occurs without phagocytosis or acute perturbation of the actin cytoskeleton. Apoptosis is not required for toxicity toward either RAW 264.7 cells or for alveolar macrophages. Transcriptional profiling shows that encounter between PAO1 and RAW 264.7 cells elicits an early inflammatory response, followed by growth arrest. As an independent strategy to understand the mechanism of toxicity, we selected variant RAW 264.7 cells that resist PAO1. Upon exposure to P. aeruginosa, they are hyper-responsive with regard to classical inflammatory cytokine production and show transient downregulation of transcripts that are required for cell growth. They do not show obvious morphologic changes. Although they do not increase interferon transcripts, when exposed to PAO1 they dramatically upregulate a subset of the responses that are characteristic of exposure to g-interferon, including several guanylate-binding proteins. The present observations provide a novel foundation for learning how to equip cells with resistance to a complex challenge.	[Roy, Sanhita] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Bonfield, Tracey] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Cell Biol Program, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Tartakoff, AM (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	amt10@case.edu		ROY, SANHITA/0000-0002-0407-8177	Cystic Fibrosis Foundation [R447-CR07]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), National Institutes of Health (NIH) [UL1 RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported through a grant from the Cystic Fibrosis Foundation (www.cff.org/mobile/index.cfm?menu = 1&)(R447-CR07) and from the Case Western Reserve University/Cleveland Clinic CTSA Grant (no. UL1 RR024989) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; APODACA G, 1995, INFECT IMMUN, V63, P1541, DOI 10.1128/IAI.63.4.1541-1551.1995; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baldwin MR, 2005, CURR TOP MICROBIOL, V291, P147; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Beutler B, 2007, WE SENSE MICROBES; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Delude RL, 1998, J IMMUNOL, V161, P3001; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Hasko G, 2002, J PHARMACOL EXP THER, V301, P103, DOI 10.1124/jpet.301.1.103; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; HORVAT RT, 1988, INFECT IMMUN, V56, P2925, DOI 10.1128/IAI.56.11.2925-2932.1988; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; JACOBS DM, 1977, J IMMUNOL, V118, P21; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Johansen HK, 1996, CLIN EXP IMMUNOL, V103, P212, DOI 10.1046/j.1365-2249.1996.d01-618.x; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Kostyk AG, 2006, AM J PATHOL, V169, P12, DOI 10.2353/ajpath.2006.051042; Koulenti D, 2006, CURR OPIN PULM MED, V12, P198; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Li Y, 2003, AM J RESP CELL MOL, V29, P779, DOI 10.1165/rcmb.2003-0087RC; LONG JS, 2012, ONCOGENE; Ma QH, 2003, BBA-BIOMEMBRANES, V1611, P223, DOI 10.1016/S0005-2736(03)00059-2; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Murphey ED, 2004, INFECT IMMUN, V72, P6892, DOI 10.1128/IAI.72.12.6892-6901.2004; Nguyen TT, 2002, J INTERF CYTOK RES, V22, P899, DOI 10.1089/107999002760274926; NISHIJIMA M, 1994, J BIOCHEM-TOKYO, V116, P1082, DOI 10.1093/oxfordjournals.jbchem.a124631; Ohki K, 2001, IMMUNOL CELL BIOL, V79, P462, DOI 10.1046/j.1440-1711.2001.01037.x; Perez Aura, 2004, Journal of Structural and Functional Genomics, V5, P179, DOI 10.1023/B:JSFG.0000028982.59273.bd; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schroder K, 2012, P NATL ACAD SCI US; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stotland PK, 2000, PEDIATR PULM, V30, P413, DOI 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Tart AH, 2008, CURR TOP MICROBIOL, V322, P193; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wu W, 2011, CRIT REV ONCOL HEMAT; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	76	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54245	10.1371/journal.pone.0054245	http://dx.doi.org/10.1371/journal.pone.0054245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358229	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600041
J	Stockman, LJ; Brooks, WA; Streatfield, PK; Rahman, M; Goswami, D; Nahar, K; Rahman, MZ; Luby, SP; Anderson, LJ				Stockman, Lauren J.; Brooks, W. Abdullah; Streatfield, Peter K.; Rahman, Mustafizur; Goswami, Doli; Nahar, Kamrun; Rahman, Mohammed Z.; Luby, Stephen P.; Anderson, Larry J.			Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004-2008	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; YOUNG-CHILDREN; ETIOLOGY; INFECTIONS; INFLUENZA; BURDEN; INFANTS; SEASON; URBAN	Background: Acute lower respiratory illness is the most common cause of death among children, globally. Data are not available to make accurate estimates on the global mortality from respiratory syncytial virus (RSV), specifically. Methods: Respiratory samples collected from children under 5 years of age during 2004 to 2008 as part of population-based respiratory disease surveillance in an urban community in Dhaka, Bangladesh were tested for RSV, human metapneumovirus (HMPV), human parainfluenza virus (PIV) types 1, 2, and 3, influenza and adenovirus by RT-PCR. Verbal autopsy data were used to identify children who died from respiratory illness in a nearby rural community. Significance of the correlation between detections and community respiratory deaths was determined using Spearman's coefficient. Results: RSV activity occurred during defined periods lasting approximately three months but with no clear seasonal pattern. There was no significant correlation between respiratory deaths and detection of any of the respiratory viruses studied. Conclusion: Outbreaks of respiratory viruses may not be associated with deaths in children in the study site; however, the few respiratory deaths observed and community-to-community variation in the timing of outbreaks may have obscured an association. An accurate assessment of respiratory virus-associated deaths will require detections and death data to come from the same location and a larger study population.	[Stockman, Lauren J.; Anderson, Larry J.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Brooks, W. Abdullah; Streatfield, Peter K.; Rahman, Mustafizur; Goswami, Doli; Nahar, Kamrun; Rahman, Mohammed Z.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Centers for Disease Control & Prevention - USA; International Centre for Diarrhoeal Disease Research (ICDDR)	Stockman, LJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	lstockman@cdc.gov	rahman, mustafizur/E-6918-2010; Brooks, W. Abdullah/AAD-3876-2021	Brooks, W. Abdullah/0000-0001-9871-5546; Nahar, Dr.Kamrun/0000-0003-3867-9920	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a grant from the Bill & Melinda Gates Foundation to the International Center for Diarrheal Diseases Research, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Anker M, 2012, STANDARD VERBAL AUTO; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; HUQ F, 1990, REV INFECT DIS, V12, pS982; International Center for Diarrheal Diseases Research Bangladesh, 2009, 114 INT CTR DIARR DI, V43; Kabir A Luthful, 2009, Mymensingh Med J, V18, pS50; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Reina J, 1997, J CLIN MICROBIOL, V35, P1900, DOI 10.1128/JCM.35.7.1900-1901.1997; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Zachariah P, 2009, PEDIATR INFECT DIS J, V28, P772, DOI 10.1097/INF.0b013e3181a3e5b6	26	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53857	10.1371/journal.pone.0053857	http://dx.doi.org/10.1371/journal.pone.0053857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365643	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600023
J	Zhang, JF; Wang, Y; Zhen, PP; Luo, X; Zhang, C; Zhou, L; Lu, YX; Yang, Y; Zhang, W; Wan, J				Zhang, Jufeng; Wang, Ying; Zhen, Pingping; Luo, Xia; Zhang, Chao; Zhou, Lin; Lu, Yanxin; Yang, Yang; Zhang, Wei; Wan, Jun			Genome-Wide Analysis of miRNA Signature Differentially Expressed in Doxorubicin-Resistant and Parental Human Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							MICRORNA EXPRESSION; MALIGNANT-TRANSFORMATION; SIGNALING PATHWAY; DRUG-RESISTANCE; MESSENGER-RNA; CANCER-CELLS; MECHANISMS; ACTIVATION; IDENTIFICATION; SENSITIVITY	Chemotherapy regiments have been widely used in the treatment of a variety of human malignancies including hepatocellular carcinoma (HCC). A major cause of failure in chemotherapy is drug resistance of cancer cells. Resistance to doxorubicin (DOX) is a common and representative obstacle to treat cancer effectively. Individual microRNA (miRNA) has been introduced in the evolution of DOX resistance in HCC in recent studies. However, a global and systematic assessment of the miRNA expression profiles contributing to DOX resistance is still lacking. In the present study, we applied high-throughput Illumina sequencing to comprehensively characterize miRNA expression profiles in both human HCC cell line (HepG2) and its DOX-resistant counterpart (HepG2/DOX). A total of 269 known miRNAs were significantly differentially expressed, of which 23 were up-regulated and 246 were down-regulated in HepG2/DOX cells, indicating that part of them might be involved in the development of DOX resistance. In addition, we have identified 9 and 13 novel miRNAs up- and down-expressed significantly in HepG2/DOX cells, respectively. miRNA profiling was then validated by quantitative real-time PCR for selected miRNAs, including 22 known miRNAs and 6 novel miRNAs. Furthermore, we predicted the putative target genes for the deregulated miRNAs in the samples. Function annotation implied that these selected miRNAs affected many target genes mainly involved in MAPK signaling pathway. This study provides us a general description of miRNA expression profiling, which is helpful to find potential miRNAs for adjunct treatment to overcome DOX resistance in future HCC chemotherapy.	[Zhang, Jufeng; Wang, Ying; Zhang, Chao; Lu, Yanxin; Yang, Yang; Zhang, Wei; Wan, Jun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China; [Zhang, Jufeng; Zhou, Lin] Guangdong Pharmaceut Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhen, Pingping] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Luo, Xia] S China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Guangdong Pharmaceutical University; Chinese Academy of Sciences; Institute of Zoology, CAS; South China Agricultural University; Hong Kong University of Science & Technology	Zhang, JF (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China.	jfzhang111@163.com; zhangweispace@gmail.com; wanj@ust.hk	Zhou, Lin/G-6524-2016	Zhou, Lin/0000-0003-4318-5132; Zheng, Pingping/0000-0002-6059-8919; Wan, Jun/0000-0001-7308-0150	National Natural Scientific Foundation of China [81171447]; Natural Science Foundation of Guangdong Province, China [104518036002006310]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81171447), and the Natural Science Foundation of Guangdong Province, China (Grant No. 104518036002006310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bonnas C, 2012, INT J CANCER, V131, P1621, DOI 10.1002/ijc.27422; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; HARRISON DJ, 1995, J PATHOL, V175, P7, DOI 10.1002/path.1711750103; Ho R, 2002, CANCER RES, V62, P6462; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Negrini M, 2008, ANTI-CANCER AGENT ME, V11, P500; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Sterpetti P, 2006, AM J PHYSIOL-GASTR L, V290, pG624, DOI 10.1152/ajpgi.00128.2005; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Tomokuni A, 2011, BIOCHEM BIOPH RES CO, V414, P675, DOI 10.1016/j.bbrc.2011.09.124; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027; Yang XY, 2012, ONCOL REP, V27, P250, DOI 10.3892/or.2011.1472; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	63	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54111	10.1371/journal.pone.0054111	http://dx.doi.org/10.1371/journal.pone.0054111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359607	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600032
J	Fukuda, T; Kino, Y; Abe, Y; Yamashiro, H; Kuwahara, Y; Nihei, H; Sano, Y; Irisawa, A; Shimura, T; Fukumoto, M; Shinoda, H; Obata, Y; Saigusa, S; Sekine, T; Isogai, E; Fukumoto, M				Fukuda, Tomokazu; Kino, Yasushi; Abe, Yasuyuki; Yamashiro, Hideaki; Kuwahara, Yoshikazu; Nihei, Hidekazu; Sano, Yosuke; Irisawa, Ayumi; Shimura, Tsutomu; Fukumoto, Motoi; Shinoda, Hisashi; Obata, Yuichi; Saigusa, Shin; Sekine, Tsutomu; Isogai, Emiko; Fukumoto, Manabu			Distribution of Artificial Radionuclides in Abandoned Cattle in the Evacuation Zone of the Fukushima Daiichi Nuclear Power Plant	PLOS ONE			English	Article							SILVER; CS-137	The Fukushima Daiichi Nuclear Power Plant (FNPP) accident released large amounts of radioactive substances into the environment. In order to provide basic information for biokinetics of radionuclides and for dose assessment of internal exposure brought by the FNPP accident, we determined the activity concentration of radionuclides in the organs of 79 cattle within a 20-km radius around the FNPP. In all the specimens examined, deposition of Cesium-134 (Cs-134, half-life: 2.065 y) and Cs-137 (30.07 y) was observed. Furthermore, organ-specific deposition of radionuclides with relatively short half-lives was detected, such as silver-110m (Ag-110m, 249.8 d) in the liver and tellurium-129m ((129)mTe, 33.6 d) in the kidney. Regression analysis showed a linear correlation between the radiocesium activity concentration in whole peripheral blood (PB) and that in each organ. The resulting slopes were organ dependent with the maximum value of 21.3 being obtained for skeletal muscles (R-2 = 0.83, standard error (SE) = 0.76). Thus, the activity concentration of Cs-134 and Cs-137 in an organ can be estimated from that in PB. The level of radioactive cesium in the organs of fetus and infants were 1.19-fold (R-2 = 0.62, SE = 0.12), and 1.51-fold (R-2 = 0.70, SE = 0.09) higher than that of the corresponding maternal organ, respectively. Furthermore, radiocesium activity concentration in organs was found to be dependent on the feeding conditions and the geographic location of the cattle. This study is the first to reveal the detailed systemic distribution of radionuclides in cattle attributed to the FNPP accident.	[Fukuda, Tomokazu; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Kino, Yasushi; Nihei, Hidekazu; Sano, Yosuke; Irisawa, Ayumi] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 980, Japan; [Abe, Yasuyuki] Yamagata Univ, Grad Sch Sci & Engn, Tsuruoka, Yamagata, Japan; [Yamashiro, Hideaki] Niigata Univ, Fac Agr, Niigata 95021, Japan; [Kuwahara, Yoshikazu; Shimura, Tsutomu; Fukumoto, Motoi; Fukumoto, Manabu] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Shinoda, Hisashi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Obata, Yuichi] RIKEN BioResource Ctr BRC, Tsukuba, Ibaraki, Japan; [Saigusa, Shin] Natl Inst Radiol Sci, Chiba 260, Japan; [Sekine, Tsutomu] Tohoku Univ, Ctr Adv Higher Educ, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Yamagata University; Niigata University; Tohoku University; Tohoku University; RIKEN; National Institutes for Quantum Science & Technology; Tohoku University	Fukumoto, M (corresponding author), Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	fukumoto@idac.tohoku.ac.jp	Kino, Yasushi/U-3909-2017; Fukumoto, Manabu/L-1444-2019; Obata, Yuichi/A-5300-2016; Kino, Yasushi/ABB-8627-2021; Fukuda, Tomokazu/O-1257-2018	Kino, Yasushi/0000-0002-8359-9383; Obata, Yuichi/0000-0003-1839-4709; Fukuda, Tomokazu/0000-0001-8456-0483	Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Tohoku University; National Cancer Center Research and Development Fund, Japan; Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan	Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Tohoku University; National Cancer Center Research and Development Fund, Japan; Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan	This study was supported by an Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Discretionary Expense of the President of Tohoku University; National Cancer Center Research and Development Fund, Japan; The Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW W F, 1972, Experientia (Basel), V28, P1444, DOI 10.1007/BF01957840; AGNEW WF, 1972, TERATOLOGY, V6, P331, DOI 10.1002/tera.1420060311; Bandazhevsky YI, 2003, SWISS MED WKLY, V133, P488; BERESFORD NA, 1989, SCI TOTAL ENVIRON, V85, P81, DOI 10.1016/0048-9697(89)90307-0; Bowyer TW, 2011, J ENVIRON RADIOACTIV, V102, P681, DOI 10.1016/j.jenvrad.2011.04.009; Calabrese E, 2011, P NATL ACAD SCI USA, V108, P19447, DOI 10.1073/pnas.1117296108; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P177, DOI 10.1007/BF00507822; Danscher G, 2010, HISTOCHEM CELL BIOL, V133, P359, DOI 10.1007/s00418-009-0670-5; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; *ICRP, 1994, ANN ICRP, V23; ICRP, 2002, ICRP PUBL, V88; Inaba J, 1967, J Radiat Res, V8, P132, DOI 10.1269/jrr.8.132; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; MULLEN AA, 1974, HEALTH PHYS, V27, P279, DOI 10.1097/00004032-197409000-00006; POLACHEK AA, 1960, J LAB CLIN MED, V56, P499; Romanenko A, 2009, CARCINOGENESIS, V30, P1821, DOI 10.1093/carcin/bgp193; Sinclair LE, 2011, J ENVIRON RADIOACTIV, V102, P1018, DOI 10.1016/j.jenvrad.2011.06.008; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	19	63	64	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54312	10.1371/journal.pone.0054312	http://dx.doi.org/10.1371/journal.pone.0054312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372703	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500055
J	Guess, AJ; Ayoob, R; Chanley, M; Manley, J; Cajaiba, MM; Agrawal, S; Pengal, R; Pyle, AL; Becknell, B; Kopp, JB; Ronkina, N; Gaestel, M; Benndorf, R; Smoyer, WE				Guess, Adam J.; Ayoob, Rose; Chanley, Melinda; Manley, Joshua; Cajaiba, Mariana M.; Agrawal, Shipra; Pengal, Ruma; Pyle, Amy L.; Becknell, Brian; Kopp, Jeffrey B.; Ronkina, Natalia; Gaestel, Matthias; Benndorf, Rainer; Smoyer, William E.			Crucial Roles of the Protein Kinases MK2 and MK3 in a Mouse Model of Glomerulonephritis	PLOS ONE			English	Article							SMALL HSP PHOSPHORYLATION; CRESCENTIC GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PODOCYTE INJURY; MAPKAP KINASES; CELLULAR STRESS; RENAL INJURY; P38 MAPK; IN-VITRO; ACTIVATION	Elevated mitogen-activated protein kinase p38 (p38 MAPK) signaling has been implicated in various experimental and human glomerulopathies, and its inhibition has proven beneficial in animal models of these diseases. p38 MAPK signaling is partially mediated through MK2 and MK3, two phylogenetically related protein kinases that are its direct substrates. The current study was designed to determine the specific roles of MK2 and MK3 in a mouse model of acute proliferative glomerulonephritis, using mice with disrupted MK2 and/or MK3 genes. We found that the absence of MK3 alone worsened the disease course and increased mortality slightly compared to wild-type mice, whereas the absence of MK2 alone exhibited no significant effect. However, in an MK3-free background, the disease course depended on the presence of MK2 in a gene dosage-dependent manner, with double knock-out mice being most susceptible to disease induction. Histological and renal functional analyses confirmed kidney damage following disease induction. Because the renal stress response plays a crucial role in kidney physiology and disease, we analyzed the stress response pattern in this disease model. We found that renal cortices of diseased mice exhibited a pronounced and specific pattern of expression and/or phosphorylation of stress proteins and other indicators of the stress response (HSPB1, HSPB6, HSPB8, CHOP, eIF2 alpha), partially in a MK2/MK3 genotype-specific manner, and without induction of a general stress response. Similarly, the expression and activation patterns of other protein kinases downstream of p38 MAPK (MNK1, MSK1) depended partially on the MK2/MK3 genotype in this disease model. In conclusion, MK2 and MK3 together play crucial roles in the regulation of the renal stress response and in the development of glomerulonephritis, which can potentially be exploited to develop novel therapeutic approaches to treat glomerular disease.	[Guess, Adam J.; Ayoob, Rose; Chanley, Melinda; Manley, Joshua; Agrawal, Shipra; Pengal, Ruma; Becknell, Brian; Benndorf, Rainer; Smoyer, William E.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Cajaiba, Mariana M.; Pyle, Amy L.] Nationwide Childrens Hosp, Dept Pathol, Columbus, OH USA; [Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Ronkina, Natalia; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany; [Benndorf, Rainer; Smoyer, William E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Hannover Medical School; University System of Ohio; Ohio State University	Benndorf, R (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA.	rainer.benndorf@nationwidechildrens.org	Kopp, Jeffrey B/O-2681-2015; Ayoob, Rose/D-2123-2013; Gaestel, Matthias/A-6560-2013; Becknell, Michael/E-6995-2014	Kopp, Jeffrey B/0000-0001-9052-186X; Ayoob, Rose/0000-0003-1890-4094; Gaestel, Matthias/0000-0002-4944-4652; 	NIH/NIDDK [RO1 DK077283]; NIDDK Intramural Research Program; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077283] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK grant RO1 DK077283 to WES, by the NIDDK Intramural Research Program to JBK, and by the Deutsche Forschungsgemeinschaft to MG and NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. web sites: http://www2.niddk.nih.gov http://www.dfg.de/index.jsp	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Benndorf R, 2000, METH MOL B, V99, P431; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cybulsky AV, 2011, J SIGNAL TRANSDUCT, V2011; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Gaestel M, 2008, FRONT BIOSCI, V13, P6050, DOI 10.2741/3136; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hirano S, 2005, AM J PHYSIOL-RENAL, V288, pF1133, DOI 10.1152/ajprenal.00210.2004; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; IWATA J, 1979, CLIN CHEM, V25, P1317; Kampinga HH, 2006, HANDB EXP PHARM, V172, P1; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Milovanceva-Popovska M, 2005, KIDNEY INT, V67, P1362, DOI 10.1111/j.1523-1755.2005.00213.x; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Musial K, 2011, PEDIATR NEPHROL, V26, P1031, DOI 10.1007/s00467-010-1709-5; Park JK, 2008, NEPHROL DIAL TRANSPL, V23, P1844, DOI 10.1093/ndt/gfm917; Pengal R, 2011, AM J PHYSIOL-RENAL, V301, pF509, DOI 10.1152/ajprenal.00661.2010; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Polzer K, 2008, ANN RHEUM DIS, V67, P602, DOI 10.1136/ard.2007.077263; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Shiryaev Alexey, 2011, J Mol Signal, V6, P4, DOI 10.1186/1750-2187-6-4; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Smoyer WE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0681com; Smoyer WE, 2000, J AM SOC NEPHROL, V11, P211, DOI 10.1681/ASN.V112211; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Stambe C, 2003, KIDNEY INT, V64, P2121, DOI 10.1046/j.1523-1755.2003.00324.x; Stambe C, 2003, J AM SOC NEPHROL, V14, P338, DOI 10.1097/01.ASN.0000048715.12315.FD; Yo Y, 2003, NEPHRON EXP NEPHROL, V93, P92, DOI 10.1159/000069551; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54239	10.1371/journal.pone.0054239	http://dx.doi.org/10.1371/journal.pone.0054239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372691	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500044
J	Suzuki, S; Shishido, T; Funayama, A; Netsu, S; Ishino, M; Kitahara, T; Sasaki, T; Katoh, S; Otaki, Y; Watanabe, T; Shibata, Y; Mantovani, A; Takeishi, Y; Kubota, I				Suzuki, Satoshi; Shishido, Tetsuro; Funayama, Akira; Netsu, Shunsuke; Ishino, Mitsunori; Kitahara, Tatsuro; Sasaki, Toshiki; Katoh, Shigehiko; Otaki, Yoichiro; Watanabe, Tetsu; Shibata, Yoko; Mantovani, Alberto; Takeishi, Yasuchika; Kubota, Isao			Long Pentraxin PTX3 Exacerbates Pressure Overload-Induced Left Ventricular Dysfunction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDUCED CARDIAC-HYPERTROPHY; CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; ACUTE MYOCARDIAL-INFARCTION; ADVERSE CLINICAL-OUTCOMES; CAMP EARLY REPRESSOR; NF-KAPPA B; INNATE IMMUNITY; ANGIOTENSIN-II	Background: Left ventricular hypertrophy is enhanced by an inflammatory state and stimulation of various cytokines. Pentraxin 3 (PTX3) is rapidly produced in response to inflammatory signals, and high plasma PTX3 levels are seen in patients with heart failure. This study aimed to examine the influence of PTX3 on cardiac hypertrophy and left ventricular dysfunction with respect to pressure overload. Methods and Results: PTX3 systemic knockout (PTX3-KO) mice, transgenic mice with cardiac-specific overexpression of PTX3 (PTX3-TG), and the respective wild-type (WT) littermate mice were subjected to transverse aortic constriction (TAC) or a sham operation. Cardiac PTX3 expression increased after TAC in WT mice. In vitro, hydrogen peroxide induced the expression of PTX3 in both cardiac myocytes and cardiac fibroblasts. Recombinant PTX3 phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) in cardiac fibroblasts. Phosphorylation of cardiac ERK1/2 and nuclear factor kappa-B after TAC was attenuated in the PTX3-KO mice but was enhanced in the PTX3-TG mice compared with WT mice. Interleukin-6 and connective tissue growth factor production was lower in the PTX3-KO mice than in the WT mice, but this was augmented in the PTX3-TG mice than in the WT mice. Echocardiography revealed that adverse remodeling with left ventricular dysfunction, as well as with increased interstitial fibrosis, was enhanced in PTX3-TG mice, while these responses were suppressed in PTX3-KO mice. Conclusion: The local inflammatory mediator PTX3 directly modulates the hypertrophic response and ventricular dysfunction following an increased afterload.	[Suzuki, Satoshi; Shishido, Tetsuro; Funayama, Akira; Netsu, Shunsuke; Ishino, Mitsunori; Kitahara, Tatsuro; Sasaki, Toshiki; Katoh, Shigehiko; Otaki, Yoichiro; Watanabe, Tetsu; Shibata, Yoko; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy	Yamagata University; Fukushima Medical University; University of Milan	Shishido, T (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	tshishid@med.id.yamagata-u.ac.jp	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X	Ministry of Education, Science, Sports, and Culture, Japan [19590804, 21590935, 21590923, 21790701, 23790830]; 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science; Italian Ministry of Health; European Commission; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Fukuda Foundation for Medical Technology; Japan Heart Foundation Research Grant	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science; Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Japan Heart Foundation Research Grant	This study was supported in part by a grant-in-aid for Scientific Research (Nos. 19590804 and 21590935 to Y.T., 21590923 to I.K., and 21790701 and 23790830 to T.S.) from the Ministry of Education, Science, Sports, and Culture, Japan, and a grant-in-aid from the 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science. A.M. was supported by the Italian Ministry of Health and by the European Commission, Project Tolerage. Y.T. was supported by the Mitsubishi Pharma Research Foundation, Takeda Science Foundation, the Uehara Memorial Foundation, and Fukuda Foundation for Medical Technology. T.S. was supported by the Japan Heart Foundation Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; Bilim O, 2010, J CARD FAIL, V16, P873, DOI 10.1016/j.cardfail.2010.05.029; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Cirillo P, 2005, CARDIOVASC RES, V68, P47, DOI 10.1016/j.cardiores.2005.05.010; Devaraj S, 2005, ARTERIOSCL THROM VAS, V25, P1359, DOI 10.1161/01.ATV.0000168573.10844.ae; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Harada M, 2007, CIRC J, V71, P276, DOI 10.1253/circj.71.276; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Introna M, 1996, BLOOD, V87, P1862; Katoh S, 2010, ANN NUCL MED, V24, P679, DOI 10.1007/s12149-010-0409-3; Kitahara T, 2010, J CARD FAIL, V16, P308, DOI 10.1016/j.cardfail.2009.12.014; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sasaki T, 2010, INT J CARDIOL; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Shishido T, 2008, CIRC RES, V102, P1416, DOI 10.1161/CIRCRESAHA.107.168138; Shishido T, 2011, CLIN EXP HYPERTENS, V33, P117, DOI 10.3109/10641963.2010.531837; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Wenzel S, 2010, BASIC RES CARDIOL, V105, P621, DOI 10.1007/s00395-010-0108-1; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Yan C, 2007, CIRC RES, V100, P510, DOI 10.1161/01.RES.0000259045.49371.9c; Yin WH, 2004, AM HEART J, V147, P931, DOI 10.1016/j.ahj.2003.11.021; Yokoyama T, 1999, AM J PHYSIOL-HEART C, V276, pH1968, DOI 10.1152/ajpheart.1999.276.6.H1968	40	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53133	10.1371/journal.pone.0053133	http://dx.doi.org/10.1371/journal.pone.0053133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372656	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500012
J	Henriques, MX; Catalao, MJ; Figueiredo, J; Gomes, JP; Filipe, SR				Henriques, Mafalda X.; Catalao, Maria Joao; Figueiredo, Joana; Gomes, Joao Paulo; Filipe, Sergio R.			Construction of Improved Tools for Protein Localization Studies in Streptococcus pneumoniae	PLOS ONE			English	Article							FLUORESCENT PROTEIN; CAPSULAR POLYSACCHARIDE; DIVISION; GENE; COMPETENCE; EXPRESSION; PLASMID	We have constructed a set of plasmids that allow efficient expression of both N- and C-terminal fusions of proteins of interest to fluorescent proteins mCherry, Citrine, CFP and GFP in the Gram-positive pathogen Streptococcus pneumoniae. In order to improve expression of the fluorescent fusions to levels that allow their detection by fluorescence microscopy, we have introduced a 10 amino acid tag, named i-tag, at the N-terminal end of the fluorescent proteins. This caused increased expression due to improved translation efficiency and did not interfere with the protein localization in pneumococcal bacteria. Localizing fluorescent derivatives of FtsZ, Wzd and Wze in dividing bacteria validated the developed tools. The availability of the new plasmids described in this work should greatly facilitate studies of protein localization in an important clinical pathogen.	[Henriques, Mafalda X.; Catalao, Maria Joao; Figueiredo, Joana; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal; [Gomes, Joao Paulo] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal	Universidade Nova de Lisboa	Filipe, SR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal.	sfilipe@itqb.unl.pt	Filipe, Sergio Raposo/B-9167-2008; Catalao, Maria Joao/P-3248-2019; Catalão, Maria João/B-6731-2017; iMed.ULisboa, HPI/B-4239-2014; Figueiredo, Joana/T-9046-2017	Filipe, Sergio Raposo/0000-0002-4485-832X; Catalao, Maria Joao/0000-0002-3794-457X; Catalão, Maria João/0000-0002-3794-457X; iMed.ULisboa, HPI/0000-0001-5934-0198; Gomes, Joao Paulo/0000-0002-2697-2399; Henriques, Mafalda X./0000-0002-5665-2142; Figueiredo, Joana/0000-0002-6804-0522	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [PTDC/SAU-MII/75696/2006, PTDC/BIA-MIC/100747/2008]; FCT [PEst-OE/EQB/LA0004/2011, SFRH/BD/43797/2008, SFRH/BPD/77758/2011]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grants PTDC/SAU-MII/75696/2006 and PTDC/BIA-MIC/100747/2008 awarded to SRF. The work performed at Instituto de Tecnologia Quimica e Biologica was supported additionally by FCT through grant PEst-OE/EQB/LA0004/2011. MXH and MJC were supported by FCT fellowships SFRH/BD/43797/2008 and SFRH/BPD/77758/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509	27	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e55049	10.1371/journal.pone.0055049	http://dx.doi.org/10.1371/journal.pone.0055049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349996	Green Published, gold			2022-12-25	WOS:000314019100117
J	Callis, M; Serrano, S; Benito, A; Laurents, DV; Vilanova, M; Bruix, M; Ribo, M				Callis, Mariona; Serrano, Soraya; Benito, Antoni; Laurents, Douglas V.; Vilanova, Maria; Bruix, Marta; Ribo, Marc			Towards Tricking a Pathogen's Protease into Fighting Infection: The 3D Structure of a Stable Circularly Permuted Onconase Variant Cleavedby HIV-1 Protease	PLOS ONE			English	Article							AMPHIBIAN RIBONUCLEASE; CONFORMATIONAL STABILITY; CYTOTOXIC RIBONUCLEASE; MOLECULAR-DYNAMICS; RANA-CATESBEIANA; DISULFIDE BOND; P-30 PROTEIN; INHIBITOR; OOCYTES; ZYMOGEN	Onconase((R)) is a highly cytotoxic amphibian homolog of Ribonuclease A. Here, we describe the construction of circularly permuted Onconase((R)) variants by connecting the N- and C-termini of this enzyme with amino acid residues that are recognized and cleaved by the human immunodeficiency virus protease. Uncleaved circularly permuted Onconase((R)) variants are unusually stable, non-cytotoxic and can internalize in human T-lymphocyte Jurkat cells. The structure, stability and dynamics of an intact and a cleaved circularly permuted Onconase((R)) variant were determined by Nuclear Magnetic Resonance spectroscopy and provide valuable insight into the changes in catalytic efficiency caused by the cleavage. The understanding of the structural environment and the dynamics of the activation process represents a first step toward the development of more effective drugs for the treatment of diseases related to pathogens expressing a specific protease. By taking advantage of the protease's activity to initiate a cytotoxic cascade, this approach is thought to be less susceptible to known resistance mechanisms.	[Callis, Mariona; Benito, Antoni; Vilanova, Maria; Ribo, Marc] Univ Girona, Dept Biol, Lab Engn Prot, Girona, Spain; [Callis, Mariona; Benito, Antoni; Vilanova, Maria; Ribo, Marc] Inst Invest Biomed Girona Dr Josep Trueta, Girona, Spain; [Serrano, Soraya; Laurents, Douglas V.; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Ribo, M (corresponding author), Univ Girona, Dept Biol, Lab Engn Prot, Girona, Spain.	marc.ribo@udg.edu	Bruix, Marta/H-4161-2011; Ribó, Marc/R-5704-2019; Ribó, Marc/M-4514-2013; Vilanova, Maria/ABG-5767-2020; Benito, Antoni/D-8537-2011; Ribo, Marc/ABG-3202-2021; Laurents, Douglas V/E-7527-2015; Vilanova, Maria/D-9525-2011	Bruix, Marta/0000-0002-0096-3558; Ribó, Marc/0000-0001-6944-6383; Ribó, Marc/0000-0001-6944-6383; Vilanova, Maria/0000-0003-0523-815X; Benito, Antoni/0000-0002-9776-1003; Ribo, Marc/0000-0001-9242-043X; Laurents, Douglas V/0000-0002-4187-165X; Vilanova, Maria/0000-0003-0523-815X	MICINN (Spain) [CTQ2008-0080, CTQ2010-21567-C02-02, BFU2009-06935/BMC]; Universitat de Girona [PUG2008A]; Ministerio de Educacion y Ciencia; Ministerio de Ciencia e Innovacion	MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universitat de Girona; Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Work was supported by grants [CTQ2008-0080, CTQ2010-21567-C02-02 and BFU2009-06935/BMC] from MICINN (Spain) and PUG2008A from the Universitat de Girona. MC and SS acknowledge their fellowships from the Ministerio de Educacion y Ciencia and Ministerio de Ciencia e Innovacion, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDELT W, 1991, J BIOL CHEM, V266, P245; Arnold U, 2006, BIOTECHNOL LETT, V28, P1615, DOI 10.1007/s10529-006-9145-0; Beck ZQ, 2000, VIROLOGY, V274, P391, DOI 10.1006/viro.2000.0420; Boix E, 1996, J MOL BIOL, V257, P992, DOI 10.1006/jmbi.1996.0218; Bosch M, 2004, BIOCHEMISTRY-US, V43, P2167, DOI 10.1021/bi035729+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang CF, 1998, J MOL BIOL, V283, P231, DOI 10.1006/jmbi.1998.2082; Costanzi J, 2005, CANCER INVEST, V23, P643, DOI 10.1080/07357900500283143; DARZYNKIEWICZ Z, 1988, CELL TISSUE KINET, V21, P169, DOI 10.1111/j.1365-2184.1988.tb00855.x; Dauer Brenda, 2005, J HIV Ther, V10, P72; DEBOUCK C, 1992, AIDS RES HUM RETROV, V8, P153, DOI 10.1089/aid.1992.8.153; Gorbatyuk VY, 2004, J BIOL CHEM, V279, P5772, DOI 10.1074/jbc.M311233200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holloway DE, 2011, FEBS J, V278, P4136, DOI 10.1111/j.1742-4658.2011.08320.x; Hsu CH, 2003, J MOL BIOL, V326, P1189, DOI 10.1016/S0022-2836(02)01472-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Kelemen BR, 1999, BIOCHEMISTRY-US, V38, P5302, DOI 10.1021/bi990325w; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laurents DV, 2009, BIOPOLYMERS, V91, P1018, DOI 10.1002/bip.21152; Lee JE, 2008, J MOL BIOL, V375, P165, DOI 10.1016/j.jmb.2007.09.089; Lee JE, 2003, BIOCHEMISTRY-US, V42, P11443, DOI 10.1021/bi035147s; Leland PA, 2000, FEBS LETT, V477, P203, DOI 10.1016/S0014-5793(00)01804-4; Liao YD, 2003, NUCLEIC ACIDS RES, V31, P5247, DOI 10.1093/nar/gkg746; Merlino A, 2005, J BIOL CHEM, V280, P17953, DOI 10.1074/jbc.M501339200; Mikulski SM, 2002, J CLIN ONCOL, V20, P274, DOI 10.1200/JCO.20.1.274; MOSIMANN SC, 1994, J MOL BIOL, V236, P1141, DOI 10.1016/0022-2836(94)90017-5; Neira JL, 1999, J MOL BIOL, V285, P627, DOI 10.1006/jmbi.1998.2365; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Notomista E, 2000, BIOCHEMISTRY-US, V39, P8711, DOI 10.1021/bi000415x; Park C, 2001, METHOD ENZYMOL, V341, P81, DOI 10.1016/S0076-6879(01)41146-3; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Ribo M, 2004, EUR J BIOCHEM, V271, P1163, DOI 10.1111/j.1432-1033.2004.04020.x; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Rutkoski TJ, 2008, CURR PHARM BIOTECHNO, V9, P185, DOI 10.2174/138920108784567344; Saxena SK, 1996, J BIOL CHEM, V271, P20783, DOI 10.1074/jbc.271.34.20783; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Serrano S, 2012, BIOMOL NMR ASSIGN IN; Tomasselli AG, 2000, BBA-PROTEIN STRUCT M, V1477, P189, DOI 10.1016/S0167-4838(99)00273-3; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turcotte RF, 2008, AIDS RES HUM RETROV, V24, P1357, DOI 10.1089/aid.2008.0146; Von Der Helm K, 2000, PROTEASES AS TARGETS; WU YN, 1993, J BIOL CHEM, V268, P10686	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54568	10.1371/journal.pone.0054568	http://dx.doi.org/10.1371/journal.pone.0054568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349931	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800063
J	Yandek, LE; Lin, HC; Harris, ME				Yandek, Lindsay E.; Lin, Hsuan-Chun; Harris, Michael E.			Alternative Substrate Kinetics of Escherichia coli Ribonuclease P DETERMINATION OF RELATIVE RATE CONSTANTS BY INTERNAL COMPETITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; RNASE-P; C5 PROTEIN; ENZYME SPECIFICITY; MESSENGER-RNA; ACTIVE-SITE; RECOGNITION; BINDING; CLEAVAGE; HOLOENZYME	A single enzyme, ribonuclease P (RNase P), processes the 5' ends of tRNA precursors (ptRNA) in cells and organelles that carry out tRNA biosynthesis. This substrate population includes over 80 different competing ptRNAs in Escherichia coli. Although the reaction kinetics and molecular recognition of a few individual model substrates of bacterial RNase P have been well described, the competitive substrate kinetics of the enzyme are comparatively unexplored. To understand the factors that determine how different ptRNA substrates compete for processing by E. coli RNase P, we compared the steady state reaction kinetics of two ptRNAs that differ at sequences that are contacted by the enzyme. For both ptRNAs, substrate cleavage is fast relative to dissociation. As a consequence, V/K, the rate constant for the reaction at limiting substrate concentrations, reflects the substrate association step for both ptRNAs. Reactions containing two or more ptRNAs follow simple competitive alternative substrate kinetics in which the relative rates of processing are determined by ptRNA concentration and their V/K. The relative V/K values for eight different ptRNAs, which were selected to represent the range of structure variation at sites contacted by RNase P, were determined by internal competition in reactions in which all eight substrates were present simultaneously. The results reveal a relatively narrow range of V/K values, suggesting that rates of ptRNA processing by RNase P are tuned for uniform specificity and consequently optimal coupling to precursor biosynthesis.	[Yandek, Lindsay E.; Lin, Hsuan-Chun; Harris, Michael E.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Harris, ME (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	meh2@case.edu			National Institutes of Health [GM056740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM056740 (to M. E. H.).	Altman S, 2005, P NATL ACAD SCI USA, V102, P11284, DOI 10.1073/pnas.0505271102; Ando T, 2002, BIOSCI BIOTECH BIOCH, V66, P1967, DOI 10.1271/bbb.66.1967; BEEBE JA, 1994, BIOCHEMISTRY-US, V33, P10294, DOI 10.1021/bi00200a009; Bremer H, 2008, BIOCHIMIE, V90, P493, DOI 10.1016/j.biochi.2007.10.008; Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004; Buck AH, 2005, EMBO J, V24, P3360, DOI 10.1038/sj.emboj.7600805; CHA S, 1968, MOL PHARMACOL, V4, P621; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cleland W. W., 2007, ENZYME KINETICS MECH, P253; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; Cook P. F., 2007, ENZYME KINETICS MECH, P253; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dale T, 2005, TRENDS BIOCHEM SCI, V30, P659, DOI 10.1016/j.tibs.2005.10.006; Dale T, 2005, RNA, V11, P1610, DOI 10.1261/rna.2130505; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Ellis JC, 2009, RNA BIOL, V6, P362, DOI 10.4161/rna.6.4.9241; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Fersht A., 1998, STRUCTURE MECH PROTE, P121; GARDINER KJ, 1985, J BIOL CHEM, V260, P5415; GAUR RK, 1993, NUCLEIC ACIDS RES, V21, P21, DOI 10.1093/nar/21.1.21; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo X, 2006, J MOL BIOL, V360, P190, DOI 10.1016/j.jmb.2006.05.001; Hansen A, 2001, MOL MICROBIOL, V41, P131, DOI 10.1046/j.1365-2958.2001.02467.x; Harris M, 2010, PROTEIN REV, V10, P135, DOI 10.1007/978-1-4419-1142-1_8; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Hiller DA, 2011, PHILOS T R SOC B, V366, P2929, DOI 10.1098/rstb.2011.0143; Hori Y, 2000, EUR J BIOCHEM, V267, P4781, DOI 10.1046/j.1432-1327.2000.01534.x; Hougland JL, 2006, COLD SPRING HARB MON, V43, P133; Hsieh J, 2010, J MOL BIOL, V400, P38, DOI 10.1016/j.jmb.2010.04.050; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Karbstein K, 2004, RNA, V10, P1730, DOI 10.1261/rna.7118104; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Kirsebom LA, 2009, IUBMB LIFE, V61, P189, DOI 10.1002/iub.160; Ko JH, 2007, P NATL ACAD SCI USA, V104, P7815, DOI 10.1073/pnas.0701715104; Koutmou KS, 2010, J MOL BIOL, V396, P195, DOI 10.1016/j.jmb.2009.11.039; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leung EKY, 2011, ANNU REV BIOCHEM, V80, P527, DOI 10.1146/annurev-biochem-082108-165150; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Liu JCH, 1998, RNA, V4, P639, DOI 10.1017/S1355838298980013; Loria A, 2000, RNA, V6, P1413, DOI 10.1017/S1355838200000959; Loria A, 1998, BIOCHEMISTRY-US, V37, P15466, DOI 10.1021/bi9816507; Marvin MC, 2011, RNA, V17, P1429, DOI 10.1261/rna.2633611; Marvin MC, 2011, RNA, V17, P1441, DOI 10.1261/rna.2737511; Mohanty BK, 2007, NUCLEIC ACIDS RES, V35, P7614, DOI 10.1093/nar/gkm917; Mohanty BK, 2008, NUCLEIC ACIDS RES, V36, P364, DOI 10.1093/nar/gkm991; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Moor N, 2003, BIOCHEMISTRY-US, V42, P10697, DOI 10.1021/bi034732q; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; Northrop DB, 1999, ADV ENZYMOL RAMB, V73, P25, DOI 10.1002/9780470123195.ch2; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Okamura K, 2012, WIRES RNA, V3, P351, DOI 10.1002/wrna.113; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; Pettersson BMF, 2005, J MOL BIOL, V351, P9, DOI 10.1016/j.jmb.2005.05.022; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Reiter NJ, 2012, NUCLEIC ACIDS RES, V40, P10384, DOI 10.1093/nar/gks744; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; ROSE IA, 1974, J BIOL CHEM, V249, P5163; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Seif E, 2008, RNA, V14, P1237, DOI 10.1261/rna.833408; Siew D, 1999, BIOCHEMISTRY-US, V38, P1873, DOI 10.1021/bi982329r; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Smith JK, 2007, BIOPOLYMERS, V87, P329, DOI 10.1002/bip.20846; Steimer L, 2012, RNA BIOL, V9, P751, DOI 10.4161/rna.20090; Sun L, 2007, RNA, V13, P1505, DOI 10.1261/rna.571007; Sun L, 2006, EMBO J, V25, P3998, DOI 10.1038/sj.emboj.7601290; Sun L, 2010, J MOL BIOL, V395, P1019, DOI 10.1016/j.jmb.2009.11.027; Suwa S, 2009, J BIOCHEM, V145, P151, DOI 10.1093/jb/mvn150; Tamura K, 1997, Nucleic Acids Symp Ser, P133; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Van Slyke DD, 1914, J BIOL CHEM, V19, P141; Wu SY, 2011, J MOL BIOL, V411, P384, DOI 10.1016/j.jmb.2011.05.049; Zahler NH, 2005, J MOL BIOL, V345, P969, DOI 10.1016/j.jmb.2004.10.080; Zahler NH, 2003, RNA, V9, P734, DOI 10.1261/rna.5220703	88	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8342	8354		10.1074/jbc.M112.435420	http://dx.doi.org/10.1074/jbc.M112.435420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362254	Green Published, hybrid			2022-12-25	WOS:000316564500034
J	Sebag, SC; Bastarache, JA; Ware, LB				Sebag, Sara C.; Bastarache, Julie A.; Ware, Lorraine B.			Mechanical Stretch Inhibits Lipopolysaccharide-induced Keratinocyte-derived Chemokine and Tissue Factor Expression While Increasing Procoagulant Activity in Murine Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; LIPID RAFTS; IN-VITRO; INJURY; VENTILATION; ENDOTOXIN; ETHANOL	Previous studies have shown that the innate immune stimulant LPS augments mechanical ventilation-induced pulmonary coagulation and inflammation. Whether these effects are mediated by alveolar epithelial cells is unclear. The alveolar epithelium is a key regulator of the innate immune reaction to pathogens and can modulate both intra-alveolar inflammation and coagulation through up-regulation of pro-inflammatory cytokines and tissue factor (TF), the principal initiator of the extrinsic coagulation pathway. We hypothesized that cyclic mechanical stretch (MS) potentiates LPS-mediated alveolar epithelial cell (MLE-12) expression of the chemokine keratinocyte-derived cytokine (KC) and TF. Contrary to our hypothesis, MS significantly decreased LPS-induced KC and TF mRNA and protein expression. Investigation into potential mechanisms showed that stretch significantly reduced LPS-induced surface expression of TLR4 that was not a result of increased degradation. Decreased cell surface TLR4 expression was concomitant with reduced LPS-mediated NF-kappa B activation. Immunofluorescence staining showed that cyclic MS markedly altered LPS-induced organization of actin filaments. In contrast to expression, MS significantly increased LPS-induced cell surface TF activity independent of calcium signaling. These findings suggest that cyclic MS of lung epithelial cells down-regulates LPS-mediated inflammatory and procoagulant expression by modulating actin organization and reducing cell surface TLR4 expression and signaling. However, because LPS-induced surface TF activity was enhanced by stretch, these data demonstrate differential pathways regulating TF expression and activity. Ultimately, loss of LPS responsiveness in the epithelium induced by MS could result in increased susceptibility of the lung to bacterial infections in the setting of mechanical ventilation.	[Sebag, Sara C.; Bastarache, Julie A.; Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Ware, LB (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, T1218 Med Ctr North, Nashville, TN 37232 USA.	lorraine.ware@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702	National Institutes of Health from NHLBI [HL103836, T32HL087738]; National Institutes of Health [HL090785]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL090785, K24HL103836, T32HL087738] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL103836 (to L. B. W.), T32HL087738 from NHLBI (to S. C. S.), and HL090785 (to J. A. B.). This work was also supported by an American Heart Association established investigator award (to L. B. W.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 1998, BLOOD COAGUL FIBRIN, V9, pS37; Banan A, 2000, J SURG RES, V88, P104, DOI 10.1006/jsre.1999.5786; Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305; Beutler B, 2004, NAT REV IMMUNOL, V4, P498, DOI 10.1038/nri1401; Bhadade RR, 2011, J POSTGRAD MED, V57, P286, DOI 10.4103/0022-3859.90077; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; CARSON SD, 1994, BLOOD, V84, P526; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chiang CH, 2011, INTENS CARE MED, V37, P1360, DOI 10.1007/s00134-011-2251-z; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chu EK, 2006, AM J RESP CELL MOL, V35, P628, DOI 10.1165/rcmb.2006-0040OC; Cohen TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038748; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Girard TD, 2007, CHEST, V131, P921, DOI 10.1378/chest.06-1515; GROSS TJ, 1992, AM J RESP CELL MOL, V6, P397, DOI 10.1165/ajrcmb/6.4.397; Henriksson CE, 2005, THROMB HAEMOSTASIS, V94, P1236, DOI 10.1160/TH05-07-0463; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Kato T, 1998, BIOCHEM BIOPH RES CO, V244, P615, DOI 10.1006/bbrc.1998.8335; Loureiro SO, 2011, TOXICOL IN VITRO, V25, P28, DOI 10.1016/j.tiv.2010.09.003; Mourgeon E, 2000, AM J PHYSIOL-LUNG C, V279, pL699, DOI 10.1152/ajplung.2000.279.4.L699; Muller M, 1999, EXP CELL RES, V248, P136, DOI 10.1006/excr.1999.4395; Parker JC, 2000, J APPL PHYSIOL, V89, P2241, DOI 10.1152/jappl.2000.89.6.2241; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Schultz MJ, 2004, THORAX, V59, P130, DOI 10.1136/thorax.2003.013888; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Silverman MD, 1996, BLOOD COAGUL FIBRIN, V7, P281, DOI 10.1097/00001721-199604000-00001; Siore AM, 2005, AM J PHYSIOL-LUNG C, V289, pL769, DOI 10.1152/ajplung.00137.2005; SITRIN RG, 1983, AM REV RESPIR DIS, V128, P282; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; SUMPIO BE, 1991, J VASC SURG, V13, P744, DOI 10.1016/0741-5214(91)90372-2; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; Ware Lorraine B., 2005, Keio Journal of Medicine, V54, P142, DOI 10.2302/kjm.54.142; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Zhu Shengsi, 2005, BMC Cardiovasc Disord, V5, P22, DOI 10.1186/1471-2261-5-22	48	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7875	7884		10.1074/jbc.M112.403220	http://dx.doi.org/10.1074/jbc.M112.403220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362270	hybrid, Green Published			2022-12-25	WOS:000316455300041
J	Lim, JY; Choi, BH; Lee, S; Jang, YH; Choi, JS; Kim, YM				Lim, Jae-Yol; Choi, Byung Hyune; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo			Regulation of Wound Healing by Granulocyte-Macrophage Colony-Stimulating Factor after Vocal Fold Injury	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EXTRACELLULAR-MATRIX PRODUCTION; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAR FORMATION; RABBIT MODEL; FIBROBLASTS; INJECTION; RAT; CULTURE; REPAIR	Objectives: Vocal fold (VF) scarring remains a therapeutic challenge. Granulocyte-macrophage colony-stimulating factor (GM-CSF) facilitates epithelial wound healing, and recently, growth factor therapy has been applied to promote tissue repair. This study was undertaken to investigate the effect of GM-CSF on VF wound healing in vivo and in vitro. Methods: VF scarring was induced in New Zealand white rabbits by direct injury. Immediately thereafter, either GM-CSF or PBS was injected into the VFs of rabbits. Endoscopic, histopathological, immunohistochemical, and biomechanical evaluations of VFs were performed at 3 months post-injury. Human vocal fold fibroblasts (hVFFs) were cultured with GMCSF. Production of type I and III collagen was examined immunocytochemically, and the synthesis of elastin and hyaluronic acids was evaluated by ELISA. The mRNA levels of genes related to ECM components and ECM production-related growth factors, such as HGF and TGF-beta 1, were examined by real time RT-PCR. Results: The GM-CSF-treated VFs showed reduced collagen deposition in comparison to the PBS-injected controls (P<0.05). Immunohistochemical staining revealed lower amounts of type I collagen and fibronectin in the GM-CSF-treated VFs (P<0.05 and P<0.01, respectively). Viscous and elastic shear moduli of VF samples were significantly lower in the GM-CSF group than in the PBS-injected group (P<0.001 and P<0.01, respectively). Mucosal waves in the GM-CSF group showed significant improvement when compared to the PBS group (P = 0.0446). GM-CSF inhibited TGF-beta 1-induced collagen synthesis by hVFFs (P<0.05) and the production of hyaluronic acids increased at 72 hours post-treatment (P<0.05). The expressions of HAS-2, tropoelastin, MMP-1, HGF, and c-Met mRNA were significantly increased by GM-CSF, although at different time points (P<0.05). Conclusion: The present study shows that GM-CSF offers therapeutic potential for the remodeling of VF wounds and the promotion of VF regeneration.	[Lim, Jae-Yol; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo] Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [Lim, Jae-Yol; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo] Inha Univ, Sch Med, Translat Res Ctr, Inchon, South Korea; [Choi, Byung Hyune] Inha Univ, Sch Med, Div Biomed & Bioengn Sci, Inchon, South Korea	Inha University; Inha University; Inha University	Lim, JY (corresponding author), Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea.	jylim@inha.ac.kr		im, jaeyeol/0000-0002-9757-6414	National Research Foundation (NRF); Korean Ministry of Education, Science and Technology [2011-0005812, 2009-0079196]; Inha University Research Grant, Republic of Korea	National Research Foundation (NRF); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Inha University Research Grant, Republic of Korea	This research was supported by the Basic Science Research Program of the National Research Foundation (NRF) funded by the Korean Ministry of Education, Science and Technology (#2011-0005812), the grant of Korean Ministry of Education, Science and Technology (#2009-0079196), and the Inha University Research Grant, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6; Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906; Chen X, 2010, LARYNGOSCOPE, V120, P1819, DOI 10.1002/lary.21037; Gauglitz GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029942; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Hirano S, 2004, LARYNGOSCOPE, V114, P548, DOI 10.1097/00005537-200403000-00030; Hirano S, 2002, ANN OTO RHINOL LARYN, V111, P661, DOI 10.1177/000348940211100801; Hu XL, 2011, BURNS, V37, P729, DOI 10.1016/j.burns.2010.08.016; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Jorgensen LN, 2002, ANN SURG, V236, P684, DOI 10.1097/00000658-200211000-00020; JYUNG RW, 1994, SURGERY, V115, P325; Lim XH, 2008, ANN OTO RHINOL LARYN, V117, P227, DOI 10.1177/000348940811700311; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365; Mann A, 2006, J INVEST DERM SYMP P, V11, P87, DOI 10.1038/sj.jidsymp.5650013; Ohno T, 2009, LARYNGOSCOPE, V119, P806, DOI 10.1002/lary.20174; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303; Thibeault SL, 2003, J VOICE, V17, P377, DOI 10.1067/S0892-1997(03)00064-X; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Thibeault SL, 2008, OTOLARYNG HEAD NECK, V139, P816, DOI 10.1016/j.otohns.2008.09.009; VAILLANT P, 1993, BIOCHEM BIOPH RES CO, V192, P879, DOI 10.1006/bbrc.1993.1497; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yamashita M, 2010, CELLS TISSUES ORGANS, V192, P262, DOI 10.1159/000315476; Zhou H, 2011, LARYNGOSCOPE, V121, P1261, DOI 10.1002/lary.21795	33	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54256	10.1371/journal.pone.0054256	http://dx.doi.org/10.1371/journal.pone.0054256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372696	gold, Green Submitted, Green Published			2022-12-25	WOS:000315210400010
J	Ferrington, DA; Roehrich, H; Chang, AA; Huang, CW; Maldonado, M; Bratten, W; Rageh, AA; Heuss, ND; Gregerson, DS; Nelson, EF; Yuan, C				Ferrington, Deborah A.; Roehrich, Heidi; Chang, Angela A.; Huang, Craig W.; Maldonado, Marcela; Bratten, Wendy; Rageh, Abrar A.; Heuss, Neal D.; Gregerson, Dale S.; Nelson, Elizabeth F.; Yuan, Ching			Corneal Wound Healing Is Compromised by Immunoproteasome Deficiency	PLOS ONE			English	Article							NF-KAPPA-B; PROTEASOME SUBUNIT; AUTOINFLAMMATORY DISORDER; OXIDATIVE STRESS; T-CELLS; INTERLEUKIN-6; LIPODYSTROPHY; TRANSPARENCY; MUTATION; COMPLEX	Recent studies have revealed roles for immunoproteasome in regulating cell processes essential for maintaining homeostasis and in responding to stress and injury. The current study investigates how the absence of immunoproteasome affects the corneal epithelium under normal and stressed conditions by comparing corneas from wildtype (WT) mice and those deficient in two immunoproteasome catalytic subunits (lmp7(-/-)/mecl-1(-/-), L7M1). Immunoproteasome expression was confirmed in WT epithelial cells and in cells of the immune system that were present in the cornea. More apoptotic cells were found in both corneal explant cultures and uninjured corneas of L7M1 compared to WT mice. Following mechanical debridement, L7M1 corneas displayed delayed wound healing, including delayed re-epithelialization and re-establishment of the epithelial barrier, as well as altered inflammatory cytokine production compared to WT mice. These results suggest that immunoproteasome plays an important role in corneal homeostasis and wound healing.	[Ferrington, Deborah A.; Roehrich, Heidi; Chang, Angela A.; Huang, Craig W.; Maldonado, Marcela; Bratten, Wendy; Rageh, Abrar A.; Heuss, Neal D.; Gregerson, Dale S.; Nelson, Elizabeth F.; Yuan, Ching] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Yuan, C (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	yuanx019@umn.edu		Ferrington, Deborah/0000-0003-2561-7464; Gregerson, Dale/0000-0001-5769-796X	Minnesota Medical Foundation; Minnesota Lions Club, National Institutes of Health [EY013623, AG032391, EY016376, EY019552, P30-EY11374]; Research to Prevent Blindness, Inc., New York, NY; NATIONAL EYE INSTITUTE [R01EY013623, P30EY011374, R01EY016376, R21EY019552, R01EY021996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R21AG032391] Funding Source: NIH RePORTER	Minnesota Medical Foundation; Minnesota Lions Club, National Institutes of Health; Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by: Minnesota Medical Foundation, Minnesota Lions Club, National Institutes of Health (EY013623 and AG032391 to DAF, EY016376 to DSG, EY019552 to CY and a Core Grant for Vision Research, P30-EY11374), and an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota from Research to Prevent Blindness, Inc., New York, NY. No additional external funding recieved for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Alexander G, 2006, EXP EYE RES, V82, P700, DOI 10.1016/j.exer.2005.09.012; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Contreras-Ruiz L, 2012, CURR EYE RES, V37, P971, DOI 10.3109/02713683.2012.700756; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Haroon N, 2012, ARTHRITIS RHEUM-US, V64, P1119, DOI 10.1002/art.33430; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kanazawa N, 2012, ALLERGOL INT, V61, P197, DOI 10.2332/allergolint.11-RAI-0416; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kloetzel PM, 1999, BIOL CHEM, V380, P293, DOI 10.1515/BC.1999.040; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Lee EJ, 2010, INVEST OPHTH VIS SCI, V51, P2101, DOI 10.1167/iovs.08-2213; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; Nakamura M, 1999, CORNEA, V18, P452, DOI 10.1097/00003226-199907000-00011; NISHIDA T, 1992, ARCH OPHTHALMOL-CHIC, V110, P1292, DOI 10.1001/archopht.1992.01080210110036; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; Odgren PR, 2003, CRIT REV EUKAR GENE, V13, P181; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ricote M, 2006, APOPTOSIS, V11, P1969, DOI 10.1007/s10495-006-0086-9; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Westra J, 2006, MINI-REV MED CHEM, V6, P867, DOI 10.2174/138955706777934982; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54347	10.1371/journal.pone.0054347	http://dx.doi.org/10.1371/journal.pone.0054347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365662	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600050
J	Johnson, TJ; Danzeisen, JL; Trampel, D; Nolan, LK; Seemann, T; Bager, RJ; Bojesen, AM				Johnson, Timothy J.; Danzeisen, Jessica L.; Trampel, Darrell; Nolan, Lisa K.; Seemann, Torsten; Bager, Ragnhild J.; Bojesen, Anders M.			Genome Analysis and Phylogenetic Relatedness of Gallibacterium anatis Strains from Poultry	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GENETIC DIVERSITY; BIOFILM FORMATION; RTX-TOXIN; SEQUENCE; SUSCEPTIBILITY; IDENTIFICATION; CHICKENS; PROGRAM; GTXA	Peritonitis is the major disease problem of laying hens in commercial table egg and parent stock operations. Despite its importance, the etiology and pathogenesis of this disease have not been completely clarified. Although avian pathogenic Escherichia coli (APEC) isolates have been incriminated as the causative agent of laying hen peritonitis, Gallibacterium anatis are frequently isolated from peritonitis lesions. Despite recent studies suggesting a role for G. anatis in the pathogenesis of peritonitis, little is known about the organism's virulence mechanisms, genomic composition and population dynamics. Here, we compared the genome sequences of three G. anatis isolates in an effort to understand its virulence mechanisms and identify novel antigenic traits. A multilocus sequence typing method was also established for G. anatis and used to characterize the genotypic relatedness of 71 isolates from commercial laying hens in Iowa and 18 international reference isolates. Genomic comparisons suggest that G. anatis is a highly diverse bacterial species, with some strains possessing previously described and potential virulence factors, but with a core genome containing several antigenic candidates. Multilocus sequence typing effectively distinguished 82 sequence types and several clonal complexes of G. anatis, and some clones seemed to predominate among G. anatis populations from commercial layers in Iowa. Biofilm formation and resistance to antimicrobial agents was also observed in several clades. Overall, the genomic diversity of G. anatis suggests that multiple lineages exist with differing pathogenic potential towards birds.	[Johnson, Timothy J.; Danzeisen, Jessica L.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Trampel, Darrell] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Nolan, Lisa K.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Bager, Ragnhild J.; Bojesen, Anders M.] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University; Monash University; University of Copenhagen	Johnson, TJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu	Seemann, Torsten/B-2318-2010; Bager, Ragnhild/K-4459-2014; Bojesen, Anders Miki/CAG-0739-2022	Seemann, Torsten/0000-0001-6046-610X; Bager, Ragnhild/0000-0003-3886-8086; Johnson, Timothy/0000-0001-7556-9347; Bojesen, Anders Miki/0000-0003-4030-0019	Midwest Poultry Research Program, Iowa Egg Council [415-49-09]; Danish Research Council for Technology and Production [09-065909]	Midwest Poultry Research Program, Iowa Egg Council; Danish Research Council for Technology and Production	Funding for this study was provided by the Midwest Poultry Research Program, grant 415-49-09, Iowa Egg Council, and the Danish Research Council for Technology and Production, grant 09-065909. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bisgaard M, 2009, INT J SYST EVOL MICR, V59, P735, DOI 10.1099/ijs.0.005694-0; Bojesen AM, 2007, AVIAN PATHOL, V36, P227, DOI 10.1080/03079450701332352; Bojesen AM, 2004, AVIAN PATHOL, V33, P145, DOI 10.1080/03079450310001652059; Bojesen AM, 2003, J CLIN MICROBIOL, V41, P2737, DOI 10.1128/JCM.41.6.2737-2740.2003; Bojesen AM, 2011, VET MICROBIOL, V148, P105, DOI 10.1016/j.vetmic.2010.08.011; Bojesen AM, 2011, VET MICROBIOL, V149, P497, DOI 10.1016/j.vetmic.2010.11.015; Bojesen AM, 2007, VET MICROBIOL, V123, P262, DOI 10.1016/j.vetmic.2007.02.013; Christensen H, 2003, INT J SYST EVOL MICR, V53, P275, DOI 10.1099/ijs.0.02330-0; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Clinical and Laboratory Standards Institute, 2005, PERFORMANCE STANDARD; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Gomez E, 2005, AVIAN PATHOL, V34, P426, DOI 10.1080/03079450500267866; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Johnson TJ, 2011, J BACTERIOL, V193, P3676, DOI 10.1128/JB.05177-11; Kristensen BM, 2011, VET MICROBIOL; Kristensen BM, 2012, APPL ENVIRON MICROB, V78, P4914, DOI 10.1128/AEM.00412-12; Kristensen BM, 2011, VET MICROBIOL, V153, P116, DOI 10.1016/j.vetmic.2011.05.019; Kristensen BM, 2010, VET RES, V41, DOI 10.1051/vetres/2009073; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin MY, 2001, AVIAN DIS, V45, P655, DOI 10.2307/1592907; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McClure M A, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P155; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P91, DOI 10.1093/jac/dkr411; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neubauer C, 2009, AVIAN PATHOL, V38, P1, DOI 10.1080/03079450802577848; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pattison M, 2008, POULTRY DIS; Saif Y. M., 2008, DIS POULTRY; Skyberg JA, 2007, J APPL MICROBIOL, V102, P548, DOI 10.1111/j.1365-2672.2006.03076.x; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Vaca S, 2011, J ANIM VET ADV, V10, P1688; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zepeda A, 2009, AVIAN DIS, V53, P115, DOI 10.1637/8375-060908-ResNote.1; Zepeda VA, 2010, AVIAN DIS, V54, P1306, DOI 10.1637/9423-061410-ResNote.1	42	24	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54844	10.1371/journal.pone.0054844	http://dx.doi.org/10.1371/journal.pone.0054844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359626	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600121
J	Kenney, MC; Chwa, M; Atilano, SR; Pavlis, JM; Falatoonzadeh, P; Ramirez, C; Malik, D; Hsu, T; Woo, G; Soe, K; Nesburn, AB; Boyer, DS; Kuppermann, BD; Jazwinski, SM; Miceli, MV; Wallace, DC; Udar, N				Kenney, M. Cristina; Chwa, Marilyn; Atilano, Shari R.; Pavlis, Janelle M.; Falatoonzadeh, Payam; Ramirez, Claudio; Malik, Deepika; Hsu, Tiffany; Woo, Grace; Soe, Kyaw; Nesburn, Anthony B.; Boyer, David S.; Kuppermann, Baruch D.; Jazwinski, S. Michal; Miceli, Michael V.; Wallace, Douglas C.; Udar, Nitin			Mitochondrial DNA Variants Mediate Energy Production and Expression Levels for CFH, C3 and EFEMP1 Genes: Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MYOSIN VIIA; DRUSEN FORMATION; RISK; HAPLOGROUPS; LONGEVITY; GLAUCOMA; DISEASES; CELLS; VARIABILITY	Background: Mitochondrial dysfunction is associated with the development and progression of age-related macular degeneration (AMD). Recent studies using populations from the United States and Australia have demonstrated that AMD is associated with mitochondrial (mt) DNA haplogroups (as defined by combinations of mtDNA polymorphisms) that represent Northern European Caucasians. The aim of this study was to use the cytoplasmic hybrid (cybrid) model to investigate the molecular and biological functional consequences that occur when comparing the mtDNA H haplogroup (protective for AMD) versus J haplogroup (high risk for AMD). Methodology/Principal Findings: Cybrids were created by introducing mitochondria from individuals with either H or J haplogroups into a human retinal epithelial cell line (ARPE-19) that was devoid of mitochondrial DNA (Rho0). In cybrid lines, all of the cells carry the same nuclear genes but vary in mtDNA content. The J cybrids had significantly lower levels of ATP and reactive oxygen/nitrogen species production, but increased lactate levels and rates of growth. Q-PCR analyses showed J cybrids had decreased expressions for CFH, C3, and EFEMP1 genes, high risk genes for AMD, and higher expression for MYO7A, a gene associated with retinal degeneration in Usher type IB syndrome. The H and J cybrids also have comparatively altered expression of nuclear genes involved in pathways for cell signaling, inflammation, and metabolism. Conclusion/Significance: Our findings demonstrate that mtDNA haplogroup variants mediate not only energy production and cell growth, but also cell signaling for major molecular pathways. These data support the hypothesis that mtDNA variants play important roles in numerous cellular functions and disease processes, including AMD.	[Kenney, M. Cristina; Chwa, Marilyn; Atilano, Shari R.; Pavlis, Janelle M.; Falatoonzadeh, Payam; Ramirez, Claudio; Malik, Deepika; Hsu, Tiffany; Woo, Grace; Soe, Kyaw; Nesburn, Anthony B.; Kuppermann, Baruch D.; Udar, Nitin] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Dept Med, New Orleans, LA 70118 USA; [Wallace, Douglas C.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	University of California System; University of California Irvine; Cedars Sinai Medical Center; Retina Vitreous Associates Medical Group; Tulane University; Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kenney, MC (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA.	mkenney@uci.edu		Atilano, Shari/0000-0002-7729-7864; Udar, Nitin/0000-0001-8533-9190	Discovery Eye Foundation; Lincy Foundation; Beckman Macular Research Initiative; Henry Guenther Foundation; Polly and Michael Smith Foundation; Research to Prevent Blindness Foundation; National Institute on Aging [AG006168]; NATIONAL INSTITUTE ON AGING [R01AG006168, R37AG006168] Funding Source: NIH RePORTER	Discovery Eye Foundation; Lincy Foundation; Beckman Macular Research Initiative; Henry Guenther Foundation; Polly and Michael Smith Foundation; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by The Discovery Eye Foundation www.discoveryeye.org, Lincy Foundation lincyinstitute.unlv.edu/lincy.html, Beckman Macular Research Initiative www.beckmanmacular.org, The Henry Guenther Foundation, Polly and Michael Smith Foundation, Research to Prevent Blindness Foundation www.rpbusa.org, and the National Institute on Aging (AG006168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2011, MOL VIS, V17, P1468; Abu-Amero KK, 2011, MOL VIS, V17, P543; Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2; Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI [10.2217/EPI.11.109, 10.2217/epi.11.109]; Bergeron-Sawitzke J, 2009, EUR J HUM GENET, V17, P1190, DOI 10.1038/ejhg.2009.23; BROWN MD, 1992, AM J HUM GENET, V51, P378; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chomyn A, 1996, PLALTELET MEDIATED T; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Czarnecka AM, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/136435; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Moreno M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00129; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-264; Ferraresi R, 2008, CYTOM PART A, V73A, P528, DOI 10.1002/cyto.a.20544; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Grassi MA, 2006, HUM MUTAT, V27, P921, DOI 10.1002/humu.20359; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Jazwinski S. M., 2012, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbr.2011.03.031; Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kaur I, 2008, INVEST OPHTH VIS SCI, V49, P1771, DOI 10.1167/iovs.07-0560; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Miceli MV, 2005, INVEST OPHTH VIS SCI, V46, P1765, DOI 10.1167/iovs.04-1327; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Okamoto H, 2006, MOL VIS, V12, P156; Pathak D, 2011, MOL VIS, V17, P1514; Penisson-Besnier I, 2001, REV NEUROL-FRANCE, V157, P537; Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293; Rodley CDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030943; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Wallace DC, 2007, MITOCHONDRIAL GENES, P194; Wang GF, 2009, INVEST OPHTH VIS SCI, V50, P3084, DOI 10.1167/iovs.08-3240; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolf C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-8; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	71	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54339	10.1371/journal.pone.0054339	http://dx.doi.org/10.1371/journal.pone.0054339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365660	Green Published, gold			2022-12-25	WOS:000314023600048
J	Kirby, BS; Bruhl, A; Sullivan, MN; Francis, M; Dinenno, FA; Earley, S				Kirby, Brett S.; Bruhl, Allison; Sullivan, Michelle N.; Francis, Michael; Dinenno, Frank A.; Earley, Scott			Robust Internal Elastic Lamina Fenestration in Skeletal Muscle Arteries	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; MYOENDOTHELIAL GAP-JUNCTIONS; BLOOD-FLOW; SMALL-CONDUCTANCE; MECHANICAL-PROPERTIES; MESENTERIC-ARTERIES; CA2+ RELEASE; ENDOTHELIUM; RECEPTOR; RAT	Holes within the internal elastic lamina (IEL) of blood vessels are sites of fenestration allowing for passage of diffusible vasoactive substances and interface of endothelial cell membrane projections with underlying vascular smooth muscle. Endothelial projections are sites of dynamic Ca2+ events leading to endothelium dependent hyperpolarization (EDH)-mediated relaxations and the activity of these events increase as vessel diameter decreases. We tested the hypothesis that IEL fenestration is greater in distal vs. proximal arteries in skeletal muscle, and is unlike other vascular beds (mesentery). We also determined ion channel protein composition within the endothelium of intramuscular and non-intramuscular skeletal muscle arteries. Popliteal arteries, subsequent gastrocnemius feed arteries, and first and second order intramuscular arterioles from rat hindlimb were isolated, cut longitudinally, fixed, and imaged using confocal microscopy. Quantitative analysis revealed a significantly larger total fenestration area in second and first order arterioles vs. feed and popliteal arteries (58% and 16% vs. 5% and 3%; N = 10 images/artery), due to a noticeably greater average size of holes (9.5 and 3.9 mu m(2) vs 1.5 and 1.9 mu m(2)). Next, we investigated via immunolabeling procedures whether proteins involved in EDH often embedded in endothelial cell projections were disparate between arterial segments. Specific proteins involved in EDH, such as inositol trisphosphate receptors, small and intermediate conductance Ca2+-activated K+ channels, and the canonical (C) transient receptor potential (TRP) channel TRPC3 were present in both popliteal and first order intramuscular arterioles. However due to larger IEL fenestration in first order arterioles, a larger spanning area of EDH proteins is observed proximal to the smooth muscle cell plasma membrane. These observations highlight the robust area of fenestration within intramuscular arterioles and indicate that the anatomical architecture and endothelial cell hyperpolarizing apparatus for distinct vasodilatory signaling is potentially present.	[Kirby, Brett S.; Bruhl, Allison; Sullivan, Michelle N.; Dinenno, Frank A.; Earley, Scott] Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA; [Dinenno, Frank A.] Colorado State Univ, Dept Hlth & Exercise Sci, Human Cardiovasc Physiol Lab, Ft Collins, CO 80523 USA; [Francis, Michael] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA	Colorado State University; Colorado State University; University of South Alabama	Earley, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA.	Scott.Earley@Colostate.edu	Earley, Scott/A-4059-2008	Earley, Scott/0000-0001-9560-2941	United States National Institutes of Health [HL091905, HL102720, HL095573]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091905, R21HL102720, R01HL095573] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was supported through United States National Institutes of Health grants HL091905 (S.E.), HL102720 (F.A.D.), and HL095573 (F.A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1979, ACTA PHYSIOL SCAND, V107, P309, DOI 10.1111/j.1748-1716.1979.tb06480.x; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Anderson KM, 1991, CIRC RES, V69, P178; AYDIN F, 1991, STROKE, V22, P1592, DOI 10.1161/01.STR.22.12.1592; Behringer EJ, 2012, CIRC RES, V110, P1311, DOI 10.1161/CIRCRESAHA.111.262592; BOURGUIGNON LYW, 1994, J CELL PHYSIOL, V159, P29, DOI 10.1002/jcp.1041590105; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Czaja K, 2002, BIOCHEM BIOPH RES CO, V293, P1138, DOI 10.1016/S0006-291X(02)00335-2; Dees MB, 1923, ANAT REC, V26, P161, DOI 10.1002/ar.1090260211; Domeier TL, 2007, J PHYSIOL-LONDON, V579, P175, DOI 10.1113/jphysiol.2006.124529; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Earley S, 2010, MOL PHARMACOL, V77, P612, DOI 10.1124/mol.109.060715; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; FIXLER DE, 1976, AM J PHYSIOL, V231, P1515, DOI 10.1152/ajplegacy.1976.231.5.1515; Francis M, 2012, AM J PHYSIOL-CELL PH, V303, pC236, DOI 10.1152/ajpcell.00016.2012; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC279, DOI 10.1152/ajpcell.00550.2009; Guo ZY, 2008, CLIN BIOMECH, V23, pS104, DOI 10.1016/j.clinbiomech.2007.08.017; Heberlein KR, 2009, MICROCIRCULATION, V16, P307, DOI 10.1080/10739680902744404; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; Jones S, 2008, BLOOD, V111, P605, DOI 10.1182/blood-2007-07-103424; Joyner MJ, 2004, J PHYSIOL-LONDON, V558, P1, DOI 10.1113/jphysiol.2004.067306; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; MARSHALL RJ, 1961, CIRCULATION, V24, P76, DOI 10.1161/01.CIR.24.1.76; Masuda H, 1999, ARTERIOSCL THROM VAS, V19, P2298, DOI 10.1161/01.ATV.19.10.2298; Milkau M, 2010, FASEB J, V24, P3572, DOI 10.1096/fj.10-158956; MULVANY MJ, 1976, NATURE, V260, P617, DOI 10.1038/260617a0; MUSCH TI, 1987, J APPL PHYSIOL, V63, P2269, DOI 10.1152/jappl.1987.63.6.2269; Roseguini BT, 2010, MICROCIRCULATION, V17, P83, DOI 10.1111/j.1549-8719.2009.00005.x; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Sandow SL, 2004, CLIN EXP PHARMACOL P, V31, P563, DOI 10.1111/j.1440-1681.2004.04048.x; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Segal SS, 2001, J PHYSIOL-LONDON, V536, P937, DOI 10.1111/j.1469-7793.2001.00937.x; SEGAL SS, 1995, MED SCI SPORT EXER, V27, P1158; Senadheera S, 2012, CARDIOVASC RES, V95, P439, DOI 10.1093/cvr/cvs208; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SIMS FH, 1989, ARTERY, V16, P159; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; TAUGNER R, 1984, CELL TISSUE RES, V235, P319; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; VanTeeffelen JWGE, 2003, J PHYSIOL-LONDON, V550, P563, DOI 10.1113/jphysiol.2003.038984; WIEDEMAN MP, 1968, CIRC RES, V22, P83, DOI 10.1161/01.RES.22.1.83; Winter P, 2007, J PHYSIOL-LONDON, V582, P335, DOI 10.1113/jphysiol.2007.135202; Wolfle SE, 2011, J PHYSIOL-LONDON, V589, P2607, DOI 10.1113/jphysiol.2010.202580; Wong LCY, 1996, CIRC RES, V78, P799, DOI 10.1161/01.RES.78.5.799; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	56	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54849	10.1371/journal.pone.0054849	http://dx.doi.org/10.1371/journal.pone.0054849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359815	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600122
J	Ku, HC; Chen, WP; Su, MJ				Ku, Hui-Chun; Chen, Wen-Pin; Su, Ming-Jai			DPP4 Deficiency Exerts Protective Effect against H2O2 Induced Oxidative Stress in Isolated Cardiomyocytes	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LEFT-VENTRICULAR DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; PRESERVES CARDIAC-FUNCTION; ACTIVATED PROTEIN-KINASE; MYOCARDIAL-INFARCTION; CELLULAR-RESPONSE; GLUCOSE-UPTAKE; GLP-1; HEART	Apart from the antihyperglycemic effects, DPP4 inhibitors and GLP-1 molecules are involved in the preservation of cardiac functions. We have demonstrated that DPP4-deficient rats possess resistance to endotoxemia and ischemia/reperfusion stress. However, whether the decrease of DPP4 activity simply augmented the GLP-1 signaling or that such decrease resulted in a change of cellular function remain unclear. Accordingly, we investigated the responses of H2O2-induced oxidative stress in adult wild-type and DPP4-deficient rats isolated cardiomyocytes. The coadministration of GLP-1 or DPP4 inhibitor was also performed to define the mechanisms. Cell viability, ROS concentration, catalase activity, glucose uptake, prosurvival, proapoptotic signaling, and contractile function were examined after cells exposed to H2O2. DPP4-deficient cardiomyocytes were found to be resistant to H2O2-induced cell death via activating AKT signaling, enhancing glucose uptake, preserving catalase activity, diminishing ROS level and proapoptotic signaling. GLP-1 concentration-dependently improved cell viability in wild-type cardiomyocyte against ROS stress, and the ceiling response concentration (200 nM) was chosen for studies. GLP-1 was shown to decrease H2O2-induced cell death by its receptor-dependent AKT pathway in wild-type cardiomyocytes, but failed to cause further activation of AKT in DPP4-deficient cardiomyocytes. Acute treatment of DPP4 inhibitor only augmented the protective effect of low dose GLP-1, but failed to alter fuel utilization or ameliorate cell viability in wild-type cardiomyocytes after H2O2 exposure. The improvement of cell viability after H2O2 exposure was correlated with the alleviation of cellular contractile dysfunction in both DPP4-deficient and GLP-1 treated wild-type cardiomyocytes. These findings demonstrated that GLP-1 receptor-dependent pathway is important and exert protective effect in wild-type cardiomyocyte. Long term loss of DPP4 activity increased the capability against ROS stress, which was more than GLP-1 dependent pathway.	[Ku, Hui-Chun; Chen, Wen-Pin; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan	National Taiwan University	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	mingja@ntu.edu.tw		SU, MING-JAI/0000-0001-8887-6899; Chen, Wen-Pin/0000-0002-0143-5642	National Science Council of Taiwan, ROC [NSC-100-2325-B-002-066]	National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	The authors work was supported by the grant from National Science Council of Taiwan, ROC (NSC-100-2325-B-002-066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Ban K, 2010, ENDOCRINOLOGY, V151, P1520, DOI 10.1210/en.2009-1197; Bao WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023570; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Duez H, 2012, BIOCHEM PHARMACOL, V83, P823, DOI 10.1016/j.bcp.2011.11.028; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Giannocco G, 2012, EUR J PHARM; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Kang KA, 2005, BIOL PHARM BULL, V28, P1154, DOI 10.1248/bpb.28.1154; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Maes MB, 2007, CLIN CHIM ACTA, V380, P31, DOI 10.1016/j.cca.2007.01.024; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Michel MC, 2008, N-S ARCH PHARMACOL, V377, P205, DOI 10.1007/s00210-008-0280-0; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Read PA, 2010, CIRC CARDIOVASC IMAG; Read PA, 2011, CIRC-CARDIOVASC INTE, V4, P266, DOI 10.1161/CIRCINTERVENTIONS.110.960476; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhong J, 2012, ATHEROSCLEROSIS	45	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54518	10.1371/journal.pone.0054518	http://dx.doi.org/10.1371/journal.pone.0054518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359639	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600064
J	Stozer, A; Dolensek, J; Rupnik, MS				Stozer, Andraz; Dolensek, Jurij; Rupnik, Marjan Slak			Glucose-Stimulated Calcium Dynamics in Islets of Langerhans in Acute Mouse Pancreas Tissue Slices	PLOS ONE			English	Article							CYTOPLASMIC CA2+ CONCENTRATION; BURSTING ELECTRICAL-ACTIVITY; RECORDED IN-VIVO; BETA-CELLS; INSULIN-RELEASE; INTACT ISLETS; INDUCED OSCILLATIONS; IDENTIFIED ALPHA; CHROMAFFIN CELLS; DELTA-CELLS	In endocrine cells within islets of Langerhans calcium ions couple cell stimulation to hormone secretion. Since the advent of modern fluorimetry, numerous in vitro studies employing primarily isolated mouse islets have investigated the effects of various secretagogues on cytoplasmic calcium, predominantly in insulin-secreting beta cells. Due to technical limitations, insights of these studies are inherently limited to a rather small subpopulation of outermost cells. The results also seem to depend on various factors, like culture conditions and duration, and are not always easily reconcilable with findings in vivo. The main controversies regard the types of calcium oscillations, presence of calcium waves, and the level of synchronized activity. Here, we set out to combine the in situ acute mouse pancreas tissue slice preparation with noninvasive fluorescent calcium labeling and subsequent confocal laser scanning microscopy to shed new light on the existing controversies utilizing an innovative approach enabling the characterization of responses in many cells from all layers of islets. Our experiments reproducibly showed stable fast calcium oscillations on a sustained plateau rather than slow oscillations as the predominant type of response in acute tissue slices, and that calcium waves are the mechanistic substrate for synchronization of oscillations. We also found indirect evidence that even a large amplitude calcium signal was not sufficient and that metabolic activation was necessary to ensure cell synchronization upon stimulation with glucose. Our novel method helped resolve existing controversies and showed the potential to help answer important physiological questions, making it one of the methods of choice for the foreseeable future.	[Stozer, Andraz; Dolensek, Jurij; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Rupnik, Marjan Slak] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Maribor	Rupnik, MS (corresponding author), Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia.	marjan.rupnik@uni-mb.si	Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882	Slovenian Research Agency [P3-0310-2334]; MPG Partner Group Program [J3-2290-2334]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); MPG Partner Group Program	This work was supported by the Slovenian Research Agency Program P3-0310-2334 (http://www.arrs.gov.si/en/dobrodoslica.asp), and Grant J3-2290-2334, MPG Partner Group Program (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; Aslanidi OV, 2001, BIOPHYS J, V80, P1195, DOI 10.1016/S0006-3495(01)76096-1; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BERGSTEN P, 1993, BIOCHEM BIOPH RES CO, V192, P1182, DOI 10.1006/bbrc.1993.1541; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BERGSTEN P, 1995, AM J PHYSIOL-ENDOC M, V268, pE282, DOI 10.1152/ajpendo.1995.268.2.E282; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertuzzi F, 1999, DIABETES, V48, P1971, DOI 10.2337/diabetes.48.10.1971; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fernandez J, 2000, FEBS LETT, V477, P33, DOI 10.1016/S0014-5793(00)01631-8; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1994, DIABETOLOGIA, V37, P1007, DOI 10.1007/BF00400464; GILON P, 1992, J BIOL CHEM, V267, P20713; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heller RS, 2010, ADV EXP MED BIOL, V654, P21, DOI 10.1007/978-90-481-3271-3_2; HELLMAN B, 1992, BIOCHIM BIOPHYS ACTA, V1113, P295, DOI 10.1016/0304-4157(92)90003-S; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Huang YC, 2011, J PHYSIOL-LONDON, V589, P395, DOI 10.1113/jphysiol.2010.200345; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; Milton F, 1937, J AM STAT ASSOC, V32, P675; Moser T, 1997, J NEUROSCI, V17, P2314; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Palti Y, 1996, DIABETES, V45, P595, DOI 10.2337/diabetes.45.5.595; POOLE CA, 1993, J CELL SCI, V106, P685; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rozzo A, 2009, ANN NY ACAD SCI, V1152, P53, DOI 10.1111/j.1749-6632.2008.04003.x; Rupnik M, 2009, ACTA PHYSIOL, V195, P123, DOI 10.1111/j.1748-1716.2008.01927.x; Sanchez-Cardenas C, 2010, NEUROENDOCRINOLOGY, V91, P239, DOI 10.1159/000274493; SANCHEZANDRES JV, 1995, J PHYSIOL-LONDON, V486, P223, DOI 10.1113/jphysiol.1995.sp020804; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Takahashi N, 2002, DIABETES, V51, pS25, DOI 10.2337/diabetes.51.2007.S25; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Valdeolmillos M, 1996, J PHYSIOL-LONDON, V493, P9, DOI 10.1113/jphysiol.1996.sp021361; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Zhang Q, 2008, PHILOS T R SOC A, V366, P3503, DOI 10.1098/rsta.2008.0110	51	55	55	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54638	10.1371/journal.pone.0054638	http://dx.doi.org/10.1371/journal.pone.0054638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358454	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600083
J	Aycrigg, JL; Davidson, A; Svancara, LK; Gergely, KJ; McKerrow, A; Scott, JM				Aycrigg, Jocelyn L.; Davidson, Anne; Svancara, Leona K.; Gergely, Kevin J.; McKerrow, Alexa; Scott, J. Michael			Representation of Ecological Systems within the Protected Areas Network of the Continental United States	PLOS ONE			English	Article							GAP ANALYSIS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; VEGETATION; WORLD; FRAMEWORK; COVERAGE; SCIENCE; REGIONS	If conservation of biodiversity is the goal, then the protected areas network of the continental US may be one of our best conservation tools for safeguarding ecological systems (i.e., vegetation communities). We evaluated representation of ecological systems in the current protected areas network and found insufficient representation at three vegetation community levels within lower elevations and moderate to high productivity soils. We used national-level data for ecological systems and a protected areas database to explore alternative ways we might be able to increase representation of ecological systems within the continental US. By following one or more of these alternatives it may be possible to increase the representation of ecological systems in the protected areas network both quantitatively (from 10% up to 39%) and geographically and come closer to meeting the suggested Convention on Biological Diversity target of 17% for terrestrial areas. We used the Landscape Conservation Cooperative framework for regional analysis and found that increased conservation on some private and public lands may be important to the conservation of ecological systems in Western US, while increased public-private partnerships may be important in the conservation of ecological systems in Eastern US. We have not assessed the pros and cons of following the national or regional alternatives, but rather present them as possibilities that may be considered and evaluated as decisions are made to increase the representation of ecological systems in the protected areas network across their range of ecological, geographical, and geophysical occurrence in the continental US into the future.	[Aycrigg, Jocelyn L.; Davidson, Anne] Univ Idaho, Dept Fish & Wildlife Sci, Natl Gap Anal Program, Moscow, ID 83843 USA; [Svancara, Leona K.] Idaho Dept Fish & Game, Moscow, ID USA; [Gergely, Kevin J.] US Geol Survey, Gap Anal Program, Boise, ID USA; [McKerrow, Alexa] US Geol Survey, Gap Anal Program, Raleigh, NC USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Aycrigg, JL (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Natl Gap Anal Program, Moscow, ID 83843 USA.	aycrigg@uidaho.edu	Aycrigg, Jocelyn/AAA-5719-2020	Aycrigg, Jocelyn/0000-0002-6511-7985	United States Geological Society [G08A00047]; Idaho Department of Fish and Game; United States Geological Survey GAP	United States Geological Society; Idaho Department of Fish and Game; United States Geological Survey GAP	The National Gap Analysis Program at the University of Idaho is supported by the United States Geological Society Gap Analysis Program under grant #G08A00047. The url: gapanalysis.usgs.gov. The agreement mentioned above supported JA and AD to do the study design, data collection and analysis as well as the decision to publish and preparation of the manuscript. LS was supported by Idaho Department of Fish and Game to help with the study design, data analysis, and preparation of the manuscript. AM and KG were funded by United States Geological Survey GAP to help with study design, data collection and analysis. KG is the program officer for this agreement and he has been involved with the study design, data collection, and data analysis for this manuscript. JMS is retired and he helped with the study design, decision to publish and preparation of the manuscript. The funders had a role in the study design, data collection, and data analysis, but not in the decision to publish or preparation of the manuscript.	Allred CS, 2007, 7675 TRANSF ADM JUR; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Baron J.S., 2008, PRELIMINARY REV ADAP; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bunce RGH, 2012, ECOL INDIC; CAICCO SL, 1995, CONSERV BIOL, V9, P498, DOI 10.1046/j.1523-1739.1995.09030498.x; Chape S., 2003, 2003 UN LIST PROTECT; Comer P., 2003, ECOLOGICAL SYSTEMS U; Crist PJ, 1996, GAP ANAL B, V5; CRUMPACKER D W, 1988, Conservation Biology, V2, P103, DOI 10.1111/j.1523-1739.1988.tb00339.x; Darst CR, 2009, NAT AREA J, V29, P224, DOI 10.3375/043.029.0304; Dietz RW, 2005, CONSERV BIOL, V19, P1478, DOI 10.1111/j.1523-1739.2005.00114.x; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; ESTES JE, 1994, PHOTOGRAMM ENG REM S, V60, P517; Fairfax S.K., 2005, BUYING NATURE LIMITS; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; GLICKSMAN R. L., 2008, NEB LAW REV, V87, P833; Groves C.R., 2003, DRAFTING CONSERVATIO; Groves CR, 2000, PRECIOUS HERITAGE ST; HARRISON J, 1982, AMBIO, V11, P238; Hazen HD, 2004, PHYS GEOGR, V25, P499, DOI 10.2747/0272-3646.25.6.499; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hogenauer A., 1991, G WRIGHT FORUM, V7, P2; Hogenauer AK, 1991, G WRIGHT FORUM, V8, P26; Kareiva P, 2010, NATURE, V466, P322, DOI 10.1038/466322a; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Langhammer P.F., 2007, IDENTIFICATION GAP A; Lemieux CJ, 2011, LAND USE POLICY, V28, P928, DOI 10.1016/j.landusepol.2011.03.008; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; Loomis J.B., 1993, INTEGRATED PUBLIC LA; Lowry J, 2007, REMOTE SENS ENVIRON, V108, P59, DOI 10.1016/j.rse.2006.11.008; Lowry J.H., 2007, SW REGIONAL GAP ANAL, P14; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Millard MJ, 2012, J FISH WILDL MANAG, V3, P175, DOI 10.3996/052011-JFWM-030; MILLER KR, 1982, AMBIO, V11, P315; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Noss R. F., 1994, SAVING NATURES LEGAC; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PCAST, 2011, SUST ENV CAP PROT SO; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Redford KH, 1999, CONSERV BIOL, V13, P1246, DOI 10.1046/j.1523-1739.1999.97463.x; Retti DR, 1995, OUR NATL PARK SYSTEM; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Sanborn, 2006, GAP ZONE 1 VEGETATIO; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scott D, 2002, GLOBAL ECOL BIOGEOGR, V11, P475, DOI 10.1046/j.1466-822X.2002.00308.x; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Scott JM, 2001, BIODIVERS CONSERV, V10, P1297, DOI 10.1023/A:1016647726583; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Shaffer Mark L., 2000, P301; Shelford VE, 1926, NATURALISTS GUIDE AM; Sodhi NS, 2011, TRENDS ECOL EVOL, V26, P585, DOI 10.1016/j.tree.2011.07.002; Stobaugh J, 2003, NOTICE PROPOSED WITH; Stoms DM, 1998, GREAT BASIN NAT, V58, P199; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Swaty R, 2011, PLOS ONE, V6, P1, DOI [10.1371/journal.-pone.0023002, DOI 10.1371/JOURNAL.-PONE.0023002]; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Thomas JW, 2005, PUBLIC LAND RESOURC, V26, P39; Towns E, 1998, USDA FOREST SERVICE; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; US Department of Interior and US Department of Agriculture, 2005, NAT LAND AC PLAN; *US GEOL SURV, 2006, NAT EL DAT; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, PROT AR DAT US VERS; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, NAT GAP LAND COV VER; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Wright RG, 2001, BIOL CONSERV, V98, P97, DOI 10.1016/S0006-3207(00)00146-4; Zhu Z, 2006, ANDFIRE PROTOTYPE PR; [No title captured]	78	86	87	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54689	10.1371/journal.pone.0054689	http://dx.doi.org/10.1371/journal.pone.0054689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372754	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500107
J	El-Far, M; Isabelle, C; Chomont, N; Bourbonniere, M; Fonseca, S; Ancuta, P; Peretz, Y; Chouikh, Y; Halwani, R; Schwartz, O; Madrenas, J; Freeman, GJ; Routy, JP; Haddad, EK; Sekaly, RP				El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Ancuta, Petronela; Peretz, Yoav; Chouikh, Younes; Halwani, Rabih; Schwartz, Olivier; Madrenas, Joaquin; Freeman, Gordon J.; Routy, Jean-Pierre; Haddad, Elias K.; Sekaly, Rafick-Pierre			Down-Regulation of CTLA-4 by HIV-1 Nef Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; LYMPHOCYTE-ASSOCIATED MOLECULE-4; SURFACE CD4; BETA-COP; PHYSICAL INTERACTION; CYTOPLASMIC DOMAIN; DILEUCINE MOTIF; ADAPTER PROTEIN; UP-REGULATION	HIV-1 Nef protein down-regulates several cell surface receptors through its interference with the cell sorting and trafficking machinery. Here we demonstrate for the first time the ability of Nef to down-regulate cell surface expression of the negative immune modulator CTLA-4. Down-regulation of CTLA-4 required the Nef motifs DD175, EE155 and LL165, all known to be involved in vesicle trafficking. Disruption of the lysosomal functions by pH-neutralizing agents prevented CTLA-4 down-regulation by Nef, demonstrating the implication of the endosomal/lysosomal compartments in this process. Confocal microscopy experiments visualized the co-localization between Nef and CTLA-4 in the early and recycling endosomes but not at the cell surface. Overall, our results provide a novel mechanism by which HIV-1 Nef interferes with the surface expression of the negative regulator of T cell activation CTLA-4. Down-regulation of CTLA-4 may contribute to the mechanisms by which HIV-1 sustains T cell activation, a critical step in viral replication and dissemination.	[El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Ancuta, Petronela; Peretz, Yoav; Chouikh, Younes; Haddad, Elias K.; Sekaly, Rafick-Pierre] Hop St Luc, CRCHUM, Montreal, PQ H2X 1P1, Canada; [El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Peretz, Yoav; Chouikh, Younes; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3C 3J7, Canada; [Chomont, Nicolas; Fonseca, Simone; Haddad, Elias K.; Sekaly, Rafick-Pierre] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Dept Pediat, Riyadh 11461, Saudi Arabia; [Schwartz, Olivier] Inst Pasteur, Dept Virol, Virus & Immun Grp, Paris, France; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ H3A 1A1, Canada; [Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Div Hematol, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	Universite de Montreal; Universite de Montreal; Vaccine & Gene Therapy Institute of Florida; King Saud University; King Saud University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Sekaly, RP (corresponding author), Hop St Luc, CRCHUM, 264 Rene Levesque Blvd E, Montreal, PQ H2X 1P1, Canada.	rpsekaly@vgtifl.org	Halwani, Rabih/AAN-1568-2021; Madrenas, Quim/P-5008-2019; Schwartz, Olivier/AAZ-3765-2021; Chomont, Nicolas/ABG-2545-2020; FONSECA, SIMONE GONÇALVES/U-9278-2019; Freeman, Gordon/AAC-5380-2019	Halwani, Rabih/0000-0002-6516-7771; Schwartz, Olivier/0000-0002-0729-1475; Chomont, Nicolas/0000-0001-9747-5018; Freeman, Gordon/0000-0002-7210-5616; El-Far, Mohamed/0000-0002-6458-4207	Canadian Institute of Health Research (CIHR); Fonds de la recherche en sante du Quebec (FRSQ); US National Institutes of Health (NIH); Canadian Foundation for AIDS Research; Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI); Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028871] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for AIDS Research; Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI); Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	M.E. and R.H. are funded by the Canadian Institute of Health Research (CIHR). J-P.R. is clinician scientist supported by Fonds de la recherche en sante du Quebec (FRSQ). This study was supported by funds from the US National Institutes of Health (NIH), the Canadian Institute of Health Research (CIHR), the Canadian Foundation for AIDS Research, the Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI) and the Canadian Network for Vaccines and Immunotherapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alegre ML, 1996, J IMMUNOL, V157, P4762; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Arora VK, 2000, J VIROL, V74, P11081, DOI 10.1128/JVI.74.23.11081-11087.2000; BACHELERIE F, 1990, J VIROL, V64, P3059, DOI 10.1128/JVI.64.6.3059-3062.1990; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chuang E, 1999, J IMMUNOL, V162, P1270; Chun T, 2004, IMMUNOL LETT, V91, P213, DOI 10.1016/j.imlet.2003.12.004; Cluet D, 2005, J VIROL, V79, P8629, DOI 10.1128/JVI.79.13.8629-8636.2005; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; DUPREZ V, 1994, J CELL SCI, V107, P1289; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Harlin H, 2002, EUR J IMMUNOL, V32, P2095, DOI 10.1002/1521-4141(200208)32:8<2095::AID-IMMU2095>3.0.CO;2-E; HARRIS MPG, 1994, J MOL BIOL, V241, P136; Hua J, 1997, VIROLOGY, V231, P231, DOI 10.1006/viro.1997.8517; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; James CO, 2004, J VIROL, V78, P3099, DOI 10.1128/JVI.78.6.3099-3109.2004; Jeong JY, 2002, IMMUNOLOGY, V105, P83, DOI 10.1046/j.0019-2805.2001.01339.x; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Leng QB, 2002, AIDS, V16, P519, DOI 10.1097/00002030-200203080-00002; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Luo TC, 1996, J VIROL, V70, P1527, DOI 10.1128/JVI.70.3.1527-1534.1996; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MANDERS EMM, 1992, J CELL SCI, V103, P857; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 1999, REV MED VIROL, V9, P111, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;111::AID-RMV245&gt;3.0.CO;2-P; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	63	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54295	10.1371/journal.pone.0054295	http://dx.doi.org/10.1371/journal.pone.0054295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372701	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500053
J	Luo, YL; Guo, HM; Zhang, YL; Chen, PX; Zhu, YX; Huang, JH; Zhou, WL				Luo, Yu-Li; Guo, Hong-Mei; Zhang, Yi-Lin; Chen, Peng-Xiao; Zhu, Yun-Xin; Huang, Jie-Hong; Zhou, Wen-Liang			Cellular Mechanism Underlying Formaldehyde-Stimulated Cl- Secretion in Rat Airway Epithelium	PLOS ONE			English	Article							FLUID SECRETION; RECEPTOR; ACTIVATION; CELLS; METHYLATION; TRPV1	Background: Recent studies suggest that formaldehyde (FA) could be synthesized endogeneously and transient receptor potential (TRP) channel might be the sensor of FA. However, the physiological significance is still unclear. Methodology/Principal Findings: The present study investigated the FA induced epithelial Cl- secretion by activation of TRPV-1 channel located in the nerve ending fiber. Exogenously applied FA induced an increase of I-SC in intact rat trachea tissue but not in the primary cultured epithelial cells. Western blot and immunofluorescence analysis identified TRPV-1 expression in rat tracheal nerve ending. Capsazepine (CAZ), a TRPV-1 specific antagonist significantly blocked the I-SC induced by FA. The TRPV-1 agonist capsaicin (Cap) induced an increase of I-SC, which was similar to the I-SC induced by FA. L-703606, an NK-1 specific inhibitor and propranolol, an adrenalin beta receptor inhibitor significantly abolished the I-SC induced by FA or Cap. In the ion substitute analysis, FA could not induce I-SC in the absence of extracelluar Cl-. The I-SC induced by FA could be blocked by the non-specific Cl- channel inhibitor DPC and the CFTR specific inhibitor CFTRi-172, but not by the Ca2+ activated Cl- channel inhibitor DIDS. Furthermore, both forskolin, an agonist of adenylate cyclase (AC) and MDL-12330A, an antagonist of AC could block FA-induced I-SC. Conclusion: Our results suggest that FA-induced epithelial I-SC response is mediated by nerve, involving the activation of TRPV-1 and release of adrenalin as well as substance P.	[Luo, Yu-Li; Guo, Hong-Mei; Zhang, Yi-Lin; Chen, Peng-Xiao; Zhu, Yun-Xin; Huang, Jie-Hong; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, JH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Grace2400@hotmail.com; lsszwl@yahoo.com.cn		Zhang, Yi-Lin/0000-0001-5350-8279	National Key Basic Research Project of China (973 program) [2009CB522102, 2010CB945403]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2011ZX09307-304]; National Natural Science Foundation of China [31071019, 31271247]	National Key Basic Research Project of China (973 program)(National Basic Research Program of China); National Major Scientific and Technological Special Project for "Significant New Drugs Development"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Key Basic Research Project of China (973 program; No. 2009CB522102 and 2010CB945403), the National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the Twelfth Five-year Plan Period (2011ZX09307-304), and the National Natural Science Foundation of China (No. 31071019 and 31271247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameredes Bill T, 2011, Front Biosci (Schol Ed), V3, P643, DOI 10.2741/s177; BOOR PJ, 1992, TOXICOLOGY, V73, P251, DOI 10.1016/0300-483X(92)90067-O; CHAN HC, 1994, BIOL REPROD, V51, P1040, DOI 10.1095/biolreprod51.5.1040; Chan HC, 1997, J PHYSIOL-LONDON, V501, P517, DOI 10.1111/j.1469-7793.1997.517bm.x; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Dib M, 2009, AM J PHYSIOL-LUNG C, V297, pL687, DOI 10.1152/ajplung.90509.2008; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Heck HD, 2004, REGUL TOXICOL PHARM, V40, P92, DOI 10.1016/j.yrtph.2004.05.001; Hizawa N, 2009, J CLIN PHARM THER, V34, P631, DOI 10.1111/j.1365-2710.2009.01066.x; Ianowski JP, 2008, PFLUG ARCH EUR J PHY, V457, P529, DOI 10.1007/s00424-008-0527-0; Iwasaki Y, 2006, NUTR NEUROSCI, V9, P169, DOI 10.1080/10284150600955164; Kalasz H, 2003, MINI-REV MED CHEM, V3, P175, DOI 10.2174/1389557033488187; Kazani S, 2010, J ALLERGY CLIN IMMUN, V125, P295, DOI 10.1016/j.jaci.2009.12.014; Khansaheb M, 2011, AM J PHYSIOL-LUNG C, V300, pL370, DOI 10.1152/ajplung.00372.2010; KHOKHLOV AP, 1989, ZH NEVROPATOL PSIKH, V89, P45; Lam PMW, 2007, J NEUROCHEM, V102, P801, DOI 10.1111/j.1471-4159.2007.04569.x; LEFKOWITZ RJ, 1982, FED PROC, V41, P2664; Lino-dos-Santos-Franco A, 2010, TOXICOL LETT, V197, P211, DOI 10.1016/j.toxlet.2010.05.022; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; McGwin G, 2010, ENVIRON HEALTH PERSP, V118, P313, DOI 10.1289/ehp.0901143; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; National Toxicology Program, 2010, REP CARCINOG BACKGR, V10-5981, pi; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Persoz C, 2012, TOXICOL LETT, V211, P159, DOI 10.1016/j.toxlet.2012.03.799; Persoz C, 2010, TOXICOL LETT, V195, P99, DOI 10.1016/j.toxlet.2010.03.003; Sakamoto Tatsuo, 2010, Acta Anatomica Nipponica, V85, P35; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; Tanaka Yoshio, 2005, Journal of Smooth Muscle Research, V41, P153, DOI 10.1540/jsmr.41.153; Taylor SJ, 2012, J PHARMACOL EXP THER, V340, P377, DOI 10.1124/jpet.111.187872; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tian Li-Juan, 2009, Shengli Xuebao, V61, P404; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; TREZL L, 1983, BIOCHEM J, V214, P289, DOI 10.1042/bj2140289; Wallace DP, 2004, AM J PHYSIOL-RENAL, V287, pF639, DOI 10.1152/ajprenal.00448.2003; Watanabe N, 2006, NEUROSCIENCE, V141, P1533, DOI 10.1016/j.neuroscience.2006.04.073; Watanabe N, 2009, ENVIRON TOXICOL, V141, P1533; Weisel CP, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110s4527; Wick EC, 2006, AM J PHYSIOL-GASTR L, V290, pG95; Yang ZH, 2008, CELL BIOL INT, V32, P679, DOI 10.1016/j.cellbi.2008.01.294; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348; Yu PH, 1996, ATHEROSCLEROSIS, V120, P189, DOI 10.1016/0021-9150(95)05701-3	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54494	10.1371/journal.pone.0054494	http://dx.doi.org/10.1371/journal.pone.0054494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372735	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500079
J	Sanbonmatsu, DM; Strayer, DL; Medeiros-Ward, N; Watson, JM				Sanbonmatsu, David M.; Strayer, David L.; Medeiros-Ward, Nathan; Watson, Jason M.			Who Multi-Tasks and Why? Multi-Tasking Ability, Perceived Multi-Tasking Ability, Impulsivity, and Sensation Seeking	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; SELF-REPORT; INDIVIDUAL-DIFFERENCES; PERSONALITY; BEHAVIOR; COMPONENTS; ATTENTION; RISKY; AGE	The present study examined the relationship between personality and individual differences in multi-tasking ability. Participants enrolled at the University of Utah completed measures of multi-tasking activity, perceived multi-tasking ability, impulsivity, and sensation seeking. In addition, they performed the Operation Span in order to assess their executive control and actual multi-tasking ability. The findings indicate that the persons who are most capable of multi-tasking effectively are not the persons who are most likely to engage in multiple tasks simultaneously. To the contrary, multi-tasking activity as measured by the Media Multitasking Inventory and self-reported cell phone usage while driving were negatively correlated with actual multi-tasking ability. Multi-tasking was positively correlated with participants' perceived ability to multi-task ability which was found to be significantly inflated. Participants with a strong approach orientation and a weak avoidance orientation - high levels of impulsivity and sensation seeking - reported greater multi-tasking behavior. Finally, the findings suggest that people often engage in multi-tasking because they are less able to block out distractions and focus on a singular task. Participants with less executive control - low scorers on the Operation Span task and persons high in impulsivity - tended to report higher levels of multi-tasking activity.	[Sanbonmatsu, David M.; Strayer, David L.; Medeiros-Ward, Nathan; Watson, Jason M.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Strayer, DL (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	David.Strayer@uah.edu	Ward, Nathan/AAB-5713-2021	Strayer, David/0000-0002-1653-730X	American Automobile Association Foundation for Traffic Safety	American Automobile Association Foundation for Traffic Safety	This research was supported by a grant from the American Automobile Association Foundation for Traffic Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton GS, 2003, SUBST USE MISUSE, V38, P67, DOI 10.1081/JA-120016566; Ajzen I., 1980, UNDERSTANDING ATTITU; Alicke MD, 2005, SELF SOCIAL JUDGMENT, P85, DOI DOI 10.1111/J.1559-1816.2011.00752.X; BACHOROWSKI JA, 1990, J PERS SOC PSYCHOL, V58, P512, DOI 10.1037/0022-3514.58.3.512; Barratt E.S., 1983, BIOL BASES SENSATION, P77; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Cain MS, 2011, PERCEPTION, V40, P1183, DOI 10.1068/p7017; Carver CS, 2000, PERS SOC PSYCHOL B, V26, P741, DOI 10.1177/0146167200268008; Cheung AM, 2004, J CLIN EXP NEUROPSYC, V26, P393, DOI 10.1080/13803390490510103; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; College Board, 1976, STUD DESCR QUEST; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; EINHORN HJ, 1981, ANNU REV PSYCHOL, V32, P53, DOI 10.1146/annurev.ps.32.020181.000413; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FRANKEN RE, 1992, PERS INDIV DIFFER, V13, P31, DOI 10.1016/0191-8869(92)90214-A; GERBING DW, 1987, MULTIVAR BEHAV RES, V22, P357, DOI 10.1207/s15327906mbr2203_6; Glassbrenner D., 2005, 809967 DOT HS NAT CT; Glicksohn J, 1998, PERS INDIV DIFFER, V25, P1085, DOI 10.1016/S0191-8869(98)00096-8; GRAY JA, 1987, J RES PERS, V21, P493, DOI 10.1016/0092-6566(87)90036-5; HORVATH P, 1993, PERS INDIV DIFFER, V14, P41, DOI 10.1016/0191-8869(93)90173-Z; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; LUENGO MA, 1991, PERS INDIV DIFFER, V12, P657, DOI 10.1016/0191-8869(91)90220-6; Martin LE, 2004, NEUROREPORT, V15, P1519, DOI 10.1097/01.wnr.0000132920.12990.b9; Miller E, 2004, PERS INDIV DIFFER, V37, P349, DOI 10.1016/j.paid.2003.09.008; Newell A., 1969, PROGR OPERATIONS RES, V3, P360; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PFEFFERBAUM B, 1994, J ADOLESCENT HEALTH, V15, P295, DOI 10.1016/1054-139X(94)90602-5; PIVIK RT, 1988, PSYCHOPHYSIOLOGY, V25, P16, DOI 10.1111/j.1469-8986.1988.tb00951.x; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; RHODEWALT F, 1986, J PERS SOC PSYCHOL, V50, P47, DOI 10.1037/0022-3514.50.1.47; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; SANBONMATSU DM, 1990, J PERS SOC PSYCHOL, V59, P614, DOI 10.1037/0022-3514.59.4.614; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stanford MS, 1996, PERS INDIV DIFFER, V21, P1073, DOI 10.1016/S0191-8869(96)00151-1; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Strayer DL, 2010, PSYCHOL LEARNING MOT, V54; Suls J, 2002, J PERS SOC PSYCHOL, V82, P252, DOI 10.1037//0022-3514.82.2.252; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Watson J. M., 2011, HDB LIFESPAN PSYCHOL, P407; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Whitney P, 2004, PERS INDIV DIFFER, V37, P417, DOI 10.1016/j.paid.2003.09.013; Zell E, 2011, J APPL SOC PSYCHOL, V41, P1175, DOI 10.1111/j.1559-1816.2011.00752.x; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; Zuckerman M., 1994, BEHAV EXPRESSIONS BI; Zuckerman M., 1979, SENSATION SEEKING OP; Zuckerman M, 2007, PERS INDIV DIFFER, V43, P1303, DOI 10.1016/j.paid.2007.03.021	52	223	226	4	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54402	10.1371/journal.pone.0054402	http://dx.doi.org/10.1371/journal.pone.0054402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372720	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500069
J	Finsterwald, C; Carrard, A; Martin, JL				Finsterwald, Charles; Carrard, Anthony; Martin, Jean-Luc			Role of Salt-Inducible Kinase 1 in the Activation of MEF2-Dependent Transcription by BDNF	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CREB COACTIVATOR TORC2; HISTONE DEACETYLASES; GENE-EXPRESSION; DENDRITIC DEVELOPMENT; NEURONAL SURVIVAL; SIGNALING CASCADE; CORTICAL-NEURONS; KEY REGULATOR; CLASS IIHDAC	Substantial evidence supports a role for myocyte enhancer factor 2 (MEF2)-mediated transcription in neuronal survival, differentiation and synaptic function. In developing neurons, it has been shown that MEF2-dependent transcription is regulated by neurotrophins. Despite these observations, little is known about the cellular mechanisms by which neurotrophins activate MEF2 transcriptional activity. In this study, we examined the role of salt-inducible kinase 1 (SIK1), a member of the AMP-activated protein kinase (AMPK) family, in the regulation of MEF2-mediated transcription by the neurotrophin brain-derived neurotrophic factor (BDNF). We show that BDNF increases the expression of SIK1 in primary cultures of rat cortical neurons through the extracellular signal-regulated kinase 1/2 (ERK1/2)-signaling pathway. In addition to inducing SIK1 expression, BDNF triggers the phosphorylation of SIK1 at Thr182 and its translocation from the cytoplasm to the nucleus of cortical neurons. The effects of BDNF on the expression, phosphorylation and, translocation of SIK1 are followed by the phosphorylation and nuclear export of histone deacetylase 5 (HDAC5). Blockade of SIK activity with a low concentration of staurosporine abolished BDNF-induced phosphorylation and nuclear export of HDAC5 in cortical neurons. Importantly, stimulation of HDAC5 phosphorylation and nuclear export by BDNF is accompanied by the activation of MEF2-mediated transcription, an effect that is suppressed by staurosporine. Consistent with these data, BDNF induces the expression of the MEF2 target genes Arc and Nur77, in a staurosporine-sensitive manner. In further support of the role of SIK1 in the regulation of MEF2-dependent transcription by BDNF, we found that expression of wild-type SIK1 or S577A SIK1, a mutated form of SIK1 which is retained in the nucleus of transfected cells, is sufficient to enhance MEF2 transcriptional activity in cortical neurons. Together, these data identify a previously unrecognized mechanism by which SIK1 mediates the activation of MEF2-dependent transcription by BDNF.	[Finsterwald, Charles; Carrard, Anthony; Martin, Jean-Luc] CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Martin, JL (corresponding author), CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland.	jean-luc.martin@unil.ch	Carrard, Anthony/C-2206-2013	Carrard, Anthony/0000-0003-0610-8680; Martin, Jean-Luc/0000-0002-5082-4687	Swiss National Science Foundation [31003A-124783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant 31003A-124783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Dietrich JB, 2012, SYNAPSE, V66, P61, DOI 10.1002/syn.20988; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Finsterwald C, 2011, EUR J NEUROSCI, V34, P1053, DOI 10.1111/j.1460-9568.2011.07839.x; Finsterwald C, 2010, J BIOL CHEM, V285, P28587, DOI 10.1074/jbc.M110.125740; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Popov S, 2012, AM J PHYSL HEART CIR; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5	51	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54545	10.1371/journal.pone.0054545	http://dx.doi.org/10.1371/journal.pone.0054545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349925	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100079
J	Rath, BH; Fair, JM; Jamal, M; Camphausen, K; Tofilon, PJ				Rath, Barbara H.; Fair, Joshlean M.; Jamal, Muhammad; Camphausen, Kevin; Tofilon, Philip J.			Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							GLIOMA-CELLS; BRAIN; EXPRESSION; GROWTH; PROTEIN; ALPHA; METALLOPROTEINASES; IDENTIFICATION; INVASIVENESS; INHIBITORS	Glioblastomas (GBMs) are characterized as highly invasive; the contribution of GBM stem-like cells (GSCs) to the invasive phenotype, however, has not been completely defined. Towards this end, we have defined the invasion potential of CD133+ GSCs and their differentiated CD133- counterparts grown under standard in vitro conditions and in co-culture with astrocytes. Using a trans-well assay, astrocytes or astrocyte conditioned media in the bottom chamber significantly increased the invasion of GSCs yet had no effect on CD133- cells. In addition, a monolayer invasion assay showed that the GSCs invaded farther into an astrocyte monolayer than their differentiated progeny. Gene expression profiles were generated from two GSC lines grown in trans-well culture with astrocytes in the bottom chamber or directly in contact with astrocyte monolayers. In each co-culture model, genes whose expression was commonly increased in both GSC lines involved cell movement and included a number of genes that have been previously associated with tumor cell invasion. Similar gene expression modifications were not detected in CD133- cells co-cultured under the same conditions with astrocytes. Finally, evaluation of the secretome of astrocytes grown in monolayer identified a number of chemokines and cytokines associated with tumor cell invasion. These data suggest that astrocytes enhance the invasion of CD133+ GSCs and provide additional support for a critical role of brain microenvironment in the regulation of GBM biology.	[Rath, Barbara H.; Fair, Joshlean M.; Jamal, Muhammad; Camphausen, Kevin; Tofilon, Philip J.] NCI, Radiat Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tofilon, PJ (corresponding author), NCI, Radiat Oncol Branch, Bldg 10, Bethesda, MD 20892 USA.	tofilonp@mail.nih.gov			Division of Basic Sciences of the National Cancer Institute [1 Z1A BC011372 01]; NATIONAL CANCER INSTITUTE [ZIABC011372] Funding Source: NIH RePORTER	Division of Basic Sciences of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the the Division of Basic Sciences of the National Cancer Institute (1 Z1A BC011372 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2009, J NEURO-ONCOL, V95, P117, DOI 10.1007/s11060-009-9910-8; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Esencay M, 2010, J NEURO-ONCOL, V99, P33, DOI 10.1007/s11060-010-0111-2; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hong X, 2006, CANCER LETT, V236, P39, DOI 10.1016/j.canlet.2005.05.011; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Jones TS, 2011, ONCOGENE; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Liang Y, 2008, J NEURO-ONCOL, V86, P153, DOI 10.1007/s11060-007-9463-7; Lin QT, 2010, NEOPLASIA, V12, P748, DOI 10.1593/neo.10602; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; MOHANAM S, 1995, CLIN EXP METASTAS, V13, P57, DOI 10.1007/BF00144019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shaw Leslie M., 2004, V294, P97; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Wang DY, 2000, ONCOGENE, V19, P5801, DOI 10.1038/sj.onc.1203917; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001	50	79	81	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54752	10.1371/journal.pone.0054752	http://dx.doi.org/10.1371/journal.pone.0054752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349962	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100095
J	Silvagno, F; Consiglio, M; Foglizzo, V; Destefanis, M; Pescarmona, G				Silvagno, Francesca; Consiglio, Marco; Foglizzo, Valentina; Destefanis, Michele; Pescarmona, Gianpiero			Mitochondrial Translocation of Vitamin D Receptor Is Mediated by the Permeability Transition Pore in Human Keratinocyte Cell Line	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; LOCALIZATION; INVOLVEMENT; METABOLISM; ACTIVATION; BINDING; GROWTH; VDR; P53	Background: Vitamin D receptor (VDR) is a well known transcriptional regulator, active as heterodimer in association with coactivators and corepressors. In addition it has been described the extranuclear distribution of the receptor and in particular the recently reported mitochondrial localization in platelets and megakaryocytes is intriguing because it appears to be a common feature of steroid receptors. Whereas for other members of the steroid receptor family the mitochondrial function has been explored, up to now nothing is known about a mitochondrial form of VDR in human proliferating cells. Methodology/Principal Findings: In this study we characterized for the first time the mitochondrial localization of VDR in the human keratinocyte cell line HaCaT. In proliferating HaCaT cells VDR was abundantly expressed in mitochondria in association with its binding partner RXR alpha and the import was ligand-independent. By immunoprecipitation studies we demonstrated the interaction of VDR with proteins of the permeability transition pore (PTP), VDAC and StAR. We then adopted different pharmacological and silencing approaches with the aim of hampering PTP function, either affecting PTP opening or abating the expression of the complex member StAR. By all means the impairment of pore function led to a reduction of mitochondrial levels of VDR. Conclusions: The results reported here demonstrate a ligand-independent mitochondrial import of VDR through the permeability transition pore, and open interesting new perspectives on PTP function as transporter and on VDR role in mitochondria.	[Silvagno, Francesca; Consiglio, Marco; Foglizzo, Valentina; Destefanis, Michele; Pescarmona, Gianpiero] Univ Turin, Dept Oncol, Turin, Italy; [Foglizzo, Valentina] S Giovanni Battista Hosp, Ctr Expt Res & Med Studies, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Silvagno, F (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	francesca.silvagno@unito.it		PESCARMONA, GIAN PIERO/0000-0003-2143-8901; Foglizzo, Valentina/0000-0001-5059-3279	Ministero dell'Istruzione Universita e Ricerca	Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione Universita e Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Capiati D, 2002, J CELL BIOCHEM, V86, P128, DOI 10.1002/jcb.10191; Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Costet P, 2000, J BIOL CHEM, V275, P28240; CROMPTON M, 1988, BIOCHEM J, V255, P357; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Ling XL, 2010, INT J BIOL SCI, V6, P773; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Matsuda H, 1996, BBA-LIPID LIPID MET, V1301, P76, DOI 10.1016/0005-2760(96)00020-3; MATSUMOTO K, 1991, BIOCHIM BIOPHYS ACTA, V1092, P311, DOI 10.1016/S0167-4889(97)90006-9; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Pardo VG, 2008, BIOGERONTOLOGY, V9, P109, DOI 10.1007/s10522-007-9118-2; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Silvagno F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008670; Thorne JL, 2011, NUCLEIC ACIDS RES, V39, P2045, DOI 10.1093/nar/gkq875; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Xiao YC, 2010, J ANDROL, V31, P365, DOI 10.2164/jandrol.109.009019	32	47	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54716	10.1371/journal.pone.0054716	http://dx.doi.org/10.1371/journal.pone.0054716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349955	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100092
J	Singh, AP; Sarkar, S; Tripathi, M; Rajender, S				Singh, Akhand Pratap; Sarkar, Saumya; Tripathi, Muktanand; Rajender, Singh			Mucuna pruriens and Its Major Constituent L-DOPA Recover Spermatogenic Loss by Combating ROS, Loss of Mitochondrial Membrane Potential and Apoptosis	PLOS ONE			English	Article							OXIDATIVE STRESS; ESTRADIOL TREATMENT; MALE-INFERTILITY; SPERM MOTILITY; ADULT-RAT; DAMAGE; UPDATE; TESTIS	Background: The Ayurvedic medicinal system claims Mucuna pruriens (MP) to possess pro-male fertility, aphrodisiac and adaptogenic properties. Some scientific evidence also supports its pro-male fertility properties; however, the mechanism of its action is not yet clear. The present study aimed at demonstrating spermatogenic restorative efficacy of MP and its major constituent L-DOPA (LD), and finding the possible mechanism of action thereof in a rat model. Methodology/Findings: Ethinyl estradiol (EE) was administered at a rate of 3 mg/kg body weight (BW)/day for a period of 14 days to generate a rat model with compromised spermatogenesis. MP and LD were administered in two separate groups of these animals starting 15th day for a period of 56 days, and the results were compared with an auto-recovery (AR) group. Sperm count and motility, testis histo-architecture, level of reactive oxygen species (ROS), mitochondrial membrane potential (MMP), apoptosis, peripheral hormone levels and testicular germ cell populations were analysed, in all experimental groups. We observed efficient and quick recovery of spermatogenesis in MP and LD groups in comparison to the auto-recovery group. The treatment regulated ROS level, apoptosis, and mitochondrial membrane potential (MMP), recovered the hypothalamic-pituitary-gonadal axis and the number of testicular germ cells, ultimately leading to increased sperm count and motility. Conclusion/Significance: M. pruriens efficiently recovers the spermatogenic loss induced due to EE administration. The recovery is mediated by reduction in ROS level, restoration of MMP, regulation of apoptosis and eventual increase in the number of germ cells and regulation of apoptosis. The present study simplified the complexity of mechanism involved and provided meaningful insights into MP/LD mediated correction of spermatogenic impairment caused by estrogens exposure. This is the first study demonstrating that L-DOPA largely accounts for pro-spermatogenic properties of M. pruriens. The manuscript bears CDRI communication number 8374.	[Singh, Akhand Pratap; Sarkar, Saumya; Tripathi, Muktanand; Rajender, Singh] Council Sci & Ind Res Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Rajender, S (corresponding author), Council Sci & Ind Res Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566; Sarkar, Saumya/0000-0003-2247-8796	Ministry of Health and Family Welfare, Government of India	Ministry of Health and Family Welfare, Government of India	This study was supported by financial grant from Ministry of Health and Family Welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Ahmad MK, 2008, FERTIL STERIL, V90, P627, DOI 10.1016/j.fertnstert.2007.07.1314; [Anonymous], 1962, RAW MAT, V6, P47; [Anonymous], 1962, RAW MAT, V6, P337; [Anonymous], 1962, RAW MAT, V6, P220; [Anonymous], 1962, RAW MAT, V6, P439; Atanassova N, 1999, ENDOCRINOLOGY, V140, P5364, DOI 10.1210/en.140.11.5364; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; Baumber J, 2000, J ANDROL, V21, P895; BlancoRodriguez J, 1997, J REPROD FERTIL, V110, P61, DOI 10.1530/jrf.0.1100061; BlancoRodriguez J, 1996, INT J ANDROL, V19, P237, DOI 10.1111/j.1365-2605.1996.tb00468.x; Carole M, 2002, HUM REPROD, V17, P1257; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Dama MS, 2011, J ANDROL; Daniel B, 1998, COVER CROPS HILLSIDE; Eduardo RP, 1998, CLIN CHEM, V44, P1616; GHOSAL S, 1971, PLANTA MED, V19, P279, DOI 10.1055/s-0028-1099642; Gow-Chin Yen, 1997, Bioscience, Biotechnology, and Biochemistry, V61, P1646; Gulcin I, 2007, AMINO ACIDS, V32, P431, DOI 10.1007/s00726-006-0379-x; Gupta N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022277; Iida Shigeru, 1997, Journal of Toxicological Sciences, V22, P397; Kasai T, 2002, ASIAN J ANDROL, V4, P97; Kazuki K, 2000, J AGR FOOD CHEM, V48, P844; King SR, 1992, DISCOVERY, V45, P23; Madhukar D, 2009, J ANDROL, V30, P95, DOI 10.2164/jandrol.108.005694; Masako K, 1999, REPROD TOXICOL, V13, P279; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; MEHTA JC, 1994, INDIAN J PHARM SCI, V6, P92; Nadzialek S, 2010, ENVIRON TOXICOL CHEM, V29, P881, DOI 10.1002/etc.100; Newbold RR, 2006, ENDOCRINOLOGY, V147, pS11, DOI 10.1210/en.2005-1164; PANIKKAR KR, 1987, PLANTA MED, P503, DOI 10.1055/s-2006-962789; Peter S, 2001, J CELL SCI, V114, P1665; Prakash D, 2001, INT J FOOD SCI NUTR, V52, P79, DOI 10.1080/09637480020027264; Sharma BK, 2012, NOVEL SCI INT J PHAR, V1, P308; Shukla KK, 2011, REPROD BIOMED ONLINE, V22, P421, DOI 10.1016/j.rbmo.2011.01.010; Shukla KK, 2009, FERTIL STERIL, V92, P1934, DOI 10.1016/j.fertnstert.2008.09.045; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Suresh S, 2010, J SEX MED; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; Suresh S, 2009, J ETHNOPHARMACOL, V122, P497, DOI 10.1016/j.jep.2009.01.032; Toshiko K, 2000, J TOXICOL SCI, V25, P43; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Volpe S, 2009, REPROD DOMEST ANIM, V44, P275, DOI 10.1111/j.1439-0531.2009.01457.x	44	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54655	10.1371/journal.pone.0054655	http://dx.doi.org/10.1371/journal.pone.0054655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349947	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100087
J	Zuo, H; Shi, ZM; Yuan, BJ; Dai, Y; Wu, GL; Hussain, A				Zuo, Hui; Shi, Zumin; Yuan, Baojun; Dai, Yue; Wu, Gaolin; Hussain, Akhtar			Association between Serum Leptin Concentrations and Insulin Resistance: A Population-Based Study from China	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA LEPTIN; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; OBESITY; ADIPOSITY; WOMEN; ADIPONECTIN; DISEASE; WEIGHT	Background: Insulin resistance contributes to the cardio-metabolic risk. The effect of leptin in obese and overweight population on insulin resistance was seldom reported. Methods: A total of 1234 subjects (572 men and 662 women) aged >= 18 y was sampled by the procedure. Adiposity measures included BMI, waist circumference, hip circumference, WHR, upper arm circumference, triceps skinfold and body fat percentage. Serum leptin concentrations were measured by an ELISA method. The homeostasis model (HOMA-IR) was applied to estimate insulin resistance. Results: In men, BMI was the variable which was most strongly correlated with leptin, whereas triceps skinfold was most sensitive for women. More importantly, serum leptin levels among insulin resistant subjects were almost double compared to the subjects who had normal insulin sensitivity at the same level of adiposity in both men and women, after controlling for potential confounders. In addition, HOMA-IR increased significantly across leptin quintiles after adjustment for age, BMI, total energy intake, physical activity and smoking status in both men and women (p for trend <0.0001). Conclusions: There was a significant association between HOMA-IR and serum leptin concentrations in Chinese men and women, independently of adiposity levels. This may suggest that serum leptin concentration is an important predictor of insulin resistance and other metabolic risks irrespective of obesity levels. Furthermore, leptin levels may be used to identify the cardio-metabolic risk in obese and overweight population.	[Zuo, Hui; Yuan, Baojun; Dai, Yue; Wu, Gaolin] Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China; [Zuo, Hui; Hussain, Akhtar] Univ Oslo, Fac Med, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [Shi, Zumin] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Jiangsu Provincial Center for Disease Control & Prevention; University of Oslo; University of Adelaide	Zuo, H (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China.	huizuo97@gmail.com	Shi, Zumin/A-1093-2009; Zuo, Hui/G-4611-2011	Shi, Zumin/0000-0002-3099-3299; Zuo, Hui/0000-0003-3918-5754	Norwegian Research Council, Norway	Norwegian Research Council, Norway(Research Council of Norway)	This work was funded by the Norwegian Research Council, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Ceddia RB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0158rev; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Esteghamati A, 2010, METABOLISM, V59, P1730, DOI 10.1016/j.metabol.2010.04.016; Esteghamati A, 2009, METAB SYNDR RELAT D, V7, P447, DOI 10.1089/met.2008.0100; Haapala I, 2002, CLIN PHYSIOL FUNCT I, V22, P383, DOI 10.1046/j.1475-097X.2002.00447.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hu FB, 2001, INT J OBESITY, V25, P121, DOI 10.1038/sj.ijo.0801480; Huang KC, 2004, INT J OBESITY, V28, P470, DOI 10.1038/sj.ijo.0802531; Laddu D, 2011, NUTR CLIN PRACT, V26, P512, DOI 10.1177/0884533611418335; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Mahabir S, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-3; Mally K, 2011, EUR J APPL PHYSIOL, V111, P1879, DOI 10.1007/s00421-010-1795-x; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mente A, 2010, DIABETES CARE, V33, P1629, DOI 10.2337/dc09-1392; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Monti V, 2006, J AM DIET ASSOC, V106, P822, DOI 10.1016/j.jada.2006.03.015; Nakhjavani M, 2011, GYNECOL ENDOCRINOL, V27, P14, DOI 10.3109/09513590.2010.487583; Panahloo A, 1997, DIABETES, V46, P1340; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Reseland JE, 2005, PROSTAG LEUKOTR ESS, V73, P43, DOI 10.1016/j.plefa.2005.04.006; Ruhl CE, 2001, AM J CLIN NUTR, V74, P295; Ruige JB, 1999, DIABETES CARE, V22, P1097, DOI 10.2337/diacare.22.7.1097; Wang ZQ, 2010, DIABETES-METAB RES, V26, P109, DOI 10.1002/dmrr.1060; Yang Y, 2005, CHINESE FOOD COMPOSI; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao W, 2006, PUBLIC HEALTH NUTR, V5, P829; Zuo H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-247	33	63	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54615	10.1371/journal.pone.0054615	http://dx.doi.org/10.1371/journal.pone.0054615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349940	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100084
J	Wu, YY; Wang, K; Karapetyan, A; Fernando, WA; Simkin, J; Han, MJ; Rugg, EL; Muneoka, K				Wu, Yuanyuan; Wang, Karen; Karapetyan, Adrine; Fernando, Warnakulusuriya Akash; Simkin, Jennifer; Han, Manjong; Rugg, Elizabeth L.; Muneoka, Ken			Connective Tissue Fibroblast Properties Are Position-Dependent during Mouse Digit Tip Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LIMB REGENERATION; COLLAGEN-MATRIX; FOOT SCALES; EXPRESSION; AMPUTATION; DIFFERENTIATION; MORPHOGENESIS; CONTRACTION; FINGER	A key factor that contributes to the regenerative ability of regeneration-competent animals such as the salamander is their use of innate positional cues that guide the regeneration process. The limbs of mammals has severe regenerative limitations, however the distal most portion of the terminal phalange is regeneration competent. This regenerative ability of the adult mouse digit is level dependent: amputation through the distal half of the terminal phalanx (P3) leads to successful regeneration, whereas amputation through a more proximal location, e. g. the subterminal phalangeal element (P2), fails to regenerate. Do the connective tissue cells of the mammalian digit play a role similar to that of the salamander limb in controlling the regenerative response? To begin to address this question, we isolated and cultured cells of the connective tissue surrounding the phalangeal bones of regeneration competent (P3) and incompetent (P2) levels. Despite their close proximity and localization, these cells show very distinctive profiles when characterized in vitro and in vivo. In vitro studies comparing their proliferation and position-specific interactions reveal that cells isolated from the P3 and P2 are both capable of organizing and differentiating epithelial progenitors, but with different outcomes. The difference in interactions are further characterized with three-dimension cultures, in which P3 regenerative cells are shown to lack a contractile response that is seen in other fibroblast cultures, including the P2 cultures. In in vivo engraftment studies, the difference between these two cell lines is made more apparent. While both P2 and P3 cells participated in the regeneration of the terminal phalanx, their survival and proliferative indices were distinct, thus suggesting a key difference in their ability to interact within a regeneration permissive environment. These studies are the first to demonstrate distinct positional characteristics of connective tissue cells that are associated with their regenerative capabilities.	[Wu, Yuanyuan; Wang, Karen; Fernando, Warnakulusuriya Akash; Simkin, Jennifer; Han, Manjong; Muneoka, Ken] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Karapetyan, Adrine; Rugg, Elizabeth L.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA	Tulane University; University of California System; University of California Irvine	Muneoka, K (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	kmuneoka@tulane.edu		Simkin, Jennifer/0000-0002-6122-4222; Muneoka, Ken/0000-0002-7520-6869	United States National Institutes of Health [(NIH)-R01HD043277]; Tulane University;  [DARPA-W911NF-06-1-0161];  [ARO-W911NF0910305]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043277] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by United States National Institutes of Health (NIH)-R01HD043277, DARPA-W911NF-06-1-0161, ARO-W911NF0910305 and the John L. and Mary Wright Ebaugh Endowment Fund at Tulane University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Civin CI, 1996, BLOOD, V88, P4102, DOI 10.1182/blood.V88.11.4102.bloodjournal88114102; DHOUAILLY D, 1980, J EMBRYOL EXP MORPH, V58, P63; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Gardiner DM, 2005, REJUV RES, V8, P141, DOI 10.1089/rej.2005.8.141; GARDINER DM, 1986, DEV BIOL, V118, P488, DOI 10.1016/0012-1606(86)90020-5; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanzler B, 1997, DEV DYNAM, V210, P274, DOI 10.1002/(SICI)1097-0177(199711)210:3<274::AID-AJA8>3.0.CO;2-D; Kaur P, 2000, J INVEST DERMATOL, V114, P413, DOI 10.1046/j.1523-1747.2000.00884.x; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Margulis A, 2004, METH MOL B, V289, P61; Masaki H, 2007, DEV GROWTH DIFFER, V49, P89, DOI 10.1111/j.1440-169X.2007.00909.x; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; NAMENWIRTH M, 1974, DEV BIOL, V41, P42, DOI 10.1016/0012-1606(74)90281-4; Neufeld Daniel A., 1995, Wound Repair and Regeneration, V3, P461, DOI 10.1046/j.1524-475X.1995.30410.x; Ngo P, 2006, METH MOL B, V341, P103; Ngo-Muller V, 2000, METH MOL B, V135, P481; Ngo-Muller V, 2000, DEV BIOL, V219, P224, DOI 10.1006/dbio.2000.9612; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okamoto H, 2006, J DERMATOL SCI, V44, P175, DOI 10.1016/j.jdermsci.2006.08.006; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; REVARDEL JL, 1987, CAN J ZOOL, V65, P3166, DOI 10.1139/z87-475; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; SINGER M, 1987, ANAT EMBRYOL, V177, P29, DOI 10.1007/BF00325287; Skalli O, 1988, MOL CELLULAR BIOL WO, P373; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Turksen K, 2005, EPIDERMAL CELLS; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Yamaguchi Y, 2001, J DERMATOL, V28, P521, DOI 10.1111/j.1346-8138.2001.tb00025.x; Yamaguchi Y, 2001, ARCH DERMATOL, V137, P621; Yamaguchi Y, 2005, J DERMATOL SCI, V40, P1, DOI 10.1016/j.jdermsci.2005.04.006; Yamaguchi Y, 1999, J INVEST DERMATOL, V112, P483, DOI 10.1046/j.1523-1747.1999.00544.x; Yu L, 2012, DEV BIOL; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424	65	48	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54764	10.1371/journal.pone.0054764	http://dx.doi.org/10.1371/journal.pone.0054764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349966	Green Published, gold			2022-12-25	WOS:000313872800076
J	Chen, XL; Shen, YP; Gao, YH; Zhao, HZ; Sheng, XM; Zou, JZ; Lip, V; Xie, H; Guo, J; Shao, H; Bao, YH; Shen, JL; Niu, B; Gusella, JF; Wu, BL; Zhang, T				Chen, Xiaoli; Shen, Yiping; Gao, Yonghui; Zhao, Huizhi; Sheng, Xiaoming; Zou, Jizhen; Lip, Va; Xie, Hua; Guo, Jin; Shao, Hong; Bao, Yihua; Shen, Jianliang; Niu, Bo; Gusella, James F.; Wu, Bai-Lin; Zhang, Ting			Detection of Copy Number Variants Reveals Association of Cilia Genes with Neural Tube Defects	PLOS ONE			English	Article							CELL POLARITY GENE; HIGH-RISK AREA; SHANXI PROVINCE; HIGH PREVALENCE; ARRAY CGH; MUTATIONS; POLYMORPHISMS; AUTOPSY; SUSCEPTIBILITY; IDENTIFICATION	Background: Neural tube defects (NTDs) are one of the most common birth defects caused by a combination of genetic and environmental factors. Currently, little is known about the genetic basis of NTDs although up to 70% of human NTDs were reported to be attributed to genetic factors. Here we performed genome-wide copy number variants (CNVs) detection in a cohort of Chinese NTD patients in order to exam the potential role of CNVs in the pathogenesis of NTDs. Methods: The genomic DNA from eighty-five NTD cases and seventy-five matched normal controls were subjected for whole genome CNVs analysis. Non-DGV (the Database of Genomic Variants) CNVs from each group were further analyzed for their associations with NTDs. Gene content in non-DGV CNVs as well as participating pathways were examined. Results: Fifty-five and twenty-six non-DGV CNVs were detected in cases and controls respectively. Among them, forty and nineteen CNVs involve genes (genic CNV). Significantly more non-DGV CNVs and non-DGV genic CNVs were detected in NTD patients than in control (41.2% vs. 25.3%, p<0.05 and 37.6% vs. 20%, p<0.05). Non-DGV genic CNVs are associated with a 2.65-fold increased risk for NTDs (95% CI: 1.24-5.87). Interestingly, there are 41 cilia genes involved in non-DGV CNVs from NTD patients which is significantly enriched in cases compared with that in controls (24.7% vs. 9.3%, p<0.05), corresponding with a 3.19-fold increased risk for NTDs (95% CI: 1.27-8.01). Pathway analyses further suggested that two ciliogenesis pathways, tight junction and protein kinase A signaling, are top canonical pathways implicated in NTD-specific CNVs, and these two novel pathways interact with known NTD pathways. Conclusions: Evidence from the genome-wide CNV study suggests that genic CNVs, particularly ciliogenic CNVs are associated with NTDs and two ciliogenesis pathways, tight junction and protein kinase A signaling, are potential pathways involved in NTD pathogenesis.	[Chen, Xiaoli; Gao, Yonghui; Zhao, Huizhi; Xie, Hua; Guo, Jin; Bao, Yihua; Zhang, Ting] Capital Inst Pediat, Beijing, Peoples R China; [Chen, Xiaoli; Shen, Yiping; Sheng, Xiaoming; Lip, Va; Shao, Hong; Wu, Bai-Lin] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Chen, Xiaoli; Shen, Yiping; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Shen, Yiping] Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Shen, Yiping; Gusella, James F.; Wu, Bai-Lin] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Yonghui] China Acad Chinese Med Sci, Inst Acumoxibust, Beijing, Peoples R China; [Zou, Jizhen] Capital Inst Pediat, Dept Pathol, Beijing, Peoples R China; [Shen, Jianliang] Navy Gen Hosp PLA, Dept Hematol, Beijing, Peoples R China; [Niu, Bo] Capital Inst Pediat, Dept Biotechnol, Beijing, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Shanghai Med Coll, Childrens Hosp, Shanghai 200433, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Capital Institute of Pediatrics (CIP); Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; China Academy of Chinese Medical Sciences; Capital Institute of Pediatrics (CIP); Sixth Medical Center of Chinese PLA General Hospital; Capital Institute of Pediatrics (CIP); Fudan University; Fudan University	Wu, BL (corresponding author), Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA.	Bai-Lin.Wu@childrens.harvard.edu; zhangtingcv@yahoo.com.cn			Ministry of Science and Technology of P. R. China; National "973" Program on Population and Health [2013CB945404, 2010CB529601]; National Nature Science Fund [81100841]; Beijing Excellent Scientist Fund [20061A0303200108]; Chinese Returned Oversea Scientist Fund; Beijing Science and Technology; Shanghai Science Fund [09JC1402400, 09ZR1404500]	Ministry of Science and Technology of P. R. China(Ministry of Science and Technology, China); National "973" Program on Population and Health; National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Beijing Excellent Scientist Fund; Chinese Returned Oversea Scientist Fund; Beijing Science and Technology; Shanghai Science Fund	This work was jointly supported by the Ministry of Science and Technology of P. R. China, the National "973" Program on Population and Health (2013CB945404 to TZ; 2010CB529601 to BLW), the National Nature Science Fund (81100841 to XLC), the Beijing Excellent Scientist Fund (20061A0303200108 to XLC), Chinese Returned Oversea Scientist Fund to XLC by Beijing Science and Technology, and the Shanghai Science Fund (09JC1402400 and 09ZR1404500 to BLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allache R, 2012, BIRTH DEFECTS RES A, V94, P176, DOI 10.1002/bdra.23002; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bosoi CM, 2011, HUM MUTAT, V32, P1371, DOI 10.1002/humu.21589; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Boyles AL, 2005, AM J MED GENET C, V135C, P9, DOI 10.1002/ajmg.c.30048; Cameron M, 2009, PRENATAL DIAG, V29, P402, DOI 10.1002/pd.2250; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen CP, 2008, TAIWAN J OBSTET GYNE, V47, P131, DOI 10.1016/S1028-4559(08)60070-4; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; De Marco P, 2012, HUM MUTAT, V33, P384, DOI 10.1002/humu.21643; Dheen ST, 2009, CURR MED CHEM, V16, P2345, DOI 10.2174/092986709788453069; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuchtbaum LB, 1999, GENET TEST, V3, P265, DOI 10.1089/109065799316572; Gao YH, 2012, REPROD SCI, V19, P764, DOI 10.1177/1933719111433886; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Guo J, 2012, GENES NUTR; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Hong E, 2010, DEV BIOL, V341, P335, DOI 10.1016/j.ydbio.2010.01.034; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Hume RF, 1996, AM J MED GENET, V61, P171, DOI 10.1002/(SICI)1096-8628(19960111)61:2<171::AID-AJMG14>3.3.CO;2-X; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kanit H, 2011, CLIN DYSMORPHOL, V20, P190, DOI 10.1097/MCD.0b013e328348d99d; Kennedy D, 1998, AM J MED GENET, V77, P317, DOI 10.1002/(SICI)1096-8628(19980526)77:4<317::AID-AJMG13>3.0.CO;2-L; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kibar Z, 2011, CLIN GENET, V80, P76, DOI 10.1111/j.1399-0004.2010.01515.x; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kibar Z, 2009, HUM MUTAT, V30, pE706, DOI 10.1002/humu.21026; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Mazzitelli N, 2002, TERATOLOGY, V66, P105, DOI 10.1002/tera.10053; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nielsen LAG, 2006, APMIS, V114, P239, DOI 10.1111/j.1600-0463.2006.apm_325.x; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinar H, 1998, PEDIATR DEVEL PATHOL, V1, P42, DOI 10.1007/s100249900005; Rajcan-Separovic E, 2010, MOL HUM REPROD, V16, P125, DOI 10.1093/molehr/gap083; Rampersaud E, 2006, NEURAL TUBE DEFECTS; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Salonen R, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2010.255; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sepulveda W, 2004, ULTRASOUND OBST GYN, V23, P352, DOI 10.1002/uog.964; Shang YL, 2008, BIRTH DEFECTS RES A, V82, P3, DOI 10.1002/bdra.20416; Shen YP, 2009, CLIN CHEM, V55, P659, DOI 10.1373/clinchem.2008.112821; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Wang JH, 2011, REPROD SCI, V18, P556, DOI 10.1177/1933719110393026; Xiao K Z, 1989, Zhonghua Yi Xue Za Zhi, V69, P189; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang T, 2009, PUBLIC HEALTH NUTR, V12, P680, DOI 10.1017/S1368980008002735; Zhao HZ, 2012, GENE, V505, P340, DOI 10.1016/j.gene.2012.05.035	67	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54492	10.1371/journal.pone.0054492	http://dx.doi.org/10.1371/journal.pone.0054492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349908	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900072
J	Wang, YT; Kuo, PH; Chiang, CH; Liang, JR; Chen, YR; Wang, SY; Shen, JCK; Yuan, HNS				Wang, Yi-Ting; Kuo, Pan-Hsien; Chiang, Chien-Hao; Liang, Jhe-Ruei; Chen, Yun-Ru; Wang, Shuying; Shen, James C. K.; Yuan, Hanna S.			The Truncated C-terminal RNA Recognition Motif of TDP-43 Protein Plays a Key Role in Forming Proteinaceous Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN-43; NEURONAL INCLUSIONS; SOLUTION SCATTERING; CELLULAR TOXICITY; AMYLOID FIBRILS; CFTR EXON-9; MUTATIONS	TDP-43 is the major pathological protein identified in the cellular inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The pathogenic forms of TDP-43 are processed C-terminal fragments containing a truncated RNA-recognition motif (RRM2) and a glycine-rich region. Although extensive studies have focused on this protein, it remains unclear how the dimeric full-length TDP-43 is folded and assembled and how the processed C-terminal fragments are misfolded and aggregated. Here, using size-exclusion chromatography, pulldown assays, and small angle x-ray scattering, we show that the C-terminal- deleted TDP-43 without the glycine-rich tail is sufficient to form a head-to-head homodimer primarily via its N-terminal domain. The truncated RRM2, as well as two beta-strands within the RRM2, form fibrils in vitro with a similar amyloid-negative staining property to those of TDP-43 pathogenic fibrils in diseases. In addition to the glycine-rich region, the truncated RRM2, but not the intact RRM2, plays a key role in forming cytoplasmic inclusions in neuronal cells. Our data thus suggest that the process that disrupts the dimeric structure, such as the proteolytic cleavage of TDP-43 within the RRM2 that removes the N-terminal dimerization domain, may produce unassembled truncated RRM2 fragments with abnormally exposed beta-strands, which can oligomerize into high-order inclusions.	[Wang, Yi-Ting; Kuo, Pan-Hsien; Chiang, Chien-Hao; Liang, Jhe-Ruei; Shen, James C. K.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chiang, Chien-Hao] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Liang, Jhe-Ruei] Natl Yang Ming Univ, Dept Life Sci, Inst Genome Sci, Taipei 11221, Taiwan; [Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70457, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70457, Taiwan; [Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10048, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Yuan, HNS (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	hanna@sinica.edu.tw	Kuo, Po-Hsiu/H-9882-2013; Yuan, Hanna S./AAA-4005-2021; shen, Che-Kun James/L-1343-2015; Chen, Yun-Ru/C-9304-2014; wang, shuying/HHZ-4516-2022	Yuan, Hanna S./0000-0001-9671-6967; Chen, Yun-Ru/0000-0002-6596-6338; 	Academia Sinica; National Science Council (Taiwan)	Academia Sinica(Academia Sinica - Taiwan); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica (to H. Y. and J. C. K. S.) and the National Science Council (Taiwan) (to H. Y. and J. C. K. S.).	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	60	74	74	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9049	9057		10.1074/jbc.M112.438564	http://dx.doi.org/10.1074/jbc.M112.438564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23372158	Green Published, hybrid			2022-12-25	WOS:000316862200024
J	Nakashima, M; Shirogane, Y; Hashiguchi, T; Yanagi, Y				Nakashima, Mai; Shirogane, Yuta; Hashiguchi, Takao; Yanagi, Yusuke			Mutations in the Putative Dimer-Dimer Interfaces of the Measles Virus Hemagglutinin Head Domain Affect Membrane Fusion Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTION; PARAMYXOVIRUS FUSION; CRYSTAL-STRUCTURE; VACCINIA VIRUS; 4-HELIX BUNDLE; HN PROTEIN; F-PROTEIN; NEURAMINIDASE; STALK; ACTIVATION	Measles virus (MV), an enveloped RNA virus belonging to the Paramyxoviridae family, enters the cell through membrane fusion mediated by two viral envelope proteins, an attachment protein hemagglutinin (H) and a fusion (F) protein. The crystal structure of the receptor-binding head domain of MV-H bound to its cellular receptor revealed that the MV-H head domain forms a tetrameric assembly (dimer of dimers), which occurs in two forms (forms I and II). In this study, we show that mutations in the putative dimer-dimer interface of the head domain in either form inhibit the ability of MV-H to support membrane fusion, without greatly affecting its cell surface expression, receptor binding, and interaction with the F protein. Notably, some anti-MV-H neutralizing monoclonal antibodies are directed to the region around the dimer-dimer interface in form I rather than receptor-binding sites. These observations suggest that the dimer-dimer interactions of the MV-H head domain, especially that in form I, contribute to triggering membrane fusion, and that conformational shift of head domain tetramers plays a role in the process. Furthermore, our results indicate that although the stalk and transmembrane regions may be mainly responsible for the tetramer formation of MV-H, the head domain alone can form tetramers, albeit at a low efficiency.	[Nakashima, Mai; Shirogane, Yuta; Yanagi, Yusuke] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan; [Nakashima, Mai] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Hashiguchi, Takao] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Kyushu University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Shirogane, Y (corresponding author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan.	yuuta@virology.med.kyushu-u.ac.jp; yyanagi@virology.med.kyushu-u.ac.jp	Shirogane, Yuta/AAO-1073-2021	Shirogane, Yuta/0000-0002-4284-0310; Hashiguchi, Takao/0000-0001-7578-7571; Yanagi, Yusuke/0000-0001-7815-1667	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21249032, 24115005]; Japan Society for the Promotion of Science	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan and by Grants-in-Aid for Scientific Research 21249032 and 24115005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad.	Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; Bair CH, 1996, J VIROL, V70, P4655, DOI 10.1128/JVI.70.7.4655-4666.1996; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Brindley MA, 2012, P NATL ACAD SCI USA, V109, pE3018, DOI 10.1073/pnas.1210925109; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Ennis MK, 2010, J VIROL, V84, P10913, DOI 10.1128/JVI.00789-10; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; MCFARLIN DE, 1980, J GEN VIROL, V48, P425, DOI 10.1099/0022-1317-48-2-425; MCGINNES L, 1993, VIROLOGY, V196, P101, DOI 10.1006/viro.1993.1458; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Navaratnarajah CK, 2012, J BIOL CHEM, V287, P38543, DOI 10.1074/jbc.M112.410563; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; YANAGI Y, 1992, VIROLOGY, V187, P280, DOI 10.1016/0042-6822(92)90316-H; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2008, VIROLOGY, V378, P282, DOI 10.1016/j.virol.2008.05.023; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	35	8	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8085	8091		10.1074/jbc.M112.427609	http://dx.doi.org/10.1074/jbc.M112.427609			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362271	hybrid, Green Published			2022-12-25	WOS:000316564500009
J	Goller, T; Seibold, UK; Kremmer, E; Voos, W; Kolanus, W				Goller, Tobias; Seibold, Ursula K.; Kremmer, Elisabeth; Voos, Wolfgang; Kolanus, Waldemar			Atad3 Function Is Essential for Early Post-Implantation Development in the Mouse	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; M-AAA PROTEASE; MITOCHONDRIAL FUSION; MAMMALIAN-CELLS; MOLECULAR CHARACTERIZATION; CRISTAE MORPHOGENESIS; ENDOPLASMIC-RETICULUM; ANTIOXIDANT ENZYMES; CANCER-CELLS; C-ELEGANS	The mitochondrial AAA+-ATPase ATAD3 is implicated in the regulation of mitochondrial and ER dynamics and was shown to be necessary for larval development in Caenorhabditis elegans. In order to elucidate the relevance of ATAD3 for mammalian development, the phenotype of an Atad3 deficient mouse line was analyzed. Atad3 deficient embryos die around embryonic day E7.5 due to growth retardation and a defective development of the trophoblast lineage immediately after implantation into the uterus. This indicates an essential function of Atad3 for the progression of the first steps of post-implantation development at a time point when mitochondrial biogenesis and ATP production by oxidative phosphorylation are required. Therefore, murine Atad3 plays an important role in the biogenesis of mitochondria in trophoblast stem cells and in differentiating trophoblasts. At the biochemical level, we report here that ATAD3 is present in five native mitochondrial protein complexes of different sizes, indicating complex roles of the protein in mitochondrial architecture and function.	[Goller, Tobias; Kolanus, Waldemar] Univ Bonn, LIMES Inst, Program Unit Mol Cell & Immune Biol, Bonn, Germany; [Seibold, Ursula K.; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Mol Immunol, Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kolanus, W (corresponding author), Univ Bonn, LIMES Inst, Program Unit Mol Cell & Immune Biol, Bonn, Germany.	wkolanus@uni-bonn.de			Deutsche Forschungsgemeinschaft (DFG) [SFB704]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, SFB704).	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Bavister BD, 2006, REPROD FERT DEVELOP, V18, P829, DOI 10.1071/RD06111; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BROWN GC, 1992, BIOCHEM J, V284, P1; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034; Fisher B, 1993, J REPROD FERTIL, V99, P673; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Geuijen CAW, 2005, EUR J CANCER, V41, P178, DOI 10.1016/j.ejca.2004.10.008; Gilquin B, 2010, MOL CELL BIOL, V30, P2724, DOI 10.1128/MCB.01468-09; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017; Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Merle N, 2012, MITOCHONDRION, V12, P441, DOI 10.1016/j.mito.2012.05.005; Neuwald AF, 1999, GENOME RES, V9, P27; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	75	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54799	10.1371/journal.pone.0054799	http://dx.doi.org/10.1371/journal.pone.0054799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372768	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400030
J	Huang, CY; Chen, YM; Zhao, JJ; Chen, YB; Jiang, SS; Yan, SM; Zhao, BW; Pan, K; Wang, DD; Lv, L; Li, YF; Wang, W; Zhou, ZW; Xia, JC				Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan			Decreased Expression of Transcription Elongation Factor A-Like 7 Is Associated with Gastric Adenocarcinoma Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; C-MYC ACTIVITY; EARLY-STAGE; TCEAL7	Background: We sought to investigate the expression levels and prognosis value of TCEAL7 in primary gastric cancer. Methods and Results: We investigated TCEAL7 and other homologous five members of the TCEAL family expression in normal gastricepithelial cell line and gastric cancer cell lines using real-time quantitative PCR. Furthermore, we examined the expression of TCEAL7 in 39 paired cancerous and matched adjacent noncancerous gastric mucosa tissues by real-time quantitative PCR and western blotting. Moreover, we analyzed TCEAL7 expression in 406 gastric cancer patients using immunohistochemistry. The relationships between the TCEAL7 expression levels, the clinicopathological factors, and patient survival were investigated. RT-qPCR data showed that mRNA expression level of TCEAL7 was significantly lower in the gastric cancer cell lines comparing with the levels of other five members of the TCEAL family. Results also revealed decreased TCEAL7 mRNA (P = 0.025) and protein (P = 0.012) expression in tumor tissue samples compared with matched adjacent non-tumor tissue samples. Immunohistochemical staining data showed that TCEAL7 expression was significantly decreased in 43.3% of gastric adenocarcinoma cases. The result also showed that the low TCEAL7 expression was significantly correlated with female, larger tumor size, higher histological grade and worse nodal status. Kaplan-Meier survival curves revealed that the reduced expression of TCEAL7 was associated with a poor prognosis in gastric adenocarcinoma patients (P<0.001). Based on a univariate analysis that included all 406 patients, TCEAL7 expression was found to have statistically significant associations with overall survival (P<0.001). Multivariate analysis also demonstrated that TCEAL7 expression (P = 0.009), age, tumor size, histological grade, lymphovascular invasion, T stage, N stage and M stage were independent risk factors in the prognosis of gastric cancer patients. Conclusions: Our study suggests that TCEAL7 might serve as a candidate tumor suppressor and a potential prognostic biomarker in gastric carcinogenesis.	[Huang, Chun-yu; Chen, Yong-ming; Zhao, Bai-wei; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-mei] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, ZW (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China.	zhouzhw@sysucc.org.cn; xiajch@mail.sysu.edu.cn	Chen, Yongming/E-3656-2015; Li, Yuan/GXV-1310-2022	Chen, Yongming/0000-0003-2843-5543; 	National Natural Science Foundation of China [30973398]; Science and Technology Projects of Guangdong Province [2008B030301103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects of Guangdong Province	This work was supported by the National Natural Science Foundation of China Grant 30973398 and Science and Technology Projects of Guangdong Province (2008B030301103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-260; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Chien J, 2005, ONCOGENE, V24, P5089, DOI 10.1038/sj.onc.1208700; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lafferty-Whyte K, 2010, NEOPLASIA, V12, P405, DOI 10.1593/neo.10180; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Makino H, 2005, DIS ESOPHAGUS, V18, P37, DOI 10.1111/j.1442-2050.2005.00432.x; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Peedicayil A, 2009, GYNECOL ONCOL, V114, P260, DOI 10.1016/j.ygyno.2009.03.038; Pillutla RC, 1999, GENOMICS, V56, P217, DOI 10.1006/geno.1998.5705; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Shridhar V, 2002, CANCER RES, V62, P262; Shridhar V, 2001, CANCER RES, V61, P5895; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019; Zhao JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026608	21	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54671	10.1371/journal.pone.0054671	http://dx.doi.org/10.1371/journal.pone.0054671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372750	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400023
J	Rink, L; Ochs, MF; Zhou, Y; von Mehren, M; Godwin, AK				Rink, Lori; Ochs, Michael F.; Zhou, Yan; von Mehren, Margaret; Godwin, Andrew K.			ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CANCER-CELL-LINES; INTERSTITIAL-CELLS; OVARIAN-CARCINOMA; AKT/PKB PATHWAY; KIT MUTATIONS; BREAST-CANCER; PHASE-II; CAS-L; EXPRESSION	Although imatinib mesylate (IM) has transformed the treatment of gastrointestinal stromal tumors (GIST), many patients experience primary/secondary drug resistance. In a previous study, we identified a gene signature, consisting mainly of Kruppel-associated box (KRAB) domain containing zinc finger (ZNF) transcriptional repressors that predict short-term response to IM. To determine if these genes have functional significance, a siRNA library targeting these genes was constructed and applied to GIST cells in vitro. These screens identified seventeen "IM sensitizing genes'' in GIST cells (sensitization index (SI) <0.85 ratio of drug/vehicle) with a false discovery rate (FDR) <15%, including twelve ZNF genes, the majority of which are located within the HSA19p12-13.1 locus. These genes were shown to be highly specific to IM and another tyrosine kinase inhibitor (TKI), sunitinib, in GIST cells. In order to determine mechanistically how these ZNFs might be modulating response to IM, RNAi approaches were used to individually silence genes within the predictive signature in GIST cells and expression profiling was performed. Knockdown of the 14 IM-sensitizing genes (10 ZNFs) universally led to downregulation of six genes, including TGFb3, periostin, and NEDD9. These studies implicate a role of KRAB-ZNFs in modulating response to TKIs in GIST.	[Rink, Lori; von Mehren, Margaret] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Hlth Sci Informat, Baltimore, MD USA; [Zhou, Yan] Fox Chase Canc Ctr, Dept Stat, Philadelphia, PA 19111 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA	Fox Chase Cancer Center; Johns Hopkins University; Johns Hopkins University; Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rink, L (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Lori.Rink@fccc.edu			NCI [R01 CA106588, K99 CA158061-01A1]; NIH [UL1 TR000001-02S1]; National Institutes of Health [CA-06927]; Kansas Bioscience Authority Eminent Scholar Program; KUMC; GIST Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA106588, K99CA158065, P30CA006927] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Bioscience Authority Eminent Scholar Program; KUMC; GIST Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the NCI R01 CA106588 (MvM & AKG), and K99 CA158061-01A1 (LR), the NIH UL1 TR000001-02S1 (AKG) and the National Institutes of Health core grant CA-06927. The authors would especially like to thank the GIST Cancer Research Fund for their continued support. The authors would also like to acknowledge support from the Kansas Bioscience Authority Eminent Scholar Program and the Chancellors Distinguished Chair in Biomedical Sciences endowment at KUMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chang MH, 2008, J MOL ENDOCRINOL, V41, P65, DOI 10.1677/JME-08-0051; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Chou A, 2012, MODERN PATHOL, V25, P1307, DOI 10.1038/modpathol.2012.77; Corless CL, 2008, ANNU REV PATHOL-MECH, V3, P557, DOI 10.1146/annurev.pathmechdis.3.121806.151538; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Couch FJ, 2012, CANCER EPIDEM BIOMAR, V21, P645, DOI 10.1158/1055-9965.EPI-11-0888; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Demetri GD, 2002, CANCER INVEST, V20, P853, DOI 10.1081/CNV-120002501; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Dupart JJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-99; El-Rifai W, 2000, CANCER RES, V60, P3899; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Frolov A, 2003, MOL CANCER THER, V2, P699; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gillan L, 2002, CANCER RES, V62, P5358; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Heinrich MC, 2005, J SURG ONCOL, V90, P195, DOI 10.1002/jso.20230; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Italiano A, 2012, EUR J CANC; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; MAZUR MT, 1983, AM J SURG PATHOL, V7, P507, DOI 10.1097/00000478-198309000-00001; Micci F, 2010, GENE CHROMOSOME CANC, V49, P1046, DOI 10.1002/gcc.20813; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Miettinen Markku, 2003, Polish Journal of Pathology, V54, P3; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sasaki T, 2005, STROKE, V36, P2457, DOI 10.1161/01.STR.0000185672.10390.30; Seyhan AA, 2012, MOL BIOSYST, V8, P1553, DOI 10.1039/c2mb05512k; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sircar K, 1999, AM J SURG PATHOL, V23, P377, DOI 10.1097/00000478-199904000-00002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Strauss LG, 2012, SCI WORLD J, DOI 10.1100/2012/721313; Streit S, 2009, PANCREATOLOGY, V9, P577, DOI 10.1159/000212084; Subramanian S, 2004, ONCOGENE, V23, P7780, DOI 10.1038/sj.onc.1208056; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tarn C, 2005, CLIN CANCER RES, V11, P3668, DOI 10.1158/1078-0432.CCR-04-2515; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Thao LB, 2009, CANCER BIOL THER, V8, P683, DOI 10.4161/cbt.8.8.7779; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	66	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54477	10.1371/journal.pone.0054477	http://dx.doi.org/10.1371/journal.pone.0054477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372733	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400018
J	Aquilina, A; Connelly, DP; Copley, JT; Green, DRH; Hawkes, JA; Hepburn, LE; Huvenne, VAI; Marsh, L; Mills, RA; Tyler, PA				Aquilina, Alfred; Connelly, Douglas P.; Copley, Jon T.; Green, Darryl R. H.; Hawkes, Jeffrey A.; Hepburn, Laura E.; Huvenne, Veerle A. I.; Marsh, Leigh; Mills, Rachel A.; Tyler, Paul A.			Geochemical and Visual Indicators of Hydrothermal Fluid Flow through a Sediment-Hosted Volcanic Ridge in the Central Bransfield Basin (Antarctica)	PLOS ONE			English	Article							SURFACE SEDIMENTS; MARINE-SEDIMENTS; GUAYMAS BASIN; SOUTH KYUSHU; HOOK RIDGE; STRAIT; WATER; OCEAN; VENT; GULF	In the austral summer of 2011 we undertook an investigation of three volcanic highs in the Central Bransfield Basin, Antarctica, in search of hydrothermal activity and associated fauna to assess changes since previous surveys and to evaluate the extent of hydrothermalism in this basin. At Hook Ridge, a submarine volcanic edifice at the eastern end of the basin, anomalies in water column redox potential (E-h) were detected close to the seafloor, unaccompanied by temperature or turbidity anomalies, indicating low-temperature hydrothermal discharge. Seepage was manifested as shimmering water emanating from the sediment and from mineralised structures on the seafloor; recognisable vent endemic fauna were not observed. Pore fluids extracted from Hook Ridge sediment were depleted in chloride, sulfate and magnesium by up to 8% relative to seawater, enriched in lithium, boron and calcium, and had a distinct strontium isotope composition (Sr-87/Sr-86 = 0.708776 at core base) compared with modern seawater (Sr-87/Sr-86 approximate to 0.70918), indicating advection of hydrothermal fluid through sediment at this site. Biogeochemical zonation of redox active species implies significant moderation of the hydrothermal fluid with in situ diagenetic processes. At Middle Sister, the central ridge of the Three Sisters complex located about 100 km southwest of Hook Ridge, small water column E-h anomalies were detected but visual observations of the seafloor and pore fluid profiles provided no evidence of active hydrothermal circulation. At The Axe, located about 50 km southwest of Three Sisters, no water column anomalies in E-h, temperature or turbidity were detected. These observations demonstrate that the temperature anomalies observed in previous surveys are episodic features, and suggest that hydrothermal circulation in the Bransfield Strait is ephemeral in nature and therefore may not support vent biota.	[Aquilina, Alfred; Copley, Jon T.; Hawkes, Jeffrey A.; Hepburn, Laura E.; Marsh, Leigh; Mills, Rachel A.; Tyler, Paul A.] Univ Southampton, Southampton, Hants, England; [Connelly, Douglas P.; Green, Darryl R. H.; Hawkes, Jeffrey A.; Huvenne, Veerle A. I.] Natl Oceanog Ctr, Southampton, Hants, England	University of Southampton; NERC National Oceanography Centre	Aquilina, A (corresponding author), Univ Southampton, Waterfront Campus,European Way, Southampton, Hants, England.	Alfred.Aquilina@noc.soton.ac.uk	Marsh, Leigh/AAT-5597-2020; Copley, Jon/I-7076-2012; Marsh, Leigh/J-6068-2013; Hepburn, Laura/AAW-4324-2021; Mills, Rachel A/A-1150-2011	Marsh, Leigh/0000-0002-4613-1538; Copley, Jon/0000-0003-3333-4325; Marsh, Leigh/0000-0002-4613-1538; Mills, Rachel A/0000-0002-9811-246X; Huvenne, Veerle A.I./0000-0001-7135-6360; Hepburn, Laura/0000-0003-3336-5340	NERC [NE/DO1249X/1, NE/DO1429X/1, NE/H524922]; NERC [NE/D01249X/1, NE/D013437/1] Funding Source: UKRI; Natural Environment Research Council [NE/D013437/1, NE/D01249X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a NERC consortium grant NE/DO1249X/1 and NERC PhD studentships NE/DO1429X/1 (LH and LM) and NE/H524922 (JH). The funders had no role in study design, data collection and analysis, decision to publish, of preparation of the manuscript.	Alt J. C., 1995, GEOPHYS MONOGR SER, V91, P85, DOI DOI 10.1029/GM091P0085; Baker ET, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002028; Baker ET, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000948; Bennett SA, 2011, GEOCHIM COSMOCHIM AC, V75, P5526, DOI 10.1016/j.gca.2011.06.039; BISCHOFF JL, 1978, AM J SCI, V278, P838, DOI 10.2475/ajs.278.6.838; Bohrmann G, 1999, GEO-MAR LETT, V18, P277, DOI 10.1007/s003670050080; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Butterfield DA., 2003, ENERGY MASS TRANSFER, P123; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Dahlmann A, 2001, EARTH PLANET SC LETT, V193, P381, DOI 10.1016/S0012-821X(01)00535-0; DeMaster DJ, 1988, US ANTARC J, V23, P94; German C.R., 2006, TREATISE GEOCHEMISTR, V6, P45, DOI 10.1016/B0-08-043751-6/06109-0; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; Gonzalez-Ferran O., 1991, GEOLOGICAL EVOLUTION, P505; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Howe JA, 2007, DEEP-SEA RES PT II, V54, P1652, DOI 10.1016/j.dsr2.2007.07.007; Ishibashi JI, 2008, J VOLCANOL GEOTH RES, V173, P84, DOI 10.1016/j.jvolgeores.2007.12.041; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; KELLER RA, 1992, EARTH PLANET SC LETT, V111, P287, DOI 10.1016/0012-821X(92)90185-X; Klinkhammer GP, 2001, EARTH PLANET SC LETT, V193, P395, DOI 10.1016/S0012-821X(01)00536-2; Klinkhammer GP, 1996, ANTARCT J US, V31, P92; Laurila TE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004247; Lawver LA, 1996, GSA TODAY, V6, P1; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; MAGENHEIM AJ, 1992, GEOCHIM COSMOCHIM AC, V56, P2329, DOI 10.1016/0016-7037(92)90192-L; MARIS CRP, 1982, SCIENCE, V216, P623, DOI 10.1126/science.216.4546.623; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Mills RA, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003157; Nakaseama M, 2008, RESOUR GEOL, V58, P289, DOI 10.1111/j.1751-3928.2008.00062.x; Petersen S, 2004, MINER DEPOSITA, V39, P358, DOI 10.1007/s00126-004-0414-3; Pontbriand CW, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004187; Prieto MJ, 1998, MAR GEOL, V149, P17, DOI 10.1016/S0025-3227(98)00038-3; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; SCHLOSSER P, 1988, DEEP-SEA RES, V35, P1919, DOI 10.1016/0198-0149(88)90117-3; Solorzano L, 1969, ANAL CHEM, V33, P592; SOUTHWAR.EC, 1972, B MAR SCI, V22, P739; Suess E, 1987, ANTARCT J US, V22, P46; VONBREYMANN MT, 1990, GEOCHIM COSMOCHIM AC, V54, P3295, DOI 10.1016/0016-7037(90)90286-T; VONBREYMANN MT, 1988, CHEM GEOL, V70, P359, DOI 10.1016/0009-2541(88)90125-8; VONDAMM KL, 1985, GEOCHIM COSMOCHIM AC, V49, P2221, DOI 10.1016/0016-7037(85)90223-6; Wang YM, 1998, GEOSTANDARD NEWSLETT, V22, P247, DOI 10.1111/j.1751-908X.1998.tb00697.x; Webb M, 1964, SARSIA, V15, P49; WHITICAR MJ, 1985, NATURE, V314, P87, DOI 10.1038/314087a0; Wilson C, 1999, J PHYS OCEANOGR, V29, P465, DOI 10.1175/1520-0485(1999)029<0465:HWTCAE>2.0.CO;2; Winckler G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042093	48	23	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54686	10.1371/journal.pone.0054686	http://dx.doi.org/10.1371/journal.pone.0054686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359806	Green Published, Green Accepted, gold			2022-12-25	WOS:000314023600093
J	Christensen, L; Joo, J; Lee, S; Wai, D; Triche, TJ; May, WA				Christensen, Laura; Joo, Jay; Lee, Sean; Wai, Daniel; Triche, Timothy J.; May, William A.			FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma	PLOS ONE			English	Article							FORKHEAD BOX M1; PROTEASOME INHIBITOR BORTEZOMIB; TRANSCRIPTION FACTOR FOXM1; CANCER-CELLS; TARGET; EXPRESSION; TUMORS; GLI1; THIOSTREPTON; GENE	Ewing Family Tumors (Ewing Sarcoma and peripheral Primitive Neuroectodermal Tumor) are common bone and soft tissue malignancies of childhood, adolescence and young adulthood. Chromosomal translocation in these tumors produces fusion oncogenes of the EWS/ETS class, with EWS/FLI1 being by far the most common. EWS/ETS chimera are the only well established driver mutations in these tumors and they function as aberrant transcription factors. Understanding the downstream genes whose expression is modified has been a central approach to the study of these tumors. FOXM1 is a proliferation associated transcription factor which has increasingly been found to play a role in the pathogenesis of a wide range of human cancers. Here we demonstrate that FOXM1 is expressed in Ewing primary tumors and cell lines. Reduction in FOXM1 expression in Ewing cell lines results in diminished potential for anchorage independent growth. FOXM1 expression is enhanced by EWS/FLI1, though, unlike other tumor systems, it is not driven by expression of the EWS/FLI1 target GLI1. Thiostrepton is a compound known to inhibit FOXM1 by direct binding. We show that Thiostrepton diminishes FOXM1 expression in Ewing cell lines and this reduction reduces cell viability through an apoptotic mechanism. FOXM1 is involved in Ewing tumor pathogenesis and may prove to be a useful therapeutic target in Ewing tumors.	[Christensen, Laura; Joo, Jay; Lee, Sean; May, William A.] Univ So Calif, Keck Sch Med, Div Hematol Oncol, Dept Pediat,Saban Res Inst,Childrens Hosp Los Ang, Los Angeles, CA 90033 USA; [Wai, Daniel; Triche, Timothy J.] Univ So Calif, Keck Sch Med, Dept Pathol, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California	May, WA (corresponding author), Univ So Calif, Keck Sch Med, Div Hematol Oncol, Dept Pediat,Saban Res Inst,Childrens Hosp Los Ang, Los Angeles, CA 90033 USA.	wmay@chla.usc.edu		Wai, Daniel H/0000-0002-4385-4941	NIH [1R21CA137485]; Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R21CA137485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by NIH grant 1R21CA137485. It has also been funded by the Alex's Lemonade Stand Foundation, the Mark Herzlich Research Award from the Sarcoma Foundation of America, and a Research Grant from the St. Baldrick's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Gartel AL, 2011, CELL CYCLE, V10, P4341, DOI 10.4161/cc.10.24.18544; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P37, DOI 10.1002/pbc.21214; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Lu GR, 2008, CANCER BIOL THER, V7, P603, DOI 10.4161/cbt.7.4.5564; Maki RG, 2005, CANCER-AM CANCER SOC, V103, P1431, DOI 10.1002/cncr.20968; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Miser JS, 2004, J CLIN ONCOL, V22, P2873, DOI 10.1200/JCO.2004.01.041; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Teh MT, 2002, CANCER RES, V62, P4773; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xia LM, 2009, J CELL BIOCHEM, V106, P247, DOI 10.1002/jcb.21996; Yau C, 2011, BREAST CANCER RES TR, V126, P803, DOI 10.1007/s10549-011-1345-1; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	40	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54556	10.1371/journal.pone.0054556	http://dx.doi.org/10.1371/journal.pone.0054556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365673	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600069
J	Huang, F; Yang, Z; Xu, BH; Bi, YF; Xu, M; Xu, Y; Lu, JL; Liu, Y; Dai, M; Zhou, WZ; Wang, WQ; Chen, YH				Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong			Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY INTIMA; RISK-FACTORS; ATHEROSCLEROSIS; PREDICTION; MEN; PREVENTION; CLASSIFICATION	Background: Previous studies indicated that apolipoprotein measurements predicted cardiovascular disease (CVD) risk; however, associations between apolipoproteins and carotid intima-media thickness (CIMT) were less explored. Methodology and Principal Findings: The cross-sectional study included 6069 participants aged 40 years or older with NGT from Shanghai, China. Serum fasting traditional lipids (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C] and triglycerides [TG]), apoA-I and apoB were assessed. A high-resolution B-mode ultrasonography was performed to measure CIMT. We found CIMT increased progressively across the quartiles of serum apoB (p for trend <0.0001). In logistic regression, concentrations of apoB (odds ratio [OR] 1.27, 95% confidence interval [CI] 1.18-1.36), TC (OR 1.23, 95% CI 1.14-1.32), LDL-C (OR 1.25, 95% CI 1.16-1.34) and TG (OR 1.11, 95% CI 1.04-1.20) were significantly related to elevated CIMT after adjusted for age and sex. Meanwhile, the apoB/apoA-I ratio (OR 1.25, 95% CI 1.17-1.34) related to elevated CIMT. ApoB (OR 1.23, 95% CI 1.00-1.51) and the apoB/apoA-I ratio (OR 1.19, 95% CI 1.04-1.36) remained significantly associated with elevated CIMT, after adjusted for the traditional CVD risk factors including traditional lipids. Conclusions and Significance: There were significant associations between serum apoB, the apoB/apoA-I ratio and elevated CIMT. Serum apoB and the apoB/apoA-I ratio might be independent predictors of early atherosclerosis in NGT.	[Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,E Inst Shangai Univ, Shanghai 200030, Peoples R China; [Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, YH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,E Inst Shangai Univ, Shanghai 200030, Peoples R China.	chenyh70@yahoo.com.cn			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Health [201002002]; Ministry of Science and Technology [2012ZX09303006-001]; Creative Research Group of Ministry of Education [IRT0932]; National Nature Science Foundation of China [81170739, 81170719, 81222008, 30911120493]; Shanghai Science and Technology Commission [09411954400, 10XD1403000]; Shanghai Natural Science Foundation [10ZR1426400]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Creative Research Group of Ministry of Education; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the Creative Research Group of Ministry of Education (IRT0932), National Nature Science Foundation of China (81170739, 81170719, 81222008, 30911120493), Shanghai Science and Technology Commission (09411954400), Shanghai Science and Technology Commission (10XD1403000), Shanghai Natural Science Foundation (NO. 10ZR1426400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; Dahlen EM, 2009, DIABETIC MED, V26, P384, DOI 10.1111/j.1464-5491.2009.02693.x; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Genest J, 2003, CAN MED ASSOC J, V169, P921; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Hsia SH, 2006, AM J CARDIOL, V98, P1047, DOI 10.1016/j.amjcard.2006.05.024; Huang Y, 2011, J CLIN ENDOCR METAB, V96, pE1461, DOI 10.1210/jc.2010-2697; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Juonala M, 2008, J AM COLL CARDIOL, V52, P293, DOI 10.1016/j.jacc.2008.03.054; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meisinger C, 2005, EUR HEART J, V26, P271, DOI 10.1093/eurheartj/ehi003; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Olofsson SO, 2007, VASC HEALTH RISK MAN, V3, P491; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Shaw JE, 2000, DIABETES CARE, V23, pB5; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; St-Pierre AC, 2003, AM J CARDIOL, V91, P555, DOI 10.1016/S0002-9149(02)03305-2; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; van Deventer HE, 2011, CLIN CHEM, V57, P490, DOI 10.1373/clinchem.2010.154773; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Williams K, 2003, CIRCULATION, V108, P2312, DOI 10.1161/01.CIR.0000097113.11419.9E	31	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54628	10.1371/journal.pone.0054628	http://dx.doi.org/10.1371/journal.pone.0054628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359805	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600081
J	Steckel, J; Peremans, H				Steckel, Jan; Peremans, Herbert			BatSLAM: Simultaneous Localization and Mapping Using Biomimetic Sonar	PLOS ONE			English	Article							CONTINUOUS ATTRACTOR NETWORKS; ECHOLOCATING BATS; PATH INTEGRATION; MODELS; SLAM; INFORMATION; ROBOTS; MAP	We propose to combine a biomimetic navigation model which solves a simultaneous localization and mapping task with a biomimetic sonar mounted on a mobile robot to address two related questions. First, can robotic sonar sensing lead to intelligent interactions with complex environments? Second, can we model sonar based spatial orientation and the construction of spatial maps by bats? To address these questions we adapt the mapping module of RatSLAM, a previously published navigation system based on computational models of the rodent hippocampus. We analyze the performance of the proposed robotic implementation operating in the real world. We conclude that the biomimetic navigation model operating on the information from the biomimetic sonar allows an autonomous agent to map unmodified (office) environments efficiently and consistently. Furthermore, these results also show that successful navigation does not require the readings of the biomimetic sonar to be interpreted in terms of individual objects/landmarks in the environment. We argue that the system has applications in robotics as well as in the field of biology as a simple, first order, model for sonar based spatial orientation and map building.	[Steckel, Jan; Peremans, Herbert] Univ Antwerp, Fac Appl Econ, Act Percept Lab, B-2020 Antwerp, Belgium	University of Antwerp	Steckel, J (corresponding author), Univ Antwerp, Fac Appl Econ, Act Percept Lab, B-2020 Antwerp, Belgium.	jan.steckel@ua.ac.be		Steckel, Jan/0000-0003-4489-466X	EU CHIROPING (Chiroptera, Robots, Sonar) project; Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics; FWO Recap Project	EU CHIROPING (Chiroptera, Robots, Sonar) project; Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics; FWO Recap Project(FWO)	This work was funded by the EU CHIROPING (Chiroptera, Robots, Sonar) project. This project is funded by the Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics and the FWO Recap Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Biber C., 1980, 67 CONV AUD ENG SOC; Blauert J., 1997, SPATIAL HEARING PSYC; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; Choset H, 2001, IEEE T ROBOTIC AUTOM, V17, P125, DOI 10.1109/70.928558; Choset HM., 2005, PRINCIPLES ROBOT MOT; Davison AJ, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1403; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; ELFES A, 1987, IEEE T ROBOTIC AUTOM, V3, P249, DOI 10.1109/JRA.1987.1087096; Fontaine B, 2009, J ACOUST SOC AM, V125, P3052, DOI 10.1121/1.3101485; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Griffin D.R., 1958, LISTENING DARK ACOUS; Jensen ME, 2005, J EXP BIOL, V208, P4399, DOI 10.1242/jeb.01901; Jose E, 2004, IEEE INT CONF ROBOT, P1321, DOI 10.1109/ROBOT.2004.1308007; Leonard J. J., 1991, Proceedings IROS '91. IEEE/RSJ International Workshop on Intelligent Robots and Systems '91. Intelligence for Mechanical Systems (Cat. No.91TH0375-6), P1442, DOI 10.1109/IROS.1991.174711; Milford M, 2011, SPRINGER TRACTS ADV; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Milford MJ, 2004, IEEE INT CONF ROBOT, P403, DOI 10.1109/ROBOT.2004.1307183; Montemerlo M., 2003, P INT JOINT C ART IN, P1151; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Mullane J, 2011, IEEE T ROBOT, V27, P268, DOI 10.1109/TRO.2010.2101370; Neuweiler G., 2000, BIOL BATS; OBRIST MK, 1993, J EXP BIOL, V180, P119; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Patterson R, 1987, 2341 APU; Peremans H, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P195; Pierce A. D., 1989, ACOUSTICS INTRO ITS; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; Reijniers J, 2010, BIOL CYBERN, V102, P311, DOI 10.1007/s00422-010-0368-8; Remolina E, 2004, ARTIF INTELL, V152, P47, DOI 10.1016/S0004-3702(03)00114-0; Schaub A, 2007, J COMP PHYSIOL A, V193, P1185, DOI 10.1007/s00359-007-0269-z; Schillebeeckx F, 2012, IET RADAR SONAR NAV, V6, P516, DOI 10.1049/iet-rsn.2011.0069; Schillebeeckx F, 2011, INT J ROBOT RES, V30, P975, DOI 10.1177/0278364910380474; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Steckel J., 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P2549, DOI 10.1109/CISP.2011.6100671; Steckel J, 2012, IEEE T ULTRASON FERR, V59, P1369, DOI 10.1109/TUFFC.2012.2337; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; Stringer SN, 2002, NETWORK-COMP NEURAL, V13, P429, DOI 10.1088/0954-898X/13/4/301; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Tardos JD, 2002, INT J ROBOT RES, V21, P311, DOI 10.1177/027836402320556340; The MathWorks Inc., 2010, MATLAB; Thomas J, 2002, ECHOLOCATION BAT DOL; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Wyeth G, 2009, IEEE ROBOT AUTOM MAG, V16, P24, DOI 10.1109/MRA.2009.933620; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yovel Y, 2011, J COMP PHYSIOL A, V197, P475, DOI 10.1007/s00359-010-0584-7; Zlot R, 2009, SPR TRA ADV ROBOT, V54, P363	53	64	65	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54076	10.1371/journal.pone.0054076	http://dx.doi.org/10.1371/journal.pone.0054076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365647	Green Published, gold			2022-12-25	WOS:000314023600029
J	Aguero, F; Degano, IR; Subirana, I; Grau, M; Zamora, A; Sala, J; Ramos, R; Treserras, R; Marrugat, J; Elosua, R				Agueero, Fernando; Degano, Irene R.; Subirana, Isaac; Grau, Maria; Zamora, Alberto; Sala, Joan; Ramos, Rafel; Treserras, Ricard; Marrugat, Jaume; Elosua, Roberto			Impact of a Partial Smoke-Free Legislation on Myocardial Infarction Incidence, Mortality and Case-Fatality in a Population-Based Registry: The REGICOR Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SECONDHAND SMOKE; HOSPITAL ADMISSIONS; 2ND-HAND SMOKE; EXPOSURE; SPAIN; LAW; HEALTH; TRENDS; RATES	Background and Objective: Coronary heart disease (CHD) is the leading cause of death, and smoking its strongest modifiable risk factor. Our aim was to determine the impact of the Spanish 2006 partial smoke-free legislation on acute myocardial infarction (AMI) incidence, hospitalization and mortality rates, and 28-day case-fatality in Girona, Spain. Methods: Using a population-based registry (the REGICOR Study), we compared population incidence, hospitalization, and mortality rates, and 28-day case-fatality in the pre- and post-ban periods (2002-2005 and 2006-2008, respectively) by binomial regression analysis adjusted for confounding factors. We also analyzed the ban's impact on the outcomes of interest using the AMI definitions of the American Heart Association (AHA)/European Society of Cardiology (ESC) and the World Health Organization (WHO)-Monitoring trends and determinants in cardiovascular diseases (MONICA). Results: In the post-ban period, AMI incidence and mortality rates significantly decreased (relative risk [RR] = 0.89; 95% confidence interval [CI] = 0.81-0.97 and RR = 0.82; 95% CI = 0.71-0.94, respectively). Incidence and mortality rates decreased in both sexes, especially in women, and in people aged 65-74 years. Former and non-smokers (passive smokers) showed diminished incidence rates. Implementation of the ban was not associated with AMI case-fatality. Models tended to be more significant with the WHO-MONICA than with the AHA/ESC definition. Conclusions: The 2006 Spanish partial smoke-free legislation was associated with a decrease in population AMI incidence and mortality, particularly in women, in people aged 65-74 years, and in passive smokers. These results clarify the association between AMI mortality and the enactment of a partial smoke-free legislation and reinforce the effectiveness of smoking regulations in preventing CHD.	[Agueero, Fernando; Degano, Irene R.; Subirana, Isaac; Grau, Maria; Marrugat, Jaume; Elosua, Roberto] IMIM Hosp Mar Med Res Inst, Dept Res Inflammatory & Cardiovasc Disorders RICA, Barcelona, Spain; [Agueero, Fernando] Parc Salut Mar Pompeu Fabra Univ Publ Hlth Agcy B, Dept Prevent Med & Publ Hlth, Barcelona, Spain; [Subirana, Isaac] Epidemiol & Publ Hlth CIBER Ctr Invest Biomed Red, Barcelona, Spain; [Zamora, Alberto] Hosp Comarcal Blanes, Dept Internal Med, Girona, Spain; [Sala, Joan] Hosp Josep Trueta, Dept Cardiol, Girona, Spain; [Ramos, Rafel] IDIAP JGol, Dept Cardiovasc Res, Girona, Spain; [Treserras, Ricard] Generalitat Catalunya, Dept Salut, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Elosua, R (corresponding author), IMIM Hosp Mar Med Res Inst, Dept Res Inflammatory & Cardiovasc Disorders RICA, Barcelona, Spain.	relosua@imim.es	Ramos, Rafel/P-2083-2019; Grau, Maria/AAX-4625-2021; Degano, Irene/ABG-5341-2020; Ramos, Rafel/D-9627-2016; Degano, Irene Roman/C-1826-2012; Grau, Maria/H-5572-2011	Ramos, Rafel/0000-0001-7970-5537; Grau, Maria/0000-0003-2807-8136; Ramos, Rafel/0000-0001-7970-5537; Grau, Maria/0000-0003-2807-8136; Marrugat, Jaume/0000-0003-3320-554X; Zamora Cervantes, Alberto/0000-0001-6907-0654; Degano, Irene R./0000-0003-1914-6934; ELOSUA, ROBERTO/0000-0001-8235-0095	Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found) [Red HERACLES RD06/0009]; Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica) [2009/SGR/1195]; Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute [CM08/00141]	Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found); Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica); Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute	This work has been supported by the Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found) [Red HERACLES RD06/0009], the Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica) [2009/SGR/1195]. Dr. Grau is supported by a research fellowship award from the Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute [CM08/00141]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, QUALITY ASSESSMENT R; Baena-Diez JM, 2009, GAC SANIT, V23, P519, DOI 10.1016/j.gaceta.2009.01.009; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Barone-Adesi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017419; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Dove MS, 2010, AM J PUBLIC HEALTH, V100, P2206, DOI 10.2105/AJPH.2009.189662; Fernandez E, 2006, TOB CONTROL, V15, P79; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Flores-Mateo G, 2011, REV ESP CARDIOL, V64, P988, DOI [10.1016/j.rec.2011.05.035, 10.1016/j.recesp.2011.05.033]; Galan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-224; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Gil M, 2007, REV ESP CARDIOL, V60, P349, DOI 10.1157/13101638; Glantz SA, 2008, PREV MED, V47, P452, DOI 10.1016/j.ypmed.2008.06.007; Grau M, 2007, EUR J CARDIOV PREV R, V14, P653, DOI 10.1097/HJR.0b013e3281764429; Gupta R, 2011, PREV CHRONIC DIS, V8; Hahn EJ, 2011, PUBLIC HEALTH REP, V126, P826, DOI 10.1177/003335491112600608; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Hurt RD, 2012, ARCH INTERN MED, V172, P1635, DOI 10.1001/2013.jamainternmed.46; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Manzanares-Laya S, 2011, GAC SANIT, V25, P495, DOI 10.1016/j.gaceta.2011.06.006; Marrugat J, 2002, REV ESP CARDIOL, V55, P337, DOI 10.1016/S0300-8932(02)76611-6; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Njolstad I, 1996, CIRCULATION, V93, P450; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Piwowarska W, 1991, Folia Med Cracov, V32, P43; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rodu B, 2012, J COMMUN HEALTH, V37, P468, DOI 10.1007/s10900-011-9464-5; SALA J, 1995, EUR HEART J, V16, P779, DOI 10.1093/oxfordjournals.eurheartj.a060996; Sargent JD, 2012, CLIN RES CARDIOL, V101, P227, DOI 10.1007/s00392-011-0385-1; Sclavo M, 2001, Ital Heart J Suppl, V2, P125; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Villalbi JR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000067; Villalbi JR, 2009, REV ESP CARDIOL, V62, P812, DOI 10.1016/S0300-8932(09)71695-1	46	47	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53722	10.1371/journal.pone.0053722	http://dx.doi.org/10.1371/journal.pone.0053722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372663	Green Published, gold			2022-12-25	WOS:000314021500018
J	Chen, L; Li, YH; Fu, YB; Peng, J; Mo, MH; Stamatakos, M; Teal, CB; Brem, RF; Stojadinovic, A; Grinkemeyer, M; McCaffrey, TA; Man, YG; Fu, SW				Chen, Liang; Li, Youhuai; Fu, Yebo; Peng, Jin; Mo, Meng-Hsuan; Stamatakos, Michael; Teal, Christine B.; Brem, Rachel F.; Stojadinovic, Alexander; Grinkemeyer, Michael; McCaffrey, Timothy A.; Man, Yan-Gao; Fu, Sidney W.			Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MYOEPITHELIAL CELL LAYER; GENE-EXPRESSION; TUMOR INVASION; MIR-200 FAMILY; REPRESSORS ZEB1; POTENTIAL ROLE; RNA; TARGETS; OPTIMIZATION	MicroRNAs (miRNAs) contribute to cancer initiation and progression by silencing the expression of their target genes, causing either mRNA molecule degradation or translational inhibition. Intraductal epithelial proliferations of the breast are histologically and clinically classified into normal, atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). To better understand the progression of ductal breast cancer development, we attempt to identify deregulated miRNAs in this process using Formalin-Fixed, Paraffin-Embedded (FFPE) tissues from breast cancer patients. Following tissue microdissection, we obtained 8 normal, 4 ADH, 6 DCIS and 7 IDC samples, which were subject to RNA isolation and miRNA expression profiling analysis. We found that miR-21, miR-200b/c, miR-141, and miR-183 were consistently up-regulated in ADH, DCIS and IDC compared to normal, while miR-557 was uniquely down-regulated in DCIS. Interestingly, the most significant miRNA deregulations occurred during the transition from normal to ADH. However, the data did not reveal a step-wise miRNA alteration among discrete steps along tumor progression, which is in accordance with previous reports of mRNA profiling of different stages of breast cancer. Furthermore, the expression of MSH2 and SMAD7, two important molecules involving TGF-beta pathway, was restored following miR-21 knockdown in both MCF-7 and Hs578T breast cancer cells. In this study, we have not only identified a number of potential candidate miRNAs for breast cancer, but also found that deregulation of miRNA expression during breast tumorigenesis might be an early event since it occurred significantly during normal to ADH transition. Consequently, we have demonstrated the feasibility of miRNA expression profiling analysis using archived FFPE tissues, typically with rich clinical information, as a means of miRNA biomarker discovery.	[Chen, Liang; Fu, Yebo; Peng, Jin; Mo, Meng-Hsuan; McCaffrey, Timothy A.; Fu, Sidney W.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Div Genom Med,Dept Med, Washington, DC 20052 USA; [Li, Youhuai] Baoji Cent Hosp, Dept Surg, Breast Canc Div, Baoji, Shaanxi, Peoples R China; [Stamatakos, Michael] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20052 USA; [Teal, Christine B.] George Washington Univ, Sch Med & Hlth Sci, Dept Surg, Washington, DC 20052 USA; [Brem, Rachel F.] George Washington Univ, Sch Med & Hlth Sci, Dept Radiol, Washington, DC 20052 USA; [Stojadinovic, Alexander; Grinkemeyer, Michael] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Man, Yan-Gao] Henry Jackson Fdn, Diagnost & Translat Res Ctr, Gaithersburg, MD USA	George Washington University; George Washington University; George Washington University; George Washington University; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Fu, SW (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Div Genom Med,Dept Med, Washington, DC 20052 USA.	sfu@gwu.edu	Peng, Jin/P-4752-2017; Chen, Liang/J-4277-2017	Chen, Liang/0000-0002-3605-8883; Stojadinovic, Alexander/0000-0002-2829-8967	Wendy Will Case Foundation; Hao Foundation; NCI/NIH [R21CA159103]; NATIONAL CANCER INSTITUTE [R21CA159103] Funding Source: NIH RePORTER	Wendy Will Case Foundation; Hao Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wendy Will Case Foundation, the Hao Foundation and the NCI/NIH awards (R21CA159103) to SWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, RNA BIOL, V8, P71, DOI 10.4161/rna.8.1.14299; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fu SW, 2011, J CANCER, V2, P116, DOI 10.7150/jca.2.116; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hsiao YH, 2011, INT J BIOL SCI, V7, P147, DOI 10.7150/ijbs.7.147; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kluk BJ, 2010, INT J BIOL SCI, V6, P513; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Templin MF, 2003, PROTEOMICS, V3, P2155, DOI 10.1002/pmic.200300600; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu Y, 2010, MOL CANCER RES, V8, P1633, DOI 10.1158/1541-7786.MCR-10-0362; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	47	79	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54213	10.1371/journal.pone.0054213	http://dx.doi.org/10.1371/journal.pone.0054213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372687	Green Published, gold			2022-12-25	WOS:000314021500041
J	Corbiere, F; Chauvineau-Perrin, C; Lacroux, C; Lugan, S; Costes, P; Thomas, M; Bremaud, I; Chartier, C; Barillet, F; Schelcher, F; Andreoletti, O				Corbiere, Fabien; Chauvineau-Perrin, Cecile; Lacroux, Caroline; Lugan, Severine; Costes, Pierrette; Thomas, Myriam; Bremaud, Isabelle; Chartier, Christophe; Barillet, Francis; Schelcher, Francois; Andreoletti, Olivier			The Limits of Test-Based Scrapie Eradication Programs in Goats	PLOS ONE			English	Article							CLASSICAL SCRAPIE; PRP GENE; TISSUE DISTRIBUTION; NATURAL SCRAPIE; VARIANT CJD; SHEEP; PRION; RESISTANCE; GENOTYPE; PROTEIN	Small ruminant post-mortem testing programs were initially designed for monitoring the prevalence of prion disease. They are now considered as a potential alternative to genetic selection for eradicating/controlling classical scrapie at population level. If such policy should be implemented, its success would be crucially dependent on the efficiency of the surveillance system used to identify infected flocks. In this study, we first determined the performance of post-mortem classical scrapie detection in eight naturally affected goat herds (total n = 1961 animals) according to the age at culling. These results provided us with necessary parameters to estimate, through a Monte Carlo simulation model, the performance of scrapie detection in a commercial population. According to this model, whatever the number of tests performed, post mortem surveillance will have limited success in identifying infected herds. These data support the contention that scrapie eradication programs relying solely on post mortem testing in goats will probably fail. Considering the epidemiological and pathological similarities of scrapie in sheep and goats, the efficiency of scrapie surveillance in both species is likely to be similar.	[Corbiere, Fabien; Lacroux, Caroline; Lugan, Severine; Costes, Pierrette; Schelcher, Francois; Andreoletti, Olivier] Ecole Natl Vet Toulouse, UMR INRA ENVT Interact Hotes Agents Pathogenes 12, Toulouse, France; [Chauvineau-Perrin, Cecile; Thomas, Myriam; Bremaud, Isabelle; Chartier, Christophe] ANSES, Lab Etud & Rech Caprines, Niort, France; [Barillet, Francis] INRA, UR 631, Stn Ameliorat Genet Anim, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE	Andreoletti, O (corresponding author), Ecole Natl Vet Toulouse, UMR INRA ENVT Interact Hotes Agents Pathogenes 12, Toulouse, France.	o.andreoletti@envt.fr		CORBIERE, Fabien/0000-0003-3006-5561	GIS PRION [31B06134]; INRA [AIP P00297]; Poitou-Charentes region [04/RPC-A-103, 05/RPC-A-13]; EU FP7 'Goat BSE' project [CT-2006-36353]; EU EMIDA 'Goat TSE free' project	GIS PRION; INRA; Poitou-Charentes region(Region Nouvelle-Aquitaine); EU FP7 'Goat BSE' project; EU EMIDA 'Goat TSE free' project	This work was funded by GIS PRION grant 31B06134, by INRA grant AIP P00297, by the Poitou-Charentes region grants 04/RPC-A-103 and 05/RPC-A-13, by the EU FP7 'Goat BSE' project CT-2006-36353 and EMIDA 2012 'Goat TSE free' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; BAKER HF, 1993, VET REC, V132, P403, DOI 10.1136/vr.132.16.403; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Bellworthy SJ, 2005, VET REC, V156, P197, DOI 10.1136/vr.156.7.197; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Dawson M, 2008, VET RES, V39, DOI 10.1051/vetres:2007064; Fediaevsky A, 2010, VET J, V185, P338, DOI 10.1016/j.tvjl.2009.06.019; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Gonzalez L, 2009, VET RES, V40, DOI 10.1051/vetres/2009048; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Hopp P, 2003, PREV VET MED, V61, P103, DOI 10.1016/S0167-5877(03)00192-2; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Ligios C, 2006, ARCH VIROL, V151, P207, DOI 10.1007/s00705-006-0759-2; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; National Agricultural Statistics Service Agricultural Statistics Board USDA, 2012, TOT SHEEP LAMB INV; National Scrapie Eradication Program, 2011, FISC YEAR 2011 REP; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reckzeh C, 2007, VET MICROBIOL; Vaccari G, 2006, J GEN VIROL, V87, P1395, DOI 10.1099/vir.0.81485-0; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009002; van Keulen LJM, 2000, ARCH VIROL, P57	29	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54911	10.1371/journal.pone.0054911	http://dx.doi.org/10.1371/journal.pone.0054911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372789	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500142
J	Gu, X; Reid, D; Higham, DJ; Gilbert, D				Gu, Xu; Reid, David; Higham, Desmond J.; Gilbert, David			Mathematical Modelling of Polyamine Metabolism in Bloodstream-Form Trypanosoma brucei: An Application to Drug Target Identification	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; DL-ALPHA-DIFLUOROMETHYLORNITHINE; TRYPANOTHIONE SYNTHETASE; ORNITHINE-DECARBOXYLASE; SPERMIDINE SYNTHASE; ALLOSTERIC REGULATION; METHIONINE; ANALOGS; INTERFERENCE; VALIDATION	We present the first computational kinetic model of polyamine metabolism in bloodstream-form Trypanosoma brucei, the causative agent of human African trypanosomiasis. We systematically extracted the polyamine pathway from the complete metabolic network while still maintaining the predictive capability of the pathway. The kinetic model is constructed on the basis of information gleaned from the experimental biology literature and defined as a set of ordinary differential equations. We applied Michaelis-Menten kinetics featuring regulatory factors to describe enzymatic activities that are well defined. Uncharacterised enzyme kinetics were approximated and justified with available physiological properties of the system. Optimisation-based dynamic simulations were performed to train the model with experimental data and inconsistent predictions prompted an iterative procedure of model refinement. Good agreement between simulation results and measured data reported in various experimental conditions shows that the model has good applicability in spite of there being gaps in the required data. With this kinetic model, the relative importance of the individual pathway enzymes was assessed. We observed that, at low-to-moderate levels of inhibition, enzymes catalysing reactions of de novo AdoMet (MAT) and ornithine production (OrnPt) have more efficient inhibitory effect on total trypanothione content in comparison to other enzymes in the pathway. In our model, prozyme and TSHSyn (the production catalyst of total trypanothione) were also found to exhibit potent control on total trypanothione content but only when they were strongly inhibited. Different chemotherapeutic strategies against T. brucei were investigated using this model and interruption of polyamine synthesis via joint inhibition of MAT or OrnPt together with other polyamine enzymes was identified as an optimal therapeutic strategy.	[Gu, Xu] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh, Midlothian, Scotland; [Reid, David] Gold Stand Simulat Ltd, Glasgow, Lanark, Scotland; [Higham, Desmond J.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Gilbert, David] Brunel Univ, Sch Informat Syst Comp & Math, Uxbridge UB8 3PH, Middx, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Strathclyde; Brunel University	Gu, X (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh, Midlothian, Scotland.	Xu.Gu@igmm.ed.ac.uk	Gilbert, David/G-1432-2011		School of Computing Science, University of Glasgow	School of Computing Science, University of Glasgow	The work was carried out under a PhD programme partly funded by Prof. Ray Welland, School of Computing Science, University of Glasgow. Further work was unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; Bacchi CJ, 1996, ANTIMICROB AGENTS CH, V40, P1448, DOI 10.1128/AAC.40.6.1448; BACCHI CJ, 1991, ANTIMICROB AGENTS CH, V35, P1315, DOI 10.1128/AAC.35.7.1315; BACCHI CJ, 1995, BIOCHEM J, V309, P737, DOI 10.1042/bj3090737; Bakker BM, 1998, THESIS VRIJE U; BELLOFATTO V, 1987, MOL BIOCHEM PARASIT, V25, P227, DOI 10.1016/0166-6851(87)90086-7; Berger BJ, 1996, P NATL ACAD SCI USA, V93, P4126, DOI 10.1073/pnas.93.9.4126; Beswick TC, 2006, BIOCHEMISTRY-US, V45, P7797, DOI 10.1021/bi0603975; BIRNBAUMER L, 1980, J BIOL CHEM, V255, P3552; BITONTI AJ, 1984, MOL BIOCHEM PARASIT, V13, P21, DOI 10.1016/0166-6851(84)90098-7; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; Checchi F, 2007, PLOS NEGLECT TROP D, V1, P1; CHRISTA L, 1988, BIOCHEM J, V255, P145, DOI 10.1042/bj2550145; DUSZENKO M, 1985, J EXP MED, V162, P1256, DOI 10.1084/jem.162.4.1256; Erez O, 2002, EXP CELL RES, V281, P148, DOI 10.1006/excr.2002.5662; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; GHODA LY, 1988, MOL BIOCHEM PARASIT, V27, P109, DOI 10.1016/0166-6851(88)90030-8; Goldberg B, 2000, ARCH BIOCHEM BIOPHYS, V377, P49, DOI 10.1006/abbi.2000.1740; Gu X, 2010, THESIS U GLASGOW GLA; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; KAUR K, 1986, J PROTOZOOL, V33, P518, DOI 10.1111/j.1550-7408.1986.tb05654.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Ljung L, 2008, PLEN SESS 17 IFAC WO; Ljung L, 2007, TECHNICAL REPORT; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Olin-Sandoval V, 2012, FEBS J, V279, P1811, DOI 10.1111/j.1742-4658.2012.08557.x; Oza SL, 2002, BIOCHEM J, V364, P679, DOI 10.1042/BJ20011370; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; PEGG AE, 1983, BIOCHEM J, V213, P495, DOI 10.1042/bj2130495; Peter S Backlund J, 1982, J BIOL CHEM, V257, P4196; PORTER CW, 1986, ANTICANCER RES, V6, P525; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Reguera RM, 2007, MOL BIOCHEM PARASIT, V152, P1, DOI 10.1016/j.molbiopara.2006.11.013; RISCOE MK, 1989, PARASITOL TODAY, V5, P330, DOI 10.1016/0169-4758(89)90128-2; Rodriguez-Caso C, 2006, J BIOL CHEM, V281, P21799, DOI 10.1074/jbc.M602756200; Soderstrom T., 1989, SYSTEM IDENTIFICATIO; Sontag ED, 2006, OPTIMIZATION CONTROL, P1; Sufrin JR, 2008, ANTIMICROB AGENTS CH, V52, P211, DOI 10.1128/AAC.00480-07; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Taylor MC, 2008, BIOCHEM J, V409, P563, DOI 10.1042/BJ20071185; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; van Riel NAW, 2006, IEE P SYST BIOL, V153, P263, DOI 10.1049/ip-syb:20050076; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Voit E. O., 2000, COMPUTATIONAL ANAL B; Willert EK, 2008, PLOS PATHOG, V4, P1; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; YARLETT N, 1993, BIOCHIM BIOPHYS ACTA, V1181, P68, DOI 10.1016/0925-4439(93)90092-F; YARLETT N, 1988, MOL BIOCHEM PARASIT, V27, P1, DOI 10.1016/0166-6851(88)90019-9; YARLETT N, 1991, J GEN MICROBIOL, V137, P717, DOI 10.1099/00221287-137-3-717	55	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53734	10.1371/journal.pone.0053734	http://dx.doi.org/10.1371/journal.pone.0053734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372667	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500022
J	Meyer, JB; Song-Wilson, Y; Foetzki, A; Luginbuhl, C; Winzeler, M; Kneubuhler, Y; Matasci, C; Mascher-Frutschi, F; Kalinina, O; Boller, T; Keel, C; Maurhofer, M				Meyer, Joana Beatrice; Song-Wilson, Yi; Foetzki, Andrea; Luginbuehl, Carolin; Winzeler, Michael; Kneubuehler, Yvan; Matasci, Caterina; Mascher-Frutschi, Fabio; Kalinina, Olena; Boller, Thomas; Keel, Christoph; Maurhofer, Monika			Does Wheat Genetically Modified for Disease Resistance Affect Root-Colonizing Pseudomonads and Arbuscular Mycorrhizal Fungi?	PLOS ONE			English	Article							ACCUMULATING POTATO PLANTS; ANTIFUNGAL GENE-EXPRESSION; COMMUNITY STRUCTURE; FLUORESCENS CHA0; BIOCONTROL PSEUDOMONADS; BIOLOGICAL-CONTROL; RHIZOSPHERE; GROWTH; CROPS; SOIL	This study aimed to evaluate the impact of genetically modified (GM) wheat with introduced pm3b mildew resistance transgene, on two types of root-colonizing microorganisms, namely pseudomonads and arbuscular mycorrhizal fungi (AMF). Our investigations were carried out in field trials over three field seasons and at two locations. Serial dilution in selective King's B medium and microscopy were used to assess the abundance of cultivable pseudomonads and AMF, respectively. We developed a denaturing gradient gel electrophoresis (DGGE) method to characterize the diversity of the pqqC gene, which is involved in Pseudomonas phosphate solubilization. A major result was that in the first field season Pseudomonas abundances and diversity on roots of GM pm3b lines, but also on non-GM sister lines were different from those of the parental lines and conventional wheat cultivars. This indicates a strong effect of the procedures by which these plants were created, as GM and sister lines were generated via tissue cultures and propagated in the greenhouse. Moreover, Pseudomonas population sizes and DGGE profiles varied considerably between individual GM lines with different genomic locations of the pm3b transgene. At individual time points, differences in Pseudomonas and AMF accumulation between GM and control lines were detected, but they were not consistent and much less pronounced than differences detected between young and old plants, different conventional wheat cultivars or at different locations and field seasons. Thus, we conclude that impacts of GM wheat on plant-beneficial root-colonizing microorganisms are minor and not of ecological importance. The cultivation-independent pqqC-DGGE approach proved to be a useful tool for monitoring the dynamics of Pseudomonas populations in a wheat field and even sensitive enough for detecting population responses to altered plant physiology.	[Meyer, Joana Beatrice; Maurhofer, Monika] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Song-Wilson, Yi; Boller, Thomas] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Foetzki, Andrea; Luginbuehl, Carolin; Winzeler, Michael] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Kneubuehler, Yvan; Matasci, Caterina; Mascher-Frutschi, Fabio] Agroscope Changins Wadenswil Res Stn ACW, Nyon, Switzerland; [Kalinina, Olena] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Keel, Christoph] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Swiss Federal Research Station Agroscope; University of Zurich; University of Lausanne	Keel, C (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	christoph.keel@unil.ch; monika.maurhofer@usys.ethz.ch	Kalinina, Olena/H-6275-2011; Boller, Thomas/G-3500-2012; Keel, Christoph/U-4071-2017; Kalinina, Olena/J-5986-2019	Boller, Thomas/0000-0001-6768-7503; Keel, Christoph/0000-0002-8968-735X; Maurhofer, Monika/0000-0001-5408-6290	Swiss National Science Foundation (National Research Program) [NRP59, 405940-115596]	Swiss National Science Foundation (National Research Program)	This study was supported by the Swiss National Science Foundation (National Research Program NRP59, project 405940-115596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022690; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Becker R, 2008, FEMS MICROBIOL ECOL, V66, P411, DOI 10.1111/j.1574-6941.2008.00562.x; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; de Werra P, 2008, APPL ENVIRON MICROB, V74, P1339, DOI 10.1128/AEM.02126-07; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Dunfield KE, 2004, J ENVIRON QUAL, V33, P806, DOI 10.2134/jeq2004.0806; Fliessbach A, 2009, MICROB ECOL, V57, P611, DOI 10.1007/s00248-009-9489-9; Frapolli M, 2008, FEMS MICROBIOL ECOL, V64, P468, DOI 10.1111/j.1574-6941.2008.00471.x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frapolli M, 2010, SOIL BIOL BIOCHEM, V42, P649, DOI 10.1016/j.soilbio.2010.01.005; Goldstein A., 1986, American Journal of Alternative Agriculture, V1, P51; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Gyamfi S, 2002, FEMS MICROBIOL ECOL, V41, P181, DOI 10.1111/j.1574-6941.2002.tb00979.x; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Jousset A, 2011, MOL PLANT MICROBE IN, V24, P352, DOI 10.1094/MPMI-09-10-0208; Kalinina O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028091; KING EO, 1954, J LAB CLIN MED, V44, P301; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Li XG, 2009, TRANSGENIC RES, V18, P757, DOI 10.1007/s11248-009-9264-1; Lindfeld A, 2011, APPL SOIL ECOL, V47, P51, DOI 10.1016/j.apsoil.2010.10.012; Liu WK, 2010, ECOTOXICOLOGY, V19, P229, DOI 10.1007/s10646-009-0423-1; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lottmann J, 1999, FEMS MICROBIOL ECOL, V29, P365; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mascher F, 2003, ENVIRON MICROBIOL, V5, P103, DOI 10.1046/j.1462-2920.2003.00388.x; McCune B., 2002, ANAL ECOLOGICAL COMM; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meyer JB, 2011, APPL ENVIRON MICROB, V77, P7345, DOI 10.1128/AEM.05434-11; Meyer JB, 2010, APPL ENVIRON MICROB, V76, P6196, DOI 10.1128/AEM.00752-10; MILLER HJ, 1990, CAN J MICROBIOL, V36, P254, DOI 10.1139/m90-044; Mulder C, 2006, PLOS COMPUT BIOL, V2, P1165, DOI 10.1371/journal.pcbi.0020128; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Notz R, 2002, APPL ENVIRON MICROB, V68, P2229, DOI 10.1128/AEM.68.5.2229-2235.2002; Peter M, 2010, PEDOBIOLOGIA, V53, P271, DOI 10.1016/j.pedobi.2009.12.006; Ramette A, 2006, FEMS MICROBIOL ECOL, V55, P369, DOI 10.1111/j.1574-6941.2005.00052.x; Rochat L, 2010, MOL PLANT MICROBE IN, V23, P949, DOI 10.1094/MPMI-23-7-0949; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stefani FOP, 2010, ENVIRON REV, V18, P441, DOI 10.1139/A10-022; Svercel M, 2009, FEMS MICROBIOL ECOL, V68, P25, DOI 10.1111/j.1574-6941.2009.00649.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Viebahn M, 2005, ENVIRON MICROBIOL, V7, P1775, DOI 10.1111/j.1462-2920.2005.00783.x; VIERHEILIG H, 1995, APPL ENVIRON MICROB, V61, P3031, DOI 10.1128/AEM.61.8.3031-3034.1995; von Burg S, 2011, BIOL LETTERS, V7, P387, DOI 10.1098/rsbl.2010.1147; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; Wagner H, 2009, VEGAN COMMUNITY ECOL; Walley FL, 1997, BIOL FERT SOILS, V24, P365, DOI 10.1007/s003740050259; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Weinert N, 2010, ENVIRON MICROBIOL, V10, P235; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Widmer F, 1998, APPL ENVIRON MICROB, V64, P2545; Widmer F, 2007, ADV BIOCHEM ENG BIOT, V107, P207, DOI 10.1007/10_2007_047; Wilson Y. S., 2010, IOBC/WPRS Bulletin, V52, P91; Xavier LJC, 2002, SOIL BIOL BIOCHEM, V34, P181, DOI 10.1016/S0038-0717(01)00165-1; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; Zhou J, 2012, METABOLOMICS, V8, P529, DOI 10.1007/s11306-011-0338-8	66	20	21	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53825	10.1371/journal.pone.0053825	http://dx.doi.org/10.1371/journal.pone.0053825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372672	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000314021500026
J	Sharma, P; Gaur, SN; Arora, N				Sharma, Prerna; Gaur, Shailendra Nath; Arora, Naveen			In silico Identification of IgE-Binding Epitopes of Osmotin Protein	PLOS ONE			English	Article							HYPOALLERGENIC MUTANTS; POLLEN ALLERGEN; TOBACCO OSMOTIN; CELL EPITOPES; EXPRESSION	The identification of B-cell epitopes is an important step to study the antigen-antibody interactions for diagnosis and therapy. The present study aimed to identify B-cell epitopes of osmotin using bioinformatic tools and further modify these regions to study the allergenic property. B-cell epitopes were predicted based on amino acid physicochemical properties. Three single point mutations M1, M2, and M3 and a multiple point mutant (M123) were selected to disrupt the IgE binding. These mutants were cloned, expressed and proteins purified to homogeneity. The IgE binding of the purified proteins was evaluated by ELISA and ELISA inhibition with patients' sera. Three regions of osmotin M1 (57-70 aa), M2 (72-85 aa) and M3 (147-165 aa) were identified as potential antibody recognition sites using in silico tools. The sequence similarity search of the predicted epitopes of osmotin using Structural Database of Allergenic proteins (SDAP) showed similarity with known allergens from tomato, kiwifruit, bell pepper, apple, mountain cedar and cypress. Mutants M1, M2 and M3 showed up to 72%, 60% and 76% reduction, respectively in IgE binding whereas M123 showed up to 90% reduction with patients' sera. The immunoblot of M123 mutant showed 40% reduction in spot density as compared to osmotin. All mutants showed decreased inhibition potency with M123 exhibiting lowest potency of 32% with osmotin positive pooled patients' sera. The three B-cell epitopes of osmotin predicted by in silico method correlated with the experimental approach. The mutant M123 showed a reduction of 90% in IgE binding. The present method may be employed for prediction of B-cell epitopes of allergenic proteins.	[Sharma, Prerna; Arora, Naveen] CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Gaur, Shailendra Nath] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Resp Med, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Arora, N (corresponding author), CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	naveen@igib.res.in			Council for Scientific and Industrial Reasearch (CSIR)	Council for Scientific and Industrial Reasearch (CSIR)	The work covered in this manuscript was funded by the Council for Scientific and Industrial Reasearch (CSIR). The URL for the funder's website is "http://rdpp.csir.res.in/csir_acsir/Home.aspx''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LR, 1996, PLANT SCI, V118, P11, DOI 10.1016/0168-9452(96)04420-2; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Bannon GA, 2004, CURR ALLERGY ASTHM R, V4, P43, DOI 10.1007/s11882-004-0042-0; Barthakur S, 2001, J PLANT BIOCHEM BIOT, V10, P31, DOI 10.1007/BF03263103; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bolhaar STHP, 2005, CLIN EXP ALLERGY, V35, P1638, DOI 10.1111/j.1365-2222.2005.02390.x; Busse PJ, 2002, INT ARCH ALLERGY IMM, V129, P93, DOI 10.1159/000065178; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Herman EM, 2003, J EXP BOT, V54, P1317, DOI 10.1093/jxb/erg164; Husaini AM, 2008, INDIAN J BIOTECHNOL, V7, P465; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; King N, 2005, MOL NUTR FOOD RES, V49, P963, DOI 10.1002/mnfr.200500073; Maleki SJ, 2011, ALLERGY, V66, P1522, DOI 10.1111/j.1398-9995.2011.02692.x; Marazuela EG, 2007, CLIN EXP ALLERGY, V37, P251, DOI 10.1111/j.1365-2222.2006.02632.x; Nair S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020020; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Noori SAS, 2008, RUSS J PLANT PHYSL+, V55, P256, DOI 10.1134/S1021443708020143; Okada T, 1998, FEBS LETT, V434, P255, DOI 10.1016/S0014-5793(98)00992-2; Parkhi V, 2009, MOL BREEDING, V23, P625, DOI 10.1007/s11032-009-9261-3; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Reese G, 2005, J IMMUNOL, V175, P8354, DOI 10.4049/jimmunol.175.12.8354; Sharma P, 2011, J AGR FOOD CHEM, V59, P9990, DOI 10.1021/jf202265d; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Srivastava D, 2009, INFLAMM RES, V58, P523, DOI 10.1007/s00011-009-0033-7; Thalhamer T, 2010, J ALLERGY CLIN IMMUN, V125, P926, DOI 10.1016/j.jaci.2010.01.031; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; Vrtala S, 2008, ALLERGY, V63, P299, DOI 10.1111/j.1398-9995.2007.01609.x; Wang HW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432830; Xiao Y, 2001, IMMUNOL LETT, V77, P3, DOI 10.1016/S0165-2478(01)00187-0	38	23	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54755	10.1371/journal.pone.0054755	http://dx.doi.org/10.1371/journal.pone.0054755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349964	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800074
J	Pierzchalski, K; Yu, JS; Norman, V; Kane, MA				Pierzchalski, Keely; Yu, Jianshi; Norman, Victoria; Kane, Maureen A.			CrbpI regulates mammary retinoic acid homeostasis and the mammary microenvironment	FASEB JOURNAL			English	Article						vitamin A; breast cancer; Rbp1; retinoids	ADENOMATOUS POLYPOSIS-COLI; BINDING-PROTEIN-I; BREAST-CANCER; OXIDATIVE STRESS; LIGAND-BINDING; DIFFERENTIAL RECOGNITION; 9-CIS-RETINOIC ACID; MATRIX-HOMEOSTASIS; CELLULAR UPTAKE; HOLO-CRBP	Cellular retinol-binding protein, type I (CrbpI), encoded by retinol-binding protein, type 1 (Rbp1), is a chaperone of vitamin A (retinol) that is epigenetically silenced in similar to 25% of human breast cancers. CrbpI delivers vitamin A to enzymes for metabolism into an active metabolite, all-trans retinoic acid (atRA), where atRA is essential to cell proliferation, apoptosis, differentiation, and migration. Here, we show the effect of CrbpI loss on mammary atRA homeostasis using the Rbp1(-/-) mouse model. Rbp1(-/-) mouse mammary tissue has disrupted retinoid homeostasis that results in 40% depleted endogenous atRA. CrbpI loss and atRA depletion precede defects in atRA biosynthesis enzyme expression. Compensation by CrbpIII as a retinoid chaperone does not functionally replace CrbpI. Mammary subcellular fractions isolated from Rbp1(-/-) mice have altered retinol dehydrogenase/reductase (Rdh) enzyme activity that results in 24-42% less atRA production. Rbp1(-/-) mammary tissue has epithelial hyperplasia, stromal hypercellularity, increased collagen, and increased oxidative stress characteristic of atRA deficiency and early tissue dysfunction that precedes tumor formation. Consistent with the findings from the Rbp1(-/-) mouse, tumorigenic epithelial cells lacking CrbpI expression produce 51% less atRA. Together, these data show that CrbpI loss disrupts atRA homeostasis in mammary tissue, resulting in microenvironmental defects similar to those observed at the early stages of tumorigenesis.-Pierzchalski, K., Yu, J., Norman, V., Kane, M. A. CrbpI regulates mammary retinoic acid homeostasis and the mammary microenvironment. FASEB J. 27, 1904-1916 (2013). www.fasebj.org	[Pierzchalski, Keely; Yu, Jianshi; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Norman, Victoria] Bryn Mawr Sch, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Kane, MA (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 N Pine St,PH 723N, Baltimore, MD 21201 USA.	mkane@rx.umaryland.edu		Norman, Victoria/0000-0002-7093-607X; Pierzchalski, Keely/0000-0002-2456-0382	University of Maryland, Department of Pharmaceutical Sciences New Faculty Start-Up funds	University of Maryland, Department of Pharmaceutical Sciences New Faculty Start-Up funds	This work was supported by University of Maryland, Department of Pharmaceutical Sciences New Faculty Start-Up funds. The authors are very grateful to Norbert Ghyselinck and Pierre Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Institut National de la Sante et de la Recherche Medicale, Illkirch, France) for the Rbp1<SUP>-/-</SUP> mice. The authors thank Elizabeth Smith (Center for Vascular and Inflammatory Diseases Histology Core, University of Maryland School of Medicine) for mammary histology.	Aiello EJ, 2005, CANCER EPIDEM BIOMAR, V14, P662, DOI 10.1158/1055-9965.EPI-04-0327; American Cancer Society, 2009, BREAST CANC SOURCEBO; Arapshian A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-13; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; BOERMAN MHEM, 1991, J BIOL CHEM, V266, P22273; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; BOERMAN MHEM, 1995, ARCH BIOCHEM BIOPHYS, V321, P434, DOI 10.1006/abbi.1995.1415; Boyd N F, 2001, Curr Oncol Rep, V3, P314, DOI 10.1007/s11912-001-0083-7; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Caren H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-66; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; CHOPRA DP, 1976, J NATL CANCER I, V56, P583, DOI 10.1093/jnci/56.3.583; Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Esteller M, 2002, CANCER RES, V62, P5902; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Farias EF, 2005, J NATL CANCER I, V97, P21, DOI 10.1093/jnci/dji004; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Fleming JM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-46; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; HARRISON EH, 1987, J LIPID RES, V28, P973; HERR F, 1992, FASEB J, V6, pA1783; JAMISON RS, 1994, BIOCHEMISTRY-US, V33, P2873, DOI 10.1021/bi00176a017; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kane MA, 2011, BBA-GEN SUBJECTS, V1810, P514, DOI 10.1016/j.bbagen.2011.02.009; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Kuppumbatti YS, 2000, J NATL CANCER I, V92, P475, DOI 10.1093/jnci/92.6.475; Kupumbati TS, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-12; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200; Lei Z, 2003, BIOCHEMISTRY-US, V42, P4190, DOI 10.1021/bi026948i; Li E, 1996, ANNU REV NUTR, V16, P205, DOI 10.1146/annurev.nu.16.070196.001225; LI E, 1991, J BIOL CHEM, V266, P3622; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Lim R, 2011, BIOCHEM BIOPH RES CO, V406, P408, DOI 10.1016/j.bbrc.2011.02.056; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; Malins DC, 2006, CELL CYCLE, V5, P1629, DOI 10.4161/cc.5.15.3098; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Markova NG, 2006, J INVEST DERMATOL, V126, P2019, DOI 10.1038/sj.jid.5700347; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; McArthur MJ, 1999, J LIPID RES, V40, P1371; Mic FA, 2002, DEVELOPMENT, V129, P2271; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; NAPOLI JL, 1993, J NUTR, V123, P362, DOI 10.1093/jn/123.suppl_2.362; NAPOLI JL, 1992, BIOCHIM BIOPHYS ACTA, V1120, P183, DOI 10.1016/0167-4838(92)90267-H; NAPOLI JL, 1990, BIOCHIM BIOPHYS ACTA, V1034, P228, DOI 10.1016/0304-4165(90)90081-7; Napoli JL, 2000, NUTR REV, V58, P230, DOI 10.1111/j.1753-4887.2000.tb01870.x; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; ONG DE, 1988, J BIOL CHEM, V263, P5789; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; PEEHL DM, 1993, PROSTATE, V23, P69, DOI 10.1002/pros.2990230107; Penzes P, 1999, BIOCHEMISTRY-US, V38, P2088, DOI 10.1021/bi982228t; Piantedosi R, 2005, J BIOL CHEM, V280, P24286, DOI 10.1074/jbc.M503906200; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Rexer BN, 2001, CANCER RES, V61, P7065; RONG D, 1994, BBA-PROTEIN STRUCT M, V1208, P136, DOI 10.1016/0167-4838(94)90170-8; ROSS AC, 1982, J LIPID RES, V23, P133; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Sun FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034525; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wang C, 2011, J BIOL CHEM, V286, P6542, DOI 10.1074/jbc.M110.198382; Wang YA, 2005, DEV DYNAM, V234, P892, DOI 10.1002/dvdy.20570; Williams JA, 2010, J BIOL CHEM, V285, P36674, DOI 10.1074/jbc.M110.151878; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zizola CF, 2008, AM J PHYSIOL-ENDOC M, V295, pE1358, DOI 10.1152/ajpendo.90464.2008	92	26	26	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1904	1916		10.1096/fj.12-219410	http://dx.doi.org/10.1096/fj.12-219410			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23362116				2022-12-25	WOS:000318226100011
J	Foley, JH; Orfeo, T; Undas, A; McLean, KC; Bernstein, IM; Rivard, GE; Mann, KG; Everse, SJ; Brummel-Ziedins, KE				Foley, Jonathan H.; Orfeo, Thomas; Undas, Anetta; McLean, Kelley C.; Bernstein, Ira M.; Rivard, Georges-Etienne; Mann, Kenneth G.; Everse, Stephen J.; Brummel-Ziedins, Kathleen E.			From Principle to Practice: Bridging the Gap in Patient Profiling	PLOS ONE			English	Article							HEMOSTATIC SYSTEM ACTIVATION; THROMBIN GENERATION; HEMOPHILIA-A; VENOUS THROMBOEMBOLISM; FACTOR-VA; PLASMA; BLOOD; MODEL; HEPARIN; GROWTH	The standard clinical coagulation assays, activated partial thromboplastin time (aPTT) and prothrombin time (PT) cannot predict thrombotic or bleeding risk. Since thrombin generation is central to haemorrhage control and when unregulated, is the likely cause of thrombosis, thrombin generation assays (TGA) have gained acceptance as "global assays'' of haemostasis. These assays generate an enormous amount of data including four key thrombin parameters (lag time, maximum rate, peak and total thrombin) that may change to varying degrees over time in longitudinal studies. Currently, each thrombin parameter is averaged and presented individually in a table, bar graph or box plot; no method exists to visualize comprehensive thrombin generation data over time. To address this need, we have created a method that visualizes all four thrombin parameters simultaneously and can be animated to evaluate how thrombin generation changes over time. This method uses all thrombin parameters to intrinsically rank individuals based on their haemostatic status. The thrombin generation parameters can be derived empirically using TGA or simulated using computational models (CM). To establish the utility and diverse applicability of our method we demonstrate how warfarin therapy (CM), factor VIII prophylaxis for haemophilia A (CM), and pregnancy (TGA) affects thrombin generation over time. The method is especially suited to evaluate an individual's thrombotic and bleeding risk during "normal'' processes (e. g pregnancy or aging) or during therapeutic challenges to the haemostatic system. Ultimately, our method is designed to visualize individualized patient profiles which are becoming evermore important as personalized medicine strategies become routine clinical practice.	[Foley, Jonathan H.; Orfeo, Thomas; Mann, Kenneth G.; Everse, Stephen J.; Brummel-Ziedins, Kathleen E.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Undas, Anetta] Jagiellonian Univ, Sch Med, Inst Cardiol, Krakow, Poland; [McLean, Kelley C.; Bernstein, Ira M.] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Rivard, Georges-Etienne] Ctr Hosp Univ St Justine, Dept Hematol Oncol, Montreal, PQ, Canada	University of Vermont; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Vermont; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Brummel-Ziedins, KE (corresponding author), Univ Vermont, Dept Biochem, Burlington, VT 05405 USA.	Kathleen.brummel@uvm.edu		Foley, Jonathan/0000-0002-4593-0469	National Institutes of Health [HL46703-Project 5, HL 71944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health to KEB-Z (HL46703-Project 5) and IMB (HL 71944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock DM, 2000, BLOOD COAGUL FIBRIN, V11, P583, DOI 10.1097/00001721-200010000-00001; Allen GA, 2004, J THROMB HAEMOST, V2, P402, DOI 10.1111/j.1538-7933.2003.00617.x; [Anonymous], 2012, NAT BIOTECHNOL, V30, P1, DOI 10.1038/nbt.2096; BELLONI PN, 1992, MICROVASC RES, V43, P20, DOI 10.1016/0026-2862(92)90004-9; Besser M, 2008, J THROMB HAEMOST, V6, P1720, DOI 10.1111/j.1538-7836.2008.03117.x; Bravo MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-45; Brodin E, 2009, TRANSL RES, V153, P124, DOI 10.1016/j.trsl.2008.12.004; Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins K, 2009, WINTROBES CLIN HEMAT, P528; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P181, DOI 10.1111/j.1538-7836.2009.03426.x; Brummel-Ziedins KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044378; Brummel-Ziedins KE, 2004, J THROMB HAEMOST, V2, P281, DOI 10.1046/j.1538-7933.2003.00576.x; BUSCH C, 1982, LAB INVEST, V47, P498; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Butenas S, 2008, THROMB HAEMOSTASIS, V99, P142, DOI 10.1160/TH07-08-0499; CONWAY EM, 1987, J CLIN INVEST, V80, P1535, DOI 10.1172/JCI113239; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Dargaud Y, 2008, J THROMB HAEMOST, V6, P962, DOI 10.1111/j.1538-7836.2008.02964.x; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Dargaud Y, 2010, THROMB HAEMOSTASIS, V103, P469, DOI 10.1160/TH09-10-0679; Eichinger S, 1999, THROMB HAEMOSTASIS, V82, P1232; Eikelboom JW, 2006, THROMB HAEMOSTASIS, V96, P547, DOI 10.1160/TH06-05-0290; Gissel M, 2012, HAEMOPHILIA, V18, P193, DOI 10.1111/j.1365-2516.2011.02638.x; Hale SA, 2009, REPROD SCI, V16, P1091, DOI 10.1177/1933719109341843; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Khor B, 2010, AM J HEMATOL, V85, P440, DOI 10.1002/ajh.21679; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; Manco-Johnson M, 2007, HAEMOPHILIA, V13, P4, DOI 10.1111/j.1365-2516.2007.01499.x; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; McLean KC, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.027; Nair SC, 2010, HAEMOPHILIA, V16, P85, DOI 10.1111/j.1365-2516.2010.02304.x; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Quick AJ, 1935, AM J MED SCI, V190, P501, DOI 10.1097/00000441-193510000-00009; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; SHATOS MA, 1995, ARTERIOSCL THROM VAS, V15, P903, DOI 10.1161/01.ATV.15.7.903; Siegemund T, 2003, THROMB HAEMOSTASIS, V90, P781, DOI 10.1160/TH03-01-0027; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Wulfkuhle KC, 2011, J THROMB HAEMOST, V9, P431	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54728	10.1371/journal.pone.0054728	http://dx.doi.org/10.1371/journal.pone.0054728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372761	gold, Green Published			2022-12-25	WOS:000315210400026
J	Morgan, AA; Rubenstein, E				Morgan, Alexander A.; Rubenstein, Edward			Proline: The Distribution, Frequency, Positioning, and Common Functional Roles of Proline and Polyproline Sequences in the Human Proteome	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; RICH REGIONS; AMINO-ACIDS; SH3 DOMAIN; II HELIX; RECOGNITION; BINDING; FAMILY; GUEST	Proline is an anomalous amino acid. Its nitrogen atom is covalently locked within a ring, thus it is the only proteinogenic amino acid with a constrained phi angle. Sequences of three consecutive prolines can fold into polyproline helices, structures that join alpha helices and beta pleats as architectural motifs in protein configuration. Triproline helices are participants in protein-protein signaling interactions. Longer spans of repeat prolines also occur, containing as many as 27 consecutive proline residues. Little is known about the frequency, positioning, and functional significance of these proline sequences. Therefore we have undertaken a systematic bioinformatics study of proline residues in proteins. We analyzed the distribution and frequency of 687,434 proline residues among 18,666 human proteins, identifying single residues, dimers, trimers, and longer repeats. Proline accounts for 6.3% of the 10,882,808 protein amino acids. Of all proline residues, 4.4% are in trimers or longer spans. We detected patterns that influence function based on proline location, spacing, and concentration. We propose a classification based on proline-rich, polyproline-rich, and proline-poor status. Whereas singlet proline residues are often found in proteins that display recurring architectural patterns, trimers or longer proline sequences tend be associated with the absence of repetitive structural motifs. Spans of 6 or more are associated with DNA/RNA processing, actin, and developmental processes. We also suggest a role for proline in Kruppel-type zinc finger protein control of DNA expression, and in the nucleation and translocation of actin by the formin complex.	[Morgan, Alexander A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Morgan, Alexander A.] Stanford Univ, Sch Med, Genome Technol Ctr, Stanford, CA 94305 USA; [Rubenstein, Edward] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rubenstein, E (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	exr@stanford.edu			Spark Fund; Stanford University; SPARK Project; DHAEV [1110504, Task 204]; Stanford University School of Medicine	Spark Fund; Stanford University(Stanford University); SPARK Project; DHAEV; Stanford University School of Medicine	This work has been supported in part by the Spark Fund, Stanford University, SPARK Project, DHAEV, Project Number 1110504, Task 204. AAM supported by a Stanford University School of Medicine Dean's Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Avbelj F, 2009, P NATL ACAD SCI USA, V106, P3137, DOI 10.1073/pnas.0813018106; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bessonov K, 2013, J MOL GRAPH MODEL, V39, P118, DOI 10.1016/j.jmgm.2012.11.006; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Gushchina LV, 2011, J BIOMOL STRUCT DYN, V29, P485, DOI 10.1080/07391102.2011.10507400; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Hodonsky CJ, 2012, MOL CELL NEUROSCI, V49, P85, DOI 10.1016/j.mcn.2011.10.004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kemper B, 2004, TOXICOL APPL PHARM, V199, P305, DOI 10.1016/j.taap.2003.11.030; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mansiaux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018401; Martin-Garcia JM, 2012, BIOCHEM J, V442, P443, DOI 10.1042/BJ20111089; McDonald CB, 2009, BIOCHEMISTRY-US, V48, P4074, DOI 10.1021/bi802291y; Moradi M, 2011, J PHYS CHEM B, V115, P8645, DOI 10.1021/jp203874f; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Rubenstein E, 2000, MEDICINE, V79, P80, DOI 10.1097/00005792-200003000-00002; Rubenstein E, 2009, PHYTOCHEMISTRY, V70, P100, DOI 10.1016/j.phytochem.2008.11.007; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Smith FJD, 1999, BRIT J DERMATOL, V141, P1010, DOI 10.1046/j.1365-2133.1999.03198.x; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	40	139	140	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53785	10.1371/journal.pone.0053785	http://dx.doi.org/10.1371/journal.pone.0053785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372670	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400007
J	Ezzikouri, S; Alaoui, R; Rebbani, K; Brahim, I; Fakhir, FZ; Nadir, S; Diepolder, H; Khakoo, SI; Thursz, M; Benjelloun, S				Ezzikouri, Sayeh; Alaoui, Rhimou; Rebbani, Khadija; Brahim, Ikram; Fakhir, Fatima-Zohra; Nadir, Salwa; Diepolder, Helmut; Khakoo, Salim I.; Thursz, Mark; Benjelloun, Soumaya			Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; IL28B; POLYMORPHISM; INFECTION; GENOTYPE; FIBROSIS; INFLAMMATION; VARIANTS	Background: Genetic variation in the IL28B gene has been strongly associated with treatment outcomes, spontaneous clearance and progression of the hepatitis C virus infection (HCV). The aim of the present study was to investigate the role of polymorphisms at this locus with progression and outcome of HCV infection in a Moroccan population. Methods: We analyzed a cohort of 438 individuals among them 232 patients with persistent HCV infection, of whom 115 patients had mild chronic hepatitis and 117 had advanced liver disease (cirrhosis and hepatocellular carcinoma), 68 individuals who had naturally cleared HCV and 138 healthy subjects. The IL28B SNPs rs12979860 and rs8099917 were genotyped using a TaqMan 5' allelic discrimination assay. Results: The protective rs12979860-C and rs8099917-T alleles were more common in subjects with spontaneous clearance (77.9% vs 55.2%; p = 0.00001 and 95.6% vs 83.2%; p = 0.0025, respectively). Individuals with clearance were 4.69 (95% CI, 1.99-11.07) times more likely to have the C/C genotype for rs12979860 polymorphism (p = 0.0017) and 3.55 (95% CI, 0.19-66.89) times more likely to have the T/T genotype at rs8099917. Patients with advanced liver disease carried the rs12979860-T/T genotype more frequently than patients with mild chronic hepatitis C (OR = 1.89; 95% CI, 0.99-3.61; p = 0.0532) and this risk was even more pronounced when we compared them with healthy controls (OR = 4.27; 95% CI, 2.08-8.76; p = 0.0005). The rs8099917-G allele was also associated with advanced liver disease (OR = 2.34; 95% CI, 1.40-3.93; p = 0.0100). Conclusions: In the Moroccan population, polymorphisms near the IL28B gene play a role both in spontaneous clearance and progression of HCV infection.	[Ezzikouri, Sayeh; Rebbani, Khadija; Brahim, Ikram; Fakhir, Fatima-Zohra; Benjelloun, Soumaya] Pasteur Inst Morocco, Viral Hepatitis Lab, Virol Unit, Casablanca, Morocco; [Alaoui, Rhimou; Nadir, Salwa] CHU Ibn Rochd, Serv Med B, Casablanca, Morocco; [Diepolder, Helmut] Univ Munich, Munich, Germany; [Khakoo, Salim I.] Univ Southampton, Southampton, Hants, England; [Thursz, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, Div Med, London, England	Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; University of Munich; University of Southampton; Imperial College London	Ezzikouri, S (corresponding author), Pasteur Inst Morocco, Viral Hepatitis Lab, Virol Unit, Casablanca, Morocco.	sayeh.ezzikouri@pasteur.ma; Soumaya.benjelloun@pasteur.ma	Fakhir, Fatima-Zohra/ABC-5592-2020; Ezzikouri, Sayeh/Q-8116-2019	FAKHIR, Fatima-Zohra/0000-0002-1144-9140; Ezzikouri, Sayeh/0000-0002-3982-6163; Thursz, Mark/0000-0002-8218-192X; Benjelloun, Soumaya/0000-0001-5573-8684; Khakoo, Salim/0000-0002-4057-9091	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project [260844]; Medical Research Council [G1001738] Funding Source: researchfish; MRC [G1001738] Funding Source: UKRI	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project [Grant Agreement no260844, www.hepacute.eu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Benjelloun S, 1996, RES VIROLOGY, V147, P247, DOI 10.1016/0923-2516(96)89656-7; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Brahim I, 2012, ARCH VIROL, V157, P515, DOI 10.1007/s00705-011-1193-7; Clark PJ, 2012, DIG DIS SCI; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Coudray C, 2006, AM J HUM BIOL, V18, P23, DOI 10.1002/ajhb.20465; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Di Marco V, 2012, HAEMATOL-HEMATOL J, V97, P679, DOI 10.3324/haematol.2011.050351; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Kobayashi M, 2012, J GASTROENTEROL, V47, P596, DOI 10.1007/s00535-012-0531-1; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rivero-Juarez A, 2012, AIDS, V26, P1009, DOI 10.1097/QAD.0b013e3283528b1c; Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647; Shi X, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0037054; Sklan EH, 2009, NAT REV GASTRO HEPAT, V6, P217, DOI 10.1038/nrgastro.2009.32; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005	34	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54793	10.1371/journal.pone.0054793	http://dx.doi.org/10.1371/journal.pone.0054793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358556	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000314023600110
J	Friedlander, SM; Herrmann, AL; Lowry, DP; Mepham, ER; Lek, M; North, KN; Organ, CL				Friedlander, Scott M.; Herrmann, Amanda L.; Lowry, Daniel P.; Mepham, Emily R.; Lek, Monkol; North, Kathryn N.; Organ, Chris L.			ACTN3 Allele Frequency in Humans Covaries with Global Latitudinal Gradient	PLOS ONE			English	Article							R577X POLYMORPHISM; EVOLUTION; PATTERNS; GENE; ALPHA-ACTININ-3; PERFORMANCE; MUSCLE; ASSOCIATION; PHYLOGENIES; POPULATION	A premature stop codon in ACTN3 resulting in alpha-actinin-3 deficiency ( the ACTN3 577XX genotype) is common in humans and reduces strength, muscle mass, and fast-twitch fiber diameter, but increases the metabolic efficiency of skeletal muscle. Linkage disequilibrium data suggest that the ACTN3 R577X allele has undergone positive selection during human evolution. The allele has been hypothesized to be adaptive in environments with scarce resources where efficient muscle metabolism would be selected. Here we test this hypothesis by using recently developed comparative methods that account for evolutionary relatedness and gene flow among populations. We find evidence that the ACTN3 577XX genotype evolved in association with the global latitudinal gradient. Our results suggest that environmental variables related to latitudinal variation, such as species richness and mean annual temperature, may have influenced the adaptive evolution of ACTN3 577XX during recent human history.	[Friedlander, Scott M.; Herrmann, Amanda L.; Lowry, Daniel P.; Mepham, Emily R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Lowry, Daniel P.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Lek, Monkol; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Lek, Monkol; North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Organ, Chris L.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Organ, Chris L.] Univ Utah, Nat Hist Museum Utah, Dept Paleontol, Salt Lake City, UT 84112 USA	Brown University; University of Michigan System; University of Michigan; University of Sydney; University of Sydney; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Organ, CL (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	chris.organ@utah.edu	North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Lowry, Daniel/0000-0002-9668-0850				Beerli Peter, 2009, V17, P42; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaston KJ, 2007, CURR BIOL, V17, pR574, DOI 10.1016/j.cub.2007.05.013; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Ginevi V., 2010, ACTA MED LITU, V17, P1, DOI DOI 10.2478/V10140-010-0001-0; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Lek M, 2010, BIOESSAYS, V32, P17, DOI 10.1002/bies.200900110; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paparini A, 2007, MED SCI SPORT EXER, V39, P810, DOI 10.1097/mss.0b013e3180317491; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAFTERY AE, 1996, MARKOV CHAIN MONTE C, P163; Rambaut A, 2014, TRACER V1 6; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Shang X, 2010, INT J SPORTS MED; Sokal R. R., 2012, BIOMETRY; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	36	26	26	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52282	10.1371/journal.pone.0052282	http://dx.doi.org/10.1371/journal.pone.0052282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359641	Green Published, gold			2022-12-25	WOS:000314023600005
J	Huang, TC; Chang, CK; Liao, CH; Ho, YJ				Huang, Tzung-Chi; Chang, Chih-Kai; Liao, Chun-Han; Ho, Yung-Jen			Quantification of Blood Flow in Internal Cerebral Artery by Optical Flow Method on Digital Subtraction Angiography in Comparison with Time-Of-Flight Magnetic Resonance Angiography	PLOS ONE			English	Article							MR PERFUSION IMAGES; ARTERIOVENOUS-MALFORMATION; TRANSCRANIAL DOPPLER; VELOCITY-MEASUREMENT; STENOSIS; SEGMENTATION	Objective: This study compared data on the blood flow velocity in the internal carotid artery, which was obtained using the optical flow method (OFM) with digital subtraction angiography (DSA) and the time-of-flight (TOF) technique using magnetic resonance angiography (MRA). Materials and Methods: Images were obtained from 12 cerebrovascular patients who underwent both brain DSA and MRA imaging. The OFM was applied on the DSA images to determine the average blood flow velocity. The calculated results were compared with the values obtained from the TOF-MRA data. A linear fit was performed on the data and Bland-Altman plots were analyzed. Results: The blood flow velocity was closely associated with vascular diseases. Color-coding of the OFM measurements were superimposed on to the DSA images, which quantitatively illustrated the relative flow in the vessels. The average blood flow velocity was calculated using OFM and DSA, which demonstrated a high correlation with the MRA measurements in the anterior-posterior (AP) view (R = 0.71). In contrast, the average blood flow velocity was low in the lateral view (R = 0.28). The consistency between the high and low blood velocity in the AP view was better compared to the lateral view. The blood flow velocity distribution in the AP view was statistically closer to the MRA measurement compared to the lateral view. Conclusions: This study evaluated the correlation of blood flow measured using DSA and TOF-MRA in a small heterogeneous group of patients with cerebrovascular lesions. OFM with DSA imaging reveals hemodynamic information and TOF-MRA.	[Huang, Tzung-Chi; Chang, Chih-Kai; Ho, Yung-Jen] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Liao, Chun-Han; Ho, Yung-Jen] China Med Univ, Dept Radiol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		 [CMU101-S-05]		This study was supported by funding CMU101-S-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chien A, 2009, SURG NEUROL, V72, P444, DOI 10.1016/j.surneu.2008.12.013; Derdeyn CP, 1998, AM J NEURORADIOL, V19, P1463; Dumoulin C L, 1995, Magn Reson Imaging Clin N Am, V3, P399; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; GREITZ T, 1956, Acta Radiol Suppl, P1; Ho YJ, 2012, THE SCIENTIFICWORLD, V2012; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huang SP, 1997, MED PHYS, V24, P677, DOI 10.1118/1.597990; Huang TC, 2012, J VASC SURG, V56, P812, DOI 10.1016/j.jvs.2012.02.041; Huang TC, 2010, MICROVASC RES, V80, P477, DOI 10.1016/j.mvr.2010.07.007; Kao YH, 2010, MAGN RESON MED, V64, P743, DOI 10.1002/mrm.22402; Kao YH, 2008, J MAGN RESON IMAGING, V28, P1125, DOI 10.1002/jmri.21537; Langevin F, 2009, IRBM, V30, P273, DOI 10.1016/j.irbm.2009.09.002; Lu CF, 2007, P ANN INT IEEE EMBS, P5547, DOI 10.1109/IEMBS.2007.4353603; Molloi S, 1998, INT J CARDIAC IMAG, V14, P137, DOI 10.1023/A:1006059709539; MONIZ E, 1927, REV NEUROL, V1, P48; Park SH, 2009, J CLIN NEUROSCI, V16, P378, DOI 10.1016/j.jocn.2008.04.025; PETTY GW, 1990, STROKE, V21, P260, DOI 10.1161/01.STR.21.2.260; Seifalian A, 1996, DEV CARDIOVASC MED, V186, P425; Serafin Z, 2012, NEURORADIOLOGY, V54, P1253, DOI 10.1007/s00234-012-1030-z; Shih TC, 2011, MICROVASC RES, V81, P68, DOI 10.1016/j.mvr.2010.10.006; Shpilfoygel SD, 2000, MED PHYS, V27, P2008, DOI 10.1118/1.1288669; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Wagner S, 2004, J MAGN RESON IMAGING, V19, P468, DOI 10.1002/jmri.20025; Wang Y, 2004, J X-RAY SCI TECHNOL, V12, P13; Yu SL, 2012, MAGN RESON IMAGING, V30, P869, DOI 10.1016/j.mri.2012.02.027	27	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54678	10.1371/journal.pone.0054678	http://dx.doi.org/10.1371/journal.pone.0054678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358555	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600090
J	Mantokoudis, G; Dahler, C; Dubach, P; Kompis, M; Caversaccio, MD; Senn, P				Mantokoudis, Georgios; Daehler, Claudia; Dubach, Patrick; Kompis, Martin; Caversaccio, Marco D.; Senn, Pascal			Internet Video Telephony Allows Speech Reading by Deaf Individuals and Improves Speech Perception by Cochlear Implant Users	PLOS ONE			English	Article							HEARING-IMPAIRED INDIVIDUALS; HARD-OF-HEARING; SIGN-LANGUAGE; DIRECTIONAL BENEFIT; OLDER-ADULTS; VISUAL CUES; IMPACT; NOISE; INTELLIGIBILITY; COMMUNICATION	Objective: To analyze speech reading through Internet video calls by profoundly hearing-impaired individuals and cochlear implant (CI) users. Methods: Speech reading skills of 14 deaf adults and 21 CI users were assessed using the Hochmair Schulz Moser (HSM) sentence test. We presented video simulations using different video resolutions (1280x720, 640x480, 320x240, 160x120 px), frame rates (30, 20, 10, 7, 5 frames per second (fps)), speech velocities (three different speakers), webcameras (Logitech Pro9000, C600 and C500) and image/sound delays (0-500 ms). All video simulations were presented with and without sound and in two screen sizes. Additionally, scores for live Skype (TM) video connection and live face-to-face communication were assessed. Results: Higher frame rate (>7 fps), higher camera resolution (>640x480 px) and shorter picture/sound delay (<100 ms) were associated with increased speech perception scores. Scores were strongly dependent on the speaker but were not influenced by physical properties of the camera optics or the full screen mode. There is a significant median gain of +8.5% pts (p = 0.009) in speech perception for all 21 CI-users if visual cues are additionally shown. CI users with poor open set speech perception scores (n = 11) showed the greatest benefit under combined audio-visual presentation (median speech perception +11.8% pts, p = 0.032). Conclusion: Webcameras have the potential to improve telecommunication of hearing-impaired individuals.	[Mantokoudis, Georgios; Daehler, Claudia; Dubach, Patrick; Kompis, Martin; Caversaccio, Marco D.; Senn, Pascal] Univ Bern, Inselspital, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Mantokoudis, G (corresponding author), Univ Bern, Inselspital, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland.	mantokoudis@gmx.ch	Mantokoudis, Georgios/J-6318-2013	Mantokoudis, Georgios/0000-0003-2268-7811; Senn, Pascal/0000-0002-4619-3341	foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern	foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern	This study was supported by a grant of the foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern. Logitech Europe S.A. provided the webcameras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria J, 2005, J DEAF STUD DEAF EDU, V10, P122, DOI 10.1093/deafed/eni013; [Anonymous], 1992, ITU T HDB TEL; Barnett S, 1999, PUBLIC HEALTH REP, V114, P330, DOI 10.1093/phr/114.4.330; Baskent D, 2011, EAR HEARING, V32, P582, DOI 10.1097/AUD.0b013e31820fca23; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bergeson TR, 2005, EAR HEARING, V26, P149, DOI 10.1097/00003446-200504000-00004; Bowe FG, 2002, AM ANN DEAF, V147, P6, DOI 10.1353/aad.2012.0251; Cavender A, 2008, DISABIL REHABIL-ASSI, V3, P93, DOI 10.1080/17483100701343475; Champoux F, 2009, NEUROPSYCHOLOGIA, V47, P17, DOI 10.1016/j.neuropsychologia.2008.08.028; Ciaramello FM, 2011, IEEE T IMAGE PROCESS, V20, P3014, DOI 10.1109/TIP.2011.2132730; Colonius H, 2011, EXP BRAIN RES; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; De Cicco L, 2008, SKYPE VIDEO RESPONSI; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; Farrera Marcos Paredes, 2010, Journal of Communications, V5, P169, DOI 10.4304/jcm.5.2.169-177; Foulds RA, 2004, IEEE T NEUR SYS REH, V12, P65, DOI 10.1109/TNSRE.2003.821371; FROWEIN HW, 1991, IEEE J SEL AREA COMM, V9, P611, DOI 10.1109/49.81956; Hellstrom Delevert Revelius, 1997, QUALITY REQUIREMENTS; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; ITU-T Recommendations, 2009, H SER PACK BAS MULT; ITU-T Recommendations, 1999, H SER APPL PROF SIGN; Lenarz M, 2012, OTOLARYNG HEAD NECK, V147, P112, DOI 10.1177/0194599812438041; Lenarz M, 2012, LARYNGOSCOPE, V122, P1126, DOI 10.1002/lary.23214; Mantokoudis G, 2012, J MED INTERNET RES, V14, P264, DOI 10.2196/jmir.1818; Mantokoudis G, 2010, OTOL NEUROTOL, V31, P1014, DOI 10.1097/MAO.0b013e3181ec1d46; PAVEL M, 1987, J OPT SOC AM A, V4, P2355, DOI 10.1364/JOSAA.4.002355; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Rouger J, 2008, BRAIN RES, V1188, P87, DOI 10.1016/j.brainres.2007.10.049; Saxe DM, 2002, IEEE T INF TECHNOL B, V6, P310, DOI 10.1109/TITB.2002.806094; Skoglund Jan, 2008, SPRINGER HDB SPEECH, P307; Strelnikov K, 2009, SCAND J PSYCHOL, V50, P437, DOI 10.1111/j.1467-9450.2009.00741.x; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; Towards Luettin J., 1997, SPEAKER INDEPENDENT, P1991; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; Tye-Murray N, 2007, EAR HEARING, V28, P656, DOI 10.1097/AUD.0b013e31812f7185; Wu YH, 2010, EAR HEARING, V31, P35, DOI 10.1097/AUD.0b013e3181bc769b; Wu YH, 2010, EAR HEARING, V31, P22, DOI 10.1097/AUD.0b013e3181bc767e	38	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54770	10.1371/journal.pone.0054770	http://dx.doi.org/10.1371/journal.pone.0054770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359119	Green Published, gold			2022-12-25	WOS:000314023600107
J	Nicoletti, A; Luca, A; Raciti, L; Contrafatto, D; Bruno, E; Dibilio, V; Sciacca, G; Mostile, G; Petralia, A; Zappia, M				Nicoletti, Alessandra; Luca, Antonina; Raciti, Loredana; Contrafatto, Donatella; Bruno, Elisa; Dibilio, Valeria; Sciacca, Giorgia; Mostile, Giovanni; Petralia, Antonio; Zappia, Mario			Obsessive Compulsive Personality Disorder and Parkinson's Disease	PLOS ONE			English	Article							DSM-IV; RISK	Objectives: To evaluate the frequency of personality disorders in Parkinson's disease (PD) patients and in a group of healthy controls. Methods: Patients affected by PD diagnosed according to the United Kingdom Parkinson's disease Society Brain Bank diagnostic criteria and a group of healthy controls were enrolled in the study. PD patients with cognitive impairment were excluded from the study. Structured Clinical Interview for Personality Disorders-II (SCID-II) has been performed to evaluate the presence of personality disorders. Presence of personality disorders, diagnosed according to the DSM-IV, was confirmed by a psychiatric interview. Clinical and pharmacological data were also recorded using a standardized questionnaire. Results: 100 PD patients (57 men; mean age 59.0 +/- 10.2 years) and 100 healthy subjects (52 men; mean age 58.1 +/- 11.4 years) were enrolled in the study. The most common personality disorder was the obsessive-compulsive personality disorder diagnosed in 40 PD patients and in 10 controls subjects (p-value<0.0001) followed by the depressive personality disorder recorded in 14 PD patients and 4 control subjects (p-value 0.02). Obsessive-compulsive personality disorder was also found in 8 out of 16 de novo PD patients with a short disease duration. Conclusion: PD patients presented a high frequency of obsessive-compulsive personality disorder that does not seem to be related with both disease duration and dopaminergic therapy.	[Nicoletti, Alessandra; Luca, Antonina; Raciti, Loredana; Contrafatto, Donatella; Bruno, Elisa; Dibilio, Valeria; Sciacca, Giorgia; Mostile, Giovanni; Zappia, Mario] Univ Catania, Dipartimento GF Ingrassia, Sez Neurosci, Catania, Italy; [Petralia, Antonio] Univ Catania, Dipartimento Biomed Clin & Mol, Sez Psichiatria, Catania, Italy	University of Catania; University of Catania	Zappia, M (corresponding author), Univ Catania, Dipartimento GF Ingrassia, Sez Neurosci, Catania, Italy.	m.zappia@unict.it	Luca, Antonina/AAA-6605-2022; Zappia, Mario/AAB-7800-2019; Sciacca, Giorgia/AAA-6704-2022; Nicoletti, Alessandra/K-4486-2018; Luca, Antonina/AAA-6614-2022; Bruno, Elisa/P-4317-2018; Mostile, Giovanni/AAA-9014-2022	Luca, Antonina/0000-0002-8397-3478; Sciacca, Giorgia/0000-0002-1629-1282; Nicoletti, Alessandra/0000-0001-6757-340X; Luca, Antonina/0000-0002-8397-3478; Bruno, Elisa/0000-0001-8166-1190; Mostile, Giovanni/0000-0002-3556-7432	AIFA-Agenzia Italiana del Farmaco; Novartis; Lundbeck; MIUR-Ministero dell'Istruzione; dell'Universita e della Ricerca; Italian Ministry of Foreign Affairs	AIFA-Agenzia Italiana del Farmaco; Novartis(Novartis); Lundbeck(Lundbeck Corporation); MIUR-Ministero dell'Istruzione; dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy))	M. Zappia received compensation for consulting services from Boehringer-Ingelheim, Lundbeck, UCB-Union Chimique Belge and scientific grants from AIFA-Agenzia Italiana del Farmaco, Novartis, Lundbeck; Intellectual Property Rights: Movement Time Analyzer patent number 01277716. A. Nicoletti received honoraria from UCB-Union Chimique Belge for medical education symposia and received scientific grants from MIUR-Ministero dell'Istruzione, dell'Universita e della Ricerca, Italian Ministry of Foreign Affairs and Lundbeck. A. Luca, L. Raciti, D. Contrafatto, E. Bruno, V. Dibilio, G. Sciacca, G. Mostile and A. Petralia have nothing to disclose. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amad A, 2013, ENCEPHALE, V39, P374, DOI 10.1016/j.encep.2012.08.006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arabia G, 2010, NEUROLOGY, V75, P349, DOI 10.1212/WNL.0b013e3181ea15fd; Bower JH, 2010, MOVEMENT DISORD, V25, P2105, DOI 10.1002/mds.23230; Bricaud M, 2012, ENCEPHALE, V38, P288, DOI 10.1016/j.encep.2011.08.001; Castelli L, 2008, J NEUROL, V255, P1515, DOI 10.1007/s00415-008-0955-y; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; de Araujo GM, 2010, PROG NEURO-PSYCHOPH, V34, P516, DOI 10.1016/j.pnpbp.2010.02.009; Fabbrini G, 2012, PARKINSONISM RELAT D, V18, P971, DOI 10.1016/j.parkreldis.2012.05.005; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Farmer RF, 2002, COMPR PSYCHIAT, V43, P285, DOI 10.1053/comp.2002.33494; First M. B., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Grant JE, 2012, J PSYCHIATR RES, V46, P469, DOI 10.1016/j.jpsychires.2012.01.009; Harbishettar V, 2005, PARKINSONISM RELAT D, V11, P85, DOI 10.1016/j.parkreldis.2004.07.006; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ishihara L, 2006, MOVEMENT DISORD, V21, P1066, DOI 10.1002/mds.20980; Kummer A, 2009, CURR PSYCHIATRY REV, V5, P55, DOI 10.2174/157340009787315280; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; MENZA MA, 1995, J NEUROPSYCH CLIN N, V7, P176; PHILLIPS KA, 1993, J PERS DISORD, V7, P30, DOI 10.1521/pedi.1993.7.1.30; PILKONIS PA, 1999, COST EFFECTIVENESS P, P279; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Starcevic V, 2013, AUST NZ J PSYCHIAT, V47, P65, DOI 10.1177/0004867412450645; *STAT, 2007, STATA STAT SOFTW REL; van Alphen S P J, 2010, Tijdschr Gerontol Geriatr, V41, P79	28	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54822	10.1371/journal.pone.0054822	http://dx.doi.org/10.1371/journal.pone.0054822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359811	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600115
J	Shao, HJ; Scott, SG; Nakata, C; Hamad, AR; Chakravarti, S				Shao, Hanjuan; Scott, Sherri-Gae; Nakata, Chiaki; Hamad, Abdel R.; Chakravarti, Shukti			Extracellular Matrix Protein Lumican Promotes Clearance and Resolution of Pseudomonas aeruginosa Keratitis in a Mouse Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PHOTOREFRACTIVE KERATECTOMY; NEUTROPHIL INFILTRATION; INFECTIOUS KERATITIS; CORNEAL INFLAMMATION; IMMUNE PRIVILEGE; IN-VIVO; INNATE; TLR4; EXPRESSION	Lumican is an extracellular protein that associates with CD14 on the surface of macrophages and neutrophils, and promotes CD14-TLR4 mediated response to bacterial lipopolysaccharides (LPS). Lumican-deficient (Lum(-/-)) mice and macrophages are impaired in TLR4 signals; raising the possibility that lumican may regulate host response to live bacterial infections. In a recent study we showed that in vitro Lum(-/-) macrophages are impaired in phagocytosis of gram-negative bacteria and in a lung infection model the Lum(-/-) mice showed poor survival. The cornea is an immune privileged barrier tissue that relies primarily on innate immunity to protect against ocular infections. Lumican is a major component of the cornea, yet its role in counteracting live bacteria in the cornea remains poorly understood. Here we investigated Pseudomonas aeruginosa infections of the cornea in Lum(-/-) mice. By flow cytometry we found that 24 hours after infection macrophage and neutrophil counts were lower in the cornea of Lum(-/-) mice compared to wild types. Infected Lum(-/-) corneas showed lower levels of the leukocyte chemoattractant CXCL1 by 24-48 hours of infection, and increased bacterial counts up to 5 days after infection, compared to Lum(+/-) mice. The pro-inflammatory cytokine TNF-alpha was comparably low 24 hours after infection, but significantly higher in the Lum(-/-) compared to Lum(+/-) infected corneas by 2-5 days after infection. Taken together, the results indicate that lumican facilitates development of an innate immune response at the earlier stages of infection and lumican deficiency leads to poor bacterial clearance and resolution of corneal inflammation at a later stage.	[Shao, Hanjuan; Scott, Sherri-Gae; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Nakata, Chiaki; Hamad, Abdel R.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Chakravarti, S (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.	schakra1@jhmi.edu			NIH [EY11654]; NATIONAL EYE INSTITUTE [R56EY011654, R01EY011654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant EY11654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Cole N, 2005, IMMUNOL CELL BIOL, V83, P301, DOI 10.1111/j.1440-1711.2005.01324.x; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fleiszig Suzanne M J, 2002, Clin Exp Optom, V85, P271; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hazlett LD, 2005, OCUL IMMUNOL INFLAMM, V13, P133, DOI 10.1080/09273940490912362; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett LD, 2002, INVEST OPHTH VIS SCI, V43, P419; Hazlett LD, 2010, OCUL IMMUNOL INFLAMM, V18, P237, DOI 10.3109/09273948.2010.501946; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jeng BH, 2003, BRIT J OPHTHALMOL, V87, P805, DOI 10.1136/bjo.87.7.805; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Karimian F, 2007, J REFRACT SURG, V23, P312; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; OCallaghan RJ, 1996, INVEST OPHTH VIS SCI, V37, P534; Robertson DM, 2008, CLIN OPHTHALMOL, V2, P907; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Shao H, 2012, J BIOL CHEM; Spandau UHM, 2003, ARCH OPHTHALMOL-CHIC, V121, P825, DOI 10.1001/archopht.121.6.825; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Vajpayee RB, 2007, SURV OPHTHALMOL, V52, P1, DOI 10.1016/j.survophthal.2006.10.001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wroblewski KJ, 2006, OPHTHALMOLOGY, V113, P520, DOI 10.1016/j.ophtha.2005.09.038; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139	42	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54765	10.1371/journal.pone.0054765	http://dx.doi.org/10.1371/journal.pone.0054765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358433	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600106
J	Hameed, A; Bennett, E; Ciani, B; Hoebers, LPC; Milner, R; Lawrie, A; Francis, SE; Grierson, AJ				Hameed, Abdul; Bennett, Ellen; Ciani, Barbara; Hoebers, Loes P. C.; Milner, Roy; Lawrie, Allan; Francis, Sheila E.; Grierson, Andrew J.			No Evidence for Cardiac Dysfunction in Kif6 Mutant Mice	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; KINESIN-LIKE PROTEIN-6; TRP719ARG POLYMORPHISM; MYOCARDIAL-INFARCTION; GENE VARIANTS; RISK; ASSOCIATION; SUPERFAMILY; TRANSPORT; EFFICACY	A KIF6 variant in man has been reported to be associated with adverse cardiovascular outcomes after myocardial infarction. No clear biological or physiological data exist for Kif6. We sought to investigate the impact of a deleterious KIF6 mutation on cardiac function in mice. Kif6 mutant mice were generated and verified. Cardiac function was assessed by serial echocardiography at baseline, after ageing and after exercise. Lipid levels were also measured. No discernable adverse lipid or cardiac phenotype was detected in Kif6 mutant mice. These data suggest that dysfunction of Kif6 is linked to other more complex biological/biochemical parameters or is unlikely to be of material consequence in cardiac function.	[Hameed, Abdul; Lawrie, Allan; Francis, Sheila E.] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Bennett, Ellen; Hoebers, Loes P. C.; Milner, Roy; Grierson, Andrew J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Ciani, Barbara] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Francis, SE (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	s.francis@sheffield.ac.uk	Ciani, Barbara/A-1679-2012; Lawrie, Allan/A-2708-2012; Grierson, Andy/A-5067-2009; Hameed, Abdul/O-1782-2019	Ciani, Barbara/0000-0001-7223-4154; Lawrie, Allan/0000-0003-4192-9505; Grierson, Andy/0000-0001-7039-6731; Hameed, Abdul/0000-0002-2128-2081; Bennett, Ellen/0000-0002-9818-827X; Francis, Sheila/0000-0001-6552-0339	University of Sheffield; MRC [G0800318] Funding Source: UKRI; Medical Research Council [G0800318] Funding Source: researchfish	University of Sheffield; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Research and Innovation Fund, University of Sheffield. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; Arsenault BJ, 2012, CIRC-CARDIOVASC GENE, V5, P51, DOI 10.1161/CIRCGENETICS.111.960252; Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Davani S, 2010, ATHEROSCLEROSIS, V210, P48, DOI 10.1016/j.atherosclerosis.2009.11.041; Ference BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028834; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoffmann MM, 2011, ATHEROSCLEROSIS, V219, P659, DOI 10.1016/j.atherosclerosis.2011.07.126; Hopewell JC, 2011, J AM COLL CARDIOL, V57, P2000, DOI 10.1016/j.jacc.2011.02.015; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Iakoubova OA, 2010, EUR J CARDIOV PREV R, V17, P455, DOI 10.1097/HJR.0b013e328336a0dd; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Li YH, 2010, AM J CARDIOL, V106, P994, DOI 10.1016/j.amjcard.2010.05.033; Marian AJ, 2008, J AM COLL CARDIOL, V51, P456, DOI 10.1016/j.jacc.2007.10.020; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Ridker PM, 2011, CIRC-CARDIOVASC GENE, V4, P312, DOI 10.1161/CIRCGENETICS.110.959353; Shiffman D, 2008, J AM COLL CARDIOL, V51, P444, DOI 10.1016/j.jacc.2007.09.044; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2010, AM J CARDIOL, V105, P1300, DOI 10.1016/j.amjcard.2009.12.049; Topol EJ, 2010, J AM COLL CARDIOL, V56, P1564, DOI 10.1016/j.jacc.2010.06.023	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54636	10.1371/journal.pone.0054636	http://dx.doi.org/10.1371/journal.pone.0054636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355886	Green Published, Green Accepted, gold			2022-12-25	WOS:000314021500100
J	Roderburg, C; Luedde, M; Cardenas, DV; Vucur, M; Scholten, D; Frey, N; Koch, A; Trautwein, C; Tacke, F; Luedde, T				Roderburg, Christoph; Luedde, Mark; Cardenas, David Vargas; Vucur, Mihael; Scholten, David; Frey, Norbert; Koch, Alexander; Trautwein, Christian; Tacke, Frank; Luedde, Tom			Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ILL PATIENTS; MIR-150; MORTALITY; DISEASE; RNAS; INFLAMMATION; BIOMARKERS; CELLS	Background and Aims: Down-regulation of miR-150 was recently linked to inflammation and bacterial infection. Furthermore, reduced serum levels of miR-150 were reported from a small cohort of patients with sepsis. We thus aimed at evaluating the diagnostic and prognostic value of miR-150 serum levels in patients with critically illness and sepsis. Methods: miR-150 serum levels were analyzed in a cohort of 223 critically ill patients of which 138 fulfilled sepsis criteria and compared to 76 healthy controls. Results were correlated with clinical data and extensive sets of routine and experimental biomarkers. Results: Measurements of miR-150 serum concentrations revealed only slightly reduced miR-150 serum levels in critically ill patients compared to healthy controls. Furthermore miR-150 levels did not significantly differ in critically ill patients with our without sepsis, indicating that miR-150 serum levels are not suitable for diagnostic establishment of sepsis. However, serum levels of miR-150 correlated with hepatic or renal dysfunction. Low miR-150 serum levels were associated with an unfavorable prognosis of patients, since low miR-150 serum levels predicted mortality with high diagnostic accuracy compared with established clinical scores and biomarkers. Conclusion: Reduced miR-150 serum concentrations are associated with an unfavorable outcome in patients with critical illness, independent of the presence of sepsis. Besides a possible pathogenic role of miR-150 in critical illness, our study indicates a potential use of circulating miRNAs as a prognostic rather than diagnostic marker in critically ill patients.	[Roderburg, Christoph; Cardenas, David Vargas; Vucur, Mihael; Scholten, David; Koch, Alexander; Trautwein, Christian; Tacke, Frank; Luedde, Tom] Rhein Westfal TH RWTH Aachen, Univ Hosp, Dept Med 3, Aachen, Germany; [Luedde, Mark; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, Kiel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Kiel	Luedde, T (corresponding author), Rhein Westfal TH RWTH Aachen, Univ Hosp, Dept Med 3, Aachen, Germany.	tluedde@ukaachen.de	Roderburg, Christoph/AHC-8101-2022; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022; Frey, Norbert/A-9695-2010; Tacke, Frank/ABF-2212-2020; Frey, Norbert/M-7749-2019	Roderburg, Christoph/0000-0002-1409-7697; Luedde, Tom/0000-0002-6288-8821; Frey, Norbert/0000-0001-7611-378X	European Research Council [ERC-2007-Stg/208237-Luedde-Med3-Aachen]; German-Research-Foundation [SFB-TRR57, P06/P09, Ta434/2-1]; Ernst-Jung-Foundation Hamburg; START-program of the medical faculty Aachen	European Research Council(European Research Council (ERC)European Commission); German-Research-Foundation(German Research Foundation (DFG)); Ernst-Jung-Foundation Hamburg; START-program of the medical faculty Aachen	This work was supported by a Starting Grant from the European Research Council within the FP 7 (ERC-2007-Stg/208237-Luedde-Med3-Aachen) the German-Research-Foundation (SFB-TRR57, P06/P09, Ta434/2-1), the Ernst-Jung-Foundation Hamburg and grants from the START-program of the medical faculty Aachen. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Archanioti P, 2011, J CROHNS COLITIS, V5, P520, DOI 10.1016/j.crohns.2011.05.007; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Gressner OA, 2008, CLIN BIOCHEM, V41, P974, DOI 10.1016/j.clinbiochem.2008.05.005; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	30	125	140	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54612	10.1371/journal.pone.0054612	http://dx.doi.org/10.1371/journal.pone.0054612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372743	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500097
J	Svensson, MND; Andersson, SEM; Erlandsson, MC; Jonsson, IM; Ekwall, AKH; Andersson, KME; Nilsson, A; Bian, L; Brisslert, M; Bokarewa, MI				Svensson, Mattias N. D.; Andersson, Sofia E. M.; Erlandsson, Malin C.; Jonsson, Ing-Marie; Ekwall, Anna-Karin H.; Andersson, Karin M. E.; Nilsson, Anders; Bian, Li; Brisslert, Mikael; Bokarewa, Maria I.			Fms-Like Tyrosine Kinase 3 Ligand Controls Formation of Regulatory T Cells in Autoimmune Arthritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; IN-VIVO; HOMEOSTASIS; BLIMP-1; MICE; ATHEROSCLEROSIS; LYMPHOCYTES	Fms-like tyrosine kinase 3 ligand (Flt3L) is known as the primary differentiation and survival factor for dendritic cells (DCs). Furthermore, Flt3L is involved in the homeostatic feedback loop between DCs and regulatory T cell (Treg). We have previously shown that Flt3L accumulates in the synovial fluid in rheumatoid arthritis (RA) and that local exposure to Flt3L aggravates arthritis in mice, suggesting a possible involvement in RA pathogenesis. In the present study we investigated the role of Flt3L on DC populations, Tregs as well as inflammatory responses in experimental antigen-induced arthritis. Arthritis was induced in mBSA-immunized mice by local knee injection of mBSA and Flt3L was provided by daily intraperitoneal injections. Flow cytometry analysis of spleen and lymph nodes revealed an increased formation of DCs and subsequently Tregs in mice treated with Flt3L. Flt3L-treatment was also associated with a reduced production of mBSA specific antibodies and reduced levels of the pro-inflammatory cytokines IL-6 and TNF-alpha. Morphological evaluation of mBSA injected joints revealed reduced joint destruction in Flt3L treated mice. The role of DCs in mBSA arthritis was further challenged in an adoptive transfer experiment. Transfer of DCs in combination with T-cells from mBSA immunized mice, predisposed naive recipients for arthritis and production of mBSA specific antibodies. We provide experimental evidence that Flt3L has potent immunoregulatory properties. Flt3L facilitates formation of Treg cells and by this mechanism reduces severity of antigen-induced arthritis in mice. We suggest that high systemic levels of Flt3L have potential to modulate autoreactivity and autoimmunity.	[Svensson, Mattias N. D.; Andersson, Sofia E. M.; Erlandsson, Malin C.; Jonsson, Ing-Marie; Ekwall, Anna-Karin H.; Andersson, Karin M. E.; Bian, Li; Brisslert, Mikael; Bokarewa, Maria I.] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Anders] Univ Gothenburg, Dept Hand Surg, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Svensson, MND (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	mattias.svensson@rheuma.gu.se	Bokarewa, Maria I/A-8114-2019; Svensson, Mattias N.D./A-9827-2012	Bokarewa, Maria I/0000-0001-9424-5145; Svensson, Mattias N.D./0000-0001-8077-9824; Andersson, Sofia/0000-0003-2933-7339; Andersson, Karin/0000-0002-9475-3040; Ekwall, Anna-Karin/0000-0001-8236-6089; Brisslert, Mikael/0000-0002-1412-5600; Erlandsson, Malin/0000-0003-1100-7577	Medical Society of Gothenburg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Anniversary Foundation; Swedish Research Council; EU Commission; Professor's Nanna Swartz Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA); Torsten Soderbergs Foundation; Ingabritt and Arne Lundberg's Foundation; Swedish Foundation; Magnus Bergwall foundation; pharmacist Hedberg foundation; University of Gothenburg; Family Tholen and Kristlers Foundation; Regional agreement on medical training and clinical research between the Western Gotaland county council; University of Goteborg (LUA/ALF)	Medical Society of Gothenburg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Anniversary Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU Commission(European CommissionEuropean Commission Joint Research Centre); Professor's Nanna Swartz Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA)(Vinnova); Torsten Soderbergs Foundation; Ingabritt and Arne Lundberg's Foundation; Swedish Foundation; Magnus Bergwall foundation; pharmacist Hedberg foundation; University of Gothenburg; Family Tholen and Kristlers Foundation; Regional agreement on medical training and clinical research between the Western Gotaland county council; University of Goteborg (LUA/ALF)	This study was supported by grants from the Medical Society of Gothenburg, the Swedish Association against Rheumatism, the King Gustaf V:s 80-year Anniversary Foundation, the Swedish Research Council, the EU Commission (FP7-HEALTH), Professor's Nanna Swartz Foundation, AME Wolff Foundation, Rune and Ulla Amlovs Trust, the Swedish Research Agency for Innovation Systems (VINNOVA), Torsten Soderbergs Foundation, Ingabritt and Arne Lundberg's Foundation, the Swedish Foundation for Strategic Research, Magnus Bergwall foundation, the pharmacist Hedberg foundation, and the University of Gothenburg, the Family Tholen and Kristlers Foundation, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bostrom EA, 2011, ARTHRITIS RHEUM-US, V63, P2894, DOI 10.1002/art.30527; Brand DD, 2004, METH MOLEC MED, V102, P295; Cavanagh LL, 2005, ARTHRITIS RES THER, V7, pR230, DOI 10.1186/ar1467; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Collins CB, 2011, GUT; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Heltemes-Harris LM, 2011, ANN NY ACAD SCI, V1217, P18, DOI 10.1111/j.1749-6632.2010.05907.x; Ibarra JM, 2011, IMMUNOBIOLOGY, V216, P971, DOI 10.1016/j.imbio.2011.03.012; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Jongbloed SL, 2009, J IMMUNOL, V182, P963, DOI 10.4049/jimmunol.182.2.963; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kavousanaki M, 2010, ARTHRITIS RHEUM-US, V62, P53, DOI 10.1002/art.25037; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Lebre MC, 2009, HUM IMMUNOL, V70, P321, DOI 10.1016/j.humimm.2009.02.006; Lindblad SS, 2011, NEUROSIGNALS; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martin E, 2007, ARTHRITIS RHEUM-US, V56, P2255, DOI 10.1002/art.22655; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Raghavan S, 2009, ANN RHEUM DIS, V68, P1908, DOI 10.1136/ard.2008.100768; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Teshima T, 2002, BLOOD, V99, P1825, DOI 10.1182/blood.V99.5.1825; van den Berg Wim B., 2007, V136, P243; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	50	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54884	10.1371/journal.pone.0054884	http://dx.doi.org/10.1371/journal.pone.0054884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349985	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000052
J	Los, FCO; Ha, C; Aroian, RV				Los, Ferdinand C. O.; Ha, Christine; Aroian, Raffi V.			Neuronal Go alpha and CAPS Regulate Behavioral and Immune Responses to Bacterial Pore-Forming Toxins	PLOS ONE			English	Article							PLASMA-MEMBRANE REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; INNATE IMMUNITY; SIGNALING NETWORK; BACILLUS-THURINGIENSIS; CRYSTAL PROTEINS; NERVOUS-SYSTEM; UNC-31 CAPS; PATHWAY	Pore-forming toxins (PFTs) are abundant bacterial virulence factors that attack host cell plasma membranes. Host defense mechanisms against PFTs described to date all function in the host tissue that is directly attacked by the PFT. Here we characterize a rapid and fully penetrant cessation of feeding of Caenorhabditis elegans in response to PFT attack. We demonstrate via analyses of C. elegans mutants that inhibition of feeding by PFT requires the neuronal G protein Go alpha subunit goa-1, and that maintenance of this response requires neuronally expressed calcium activator for protein secretion (CAPS) homolog unc-31. Independently from their role in feeding cessation, we find that goa-1 and unc-31 are additionally required for immune protection against PFTs. We thus demonstrate that the behavioral and immune responses to bacterial PFT attack involve the cross-talk between the nervous system and the cells directly under attack.	[Los, Ferdinand C. O.; Ha, Christine; Aroian, Raffi V.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu			National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [R01GM071603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071603] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant R01GM071603 to RVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1993, Genetics, V134, P455; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof Larry J., 2006, V351, P139; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Goehler LE, 2007, BRAIN BEHAV IMMUN, V21, P721, DOI 10.1016/j.bbi.2007.02.005; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; RAIZEN DM, 1995, GENETICS, V141, P1365; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van Swinderen B, 2001, GENETICS, V158, P643; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	54	15	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54528	10.1371/journal.pone.0054528	http://dx.doi.org/10.1371/journal.pone.0054528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349920	Green Submitted, gold, Green Published			2022-12-25	WOS:000313738900075
J	Kim, Y; Cunningham, MA; Mire, J; Tesar, C; Sacchettini, J; Joachimiak, A				Kim, Youngchang; Cunningham, Mark A.; Mire, Joseph; Tesar, Christine; Sacchettini, James; Joachimiak, Andrzej			NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism	FASEB JOURNAL			English	Article						metallo-beta-lactamase; antibiotic resistance; pH dependence	METALLO-BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MODEL; ZINC; DIFFRACTION; INSIGHTS; REVEALS	The specter of a return to an era in which infectious disease looms as a significant threat to human health is not just hyperbole; there are serious concerns about the widespread overuse and misuse of antibiotics contributing to increased antibiotic resistance in pathogens. The recent discovery of a new enzyme, first identified in Klebsiella pneumoniae from a patient from New Delhi and denoted as NDM-1, represents an example of extreme promiscuity: It hydrolyzes and inactivates nearly all known beta-lactam-based antibiotics with startling efficiency. NDM-1 can utilize different metal cofactors and seems to exploit an alternative mechanism based on the reaction conditions. Here we report the results of a combined experimental and theoretical study that examines the substrate, metal binding, and catalytic mechanism of the enzyme. We utilize structures obtained through X-ray crystallography, biochemical assays, and numerical simulation to construct a model of the enzyme catalytic pathway. The NDM-1 enzyme interacts with the substrate solely through zinc, or other metals, bound in the active site, explaining the observed lack of specificity against a broad range of beta-lactam antibiotic agents. The zinc ions also serve to activate a water molecule that hydrolyzes the beta-lactam ring through a proton shuttle.-Kim, Y., Cunningham, M. A.; Mire, J., Tesar, C., Sacchettini, J., Joachimiak, A. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J. 27, 1917-1927 (2013). www.fasebj.org	[Kim, Youngchang; Tesar, Christine; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Kim, Youngchang; Tesar, Christine; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Cunningham, Mark A.] Univ Texas Pan Amer, Dept Phys & Geol, Edinburg, TX 78539 USA; [Mire, Joseph; Sacchettini, James] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Rio Grande Valley; Texas A&M University System; Texas A&M University College Station	Joachimiak, A (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	cunningham@utpa.edu; andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Kim, Youngchang/0000-0002-1610-4889	U.S. National Institutes of Health [GM094585, GM094568]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Science Foundation's FaST program [HRD-0703584]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U01GM094568] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation's FaST program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the members of the Midwest Center for Structural Genomics and the Structural Biology Center at Argonne National Laboratory for their support, specifically Robert Jedrzejczak for cloning the truncated NDM-1 gene. This research has been funded in part by a grant from the U.S. National Institutes of Health GM094585 (A.J.), GM094568 (J.S.), and by the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. M.A.C. has also received support through the National Science Foundation's FaST program (HRD-0703584), administered by the Department of Educational Programs at Argonne National Laboratory. The authors acknowledge the Texas Advanced Computing Center (TACC; http://www.tacc.utexas.edu) at the University of Texas at Austin for providing HPC resources that have contributed to the research results reported within this article. Additional computational resources were provided by the HiPAC cluster at the University of Texas-Pan American. The authors thank Gekleng Chhor for proofreading of the manuscript. The atomic coordinates and structure factors have been deposited to the Protein Data Bank (PDB IDs: 4H0D, 4HL2, 4HL1, 4HKY; http://www.pdb.org).	Badarau A, 2006, BIOCHEMISTRY-US, V45, P10654, DOI 10.1021/bi060934l; Bebrone C, 2008, BIOCHEM J, V414, P151, DOI 10.1042/BJ20080375; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blakeley MP, 2008, P NATL ACAD SCI USA, V105, P1844, DOI 10.1073/pnas.0711659105; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Green VL, 2011, ACTA CRYSTALLOGR F, V67, P1160, DOI 10.1107/S1744309111029654; HOOVER WG, 1986, PHYS REV A, V34, P2499, DOI 10.1103/PhysRevA.34.2499; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Page MI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/576297; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Riondet C, 1997, BIOTECHNOL TECH, V11, P735, DOI 10.1023/A:1018492217623; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Tamilselvi A, 2008, J BIOL INORG CHEM, V13, P1039, DOI 10.1007/s00775-008-0407-2; Thomas PA, 2011, CURR CLIN PATHOL, P1, DOI 10.1007/978-1-60327-154-7_1; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	44	88	93	1	58	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1917	1927		10.1096/fj.12-224014	http://dx.doi.org/10.1096/fj.12-224014			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23363572	Green Published			2022-12-25	WOS:000318226100012
J	Korner, C; Keklikoglou, I; Bender, C; Worner, A; Munstermann, E; Wiemann, S				Koerner, Cindy; Keklikoglou, Ioanna; Bender, Christian; Woerner, Angelika; Muenstermann, Ewald; Wiemann, Stefan			MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C epsilon (PKC epsilon)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; ACTIVATION; MIR-31; PROLIFERATION; METASTASIS; GENES; SUPPRESSION; EXPRESSION; INVASION	MicroRNAs post-transcriptionally regulate gene expression and thereby contribute to the modulation of numerous complex and disease-relevant cellular phenotypes, including cell proliferation, cell motility, apoptosis, and stress response. In breast cancer cell systems, miR-31 has been shown to inhibit cell migration, invasion, and metastasis. Here, we link enhanced expression of miR-31 to the inhibition of the oncogenic NF-kappa B pathway, thus supporting the tumor-suppressive function of this microRNA. We identified protein kinase C epsilon (PKC epsilon encoded by the PRKCE gene) as a novel direct target of miR-31 and show that down-regulation of PKC epsilon results in impaired NF-kappa B signaling, enhanced apoptosis, and increased sensitivity of MCF10A breast epithelial and MDA-MB-231 triple-negative breast cancer cells toward ionizing radiation as well as treatment with chemotherapeutics. Mechanistically, we attribute this sensitization to anti-cancer treatments to the PRKCE-mediated down-regulation of the anti-apoptotic factor BCL2. In clinical breast cancer samples, high BCL2 expression was associated with poor prognosis. Furthermore, we found an inverse correlation between miR-31 and BCL2 expression, highlighting the functional relevance of the indirect down-regulation of BCL2 via direct targeting of PRKCE by miR-31.	[Koerner, Cindy; Keklikoglou, Ioanna; Bender, Christian; Woerner, Angelika; Muenstermann, Ewald; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Wiemann, S (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	s.wiemann@dkfz-heidelberg.de	Wiemann, Stefan/E-4424-2013	Wiemann, Stefan/0000-0003-4683-3174; Keklikoglou, Ioanna/0000-0003-1219-6912; Koerner, Cindy/0000-0003-1150-9462	German Research Foundation within the German-Israeli Funding Program; National Genome Research Network of the German Federal Ministry of Education and Research; DKFZ International Ph.D. program	German Research Foundation within the German-Israeli Funding Program; National Genome Research Network of the German Federal Ministry of Education and Research; DKFZ International Ph.D. program	This work was supported by the German Research Foundation within the German-Israeli Funding Program and by the National Genome Research Network of the German Federal Ministry of Education and Research.; Supported by the DKFZ International Ph.D. program.	Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2003, CANCER RES, V63, P290; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garg Amit K., 2003, Current Opinion in Oncology, V15, P405, DOI 10.1097/00001622-200311000-00001; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perego P, 2001, CURR MED CHEM, V8, P31, DOI 10.2174/0929867013373994; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Shankar E, 2010, INT J ONCOL, V36, P883, DOI 10.3892/ijo_00000566; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	115	119	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8750	8761		10.1074/jbc.M112.414128	http://dx.doi.org/10.1074/jbc.M112.414128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364795	Green Published, hybrid			2022-12-25	WOS:000316564500074
J	Robertson, DR				Robertson, D. Ross			Who Resembles Whom? Mimetic and Coincidental Look-Alikes among Tropical Reef Fishes	PLOS ONE			English	Article							CORAL-REEF; AGGRESSIVE MIMICRY; COLOR MORPHS; HYPOPLECTRUS; EVOLUTION; HAMLETS; SOCIOBIOLOGY; POLYMORPHISM; MECHANISMS; SPECIATION	Studies of mimicry among tropical reef-fishes usually give little or no consideration to alternative explanations for behavioral associations between unrelated, look-alike species that benefit the supposed mimic. I propose and assess such an alternative explanation. With mimicry the mimic resembles its model, evolved to do so in response to selection by the mimicry target, and gains evolved benefits from that resemblance. In the alternative, the social-trap hypothesis, a coincidental resemblance of the model to the "mimic" inadvertently attracts the latter to it, and reinforcement of this social trapping by learned benefits leads to the "mimic" regularly associating with the model. I examine three well known cases of supposed aggressive mimicry among reef-fishes in relation to nine predictions from these hypotheses, and assess which hypothesis offers a better explanation for each. One case, involving precise and complex morphological and behavioral resemblance, is strongly consistent with mimicry, one is inconclusive, and one is more consistent with a social-trap based on coincidental, imprecise resemblance. Few cases of supposed interspecific mimicry among tropical reef fishes have been examined in depth, and many such associations may involve social traps arising from generalized, coincidental resemblance. Mimicry may be much less common among these fishes than is generally thought.	Smithsonian Trop Res Inst, Balboa, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Robertson, DR (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	drr@stri.org						Aguilar-Perera A, 2004, CARIBB J SCI, V40, P150; Aguilar-Perera A, 2003, CARIBB J SCI, V39, P147; [Anonymous], REEF FISH IDENTIFICA; [Anonymous], 2011, FIELD GUIDE COASTAL; BARLOW GW, 1975, MAR BIOL, V33, P295, DOI 10.1007/BF00390567; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Bshary A, 2010, ETHOLOGY, V116, P681, DOI 10.1111/j.1439-0310.2010.01781.x; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, P667, DOI 10.1098/rspb.2002.2263; Cheney KL, 2008, CORAL REEFS, V27, P527, DOI 10.1007/s00338-008-0360-0; Cheney KL, 2008, P R SOC B, V275, P117, DOI 10.1098/rspb.2007.0966; Cheney KL, 2012, BIOL LETTERS, V8, P10, DOI 10.1098/rsbl.2011.0687; Cheney KL, 2010, P ROY SOC B-BIOL SCI, V277, P1849, DOI 10.1098/rspb.2009.2218; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Cheney KL, 2009, P R SOC B, V276, P1565, DOI 10.1098/rspb.2008.1819; Cheney KL, 2005, P ROY SOC B-BIOL SCI, V272, P2635, DOI 10.1098/rspb.2005.3256; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; Cote IM, 2007, P ROY SOC B-BIOL SCI, V274, P2445, DOI 10.1098/rspb.2007.0797; Deloach N., 1999, REEF FISH BEHAV FLOR; DOMEIER ML, 1994, B MAR SCI, V54, P103; Eagle JV, 2004, J ZOOL, V264, P33, DOI 10.1017/S0952836904005473; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; Edwards DP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1321, DOI 10.1007/s00265-007-0369-3; FEDDERN HENRY A., 1965, BULL MAR SCI, V15, P896; FISCHER EA, 1980, ANIM BEHAV, V28, P620, DOI 10.1016/S0003-3472(80)80070-4; FISCHER EA, 1980, COPEIA, P649, DOI 10.2307/1444441; FISHELSON L, 1977, ISR J ZOOL, V26, P114; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Hastings PA, 2009, ZOOTAXA, P3, DOI 10.11646/zootaxa.2120.1.2; Holt BG, 2008, MAR ECOL PROG SER, V357, P283, DOI 10.3354/meps07339; Johnstone RA, 2002, NATURE, V418, P524, DOI 10.1038/nature00845; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kuwamura T., 1983, J ETHOL, V1, P22, DOI [10.1007/BF02347828, DOI 10.1007/BF02347828]; Lin HC, 2011, MOL PHYLOGENET EVOL, V60, P236, DOI 10.1016/j.ympev.2011.04.018; Lobel PS, 2011, ZOOTAXA, P1; Longley W. H., 1940, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V32, P223; Lukoschek V, 2000, P 9 INT COR REEF S, P467; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; Marshall N.J., 1999, ADAPTIVE MECH ECOLOG, P285, DOI [10.1016/0042-6989(94)90221-6, DOI 10.1016/0042-6989(94)90221-6]; Marshall N. Justin, 2000, P83; Moland E, 2005, OCEANOGR MAR BIOL, V43, P455; Munday PL, 2003, OECOLOGIA, V137, P519, DOI 10.1007/s00442-003-1356-7; OGDEN JC, 1973, ECOLOGY, V54, P589, DOI 10.2307/1935344; ORMOND RFG, 1980, J ZOOL, V191, P247, DOI 10.1111/j.1469-7998.1980.tb01458.x; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Pfennig DW, 2012, CURR ZOOL, V58, P608, DOI 10.1093/czoolo/58.4.608; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; Rainey MM, 2009, J ZOOL, V279, P78, DOI 10.1111/j.1469-7998.2009.00592.x; Randall JE, 2005, ZOOL STUD, V44, P299; RANDALL JE, 1998, CARIBBEAN REEF FISHE; RANDALL JOHN E., 1960, BULL MAR SCI GULF AND CARIBBEAN, V10, P444; Randall John E., 1993, Revue Francaise d'Aquariologie Herpetologie, V20, P5; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Reefnet Inc, 2007, REEF FISH ID FLOR CA; ROBERTSON DR, 1976, ECOLOGY, V57, P1208, DOI 10.2307/1935045; RUSSELL BC, 1976, J ZOOL, V180, P407; Sazima Cristina, 2005, Neotrop. ichthyol., V3, P445, DOI 10.1590/S1679-62252005000300014; Sazima I, 2002, ENVIRON BIOL FISH, V65, P37, DOI 10.1023/A:1019654721236; Sazima I., 2002, AQUA INT J ICHTHYOLO, V6, P61; Shand J, 1997, ENVIRON BIOL FISH, V49, P307, DOI 10.1023/A:1007353003066; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; SIKKEL PC, 1992, COPEIA, P914; Smith-Vaniz WF., 1976, MONOGR ACAD NAT SCI, V19, P1; SMITHVANIZ WF, 1987, P ACAD NAT SCI PHILA, V139, P1; Springer V.G., 1972, Smithsonian Contributions to Zoology, VNo. 112, P1; STEPHENS JOHN STEWART, 1963, UNIV CALIF PUBLICATIONS ZOOL, V68, P1; THRESHER RE, 1978, B MAR SCI, V28, P345; Vereecken NJ, 2008, P NATL ACAD SCI USA, V105, P7484, DOI 10.1073/pnas.0800194105; VICTOR BC, 2012, J OCEAN SCI FOUND, V5, P2; WALDNER R. E., 1980, B MAR SCI, V30, P171; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; Whiteman EA, 2007, J ZOOL, V272, P305, DOI 10.1111/j.1469-7998.2006.00270.x; Whiteman EA, 2007, J FISH BIOL, V71, P235, DOI 10.1111/j.1095-8649.2007.01485.x; Wickler W., 1968, MIMICRY PLANTS ANIMA	73	23	23	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54939	10.1371/journal.pone.0054939	http://dx.doi.org/10.1371/journal.pone.0054939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372795	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400041
J	Sano, K; Satoh, K; Atarashi, R; Takashima, H; Iwasaki, Y; Yoshida, M; Sanjo, N; Murai, H; Mizusawa, H; Schmitz, M; Zerr, I; Kim, YS; Nishida, N				Sano, Kazunori; Satoh, Katsuya; Atarashi, Ryuichiro; Takashima, Hiroshi; Iwasaki, Yasushi; Yoshida, Mari; Sanjo, Nobuo; Murai, Hiroyuki; Mizusawa, Hidehiro; Schmitz, Matthias; Zerr, Inga; Kim, Yong-Sun; Nishida, Noriyuki			Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HETEROGENEITY	Introduction: The definitive diagnosis of genetic prion diseases (gPrD) requires pathological confirmation. To date, diagnosis has relied upon the finding of the biomarkers 14-3-3 protein and total tau (t-tau) protein in the cerebrospinal fluid (CSF), but many researchers have reported that these markers are not sufficiently elevated in gPrD, especially in Gerstmann-Straussler-Scheinker syndrome (GSS). We recently developed a new in vitro amplification technology, designated "real-time quaking-induced conversion (RT-QUIC)", to detect the abnormal form of prion protein in CSF from sporadic Creutzfeldt-Jakob disease (sCJD) patients. In the present study, we aimed to investigate the presence of biomarkers and evaluate RT-QUIC assay in patients with gPrD, as the utility of RT-QUIC as a diagnostic tool in gPrD has yet to be determined. Method/Principal Findings: 56 CSF samples were obtained from gPrD patients, including 20 cases of GSS with P102L mutation, 12 cases of fatal familial insomnia (FFI; D178N), and 24 cases of genetic CJD (gCJD), comprising 22 cases with E200K mutation and 2 with V203I mutation. We subjected all CSF samples to RT-QUIC assay, analyzed 14-3-3 protein by Western blotting, and measured t-tau protein using an ELISA kit. The detection sensitivities of RT-QUIC were as follows: GSS (78%), FFI (100%), gCJD E200K (87%), and gCJD V203I (100%). On the other hand the detection sensitivities of biomarkers were considerably lower: GSS (11%), FFI (0%), gCJD E200K (73%), and gCJD V203I (67%). Thus, RT-QUIC had a much higher detection sensitivity compared with testing for biomarkers, especially in patients with GSS and FFI. Conclusion/Significance: RT-QUIC assay is more sensitive than testing for biomarkers in gPrD patients. RT-QUIC method would thus be useful as a diagnostic tool when the patient or the patient's family does not agree to genetic testing, or to confirm the diagnosis in the presence of a positive result for genetic testing.	[Sano, Kazunori; Satoh, Katsuya; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Takashima, Hiroshi] Kagoshima Univ, Dept Neurol & Geriatr, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Iwasaki, Yasushi; Yoshida, Mari] Aichi Med Univ, Dept Neuropathol, Inst Med Sci Aging, Nagakute, Aichi, Japan; [Sanjo, Nobuo; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Tokyo, Japan; [Murai, Hiroyuki] Iizuka Hosp, Dept Neurol, Fukuoka, Japan; [Schmitz, Matthias; Zerr, Inga] Univ Gottingen, Dementia Res Unit, Natl Reference Ctr TSE, D-37073 Gottingen, Germany; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Gyeonggi Do, South Korea; [Sano, Kazunori; Nishida, Noriyuki] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Atarashi, Ryuichiro] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 852, Japan	Nagasaki University; Kagoshima University; Aichi Medical University; Tokyo Medical & Dental University (TMDU); University of Gottingen; Hallym University; Nagasaki University; Nagasaki University	Satoh, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	satoh-prion@nagasaki-u.ac.jp		Sanjo, Nobuo/0000-0002-1226-2425	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare of Japan; Global COE Program for tropical and emerging diseases, Nagasaki University, Japan; Ministry of Education, Culture, Sports, Science and Technology [24591268]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [23300127, 23790998]; Ministry of Health, Labour, and Welfare; Takeda Science Foundation	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global COE Program for tropical and emerging diseases, Nagasaki University, Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grants-in-Aid from the Research Committee of Surveillance and Infection Control of Prion Disease and from the Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labour and Welfare of Japan. Dr. Sano and Professor Nishida are supported by the Global COE Program for tropical and emerging diseases, Nagasaki University, Japan. Dr. Satoh has received research support from Grant-in Aid for Scientific Research (C) (24591268) and from the Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid from the Research Committee on Surveillance and Infection Control of Prion Disease, the Ministry of Health, Labour and Welfare of Japan. Dr. Atarashi has received research support from Grant-in-Aid for Scientific Research (B) (23300127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labour, and Welfare, and a grant from Takeda Science Foundation. Dr. Sano has received research support from Grant-in-Aid for Young Scientific Research (B) (23790998) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Ladogana A, 2009, J NEUROL, V256, P1620, DOI 10.1007/s00415-009-5163-x; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Popova SN, 2012, ACTA NEUROL SCAND, V126, P315, DOI 10.1111/j.1600-0404.2011.01628.x; Satoh K, 2010, LAB INVEST, V90, P1637, DOI 10.1038/labinvest.2009.68; Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202	7	90	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54915	10.1371/journal.pone.0054915	http://dx.doi.org/10.1371/journal.pone.0054915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372790	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400040
J	Aguirre, CE; Murgan, S; Carrasco, AE; Lopez, SL				Aguirre, Cecilia E.; Murgan, Sabrina; Carrasco, Andres E.; Lopez, Silvia L.			An Intact Brachyury Function Is Necessary to Prevent Spurious Axial Development in Xenopus laevis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BOX TRANSCRIPTION FACTOR; MESODERM FORMATION; HOMEOBOX GENE; SPEMANNS ORGANIZER; NEURAL INDUCTION; BETA-CATENIN; CONJOINED TWINS; FLOOR PLATE; NO-TAIL	We have previously shown that the member of the HES family hairy2 induces the ectopic expression of dorsal markers when it is overexpressed in the ventral side of Xenopus embryos. Intriguingly, hairy2 represses the mesoderm transcription factor brachyury (bra) throughout its domain in the marginal zone. Here we show that in early gastrula, bra and hairy2 are expressed in complementary domains. Overexpression of bra repressed hairy2. Interference of bra function with a dominant-negative construct expanded the hairy2 domain and, like hairy2 overexpression, promoted ectopic expression of dorsal axial markers in the ventral side and induced secondary axes without head and notochord. Hairy2 depletion rescued the ectopic dorsal development induced by interference of bra function. We concluded that an intact bra function is necessary to exclude hairy2 expression from the non-organiser field, to impede the ectopic specification of dorsal axial fates and the appearance of incomplete secondary axes. This evidence supports a previously unrecognised role for bra in maintaining the dorsal fates inhibited in the ventral marginal zone, preventing the appearance of trunk duplications.	[Aguirre, Cecilia E.; Murgan, Sabrina; Carrasco, Andres E.; Lopez, Silvia L.] Univ Buenos Aires, Fac Med, Mol Embryol Lab, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina	University of Buenos Aires	Lopez, SL (corresponding author), Univ Buenos Aires, Fac Med, Mol Embryol Lab, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina.	slopez@fmed.uba.ar		Lopez, Silvia/0000-0002-3760-7549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 6123/05]; Universidad de Buenos Aires [M803/05]; Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT 767/06, BID PICT 32024/05, PME-2006-00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 6123/05), Universidad de Buenos Aires (M803/05), and Agencia Nacional de Promocion Cientifica y Tecnologica (BID PICT 767/06, BID PICT 32024/05, PME-2006-00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABA ARI, 1992, DEVELOPMENT, V116, P81; Amacher SL, 2002, DEVELOPMENT, V129, P3311; Artinger M, 1997, MECH DEVELOP, V65, P187, DOI 10.1016/S0925-4773(97)00073-7; Barbosky L, 2006, DEV DYNAM, V235, P2592, DOI 10.1002/dvdy.20885; Beck CW, 1999, DEVELOPMENT, V126, P1611; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Brand A, 2004, J PEDIATR SURG, V39, P616, DOI 10.1016/j.jpedsurg.2003.12.029; Carnac G, 1996, DEVELOPMENT, V122, P3055; Cha YR, 2006, DEV BIOL, V290, P246, DOI 10.1016/j.ydbio.2005.10.043; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Conlon FL, 1999, DEV BIOL, V213, P85, DOI 10.1006/dbio.1999.9330; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Cui YZ, 2005, DEV GROWTH DIFFER, V47, P609; CUNLIFFE V, 1994, EMBO J, V13, P349, DOI 10.1002/j.1460-2075.1994.tb06268.x; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Davis RL, 2001, DEV CELL, V1, P553, DOI 10.1016/S1534-5807(01)00054-5; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Escobar MA, 2008, J PEDIATR SURG, V43, P943, DOI 10.1016/j.jpedsurg.2008.01.061; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Franco PG, 1999, DEVELOPMENT, V126, P4257; FRANK D, 1991, DEVELOPMENT, V113, P1387; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gluecksohn-Schoenheimer S, 1938, GENETICS, V23, P573; GONT LK, 1993, DEVELOPMENT, V119, P991; GREEN JBA, 1994, DEVELOPMENT, V120, P2271; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gupta Saurabh Kumar, 2010, J Surg Tech Case Rep, V2, P77, DOI 10.4103/2006-8808.73621; GURDON JB, 1995, NATURE, V376, P520, DOI 10.1038/376520a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayata T, 1999, DEV GENES EVOL, V209, P560, DOI 10.1007/s004270050289; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heasman J, 1997, DEVELOPMENT, V124, P4179; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Holland PWH, 1995, DEVELOPMENT, V121, P4283; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; Horb ME, 1997, DEVELOPMENT, V124, P1689; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kaufman MH, 2004, CHILD NERV SYST, V20, P508, DOI 10.1007/s00381-004-0985-4; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Kumano G, 2001, DEV BIOL, V236, P465, DOI 10.1006/dbio.2001.0341; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Lopez SL, 2005, DEVELOPMENT, V132, P1035, DOI 10.1242/dev.01659; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Murato Y, 2007, DEV GENES EVOL, V217, P665, DOI 10.1007/s00427-007-0176-x; Murato Y, 2006, INT J DEV BIOL, V50, P463, DOI 10.1387/ijdb.052106ym; Nagatomo KI, 2007, DEV DYNAM, V236, P1475, DOI 10.1002/dvdy.21152; Nelson RW, 1999, J CELL BIOL, V147, P367, DOI 10.1083/jcb.147.2.367; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Nichane M, 2008, DEV BIOL, V322, P368, DOI 10.1016/j.ydbio.2008.07.026; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Panitz F, 1998, EMBO J, V17, P4414, DOI 10.1093/emboj/17.15.4414; PANNESE M, 1995, DEVELOPMENT, V121, P707; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; Revinski DR, 2010, DEV BIOL, V339, P477, DOI 10.1016/j.ydbio.2010.01.010; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Smith JC, 1997, COLD SPRING HARB SYM, V62, P337; Smith JC, 2001, INT J DEV BIOL, V45, P219; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Spencer R, 2000, CLIN ANAT, V13, P36, DOI 10.1002/(SICI)1098-2353(2000)13:1<36::AID-CA5>3.0.CO;2-3; Spencer R, 2001, CLIN ANAT, V14, P428, DOI 10.1002/ca.1079; STEINBEISSER H, 1993, DEVELOPMENT, V118, P499; STEINBEISSER H, 1993, CR ACAD SCI III-VIE, V316, P966; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Tada M, 1997, DEVELOPMENT, V124, P2225; Tsuji S, 2003, DEV GENES EVOL, V213, P407, DOI 10.1007/s00427-003-0338-4; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; VODICKA MA, 1995, DEVELOPMENT, V121, P3505; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILSON V, 1993, DEVELOPMENT, V117, P1321; WILSON V, 1995, DEVELOPMENT, V121, P877; Yamada A, 2010, DEV BIOL, V339, P212, DOI 10.1016/j.ydbio.2009.12.019; Yamaguti M, 2005, DEV DYNAM, V234, P102, DOI 10.1002/dvdy.20523; Zucker RM, 1999, METHODS, V18, P473, DOI 10.1006/meth.1999.0815	120	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54777	10.1371/journal.pone.0054777	http://dx.doi.org/10.1371/journal.pone.0054777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359630	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600108
J	Schymanski, SJ; Or, D; Zwieniecki, M				Schymanski, Stanislaus J.; Or, Dani; Zwieniecki, Maciej			Stomatal Control and Leaf Thermal and Hydraulic Capacitances under Rapid Environmental Fluctuations	PLOS ONE			English	Article							BOUNDARY-LAYER RESISTANCE; GAS-EXCHANGE; PHOTOSYNTHETIC RESPONSES; RAIN-FOREST; TEMPERATURE DISTRIBUTION; TROPICAL SAVANNA; FLAPPING LEAVES; WATER RELATIONS; DYNAMIC LIGHT; ELEVATED CO2	Leaves within a canopy may experience rapid and extreme fluctuations in ambient conditions. A shaded leaf, for example, may become exposed to an order of magnitude increase in solar radiation within a few seconds, due to sunflecks or canopy motions. Considering typical time scales for stomatal adjustments, (2 to 60 minutes), the gap between these two time scales raised the question whether leaves rely on their hydraulic and thermal capacitances for passive protection from hydraulic failure or over-heating until stomata have adjusted. We employed a physically based model to systematically study effects of short-term fluctuations in irradiance on leaf temperatures and transpiration rates. Considering typical amplitudes and time scales of such fluctuations, the importance of leaf heat and water capacities for avoiding damaging leaf temperatures and hydraulic failure were investigated. The results suggest that common leaf heat capacities are not sufficient to protect a non-transpiring leaf from over-heating during sunflecks of several minutes duration whereas transpirative cooling provides effective protection. A comparison of the simulated time scales for heat damage in the absence of evaporative cooling with observed stomatal response times suggested that stomata must be already open before arrival of a sunfleck to avoid over-heating to critical leaf temperatures. This is consistent with measured stomatal conductances in shaded leaves and has implications for water use efficiency of deep canopy leaves and vulnerability to heat damage during drought. Our results also suggest that typical leaf water contents could sustain several minutes of evaporative cooling during a sunfleck without increasing the xylem water supply and thus risking embolism. We thus submit that shaded leaves rely on hydraulic capacitance and evaporative cooling to avoid over-heating and hydraulic failure during exposure to typical sunflecks, whereas thermal capacitance provides limited protection for very short sunflecks (tens of seconds).	[Schymanski, Stanislaus J.; Or, Dani] ETH, Dept Environm Syst Sci, Zurich, Switzerland; [Zwieniecki, Maciej] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Davis	Schymanski, SJ (corresponding author), ETH, Dept Environm Syst Sci, Zurich, Switzerland.	stanislaus.schymanski@env.ethz.ch	Schymanski, Stan/AAV-3862-2021; Schymanski, Stanislaus J/A-5303-2012; Or, Dani/D-8768-2012	Schymanski, Stan/0000-0002-0950-2942; Schymanski, Stanislaus J/0000-0002-0950-2942; Or, Dani/0000-0002-3236-2933; Zwieniecki, Maciej/0000-0002-3774-4455	ETH Zurich; Harvard University	ETH Zurich(ETH Zurich); Harvard University	The research was funded by ETH Zurich and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerle WL, 2003, TREE PHYSIOL, V23, P841, DOI 10.1093/treephys/23.12.841; Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Chazdon RL, 1988, ADV ECOLOGICAL RES, V18, P1; Chen JW, 2010, TREE PHYSIOL, V30, P876, DOI 10.1093/treephys/tpq043; Chen JW, 2009, PLANTA, V230, P459, DOI 10.1007/s00425-009-0959-6; COLOMBO SJ, 1992, TREE PHYSIOL, V11, P95, DOI 10.1093/treephys/11.1.95; Edwards DS, 1993, TROPICAL RAINFOREST; FAY PA, 1993, AM J BOT, V80, P1369, DOI 10.2307/2445664; FAY PA, 1995, PHYSIOL PLANTARUM, V94, P613, DOI 10.1111/j.1399-3054.1995.tb00975.x; Hao GY, 2008, OECOLOGIA, V155, P405, DOI 10.1007/s00442-007-0918-5; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hartmann H, 2011, GLOBAL CHANGE BIOL, V17, P642, DOI 10.1111/j.1365-2486.2010.02248.x; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; HOLLINGER DY, 1987, J ECOL, V75, P925, DOI 10.2307/2260304; Incropera F.P., 2018, FUNDAMENTALS HEAT MA; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; KNAPP AK, 1990, PHYSIOL PLANTARUM, V78, P160, DOI 10.1111/j.1399-3054.1990.tb08731.x; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Leakey ADB, 2005, J EXP BOT, V56, P469, DOI 10.1093/jxb/eri055; Leakey ADB, 2003, PLANT CELL ENVIRON, V26, P1681, DOI 10.1046/j.1365-3040.2003.01086.x; Leigh A, 2012, NEW PHYTOL, V194, P477, DOI 10.1111/j.1469-8137.2012.04058.x; Monteith J., 2007, PRINCIPLES ENV PHYS; Myers BA, 1997, AUST J BOT, V45, P225, DOI 10.1071/BT96015; Naumburg E, 2000, OECOLOGIA, V122, P163, DOI 10.1007/PL00008844; Okajima Y, 2012, ECOL RES, V27, P333, DOI 10.1007/s11284-011-0905-5; Ortiz C, 2001, J EXP BOT, V52, P1711, DOI 10.1093/jexbot/52.361.1711; PARLANGE JY, 1971, PLANT PHYSIOL, V48, P437, DOI 10.1104/pp.48.4.437; PARLANGE JY, 1972, PLANT PHYSIOL, V50, P60, DOI 10.1104/pp.50.1.60; Pearcy RW, 1987, FUNCT ECOL, V1, P169, DOI 10.2307/2389419; Pearcy R. W., 2004, PHOTOSYNTHESIS ENV, P321; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; Peng Y, 2012, CROP SCI, V52, P807, DOI 10.2135/cropsci2011.06.0327; Pinker RT, 1997, PHOTOSYNTHETICALLY A; Roderick ML, 2005, PLANT PHYSIOL BIOCH, V43, P323, DOI 10.1016/j.plaphy.2005.02.014; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SCHUEPP PH, 1993, NEW PHYTOL, V125, P477, DOI 10.1111/j.1469-8137.1993.tb03898.x; Schultz HR, 1997, OECOLOGIA, V110, P312, DOI 10.1007/s004420050164; Tausz M, 2005, NEW PHYTOL, V165, P143, DOI 10.1111/j.1469-8137.2004.01232.x; THIMIJAN RW, 1983, HORTSCIENCE, V18, P818; Valladares F, 1997, OECOLOGIA, V111, P505, DOI 10.1007/s004420050264; Vico G, 2011, NEW PHYTOL, V192, P640, DOI 10.1111/j.1469-8137.2011.03847.x; Warren JM, 2011, TREE PHYSIOL, V31, P117, DOI 10.1093/treephys/tpr002; Way DA, 2012, TREE PHYSL; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Zeppel MJB, 2011, NEW PHYTOL, V192, P800, DOI 10.1111/j.1469-8137.2011.03960.x; Zimmermann M. H., 1983, Xylem structure and the ascent of sap.; Zweifel R, 2000, TREES-STRUCT FUNCT, V15, P50, DOI 10.1007/s004680000072; Zwieniecki MA, 2000, PLANT CELL ENVIRON, V23, P407, DOI 10.1046/j.1365-3040.2000.00554.x; Zwieniecki MA, 2007, PLANT CELL ENVIRON, V30, P910, DOI 10.1111/j.1365-3040.2007.001681.x	51	104	106	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54231	10.1371/journal.pone.0054231	http://dx.doi.org/10.1371/journal.pone.0054231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359800	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600039
J	Zhu, Y; Carido, M; Meinhardt, A; Kurth, T; Karl, MO; Ader, M; Tanaka, EM				Zhu, Yu; Carido, Madalena; Meinhardt, Andrea; Kurth, Thomas; Karl, Mike O.; Ader, Marius; Tanaka, Elly M.			Three-Dimensional Neuroepithelial Culture from Human Embryonic Stem Cells and Its Use for Quantitative Conversion to Retinal Pigment Epithelium	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; OPTIC VESICLE; IPS CELLS; IN-VITRO; HUMAN ES; GENERATION; NEURONS; DISEASE; MOUSE; RPE	A goal in human embryonic stem cell (hESC) research is the faithful differentiation to given cell types such as neural lineages. During embryonic development, a basement membrane surrounds the neural plate that forms a tight, apico-basolaterally polarized epithelium before closing to form a neural tube with a single lumen. Here we show that the three-dimensional epithelial cyst culture of hESCs in Matrigel combined with neural induction results in a quantitative conversion into neuroepithelial cysts containing a single lumen. Cells attain a defined neuroepithelial identity by 5 days. The neuroepithelial cysts naturally generate retinal epithelium, in part due to IGF-1/insulin signaling. We demonstrate the utility of this epithelial culture approach by achieving a quantitative production of retinal pigment epithelial (RPE) cells from hESCs within 30 days. Direct transplantation of this RPE into a rat model of retinal degeneration without any selection or expansion of the cells results in the formation of a donor-derived RPE monolayer that rescues photoreceptor cells. The cyst method for neuroepithelial differentiation of pluripotent stem cells is not only of importance for RPE generation but will also be relevant to the production of other neuronal cell types and for reconstituting complex patterning events from three-dimensional neuroepithelia.	[Zhu, Yu; Carido, Madalena; Meinhardt, Andrea; Kurth, Thomas; Karl, Mike O.; Ader, Marius; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany	Technische Universitat Dresden	Tanaka, EM (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany.	elly.tanaka@crt-dresden.de	Karl, Mike O./E-7246-2010; Ader, Marius/E-7535-2010; Meinhardt, Andrea/P-6161-2014; Tanaka, Elly M/F-8572-2010	Karl, Mike O./0000-0002-0926-6556; Ader, Marius/0000-0001-9467-7677; Meinhardt, Andrea/0000-0003-3833-8210; Tanaka, Elly/0000-0003-4240-2158; Carido, Madalena/0000-0001-8969-0877; Kurth, Thomas/0000-0001-5624-1717	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]; DIGS-BB Graduate Program; Fundacao para a Ciencia e Tecnologia	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence(German Research Foundation (DFG)); DIGS-BB Graduate Program; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the FZT 111 (Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence), the DIGS-BB Graduate Program and the Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Carr AJ, 2009, MOL VIS, V15, P283; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; FRAMBACH DA, 1990, INVEST OPHTH VIS SCI, V31, P1767; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu Q, 2010, STEM CELLS; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; LACOUR M, 1994, INVEST OPHTH VIS SCI, V35, P434; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Okamoto S, 2011, INVEST OPHTH VIS SCI, V52, P8785, DOI 10.1167/iovs.11-8129; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; SCHWARTZ SD, 2012, LANCET; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	46	71	76	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54552	10.1371/journal.pone.0054552	http://dx.doi.org/10.1371/journal.pone.0054552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358448	Green Published, gold			2022-12-25	WOS:000314023600068
J	Alsallaq, RA; Baeten, JM; Celum, CL; Hughes, JP; Abu-Raddad, LJ; Barnabas, RV; Hallett, TB				Alsallaq, Ramzi A.; Baeten, Jared M.; Celum, Connie L.; Hughes, James P.; Abu-Raddad, Laith J.; Barnabas, Ruanne V.; Hallett, Timothy B.			Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; SOUTH-AFRICA; SEXUAL TRANSMISSION; TREATMENT PROGRAM; PROJECT ACCEPT; HPTN 043; RISK; SPREAD	Objectives: Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention interventions could offer a powerful strategy when combined. In anticipation of combination HIV prevention programs and research studies we estimated the population-level impact of combining effective scalable interventions at high population coverage, determined the factors that influence this impact, and estimated the synergy between the components. Methods: We used a mathematical model to investigate the effect on HIV incidence of a combination HIV prevention intervention comprised of high coverage of HIV testing and counselling, risk reduction following HIV diagnosis, male circumcision for HIV-uninfected men, and antiretroviral therapy (ART) for HIV-infected persons. The model was calibrated to data for KwaZulu-Natal, South Africa, where adult HIV prevalence is approximately 23%. Results: Compared to current levels of HIV testing, circumcision, and ART, the combined intervention with ART initiation according to current guidelines could reduce HIV incidence by 47%, from 2.3 new infections per 100 person-years (pyar) to 1.2 per 100 pyar within 4 years and by almost 60%, to 1 per 100 pyar, after 25 years. Short-term impact is driven primarily by uptake of testing and reductions in risk behaviour following testing while long-term effects are driven by periodic HIV testing and retention in ART programs. If the combination prevention program incorporated HIV treatment upon diagnosis, incidence could be reduced by 63% after 4 years and by 76% (to about 0.5 per 100 pyar) after 15 years. The full impact of the combination interventions accrues over 10-15 years. Synergy is demonstrated between the intervention components. Conclusion: High coverage combination of evidence-based strategies could generate substantial reductions in population HIV incidence in an African generalized HIV epidemic setting. The full impact could be underestimated by the short assessment duration of typical evaluations.	[Alsallaq, Ramzi A.; Baeten, Jared M.; Celum, Connie L.; Hughes, James P.; Barnabas, Ruanne V.] Univ Washington, Seattle, WA 98195 USA; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Barnabas, Ruanne V.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Abu-Raddad, Laith J.] Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Imperial College London	Alsallaq, RA (corresponding author), Univ Washington, Seattle, WA 98195 USA.	ramzi.alsallaq@gmail.com	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Hallett, Timothy/0000-0002-9681-0424	National Institutes of Health [1R01AI083034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, G0600719B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by a grant from the National Institutes of Health (1R01AI083034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aids2031, 2010, LONG TERM COSTS HIV; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; Anderson RM, 2000, SEX TRANSM DIS, V27, P636, DOI 10.1097/00007435-200011000-00012; Assefa Y, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60647-4; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2011, NEW ENGL J MED, V365, P1; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Department of Health SA, 2003, DEM HLTH SURV; Department of Health SA, 2009, NAT ANT SENT HIV SYP; Department of Health SA, 2012, HIV AIDS STI STRAT P; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Epstein H, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60643-7; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Hsieh YH, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60645-0; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Jurgens R, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60644-9; Kaldor JM, 2010, AIDS, V24, P2564, DOI 10.1097/QAD.0b013e32833ead96; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; KwaZulu-Natal Department of Health, 2006, POP DAT; Lange JMA, 2011, CLIN INFECT DIS, V52, P801, DOI 10.1093/cid/ciq254; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Mugglin C, 2012, 19 C RETR OPP INF MA; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Naik R, 2010, 18 INT AIDS C 18 23; NICOLOSI A, 1994, J ACQ IMMUN DEF SYND, V7, P296; Nuwaha F, 2009, 16 C RETR OPP INF 8; Over M., 2010, GLOBAL AIDS TRANSITI; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V58, pE23, DOI 10.1097/QAI.0b013e318227af37; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Pearson CR, 2007, AIDS CARE, V19, P594, DOI 10.1080/09540120701203337; Poole D, 2000, INFERENCE DETERMINIS; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rehle T, 2010, COMMUNICATION; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shisana O, 2009, S AFRICAN NATL HIV P; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; The Epidemiology Unit of KwaZulu-Natal Department of Health, 2005, KWAZULU NAT EP B; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Tumwebaze H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051620; Tumwesigye E, 2008, 15 C RETR OPP INF 3; Tumwesigye E, 2011, 6 IAS C HIV PATH TRE; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2010, ANT THER HIV INF AD; [World Health Organization; WHO UNAIDS UNICEF], 2011, EP UPD HLTH SECT PRO; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	83	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54575	10.1371/journal.pone.0054575	http://dx.doi.org/10.1371/journal.pone.0054575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372738	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500087
J	van de Waterbeemd, B; Zomer, G; van den IJssel, J; van Keulen, L; Eppink, MH; van der Ley, P; van der Pol, LA				van de Waterbeemd, Bas; Zomer, Gijsbert; van den IJssel, Jan; van Keulen, Lonneke; Eppink, Michel H.; van der Ley, Peter; van der Pol, Leo A.			Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; SEROGROUP-B; TRANSCRIPTOME ANALYSIS; MENINGOCOCCAL DISEASE; CHELATING-AGENTS; DNA MICROARRAYS; STRAINS; LIPOPOLYSACCHARIDE	Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial pathogens. The first OMV vaccines successfully stopped Neisseria meningitidis serogroup B outbreaks but required detergent-extraction for endotoxin removal. Current vaccines use attenuated endotoxin, to preserve immunological properties and allow a detergent-free process. The preferred process is based on spontaneously released OMV (sOMV), which are most similar to in vivo vesicles and easier to purify. The release mechanism however is poorly understood resulting in low yield. This study with N. meningitidis demonstrates that an external stimulus, cysteine depletion, can trigger growth arrest and sOMV release in sufficient quantities for vaccine production (+/- 1500 human doses per liter cultivation). Transcriptome analysis suggests that cysteine depletion impairs iron-sulfur protein assembly and causes oxidative stress. Involvement of oxidative stress is confirmed by showing that addition of reactive oxygen species during cysteine-rich growth also triggers vesiculation. The sOMV in this study are similar to vesicles from natural infection, therefore cysteine-dependent vesiculation is likely to be relevant for the in vivo pathogenesis of N. meningitidis.	[van de Waterbeemd, Bas; Zomer, Gijsbert; van den IJssel, Jan; van Keulen, Lonneke; van der Ley, Peter; van der Pol, Leo A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Eppink, Michel H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	van de Waterbeemd, B (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	bas.van.de.waterbeemd@rivm.nl	Eppink, Michel/AAB-6866-2022	Eppink, Michel/0000-0001-8297-9985	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport (www.minvws.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baart GJE, 2008, BIOTECHNOL BIOENG, V101, P1022, DOI 10.1002/bit.22016; Baart GJE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r136; Baart GJE, 2007, VACCINE, V25, P6399, DOI 10.1016/j.vaccine.2007.06.008; Baart GJE, 2010, MICROBIOL-SGM, V156, P530, DOI 10.1099/mic.0.031641-0; Bartolini E, 2006, MOL MICROBIOL, V60, P963, DOI 10.1111/j.1365-2958.2006.05163.x; BISHOP DG, 1965, BIOCHEM J, V96, P567, DOI 10.1042/bj0960567; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; CATLIN BW, 1973, J INFECT DIS, V128, P178, DOI 10.1093/infdis/128.2.178; CHATTERJ.SN, 1967, J GEN MICROBIOL, V49, P1; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Guckenberger M, 2002, J BACTERIOL, V184, P2546, DOI 10.1128/JB.184.9.2546-2551.2002; HAQUE H, 1974, ANTIMICROB AGENTS CH, V5, P447, DOI 10.1128/AAC.5.5.447; HAQUE H, 1974, ANTIMICROB AGENTS CH, V6, P200, DOI 10.1128/AAC.6.2.200; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; HOLBEIN BE, 1981, CURR MICROBIOL, V6, P213, DOI 10.1007/BF01566974; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982; Keiser PB, 2010, VACCINE; KLUGMAN KP, 1989, INFECT IMMUN, V57, P2066, DOI 10.1128/IAI.57.7.2066-2071.1989; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; Koeberling O, 2008, CLIN VACCINE IMMUNOL; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MOSLEN MT, 1994, ADV EXP MED BIOL, V366, P17; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; PORT JL, 1984, CAN J MICROBIOL, V30, P1453, DOI 10.1139/m84-232; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prachayasittikul V, 2007, ACTA BIOCH BIOPH SIN, V39, P901, DOI 10.1111/j.1745-7270.2007.00350.x; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thornton V, 2006, VACCINE, V24, P1395, DOI 10.1016/j.vaccine.2005.09.043; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; van de Waterbeemd B, 2012, VACCINE, V30, P3683, DOI 10.1016/j.vaccine.2012.03.028; van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; VANDERLEY P, 1995, VACCINE, V13, P401, DOI 10.1016/0264-410X(95)98264-B; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; WORK E, 1966, ANN NY ACAD SCI, V133, P438, DOI 10.1111/j.1749-6632.1966.tb52382.x; ZOLLINGE.WD, 1972, INFECT IMMUN, V6, P835, DOI 10.1128/IAI.6.5.835-851.1972; Zollinger WD, 2010, VACCINE; ZOLLINGER WD, 2003, Patent No. 6558677; Zollinger WD, 2011, EXPERT REV VACCINES, V10, P559, DOI [10.1586/erv.11.41, 10.1586/ERV.11.41]	63	41	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54314	10.1371/journal.pone.0054314	http://dx.doi.org/10.1371/journal.pone.0054314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372704	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500056
J	Zhao, L; Wang, YH				Zhao, Liang; Wang, Yonghui			Conflict Background Triggered Congruency Sequence Effects in Graphic Judgment Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; SIMON TASK; FLANKER TASK; RESPONSE ACTIVATION; PREFRONTAL CORTEX; STROOP TASK; ADAPTATION; ADJUSTMENTS; INTEGRATION	Congruency sequence effects refer to the reduction of congruency effects when following an incongruent trial than following a congruent trial. The conflict monitoring account, one of the most influential contributions to this effect, assumes that the sequential modulations are evoked by response conflict. The present study aimed at exploring the congruency sequence effects in the absence of response conflict. We found congruency sequence effects occurred in graphic judgment task, in which the conflict stimuli acted as irrelevant information. The findings reveal that processing task-irrelevant conflict stimulus features could also induce sequential modulations of interference. The results do not support the interpretation of conflict monitoring and favor a feature integration account that the congruency sequence effects are attributed to the repetitions of stimulus and response features.	[Zhao, Liang; Wang, Yonghui] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Zhao, Liang; Wang, Yonghui] Shaanxi Prov Key Lab Behav & Cognit Neurosci, Xian, Peoples R China	Shaanxi Normal University	Wang, YH (corresponding author), Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China.	wyonghui@snnu.edu.cn			Program for New Century Excellent Talents in University [NCET-08-0801]; Key Program of the 11th Five year Plan of National Education Science [DBA070070]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Program of the 11th Five year Plan of National Education Science	This study was supported by grants from the Program for New Century Excellent Talents in University (NCET-08-0801) and the Key Program of the 11th Five year Plan of National Education Science (DBA070070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Davelaar EJ, 2009, PSYCHON B REV, V16, P121, DOI 10.3758/PBR.16.1.121; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Notebaert W, 2006, PSYCHON B REV, V13, P1078, DOI 10.3758/BF03213929; Spape MM, 2011, BIOL PSYCHOL, V88, P116, DOI 10.1016/j.biopsycho.2011.07.001; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2003, EXP BRAIN RES, V153, P35, DOI 10.1007/s00221-003-1579-1; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Wuhr P, 2005, PSYCHON B REV, V12, P282, DOI 10.3758/BF03196373; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269	30	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54780	10.1371/journal.pone.0054780	http://dx.doi.org/10.1371/journal.pone.0054780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372766	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500124
J	Zhu, YS; Wang, YP; Zhao, B; Wei, SG; Xu, M; Liu, EQ; Lai, JH				Zhu, Yongsheng; Wang, Yunpeng; Zhao, Bin; Wei, Shuguang; Xu, Ming; Liu, Enqi; Lai, Jianghua			Differential Phosphorylation of GluN1-MAPKs in Rat Brain Reward Circuits following Long-Term Alcohol Exposure	PLOS ONE			English	Article							ETHANOL WITHDRAWAL SYNDROME; NMDA RECEPTOR SUBUNITS; ACTIVATED PROTEIN-KINASES; SIGNAL-REGULATED KINASE; NUCLEUS-ACCUMBENS; MEDIATED INHIBITION; PREFRONTAL CORTEX; DRUG-ADDICTION; ERK; STRIATUM	The effects of long-term alcohol consumption on the mitogen-activated protein kinases (MAPKs) pathway and N-methyl-D-aspartate-type glutamate receptor 1 (GluN1) subunits in the mesocorticolimbic system remain unclear. In the present study, rats were allowed to consume 6% (v/v) alcohol solution for 28 consecutive days. Locomotor activity and behavioral signs of withdrawal were observed. Phosphorylation and expression of extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), p38 protein kinase and GluN1 in the nucleus accumbens, caudate putamen, amygdala, hippocampus and prefrontal cortex of these rats were also measured. Phosphorylation of ERK, but not JNK or p38, was decreased in all five brain regions studied in alcohol-drinking rats. The ratio of phospho/total-GluN1 subunit was reduced in all five brain regions studied. Those results suggest that the long-term alcohol consumption can inhibits GluN1 and ERK phosphorylation, but not JNK or p38 in the mesocorticolimbic system, and these changes may be relevant to alcohol dependence. To differentiate alcohol-induced changes in ERK and GluN1 between acute and chronic alcohol exposure, we have determined levels of phospho-ERK, phospho-GluN1 and total levels of GluN1 after acute alcohol exposure. Our data show that 30 min following a 2.5 g/kg dose of alcohol (administered intragastrically), levels of phospho-ERK are decreased while those of phospho-GluN1 are elevated with no change in total GluN1 levels. At 24 h following the single alcohol dose, levels of phospho-ERK are elevated in several brain regions while there are no differences between controls and alcohol treated animals in phospho-GluN1 or total GluN1. Those results suggest that alcohol may differentially regulate GluN1 function and ERK activation depending on alcohol dose and exposure time in the central nervous system.	[Zhu, Yongsheng; Wang, Yunpeng; Zhao, Bin; Wei, Shuguang; Liu, Enqi; Lai, Jianghua] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Key Lab,Minist Publ Hlth Forens Sci, Xian 710049, Peoples R China; [Lai, Jianghua] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ, Xian 710049, Peoples R China; [Zhu, Yongsheng] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Yinchuan, Peoples R China; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Ningxia Medical University; University of Chicago	Lai, JH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Key Lab,Minist Publ Hlth Forens Sci, Xian 710049, Peoples R China.	laijh1011@hotmail.com	liu, enqi/S-7771-2019		National Science Foundation of China [NSFC 81172910, NSFC 31100900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (NSFC 81172910 and NSFC 31100900; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Allgaier C, 2002, NEUROCHEM INT, V41, P377, DOI 10.1016/S0197-0186(02)00046-3; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bertotto ME, 2011, EUR NEUROPSYCHOPHARM; Braconi S, 2010, ALCOHOL CLIN EXP RES, V34, P538, DOI 10.1111/j.1530-0277.2009.01119.x; BURNS LH, 1994, PSYCHOPHARMACOLOGY, V115, P516, DOI 10.1007/BF02245576; Celikyurt IK, 2011, PROG NEURO-PSYCHOPH, V35, P528, DOI 10.1016/j.pnpbp.2010.12.009; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clapp P, 2008, ALCOHOL RES HEALTH, V31, P310; Deadwyler SA, 2004, NEUROSCI BIOBEHAV R, V27, P703, DOI 10.1016/j.neubiorev.2003.11.011; Elberger AJ, 2011, NEUROTOXICOL TERATOL; Erden BF, 1999, PHARMACOL BIOCHEM BE, V62, P537, DOI 10.1016/S0091-3057(98)00175-0; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Floyd DW, 2003, J PHARMACOL EXP THER, V307, P1020, DOI 10.1124/jpet.103.057505; Gorelova N, 1997, NEUROSCIENCE, V76, P689, DOI 10.1016/S0306-4522(96)00380-6; Hatt H, 1999, NATURWISSENSCHAFTEN, V86, P177, DOI 10.1007/s001140050593; Hoffman PL, 2003, INT REV NEUROBIOL, V56, P35, DOI 10.1016/S0074-7742(03)56002-0; HOFFMAN PL, 1989, NEUROPHARMACOLOGY, V28, P1239, DOI 10.1016/0028-3908(89)90217-7; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kalluri HSG, 2002, EUR J PHARMACOL, V451, P51, DOI 10.1016/S0014-2999(02)02100-3; Kalluri HSG, 2002, EUR J PHARMACOL, V439, P53, DOI 10.1016/S0014-2999(01)01599-0; Kalsi G, 2009, TRENDS GENET, V25, P49, DOI 10.1016/j.tig.2008.10.005; Klann E, 2002, LEARN MEMORY, V9, P153, DOI 10.1101/lm.52802; Klugmann M, 2011, INT J NEUROPSYCHOPH, V14, P505, DOI 10.1017/S1461145710001562; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Leggio L, 2008, PROG NEURO-PSYCHOPH, V32, P1106, DOI 10.1016/j.pnpbp.2007.09.021; Liu Y, 2000, CHINESE MED J-PEKING, V113, P948; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Nagy Jozsef, 2005, Current Neuropharmacology, V3, P281, DOI 10.2174/157015905774322499; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; RAYMOND LA, 1994, J PHYSIOLOGY-PARIS, V88, P181, DOI 10.1016/0928-4257(94)90004-3; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Roh MS, 2011, ALCOHOL ALCOHOLISM, V46, P672, DOI 10.1093/alcalc/agr124; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Sanna PP, 2002, BRAIN RES, V948, P186, DOI 10.1016/S0006-8993(02)03191-8; Snell LD, 1996, MOL BRAIN RES, V40, P71; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Swift RM, 1999, NEW ENGL J MED, V340, P1482, DOI 10.1056/NEJM199905133401907; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Turchan J, 1999, NEUROSCIENCE, V91, P971, DOI 10.1016/S0306-4522(98)00637-X; UZBAY IT, 1994, PHARMACOL BIOCHEM BE, V49, P969, DOI 10.1016/0091-3057(94)90251-8; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang YP, 2012, BRAIN RES BULL, V89, P191, DOI 10.1016/j.brainresbull.2012.08.007; Wu PH, 2010, J NEUROCHEM, V115, P1112, DOI 10.1111/j.1471-4159.2010.06991.x; Xu MF, 2006, J NEUROCHEM, V96, P1760, DOI 10.1111/j.1471-4159.2006.03703.x; Zhai HF, 2008, CELL MOL NEUROBIOL, V28, P157, DOI 10.1007/s10571-007-9240-3; Zhao HWW, 2006, J NEUROSCI RES, V84, P291, DOI 10.1002/jnr.20893; Zhou FC, 2007, BRAIN RES, V1134, P148, DOI 10.1016/j.brainres.2006.11.046	66	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54930	10.1371/journal.pone.0054930	http://dx.doi.org/10.1371/journal.pone.0054930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372792	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500145
J	McMahon, SJ; Butterworth, KT; Trainor, C; McGarry, CK; O'Sullivan, JM; Schettino, G; Hounsell, AR; Prise, KM				McMahon, Stephen J.; Butterworth, Karl T.; Trainor, Colman; McGarry, Conor K.; O'Sullivan, Joe M.; Schettino, Giuseppe; Hounsell, Alan R.; Prise, Kevin M.			A Kinetic-Based Model of Radiation-Induced Intercellular Signalling	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; X-RAYS; CELLULAR-RESPONSE; BYSTANDER; CELLS; FIELDS; IRRADIATION; SURVIVAL; INDUCTION; TISSUES	It is now widely accepted that intercellular communication can cause significant variations in cellular responses to genotoxic stress. The radiation-induced bystander effect is a prime example of this effect, where cells shielded from radiation exposure see a significant reduction in survival when cultured with irradiated cells. However, there is a lack of robust, quantitative models of this effect which are widely applicable. In this work, we present a novel mathematical model of radiation- induced intercellular signalling which incorporates signal production and response kinetics together with the effects of direct irradiation, and test it against published data sets, including modulated field exposures. This model suggests that these so-called "bystander'' effects play a significant role in determining cellular survival, even in directly irradiated populations, meaning that the inclusion of intercellular communication may be essential to produce robust models of radio-biological outcomes in clinically relevant in vivo situations.	[McMahon, Stephen J.; Butterworth, Karl T.; Trainor, Colman; McGarry, Conor K.; O'Sullivan, Joe M.; Schettino, Giuseppe; Hounsell, Alan R.; Prise, Kevin M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McGarry, Conor K.; O'Sullivan, Joe M.; Hounsell, Alan R.] Belfast Hlth & Social Care Trust, No Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast	McMahon, SJ (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	stephen.mcmahon@qub.ac.uk	Schettino, Giuseppe/X-1983-2018; Prise, Kevin/N-7872-2015; Butterworth, Karl/I-7476-2019	Schettino, Giuseppe/0000-0003-3284-3953; Prise, Kevin/0000-0001-6134-7946; Butterworth, Karl/0000-0001-7170-6789; McGarry, Conor/0000-0001-6396-2184; McMahon, Stephen/0000-0001-5980-6728; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research United Kingdom [C1513/A7047, C212/A11342]; Health and Social Care Research and Development of the Public Health Agency training fellowship award; DEL studentship	Cancer Research United Kingdom(Cancer Research UK); Health and Social Care Research and Development of the Public Health Agency training fellowship award; DEL studentship	This work was supported by grants from Cancer Research United Kingdom (Grant no. C1513/A7047 to KMP, and C212/A11342 for SMM and ARH). CKM is supported by a Health and Social Care Research and Development of the Public Health Agency training fellowship award. CT is supported by a DEL studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asur RS, 2009, MUTAT RES-GEN TOX EN, V676, P11, DOI 10.1016/j.mrgentox.2009.02.012; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Banerjee G, 2005, CANCER LETT, V223, P275, DOI 10.1016/j.canlet.2004.09.035; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Botchway SW, 1997, RADIAT RES, V148, P317, DOI 10.2307/3579516; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Butterworth KT, 2012, PHYS MED BIOL, V57, P3197, DOI 10.1088/0031-9155/57/10/3197; Butterworth KT, 2011, INT J RADIAT ONCOL, V79, P1516, DOI 10.1016/j.ijrobp.2010.11.034; Butterworth KT, 2010, PHYS MED BIOL, V55, P1607, DOI 10.1088/0031-9155/55/6/005; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Ebert MA, 2010, ACTA ONCOL, V49, P1334, DOI 10.3109/0284186X.2010.487874; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Little MP, 2001, RADIAT RES, V156, P695, DOI 10.1667/0033-7587(2001)156[0695:TBEICC]2.0.CO;2; Little MP, 2005, J THEOR BIOL, V232, P329, DOI 10.1016/j.jtbi.2004.08.016; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; MASTRO AM, 1984, P NATL ACAD SCI-BIOL, V81, P3414, DOI 10.1073/pnas.81.11.3414; McMahon SJ, 2012, INT J RADIAT ONCOL, V84, P250, DOI 10.1016/j.ijrobp.2011.10.058; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Partridge M, 2008, PHYS MED BIOL, V53, P3595, DOI 10.1088/0031-9155/53/13/014; Ponnaiya B, 2004, RADIAT RES, V162, P426, DOI 10.1667/RR3236; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Przybyszewski WM, 2004, CANCER LETT, V214, P91, DOI 10.1016/j.canlet.2004.03.046; Purschke M, 2010, J INVEST DERMATOL, V130, P86, DOI 10.1038/jid.2009.205; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; Schettino G, 2005, RADIAT RES, V163, P332, DOI 10.1667/RR3319; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Suchowerska N, 2005, PHYS MED BIOL, V50, P3041, DOI 10.1088/0031-9155/50/13/005; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Vines AM, 2008, INT J RADIAT BIOL, V84, P83, DOI 10.1080/09553000701797062; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Zhang Y, 2009, MUTAT RES-FUND MOL M, V671, P20, DOI 10.1016/j.mrfmmm.2009.08.006	40	49	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54526	10.1371/journal.pone.0054526	http://dx.doi.org/10.1371/journal.pone.0054526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349919	gold, Green Published			2022-12-25	WOS:000314019100077
J	Damm, TB; Richard, S; Tanner, S; Wyss, F; Egli, M; Franco-Obregon, A				Damm, Tatiana Benavides; Richard, Stephane; Tanner, Samuel; Wyss, Fabienne; Egli, Marcel; Franco-Obregon, Alfredo			Calcium-dependent deceleration of the cell cycle in muscle cells by simulated microgravity	FASEB JOURNAL			English	Article						mechanotransduction; transient receptor potential canonical type 1; TRPC1; insulin-like growth factor 1; IGF-1	CAPACITATIVE CA2+ ENTRY; SKELETAL-MUSCLE; GROWTH-FACTOR; MECHANICAL SIGNALS; C2C12 MYOBLASTS; CATION CHANNEL; IN-VIVO; DIFFERENTIATION; EXPRESSION; TRPC1	Of all our mechanosensitive tissues, skeletal muscle is the most developmentally responsive to physical activity. Conversely, restricted mobility due to injury or disease results in muscle atrophy. Gravitational force is another form of mechanical input with profound developmental consequences. The mechanical unloading resulting from the reduced gravitational force experienced during spaceflight results in oxidative muscle loss. We examined the early stages of myogenesis under conditions of simulated microgravity (SM). C2C12 mouse myoblasts in SM proliferated more slowly (2.23 x less) as a result of their being retained longer within the G(2)/M phase of the cell cycle (2.10 x more) relative to control myoblasts at terrestrial gravity. Blocking calcium entry via TRP channels with SKF-96365 (10-20 mu M) accumulated myoblasts within the G(2)/M phase of the cell cycle and retarded their proliferation. On the genetic level, SM resulted in the reduced expression of TRPC1 and IGF-1 isoforms, transcriptional events regulated by calcium downstream of mechanical input. A decrease in TRPC1-mediated calcium entry thus appears to be a pivotal event in the muscle atrophy brought on by gravitational mechanical unloading. Hence, relieving the constant force of gravity on cells might prove one valid experimental approach to expose the underlying mechanisms modulating mechanically regulated developmental programs.	[Damm, Tatiana Benavides; Richard, Stephane; Tanner, Samuel; Wyss, Fabienne; Egli, Marcel; Franco-Obregon, Alfredo] Swiss Fed Inst Technol, Space Biol Grp, CH-8005 Zurich, Switzerland; [Franco-Obregon, Alfredo] Swiss Fed Inst Technol, Rehabil & Regenerat Strategies Grp, CH-8005 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Franco-Obregon, A (corresponding author), Swiss Fed Inst Technol, Space Biol Grp, Rehabil & Regenerat Strategies Grp, Technopk Str 1, CH-8005 Zurich, Switzerland.	franco@spacebiol.ethz.ch	Franco-Obregon, Alfredo/F-3056-2019	Franco-Obregon, Alfredo/0000-0002-2514-1083; Benavides, Tatiana/0000-0002-0992-5240	European Space Agency	European Space Agency(European Space AgencyEuropean Commission)	The authors gratefully acknowledge the technical assistance of Dr. Malgorzata Kisielow and Ms. Anette Schutz (Flow Cytometry Laboratory, ETH Zurich) and of Krzysztof Krawczyk. The authors also thank Prof. Dr. Ralph Muller for insightful comments. This work was supported by the European Space Agency.	Alfieri CM, 2007, AM J PHYSIOL-CELL PH, V292, pC1887, DOI 10.1152/ajpcell.00506.2006; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Bajotto G, 2006, J NUTR SCI VITAMINOL, V52, P233, DOI 10.3177/jnsv.52.233; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bidaud I, 2006, J MUSCLE RES CELL M, V27, P75, DOI 10.1007/s10974-006-9058-5; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bomben VC, 2010, GLIA, V58, P1145, DOI 10.1002/glia.20994; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Chang KC, 2007, ANIMAL, V1, P681, DOI 10.1017/S1751731107702070; Cheema U, 2005, J CELL PHYSIOL, V202, P67, DOI 10.1002/jcp.20107; Chu Lily, 2005, V308, P107; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Fitts RH, 2001, J EXP BIOL, V204, P3201; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Goldspink G, 2002, BIOCHEM SOC T, V30, P285, DOI 10.1042/bst0300285; Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Guo RW, 2012, CARDIOVASC RES, V93, P360, DOI 10.1093/cvr/cvr307; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hill M, 2003, J PHYSIOL-LONDON, V549, P409, DOI 10.1113/jphysiol.2002.035832; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Iida K, 2004, J PHYSIOL-LONDON, V560, P341, DOI 10.1113/jphysiol.2004.069500; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Ju YK, 2003, J CELL PHYSIOL, V197, P53, DOI 10.1002/jcp.10347; KNUDSEN KA, 1977, DEV BIOL, V58, P328, DOI 10.1016/0012-1606(77)90095-1; Kook SH, 2008, MOL CELLS, V25, P479; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kurth F, 2012, CURR OPIN CHEM BIOL, V16, P400, DOI 10.1016/j.cbpa.2012.03.014; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P433, DOI 10.1210/endo-123-1-433; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Philippou A, 2007, IN VIVO, V21, P45; Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010; Rotwein P, 2003, GROWTH HORM IGF RES, V13, P303, DOI 10.1016/j.ghir.2003.09.001; Santella L, 2005, CELL MOL LIFE SCI, V62, P2405, DOI 10.1007/s00018-005-5083-6; Santella L, 1998, BIOCHEM BIOPH RES CO, V244, P317, DOI 10.1006/bbrc.1998.8086; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandenburgh H, 1999, FASEB J, V13, P1031, DOI 10.1096/fasebj.13.9.1031; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; YIP DK, 1972, IN VITRO CELL DEV B, V7, P323	67	26	27	2	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2045	2054		10.1096/fj.12-218693	http://dx.doi.org/10.1096/fj.12-218693			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23363573				2022-12-25	WOS:000318226100024
J	Shan, TZ; Liang, XR; Bi, PP; Kuang, SH				Shan, Tizhong; Liang, Xinrong; Bi, Pengpeng; Kuang, Shihuan			Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1 alpha-Fndc5 pathway in muscle	FASEB JOURNAL			English	Article						irisin; UCP1	SKELETAL-MUSCLE; ADIPOCYTE PROGENITORS; INDUCED OBESITY; SELF-RENEWAL; FAT; ADIPOGENESIS; INHIBITION; DIFFERENTIATION; EXPRESSION; PROMOTES	Myostatin (Mstn) is predominantly expressed in skeletal muscles and plays important roles in regulating muscle growth and development, as well as fat deposition. Mstn-knockout (Mstn(-/-)) mice exhibit increased muscle mass due to both hypertrophy and hyperplasia, and leaner body composition due to reduced fat mass. Here, we show that white adipose tissue (WAT) of Mstn(-/-) develops characteristics of brown adipose tissue (BAT) with dramatically increased expression of BAT signature genes, including Ucp1 and Pgc1 alpha, and beige adipocyte markers Tmem26 and CD137. Strikingly, the observed browning phenotype is non-cell autonomous and is instead driven by the newly defined myokine irisin (Fndc5) secreted from Mstn(-/-) skeletal muscle. Within the muscle, Mstn(-/-) leads to increased expression of AMPK and its phosphorylation, which subsequently activates PGC1 alpha and Fndc5. Together, our study defines a paradigm of muscle-fat crosstalk mediated by Fndc5, which is up-regulated and secreted from muscle to induce beige cell markers and the browning of WAT in Mstn(-/-) mice. These results suggest that targeting muscle Mstn and its downstream signaling represents a therapeutic approach to treat obesity and type 2 diabetes.	[Shan, Tizhong; Liang, Xinrong; Bi, Pengpeng; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), 174B Smith Hall,901 West State St, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Shan, Tizhong/G-1947-2015; Bi, Pengpeng/P-4936-2016	Bi, Pengpeng/0000-0002-9871-6773; Kuang, Shihuan/0000-0001-9180-3180	Muscular Dystrophy Association; U.S. National Institutes of Health; U.S. Department of Agriculture; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project is partially supported by funding from the Muscular Dystrophy Association, the U.S. National Institutes of Health, and the U.S. Department of Agriculture to S.K. The authors thank Yong-Soo Kim (University of Hawaii, Manoa, HI, USA) for providing anti-Mstn and ActRIIB. The authors are grateful to Jun Wu and Pengpeng Zhang for mouse colony and technical support. The authors declare no conflicts of interests.	Argiles JM, 2012, DRUG DISCOV TODAY, V17, P702, DOI 10.1016/j.drudis.2012.02.001; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Guo TQ, 2012, DIABETES, V61, P2414, DOI 10.2337/db11-0915; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kelly DP, 2012, SCIENCE, V336, P42, DOI 10.1126/science.1221688; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Koncarevic A, 2012, ENDOCRINOLOGY, V153, P3133, DOI 10.1210/en.2012-1016; LeBrasseur NK, 2012, DIABETOLOGIA, V55, P13, DOI 10.1007/s00125-011-2361-8; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Liu WY, 2012, DEV BIOL, V361, P27, DOI 10.1016/j.ydbio.2011.10.011; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Tsurutani Y, 2009, DIABETES, V58, pA436; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang M, 2012, BIOCHEM BIOPH RES CO, V426, P83, DOI 10.1016/j.bbrc.2012.08.040; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav Hariom, 2012, Front Endocrinol (Lausanne), V3, P35, DOI 10.3389/fendo.2012.00035; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7	50	225	244	2	101	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1981	1989		10.1096/fj.12-225755	http://dx.doi.org/10.1096/fj.12-225755			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23362117	Green Published			2022-12-25	WOS:000318226100018
J	Rowat, AC; Jaalouk, DE; Zwerger, M; Ung, WL; Eydelnant, IA; Olins, DE; Olins, AL; Herrmann, H; Weitz, DA; Lammerding, J				Rowat, Amy C.; Jaalouk, Diana E.; Zwerger, Monika; Ung, W. Lloyd; Eydelnant, Irwin A.; Olins, Don E.; Olins, Ada L.; Herrmann, Harald; Weitz, David A.; Lammerding, Jan			Nuclear Envelope Composition Determines the Ability of Neutrophil-type Cells to Passage through Micron-scale Constrictions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVE MECHANICAL-BEHAVIOR; LAMIN-A; DIFFERENTIATION; HL-60; MIGRATION; LEUKOCYTES; CHROMATIN; RETENTION; LINE; SEQUESTRATION	Neutrophils are characterized by their distinct nuclear shape, which is thought to facilitate the transit of these cells through pore spaces less than one-fifth of their diameter. We used human promyelocytic leukemia (HL-60) cells as a model system to investigate the effect of nuclear shape in whole cell deformability. We probed neutrophil-differentiated HL-60 cells lacking expression of lamin B receptor, which fail to develop lobulated nuclei during granulopoiesis and present an in vitro model for Pelger-Huet anomaly; despite the circular morphology of their nuclei, the cells passed through micron-scale constrictions on similar timescales as scrambled controls. We then investigated the unique nuclear envelope composition of neutrophil-differentiated HL-60 cells, which may also impact their deformability; although lamin A is typically down-regulated during granulopoiesis, we genetically modified HL-60 cells to generate a subpopulation of cells with well defined levels of ectopic lamin A. The lamin A-overexpressing neutrophil-type cells showed similar functional characteristics as the mock controls, but they had an impaired ability to pass through micron-scale constrictions. Our results suggest that levels of lamin A have a marked effect on the ability of neutrophils to passage through micron-scale constrictions, whereas the unusual multilobed shape of the neutrophil nucleus is less essential.	[Rowat, Amy C.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rowat, Amy C.; Jaalouk, Diana E.; Zwerger, Monika; Lammerding, Jan] Harvard Univ, Dept Med, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA; [Rowat, Amy C.; Ung, W. Lloyd; Eydelnant, Irwin A.; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rowat, Amy C.; Ung, W. Lloyd; Eydelnant, Irwin A.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Olins, Don E.; Olins, Ada L.] Univ New England, Dept Pharmaceut Sci, Coll Pharm, Portland, ME 04103 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Biomed Engn, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; University of New England - Maine; Helmholtz Association; German Cancer Research Center (DKFZ); Cornell University	Rowat, AC (corresponding author), Dept Integrat Biol & Physiol, Terasaki Life Sci Bldg 1125,610 Charles E Young D, Los Angeles, CA 90095 USA.	rowat@ucla.edu	Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611; Ung, Warren/0000-0003-3352-9974	Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP); National Institutes of Health [R01 NS059348, R01 HL082792, CA-16042, AI-28697]; Department of Defense [BC102152]; Natural Sciences and Engineering Research Council of Canada (NSERC); American Heart Association (AHA) [09POST2320042]; HFSP [RGP0004/2005-C102]; National Science Foundation (NSF) [DMR-1006546, DBI-649865]; Harvard Materials Research Science and Engineering Center (MRSEC) [DMR-0820484]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER	Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Association (AHA)(American Heart Association); HFSP(Human Frontier Science Program); National Science Foundation (NSF)(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Cross-Disciplinary Fellowship of the International Human Frontiers Science Program (HFSP) (to A. C. R.) and National Institutes of Health Grants R01 NS059348 and R01 HL082792 and Department of Defense Breast Cancer Idea Award BC102152 (to J. L.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (to W. L. U. and I. A. E.), an American Heart Association fellowship (AHA Award 09POST2320042) (to D. E. J.), and HFSP Grant RGP0004/2005-C102, National Science Foundation (NSF) Contracts DMR-1006546 and DBI-649865, and Harvard Materials Research Science and Engineering Center (MRSEC) Contract DMR-0820484.; We acknowledge the Center for Nanoscale Systems, Harvard University, for access to the profilometer and Bino Varghese for advice on data analysis protocols. Cell sorting was performed by Brian Tilton, Bauer Center at Harvard University, and Jeff Calimlim in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility. The UCLA JCCC and Center for AIDS Research Flow Cytometry Core Facility are supported by National Institutes of Health Awards CA-16042 and AI-28697 and by the JCCC, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, and the UCLA Chancellor's Office.	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bathe M, 2002, BIOPHYS J, V83, P1917, DOI 10.1016/S0006-3495(02)73955-6; Batrakou D. G., 2012, SEMIN CANC IN PRESS; Berliner N., 2005, CURRENT PROTOCOLS IM; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Campbell MS, 1995, J LEUKOCYTE BIOL, V58, P659, DOI 10.1002/jlb.58.6.659; CANO ML, 1991, J CELL BIOL, V115, P677, DOI 10.1083/jcb.115.3.677; COLLINS SJ, 1987, BLOOD, V70, P1233; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; DOWNEY GP, 1990, J APPL PHYSIOL, V69, P1767, DOI 10.1152/jappl.1990.69.5.1767; DOWNEY GP, 1993, AM REV RESPIR DIS, V147, P168, DOI 10.1164/ajrccm/147.1.168; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Ekpenyong AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045237; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; ERZURUM SC, 1991, AM J RESP CELL MOL, V5, P230, DOI 10.1165/ajrcmb/5.3.230; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Fleck RA, 2003, IN VITRO CELL DEV-AN, V39, P235; Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j; Gaines P, 2008, EXP HEMATOL, V36, P965, DOI 10.1016/j.exphem.2008.04.006; GALLAGHER R, 1979, BLOOD, V54, P713; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gonzalez AL, 2007, J LEUKOCYTE BIOL, V81, P686, DOI 10.1189/jlb.0906553; HIRSCH JG, 1959, BACTERIOL REV, V23, P48, DOI 10.1128/MMBR.23.2.48-60.1959; Jaalouk DE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-97; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; MATSUMOTO T, 1984, ACTA HAEMATOL-BASEL, V72, P264, DOI 10.1159/000206399; MEYER PA, 1990, ENVIRON HEALTH PERSP, V88, P179, DOI 10.2307/3431071; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Olins AL, 2000, EXP CELL RES, V254, P130, DOI 10.1006/excr.1999.4727; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olins AL, 1998, EXP CELL RES, V245, P91, DOI 10.1006/excr.1998.4210; Olins AL, 2010, NUCLEUS, V1, P1, DOI DOI 10.4161/NUCL.1.6.13271; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PARK BH, 1977, P SOC EXP BIOL MED, V155, P51; REPO H, 1979, CLIN EXP IMMUNOL, V36, P326; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Spitzer D, 2006, J IMMUNOL, V177, P4953, DOI 10.4049/jimmunol.177.8.4953; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; TINGBEALL HP, 1995, ANN BIOMED ENG, V23, P666, DOI 10.1007/BF02584463; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; Tsai MA, 1998, BIOPHYS J, V74, P3282, DOI 10.1016/S0006-3495(98)78035-X; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	48	202	203	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8610	8618		10.1074/jbc.M112.441535	http://dx.doi.org/10.1074/jbc.M112.441535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23355469	Green Published, hybrid			2022-12-25	WOS:000316564500061
J	King, M; Vasanthan, M; Petersen, I; Jones, L; Marston, L; Nazareth, I				King, Michael; Vasanthan, Mira; Petersen, Irene; Jones, Louise; Marston, Louise; Nazareth, Irwin			Mortality and Medical Care after Bereavement: A General Practice Cohort Study	PLOS ONE			English	Article							SPECIALIST PALLIATIVE CARE; MARITAL-STATUS; DISTRESS; ADULT; LIFE	Bereaved spouses or partners are thought to be at increased risk of morbidity and mortality. However, there are few large prospective studies and results are inconsistent. We estimated the relative mortality, prescription of psychotropic medication and use of primary medical care services in adults whose cohabitee died of cancer. To do this, we undertook a cohort study using The Health Improvement Network (THIN) UK primary care database. Participants were 1) people aged over 40, who were registered with general practices and had been exposed to the death of a cohabitee from cancer; and 2) a comparison cohort frequency matched on five year age bands and sex who were cohabiting with a living partner. The baseline was chosen as six months before the date of the cancer death for the exposed group and a random date for the unexposed group. Incidence rate ratios (IRR) with 95% confidence intervals (CI) were estimated using random effects Poisson regression to account for clustering within general practices and adjusting for other key variables. 92,129 patients were studied for a median follow up of 4 years. Cohabitees of patients who died of cancer were less likely to die of any cause (IRR 0.71, CI 0.68-0.74) after adjustment for age, gender, number of non-psychotropic prescriptions 6 months before the cancer death/index date, use of psychotropic medication 6 months before the cancer death/index date, smoking, alcohol and area deprivation score. Exposed patients were more likely to receive a prescription for antidepressant or hypnotic medication and to attend their GP both before and after the death of the cohabitee. In conclusion, we did not confirm increased mortality in cohabitees of people dying from cancer.	[King, Michael; Vasanthan, Mira; Jones, Louise] UCL, Sch Med, Fac Brain Sci, Unit Mental Hlth Sci, London W1N 8AA, England; [Vasanthan, Mira; Petersen, Irene; Marston, Louise; Nazareth, Irwin] UCL, Sch Med, Res Dept Primary Care & Populat Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	King, M (corresponding author), UCL, Sch Med, Fac Brain Sci, Unit Mental Hlth Sci, Mortimer St, London W1N 8AA, England.	michael.king@ucl.ac.uk	Petersen, Irene/C-5702-2009; Marston, Louise/A-8535-2012	Petersen, Irene/0000-0002-0037-7524; Marston, Louise/0000-0002-9973-1131; Nazareth, Irwin/0000-0003-2146-9628	Marie Curie Cancer Care	Marie Curie Cancer Care	Louise Jones and Mira Vasanthan were funded by Marie Curie Cancer Care. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew A, 2010, PALLIATIVE MED, V24, P46, DOI 10.1177/0269216309107013; Agnew A, 2011, BRIT J SOC WORK, V41, P111, DOI 10.1093/bjsw/bcq055; Bennett KM, 2010, OMEGA-J DEATH DYING, V61, P315, DOI 10.2190/OM.61.4.d; Blak Betina T, 2011, Inform Prim Care, V19, P251; BLYTH AC, 1990, BRIT MED J, V300, P983, DOI 10.1136/bmj.300.6730.983; Carter PA, 2006, CANCER NURS, V29, P95, DOI 10.1097/00002820-200603000-00003; Cartwright A, 1982, J R Coll Gen Pract, V32, P215; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; Department of Health, 2008, END LIF CAR STRAT PR; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Fardet L, 2012, BMJ, V345; GUNNELL DJ, 1990, BMJ-BRIT MED J, V300, P1400, DOI 10.1136/bmj.300.6736.1400-e; HELSING KJ, 1981, AM J EPIDEMIOL, V114, P41, DOI 10.1093/oxfordjournals.aje.a113172; Horsfall L, 2012, PHARMACOEPI IN PRESS; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Main J, 2000, BRIT J GEN PRACT, V50, P863; Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; National Council for Palliative Care, 2011, NAT SURV PAT ACT DAT; National Institute for Clinical Excellence, 2004, GUID CANC SERV IMPR; National Institute for Clinical Excellence, 2012, QUAL OUTC FRAM; Oksuzyan A, 2011, J AGING RES; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Smith KR, 1996, SOC BIOL, V43, P59; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; THOMPSON LW, 1991, PSYCHOL AGING, V6, P434, DOI 10.1037/0882-7974.6.3.434; Walsh K, 2007, BRIT J PSYCHIAT, V190, P142, DOI 10.1192/bjp.bp.106.023960; Woof WR, 1997, BRIT J GEN PRACT, V47, P443	33	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52561	10.1371/journal.pone.0052561	http://dx.doi.org/10.1371/journal.pone.0052561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372651	Green Published, gold			2022-12-25	WOS:000315210400004
J	Rioja, C; Van Wees, SC; Charlton, KA; Pieterse, CMJ; Lorenzo, O; Garcia-Sanchez, S				Rioja, Cristina; Van Wees, Saskia C.; Charlton, Keith A.; Pieterse, Corne M. J.; Lorenzo, Oscar; Garcia-Sanchez, Susana			Wide Screening of Phage-Displayed Libraries Identifies Immune Targets in Planta	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; TRANSCRIPTION FACTOR; INNATE IMMUNITY; ARABIDOPSIS-THALIANA; HIGH-THROUGHPUT; TRANSIENT EXPRESSION; DEFENSE RESPONSES; CELL-SURFACE; RESISTANCE; PROTEIN	Microbe-Associated Molecular Patterns and virulence effectors are recognized by plants as a first step to mount a defence response against potential pathogens. This recognition involves a large family of extracellular membrane receptors and other immune proteins located in different sub-cellular compartments. We have used phage-display technology to express and select for Arabidopsis proteins able to bind bacterial pathogens. To rapidly identify microbe-bound phage, we developed a monitoring method based on microarrays. This combined strategy allowed for a genome-wide screening of plant proteins involved in pathogen perception. Two phage libraries for high-throughput selection were constructed from cDNA of plants infected with Pseudomonas aeruginosa PA14, or from combined samples of the virulent isolate DC3000 of Pseudomonas syringae pv. tomato and its avirulent variant avrRpt2. These three pathosystems represent different degrees in the specificity of plant-microbe interactions. Libraries cover up to 2610 7 different plant transcripts that can be displayed as functional proteins on the surface of T7 bacteriophage. A number of these were selected in a bio-panning assay for binding to Pseudomonas cells. Among the selected clones we isolated the ethylene response factor ATERF-1, which was able to bind the three bacterial strains in competition assays. ATERF-1 was rapidly exported from the nucleus upon infiltration of either alive or heat-killed Pseudomonas. Moreover, aterf-1 mutants exhibited enhanced susceptibility to infection. These findings suggest that ATERF-1 contains a microbe-recognition domain with a role in plant defence. To identify other putative pathogen-binding proteins on a genome-wide scale, the copy number of selected-vs.-total clones was compared by hybridizing phage cDNAs with Arabidopsis microarrays. Microarray analysis revealed a set of 472 candidates with significant fold change. Within this set defence-related genes, including well-known targets of bacterial effectors, are over-represented. Other genes non-previously related to defence can be associated through this study with general or strain-specific recognition of Pseudomonas.	[Rioja, Cristina; Lorenzo, Oscar] Univ Salamanca, Dpto Fisiol Vegetal, Ctr Hispanoluso Invest Agr CIALE, E-37008 Salamanca, Spain; [Van Wees, Saskia C.; Pieterse, Corne M. J.] Univ Utrecht, Dept Biol Plant Microbe Interact, Utrecht, Netherlands; [Charlton, Keith A.] Scotia Biol Ltd, Aberdeen, Scotland; [Garcia-Sanchez, Susana] CIC Biogune, Funct Genom Unit, Derio, Spain; [Garcia-Sanchez, Susana] Univ Basque Country IKERBASQUE, Dept Physiol, Leioa, Spain	University of Salamanca; Utrecht University; CIC bioGUNE; Basque Foundation for Science; University of Basque Country	Garcia-Sanchez, S (corresponding author), Inst Vasco Invest & Desarrollo Agrario NEIKER Tec, Vitoria, Spain.	susana.garcias@ehu.es	Pieterse, Corné/A-9326-2011; García-Sánchez, Susana/AAM-5901-2020; Lorenzo, Oscar/K-8170-2014; Garcia-Sanchez, Susana/B-4670-2013; Van Wees, Saskia/B-8595-2011	Pieterse, Corné/0000-0002-5473-4646; Lorenzo, Oscar/0000-0001-9523-0789; Rioja, Cristina/0000-0001-9713-1944; Van Wees, Saskia/0000-0002-2295-7271	Ministerio de Ciencia e Innovacion (MICINN) [BIO2006-01299, BIO2008-04698, BIO2011-26940, CSD2007-00057]; Gobierno Vasco [PI-2006-10]; Junta de Castilla y Leon [SA048A10-2]; FPI fellowship from the MICINN	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno Vasco(Basque Government); Junta de Castilla y Leon(Junta de Castilla y Leon); FPI fellowship from the MICINN	This work was supported by grants BIO2006-01299 from the Ministerio de Ciencia e Innovacion (MICINN, http://www.micinn.es/portal/site/MICINN) and PI-2006-10 from Gobierno Vasco to SG; BIO2008-04698, BIO2011-26940, CSD2007-00057 (TRANSPLANTA) from the MICINN and SA048A10-2 from Junta de Castilla y Leon to OL. CR was supported by a FPI fellowship from the MICINN. The publication of this work was supported by IKERBASQUE, Basque Foundation for Science. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Book AJ, 2010, J BIOL CHEM, V285, P25554, DOI 10.1074/jbc.M110.136622; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Goritschnig S, 2007, PLANT J, V49, P540, DOI 10.1111/j.1365-313X.2006.02978.x; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lipes BD, 2008, J MOL BIOL, V379, P261, DOI 10.1016/j.jmb.2008.03.072; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lytle BL, 2006, ACTA CRYSTALLOGR F, V62, P490, DOI 10.1107/S1744309106015946; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; O'Brien PM, 1999, P NATL ACAD SCI USA, V96, P640, DOI 10.1073/pnas.96.2.640; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Willats WGT, 2002, PLANT MOL BIOL, V50, P837, DOI 10.1023/A:1021215516430; Wu SJ, 2011, MOL PLANT MICROBE IN, V24, P585, DOI 10.1094/MPMI-07-10-0150; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	76	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54654	10.1371/journal.pone.0054654	http://dx.doi.org/10.1371/journal.pone.0054654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372747	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400022
J	Cao, SR; Li, S; Li, HY; Xiong, LP; Zhou, Y; Fan, JJ; Yu, XQ; Mao, HP				Cao, Shirong; Li, Shu; Li, Huiyang; Xiong, Liping; Zhou, Yi; Fan, Jinjin; Yu, Xueqing; Mao, Haiping			The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; MESOTHELIAL CELL; PROTEIN HMGB1; LATE MEDIATOR; INFLAMMATION; PATHWAY; DISEASE; SEPSIS; MECHANISM; INFECTION	High mobility group box 1 (HMGB1), a DNA-binding nuclear protein, has been implicated as an endogenous danger signal in the pathogenesis of infection diseases. However, the potential role and source of HMGB1 in the peritoneal dialysis (PD) effluence of patients with peritonitis are unknown. First, to evaluate HMDB1 levels in peritoneal dialysis effluence (PDE), a total of 61 PD patients were enrolled in this study, including 42 patients with peritonitis and 19 without peritonitis. Demographic characteristics, symptoms, physical examination findings and laboratory parameters were recorded. HMGB1 levels in PDE were determined by Western blot and ELISA. The concentrations of TNF-alpha and IL-6 in PDE were quantified by ELISA. By animal model, inhibition of HMGB1 with glycyrrhizin was performed to determine the effects of HMGB1 in LPS-induced mice peritonitis. In vitro, a human peritoneal mesothelial cell line (HMrSV5) was stimulated with lipopolysaccharide (LPS), HMGB1 extracellular content in the culture media and intracellular distribution in various cellular fractions were analyzed by Western blot or immunofluorescence. The results showed that the levels of HMGB1 in PDE were higher in patients with peritonitis than those in controls, and gradually declined during the period of effective antibiotic treatments. Furthermore, the levels of HMGB1 in PDE were positively correlated with white blood cells (WBCs) count, TNF-a and IL-6 levels. However, pretreatment with glycyrrhizin attenuated LPS-induced acute peritoneal inflammation and dysfunction in mice. In cultured HMrSV5 cells, LPS actively induced HMGB1 nuclear-cytoplasmic translocation and release in a time and dose-dependent fashion. Moreover, cytosolic HMGB1 was located in lysosomes and secreted via a lysosome-mediated secretory pathway following LPS stimulation. Our study demonstrates that elevated HMGB1 levels in PDE during PD-related peritonitis, at least partially, from peritoneal mesothelial cells, which may be involved in the process of PD-related peritonitis and play a critical role in acute peritoneal dysfunction.	[Cao, Shirong; Li, Shu; Li, Huiyang; Xiong, Liping; Zhou, Yi; Fan, Jinjin; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Li, Shu] Cent S Univ, Xiangya Hosp 2, Dept Rheumatol, Changsha, Hunan, Peoples R China	Sun Yat Sen University; Central South University	Mao, HP (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	haipingmao@126.com	cao, shirong/AAX-5688-2021	Cao, Shirong/0000-0002-6593-4600; Mao, Haiping/0000-0002-3608-3851	National Natural Science Foundation of China [81070553, 81270783]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81070553, 81270783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145; Bruchfeld A, 2008, MOL MED, V14, P109, DOI 10.2119/2007-00107.Bruchfeld; Dehbi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044100; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein; Li PK, 2011, PERITON DIALYSIS INT, V30, P393; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maugeri N, 2012, AUTOIMMUNITY, V45, P584, DOI 10.3109/08916934.2012.719946; Nessim SJ, 2011, SEMIN NEPHROL, V31, P199, DOI 10.1016/j.semnephrol.2011.01.008; Ni J, 2010, NEPHROL DIAL TRANSPL, V25, P86, DOI 10.1093/ndt/gfp415; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; TOPLEY N, 1995, PERITON DIALYSIS INT, V15, P116; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HC, 1999, SURGERY, V126, P389, DOI 10.1016/S0039-6060(99)70182-0; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	31	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54647	10.1371/journal.pone.0054647	http://dx.doi.org/10.1371/journal.pone.0054647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359306	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600086
J	Chang, SW; Pan, WS; Beltran, DL; Baldelomar, LO; Solano, MA; Tuero, I; Friedland, JS; Torrico, F; Gilman, RH				Chang, Suzanne W.; Pan, William S.; Lozano Beltran, Daniel; Oleyda Baldelomar, Lizet; Antonio Solano, Marco; Tuero, Iskra; Friedland, Jon S.; Torrico, Faustino; Gilman, Robert H.			Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TB	PLOS ONE			English	Article							PLASMA GHRELIN LEVEL; PEPTIDE YY LEVELS; ANOREXIA-NERVOSA; CANCER CACHEXIA; GASTRIC-CANCER; FOOD-INTAKE; TUBERCULOSIS; LEPTIN; RESISTIN; MALNUTRITION	Background: Cachexia is a hallmark of pulmonary tuberculosis and is associated with poor prognosis. A better understanding of the mechanisms behind such weight loss could reveal targets for therapeutic intervention. The role of appetite-regulatory hormones in tuberculosis is unknown. Methods and Findings: 41 subjects with newly-diagnosed pulmonary TB (cases) were compared to 82 healthy controls. We measured appetite, body mass index (BMI), % body fat (BF), plasma peptide YY (PYY), leptin, ghrelin, and resistin for all subjects. Measurements were taken at baseline for controls and at treatment days 0, 30, and 60 for cases. Baseline appetite, BMI, and BF were lower in cases than in controls and improved during treatment. PYY, ghrelin, and resistin were significantly elevated in cases and fell during treatment. Leptin was lower in cases and rose with treatment. Appetite was inversely related to PYY in cases. High pre-treatment PYY predicted reduced gains in appetite and BF. PYY was the strongest independent predictor of appetite in cases across all time points. Conclusions: Appetite-regulatory hormones are altered in TB patients. As hormones normalize during treatment, appetite is restored and nutritional status improves. High baseline PYY is an indicator of poor prognosis for improvement in appetite and nutrition during treatment. Wasting in TB patients may partly be mediated by upregulation of PYY with resulting appetite suppression.	[Chang, Suzanne W.] George Washington Univ, Dept Med, Washington, DC 20052 USA; [Pan, William S.; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Lozano Beltran, Daniel; Oleyda Baldelomar, Lizet; Antonio Solano, Marco; Torrico, Faustino] CEADES Colect Estudios Aplicados & Desarollo Soci, Cochabamba, Bolivia; [Tuero, Iskra; Gilman, Robert H.] Univ Peruano Cayetano Heredia, Lima, Peru; [Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London, England	George Washington University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Imperial College London; Imperial College London	Chang, SW (corresponding author), George Washington Univ, Dept Med, Washington, DC 20052 USA.	suzannewchang@gmail.com; gilmanbob@gmail.com		Tuero, Iskra/0000-0002-5788-1051; Friedland, Jonathan S/0000-0001-7789-9649; SOLANO, MARCO/0000-0003-1057-8298	RLK NSRA; National Institutes of Health (NIH); Fogarty scholars program; NIHR Biomedical Research Centre; National Institute of Allergy and Infectious Diseases (NIAID), NIH;  [T 35 (AI065385)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI065385] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	RLK NSRA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty scholars program; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the T 35 (AI065385) and the RLK NSRA for partially funding SC, and the National Institutes of Health (NIH), Fogarty scholars program for funding DL and anonymous RG/ER fund for funding a portion of this work. JSF is grateful for support from the NIHR Biomedical Research Centre funding scheme. We also thank for their technical support JB Phu and D Sara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. *RG-ER fund is an anonymous donor who is a person and not a fund. There is no expansion of the name possible. There is no conflict of interest with this fund. It is not an organization or a company. *The T35 refers to Training Grant 35. It is funded by the National Institute of Allergy and Infectious Diseases (NIAID), NIH. *The RLK-NSRA-NIH award to Suzanne Chang is the Ruth L. Kirschstein National Service Research Award, NIH. *No additional external funding received for this study.	ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; [Anonymous], 2007, QUANTUM II AND QUANT; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Beck AL, 2008, J PEDIATR-US, V153, P677, DOI 10.1016/j.jpeds.2008.04.065; Buyukoglan H, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64859; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506; Cifani C, 2009, ACTA PHYSIOL, V196, P395, DOI 10.1111/j.1748-1716.2008.01949.x; Eddleston M, 2008, OXFORD HANDBOOK OF T; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Faggioni R, 1998, AM J PHYSIOL-REG I, V274, pR204, DOI 10.1152/ajpregu.1998.274.1.R204; Fauci AS, 2009, HARRISONS PRINCIPLES; Instituto Nacional de Estadistica de Bolivia, 2001, CENSO DE POBLACION Y; Itoh T, 2004, AM J RESP CRIT CARE, V170, P879, DOI 10.1164/rccm.200310-1404OC; Kamiji MM, 2008, CURR OPIN CLIN NUTR, V11, P443, DOI 10.1097/MCO.0b013e328303dee4; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Misra M, 2006, J CLIN ENDOCR METAB, V91, P1027, DOI 10.1210/jc.2005-1878; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moschovi M, 2008, J PEDIAT HEMATOL ONC, V30, P733, DOI 10.1097/MPH.0b013e318179a1d8; Nakahara T, 2007, J PSYCHIATR RES, V41, P814, DOI 10.1016/j.jpsychires.2006.07.021; Nakajima TE, 2010, CANCER SCI, V101, P1286, DOI 10.1111/j.1349-7006.2010.01518.x; Nakajima TE, 2010, J CANCER RES CLIN, V136, P261, DOI 10.1007/s00432-009-0657-6; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Neelemaat F, 2008, CLIN NUTR, V27, P439, DOI 10.1016/j.clnu.2008.02.002; Renshaw D, 2005, CURR DRUG TARGETS, V6, P171, DOI 10.2174/1389450053174523; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Santo AH, 2003, REV SAUDE PUBL, V37, P714, DOI 10.1590/S0034-89102003000600005; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Shimizu Y, 2003, CLIN CANCER RES, V9, P774; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Ukkola O, 2004, J ENDOCRINOL INVEST, V27, P96, DOI 10.1007/BF03350918; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Vincent RP, 2008, J CLIN PATHOL, V61, P548, DOI 10.1136/jcp.2007.048488; Wahab PJ, 2001, DIGEST DIS SCI, V46, P2504, DOI 10.1023/A:1012344424300; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, 2010 GLOBAL REPORT O; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; World Health Organization, 2007, USE OF LIQUID TB CUL; World Health Organization, 2010, GLOBAL TUBERCULOSIS; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	44	161	163	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54564	10.1371/journal.pone.0054564	http://dx.doi.org/10.1371/journal.pone.0054564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358528	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600070
J	Goodwin, PR; Juo, P				Goodwin, Patricia R.; Juo, Peter			The Scaffolding Protein SYD-2/Liprin-alpha Regulates the Mobility and Polarized Distribution of Dense-Core Vesicles in C. elegans Motor Neurons	PLOS ONE			English	Article							ACTIVE ZONE; LIPRIN-ALPHA; PRESYNAPTIC COMPONENTS; NERVOUS-SYSTEM; SAD-1 KINASE; TRANSPORT; RELEASE; TRAFFICKING; MATURATION; SECRETION	The polarized trafficking of axonal and dendritic components is essential for the development and maintenance of neuronal structure and function. Neuropeptide-containing dense-core (DCVs) vesicles are trafficked in a polarized manner from the cell body to their sites of release; however, the molecules involved in this process are not well defined. Here we show that the scaffolding protein SYD-2/Liprin-alpha is required for the normal polarized localization of Venus-tagged neuropeptides to axons of cholinergic motor neurons in C. elegans. In syd-2 loss of function mutants, the normal polarized localization of INS-22 neuropeptide-containing DCVs in motor neurons is disrupted, and DCVs accumulate in the cell body and dendrites. Time-lapse microscopy and kymograph analysis of mobile DCVs revealed that syd-2 mutants exhibit decreased numbers of DCVs moving in both anterograde and retrograde directions, and a corresponding increase in stationary DCVs in both axon commissures and dendrites. In addition, DCV run lengths and velocities were decreased in both axon commissures and dendrites of syd-2 mutants. This study shows that SYD-2 promotes bi-directional mobility of DCVs and identifies SYD-2 as a novel regulator of DCV trafficking and polarized distribution.	[Goodwin, Patricia R.; Juo, Peter] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Goodwin, Patricia R.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Neurosci, Boston, MA 02111 USA	Tufts University; Tufts University	Juo, P (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	peter.juo@tufts.edu	Juo, Peter/CJY-3695-2022	Juo, Peter/0000-0002-3039-2266	National Institutes of Health (NIH) [NS059953]; Basil O'Connor March of Dimes Scholar Award; Tufts Center for Neuroscience Research [P30 NS047243]; Synapse Neurobiology Training Program [T32 NS061764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R56NS059953, R01NS059953, T32NS061764] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor March of Dimes Scholar Award(March of Dimes); Tufts Center for Neuroscience Research; Synapse Neurobiology Training Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from the National Institutes of Health (NIH) to PJ (NS059953), a Basil O'Connor March of Dimes Scholar Award to PJ, and the Tufts Center for Neuroscience Research (P30 NS047243). PRG was supported by a Dean's Fellowship and the Synapse Neurobiology Training Program (T32 NS061764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; BRENNER S, 1974, GENETICS, V77, P71; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Goodwin PR, 2012, J NEUROSCI, V32, P8158, DOI 10.1523/JNEUROSCI.0251-12.2012; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hannemann M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002722; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hsu CC, 2011, NEUROSCIENCE, V176, P39, DOI 10.1016/j.neuroscience.2010.12.044; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Ko J, 2003, J NEUROSCI, V23, P1667; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Shakiryanova D, 2006, NAT NEUROSCI, V9, P896, DOI 10.1038/nn1719; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Taru H, 2011, J NEUROSCI, V31, P16261, DOI 10.1523/JNEUROSCI.0002-11.2011; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Wagner OI, 2009, P NATL ACAD SCI USA, V106, P19605, DOI 10.1073/pnas.0902949106; West AE, 1997, J CELL BIOL, V139, P917, DOI 10.1083/jcb.139.4.917; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wong MY, 2009, J MOL NEUROSCI, V37, P146, DOI 10.1007/s12031-008-9080-8; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	59	13	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54763	10.1371/journal.pone.0054763	http://dx.doi.org/10.1371/journal.pone.0054763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358451	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600105
J	Savitz, J; Hodgkinson, CA; Martin-Soelch, C; Shen, PH; Szczepanik, J; Nugent, A; Herscovitch, P; Grace, AA; Goldman, D; Drevets, WC				Savitz, Jonathan; Hodgkinson, Colin A.; Martin-Soelch, Chantal; Shen, Pei-Hong; Szczepanik, Joanna; Nugent, Allison; Herscovitch, Peter; Grace, Anthony A.; Goldman, David; Drevets, Wayne C.			The Functional DRD3 Ser9Gly Polymorphism (rs6280) Is Pleiotropic, Affecting Reward as Well as Movement	PLOS ONE			English	Article							D3 RECEPTOR GENE; STRIATAL DOPAMINE RELEASE; PREDICTS AMYGDALA REACTIVITY; HUMAN VENTRAL STRIATUM; D-3 RECEPTORS; IN-VIVO; NUCLEUS-ACCUMBENS; RAT-BRAIN; INDUCED REINSTATEMENT; PERSONALITY-TRAITS	Abnormalities of motivation and behavior in the context of reward are a fundamental component of addiction and mood disorders. Here we test the effect of a functional missense mutation in the dopamine 3 receptor (DRD3) gene (ser9gly, rs6280) on reward-associated dopamine (DA) release in the striatum. Twenty-six healthy controls (HCs) and 10 unmedicated subjects with major depressive disorder (MDD) completed two positron emission tomography (PET) scans with [C-11] raclopride using the bolus plus constant infusion method. On one occasion subjects completed a sensorimotor task (control condition) and on another occasion subjects completed a gambling task (reward condition). A linear regression analysis controlling for age, sex, diagnosis, and self-reported anhedonia indicated that during receipt of unpredictable monetary reward the glycine allele was associated with a greater reduction in D2/3 receptor binding (i.e., increased reward-related DA release) in the middle (anterior) caudate (p, 0.01) and the ventral striatum (p, 0.05). The possible functional effect of the ser9gly polymorphism on DA release is consistent with previous work demonstrating that the glycine allele yields D3 autoreceptors that have a higher affinity for DA and display more robust intracellular signaling. Preclinical evidence indicates that chronic stress and aversive stimulation induce activation of the DA system, raising the possibility that the glycine allele, by virtue of its facilitatory effect on striatal DA release, increases susceptibility to hyperdopaminergic responses that have previously been associated with stress, addiction, and psychosis.	[Savitz, Jonathan; Drevets, Wayne C.] Univ Oklahoma, Coll Med, Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan; Drevets, Wayne C.] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Savitz, Jonathan] Tulsa Sch Community Med, Dept Med, Tulsa, OK USA; [Savitz, Jonathan; Szczepanik, Joanna; Drevets, Wayne C.] NIMH, Sect Neuroimaging Mood & Anxiety Disorders, Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; [Hodgkinson, Colin A.; Shen, Pei-Hong; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Martin-Soelch, Chantal] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, CH-8091 Zurich, Switzerland; [Nugent, Allison] NIMH, Expt Therapeut Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; [Herscovitch, Peter] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Psychiat & Psychol, Pittsburgh, PA USA	Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Savitz, J (corresponding author), Univ Oklahoma, Coll Med, Laureate Inst Brain Res, Tulsa, OK USA.	jonathansavitz@hotmail.com	Savitz, Jonathan/C-3088-2009; Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020; Martin-Soelch, Chantal/F-2486-2017	Savitz, Jonathan/0000-0001-8143-182X; Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Martin-Soelch, Chantal/0000-0003-3859-9023; Nugent, Allison/0000-0003-2569-2480; Grace, Anthony/0000-0003-1864-5504; Shen, Pei-Hong/0000-0002-8031-9374; Hodgkinson, Colin/0000-0002-5365-8119	intramural program at the National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA); William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	intramural program at the National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by the intramural program at the National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Drs. Savitz and Drevets also received support from The William K. Warren Foundation. The Foundation played no role in the writing of the manuscript or in the decision to publish. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, ADDICT BEHAV, V38, P1501, DOI 10.1016/j.addbeh.2012.03.021; Aiken CB, 2007, J CLIN PSYCHIAT, V68, P1230, DOI 10.4088/JCP.v68n0810; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogdan R, 2013, NEUROBIOL DIS, V52, P12, DOI 10.1016/j.nbd.2012.05.007; Bombin I, 2008, AM J MED GENET B, V147B, P873, DOI 10.1002/ajmg.b.30710; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Carson RE, 1997, J CEREBR BLOOD F MET, V17, P437, DOI 10.1097/00004647-199704000-00009; Chernoloz O, 2009, NEUROPSYCHOPHARMACOL, V34, P651, DOI 10.1038/npp.2008.114; Costas J, 2009, HUM GENET, V124, P607, DOI 10.1007/s00439-008-0584-7; Dannlowski U, 2011, INT J NEUROPSYCHOPH, V16, P1; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Diaz J, 2000, J NEUROSCI, V20, P8677; Dikeos DG, 1999, PSYCHIATR GENET, V9, P189, DOI 10.1097/00041444-199912000-00005; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Fisher PM, 2006, NAT NEUROSCI, V9, P1362, DOI 10.1038/nn1780; Goeders NE, 1996, BRAIN RES, V722, P145, DOI 10.1016/0006-8993(96)00206-5; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HEIMER L, 1991, ADV EXP MED BIOL, V295, P1; Henderson AS, 2000, AM J MED GENET, V96, P102, DOI 10.1002/(SICI)1096-8628(20000207)96:1<102::AID-AJMG20>3.0.CO;2-3; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Hwang R, 2010, PHARMACOGENOMICS J, V10, P200, DOI 10.1038/tpj.2009.65; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Jonsson EG, 2003, AM J MED GENET B, V117B, P61, DOI 10.1002/ajmg.b.10009; Jonsson EG, 2003, PSYCHIAT GENET, V13, P1, DOI 10.1097/01.ypg.0000051094.88669.4b; Joutsa J, 2012, NEUROIMAGE, V60, P1992, DOI 10.1016/j.neuroimage.2012.02.006; Khaled MATM, 2010, INT J NEUROPSYCHOPH, V13, P181, DOI 10.1017/S1461145709991064; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Koenig HN, 2004, PSYCHONEUROENDOCRINO, V29, P999, DOI 10.1016/j.psyneuen.2003.09.004; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Lammers CH, 2000, MOL PSYCHIATR, V5, P378, DOI 10.1038/sj.mp.4000754; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; LASSEN NA, 1992, J CEREBR BLOOD F MET, V12, P709, DOI 10.1038/jcbfm.1992.101; Lerer B, 2002, NEUROPSYCHOPHARMACOL, V27, P105, DOI 10.1016/S0893-133X(02)00293-2; Liu X, 2011, MOL PSYCHIATR, V16, P584, DOI 10.1038/mp.2011.1; Liu YZ, 2009, EUR J CLIN PHARMACOL, V65, P679, DOI 10.1007/s00228-009-0658-z; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Maj J, 1998, EUR J PHARMACOL, V351, P31, DOI 10.1016/S0014-2999(98)00297-0; MALMBERG A, 1994, MOL PHARMACOL, V46, P299; Martin-Soelch C, 2011, EUR J NEUROSCI, V33, P1706, DOI 10.1111/j.1460-9568.2011.07642.x; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Novak G, 2010, ANN HUM GENET, V74, P291, DOI 10.1111/j.1469-1809.2010.00578.x; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pecina M, 2012, CORTEX, DOI [10.1016/j.cortex.2012.01.010, DOI 10.1016/J.COR-TEX.2012.01.010]; Perlis RH, 2010, J CLIN PSYCHIAT, V71, P599, DOI 10.4088/JCP.08m04632gre; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Proitsi P, 2012, NEUROBIOL AGING, V33, P791, DOI 10.1016/j.neurobiolaging.2010.06.011; Rabiner EA, 2009, SYNAPSE, V63, P782, DOI 10.1002/syn.20658; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Ridray S, 1998, EUR J NEUROSCI, V10, P1676, DOI 10.1046/j.1460-9568.1998.00173.x; ROWLANDS GJ, 1980, EUR J PHARMACOL, V62, P241, DOI 10.1016/0014-2999(80)90285-X; Sambataro F, 2011, SCHIZOPHR B, V39, P206; Schosser A, 2011, AM J MED GENET B, V156B, P640, DOI 10.1002/ajmg.b.31204; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Segal DM, 1997, MOL BRAIN RES, V45, P335, DOI 10.1016/S0169-328X(97)00025-9; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Taylor S, 2013, MOL PSYCHIATR, V18, P799, DOI 10.1038/mp.2012.76; Toma C, 2013, WORLD J BIOL PSYCHIA, V14, P516, DOI 10.3109/15622975.2011.602719; Tsuchimine S, 2012, J CLIN PSYCHOPHARM, V32, P724, DOI 10.1097/JCP.0b013e318267b6da; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; Vandenbergh DJ, 2007, ADDICT BIOL, V12, P106, DOI 10.1111/j.1369-1600.2007.00054.x; Vengeliene V, 2006, FASEB J, V20, P2223, DOI 10.1096/fj.06-6110com; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Xi ZX, 2004, PSYCHOPHARMACOLOGY, V176, P57, DOI 10.1007/s00213-004-1858-y; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013; Zhang FQ, 2011, AM J MED GENET B, V156B, P613, DOI 10.1002/ajmg.b.31203	79	39	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54108	10.1371/journal.pone.0054108	http://dx.doi.org/10.1371/journal.pone.0054108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365649	Green Published, Green Accepted, gold			2022-12-25	WOS:000314023600031
J	Zhang, H; Eisenried, A; Zimmermann, W; Shively, JE				Zhang, Hui; Eisenried, Andreas; Zimmermann, Wolfgang; Shively, John E.			Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; CYTOPLASMIC DOMAIN; CARCINOMA-CELLS; LUMEN FORMATION; 3D CULTURE; CANCER; EXPRESSION; IDENTIFICATION; BINDING; BREAST	CEACAM20, a novel member of the CEACAM1 gene family with expression limited to the lumen of small intestine, testes, and prostate, is co-expressed with CEACAM1 in adult prostate tissue and down-regulated to the same extent as CEACAM1 in prostate cancer. Since prostate cancer often involves loss of epithelial lumen formation, we hypothesized that CEACAM20 and CEACAM1 play important roles in lumen formation of normal prostate epithelium. When prostate cells were grown on Matrigel as a source of extracellular matrix (ECM), they differentiated into acinar structures with single tubules and well-defined lumina closely resembling embryonic prostate organoids. Confocal microscopic analysis revealed restriction of CEACAM20 to acini and CEACAM1 to tubule structures, respectively. Inhibition of CEACAM1 with antibodies or soluble CEACAM1 or antisense oligonucleotides inhibited tubule formation by over 50% while the remaining tubules were stunted. Inhibition of CEACAM20 with antisense oligonucleotides completely inhibited tubule formation and stunted the growth of acini. We conclude that CEACAM20 and CEACAM1 not only mark the lumina of adult prostate tissue but also play a critical role in the vitro generation of prostate organoids.	[Zhang, Hui] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Zhang, Hui; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Eisenried, Andreas] Univ Klinikum Erlangen, Anasthesiol Klin, Erlangen, Germany; [Zimmermann, Wolfgang] LIFE Zentrum, Lab Tumorimmunol, Munich, Germany	City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Erlangen Nuremberg; University of Munich	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA.	JShively@coh.org			National Institutes of Health grant [CA 84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health grant CA 84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Comegys MM, 1999, ONCOGENE, V18, P3261, DOI 10.1038/sj.onc.1202666; Dellinger DJ, 2004, CURR PROTOC NUCL ACI, V4; Garraway LA, 2003, PROSTATE, V55, P206, DOI 10.1002/pros.10244; Gencheva M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-79; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hawley P, 1992, Antisense Res Dev, V2, P119; Huang J, 1999, J CELL SCI, V112, P4193; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lauke H, 2004, MOL HUM REPROD, V10, P247, DOI 10.1093/molehr/gah020; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Pearson JF, 2009, CELL DEATH DIFFER, V16, P475, DOI 10.1038/cdd.2008.181; Prakash TP, 2007, CURR TOP MED CHEM, V7, P641, DOI 10.2174/156802607780487713; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Schumann D, 2004, BIOCHEM BIOPH RES CO, V318, P227, DOI 10.1016/j.bbrc.2004.04.024; Soifer HS, 2012, METHODS MOL BIOL, V815, P333, DOI 10.1007/978-1-61779-424-7_25; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tilki D, 2006, ONCOGENE, V25, P4965, DOI 10.1038/sj.onc.1209514; Tilki D, 2010, EUR UROL, V57, P648, DOI 10.1016/j.eururo.2009.05.040; Timms BG, 2008, DIFFERENTIATION, V76, P565, DOI 10.1111/j.1432-0436.2008.00278.x; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; You YH, 1998, ANTICANCER RES, V18, P3193; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985	41	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53359	10.1371/journal.pone.0053359	http://dx.doi.org/10.1371/journal.pone.0053359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358633	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600014
J	Caller, G; Brown, C				Caller, Georgina; Brown, Culum			Evolutionary Responses to Invasion: Cane Toad Sympatric Fish Show Enhanced Avoidance Learning	PLOS ONE			English	Article							BUFO-MARINUS ANURA; NATIVE FAUNA; PREDATOR; BUFONIDAE; TADPOLES; AUSTRALIA; LARVAE; POPULATIONS; RAINBOWFISH; COMPETITION	The introduced cane toad (Bufo marinus) poses a major threat to biodiversity due to its lifelong toxicity. Several terrestrial native Australian vertebrates are adapting to the cane toad's presence and lab trials have demonstrated that repeated exposure to B. marinus can result in learnt avoidance behaviour. Here we investigated whether aversion learning is occurring in aquatic ecosystems by comparing cane toad naive and sympatric populations of crimson spotted rainbow fish (Melanotaenia duboulayi). The first experiment indicated that fish from the sympatric population had pre-existing aversion to attacking cane toad tadpoles but also showed reduced attacks on native tadpoles. The second experiment revealed that fish from both naive and sympatric populations learned to avoid cane toad tadpoles following repeated, direct exposure. Allopatric fish also developed a general aversion to tadpoles. The aversion learning abilities of both groups was examined using an experiment involving novel distasteful prey items. While both populations developed a general avoidance of edible pellets in the presence of distasteful pellets, only the sympatric population significantly reduced the number of attacks on the novel distasteful prey item. These results indicate that experience with toxic prey items over multiple generations can enhance avoidance leaning capabilities via natural selection.	[Caller, Georgina; Brown, Culum] Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Brown, C (corresponding author), Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia.	Culum.Brown@mq.edu.au	Brown, Culum/S-9826-2017	Brown, Culum/0000-0002-0210-1820	Macquarei University	Macquarei University	This work was funded by Macquarei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw CJA, 2007, WILDLIFE RES, V34, P419, DOI 10.1071/WR06056; Brown C, 2003, ECOL FRESHW FISH, V12, P118, DOI 10.1034/j.1600-0633.2003.00007.x; Brown C, 1999, ENVIRON BIOL FISH, V56, P455, DOI 10.1023/A:1007518710790; Brown C, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P46; Brown Culum, 2001, Animal Cognition, V4, P109, DOI 10.1007/s100710100105; Campbell N., 2006, BIOLOGY-BASEL, V7th; Carroll SP, 2007, ECOL RES, V22, P892, DOI 10.1007/s11284-007-0352-5; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; Catling PC, 1999, WILDLIFE RES, V26, P161, DOI 10.1071/WR98025; COVACEVICH J, 1975, Memoirs of the Queensland Museum, V17, P305; Crossland MR, 2008, BIOL CONSERV, V141, P2387, DOI 10.1016/j.biocon.2008.07.005; Crossland MR, 2000, ECOGRAPHY, V23, P283, DOI 10.1034/j.1600-0587.2000.d01-1636.x; Crossland MR, 1998, AUST J ECOL, V23, P129, DOI 10.1111/j.1442-9993.1998.tb00711.x; Crossland MR, 1999, HERPETOLOGICA, V55, P192; Crossland MR, 2001, J FISH BIOL, V59, P319, DOI 10.1111/j.1095-8649.2001.tb00132.x; CROWDER LB, 1986, ENVIRON BIOL FISH, V16, P147, DOI 10.1007/BF00005167; Day T, 1996, OECOLOGIA, V108, P380, DOI 10.1007/BF00334665; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Doody JS, 2006, WILDLIFE RES, V33, P349, DOI 10.1071/WR05042; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; EASTEAL S, 1985, J HERPETOL, V19, P185, DOI 10.2307/1564171; Greenlees MJ, 2011, AUSTRAL ECOL, V36, P53, DOI 10.1111/j.1442-9993.2010.02116.x; Greenlees MJ, 2010, BEHAV ECOL, V21, P966, DOI 10.1093/beheco/arq095; Groves R.H., 1991, BIOGEOGRAPHY MEDITER; Hayes RA, 2009, J CHEM ECOL, V35, P391, DOI 10.1007/s10886-009-9608-6; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Kasumyan AO, 2003, FISH FISH, V4, P289, DOI 10.1046/j.1467-2979.2003.00121.x; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Kiesecker JM, 1997, ECOLOGY, V78, P1752; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; Mitchell David, 1995, Memoirs of the Queensland Museum, V38, P512; Nelson DWM, 2011, AUSTRAL ECOL, V36, P605, DOI 10.1111/j.1442-9993.2010.02187.x; Nelson DWM, 2010, BIOL INVASIONS, V12, P3363, DOI 10.1007/s10530-010-9729-4; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PRIMACK R.B., 1998, ESSENTIALS CONSERVAT; ROBINSON M, 1998, FIELD GUIDE FROGS AU; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; SABATH MD, 1981, COPEIA, P676, DOI 10.2307/1444573; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Tyler MJ, 1989, TOXIC PLANTS ANIMALS; WADEC, 2009, CAN TOADS ARR W AUST; WASSERSUG R, 1971, AM MIDL NAT, V86, P101, DOI 10.2307/2423690; Webb JK, 2008, AUSTRAL ECOL, V33, P821, DOI 10.1111/j.1442-9993.2008.01847.x; Williamson I, 1999, AUST J ECOL, V24, P636, DOI 10.1046/j.1442-9993.1999.00993.x	48	18	18	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54909	10.1371/journal.pone.0054909	http://dx.doi.org/10.1371/journal.pone.0054909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372788	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500141
J	Compagnucci, C; Di Siena, S; Bustamante, MB; Di Giacomo, D; Di Tommaso, M; Maccarrone, M; Grimaldi, P; Sette, C				Compagnucci, Claudia; Di Siena, Sara; Bustamante, Maria Blaire; Di Giacomo, Daniele; Di Tommaso, Monia; Maccarrone, Mauro; Grimaldi, Paola; Sette, Claudio			Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ADULT NEUROGENESIS; PROGENITOR PROLIFERATION; SUBVENTRICULAR ZONE; GENE-EXPRESSION; BRAIN; FATE; IDENTIFICATION; MECHANISMS; PLASTICITY	Neural stem cells (NSCs) are self-renewing cells that can differentiate into multiple neural lineages and repopulate regions of the brain after injury. We have investigated the role of endocannabinoids (eCBs), endogenous cues that modulate neuronal functions including neurogenesis, and their receptors CB1 and CB2 in mouse NSCs. Real-time PCR and Western blot analyses indicated that CB1 is present at higher levels than CB2 in NSCs. The eCB anandamide (AEA) or the CB1-specific agonist ACEA enhanced NSC differentiation into neurons, but not astrocytes and oligodendrocytes, whereas the CB2-specific agonist JWH133 was ineffective. Conversely, the effect of AEA was inhibited by CB1, but not CB2, antagonist, corroborating the specificity of the response. CB1 activation also enhanced maturation of neurons, as indicated by morphometric analysis of neurites. CB1 stimulation caused long-term inhibition of the ERK1/2 pathway. Consistently, pharmacological inhibition of the ERK1/2 pathway recapitulated the effects exerted by CB1 activation on neuronal differentiation and maturation. Lastly, gene array profiling showed that CB1 activation augmented the expression of genes involved in neuronal differentiation while decreasing that of stemness genes. These results highlight the role of CB1 in the regulation of NSC fate and suggest that its activation may represent a pro-neuronal differentiation signal.	[Compagnucci, Claudia; Di Siena, Sara; Bustamante, Maria Blaire; Di Giacomo, Daniele; Grimaldi, Paola; Sette, Claudio] Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Anat, Rome, Italy; [Compagnucci, Claudia; Bustamante, Maria Blaire; Sette, Claudio] Fdn Santa Lucia IRCCS, Lab Neuroembryol, Rome, Italy; [Di Tommaso, Monia; Maccarrone, Mauro] Fdn Santa Lucia IRCCS, Lab Lipid Neurochem, Rome, Italy; [Di Tommaso, Monia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Santa Lucia; University of Teramo	Grimaldi, P (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Anat, Rome, Italy.	p.grimaldi@med.uniroma2.it; claudio.sette@uniroma2.it	Grimaldi, Paola/AAW-8721-2020; GRIMALDI, PAOLA/AAJ-7920-2020; Compagnucci, Claudia/J-3608-2016; Maccarrone, Mauro/K-5398-2012; Sette, Claudio/S-4307-2019	GRIMALDI, PAOLA/0000-0001-6724-7604; Compagnucci, Claudia/0000-0003-0877-6172; Maccarrone, Mauro/0000-0002-3990-2963; Sette, Claudio/0000-0003-2864-8266	Muscular Dystrophy Association [186711]; Telethon [GGP09154]; Fondazione Santa Lucia "Ricerca Corrente"; Fondazione TERCAS	Muscular Dystrophy Association(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Fondazione Santa Lucia "Ricerca Corrente"; Fondazione TERCAS	This work was supported by funds from the Muscular Dystrophy Association (186711) and Telethon (GGP09154), the Fondazione Santa Lucia "Ricerca Corrente" and partly from Fondazione TERCAS (grant 2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bertram B, 2012, J NEUROSCI METH, V209, P420, DOI 10.1016/j.jneumeth.2012.06.024; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Galve-Roperh I, 2009, EUR ARCH PSY CLIN N, V259, P371, DOI 10.1007/s00406-009-0028-y; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Herkenham M, 1991, NIDA Res Monogr, V112, P129; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Moritz S, 2008, STEM CELLS, V26, P2321, DOI 10.1634/stemcells.2007-1095; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Patel KD, 2010, CURR MED CHEM, V17, P1394, DOI 10.2174/092986710790980041; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Radio Nicholas M, 2012, Methods Mol Biol, V846, P247, DOI 10.1007/978-1-61779-536-7_22; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Spires TL, 2007, J NEUROCHEM, V100, P874, DOI 10.1111/j.1471-4159.2006.04275.x; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740	56	60	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54271	10.1371/journal.pone.0054271	http://dx.doi.org/10.1371/journal.pone.0054271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372698	Green Published, gold			2022-12-25	WOS:000314021500050
J	Lanotte, P; Perivier, M; Haguenoer, E; Mereghetti, L; Burucoa, C; Claverol, S; Atanassov, C				Lanotte, Philippe; Perivier, Marylise; Haguenoer, Eve; Mereghetti, Laurent; Burucoa, Christophe; Claverol, Stephane; Atanassov, Christo			Proteomic Biomarkers Associated with Streptococcus agalactiae Invasive Genogroups	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; DESORPTION IONIZATION-TIME; RIBOSOMAL-PROTEIN L7/L12; FLIGHT MASS-SPECTROMETRY; SELDI-TOF-MS; HELICOBACTER-PYLORI; NEONATAL DISEASE; RAPID DETECTION; EF-G; IDENTIFICATION	Group B streptococcus (GBS, Streptococcus agalactiae) is a leading cause of meningitis and sepsis in newborns and an etiological agent of meningitis, endocarditis, osteoarticular and soft tissue infections in adults. GBS isolates are routinely clustered in serotypes and in genotypes. At present one GBS sequence type (i.e. ST17) is considered to be closely associated with bacterial invasiveness and novel proteomic biomarkers could make a valuable contribution to currently available GBS typing data. For that purpose we analyzed the protein profiles of 170 genotyped GBS isolates by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI). Univariate statistical analysis of the SELDI profiles identified four protein biomarkers significantly discriminating ST17 isolates from those of the other sequence types. Two of these biomarkers (MW of 7878 Da and 12200 Da) were overexpressed and the other two (MW of 6258 Da and 10463 Da) were underexpressed in ST17. The four proteins were isolated by mass spectrometry-assisted purification and their tryptic peptides analyzed by LC-MS/MS. They were thereby identified as the small subunit of exodeoxyribonuclease VII, the 50S ribosomal protein L7/L12, a CsbD-like protein and thioredoxin, respectively. In conclusion, we identified four candidate biomarkers of ST17 by SELDI for high-throughput screening. These markers may serve as a basis for further studies on the pathophysiology of GBS infection, and for the development of novel vaccines.	[Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] Univ Tours, Equipe Bacteries & Risque Maternofoetal, UMR ISP 1282, Tours, France; [Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] INRA, Equipe Bacteries & Risque Maternofoetal, UMR ISP 1282, F-37380 Nouzilly, France; [Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] CHRU Tours, Serv Bacteriol & Virol, Tours, France; [Perivier, Marylise; Burucoa, Christophe; Atanassov, Christo] CHU Poitiers, Serv Bacteriol Hyg, Poitiers, France; [Burucoa, Christophe; Atanassov, Christo] Univ Poitiers, Equipe Accueil 4331, Lab Inflammat Tissus Epitheliaux & Cytokines, Poitiers, France; [Claverol, Stephane] Univ Bordeaux 2, Pole Prote Ctr Genom Fonct, F-33076 Bordeaux, France	Universite de Tours; INRAE; CHU Tours; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; UDICE-French Research Universities; Universite de Bordeaux	Atanassov, C (corresponding author), CHU Poitiers, Serv Bacteriol Hyg, Poitiers, France.	h.atanassov@chu-poitiers.fr	Burucoa, Christophe/AAG-3664-2021					Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bernarde C, 2009, PROTEOM CLIN APPL, V3, P672, DOI 10.1002/prca.200800158; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; BLUMBERG HM, 1992, J INFECT DIS, V166, P574, DOI 10.1093/infdis/166.3.574; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Chatellier S, 1996, J CLIN MICROBIOL, V34, P2741, DOI 10.1128/JCM.34.11.2741-2747.1996; Chatellier S, 1997, J CLIN MICROBIOL, V35, P2573, DOI 10.1128/JCM.35.10.2573-2579.1997; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Haguenoer E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-171; Herbert MA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-31; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jomaa M, 2005, FEMS IMMUNOL MED MIC, V44, P59, DOI 10.1016/j.femsim.2004.12.001; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kimmel B, 2000, INFECT IMMUN, V68, P915, DOI 10.1128/IAI.68.2.915-920.2000; Kolberg J, 1997, MICROBIOL-UK, V143, P55, DOI 10.1099/00221287-143-1-55; KOTELIANSKY VE, 1978, EUR J BIOCHEM, V90, P319, DOI 10.1111/j.1432-1033.1978.tb12607.x; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; Lartigue MF, 2011, J MICROBIOL METH, V86, P262, DOI 10.1016/j.mimet.2011.05.017; Lartigue MF, 2009, J CLIN MICROBIOL, V47, P2284, DOI 10.1128/JCM.00175-09; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2005, J CLIN MICROBIOL, V43, P6113, DOI 10.1128/JCM.43.12.6113-6116.2005; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mini R, 2006, J CHROMATOGR B, V833, P63, DOI 10.1016/j.jchromb.2005.12.052; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Nanninga N, 1998, MICROBIOL MOL BIOL R, V62, P110, DOI 10.1128/MMBR.62.1.110-129.1998; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; Oliveira SC, 1996, VACCINE, V14, P959, DOI 10.1016/0264-410X(96)00018-7; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; Reder A, 2012, J BACTERIOL, V194, P3601, DOI 10.1128/JB.00528-12; Ribeiro LA, 2002, APPL ENVIRON MICROB, V68, P910, DOI 10.1128/AEM.68.2.910-916.2002; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; Schuchat A, 2001, CLIN INFECT DIS, V33, P751, DOI 10.1086/322697; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Voland P, 2002, ALIMENT PHARM THER, V16, P533, DOI 10.1046/j.1365-2036.2002.01221.x; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009	55	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54393	10.1371/journal.pone.0054393	http://dx.doi.org/10.1371/journal.pone.0054393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372719	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500068
J	Chou, J; Ito, T; Bishop, D; Otsuka, M; Ben-Nissan, B; Milthorpe, B				Chou, Joshua; Ito, Tomoko; Bishop, David; Otsuka, Makoto; Ben-Nissan, Besim; Milthorpe, Bruce			Controlled Release of Simvastatin from Biomimetic beta-TCP Drug Delivery System	PLOS ONE			English	Article							BONE-FORMATION	Simvastatin have been shown to induce bone formation and there is currently a urgent need to develop an appropriate delivery system to sustain the release of the drug to increase therapeutic efficacy whilst reducing side effects. In this study, a novel drug delivery system for simvastatin by means of hydrothermally converting marine exoskeletons to biocompatible beta-tricalcium phosphate was investigated. Furthermore, the release of simvastatin was controlled by the addition of an outer apatite coating layer. The samples were characterized by x-ray diffraction analysis, fourier transform infrared spectroscopy, scanning electron microscopy and mass spectroscopy confirming the conversion process. The in-vitro dissolution of key chemical compositional elements and the release of simvastatin were measured in simulated body fluid solution showing controlled release with reduction of approximately 25% compared with un-coated samples. This study shows the potential applications of marine structures as a drug delivery system for simvastatin.	[Chou, Joshua] Univ Technol Sydney, Sch Med & Mol Sci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia; [Ito, Tomoko; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Nishi Tokyo, Japan; [Bishop, David; Ben-Nissan, Besim] Univ Technol Sydney, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia; [Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney; University of Technology Sydney	Chou, J (corresponding author), Univ Technol Sydney, Sch Med & Mol Sci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia.	Joshua.chou@uts.edu.au	Milthorpe, Bruce/Z-1153-2019; Milthorpe, Bruce K/A-7014-2008; Bishop, David P/F-2891-2019; Ben-Nissan, Besim/AAR-4445-2020; Chou, Joshua/G-7746-2013	Milthorpe, Bruce/0000-0002-0867-9586; Bishop, David P/0000-0002-6533-4410; Ben-Nissan, Besim/0000-0003-0433-3593; Chou, Joshua/0000-0002-7472-8016	University of Technology Sydney Chancellor Postdoctoral Fellowship; Australia Endeavour Cheung Kuong Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057083, R01AR048756] Funding Source: NIH RePORTER	University of Technology Sydney Chancellor Postdoctoral Fellowship; Australia Endeavour Cheung Kuong Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the University of Technology Sydney Chancellor Postdoctoral Fellowship and the Australia Endeavour Cheung Kuong Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukawa Y, 2004, CLIN ORAL IMPLAN RES, V404, P343; Du ZB, 2009, CLIN ORAL IMPLAN RES, V20, P145, DOI 10.1111/j.1600-0501.2008.01630.x; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Junqueira Juliana C, 2002, J Oral Sci, V44, P117; Kiliccoglu SS, 2007, J TRAUMA, V63, P187, DOI 10.1097/01.TA.0000240974.07999.bc; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lee YJ, 2008, BIOMATERIALS, V29, P1940, DOI 10.1016/j.biomaterials.2007.12.045; LeGeros RZ, 1996, ADV DENT RES, V10, P252; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184; Pytlik M, 2003, POL J PHARMACOL, V55, P63; Rizzoli R, 2005, J Endocrinol Invest, V28, P50; Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004; Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861; Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697; Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0	17	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54676	10.1371/journal.pone.0054676	http://dx.doi.org/10.1371/journal.pone.0054676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349949	gold, Green Published, Green Submitted			2022-12-25	WOS:000313872800070
J	Lind, O; Karlsson, S; Kelber, A				Lind, Olle; Karlsson, Sandra; Kelber, Almut			Brightness Discrimination in Budgerigars (Melopsittacus undulatus)	PLOS ONE			English	Article							SPATIAL CONTRAST SENSITIVITY; VISION	Birds have excellent spatial acuity and colour vision compared to other vertebrates while spatial contrast sensitivity is relatively poor for unknown reasons. Contrast sensitivity describes the detection of gratings of varying spatial frequency. It is unclear whether bird brightness discrimination between large uniform fields is poor as well. Here we show that budgerigars (Melopsittacus undulatus) need a Michelson contrast of 0.09 to discriminate between large spatially separated achromatic fields in bright light conditions. This is similar to the peak contrast sensitivity of 10.2 (0.098 Michelson contrast) for achromatic grating stimuli established in earlier studies. The brightness discrimination threshold described in Weber fractions is 0.18, which is modest compared to other vertebrates.	[Lind, Olle; Karlsson, Sandra; Kelber, Almut] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Lind, O (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	olle.lind@biol.lu.se	Chaib, Sandra/G-4671-2016; Kelber, Almut/H-6216-2014	Chaib, Sandra/0000-0001-5098-1634; Kelber, Almut/0000-0003-3937-2808	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Swedish Research Council, Stockholm [2006-4510, 2009-5683]	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Swedish Research Council, Stockholm(Swedish Research Council)	This work was supported by the Royal Physiographic Society in Lund (http://www.fysiografen.se/), the Royal Swedish Academy of Sciences (http://www.kva.se/en/), and the Swedish Research Council, Stockholm (Grant Numbers 2006-4510 and 2009-5683) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Coletta NJ, 2003, OPTOMETRY VISION SCI, V80, P50, DOI 10.1097/00006324-200301000-00008; DeValois RL, 1990, SPATIAL VISION; Geisbauer G, 2004, CAN J ZOOL, V82, P660, DOI [10.1139/z04-026, 10.1139/Z04-026]; Ghim MM, 2006, J COMP PHYSIOL A, V192, P523, DOI 10.1007/s00359-005-0090-5; Griebel U, 1997, J EXP BIOL, V200, P1587; Harmening WM, 2007, VISION RES, V47, P2934, DOI 10.1016/j.visres.2007.08.001; Harmening WM, 2009, J VISION, V9, DOI 10.1167/9.7.13; HODOS W, 1985, VISION RES, V25, P1525, DOI 10.1016/0042-6989(85)90231-7; Hodos William, 1993, P63; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Lind O, 2012, J COMP PHYSIOL A, V198, P69, DOI 10.1007/s00359-011-0689-7; Lind O, 2011, J VISION, V11, DOI 10.1167/11.7.2; Scholtyssek C, 2012, THESIS U ROSTOCK ROS; Scholtyssek C, 2008, VISION RES, V48, P96, DOI 10.1016/j.visres.2007.10.012; Stone CP, 1921, J COMP PSYCHOL, V1, P413, DOI 10.1037/h0072941; VONCAMPENHAUSE C, 1986, NATURWISSENSCHAFTEN, V73, P674; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	19	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54650	10.1371/journal.pone.0054650	http://dx.doi.org/10.1371/journal.pone.0054650			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349946	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800069
J	Sikora, D; Zhang, DJ; Bojic, T; Beeharry, Y; Tanara, A; Pelchat, M				Sikora, Dorota; Zhang, Dajiang; Bojic, Teodora; Beeharry, Yasnee; Tanara, Ali; Pelchat, Martin			Identification of a Binding Site for ASF/SF2 on an RNA Fragment Derived from the Hepatitis delta Virus Genome	PLOS ONE			English	Article							SPLICING FACTOR ASF/SF2; C-TERMINAL DOMAIN; MESSENGER-RNA; POLYMERASE-II; SR PROTEINS; RECOGNITION MOTIF; GENE-EXPRESSION; AMINO-ACIDS; IN-VITRO; B-VIRUS	The hepatitis delta virus (HDV) is a small (similar to 1700 nucleotides) RNA pathogen which encodes only one open reading frame. Consequently, HDV is dependent on host proteins to replicate its RNA genome. Recently, we reported that ASF/SF2 binds directly and specifically to an HDV-derived RNA fragment which has RNA polymerase II promoter activity. Here, we localized the binding site of ASF/SF2 on the HDV RNA fragment by performing binding experiments using purified recombinant ASF/SF2 combined with deletion analysis and site-directed mutagenesis. In addition, we investigated the requirement of ASF/SF2 for HDV RNA replication using RNAi-mediated knock-down of ASF/SF2 in 293 cells replicating HDV RNA. Overall, our results indicate that ASF/SF2 binds to a purine-rich region distant from both the previously published initiation site of HDV mRNA transcription and binding site of RNAP II, and suggest that this protein is not involved in HDV replication in the cellular system used.	[Sikora, Dorota; Zhang, Dajiang; Bojic, Teodora; Beeharry, Yasnee; Tanara, Ali; Pelchat, Martin] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Pelchat, M (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	mpelchat@uottawa.ca	Beeharry, Y./V-3167-2019	Beeharry, Y./0000-0001-9074-3008	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahem A, 2008, NUCLEIC ACIDS RES, V36, P5201, DOI 10.1093/nar/gkn501; Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; Beard MR, 1996, J VIROL, V70, P4986, DOI 10.1128/JVI.70.8.4986-4995.1996; Benzaghou I, 2006, FEBS LETT, V580, P867, DOI 10.1016/j.febslet.2006.01.006; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bougie I, 2004, BIOCHEM J, V384, P411, DOI 10.1042/BJ20041112; Bougie I, 2007, YEAST, V24, P431, DOI 10.1002/yea.1482; BRUN F, 1975, BIOCHEMISTRY-US, V14, P558, DOI 10.1021/bi00674a015; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Chang JH, 2005, J VIROL, V79, P8182, DOI 10.1128/JVI.79.13.8182-8188.2005; Chang JH, 2008, J VIROL, V82, P1118, DOI 10.1128/JVI.01758-07; CHAO M, 1990, J VIROL, V64, P5066, DOI 10.1128/JVI.64.10.5066-5069.1990; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Flowers S, 2003, BIOCHEMISTRY-US, V42, P1910, DOI 10.1021/bi025992v; FU TB, 1993, J VIROL, V67, P6965, DOI 10.1128/JVI.67.12.6965-6972.1993; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Greco-Stewart V, 2010, VIRUSES-BASEL, V2, P189, DOI 10.3390/v2010189; Greco-Stewart VS, 2007, VIROLOGY, V357, P68, DOI 10.1016/j.virol.2006.08.010; Greco-Stewart VS, 2009, VIROLOGY, V386, P12, DOI 10.1016/j.virol.2009.02.007; Gudima S, 1999, J VIROL, V73, P6533, DOI 10.1128/JVI.73.8.6533-6539.1999; Gudima S, 2000, J VIROL, V74, P7204, DOI 10.1128/JVI.74.16.7204-7210.2000; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LEE CZ, 1995, J VIROL, V69, P5332, DOI 10.1128/JVI.69.9.5332-5336.1995; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Millhouse S, 2005, MOL CELL BIOL, V25, P533, DOI 10.1128/MCB.25.2.533-544.2005; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Moraleda G, 2001, J VIROL, V75, P10161, DOI 10.1128/JVI.75.21.10161-10169.2001; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Rocheleau L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-24; RYU WS, 1992, J VIROL, V66, P2310, DOI 10.1128/JVI.66.4.2310-2315.1992; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Showalter SA, 2004, J MOL BIOL, V335, P465, DOI 10.1016/j.jmb.2003.10.055; Sikora D, 2009, VIROLOGY, V390, P71, DOI 10.1016/j.virol.2009.04.022; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Souliere MF, 2008, NUCLEIC ACIDS RES, V36, P451, DOI 10.1093/nar/gkm1067; SUREAU C, 1992, J VIROL, V66, P1241, DOI 10.1128/JVI.66.2.1241-1245.1992; Taylor JM, 2009, ADV VIRUS RES, V74, P103, DOI 10.1016/S0065-3527(09)74003-5; TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tintaru AM, 2007, EMBO REP, V8, P756, DOI 10.1038/sj.embor.7401031; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1075, P181, DOI 10.1016/0304-4165(91)90249-G; Wang X, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S8; Wu TT, 1997, J VIROL, V71, P5408, DOI 10.1128/JVI.71.7.5408-5414.1997; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54832	10.1371/journal.pone.0054832	http://dx.doi.org/10.1371/journal.pone.0054832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349975	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800078
J	Pericacho, M; Velasco, S; Prieto, M; Llano, E; Lopez-Novoa, JM; Rodriguez-Barbero, A				Pericacho, Miguel; Velasco, Soraya; Prieto, Marta; Llano, Elena; Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia			Endoglin Haploinsufficiency Promotes Fibroblast Accumulation during Wound Healing through Akt Activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UP-REGULATION; TRANSFORMING GROWTH-FACTOR-BETA-1; CELLULAR-RESPONSES; BINDING PROTEIN; MESANGIAL CELLS; EXPRESSION; RECEPTOR; ANGIOGENESIS; FIBROSIS	Accurate regulation of dermal fibroblast function plays a crucial role in wound healing. Many fibrotic diseases are characterized by a failure to conclude normal tissue repair and the persistence of fibroblasts inside lesions. In the present study we demonstrate that endoglin haploinsufficiency promotes fibroblast accumulation during wound healing. Moreover, scars from endoglin-heterozygous (Eng(+/-)) mice show persisting fibroblasts 12 days after wounding, which could lead to a fibrotic scar. Endoglin haploinsufficiency results in increased proliferation and migration of primary cultured murine dermal fibroblasts (MDFs). Moreover, Eng(+/-) MDF have diminished responses to apoptotic signals compared with control cells. Altogether, these modifications could explain the augmented presence of fibroblasts in Eng(+/-) mice wounds. We demonstrate that endoglin expression regulates Akt phosphorylation and that PI3K inhibition abolishes the differences in proliferation between endoglin haploinsufficient and control cells. Finally, persistent fibroblasts in Eng(+/-) mice wound co-localize with a greater degree of Akt phosphorylation. Thus, endoglin haploinsufficiency seems to promote fibroblast accumulation during wound healing through the activation of the PI3K/Akt pathway. These studies open new non-Smad signaling pathway for endoglin regulating fibroblast cell function during wound healing, as new therapeutic opportunities for the treatment of fibrotic wounds.	[Pericacho, Miguel; Velasco, Soraya; Prieto, Marta; Llano, Elena; Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia] Univ Salamanca, Renal & Cardiovasc Physiopathol Unit, Inst Reina Sofia Invest Nefrol, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia] Biomed Res Inst Salamanca, Salamanca, Spain	University of Salamanca	Rodriguez-Barbero, A (corresponding author), Univ Salamanca, Renal & Cardiovasc Physiopathol Unit, Inst Reina Sofia Invest Nefrol, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain.	barberoa@usal.es	Pericacho, Miguel/H-1786-2016; Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Llano, Elena/K-1723-2014; Llano, Elena/AAS-5517-2021; Prieto, Marta/A-5445-2016	Pericacho, Miguel/0000-0003-0226-482X; Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Llano, Elena/0000-0002-2626-5723; Llano, Elena/0000-0002-2626-5723; Lopez-Novoa, Jose M./0000-0002-6211-7269; Pendas, Alberto M/0000-0001-9264-3721; Prieto, Marta/0000-0002-2540-4461	Junta de Castilla y Leon [SA052A06, SA029A09, SA001/C05]; Ministerio de Ciencia e Innovacion [BFU2004-00285/BFI, SAF2007-63893]; Instituto de Salud Carlos III [RETIC RedInRen RD/0016]; Spanish Ministerio de Educacion y Ciencia	Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants from the Junta de Castilla y Leon (SA052A06 and SA029A09) to ARB and SA001/C05 to JMLN, and Ministerio de Ciencia e Innovacion (BFU2004-00285/BFI, and SAF2007-63893 to JMLN) and the Instituto de Salud Carlos III, (RETIC RedInRen RD/0016). MP was a holder of a fellowship from the Junta de Castilla y Leon, and SV was a fellowship holder of the Spanish Ministerio de Educacion y Ciencia. The Renal and Cardiovascular Physiology Unit is an Excellence Research Group awarded by Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cudmore MJ, 2012, EUR HEART J, V33, P1150, DOI 10.1093/eurheartj/ehr065; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Diez-Marques L, 2002, BBA-MOL BASIS DIS, V1587, P36, DOI 10.1016/S0925-4439(02)00051-0; Docherty NG, 2006, NEPHROL DIAL TRANSPL, V21, P2106, DOI 10.1093/ndt/gfl179; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Fujita D, 2010, J ENDOCRINOL, V206, P131, DOI 10.1677/JOE-10-0027; GE AZ, 1994, GENE, V138, P201, DOI 10.1016/0378-1119(94)90808-7; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Institute of Laboratory Animal Resources (U.S.), 1996, GUID CAR US LAB AN, Vxii; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lee NY, 2012, MOL BIOL CELL; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Obreo J, 2004, CELL PHYSIOL BIOCHEM, V14, P301, DOI 10.1159/000080340; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Robledo MM, 1998, BRIT J HAEMATOL, V102, P804, DOI 10.1046/j.1365-2141.1998.00820.x; Rodriguez-Barbero A, 2001, BIOCHEM BIOPH RES CO, V282, P142, DOI 10.1006/bbrc.2001.4526; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Rodriguez-Pena A, 2001, NEPHROL DIAL TRANSPL, V16, P34, DOI 10.1093/ndt/16.suppl_1.34; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; RoyChaudhury P, 1997, EXP NEPHROL, V5, P55; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shyu KG, 2010, EUR J HEART FAIL, V12, P219, DOI 10.1093/eurjhf/hfq011; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Subramaniam V, 2010, ANTI-CANCER DRUG, V21, P351, DOI 10.1097/CAD.0b013e328334992c; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	72	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54687	10.1371/journal.pone.0054687	http://dx.doi.org/10.1371/journal.pone.0054687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349951	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900083
J	Lai, LH; Song, YJ; Liu, Y; Chen, QY; Han, Q; Chen, WL; Pan, T; Zhang, YY; Cao, XT; Wang, QQ				Lai, Lihua; Song, Yinjing; Liu, Yang; Chen, Qingyun; Han, Quan; Chen, Weilin; Pan, Ting; Zhang, Yuanyuan; Cao, Xuetao; Wang, Qingqing			MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; DENDRITIC CELLS; PROTEIN; ACTIVATION; INDUCTION; CYTOKINE; CANCER; EXPRESSION; CLUSTER	Toll-like receptors (TLRs) play a critical role in the initiation of immune responses against invading pathogens. MicroRNAs have been shown to be important regulators of TLR signaling. In this study, we have found that the stimulation of multiple TLRs rapidly reduced the levels of microRNA-92a (miRNA-92a) and some other members of the miRNA-92a family in macrophages. miR-92a mimics significantly decreased, whereas miR-92a knockdown increased, the activation of the JNK/c-Jun pathway and the production of inflammatory cytokines in macrophages when stimulated with ligands for TLR4. Furthermore, mitogen-activated protein kinase kinase 4 (MKK4), a kinase that activates JNK/stress-activated protein kinase, was found to be directly targeted by miR-92a. Similar to the effects of the miR-92a mimics, knockdown of MKK4 inhibited the activation of JNK/c-Jun signaling and the production of TNF-alpha and IL-6. In conclusion, we have demonstrated that TLR-mediated miR-92a reduction feedback enhances TLR-triggered production of inflammatory cytokines in macrophages, thus outlining new mechanisms for fine-tuning the TLR-triggered inflammatory response.	[Lai, Lihua; Song, Yinjing; Liu, Yang; Chen, Qingyun; Han, Quan; Chen, Weilin; Pan, Ting; Zhang, Yuanyuan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol & Inst Immunol, Shanghai 200433, Peoples R China	Zhejiang University; Naval Medical University	Wang, QQ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, 388 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; zhang, yuanyuan/GYA-4428-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81230074]; National Basic Research Program of China [2013CB530502]; Zhejiang Provincial Natural Science Foundation [R2100528]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents in Zhejiang Province; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents in Zhejiang Province; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province	This work was supported by National Natural Science Foundation of China Grant 81230074, National Basic Research Program of China Grant 2013CB530502, Zhejiang Provincial Natural Science Foundation Grant R2100528, and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Inoue T, 2006, ARTHRITIS RHEUM-US, V54, P2127, DOI 10.1002/art.21919; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shin D, 2012, NEUROSCIENCE, V213, P29, DOI 10.1016/j.neuroscience.2012.03.054; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; YASHAR BM, 1993, MOL CELL BIOL, V13, P5738, DOI 10.1128/MCB.13.9.5738; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	65	104	111	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7956	7967		10.1074/jbc.M112.445429	http://dx.doi.org/10.1074/jbc.M112.445429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355465	hybrid, Green Published			2022-12-25	WOS:000316455300048
J	Ohira, T; Suzuki, T; Miyauchi, K; Suzuki, T; Yokobori, S; Yamagishi, A; Watanabe, K				Ohira, Takayuki; Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu; Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna			Decoding Mechanism of Non-universal Genetic Codes in Loligo bleekeri Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTICODON WOBBLE POSITION; METHIONINE TRANSFER-RNA; TRANSLATION; TAURINE; CODON; 7-METHYLGUANOSINE; BIOSYNTHESIS; SEQUENCES; INSIGHTS; RULE	Non-universal genetic codes are frequently found in animal mitochondrial decoding systems. In squid mitochondria, four codons deviate from the universal genetic code, namely AUA, UGA, and AGA/AGG (AGR) for Met, Trp, and Ser, respectively. To understand the molecular basis for establishing the non-universal genetic code, we isolated and analyzed five mitochondrial tRNAs from a squid, Loligo bleekeri. Primary structures of the isolated tRNAs, including their post-transcriptional modifications, were analyzed by mass spectrometry. tRNA(Met)(AUR) possessed an unmodified cytidine at the first position of the anticodon, suggesting that the AUA codon is deciphered by CAU anticodon via non-canonical A-C pairing. We identified 5-taurinomethyluridine (tau m(5)U) at the first position of the anticodon in tRNA(Trp)(UGR). tau m(5)U enables tRNA(Trp) to decipher UGR codons as Trp. In addition, 5-taurinomethyl-2-thiouridine (tau m(5)s(2)U) was found in mitochondrial tRNAs for Leu(UUR) and Lys in L. bleekeri. This is the first discovery of tau m(5)U and tau m(5)s(2)U in molluscan mitochondrial tRNAs.	[Ohira, Takayuki; Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, Hachioji, Tokyo 1920392, Japan; [Watanabe, Kimitsuna] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Watanabe, Kimitsuna] RIKEN SPring 8 Ctr, Harima Inst, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; Tokyo University of Pharmacy & Life Sciences; University of Tokyo; RIKEN	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp; kim-wata@toyaku.ac.jp	Suzuki, Tsutomu/J-1776-2015; Yokobori, Shin-ichi/K-9537-2017	Suzuki, Tsutomu/0000-0002-9731-1731; Yokobori, Shin-ichi/0000-0002-7356-3299; Yamagishi, Akihiko/0000-0001-5162-3927	Japan Society for the promotion of Science; Ministry of Education, Science, Sports, and Culture of Japan	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (B) from the Japan Society for the promotion of Science (to K. W.) and by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Takeo Suzuki and Tsutomu Suzuki).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; CANADAY J, 1980, NUCLEIC ACIDS RES, V8, P1445, DOI 10.1093/nar/8.7.1445; DUBIN DT, 1984, NUCLEIC ACIDS RES, V12, P4185, DOI 10.1093/nar/12.10.4185; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; HIRSH D, 1970, NATURE, V228, P57, DOI 10.1038/228057a0; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Lusic H, 2008, NUCLEIC ACIDS RES, V36, P6548, DOI 10.1093/nar/gkn703; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Nobles KN, 2002, NUCLEIC ACIDS RES, V30, P4751, DOI 10.1093/nar/gkf595; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009; Sasuga J, 1999, J MOL EVOL, V48, P692, DOI 10.1007/PL00006513; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Shimayama T, 1990, NUCL ACIDS S SERIES, V22, P73; SIBLER AP, 1985, NUCLEIC ACIDS RES, V13, P1341, DOI 10.1093/nar/13.4.1341; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Suzuki T, 2011, J BIOL CHEM, V286, P35494, DOI 10.1074/jbc.M111.279810; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P4291, DOI 10.1093/nar/27.21.4291; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; Tomita K, 2002, J MOL EVOL, V54, P486, DOI 10.1007/s00239-001-0039-4; Tomita Kozo, 1997, Nucleic Acids Symposium Series, V37, P197; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Watanabe K, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/623095; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	39	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7645	7652		10.1074/jbc.M112.439554	http://dx.doi.org/10.1074/jbc.M112.439554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362261	Green Published, hybrid			2022-12-25	WOS:000316455300021
J	Chellan, B; Koroleva, EP; Sontag, TJ; Tumanov, AV; Fu, YX; Getz, GS; Reardon, CA				Chellan, Bijoy; Koroleva, Ekaterina P.; Sontag, Timothy J.; Tumanov, Alexei V.; Fu, Yang-Xin; Getz, Godfrey S.; Reardon, Catherine A.			LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells	PLOS ONE			English	Article							LYMPHOTOXIN BETA-RECEPTOR; TRIGLYCERIDE LIPASE; LIVER; LIGHT; ACTIVATION; INTERLEUKIN-1; ALPHA; PATHOGENESIS; LYMPHOCYTES; METABOLISM	LIGHT/TNFSF14 is a costimulatory molecule expressed on activated T cells for activation and maintenance of T cell homeostasis. LIGHT over expressed in T cells also down regulates hepatic lipase levels in mice through lymphotoxin beta receptor (LT beta R) signaling. It is unclear whether LIGHT regulates hepatic lipase directly by interacting with LT beta R expressing cells in the liver or indirectly by activation of T cells, and whether Kupffer cells, a major cell populations in the liver that expresses the LT beta R, are required. Here we report that LIGHT expression via an adenoviral vector (Ad-LIGHT) is sufficient to down regulate hepatic lipase expression in mice. Depletion of Kupffer cells using clodronate liposomes had no effect on LIGHT-mediated down regulation of hepatic lipase. LIGHT-mediated regulation of hepatic lipase is also independent of LIGHT expression by T cells or activation of T cells. This is demonstrated by the decreased hepatic lipase expression in the liver of Ad-LIGHT infected recombination activating gene deficient mice that lack mature T cells and by the Ad-LIGHT infection of primary hepatocytes. Hepatic lipase expression was not responsive to LIGHT when mice lacking LT beta R globally or only on hepatocytes were infected with Ad-LIGHT. Therefore, our data argues that interaction of LIGHT with LT beta R on hepatocytes, but not Kupffer cells, is sufficient to down regulate hepatic lipase expression and that this effect can be independent of LIGHT's costimulatory function.	[Chellan, Bijoy; Sontag, Timothy J.; Fu, Yang-Xin; Getz, Godfrey S.; Reardon, Catherine A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Koroleva, Ekaterina P.; Tumanov, Alexei V.] Trudeau Inst Inc, Saranac Lake, NY USA	University of Chicago; Trudeau Institute	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yfu@uchicago.edu; reardon@uchicago.edu	Tumanov, Alexei/AAR-1607-2021	Tumanov, Alexei/0000-0001-6042-0152; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [HL85516, HL86675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086675, R01HL085516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health grants HL85516 and HL86675. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; Bertolino P, 1999, INT IMMUNOL, V11, P1225, DOI 10.1093/intimm/11.8.1225; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V85, P128; Brunzell JD, 2011, BIOCHIM BIOPHYS ACTA, P365, DOI [DOI 10.1016/J.BBALIP.2011.09.008), 10.1016/j.bbalip.2011.09.008]; Cartmell T, 1999, J NEUROSCI, V19, P1517; Cohen JI, 2011, J DIGEST DIS, V12, P3, DOI 10.1111/j.1751-2980.2010.00468.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dahl CP, 2008, EUR J HEART FAIL, V10, P352, DOI 10.1016/j.ejheart.2008.02.010; Feingold KR, 1999, ATHEROSCLEROSIS, V142, P379, DOI 10.1016/S0021-9150(98)00265-2; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gregory SH, 1998, J IMMUNOL, V160, P6056; Jansen Hans, 2004, Curr Atheroscler Rep, V6, P343, DOI 10.1007/s11883-004-0044-3; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; KAWAKAMI M, 1986, MICROBIOL IMMUNOL, V30, P849, DOI 10.1111/j.1348-0421.1986.tb03012.x; Lee CM, 2005, J GASTROEN HEPATOL, V20, P1762, DOI 10.1111/j.1440-1746.2005.04065.x; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Li W, 2003, IMMUNOLOGY, V109, P336, DOI 10.1046/j.1365-2567.2003.01658.x; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; MAGILAVY DB, 1993, BIOCHEM J, V292, P249, DOI 10.1042/bj2920249; MERAIHI Z, 1991, NUTRITION, V7, P93; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Otterdal K, 2008, AM J RESP CRIT CARE, V177, P202, DOI 10.1164/rccm.200703-506OC; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Perry BC, 2011, J INVEST SURG, V24, P178, DOI 10.3109/08941939.2011.568594; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Remouchamps C, 2011, CYTOKINE GROWTH F R, V22, P301, DOI 10.1016/j.cytogfr.2011.11.007; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Sacci John B Jr, 2002, Methods Mol Med, V72, P503, DOI 10.1385/1-59259-271-6:503; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Scholz H, 2005, CIRCULATION, V112, P2121, DOI 10.1161/CIRCULATIONAHA.105.544676; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Xu YH, 2007, IMMUNOL RES, V37, P17, DOI 10.1007/BF02686093; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54719	10.1371/journal.pone.0054719	http://dx.doi.org/10.1371/journal.pone.0054719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355893	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500116
J	Drell, T; Lillsaar, T; Tummeleht, L; Simm, J; Aaspollu, A; Vain, E; Saarma, I; Salumets, A; Donders, GGG; Metsis, M				Drell, Tiina; Lillsaar, Triin; Tummeleht, Lea; Simm, Jaak; Aaspollu, Anu; Vaein, Edda; Saarma, Ivo; Salumets, Andres; Donders, Gilbert G. G.; Metsis, Madis			Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BACTERIAL VAGINOSIS; MOLECULAR-IDENTIFICATION; VAGINITIS; FLORA; COMMUNITIES; CANDIDOSIS; TAXONOMY; HEALTH; FUNGI	The application of high-throughput sequencing methods has raised doubt in the concept of the uniform healthy vaginal microbiota consisting predominantly of lactobacilli by revealing the existence of more variable bacterial community composition. As this needs to be analyzed more extensively and there is little straightforward data regarding the vaginal mycobiome of asymptomatic women we aimed to define bacterial and fungal communities in vaginal samples from 494 asymptomatic, reproductive-age Estonian women. The composition of the vaginal microbiota was determined by amplifying bacterial 16S rRNA and fungal internal transcribed spacer-1 (ITS-1) regions and subsequently sequencing them using 454 Life Sciences pyrosequencing. We delineated five major bacterial community groups with distinctive diversity and species composition. Lactobacilli were among the most abundant bacteria in all groups, but also members of genus Gardnerella had high relative abundance in some of the groups. Microbial diversity increased with higher vaginal pH values, and was also higher when a malodorous discharge was present, indicating that some of the women who consider themselves healthy may potentially have asymptomatic bacterial vaginosis (BV). Our study is the first of its kind to analyze the mycobiome that colonizes the healthy vaginal environment using barcoded pyrosequencing technology. We observed 196 fungal operational taxonomic units (OTUs), including 16 OTUs of Candida spp., which is more diverse than previously recognized. However, assessing true fungal diversity was complicated because of the problems regarding the possible airborne contamination and bioinformatics used for identification of fungal taxons as significant proportion of fungal sequences were assigned to unspecified OTUs.	[Drell, Tiina; Lillsaar, Triin; Tummeleht, Lea; Simm, Jaak; Aaspollu, Anu; Metsis, Madis] Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia; [Drell, Tiina; Lillsaar, Triin; Salumets, Andres; Metsis, Madis] Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Vaein, Edda; Saarma, Ivo] Fertilitas Hosp, Haabneeme, Estonia; [Salumets, Andres] Univ Tartu, Dept Obstet & Gynaecol, EE-50090 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Biomed, EE-50090 Tartu, Estonia; [Donders, Gilbert G. G.] Reg Hosp H Hart, Dept Obstet & Gynecol, Tienen, Belgium; [Donders, Gilbert G. G.] Femicare Vzw, Clin Res Women, Tienen, Belgium	Tallinn University of Technology; University of Tartu; University of Tartu	Drell, T (corresponding author), Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia.	tiinadrell@gmail.com	Salumets, Andres/J-2278-2015; Metsis, Madis/F-7080-2016; Donders, Gilbert/AAA-9004-2021	Salumets, Andres/0000-0002-1251-8160; Metsis, Madis/0000-0003-1667-677X; Donders, Gilbert/0000-0001-9890-6254	BiotaP LCC Laboratories, Tallinn University of Technology PhD program; Estonian Ministry of Education and Research [SF0180044s09]; Enterprise Estonia [EU30200]; BiotaP LCC	BiotaP LCC Laboratories, Tallinn University of Technology PhD program; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia; BiotaP LCC	This research was funded by BiotaP LCC Laboratories, Tallinn University of Technology PhD program and Estonian Ministry of Education and Research (SF0180044s09) and Enterprise Estonia (EU30200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study received funding from a commercial source, BiotaP LCC. The company partly financed and provided sequencing service for the project as part of their workflow development for metagenomic sequencing service. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Foster JA, 2008, INTERDISCIP PERSPECT; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Haggerty CL, 2009, SEX TRANSM INFECT, V85, P242, DOI 10.1136/sti.2008.032821; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Jenkinson HF, 2002, POLYMICROBIAL DISEASES, P357; Kennedy Melissa A, 2010, Curr Infect Dis Rep, V12, P465, DOI 10.1007/s11908-010-0137-9; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mikamo H, 2000, J Infect Chemother, V6, P173, DOI 10.1007/s101560070018; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwebke Jane R., 2001, Curr Infect Dis Rep, V3, P152, DOI 10.1007/s11908-996-0040-6; Singh S, 2002, CLIN INFECT DIS, V35, P1066, DOI 10.1086/343826; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2000, CLIN INFECT DIS, V30, P652, DOI 10.1086/313746; SRINIVASAN S, 2008, INTERDISCIP PERSPECT; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Trama JP, 2005, MOL CELL PROBE, V19, P145, DOI 10.1016/j.mcp.2004.10.004; Us E, 2007, MYCOSES, V50, P13, DOI 10.1111/j.1439-0507.2006.01289.x; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	45	153	157	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54379	10.1371/journal.pone.0054379	http://dx.doi.org/10.1371/journal.pone.0054379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372716	gold, Green Submitted, Green Published			2022-12-25	WOS:000314021500066
J	Koiv, V; Andresen, L; Broberg, M; Frolova, J; Somervuo, P; Auvinen, P; Pirhonen, M; Tenson, T; Mae, A				Koiv, Viia; Andresen, Liis; Broberg, Martin; Frolova, Jekaterina; Somervuo, Panu; Auvinen, Petri; Pirhonen, Minna; Tenson, Tanel; Maee, Andres			Lack of RsmA-Mediated Control Results in Constant Hypervirulence, Cell Elongation, and Hyperflagellation in Pectobacterium wasabiae	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; ENTERICA SEROVAR TYPHIMURIUM; SWARMING MOTILITY; ESCHERICHIA-COLI; GENE-EXPRESSION; GLYCOGEN BIOSYNTHESIS; VIRULENCE FACTORS; INNATE IMMUNITY; SENSING SIGNAL; RNA REGULATOR	The posttranscriptional regulator RsmA controls the production of plant cell wall degrading enzymes (PCWDE) and cell motility in the Pectobacterium genus of plant pathogens. In this study the physiological role of gene regulation by RsmA is under investigation. Disruption of rsmA gene of the Pectobacterium wasabiae strain, SCC3193 resulted in 3-fold decrease in growth rate and increased virulence. The comparison of mRNA levels of the rsmA(-) mutant and wild-type using a genome-wide microarray showed, that genes responsible for successful infection, i.e. virulence factors, motility, butanediol fermentation, various secretion systems etc. were up-regulated in the rsmA(-) strain. The rsmA(-) strain exhibited a higher propensity to swarm and produce PCWDE compared to the wild-type strain. Virulence experiments in potato tubers demonstrated that in spite of its more efficient tissue maceration, the rsmA(-) strain's ability to survive within the host is reduced and the infection site is taken over by resident bacteria. Taken together, in the absence of RsmA, cells revert to a constitutively infective phenotype characterized by expression of virulence factors and swarming. We hypothesize that lack of control over these costly energetic processes results in decreased growth rate and fitness. In addition, our findings suggest a relationship between swarming and virulence in plant pathogens.	[Koiv, Viia; Andresen, Liis; Frolova, Jekaterina; Maee, Andres] Univ Tartu, Inst Mol & CellBiol, EE-50090 Tartu, Estonia; [Broberg, Martin] Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; [Somervuo, Panu; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, DNA Sequencing & GenomicsLab, Helsinki, Finland; [Pirhonen, Minna] Univ Helsinki, Dept AgriculturalSci, Helsinki, Finland; [Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu; University of Helsinki; University of Helsinki; University of Helsinki; University of Tartu	Koiv, V (corresponding author), Univ Tartu, Inst Mol & CellBiol, Ulikooli 18, EE-50090 Tartu, Estonia.	pontu55@hot.ee	Auvinen, Petri/AAP-8117-2021; Auvinen, Petri/D-5044-2009; Mäe, Andres/AAE-8876-2021; Andresen, Liis/AAB-2147-2021; Tenson, Tanel/I-6431-2015	Auvinen, Petri/0000-0002-3947-4778; Tenson, Tanel/0000-0002-0260-3601; Broberg, Martin/0000-0002-5419-9479; Pirhonen, Minna/0000-0001-5249-563X	Estonian Ministry of Education and Research [SF0180088s08, SF0180166s08]; EU through the European Regional Development Fund; EU through the Estonian Centre of Excellence in Genomics; EU through the Center of Excellence in Chemical Biology; Academy of Finland [213509, 129628, 136470, 120821, 128566]; University of Helsinki; Biocentrum Helsinki; Biocenter Finland; Finnish Doctoral Program in Plant Science	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); EU through the European Regional Development Fund; EU through the Estonian Centre of Excellence in Genomics; EU through the Center of Excellence in Chemical Biology; Academy of Finland(Academy of Finland); University of Helsinki; Biocentrum Helsinki; Biocenter Finland; Finnish Doctoral Program in Plant Science	This work was funded by grants SF0180088s08 and SF0180166s08 from the Estonian Ministry of Education and Research; by the EU through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology; by Academy of Finland grants (Center of Excellence program 2006-2011 grants 213509, 129628, and grants 136470, 120821 and 128566); by University of Helsinki; by Biocentrum Helsinki; by Biocenter Finland; by Finnish Doctoral Program in Plant Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Andresen L, 2010, MICROBIOL-SGM, V156, P1323, DOI 10.1099/mic.0.033936-0; Ang S, 2001, J BIOMED SCI, V8, P160, DOI 10.1159/000054028; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; CHATTERJEE A, 1995, APPL ENVIRON MICROB, V61, P1959, DOI 10.1128/AEM.61.5.1959-1967.1995; Chatterjee A, 2010, MOL PLANT MICROBE IN, V23, P1316, DOI 10.1094/MPMI-01-10-0017; Chen BG, 2007, J BACTERIOL, V189, P8750, DOI 10.1128/JB.01109-07; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cronan JEJ, 2006, ECOSAL PLUS, P206; Cui Y, 2008, J BACTERIOL, V190, P4610, DOI 10.1128/JB.01828-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Effantin G, 2011, MOL MICROBIOL, V82, P988, DOI 10.1111/j.1365-2958.2011.07881.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; GYGI D, 1995, MOL MICROBIOL, V17, P1167, DOI 10.1111/j.1365-2958.1995.mmi_17061167.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Hyytiainen H, 2001, MOL PLANT MICROBE IN, V14, P931, DOI 10.1094/MPMI.2001.14.8.931; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kania A, 2003, PLANT SOIL, V248, P117, DOI 10.1023/A:1022371115788; KARLSSON MB, 1991, MOL GEN GENET, V226, P353, DOI 10.1007/BF00260646; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Koiv V, 2001, MOL GENET GENOMICS, V265, P287, DOI 10.1007/s004380000413; Koiv V, 2010, MOL GENET GENOMICS, V283, P541, DOI 10.1007/s00438-010-0540-9; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Lindum PW, 1998, J BACTERIOL, V180, P6384; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Liu Y, 1999, J BACTERIOL, V181, P2411, DOI 10.1128/JB.181.8.2411-2421.1999; Liu Y, 1998, MOL MICROBIOL, V29, P219, DOI 10.1046/j.1365-2958.1998.00924.x; MacFaddin J.F., 1980, BIOCH TESTS IDENTIFI, V2nd; Marits R, 2002, MICROBIOL-SGM, V148, P835, DOI 10.1099/00221287-148-3-835; Marquez-Villavicencio MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022974; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Mukherjee A, 1996, MICROBIOL-SGM, V142, P427, DOI 10.1099/13500872-142-2-427; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nykyri J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003013; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; PIRHONEN M, 1988, MICROB PATHOGENESIS, V4, P359, DOI 10.1016/0882-4010(88)90063-0; Pollumaa L, 2012, SENSORS-BASEL, V12, P3327, DOI 10.3390/s120303327; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Sambrook J., 2001, MOL CLONING LAB MANU; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Urbany C, 2008, MOL PLANT MICROBE IN, V21, P547, DOI 10.1094/MPMI-21-5-0547; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; WEST M, 1977, J CLIN MICROBIOL, V6, P414	61	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54248	10.1371/journal.pone.0054248	http://dx.doi.org/10.1371/journal.pone.0054248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372695	gold, Green Published			2022-12-25	WOS:000314021500048
J	Li, YP; Fang, LQ; Gao, SQ; Wang, Z; Gao, HW; Liu, P; Wang, ZR; Li, YL; Zhu, XG; Li, XL; Xu, B; Li, YJ; Yang, H; de Vlas, SJ; Shi, TX; Cao, WC				Li, Ya-pin; Fang, Li-qun; Gao, Su-qing; Wang, Zhen; Gao, Hong-wei; Liu, Peng; Wang, Ze-rui; Li, Yan-li; Zhu, Xu-guang; Li, Xin-lou; Xu, Bo; Li, Yin-jun; Yang, Hong; de Vlas, Sake J.; Shi, Tao-xing; Cao, Wu-chun			Decision Support System for the Response to Infectious Disease Emergencies Based on WebGIS and Mobile Services in China	PLOS ONE			English	Article							HEALTH SURVEILLANCE; TECHNOLOGIES; INFORMATION; PHONES; TRENDS	Background: For years, emerging infectious diseases have appeared worldwide and threatened the health of people. The emergence and spread of an infectious-disease outbreak are usually unforeseen, and have the features of suddenness and uncertainty. Timely understanding of basic information in the field, and the collection and analysis of epidemiological information, is helpful in making rapid decisions and responding to an infectious-disease emergency. Therefore, it is necessary to have an unobstructed channel and convenient tool for the collection and analysis of epidemiologic information in the field. Methodology/Principal Findings: Baseline information for each county in mainland China was collected and a database was established by geo-coding information on a digital map of county boundaries throughout the country. Google Maps was used to display geographic information and to conduct calculations related to maps, and the 3G wireless network was used to transmit information collected in the field to the server. This study established a decision support system for the response to infectious-disease emergencies based on WebGIS and mobile services (DSSRIDE). The DSSRIDE provides functions including data collection, communication and analyses in real time, epidemiological detection, the provision of customized epidemiological questionnaires and guides for handling infectious disease emergencies, and the querying of professional knowledge in the field. These functions of the DSSRIDE could be helpful for epidemiological investigations in the field and the handling of infectious-disease emergencies. Conclusions/Significance: The DSSRIDE provides a geographic information platform based on the Google Maps application programming interface to display information of infectious disease emergencies, and transfers information between workers in the field and decision makers through wireless transmission based on personal computers, mobile phones and personal digital assistants. After a 2-year practice and application in infectious disease emergencies, the DSSRIDE is becoming a useful platform and is a useful tool for investigations in the field carried out by response sections and individuals. The system is suitable for use in developing countries and low-income districts.	[Li, Ya-pin; Fang, Li-qun; Gao, Hong-wei; Li, Yan-li; Li, Xin-lou; Li, Yin-jun; Yang, Hong; Shi, Tao-xing; Cao, Wu-chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Gao, Su-qing; Wang, Zhen; Liu, Peng; Wang, Ze-rui; Zhu, Xu-guang; Xu, Bo] PLA Univ Sci & Technol, Inst Command Automat, Nanjing, Jiangsu, Peoples R China; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr MC, Dept Publ Hlth, Rotterdam, Netherlands	Beijing Institute of Microbiology & Epidemiology; Army Engineering University of PLA; Erasmus University Rotterdam; Erasmus MC	Shi, TX (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	shitaoxing@sina.com; caowc@bmi.ac.cn	li, xinlou/ABF-8578-2021; Fang, Li-Qun/GWD-0296-2022; WANG, ZERUI/AAU-3671-2021	WANG, ZERUI/0000-0002-8219-1458; de Vlas, Sake J./0000-0002-1830-5668	Chinese National Science Fund for Distinguished Young Scholars [30725032]; Special Program for Prevention and Control of Infectious Diseases in China [2008ZX10004-012, 2009ZX10004-720]; Natural Science Foundation of China [30590374, 3097252 1]	Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Special Program for Prevention and Control of Infectious Diseases in China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Chinese National Science Fund for Distinguished Young Scholars (grant 30725032), the Special Program for Prevention and Control of Infectious Diseases in China (grants 2008ZX10004-012 and 2009ZX10004-720), and the Natural Science Foundation of China (grants 30590374and 3097252 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All China Data Center, 2010, CHIN DAT ONL; Blaya JA, 2010, HEALTH AFFAIR, V29, P244, DOI 10.1377/hlthaff.2009.0894; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Castillo-Salgado C, 2010, EPIDEMIOL REV, V32, P93, DOI 10.1093/epirev/mxq008; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005; Chanlekha H, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-1; Chib A, 2010, J COMPUT-MEDIAT COMM, V15, P500, DOI 10.1111/j.1083-6101.2010.01515.x; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; de Vlas SJ, 2009, TROP MED INT HEALTH, V14, P1, DOI 10.1111/j.1365-3156.2009.02349.x; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Foley DH, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-11; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Garcia-Perez J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-1; Gow GA, 2009, IEEE P, P366; Johnson LE, 2009, CLIN INFECT DIS, V48, P1585, DOI 10.1086/598974; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Li Ya-pin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1102; Lin YB, 2011, PREV VET MED, V98, P209, DOI 10.1016/j.prevetmed.2010.10.003; Liu DH, 2008, INT J MED INFORM, V77, P630, DOI 10.1016/j.ijmedinf.2007.10.011; Lopez J, 2009, EMERG INFECT DIS, V15, P1674, DOI 10.3201/eid1510.081596; Nelson R, 2008, LANCET INFECT DIS, V8, P596, DOI 10.1016/S1473-3099(08)70219-6; Robertson C, 2010, EMERG INFECT DIS, V16, P1524, DOI 10.3201/eid1610.100249; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; Yang CH, 2009, B WORLD HEALTH ORGAN, V87, P619, DOI 10.2471/BLT.08.060905; Yoo HS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-93; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	30	18	20	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54842	10.1371/journal.pone.0054842	http://dx.doi.org/10.1371/journal.pone.0054842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372780	gold, Green Published			2022-12-25	WOS:000314021500136
J	Nikaido, M; Law, EWP; Kelsh, RN				Nikaido, Masataka; Law, Edward W. P.; Kelsh, Robert N.			A Systematic Survey of Expression and Function of Zebrafish frizzled Genes	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; NEURAL CREST DEVELOPMENT; WNT SIGNALING PATHWAY; CELL-MIGRATION; GASTRULATION MOVEMENTS; WNT/BETA-CATENIN; BETA-CATENIN; EMBRYONIC-DEVELOPMENT; VENTRICULAR SEPTUM; SPEMANN ORGANIZER	Wnt signaling is crucial for the regulation of numerous processes in development. Consistent with this, the gene families for both the ligands (Wnts) and receptors (Frizzleds) are very large. Surprisingly, while we have a reasonable understanding of the Wnt ligands likely to mediate specific Wnt-dependent processes, the corresponding receptors usually remain to be elucidated. Taking advantage of the zebrafish model's excellent genomic and genetic properties, we undertook a comprehensive analysis of the expression patterns of frizzled (fzd) genes in zebrafish. To explore their functions, we focused on testing their requirement in several developmental events known to be regulated by Wnt signaling, convergent extension movements of gastrulation, neural crest induction, and melanocyte specification. We found fourteen distinct fzd genes in the zebrafish genome. Systematic analysis of their expression patterns between 1-somite and 30 hours post-fertilization revealed complex, dynamic and overlapping expression patterns. This analysis demonstrated that only fzd3a, fzd9b, and fzd10 are expressed in the dorsal neural tube at stages corresponding to the timing of melanocyte specification. Surprisingly, however, morpholino knockdown of these, alone or in combination, gave no indication of reduction of melanocytes, suggesting the important involvement of untested fzds or another type of Wnt receptor in this process. Likewise, we found only fzd7b and fzd10 expressed at the border of the neural plate at stages appropriate for neural crest induction. However, neural crest markers were not reduced by knockdown of these receptors. Instead, these morpholino knockdown studies showed that fzd7a and fzd7b work co-operatively to regulate convergent extension movement during gastrulation. Furthermore, we show that the two fzd7 genes function together with fzd10 to regulate epiboly movements and mesoderm differentiation.	[Nikaido, Masataka; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Claverton Down, England	University of Bath	Kelsh, RN (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, England.	bssrnk@bath.ac.uk	Kelsh, Robert/B-6445-2008	Kelsh, Robert/0000-0002-9381-0066; Law, Edward/0000-0001-5089-6341	Uehara Memorial Foundation; University of Bath	Uehara Memorial Foundation(Uehara Memorial Foundation); University of Bath	This work was supported by a Uehara Memorial Foundation research fellowship (MN) and the University of Bath. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd M, 2006, DEV BIOL, V298, P285, DOI 10.1016/j.ydbio.2006.06.037; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Conway SJ, 1997, DEVELOPMENT, V124, P505; Djiane A, 2000, DEVELOPMENT, V127, P3091; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; FoerstPotts L, 1997, DEV DYNAM, V209, P70, DOI 10.1002/(SICI)1097-0177(199705)209:1<70::AID-AJA7>3.0.CO;2-U; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Forrester WC, 2004, GENETICS, V168, P1951, DOI 10.1534/genetics.104.031781; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Granato M, 1996, DEVELOPMENT, V123, P399; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lamoreux ML., 2010, COLORS MICE MODEL GE; Le Douarin NM, 1999, NEURAL CREST, V2; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Lister JA, 1999, DEVELOPMENT, V126, P3757; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; PARR BA, 1993, DEVELOPMENT, V119, P247; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; Thisse B, 2004, ZFIN DIRECT DATA SUB; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533	92	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54833	10.1371/journal.pone.0054833	http://dx.doi.org/10.1371/journal.pone.0054833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349976	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100100
J	Ylosmaki, E; Lavilla-Alonso, S; Jaamaa, S; Vaha-Koskela, M; af Hallstrom, T; Hemminki, A; Arola, J; Makisalo, H; Saksela, K				Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Vaha-Koskela, Markus; af Hallstrom, Taija; Hemminki, Akseli; Arola, Johanna; Makisalo, Heikki; Saksela, Kalle			MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver	PLOS ONE			English	Article							GENE-TRANSFER; VIRUS-INFECTION; IN-VITRO; EXPRESSION; CANCER; ROLES; MOUSE; IDENTIFICATION; HEPATOCYTES; VIROTHERAPY	MicroRNAs (miRNAs) are important and ubiquitous regulators of gene expression that can suppress their target genes by translational inhibition as well as mRNA destruction. Cell type-specific miRNA expression patterns have been successfully exploited for targeting the expression of experimental and therapeutic gene constructs, for example to reduce pathogenic effects of cancer virotherapy in normal tissues. In order to avoid liver damage associated with systemic or intrahepatic delivery of oncolytic adenoviruses we have introduced the concept of suppressing adenovirus replication in hepatic cells by inserting target elements for the liver-specific miR122 into the viral genome. Here we show using ex vivo cultured tissue specimens that six perfectly complementary miR122 target sites in the 39 untranslated region of the viral E1A gene are sufficient in the absence of any other genetic modifications to prevent productive replication of serotype 5 adenovirus (Ad5) in normal human liver. This modification did not compromise the replicative capacity of the modified virus in cancer tissue derived from a colon carcinoma liver metastasis or its oncolytic potency in a human lung cancer xenograft mouse model. Unlike wild-type Ad5, the modified virus did not result in increased serum levels of liver enzymes in infected mice. These results provide a strong preclinical proof of concept for the use of miR122 target sites for reducing the risk of liver damage caused by oncolytic adenoviruses, and suggest that ectopic miR122 target elements should be considered as an additional safety measure included in any therapeutic virus or viral vector posing potential hazard to the liver.	[Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Saksela, Kalle] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Arola, Johanna; Saksela, Kalle] Helsinki Univ Cent Hosp, HUSLAB, Helsinki, Finland; [Jaamaa, Sari] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, Helsinki, Finland; [Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland; [Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Helsinki, Finland; [af Hallstrom, Taija] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Arola, Johanna] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Makisalo, Heikki] Helsinki Univ Cent Hosp, Dept Gastrointestinal Surg, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Saksela, K (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	kalle.saksela@helsinki.fi		Vaha-Koskela, Markus/0000-0001-7764-7820; Saksela, Kalle/0000-0003-0827-122X	Academy of Finland [127197]; Helsinki University Central Hospital Research Council [TYH2008307]; Sigrid Juselius Foundation; Jenny and Antti Wihuri Foundation; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Council; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jenny and Antti Wihuri Foundation; Helsinki Biomedical Graduate School	This study was supported by grants from the Academy of Finland (127197), Helsinki University Central Hospital Research Council (TYH2008307), and the Sigrid Juselius Foundation to KS, and from Jenny and Antti Wihuri Foundation to EY. SLA and EY were supported in part by Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Cawood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016152; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cody JJ, 2009, CANCER GENE THER, V16, P473, DOI 10.1038/cgt.2009.3; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; de Kanter R, 1999, TOXICOL IN VITRO, V13, P737, DOI 10.1016/S0887-2333(99)00047-8; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Habib NA, 2001, HUM GENE THER, V12, P219, DOI 10.1089/10430340150218369; Hamid O, 2003, J CLIN ONCOL, V21, P1498, DOI 10.1200/JCO.2003.09.114; Hamilton MA, 1977, ENV SCI TECHNOL, V11; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heise C, 2000, J CLIN INVEST, V105, P847, DOI 10.1172/JCI9762; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; IKEDA T, 1989, EXP CELL RES, V185, P292, DOI 10.1016/0014-4827(89)90058-X; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jogler C, 2006, J VIROL, V80, P3549, DOI 10.1128/JVI.80.7.3549-3558.2006; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Olinga P, 1997, J PHARMACOL TOXICOL, V38, P59, DOI 10.1016/S1056-8719(97)00060-9; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sullivan DE, 1997, HUM GENE THER, V8, P1195, DOI 10.1089/hum.1997.8.10-1195; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Yu SL, 2007, DNA CELL BIOL, V26, P283, DOI 10.1089/dna.2006.0555	54	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54506	10.1371/journal.pone.0054506	http://dx.doi.org/10.1371/journal.pone.0054506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349911	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100076
J	Munoz, A; Harries, E; Contreras-Valenzuela, A; Carmona, L; Read, ND; Marcos, JF				Munoz, Alberto; Harries, Eleonora; Contreras-Valenzuela, Adriana; Carmona, Lourdes; Read, Nick D.; Marcos, Jose F.			Two Functional Motifs Define the Interaction, Internalization and Toxicity of the Cell-Penetrating Antifungal Peptide PAF26 on Fungal Cells	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; HEXAPEPTIDE PAF26; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ANTIBACTERIAL ACTIVITY; PHYTOPATHOGENIC FUNGI; NEUROSPORA-CRASSA	The synthetic, cell penetrating hexapeptide PAF26 (RKKWFW) is antifungal at low micromolar concentrations and has been proposed as a model for cationic, cell-penetrating antifungal peptides. Its short amino acid sequence facilitates the analysis of its structure-activity relationships using the fungal models Neurospora crassa and Saccharomyces cerevisiae, and human and plant pathogens Aspergillus fumigatus and Penicillium digitatum, respectively. Previously, PAF26 at low fungicidal concentrations was shown to be endocytically internalized, accumulated in vacuoles and then actively transported into the cytoplasm where it exerts its antifungal activity. In the present study, two PAF26 derivatives, PAF95 (AAAWFW) and PAF96 (RKKAAA), were designed to characterize the roles of the N-terminal cationic and the C-terminal hydrophobic motifs in PAF26's mode-of-action. PAF95 and PAF96 exhibited substantially reduced antifungal activity against all the fungi analyzed. PAF96 localized to fungal cell envelopes and was not internalized by the fungi. In contrast, PAF95 was taken up into vacuoles of N. crassa, wherein it accumulated and was trapped without toxic effects. Also, the PAF26 resistant Delta arg1 strain of S. cerevisiae exhibited increased PAF26 accumulation in vacuoles. Live-cell imaging of GFP-labelled nuclei in A. fumigatus showed that transport of PAF26 from the vacuole to the cytoplasm was followed by nuclear breakdown and dissolution. This work demonstrates that the amphipathic PAF26 possesses two distinct motifs that allow three stages in its antifungal action to be defined: (i) its interaction with the cell envelope; (ii) its internalization and transport to vacuoles mediated by the aromatic hydrophobic domain; and (iii) its transport from vacuoles to the cytoplasm. Significantly, cationic residues in PAF26 are important not only for the electrostatic attraction and interaction with the fungal cell but also for transport from the vacuole to the cytoplasm, which coincides with cell death. Peptide containment within vacuoles preserves fungal cells from peptide toxicity.	[Munoz, Alberto; Harries, Eleonora; Contreras-Valenzuela, Adriana; Read, Nick D.] Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Harries, Eleonora; Carmona, Lourdes; Marcos, Jose F.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Food Sci, E-46010 Valencia, Spain	University of Edinburgh; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Read, ND (corresponding author), Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	Nick.Read@ed.ac.uk; jmarcos@iata.csic.es	Carmona López, Lourdes/M-8661-2014; Marcos, Jose F./A-7121-2011	Marcos, Jose F./0000-0003-3339-2584; Munoz, Alberto/0000-0002-1622-5074; Read, Nick/0000-0002-2286-2862	Ministerio de Ciencia e Innovacion (MICINN, Spain); Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico); Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) [BB/E010741/1]; Wellcome Trust [093596/B/10Z]; MICINN (Spain) [BIO2009-12919]; Generalitat Valenciana, Valencia, Spain [ACOMP2012-018]; Biotechnology and Biological Sciences Research Council [BB/E010741/1] Funding Source: researchfish; BBSRC [BB/E010741/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council (BBSRC, U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana, Valencia, Spain(Center for Forestry Research & Experimentation (CIEF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AM was funded by the Postdoctoral Mobility Program of Ministerio de Ciencia e Innovacion (MICINN, Spain). EH fellowship and short stay at the University of Edinburgh were funded by the JAE-PREDOC Program of Consejo Superior de Investigaciones Cientificas (CSIC, Spain). ACV was funded by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico). The work was supported by research grants BB/E010741/1 from Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) and grant #093596/B/10Z from the Wellcome Trust to NDR, and BIO2009-12919 from MICINN (Spain) and ACOMP2012-018 (Generalitat Valenciana, Valencia, Spain) to JFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2010, EXPERT REV ANTI-INFE, V8, P359, DOI [10.1586/eri.10.13, 10.1586/ERI.10.13]; Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Carmona L, 2012, BIOCHEM BIOPH RES CO, V417, P56, DOI 10.1016/j.bbrc.2011.11.050; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Gupte M, 2002, APPL MICROBIOL BIOT, V58, P46, DOI 10.1007/s002530100822; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V345, P222, DOI 10.1016/j.bbrc.2006.04.059; Kragol G, 2002, EUR J BIOCHEM, V269, P4226, DOI 10.1046/j.1432-1033.2002.03119.x; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Lopez-Garcia B, 2000, MOL PLANT MICROBE IN, V13, P837, DOI 10.1094/MPMI.2000.13.8.837; Lopez-Garcia B, 2007, BIOCHEM BIOPH RES CO, V356, P107, DOI 10.1016/j.bbrc.2007.02.093; Lopez-Garcia B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-289; Lupetti A, 2008, EUR J CLIN MICROBIOL, V27, P1125, DOI 10.1007/s10096-008-0553-z; Mania D, 2010, APPL ENVIRON MICROB, V76, P7102, DOI 10.1128/AEM.01560-10; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Marcos JF, 2009, EXPERT OPIN DRUG DIS, V4, P659, DOI 10.1517/17460440902992888; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Munoz A, 2007, BIOCHEM BIOPH RES CO, V354, P172, DOI 10.1016/j.bbrc.2006.12.173; Munoz A, 2006, ANTIMICROB AGENTS CH, V50, P3847, DOI 10.1128/AAC.00650-06; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; Narasimhan ML, 2003, PLANT J, V36, P390, DOI 10.1046/j.1365-313X.2003.01886.x; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Powers JPS, 2006, ANTIMICROB AGENTS CH, V50, P1522, DOI 10.1128/AAC.50.4.1522-1524.2006; Roilides E, 1999, INFECT IMMUN, V67, P3047, DOI 10.1128/IAI.67.6.3047-3050.1999; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; Sun JNN, 2008, MOL MICROBIOL, V70, P1246, DOI 10.1111/j.1365-2958.2008.06480.x; Vallon-Eberhard A, 2008, ANTIMICROB AGENTS CH, V52, P3118, DOI 10.1128/AAC.00526-08; van der Kraan MIA, 2005, PEPTIDES, V26, P1537, DOI 10.1016/j.peptides.2005.02.011; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Yun DJ, 1997, P NATL ACAD SCI USA, V94, P7082, DOI 10.1073/pnas.94.13.7082; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	54	30	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54813	10.1371/journal.pone.0054813	http://dx.doi.org/10.1371/journal.pone.0054813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349973	Green Submitted, Green Published, gold			2022-12-25	WOS:000313943000051
J	McLaughlin, MF; Woodward, J; Boll, RA; Wall, JS; Rondinone, AJ; Kennel, SJ; Mirzadeh, S; Robertson, JD				McLaughlin, Mark F.; Woodward, Jonathan; Boll, Rose A.; Wall, Jonathan S.; Rondinone, Adam J.; Kennel, Stephen J.; Mirzadeh, Saed; Robertson, J. David			Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy	PLOS ONE			English	Article							RADIOIMMUNOTHERAPY; THERAPY; FATE	Targeted radiotherapies maximize cytotoxicty to cancer cells. In vivo a-generator targeted radiotherapies can deliver multiple alpha particles to a receptor site dramatically amplifying the radiation dose delivered to the target. The major challenge with alpha-generator radiotherapies is that traditional chelating moieties are unable to sequester the radioactive daughters in the bioconjugate which is critical to minimize toxicity to healthy, non-target tissue. The recoil energy of the Ac-225 daughters following alpha decay will sever any metal-ligand bond used to form the bioconjugate. This work demonstrates that an engineered multilayered nanoparticle-antibody conjugate can deliver multiple alpha radiations and contain the decay daughters of Ac-225 while targeting biologically relevant receptors in a female BALB/c mouse model. These multi-shell nanoparticles combine the radiation resistance of lanthanide phosphate to contain Ac-225 and its radioactive decay daughters, the magnetic properties of gadolinium phosphate for easy separation, and established gold chemistry for attachment of targeting moieties.	[McLaughlin, Mark F.; Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [McLaughlin, Mark F.; Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [McLaughlin, Mark F.; Woodward, Jonathan; Boll, Rose A.; Rondinone, Adam J.; Mirzadeh, Saed] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Wall, Jonathan S.; Kennel, Stephen J.] Univ Tennessee, Grad Sch Med, Knoxville, TN USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Robertson, JD (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	robertsonjo@missouri.edu	Rondinone, Adam J/F-6489-2013; Boll, Rose/C-4138-2016	Rondinone, Adam J/0000-0003-0020-4612; Boll, Rose/0000-0003-2507-4834; Robertson, John/0000-0002-6675-8469; Wall, Jonathan/0000-0002-5516-8578	Isotope Production/Distribution Program; Office of Nuclear Physics of the U. S. Department of Energy (DOE); DOE Nuclear Energy University Program Graduate Fellowship; University of Tennessee; Graduate School of Medicine; Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy; ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy [DE-AC05-00OR22725]	Isotope Production/Distribution Program; Office of Nuclear Physics of the U. S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE Nuclear Energy University Program Graduate Fellowship; University of Tennessee; Graduate School of Medicine; Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy; ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy(United States Department of Energy (DOE))	Research supported in part by the Isotope Production/Distribution Program, Office of Nuclear Physics of the U. S. Department of Energy (DOE), and under a DOE Nuclear Energy University Program Graduate Fellowship. The work was also supported by the University of Tennessee, Graduate School of Medicine through funding of the cancer imaging and tracer development program. A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FDA GRANTS FAST TRAC; Bruland OS, 2006, CLIN CANCER RES, V12, p6250S, DOI 10.1158/1078-0432.CCR-06-0841; Buissette V, 2006, J MATER CHEM, V16, P529, DOI 10.1039/b508656f; Burdick M.J., 2010, DRUG DISC TODAY THER, V7, P23; Essler M, 2012, EUR J NUCL MED MOL I, V39, P602, DOI 10.1007/s00259-011-2023-6; EWING RC, 1975, AM MINERAL, V60, P728; Gadbois DM, 1996, RADIAT RES, V146, P414, DOI 10.2307/3579303; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hifumi H, 2009, J MATER CHEM, V19, P6393, DOI 10.1039/b902134e; HUMM JL, 1986, J NUCL MED, V27, P1490; Jacene HA, 2007, J NUCL MED, V48, P1767, DOI 10.2967/jnumed.107.043489; Jaggi JS, 2005, CANCER RES, V65, P4888; KAMPF G, 1988, Radiobiologia Radiotherapia, V29, P631; KARIORIS FG, 1981, RADIAT EFF LETT, V58, P1, DOI 10.1080/01422448108226520; Kennel SJ, 2008, NUCL MED BIOL, V35, P501, DOI 10.1016/j.nucmedbio.2008.02.001; Kennel Stephen J., 2010, Current Drug Delivery, V7, P428; Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y; KOLSKY KL, 1993, APPL RADIAT ISOTOPES, V44, P553, DOI 10.1016/0969-8043(93)90169-B; Lasbury ME, 2006, J IMMUNOL, V176, P6443, DOI 10.4049/jimmunol.176.11.6443; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; Meiser F, 2004, ANGEW CHEM INT EDIT, V43, P5954, DOI 10.1002/anie.200460856; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; MIRZADEH S, 1993, RADIOCHIM ACTA, V60, P1; Mulford DA, 2005, J NUCL MED, V46, p199S; Schwartz J, 2011, PHYS MED BIOL, V56, P721, DOI 10.1088/0031-9155/56/3/012; Sofou S, 2004, J NUCL MED, V45, P253; Song H, 2009, CANCER RES, V69, P8941, DOI 10.1158/0008-5472.CAN-09-1828; TABUTEAU A, 1988, J MATER SCI LETT, V7, P1315, DOI 10.1007/BF00719969; van Vlerken LE, 2007, PHARM RES-DORDR, V24, P1405, DOI 10.1007/s11095-007-9284-6; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Woodward J, 2011, BIOCONJUGATE CHEM, V22, P766, DOI 10.1021/bc100574f; Woodward JD, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/17/175103; Zalutsky MR, 2004, Q J NUCL MED MOL IM, V48, P289	34	94	97	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54531	10.1371/journal.pone.0054531	http://dx.doi.org/10.1371/journal.pone.0054531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349921	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800061
J	Hendricks, GL; Weirich, KL; Viswanathan, K; Li, J; Shriver, ZH; Ashour, J; Ploegh, HL; Kurt-Jones, EA; Fygenson, DK; Finberg, RW; Comolli, JC; Wang, JP				Hendricks, Gabriel L.; Weirich, Kim L.; Viswanathan, Karthik; Li, Jing; Shriver, Zachary H.; Ashour, Joseph; Ploegh, Hidde L.; Kurt-Jones, Evelyn A.; Fygenson, Deborah K.; Finberg, Robert W.; Comolli, James C.; Wang, Jennifer P.			Sialylneolacto-N-tetraose c (LSTc)-bearing Liposomal Decoys Capture Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRONGLY INHIBIT AGGLUTINATION; SIALIC-ACID; RECEPTOR-BINDING; GLYCAN TOPOLOGY; HEMAGGLUTININS; ERYTHROCYTES; SPECIFICITY; FUSION; RECOGNITION; ATTACHMENT	Influenza is a severe disease in humans and animals with few effective therapies available. All strains of influenza virus are prone to developing drug resistance due to the high mutation rate in the viral genome. A therapeutic agent that targets a highly conserved region of the virus could bypass resistance and also be effective against multiple strains of influenza. Influenza uses many individually weak ligand binding interactions for a high avidity multivalent attachment to sialic acid-bearing cells. Polymerized sialic acid analogs can form multivalent interactions with influenza but are not ideal therapeutics due to solubility and toxicity issues. We used liposomes as a novel means for delivery of the glycan sialylneolacto-N-tetraose c (LSTc). LSTc-bearing decoy liposomes form multivalent, polymer-like interactions with influenza virus. Decoy liposomes competitively bind influenza virus in hemagglutination inhibition assays and inhibit infection of target cells in a dose-dependent manner. Inhibition is specific for influenza virus, as inhibition of Sendai virus and respiratory syncytial virus is not observed. In contrast, monovalent LSTc does not bind influenza virus or inhibit infectivity. LSTc decoy liposomes prevent the spread of influenza virus during multiple rounds of replication in vitro and extend survival of mice challenged with a lethal dose of virus. LSTc decoy liposomes co-localize with fluorescently tagged influenza virus, whereas control liposomes do not. Considering the conservation of the hemagglutinin binding pocket and the ability of decoy liposomes to form high avidity interactions with influenza hemagglutinin, our decoy liposomes have potential as a new therapeutic agent against emerging influenza strains.	[Hendricks, Gabriel L.; Kurt-Jones, Evelyn A.; Finberg, Robert W.; Wang, Jennifer P.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Weirich, Kim L.; Fygenson, Deborah K.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Fygenson, Deborah K.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Viswanathan, Karthik; Li, Jing; Shriver, Zachary H.] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ashour, Joseph; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Comolli, James C.] Charles Stark Draper Lab, Dept Bioengn, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; The Charles Stark Draper Laboratory, Inc.	Wang, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, 364 Plantation St, Worcester, MA 01605 USA.	Jennifer.Wang@umassmed.edu	Fygenson, Deborah K/U-3105-2017	Fygenson, Deborah K/0000-0002-5681-3938; Li, Jing/0000-0002-2414-8523; Weirich, Kimberly/0000-0003-0440-8612; wang, jennifer/0000-0002-2556-9100; Hendricks, Gabriel/0000-0003-4419-1235; Ashour, Joseph/0000-0003-3809-2783	Defense Advanced Research Projects Agency, Defense Sciences Office [W911NF-10-1-0268]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092105] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency, Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Defense Advanced Research Projects Agency, Defense Sciences Office W911NF-10-1-0268.	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Choi SK, 1996, CHEM BIOL, V3, P97, DOI 10.1016/S1074-5521(96)90285-9; Deol P, 1997, BBA-GEN SUBJECTS, V1334, P161, DOI 10.1016/S0304-4165(96)00088-8; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gambaryan AS, 2002, ANTIVIR RES, V55, P201, DOI 10.1016/S0166-3542(02)00020-7; GAMIAN A, 1991, CAN J MICROBIOL, V37, P233, DOI 10.1139/m91-035; GLICK GD, 1991, J BIOL CHEM, V266, P23660; Guo CT, 2002, GLYCOBIOLOGY, V12, P183, DOI 10.1093/glycob/12.3.183; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; ITOH M, 1995, VIROLOGY, V212, P340, DOI 10.1006/viro.1995.1491; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; KINGERYWOOD JE, 1992, J AM CHEM SOC, V114, P7303, DOI 10.1021/ja00044a057; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11; LEES WJ, 1994, J MED CHEM, V37, P3419, DOI 10.1021/jm00046a027; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; MARKWELL MAK, 1980, P NATL ACAD SCI-BIOL, V77, P5693, DOI 10.1073/pnas.77.10.5693; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MOCHALOVA LV, 1994, ANTIVIR RES, V23, P179, DOI 10.1016/0166-3542(94)90016-7; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Popp MWL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002604; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; PRITCHETT TJ, 1987, VIROLOGY, V160, P502, DOI 10.1016/0042-6822(87)90026-2; Reuter JD, 1999, BIOCONJUGATE CHEM, V10, P271, DOI 10.1021/bc980099n; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053; SPARKS MA, 1993, TETRAHEDRON, V49, P1, DOI 10.1016/S0040-4020(01)80502-0; SPEVAK W, 1993, J AM CHEM SOC, V115, P1146, DOI 10.1021/ja00056a047; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Sullivan KM, 1996, PHARMACOECONOMICS, V9, P26, DOI 10.2165/00019053-199600093-00008; TOOGOOD PL, 1991, J MED CHEM, V34, P3138, DOI 10.1021/jm00114a025; Tuzikov AB, 2000, J CARBOHYD CHEM, V19, P1191, DOI 10.1080/07328300008544143; VAN MEER G, 1985, BIOCHEMISTRY-US, V24, P3593, DOI 10.1021/bi00335a030; vanSteensel B, 1996, J CELL SCI, V109, P787; WEINHOLD EG, 1992, J AM CHEM SOC, V114, P9270, DOI 10.1021/ja00050a004; Weirich KL, 2010, BIOPHYS J, V98, P85, DOI 10.1016/j.bpj.2009.09.050; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040	47	50	52	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8061	8073		10.1074/jbc.M112.437202	http://dx.doi.org/10.1074/jbc.M112.437202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362274	Green Published, hybrid			2022-12-25	WOS:000316564500007
J	Zhu, L; Wasey, A; White, SH; Dalbey, RE				Zhu, Lu; Wasey, Abdul; White, Stephen H.; Dalbey, Ross E.			Charge Composition Features of Model Single-span Membrane Proteins That Determine Selection of YidC and SecYEG Translocase Pathways in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1F0 ATP SYNTHASE; PROTON MOTIVE FORCE; INNER MEMBRANE; SUBUNIT-C; TRANSMEMBRANE HELICES; LEADER PEPTIDASE; TERMINAL DOMAINS; PROCOAT PROTEIN; PLASMA-MEMBRANE; INSERTION	We have investigated the features of single-span model membrane proteins based upon leader peptidase that determines whether the proteins insert by a YidC/Sec-independent, YidC-only, or YidC/Sec mechanism. We find that a protein with a highly hydrophobic transmembrane segment that inserts into the membrane by a YidC/Sec-independent mechanism becomes YidC-dependent if negatively charged residues are inserted into the translocated periplasmic domain or if the hydrophobicity of the transmembrane segment is reduced by substituting polar residues for nonpolar ones. This suggests that charged residues in the translocated domain and the hydrophobicity within the transmembrane segment are important determinants of the insertion pathway. Strikingly, the addition of a positively charged residue to either the translocated region or the transmembrane region can switch the insertion requirements such that insertion requires both YidC and SecYEG. To test conclusions from the model protein studies, we confirmed that a positively charged residue is a SecYEG determinant for the endogenous proteins ATP synthase subunits a and b and the TatC subunit of the Tat translocase. These findings provide deeper insights into how pathways are selected for the insertion of proteins into the Escherichia coli inner membrane.	[Zhu, Lu; Wasey, Abdul; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University System of Ohio; Ohio State University; University of California System; University of California Irvine	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu	White, Stephen/N-1507-2019; White, Stephen H/B-1053-2009	White, Stephen H/0000-0001-8540-7907	National Institutes of Health [GM074637]; National Science Foundation [MCB-1052033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074637 (to S. H. W.). This work was also supported by National Science Foundation Grant MCB-1052033 (to R. E. D.).	Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; BOYD D, 1989, P NATL ACAD SCI USA, V86, P9446, DOI 10.1073/pnas.86.23.9446; CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Ernst S, 2011, J MOL BIOL, V412, P165, DOI 10.1016/j.jmb.2011.07.023; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2003, EUR J BIOCHEM, V270, P1724, DOI 10.1046/j.1432-1033.2003.03531.x; Fillingame RH, 2000, J EXP BIOL, V203, P9; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x; Gray AN, 2011, MBIO, V2, DOI 10.1128/mBio.00238-11; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAWS JK, 1989, EMBO J, V8, P2095, DOI 10.1002/j.1460-2075.1989.tb03618.x; LEE JI, 1992, J BIOL CHEM, V267, P938; Maniatis T., 1982, MOL CLONING LAB MANU; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	55	26	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7704	7716		10.1074/jbc.M112.429431	http://dx.doi.org/10.1074/jbc.M112.429431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355473	hybrid, Green Published			2022-12-25	WOS:000316455300027
J	Hayata, K; Iwahashi, M; Ojima, T; Katsuda, M; Iida, T; Nakamori, M; Ueda, K; Nakamura, M; Miyazawa, M; Tsuji, T; Yamaue, H				Hayata, Keiji; Iwahashi, Makoto; Ojima, Toshiyasu; Katsuda, Masahiro; Iida, Takeshi; Nakamori, Mikihito; Ueda, Kentaro; Nakamura, Masaki; Miyazawa, Motoki; Tsuji, Toshiaki; Yamaue, Hiroki			Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice	PLOS ONE			English	Article							SUPPRESSOR-CELLS; T-CELLS; INTESTINAL INFLAMMATION; HUMAN INTERLEUKIN-17; ENDOGENOUS IL-17; LUNG-CANCER; TH17 CELLS; GROWTH; ANGIOGENESIS; INDUCTION	It remains controversial whether IL-17A promotes or inhibits cancer progression. We hypothesized that IL-17A that is locally produced in the tumor microenvironment has an important role in angiogenesis and tumor immunity. We investigated the effect of inhibiting IL-17A at tumor sites on tumor growth and on local and systemic anti-tumor immunity. MC38 or B16 cells were inoculated subcutaneously into mice, and intratumoral injection of an adenovirus vector expressing siRNA against the mouse IL-17A gene (Ad-si-IL-17) significantly inhibited tumor growth in both tumor models compared with control mice. Inhibition of IL-17A at tumor sites significantly suppressed CD31, MMP9, and VEGF expression in tumor tissue. The cytotoxic activity of CD8(+) T cells from tumor-infiltrating lymphocytes in mice treated with Ad-si-IL-17 was significantly higher than in control mice; however, CD8(+) T cells from splenocytes had similar activity levels. Suppression of IL-17A at tumor sites led to a Th1-dominant environment, and moreover, eliminated myeloid-derived suppressor cells and regulatory T cells at tumor sites but not in splenocytes. In conclusion, blockade of IL-17A at tumor sites helped suppress tumor growth by inhibiting angiogenesis as well as cytotoxic T lymphocytes activation at tumor sites.	[Hayata, Keiji; Iwahashi, Makoto; Ojima, Toshiyasu; Katsuda, Masahiro; Iida, Takeshi; Nakamori, Mikihito; Ueda, Kentaro; Nakamura, Masaki; Miyazawa, Motoki; Tsuji, Toshiaki; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan	Wakayama Medical University	Iwahashi, M (corresponding author), Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan.	makoto@wakayama-med.ac.jp			Japan Society for the Promotion of Science [22591415]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22791296]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science grants 22591415 and Ministry of Education, Culture, Sports, Science and Technology, Japan grants 22791296. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ojima T, 2007, INT J CANCER, V120, P585, DOI 10.1002/ijc.22298; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Reppert S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1609; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Tartour E, 1999, CANCER RES, V59, P3698; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhao QY, 2011, EUR J IMMUNOL, V41, P2314, DOI 10.1002/eji.201041282; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	49	42	42	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53131	10.1371/journal.pone.0053131	http://dx.doi.org/10.1371/journal.pone.0053131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372655	Green Submitted, gold, Green Published			2022-12-25	WOS:000315210400005
J	Cheng, L; Jin, XK; Li, WW; Li, S; Guo, XN; Wang, J; Gong, YN; He, L; Wang, Q				Cheng, Lin; Jin, Xing-Kun; Li, Wei-Wei; Li, Shuang; Guo, Xiao-Nv; Wang, Juan; Gong, Ya-Nan; He, Lin; Wang, Qun			Fatty Acid Binding Proteins FABP9 and FABP10 Participate in Antibacterial Responses in Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							C-TYPE LECTIN; DIFFERENTIALLY EXPRESSED GENES; SPOT SYNDROME VIRUS; INNATE IMMUNITY; SHRIMP; INVERTEBRATES; RECOGNITION; CELLS; LIVER; HEPATOPANCREAS	Invertebrates rely solely on the innate immune system for defense against pathogens and other stimuli. Fatty acid binding proteins (FABP), members of the lipid binding proteins superfamily, play a crucial role in fatty acid transport and lipid metabolism and are also involved in gene expression induced by fatty acids. In the vertebrate immune system, FABP is involved in inflammation regulated by fatty acids through its interaction with peroxidase proliferator activate receptors (PPARs). However, the immune functions of FABP in invertebrates are not well characterized. For this reason, we investigated the immune functionality of two fatty acid binding proteins, Es-FABP9 and Es-FABP10, following lipopolysaccharide (LPS) challenge in the Chinese mitten crab (Eriocheir sinensis). An obvious variation in the expression of Es-FABP9 and Es-FABP10 mRNA in E. sinensis was observed in hepatopancreas, gills, and hemocytes post-LPS challenge. Recombinant proteins rEs-FABP9 and rEs-FABP10 exhibited distinct bacterial binding activity and bacterial agglutination activity against Escherichia coli and Staphylococcus aureus. Furthermore, bacterial growth inhibition assays demonstrated that rEs-FABP9 responds positively to the growth inhibition of Vibrio parahaemolyticuss and S. aureus, while rEs-FABP10 responds positively to the growth inhibition of Aeromonas hydrophila and Bacillus subtilis. Coating of agarose beads with recombinant rEs-FABP9 and rEs-FABP10 dramatically enhanced encapsulation of the beads by crab hemocytes in vitro. In conclusion, the data presented here demonstrate the participation of these two lipid metabolism-related proteins in the innate immune system of E. sinensis.	[Li, Shuang; Guo, Xiao-Nv; Wang, Juan; Gong, Ya-Nan; He, Lin; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Jin, Xingkun/H-4366-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; 	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Espino AM, 2001, J PARASITOL, V87, P426, DOI 10.1645/0022-3395(2001)087[0426:IOFAMI]2.0.CO;2; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Fonseca CT, 2006, MICROBES INFECT, V8, P2509, DOI 10.1016/j.micinf.2006.06.008; Gerstner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015890; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gong YN, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-71; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021; Jin XK, 2012, FISH SHELLFISH IMMUN, V33, P1149, DOI 10.1016/j.fsi.2012.08.027; Jin XK, 2011, FISH SHELLFISH IMMUN, V30, P263, DOI 10.1016/j.fsi.2010.10.016; Karanth S, 2008, FEBS J, V275, P3031, DOI 10.1111/j.1742-4658.2008.06455.x; Kitanaka N, 2003, HISTOCHEM CELL BIOL, V120, P465, DOI 10.1007/s00418-003-0590-8; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li WW, 2011, MOL BIOL REP, V38, P5169, DOI 10.1007/s11033-010-0666-1; Lin XH, 2011, BLOOD, V117, P6417, DOI 10.1182/blood-2010-11-320614; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Owada Y, 2001, HISTOCHEM J, V33, P453, DOI 10.1023/A:1014420330284; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Smith Valerie J., 1991, Comparative Haematology International, V1, P61, DOI 10.1007/BF00422876; Snedecor G., 1971, STAT METHODS; Soderhall I, 2006, FEBS J, V273, P2902, DOI 10.1111/j.1742-4658.2006.05303.x; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang B, 2008, MAR BIOTECHNOL, V10, P664, DOI 10.1007/s10126-008-9105-x; Wang N, 2008, DEV COMP IMMUNOL, V32, P1034, DOI 10.1016/j.dci.2008.02.001; Wood LG, 2009, PROG LIPID RES, V48, P27, DOI 10.1016/j.plipres.2008.10.001; Yamamoto N, 2008, PROSTAG LEUKOTR ESS, V79, P21, DOI 10.1016/j.plefa.2008.06.003; Yang HJ, 2007, FISH SHELLFISH IMMUN, V22, P88, DOI 10.1016/j.fsi.2006.03.015; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	59	20	20	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54053	10.1371/journal.pone.0054053	http://dx.doi.org/10.1371/journal.pone.0054053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365646	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600027
J	Hao, K; Qi, Q; Hao, HP; Wang, GJ; Chen, YC; Liang, Y; Xie, L				Hao, Kun; Qi, Qu; Hao, Haiping; Wang, Guangji; Chen, Yuancheng; Liang, Yan; Xie, Lin			The Pharmacokinetic-Pharmacodynamic Model of Azithromycin for Lipopolysaccharide-Induced Depressive-Like Behavior in Mice	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-ALPHA; QUINOLINIC ACID; CANCER-PATIENTS; BRAIN; TRYPTOPHAN; MECHANISM; BUPRENORPHINE; KYNURENINE; INDUCTION	A mechanism-based model was developed to describe the time course of lipopolysaccharide-induced depressive-like behavior and azithromycin pharmacodynamics in mice. The lipopolysaccharide-induced disease progression was monitored by lipopolysaccharide, proinflammatory cytokines, and kynrenine concentration in plasma. The depressive-like behavior was investigated by forced swimming test and tail suspension test. Azithromycin was selected to inhibit the surge of proinflammatory cytokines induced by lipopolysaccharide. Disease progression model and azithromycin pharmacodynamics were constructed from transduction and indirect response models. A delay in the onset of increased proinflammatory cytokines, kynrenine, and behavior test compared to lipopolysaccharide was successfully characterized by series transduction models. The inhibition of azithromycin on proinflammatory cytokines was described by an indirect response model. After lipopolysaccharide challenging, the proinflammatory cytokines, kynrenine and behavior tests would peak approximately at 3, 12, and 24 h respectively, and then the time courses slowly declined toward a baseline state after peak response. During azithromycin administration, the peak levels of proinflammatory cytokines, kynrenine and behavior indexes decreased. Model parameters indicated that azithromycin significantly inhibited the proinflammatory cytokines level in plasma and improved the depressive-like behavior induced by inflammation. The integrated model for disease progression and drug intervention captures turnovers of proinflammatory cytokines, kynrenine and the behavior results in the different time phases and conditions.	[Hao, Kun; Qi, Qu; Hao, Haiping; Wang, Guangji; Liang, Yan; Xie, Lin] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Chen, Yuancheng] Fudan Univ, Inst Antibiot, Huashan Hosp, Shanghai 200433, Peoples R China	China Pharmaceutical University; Fudan University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	guangjiwang@hotmail.com	Chen, Yuancheng/L-9013-2016; Hao, Haiping/L-8265-2019	Chen, Yuancheng/0000-0002-5731-9114; Hao, Haiping/0000-0003-2522-7546	Project Program of State Key Laboratory of Natural Medicines [02410346]; Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects [BM2012012]; Natural Science Foundation of Jiangsu province [SBK201240220]	Project Program of State Key Laboratory of Natural Medicines; Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	This study was supported by the Project Program of State Key Laboratory of Natural Medicines (No. 02410346), Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects (BM2012012) and Natural Science Foundation of Jiangsu province (SBK201240220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Aubert JD, 1998, PULM PHARMACOL THER, V11, P263, DOI 10.1006/pupt.1998.0123; AZOULAYDUPUIS E, 1991, ANTIMICROB AGENTS CH, V35, P1024, DOI 10.1128/AAC.35.6.1024; Barrett B, 2005, ANAL BIOANAL CHEM, V383, P210, DOI 10.1007/s00216-005-0018-5; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Capuron L, 2003, BRAIN BEHAV IMMUN, V17, pS119; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Chen YC, 2009, PHARM RES-DORDR, V26, P1863, DOI 10.1007/s11095-009-9899-x; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; D'Argenio DZ, 1997, ADAPT 2 USERS GUIDE; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; de Lange ECM, 2005, AAPS J, V7, pE532, DOI 10.1208/aapsj070354; FIESE EF, 1990, J ANTIMICROB CHEMOTH, V25, P39, DOI 10.1093/jac/25.suppl_A.39; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Fuller-Thomson E, 2006, INFLAMM BOWEL DIS, V12, P697, DOI 10.1097/00054725-200608000-00005; GAL EM, 1980, NEUROCHEM RES, V5, P223, DOI 10.1007/BF00964611; GIRARD AE, 1987, ANTIMICROB AGENTS CH, V31, P1948, DOI 10.1128/AAC.31.12.1948; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; HEYES MP, 1993, BRAIN, V116, P1425, DOI 10.1093/brain/116.6.1425; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Josa M, 2001, J PHARMACOL EXP THER, V297, P198; Kikuchi T, 2002, J ANTIMICROB CHEMOTH, V49, P745, DOI 10.1093/jac/dkf008; Kronenberg S, 2008, PHARMACOGENOMICS, V9, P1725, DOI 10.2217/14622416.9.11.1725; Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235; Lestage J, 2002, BRAIN BEHAV IMMUN, V16, P596, DOI 10.1016/S0889-1591(02)00014-4; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Mormede U, 2004, BRAIN BEHAV IMMUN, V18, P186, DOI 10.1016/S0889-1591(03)00133-8; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; OHTANI M, 1995, J PHARMACOL EXP THER, V272, P505; Pechnick RN, 2004, NEUROPSYCHOPHARMACOL, V29, P770, DOI 10.1038/sj.npp.1300402; Pitossi F, 1997, J NEUROSCI RES, V48, P287, DOI 10.1002/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rajman I, 2008, DRUG DISCOV TODAY, V13, P341, DOI 10.1016/j.drudis.2008.01.003; Scaglione F., 1998, Journal of Antimicrobial Chemotherapy, V41, P47, DOI 10.1093/jac/41.suppl_2.47; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Shapiro L, 1993, New Horiz, V1, P13; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Sun YN, 1998, J PHARM SCI, V87, P732, DOI 10.1021/js970414z; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tkalcevic VI, 2006, EUR J PHARMACOL, V539, P131, DOI 10.1016/j.ejphar.2006.03.074; Watanabe S, 2004, PHYSIOL BEHAV, V81, P605, DOI 10.1016/j.physbeh.2004.02.021; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Yassen A, 2005, J PHARMACOL EXP THER, V313, P1136, DOI 10.1124/jpet.104.082560; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	54	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54981	10.1371/journal.pone.0054981	http://dx.doi.org/10.1371/journal.pone.0054981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358536	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600142
J	Martinez, P; Hernandez-Losa, J; Montero, MA; Cedres, S; Castellvi, J; Martinez-Marti, A; Tallada, N; Murtra-Garrell, N; Navarro-Mendivill, A; Rodriguez-Freixinos, V; Canela, M; Cajal, SRY; Felip, E				Martinez, Pablo; Hernandez-Losa, Javier; Angeles Montero, M.; Cedres, Susana; Castellvi, Josep; Martinez-Marti, Alex; Tallada, Natalia; Murtra-Garrell, Nuria; Navarro-Mendivill, Alejandro; Rodriguez-Freixinos, Victor; Canela, Mercedes; Ramon y Cajal, Santiago; Felip, Enriqueta			Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							EML4-ALK FUSION GENE; REARRANGEMENT; ADENOCARCINOMAS; INHIBITOR; MUTATIONS; SURVIVAL; EGFR	Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods for ALK positive patients and to describe its prevalence and outcomes in a population of NSCLC patients. Methods: NSCLC patients previously screened for Epidermal Growth Factor Receptor (EGFR) at our institution were selected. ALK positive patients were identified by FISH and the value of IHC (D5F3) was explored. Results: ninety-nine patients were identified. Median age was 61.5 years (range 35-83), all were caucasians, eighty percent were adenocarcinomas, fifty-one percent were male and thirty-eight percent were current smokers. Seven (7.1%) patients were ALK positive by FISH, thirteen (13.1%) were EGFR mutant, and 65 (65.6%) were negative/Wild Type (WT) for both ALK and EGFR. ALK positivity and EGFR mutations were mutually exclusive. ALK positive patients tend to be younger than EGFR mutated or wt patients. ALK positive patients were predominantly never smokers (71.4%) and adenocarcinoma (71.4%). ALK positive and EGFR mutant patients have a better outcome than negative/WT. All patients with ALK FISH negative tumours were negative for ALK IHC. Out of 6 patients positive for ALK FISH with more tissue available, 5 were positive for ALK IHC and 1 negative. Conclusions: ALK positive patients represent 7.1% of a population of selected NSCLC. ALK positive patients have different clinical features and a better outcome than EGFR WT and ALK negative patients. IHC is a promising method for detecting ALK positive NSCLC patients.	[Martinez, Pablo; Cedres, Susana; Martinez-Marti, Alex; Murtra-Garrell, Nuria; Navarro-Mendivill, Alejandro; Rodriguez-Freixinos, Victor; Felip, Enriqueta] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain; [Hernandez-Losa, Javier; Angeles Montero, M.; Castellvi, Josep; Tallada, Natalia; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain; [Canela, Mercedes] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Thorac Oncol Dept, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Martinez, P (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain.	pamartinez@vhebron.net	Ramon y Cajal, Santiago/H-4955-2016; Castellvi, Josep/C-5092-2014; Javier, Hernandez Losa/C-1173-2008	Ramon y Cajal, Santiago/0000-0002-3867-1390; Castellvi, Josep/0000-0001-5745-9996; Javier, Hernandez Losa/0000-0003-1526-3201; FELIP, ENRIQUETA/0000-0002-7620-0098; Balmana, Judith/0000-0002-0762-6415; MARTINEZ-MARTI, ALEX/0000-0002-6714-9526				Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lee JK, 2012, CANCER-AM CANCER SOC, V118, P3579, DOI 10.1002/cncr.26668; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mitsudomi T, 2011, P AM SOC CLIN ONCO S, V29; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tong J, 2011, J THORACIC ONCOLOGY, V6; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wong K, 2011, JSCLC J CLIN ONCOL S, V29; Yoshida A, 2011, J THORAC ONCOL, V6, P1677, DOI 10.1097/JTO.0b013e3182286d25	24	53	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52261	10.1371/journal.pone.0052261	http://dx.doi.org/10.1371/journal.pone.0052261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359795	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600004
J	Pagonabarraga, J; Corcuera-Solano, I; Vives-Gilabert, Y; Llebaria, G; Garcia-Sanchez, C; Pascual-Sedano, B; Delfino, M; Kulisevsky, J; Gomez-Anson, B				Pagonabarraga, Javier; Corcuera-Solano, Idoia; Vives-Gilabert, Yolanda; Llebaria, Gisela; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Delfino, Manuel; Kulisevsky, Jaime; Gomez-Anson, Beatriz			Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBRAL ATROPHY; HUMAN BRAIN; VISUAL HALLUCINATIONS; DIAGNOSTIC-CRITERIA; ENTORHINAL CORTEX; RATING-SCALE; DEMENTIA; IMPAIRMENT; THICKNESS	Background: Dementia is a frequent and devastating complication in Parkinson's disease (PD). There is an intensive search for biomarkers that may predict the progression from normal cognition (PD-NC) to dementia (PDD) in PD. Mild cognitive impairment in PD (PD-MCI) seems to represent a transitional state between PD-NC and PDD. Few studies have explored the structural changes that differentiate PD-NC from PD-MCI and PDD patients. Objectives and Methods: We aimed to analyze changes in cortical thickness on 3.0T Magnetic Resonance Imaging (MRI) across stages of cognitive decline in a prospective sample of PD-NC (n = 26), PD-MCI (n = 26) and PDD (n = 20) patients, compared to a group of healthy subjects (HC) (n = 18). Cortical thickness measurements were made using the automatic software Freesurfer. Results: In a sample of 72 PD patients, a pattern of linear and progressive cortical thinning was observed between cognitive groups in cortical areas functionally specialized in declarative memory (entorhinal cortex, anterior temporal pole), semantic knowledge (parahippocampus, fusiform gyrus), and visuoperceptive integration (banks of the superior temporal sulcus, lingual gyrus, cuneus and precuneus). Positive correlation was observed between confrontation naming and thinning in the fusiform gyrus, parahippocampal gyrus and anterior temporal pole; clock copy with thinning of the precuneus, parahippocampal and lingual gyrus; and delayed memory with thinning of the bilateral anteromedial temporal cortex. Conclusions: The pattern of regional decreased cortical thickness that relates to cognitive deterioration is present in PD-MCI patients, involving areas that play a central role in the storage of prior experiences, integration of external perceptions, and semantic processing.	[Pagonabarraga, Javier; Llebaria, Gisela; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Kulisevsky, Jaime] St Pau Hosp, Movement Disorders Unit, Dept Neurol, Barcelona, Spain; [Corcuera-Solano, Idoia; Gomez-Anson, Beatriz] St Pau Hosp, Neuroradiol Unit, Barcelona, Spain; [Corcuera-Solano, Idoia; Vives-Gilabert, Yolanda; Delfino, Manuel; Gomez-Anson, Beatriz] PIC, Barcelona, Spain; [Vives-Gilabert, Yolanda] IFAE, Barcelona, Spain; [Pagonabarraga, Javier; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Delfino, Manuel; Kulisevsky, Jaime; Gomez-Anson, Beatriz] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Kulisevsky, Jaime; Gomez-Anson, Beatriz] IIB St Pau, Barcelona, Spain; [Llebaria, Gisela; Kulisevsky, Jaime] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Autonomous University of Barcelona; CIBERNED	Kulisevsky, J (corresponding author), St Pau Hosp, Movement Disorders Unit, Dept Neurol, Barcelona, Spain.	jkulisevsky@santpau.cat	Delfino, Manuel/A-1545-2012; Pages, Andres Pacheco/C-5353-2011; Vives-Gilabert, Yolanda/ABB-7461-2021; Pascual-Sedano, Berta/AAF-4428-2021; Casals, Jordi/AAB-3249-2019	Delfino, Manuel/0000-0002-9468-4751; Pages, Andres Pacheco/0000-0001-8210-1734; Pascual-Sedano, Berta/0000-0002-9298-8241; Vives-Gilabert, Yolanda/0000-0002-3744-5893	Fondo de Investigaciones Sanitarias ISCIII [FIS PI10/01498, FIS PI07/770]; Sociedad Espanola de Radiologia Medica [SERAM 06-09]	Fondo de Investigaciones Sanitarias ISCIII(Instituto de Salud Carlos III); Sociedad Espanola de Radiologia Medica	Granted by Fondo de Investigaciones Sanitarias ISCIII (FIS PI10/01498, FIS PI07/770), and Sociedad Espanola de Radiologia Medica (SERAM 06-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Espeseth T, 2012, NEUROBIOL AGING, V33, P304, DOI 10.1016/j.neurobiolaging.2009.12.027; Ferrer I, 2009, PROG NEUROBIOL, V88, P89, DOI 10.1016/j.pneurobio.2009.02.004; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fortea J, 2011, BIOL PSYCHIAT, V70, P183, DOI 10.1016/j.biopsych.2011.02.017; Galvin JE, 2005, ARCH NEUROL-CHICAGO, V62, P758, DOI 10.1001/archneur.62.5.758; Grosset K, 2004, MOVEMENT DISORD, V19, P1370, DOI 10.1002/mds.20210; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Mattis S, 1988, DEMENTIA RATING SCAL; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pereira JB, 2011, HUM BRAIN MAPP; Ramirez-Ruiz B, 2007, EUR J NEUROL, V14, P750, DOI 10.1111/j.1468-1331.2007.01768.x; Rockwood K, 2000, J AM GERIATR SOC, V48, P558, DOI 10.1111/j.1532-5415.2000.tb05004.x; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; SCHMIDT R, 1994, NEUROLOGY, V44, P964, DOI 10.1212/WNL.44.5.964; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Shin S, 2012, J NEUROL NEUROSUR PS, V83, P1155, DOI 10.1136/jnnp-2012-303391; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	54	101	105	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54980	10.1371/journal.pone.0054980	http://dx.doi.org/10.1371/journal.pone.0054980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359616	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600141
J	Roubelakis, MG; Tsaknakis, G; Pappa, KI; Anagnou, NP; Watt, SM				Roubelakis, Maria G.; Tsaknakis, Grigorios; Pappa, Kalliopi I.; Anagnou, Nicholas P.; Watt, Suzanne M.			Spindle Shaped Human Mesenchymal Stem/Stromal Cells from Amniotic Fluid Promote Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; COLONY-FORMING CELLS; STEM-CELLS; IN-VITRO; UMBILICAL-CORD; STROMAL CELLS; HUMAN ADULT; BONE-MARROW; MATRIX METALLOPROTEINASES; CHROMOSOMAL-ABERRATIONS	Human amniotic fluid obtained at amniocentesis, when cultured, generates at least two morphologically distinct mesenchymal stem/stromal cell (MSC) subsets. Of these, the spindle shaped amniotic fluid MSCs (SS-AF-MSCs) contain multipotent cells with enhanced adipogenic, osteogenic and chondrogenic capacity. Here, we demonstrate, for the first time, the capacity of these SS-AF-MSCs to support neovascularization by umbilical cord blood (UCB) endothelial colony forming cell (ECFC) derived cells in both in vitro and in vivo models. Interestingly, although the kinetics of vascular tubule formation in vitro were similar when the supporting SS-AF-MSCs were compared with the best vasculogenic supportive batches of bone marrow MSCs (BMSCs) or human dermal fibroblasts (hDFs), SS-AF-MSCs supported vascular tubule formation in vivo more effectively than BMSCs. In NOD/SCID mice, the human vessels inosculated with murine vessels demonstrating their functionality. Proteome profiler array analyses revealed both common and distinct secretion profiles of angiogenic factors by the SS-AF-MSCs as opposed to the hDFs and BMSCs. Thus, SS-AF-MSCs, which are considered to be less mature developmentally than adult BMSCs, and intermediate between adult and embryonic stem cells in their potentiality, have the additional and very interesting potential of supporting increased neovascularisation, further enhancing their promise as vehicles for tissue repair and regeneration.	[Roubelakis, Maria G.; Anagnou, Nicholas P.] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece; [Roubelakis, Maria G.; Anagnou, Nicholas P.] Acad Athens BRFAA, Biomed Res Fdn, Ctr Basic Res, Cell & Gene Therapy Lab, Athens, Greece; [Roubelakis, Maria G.; Tsaknakis, Grigorios; Watt, Suzanne M.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Roubelakis, Maria G.; Tsaknakis, Grigorios; Watt, Suzanne M.] John Radcliffe Hosp, Stem Cell Res Lab, NHS Blood & Transplant, Oxford OX3 9DU, England; [Pappa, Kalliopi I.] Univ Athens, Sch Med, Dept Obstet & Gynecol 1, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; University of Oxford; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens	Watt, SM (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England.	suzanne.watt@nhsbt.nhs.uk	Anagnou, Nicholas/GLR-3609-2022; Watt, Suzanne/AAV-4908-2021; PAPPA, KALLIOPI/K-9345-2018	Roubelakis, Maria G./0000-0001-5790-6581; PAPPA, KALLIOPI/0000-0002-1061-7405; Watt, Suzanne/0000-0001-7684-8022	NHS Blood and Transplant; National Institutes of Health Research; Restore Burns and Wound Healing Trust; EU Framework VII Cascade grant; National Institute for Health Research [RP-PG-0310-1003] Funding Source: researchfish	NHS Blood and Transplant; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Restore Burns and Wound Healing Trust; EU Framework VII Cascade grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by research funding from NHS Blood and Transplant (GT, MGR, SMW), National Institutes of Health Research (SMW, GT), Restore Burns and Wound Healing Trust (SMW) and the EU Framework VII Cascade grant (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2010, J R SOC INTERFACE, V7, pS689, DOI 10.1098/rsif.2010.0347.focus; Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bitsika V, 2012, STEM CELLS DEV, V21, P1097, DOI 10.1089/scd.2011.0151; Campagnoli C, 2002, BJOG-INT J OBSTET GY, V109, P952, DOI 10.1111/j.1471-0528.2002.t01-1-02011.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chan J, 2008, HUM REPROD, V23, P2427, DOI 10.1093/humrep/den302; Coldwell KE, 2011, ANGIOGENESIS, V14, P381, DOI 10.1007/s10456-011-9222-4; Da Sacco S, 2010, J UROLOGY, V183, P1193, DOI 10.1016/j.juro.2009.11.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Spiegelaere W, 2011, CLIN HEMORHEOL MICRO, V48, P15, DOI 10.3233/CH-2011-1393; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Diamanti P, 2012, LEUKEMIA, V26, P376, DOI 10.1038/leu.2011.212; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eddleman KA, 2006, OBSTET GYNECOL, V108, P1067, DOI 10.1097/01.AOG.0000240135.13594.07; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Farace P, 2009, BRIT J CANCER, V100, P1575, DOI 10.1038/sj.bjc.6605041; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Laird AD, 2002, FASEB J, V16, DOI 10.1096/fj.01-0700com; LESCHOT NJ, 1985, BRIT J OBSTET GYNAEC, V92, P804, DOI 10.1111/j.1471-0528.1985.tb03049.x; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Makridalds M, 2010, J PROTEOME RES, V9, P3243, DOI 10.1021/pr100189d; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Rissanen TT, 2002, FASEB J, V16, P100, DOI 10.1096/fj.02-0377fje; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; Roelen DL, 2009, HUM IMMUNOL, V70, P16, DOI 10.1016/j.humimm.2008.10.016; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Walker NG, 2012, TISSUE ENG PART C-ME, V18, P143, DOI [10.1089/ten.tec.2011.0037, 10.1089/ten.TEC.2011.0037]; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Watt SM, 2010, J R SOC INTERFACE, V7, pS731, DOI [10.1098/rsif.2010.0377.focus, 10.1098/rsif.2010.0377.focas]; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908; Zhang DL, 2010, MOL CELL BIOCHEM, V335, P1, DOI 10.1007/s11010-009-0234-y; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhang YY, 2009, STEM CELLS DEV, V18, P359, DOI 10.1089/scd.2008.0071; Zhou B, 2012, BRIT J HAEMATOL, V157, P299, DOI 10.1111/j.1365-2141.2012.09050.x; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	70	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54747	10.1371/journal.pone.0054747	http://dx.doi.org/10.1371/journal.pone.0054747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359810	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600104
J	Chikovore, J; Nystrom, L; Lindmark, G; Ahlberg, BM				Chikovore, Jeremiah; Nystrom, Lennarth; Lindmark, Gunilla; Ahlberg, Beth Maina			"How Can I Gain Skills if I Don't Practice?'' The Dynamics of Prohibitive Silence against Pre-Marital Pregnancy and Sex in Zimbabwe	PLOS ONE			English	Article							HIV PREVENTION; AIDS; BEHAVIOR; CULTURE; WOMEN	Young people face sexual and reproductive health (SRH) problems including Human immunodeficiency virus (HIV) and Acquired immunodeficiency syndrome (AIDS). It is critical to continue documenting their situation including the contexts they live in. As part of a larger study that explored perspectives of men to SRH and more specifically abortion and contraceptive use, 546 pupils (51% female; age range 9-25 years) from a rural area in Zimbabwe were invited to write anonymously questions about growing up or other questions they could not ask adults for fear or shame. The pupils were included following descriptions by adults of the violence that is unleashed on unmarried young people who engaged in sex, used contraceptives, or simply suggested doing so. The questions by the young people pointed to living in a context of prohibitive silence; their sexuality was silenced and denied. As a consequence they had poor knowledge and their fears and internal conflicts around sexuality and pregnancy were not addressed. Current action suggests concerted effort at the policy level to deal with young people's SRH in Zimbabwe. It nevertheless remains necessary, as a way to provide support to these efforts, to continue examining what lessons can be drawn from the past, and how the past continues to reflect in and shape present dynamics and relations. There is also need to look more critically at life skill education, which has previously been described as having failed to address adequately the practical needs of young people. Life skill education in Zimbabwe has rarely been systematically evaluated. A fuller understanding is also needed of the different factors co-existing in contemporary African societies and how they have been and continue to be constituted within history, and the implications to the promotion of adolescent SRH.	[Chikovore, Jeremiah] Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB Unit, Durban, South Africa; [Chikovore, Jeremiah] Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi; [Nystrom, Lennarth] Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Publ Hlth Sci, Umea, Sweden; [Lindmark, Gunilla] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Sect Int Maternal & Child Hlth, Uppsala, Sweden; [Ahlberg, Beth Maina] Uppsala Univ, Fac Med, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Ahlberg, Beth Maina] Skaraborg Inst Res & Dev, Skovde, Sweden	Human Sciences Research Council-South Africa; University of Malawi; Umea University; Uppsala University; Uppsala University Hospital; Uppsala University	Chikovore, J (corresponding author), Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB Unit, Durban, South Africa.	JChikovore@hsrc.ac.za		Chikovore, Jeremiah/0000-0002-4910-6952	Sida/SAREC of Sweden;  [WT085411MA]	Sida/SAREC of Sweden; 	The study was supported by Sida/SAREC of Sweden. Jeremiah Chikovore is a Wellcome Trust Fellow supported by Grant WT085411MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocates for Youth, 2008, OUT HAND GLOB AIDS P; Agar M., 1996, PROFESSIONAL STRANGE; Ahlberg BM, 2001, REPROD HEALTH MATTER, V9, P26, DOI 10.1016/S0968-8080(01)90005-9; [Anonymous], AD SEX REPR HLTH; Ashcroft B., 1998, KEY CONCEPTS POSTCOL; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bhana D, 2010, EARLY CHILD DEV CARE, V180, P1079, DOI 10.1080/03004430902742633; Birdthistle I, 2012, AIDS 2012 WASH DC 22; Boler T, 2005, LIFE SKILL BASED ED; Campbell C, 2009, J YOUTH STUD, V12, P93, DOI 10.1080/13676260802345757; Chikovore J, 2002, J BIOSOC SCI, V34, P317, DOI 10.1017/S0021932002003176; Chikovore J, 2009, AJAR-AFR J AIDS RES, V8, P503, DOI 10.2989/AJAR.2009.8.4.14.1051; Cowan FM, 2002, AIDS, V16, P1673, DOI 10.1097/00002030-200208160-00013; Dixon-Mueller R, 2009, AIDS BEHAV, V13, P100, DOI 10.1007/s10461-008-9376-2; Erulkar Annabel S, 2005, Afr J Reprod Health, V9, P51; Family Health International, 2010, YOUNG PEOPL MOST RIS; Fielder A, 1999, POLITICS READING POS; Government of Zimbabwe, 1999, NAT HIV AIDS POL; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gurevitz R., 2000, ETHICS ENVIRON, V3, P253, DOI [DOI 10.1080/713665905, 10.1080/713665905]; Gusrang J. L., 2010, THESIS U CONNECTICUT; Hallberg L.R.M., 2006, INT J QUALITATIVE ST, V1, P141, DOI [https://doi.org/10.1080/17482620600858399, 10.1080/17482620600858399, DOI 10.1080/17482620600858399]; Helleve A., 2011, SEX ED, V11, P13, DOI [DOI 10.1080/14681811.2011.538143, DOI 10.1080/14681811.2011]; Hindin MJ, 2009, INT PERSPECT SEX R H, V35, P58, DOI 10.1363/ipsrh.35.058.09; Irvine JM, 2000, CRIT INQUIRY, V27, P58, DOI 10.1086/448998; Kaufman C, 1998, VIEW SCH PREPARATION, P58; Kim YM, 1997, E AFR MED J, V74, P514; Ladner J, 2002, LANCET, V360, P1889, DOI 10.1016/S0140-6736(02)11757-0; Langhaug LF, 2003, AIDS CARE, V15, P147, DOI 10.1080/0954012031000068290; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lupton D, 1998, BODY SOC, V4, P19, DOI DOI 10.1177/1357034X98004002002; Marindo-Ranganayi R, 2003, POLICY RES DIVISION, V170; Nare C, 1997, Afr J Reprod Health, V1, P15, DOI 10.2307/3583373; National AIDS Council Ministry of Health and Child Care UNAIDS, 2006, ZIMBABWE NATL HIV AI; O'Donoghue J, 2002, EVAL PROGRAM PLANN, V25, P387, DOI 10.1016/S0149-7189(02)00050-2; Ottemoller-Gwanzura FP, 2005, CHILDRENS GEOGRAPHIE, V3, P253; Pattman R., 2007, BOYS MEN SOCIAL CONS, P33; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Pelto PJ, 1997, MED ANTHROPOL Q, V11, P147, DOI 10.1525/maq.1997.11.2.147; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Schoepf BG, 1995, CULTURE SEXUAL RISK, P29; Setel P, 1996, SOC SCI MED, V43, P1169, DOI 10.1016/0277-9536(95)00360-6; Shanahan S, 2007, ANNU REV SOCIOL, V33, P407, DOI 10.1146/annurev.soc.33.040406.131808; Shroufi A, 2012, AIDS 2012 WASH DC 22; UNAIDS, 2010, YOUNG PEOPL AR LEAD; UNICEF, 2011, OPP CRIS PREV HIV EA; Van Eeuwijk BO, 1997, POWER REPROD GENDER, P35; Van Onselen Charles, 1976, CHIBARO AFRICAN MINE	48	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53058	10.1371/journal.pone.0053058	http://dx.doi.org/10.1371/journal.pone.0053058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372653	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500010
J	Liu, MZ; Wang, BX; Osborne, CP; Jiang, GM				Liu, Meizhen; Wang, Bingxue; Osborne, Colin P.; Jiang, Gaoming			Chicken Farming in Grassland Increases Environmental Sustainability and Economic Efficiency	PLOS ONE			English	Article							INNER-MONGOLIA; DESERTIFICATION; SOIL; ROOTS; CHINA; DUST	Background: Grassland degradation caused by overgrazing poses a threat to both animal husbandry and environmental sustainability in most semi-arid areas especially north China. Although the Chinese Government has made huge efforts to restore degraded grasslands, a considerable attempt has unfortunately failed due to an inadequate consideration of economic benefits to local communities. Methodology/Principal Findings: A controlled field experiment was conducted to test our hypothesis that utilizing natural grasslands as both habitat and feed resources for chickens and replacing the traditional husbandry system with chicken farming would increase environmental sustainability and raise income. Aboveground plant biomass elevated from 25 g m 22 for grazing sheep to 84 g m 22 for chicken farming. In contrast to the fenced (unstocked) grassland, chicken farming did not significantly decrease aboveground plant biomass, but did increase the root biomass by 60% (p<0.01). Compared with traditional sheep grazing, chicken farming significantly improved soil surface water content (0-10 cm), from 5% to 15%. Chicken farming did not affect the soil bulk density, while the traditional sheep grazing increased the soil bulk density in the 0-10 cm soil layer by 35% of the control (p<0.05). Most importantly, the economic income of local herdsmen has been raised about six times compared with the traditional practice of raising sheep. Ecologically, such an innovative solution allowed large degraded grasslands to naturally regenerate. Grasslands also provided a high quality organic poultry product which could be marketed in big cities. Conclusion/Significance: Chicken farming is an innovative alternative strategy for increasing environmental sustainability and economic income, rather than a challenge to the traditional nomadic pastoral system. Our approach might be technically applicable to other large degraded grasslands of the world, especially in China.	[Liu, Meizhen; Wang, Bingxue; Jiang, Gaoming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Osborne, Colin P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Chinese Academy of Sciences; Institute of Botany, CAS; University of Sheffield	Liu, MZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	liumzh@ibcas.ac.cn; jianggm@126.com			Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050403]; National Scientific Foundation of China [40501009, 50875007]	Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (XDA05050403), and the National Scientific Foundation of China (No. 40501009, 50875007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; [Anonymous], EREMOLOGY; Boehm W., 1979, METHODS STUDYING ROO; BROWN L, 2001, DYNAMIC AGR BOOK 3; Chen SP, 2009, AGR FOREST METEOROL, V149, P1800, DOI 10.1016/j.agrformet.2009.06.009; China Stock Breeding Year book Edition Committee, 2004, YB CHIN STOCKBR 2004; China's State Environmental Protection Administration, 2003, REP STAT ENV CHIN 20; Curtis JT, 1959, VEGETATION WISCONSIN; Du Q. L., 2006, SUSTAINABLE DEV STRA; Glantz M., 2003, CLIMATE AFFAIRS PRIM; Jiang Gaoming, 2011, Science & Technology Review, V29, P19, DOI 10.3981/j.issn.1000-7857.2011.25.002; Jiang Gaoming, 2007, CHINA DIALOGUE; Jiang GM, 2006, CHINA DIALOGUE; Jing D, 2002, THESIS ROYAL I TECHN; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Li G, 2007, ENVIRON CONSERV, V34, P95, DOI 10.1017/S0376892907003864; Li WJ, 2009, READING PUZZLEDOM GR; Liu MZ, 2009, RESTOR ECOL, V17, P127, DOI 10.1111/j.1526-100X.2008.00366.x; Liu MZ, 2004, ENVIRON CONSERV, V31, P269, DOI 10.1017/S0376892904001675; MAC (Department of Animal Husbandry and Veterinary & General Station of Animal Husbandry and Veterinary of Ministry of Agriculture of China), 1996, RANG RES CHIN; National Environmental Protection General Agency, 2005, CHIN ENV COND B 2005; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; SMUCKER AJM, 1982, AGRON J, V74, P500, DOI 10.2134/agronj1982.00021962007400030023x; Stubbendieck J, 2008, NAT AREA J, V28, P58, DOI 10.3375/0885-8608(2008)28[58:SYOVDI]2.0.CO;2; Wang B., 2011, ACTA ECOLOGICA SINIC, V31, P14, DOI [10.1016/j.chnaes.2010.11.003., DOI 10.1016/J.CHNAES.2010.11.003]; Wang GX, 2004, J ARID ENVIRON, V58, P373, DOI 10.1016/j.jaridenv.2003.11.001; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wu Jianguo, 1992, P67; [乌云塔娜 Wuyun Tana], 2010, [河北农业大学学报, Journal of Agricultural University of Hebei], V33, P10; [Yale Center for Environmental Law & Policy Center for International Earth Science Information Network at Columbia University], 2010, ENV PERF IND EPI REP; Yang X, 2005, J ARID ENVIRON, V63, P517, DOI 10.1016/j.jaridenv.2005.03.032; Zhao HL, 2006, SOIL TILL RES, V87, P175, DOI 10.1016/j.still.2005.03.009	32	5	8	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53977	10.1371/journal.pone.0053977	http://dx.doi.org/10.1371/journal.pone.0053977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372678	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000314021500032
J	Malmo, J; Sandvig, A; Varum, KM; Strand, SP				Malmo, Jostein; Sandvig, Axel; Varum, Kjell M.; Strand, Sabina P.			Nanoparticle Mediated P-Glycoprotein Silencing for Improved Drug Delivery across the Blood-Brain Barrier: A siRNA-Chitosan Approach	PLOS ONE			English	Article							N-ACETYLATED CHITOSANS; IN-VITRO; ENDOTHELIAL-CELLS; RNA INTERFERENCE; MOLECULAR-WEIGHT; DOWN-REGULATION; GENE; RESISTANCE; EXPRESSION; MDR1	The blood-brain barrier (BBB), composed of tightly organized endothelial cells, limits the availability of drugs to therapeutic targets in the central nervous system. The barrier is maintained by membrane bound efflux pumps efficiently transporting specific xenobiotics back into the blood. The efflux pump P-glycoprotein (P-gp), expressed at high levels in brain endothelial cells, has several drug substrates. Consequently, siRNA mediated silencing of the P-gp gene is one possible strategy how to improve the delivery of drugs to the brain. Herein, we investigated the potential of siRNA-chitosan nanoparticles in silencing P-gp in a BBB model. We show that the transfection of rat brain endothelial cells mediated effective knockdown of P-gp with subsequent decrease in P-gp substrate efflux. This resulted in increased cellular delivery and efficacy of the model drug doxorubicin.	[Malmo, Jostein; Varum, Kjell M.; Strand, Sabina P.] Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway; [Malmo, Jostein; Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, Dept Lab Med, Trondheim, Norway; [Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, MI Lab, Trondheim, Norway; [Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Sandvig, Axel] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Umea University	Malmo, J (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway.	jostein.malmo@ntnu.no			NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology)	NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology)	This work was supported by a Ph.D. grant from NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology) to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Babakhanian K, 2007, BIOCHEM BIOPH RES CO, V361, P301, DOI 10.1016/j.bbrc.2007.06.176; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Begley DJ, 1996, J NEUROCHEM, V67, P988; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; de Klerk OL, 2010, PSYCHIAT RES-NEUROIM, V183, P151, DOI 10.1016/j.pscychresns.2010.05.002; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Fuest C, 2009, NEUROSCI LETT, V464, P47, DOI 10.1016/j.neulet.2009.08.014; Goralski KB, 2003, BRIT J PHARMACOL, V139, P35, DOI 10.1038/sj.bjp.0705227; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Gupta Y, 2007, J PHARM PHARMACOL, V59, P935, DOI 10.1211/jpp.59.7.0004; Han HD, 2010, CLIN CANCER RES, V16, P3910, DOI 10.1158/1078-0432.CCR-10-0005; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Jeong JH, 2007, BIOMATERIALS, V28, P1912, DOI 10.1016/j.biomaterials.2006.12.019; Kemper EM, 2003, CLIN CANCER RES, V9, P2849; Khoury M, 2006, ARTHRITIS RHEUM, V54, P1867, DOI 10.1002/art.21876; Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004; Malmo J, 2012, J CONTROL RELEASE, V158, P261, DOI 10.1016/j.jconrel.2011.11.012; Malmo J, 2011, BIOMACROMOLECULES, V12, P721, DOI 10.1021/bm1013525; Matsui Y, 2005, PHARM RES-DORDR, V22, P2091, DOI 10.1007/s11095-005-8178-8; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; MULLER C, 1995, J CELL PHYSIOL, V163, P538, DOI 10.1002/jcp.1041630314; Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3; Regina A, 1998, J NEUROCHEM, V71, P705; Rojanarata T, 2008, PHARM RES-DORDR, V25, P2807, DOI 10.1007/s11095-008-9648-6; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Saito Takaya, 2012, Silence, V3, P3, DOI 10.1186/1758-907X-3-3; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Strand SP, 2010, BIOMATERIALS, V31, P975, DOI 10.1016/j.biomaterials.2009.09.102; Susa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010764; Techaarpornkul S, 2010, AAPS PHARMSCITECH, V11, P64, DOI 10.1208/s12249-009-9355-6; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tommeraas K, 2001, CARBOHYD RES, V333, P137, DOI 10.1016/S0008-6215(01)00130-6; Varum K.M., 2005, VERSATILITY, P625; Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu H, 2003, CANCER RES, V63, P1515	49	62	63	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54182	10.1371/journal.pone.0054182	http://dx.doi.org/10.1371/journal.pone.0054182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372682	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500036
J	Rappa, F; Greco, A; Podrini, C; Cappello, F; Foti, M; Bourgoin, L; Peyrou, M; Marino, A; Scibetta, N; Williams, R; Mazzoccoli, G; Federici, M; Pazienza, V; Vinciguerra, M				Rappa, Francesca; Greco, Azzura; Podrini, Christine; Cappello, Francesco; Foti, Michelangelo; Bourgoin, Lucie; Peyrou, Marion; Marino, Arianna; Scibetta, Nunzia; Williams, Roger; Mazzoccoli, Gianluigi; Federici, Massimo; Pazienza, Valerio; Vinciguerra, Manlio			Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							FATTY LIVER; DOWN-REGULATION; KAPPA-B; CANCER; PTEN; INFLAMMATION; PROGRESSION; OBESITY; IL-6	Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p < 0.01) in number of positive nuclei in HCC (100% of tumor cells positive for either macroH2A1.1 or macroH2A1.2), when compared to steatosis (<2% of hepatocytes positive for either isoform). The steatotic areas flanking the tumors were highly immunopositive for macroH2A1.1 and macroH2A1.2. Conclusions: These data obtained in mice and humans suggest that both macroH2A1 isoforms may play a role in HCC pathogenesis and moreover may be considered as novel diagnostic markers for human HCC.	[Rappa, Francesca; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Rappa, Francesca; Cappello, Francesco; Vinciguerra, Manlio] Euromediterranean Inst Sci & Technol, Palermo, Italy; [Greco, Azzura; Podrini, Christine; Williams, Roger; Vinciguerra, Manlio] Fdn Liver Res, Inst Hepatol, London, England; [Cappello, Francesco] Libera Univ Studi Sci Umane & Tecnol, Ist Paolo Sotgiu, Lugano, Switzerland; [Foti, Michelangelo; Bourgoin, Lucie; Peyrou, Marion] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Marino, Arianna; Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Scibetta, Nunzia] Civ Hosp, Anat Pathol Unit, Palermo, Italy; [Mazzoccoli, Gianluigi] IRCCS Casa Sollievo Sofferenza, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, Italy; [Mazzoccoli, Gianluigi] IRCCS Casa Sollievo Sofferenza, Chronobiol Unit, San Giovanni Rotondo, Italy; [Pazienza, Valerio] IRCCS Casa Sollievo Sofferenza, Div & Lab Gastroenterol, San Giovanni Rotondo, Italy	University of Palermo; University of London; University College London; University of Geneva; University of Rome Tor Vergata; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Vinciguerra, M (corresponding author), UCL, Inst Liver & Digest Hlth, Div Med, London, England.	manliovinciguerra@iemest.eu	Vinciguerra, Manlio/N-1309-2015; Pazienza, Valerio/K-5073-2012; Federici, Massimo/G-9940-2012; Podrini, Christine/K-8621-2016; Mazzoccoli, Gianluigi/H-2447-2016; Francesca, Rappa/ADW-8431-2022; Peyrou, Marion/A-7190-2015; Cappello, Francesco/F-9153-2012	Vinciguerra, Manlio/0000-0002-1768-3894; Pazienza, Valerio/0000-0002-3492-1153; Federici, Massimo/0000-0003-4989-5194; Podrini, Christine/0000-0002-5391-3378; Mazzoccoli, Gianluigi/0000-0003-3535-7635; Peyrou, Marion/0000-0002-1210-6094; rappa, francesca/0000-0001-6610-5268; Cappello, Francesco/0000-0001-9288-1148; Foti, Michelangelo/0000-0001-7199-4135				Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Farina F, 2000, J HISTOCHEM CYTOCHEM, V48, P57, DOI 10.1177/002215540004800106; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Kantartzis K, 2010, DIGEST DIS, V28, P169, DOI 10.1159/000282082; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lou-Bonafonte JM, 2011, CURR OPIN LIPIDOL, V22, P159, DOI 10.1097/MOL.0b013e3283462288; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Myers RP, 2009, ANN HEPATOL, V8, pS25, DOI 10.1016/S1665-2681(19)31823-X; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Salamone F, 2012, TRANSL RES, V159, P477, DOI 10.1016/j.trsl.2011.12.003; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Vinciguerra M, 2012, AGING CELL, V11, P139, DOI 10.1111/j.1474-9726.2011.00766.x; Vinciguerra M, 2010, DIS MODEL MECH, V3, P298, DOI 10.1242/dmm.004655; Vinciguerra M, 2009, J HEPATOL, V50, P1132, DOI 10.1016/j.jhep.2009.01.027; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737	39	52	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54458	10.1371/journal.pone.0054458	http://dx.doi.org/10.1371/journal.pone.0054458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372727	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500074
J	Blamires, SJ; Tso, IM				Blamires, Sean J.; Tso, I-Min			Nutrient-Mediated Architectural Plasticity of a Predatory Trap	PLOS ONE			English	Article							SPIDER SILK; DRAGLINE SILK; MECHANICAL-PROPERTIES; ARGIOPE-KEYSERLINGI; NEPHILA-CLAVIPES; PREY VARIATION; ORB WEBS; ARANEIDAE; ARANEAE; PROTEIN	Background: Nutrients such as protein may be actively sought by foraging animals. Many predators exhibit foraging plasticity, but how their foraging strategies are affected when faced with nutrient deprivation is largely unknown. In spiders, the assimilation of protein into silk may be in conflict with somatic processes so we predicted web building to be affected under protein depletion. Methodology/Principal Findings: To assess the influence of protein intake on foraging plasticity we fed the orb-web spiders Argiope aemula and Cyclosa mulmeinensis high, low or no protein solutions over 10 days and allowed them to build webs. We compared post-feeding web architectural components and major ampullate (MA) silk amino acid compositions. We found that the number of radii in webs increased in both species when fed high protein solutions. Mesh size increased in A. aemula when fed a high protein solution. MA silk proline and alanine compositions varied in each species with contrasting variations in alanine between the two species. Glycine compositions only varied in C. mulmeinensis silk. No spiders significantly lost or gained mass on any feeding treatment, so they did not sacrifice somatic maintenance for amino acid investment in silk. Conclusions/Significance: Our results show that the amount of protein taken in significantly affects the foraging decisions of trap-building predators, such as orb web spiders. Nevertheless, the subtle differences found between species in the association between protein intake, the amino acids invested in silk and web architectural plasticity show that the influence of protein deprivation on specific foraging strategies differs among different spiders.	[Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Tso, I-Min] Tunghai Univ, Ctr Trop Ecol & Biodivers, Taichung 40704, Taiwan	Tunghai University; Tunghai University	Tso, IM (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	spider@thu.edu.tw			National Science Council (NSC) [NSC-98-2811-B-029-002]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	The study was assisted financially by a National Science Council (NSC)postdoctoral fellowship (NSC-98-2811-B-029-002) to SJB and an NSC grant to IMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2007, ANIM BEHAV, V73, P855, DOI 10.1016/j.anbehav.2006.10.014; Blamires SJ, 2012, J R SOC INTERFACE, V9, P2479, DOI 10.1098/rsif.2012.0277; Blamires SJ, 2012, BIOL J LINN SOC, V106, P580, DOI 10.1111/j.1095-8312.2012.01884.x; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Blamires SJ, 2011, AUSTRAL ECOL, V36, P389, DOI 10.1111/j.1442-9993.2010.02161.x; Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; Blamires SJ, 2010, ANIM BEHAV, V80, P947, DOI 10.1016/j.anbehav.2010.09.011; Blamires SJ, 2010, J EXP BIOL, V213, P3207, DOI 10.1242/jeb.045583; Blamires SJ, 2009, ECOL ENTOMOL, V34, P545, DOI 10.1111/j.1365-2311.2009.01095.x; Cheng RC, 2007, BEHAV ECOL, V18, P1085, DOI 10.1093/beheco/arm081; Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; Craig CL, 2003, SPIDERWEBS SILK TRAC; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Denno RF, 2004, ECOL ENTOMOL, V29, P566, DOI 10.1111/j.0307-6946.2004.00628.x; Gan WJ, 2011, J NAT HIST, V45, P35, DOI 10.1080/00222933.2010.512398; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Herberstein ME, 2000, J ARACHNOL, V28, P180, DOI 10.1636/0161-8202(2000)028[0180:EOFTET]2.0.CO;2; Herberstein ME, 2000, EVOL ECOL RES, V2, P69; Herberstein ME, 2000, BIOL REV, V75, P649, DOI 10.1111/j.1469-185X.2000.tb00056.x; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Krebs J.R., 1987, BEHAV ECOL, Vsecond; Lee KP, 2006, J EXP BIOL, V209, P2076, DOI 10.1242/jeb.02253; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; MASTERS WM, 1984, BEHAV ECOL SOCIOBIOL, V15, P217, DOI 10.1007/BF00292978; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2009, BIOL LETTERS, V5, P735, DOI 10.1098/rsbl.2009.0431; Moyes CD, 2008, PRINCIPALS ANIMAL PH; Nakata K, 2007, NATURWISSENSCHAFTEN, V94, P853, DOI 10.1007/s00114-007-0264-9; Nakata K, 2009, ANIM BEHAV, V78, P1255, DOI 10.1016/j.anbehav.2009.08.012; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Salomon M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1191, DOI 10.1007/s00265-010-1132-8; Scharf I, 2011, BIOL REV, V86, P626, DOI 10.1111/j.1469-185X.2010.00163.x; Seah WK, 2002, J ZOOL, V258, P531, DOI 10.1017/S0952836902001693; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2011, AUST J ZOOL, V59, P350, DOI 10.1071/ZO11068; Sokal RR, 1995, BIOMETRY; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Tan EJ, 2009, J EXP BIOL, V212, P1832, DOI 10.1242/jeb.030502; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; TOWNLEY MA, 1988, J ARACHNOL, V16, P303; Tseng L, 2009, ANIM BEHAV, V78, P425, DOI 10.1016/j.anbehav.2009.05.017; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Walter A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1909, DOI 10.1007/s00265-011-1200-8; WORK RW, 1987, J ARACHNOL, V15, P65; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x	54	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54558	10.1371/journal.pone.0054558	http://dx.doi.org/10.1371/journal.pone.0054558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349928	gold, Green Published			2022-12-25	WOS:000314019100081
J	Pooran, A; Pieterson, E; Davids, M; Theron, G; Dheda, K				Pooran, Anil; Pieterson, Elize; Davids, Malika; Theron, Grant; Dheda, Keertan			What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?	PLOS ONE			English	Article							PREVALENCE; EPIDEMIOLOGY; HIV; FEASIBILITY; STRATEGIES; COMMUNITY; COHORT; IMPACT; TB	Background: Drug-resistant tuberculosis (DR-TB) is undermining TB control in South Africa. However, there are hardly any data about the cost of treating DR-TB in high burden settings despite such information being quintessential for the rational planning and allocation of resources by policy-makers, and to inform future cost-effectiveness analyses. Methodology: We analysed the comparative 2011 United States dollar ($) cost of diagnosis and treatment of drug sensitive TB (DS-TB), MDR-TB and XDR-TB, based on National South African TB guidelines, from the perspective of the National TB Program using published clinical outcome data. Principal Findings: Assuming adherence to national DR-TB management guidelines, the per patient cost of XDR-TB was $ 26,392, four times greater than MDR-TB ($ 6772), and 103 times greater than drug-sensitive TB ($ 257). Despite DR-TB comprising only 2.2% of the case burden, it consumed,similar to 32% of the total estimated 2011 national TB budget of US $ 218 million. 45% and 25% of the DR-TB costs were attributed to anti-TB drugs and hospitalization, respectively. XDR-TB consumed 28% of the total DR-TB diagnosis and treatment costs. Laboratory testing and anti-TB drugs comprised the majority (71%) of MDR-TB costs while hospitalization and anti-TB drug costs comprised the majority (92%) of XDR-TB costs. A decentralized XDR-TB treatment programme could potentially reduce costs by $ 6930 (26%) per case and reduce the total amount spent on DR-TB by,similar to 7%. Conclusion/Significance: Although DR-TB forms a very small proportion of the total case burden it consumes a disproportionate and substantial amount of South Africa's total annual TB budget. These data inform rational resource allocation and selection of management strategies for DR-TB in high burden settings.	[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415	European Union Seventh Framework Programme (TBsusgent); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (EDCTP); National Research Foundation (NRF); Claude Leon Foundation	European Union Seventh Framework Programme (TBsusgent); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (EDCTP); National Research Foundation (NRF); Claude Leon Foundation	This work was funded by the European Union Seventh Framework Programme (TBsusgent) and the South African National Research Foundation Research Chairs Initiative (SARChI). GT is supported by the the European and Developing Countries Clinical Trials Partnership (EDCTP), National Research Foundation (NRF) and Claude Leon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REP 2011 GLOB TU; Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Iddriss A, 2011, JOINT M 19 ASCVTS 21; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Mehta U, 2008, BRIT J CLIN PHARMACO, V65, P396, DOI 10.1111/j.1365-2125.2007.03034.x; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Oxlade O, 2012, EUR RESPIR J, V39, P626, DOI 10.1183/09031936.00065311; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Schaaf HS, 2009, CLIN CHEST MED, V30, P667, DOI 10.1016/j.ccm.2009.08.019; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; South Africa Department of Health, 2007, TUB STRAT PLAN S AFR; South Africa Dept. of Health, 2009, NAT TUB MAN GUID 200; South African Department of Health, 2011, MAN DRUG RES TUB POL; Statistics South Africa, 2012, STAT REL P0141 CONS; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suh DC, 2000, ANN PHARMACOTHER, V34, P1373, DOI 10.1345/aph.10094; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; UN, 2011, UN MILL DEV GOALS RE; United Nations, 2011, OP RAT EXCH; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; *WHO, 2005, WHOHTMTB2004343; WHO, 2002, GUID COST COST EFF A; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2011, TUB COUNTR PROF S AF; World Health Organization, 2006, GUID PROGR MAN DRUG	43	123	124	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54587	10.1371/journal.pone.0054587	http://dx.doi.org/10.1371/journal.pone.0054587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349933	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800064
J	Zelazny, E; Santambrogio, M; Pourcher, M; Chambrier, P; Berne-Dedieu, A; Fobis-Loisy, I; Miege, C; Jaillais, Y; Gaude, T				Zelazny, Enric; Santambrogio, Martina; Pourcher, Mikael; Chambrier, Pierre; Berne-Dedieu, Annick; Fobis-Loisy, Isabelle; Miege, Christine; Jaillais, Yvon; Gaude, Thierry			Mechanisms Governing the Endosomal Membrane Recruitment of the Core Retromer in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; MAMMALIAN RETROMER; COMPLEX; RECEPTOR; RETRIEVAL; THALIANA; VPS35P; YEAST; COMPONENT; IDENTIFICATION	The retromer complex localizes to endosomal membranes and is involved in protein trafficking. In mammals, it is composed of a dimer of sorting nexins and of the core retromer consisting of vacuolar protein sorting (VPS)26, VPS29, and VPS35. Although homologs of these proteins have been identified in plants, how the plant retromer functions remains elusive. To better understand the role of VPS components in the assembly and function of the core retromer, we characterize here Arabidopsis vps26-null mutants. We show that impaired VPS26 function has a dramatic effect on VPS35 levels and causes severe phenotypic defects similar to those observed in vps29-null mutants. This implies that functions of plant VPS26, VPS29, and VPS35 are tightly linked. Then, by combining live-cell imaging with immunochemical and genetic approaches, we report that VPS35 alone is able to bind to endosomal membranes and plays an essential role in VPS26 and VPS29 membrane recruitment. We also show that the Arabidopsis Rab7 homolog RABG3f participates in the recruitment of the core retromer to the endosomal membrane by interacting with VPS35. Altogether our data provide original information on the molecular interactions that mediate assembly of the core retromer in plants.	CNRS, F-69342 Lyon, France; Inst Natl Rech Agron, F-69364 Lyon, France; Ecole Normale Super Lyon, F-69342 Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France; Unite Mixte Serv Biosci Gerland, F-69366 Lyon, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), ENS Lyon, Plant Reprod & Dev Lab, 46 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; BERNE DEDIEU, Annick/0000-0002-9982-8793	Agence Nationale de la Recherche BLANC RETROMER Project [ANR-08-BLAN-0142]	Agence Nationale de la Recherche BLANC RETROMER Project(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche BLANC RETROMER Project Grant ANR-08-BLAN-0142.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Fobis-Loisy I, 2007, PLANT CELL REP, V26, P745, DOI 10.1007/s00299-006-0282-7; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gokool S, 2007, BIOCHEM J, V408, P287, DOI 10.1042/BJ20070555; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Hashiguchi Y, 2010, PLANT CELL, V22, P159, DOI 10.1105/tpc.109.069294; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Liu TT, 2012, MOL BIOL CELL, V23, P2505, DOI 10.1091/mbc.E11-11-0915; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Pourcher M, 2010, PLANT CELL, V22, P3980, DOI 10.1105/tpc.110.078451; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Restrepo R, 2007, TRAFFIC, V8, P1841, DOI 10.1111/j.1600-0854.2007.00659.x; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shimada T, 2003, P NATL ACAD SCI USA, V100, P16095, DOI 10.1073/pnas.2530568100; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; Zhao X, 2007, TRAFFIC, V8, P1829, DOI 10.1111/j.1600-0854.2007.00658.x	44	46	49	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8815	8825		10.1074/jbc.M112.440503	http://dx.doi.org/10.1074/jbc.M112.440503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23362252	Green Published, hybrid			2022-12-25	WOS:000316862200004
J	Kateb, F; Perrin, H; Tripsianes, K; Zou, P; Spadaccini, R; Bottomley, M; Franzmann, TM; Buchner, J; Ansieau, S; Sattler, M				Kateb, Fatiha; Perrin, Helene; Tripsianes, Konstantinos; Zou, Peijian; Spadaccini, Roberta; Bottomley, Matthew; Franzmann, Titus M.; Buchner, Johannes; Ansieau, Stephane; Sattler, Michael			Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; PROTEIN STRUCTURES; AUTOMATED ASSIGNMENT; DIPOLAR COUPLINGS; N-COR; NMR; TRANSCRIPTION; MACROMOLECULES; REPRESSION	DEAF-1 is an important transcriptional regulator that is required for embryonic development and is linked to clinical depression and suicidal behavior in humans. It comprises various structural domains, including a SAND domain that mediates DNA binding and a MYND domain, a cysteine-rich module organized in a Cys(4)-Cys(2)-His-Cys (C4-C2HC) tandem zinc binding motif. DEAF-1 transcription regulation activity is mediated through interactions with cofactors such as NCoR and SMRT. Despite the important biological role of the DEAF-1 protein, little is known regarding the structure and binding properties of its MYND domain. Here, we report the solution structure, dynamics and ligand binding of the human DEAF-1 MYND domain encompassing residues 501-544 determined by NMR spectroscopy. The structure adopts a beta beta alpha fold that exhibits tandem zinc-binding sites with a cross-brace topology, similar to the MYND domains in AML1/ETO and other proteins. We show that the DEAF-1 MYND domain binds to peptides derived from SMRT and NCoR corepressors. The binding surface mapped by NMR titrations is similar to the one previously reported for AML1/ETO. The ligand binding and molecular functions of the related BS69 MYND domain were studied based on a homology model and mutational analysis. Interestingly, the interaction between BS69 and its binding partners (viral and cellular proteins) seems to require distinct charged residues flanking the predicted MYND domain fold, suggesting a different binding mode. Our findings demonstrate that the MYND domain is a conserved zinc binding fold that plays important roles in transcriptional regulation by mediating distinct molecular interactions with viral and cellular proteins.	[Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany; [Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Franzmann, Titus M.; Buchner, Johannes; Sattler, Michael] Tech Univ Munich, Biomol NMR, Garching, Germany; [Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Franzmann, Titus M.; Buchner, Johannes; Sattler, Michael] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany; [Perrin, Helene; Ansieau, Stephane] Univ Lyon 1, Ctr Leon Berard, Inst Natl Sante & Rech Med U590, F-69365 Lyon, France; [Zou, Peijian; Sattler, Michael] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Spadaccini, Roberta] Univ Naples Federico II, Dipartimento Chim, Naples, Italy; [Bottomley, Matthew] Novartis Vaccines & Diagnost, Siena, Italy	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Naples Federico II; Novartis	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Buchner, Johannes/A-2651-2010; Tripsianes, Konstantinos/I-8382-2014; Ansieau, Stephane/I-6195-2016; Franzmann, Titus M/D-1962-2011	Sattler, Michael/0000-0002-1594-0527; Tripsianes, Konstantinos/0000-0003-0948-813X; Buchner, Johannes/0000-0003-1282-7737; SPADACCINI, Roberta/0000-0002-2262-1065; ANSIEAU, Stephane/0000-0003-0989-2108; Franzmann, Titus/0000-0002-4281-7209	Alexander von Humboldt foundation; long-term EMBO fellowship; Marie-Curie fellowship; Chinese Academy of Science [KSCX2-YW-BR-4]; Deutsche Forschungsgemeinschaft	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); long-term EMBO fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie fellowship(European Commission); Chinese Academy of Science(Chinese Academy of Sciences); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	F.K and K. T. acknowledge support by the Alexander von Humboldt foundation. R. S. and M.J.B. are grateful for long-term EMBO and Marie-Curie fellowships, respectively. P.Z. is supported by the grant (KSCX2-YW-BR-4) from the Chinese Academy of Science. M. S. is supported by the Deutsche Forschungsgemeinschaft. M. S. holds a Visiting Professorship for Senior International Scientists at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2003, PATHOL BIOL, V51, P397, DOI 10.1016/S0369-8114(03)00019-1; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, TENSOR2; Eswar N., 2002, COMP PROTEIN STRUCTU; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foreman KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022290; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Goddard T. D., 2008, SPARKY 3; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Lemonde S, 2003, J NEUROSCI, V23, P8788; Linge J. P, 2001, NEW METHODS AUTOMATE; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu Y, 2007, CANCER CELL, V11, P1; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; PELTON JG, 1993, PROTEIN SCI, V2, P543; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SAVAGE CR, 1973, J BIOL CHEM, V248, P7669; Schwabe JWR, 1994, STRUCT BIOL, V1, P345; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spadaccini R, 2006, J MOL BIOL, V358, P498, DOI 10.1016/j.jmb.2006.01.087; Spadaccini R, 2008, J MOL BIOL, V376, P1523, DOI 10.1016/j.jmb.2008.01.071; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Velasco G, 2006, J BIOL CHEM, V281, P16546, DOI 10.1074/jbc.M600573200; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 1998, J BIOMOL NMR, V12, P325, DOI 10.1023/A:1008223017233	65	18	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54715	10.1371/journal.pone.0054715	http://dx.doi.org/10.1371/journal.pone.0054715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372760	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400025
J	Le, J; Kim, S; Kim, P; Liu, XJ; Lee, T; Kim, KM; Do, IG; Park, JO; Park, SH; Jang, J; Hoe, N; Harvie, G; Kuller, A; Jain, A; Meyer, G; Leesman, G; Park, YS; Choi, MG; Sohn, TS; Bae, JM; Lim, HY; Singh, S; Kang, WK				Le, Jeeyun; Kim, Sung; Kim, Phillip; Liu, Xinjun; Lee, Tani; Kim, Kyoung-Mee; Do, In-Gu; Park, Joon Oh; Park, Se Hoon; Jang, Jiryeon; Hoe, Nicholas; Harvie, Gulia; Kuller, Anne; Jain, Anjali; Meyer, Gary; Leesman, Glen; Park, Young Suk; Choi, Min Gew; Sohn, Tae Sung; Bae, Jae Moon; Lim, Ho Yeong; Singh, Sharat; Kang, Won Ki			A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; INTESTINAL-TYPE; TUMOR-CELLS; HER2 STATUS; HIGH-RISK; EXPRESSION; CARCINOMA; RECEPTOR; REVEALS	Purpose: The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs). Experimental Design: Protein lysates from fresh-frozen 434 advanced stage GCs were analyzed for phosphorylation of HER1, HER2, p95HER2, HER3, cMET, IGF1R and PI3K. The pathway activation patterns were segregated based on the tumor HER2 status. Hierarchical clustering was utilized to determine pathway coactivations in GCs. Prognostic value of pathway activation patterns was determined by correlating disease-free survival times of the various GC subgroups using Kaplan-Meier survival analysis. CEER was also used to determine the presence of tyrosine phosphorylated signaling cascades in circulating tumor cells (CTCs) and ascites tumor cells (ATCs). Results: Utilizing a novel diagnostics immunoassay, CEER, we demonstrate the presence of p95HER2 and concomitantly activated signaling pathways in GC tumor tissues, CTCs and ATCs isolated from GC patients for the first time. p95HER2 is expressed in similar to 77% of HER2(+) GCs. Approximately 54% of GCs have an activated HER1, HER2, HER3, cMET or IGF1R and demonstrate a poorer prognosis than those where these receptor tyrosine kinases (RTKs) are not activated. Hierarchical clustering of RTKs reveals co-clustering of phosphorylated HER1: cMET, HER2: HER3 and IGF1R-PI3K. Coactivation of HER1 with cMET renders GCs with a shorter disease-free survival as compared to only cMET activated GCs. Conclusions: Our study highlights the utility of a novel companion diagnostics technology, CEER that has strong implications for drug development and therapeutic monitoring. CEER is used to provide an increased understanding of activated signaling pathways in advanced GCs that can significantly improve their clinical management through accurate patient selection for targeted therapeutics.	[Le, Jeeyun; Park, Joon Oh; Park, Se Hoon; Jang, Jiryeon; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Kim, Sung; Choi, Min Gew; Sohn, Tae Sung] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea; [Kim, Kyoung-Mee; Do, In-Gu; Bae, Jae Moon] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea; [Kim, Phillip; Liu, Xinjun; Lee, Tani; Hoe, Nicholas; Harvie, Gulia; Kuller, Anne; Jain, Anjali; Meyer, Gary; Leesman, Glen; Singh, Sharat] Prometheus Labs, San Diego, CA USA; [Do, In-Gu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Canc Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, S (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea.	sungkimm@skku.edu; wkkang@skku.edu	Kim, Sung/G-4114-2014; Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015; Park, Se Hoon/GMX-1199-2022	Park, Se Hoon/0000-0001-5084-9326				Arribas J, 2011, CANCER RES, V71, P1515, DOI 10.1158/0008-5472.CAN-10-3795; Bae Jong Myon, 2002, Cancer Res Treat, V34, P77, DOI 10.4143/crt.2002.34.2.77; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; CORREA P, 1990, CANCER RES, V50, P4731; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2005, ANN ONCOL, V16, P22, DOI 10.1093/annonc/mdi812; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hazra S, 2012, J CLIN ONCOL S, V30; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hoe N, 2011, P 102 ANN M AM ASS C; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Jhawer MP, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4572; Kim P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-75; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Loibl S BJ, 2011, J CLIN ONCOL, V29; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tay ST, 2003, CANCER RES, V63, P3309; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ward TM, 2012, ONCOGENE IN PRESS; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; YOU WC, 1993, CANCER RES, V53, P1317	38	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54644	10.1371/journal.pone.0054644	http://dx.doi.org/10.1371/journal.pone.0054644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372746	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400021
J	Dentler, W				Dentler, William			A Role for the Membrane in Regulating Chlamydomonas Flagellar Length	PLOS ONE			English	Article							NIMA-RELATED KINASE; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; PROTEIN; CILIARY; COMPLEX; REGENERATION; ELONGATION; MICROTUBULES; TURNOVER	Flagellar assembly requires coordination between the assembly of axonemal proteins and the assembly of the flagellar membrane and membrane proteins. Fully grown steady-state Chlamydomonas flagella release flagellar vesicles from their tips and failure to resupply membrane should affect flagellar length. To study vesicle release, plasma and flagellar membrane surface proteins were vectorially pulse-labeled and flagella and vesicles were analyzed for biotinylated proteins. Based on the quantity of biotinylated proteins in purified vesicles, steady-state flagella appeared to shed a minimum of 16% of their surface membrane per hour, equivalent to a complete flagellar membrane being released every 6 hrs or less. Brefeldin-A destroyed Chlamydomonas Golgi, inhibited the secretory pathway, inhibited flagellar regeneration, and induced full-length flagella to disassemble within 6 hrs, consistent with flagellar disassembly being induced by a failure to resupply membrane. In contrast to membrane lipids, a pool of biotinylatable membrane proteins was identified that was sufficient to resupply flagella as they released vesicles for 6 hrs in the absence of protein synthesis and to support one and nearly two regenerations of flagella following amputation. These studies reveal the importance of the secretory pathway to assemble and maintain full-length flagella.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Dentler, W (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	wdent@ku.edu			National Center for Research Resources [P20RR016475]; National Institute of General Medical Science from the National Institutes of Health [P20GM133418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Science from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Portions of this work were supported by a grant from the National Center for Research Resources (P20RR016475) and the National Institute of General Medical Science (P20GM133418) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azencott HR, 2007, ULTRASOUND MED BIOL, V33, P1805, DOI 10.1016/j.ultrasmedbio.2007.05.008; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; BERGMAN K, 1975, J CELL BIOL, V67, P606, DOI 10.1083/jcb.67.3.606; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; BLOODGOOD RA, 1984, EXP CELL RES, V150, P488, DOI 10.1016/0014-4827(84)90594-9; Bloodgood RA, 2012, MOL BIOL CELL, V23, P2407, DOI 10.1091/mbc.E12-01-0073; Bouck G.B., 1990, P65; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; BROWN RM, 1968, J PHYCOL, V4, P100, DOI 10.1111/j.1529-8817.1968.tb04683.x; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Cifuentes F, 2001, CELL SIGNAL, V13, P353, DOI 10.1016/S0898-6568(01)00132-2; COYNE B, 1970, J CELL BIOL, V47, P777, DOI 10.1083/jcb.47.3.777; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dentler W, 2005, J CELL BIOL, V170, P649, DOI 10.1083/jcb.200412021; Dentler W, 2009, METHOD CELL BIOL, V93, P145, DOI 10.1016/S0091-679X(08)93008-9; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1995, METHOD CELL BIOL, V47, P407, DOI 10.1016/S0091-679X(08)60838-9; DENTLER WL, 1980, J CELL SCI, V42, P207; Dentler WL, 2009, CHLAMYDOMONAS SOURCE, P283; Eckmiller MS, 1996, CELL TISSUE RES, V285, P165, DOI 10.1007/s004410050632; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; Ghossoub R, 2011, BIOL CELL, V103, P131, DOI 10.1042/BC20100128; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haller K, 1998, BIOCHEM BIOPH RES CO, V242, P597, DOI 10.1006/bbrc.1997.8015; He Q, 2012, MOL BIOL CELL, V23, P3156, DOI 10.1091/mbc.E12-02-0079; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Hunnicutt GR, 1990, J CELL BIOL, V179, P501; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P13225, DOI 10.1073/pnas.1202509109; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kaplan OI, 2012, CURR BIOL, V22, P451, DOI 10.1016/j.cub.2012.01.060; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Langhans M, 2007, PLANT PHYSIOL, V145, P527, DOI 10.1104/pp.107.104919; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; LEFEBVRE PA, 1995, METHOD CELL BIOL, V47, P3, DOI 10.1016/S0091-679X(08)60782-7; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakamura S, 1996, J CELL SCI, V109, P57; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Quarmby L.M., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition, P43, DOI [10.1016/b978-0-12-370873-1.00040-x, DOI 10.1016/B978-0-12-370873-1.00040-X]; REINHART FD, 1988, J CELL SCI, V89, P521; REMILLARD SP, 1982, J CELL BIOL, V93, P615, DOI 10.1083/jcb.93.3.615; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Song L, 2001, J BIOL CHEM, V276, P29754, DOI 10.1074/jbc.M103184200; STEPHENS RE, 1994, J CELL SCI, V107, P683; Stephens RE, 2001, J EXP ZOOL, V289, P335, DOI 10.1002/jez.1015; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	79	21	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53366	10.1371/journal.pone.0053366	http://dx.doi.org/10.1371/journal.pone.0053366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359798	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600015
J	Tessier, MB; Grant, OC; Heimburg-Molinaro, J; Smith, D; Jadey, S; Gulick, AM; Glushka, J; Deutscher, SL; Rittenhouse-Olson, K; Woods, RJ				Tessier, Matthew B.; Grant, Oliver C.; Heimburg-Molinaro, Jamie; Smith, David; Jadey, Snehal; Gulick, Andrew M.; Glushka, John; Deutscher, Susan L.; Rittenhouse-Olson, Kate; Woods, Robert J.			Computational Screening of the Human TF-Glycome Provides a Structural Definition for the Specificity of Anti-Tumor Antibody JAA-F11	PLOS ONE			English	Article							THOMSEN-FRIEDENREICH; CARBOHYDRATE ANTIGEN; MONOCLONAL-ANTIBODY; BINDING-SITES; FORCE-FIELD; LIGAND; GLYCOBIOLOGY; CONFORMATION; NMR	Recombinant antibodies are of profound clinical significance; yet, anti-carbohydrate antibodies are prone to undesirable cross-reactivity with structurally related-glycans. Here we introduce a new technology called Computational Carbohydrate Grafting (CCG), which enables a virtual library of glycans to be assessed for protein binding specificity, and employ it to define the scope and structural origin of the binding specificity of antibody JAA-F11 for glycans containing the Thomsen-Friedenreich (TF) human tumor antigen. A virtual library of the entire human glycome (GLibrary-3D) was constructed, from which 1,182 TF-containing human glycans were identified and assessed for their ability to fit into the antibody combining site. The glycans were categorized into putative binders, or non-binders, on the basis of steric clashes with the antibody surface. The analysis employed a structure of the immune complex, generated by docking the TF-disaccharide (Gal beta 1-GalNAc alpha) into a crystal structure of the JAA-F11 antigen binding fragment, which was shown to be consistent with saturation transfer difference (STD) NMR data. The specificities predicted by CCG were fully consistent with data from experimental glycan array screening, and confirmed that the antibody is selective for the TF-antigen and certain extended core-2 type mucins. Additionally, the CCG analysis identified a limited number of related putative binding motifs, and provided a structural basis for interpreting the specificity. CCG can be utilized to facilitate clinical applications through the determination of the three-dimensional interaction of glycans with proteins, thus augmenting drug and vaccine development techniques that seek to optimize the specificity and affinity of neutralizing proteins, which target glycans associated with diseases including cancer and HIV.	[Tessier, Matthew B.; Glushka, John; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tessier, Matthew B.; Glushka, John; Woods, Robert J.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Grant, Oliver C.; Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Heimburg-Molinaro, Jamie; Jadey, Snehal; Rittenhouse-Olson, Kate] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Smith, David] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Gulick, Andrew M.] SUNY Buffalo, Hauptman Woodward Inst, Dept Biol Struct, Buffalo, NY 14260 USA; [Deutscher, Susan L.] Univ Missouri, Dept Biochem, Columbia, MO USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Emory University; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Missouri System; University of Missouri Columbia	Rittenhouse-Olson, K (corresponding author), SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA.	krolson@buffalo.edu; rwoods@ccrc.uga.edu		Rittenhouse-Olson, Kate/0000-0001-8905-861X; Gulick, Andrew/0000-0003-4238-7453; Grant, Oliver/0000-0003-4835-5161; Woods, Robert/0000-0002-2400-6293	National Institutes for Health [GM085448, GM062116, GM094919]; Science Foundation of Ireland [08/IN.1/B2070]; European Research Development Fund; National Science Foundation [DMR 0225180]; Department of Defense (CDMRP) [W81XWH-04-1-0342]; National Institutes of Health [RR001646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103390, P41GM103694, R01GM085448, R24GM098791, R01GM094919] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); European Research Development Fund; National Science Foundation(National Science Foundation (NSF)); Department of Defense (CDMRP)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RJW would like to thank the National Institutes for Health (GM085448 to DFS, GM062116, GM094919 (EUREKA), www.nih.gov) as well as the Science Foundation of Ireland (08/IN.1/B2070, www.sfi.ie) and the European Research Development Fund for support. Diffraction data were collected at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation under award DMR 0225180 (www.nsf.gov) and the National Institutes of Health (RR001646). KRO would like to acknowledge the Department of Defense (CDMRP # W81XWH-04-1-0342, www.defense.gov) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2011, BIOPOLYMERS, V96, P193, DOI 10.1002/bip.21427; Almogren Adel, 2012, Front Biosci (Schol Ed), V4, P840; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bukowski R, 2001, EUR J ORG CHEM, V2001, P2697; Chaturvedi R, 2008, APPL RADIAT ISOTOPES, V66, P278, DOI 10.1016/j.apradiso.2007.07.029; Cobas C, 2011, MESTRE NOVA; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; GRONENBORN AM, 1985, PROG NUCL MAG RES SP, V17, P1, DOI 10.1016/0079-6565(85)80004-2; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; Henderson G, 2011, GLYCOBIOLOGY, V21, P1277, DOI 10.1093/glycob/cwr058; HOMANS SW, 1993, GLYCOBIOLOGY, V3, P551, DOI 10.1093/glycob/3.6.551; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Irazoqui FJ, 2005, IMMUNOL CELL BIOL, V83, P405, DOI 10.1111/j.1440-1711.2005.01348.x; JEFFREY PD, 1995, NAT STRUCT BIOL, V2, P466, DOI 10.1038/nsb0695-466; Johnson MA, 2008, TOP CURR CHEM, V273, P55, DOI 10.1007/128_2007_18; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kosma P, 2011, ANTICARBOHYDRATE ANT; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Lewallen DM, 2009, CHEMBIOCHEM, V10, P1486, DOI 10.1002/cbic.200900211; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRIS GM, 1999, AUTODOCK; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi T, 2008, PROTEIN SCI, V17, P261, DOI 10.1110/ps.073156708; Orntoft TF, 1999, ELECTROPHORESIS, V20, P362, DOI 10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.3.CO;2-M; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POPPE L, 1992, J BIOMOL NMR, V2, P109, DOI 10.1007/BF01875524; Ranzinger R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-384; Rao V. S. R., 1998, CONFORMATION CARBOHY; Rittenhouse-Diakun K, 1998, HYBRIDOMA, V17, P165, DOI 10.1089/hyb.1998.17.165; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Woods R.J., 2005, GLYCAM WEB; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yarema KJ, 1998, CURR OPIN CHEM BIOL, V2, P49, DOI 10.1016/S1367-5931(98)80035-5; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	53	29	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54874	10.1371/journal.pone.0054874	http://dx.doi.org/10.1371/journal.pone.0054874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365681	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600126
J	Wood, S; Pithadia, R; Rehman, T; Zhang, LJ; Plichta, J; Radek, KA; Forsyth, C; Keshavarzian, A; Shafikhani, SH				Wood, Stephen; Pithadia, Ravi; Rehman, Tooba; Zhang, Lijuan; Plichta, Jennifer; Radek, Katherine A.; Forsyth, Christopher; Keshavarzian, Ali; Shafikhani, Sasha H.			Chronic Alcohol Exposure Renders Epithelial Cells Vulnerable to Bacterial Infection	PLOS ONE			English	Article							SECRETED TOXIN EXOT; PSEUDOMONAS-AERUGINOSA; INTESTINAL PERMEABILITY; MESENCHYMAL TRANSITION; BARRIER DYSFUNCTION; LIVER-DISEASE; ETHANOL; MICROFLORA; APOPTOSIS; GROWTH	Despite two centuries of reports linking alcohol consumption with enhanced susceptibility to bacterial infections and in particular gut-derived bacteria, there have been no studies or model systems to assess the impact of long-term alcohol exposure on the ability of the epithelial barrier to withstand bacterial infection. It is well established that acute alcohol exposure leads to reduction in tight and adherens junctions, which in turn leads to increases in epithelial cellular permeability to bacterial products, leading to endotoxemia and a variety of deleterious effects in both rodents and human. We hypothesized that reduced fortification at junctional structures should also reduce the epithelial barrier's capacity to maintain its integrity in the face of bacterial challenge thus rendering epithelial cells more vulnerable to infection. In this study, we established a cell-culture based model system for long-term alcohol exposure to assess the impact of chronic alcohol exposure on the ability of Caco-2 intestinal epithelial cells to withstand infection when facing pathogenic bacteria under the intact or wounded conditions. We report that daily treatment with 0.2% ethanol for two months rendered Caco-2 cells far more susceptible to wound damage and cytotoxicity caused by most but not all bacterial pathogens tested in our studies. Consistent with acute alcohol exposure, long-term ethanol exposure also adversely impacted tight junction structures, but in contrast, it did not affect the adherens junction. Finally, alcohol-treated cells partially regained their ability to withstand infection when ethanol treatment was ceased for two weeks, indicating that alcohol's deleterious effects on cells may be reversible.	[Wood, Stephen; Pithadia, Ravi; Rehman, Tooba; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Plichta, Jennifer; Radek, Katherine A.] Loyola Univ Chicago, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL USA; [Zhang, Lijuan; Forsyth, Christopher; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA	Rush University; Loyola University Chicago; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Plichta, Jennifer K/L-5450-2016; Shafikhani, Sasha/AAM-3460-2021	Plichta, Jennifer K/0000-0002-7411-0558; Wood, Stephen/0000-0002-1306-1027; Shafikhani, Sasha/0000-0003-1755-9997	Rush Startup funds;  [AA020216]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	Rush Startup funds; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by grant AA020216 (AK, CBF) and by Rush Startup funds to S. H. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; BODE JC, 1984, HEPATO-GASTROENTEROL, V31, P30; Bode JC, 2001, ALCOHOL IN HEALTH AND DISEASE, P369; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Gao LY, 2000, MICROBES INFECT, V2, P1705, DOI 10.1016/S1286-4579(00)01326-5; GARCIA JMA, 1984, REV CLIN ESP, V174, P85; Garrity-Ryan L, 2004, INFECT IMMUN, V72, P546, DOI 10.1128/IAI.72.1.546-558.2004; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Huang DB, 2004, J TRAVEL MED, V11, P143, DOI 10.2310/7060.2004.18560; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; KOLB D, 1982, DRUG ALCOHOL DEPEN, V9, P181, DOI 10.1016/0376-8716(82)90043-6; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lerner A M, 1968, Mich Med, V67, P35; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Murdoch EL, 2011, SHOCK, V35, P403, DOI 10.1097/SHK.0b013e31820217c9; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; NOLAN JP, 1965, AM J MED SCI, V249, P135; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Robson MC, 1997, SURG CLIN N AM, V77, P637, DOI 10.1016/S0039-6109(05)70572-7; Rush B, 1814, AN INQUIRY INTO THE, P321; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Simet SM, 2012, ALCOHOL CLIN EXP RES, V36, P432, DOI 10.1111/j.1530-0277.2011.01640.x; SMITH FE, 1976, J CHRON DIS, V29, P35, DOI 10.1016/0021-9681(76)90066-7; SPACH DH, 1995, NEW ENGL J MED, V332, P424, DOI 10.1056/NEJM199502163320703; Stephens P, 2003, BRIT J DERMATOL, V148, P456, DOI 10.1046/j.1365-2133.2003.05232.x; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; TILLOTSON JR, 1966, MEDICINE, V45, P65, DOI 10.1097/00005792-196601000-00003; Wood S, 2011, CELL CYCLE, V10, P648, DOI 10.4161/cc.10.4.14813	46	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54646	10.1371/journal.pone.0054646	http://dx.doi.org/10.1371/journal.pone.0054646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358457	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600085
J	Carmona, FD; Martin, JE; Beretta, L; Simeon, CP; Carreira, PE; Callejas, JL; Fernandez-Castro, M; Saez-Comet, L; Beltran, E; Camps, MT; Egurbide, MV; Airo, P; Scorza, R; Lunardi, C; Hunzelmann, N; Riemekasten, G; Witte, T; Kreuter, A; Distler, JHW; Madhok, R; Shiels, P; van Laar, JM; Fonseca, C; Denton, C; Herrick, A; Worthington, J; Schuerwegh, AJ; Vonk, MC; Voskuyl, AE; Radstake, TRDJ; Martin, J				David Carmona, F.; Martin, Jose-Ezequiel; Beretta, Lorenzo; Simeon, Carmen P.; Carreira, Patricia E.; Luis Callejas, Jose; Fernandez-Castro, Monica; Saez-Comet, Luis; Beltran, Emma; Teresa Camps, Maria; Victoria Egurbide, Maria; Airo, Paolo; Scorza, Raffaella; Lunardi, Claudio; Hunzelmann, Nicolas; Riemekasten, Gabriela; Witte, Torsten; Kreuter, Alexander; Distler, Joerg H. W.; Madhok, Rajan; Shiels, Paul; van Laar, Jacob M.; Fonseca, Carmen; Denton, Christopher; Herrick, Ariane; Worthington, Jane; Schuerwegh, Annemie J.; Vonk, Madelon C.; Voskuyl, Alexandre E.; Radstake, Timothy R. D. J.; Martin, Javier		Spanish Scleroderma Grp	The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERFERON-ALPHA ACTIVITY; FUNCTIONAL POLYMORPHISM; RHEUMATOID-ARTHRITIS; SCLERODERMA; GENE; EXPRESSION; SUBSETS	Systemic sclerosis (SSc) is a fibrotic autoimmune disease in which the genetic component plays an important role. One of the strongest SSc association signals outside the human leukocyte antigen (HLA) region corresponds to interferon (IFN) regulatory factor 5 (IRF5), a major regulator of the type I IFN pathway. In this study we aimed to evaluate whether three different haplotypic blocks within this locus, which have been shown to alter the protein function influencing systemic lupus erythematosus (SLE) susceptibility, are involved in SSc susceptibility and clinical phenotypes. For that purpose, we genotyped one representative single-nucleotide polymorphism (SNP) of each block (rs10488631, rs2004640, and rs4728142) in a total of 3,361 SSc patients and 4,012 unaffected controls of Caucasian origin from Spain, Germany, The Netherlands, Italy and United Kingdom. A meta-analysis of the allele frequencies was performed to analyse the overall effect of these IRF5 genetic variants on SSc. Allelic combination and dependency tests were also carried out. The three SNPs showed strong associations with the global disease (rs4728142: P = 1.34x10(-8), OR = 1.22, CI 95% = 1.14-1.30; rs2004640: P = 4.60x10(-7), OR = 0.84, CI 95% = 0.78-0.90; rs10488631: P = 7.53x10(-20), OR = 1.63, CI 95% = 1.47-1.81). However, the association of rs2004640 with SSc was not independent of rs4728142 (conditioned P = 0.598). The haplotype containing the risk alleles (rs4728142* A-rs2004640* T-rs10488631* C: P = 9.04x10(-22), OR = 1.75, CI 95% = 1.56-1.97) better explained the observed association (likelihood P-value = 1.48x10(-4)), suggesting an additive effect of the three haplotypic blocks. No statistical significance was observed in the comparisons amongst SSc patients with and without the main clinical characteristics. Our data clearly indicate that the SLE risk haplotype also influences SSc predisposition, and that this association is not sub-phenotype-specific.	[David Carmona, F.; Martin, Jose-Ezequiel; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Beretta, Lorenzo; Scorza, Raffaella] Univ Milan, Referral Ctr Syst Autoimmune Dis, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Simeon, Carmen P.] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Carreira, Patricia E.] Hosp 12 Octubre, Dept Rheumatol, E-28041 Madrid, Spain; [Luis Callejas, Jose] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [Fernandez-Castro, Monica] Hosp Puerta Hierro Majadahonda, Dept Rheumatol, Madrid, Spain; [Saez-Comet, Luis] Hosp Univ Miguel Servet, Dept Internal Med, Zaragoza, Spain; [Beltran, Emma] Hosp Gen Univ Valencia, Dept Rheumatol, Valencia, Spain; [Teresa Camps, Maria] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Victoria Egurbide, Maria] Hosp Cruces, Dept Internal Med, Baracaldo, Spain; [Airo, Paolo] Clin Spedali Civili, Serv Reumatol & Immunol, Brescia, Italy; [Lunardi, Claudio] Univ Verona, Dept Med, I-37100 Verona, Italy; [Hunzelmann, Nicolas] Univ Cologne, Dept Dermatol, Cologne, Germany; [Riemekasten, Gabriela] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Witte, Torsten] Hannover Med Sch, Hannover, Germany; [Kreuter, Alexander] Ruhr Univ Bochum, Bochum, Germany; [Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol, D-91054 Erlangen, Germany; [Madhok, Rajan; Shiels, Paul] Univ Glasgow, Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G31 2ER, Lanark, Scotland; [van Laar, Jacob M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fonseca, Carmen; Denton, Christopher] Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London WC1E 6BT, England; [Herrick, Ariane; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Schuerwegh, Annemie J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Vonk, Madelon C.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Voskuyl, Alexandre E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; Hospital Universitario San Cecilio; Hospital Puerta de Hierro-Majadahonda; Miguel Servet University Hospital; Hospital Carlos Haya; Hospital Universitario Cruces; University of Verona; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Ruhr University Bochum; University of Erlangen Nuremberg; University of Glasgow; Newcastle University - UK; University of London; University College London; University of Manchester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Carmona, FD (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	dcarmona@ipb.csic.es	Witte, Torsten/B-5783-2016; Beretta, Lorenzo/AAB-8605-2019; Espinosa, Gerard/J-2603-2016; Riemekasten, Gabriela/B-5019-2017; González-Gay, Miguel A./B-2306-2008; Narvaez, Javier/AAD-7456-2020; Vonk, M.C./L-4726-2015; Worthington, Jane/M-9770-2014; Martin, Javier/B-8141-2008; Carballeir, Monica Rodriguez/AAQ-8337-2021; Martín, María/HDL-9512-2022; Comet, Luis Sáez/I-7301-2017; Catalán, Emma EBC Beltrán/H-5606-2016; Martin, Jose-Ezequiel/A-6136-2011; Martín, Javier/AAV-5209-2021; IBIS, EPIDEMIOLOGIA/O-8791-2015; Centeno, Norberto Ortego/C-4793-2019; Andreu, José Luis/E-5115-2012; Carmona, F. David/F-9953-2016; Castro, Monica Fernandez/ABH-4410-2020; Carreira, Patricia E/D-4429-2018; Fernandez-Nebro, Antonio/K-7628-2012; Martin, Jose Ezequiel/F-4869-2012	Beretta, Lorenzo/0000-0002-6529-6258; Espinosa, Gerard/0000-0003-1336-0163; González-Gay, Miguel A./0000-0002-7924-7406; Narvaez, Javier/0000-0002-1614-8064; Vonk, M.C./0000-0002-2266-9907; Worthington, Jane/0000-0003-0544-042X; Martin, Javier/0000-0002-2202-0622; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Catalán, Emma EBC Beltrán/0000-0001-8070-6916; Centeno, Norberto Ortego/0000-0003-2325-0937; Andreu, José Luis/0000-0002-6002-1239; Carmona, F. David/0000-0002-1427-7639; Castro, Monica Fernandez/0000-0003-4081-2751; Carreira, Patricia E/0000-0001-8279-3806; Saez Comet, Luis/0000-0002-9868-6498; Fernandez-Nebro, Antonio/0000-0002-2962-9844; callejas, jose luis/0000-0002-1653-0087; Kreuter, Alexander/0000-0003-2275-499X; Herrick, Ariane/0000-0003-4941-7926; Shiels, Paul/0000-0002-7577-9843; Garcia-Hernandez, Francisco Jose/0000-0002-2600-0485; Castellvi, Ivan/0000-0002-5410-5807; Martin, Jose Ezequiel/0000-0002-0051-8868; Voskuyl, Alexandre/0000-0002-9699-1827; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786; Andreu Sanchez, Jose Luis/0000-0001-9126-8819	GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science [SAF2009-11110]; Junta de Andalucia [CTS-4977, CTS-180]; RETICS Program; Instituto de Salud Carlos III (ISCIII), Spain within the VI PN de I+D+i (FEDER); European League Against Rheumatism (EULAR); Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain [PI-0590-2010]; Consejeria de Salud, Junta de Andalucia [PI-0590-2010]; Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC; VIDI laureate from the Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); DFG [WI 1031/6.1]	GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); RETICS Program; Instituto de Salud Carlos III (ISCIII), Spain within the VI PN de I+D+i (FEDER); European League Against Rheumatism (EULAR); Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC; VIDI laureate from the Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); DFG(German Research Foundation (DFG))	This work was supported by the following grants: JM was funded by GEN-FER from the Spanish Society of Rheumatology, SAF2009-11110 from the Spanish Ministry of Science, CTS-4977, and CTS-180 from Junta de Andalucia, RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), Spain, within the VI PN de I+D+i 2008-2011 (FEDER), and is sponsored by the Orphan Disease Program grant from the European League Against Rheumatism (EULAR). This study was also funded by PI-0590-2010, from Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain. NH and JM are funded by Consejeria de Salud, Junta de Andalucia, through PI-0590-2010. FDC was supported by Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC. TRDJR was funded by the VIDI laureate from the Dutch Association of Research (NWO) and Dutch Arthritis Foundation (National Reumafonds). TW was granted by DFG WI 1031/6.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2010, CURR OPIN RHEUMATOL, V22, P133, DOI 10.1097/BOR.0b013e3283367c17; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Dieude P, 2010, J RHEUMATOL, V37, P987, DOI 10.3899/jrheum.091163; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; LEROY EC, 1988, J RHEUMATOL, V15, P202; Martin JE, 2012, HUM MOL GENET, V21, P2825, DOI 10.1093/hmg/dds099; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Niewold TB, 2012, ANN RHEUM DIS, V71, P463, DOI 10.1136/annrheumdis-2011-200463; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sozzani S, 2010, AUTOIMMUNITY, V43, P196, DOI 10.3109/08916930903510872	25	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54419	10.1371/journal.pone.0054419	http://dx.doi.org/10.1371/journal.pone.0054419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372721	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000314021500070
J	Moy, AJ; Wiersma, MP; Choi, B				Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard			Optical Histology: A Method to Visualize Microvasculature in Thick Tissue Sections of Mouse Brain	PLOS ONE			English	Article							NORMALIZATION; MICROENVIRONMENT; ANGIOGENESIS; RESOLUTION; DISEASES; DENSITY; CANCER; SKIN	Background: The microvasculature is the network of blood vessels involved in delivering nutrients and gases necessary for tissue survival. Study of the microvasculature often involves immunohistological methods. While useful for visualizing microvasculature at the mm scale in specific regions of interest, immunohistology is not well suited to visualize the global microvascular architecture in an organ. Hence, use of immunohistology precludes visualization of the entire microvasculature of an organ, and thus impedes study of global changes in the microvasculature that occur in concert with changes in tissue due to various disease states. Therefore, there is a critical need for a simple, relatively rapid technique that will facilitate visualization of the microvascular network of an entire tissue. Methodology/Principal Findings: The systemic vasculature of a mouse is stained with the fluorescent lipophilic dye DiI using a method called "vessel painting". The brain, or other organ of interest, is harvested and fixed in 4% paraformaldehyde. The organ is then sliced into 1 mm sections and optically cleared, or made transparent, using FocusClear, a proprietary optical clearing agent. After optical clearing, the DiI-labeled tissue microvasculature is imaged using confocal fluorescence microscopy and adjacent image stacks tiled together to produce a depth-encoded map of the microvasculature in the tissue slice. We demonstrated that the use of optical clearing enhances both the tissue imaging depth and the estimate of the vascular density. Using our "optical histology" technique, we visualized microvasculature in the mouse brain to a depth of 850 mu m. Conclusions/Significance: Presented here are maps of the microvasculature in 1 mm thick slices of mouse brain. Using combined optical clearing and optical imaging techniques, we devised a methodology to enhance the visualization of the microvasculature in thick tissues. We believe this technique could potentially be used to generate a three-dimensional map of the microvasculature in an entire organ.	[Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA; [Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Choi, Bernard] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Choi, B (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA.	choib@uci.edu		Choi, Bernard/0000-0002-4380-8291	Arnold and Mabel Beckman Foundation; National Institutes of Health [R01 HD065536]; National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource) [EB015890]; CelExplorer Labs (Hsinchu, Taiwan); University of California, Irvine; Tufts University School of Medicine; Princeton University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015890] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource); CelExplorer Labs (Hsinchu, Taiwan); University of California, Irvine(University of California System); Tufts University School of Medicine; Princeton University(Princeton University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the Arnold and Mabel Beckman Foundation, the National Institutes of Health grant award R01 HD065536, and the National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource, grant number EB015890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge CelExplorer Labs (Hsinchu, Taiwan) for generously donating FocusClear, Dr. Tatiana Krasieva (University of California, Irvine), Sean White (University of California, Irvine), Henry Shih (Tufts University School of Medicine), and Lawrence Chang (Princeton University) for their support.	Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Choi B, 2005, LASER SURG MED, V36, P72, DOI 10.1002/lsm.20116; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; Choi B, 2008, J INVEST DERMATOL, V128, P485, DOI 10.1038/sj.jid.5700991; De Silva DA, 2011, NEUROLOGY, V77, P896, DOI 10.1212/WNL.0b013e31822c623b; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fanelli M, 1999, INT J BIOL MARKER, V14, P218, DOI 10.1177/172460089901400405; Fu YY, 2010, MICROVASC RES, V80, P512, DOI 10.1016/j.mvr.2010.06.003; Fu YY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470241; Fu YY, 2009, GASTROENTEROLOGY, V137, P453, DOI 10.1053/j.gastro.2009.05.008; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hoenig MR, 2008, CURR VASC PHARMACOL, V6, P292, DOI 10.2174/157016108785909779; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Khan F, 2003, J PHYSIOL-LONDON, V551, P705, DOI 10.1113/jphysiol.2003.045351; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Malpass Katy, 2011, Nat Rev Neurol, V7, P538, DOI 10.1038/nrneurol.2011.148; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Oldham M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907968; Ravnic DJ, 2005, MICROVASC RES, V70, P90, DOI 10.1016/j.mvr.2005.06.002; Rylander CG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2343208; Tuchin VV, 2005, J PHYS D APPL PHYS, V38, P2497, DOI 10.1088/0022-3727/38/15/001; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Vargas G, 2001, LASER SURG MED, V29, P213, DOI 10.1002/lsm.1110; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; White SM, 2011, MICROVASC RES, V82, P92, DOI 10.1016/j.mvr.2011.03.006; Yeh AT, 2003, J INVEST DERMATOL, V121, P1332, DOI 10.1046/j.1523-1747.2003.12634.x; Zanini A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-132; Zhao L-A, 2002, INVEST OPHTHALMOL VI, V43	36	94	97	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53753	10.1371/journal.pone.0053753	http://dx.doi.org/10.1371/journal.pone.0053753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372668	gold, Green Published			2022-12-25	WOS:000314021500023
J	Nguyen, THT; Lam, PK; Huynh, TLD; Ngoc, TV; Phan, TTH; Nguyen, TTK; Simmons, C; Wolbers, M; Wills, B				Nguyen Thi Hanh Tien; Phung Khanh Lam; Huynh Thi Le Duyen; Tran Van Ngoc; Phan Thi Thanh Ha; Nguyen Tan Thanh Kieu; Simmons, Cameron; Wolbers, Marcel; Wills, Bridget			Assessment of Microalbuminuria for Early Diagnosis and Risk Prediction in Dengue Infections	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; DIFFERENTIATE DENGUE; FEBRILE ILLNESSES; CREATININE RATIO; SHOCK SYNDROME; CHILDREN; CLASSIFICATION; VARIABILITY; PROTEINURIA; FEATURES	Background: Dengue is the most important arboviral infection of humans. Following an initial febrile period, a small proportion of infected patients develop a vasculopathy, with children at particular risk for severe vascular leakage and shock. Differentiation between dengue and other common childhood illnesses is difficult during the early febrile phase, and risk prediction for development of shock is poor. The presence of microalbuminuria is recognized as a useful early predictor for subsequent complications in a number of other disorders with vascular involvement. Significant proteinuria occurs in association with dengue shock syndrome and it is possible that early-phase microalbuminuria may be helpful both for diagnosis of dengue and for identification of patients likely to develop severe disease. Methodology/Principal Findings: We measured formal urine albumin to creatinine ratios (UACRs) in daily samples obtained from a large cohort of children with suspected dengue recruited at two outpatient clinics in Ho Chi Minh City, Vietnam. Although UACRs were increased in the 465 confirmed dengue patients, with a significant time trend showing peak values around the critical period for dengue-associated plasma leakage, urine albumin excretion was also increased in the comparison group of 391 patients with other febrile illnesses (OFI). The dengue patients generally had higher UACRs than the OFI patients, but microalbuminuria, using the conventional cutoff of 30 mg albumin/g creatinine discriminated poorly between the two diagnostic groups in the early febrile phase. Secondly UACRs did not prove useful in predicting either development of warning signs for severe dengue or need for hospitalization. Conclusion/Significance: Low-level albuminuria is common, even in relatively mild dengue infections, but is also present in many OFIs. Simple point-of-care UACR tests are unlikely to be useful for early diagnosis or risk prediction in dengue endemic areas.	[Nguyen Thi Hanh Tien; Phung Khanh Lam; Huynh Thi Le Duyen; Nguyen Tan Thanh Kieu; Simmons, Cameron; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Simmons, Cameron; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Phan Thi Thanh Ha] Dist 8 Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Wills, B (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Dist 5, Ho Chi Minh City, Vietnam.	bwills@oucru.org	Simmons, Cameron P/ABA-3896-2021; Lam, Phung/AAW-4108-2020	Simmons, Cameron P/0000-0002-9039-7392; Lam, Phung/0000-0001-7968-473X; Wills, Bridget/0000-0001-9086-8804	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by the Wellcome Trust, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Bates D, 2012, LME4 LINEAR MIXED EF; Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Chau NP, 2000, DIABETES METAB, V26, P36; Daoussis D, 2011, CLIN RHEUMATOL, V30, P477, DOI 10.1007/s10067-010-1446-y; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Drumheller BC, 2012, ACAD EMERG MED, V19, P259, DOI 10.1111/j.1553-2712.2011.01266.x; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Carvalho JF, 2007, J CLIN IMMUNOL, V27, P246, DOI 10.1007/s10875-007-9083-1; Garcia S, 1995, Bol Asoc Med P R, V87, P2; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552; Incerti J, 2005, NEPHROL DIAL TRANSPL, V20, P2402, DOI 10.1093/ndt/gfi074; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Phuong CXT, 2004, TROP MED INT HEALTH, V9, P573, DOI 10.1111/j.1365-3156.2004.01232.x; Potts JA, 2010, AM J TROP MED HYG, V83, P781, DOI 10.4269/ajtmh.2010.10-0135; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Pugia MJ, 1999, CLIN CHEM LAB MED, V37, P149, DOI 10.1515/CCLM.1999.027; R Core Team, 2012, R LANG ENV STAT COMP; Rademacher ER, 2009, CURR OPIN NEPHROL HY, V18, P246, DOI 10.1097/MNH.0b013e3283294b98; Rein P, 2011, AM J CARDIOL, V107, P1144, DOI 10.1016/j.amjcard.2010.12.011; ROWE DJF, 1985, BMJ-BRIT MED J, V291, P693, DOI 10.1136/bmj.291.6497.693; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Smink PA, 2012, AM J KIDNEY DIS; Smulders YM, 1998, J LAB CLIN MED, V132, P39, DOI 10.1016/S0022-2143(98)90023-3; Thorevska N, 2003, CRIT CARE MED, V31, P1075, DOI 10.1097/01.CCM.0000059316.90804.0B; Trachtenberg F, 2007, AM J KIDNEY DIS, V50, P938, DOI 10.1053/j.ajkd.2007.08.014; Vasanwala FF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-212; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; World Health Organization, 2009, DENGUE GUIDELINES DI; Younes N, 2010, CLIN J AM SOC NEPHRO, V5, P1235, DOI 10.2215/CJN.07901109	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54538	10.1371/journal.pone.0054538	http://dx.doi.org/10.1371/journal.pone.0054538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349922	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100078
J	Smee, MR; Pauchet, Y; Wilkinson, P; Wee, B; Singer, MC; Ffrench-Constant, RH; Hodgson, DJ; Mikheyev, AS				Smee, Melanie R.; Pauchet, Yannick; Wilkinson, Paul; Wee, Brian; Singer, Michael C.; Ffrench-Constant, Richard H.; Hodgson, David J.; Mikheyev, Alexander S.			Microsatellites for the Marsh Fritillary Butterfly: De Novo Transcriptome Sequencing, and a Comparison with Amplified Fragment Length Polymorphism (AFLP) Markers	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; LONG-DISTANCE DISPERSAL; PARNASSIUS-APOLLO; EUPHYDRYAS-EDITHA; HARDY-WEINBERG; LEPIDOPTERA; LOCI; CONSERVATION; DNA; CONSTRUCTION	Background: Until recently the isolation of microsatellite markers from Lepidoptera has proved troublesome, expensive and time-consuming. Following on from a previous study of Edith's checkerspot butterfly, Euphydryas editha, we developed novel microsatellite markers for the vulnerable marsh fritillary butterfly, E. aurinia. Our goal was to optimize the process in order to reduce both time and cost relative to prevailing techniques. This was accomplished by using a combination of previously developed techniques: in silico mining of a de novo assembled transcriptome sequence, and genotyping the microsatellites found there using an economic method of fluorescently labelling primers. Principal Findings: In total, we screened nine polymorphic microsatellite markers, two of which were previously published, and seven that were isolated de novo. These markers were able to amplify across geographically isolated populations throughout Continental Europe and the UK. Significant deviations from Hardy-Weinberg equilibrium were evident in some populations, most likely due to the presence of null alleles. However, we used an F-st outlier approach to show that these markers are likely selectively neutral. Furthermore, using a set of 128 individuals from 11 populations, we demonstrate consistency in population differentiation estimates with previously developed amplified fragment length polymorphism (AFLP) markers (r = 0.68, p<0.001). Significance: Rapid development of microsatellite markers for difficult taxa such as Lepidoptera, and concordant results with other putatively neutral molecular markers, demonstrate the potential of de novo transcriptional sequencing for future studies of population structure and gene flow that are desperately needed for declining species across fragmented landscapes.	[Smee, Melanie R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Smee, Melanie R.; Pauchet, Yannick; Wilkinson, Paul; Ffrench-Constant, Richard H.; Hodgson, David J.] Univ Exeter, Ctr Ecol & Conservat, Sch Biosci, Penryn, Cornwall, England; [Pauchet, Yannick] Max Planck Inst Chem Ecol, Jena, Germany; [Wilkinson, Paul] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Wee, Brian] Natl Ecol Observ Network Inc, Washington, DC USA; [Singer, Michael C.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Mikheyev, Alexander S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan	University of York - UK; University of Exeter; Max Planck Society; University of Bristol; University of Texas System; University of Texas Austin; Okinawa Institute of Science & Technology Graduate University	Smee, MR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	melaniesmee@gmail.com	Wee, Brian Peck-Sheng/P-3240-2019; Mikheyev, Alexander/E-7999-2013; Pauchet, Yannick/AAU-9751-2021; Wee, Brian Peck-Sheng/B-8774-2016; Smee, Melanie/K-4201-2015	Wee, Brian Peck-Sheng/0000-0002-0038-9381; Mikheyev, Alexander/0000-0003-4369-1019; Pauchet, Yannick/0000-0002-2918-8946; Wee, Brian Peck-Sheng/0000-0002-0038-9381; Smee, Melanie/0000-0002-6973-0365; ffrench-Constant, Richard/0000-0001-5385-9888	BBSRC CASE studentship; Okinawa Institute for Science and Technology (OIST)	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Okinawa Institute for Science and Technology (OIST)(Okinawa Institute of Science & Technology Graduate University)	This work was funded by a BBSRC CASE studentship awarded to RHffC. ASM is supported by funding from the Okinawa Institute for Science and Technology (OIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; ASHER J, 2001, MILLENIUM ATLAS BUTT; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BEAUMONT MA, 1999, MICROSATELLITES EVOL, P165; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EHRLICH PR, 1965, EVOLUTION, V19, P327, DOI 10.2307/2406442; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ford HD, 1930, T ROYAL ENTOMOLOGICA, V78, P345; Fox R, 2010, INSECT CONSERVATION; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanski I., 1999, METAPOPULATION ECOLO; HARRISON S, 1989, ECOLOGY, V70, P1236, DOI 10.2307/1938181; Ji Ya-Jie, 2004, Acta Zoologica Sinica, V50, P608; Ji YJ, 2003, MOL ECOL NOTES, V3, P102, DOI 10.1046/j.1471-8286.2003.00366.x; KANDPAL RP, 1994, P NATL ACAD SCI USA, V91, P88, DOI 10.1073/pnas.91.1.88; Keyghobadi N, 1999, MOL ECOL, V8, P1481, DOI 10.1046/j.1365-294x.1999.00726.x; Kong LF, 2008, MOL ECOL RESOUR, V8, P152, DOI 10.1111/j.1471-8286.2007.01906.x; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Meglecz E, 1998, HEREDITAS, V128, P179, DOI 10.1111/j.1601-5223.1998.00179.x; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Metzger C, 2011, CONSERVATION GENETIC; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Neve G, 2000, TRENDS ECOL EVOL, V15, P376, DOI 10.1016/S0169-5347(00)01921-2; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Petenian F, 2005, MOL ECOL NOTES, V5, P243, DOI 10.1111/j.1471-8286.2005.00891.x; PORTER K, 1982, OIKOS, V38, P308, DOI 10.2307/3544670; Porter K, 1981, THESIS OXFORD U OXFO; Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/genetics.104.031005; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sigaard P, 2008, BIOL J LINN SOC, V95, P677, DOI 10.1111/j.1095-8312.2008.01078.x; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; THURSTON MI, 2005, MSATFINDER DETECTION; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Vila M, 2009, EUR J ENTOMOL, V106, P485, DOI 10.14411/eje.2009.061; Wee P-S, 2004, THESIS U TEXAS AUSTI; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zimmermann K, 2011, ECOL ENTOMOL, V36, P499, DOI 10.1111/j.1365-2311.2011.01293.x	52	9	9	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54721	10.1371/journal.pone.0054721	http://dx.doi.org/10.1371/journal.pone.0054721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349956	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000047
J	Matar, RNB; Klein, JD; Sands, JM				Matar, Raed N. Bou; Klein, Janet D.; Sands, Jeff M.			Erlotinib Preserves Renal Function and Prevents Salt Retention in Doxorubicin Treated Nephrotic Rats	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNELS; CELL LUNG-CANCER; GROWTH-FACTOR; INCREASED EXPRESSION; ENAC SUBUNITS; BINDING; INHIBITION; TRANSPORTERS; NEPHROPATHY; PLASMIN	Nephrotic syndrome is associated with up-regulation of the heparin-binding epidermal growth factor (HB-EGF). Erlotinib blocks the activation of the epidermal growth factor receptor (EGFR) in response to HB-EGF. This study investigates the effect of Erlotinib on the progression of proteinuria, renal dysfunction, and salt retention in doxorubicin treated nephrotic rats. Male rats were divided into 3 pair-fed groups (n = 13/group) as follows: Control rats (Ctrl); rats receiving intravenous doxorubicin (Dox); and rats receiving intravenous doxorubicin followed by daily oral Erlotinib (Dox + Erl). Upon establishment of high grade proteinuria, urine sodium and creatinine clearance were measured. Kidney tissue was dissected and analyzed for gamma-epithelial sodium channel (gamma ENaC), sodium-potassium -chloride co-transporter 2 (NKCC2), sodium chloride co-transporter (NCC), aquaporin 2 (AQP2), and EGFR abundances using western blot. Creatinine clearance was preserved in the Dox + Erl rats as compared to the Dox group (in ml/min: Ctrl: 5.2 +/-.5, Dox: 1.9 +/- 0.3, Dox + Erl: 3.6 +/- 0.5). Despite a minimal effect on the degree of proteinuria, Erlotinib prevented salt retention (Urinary Na in mEq/d: Ctrl: 2.2 +/- 0.2, Dox: 1.8 +/- 0.3, Dox + Erl: 2.2 +/- 0.2). The cleaved/uncleaved gamma ENaC ratio was increased by 41 +/- 16% in the Dox group but unchanged in the Dox + Erl group when compared to Ctrl. The phosphorylated EGFR/total EGFR ratio was reduced by 74 +/- 7% in the Dox group and by 77 +/- 4% in the Dox + Erl group. In conclusion, Erlotinib preserved renal function and prevented salt retention in nephrotic rats. The observed effects do not appear to be mediated by direct blockade of EGFR.	[Matar, Raed N. Bou] Emory Univ, Dept Pediat Med, Atlanta, GA 30322 USA; [Matar, Raed N. Bou] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Klein, Janet D.; Sands, Jeff M.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Klein, Janet D.; Sands, Jeff M.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University	Sands, JM (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.	jeff.sands@emory.edu			National Institutes of Health (NIH) [R01-DK41707, R01-DK89828, R21-DK91147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK091147, R01DK041707, R01DK089828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R01-DK41707, R01-DK89828, and R21-DK91147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Agarwal R, 2000, J AM SOC NEPHROL, V11, P1100, DOI 10.1681/ASN.V1161100; Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Braun N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003233.pub2; Cohen MH, 2010, ONCOLOGIST, V15, P1344, DOI 10.1634/theoncologist.2010-0257; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; Kim SW, 2006, AM J PHYSIOL-RENAL, V290, pF674, DOI 10.1152/ajprenal.00084.2005; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Matar RNB, 2012, AM J PHYSIOL-RENAL, V302, pF1545, DOI 10.1152/ajprenal.00686.2011; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Orcutt KP, 2011, CANCER RES, V71, P3932, DOI 10.1158/0008-5472.CAN-10-3425; Paizis K, 1998, KIDNEY INT, V53, P1162, DOI 10.1046/j.1523-1755.1998.00846.x; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Troiani T, 2012, CURR DRUG TARGETS, V13, P802, DOI 10.2174/138945012800564158; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54738	10.1371/journal.pone.0054738	http://dx.doi.org/10.1371/journal.pone.0054738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349960	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800073
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			Activation of a PGC-1-related Coactivator (PRC)-dependent Inflammatory Stress Program Linked to Apoptosis and Premature Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELLULAR SENESCENCE; ENERGY-METABOLISM; CANCER; TRANSCRIPTION; EXPRESSION; INTEGRATION; PGC-1-ALPHA; MECHANISMS; REGULATOR	PGC-1-related coactivator (PRC), a growth-regulated member of the PGC-1 coactivator family, contributes to the expression of the mitochondrial respiratory apparatus. PRC also orchestrates a robust response to metabolic stress by promoting the expression of multiple genes specifying inflammation, proliferation, and metabolic reprogramming. Here, we demonstrate that this PRC-dependent stress program is activated during apoptosis and senescence, two major protective mechanisms against cellular dysfunction. Both PRC and its targets (IL1 alpha, SPRR2D, and SPRR2F) were rapidly induced by menadione, an agent that promotes apoptosis through the generation of intracellular oxidants. Menadione-induced apoptosis and the PRC stress program were blocked by the antioxidant N-acetylcysteine. The PRC stress response was also activated by the topoisomerase I inhibitor 7-ethyl-10-hydroxycamptothecin (SN-38), an inducer of premature senescence in tumor cells. Cells treated with SN-38 displayed morphological characteristics of senescence and express senescence-associated beta-galactosidase activity. In contrast to menadione, the SN-38 induction of the PRC program occurred over an extended time course and was antioxidant-insensitive. The potential adaptive function of the PRC stress response was investigated by treating cells with meclizine, a drug that promotes glycolytic energy metabolism and has been linked to cardio- and neuroprotection against ischemia-reperfusion injury. Meclizine increased lactate production and was a potent inducer of the PRC stress program, suggesting that PRC may contribute to the protective effects of meclizine. Finally, c-MYC and PRC were coordinately induced under all conditions tested, implicating c-MYC in the biological response to metabolic stress. The results suggest a general role for PRC in the adaptive response to cellular dysfunction.	[Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health, NIGMS [GM 32525-29]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032525, R56GM032525] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 32525-29 from the NIGMS.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Bihani T, 2004, CELL CYCLE, V3, P1201; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Dominy JE, 2011, COLD SH Q B, V76, P203, DOI 10.1101/sqb.2012.76.010843; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gilbert DC, 2012, BRIT J CANCER, V106, P18, DOI 10.1038/bjc.2011.498; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Roninson IB, 2003, CANCER RES, V63, P2705; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; te Poele RH, 2002, CANCER RES, V62, P1876; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Vermeij WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011957; Verrax J, 2004, APOPTOSIS, V9, P223, DOI 10.1023/B:APPT.0000018804.26026.1a; Verrax J, 2009, CURR MED CHEM, V16, P1821, DOI 10.2174/092986709788186057; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8004	8015		10.1074/jbc.M112.426841	http://dx.doi.org/10.1074/jbc.M112.426841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364789	Green Published, hybrid			2022-12-25	WOS:000316564500002
J	Takahashi, M; Izawa, K; Kashiwakura, J; Yamanishi, Y; Enomoto, Y; Kaitani, A; Maehara, A; Isobe, M; Ito, S; Matsukawa, T; Nakahara, F; Oki, T; Kajikawa, M; Ra, C; Okayama, Y; Kitamura, T; Kitaura, J				Takahashi, Mariko; Izawa, Kumi; Kashiwakura, Jun-ichi; Yamanishi, Yoshinori; Enomoto, Yutaka; Kaitani, Ayako; Maehara, Akie; Isobe, Masamichi; Ito, Shinichi; Matsukawa, Toshihiro; Nakahara, Fumio; Oki, Toshihiko; Kajikawa, Masunori; Ra, Chisei; Okayama, Yoshimichi; Kitamura, Toshio; Kitaura, Jiro			Human CD300C Delivers an Fc Receptor-gamma-dependent Activating Signal in Mast Cells and Monocytes and Differs from CD300A in Ligand Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; INHIBITORY RECEPTOR; APOPTOTIC CELLS; INFLAMMATORY RESPONSES; DENDRITIC CELLS; IRP60 CD300A; EPSILON-RI; DEAD CELLS; NK CELLS; PHOSPHATIDYLSERINE	CD300C is highly homologous with an inhibitory receptor CD300A in an immunoglobulin-like domain among the human CD300 family of paired immune receptors. To clarify the precise expression and function of CD300C, we generated antibodies discriminating between CD300A and CD300C, which recognized a unique epitope involving amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Notably, CD300C was highly expressed in human monocytes and mast cells. Cross-linking of CD300C by its specific antibody caused cytokine/chemokine production of human monocytes and mast cells. Fc receptor gamma was indispensable for both efficient surface expression and activating functions of CD300C. To identify a ligand for CD300A or CD300C, we used reporter cell lines expressing a chimera receptor harboring extracellular CD300A or CD300C and intracellular CD3 zeta, in which its unknown ligand induced GFP expression. Our results indicated that phosphatidylethanolamine (PE) among the lipids tested and apoptotic cells were possible ligands for both CD300C and CD300A. PE and apoptotic cells more strongly induced GFP expression in the reporter cells through binding to extracellular CD300A as compared with CD300C. Differential recognition of PE by extracellular CD300A and CD300C depended on different amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Interestingly, GFP expression induced by extracellular CD300C-PE binding in the reporter cells was dampened by co-expression of full-length CD300A, indicating the predominance of CD300A over CD300C in PE recognition/signaling. PE consistently failed to stimulate cytokine production in monocytes expressing CD300C with CD300A. In conclusion, specific engagement of CD300C led to Fc receptor gamma-dependent activation of mast cells and monocytes.	[Takahashi, Mariko; Izawa, Kumi; Yamanishi, Yoshinori; Enomoto, Yutaka; Kaitani, Ayako; Maehara, Akie; Isobe, Masamichi; Ito, Shinichi; Matsukawa, Toshihiro; Nakahara, Fumio; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Adv Clin Res Ctr, Div Cellular Therapy, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Kashiwakura, Jun-ichi; Ra, Chisei; Okayama, Yoshimichi] Nihon Univ, Sch Med, Dept Mol Cell Immunol & Allergol, Itabashi Ku, Tokyo 1738610, Japan; [Kashiwakura, Jun-ichi] RIKEN Res Ctr Allergy & Immunol, Res Unit Allergy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kajikawa, Masunori] ACTGen Inc, Komagane, Nagano 3994117, Japan	University of Tokyo; University of Tokyo; Nihon University; RIKEN	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021; Okayama, Yoshimichi/AAG-4352-2021; Matsukawa, Toshihiro/A-4194-2016	Enomoto, Yutaka/0000-0002-6346-9362; Matsukawa, Toshihiro/0000-0003-2371-3778; Nakahara, Fumio/0000-0003-1515-8284	Ministry of Education, Science, Technology, Sports and Culture, Japan; Grants-in-Aid for Scientific Research [10J07783] Funding Source: KAKEN	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bachelet I, 2006, J ALLERGY CLIN IMMUN, V117, P1314, DOI 10.1016/j.jaci.2006.04.031; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Comas-Casellas E, 2012, J BIOL CHEM, V287, P9682, DOI 10.1074/jbc.M111.279224; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lankry D, 2010, J IMMUNOL, V185, P2877, DOI 10.4049/jimmunol.0903347; Lu Y, 2007, LEUKEMIA, V21, P2246, DOI 10.1038/sj.leu.2404883; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Munitz A, 2006, J ALLERGY CLIN IMMUN, V118, P1082, DOI 10.1016/j.jaci.2006.07.041; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Okumura S, 2003, BLOOD, V102, P2547, DOI 10.1182/blood-2002-12-3929; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	51	27	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7662	7675		10.1074/jbc.M112.434746	http://dx.doi.org/10.1074/jbc.M112.434746			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23372157	Green Published, hybrid			2022-12-25	WOS:000316455300023
J	Prat-Vidal, C; Galvez-Monton, C; Nonell, L; Puigdecanet, E; Astier, L; Sole, F; Bayes-Genis, A				Prat-Vidal, Cristina; Galvez-Monton, Carolina; Nonell, Lara; Puigdecanet, Eulalia; Astier, Laura; Sole, Francesc; Bayes-Genis, Antoni			Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine	PLOS ONE			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; POLYMERASE-CHAIN-REACTION; ASSIST DEVICE SUPPORT; CYTOCHROME-C RELEASE; GUANYLYL CYCLASE-A; HEART-FAILURE; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; NONISCHEMIC CARDIOMYOPATHY; CORONARY-ARTERIES	Molecular mechanisms associated with pathophysiological changes in ventricular remodelling due to myocardial infarction (MI) remain poorly understood. We analyzed changes in gene expression by microarray technology in porcine myocardial tissue at 1, 4, and 6 weeks post-MI. MI was induced by coronary artery ligation in 9 female pigs (30-40 kg). Animals were randomly sacrificed at 1, 4, or 6 weeks post-MI (n = 3 per group) and 3 healthy animals were also included as control group. Total RNA from myocardial samples was hybridized to GeneChip (R) Porcine Genome Arrays. Functional analysis was obtained with the Ingenuity Pathway Analysis (IPA) online tool. Validation of microarray data was performed by quantitative real-time PCR (qRT-PCR). More than 8,000 different probe sets showed altered expression in the remodelling myocardium at 1, 4, or 6 weeks post-MI. Ninety-seven percent of altered transcripts were detected in the infarct core and 255 probe sets were differentially expressed in the remote myocardium. Functional analysis revealed 28 genes de-regulated in the remote myocardial region in at least one of the three temporal analyzed stages, including genes associated with heart failure (HF), systemic sclerosis and coronary artery disease. In the infarct core tissue, eight major time-dependent gene expression patterns were recognized among 4,221 probe sets commonly altered over time. Altered gene expression of ACVR2B, BID, BMP2, BMPR1A, LMNA, NFKBIA, SMAD1, TGFB3, TNFRSF1A, and TP53 were further validated. The clustering of similar expression patterns for gene products with related function revealed molecular footprints, some of them described for the first time, which elucidate changes in biological processes at different stages after MI.	[Prat-Vidal, Cristina; Galvez-Monton, Carolina; Astier, Laura; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol, Imperial Coll Res Ethics Comm Heart Failure & Car, Badalona, Barcelona, Spain; [Nonell, Lara; Puigdecanet, Eulalia; Sole, Francesc] Inst Hosp Mar Invest Med, Serv Anal Microarrays, Barcelona, Spain; [Sole, Francesc] Hosp del Mar, Serv Patol, Lab Citogenet Mol, Barcelona, Spain; [Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Prat-Vidal, C (corresponding author), Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol, Imperial Coll Res Ethics Comm Heart Failure & Car, Badalona, Barcelona, Spain.	cprat@igtp.cat; abayes.germanstrias@gencat.cat	Galvez-Monton, Carolina/K-4480-2014; Prat-Vidal, Cristina/AAP-9571-2020; Bayes-Genis, Antoni/C-4002-2015; Solé, Francesc/K-8373-2012; Bayes-Genis, Antonio/AAV-9422-2021; Prat-Vidal, Cristina/C-2726-2013; Puigdecanet, Eulàlia/U-7568-2019	Galvez-Monton, Carolina/0000-0003-2254-9371; Prat-Vidal, Cristina/0000-0002-5621-1101; Bayes-Genis, Antoni/0000-0002-3044-197X; Solé, Francesc/0000-0002-3251-2161; Bayes-Genis, Antonio/0000-0002-3044-197X; Prat-Vidal, Cristina/0000-0002-5621-1101; 	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant [CD07/00163]; Ministerio de Ciencia e Innovacion [SAF2008-05144-C02-01, SAF2011-30067-C02-01]; Fundacio Privada Daniel Bravo Andreu; La Marato de TV3 [080330]	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Privada Daniel Bravo Andreu; La Marato de TV3	This work was supported by the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant (CD07/00163 to CP-V), Ministerio de Ciencia e Innovacion (SAF2008-05144-C02-01 and SAF2011-30067-C02-01 to AB-G), Fundacio Privada Daniel Bravo Andreu, and La Marato de TV3 (080330 to AB-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SH, 1978, J ANAT, V126, P51; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar S, 2012, METHODS MOL BIOL, V798, P311, DOI 10.1007/978-1-61779-343-1_18; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; FISHBEIN MC, 1978, CHEST, V73, P843, DOI 10.1378/chest.73.6.843; Galvez-Monton C, 2011, CARDIOVASC RES, V91, P659, DOI 10.1093/cvr/cvr136; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Hochhauser E, 2007, CELL BIOCHEM BIOPHYS, V47, P11, DOI 10.1385/CBB:47:1:11; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Icardo JM, 2001, J ANAT, V199, P473, DOI 10.1046/j.1469-7580.2001.19940473.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin H, 2001, CIRCULATION, V103, P736; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kittleson MM, 2004, CIRCULATION, V110, P3444, DOI 10.1161/01.CIR.0000148178.19465.11; Kupfahl C, 2000, CARDIOVASC RES, V46, P463, DOI 10.1016/S0008-6363(00)00037-7; Kuster DWD, 2011, BASIC RES CARDIOL, V106, P1269, DOI 10.1007/s00395-011-0229-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Lu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019251; Lyn D, 2000, PHYSIOL GENOMICS, V2, P93, DOI 10.1152/physiolgenomics.2000.2.3.93; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Panguluri SK, 2012, METHODS MOL BIOL, V815, P131, DOI 10.1007/978-1-61779-424-7_11; Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Sandmann S, 2001, J AM COLL CARDIOL, V37, P2154, DOI 10.1016/S0735-1097(01)01287-6; Sehl PD, 2000, CIRCULATION, V101, P1990, DOI 10.1161/01.CIR.101.16.1990; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Steenman M, 2003, PHYSIOL GENOMICS, V12, P97, DOI 10.1152/physiolgenomics.00148.2002; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tschope C, 2000, J HYPERTENS, V18, P223, DOI 10.1097/00004872-200018020-00014; WEAVER ME, 1986, CARDIOVASC RES, V20, P907, DOI 10.1093/cvr/20.12.907; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	59	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54785	10.1371/journal.pone.0054785	http://dx.doi.org/10.1371/journal.pone.0054785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372767	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400029
J	Peng, T; Sun, HZ; Du, YX; Zhang, J; Li, JZ; Liu, YX; Zhao, YF; Zhao, QZ				Peng, Ting; Sun, Hongzheng; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Liu, Yanxia; Zhao, Yafan; Zhao, Quanzhi			Characterization and Expression Patterns of microRNAs Involved in Rice Grain Filling	PLOS ONE			English	Article							SMALL RNAS; POSTANTHESIS DEVELOPMENT; INFERIOR SPIKELETS; SUPERIOR SPIKELETS; ABSCISIC-ACID; PLANT; ARABIDOPSIS; AUXIN; MIRNAS; YIELD	MicroRNAs (miRNAs) are upstream gene regulators of plant development and hormone homeostasis through their directed cleavage or translational repression of the target mRNAs, which may play crucial roles in rice grain filling and determining the final grain weight and yield. In this study, high-throughput sequencing was performed to survey the dynamic expressions of miRNAs and their corresponding target genes at five distinct developmental stages of grain filling. In total, 445 known miRNAs and 45 novel miRNAs were detected with most of them expressed in a developmental stage dependent manner, and the majority of known miRNAs, which increased gradually with rice grain filling, showed negatively related to the grain filling rate. Detailed expressional comparisons revealed a clear negative correlation between most miRNAs and their target genes. It was found that specific miRNA cohorts are expressed in a developmental stage dependent manner during grain filling and the known functions of these miRNAs are involved in plant hormone homeostasis and starch accumulation, indicating that the expression dynamics of these miRNAs might play key roles in regulating rice grain filling.	[Zhao, Quanzhi] Henan Agr Univ, Res Ctr Rice Engn, Zhengzhou, Peoples R China; Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Zhao, QZ (corresponding author), Henan Agr Univ, Res Ctr Rice Engn, Zhengzhou, Peoples R China.	qzzhaoh@126.com			National Natural Science Foundation of China [30471018, 31271651, 31200973]; Program for New Century Excellent Talents in University [NCET-08-0663]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [94200510003]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [2010IRTSTHN005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by the National Natural Science Foundation of China (30471018, 31271651, 31200973), Program for New Century Excellent Talents in University (NCET-08-0663), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (94200510003), and Program for Innovative Research Team (in Science and Technology) in University of Henan Province (2010IRTSTHN005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu Q, 2009, BIOCHEM BIOPH RES CO, V384, P1, DOI 10.1016/j.bbrc.2009.04.028; Lunn JE, 2003, CURR OPIN PLANT BIOL, V6, P208, DOI 10.1016/S1369-5266(03)00033-5; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Meng Y, 2011, RNA BIOL, V8; Meng YJ, 2010, J EXP BOT, V61, P3833, DOI 10.1093/jxb/erq209; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Van Ex F, 2011, CURR OPIN PLANT BIOL, V14, P588, DOI 10.1016/j.pbi.2011.07.003; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang H, 2012, J EXP BOT, V63, P215, DOI 10.1093/jxb/err263; Zhang H, 2010, J EXP BOT, V61, P3719, DOI 10.1093/jxb/erq198; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1092, 10.1155/2012/360358]; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	68	51	56	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54148	10.1371/journal.pone.0054148	http://dx.doi.org/10.1371/journal.pone.0054148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365650	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600035
J	Andersen, JP; Blosnich, J				Andersen, Judith P.; Blosnich, John			Disparities in Adverse Childhood Experiences among Sexual Minority and Heterosexual Adults: Results from a Multi-State Probability-Based Sample	PLOS ONE			English	Article							PHYSICAL ABUSE; UNITED-STATES; GAY; VICTIMIZATION; HEALTH; ORIENTATION; LESBIANS; RISK; LIFE; MALTREATMENT	Background: Adverse childhood experiences (e. g., physical, sexual and emotional abuse, neglect, exposure to domestic violence, parental discord, familial mental illness, incarceration and substance abuse) constitute a major public health problem in the United States. The Adverse Childhood Experiences (ACE) scale is a standardized measure that captures multiple developmental risk factors beyond sexual, physical and emotional abuse. Lesbian, gay, and bisexual (i.e., sexual minority) individuals may experience disproportionately higher prevalence of adverse childhood experiences. Purpose: To examine, using the ACE scale, prevalence of childhood physical, emotional, and sexual abuse and childhood household dysfunction among sexual minority and heterosexual adults. Methods: Analyses were conducted using a probability-based sample of data pooled from three U. S. states' Behavioral Risk Factor Surveillance System (BRFSS) surveys (Maine, Washington, Wisconsin) that administered the ACE scale and collected information on sexual identity (n = 22,071). Results: Compared with heterosexual respondents, gay/lesbian and bisexual individuals experienced increased odds of six of eight and seven of eight adverse childhood experiences, respectively. Sexual minority persons had higher rates of adverse childhood experiences (IRR = 1.66 gay/lesbian; 1.58 bisexual) compared to their heterosexual peers. Conclusions: Sexual minority individuals have increased exposure to multiple developmental risk factors beyond physical, sexual and emotional abuse. We recommend the use of the Adverse Childhood Experiences scale in future research examining health disparities among this minority population.	[Andersen, Judith P.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Blosnich, John] Univ Rochester, Dept Psychiat, Ctr Study & Prevent Suicide, Rochester, NY USA; [Blosnich, John] VISN 2 Ctr Excellence Suicide Prevent, Dept Vet Affairs, Canandaigua, NY USA	University of Toronto; University Toronto Mississauga; University of Rochester	Andersen, JP (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	judith.andersen@utoronto.ca	Wilson, Gregory/AAA-9035-2021	Andersen, Judith/0000-0001-8477-1432	Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health [5T32MH020061]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020061] Funding Source: NIH RePORTER	Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Blosnich was supported by a Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health (5T32MH020061). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Alvy L, 2012, CHILD ABUSE IN PRESS; Anda R. F., 2010, BEHAV RISK FACTOR SU, P1; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; [Anonymous], 2011, CHILD MALTR 2010; [Anonymous], 2011, HLTH LESBIAN GAY BIS; Aveline D, 2006, J FAM ISSUES, V27, P777, DOI 10.1177/0192513X05285613; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Berlan ED, 2010, J ADOLESCENT HEALTH, V46, P366, DOI 10.1016/j.jadohealth.2009.10.015; Blosnich J, 2012, J AM COLL HEALTH, V60, P141, DOI 10.1080/07448481.2011.623332; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; Corliss HL, 2002, CHILD ABUSE NEGLECT, V26, P1165, DOI 10.1016/S0145-2134(02)00385-X; D'Augelli AR, 2006, J INTERPERS VIOLENCE, V21, P1462, DOI 10.1177/0886260506293482; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Frankowski BL, 2004, PEDIATRICS, V113, P1827, DOI 10.1542/peds.113.6.1827; Fredriksen-Goldsen KI, 2010, AM J PUBLIC HEALTH, V100, P2255, DOI 10.2105/AJPH.2009.177329; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; Gartner R. B., 2000, J GAY LESBIAN PSYCHO, V3, P1, DOI [DOI 10.1300/J236V03N02_01, 10. 1300/J236v03n02_01]; Gates GJ, 2012, 34 GALL POLL; Goodrich KM, 2009, J LGBT ISS COUNS, V3, P37, DOI 10.1080/15538600902754478; Heck JE, 2006, J ASTHMA, V43, P579, DOI 10.1080/02770900600878289; HOLM S, 1979, SCAND J STAT, V6, P65; HUGHES TL, 2000, J GAY LESBIAN SOCIAL, V11, P57, DOI DOI 10.1300/J041V11N01_03; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; Lehavot KM, 2012, SEX ROLES, DOI [10.1007/211199-012-0171-1, DOI 10.1007/211199-012-0171-1]; Lester P, 2003, ADOLESCENT PSYCHIAT, V27, P259; Levitt H. M., 2007, BECOMING VISIBLE COU, P297; Long J.S., 2006, REGRESSION MODELS CA; Martin SL, 2011, WOMEN HEALTH ISS, V21, P199, DOI 10.1016/j.whi.2010.12.002; Marvasti J. A., 2004, PSYCHIAT TREATMENT V, P3; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Roberts AL, 2013, ARCH SEX BEHAV, V42, P161, DOI 10.1007/s10508-012-0021-9; Roberts AL, 2012, PEDIATRICS, V129, P410, DOI 10.1542/peds.2011-1804; Rosario M, 2009, ARCH SEX BEHAV, V38, P34, DOI 10.1007/s10508-007-9221-0; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Saltzburg S, 2004, SOC WORK, V49, P109, DOI 10.1093/sw/49.1.109; Stoddard J, 2009, J HOMOSEXUAL, V56, P407, DOI 10.1080/00918360902821395; Wilsnack SC, 2012, CHILD ABUSE NEGLECT, V36, P260, DOI 10.1016/j.chiabu.2011.10.008	45	50	52	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54691	10.1371/journal.pone.0054691	http://dx.doi.org/10.1371/journal.pone.0054691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372755	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500108
J	Ryder, M; Gild, M; Hohl, TM; Pamer, E; Knauf, J; Ghossein, R; Joyce, JA; Fagin, JA				Ryder, Mabel; Gild, Matti; Hohl, Tobias M.; Pamer, Eric; Knauf, Jeff; Ghossein, Ronald; Joyce, Johanna A.; Fagin, James A.			Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression	PLOS ONE			English	Article							INFLAMMATORY MONOCYTES; PROSTATE-CANCER; MAMMARY-TUMORS; BREAST-CANCER; MOUSE MODEL; EXPRESSION; PAPILLARY; CELLS; CCR2; MUTATIONS	Advanced human thyroid cancers are densely infiltrated with tumor-associated macrophages (TAMs) and this correlates with a poor prognosis. We used BRAF-induced papillary thyroid cancer (PTC) mouse models to examine the role of TAMs in PTC progression. Following conditional activation of BRAF(V600E) in murine thyroids there is an increased expression of the TAM chemoattractants Csf-1 and Ccl-2. This is followed by the development of PTCs that are densely infiltrated with TAMs that express Csf-1r and Ccr2. Targeting CCR2-expressing cells during BRAF-induction reduced TAM density and impaired PTC development. This strategy also induced smaller tumors, decreased proliferation and restored a thyroid follicular architecture in established PTCs. In PTCs from mice that lacked CSF-1 or that received a c-FMS/CSF-1R kinase inhibitor, TAM recruitment and PTC progression was impaired, recapitulating the effects of targeting CCR2-expressing cells. Our data demonstrate that TAMs are pro-tumorigenic in advanced PTCs and that they can be targeted pharmacologically, which may be potentially useful for patients with advanced thyroid cancers.	[Ryder, Mabel; Gild, Matti; Knauf, Jeff; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Ryder, Mabel; Hohl, Tobias M.; Pamer, Eric; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Hohl, Tobias M.; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Dept Infect Dis Serv, New York, NY 10021 USA; [Hohl, Tobias M.; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Ghossein, Ronald] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fagin, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	faginj@mkscc.org		Hohl, Tobias/0000-0002-9097-5412; Gild, Matti/0000-0002-6670-2254; Knauf, Jeffrey/0000-0003-4456-8792	American Thyroid Association THANC; Lefkovsky Family Foundation; Byrne fund;  [K08 CA133183];  [K08 AI071998];  [RO1 CA50706];  [R01 CA72597]; NATIONAL CANCER INSTITUTE [R01CA050706, P30CA008748, R01CA072597, K08CA133183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031, K08AI071998] Funding Source: NIH RePORTER	American Thyroid Association THANC; Lefkovsky Family Foundation; Byrne fund; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded, in part, by K08 CA133183 and American Thyroid Association THANC award (MR), K08 AI071998 (TMH), RO1 CA50706 and R01 CA72597 (JAF), the Lefkovsky Family Foundation and the Byrne fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ekert JE, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-23; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanna J, 2005, BLOOD, V106, P3465, DOI 10.1182/blood-2005-03-0855; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kimura ET, 2003, CANCER RES, V63, P1454; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; KORNFEHL J, 1994, LARYNGO RHINO OTOL, V73, P183, DOI 10.1055/s-2007-997107; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ohno S, 2003, ANTICANCER RES, V23, P4395; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pyonteck SM, 2012, ONCOGENE, V31, P1459, DOI 10.1038/onc.2011.337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sedliarou I, 2004, INT J ONCOL, V25, P1729; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tsutsui S, 2005, ONCOL REP, V14, P425; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; Wei Q, 2012, THYROID	49	101	109	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54302	10.1371/journal.pone.0054302	http://dx.doi.org/10.1371/journal.pone.0054302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372702	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500054
J	Dmochewitz, L; Fortsch, C; Zwerger, C; Vaeth, M; Felder, E; Huber-Lang, M; Barth, H				Dmochewitz, Lydia; Foertsch, Christina; Zwerger, Christian; Vaeth, Martin; Felder, Edward; Huber-Lang, Markus; Barth, Holger			A Recombinant Fusion Toxin Based on Enzymatic Inactive C3bot1 Selectively Targets Macrophages	PLOS ONE			English	Article							BOTULINUM C2 TOXIN; ADP-RIBOSYLATING TOXINS; CLOSTRIDIUM-BOTULINUM; MAMMALIAN-CELLS; MEMBRANE TRANSLOCATION; BACTERIAL TOXINS; ACTIN-FILAMENTS; CELLULAR UPTAKE; RIBOSYLTRANSFERASE; C3	Background: The C3bot1 protein (similar to 23 kDa) from Clostridium botulinum ADP-ribosylates and thereby inactivates Rho. C3bot1 is selectively taken up into the cytosol of monocytes/macrophages but not of other cell types such as epithelial cells or fibroblasts. Most likely, the internalization occurs by a specific endocytotic pathway via acidified endosomes. Methodology/Principal Findings: Here, we tested whether enzymatic inactive C3bot1E174Q serves as a macrophage-selective transport system for delivery of enzymatic active proteins into the cytosol of such cells. Having confirmed that C3bot1E174Q does not induce macrophage activation, we used the actin ADP-ribosylating C2I (similar to 50 kDa) from Clostridium botulinum as a reporter enzyme for C3bot1E174Q-mediated delivery into macrophages. The recombinant C3bot1E174Q-C2I fusion toxin was cloned and expressed as GST-protein in Escherichia coli. Purified C3bot1E174Q-C2I was recognized by antibodies against C2I and C3bot and showed C2I-specific enzyme activity in vitro. When applied to cultured cells C3bot1E174Q-C2I ADP-ribosylated actin in the cytosol of macrophages including J774A.1 and RAW264.7 cell lines as well as primary cultured human macrophages but not of epithelial cells. Together with confocal fluorescence microscopy experiments, the biochemical data indicate the selective uptake of a recombinant C3-fusion toxin into the cytosol of macrophages. Conclusions/Significance: In summary, we demonstrated that C3bot1E174Q can be used as a delivery system for fast, selective and specific transport of enzymes into the cytosol of living macrophages. Therefore, C3-based fusion toxins can represent valuable molecular tools in experimental macrophage pharmacology and cell biology as well as attractive candidates to develop new therapeutic approaches against macrophage-associated diseases.	[Dmochewitz, Lydia; Foertsch, Christina; Zwerger, Christian; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany; [Vaeth, Martin] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Felder, Edward] Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany; [Huber-Lang, Markus] Univ Ulm, Med Ctr, Inst Traumatol Hand & Reconstruct Surg, D-89069 Ulm, Germany	Ulm University; University of Wurzburg; Ulm University; Ulm University	Barth, H (corresponding author), Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany.	holger.barth@uni-ulm.de	Barth, Holger/E-7920-2013; Huber-Lang, Markus/AAJ-2209-2020	Vaeth, Martin/0000-0001-8974-7052	Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm	Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm	This work was financially supported by the Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm by a fellowship for Lydia Dmochewitz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1995, BIOCHIMIE, V77, P326, DOI 10.1016/0300-9084(96)88142-9; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; ALON R, 1990, BIOCHEM BIOPH RES CO, V170, P1236, DOI 10.1016/0006-291X(90)90526-S; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 2008, CURR MED CHEM, V15, P459, DOI 10.2174/092986708783503195; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Fujii N, 1996, BIOCHEM BIOPH RES CO, V220, P353, DOI 10.1006/bbrc.1996.0409; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; JUST I, 1992, J BIOL CHEM, V267, P10274; Kaiser E, 2006, BIOCHEMISTRY-US, V45, P13361, DOI 10.1021/bi061459u; Kaiser E, 2012, CELL MICROBIOL, V14, P1193, DOI 10.1111/j.1462-5822.2012.01788.x; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lillich M, 2012, BIOCONJUGATE CHEM, V23, P1426, DOI 10.1021/bc300041z; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; OHISHI I, 1980, INFECT IMMUN, V30, P668; Olsnes S, 2000, HANDB EXP PHARM, V145, P1; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Rohrbeck A, 2012, FEBS J, V279, P2657, DOI 10.1111/j.1742-4658.2012.08645.x; Sandvig K, 1984, Acta Histochem Suppl, V29, P79; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stiles BG, 2002, TOXICON, V40, P1135, DOI 10.1016/S0041-0101(02)00113-7; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237	42	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54517	10.1371/journal.pone.0054517	http://dx.doi.org/10.1371/journal.pone.0054517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349915	Green Published, gold, Green Submitted			2022-12-25	WOS:000313943000043
J	Holtermann, A; Marott, JL; Gyntelberg, F; Sogaard, K; Suadicani, P; Mortensen, OS; Prescott, E; Schnohr, P				Holtermann, Andreas; Marott, Jacob Louis; Gyntelberg, Finn; Sogaard, Karen; Suadicani, Poul; Mortensen, Ole Steen; Prescott, Eva; Schnohr, Peter			Does the Benefit on Survival from Leisure Time Physical Activity Depend on Physical Activity at Work? A Prospective Cohort Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK; MEN; DEMANDS	Purpose: To investigate if persons with high physical activity at work have the same benefits from leisure time physical activity as persons with sedentary work. Methods: In the Copenhagen City Heart Study, a prospective cohort of 7,411 males and 8,916 females aged 25-66 years without known cardiovascular disease at entry in 1976-78, 1981-83, 1991-94, or 2001-03, the authors analyzed with sex-stratified multivariate Cox proportional hazards regression the association between leisure time physical activity and cardiovascular and all-cause mortality among individuals with different levels of occupational physical activity. Results: During a median follow-up of 22.4 years, 4,003 individuals died from cardiovascular disease and 8,935 from all-causes. Irrespective of level of occupational physical activity, a consistently lower risk with increasing leisure time physical activity was found for both cardiovascular and all-cause mortality among both men and women. Compared to low leisure time physical activity, the survival benefit ranged from 1.5-3.6 years for moderate and 2.6-4.7 years for high leisure time physical activity among the different levels of occupational physical activity. Conclusion: Public campaigns and initiatives for increasing physical activity in the working population should target everybody, irrespective of physical activity at work.	[Holtermann, Andreas; Mortensen, Ole Steen] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Marott, Jacob Louis; Prescott, Eva; Schnohr, Peter] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Gyntelberg, Finn; Suadicani, Poul; Mortensen, Ole Steen] Bispebjerg Hosp, Copenhagen Male Study, Epidemiol Res Unit, Dept Occupat & Environm Med, Copenhagen, Denmark; [Sogaard, Karen] Univ So Denmark, Inst Sport Sci & Clin Biomech, Odense, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark	National Research Centre for the Working Environment; Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Holtermann, A (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.	aho@nrcwe.dk	Søgaard, Karen/B-7933-2008; Prescott, Eva/AAJ-7441-2020	Søgaard, Karen/0000-0003-3968-6364; Prescott, Eva/0000-0002-4134-0349; Mortensen, Ole Steen/0000-0002-4655-8048	Danish Working Environment Research Foundation	Danish Working Environment Research Foundation	The study is a part of the Physical Work Demands and Fitness Project, financed by the Danish Working Environment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M, 1984, SCANDINAVIAN J SOCIA; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2012, BMJ OPEN, V13, P2; Holtermann A, 2012, INT ARCH OCC ENV HEA, V85, P305, DOI 10.1007/s00420-011-0668-x; Holtermann A, 2011, J OCCUP ENVIRON MED, V53, P1221, DOI 10.1097/JOM.0b013e318233865f; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Holtermann A, 2009, SCAND J WORK ENV HEA, V35, P466, DOI 10.5271/sjweh.1357; Jans MP, 2007, AM J PREV MED, V33, P450, DOI 10.1016/j.amepre.2007.07.033; Karlqvist LK, 2003, SCAND J WORK ENV HEA, V29, P363, DOI 10.5271/sjweh.743; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Krause N, 2007, SCAND J WORK ENV HEA, V33, P405, DOI 10.5271/sjweh.1171; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MORRIS JN, 1980, LANCET, V2, P1207; MORRIS JN, 1953, LANCET, V265, P1111; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	22	41	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54548	10.1371/journal.pone.0054548	http://dx.doi.org/10.1371/journal.pone.0054548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349926	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900077
J	Gortazar, AR; Martin-Millan, M; Bravo, B; Plotkin, LI; Bellido, T				Gortazar, Arancha R.; Martin-Millan, Marta; Bravo, Beatriz; Plotkin, Lilian I.; Bellido, Teresita			Crosstalk between Caveolin-1/Extracellular Signal-regulated Kinase (ERK) and beta-Catenin Survival Pathways in Osteocyte Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; FRIZZLED-RELATED PROTEIN-1; ESTROGEN-RECEPTOR; MECHANICAL STIMULATION; OSTEOBLAST APOPTOSIS; BONE; ACTIVATION; CELLS; BISPHOSPHONATES; SCLEROSTIN	Osteocyte viability is a critical determinant of bone strength and is promoted by both mechanical stimulation and activation of the Wnt signaling pathway. Earlier studies demonstrated that both stimuli promote survival of osteocytes by activating the ERKs. Here, we show that there is interaction between the caveolin-1/ERK and Wnt/beta-catenin signaling pathways in the transduction of mechanical cues into osteocyte survival. Thus, ERK nuclear translocation and anti-apoptosis induced by mechanical stimulation are abolished by the Wnt antagonist Dkk1 and the beta-catenin degradation stimulator Axin2. Conversely, GSK3 beta phosphorylation and beta-catenin accumulation induced by mechanical stimulation are abolished by either pharmacologic inhibition of ERKs or silencing caveolin-1. In contrast, the canonical Wnt signaling inhibitor dominant-negative T cell factor does not alter ERK nuclear translocation or survival induced by mechanical stimulation. These findings demonstrate that beta-catenin accumulation is an essential component of the mechanotransduction machinery in osteocytes, albeit beta-catenin/T cell factor-mediated transcription is not required. The simultaneous requirement of beta-catenin for ERK activation and of ERK activation for beta-catenin accumulation suggests a bidirectional crosstalk between the caveolin-1/ERK and Wnt/beta-catenin pathways in mechanotransduction leading to osteocyte survival.	[Gortazar, Arancha R.; Bravo, Beatriz] San Pablo CEU Univ, Sch Med, IMMA, Madrid 28003, Spain; [Martin-Millan, Marta] Inst Formac & Invest Marques Valdecilla IFIVAV, Santander 39011, Spain; [Plotkin, Lilian I.; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA	San Pablo CEU University; Hospital Universitario Marques de Valdecilla (HUMV); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	tbellido@iupui.edu	Gortazar, Arancha/G-5385-2017; Plotkin, Lilian/H-7188-2019	Gortazar, Arancha/0000-0001-5072-3141; Plotkin, Lilian/0000-0002-9537-4544	National Institutes of Health [R01 AR059357]; Fundacion Universitaria San Pablo CEU Grant [USPPPCO07/09]; Conchita Rabago Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Universitaria San Pablo CEU Grant; Conchita Rabago Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR059357 (to T.B.). This work was also supported by Fundacion Universitaria San Pablo CEU Grant USPPPCO07/09 and a fellowship from the Conchita Rabago Foundation (to A.R.G.).	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Javaheri B, 2011, J BONE MINER RES, V26, pS24; Jilka RL, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P237, DOI 10.1016/B978-0-12-373884-4.00032-X; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2007, J BIOL CHEM, V282, P24120, DOI 10.1074/jbc.M611435200; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547	43	57	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8168	8175		10.1074/jbc.M112.437921	http://dx.doi.org/10.1074/jbc.M112.437921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362257	Green Published, hybrid			2022-12-25	WOS:000316564500017
J	Fluharty, BR; Biasini, E; Stravalaci, M; Sclip, A; Diomede, L; Balducci, C; La Vitola, P; Messa, M; Colombo, L; Forloni, G; Borsello, T; Gobbi, M; Harris, DA				Fluharty, Brian R.; Biasini, Emiliano; Stravalaci, Matteo; Sclip, Alessandra; Diomede, Luisa; Balducci, Claudia; La Vitola, Pietro; Messa, Massimo; Colombo, Laura; Forloni, Gianluigi; Borsello, Tiziana; Gobbi, Marco; Harris, David A.			An N-terminal Fragment of the Prion Protein Binds to Amyloid-beta Oligomers and Inhibits Their Neurotoxicity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; IMPAIRMENT; CLEAVAGE; BRAIN	A hallmark of Alzheimer disease (AD) is the accumulation of the amyloid-beta (A beta) peptide in the brain. Considerable evidence suggests that soluble A beta oligomers are responsible for the synaptic dysfunction and cognitive deficit observed in AD. However, the mechanism by which these oligomers exert their neurotoxic effect remains unknown. Recently, it was reported that A beta oligomers bind to the cellular prion protein with high affinity. Here, we show that N1, the main physiological cleavage fragment of the cellular prion protein, is necessary and sufficient for binding early oligomeric intermediates during A beta polymerization into amyloid fibrils. The ability of N1 to bind A beta oligomers is influenced by positively charged residues in two sites (positions 23-31 and 95-105) and is dependent on the length of the sequence between them. Importantly, we also show that N1 strongly suppresses A beta oligomer toxicity in cultured murine hippocampal neurons, in a Caenorhabditis elegans-based assay, and in vivo in a mouse model of A beta-induced memory dysfunction. These data suggest that N1, or small peptides derived from it, could be potent inhibitors of A beta oligomer toxicity and represent an entirely new class of therapeutic agents for AD.	[Fluharty, Brian R.; Biasini, Emiliano; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Stravalaci, Matteo; Diomede, Luisa; Messa, Massimo; Colombo, Laura; Gobbi, Marco] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Sclip, Alessandra; Balducci, Claudia; La Vitola, Pietro; Forloni, Gianluigi; Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy	Boston University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Biasini, E (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 East Concord St, Boston, MA 02118 USA.	biasini@bu.edu	Borsello, Tiziana/ABG-7759-2020; Balducci, Claudia/AAA-8465-2020; Gobbi, Marco/J-2638-2016; Forloni, Gianluigi/AAB-2115-2020; Biasini, Emiliano/A-3147-2011; Stravalaci, Matteo/AAB-8963-2019; colombo, laura/AAA-6716-2020; Diomede, Luisa/P-3417-2014; La Vitola, Pietro/AHE-9241-2022; Borsello, Tiziana/J-8232-2016	Balducci, Claudia/0000-0002-3870-835X; Gobbi, Marco/0000-0003-1014-6225; Forloni, Gianluigi/0000-0001-5374-3914; Biasini, Emiliano/0000-0002-3927-6341; Stravalaci, Matteo/0000-0002-5636-4204; colombo, laura/0000-0002-3243-0270; Diomede, Luisa/0000-0002-2258-0531; Harris, David/0000-0002-6985-5790; Borsello, Tiziana/0000-0002-9729-7642	National Institutes of Health [R01 NS065244, R01 NS040975]; Eben Ellison Foundation; Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy) [2009-2425, 2009-2543]; Alzheimer's Drug Discovery Foundation (ADDF); Telethon Foundation [GGP10120]; Alzheimer's Association [NIRG-10-171655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, R01NS065244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eben Ellison Foundation(Lawrence Ellison Foundation); Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy); Alzheimer's Drug Discovery Foundation (ADDF); Telethon Foundation(Fondazione Telethon); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS065244 and R01 NS040975 (to D. A. H.). This work was also supported by the Eben Ellison Foundation (to D. A. H.), Cassa di Risparmio delle Provincie Lombarde (CARIPLO, Italy) Grants 2009-2425 (to T. B.) and 2009-2543 (to L. D.), the Alzheimer's Drug Discovery Foundation (ADDF; to T. B.), Telethon Foundation Grant GGP10120 (to L. D.), and Alzheimer's Association Grant NIRG-10-171655 (to L.D.).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cisse MA, 2008, MOL CELL NEUROSCI, V39, P400, DOI 10.1016/j.mcn.2008.07.013; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Panza F, 2012, IMMUNOTHERAPY-UK, V4, P213, DOI [10.2217/IMT.11.170, 10.2217/imt.11.170]; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vincent B, 2001, J BIOL CHEM, V276, P37743; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	34	148	153	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7857	7866		10.1074/jbc.M112.423954	http://dx.doi.org/10.1074/jbc.M112.423954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362282	Green Published, hybrid			2022-12-25	WOS:000316455300039
J	Ishida, E; Hashimoto, K; Okada, S; Satoh, T; Yamada, M; Mori, M				Ishida, Emi; Hashimoto, Koshi; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo			Crosstalk between Thyroid Hormone Receptor and Liver X Receptor in the Regulation of Selective Alzheimer's Disease Indicator-1 Gene Expression	PLOS ONE			English	Article							TERM CELL-CULTURES; NERVOUS-SYSTEM; RESPONSE ELEMENT; MOUSE MODEL; IN-VIVO; CHOLESTEROL-BIOSYNTHESIS; OXIDATIVE STRESS; CO-REPRESSOR; T-TEST; BETA	Selective Alzheimer's disease (AD) indicator 1 (Seladin-1) has been identified as a gene down-regulated in the degenerated lesions of AD brain. Up-regulation of Seladin-1 reduces the accumulation of beta-amyloid and neuronal death. Thyroid hormone (TH) exerts an important effect on the development and maintenance of central nervous systems. In the current study, we demonstrated that Seladin-1 gene and protein expression in the forebrain was increased in thyrotoxic mice compared with that of euthyroid mice. However, unexpectedly, no significant decrease in the gene and protein expression was observed in hypothyroid mice. Interestingly, an agonist of liver X receptor (LXR), TO901317 (TO) administration in vivo increased Seladin-1 gene and protein expression in the mouse forebrain only in a hypothyroid state and in the presence of mutant TR-beta, suggesting that LXR-alpha would compensate for TR-beta function to maintain Seladin-1 gene expression in hypothyroidism and resistance to TH. TH activated the mouse Seladin-1 gene promoter (-1936/+21 bp) and site 2 including canonical TH response element (TRE) half-site in the region between -159 and -154 bp is responsible for the positive regulation. RXR-alpha/TR-beta heterodimerization was identified on site 2 by gel-shift assay, and chromatin immunoprecipitation assay revealed the recruitment of TR-beta to site 2 and the recruitment was increased upon TH administration. On the other hand, LXR-alpha utilizes a distinct region from site 2 (-120 to -102 bp) to activate the mouse Seladin-1 gene promoter. Taking these findings together, we concluded that TH up-regulates Seladin-1 gene expression at the transcriptional level and LXR-alpha maintains the gene expression.	[Ishida, Emi; Hashimoto, Koshi; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan	Gunma University	Hashimoto, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	khashimo@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Japan Intractable Disease Research Foundation	Japan Intractable Disease Research Foundation	This work was supported by grant from Japan Intractable Disease Research Foundation to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Behl C, 2002, J STEROID BIOCHEM, V83, P195, DOI 10.1016/S0960-0760(02)00271-6; Benvenuti S, 2008, J ENDOCRINOL, V197, P437, DOI 10.1677/JOE-07-0324; Benvenuti S, 2005, J CLIN ENDOCR METAB, V90, P1775, DOI 10.1210/jc.2004-0066; Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BRETELER MMB, 1991, INT J EPIDEMIOL, V20, pS36, DOI 10.1093/ije/20.Supplement_2.S36; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Davis Jennifer Duncan, 2003, Curr Psychiatry Rep, V5, P384, DOI 10.1007/s11920-003-0073-6; de Jong FJ, 2006, J CLIN ENDOCR METAB, V91, P2569, DOI 10.1210/jc.2006-0449; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9; Fatourechi V, 2009, MAYO CLIN PROC, V84, P65, DOI 10.1016/S0025-6196(11)60809-4; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; FLYNN TR, 1994, J BIOL CHEM, V269, P32713; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Fu AL, 2010, NEUROPHARMACOLOGY, V58, P722, DOI 10.1016/j.neuropharm.2009.12.020; Ganguli M, 1996, BIOL PSYCHIAT, V40, P714, DOI 10.1016/0006-3223(95)00489-0; Greeve I, 2000, J NEUROSCI, V20, P7345; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Hashimoto K, 2005, MOL CELL ENDOCRINOL, V229, P11, DOI 10.1016/j.mce.2004.10.005; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hashimoto K, 2007, ENDOCRINOLOGY, V148, P4667, DOI 10.1210/en.2007-0150; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Hashimoto K, 2011, ENDOCR J, V58, P921, DOI 10.1507/endocrj.EJ11-0114; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huuskonen J, 2004, BIOCHEMISTRY-US, V43, P1626, DOI 10.1021/bi0301643; Jones I, 2003, THYROID, V13, P1057, DOI 10.1089/105072503770867228; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Konig S, 2002, CELL MOL NEUROBIOL, V22, P517, DOI 10.1023/A:1021828218454; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Luciani P, 2008, ENDOCRINOLOGY, V149, P4256, DOI 10.1210/en.2007-1795; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339, DOI 10.1210/mend-5-9-1339; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; MOSER BK, 1989, COMMUN STAT THEORY, V18, P3963, DOI 10.1080/03610928908830135; Nunez J, 2008, MOL CELL ENDOCRINOL, V287, P1, DOI 10.1016/j.mce.2008.03.006; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rivas M, 2007, GENES BRAIN BEHAV, V6, P40, DOI 10.1111/j.1601-183X.2007.00321.x; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Safer JD, 1997, MOL ENDOCRINOL, V11, P16, DOI 10.1210/me.11.1.16; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tan XJ, 2010, P NATL ACAD SCI USA, V107, P12305, DOI 10.1073/pnas.1006162107; USALA SJ, 1991, MOL ENDOCRINOL, V5, P327, DOI 10.1210/mend-5-3-327; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Zhang YQ, 2001, J BIOL CHEM, V276, P974, DOI 10.1074/jbc.M005894200	64	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54901	10.1371/journal.pone.0054901	http://dx.doi.org/10.1371/journal.pone.0054901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359226	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600134
J	Li, MF; Sun, HX; Feng, Q; Lu, HM; Zhao, Y; Zhang, H; Xu, X; Jiao, JD; Wang, LY; Hua, YJ				Li, Mingfeng; Sun, Hongxing; Feng, Qiong; Lu, Huiming; Zhao, Ye; Zhang, Hui; Xu, Xin; Jiao, Jiandong; Wang, Liangyan; Hua, Yuejin			Extracellular dGMP Enhances Deinococcus radiodurans Tolerance to Oxidative Stress	PLOS ONE			English	Article							MICROCOCCUS-RADIODURANS; IONIZING-RADIATION; GENE-TRANSFER; EXTREME RADIORESISTANCE; NATURAL TRANSFORMATION; NEISSERIA-GONORRHOEAE; SUPEROXIDE-DISMUTASE; DNA-REPAIR; BACTERIA; ENVIRONMENT	Free extracellular DNA provides nutrition to bacteria and promotes bacterial evolution by inducing excessive mutagenesis of the genome. To understand the influence of extracellular DNA fragments on D. radiodurans, we investigated cell growth and survival after extracellular DNA or dNMPs treatment. The results showed that the extracellular DNA fragments inhibited the growth of D. radiodurans. Interestingly, dGMP, a DNA component, enhanced D. radiodurans tolerance to H2O2 and gamma-radiation significantly. Further experiments indicated that extracellular dGMP stimulated the activity of one catalase (KatA, DR1998), and induced gene transcription including the extracellular nuclease (drb0067). When this only extracellular nuclease gene (drb0067) in D. radiodurans was deleted, the mutant strain showed more sensitive to H2O2 and gamma-radiation than the wild type strain. These results suggest that DRB0067 plays an important role in oxidative stress resistance. Taken together, we proposed a new anti-oxidation mechanism in D. radiodurans. This mechanism acts to increase expression levels of DRB0067 which then secretes active nuclease to degrade extracellular DNA fragments. The extracellular nuclease has a two-fold benefit, creating more free dNTPs for further cell protection and the removal of extracellular DNA fragments.	[Li, Mingfeng; Sun, Hongxing; Feng, Qiong; Lu, Huiming; Zhao, Ye; Zhang, Hui; Xu, Xin; Jiao, Jiandong; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hongxing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Sun, Hongxing] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, LY (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China.	liangyanwang@zju.edu.cn; yjhua@zju.edu.cn	Sun, Hongxing/AAV-6028-2020; LU, HUIMING/C-1996-2014; Zhao, Ye/I-2936-2014; Lu, Huiming/ABG-1372-2021	Zhao, Ye/0000-0002-5455-2586; Lu, Huiming/0000-0002-2743-7419	National Natural Science Foundation of China [30830006, 31070080]; major project for genetically modified organisms breeding from the Ministry of Agriculture of China [2009ZX08009-075B, 2011ZX08009-003-002]; Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China [201103007]; Fundamental Research Funds for the Central Universities from Zhejiang University [2012FZA6014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); major project for genetically modified organisms breeding from the Ministry of Agriculture of China; Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China; Fundamental Research Funds for the Central Universities from Zhejiang University	This work was supported by grants from National Natural Science Foundation of China (30830006, 31070080), a major project for genetically modified organisms breeding from the Ministry of Agriculture of China (2009ZX08009-075B, 2011ZX08009-003-002), a grant from Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China (201103007), and the Fundamental Research Funds for the Central Universities from Zhejiang University (2012FZA6014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; BOLING ME, 1966, BIOCHIM BIOPHYS ACTA, V123, P26, DOI 10.1016/0005-2787(66)90155-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brnakova Z, 2005, BBA-GEN SUBJECTS, V1721, P116, DOI 10.1016/j.bbagen.2004.10.008; Curatola AM, 2011, ANGIOGENESIS, V14, P267, DOI 10.1007/s10456-011-9211-7; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dodd HN, 1999, FEMS MICROBIOL LETT, V173, P41, DOI 10.1016/S0378-1097(99)00054-3; DREISEIKELMANN B, 1994, MICROBIOL REV, V58, P293, DOI 10.1128/MMBR.58.3.293-316.1994; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; GENTNER NE, 1975, RADIAT RES, V61, P204, DOI 10.2307/3574039; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; ICHIGE A, 1988, J BACTERIOL, V170, P3537, DOI 10.1128/jb.170.8.3537-3542.1988; Kamble VA, 2010, FEMS MICROBIOL LETT, V303, P18, DOI 10.1111/j.1574-6968.2009.01855.x; Linder JU, 2010, MOL CELL BIOCHEM, V334, P215, DOI 10.1007/s11010-009-0321-0; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Meima R, 2000, APPL ENVIRON MICROB, V66, P3856, DOI 10.1128/AEM.66.9.3856-3867.2000; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; MITCHEL REJ, 1975, RADIAT RES, V64, P380, DOI 10.2307/3574274; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tanaka A, 1996, RADIAT ENVIRON BIOPH, V35, P95, DOI 10.1007/BF02434031; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; VUKOVICNAGY B, 1974, INT J RADIAT BIOL, V25, P329, DOI 10.1080/09553007414550401; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yin XM, 1997, ADV APPL MICROBIOL, V45, P153, DOI 10.1016/S0065-2164(08)70263-6; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	45	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54420	10.1371/journal.pone.0054420	http://dx.doi.org/10.1371/journal.pone.0054420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365666	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600054
J	Tang, B; Li, ZX; Huang, DD; Zheng, L; Li, QW				Tang, Bo; Li, Zhexu; Huang, Dingde; Zheng, Lei; Li, Qianwei			Screening of a Specific Peptide Binding to VPAC1 Receptor from a Phage Display Peptide Library	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; SIGNAL-TRANSDUCTION; VIP ANALOG; IDENTIFICATION; GROWTH; INHIBIT; PACAP; PROLIFERATION; STIMULATION	Background/Purpose: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies. Recently, phage display has become widely used for many applications, including ligand generation for targeted imaging, drug delivery and therapy. In this work, we developed a panning procedure using a phage display peptide library to select a peptide that specifically binds to the VPAC1 receptor to develop a novel targeted probe for molecular imaging and therapy. Methods: CHO-K1 cells stably expressing VPAC1 receptors (CHO-K1/VPAC1 cells) were used to select a VPAC1-binding peptide from a 12-mer phage peptide library. DNA sequencing and homologous analysis of the randomly selected phage clones were performed. A cellular ELISA was used to determine the most selectively binding peptide for further investigation. Binding specificity to the VPAC1 receptor was analyzed by competitive inhibition ELISA and flow cytometry. The binding ability of the selected peptide to CHO-K1/VPAC1 cells and colorectal cancer (CRC) cell lines was confirmed using fluorescence microscopy and flow cytometry. Results: A significant enrichment of phages that specifically bound to CHO-K1/VPAC1 cells was obtained after four rounds of panning. Of the selected phage clones, 16 out of 60 shared the same peptide sequence, GFRFGALHEYNS, which we termed the VP2 peptide. VP2 and vasoactive intestinal peptide (VIP) competitively bound to the VPAC1 receptor. More importantly, we confirmed that VP2 specifically bound to CHO-K1/VPAC1 cells and several CRC cell lines. Conclusion: Our results demonstrate that the VP2 peptide could specifically bind to VPAC1 receptor and several CRC cell lines. And VP2 peptide may be a potential candidate to be developed as a useful diagnostic molecular imaging probe for early detection of CRC.	[Tang, Bo; Li, Zhexu; Huang, Dingde; Zheng, Lei; Li, Qianwei] Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China	Army Medical University	Li, QW (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China.	lqw_swhospital@163.com			Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation [120204]	Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation	This research was supported by the Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation (Grant No. 120204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; Beck S, 2011, BIOMATERIALS, V32, P8518, DOI 10.1016/j.biomaterials.2011.07.048; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Carrasquillo JA, 2011, J NUCL MED, V52, P1173, DOI 10.2967/jnumed.110.086165; Cheng DF, 2007, J FLUORINE CHEM, V128, P196, DOI 10.1016/j.jfluchem.2006.12.007; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Hamzeh-Mivehroud M, 2012, CHEM BIOL DRUG DES, V79, P246, DOI 10.1111/j.1747-0285.2011.01282.x; Jaggi M, 2008, INVEST NEW DRUG, V26, P489, DOI 10.1007/s10637-008-9117-4; Kothari K, 2007, APPL RADIAT ISOTOPES, V65, P382, DOI 10.1016/j.apradiso.2006.11.001; Kuipers EJ, 2005, J SURG ONCOL, V92, P203, DOI 10.1002/jso.20361; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lelievre V, 1998, J BIOL CHEM, V273, P19685, DOI 10.1074/jbc.273.31.19685; Liang SH, 2006, J MOL MED, V84, P764, DOI 10.1007/s00109-006-0064-2; Moody TW, 2007, PEPTIDES, V28, P1883, DOI 10.1016/j.peptides.2007.04.017; MOODY TW, 1993, P NATL ACAD SCI USA, V90, P4345, DOI 10.1073/pnas.90.10.4345; Moody TW, 2004, REGUL PEPTIDES, V123, P187, DOI 10.1016/j.regpep.2004.03.021; Moody TW, 2002, J MOL NEUROSCI, V18, P29, DOI 10.1385/JMN:18:1-2:29; Moody TW, 2002, LIFE SCI, V71, P1005, DOI 10.1016/S0024-3205(02)01741-1; Muller JM, 2006, REGUL PEPTIDES, V137, P34, DOI 10.1016/j.regpep.2006.06.014; Muller JM, 2007, PEPTIDES, V28, P1655, DOI 10.1016/j.peptides.2007.04.006; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Pan WH, 2004, BRAIN RES REV, V46, P32, DOI 10.1016/j.brainresrev.2004.04.006; Park HY, 2012, MOL BIOTECHNOL, V51, P212, DOI 10.1007/s12033-011-9458-7; Pfau PR, 2001, GASTROENTEROLOGY, V120, P763, DOI 10.1053/gast.2001.22429; Qin X, 2007, J BIOCHEM, V142, P79, DOI 10.1093/jb/mvm109; Raderer M, 1998, BRIT J CANCER, V78, P1, DOI 10.1038/bjc.1998.433; Rao PS, 2001, NUCL MED BIOL, V28, P445, DOI 10.1016/S0969-8051(01)00205-0; Reubi JC, 2004, EUR J NUCL MED MOL I, V31, P803, DOI 10.1007/s00259-004-1476-2; Reubi JC, 2000, CANCER RES, V60, P3105; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Straub SG, 1996, J BIOL CHEM, V271, P1660, DOI 10.1074/jbc.271.3.1660; Thakur ML, 2000, ANN NY ACAD SCI, V921, P37; Torizuka T, 2002, EUR J NUCL MED MOL I, V29, P797, DOI 10.1007/s00259-001-0750-9; Tung CH, 2004, BIOPOLYMERS, V76, P391, DOI 10.1002/bip.20139; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Valdehita A, 2012, MOL CELL ENDOCRINOL, V348, P241, DOI 10.1016/j.mce.2011.08.031; Valdehita A, 2009, MOL CELL ENDOCRINOL, V302, P41, DOI 10.1016/j.mce.2008.11.024; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vaudry H, 2006, ANN NY ACAD SCI, V1070, P1; Wang FY, 2006, BIOSCI BIOTECH BIOCH, V70, P2035, DOI 10.1271/bbb.50654; Xu R, 2006, HISTOL HISTOPATHOL, V21, P867, DOI 10.14670/HH-21.867; Zang LQ, 2009, CANCER LETT, V281, P64, DOI 10.1016/j.canlet.2009.02.021; Zhang WJ, 2012, WORLD J GASTROENTERO, V18, P2053, DOI 10.3748/wjg.v18.i17.2053; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022203	46	16	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54264	10.1371/journal.pone.0054264	http://dx.doi.org/10.1371/journal.pone.0054264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365656	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600044
J	Domenyuk, V; Loskutov, A; Johnston, SA; Diehnelt, CW				Domenyuk, Valeriy; Loskutov, Andrey; Johnston, Stephen Albert; Diehnelt, Chris W.			A Technology for Developing Synbodies with Antibacterial Activity	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; ANTIBIOTICS; SELECTIVITY; SEQUENCE; DESIGN	The rise in antibiotic resistance has led to an increased research focus on discovery of new antibacterial candidates. While broad-spectrum antibiotics are widely pursued, there is evidence that resistance arises in part from the wide spread use of these antibiotics. Our group has developed a system to produce protein affinity agents, called synbodies, which have high affinity and specificity for their target. In this report, we describe the adaptation of this system to produce new antibacterial candidates towards a target bacterium. The system functions by screening target bacteria against an array of 10,000 random sequence peptides and, using a combination of membrane labeling and intracellular dyes, we identified peptides with target specific binding or killing functions. Binding and lytic peptides were identified in this manner and in vitro tests confirmed the activity of the lead peptides. A peptide with antibacterial activity was linked to a peptide specifically binding Staphylococcus aureus to create a synbody with increased antibacterial activity. Subsequent tests showed that this peptide could block S. aureus induced killing of HEK293 cells in a co-culture experiment. These results demonstrate the feasibility of using the synbody system to discover new antibacterial candidate agents.	[Domenyuk, Valeriy; Loskutov, Andrey; Johnston, Stephen Albert; Diehnelt, Chris W.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Diehnelt, CW (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	chris.diehnelt@asu.edu	Diehnelt, Chris/AAT-9271-2020	Diehnelt, Chris/0000-0003-4565-9338	DARPA [W911NF-10-1-0299]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a grant from DARPA (http://www.darpa.mil/) under the 7 Day Biodefense Program to SAJ (grant number W911NF-10-1-0299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betanzos CM, 2009, CHEMBIOCHEM, V10, P877, DOI 10.1002/cbic.200800716; Casadevall A, 1996, CLIN INFECT DIS, V23, P790, DOI 10.1093/clinids/23.4.790; Casadevall A, 2009, EXPERT OPIN PHARMACO, V10, P1699, DOI 10.1517/14656560903066837; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; CLSI, 2009, M07A8 CLSI, P26; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Diehnelt CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010728; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P1480, DOI 10.1128/AAC.50.4.1480-1488.2006; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Greving MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015432; Gupta N, 2011, BIOCONJUGATE CHEM, V22, P1473, DOI 10.1021/bc200091c; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; He J, 2010, ANTIMICROB AGENTS CH, V54, P2143, DOI 10.1128/AAC.01391-09; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Loutet SA, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00006; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; Reichert JM, 2006, NAT REV DRUG DISCOV, V5, P191, DOI 10.1038/nrd1987; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Saylor C, 2009, VACCINE, V27, pG38, DOI 10.1016/j.vaccine.2009.09.105; Schneider CR, 2005, TRANSPLANT P, V37, P1243, DOI 10.1016/j.transproceed.2005.01.059; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; SILVER LL, 1993, ANTIMICROB AGENTS CH, V37, P377, DOI 10.1128/AAC.37.3.377; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tencza SB, 1999, J ANTIMICROB CHEMOTH, V44, P33, DOI 10.1093/jac/44.1.33; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wiegand C, 2009, WOUND REPAIR REGEN, V17, P730, DOI 10.1111/j.1524-475X.2009.00536.x; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	35	16	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54162	10.1371/journal.pone.0054162	http://dx.doi.org/10.1371/journal.pone.0054162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372679	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500033
J	Auld, AF; Mbofana, F; Shiraishi, RW; Alfredo, C; Sanchez, M; Ellerbrock, TV; Nelson, LJ				Auld, Andrew F.; Mbofana, Francisco; Shiraishi, Ray W.; Alfredo, Charity; Sanchez, Mauro; Ellerbrock, Tedd V.; Nelson, Lisa J.			Incidence and Determinants of Tuberculosis among Adults Initiating Antiretroviral Therapy - Mozambique, 2004-2008	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; HIV-ASSOCIATED TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; RISK-FACTORS; MULTIPLE IMPUTATION; POSITIVE PATIENTS; MISSING VALUES; SOUTH-AFRICA; TERM; ADHERENCE	Background: In Mozambique, tuberculosis (TB) is thought to be the most common cause of death among antiretroviral therapy (ART) enrollees. Monitoring proportions of enrollees screened for TB, and incidence and determinants of TB during ART can help clinicians and program managers identify program improvement opportunities. Methodology/Principal Findings: We conducted a retrospective cohort study among a nationally representative sample of the 79,500 adults (>14 years old) initiating ART during 2004-2007 to estimate clinician compliance with TB screening guidelines, factors associated with active TB at ART initiation, and incidence and predictors of documented TB during ART follow-up. Of 94 sites enrolling >= 50 adults on ART, 30 were selected using probability-proportional-to-size sampling; 2,596 medical records at these sites were randomly selected for abstraction and analysis. At ART initiation, median age of patients was 34, 62% were female, median baseline CD4(+) T-cell count was 153/mu L, and 11% were taking TB treatment. Proportions of records with TB screening documentation before ART initiation improved from 31% to 66% during 2004-2007 (p<0.001). TB screening compliance varied widely by ART clinic [n = 30, 2%-98% (p<0.001)] and supporting non-Governmental Organization (NGO) [n = 7, 27%-83% (p<0.001)]. Receiving TB treatment at ART enrollment was associated with male sex (p<0.001), weight <45 kg (p<0.001) and CD4<50/mu L (p=0.001). Isoniazid preventive therapy (IPT) was prescribed to <1% of ART enrollees not taking TB treatment. TB incidence during ART was 2.32 cases per 100 person-years. Factors associated with TB incidence included adherence to ART<95% (AHR 2.06; 95% CI, 1.32-3.21). Conclusion: Variations in TB screening by clinic and NGO may reflect differing investments in TB screening activities. Future scale-up should target under-performing clinics. Scale-up of TB screening at ART initiation, IPT, and ART adherence interventions could significantly reduce incident TB during ART.	[Auld, Andrew F.; Shiraishi, Ray W.; Ellerbrock, Tedd V.] Ctr Dis Control & Prevent, DGHA, CGH, Atlanta, GA 30333 USA; [Mbofana, Francisco] Minist Hlth, Insituto Nacl Saude, Maputo, Mozambique; [Alfredo, Charity] Ctr Dis Control & Prevent, DGHA, CGH, Maputo, Mozambique; [Sanchez, Mauro] Univ Brasilia, Sch Hlth Sci, Dept Publ Hlth, Brasilia, DF, Brazil	Centers for Disease Control & Prevention - USA; Universidade de Brasilia	Auld, AF (corresponding author), Ctr Dis Control & Prevent, DGHA, CGH, Atlanta, GA 30333 USA.	aauld@cdc.gov	Sanchez, Mauro/AAU-2404-2020	Sanchez, Mauro/0000-0002-0472-1804; Auld, Andrew/0000-0001-5089-9163; Shiraishi, Ray/0000-0001-7640-0666	United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	All parts of the study were funded by the United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the U.S. Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). Authors Auld, Shiraishi, Alfredo, Nelson, and Ellerbrock are employed by the CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], GUID INT TUB CAS FIN; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Nachega J, 2011, 6 INT AIDS SOC C ROM; Namuwenge PM, 2012, T ROY SOC TROP MED H, V106, P84, DOI 10.1016/j.trstmh.2011.10.015; Prasso JE, 2010, 18 INT AIDS C 18 23; Rana F, 1997, J ACQ IMMUN DEF SYND, V14, P83, DOI 10.1097/00042560-199701010-00017; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2012, GLOB REP GLOB AIDS E; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; World Health Organization, 2006, ANT THER HIV INF AD	42	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54665	10.1371/journal.pone.0054665	http://dx.doi.org/10.1371/journal.pone.0054665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349948	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100089
J	Saito, K; Horiuchi, K; Kimura, T; Mizuno, S; Yoda, M; Morioka, H; Akiyama, H; Threadgill, D; Okada, Y; Toyama, Y; Sato, K				Saito, Kenta; Horiuchi, Keisuke; Kimura, Tokuhiro; Mizuno, Sakiko; Yoda, Masaki; Morioka, Hideo; Akiyama, Haruhiko; Threadgill, David; Okada, Yasunori; Toyama, Yoshiaki; Sato, Kazuki			Conditional Inactivation of TNF alpha-Converting Enzyme in Chondrocytes Results in an Elongated Growth Plate and Shorter Long Bones	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR-DEFICIENT MICE; EGF-RECEPTOR; ENDOCHONDRAL OSSIFICATION; METALLOPROTEINASE; ADAM17; ROLES; TACE; DIFFERENTIATION; MACROPHAGES	TNF alpha-converting enzyme (TACE) is a membrane-bound proteolytic enzyme with essential roles in the functional regulation of TNF alpha and epidermal growth factor receptor (EGFR) ligands. Previous studies have demonstrated critical roles for TACE in vivo, including epidermal development, immune response, and pathological neoangiogenesis, among others. However, the potential contribution of TACE to skeletal development is still unclear. In the present study, we generated a Tace mutant mouse in which Tace is conditionally disrupted in chondrocytes under the control of the Col2a1 promoter. These mutant mice were fertile and viable but all exhibited long bones that were approximately 10% shorter compared to those of wildtype animals. Histological analyses revealed that Tace mutant mice exhibited a longer hypertrophic zone in the growth plate, and there were fewer osteoclasts at the chondro-osseous junction in the Tace mutant mice than in their wild-type littermates. Of note, we found an increase in osteoprotegerin transcripts and a reduction in Rankl and Mmp-13 transcripts in the TACE-deficient cartilage, indicating that dysregulation of these genes is causally related to the skeletal defects in the Tace mutant mice. Furthermore, we also found that phosphorylation of EGFR was significantly reduced in the cartilage tissue lacking TACE, and that suppression of EGFR signaling increases osteoprotegerin transcripts and reduces Rankl and Mmp-13 transcripts in primary chondrocytes. In accordance, chondrocyte-specific abrogation of Egfr in vivo resulted in skeletal defects nearly identical to those observed in the Tace mutant mice. Taken together, these data suggest that TACE-EGFR signaling in chondrocytes is involved in the turnover of the growth plate during postnatal development via the transcriptional regulation of osteoprotegerin, Rankl, and Mmp-13.	[Saito, Kenta; Horiuchi, Keisuke; Mizuno, Sakiko; Morioka, Hideo; Toyama, Yoshiaki; Sato, Kazuki] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Horiuchi, Keisuke; Yoda, Masaki] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo, Japan; [Kimura, Tokuhiro; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthoped, Kyoto, Japan; [Threadgill, David] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Keio University; Keio University; Keio University; Kyoto University; University of North Carolina; North Carolina State University	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan.	horiuchi@z3.keio.jp	Horiuchi, Keisuke/L-2277-2013; Threadgill, David W/N-4425-2013; Sato, Kazuki/AAL-2166-2021; Toyama, Yoshiaki/K-5743-2013; Okada, Yasunori/B-5550-2014	Horiuchi, Keisuke/0000-0001-7063-9609; Threadgill, David W/0000-0003-3538-1635; Okada, Yasunori/0000-0001-9208-4755; Mizuno, Sakiko/0000-0003-4081-3973	Keio University Kanrinmaru project; MEXT KAKENHI [30327564]	Keio University Kanrinmaru project; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Keio University Kanrinmaru project, and MEXT KAKENHI (30327564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dreymueller D, 2011, EUR J CELL BIOL; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hakozaki A, 2010, J IMMUNOL, V184, P2442, DOI 10.4049/jimmunol.0901188; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Isshiki H, 2011, J ORTHOP SCI, V16, P670, DOI 10.1007/s00776-011-0119-2; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peschon JJ, 1998, J IMMUNOL, V160, P943; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295	39	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54853	10.1371/journal.pone.0054853	http://dx.doi.org/10.1371/journal.pone.0054853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349978	Green Published, gold			2022-12-25	WOS:000313872800079
J	Christen, S; Coppieters, K; Rose, K; Holdener, M; Bayer, M; Pfeilschifter, JM; Hintermann, E; von Herrath, MG; Aurrand-Lions, M; Imhof, BA; Christen, U				Christen, Selina; Coppieters, Ken; Rose, Kerstin; Holdener, Martin; Bayer, Monika; Pfeilschifter, Josef M.; Hintermann, Edith; von Herrath, Matthias G.; Aurrand-Lions, Michel; Imhof, Beat A.; Christen, Urs			Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice	PLOS ONE			English	Article							ISLET-SPECIFIC EXPRESSION; ACUTE-PANCREATITIS; JAM-C; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE ADHESION; TRANSGENIC MODEL; IN-VITRO; INFLAMMATION; CELLS; PATHOGENESIS	Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing beta-cells in the pancreas. Recruitment of inflammatory cells is prerequisite to beta-cell-injury. The junctional adhesion molecule (JAM) family proteins JAM-B and JAM-C are involved in polarized leukocyte transendothelial migration and are expressed by vascular endothelial cells of peripheral tissue and high endothelial venules in lympoid organs. Blocking of JAM-C efficiently attenuated cerulean-induced pancreatitis, rheumatoid arthritis or inflammation induced by ischemia and reperfusion in mice. In order to investigate the influence of JAM-C on trafficking and transmigration of antigen-specific, autoaggressive T-cells, we used transgenic mice that express a protein of the lymphocytic choriomeningitis virus (LCMV) as a target autoantigen in the beta-cells of the islets of Langerhans under the rat insulin promoter (RIP). Such RIP-LCMV mice turn diabetic after infection with LCMV. We found that upon LCMV-infection JAM-C protein was upregulated around the islets in RIP-LCMV mice. JAM-C expression correlated with islet infiltration and functional beta-cell impairment. Blockade with a neutralizing anti-JAM-C antibody reduced the T1D incidence. However, JAM-C overexpression on endothelial cells did not accelerate diabetes in the RIP-LCMV model. In summary, our data suggest that JAM-C might be involved in the final steps of trafficking and transmigration of antigen-specific autoaggressive T-cells to the islets of Langerhans.	[Christen, Selina; Rose, Kerstin; Holdener, Martin; Bayer, Monika; Pfeilschifter, Josef M.; Hintermann, Edith; Christen, Urs] Goethe Univ Hosp, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Coppieters, Ken; von Herrath, Matthias G.] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Aurrand-Lions, Michel] Aix Marseille Univ, CNRS, INSERM, Ctr Rech Cancerol Marseille,UMR 891, Marseille, France; [Imhof, Beat A.] Ctr Med Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Christen, U (corresponding author), Goethe Univ Hosp, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	christen@med.uni-frankfurt.de	Aurrand-Lions, Michel/O-9953-2016	Aurrand-Lions, Michel/0000-0002-8361-3034; Christen, Urs/0000-0003-4165-7976	University Hospital Frankfurt, Frankfurt am Main, Germany; German Research Foundation (DFG)	University Hospital Frankfurt, Frankfurt am Main, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	This research project was funded by the University Hospital Frankfurt, Frankfurt am Main, Germany and a grant of the German Research Foundation (DFG) to UC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Christen S, 2011, CLIN EXP IMMUNOL, V165, P318, DOI 10.1111/j.1365-2249.2011.04426.x; Christen U, 2004, J CLIN INVEST, V113, P74, DOI 10.1172/JCI200417005; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Christen U, 2010, J AUTOIMMUN, V34, P38, DOI 10.1016/j.jaut.2009.08.001; Coppieters K, 2012, FUNCTIONAL RED UNPUB; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Coppieters K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015732; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Frossard JL, 1999, GASTROENTEROLOGY, V116, P694, DOI 10.1016/S0016-5085(99)70192-7; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; Martin S, 2001, J AUTOIMMUN, V17, P109, DOI 10.1006/jaut.2001.0526; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Petri B, 2006, FEBS J, V273, P4399, DOI 10.1111/j.1742-4658.2006.05439.x; Rabquer BJ, 2008, ARTHRITIS RHEUM, V58, P3020, DOI 10.1002/art.23867; Rau B, 2001, PANCREAS, V23, P80, DOI 10.1097/00006676-200107000-00012; Rhode A, 2005, J IMMUNOL, V175, P3516, DOI 10.4049/jimmunol.175.6.3516; Sircar M, 2007, J IMMUNOL, V178, P5879, DOI 10.4049/jimmunol.178.9.5879; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Vonlaufen A, 2007, J PATHOL, V213, P239, DOI 10.1002/path.2231; Vonlaufen A, 2006, J PATHOL, V209, P540, DOI 10.1002/path.2007; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54675	10.1371/journal.pone.0054675	http://dx.doi.org/10.1371/journal.pone.0054675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372751	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400024
J	Leszczynska, D; Matuszewska, E; Kuczynska-Wisnik, D; Furmanek-Blaszk, B; Laskowska, E				Leszczynska, Daria; Matuszewska, Ewelina; Kuczynska-Wisnik, Dorota; Furmanek-Blaszk, Beata; Laskowska, Ewa			The Formation of Persister Cells in Stationary-Phase Cultures of Escherichia Coli Is Associated with the Aggregation of Endogenous Proteins	PLOS ONE			English	Article							BACTERIAL PERSISTENCE; MULTIPLE ANTIBIOTICS; MULTIDRUG TOLERANCE; GLYCINE-BETAINE; IN-VITRO; CHAPERONES; MECHANISM; FREQUENCY; STRESSES; GROWTH	Persister cells (persisters) are transiently tolerant to antibiotics and usually constitute a small part of bacterial populations. Persisters remain dormant but are able to re-grow after antibiotic treatment. In this study we found that the frequency of persisters correlated to the level of protein aggregates accumulated in E. coli stationary-phase cultures. When 3-(N-morpholino) propanesulfonic acid or an osmolyte (trehalose, betaine, glycerol or glucose) were added to the growth medium at low concentrations, proteins were prevented from aggregation and persister formation was inhibited. On the other hand, acetate or high concentrations of osmolytes enhanced protein aggregation and the generation of persisters. We demonstrated that in the E. coli stationary-phase cultures supplemented with MOPS or a selected osmolyte, the level of protein aggregates and persister frequency were not correlated with such physiological parameters as the extent of protein oxidation, culturability, ATP level or membrane integrity. The results described here may help to understand the mechanisms underlying persister formation.	[Leszczynska, Daria; Matuszewska, Ewelina; Kuczynska-Wisnik, Dorota; Laskowska, Ewa] Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland; [Furmanek-Blaszk, Beata] Univ Gdansk, Fac Biol, Dept Microbiol, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Laskowska, E (corresponding author), Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland.	lasko@biotech.ug.gda.pl		Furmanek-Blaszk, Beata/0000-0002-9104-4177; Laskowska, Ewa/0000-0002-7138-1125; Kuczynska-Wisnik, Dorota/0000-0002-3678-2660	Polish Ministry of Science and Higher Education [0923/B/P01/2009/36]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grant 0923/B/P01/2009/36 from the Polish Ministry of Science and Higher Education (www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Caldas T, 1999, MICROBIOL-SGM, V145, P2543, DOI 10.1099/00221287-145-9-2543; CAYLEY S, 1989, J BACTERIOL, V171, P3597, DOI 10.1128/jb.171.7.3597-3602.1989; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; De Spiegeleer P, 2004, J APPL MICROBIOL, V97, P124, DOI 10.1111/j.1365-2672.2004.02285.x; Diamant S, 2003, MOL MICROBIOL, V49, P401, DOI 10.1046/j.1365-2958.2003.03553.x; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim JS, 2011, BIOCHEM BIOPH RES CO, V413, P105, DOI 10.1016/j.bbrc.2011.08.063; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kitko RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010078; Klapper I, 2007, MICROBIOL-SGM, V153, P3623, DOI 10.1099/mic.0.2007/006734-0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Ksiazek K, 2010, BIOGERONTOLOGY, V11, P717, DOI 10.1007/s10522-010-9278-3; KUCHARCZYK K, 1991, MOL MICROBIOL, V5, P2935, DOI 10.1111/j.1365-2958.1991.tb01853.x; Kwiatkowska J, 2008, RES MICROBIOL, V159, P651, DOI 10.1016/j.resmic.2008.09.008; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samuel D, 2000, PROTEIN SCI, V9, P344; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh LR, 2011, LIFE SCI, V88, P117, DOI 10.1016/j.lfs.2010.10.020; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	49	49	49	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54737	10.1371/journal.pone.0054737	http://dx.doi.org/10.1371/journal.pone.0054737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358116	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600100
J	Maes, PJ; Leman, M				Maes, Pieter-Jan; Leman, Marc			The Influence of Body Movements on Children's Perception of Music with an Ambiguous Expressive Character	PLOS ONE			English	Article							EMOTIONAL RESPONSES; INDIVIDUAL-DIFFERENCES; SEEING MUSIC; HEARING; RECOGNITION; CONTEXT; SOUND; BIG-5	The theory of embodied music cognition states that the perception and cognition of music is firmly, although not exclusively, linked to action patterns associated with that music. In this regard, the focus lies mostly on how music promotes certain action tendencies (i.e., dance, entrainment, etc.). Only recently, studies have started to devote attention to the reciprocal effects that people's body movements may exert on how people perceive certain aspects of music and sound (e. g., pitch, meter, musical preference, etc.). The present study positions itself in this line of research. The central research question is whether expressive body movements, which are systematically paired with music, can modulate children's perception of musical expressiveness. We present a behavioral experiment in which different groups of children (7-8 years, N = 46) either repetitively performed a happy or a sad choreography in response to expressively ambiguous music or merely listened to that music. The results of our study show indeed that children's perception of musical expressiveness is modulated in accordance with the expressive character of the dance choreography performed to the music. This finding supports theories that claim a strong connection between action and perception, although further research is needed to uncover the details of this connection.	[Maes, Pieter-Jan; Leman, Marc] Univ Ghent, IPEM Dept Musicol, B-9000 Ghent, Belgium	Ghent University	Maes, PJ (corresponding author), Univ Ghent, IPEM Dept Musicol, B-9000 Ghent, Belgium.	pieterjan.maes@UGent.be		Maes, Pieter-Jan/0000-0002-9237-3298	Flemish government	Flemish government(European Commission)	This work is carried out in context of the EmcoMetecca project funded by the Flemish government (http://www.ipem.ugent.be/EmcoMetecca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Boone RT, 2001, J NONVERBAL BEHAV, V25, P21, DOI 10.1023/A:1006733123708; Boone RT, 1998, DEV PSYCHOL, V34, P1007, DOI 10.1037/0012-1649.34.5.1007; Camurri A, 2003, INT J HUM-COMPUT ST, V59, P213, DOI 10.1016/S1071-5819(03)00050-8; Caramiaux B, 2010, LECT NOTES ARTIF INT, V5934, P158, DOI 10.1007/978-3-642-12553-9_14; Cox Arnie, 2011, MUSIC THEORY, V17; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeBruyn L., 2012, MUSIC MED, V4, P28, DOI [DOI 10.1177/1943862111415116, 10.1177/1943862111415116]; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229; Eerola T., 2006, P 9 INT C MUSIC PERC, P472; FUJIHARA T, 1984, JPN J PSYCHOL, V55, P75, DOI 10.4992/jjpsy.55.75; Glenberg AM, 2010, WIRES COGN SCI, V1, P586, DOI 10.1002/wcs.55; Godoy R.I., 2010, MUSICAL GESTURES SOU, P103; Godoy RI, 2003, LEONARDO, V36, P317, DOI 10.1162/002409403322258781; Gregory AH, 1996, MOTIV EMOTION, V20, P341, DOI 10.1007/BF02856522; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Holochwost SJ, 2008, BEHAV BRAIN SCI, V31, P581, DOI 10.1017/S0140525X08005360; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Juchniewicz J, 2008, PSYCHOL MUSIC, V36, P417, DOI 10.1177/0305735607086046; KASTNER MP, 1990, MUSIC PERCEPT, V8, P189; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Larsen JT, 2011, EMOTION, V11, P1469, DOI 10.1037/a0024081; Lee S., 2006, HDB HUMAN PERFORMANC, P760; Leman M., 2007, EMBODIED MUSIC COGNI, DOI [10.7551/mitpress/7476.001.0001, DOI 10.7551/MITPRESS/7476.001.0001]; Leman M, 2009, MUSIC PERCEPT, V26, P263, DOI 10.1525/MP.2009.26.3.263; Mead A, 1999, J MUSIC THEORY, V43, P1, DOI 10.2307/3090688; MERVIELDE I, 1995, PERS INDIV DIFFER, V18, P525, DOI 10.1016/0191-8869(94)00175-R; Murakami T, 2003, MULTIVAR BEHAV RES, V38, P247, DOI 10.1207/S15327906MBR3802_5; Nielzen S., 1981, PSYCHOL MUSIC, V9, P17; OBRIANT MP, 1978, B PSYCHONOMIC SOC, V12, P441; Osgood C. E., 1957, MEASUREMENT MEANING, V47; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Repp BH, 2009, Q J EXP PSYCHOL, V62, P2156, DOI 10.1080/17470210902745009; Saint-Germier P, 2010, P EUR SOC PHIL PSYCH; Salkind NJ, 2007, ENCY MEMASUREMENT ST; Schutz M, 2007, PERCEPTION, V36, P888, DOI 10.1068/p5635; Sedlmeier P, 2011, MUSIC PERCEPT, V28, P297, DOI 10.1525/MP.2011.28.3.297; SENJU M, 1987, MUSIC PERCEPT, V4, P311; Shapiro L, 2011, NEW PROBL PHILOS, P1; SWANWICK K., 1973, PSYCHOL MUSIC, V1, P7; Terwogt M. M., 1991, PSYCHOL MUSIC, V19, P99, DOI [10.1177/0305735691192001, DOI 10.1177/0305735691192001]; Thompson WF, 2005, SEMIOTICA, V156, P203, DOI 10.1515/semi.2005.2005.156.203; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; WHITE WF, 1968, J PSYCHOL, V70, P261, DOI 10.1080/00223980.1968.10544957; Wong D.L., 1996, HOME HLTH FOCUS, V2, P62; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	57	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54682	10.1371/journal.pone.0054682	http://dx.doi.org/10.1371/journal.pone.0054682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	077JK	23358805	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600091
J	Renaud, E; Rosselli, F				Renaud, Emilie; Rosselli, Filippo			FANC Pathway Promotes UV-Induced Stalled Replication Forks Recovery by Acting Both Upstream and Downstream Pol eta and Rev1	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; NUCLEOTIDE EXCISION-REPAIR; TRANSLESION SYNTHESIS; ANEMIA PROTEINS; ATR ACTIVATION; HISTONE H2AX; DAMAGE; MDC1; MONOUBIQUITINATION; UBIQUITINATION	To cope with ultraviolet C (UVC)-stalled replication forks and restart DNA synthesis, cells either undergo DNA translesion synthesis (TLS) by specialised DNA polymerases or tolerate the lesions using homologous recombination (HR)-based mechanisms. To gain insight into how cells manage UVC-induced stalled replication forks, we analysed the molecular crosstalk between the TLS DNA polymerases Pol eta and Rev1, the double-strand break repair (DSB)-associated protein MDC1 and the FANC pathway. We describe three novel functional interactions that occur in response to UVC-induced DNA lesions. First, Pol eta and Rev1, whose optimal expression and/or relocalisation depend on the FANC core complex, act upstream of FANCD2 and are required for the proper relocalisation of monoubiquitinylated FANCD2 (Ub-FANCD2) to subnuclear foci. Second, during S-phase, Ub-FANCD2 and MDC1 relocalise to UVC-damaged nuclear areas or foci simultaneously but independently of each other. Third, Ub-FANCD2 and MDC1 are independently required for optimal BRCA1 relocalisation. While RPA32 phosphorylation (p-RPA32) and RPA foci formation were reduced in parallel with increasing levels of H2AX phosphorylation and MDC1 foci in UVC-irradiated FANC pathway-depleted cells, MDC1 depletion was associated with increased UVC-induced Ub-FANCD2 and FANCD2 foci as well as p-RPA32 levels and p-RPA32 foci. On the basis of the previous observations, we propose that the FANC pathway participates in the rescue of UVC-stalled replication forks in association with TLS by maintaining the integrity of ssDNA regions and by preserving genome stability and preventing the formation of DSBs, the resolution of which would require the intervention of MDC1.	[Renaud, Emilie; Rosselli, Filippo] Univ Paris 11, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France; [Renaud, Emilie; Rosselli, Filippo] CNRS, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy	Rosselli, F (corresponding author), Univ Paris 11, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France.	rosselli@igr.fr	Filippo, Rosselli/AAO-6393-2020	Filippo, Rosselli/0000-0003-1080-5745	Agence Nationale pour la Recherche (ANR, Genopat); Ligue Nationale contre le Cancer (Equipe Labellisee)	Agence Nationale pour la Recherche (ANR, Genopat)(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer)	ER was supported by a grant from Agence Nationale pour la Recherche (ANR, Genopat 2008). This work was supported by grants from the Ligue Nationale contre le Cancer (Equipe Labellisee 2009 and 2012) and Agence Nationale pour la Recherche (ANR, Genopat 2008) to FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; BILLARDON B, 1986, MUTAT RES, V174, P241, DOI 10.1016/0165-7992(86)90158-2; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 1999, CANCER RES, V59, P1102; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Guervilly JH, 2011, HUM MOL GENET, V20, P2171, DOI 10.1093/hmg/ddr103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Lehmann AR, 2000, GENE, V253, P1, DOI 10.1016/S0378-1119(00)00250-X; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Naim V, 2009, CELL CYCLE, V8, P2907, DOI 10.4161/cc.8.18.9538; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Pichierri P, 2004, CELL CYCLE, V3, P698; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pichierri P, 2002, HUM MOL GENET, V11, P2531, DOI 10.1093/hmg/11.21.2531; Roques C, 2009, EMBO J, V28, P2400, DOI 10.1038/emboj.2009.193; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; STEINGRIMSDOTTIR H, 1993, MUTAT RES, V294, P29, DOI 10.1016/0921-8777(93)90055-L; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53693	10.1371/journal.pone.0053693	http://dx.doi.org/10.1371/journal.pone.0053693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365640	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600019
J	Saito, S; Yamamoto, H; Mukaisho, K; Sato, S; Higo, T; Hattori, T; Yamamoto, G; Sugihara, H				Saito, Shota; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Sato, Sho; Higo, Tomoki; Hattori, Takanori; Yamamoto, Gaku; Sugihara, Hiroyuki			Mechanisms Underlying Cancer Progression Caused by Ezrin Overexpression in Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CADHERIN/BETA-CATENIN COMPLEX; MESENCHYMAL TRANSITION; ERM PROTEINS; IMMUNOHISTOCHEMICAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ORGANIZER EZRIN; LINKER EZRIN; RHO-GTPASES; HIGH-GRADE; INVASION	Background: Ezrin is a member of the ezrin, radixin, and moesin family that provides a functional link between the plasma membrane and the cortical actin cytoskeleton. A correlation between ezrin overexpression and aggressive cancer behavior has been recently reported in various tumor types. However, its roles in the mechanisms underlying progression of tongue squamous cell carcinoma (SCC) are unclear. Method: We used human tongue SCC and noncancerous tissue microarrays to immunohistochemically analyze the ezrin expression level and its relationship with proliferative activity. The human tongue SCC cell line HSC-3 was used to determine the effects of ezrin RNA interference (RNAi) on cancer cells during MTT; wound healing and invasion assays; immunofluorescence of the actin cytoskeleton; and western blotting of E-cadherin, N-cadherin, beta-catenin, and the active and total RhoA/Rac1/cdc42. Results: Ezrin was overexpressed in 46.4% of the tumors examined in human tongue SCC tissue microarrays. Ezrin expression was correlated with the Ki-67 index. Ezrin depletion by RNAi in the HSC-3 cells significantly reduced cell proliferation, migration, and invasiveness and disturbed actin reorganization during podia formation. Its effects on RhoA/Rac1/cdc42 expression were not significant, whereas it enhanced E-cadherin and b-catenin expression and decreased N-cadherin expression. Conclusions: Ezrin is often overexpressed in primary tongue SCCs and may have an important role in their growth, migration, and invasiveness possibly via its relationship with the E-cadherin/beta-catenin complex and the cadherin switch. Thus, ezrin could be a therapeutic target in tongue SCC.	[Saito, Shota; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Sato, Sho; Higo, Tomoki; Hattori, Takanori; Sugihara, Hiroyuki] Shiga Univ Med Sci, Dept Pathol, Div Mol Diagnost Pathol, Otsu, Shiga 52021, Japan; [Saito, Shota; Sato, Sho; Higo, Tomoki; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Mukaisho, K (corresponding author), Shiga Univ Med Sci, Dept Pathol, Div Mol Diagnost Pathol, Otsu, Shiga 52021, Japan.	mukaisho@belle.shiga-med.ac.jp	Mukaisho, Ken-ichi/AAI-7262-2020					Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Chandler K, 2011, HEAD NECK PATHOL, V5, P359, DOI 10.1007/s12105-011-0296-5; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Ferrari S, 2008, PEDIATR BLOOD CANCER, V50, P752, DOI 10.1002/pbc.21360; Fischer CA, 2011, HEAD NECK-J SCI SPEC, V33, P267, DOI 10.1002/hed.21440; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Japan Society for Head and Neck Cancer Cancer Registry Committee, 2002, JPN J HEAD NECK CA S, V32, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang HB, 2010, J CANCER RES CLIN, V136, P1295, DOI 10.1007/s00432-010-0780-4; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Kruaysawat Watcharin, 2010, Journal of the Medical Association of Thailand, V93, P278; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P602, DOI 10.1111/j.1600-0714.2005.00358.x; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Ling ZQ, 2010, CANCER SCI, V101, P624, DOI 10.1111/j.1349-7006.2009.01470.x; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Madan R, 2006, HEAD NECK-J SCI SPEC, V28, P1018, DOI 10.1002/hed.20435; Mahomed F, 2007, ORAL DIS, V13, P386, DOI 10.1111/j.1601-0825.2006.01295.x; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Musial Jacek, 2007, Polish Journal of Pathology, V58, P235; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Park HR, 2006, PATHOL RES PRACT, V202, P509, DOI 10.1016/j.prp.2006.01.015; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Schlecht NF, 2012, HEAD NECK PATHOL; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Shen Zhi-Hua, 2008, Ai Zheng, V27, P165; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Sun Chuan-zheng, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P650; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wang YH, 2011, MED ONCOL, V28, pS360, DOI 10.1007/s12032-010-9737-3; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5; Ziober BL, 2001, CRIT REV ORAL BIOL M, V12, P499, DOI 10.1177/10454411010120060401	57	34	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54881	10.1371/journal.pone.0054881	http://dx.doi.org/10.1371/journal.pone.0054881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357878	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600127
J	Bolhuis, DP; Lakemond, CMM; de Wijk, RA; Luning, PA; de Graaf, C				Bolhuis, Dieuwerke P.; Lakemond, Catriona M. M.; de Wijk, Rene A.; Luning, Pieternel A.; de Graaf, Cees			Consumption with Large Sip Sizes Increases Food Intake and Leads to Underestimation of the Amount Consumed	PLOS ONE			English	Article							INCREASED MEAL INTAKE; PORTION SIZE; BITE SIZE; COGNITIVE-FACTORS; ENERGY-INTAKE; FAT; CARBOHYDRATE; INFORMATION; INTENSITY; VISCOSITY	Background: A number of studies have shown that bite and sip sizes influence the amount of food intake. Consuming with small sips instead of large sips means relatively more sips for the same amount of food to be consumed; people may believe that intake is higher which leads to faster satiation. This effect may be disturbed when people are distracted. Objective: The objective of the study is to assess the effects of sip size in a focused state and a distracted state on ad libitum intake and on the estimated amount consumed. Design: In this 3 x 2 cross-over design, 53 healthy subjects consumed ad libitum soup with small sips (5 g, 60 g/min), large sips (15 g, 60 g/min), and free sips (where sip size was determined by subjects themselves), in both a distracted and focused state. Sips were administered via a pump. There were no visual cues toward consumption. Subjects then estimated how much they had consumed by filling soup in soup bowls. Results: Intake in the small-sip condition was similar to 30% lower than in both the large-sip and free-sip conditions (P < 0.001). In addition, subjects underestimated how much they had consumed in the large-sip and free-sip conditions (P < 0.03). Distraction led to a general increase in food intake (P = 0.003), independent of sip size. Distraction did not influence sip size or estimations. Conclusions: Consumption with large sips led to higher food intake, as expected. Large sips, that were either fixed or chosen by subjects themselves led to underestimations of the amount consumed. This may be a risk factor for over-consumption. Reducing sip or bite sizes may successfully lower food intake, even in a distracted state.	[Bolhuis, Dieuwerke P.; Lakemond, Catriona M. M.; Luning, Pieternel A.] Wageningen Univ, Prod Design & Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [de Wijk, Rene A.] Wageningen Univ & Res, Wageningen, Netherlands; [de Graaf, Cees] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Bolhuis, DP (corresponding author), Wageningen Univ, Prod Design & Qual Management Grp, NL-6700 AP Wageningen, Netherlands.	dieuwerke.bolhuis@wur.nl	Luning, Pieternel/H-3318-2013	Bolhuis, Dieuwerke/0000-0001-6734-5191	Science and Technology Foundation of the Netherlands Organization for Scientific Research [07438]; Unilever; Danone Nederland; FrieslandCampina; Top Institute Food and Nutrition	Science and Technology Foundation of the Netherlands Organization for Scientific Research; Unilever(Unilever); Danone Nederland(Danone Nutricia); FrieslandCampina; Top Institute Food and Nutrition	This work was supported by the Science and Technology Foundation of the Netherlands Organization for Scientific Research (grant number 07438) with: Unilever, Danone Nederland, FrieslandCampina, and Top Institute Food and Nutrition. The funders had no role in study design, data collection and analysis, or preparation of the manuscript, or decision to publish.	Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Bailey EF, 2008, AM J PHYSIOL-REG I, V295, pR1048, DOI 10.1152/ajpregu.90701.2008; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bellisle F, 2001, AM J CLIN NUTR, V74, P197; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Bolhuis DP, 2012, APPETITE, V58, P48, DOI 10.1016/j.appet.2011.09.001; Bolhuis DP, 2011, J NUTR, V141, P2242, DOI 10.3945/jn.111.143867; Bolhuis DP, BOTH HIGHER NU UNPUB; Burger KS, 2011, OBESITY, V19, P546, DOI 10.1038/oby.2010.233; CAPUTO FA, 1992, AM J CLIN NUTR, V56, P36, DOI 10.1093/ajcn/56.1.36; Cecil JE, 1999, PHYSIOL BEHAV, V67, P299, DOI 10.1016/S0031-9384(99)00069-4; Cecil JE, 1998, APPETITE, V31, P377, DOI 10.1006/appe.1998.0177; Chandon P, 2002, J MARKETING RES, V39, P321, DOI 10.1509/jmkr.39.3.321.19111; CHAPELOT D, 1995, APPETITE, V25, P155, DOI 10.1006/appe.1995.0052; Davis JD, 2009, PHYSIOL BEHAV, V97, P293, DOI 10.1016/j.physbeh.2009.03.028; de Wijk RA, 2008, PHYSIOL BEHAV, V95, P527, DOI 10.1016/j.physbeh.2008.07.026; Fisher JO, 2003, AM J CLIN NUTR, V77, P1164, DOI 10.1093/ajcn/77.5.1164; French SJ, 2001, PHYSIOL BEHAV, V74, P729, DOI 10.1016/S0031-9384(01)00617-5; HABER GB, 1977, LANCET, V2, P679; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Higgs S, 2008, PHYSIOL BEHAV, V94, P734, DOI 10.1016/j.physbeh.2008.04.012; Hiiemae K, 1996, ARCH ORAL BIOL, V41, P175, DOI 10.1016/0003-9969(95)00112-3; Hogenkamp PS, 2010, AM J CLIN NUTR, V91, P841, DOI 10.3945/ajcn.2009.28360; Hubel R, 2006, APPETITE, V46, P57, DOI 10.1016/j.appet.2005.10.006; Hulshof KFAM, 2003, 3500300022004 RIVM, P28; Kral TVE, 2006, APPETITE, V46, P103, DOI 10.1016/j.appet.2005.05.006; Lavin JH, 2002, INT J OBESITY, V26, P80, DOI 10.1038/sj.ijo.0801828; Lavin JH, 2002, INT J OBESITY, V26, P384, DOI 10.1038/sj.ijo.0801829; Lawless HT, 2003, DYSPHAGIA, V18, P196, DOI 10.1007/s00455-002-0105-0; Maas J, 2012, PSYCHOL HEALTH, V27, P59, DOI 10.1080/08870446.2011.565341; McGee TL, 2012, OBESITY, V20, P126, DOI 10.1038/oby.2011.303; Medicis SW, 1998, J DENT RES, V77, P295; Miller DL, 1998, AM J CLIN NUTR, V68, P282, DOI 10.1093/ajcn/68.2.282; Mitchell GL, 2005, APPETITE, V45, P344, DOI 10.1016/j.appet.2005.06.001; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; Phan VA, 2012, FOOD QUAL PREFER, V26, P119, DOI 10.1016/j.foodqual.2012.04.005; PLINER P, 1990, J EXP SOC PSYCHOL, V26, P240, DOI 10.1016/0022-1031(90)90037-M; Raynor HA, 2007, OBESITY, V15, P2311, DOI 10.1038/oby.2007.274; Rolls ET, 2007, OBES REV, V8, P67, DOI 10.1111/j.1467-789X.2007.00321.x; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Spiegel TA, 2000, NEUROSCI BIOBEHAV R, V24, P229, DOI 10.1016/S0149-7634(99)00076-7; Stroebele N, 2006, APPETITE, V47, P285, DOI 10.1016/j.appet.2006.04.001; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; Ueland O, 2009, J AM DIET ASSOC, V109, P124, DOI 10.1016/j.jada.2008.10.002; Viskaal-van Dongen M, 2011, APPETITE, V56, P25, DOI 10.1016/j.appet.2010.11.141; Walden HM, 2004, OBES RES, V12, P1773, DOI 10.1038/oby.2004.220; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2006, AM J PREV MED, V31, P240, DOI 10.1016/j.amepre.2006.04.003; Weijzen PLG, 2008, APPETITE, V50, P435, DOI 10.1016/j.appet.2007.09.008; Weijzen PLG, 2009, BRIT J NUTR, V102, P1091, DOI 10.1017/S000711450932574X; WHO, 1985, PRINC EST EN REQ EN, P34; WOOLEY SC, 1972, PSYCHOSOM MED, V34, P62, DOI 10.1097/00006842-197201000-00007; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	56	29	29	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53288	10.1371/journal.pone.0053288	http://dx.doi.org/10.1371/journal.pone.0053288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372657	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500013
J	Cuconati, A; Mills, C; Goddard, C; Zhang, XC; Yu, WQ; Guo, HT; Xu, XD; Block, TM				Cuconati, Andrea; Mills, Courtney; Goddard, Cally; Zhang, Xianchao; Yu, Wenquan; Guo, Haitao; Xu, Xiaodong; Block, Timothy M.			Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HEPATITIS-B; DISCOVERY; SURVIVAL; PATHWAY; CANCER; LIVER; LINES; GENE; SORAFENIB; MUTATIONS	Hepatocellular carcinoma (HCC) is the third most common cause of cancer fatalities worldwide, with limited treatment options and five year survival rates of between <5 and 15%. To address this medical need, we conducted a screen of a drug-like small molecule library for HCC-selective cytotoxins. We report here the identification of a disubstituted aminothiazole termed HBF-0079, with remarkable selective toxicity for HCC-derived cell lines versus non-HCC liver lines and most other cancer lines. HBF-0079 caused irreversible growth arrest and apoptosis of the HCC lines Huh7, Hep3B, HepaRG as well as the hepatoblastoma line HepG2, with CC50 values from similar to 0.7-7.7 mu M, while more than 45 mu M was needed to achieve CC50 values for the immortalized normal hepatocyte lines THLE-2 and PH5CH. Of the sixty cancer lines from the National Cancer Institute panel, only five exhibited >50% growth inhibition by HBF-0079. In Huh7 cells, HBF-0079 induced cell cycle arrest in G1 and concomitant apoptosis, and its effects were irreversible after removal of the compound. These observations corroborate a loss of AKT phosphorylation at the mTORC2-targeted residue S473, with concurrent loss of phosphorylation of the mTORC1 targets SK6 and 4EBP1 in Huh7 but not PH5CH cells. Finally, growth of Hep3B-derived tumors in a murine xenograft model was significantly repressed by the compound through either systemic or intratumoral administration of formulated HBF-0079. The potential for development of this drug candidate is discussed.	[Cuconati, Andrea; Mills, Courtney; Goddard, Cally; Yu, Wenquan; Xu, Xiaodong; Block, Timothy M.] Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA; [Zhang, Xianchao; Guo, Haitao; Block, Timothy M.] Drexel Univ Coll Med, Drexel Inst Biotechnol & Virol Res, Doylestown, PA USA; [Xu, Xiaodong] Enantigen Therapeut Inc, Doylestown, PA USA; [Yu, Wenquan] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Drexel University; Tianjin University	Cuconati, A (corresponding author), Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA.	acuconati.research@hepb.org; Timothy.Block@drexelmed.edu	Yu, Wenquan/S-7342-2017; Cuconati, Andrea/AAI-7533-2020; Sharma, Ashwani/AAK-3879-2020; Cuconati, Andrea/GWV-4662-2022	Yu, Wenquan/0000-0002-3711-0006; Sharma, Ashwani/0000-0001-9835-1973; Cuconati, Andrea/0000-0001-5123-0381	Hepatitis B Foundation; Pennsylvania Commonwealth Institute; Enantigen, Inc.	Hepatitis B Foundation; Pennsylvania Commonwealth Institute; Enantigen, Inc.	Funding for this study was provided by the Hepatitis B Foundation, the Pennsylvania Commonwealth Institute, and Enantigen, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gallardo-Godoy A, 2011, J MED CHEM, V54, P1010, DOI 10.1021/jm101250y; Gentles RG, 2008, BIOORG MED CHEM LETT, V18, P5316, DOI 10.1016/j.bmcl.2008.08.023; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hay MP, 2010, J MED CHEM, V53, P787, DOI 10.1021/jm901457w; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kew M, 2006, SLEISENGER FORDTRANS; Kew MC, 1996, CLIN LAB MED, V16, P395, DOI 10.1016/S0272-2712(18)30276-2; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lazo JS, 2007, MOL PHARMACOL, V72, P1, DOI 10.1124/mol.107.035113; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Noguchi M, 1996, IN VITRO CELL DEV-AN, V32, P135; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Ries LAG, 2008, SEER CANC STAT REV; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Tang TC, 2010, NEOPLASIA, V12, P928, DOI 10.1593/neo.10804; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; WESTLEY B, 1979, BIOCHEM BIOPH RES CO, V90, P410, DOI 10.1016/0006-291X(79)91250-6; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	50	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54595	10.1371/journal.pone.0054595	http://dx.doi.org/10.1371/journal.pone.0054595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355882	gold, Green Submitted, Green Published			2022-12-25	WOS:000314021500092
J	Gu, Y; Shimada, T; Yasui, Y; Tada, Y; Kaku, M; Okabe, N				Gu, Yoshiaki; Shimada, Tomoe; Yasui, Yoshinori; Tada, Yuki; Kaku, Mitsuo; Okabe, Nobuhiko			National Surveillance of Influenza-Associated Encephalopathy in Japan over Six Years, before and during the 2009-2010 Influenza Pandemic	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; NEUROLOGIC COMPLICATIONS; ENCEPHALITIS; CHILDREN; SYSTEM	Influenza-associated encephalopathy (IAE) is a serious complication of influenza and is reported most frequently in Japan. This paper presents an assessment of the epidemiological characteristics of influenza A (H1N1) 2009-associated encephalopathy in comparison to seasonal IAE, based on Japanese national surveillance data of influenza-like illness (ILI) and IAE during flu seasons from 2004-2005 through 2009-2010. In each season before the pandemic, 34-55 IAE cases (mean 47.8; 95% confidence interval: 36.1-59.4) were reported, and these cases increased drastically to 331 during the 2009 pandemic (6.9-fold the previous seasons). Of the 331 IAE cases, 322 cases were reported as influenza A (H1N1) 2009-associated encephalopathy. The peaks of IAE were consistent with the peaks of the influenza epidemics and pandemics. A total of 570 cases of IAE (seasonal A, 170; seasonal B, 50; influenza A (H1N1) 2009, 322; unknown, 28) were reported over six seasons. The case fatality rate (CFR) ranged from 4.8 to 18.2% before the pandemic seasons and 3.6% in the 2009 pandemic season. The CFR of pandemic-IAE was 3.7%, which is lower than that of influenza A-/B-associated encephalopathy (12.9%, p<0.001; 14.0%, p = 0.002; respectively). The median age of IAE was 7 years during the pandemic, which is higher than that of influenza A-/B-associated encephalopathy (4, p<0.001; 4.5, p = 0.006; respectively). However, the number of pandemic-IAE cases per estimated ILI outpatients peaked in the 0-4-year age group and data both before and during the pandemic season showed a U-shape pattern. This suggests that the high incidence of influenza infection in the 0-4 year age group may lead to a high incidence of IAE in the same age group in a future influenza season. Further studies should include epidemiologic case definitions and clinical details of IAE to gain a more accurate understanding of the epidemiologic status of IAE.	[Gu, Yoshiaki] Tohoku Univ, Grad Sch Med, Dept Reg Cooperat Infect Dis, Sendai, Miyagi 980, Japan; [Gu, Yoshiaki] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program Japan, Tokyo, Japan; [Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 980, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kawasaki, Kanagawa 2100834, Japan	Tohoku University; National Institute of Infectious Diseases (NIID); Tohoku University	Gu, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Reg Cooperat Infect Dis, Sendai, Miyagi 980, Japan.	ygu@med.tohoku.ac.jp	Kaku, Mitsuo/E-5811-2017		Study Group of Influenza-Associated Encephalopathy under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan [H23-Shinkou-10]	Study Group of Influenza-Associated Encephalopathy under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan	This work was supported by the Study Group of Influenza-Associated Encephalopathy (H23-Shinkou-10) under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins PT, 2010, NEUROCRIT CARE, V13, P396, DOI 10.1007/s12028-010-9436-0; Amin R, 2008, PEDIATR INFECT DIS J, V27, P390, DOI 10.1097/INF.0b013e31816507b2; [Anonymous], 2010, IASR, V31, P248; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fujii H, 2002, JPN J INFECT DIS, V55, P23; Gejyo F, 2005, KIDNEY INT, V68, P188, DOI 10.1111/j.1523-1755.2005.00393.x; Gonzalez BE, 2009, CLIN INFECT DIS, V49, P1966, DOI 10.1086/649014; Hashimoto S, 2003, J EPIDEMIOL, V13, P136, DOI 10.2188/jea.13.136; Hjalmarsson A, 2009, EUR NEUROL, V61, P289, DOI 10.1159/000206854; Infectious Disease Surveillance Center, IS DET VIR REP PREF; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Kawashima H, 2012, J MED VIROL, V84, P1151, DOI 10.1002/jmv.23317; Kwong KL, 2009, J PAEDIATR CHILD H, V45, P660, DOI 10.1111/j.1440-1754.2009.01591.x; Lee N, 2010, EMERG INFECT DIS, V16, P139, DOI [10.3201/eid1601.090077, 10.3201/eid1601.090007]; Lyon JB, 2010, PEDIATR RADIOL, V40, P200, DOI 10.1007/s00247-009-1487-z; Maricich SM, 2004, PEDIATRICS, V114, pE626, DOI 10.1542/peds.2004-0143; Martin A, 2010, CLIN INFECT DIS, V50, pE50, DOI 10.1086/651501; *MIN HLTH LAB WELF, 2007, INFECT AGENTS SURVEI, V28, P311; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Ministry of Health Labour and Welfare, 2009, RES BAS RES OS WORK; Ministry of Health Labour and Welfare, 2010, EST NUMB VACC PERS R; Ministry of Health Labour and Welfare, 2001, INFECT AGENTS SURVEI, V22, P309; Ministry of Health Labour and Welfare, 2009, RES CLIN RES OS WORK; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2010, INFL A H1N1 PDM ASS; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2010, INF DIS WEEKL REP 50; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2008, INECT AGENTS SURVEIL, V29, P297; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2009, INFECT AGENTS SURVEI, V30, P285; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2005, INFECT AGENTS SURVEI, V26, P287; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2009, INFL A H1N1 PDM ASS; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2000, WEEKL REP INFL VIR I; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2006, INFECT AGENTS SURVEI, V27, P293; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2007, INFECT AGENTS SURVEI, V28, P339; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Morishima Tsuneo, 2009, Virus (Nagoya), V59, P59; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Okabe N, 2000, PEDIATR INT, V42, P187, DOI 10.1046/j.1442-200x.2000.01206.x; Okamoto S, 2005, PEDIATR INFECT DIS J, V24, P575, DOI 10.1097/01.inf.0000164799.33635.fe; Okumura A, 2011, EMERG INFECT DIS, V17, P1993, DOI 10.3201/eid1711.110649; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Statistics Bureau, RES POP EST; Steininger C, 2003, CLIN INFECT DIS, V36, P567, DOI 10.1086/367623; The Study Group of Influenza-Associated Encephalopathy, 2009, GUID DIAGN TREATM IN; The Study Group of Influenza-Associated Encephalopathy, 2005, GUID DIAGN TREATM IN; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Wada T, 2009, MICROBIOL IMMUNOL, V53, P83, DOI 10.1111/j.1348-0421.2008.00100.x; Wang GF, 2010, CURR OPIN NEUROL, V23, P305, DOI 10.1097/WCO.0b013e328338f6c9; Yamada Shinichiro, 2012, Rinsho Shinkeigaku, V52, P480	50	28	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54786	10.1371/journal.pone.0054786	http://dx.doi.org/10.1371/journal.pone.0054786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355899	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500126
J	Shiely, F; Hayes, K; Perry, IJ; Kelleher, CC				Shiely, Frances; Hayes, Kevin; Perry, Ivan J.; Kelleher, C. Cecily			Height and Weight Bias: The Influence of Time	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; BODY-MASS INDEX; VALIDITY; OBESITY; BMI; HEALTH	Background: We have previously identified in a study of both self-reported body mass index (BMI) and clinically measured BMI that the sensitivity score in the obese category has declined over a 10-year period. It is known that self-reported weight is significantly lower that measured weight and that self-reported height is significantly higher than measured height. The purpose of this study is to establish if self-reported height bias or weight bias, or both, is responsible for the declining sensitivity in the obese category between self-reported and clinically measured BMI. Methods: We report on self-reported and clinically measured height and weight from three waves of the Surveys of Lifestyle Attitudes and Nutrition (SLAN) involving a nationally representative sample of Irish adults. Data were available from 66 men and 142 women in 1998, 147 men and 184 women in 2002 and 909 men and 1128 women in 2007. Respondents were classified into BMI categories normal (<25 kg/m(2)), overweight (25-<30 kg/m(2)) and obese (>= 30 kg/m(2)). Results: Self-reported height bias has remained stable over time regardless of gender, age or clinical BMI category. Self-reported weight bias increases over time for both genders and in all age groups. The increased weight bias is most notable in the obese category. Conclusions: BMI underestimation is increasing across time. Knowledge that the widening gap between self-reported BMI and measured BMI is attributable to an increased weight bias brings us one step closer to accurately estimating true obesity levels in the population using self-reported data.	[Shiely, Frances; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Hayes, Kevin] Univ Limerick, Dept Math & Stat, Limerick, Ireland; [Kelleher, C. Cecily] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	University College Cork; University of Limerick; University College Dublin	Shiely, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	f.shiely@ucc.ie	kelleher, cecily c/A-4233-2013	kelleher, cecily c/0000-0001-9548-4914; Perry, Ivan/0000-0002-4965-9792	HRB Centre for Diet and Health Research	HRB Centre for Diet and Health Research	This work was not funded but was conducted under the auspices of the HRB Centre for Diet and Health Research. The HRB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZTORICES JC, 1993, INT J OBESITY, V17, P663; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bopp M, 2008, BMJ-BRIT MED J, V337, P1463; Dauphinot V, 2009, J EPIDEMIOL COMMUN H, V63, P128, DOI 10.1136/jech.2008.077800; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Faeh D, 2008, SWISS MED WKLY, V138, P204, DOI 2008/13/smw-12065; Friel S, 1999, MAIN RESULTS NATL HL; Giacchi M, 1998, INT J OBESITY, V22, P673, DOI 10.1038/sj.ijo.0800646; Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gorber SC, 2010, OBESITY, V18, P354, DOI 10.1038/oby.2009.206; Hayes AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-53; Hayes K, 2004, P NUTR SOC, V63, p137A; International Obesity Task Force, 2005, OB EUR; Johnson F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a494; Johnson WD, 2009, OBESITY, V17, P571, DOI 10.1038/oby.2008.582; Kelleher C, 2003, NATL HLTH LIFESTYLE; Krul AJ, 2011, EUR J PUBLIC HEALTH, V21, P414, DOI 10.1093/eurpub/ckp228; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lee DH, 2011, J EPIDEMIOL, V21, P30, DOI 10.2188/jea.JE20100058; Morgan K, 2008, SLAN 2007 SURVEY LIF; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Oliveira A, 2009, EUR J PUBLIC HEALTH, V19, P548, DOI 10.1093/eurpub/ckp022; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Plankey MW, 1997, OBES RES, V5, P308, DOI 10.1002/j.1550-8528.1997.tb00556.x; R Development Core Team, 2003, R LANG ENV STAT COMP; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; STEWART AL, 1982, J CHRON DIS, V35, P295, DOI 10.1016/0021-9681(82)90085-6; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Stommel M, 2013, INT J OBESITY, V37, P461, DOI 10.1038/ijo.2012.67; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Vailas LI, 1998, J GERONTOL A-BIOL, V53, pM481, DOI 10.1093/gerona/53A.6.M481; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Yong V, 2012, GERIATR GERONTOL INT, V12, P247, DOI 10.1111/j.1447-0594.2011.00759.x	37	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54386	10.1371/journal.pone.0054386	http://dx.doi.org/10.1371/journal.pone.0054386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372717	Green Published, gold			2022-12-25	WOS:000314021500067
J	Varotto, L; Domeneghetti, S; Rosani, U; Manfrin, C; Cajaraville, MP; Raccanelli, S; Pallavicini, A; Venier, P				Varotto, Laura; Domeneghetti, Stefania; Rosani, Umberto; Manfrin, Chiara; Cajaraville, Miren P.; Raccanelli, Stefano; Pallavicini, Alberto; Venier, Paola			DNA Damage and Transcriptional Changes in the Gills of Mytilus galloprovincialis Exposed to Nanomolar Doses of Combined Metal Salts (Cd, Cu, Hg)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENE-EXPRESSION; OXIDATIVE STRESS; HEAVY-METALS; METALLOTHIONEIN GENES; QUANTITATIVE PCR; DIGESTIVE GLAND; BLUE MUSSEL; MERCURY; CADMIUM	Aiming at an integrated and mechanistic view of the early biological effects of selected metals in the marine sentinel organism Mytilus galloprovincialis, we exposed mussels for 48 hours to 50, 100 and 200 nM solutions of equimolar Cd, Cu and Hg salts and measured cytological and molecular biomarkers in parallel. Focusing on the mussel gills, first target of toxic water contaminants and actively proliferating tissue, we detected significant dose-related increases of cells with micronuclei and other nuclear abnormalities in the treated mussels, with differences in the bioconcentration of the three metals determined in the mussel flesh by atomic absorption spectrometry. Gene expression profiles, determined in the same individual gills in parallel, revealed some transcriptional changes at the 50 nM dose, and substantial increases of differentially expressed genes at the 100 and 200 nM doses, with roughly similar amounts of up-and down-regulated genes. The functional annotation of gill transcripts with consistent expression trends and significantly altered at least in one dose point disclosed the complexity of the induced cell response. The most evident transcriptional changes concerned protein synthesis and turnover, ion homeostasis, cell cycle regulation and apoptosis, and intracellular trafficking (transcript sequences denoting heat shock proteins, metal binding thioneins, sequestosome 1 and proteasome subunits, and GADD45 exemplify up-regulated genes while transcript sequences denoting actin, tubulins and the apoptosis inhibitor 1 exemplify down-regulated genes). Overall, nanomolar doses of co-occurring free metal ions have induced significant structural and functional changes in the mussel gills: the intensity of response to the stimulus measured in laboratory supports the additional validation of molecular markers of metal exposure to be used in Mussel Watch programs.	[Varotto, Laura; Domeneghetti, Stefania; Rosani, Umberto; Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Manfrin, Chiara; Pallavicini, Alberto] Univ Trieste, Dept Life Sci, Trieste, Italy; [Cajaraville, Miren P.] Univ Basque Country UPV EHU, Dept Zool & Cell Biol, Bilbao, Basque Country, Spain; [Raccanelli, Stefano] Consorzio INCA Marghera, Venice, Italy	University of Padua; University of Trieste; University of Basque Country	Venier, P (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	paola.venier@unipd.it	Venier, Paola/J-6302-2019; Pallavicini, Alberto/H-9281-2019; Pallavicini, Alberto/J-4158-2012; Cajaraville, Miren P/I-4757-2015; rosani, umbero/I-6007-2019	Venier, Paola/0000-0001-9634-3662; Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Cajaraville, Miren P/0000-0001-6527-6137; rosani, umbero/0000-0003-0685-1618	MIUR; Co.Ri.La.; Basque Government [GIC07/26-IT-393-07]; University of the Basque Country [11/37]; UE 7th FP [CP-FP 214478-2]; Spanish Ministry of Science and Innovation [CTM2009-13477];  [FP7-KBBE-2010-4-266157 Bivalife]	MIUR(Ministry of Education, Universities and Research (MIUR)); Co.Ri.La.(Keygene N.V.); Basque Government(Basque Government); University of the Basque Country; UE 7th FP; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	Work granted by MIUR and Co.Ri.La. to PV. LV is currently supported by the FP7-KBBE-2010-4-266157 Bivalife project. Work in the laboratory of MPC is funded by grants to consolidated research groups (ref GIC07/26-IT-393-07, Basque Government), and to the unit of formation and research (UFI ref 11/37, University of the Basque Country) and projects Nanoretox (ref CP-FP 214478-2, UE 7th FP) and Nanocancer (ref CTM2009-13477, Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada PB, 2012, MOL PHARMACOL, V82, P510, DOI 10.1124/mol.112.079822; Aceto S, 2011, MAR GENOM, V4, P61, DOI 10.1016/j.margen.2011.01.001; Ahmad I, 2011, CHEMOSPHERE, V82, P1541, DOI 10.1016/j.chemosphere.2010.11.064; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auffret M, 2006, ECOTOX ENVIRON SAFE, V63, P393, DOI 10.1016/j.ecoenv.2005.10.016; Ba LA, 2009, METALLOMICS, V1, P292, DOI 10.1039/b904533c; Balshaw S., 2007, Reviews on Environmental Health, V22, P91; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Besada V, 2002, SCI TOTAL ENVIRON, V288, P239, DOI 10.1016/S0048-9697(01)01010-5; Bolognesi C, 1999, ENVIRON MOL MUTAGEN, V33, P287, DOI 10.1002/(SICI)1098-2280(1999)33:4<287::AID-EM5>3.0.CO;2-G; Bolognesi C, 2011, MUTAGENESIS, V26, P205, DOI 10.1093/mutage/geq073; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027; Chapman PM, 2008, HUM ECOL RISK ASSESS, V14, P5, DOI 10.1080/10807030701790272; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Comuzzi C, 2011, J HAZARD MATER, V193, P177, DOI 10.1016/j.jhazmat.2011.07.047; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Connor KM, 2011, P NATL ACAD SCI USA, V108, P16110, DOI 10.1073/pnas.1111076108; Cosson RP, 2008, MAR ENVIRON RES, V65, P405, DOI 10.1016/j.marenvres.2008.01.005; Dimitriadis VK, 2003, ENVIRON POLLUT, V125, P345, DOI 10.1016/S0269-7491(03)00122-2; Dolcetti L, 2002, MAR ENVIRON RES, V54, P487, DOI 10.1016/S0141-1136(02)00142-3; Domeneghetti S, 2011, ISJ-INVERT SURVIV J, V8, P179; Domouhtsidou GP, 2000, ARCH ENVIRON CON TOX, V38, P472, DOI 10.1007/s002449910062; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Durrnagel S, 2012, J GEN PHYSIOL, V140, P391, DOI 10.1085/jgp.201210798; Duffus JH, 2002, PURE APPL CHEM, V74, P793, DOI 10.1351/pac200274050793; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fasulo S, 2008, AQUAT TOXICOL, V88, P62, DOI 10.1016/j.aquatox.2008.03.009; Fernandez B, 2011, ENVIRON MOL MUTAGEN, V52, P479, DOI 10.1002/em.20646; Fields PA, 2012, J EXP BIOL, V215, P1106, DOI 10.1242/jeb.062273; Flora SJS, 2008, INDIAN J MED RES, V128, P501; FUNK AE, 1987, COMP BIOCHEM PHYS C, V86, P1, DOI 10.1016/0742-8413(87)90133-2; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Goldberg E.D., 1975, MAR POLLUT B, V6, P111, DOI [10.1016/0025-326X(75)90271-4, DOI 10.1016/0025-326X(75)90271-4]; Gomez-Mendikute A, 2005, CELL TISSUE RES, V321, P131, DOI 10.1007/s00441-005-1093-9; Gomez-Mendikute A, 2003, TOXICOL IN VITRO, V17, P539, DOI 10.1016/S0887-2333(03)00093-6; Greenough MA, 2012, NEUROCHEM I IN PRESS; Gueguen M, 2011, REV ENVIRON CONTAM T, V213, P55, DOI 10.1007/978-1-4419-9860-6_3; Gutierrez AJ, 2006, J FOOD PROTECT, V69, P2237, DOI 10.4315/0362-028X-69.9.2237; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kadar E, 2006, ENVIRON RES, V101, P221, DOI 10.1016/j.envres.2005.08.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kimbrough K.L, 2008, 74 NOAA NOS NCCOS, P105; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Li J, 2012, FISH SHELLFISH IMMUN, V32, P368, DOI 10.1016/j.fsi.2011.10.030; Lin Y, 2012, ENVIRON TOXICOL CHEM, V31, P2431, DOI 10.1002/etc.1980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QY, 2012, BIOMATERIALS, V33, P1903, DOI 10.1016/j.biomaterials.2011.11.021; Lyons BP, 2010, MAR POLLUT BULL, V60, P1647, DOI 10.1016/j.marpolbul.2010.06.005; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Marchi B, 2004, AQUAT TOXICOL, V66, P197, DOI 10.1016/j.aquatox.2003.09.003; Maret W, 2012, METALLOMICS, V4, P1017, DOI 10.1039/c2mt90041f; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Neser G, 2012, MAR POLLUT BULL, V64, P882, DOI 10.1016/j.marpolbul.2012.02.006; Nguyen TTT, 2011, J ANIM BREED GENET, V128, P482, DOI 10.1111/j.1439-0388.2011.00948.x; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Place SP, 2012, FUNCT ECOL, V26, P144, DOI 10.1111/j.1365-2435.2011.01924.x; Potrykus J, 2009, OCEANOLOGIA, V51, P525, DOI 10.5697/oc.51-4.525; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Raftopoulou EK, 2011, CHEMOSPHERE, V83, P1155, DOI 10.1016/j.chemosphere.2011.01.003; Sakellari A, 2012, ENV MONIT A IN PRESS; Sen Arpita, 2012, Biomol Concepts, V3, P117; Shaw JP, 2011, MAR ENVIRON RES, V72, P13, DOI 10.1016/j.marenvres.2011.05.003; Singh BK, 2011, MOL CELL BIOCHEM, V357, P373, DOI 10.1007/s11010-011-0908-0; Sinicropi MS, 2010, ARCH TOXICOL, V84, P501, DOI 10.1007/s00204-010-0544-6; Soundararajan R, 2012, CRIT REV BIOCHEM MOL, V47, P349, DOI 10.3109/10409238.2012.678285; Storey John D, 2003, Methods Mol Biol, V224, P149; Strogyloudi E, 2012, ENVIRON MONIT ASSESS, V184, P7189, DOI 10.1007/s10661-011-2490-z; Syversen T, 2012, J TRACE ELEM MED BIO, V26, P215, DOI 10.1016/j.jtemb.2012.02.004; Szefer P, 2006, ENVIRON POLLUT, V139, P70, DOI 10.1016/j.envpol.2005.04.031; Takahashi S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-41; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueki T, 2011, BBA-GEN SUBJECTS, V1810, P457, DOI 10.1016/j.bbagen.2010.12.006; van Kolck M, 2008, ENVIRON TOXICOL CHEM, V27, P272, DOI 10.1897/07-224R.1; Veltman K, 2008, ENVIRON SCI TECHNOL, V42, P852, DOI 10.1021/es071331f; Veltman K, 2010, ENVIRON SCI TECHNOL, V44, P5022, DOI 10.1021/es903697c; Venier P, 2005, ENVIRON INT, V31, P1053, DOI 10.1016/j.envint.2005.05.016; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vergani L, 2007, ARCH BIOCHEM BIOPHYS, V465, P247, DOI 10.1016/j.abb.2007.05.023; Voulgaridou GP, 2011, MUTAT RES-FUND MOL M, V711, P13, DOI 10.1016/j.mrfmmm.2011.03.006; Wang WX, 2010, COMP BIOCHEM PHYS C, V152, P1, DOI 10.1016/j.cbpc.2010.02.015; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zorita I, 2007, TOXICOL APPL PHARM, V220, P186, DOI 10.1016/j.taap.2007.01.003; Zorita I, 2006, AQUAT TOXICOL, V78, pS109, DOI 10.1016/j.aquatox.2006.02.032	93	53	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54602	10.1371/journal.pone.0054602	http://dx.doi.org/10.1371/journal.pone.0054602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355883	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500094
J	Parruti, G; Vadini, F; Sozio, F; Mazzott, E; Ursini, T; Polill, E; Di Stefano, P; Tontodonati, M; Verrocchio, MC; Fulcheri, M; Calella, G; Santilli, F; Manzoli, L				Parruti, Giustino; Vadini, Francesco; Sozio, Federica; Mazzott, Elena; Ursini, Tamara; Polill, Ennio; Di Stefano, Paola; Tontodonati, Monica; Verrocchio, Maria C.; Fulcheri, Mario; Calella, Giulio; Santilli, Francesca; Manzoli, Lamberto			Psychological Factors, Including Alexithymia, in the Prediction of Cardiovascular Risk in HIV Infected Patients: Results of a Cohort Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ACTIVE ANTIRETROVIRAL THERAPY; D PERSONALITY; NEGATIVE AFFECTIVITY; PLATELET ACTIVATION; EMOTION REGULATION; METABOLIC SYNDROME; SOCIAL INHIBITION	Background: Psychological factors are known predictors of cardiovascular disease in many clinical settings, but data are lacking for HIV infection. We carried out a prospective cohort study to evaluate potential psychological predictors of preclinical and clinical vascular disease in HIV patients. Methodology/Principal Findings: HIV patients were consecutively enrolled. Demographics, viral and immune parameters and traditional cardiovascular predictors were considered; Intima-Media Thickness (c-IMT, continuous measure) and Carotid Plaques (CPs, focal thickening >= 1.5 mm) were investigated by B-mode ultrasonography; depressive symptoms by the Beck Depression Inventory (BDI-II), Type D personality (Distressed Personality or Type D) by the DS14, alexithymia by the Toronto Alexithymia Scale (TAS-20). Vascular outcomes included transient ischemic attacks or stroke, acute coronary syndrome, myocardial or other organ infarction. We enrolled 232 HIV subjects, 73.9% males, aged 44.5 +/- 9.9 y, 38.2% with AIDS diagnosis, 18.3% untreated. Mean Nadir CD4 T-cell counts were 237.5 +/- 186.2/mmc. Of them, 224 (96.5%) attended IMT measurements; 201 (86.6%) attended both IMT assessment and psychological profiling. Mean follow-up was 782 +/- 308 days. Fifty-nine patients (29.4%) had CPs at baseline. Nineteen patients (9.5%) had >= 1 vascular event; 12 (6.0%) died due to such events (n = 4) or any cause. At baseline cross-sectional multivariate analysis, increasing age, total cholesterol, current smoking and Alexithymia score >= 50 were significantly associated with both increased cIMT (linear regression) and CPs (logistic regression). At follow-up analysis, log-rank tests and Cox's regression revealed that only older age (p = 0.001), current smoking (p = 0.019) and alexithymia score >= 50 (p = 0.013) were independently associated with vascular events. Conclusions/Significance: In HIV-infected subjects, the Alexithymic trait emerges as a strong predictor of increased IMT, presence of CPs and vascular events. Such results are preliminary and require confirmation from studies with larger sample size and longer follow-up.	[Parruti, Giustino; Vadini, Francesco; Sozio, Federica; Mazzott, Elena; Ursini, Tamara; Polill, Ennio; Di Stefano, Paola; Tontodonati, Monica; Calella, Giulio] Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy; [Verrocchio, Maria C.; Fulcheri, Mario] Univ G dAnnunzio, Clin Psychol Div, Chieti, Italy; [Santilli, Francesca] Univ G dAnnunzio, Dept Med & Aging, Chieti, Italy; [Manzoli, Lamberto] Univ G dAnnunzio, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Parruti, G (corresponding author), Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy.	parruti@tin.it	Ursini, Tamara/AAB-3891-2019; Santilli, Francesca/ABC-6243-2021; Manzoli, Lamberto/K-1895-2018; Verrocchio, Maria Cristina/S-5080-2019	Ursini, Tamara/0000-0002-6012-0667; Santilli, Francesca/0000-0002-4593-905X; Manzoli, Lamberto/0000-0002-8129-9344; Verrocchio, Maria Cristina/0000-0003-2549-1152; Verrocchio, Maria Cristina/0000-0003-0326-619X; Fulcheri, Mario/0000-0002-2389-9800	"Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy	"Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy	This work was partly supported by a grant by the "Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bogdanova Y, 2010, NEUROPSYCHOLOGIA, V48, P1295, DOI 10.1016/j.neuropsychologia.2009.12.033; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Chatzi L, 2009, J PSYCHOSOM RES, V67, P307, DOI 10.1016/j.jpsychores.2009.04.011; Clark US, 2010, J INT NEUROPSYCH SOC, V16, P1127, DOI 10.1017/S1355617710001037; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Grabe HJ, 2010, J PSYCHOSOM RES, V68, P139, DOI 10.1016/j.jpsychores.2009.07.015; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Grynberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042429; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Jula A, 1999, HYPERTENSION, V33, P1057, DOI 10.1161/01.HYP.33.4.1057; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Karmochkine M, 1998, THROMB HAEMOSTASIS, V80, P208; Lavoie KL, 2010, PSYCHOSOM MED, V72, P20, DOI 10.1097/PSY.0b013e3181c2d6b8; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; McComsey GA, 2007, AIDS, V21, P921, DOI 10.1097/QAD.0b013e328133f29c; Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714; Needham BL, 2010, AM J PUBLIC HEALTH, V100, P1040, DOI 10.2105/AJPH.2009.172809; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Oyefeso A, 2008, DRUG ALCOHOL DEPEN, V98, P227, DOI 10.1016/j.drugalcdep.2008.06.004; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; Pedersen SS, 2004, J AM COLL CARDIOL, V44, P997, DOI 10.1016/j.jacc.2004.05.064; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Plante GE, 2005, METABOLISM, V54, P45, DOI 10.1016/j.metabol.2005.01.013; Pollatos O, 2011, J PSYCHOSOM RES, V70, P525, DOI 10.1016/j.jpsychores.2010.12.003; Reich J, 2010, J PSYCHIATR RES, V44, P1017, DOI 10.1016/j.jpsychires.2010.03.016; Reid GJ, 2009, PSYCHOSOM MED, V71, P438, DOI 10.1097/PSY.0b013e31819cc751; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Serrano CV, 2011, VASC HEALTH RISK MAN, V7, P159, DOI 10.2147/VHRM.S10783; Shen YMP, 2004, CLIN APPL THROMB-HEM, V10, P277, DOI 10.1177/107602960401000311; Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Steptoe A, 2003, ATHEROSCLEROSIS, V168, P57, DOI 10.1016/S0021-9150(02)00453-7; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; Taylor SF, 2007, TRENDS COGN SCI, V11, P413, DOI 10.1016/j.tics.2007.08.006; Thiebaut F, 2005, AIDS, V19, P729, DOI 10.1097/01.aids.0000166097.46940.35; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; Tolmunen T, 2010, PSYCHOSOM MED, V72, P187, DOI 10.1097/PSY.0b013e3181c65d00; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Troll JG, 2011, CURR ATHEROSCLER REP, V13, P51, DOI 10.1007/s11883-010-0152-1; Vella EJ, 2009, INT J PSYCHOPHYSIOL, V72, P253, DOI 10.1016/j.ijpsycho.2009.01.003; Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	73	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54555	10.1371/journal.pone.0054555	http://dx.doi.org/10.1371/journal.pone.0054555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349927	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100080
J	Kim, H; Lee, SA; Kim, DW; Lee, SH; Kim, BJ				Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Lee, Sueng-Hyun; Kim, Bum-Joon			Naturally Occurring Mutations in Large Surface Genes Related to Occult Infection of Hepatitis B Virus Genotype C	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; KOREAN PATIENTS; HBV INFECTION; DNA; RISK; PREVALENCE; ANTIBODIES; STRESS; GENOME	Molecular mechanisms related to occult hepatitis B virus (HBV) infection, particularly those based on genotype C infection, have rarely been determined thus far in the ongoing efforts to determine infection mechanisms. Therefore, we aim to elucidate the mutation patterns in the surface open reading frame (S ORF) underlying occult infections of HBV genotype C in the present study. Nested PCRs were applied to 624 HBV surface antigen (HBsAg) negative Korean subjects. Cloning and sequencing of the S ORF gene was applied to 41 occult cases and 40 control chronic carriers. Forty-one (6.6%) of the 624 Korean adults with HBsAg-negative serostatus were found to be positive for DNA according to nested PCR tests. Mutation frequencies in the three regions labeled here as preS1, preS2, and S were significantly higher in the occult subjects compared to the carriers in all cases. A total of two types of deletions, preS1 deletions in the start codon and preS2 deletions as well as nine types of point mutations were significantly implicated in the occult infection cases. Mutations within the "a'' determinant region in HBsAg were found more frequently in the occult subjects than in the carriers. Mutations leading to premature termination of S ORF were found in 16 occult subjects (39.0%) but only in one subject from among the carriers (2.5%). In conclusion, our data suggest that preS deletions, the premature termination of S ORF, and "a'' determinant mutations are associated with occult infections of HBV genotype C among a HBsAg-negative population. The novel mutation patterns related to occult infection introduced in the present study can help to broaden our understanding of HBV occult infections.	[Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea; [Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, SNUMRC, Seoul, South Korea; [Lee, Sueng-Hyun] Konkuk Univ, Sch Med, Dept Microbiol Family Med & Internal Med, Chungju, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Konkuk University; Konkuk University Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022; Kim, Bum Joon/J-2739-2012	Kim, Bum Joon/0000-0003-0085-6709; Kim, Hong/0000-0003-1383-6803	National Research Foundation of Korea (NRF); Korea government (MEST, the Korean Ministry of Education, Science, and Technology) [2010-0014269]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST, the Korean Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, the Korean Ministry of Education, Science, and Technology) (No. 2010-0014269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Banerjee A, 2007, J CLIN VIROL, V40, P312, DOI 10.1016/j.jcv.2007.08.009; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; BRECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P3906, DOI 10.1073/pnas.78.6.3906; Bruss V, 2002, HEPATOLOGY, V36, P1327, DOI 10.1053/jhep.2002.37351; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Chemin I, 2001, J HEPATOL, V34, P447, DOI 10.1016/S0168-8278(00)00100-8; Conjeevaram H, 2001, HEPATOLOGY, V34, P204, DOI 10.1053/jhep.2001.25225; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; De Maria N, 2000, AM J GASTROENTEROL, V95, P3529, DOI 10.1111/j.1572-0241.2000.03371.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Jeantet D, 2002, HEPATOLOGY, V35, P1215, DOI 10.1053/jhep.2002.32710; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim H, 2007, INTERVIROLOGY, V50, P52, DOI 10.1159/000096313; Kim HJ, 2008, J MED VIROL, V80, P1337, DOI 10.1002/jmv.21219; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee DH, 2002, J KOREAN MED SCI, V17, P457, DOI 10.3346/jkms.2002.17.4.457; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIANG TJ, 1991, HEPATOLOGY, V13, P1044, DOI 10.1002/hep.1840130607; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Mun HS, 2011, J VIROL, V85, P123, DOI 10.1128/JVI.01524-10; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Park NH, 2010, INTERVIROLOGY, V53, P20, DOI 10.1159/000252780; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Sagnelli E, 2001, J MED VIROL, V64, P350, DOI 10.1002/jmv.1057; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Yao JDC, 2003, HEPATOLOGY, V38, p718A; ZHANG YY, 1993, HEPATOLOGY, V17, P538, DOI 10.1002/hep.1840170403	41	96	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54486	10.1371/journal.pone.0054486	http://dx.doi.org/10.1371/journal.pone.0054486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349904	Green Submitted, gold, Green Published			2022-12-25	WOS:000313872800057
J	Newton, HJ; McDonough, JA; Roy, CR				Newton, Hayley J.; McDonough, Justin A.; Roy, Craig R.			Effector Protein Translocation by the Coxiella burnetii Dot/Icm Type IV Secretion System Requires Endocytic Maturation of the Pathogen-Occupied Vacuole	PLOS ONE			English	Article							LARGE-SCALE IDENTIFICATION; LEGIONELLA-PNEUMOPHILA; HOST-CELL; PARASITOPHOROUS VACUOLE; MACROPHAGES; INFECTION; APOPTOSIS; PATHWAYS; FAMILY; GROWTH	The human pathogen Coxiella burnetii encodes a type IV secretion system called Dot/Icm that is essential for intracellular replication. The Dot/Icm system delivers bacterial effector proteins into the host cytosol during infection. The effector proteins delivered by C. burnetii are predicted to have important functions during infection, but when these proteins are needed during infection has not been clearly defined. Here, we use a reporter system consisting of fusion proteins that have a beta-lactamase enzyme (BlaM) fused to C. burnetii effector proteins to study protein translocation by the Dot/Icm system. Translocation of BlaM fused to the effector proteins CBU0077, CBU1823 and CBU1524 was not detected until 8-hours after infection of HeLa cells, which are permissive for C. burnetii replication. Translocation of these effector fusion proteins by the Dot/Icm system required acidification of the Coxiella-containing vacuole. Silencing of the host genes encoding the membrane transport regulators Rab5 or Rab7 interfered with effector translocation, which indicates that effectors are not translocated until bacteria traffic to a late endocytic compartment in the host cell. Similar requirements for effector translocation were discerned in bone marrow macrophages derived from C57BL/6 mice, which are primary cells that restrict the intracellular replication of C. burnetii. In addition to requiring endocytic maturation of the vacuole for Dot/Icm-mediated translocation of effectors, bacterial transcription was required for this process. Thus, translocation of effector proteins by the C. burnetii Dot/Icm system occurs after acidification of the CCV and maturation of this specialized organelle to a late endocytic compartment. This indicates that creation of the specialized vacuole in which C. burnetii replicates represents a two-stage process mediated initially by host factors that regulate endocytic maturation and then by bacterial effectors delivered into host cells after bacteria establish residency in a lysosome-derived organelle.	[Newton, Hayley J.; McDonough, Justin A.; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Newton, HJ (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	hayley.newton@yale.edu		Roy, Craig/0000-0003-4490-440X; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council Overseas Training Fellowship; Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship [F32-AI0829272]; National Institutes of Health (NIH) [R01-AI064559]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI064559] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council Overseas Training Fellowship; Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an Australian National Health and Medical Research Council Overseas Training Fellowship to HJN, a Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship (F32-AI0829272) to JAM and by National Institutes of Health (NIH) grants (R01-AI064559 and Northeast Biodefense Center U54-AI057158-Lipkin) to CRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delsing CE, 2011, ADV EXP MED BIOL, V719, P133, DOI 10.1007/978-1-4614-0204-6_12; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; Morgan JK, 2010, FEMS MICROBIOL LETT, V311, P61, DOI 10.1111/j.1574-6968.2010.02072.x; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nakano N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001129; Newton HJ, 2011, MBIO, V2, DOI 10.1128/mBio.00226-11; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Ornsland A, 2008, J BACTERIOL, V190, P3203, DOI 10.1128/JB.01911-07; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rodman JS, 2000, J CELL SCI, V113, P183; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Voth DE, 2007, INFECT IMMUN, V75, P4263, DOI 10.1128/IAI.00594-07; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	42	84	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54566	10.1371/journal.pone.0054566	http://dx.doi.org/10.1371/journal.pone.0054566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349930	Green Submitted, Green Published, gold			2022-12-25	WOS:000313738900079
J	Corvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S; Valli, E; Piotrowska, I; Perini, G; Sala, A				Corvetta, Daisy; Chayka, Olesya; Gherardi, Samuele; D'Acunto, Cosimo W.; Cantilena, Sandra; Valli, Emanuele; Piotrowska, Izabela; Perini, Giovanni; Sala, Arturo			Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma FUNCTIONAL AND THERAPEUTIC IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TUMOR-SUPPRESSOR GENES; CELL-LINES; DNA HYPERMETHYLATION; HDAC INHIBITORS; EXPRESSION; TUMORIGENESIS; TRANSCRIPTION; CLUSTERIN; PATTERN	CLU (clusterin) is a tumor suppressor gene that we have previously shown to be negatively modulated by the MYCN protooncogene, but the mechanism of repression was unclear. Here, we show that MYCN inhibits the expression of CLU by direct interaction with the non-canonical E box sequence CACGCG in the 5'-flanking region. Binding of MYCN to the CLU gene induces bivalent epigenetic marks and recruitment of repressive proteins such as histone deacetylases and Polycomb members. MYCN physically binds in vitro and in vivo to EZH2, a component of the Polycomb repressive complex 2, required to repress CLU. Notably, EZH2 interacts with the Myc box domain 3, a segment of MYC known to be essential for its transforming effects. The expression of CLU can be restored in MYCN-amplified cells by epigenetic drugs with therapeutic results. Importantly, the anticancer effects of the drugs are ablated if CLU expression is blunted by RNA interference. Our study implies that MYC tumorigenesis can be effectively antagonized by epigenetic drugs that interfere with the recruitment of chromatin modifiers at repressive E boxes of tumor suppressor genes such as CLU.	[Piotrowska, Izabela; Sala, Arturo] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1N 1EH, England; [Sala, Arturo] Brunel Univ, Inst Canc Genet & Pharmacogen, London UB8 3PH, England; [Gherardi, Samuele; Valli, Emanuele; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy	University of London; University College London; Brunel University; University of Bologna	Perini, G (corresponding author), Univ Bologna, Dept Biol, Via Belmeloro 8, I-40126 Bologna, Italy.	giovanni.perini@unibo.it; Arturo.Sala@brunel.ac.uk	Valli, Emanuele/ABD-7213-2020	Valli, Emanuele/0000-0002-0928-8624; Sala, Arturo/0000-0002-2841-7866	SPARKS; Neuroblastoma Society; Wellcome Trust; Italian Association for Cancer Research	SPARKS; Neuroblastoma Society; Wellcome Trust(Wellcome TrustEuropean Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from SPARKS, The Neuroblastoma Society, a Wellcome Trust grant (to A. S.), and the Italian Association for Cancer Research (to G. P.).	Balch C, 2007, BIOESSAYS, V29, P842, DOI 10.1002/bies.20619; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fox E, 2009, J NATL CANCER I, V101, P1105, DOI 10.1093/jnci/djp238; Garinis GA, 2002, HUM GENET, V111, P115, DOI 10.1007/s00439-002-0783-6; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Lutz W, 1996, ONCOGENE, V13, P803; Marchion D, 2007, EXPERT REV ANTICANC, V7, P583, DOI 10.1586/14737140.7.4.583; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1977, CANCER RES, V37, P1364; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	34	59	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8332	8341		10.1074/jbc.M113.454280	http://dx.doi.org/10.1074/jbc.M113.454280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362253	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000316564500033
J	Malik, AR; Urbanska, M; Gozdz, A; Swiech, LJ; Nagalski, A; Perycz, M; Blazejczyk, M; Jaworski, J				Malik, Anna R.; Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Nagalski, Andrzej; Perycz, Malgorzata; Blazejczyk, Magdalena; Jaworski, Jacek			Cyr61, a Matricellular Protein, Is Needed for Dendritic Arborization of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-ANGIOGENIC ACTIVITIES; GENE-EXPRESSION; MAMMALIAN TARGET; CCN1 CYR61; GROWTH; MTOR; ACTIVATION; CELLS; PHOSPHORYLATION; ALPHA(V)BETA(3)	The shape of the dendritic arbor is one of the criteria of neuron classification and reflects functional specialization of particular classes of neurons. The development of a proper dendritic branching pattern strongly relies on interactions between the extracellular environment and intracellular processes responsible for dendrite growth and stability. We previously showed that mammalian target of rapamycin (mTOR) kinase is crucial for this process. In this work, we performed a screen for modifiers of dendritic growth in hippocampal neurons, the expression of which is potentially regulated by mTOR. As a result, we identified Cyr61, an angiogenic factor with unknown neuronal function, as a novel regulator of dendritic growth, which controls dendritic growth in a beta 1-integrin-dependent manner.	[Malik, Anna R.; Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Perycz, Malgorzata; Blazejczyk, Magdalena; Jaworski, Jacek] Int Inst Mol & Cell Biol, Lab Mol & Cellular Neurobiol, PL-02109 Warsaw, Poland; [Nagalski, Andrzej] Int Inst Mol & Cell Biol, Lab Neurodegenerat, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Jaworski, J (corresponding author), Int Inst Mol & Cell Biol, Lab Mol & Cellular Neurobiol, 4 Ks Trojdena St, PL-02109 Warsaw, Poland.	jaworski@iimcb.gov.pl	Nagalski, Andrzej/AAH-3366-2019; Nagalski, Andrzej/O-3173-2015; Gozdz, Agata/AAD-2974-2022; Perycz, Malgorzata/HHN-0050-2022; Malik, Anna R/O-7126-2017	Nagalski, Andrzej/0000-0002-4864-5604; Nagalski, Andrzej/0000-0002-4864-5604; Gozdz, Agata/0000-0001-8421-0598; Perycz, Malgorzata/0000-0003-3154-6594; Malik, Anna R/0000-0001-7732-0756; Jaworski, Jacek/0000-0001-8760-7865; Urbanska, Malgorzata/0000-0001-9521-0366	FP-7Health-Prot Grant [229697]; National Center for Research and Development; National Science Center [OPUS 2011/03/B/NZ3/01970]; European Union;  [ERA-NET-Neuron/03/2010]	FP-7Health-Prot Grant; National Center for Research and Development(National Centre for Research & Development, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission); 	This work was supported by FP-7Health-Prot Grant 229697, ERA-NET-Neuron/03/2010 (co-financed by the National Center for Research and Development) and National Science Center Grant OPUS 2011/03/B/NZ3/01970 (JJ). Also co-financed by European Union funds from European Social Fund (M.U.).	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang YF, 2010, J NEUROSCI, V30, P6080, DOI 10.1523/JNEUROSCI.5493-09.2010; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Konopka W, 2005, NEUROBIOL DIS, V19, P283, DOI 10.1016/j.nbd.2005.01.018; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Latinkic BV, 2001, ENDOCRINOLOGY, V142, P2549, DOI 10.1210/en.142.6.2549; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035754; Licht T, 2010, DEVELOPMENT, V137, P261, DOI 10.1242/dev.039636; Loewith R, 2010, ENZYMES, V27, P147, DOI 10.1016/S1874-6047(10)27009-9; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Ohkawa Y, 2011, BIOCHEM BIOPH RES CO, V411, P483, DOI 10.1016/j.bbrc.2011.06.118; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Sampath D, 2002, ENDOCRINE, V18, P147, DOI 10.1385/ENDO:18:2:147; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlomann U, 2009, J CELL SCI, V122, P2034, DOI 10.1242/jcs.038232; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHOLL DA, 1953, J ANAT, V87, P387; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Stuart G, 2007, DENDRITES; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Ward NL, 2005, J COMP NEUROL, V482, P244, DOI 10.1002/cne.20422; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006; Zhang XD, 2012, AM J REPROD IMMUNOL, V67, P216, DOI 10.1111/j.1600-0897.2011.01080.x	70	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8544	8559		10.1074/jbc.M112.411629	http://dx.doi.org/10.1074/jbc.M112.411629			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362279	Green Published, hybrid			2022-12-25	WOS:000316564500050
J	Morel, L; Regan, M; Higashimori, H; Ng, SK; Esau, C; Vidensky, S; Rothstein, J; Yang, YJ				Morel, Lydie; Regan, Melissa; Higashimori, Haruki; Seng Kah Ng; Esau, Christine; Vidensky, Svetlana; Rothstein, Jeffrey; Yang, Yongjie			Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA EXPRESSION; ASTROCYTES; SECRETION; VARIANTS; BRAIN; EAAT2; LOCALIZATION; BIOGENESIS; MECHANISMS; PEPTIDES	Perisynaptic astrocytes express important glutamate transporters, especially excitatory amino acid transporter 2 (EAAT2, rodent analog GLT1) to regulate extracellular glutamate levels and modulate synaptic activation. In this study, we investigated an exciting new pathway, the exosome-mediated transfer of microRNA (in particular, miR-124a), in neuron-to-astrocyte signaling. Exosomes isolated from neuron-conditioned medium contain abundant microRNAs and small RNAs. These exosomes can be directly internalized into astrocytes and increase astrocyte miR-124a and GLT1 protein levels. Direct miR-124a transfection also significantly and selectively increases protein (but not mRNA) expression levels of GLT1 in cultured astrocytes. Consistent with our in vitro findings, intrastriatal injection of specific antisense against miR-124a into adult mice dramatically reduces GLT1 protein expression and glutamate uptake levels in striatum without reducing GLT1 mRNA levels. MiR-124a-mediated regulation of GLT1 expression appears to be indirect and is not mediated by its suppression of the putative GLT1 inhibitory ligand ephrinA3. Moreover, miR-124a is selectively reduced in the spinal cord tissue of end-stage SOD1 G93A mice, the mouse model of ALS. Subsequent exogenous delivery of miR-124a in vivo through stereotaxic injection significantly prevents further pathological loss of GLT1 proteins, as determined by GLT1 immunoreactivity in SOD1 G93A mice. Together, our study characterized a new neuron-to-astrocyte communication pathway and identified miRNAs that modulate GLT1 protein expression in astrocytes in vitro and in vivo.	[Morel, Lydie; Higashimori, Haruki; Seng Kah Ng; Yang, Yongjie] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Yang, Yongjie] Tufts Sackler Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA; [Regan, Melissa; Vidensky, Svetlana; Rothstein, Jeffrey] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 20215 USA; [Esau, Christine] Regulus Therapeut Inc, San Diego, CA 92121 USA	Tufts University; Johns Hopkins University; Isis Pharmaceuticals Inc	Yang, YJ (corresponding author), Tufts Univ, Sackler Sch Biomed Sci, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	yongjie.yang@tufts.edu			National Institutes of Health [MH099554, NS233958, NS36465]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, P30NS047243, P30NS069254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH099554 (to Y. Y.) and NS233958 and NS36465 (to J. D. R.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Berger UV, 2005, J COMP NEUROL, V492, P78, DOI 10.1002/cne.20737; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Flowers JM, 2001, ANN NEUROL, V49, P643, DOI 10.1002/ana.1029; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim SY, 2003, J NEUROCHEM, V86, P1458, DOI 10.1046/j.1471-4159.2003.01958.x; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; O'Loughlin AJ, 2012, CURR GENE THER, V12, P262, DOI 10.2174/156652312802083594; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Peacey E, 2009, MOL PHARMACOL, V75, P1062, DOI 10.1124/mol.108.052829; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; ROBINSON MB, 1991, BRAIN RES, V544, P196, DOI 10.1016/0006-8993(91)90054-Y; Rogelj B, 2004, REV NEUROSCIENCE, V15, P185; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Swanson RA, 1997, J NEUROSCI, V17, P932; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x	51	250	269	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7105	7116		10.1074/jbc.M112.410944	http://dx.doi.org/10.1074/jbc.M112.410944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23364798	Green Published, hybrid			2022-12-25	WOS:000316002400032
J	Fetter-Pruneda, I; Geovannini-Acuna, H; Santiago, C; Ibarraran-Viniegra, AS; Martinez-Martinez, E; Sandoval-Velasco, M; Uribe-Figueroa, L; Padilla-Cortes, P; Mercado-Celis, G; Gutierrez-Ospina, G				Fetter-Pruneda, Ingrid; Geovannini-Acuna, Helga; Santiago, Cecilia; Sofia Ibarraran-Viniegra, Ana; Martinez-Martinez, Eduardo; Sandoval-Velasco, Marcela; Uribe-Figueroa, Laura; Padilla-Cortes, Patricia; Mercado-Celis, Gabriela; Gutierrez-Ospina, Gabriel			Shifts in Developmental Timing, and Not Increased Levels of Experience-Dependent Neuronal Activity, Promote Barrel Expansion in the Primary Somatosensory Cortex of Rats Enucleated at Birth	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; SOMATIC SENSORY CORTEX; ALTERING THALAMOCORTICAL PROJECTIONS; VIBRISSA-RELATED PATTERNS; DEVELOPING VISUAL-CORTEX; DNA METHYLATION; HISTONE MODIFICATIONS; ELECTRICAL-ACTIVITY; CEREBRAL-CORTEX; CRITICAL-PERIOD	Birth-enucleated rodents display enlarged representations of whiskers (i.e., barrels of the posteromedial subfield) in the primary somatosensory cortex. Although the historical view maintains that barrel expansion is due to incremental increases in neuronal activity along the trigeminal pathway during postnatal development, recent evidence obtained in experimental models of intramodal plasticity challenges this view. Here, we re-evaluate the role of experience-dependent neuronal activity on barrel expansion in birth-enucleated rats by combining various anatomical methods and sensory deprivation paradigms. We show that barrels in birth-enucleated rats were already enlarged by the end of the first week of life and had levels of metabolic activity comparable to those in control rats at different ages. Dewhiskering after the postnatal period of barrel formation did not prevent barrel expansion in adult, birth-enucleated rats. Further, dark rearing and enucleation after barrel formation did not lead to expanded barrels in adult brains. Because incremental increases of somatosensory experience did not promote barrel expansion in birth-enucleated rats, we explored whether shifts of the developmental timing could better explain barrel expansion during the first week of life. Accordingly, birth-enucleated rats show earlier formation of barrels, accelerated growth of somatosensory thalamocortical afferents, and an earlier H4 deacetylation. Interestingly, when H4 deacetylation was prevented with a histone deacetylases inhibitor (valproic acid), barrel specification timing returned to normal and barrel expansion did not occur. Thus, we provide evidence supporting that shifts in developmental timing modulated through epigenetic mechanisms, and not increased levels of experience dependent neuronal activity, promote barrel expansion in the primary somatosensory cortex of rats enucleated at birth.	[Fetter-Pruneda, Ingrid; Geovannini-Acuna, Helga; Santiago, Cecilia; Sofia Ibarraran-Viniegra, Ana; Martinez-Martinez, Eduardo; Sandoval-Velasco, Marcela; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Programa Posgrad Ciencias Bil, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico; [Mercado-Celis, Gabriela] Inst Nacl Med Genom, Direcc Invest Med, Lab Oncogenom, Mexico City, DF, Mexico; [Uribe-Figueroa, Laura] Inst Nacl Med Genom, Unidad Genotipificac & Anal Expres Affymetrix, Mexico City, DF, Mexico; [Padilla-Cortes, Patricia] Inst Nacl Med Genom, Inst Invest Biomed, Unidad HPLC, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Fetter-Pruneda, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Programa Posgrad Ciencias Bil, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico.	ifetter@rockefeller.edu; gabo@biomedicas.unam.mx	Sandoval-Velasco, Marcela/AAS-6478-2021; Martínez, Eduardo Martínez/A-2558-2009; Mercado-Celis, Gabriela E./AAR-7836-2020	Sandoval-Velasco, Marcela/0000-0002-4635-6171; Martínez, Eduardo Martínez/0000-0002-9020-559X; Mercado-Celis, Gabriela E./0000-0003-3113-0687; Gutierrez Ospina, Gabriel/0000-0002-6286-8281; Geovannini Acuna, Helga/0000-0002-0345-9787; Fetter-Pruneda, Ingrid/0000-0002-9122-3159	CONACyT [J28035N, 38615N, P45872-M]; PAPIIT; DGAPA [IN203702, IN232604]; The Ricardo Zevada Foundation; The Miguel Aleman Foundation; Roche-Syntex	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); DGAPA; The Ricardo Zevada Foundation; The Miguel Aleman Foundation; Roche-Syntex	Financial aid came from CONACyT (J28035N, 38615N, P45872-M to GGO), PAPIIT, DGAPA (IN203702, IN232604 to GGO). The Ricardo Zevada and Miguel Aleman Foundations, Roche-Syntex provided additional funds. IFP and EMM were fellows of the National Council of Science and Technology (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: Roche-Syntex provided additional funds for this study. Their research group received a national award from Roche-Syntex that they used for purchasing lab equipment. Roche-Syntex is not subsidizing the authors' research and they have no interests on the results and experiments. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Allis C. D., 2006, EPIGENETICS; ANTONINI A, 1993, J NEUROSCI, V13, P3549; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; Baird DH, 1996, J NEUROSCI, V16, P2642; Barber PR, 2007, P SOC PHOTO-OPT INS, V6441, P1; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Boylan CB, 2001, DEV BRAIN RES, V129, P95, DOI 10.1016/S0165-3806(01)00163-8; BRONCHTI G, 1992, NEUROREPORT, V3, P489, DOI 10.1097/00001756-199206000-00008; Burton H, 2003, J NEUROSCI, V23, P4005; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CATALANO SM, 1995, P NATL ACAD SCI USA, V92, P2549, DOI 10.1073/pnas.92.7.2549; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; Chubb JR, 2006, DEV BIOL, V292, P519, DOI 10.1016/j.ydbio.2005.12.054; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Davis CD, 2007, NUTR REV, V65, P88, DOI [10.1111/j.1753-4887.2007.tb00285.x, 10.1301/nr.2007.feb.88-94]; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; DUNNMEYNELL AA, 1992, J COMP NEUROL, V315, P160, DOI 10.1002/cne.903150204; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gao WJ, 1999, J NEUROSCI, V19, P7940; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Gutierrez-Ospina G, 1998, NEUROSCI LETT, V247, P5, DOI 10.1016/S0304-3940(98)00218-3; GutierrezOspina G, 1996, ENDOCRINOLOGY, V137, P5484, DOI 10.1210/en.137.12.5484; HARRIS WA, 1984, J NEUROSCI, V4, P1153; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 2008, NEURON, V59, P355, DOI 10.1016/j.neuron.2008.07.029; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Keyes MK, 2007, J NUTR, V137, P1713, DOI 10.1093/jn/137.7.1713; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; KILLACKEY HP, 1989, EUR J NEUROSCI, V1, P210, DOI 10.1111/j.1460-9568.1989.tb00790.x; KORALEK KA, 1990, P NATL ACAD SCI USA, V87, P1396, DOI 10.1073/pnas.87.4.1396; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Lane RD, 2006, NEUROSCI LETT, V395, P165, DOI 10.1016/j.neulet.2005.10.063; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Mah L-J, 2010, J VIS EXP; Mann F, 2002, DEVELOPMENT, V129, P3945; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Maurer D, 2005, TRENDS COGN SCI, V9, P144, DOI 10.1016/j.tics.2005.01.006; MCCANDLISH CA, 1993, EXP BRAIN RES, V92, P369; MCCASLAND JS, 1992, P NATL ACAD SCI USA, V89, P1832, DOI 10.1073/pnas.89.5.1832; McIlvain VA, 2003, J COMP NEUROL, V462, P252, DOI 10.1002/cne.10725; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McNamara K. J., 1997, SHAPES TIME EVOLUTIO; Merabet LB, 2005, NAT REV NEUROSCI, V6, P71, DOI 10.1038/nrn1586; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mire E, 2012, NAT NEUROSCI; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Pallas SL, 1999, P NATL ACAD SCI USA, V96, P8751, DOI 10.1073/pnas.96.15.8751; PASCUALLEONE A, 1993, ANN NEUROL, V34, P33, DOI 10.1002/ana.410340108; Penschuck S, 1999, DEV BRAIN RES, V112, P117, DOI 10.1016/S0165-3806(98)00171-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PINA B, 1988, EUR J BIOCHEM, V174, P311, DOI 10.1111/j.1432-1033.1988.tb14099.x; RAUSCHECKER JP, 1992, P NATL ACAD SCI USA, V89, P5063, DOI 10.1073/pnas.89.11.5063; REBILLARD G, 1977, BRAIN RES, V129, P162, DOI 10.1016/0006-8993(77)90980-5; Rhoades RW, 1997, J COMP NEUROL, V389, P185, DOI 10.1002/(SICI)1096-9861(19971208)389:1<185::AID-CNE14>3.0.CO;2-K; RIDDLE D, 1992, J NEUROSCI, V12, P3509; RIDDLE DR, 1993, J NEUROSCI, V13, P4193; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sathian K, 2000, NEUROLOGY, V54, P2203, DOI 10.1212/WNL.54.12.2203; Seelke AMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032322; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Smith KK, 2003, INT J DEV BIOL, V47, P613; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tang MM, 2010, J VIS EXP; Toscano-Marquez B, 2008, P NATL ACAD SCI USA, V105, P15973, DOI 10.1073/pnas.0808431105; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Wang ZP, 2010, ANAT REC, V293, P1947, DOI 10.1002/ar.21232; Weeks R, 2000, J NEUROSCI, V20, P2664; WELKER E, 1992, J NEUROSCI, V12, P153; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; White EL, 1997, SOMATOSENS MOT RES, V14, P34, DOI 10.1080/08990229771204; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhang SY, 2006, NAT PROTOC, V1, P3101, DOI 10.1038/nprot.2006.445; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHENG D, 1995, P NATL ACAD SCI USA, V92, P1802, DOI 10.1073/pnas.92.6.1802	109	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54940	10.1371/journal.pone.0054940	http://dx.doi.org/10.1371/journal.pone.0054940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372796	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400042
J	De La Fuente, GN; Murray, SC; Isakeit, T; Park, YS; Yan, Y; Warburton, ML; Kolomiets, MV				De La Fuente, Gerald N.; Murray, Seth C.; Isakeit, Thomas; Park, Yong-Soon; Yan, Yuanxin; Warburton, Marilyn L.; Kolomiets, Michael V.			Characterization of Genetic Diversity and Linkage Disequilibrium of ZmLOX4 and ZmLOX5 Loci in Maize	PLOS ONE			English	Article							DNA POLYMORPHISM; JASMONIC ACID; ZEA-MAYS; POPULATIONS; GENOME; LIPOXYGENASE; DISRUPTION; RESISTANCE; AFLATOXIN; PATTERNS	Maize (Zea mays L.) lipoxygenases (ZmLOXs) are well recognized as important players in plant defense against pathogens, especially in cross kingdom lipid communication with pathogenic fungi. This study is among the first to investigate genetic diversity at important gene paralogs ZmLOX4 and ZmLOX5. Sequencing of these genes in 400 diverse maize lines showed little genetic diversity and low linkage disequilibrium in the two genes. Importantly, we identified one inbred line in which ZmLOX5 has a disrupted open reading frame, a line missing ZmLOX5, and five lines with a duplication of ZmLOX5. Tajima's D test suggests that both ZmLOX4 and ZmLOX5 have been under neutral selection. Further investigation of haplotype data revealed that within the ZmLOX family members only ZmLOX12, a monocot specific ZmLOX, showed strong linkage disequilibrium that extends further than expected in maize. Linkage disequilibrium patterns at these loci of interest are crucial for future candidate gene association mapping studies. ZmLOX4 and ZmLOX5 mutations and copy number variants are under further investigation for crop improvement.	[De La Fuente, Gerald N.; Murray, Seth C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Isakeit, Thomas; Park, Yong-Soon; Yan, Yuanxin; Kolomiets, Michael V.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Jackson, MS USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Murray, SC (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	sethmurray@tamu.edu	Warburton, Marilyn/J-2250-2017	Warburton, Marilyn/0000-0002-9542-9912; Murray, Seth/0000-0002-2960-8226	USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) Plant Breeding and Education grant [2010-85117-20539]; National Science Foundation [IOS-0951272]; Texas Corn Producers Board	USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) Plant Breeding and Education grant; National Science Foundation(National Science Foundation (NSF)); Texas Corn Producers Board	This study was funded by the USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) (http://www.nifa.usda.gov/funding/rfas/afri.html) Plant Breeding and Education grant #2010-85117-20539, the National Science Foundation (www.nsf.gov) grant # IOS-0951272, and the Texas Corn Producers Board (www.texascorn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Castegnaro M, 1998, REV MED VET-TOULOUSE, V149, P671; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; DOEBLEY J, 1990, ECON BOT, V44, P6, DOI 10.1007/BF02860472; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Kim J, 2011, PHYTOCHEMISTRY, V72, P1624, DOI 10.1016/j.phytochem.2011.03.026; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Mayfield KL, 2011, CROP SCI, V51, P2489, DOI 10.2135/cropsci2011.02.0112; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; NEI M, 1990, GENETICS, V125, P873; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; Park YS, 2010, PLANTA, V231, P1425, DOI 10.1007/s00425-010-1143-8; Paul C, 2003, THEOR APPL GENET, V107, P263, DOI 10.1007/s00122-003-1241-0; Pingali P.L., 2001, CIMMYT 1999 2000 WOR; Pollak LM, 2003, ADV AGRON, V78, P45, DOI 10.1016/S0065-2113(02)78002-4; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stitz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025925; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; USDA-FAS, 2011, CURR WORLD PROD MARK; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Zhang JL, 2005, PLANT MOL BIOL, V59, P323, DOI 10.1007/s11103-005-8883-z; Zhang PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022378	42	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53973	10.1371/journal.pone.0053973	http://dx.doi.org/10.1371/journal.pone.0053973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365644	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600024
J	Du, MR; Qiu, Q; Gruslin, A; Gordon, J; He, M; Chan, CC; Li, DJ; Tsang, BK				Du, Meirong; Qiu, Qing; Gruslin, Andree; Gordon, John; He, Miao; Chan, Chi Chung; Li, Dajin; Tsang, Benjamin K.			SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro	PLOS ONE			English	Article							NONPEPTIDE CXCR2 ANTAGONIST; CISPLATIN RESISTANCE; INHIBITORY PROTEIN; CHECKPOINT; APOPTOSIS; PATHWAY; DEATH; CHEMORESISTANCE; RECEPTORS; UCN-01	Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist SB225002 induces apoptosis in Wilms' tumor cells. Here, we investigated the effect of SB225002 on cell cycle progression and apoptosis induction in vitro, using CDDP-sensitive and -resistant OVCA cell lines with different p53 status (wild type, mutant or null). Adenovirus infection of wild-type p53 or transfection of p53 siRNA was used to over-express or knock-down p53. Cell cycle and apoptosis were determined by flow cytometry or Hoechst staining and observation of nuclear morphology. Our data demonstrated that SB225002 induced apoptosis in both wild-type and p53-deficient ovarian cancer (OVCA) cells through alternative mechanisms. SB225002 promoted mitotic catastrophe, as evidenced by the accumulation of mitotic cells with spindle abnormalities, chromosome mis-segregation, multi-polar cell division, multiple nuclei, aneuploidy/polyploidy and subsequent extensive apoptosis. SB225002-induced mitotic catastrophe appeared to be mediated by down-regulation of checkpoint kinase Chk1 and Cdk1-cyclin B activation. In cells expressing wild-type p53 (OV2008 and C13*), SB225002 increased total and phospho-Ser p53 levels, and p53 knock-down decreased SB225002-induced apoptosis, without affecting premature mitosis. These results suggest that SB225002 induces p53-dependent apoptosis, and provokes mitotic catastrophe in p53-independent manner in p53 wild-type cells. Reconstitution with wild-type P53 in P53-null SKOV3 cell attenuated SB225002-induced mitotic catastrophe, suggesting p53 prevented mitotic catastrophe induced by SB225002 in p53-deficient OVCA cells. Finally, the effect of SB225002 could not be prevented by pretreatment with CXCR2 ligand or its neutralizing antibody. The present studies demonstrate for the first time that SB225002 has dual actions in OVCA cells, inducing classic apoptosis through p53 activation and provoking mitotic catastrophe in both p53 wild-type and deficient cells by Chk1 inhibition and Cdk activation. These findings raise the possibility of SB225002 as a new candidate molecule for OVCA therapy independent of the p53 status.	[Du, Meirong; Li, Dajin] Fudan Univ, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol, Inst Biomed Sci,Med Coll, Shanghai 200433, Peoples R China; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Gordon, John] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [He, Miao; Chan, Chi Chung] WuXi AppTech Co Ltd, Shanghai, Peoples R China; [Li, Dajin; Tsang, Benjamin K.] Hainan Med Coll Affiliated Hosp, Dept Obstet & Gynecol, Haikou, Peoples R China; [Tsang, Benjamin K.] Seoul Natl Univ, World Class Univ WCU Biomodulat Major, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151, South Korea	Fudan University; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Saskatchewan; Hainan Medical University; Seoul National University (SNU)	Li, DJ (corresponding author), Fudan Univ, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol, Inst Biomed Sci,Med Coll, Shanghai 200433, Peoples R China.	djli@shmu.edu.cn; btsang@ohri.ca		Gordon, John/0000-0003-3830-8070; Tsang, Benjamin K./0000-0003-1213-3946	National Natural Science Foundation of China [30910103909, 81070537, 31171437]; National and Shanghai Leading Academic Discipline Project [211XK22]; Program for Outstanding Medical Academic Leader of Shanghai; Shanghai PuJiang Talent Program [10PJ1401600]; Canadian Institutes of Health Research [MOP-15691]; World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea [R31-10056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National and Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Program for Outstanding Medical Academic Leader of Shanghai; Shanghai PuJiang Talent Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Major International Joint Research Project of National Natural Science Foundation of China (30910103909 to DJ Li), National and Shanghai Leading Academic Discipline Project (211XK22 to DJL), Program for Outstanding Medical Academic Leader of Shanghai (to DJL), and National Natural Science Foundation of China (81070537 to MRD), National Natural Science Foundation of China (31171437 to MRD), and Shanghai PuJiang Talent Program (10PJ1401600 to MRD), and grants from the Canadian Institutes of Health Research (MOP-15691 to BKT) and the World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea and funded by the National Research Foundation of Korea (R31-10056 to BKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bakshi P, 2009, BIOORGAN MED CHEM, V17, P8102, DOI 10.1016/j.bmc.2009.09.051; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779; Buhmann R, 2002, BRIT J HAEMATOL, V118, P968, DOI 10.1046/j.1365-2141.2002.03719.x; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Hirose Y, 2001, CANCER RES, V61, P5843; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Husain A, 1997, CLIN CANCER RES, V3, P2089; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li F, 2002, BIOCHEM BIOPH RES CO, V293, P939, DOI 10.1016/S0006-291X(02)00318-2; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Matsuo Y, 2009, MOL CANCER RES, V7, P799, DOI 10.1158/1541-7786.MCR-08-0577; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Romano G, 2010, CELL CYCLE, V9, P4262, DOI 10.4161/cc.9.21.13605; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Wang GD, 2004, ONCOL REP, V12, P955; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zenvirt S, 2010, ONCOGENE, V29, P6149, DOI 10.1038/onc.2010.343	45	16	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54572	10.1371/journal.pone.0054572	http://dx.doi.org/10.1371/journal.pone.0054572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359652	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600073
J	Nagasaka, K; Seiki, T; Yamashita, A; Massimi, P; Subbaiah, VK; Thomas, M; Kranjec, C; Kawana, K; Nakagawa, S; Yano, T; Taketani, Y; Fujii, T; Kozuma, S; Banks, L				Nagasaka, Kazunori; Seiki, Takayuki; Yamashita, Aki; Massimi, Paola; Subbaiah, Vanitha Krishna; Thomas, Miranda; Kranjec, Christian; Kawana, Kei; Nakagawa, Shunsuke; Yano, Tetsu; Taketani, Yuji; Fujii, Tomoyuki; Kozuma, Shiro; Banks, Lawrence			A Novel Interaction between hScrib and PP1 gamma Downregulates ERK Signaling and Suppresses Oncogene-Induced Cell Transformation	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASES; DISCS-LARGE; MAP KINASE; IN-VIVO; POLARITY; DROSOPHILA; SCRIBBLE; DEPHOSPHORYLATION; ACTIVATION; EXPRESSION	Previous studies have shown that the cell polarity regulator hScrib interacts with, and consequently controls, the ERK signaling pathway. This interaction occurs through two well-conserved Kinase Interacting Motifs, which allow hScrib to bind ERK1 directly, resulting in a reduction in the levels of phospho-ERK. This suggests that hScrib might recruit a phosphatase to regulate this signaling pathway. Using a proteomic approach we now show that Protein Phosphatase 1 gamma (PP1 gamma) is a major interacting partner of hScrib. This interaction is direct and occurs through a conserved PP1 gamma interaction motif on the hScrib protein, and this interaction appears to be required for hScrib's ability to downregulate ERK phosphorylation. In addition, hScrib also controls the pattern of PP1 gamma localization, where loss of hScrib enhances the nuclear translocation of PP1 gamma. Furthermore, we also show that the ability of hScrib to interact with PP1 gamma is important for the ability of hScrib to suppress oncogene-induced transformation of primary rodent cells. Taken together, these results demonstrate that hScrib acts as a scaffold to integrate the control of the PP1 gamma and ERK signaling pathways and explains how disruption of hScrib localisation can contribute towards the development of human malignancy.	[Nagasaka, Kazunori; Seiki, Takayuki; Yamashita, Aki; Kawana, Kei; Yano, Tetsu; Taketani, Yuji; Fujii, Tomoyuki; Kozuma, Shiro] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Massimi, Paola; Subbaiah, Vanitha Krishna; Thomas, Miranda; Kranjec, Christian; Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Nakagawa, Shunsuke] Teikyo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 173, Japan	University of Tokyo; International Center for Genetic Engineering & Biotechnology (ICGEB); Teikyo University	Banks, L (corresponding author), Int Ctr Genet Engn & Biotechnol, Area Sci Pk, Trieste, Italy.	banks@icgeb.org	, Subbaiah/AAB-9747-2021; Nagasaka, Kazunori/AAM-4311-2020; Kranjec, Christian/ABA-9194-2021	Nagasaka, Kazunori/0000-0002-0696-5175; Kranjec, Christian/0000-0001-9713-7406; Krishna, Vanitha/0000-0002-0444-531X	Okinaka Memorial Institute for Medical Research; Ministry of Education, Science and Culture, Japan [24592506]; Associazione Italiana per la Ricerca sul Cancro; Wellcome Trust	Okinaka Memorial Institute for Medical Research; Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by research grants from the Okinaka Memorial Institute for Medical Research (to K.N.) and by a Grant-in-Aid for Scientific Research (no. 24592506, to K.N.) from the Ministry of Education, Science and Culture, Japan, and by research grants from the Associazione Italiana per la Ricerca sul Cancro and the Wellcome Trust (to L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Bilder D, 2003, CURR BIOL, V13, pR661, DOI 10.1016/S0960-9822(03)00599-2; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Cohen PTW, 2002, J CELL SCI, V115, P241; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Shimada M, 2010, EMBO REP, V11, P883, DOI 10.1038/embor.2010.152; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Vieira V, 2008, MOL VIS, V14, P2390; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Watson RA, 2002, CARCINOGENESIS, V23, P1791, DOI 10.1093/carcin/23.11.1791; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	52	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53752	10.1371/journal.pone.0053752	http://dx.doi.org/10.1371/journal.pone.0053752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359326	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600021
J	Rodriguez-Rubio, L; Martinez, B; Donovan, DM; Garcia, P; Rodriguez, A				Rodriguez-Rubio, Lorena; Martinez, Beatriz; Donovan, David M.; Garcia, Pilar; Rodriguez, Ana			Potential of the Virion-Associated Peptidoglycan Hydrolase HydH5 and Its Derivative Fusion Proteins in Milk Biopreservation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LYTIC ACTIVITY; LISTERIA-MONOCYTOGENES; BIOCONTROL AGENTS; MAMMARY-GLANDS; ENTEROTOXIN-A; BOVINE-MILK; PHAGE-K; BACTERIOPHAGE; MASTITIS	Bacteriophage lytic enzymes have recently attracted considerable interest as novel antimicrobials against Gram-positive bacteria. In this work, antimicrobial activity in milk of HydH5 [a virion-associated peptidoglycan hydrolase (VAPGH) encoded by the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88], and three different fusion proteins created between HydH5 and lysostaphin has been assessed. The lytic activity of the five proteins (HydH5, HydH5Lyso, HydH5SH3b, CHAPSH3b and lysostaphin) was confirmed using commercial whole extended shelf-life milk (ESL) in challenge assays with 10(4) CFU/mL of the strain S. aureus Sa9. HydH5, HydH5Lyso and HydH5SH3b (3.5 mu M) kept the staphylococcal viable counts below the control cultures for 6 h at 37 degrees C. The effect is apparent just 15 minutes after the addition of the lytic enzyme. Of note, lysostaphin and CHAPSH3b showed the highest staphylolytic protection as they were able to eradicate the initial staphylococcal challenge immediately or 15 min after addition, respectively, at lower concentration (1 mu M) at 37 degrees C. CHAPSH3b showed the same antistaphyloccal effect at room temperature (1.65 mu M). No re-growth was observed for the remainder of the experiment (up to 6 h). CHAPSH3b activity (1.65 mu M) was also assayed in raw (whole and skim) and pasteurized (whole and skim) milk. Pasteurization of milk clearly enhanced CHAPSH3b staphylolytic activity in both whole and skim milk at both temperatures. This effect was most dramatic at room temperature as this protein was able to reduce S. aureus viable counts to undetectable levels immediately after addition with no re-growth detected for the duration of the experiment (360 min). Furthermore, CHAPSH3b protein is known to be heat tolerant and retained some lytic activity after pasteurization treatment and after storage at 4 degrees C for 3 days. These results might facilitate the use of the peptidoglycan hydrolase HydH5 and its derivative fusions, particularly CHAPSH3b, as biocontrol agents for controlling undesirable bacteria in dairy products.	[Rodriguez-Rubio, Lorena; Martinez, Beatriz; Garcia, Pilar; Rodriguez, Ana] CSIC, DairySafe Grp, Dept Technol & Biotechnol Dairy Prod, IPLA, Villaviciosa, Asturias, Spain; [Donovan, David M.] ARS, Anim Biosci & Biotechnol Lab, Anim & Nat Resources Inst, BARC,USDA, Beltsville, MD USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); United States Department of Agriculture (USDA)	Rodriguez, A (corresponding author), CSIC, DairySafe Grp, Dept Technol & Biotechnol Dairy Prod, IPLA, Villaviciosa, Asturias, Spain.	anarguez@ipla.csic.es	Suárez, Pilar García/H-2544-2012; Rodríguez, Ana/GQR-0554-2022; Garcia, Pilar/AAP-3768-2020; Rodriguez-Rubio, Lorena/D-2888-2017; Rodriguez, Ana/GLQ-7829-2022; Rodriguez, Ana/H-4846-2012; Martinez, Beatriz/H-2953-2012	Suárez, Pilar García/0000-0003-1213-8165; Garcia, Pilar/0000-0003-1213-8165; Rodriguez-Rubio, Lorena/0000-0002-7846-4791; Rodriguez, Ana/0000-0002-1577-9905; Rodriguez, Ana/0000-0002-1577-9905; Martinez, Beatriz/0000-0001-7692-1963	Ministerio de Ciencia e Innovacion, Spain [AGL2009-13144-C02-01, BFU2010-10469-E]; CSIC, Spain [PIE200970I090]; Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain [IB08-052, COF07-006]; National Institutes of Health [1RO1AI075077-01A1]; National Research Initiative [2007-35204-18395]; US State Dept funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075077] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC, Spain; Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Initiative(United States Department of Agriculture (USDA)); US State Dept funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants AGL2009-13144-C02-01 and BFU2010-10469-E (Ministerio de Ciencia e Innovacion, Spain), PIE200970I090 (CSIC, Spain), IB08-052 and COF07-006 (Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain), National Institutes of Health, grant 1RO1AI075077-01A1 (to DMD); National Research Initiative grant 2007-35204-18395 (to DMD) and US State Dept funds (to DMD). LR-R is a fellow of the Programa de Ciencia, Tecnologia e Investigacion (Principado de Asturias, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 152 IDF; ANUNCIACAO LLC, 1995, INT J FOOD MICROBIOL, V26, P259; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Becker SC, 2008, FEMS MICROBIOL LETT, V287, P185, DOI 10.1111/j.1574-6968.2008.01308.x; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Belay N, 2002, J FOOD PROTECT, V65, P199, DOI 10.4315/0362-028X-65.1.199; Bernard D, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P971; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643; Devlieghere F, 2004, J FOOD PROTECT, V67, P1977, DOI 10.4315/0362-028X-67.9.1977; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Fenton Mark, 2010, Bioeng Bugs, V1, P404, DOI 10.4161/bbug.1.6.13422; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Galvez A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI [10.1080/07388550802107202, 10.1080/07388550802107202 ]; Garcia P, 2009, J DAIRY SCI, V92, P3019, DOI 10.3168/jds.2008-1744; Garcia P, 2011, NATURAL ANTIMICROBIALS IN FOOD SAFETY AND QUALITY, P10, DOI 10.1079/9781845937690.0010; Garcia P, 2010, TRENDS FOOD SCI TECH, V21, P373, DOI 10.1016/j.tifs.2010.04.010; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; IDF, 1982, 4A IDF; International Dairy Federation (IDF), 1993, 20B IDF; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Korhonen H, 2000, BRIT J NUTR, V84, pS75; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Montville TJ, 2008, FOOD MICROBIOLOGY IN, P189; Mork T, 2005, J CLIN MICROBIOL, V43, P3979, DOI 10.1128/JCM.43.8.3979-3984.2005; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P274, DOI 10.1111/j.1472-765X.2005.01762.x; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Paul VD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-226; Rashel M, 2008, FEMS MICROBIOL LETT, V284, P9, DOI 10.1111/j.1574-6968.2008.01152.x; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138; Rodriguez-Rubio L, 2012, CRIT REV MICROBIOL, DOI [10.3109/1040841X.2012.723675, DOI 10.3109/1040841X.2012.723675)]; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P2241, DOI 10.1128/AEM.07621-11; Rosengren A, 2010, INT J FOOD MICROBIOL, V144, P263, DOI 10.1016/j.ijfoodmicro.2010.10.004; Schmelcher M, 2012, APPL ENVIRON MICROB, V78, P2297, DOI 10.1128/AEM.07050-11; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Takac M, 2005, ANTIMICROB AGENTS CH, V49, P2934, DOI 10.1128/AAC.49.7.2934-2940.2005; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Walstra P., 1984, DAIRY CHEM PHYS; Zhang H, 2012, FOOD MICROBIOL, V31, P133, DOI 10.1016/j.fm.2012.01.005	61	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54828	10.1371/journal.pone.0054828	http://dx.doi.org/10.1371/journal.pone.0054828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359813	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600117
J	Yoshimi, A; Sano, M; Inaba, A; Kokubun, Y; Fujioka, T; Mizutani, O; Hagiwara, D; Fujikawa, T; Nishimura, M; Yano, S; Kasahara, S; Shimizu, K; Yamaguchi, M; Kawakami, K; Abe, K				Yoshimi, Akira; Sano, Motoaki; Inaba, Azusa; Kokubun, Yuko; Fujioka, Tomonori; Mizutani, Osamu; Hagiwara, Daisuke; Fujikawa, Takashi; Nishimura, Marie; Yano, Shigekazu; Kasahara, Shin; Shimizu, Kiminori; Yamaguchi, Masashi; Kawakami, Kazuyoshi; Abe, Keietsu			Functional Analysis of the alpha-1,3-Glucan Synthase Genes agsA and agsB in Aspergillus nidulans: AgsB Is the Major alpha-1,3-Glucan Synthase in This Fungus	PLOS ONE			English	Article							FUMIGATUS CELL-WALL; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; HISTOPLASMA-CAPSULATUM; FISSION YEAST; EXPRESSION; VIRULENCE; NIGER; POLYSACCHARIDES; MORPHOGENESIS	Although alpha-1,3-glucan is one of the major cell wall polysaccharides in filamentous fungi, the physiological roles of alpha-1,3-glucan remain unclear. The model fungus Aspergillus nidulans possesses two alpha-1,3-glucan synthase (AGS) genes, agsA and agsB. For functional analysis of these genes, we constructed several mutant strains in A. nidulans: agsA disruption, agsB disruption, and double-disruption strains. We also constructed several CagsB strains in which agsB expression was controlled by the inducible alcA promoter, with or without the agsA-disrupting mutation. The agsA disruption strains did not show markedly different phenotypes from those of the wild-type strain. The agsB disruption strains formed dispersed hyphal cells under liquid culture conditions, regardless of the agsA genetic background. Dispersed hyphal cells were also observed in liquid culture of the CagsB strains when agsB expression was repressed, whereas these strains grew normally in plate culture even under the agsB-repressed conditions. Fractionation of the cell wall based on the alkali solubility of its components, quantification of sugars, and C-13-NMR spectroscopic analysis revealed that alpha-1,3-glucan was the main component of the alkali-soluble fraction in the wild-type and agsA disruption strains, but almost no alpha-1,3-glucan was found in the alkali-soluble fraction derived from either the agsB disruption strain or the CagsB strain under the agsB-repressed conditions, regardless of the agsA genetic background. Taken together, our data demonstrate that the two AGS genes are dispensable in A. nidulans, but that AgsB is required for normal growth characteristics under liquid culture conditions and is the major AGS in this species.	[Yoshimi, Akira; Abe, Keietsu] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan; [Sano, Motoaki] Kanazawa Inst Technol, Genome Biotechnol Lab, Kanazawa, Ishikawa, Japan; [Inaba, Azusa; Kokubun, Yuko; Abe, Keietsu] Tohoku Univ, Dept Microbial Biotechnol, Sendai, Miyagi, Japan; [Fujioka, Tomonori] Kumiai Chem Ind Co Ltd, Tokyo, Japan; [Mizutani, Osamu] Natl Res Inst Brewing, Higashihiroshima, Japan; [Hagiwara, Daisuke; Shimizu, Kiminori; Yamaguchi, Masashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Fujikawa, Takashi; Nishimura, Marie] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Yano, Shigekazu] Ritsumeikan Univ, Dept Biotechnol, Kusatsu, Japan; [Kasahara, Shin] Miyagi Univ, Dept Environm Sci, Sendai, Miyagi, Japan; [Kawakami, Kazuyoshi] Tohoku Univ, Natl Dept Med Microbiol, Sendai, Miyagi 980, Japan	Tohoku University; Kanazawa Institute of Technology; Tohoku University; Chiba University; National Institute of Agrobiological Sciences - Japan; Ritsumeikan University; Miyagi University; Tohoku University	Abe, K (corresponding author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan.	kabe@niche.tohoku.ac.jp	Hagiwara, Daisuke/A-3488-2016; Fujikawa, Takashi/V-8150-2019	Hagiwara, Daisuke/0000-0003-1382-3914; Fujikawa, Takashi/0000-0001-5659-0407; YOSHIMI, Akira/0000-0003-4331-2744; Mizutani, Osamu/0000-0001-5372-1782	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Science and Technology Agency (JST); Tohoku Bureau of Economy, Trade and Industry	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Tohoku Bureau of Economy, Trade and Industry	This study was supported in part by grants from the Bio-oriented Technology Research Advancement Institution (BRAIN), from the Japan Science and Technology Agency (JST), and from the Tohoku Bureau of Economy, Trade and Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Denning DW, 2002, J ANTIMICROB CHEMOTH, V49, P889, DOI 10.1093/jac/dkf045; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2010, FUNGAL GENET BIOL, V47, P707, DOI 10.1016/j.fgb.2010.04.006; Fujikawa T, 2009, MOL MICROBIOL, V73, P553, DOI 10.1111/j.1365-2958.2009.06786.x; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; Hochstenbach F, 1998, P NATL ACAD SCI USA, V95, P9161, DOI 10.1073/pnas.95.16.9161; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Izumitsu K, 2009, CURR GENET, V55, P439, DOI 10.1007/s00294-009-0257-7; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KANETSUNA F, 1974, MYCOPATH MYCOL APPL, V54, P1, DOI 10.1007/BF02055967; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Sugawara T, 2004, CARBOHYD RES, V339, P2255, DOI 10.1016/j.carres.2004.05.033; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Yamaguchi M., 2005, PLANT MORPHOL, V17, P57; Yamaguchi M, 2009, J ELECTRON MICROSC, V58, P261, DOI 10.1093/jmicro/dfp013; Yano S, 2006, BIOSCI BIOTECH BIOCH, V70, P1754, DOI 10.1271/bbb.60095	40	65	89	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54893	10.1371/journal.pone.0054893	http://dx.doi.org/10.1371/journal.pone.0054893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365684	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600131
J	Liu, LB; Chu, KK; Houser, GH; Diephuis, BJ; Li, Y; Wilsterman, EJ; Shastry, S; Dierksen, G; Birket, SE; Mazur, M; Byan-Parker, S; Grizzle, WE; Sorscher, EJ; Rowe, SM; Tearney, GJ				Liu, Linbo; Chu, Kengyeh K.; Houser, Grace H.; Diephuis, Bradford J.; Li, Yao; Wilsterman, Eric J.; Shastry, Suresh; Dierksen, Gregory; Birket, Susan E.; Mazur, Marina; Byan-Parker, Suzanne; Grizzle, William E.; Sorscher, Eric J.; Rowe, Steven M.; Tearney, Guillermo J.			Method for Quantitative Study of Airway Functional Microanatomy Using Micro-Optical Coherence Tomography	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; PERICILIARY LIQUID; MUCUS; SECRETION; TRANSPORT; CLEARANCE; TRACHEAL; STIMULATION; EPITHELIUM	We demonstrate the use of a high resolution form of optical coherence tomography, termed micro-OCT (mu OCT), for investigating the functional microanatomy of airway epithelia. mu OCT captures several key parameters governing the function of the airway surface (airway surface liquid depth, periciliary liquid depth, ciliary function including beat frequency, and mucociliary transport rate) from the same series of images and without exogenous particles or labels, enabling non-invasive study of dynamic phenomena. Additionally, the high resolution of mu OCT reveals distinguishable phases of the ciliary stroke pattern and glandular extrusion. Images and functional measurements from primary human bronchial epithelial cell cultures and excised tissue are presented and compared with measurements using existing gold standard methods. Active secretion from mucus glands in tissue, a key parameter of epithelial function, was also observed and quantified.	[Liu, Linbo; Chu, Kengyeh K.; Diephuis, Bradford J.; Wilsterman, Eric J.; Dierksen, Gregory; Tearney, Guillermo J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Liu, Linbo; Chu, Kengyeh K.; Wilsterman, Eric J.; Dierksen, Gregory] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Houser, Grace H.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Diephuis, Bradford J.; Tearney, Guillermo J.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Diephuis, Bradford J.] Harvard Univ, Sch Med, Boston, MA USA; [Li, Yao; Shastry, Suresh; Mazur, Marina; Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Birket, Susan E.; Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Byan-Parker, Suzanne; Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital	Rowe, SM (corresponding author), Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA.	smrowe@uab.edu; gtearney@partners.org	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253; Sorscher, Eric J./0000-0001-9341-3354	US National Institute of Health [P30 DK072482, R01 HL105487, R01 HL076398]; Cystic Fibrosis Foundation [R464-CF, SORSCH05XX0, ROWE10XX0, CLANCY09Y2, TEARNE07XX0]; Massachusetts General Hospital ECOR Postdoctoral fellowship [2011A052538]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116213, R01HL076398, R01HL105487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Massachusetts General Hospital ECOR Postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institute of Health (http://www.nih.gov/; Contracts P30 DK072482 to EJS, R01 HL105487 to SMR, and R01 HL076398 to GJT), Cystic Fibrosis Foundation (http://www.cff.org/; Contracts R464-CF and SORSCH05XX0 to EJS, ROWE10XX0 and CLANCY09Y2 to SMR, and TEARNE07XX0 to GJT), and Massachusetts General Hospital ECOR Postdoctoral fellowship (http://www.massgeneral.org/; Award 2011A052538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Ballard ST, 2002, AM J PHYSIOL-LUNG C, V283, pL329, DOI 10.1152/ajplung.00277.2001; Barnes PJ, 2004, NEW ENGL J MED, V350, P2635, DOI 10.1056/NEJMp048102; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Crews A, 2001, J APPL PHYSIOL, V91, P797, DOI 10.1152/jappl.2001.91.2.797; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; DIBENEDETTO G, 1991, J PHYSIOL-LONDON, V439, P103, DOI 10.1113/jphysiol.1991.sp018659; Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; FOSTER WM, 1980, J APPL PHYSIOL, V48, P965, DOI 10.1152/jappl.1980.48.6.965; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; Hayashi S, 2008, J CELL SCI, V121, P2833, DOI 10.1242/jcs.031195; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lansley AB, 1999, BIOPHYS J, V77, P629, DOI 10.1016/S0006-3495(99)76919-5; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Li DC, 2000, AM J RESP CELL MOL, V23, P175, DOI 10.1165/ajrcmb.23.2.4022; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Martens CJ, 2011, AM J PHYSIOL-LUNG C, V301, pL236, DOI 10.1152/ajplung.00388.2010; Martens CJ, 2010, AM J PHYSIOL-LUNG C, V298, pL270, DOI 10.1152/ajplung.00253.2009; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Michel RG, 2010, CHEST, V138, P984, DOI 10.1378/chest.10-0753; Oldenburg AL, 2012, BIOMED OPT EXPRESS, V3, P1978, DOI 10.1364/BOE.3.001978; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1981, J CELL SCI, V47, P331; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SLEIGH MA, 1989, COMP BIOCHEM PHYS A, V94, P359, DOI 10.1016/0300-9629(89)90559-8; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5	44	33	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54473	10.1371/journal.pone.0054473	http://dx.doi.org/10.1371/journal.pone.0054473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372732	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500077
J	Alvarado-Esquivel, C				Alvarado-Esquivel, Cosme			Toxocariasis in Waste Pickers: A Case Control Seroprevalence Study	PLOS ONE			English	Article							ZOONOTIC INFECTIONS; TOXOPLASMA-GONDII; RISK-FACTORS; SEROEPIDEMIOLOGY; EPIDEMIOLOGY; COMMUNITIES; CITY	Background: The epidemiology of Toxocara infection in humans in Mexico has been poorly explored. There is a lack of information about Toxocara infection in waste pickers. Aims: Determine the seroepidemiology of Toxocara infection in waste pickers. Methods: Through a case control study design, the presence of anti-Toxocara IgG antibodies was determined in 90 waste pickers and 90 age-and gender-matched controls using an enzyme-linked immunoassay. Associations of Toxocara exposure with socio-demographic, work, clinical, and behavioral data of the waste pickers were also evaluated. Results: The seroprevalence of anti-Toxocara IgG antibodies was significantly higher in waste pickers (12/90: 13%) than in control subjects (1/90: 1%) (OR = 14; 95% CI: 2-288). The seroprevalence was not influenced by socio-demographic or work characteristics. In contrast, increased seroprevalence was found in waste pickers suffering from gastritis, and reflex and visual impairments. Multivariate analysis showed that Toxocara exposure was associated with a low frequency of eating out of home (OR = 26; 95% CI: 2-363) and negatively associated with consumption of chicken meat (OR = 0.03; 95% CI: 0.003-0.59). Other behavioral characteristics such as animal contacts or exposure to soil were not associated with Toxocara seropositivity. Conclusions: 1) Waste pickers are a risk group for Toxocara infection. 2) Toxocara is impacting the health of waste pickers. This is the first report of Toxocara exposure in waste pickers and of associations of gastritis and reflex impairment with Toxocara seropositivity. Results warrant for further research.	Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico	Universidad Juarez del Estado de Durango	Alvarado-Esquivel, C (corresponding author), Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico.	alvaradocosme@yahoo.com			Universidad Juarez del Estado de Durango	Universidad Juarez del Estado de Durango	The study was financially supported by the Universidad Juarez del Estado de Durango. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OO, 2000, MEM I OSWALDO CRUZ, V95, P147, DOI 10.1590/S0074-02762000000200002; Alvarado-Esquivel C, 2008, ZOONOSES PUBLIC HLTH, V55, P306, DOI 10.1111/j.1863-2378.2008.01133.x; Alvarado-Esquivel C, 2011, J PARASITOL, V97, P40, DOI 10.1645/GE-2612.1; Cancrini G., 1998, Parassitologia (Rome), V40, P473; Chiodo P, 2006, MEM I OSWALDO CRUZ, V101, P397, DOI 10.1590/S0074-02762006000400009; Demirci M, 2010, IRAN J PARASITOL, V5, P52; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; El-Shazly Atef M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P731; Espinoza YA, 2010, REV INST MED TROP SP, V52, P31, DOI 10.1590/S0036-46652010000100005; Fillaux J, 2007, AM J TROP MED HYG, V76, P1144, DOI 10.4269/ajtmh.2007.76.1144; Finsterer Josef, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P279, DOI 10.1590/S0036-46652007000500002; Guillot J, 2007, B ACAD NAT MED PARIS, V191, P67, DOI 10.1016/S0001-4079(19)33116-4; Jimenez JF, 1997, AM J TROP MED HYG, V56, P113, DOI 10.4269/ajtmh.1997.56.113; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1, DOI 10.3347/kjp.2001.39.1.1; Malla N, 2002, NATL MED J INDIA, V15, P145; Messier V, 2012, ZOONOSES PUBLIC HLTH, V59, P107, DOI 10.1111/j.1863-2378.2011.01424.x; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P215, DOI 10.3109/10408419709115137; Park Hyun-Young, 2002, Korean Journal of Parasitology, V40, P113, DOI 10.3347/kjp.2002.40.3.113; Pelloux H, 2004, REV MED INTERNE, V25, P201, DOI 10.1016/S0248-8663(03)00258-3; Prestes-Carneiro LE, 2009, PARASITOLOGY, V136, P681, DOI 10.1017/S0031182009005769; Radman NE, 2000, MEM I OSWALDO CRUZ, V95, P281, DOI 10.1590/S0074-02762000000300001; Rai Shiba Kumar, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P286; Roldan WH, 2010, REV INST MED TROP SP, V52, P37, DOI 10.1590/S0036-46652010000100006; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Rubinsky-Elefant G, 2008, AM J TROP MED HYG, V79, P93, DOI 10.4269/ajtmh.2008.79.93; Sampasa-Kanyinga H, 2012, VECTOR-BORNE ZOONOT, V12, P473, DOI 10.1089/vbz.2011.0739; Sariego I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001382; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Stensvold CR, 2009, CLIN VACCINE IMMUNOL, V16, P1372, DOI 10.1128/CVI.00234-09; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552; Woodhall D, 2012, OPHTHALMOLO IN PRESS	31	15	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54897	10.1371/journal.pone.0054897	http://dx.doi.org/10.1371/journal.pone.0054897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349987	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100109
J	Cade, F; Cruzat, A; Paschalis, EI; Santo, LE; Pineda, R				Cade, Fabiano; Cruzat, Andrea; Paschalis, Eleftherios I.; Santo, Lilian Espirito; Pineda, Roberto			Analysis of Four Aberrometers for Evaluating Lower and Higher Order Aberrations	PLOS ONE			English	Article							FOURIER-TRANSFORMS; WAVE-ABERRATION; PUPIL LOCATION; ZERNIKE; EYE; PRINCIPLES; LADARWAVE; HISTORY; QUALITY; ERRORS	Purpose: To compare the measurements of lower and higher order aberrations (HOA) of 4 commonly used aberrometers. Setting: Massachusetts Eye & Ear Infirmary, Boston, USA. Design: Prospective, cross-sectional study, in a controlled, single-blinded fashion. Methods: Multiple readings were obtained in 42 eyes of 21 healthy volunteers, at a single visit, with each of the following aberrometers: Alcon LADARWave (R), Visx WaveScan (R), B & L Zywave (R), and Wavelight Allegro Analyzer (R). Results were compared and analyzed in regards to the lower and HOA, to the different wavefront sensing devices and software, Tscherning and Hartmann-Shack and between the Fourier and Zernike algorithms. Statistical analysis included Bland-Altman plots, Intraclass Correlation Coefficient (ICC), multiple comparison tests with Analysis of Variance and Kruskal-Wallis. Significant level was set to p<0.05 and alpha level correction was adjusted under the Bonferroni criteria. Results: Most measurements of all 4 aberrometers were comparable. However, statistically significant differences were found between the aberrometers in total HOA (tHOA), spherical aberration (SA), horizontal coma and astigmatism (2,2). LADARwave and Wavescan showed significant differences in tHOA (P<0.001, ICC = 0.549, LoA = 0.19 +/- 0.5) and in SA (P<0.001, ICC = 0.733, LoA = 0.16 +/- 0.37). Wavescan showed a significant difference compared to Zywave (p<0.001, ICC = 0.920, LoA = 0.09 +/- 0.13) in SA. Comparisons between Allegro Analyzer and Zywave demonstrated significant differences in both Horizontal Coma (3,1) (p < 0.001, ICC = 20.207, LoA = -0.15 +/- 0.48) and Astigmatism (2,2) (P = 0.003, ICC = -0.965, LoA = 0.2 +/- 2.5). Allegro Analyzer also differed from Wavescan in Horizontal Coma (3,1) (P < 0.001, ICC = 0.725, LoA = -0.07 +/- 0.25). Conclusions: Although some measurements were comparable predominately in the lower order aberrations, significant differences were found in the tHOA, SA, horizontal coma and astigmatism. Our analysis suggests that sensor design contributes to agreement in lower order aberrations, and Fourier and Zernike expansion might disagree in higher order aberrations. Therefore, comparison between aberrometers was generally possible with some exceptions in higher order measurements.	[Cade, Fabiano; Cruzat, Andrea; Paschalis, Eleftherios I.; Santo, Lilian Espirito; Pineda, Roberto] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Paschalis, EI (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA.	Eleftherios_paschalis@meei.harvard.edu	Paschalis, Eleftherios/AAO-4613-2020	Cruzat, Andrea/0000-0002-3724-7037; Paschalis, Eleftherios/0000-0002-4544-4452	Alcon	Alcon(Novartis)	Financial support: R.P. (Alcon), unrestricted grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2006, OPHTHALMOLOGY, V113, P191, DOI 10.1016/j.ophtha.2005.10.004; Awwad ST, 2006, J CATARACT REFR SURG, V32, P203, DOI 10.1016/j.jcrs.2005.08.058; Buhren J, 2009, J REFRACT SURG, V25, P559, DOI 10.3928/1081597X-20090610-01; Burakgazi AZ, 2006, J REFRACT SURG, V22, P898, DOI 10.3928/1081-597X-20061101-10; Burns SA, 2000, J REFRACT SURG, V16, pS566, DOI 10.3928/1081-597X-20000901-15; Carkeet A, 2003, INVEST OPHTH VIS SCI, V44, P3248, DOI 10.1167/iovs.02-1064; Cervino A, 2007, J REFRACT SURG, V23, P603, DOI 10.3928/1081-597X-20070601-12; Dai GM, 2006, J REFRACT SURG, V22, P943, DOI 10.3928/1081-597X-20061101-21; Dobos MJ, 2009, CLIN EXP OPTOM, V92, P238, DOI 10.1111/j.1444-0938.2009.00360.x; HOWLAND B, 1976, SCIENCE, V193, P580, DOI 10.1126/science.959814; Howland HC, 2000, J REFRACT SURG, V16, pS552; Klyce SD, 2004, J REFRACT SURG, V20, pS537; Knapp S, 2009, J REFRACT SURG, V25, P201, DOI 10.3928/1081597X-20090201-05; LAWRENCE GN, 1984, OPT LETT, V9, P267, DOI 10.1364/OL.9.000267; Liang CL, 2005, J CATARACT REFR SURG, V31, P2153, DOI 10.1016/j.jcrs.2005.04.040; Lombardo M, 2010, J CATARACT REFR SURG, V36, P313, DOI 10.1016/j.jcrs.2009.09.026; MacRae SM, 2001, AM J OPHTHALMOL, V132, P915, DOI 10.1016/S0002-9394(01)01319-8; Maeda N, 2009, CLIN EXP OPHTHALMOL, V37, P118, DOI 10.1111/j.1442-9071.2009.02005.x; Molebny VV, 2000, J REFRACT SURG, V16, pS572; Mrochen M, 2000, J REFRACT SURG, V16, pS570; Pepose JS, 2005, AM J OPHTHALMOL, V139, P335, DOI 10.1016/j.ajo.2004.11.010; Platt BC, 2001, J REFRACT SURG, V17, pS573; RODDIER F, 1991, APPL OPTICS, V30, P1325, DOI 10.1364/AO.30.001325; Rozema JJ, 2006, J CATARACT REFR SURG, V32, P33, DOI 10.1016/j.jcrs.2004.11.052; Rozema JJ, 2005, J CATARACT REFR SURG, V31, P1114, DOI 10.1016/j.jcrs.2004.11.051; Salmon TO, 2006, J CATARACT REFR SURG, V32, P2064, DOI 10.1016/j.jcrs.2006.07.022; Tabernero J, 2009, INVEST OPHTH VIS SCI, V50, P1964, DOI 10.1167/iovs.08-2111; Visser N, 2011, INVEST OPHTH VIS SCI, V52, P1302, DOI 10.1167/iovs.10-5841; WALSH G, 1984, J OPT SOC AM A, V1, P987, DOI 10.1364/JOSAA.1.000987; Yang YB, 2002, INVEST OPHTH VIS SCI, V43, P2508; Yoon G, 2008, J REFRACT SURG, V24, P582, DOI 10.3928/1081597X-20080601-06	31	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54990	10.1371/journal.pone.0054990	http://dx.doi.org/10.1371/journal.pone.0054990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349995	Green Submitted, gold, Green Published			2022-12-25	WOS:000314019100116
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Altered Protozoan and Bacterial Communities and Survival of Escherichia coli O157:H7 in Monensin-Treated Wastewater from a Dairy Lagoon	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; MYCOBACTERIUM-AVIUM; O157-H7 SURVIVAL; RUMEN; GROWTH; POPULATIONS; MILK; COWS; PARATUBERCULOSIS; DEGRADATION	Surviving predation is a fitness trait of Escherichia coli O157:H7 (EcO157) that provides ample time for the pathogen to be transported from reservoirs (e.g. dairies and feedlots) to farm produce grown in proximity. Ionophore dietary supplements that inhibit rumen protozoa may provide such a selective advantage for EcO157 to proliferate in lagoons as the pathogen is released along with the undigested supplement as manure washings. This study evaluated the fate of an outbreak strain of EcO157, protozoan and bacterial communities in wastewater treated with monensin. Although total protozoa and native bacteria were unaffected by monensin, the time for 90% decrease in EcO157 increased from 0.8 to 5.1 days. 18S and 16S rRNA gene sequencing of wastewater samples revealed that monensin eliminated almost all colpodean and oligohymenophorean ciliates, probably facilitating the extended survival of EcO157. Total protozoan numbers remained high in treated wastewater as monensin enriched 94% of protozoan sequences undetected with untreated wastewater. Monensin stimulated 30-fold increases in Cyrtohymena citrina, a spirotrichean ciliate, and also biflagellate bicosoecids and cercozoans. Sequences of gram-negative Proteobacteria increased from 1% to 46% with monensin, but gram-positive Firmicutes decreased from 93% to 46%. It is noteworthy that EcO157 numbers increased significantly (P<0.01) in Sonneborn medium containing monensin, probably due to monensin-inhibited growth of Vorticella microstoma (P<0.05), a ciliate isolated from wastewater. We conclude that dietary monensin inhibits ciliate protozoa that feed on EcO157. Feed supplements or other methods that enrich these protozoa in cattle manure could be a novel strategy to control the environmental dissemination of EcO157 from dairies to produce production environments.	[Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U.S. Department of Agriculture, Agricultural Research Service [5325-32000-005, 5325-42000-044]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the U.S. Department of Agriculture, Agricultural Research Service under CRIS projects 5325-32000-005 and 5325-42000-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; [Anonymous], 2010, THE JUDICIOUS USE OF; Artz RRE, 2002, FEMS MICROBIOL LETT, V216, P117, DOI 10.1016/S0378-1097(02)01002-9; Bach SJ, 2002, CAN VET J, V43, P718; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; Caracciolo AB, 2010, FEMS MICROBIOL ECOL, V71, P127, DOI 10.1111/j.1574-6941.2009.00787.x; Brumbaugh GW, 2004, CAN J VET RES, V68, P175; Burow LC, 2005, LETT APPL MICROBIOL, V40, P117, DOI 10.1111/j.1472-765X.2004.01642.x; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; DeWaal CS, 2009, OUTBREAK ALERT 2009; Dolliver HAS, 2008, J ENVIRON QUAL, V37, P1238, DOI 10.2134/jeq2007.0391; DONOHO AL, 1984, J ANIM SCI, V58, P1528, DOI 10.2527/jas1984.5861528x; Dorkov P, 2008, J INORG BIOCHEM, V102, P26, DOI 10.1016/j.jinorgbio.2007.06.033; Furtula V, 2010, POULTRY SCI, V89, P180, DOI 10.3382/ps.2009-00198; Gourabathini P, 2007, PHYTOPATHOLOGY, V97, pS141; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Grainger C, 2008, J DAIRY SCI, V91, P1159, DOI 10.3168/jds.2007-0319; Hernlem BJ, 2007, J ENVIRON MONITOR, V9, P1317, DOI 10.1039/b710512f; Herriott DE, 1998, J FOOD PROTECT, V61, P802, DOI 10.4315/0362-028X-61.7.802; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; Karnati SKR, 2009, J DAIRY SCI, V92, P3861, DOI 10.3168/jds.2008-1437; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Kisidayova S, 2009, FOLIA MICROBIOL, V54, P527, DOI 10.1007/s12223-009-0076-8; Kiss AK, 2009, EUR J PROTISTOL, V45, P121, DOI 10.1016/j.ejop.2008.08.002; Kohler B, 2000, MICROBIOL-UK, V146, P1085, DOI 10.1099/00221287-146-5-1085; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mandrell R. E., 2009, MICROBIAL SAFETY FRE, P5; Martin-Cereceda M, 2001, MICROBIOL RES, V156, P225, DOI 10.1078/0944-5013-00105; McGarvey JA, 2004, APPL ENVIRON MICROB, V70, P4267, DOI 10.1128/AEM.70.7.4267-4275.2004; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; NEWBOLD CJ, 1993, J APPL BACTERIOL, V75, P129, DOI 10.1111/j.1365-2672.1993.tb02757.x; NEWBOLD CJ, 1988, APPL ENVIRON MICROB, V54, P544, DOI 10.1128/AEM.54.2.544-547.1988; Newsome AL, 1998, APPL ENVIRON MICROB, V64, P1688; PETZEL JP, 1985, APPL ENVIRON MICROB, V49, P925, DOI 10.1128/AEM.49.4.925-933.1985; PHILLIPS JD, 1986, J APPL BACTERIOL, V60, P491, DOI 10.1111/j.1365-2672.1986.tb01088.x; Priya M, 2008, BIODEGRADATION, V19, P179, DOI 10.1007/s10532-007-9124-8; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2007, APPL ENVIRON MICROB, V73, P2191, DOI 10.1128/AEM.02213-06; Ravva SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017281; Ravva SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015671; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sassman SA, 2007, ENVIRON TOXICOL CHEM, V26, P1614, DOI 10.1897/07-073R.1; Shin EC, 2004, J APPL MICROBIOL, V97, P378, DOI 10.1111/j.1365-2672.2004.02304.x; Takahashi M, 2004, FEMS IMMUNOL MED MIC, V41, P219, DOI 10.1016/j.femsim.2004.03.010; USDA:APHIS:VS, 1994, ESCHERICHIA COLI O15, P88; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe N, 2008, J ENVIRON QUAL, V37, pS78, DOI 10.2134/jeq2007.0371; Weimer PJ, 2010, J DAIRY SCI, V93, P265, DOI 10.3168/jds.2009-2206; Weimer PJ, 2008, APPL MICROBIOL BIOT, V80, P135, DOI 10.1007/s00253-008-1528-9; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x; [No title captured]	61	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54782	10.1371/journal.pone.0054782	http://dx.doi.org/10.1371/journal.pone.0054782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349969	gold, Green Submitted, Green Published			2022-12-25	WOS:000314019100097
J	Coutinho, AE; Brown, JK; Yang, F; Brownstein, DG; Gray, M; Seckl, JR; Savill, JS; Chapman, KE				Coutinho, Agnes E.; Brown, Jeremy K.; Yang, Fu; Brownstein, David G.; Gray, Mohini; Seckl, Jonathan R.; Savill, John S.; Chapman, Karen E.			Mast Cells Express 11 beta-hydroxysteroid Dehydrogenase Type 1: A Role in Restraining Mast Cell Degranulation	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; IN-VIVO; GLUCOCORTICOIDS; INFLAMMATION; ACTIVATION; ARTHRITIS; MICE; 11-BETA-HSD1; HOMOLOGS; PROMOTES	Mast cells are key initiators of allergic, anaphylactic and inflammatory reactions, producing mediators that affect vascular permeability, angiogenesis and fibrosis. Glucocorticoid pharmacotherapy reduces mast cell number, maturation and activation but effects at physiological levels are unknown. Within cells, glucocorticoid concentration is modulated by the 11 beta-hydroxysteroid dehydrogenases ( 11 beta-HSDs). Here we show expression and activity of 11 beta-HSD1, but not 11 beta-HSD2, in mouse mast cells with 11 beta-HSD activity only in the keto-reductase direction, regenerating active glucocorticoids (cortisol, corticosterone) from inert substrates (cortisone, 11-dehydrocorticosterone). Mast cells from 11 beta-HSD1-deficient mice show ultrastructural evidence of increased activation, including piecemeal degranulation and have a reduced threshold for IgG immune complex-induced mast cell degranulation. Consistent with reduced intracellular glucocorticoid action in mast cells, levels of carboxypeptidase A3 mRNA, a glucocorticoid-inducible mast cell-specific transcript, are lower in peritoneal cells from 11 beta-HSD1-deficient than control mice. These findings suggest that 11 beta-HSD1-generated glucocorticoids may tonically restrain mast cell degranulation, potentially influencing allergic, anaphylactic and inflammatory responses.	[Coutinho, Agnes E.; Yang, Fu; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Res, Edinburgh, Midlothian, Scotland; [Coutinho, Agnes E.; Yang, Fu; Gray, Mohini; Savill, John S.] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Brownstein, David G.] Univ Edinburgh, Mouse Pathol Core Lab, Edinburgh, Midlothian, Scotland; [Brown, Jeremy K.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Chapman, KE (corresponding author), Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Res, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Seckl, Jonathan R/C-3555-2013	Chapman, Karen/0000-0001-7777-6817	MRC [86642]; Wellcome Trust [083184, 064497]; Moray Endowment fund (University of Edinburgh); Arthritis Research Campaign Clinician Scientist Fellowship; Cancer Research UK [20035] Funding Source: researchfish; Medical Research Council [G9900991, G0802069, G0700704B, G0800235, MR/K026992/1] Funding Source: researchfish; MRC [G9900991, G0802069, G0800235] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Moray Endowment fund (University of Edinburgh); Arthritis Research Campaign Clinician Scientist Fellowship(Versus Arthritis); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an MRC project grant (KEC, MG, JSS, JRS, grant number 86642) and 2 Wellcome Trust Programme grants (JRS and KEC, grant number 083184 and separately, JSS, grant number 064497). Funding was also provided by the Moray Endowment fund (University of Edinburgh). MG is supported by an Arthritis Research Campaign Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER SA, 1997, IMMUNOLOGY METHODS M; Brown JK, 2003, CLIN EXP ALLERGY, V33, P132, DOI 10.1046/j.1365-2222.2003.01571.x; Bruley C, 2006, ENDOCRINOLOGY, V147, P2879, DOI 10.1210/en.2005-1621; Bryndova J, 2004, SCAND J GASTROENTERO, V39, P549, DOI 10.1080/00365520410004659; Carter RN, 2009, J NEUROENDOCRINOL, V21, P879, DOI 10.1111/j.1365-2826.2009.01899.x; Chapman KE, 2008, NEUROCHEM RES, V33, P624, DOI 10.1007/s11064-007-9504-9; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Coutinho AE, 2012, ENDOCRINOLOGY, V153, P234, DOI 10.1210/en.2011-1398; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Eklund KK, 1997, J IMMUNOL, V158, P4373; Ergang P, 2010, MOL CELL ENDOCRINOL, V323, P155, DOI 10.1016/j.mce.2010.03.003; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Finotto S, 1997, J CLIN INVEST, V99, P1721, DOI 10.1172/JCI119336; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; Freeman L, 2005, BLOOD, V106, P2042, DOI 10.1182/blood-2005-01-0186; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Harbuz MS, 2003, ANN NY ACAD SCI, V992, P99, DOI 10.1111/j.1749-6632.2003.tb03141.x; HEIMAN AS, 1984, PROSTAGLANDINS, V27, P335, DOI 10.1016/0090-6980(84)90084-4; Kardon T, 2008, FEBS LETT, V582, P1809, DOI 10.1016/j.febslet.2008.04.045; Kinet JP, 2007, IMMUNOL REV, V217, P5, DOI 10.1111/j.1600-065X.2007.00528.x; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; MOISAN MP, 1992, MOL ENDOCRINOL, V6, P1082, DOI 10.1210/me.6.7.1082; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Peixoto RADS, 2008, ENDOCRINOLOGY, V149, P1861, DOI 10.1210/en.2007-1028; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; Pemberton AD, 2006, PROTEOMICS, V6, P623, DOI 10.1002/pmic.200500211; PESCI A, 1993, AM REV RESPIR DIS, V147, P684, DOI 10.1164/ajrccm/147.3.684; Rider LG, 1996, J IMMUNOL, V157, P2374; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Yau JLW, 2007, J NEUROSCI, V27, P10487, DOI 10.1523/JNEUROSCI.2190-07.2007; Zbankova S, 2007, J GASTROEN HEPATOL, V22, P1019, DOI 10.1111/j.1440-1746.2006.04529.x; Zhang TY, 2005, J IMMUNOL, V174, P879, DOI 10.4049/jimmunol.174.2.879	36	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54640	10.1371/journal.pone.0054640	http://dx.doi.org/10.1371/journal.pone.0054640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349944	Green Submitted, Green Published, gold			2022-12-25	WOS:000313872800067
J	Stone, RC; Du, PC; Feng, D; Dhawan, K; Ronnblom, L; Eloranta, ML; Donnelly, R; Barnes, BJ				Stone, Rivka C.; Du, Peicheng; Feng, Di; Dhawan, Kopal; Ronnblom, Lars; Eloranta, Maija-Leena; Donnelly, Robert; Barnes, Betsy J.			RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON REGULATORY FACTOR; GREEN FLUORESCENT PROTEIN; GENETIC-VARIANTS; RISK HAPLOTYPE; DISEASE; ACTIVATION; ALPHA; ASSOCIATION; INTERFERON-REGULATORY-FACTOR-5	Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype.	[Stone, Rivka C.; Feng, Di; Barnes, Betsy J.] UMDNJ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Stone, Rivka C.; Feng, Di; Barnes, Betsy J.] UMDNJ, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ USA; [Du, Peicheng] UMDNJ, Dept Informat Syst & Technol, Newark, NJ USA; [Dhawan, Kopal; Donnelly, Robert] UMDNJ, New Jersey Med Sch, Mol Resource Facil, Newark, NJ USA; [Ronnblom, Lars; Eloranta, Maija-Leena] Uppsala Univ, Rheumatol Sect, Dept Med Sci, Uppsala, Sweden	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Uppsala University	Barnes, BJ (corresponding author), UMDNJ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA.	barnesbe@umdnj.edu		Stone, Rivka C./0000-0002-7489-2123	National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [5R03AR054070]; Arthritis Foundation; Swedish Research Council; Swedish Rheumatism Association; Torsten and Ragnar Soderberg Foundation; King Gustaf V 80-year Foundation Combine; Alliance for Lupus Research; King Gustaf V 80-year Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054070] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Torsten and Ragnar Soderberg Foundation; King Gustaf V 80-year Foundation Combine; Alliance for Lupus Research; King Gustaf V 80-year Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; 5R03AR054070), the Arthritis Foundation and the Alliance for Lupus Research (to BJB), the Swedish Research Council, the Swedish Rheumatism Association, the Torsten and Ragnar Soderberg Foundation, the King Gustaf V 80-year Foundation and Combine, the Alliance for Lupus Research (to LR), and the King Gustaf V 80-year Foundation (to MLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3343; Aringer M, 2003, ARTHRITIS RES THER, V5, P172, DOI 10.1186/ar770; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Jiang X, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r81; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauwerys BR, 2002, LUPUS, V11, P384, DOI 10.1191/0961203302lu213oa; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niewold TB, 2007, GENES IMMUN, V56, P3995; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rullo OJ, 2010, ANN RHEUM DIS, V69, P611, DOI 10.1136/ard.2009.118315; Sambrook J, 2001, MOL CLONING LAB MANU, P1169; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shen H, 2010, J MOL CELL BIOL, V2, P284, DOI 10.1093/jmcb/mjq023; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Stone RC, 2012, ARTHRITIS RHEUM-US, V64, P788, DOI 10.1002/art.33395; Tada Y, 2011, ARTHRITIS RHEUM-US, V63, P738, DOI 10.1002/art.30183; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wen F, 2011, AUTOIMMUNITY, V44, P82, DOI 10.3109/08916934.2010.491842; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876	65	37	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54487	10.1371/journal.pone.0054487	http://dx.doi.org/10.1371/journal.pone.0054487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349905	Green Published, gold			2022-12-25	WOS:000313872800058
J	Zorzi, F; Monteleone, I; Sarra, M; Calabrese, E; Marafini, I; Cretella, M; Sedda, S; Biancone, L; Pallone, F; Monteleone, G				Zorzi, Francesca; Monteleone, Ivan; Sarra, Massimiliano; Calabrese, Emma; Marafini, Irene; Cretella, Micaela; Sedda, Silvia; Biancone, Livia; Pallone, Francesco; Monteleone, Giovanni			Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; TGF-BETA; CELLS; INTERLEUKIN-12; SMAD7; GAMMA; RECURRENCE; TGF-BETA-1	Objective: Crohn's Disease (CD)-associated inflammation is supposed to be driven by T helper (Th)1/Th17 cell-derived cytokines, even though there is evidence that the mucosal profile of cytokine may vary with the evolution of the disease. We aimed at comparing the pattern of effector cytokines in early and established lesions of CD. Design: Mucosal samples were taken from the neo-terminal ileum of CD patients undergoing ileocolonic resection, with (early lesions) or without post-operative recurrence, and terminal ileum of CD patients with long-standing disease undergoing intestinal resection (established lesions). Inflammatory cell infiltrate was examined by immunofluorescence and cytokine expression was analysed by real-time PCR, flow-cytometry and ELISA. Results: Before the appearance of endoscopic lesions, the mucosa of the neo-terminal ileum contained high number of T cells and macrophages, elevated levels of Th1-related cytokines and TNF-alpha and slightly increased IL-17A expression. Transition from this stage to endoscopic recurrence was marked by abundance of Th1 cytokines, marked increase in IL-17A, and induction of IL-6 and IL-23, two cytokines involved in the control of Th17 cell responses. In samples with established lesions, there was a mixed Th1/Th17 response with no TNF-alpha induction. Expression of IL-4 and IL-5 was up-regulated in both early and established lesions even though the fraction of IL-4-producing cells was lower than that of cells producing either interferon-gamma or IL-17A. Conclusions: Distinct mucosal profiles of cytokines are produced during the different phases of CD. A better understanding of the cytokines temporally regulated in CD tissue could help optimize therapeutic interventions in CD.	[Zorzi, Francesca; Monteleone, Ivan; Sarra, Massimiliano; Calabrese, Emma; Marafini, Irene; Cretella, Micaela; Sedda, Silvia; Biancone, Livia; Pallone, Francesco; Monteleone, Giovanni] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	University of Rome Tor Vergata	Monteleone, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	Gi.monteleone@med.uniroma2.it	Monteleone, Giovanni/AAE-1418-2021; Monteleone, Ivan/AEW-2892-2022; Calabrese, Emma/AHD-4752-2022	Monteleone, Ivan/0000-0002-3212-832X	"Fondazione Umberto Di MarioOnlus'' (Rome, Italy); Giuliani SpA, Milan, Italy	"Fondazione Umberto Di MarioOnlus'' (Rome, Italy); Giuliani SpA, Milan, Italy	This work was supported by "Fondazione Umberto Di MarioOnlus'' (Rome, Italy) and Giuliani SpA, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors state that this work was supported by "Fondazione Umberto Di Mario Onlus'' (Rome, Italy) and Giuliani SpA, Milan, Italy. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Biank V, 2007, INFLAMM BOWEL DIS, V13, P1430, DOI 10.1002/ibd.20213; Desreumaux P, 1997, GASTROENTEROLOGY, V113, P118, DOI 10.1016/S0016-5085(97)70116-1; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; McLeod RS, 1997, GASTROENTEROLOGY, V113, P1823, DOI 10.1016/S0016-5085(97)70001-5; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 1999, J IMMUNOL, V163, P143; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Monteleone G, 1998, GUT, V43, P620, DOI 10.1136/gut.43.5.620; Monteleone G, 2010, CLIN SCI, V118, P707, DOI 10.1042/CS20100027; Monteleone I, 2011, ANN MED, V43, P172, DOI 10.3109/07853890.2010.531758; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; OLAISON G, 1992, GUT, V33, P331, DOI 10.1136/gut.33.3.331; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reinisch W, 2012, INFLAMM BOWEL DIS, V16, P233; Renna S, 2008, GASTROENTEROLOGY, V135, P1500, DOI 10.1053/j.gastro.2008.07.066; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	37	67	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54562	10.1371/journal.pone.0054562	http://dx.doi.org/10.1371/journal.pone.0054562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349929	gold, Green Submitted, Green Published			2022-12-25	WOS:000313738900078
J	Honsa, ES; Owens, CP; Goulding, CW; Maresso, AW				Honsa, Erin S.; Owens, Cedric P.; Goulding, Celia W.; Maresso, Anthony W.			The Near-iron Transporter (NEAT) Domains of the Anthrax Hemophore IsdX2 Require a Critical Glutamine to Extract Heme from Methemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS VACCINE; HEMOGLOBIN RECEPTOR; STRUCTURAL BASIS; SURFACE PROTEIN; ACQUISITION; DETERMINANT; BINDING; SYSTEM; IMMUNOGENICITY; STREPTOCOCCUS	Several Gram-positive pathogenic bacteria employ near-iron transporter (NEAT) domains to acquire heme from hemoglobin during infection. However, the structural requirements and mechanism of action for NEAT-mediated heme extraction remains unknown. Bacillus anthracis exhibits a rapid growth rate during systemic infection, suggesting that the bacterium expresses efficient iron acquisition systems. To understand how B. anthracis acquires iron from heme sources, which account for 80% of mammalian iron stores, we investigated the properties of the five-NEAT domain hemophore IsdX2. Using a combination of bioinformatics and site-directed mutagenesis, we determined that the heme extraction properties of IsdX2 are dependent on an amino acid with an amide side chain within the 3(10)-helix of the NEAT domain. Additionally, we used a spectroscopic analysis to show that IsdX2 NEAT domains only scavenge heme from methemoglobin (metHb) and that autoxidation of oxyhemoglobin to metHb must occur prior to extraction. We also report the crystal structures of NEAT5 wild type and a Q29T mutant and present surface plasmon resonance data that indicate that the loss of this amide side chain reduces the affinity of the NEAT domain for metHb. We propose a model whereby the amide side chain is first required to drive an interaction with metHb that destabilizes heme, which is subsequently extracted and coordinated in the aliphatic heme-binding environment of the NEAT domain. Because an amino acid with an amide side chain in this position is observed in NEAT domains of several genera of Gram-positive pathogenic bacteria, these results suggest that specific targeting of this or nearby residues may be an entry point for inhibitor development aimed at blocking bacterial iron acquisition during infection.	[Honsa, Erin S.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Owens, Cedric P.; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol, Irvine, CA 92617 USA; [Owens, Cedric P.; Goulding, Celia W.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92617 USA	Baylor College of Medicine; University of California System; University of California Irvine; University of California System; University of California Irvine	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.edu		Owens, Cedric/0000-0002-8102-8181	National Institutes of Health [AI097167, AI069697, AI081161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161, R01AI097167, F32AI069697, R21AI096314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI097167 and AI069697 (to A. W. M.) and AI081161 (to C. W. G.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Crosa JH., 2004, IRON TRANSPORT BACTE; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Harro CD, 2012, VACCINE, V30, P1729, DOI 10.1016/j.vaccine.2011.12.045; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; HILLIER J, 1953, J CELL COMPAR PHYSL, V42, P203, DOI 10.1002/jcp.1030420205; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lei Benfang, 2010, World J Biol Chem, V1, P286, DOI 10.4331/wjbc.v1.i9.286; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Murphy M., 2006, CURR PROTOC PROTEIN; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Tsuruga M, 1997, BBA-PROTEIN STRUCT M, V1337, P96, DOI 10.1016/S0167-4838(96)00156-2; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	56	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8479	8490		10.1074/jbc.M112.430009	http://dx.doi.org/10.1074/jbc.M112.430009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364793	Green Published, hybrid			2022-12-25	WOS:000316564500045
J	Reidy, T; Rittenberg, A; Dwyer, M; D'Ortona, S; Pier, G; Gadjeva, M				Reidy, Thomas; Rittenberg, Alexander; Dwyer, Markryan; D'Ortona, Samantha; Pier, Gerald; Gadjeva, Mihaela			Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURE; INTERNALIZATION; PATHOGENESIS; EXPRESSION; ARTHRITIS; COMPONENT; CYTOKINE	A cute inflammation that arises during Pseudomonas aeruginosa- induced ocular infection can trigger tissue damage resulting in long term impairment of visual function, suggesting that the appropriate treatment strategy should include the use of anti-inflammatory agents in addition to antibiotics. We recently identified a potential target for modulation during ocular infection, macrophage migration inhibitory factor (MIF). MIF deficiency protected mice from inflammatory-mediated corneal damage resulting from acute bacterial keratitis. To gain a better understanding of the molecular mechanisms of MIF activity, we analyzed the oligomeric states and functional properties of MIF during infection. We found that in human primary corneal cells infected with P. aeruginosa, MIF is primarily in a homotrimeric state. Homotrimeric MIF levels correlated with the severity of infection in the corneas of infected mice, suggesting that the MIF homotrimers were the functionally active form of MIF. During infection, human primary corneal cells released more IL-8 when treated with recombinant, locked MIF trimers than when treated with lower MIF oligomers. MIF promoted P. aeruginosa-induced IL-8 responses via the formation of caveolin-1-rich "signaling hubs" in the corneal cells that led to elevated MAPKp42/p44 activation and sustained inflammatory signaling. These findings suggest that inhibiting homotrimerization of MIF or the functional activities of MIF homotrimers could have therapeutic benefits during ocular inflammation.	[Reidy, Thomas; Rittenberg, Alexander; Dwyer, Markryan; D'Ortona, Samantha; Pier, Gerald; Gadjeva, Mihaela] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gadjeva, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis,Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	mgadjeva@rics.bwh.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331	National Eye Institute [1R21EY019944, R01 EY022054, R01EY016144]; NATIONAL EYE INSTITUTE [R01EY016144, R21EY019944, R01EY022054] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute Grants 1R21EY019944 (to M.G.), R01 EY022054 (to M.G.), and R01EY016144 (to G.P.).	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 1995, BIOTHERAPY, V8, P123, DOI 10.1007/BF01878495; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brown FG, 2002, J AM SOC NEPHROL, V13, pS7; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1996, J INFLAMM, V47, P39; Cherepkova O, 2005, NEUROCHEM RES, V30, P151, DOI 10.1007/s11064-004-9696-1; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Evans DJ, 2002, FEMS MICROBIOL LETT, V213, P73, DOI 10.1016/S0378-1097(02)00784-X; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jorgensen WL, 2011, BIOORG MED CHEM LETT, V21, P4545, DOI 10.1016/j.bmcl.2011.05.127; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; McClellan SA, 2006, OCUL IMMUNOL INFLAMM, V14, P21, DOI 10.1080/09273940500545650; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Potolicchio I, 2003, J BIOL CHEM, V278, P30889, DOI 10.1074/jbc.M302854200; PRESTON MJ, 1995, INFECT IMMUN, V63, P3497, DOI 10.1128/IAI.63.9.3497-3501.1995; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Srinivasan M, 2012, ARCH OPHTHALMOL-CHIC, V130, P143, DOI 10.1001/archophthalmol.2011.315; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun HW, 1996, PROTEIN ENG, V9, P631, DOI 10.1093/protein/9.8.631; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Thakur A, 2001, CLIN EXP OPHTHALMOL, V29, P179, DOI 10.1046/j.1442-9071.2001.00405.x; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zaidi T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00058; Zaidi TS, 1999, INFECT IMMUN, V67, P1481, DOI 10.1128/IAI.67.3.1481-1492.1999	46	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8269	8278		10.1074/jbc.M112.351064	http://dx.doi.org/10.1074/jbc.M112.351064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372160	hybrid, Green Published			2022-12-25	WOS:000316564500027
J	Kimani, J; McKinnon, LR; Wachihi, C; Kusimba, J; Gakii, G; Birir, S; Muthui, M; Kariri, A; Muriuki, FK; Muraguri, N; Musyoki, H; Ball, TB; Kaul, R; Gelmon, L				Kimani, Joshua; McKinnon, Lyle R.; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Birir, Sarah; Muthui, Mercy; Kariri, Anthony; Muriuki, Festus K.; Muraguri, Nicholas; Musyoki, Helgar; Ball, T. Blake; Kaul, Rupert; Gelmon, Lawrence			Enumeration of Sex Workers in the Central Business District of Nairobi, Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANS-AFRICA HIGHWAY; HIV TRANSMISSION; FEMALE; PREVENTION; UGANDA	Accurate program planning for populations most at risk for HIV/STI acquisition requires knowledge of the size and location where these populations can best be reached. To obtain this information for sex workers operating at 137 hotspots in the central business district (CBD) in Nairobi, Kenya, we utilized a combined mapping and capture-recapture enumeration exercise. The majority of identified hotspots in this study were bars. Based on this exercise, we estimate that 6,904 male and female sex workers (95% confidence intervals, 6690 and 7118) were working nightly in the Nairobi CBD in April 2009. Wide ranges of captures per spot were obtained, suggesting that relatively few hot spots (18%) contain a relatively high proportion of the area's sex workers (65%). We provide geographic data including relatively short distances from hotspots to our dedicated sex worker outreach program in the CBD (mean<1 km), and clustering of hotspots within a relatively small area. Given the size covered and areas where sex work is likely taking place in Nairobi, the estimate is several times lower than what would be obtained if the entire metropolitan area was enumerated. These results have important practical and policy implications for enhancing HIV/STI prevention efforts.	[Kimani, Joshua; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Kariri, Anthony; Muriuki, Festus K.; Ball, T. Blake; Gelmon, Lawrence] Univ Manitoba, Kenya AIDS Control Project, Nairobi, Kenya; [Kimani, Joshua; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Kariri, Anthony; Muriuki, Festus K.; Ball, T. Blake; Gelmon, Lawrence] Univ Nairobi, Kenya AIDS Control Project, Nairobi, Kenya; [Kimani, Joshua; McKinnon, Lyle R.; Ball, T. Blake; Kaul, Rupert; Gelmon, Lawrence] Univ Nairobi, Nairobi, Kenya; [McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Toronto, ON, Canada; [Birir, Sarah; Muraguri, Nicholas; Musyoki, Helgar] CDC, Global AIDS Program, Nairobi, Kenya; [Muthui, Mercy] Minist Publ Hlth & Sanitat, Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Ball, T. Blake] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Nairobi; University of Nairobi; University of Toronto; Public Health Agency of Canada	Kimani, J (corresponding author), Univ Manitoba, Kenya AIDS Control Project, Nairobi, Kenya.	jkimani@csrtkenya.org		McKinnon, Lyle/0000-0002-7157-0700; Kaul, Rupert/0000-0002-1586-4093	Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR)	Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR)	This enumeration was made possible by a grant from the Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR). The funders had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. The funders participated in the study design since this was a part of HIV prevention programming.	[Anonymous], 2003, UNAID WHO EST SIZ PO; [Anonymous], 2000, APNSW STAT MAK SEX W; [Anonymous], 2005, MAP REPORT SEX WORK; [Anonymous], 2009, HIV AIDS SITUATIONAL; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Family Health International, 2002, MAPP CENS FEM SEX WO; Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; Morse T, 2001, AM J IND MED, V39, P636, DOI 10.1002/ajim.1063; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; Rollinson SW, 2004, ESTIMATING POPULATIO; *UNAIDS WHO WORK G, 2003, EST SIZ POP RISK HIV; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Wariki WM, COCHRANE DATABASE SY, V2	17	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54354	10.1371/journal.pone.0054354	http://dx.doi.org/10.1371/journal.pone.0054354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372713	Green Published, gold			2022-12-25	WOS:000315210400012
J	Brennan, GP; Jimenez-Mateos, EM; McKiernan, RC; Engel, T; Tzivion, G; Henshall, DC				Brennan, Gary P.; Jimenez-Mateos, Eva M.; McKiernan, Ross C.; Engel, Tobias; Tzivion, Guri; Henshall, David C.			Transgenic Overexpression of 14-3-3 Zeta Protects Hippocampus against Endoplasmic Reticulum Stress and Status Epilepticus In Vivo	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INDUCED NEURONAL DEATH; EXPERIMENTALLY EVOKED SEIZURES; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; ER STRESS; MISFOLDED PROTEINS; CELL-DEATH; APOPTOSIS; MICE	14-3-3 proteins are ubiquitous molecular chaperones that are abundantly expressed in the brain where they regulate cell functions including metabolism, the cell cycle and apoptosis. Brain levels of several 14-3-3 isoforms are altered in diseases of the nervous system, including epilepsy. The 14-3-3 zeta (zeta) isoform has been linked to endoplasmic reticulum (ER) function in neurons, with reduced levels provoking ER stress and increasing vulnerability to excitotoxic injury. Here we report that transgenic overexpression of 14-3-3 zeta in mice results in selective changes to the unfolded protein response pathway in the hippocampus, including down-regulation of glucose-regulated proteins 78 and 94, activating transcription factors 4 and 6, and Xbp1 splicing. No differences were found between wild-type mice and transgenic mice for levels of other 14-3-3 isoforms or various other 14-3-3 binding proteins. 14-3-3 zeta overexpressing mice were potently protected against cell death caused by intracerebroventricular injection of the ER stressor tunicamycin. 14-3-3 zeta overexpressing mice were also potently protected against neuronal death caused by prolonged seizures. These studies demonstrate that increased 14-3-3 zeta levels protect against ER stress and seizure-damage despite down-regulation of the unfolded protein response. Delivery of 14-3-3 zeta may protect against pathologic changes resulting from prolonged or repeated seizures or where injuries provoke ER stress.	[Brennan, Gary P.; Jimenez-Mateos, Eva M.; McKiernan, Ross C.; Engel, Tobias; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Tzivion, Guri] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Royal College of Surgeons - Ireland; University of Mississippi; University of Mississippi Medical Center	Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Jimenez-Mateos, Eva/AAG-8072-2019; Brennan, Gary/K-4009-2019	Brennan, Gary/0000-0002-4262-0481; Engel, Tobias/0000-0001-9137-0637; Jimenez-Mateos, Eva/0000-0001-6417-6580; Henshall, David/0000-0001-6237-9632	Science Foundation Ireland [08/IN.1/B1875, 08/RFP/1745]; Health Research Board award [HRA-POR/2011/41]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board award	This study was funded by Science Foundation Ireland awards 08/IN.1/B1875 and 08/RFP/1745 and by Health Research Board award HRA-POR/2011/41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Concannon CG, 2008, J NEUROCHEM, V105, P891, DOI 10.1111/j.1471-4159.2007.05187.x; Dunleavy M, 2010, AM J PATHOL, V176, P330, DOI 10.2353/ajpath.2010.090119; Engel T, 2012, FASEB J, V26, P1616, DOI 10.1096/fj.11-196089; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Engel T, 2010, J NEUROCHEM, V115, P92, DOI 10.1111/j.1471-4159.2010.06909.x; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Fujikawa DG, 2006, STATUS EPILEPTICUS M, V36, P463; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Henshall DC, 2002, J NEUROSCI, V22, P8458; Henshall DC, 2012, JASPERS BASIC MECH E, P262; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Lin JH, 2007, ANN REV PATHOL; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu GL, 2012, NEUROL SCI; Liu GL, 2011, BRAIN RES BULL, V84, P94, DOI 10.1016/j.brainresbull.2010.10.004; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Maruo K, 2003, BRAIN RES, V977, P294, DOI 10.1016/S0006-8993(03)02838-5; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Murphy N, 2008, BIOMARKERS, V13, P377, DOI 10.1080/13547500802027971 ; Murphy N, 2008, J NEUROCHEM, V106, P978, DOI 10.1111/j.1471-4159.2008.05447.x; Nellist M, 2002, J BIOL CHEM, V277, P39417, DOI 10.1074/jbc.M204802200; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Olney J W, 1986, Adv Neurol, V44, P857; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Ramser EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013462; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tanaka K, 2010, EPILEPSY RES, V88, P151, DOI 10.1016/j.eplepsyres.2009.10.012; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Umahara T, 2011, BRAIN RES, V1410, P1, DOI 10.1016/j.brainres.2011.06.036; van der Brug MP, 2002, BRAIN RES, V956, P110, DOI 10.1016/S0006-8993(02)03487-X; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; WANG S, 1993, NEUROCHEM INT, V23, P575, DOI 10.1016/0197-0186(93)90106-F; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	55	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54491	10.1371/journal.pone.0054491	http://dx.doi.org/10.1371/journal.pone.0054491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359526	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600061
J	Galic, N; Hengeveld, GM; Van den Brink, PJ; Schmolke, A; Thorbek, P; Bruns, E; Baveco, HM				Galic, Nika; Hengeveld, Geerten M.; Van den Brink, Paul J.; Schmolke, Amelie; Thorbek, Pernille; Bruns, Eric; Baveco, Hans M.			Persistence of Aquatic Insects across Managed Landscapes: Effects of Landscape Permeability on Re-Colonization and Population Recovery	PLOS ONE			English	Article							MIDGE CHIRONOMUS-RIPARIUS; FRESH-WATER BIODIVERSITY; CORRELATED RANDOM-WALKS; DIPTERA-CHIRONOMIDAE; DISPERSAL STRATEGIES; PATCHY LANDSCAPES; FOOD AVAILABILITY; MODELING APPROACH; SPATIAL DYNAMICS; STREAM INSECTS	Human practices in managed landscapes may often adversely affect aquatic biota, such as aquatic insects. Dispersal is often the limiting factor for successful re-colonization and recovery of stressed habitats. Therefore, in this study, we evaluated the effects of landscape permeability, assuming a combination of riparian vegetation (edge permeability) and other vegetation (landscape matrix permeability), and distance between waterbodies on the colonization and recovery potential of weakly flying insects. For this purpose, we developed two models, a movement and a population model of the non-biting midge, Chironomus riparius, an aquatic insect with weak flying abilities. With the movement model we predicted the outcome of dispersal in a landscape with several linear water bodies (ditches) under different assumptions regarding landscape-dependent movement. Output from the movement model constituted the probabilities of encountering another ditch and of staying in the natal ditch or perishing in the landscape matrix, and was used in the second model. With this individual-based model of midge populations, we assessed the implications for population persistence and for recovery potential after an extreme stress event. We showed that a combination of landscape attributes from the movement model determines the fate of dispersing individuals and, once extrapolated to the population level, has a big impact on the persistence and recovery of populations. Population persistence benefited from low edge permeability as it reduced the dispersal mortality which was the main factor determining population persistence and viability. However, population recovery benefited from higher edge permeability, but this was conditional on the low effective distance that ensured fewer losses in the landscape matrix. We discuss these findings with respect to possible landscape management scenarios.	[Galic, Nika; Van den Brink, Paul J.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [Hengeveld, Geerten M.; Van den Brink, Paul J.; Baveco, Hans M.] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [Hengeveld, Geerten M.] NIOO KNAW, Workgrp Movement Ecol, Netherlands Inst Ecol, Wageningen, Netherlands; [Schmolke, Amelie] UFZ, Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Thorbek, Pernille] Syngenta Ltd, Bracknell, Berks, England; [Bruns, Eric] Bayer CropSci, Monheim, Germany	Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Syngenta; Bayer AG; Bayer CropScience	Galic, N (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	ngalic@gmail.com	van den brink, Paul/AAT-7144-2020; van den Brink, Paul J/E-8315-2013; Thorbek, Pernille/HGV-0078-2022; Hengeveld, Geerten/O-8943-2019; Schmolke, Amelie/AAX-1810-2021; KNAW, NIOO-KNAW/A-4320-2012	van den brink, Paul/0000-0002-7241-4347; KNAW, NIOO-KNAW/0000-0002-3835-159X; Galic, Nika/0000-0002-4344-3464; Schmolke, Amelie/0000-0002-8114-7287; Hengeveld, Geerten/0000-0002-9592-3080	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Wageningen University and Research centre; Syngenta LtD.; Bayer CropScience	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Wageningen University and Research centre; Syngenta LtD.; Bayer CropScience(Bayer AG)	This study was supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation, Wageningen University and Research centre, Syngenta LtD. and Bayer CropScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2007, AM NAT, V170, P819, DOI 10.1086/522837; Armitage P.D., 1995, THE CHIRONOMIDAE; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; BERG M, 1992, AQUATIC ECOLOGY, V26, P471; Best D. J., 1979, J R STAT SOC C, V28, P152, DOI DOI 10.2307/2346732); Blakely TJ, 2006, FRESHWATER BIOL, V51, P1634, DOI 10.1111/j.1365-2427.2006.01601.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bond N. R., 2003, Ecological Management & Restoration, V4, P193, DOI 10.1046/j.1442-8903.2003.00156.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Briers RA, 2004, HYDROL EARTH SYST SC, V8, P545, DOI 10.5194/hess-8-545-2004; Briers RA, 2004, FRESHWATER BIOL, V49, P425, DOI 10.1111/j.1365-2427.2004.01198.x; Briers RA, 2002, ARCH HYDROBIOL, V155, P627; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Caquet T, 2007, ENVIRON TOXICOL CHEM, V26, P1280, DOI 10.1897/06-250R.1; Chan EKW, 2007, MAR FRESHWATER RES, V58, P725, DOI 10.1071/MF07033; Chaput-Bardy A, 2009, ECOL MODEL, V220, P3589, DOI 10.1016/j.ecolmodel.2009.06.027; Charles S, 2004, ECOL MODEL, V175, P217, DOI 10.1016/j.ecolmodel.2003.10.016; DELETTRE Y, 1992, LANDSCAPE ECOL, V6, P175; Delettre YR, 2000, FRESHWATER BIOL, V44, P399, DOI 10.1046/j.1365-2427.2000.00578.x; Delettre YR, 2005, PEDOBIOLOGIA, V49, P15, DOI 10.1016/j.pedobi.2004.06.010; Didham RK, 2012, FUND APPL LIMNOL, V180, P27, DOI 10.1127/1863-9135/2012/0243; DOWNE AER, 1973, CAN ENTOMOL, V105, P291, DOI 10.4039/Ent105291-2; Ducrot V, 2004, ENVIRON TOXICOL CHEM, V23, P225, DOI 10.1897/03-52; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dudgeon D, 2010, CURR OPIN ENV SUST, V2, P422, DOI 10.1016/j.cosust.2010.09.001; Eggermont H, 2011, BIOL REV; Elkin CM, 2008, AM NAT, V172, P563, DOI 10.1086/590962; Galic N, 2012, ENVIRON POLLUT, V163, P91, DOI 10.1016/j.envpol.2011.12.024; Greenwood MJ, 2011, J APPL ECOL, P213; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Hladyz S, 2011, ADV ECOL RES, V44, P211, DOI 10.1016/B978-0-12-374794-5.00004-3; JACKSON JK, 1989, ENVIRON ENTOMOL, V18, P278, DOI 10.1093/ee/18.2.278; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Macneale KH, 2005, FRESHWATER BIOL, V50, P1117, DOI 10.1111/j.1365-2427.2005.01387.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Moreno-Mateos D, 2012, NATURE, V482, P8; OLIVER DR, 1971, ANNU REV ENTOMOL, V16, P211, DOI 10.1146/annurev.en.16.010171.001235; Pery ARR, 2004, ECOTOXICOLOGY, V13, P647, DOI 10.1007/s10646-003-4425-0; Pery ARR, 2002, ENVIRON TOXICOL CHEM, V21, P2507, DOI [10.1897/1551-5028(2002)021<2507:AMATLF>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2507:AMATLF&gt;2.0.CO;2]; Petersen I, 2004, J APPL ECOL, V41, P934, DOI 10.1111/j.0021-8901.2004.00942.x; Petersen I, 1999, FRESHWATER BIOL, V42, P401, DOI 10.1046/j.1365-2427.1999.00466.x; Reynolds AM, 2010, J R SOC INTERFACE, V7, P1753, DOI 10.1098/rsif.2010.0292; Silver P, 2000, OECOLOGIA, V124, P216, DOI 10.1007/s004420050009; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Spanhoff B, 2007, RESTOR ECOL, V15, P317, DOI 10.1111/j.1526-100X.2007.00216.x; Tokeshi M, 1996, J ZOOL, V240, P103, DOI 10.1111/j.1469-7998.1996.tb05488.x; Trekels H, 2011, J APPL ECOL, V48, P1480, DOI 10.1111/j.1365-2664.2011.02053.x; Veraart AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018508; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wesner JS, 2010, OIKOS, V119, P170, DOI 10.1111/j.1600-0706.2009.17687.x; Whitaker DM, 2000, CAN J ZOOL, V78, P740, DOI 10.1139/cjz-78-5-740; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	60	24	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54584	10.1371/journal.pone.0054584	http://dx.doi.org/10.1371/journal.pone.0054584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365675	gold, Green Published			2022-12-25	WOS:000314023600076
J	Golic, A; Vaneechoutte, M; Nemec, A; Viale, AM; Actis, LA; Mussi, MA				Golic, Adrian; Vaneechoutte, Mario; Nemec, Alexandr; Viale, Alejandro M.; Actis, Luis A.; Alejandra Mussi, Maria			Staring at the Cold Sun: Blue Light Regulation Is Distributed within the Genus Acinetobacter	PLOS ONE			English	Article							SP NOV.; BIOFILM FORMATION; ABIOTIC SURFACES; GENOME SEQUENCE; BAUMANNII; CALCOACETICUS; IDENTIFICATION; PATHOGEN; MOTILITY	We previously showed that the opportunistic nosocomial pathogen Acinetobacter baumannii is able to sense and respond to light via BlsA, a BLUF (Blue-Light-sensing Using FAD)-domain photoreceptor protein. Here, we extend our previous studies showing that light regulation is not restricted to A. baumannii, but rather widespread within the genus Acinetobacter. First, we found that blue light modulates motility and biofilm formation in many species of the genus, including members of the Acinetobacter calcoaceticus-A. baumannii complex. In many of these species blue light acts as a key factor guiding the decision between motility or sessility at 24 degrees C, whereas in A. baumannii, light inhibits both motility and biofilm formation. We also show that light regulation of motility occurred not only at 24 degrees C but also at 37 degrees C in non-A. baumannii species, contrasting the situation of A. baumannii which only shows photoregulation at 24 degrees C. Second, we show that Acinetobacter baylyi (strain ADP1) BLUF-photoreceptors can functionally replace in vivo the A. baumannii 17978 BlsA protein and that the pathways leading to biofilm formation are inversely regulated at 24 degrees C between these two microorganisms. Finally, we found the presence of predicted genes coding BLUF-containing proteins in all Acinetobacter sequenced genomes, even though the copy number is variable among them. Phylogenetic analysis suggests a common origin for all BLUF domains present in members of this genus, and could distinguish well-differentiated clusters that group together BLUF homologs from different species, a situation particularly clear for members of the ACB complex. Despite a role played by these BLUF domain-containing proteins in the photoregulation observed in the members of the genus Acinetobacter is a likely scenario given our findings in A. baumannii and A. baylyi, further research will contribute to confirm this possibility.	[Golic, Adrian; Viale, Alejandro M.; Alejandra Mussi, Maria] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Vaneechoutte, Mario] Univ Ghent, Ghent Univ Hosp, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Nemec, Alexandr] Natl Inst Publ Hlth, Lab Bacterial Genet, Prague, Czech Republic	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University System of Ohio; Miami University; Ghent University; Ghent University Hospital; National Institute of Public Health (SZU) - Czech Republic	Mussi, MA (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Santa Fe, Argentina.	mussi@ibr.gov.ar	Vaneechoutte, Mario/A-6189-2009; Nemec, Alexandr/C-4447-2008	Vaneechoutte, Mario/0000-0002-4586-203X; Nemec, Alexandr/0000-0003-0608-9598	CONICET [PIP 326 2011-2013, PIP 114-200801-00469]; ANPCyT [PICT 25972]; Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe	CONICET PIP 326 2011-2013 (www.conicet.gov.ar), PIP 114-200801-00469 (www.conicet.gov.ar), ANPCyT PICT 25972 (www.agencia.gov.ar), Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe, Grant 2012 (www.santafe.gov.ar/index.php/web/content/view/full/93773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2010, J MICROBIOL, V48, P36, DOI 10.1007/s12275-009-0132-8; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Carr EL, 2003, INT J SYST EVOL MICR, V53, P953, DOI 10.1099/ijs.0.02486-0; Clinical and Laboratory Standards Institute, 2006, PERFORMANCE STANDARD; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Malhotra J, 2012, INT J SYST EVOL MICR; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Mussi MA, 2011, J BACTERIOL, V193, P4736, DOI 10.1128/JB.01533-10; Nemec A, 2003, INT J SYST EVOL MICR, V53, P1563, DOI 10.1099/ijs.0.02631-0; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nemec A, 2010, INT J SYST EVOL MICR, V60, P896, DOI 10.1099/ijs.0.013656-0; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; NISHIMURA Y, 1981, Z ALLG MIKROBIOL, V21, P125, DOI 10.1002/jobm.3630210208; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Sambrook J., 2001, MOL CLONING LAB MANU; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Soslau G, 2011, FEMS MICROBIOL LETT, V322, P166, DOI 10.1111/j.1574-6968.2011.02346.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; TOWNER KJ, 1991, FEMS SYMP, V57, P1; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006; Vaneechoutte M., 2011, MANUAL CLIN MICROBIO, P714; Vaneechoutte M, 2009, INT J SYST EVOL MICR, V59, P1376, DOI 10.1099/ijs.0.003541-0; Vaz-Moreira I, 2011, INT J SYST EVOL MICR, V61, P2837, DOI 10.1099/ijs.0.027045-0; Zan J, 2012, MOL MICROBIOL IN PRE; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11	41	29	31	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55059	10.1371/journal.pone.0055059	http://dx.doi.org/10.1371/journal.pone.0055059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358859	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600147
J	Huang, ZYX; de Boer, WF; van Langevelde, F; Olson, V; Blackburn, TM; Prins, HHT				Huang, Zheng Y. X.; de Boer, Willem F.; van Langevelde, Frank; Olson, Valerie; Blackburn, Tim M.; Prins, Herbert H. T.			Species' Life-History Traits Explain Interspecific Variation in Reservoir Competence: A Possible Mechanism Underlying the Dilution Effect	PLOS ONE			English	Article							WEST-NILE-VIRUS; IMMUNE DEFENSES; BODY-SIZE; DISEASE; DIVERSITY; BIODIVERSITY; INFECTION; BIRDS; TRANSMISSION; COMMUNITY	Hosts species for multi-host pathogens show considerable variation in the species' reservoir competence, which is usually used to measure species' potential to maintain and transmit these pathogens. Although accumulating research has proposed a trade-off between life-history strategies and immune defences, only a few studies extended this to host species' reservoir competence. Using a phylogenetic comparative approach, we studied the relationships between some species' life-history traits and reservoir competence in three emerging infectious vector-borne disease systems, namely Lyme disease, West Nile Encephalitis (WNE) and Eastern Equine Encephalitis (EEE). The results showed that interspecific variation in reservoir competence could be partly explained by the species' life histories. Species with larger body mass (for hosts of Lyme disease and WNE) or smaller clutch size (for hosts of EEE) had a higher reservoir competence. Given that both larger body mass and smaller clutch size were linked to higher extinction risk of local populations, our study suggests that with decreasing biodiversity, species with a higher reservoir competence are more likely to remain in the community, and thereby increase the risk of transmitting these pathogens, which might be a possible mechanism underlying the dilution effect.	[Huang, Zheng Y. X.; de Boer, Willem F.; van Langevelde, Frank; Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Olson, Valerie] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Olson, Valerie; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Blackburn, Tim M.] King Saud Univ, Distinguished Scientist Fellowship Program, Riyadh, Saudi Arabia	Wageningen University & Research; University of Bath; Zoological Society of London; King Saud University	Huang, ZYX (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	zheng.huang@wur.nl	Blackburn, Tim/AAC-3144-2019; Blackburn, Tim M/A-7685-2011	Blackburn, Tim/0000-0003-0152-2663; Van Langevelde, Frank/0000-0001-8870-0797; Prins, Herbert/0000-0003-1131-5107	Chinese Scholarship Council	Chinese Scholarship Council(China Scholarship Council)	This work is funded by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cunningham AA, 2012, PHILOS T R SOC B, V367, P2804, DOI 10.1098/rstb.2012.0331; Eisen L, 2003, J MED ENTOMOL, V40, P311, DOI 10.1603/0022-2585-40.3.311; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2009, P ROY SOC B-BIOL SCI, V276, P1657, DOI 10.1098/rspb.2008.1718; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Martin II LB, 2006, OECOLOGIA, V147, P565, DOI 10.1007/s00442-005-0314-y; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; ROBINSON JG, 1986, AM NAT, V128, P665, DOI 10.1086/284596; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011	41	89	91	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54341	10.1371/journal.pone.0054341	http://dx.doi.org/10.1371/journal.pone.0054341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365661	gold, Green Published			2022-12-25	WOS:000314023600049
J	Jin, Y; Qiu, MZ; Wang, DS; Zhang, DS; Ren, C; Bai, L; Luo, HY; Wang, ZQ; Wang, FH; Li, YH; Xu, RH				Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy	PLOS ONE			English	Article							CURATIVE RESECTION; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; METAANALYSIS; THERAPY; SURGERY; ADENOCARCINOMA; STOMACH; AGE	Background: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly. This study aims to investigate the use of adjuvant chemotherapy for gastric cancer after D2 gastrectomy among the elderly and identify its impact on survival. Methods: We retrospectively reviewed 360 patients who had undergone D2 gastrectomy, aged 65 years or older, with non-metastatic gastric cancer in a single institution. We analyzed the predictors and survival benefits of adjuvant chemotherapy use in the elderly. Further, we analyzed the survival benefits of adjuvant chemotherapy by dividing the patients into groups according to disease stages and chemotherapeutic regimens. Results: Among the 360 patients, only 34.7% of patients received adjuvant chemotherapy. Age, tumor location, lymph node involvement and tumor invasion were associated with the receipt of adjuvant chemotherapy. Adjuvant chemotherapy improved the overall survival for non-metastatic elderly patients (HR 0.60, 95%CI 0.42-0.83, P = 0.003). Significant survival benefits were found with adjuvant chemotherapy in stage III patients (HR 0.67, 95%CI 0.47-0.97, P = 0.033), but not in stage I patients or in stage II patients (HR 0.52, 95%CI 0.21-1.30 P = 0.161). Compared to adjuvant chemotherapy without platinum, no significant survival benefits were observed with platinum-containing chemotherapy (HR 0.84, 95%CI 0.49-1.45, P = 0.530). Besides adjuvant chemotherapy, other independent prognostic factors of survival included tumor location, tumor size, histologic grade, depth of tumor invasion, and lymph node status. Conclusions: This study demonstrated the survival benefits of adjuvant fluoropyrimidine-based chemotherapy among the elderly patients with non-metastatic gastric cancer after D2 gastrectomy. However, due to the limitations of this study, further well-designed prospective studies with large populations are needed to confirm these findings and identify the patients that can tolerate and benefit from adjuvant chemotherapy.	[Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, RH (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	骆, 卉妍/GWR-3383-2022; Xu, Rui-Hua/AAW-4766-2021; xu, rui/GRX-5734-2022	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534; 				Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Barthelemy P, 2011, CRIT REV ONCOL HEMAT, V79, P196, DOI 10.1016/j.critrevonc.2010.06.005; Bouvier AM, 2008, CANCER, V113, P879, DOI 10.1002/cncr.23629; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen SM, 2004, DRUG AGING, V21, P437, DOI 10.2165/00002512-200421070-00003; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dittmar Y, 2012, WORLD J SURG, V36, P338, DOI 10.1007/s00268-011-1395-x; Dudeja V, 2011, ANN SURG ONCOL, V18, P26, DOI 10.1245/s10434-010-1215-9; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Hoffman KE, 2012, CANCER-AM CANCER SOC, V118, P248, DOI 10.1002/cncr.26248; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Liu TS, 2008, EJSO-EUR J SURG ONC, V34, P1208, DOI 10.1016/j.ejso.2008.02.002; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; Msika S, 2000, EUR J CANCER, V36, P390, DOI 10.1016/S0959-8049(99)00308-1; Panzini I, 2002, TUMORI J, V88, P21; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Sakuramoto S, 2009, WORLD J GASTRO ONCOL, V1, P47, DOI 10.4251/wjgo.v1.i1.47; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Strauss J, 2010, INT J RADIAT ONCOL, V76, P1404, DOI 10.1016/j.ijrobp.2009.03.050; YU CCW, 1995, BRIT J CANCER, V71, P1106, DOI 10.1038/bjc.1995.214; Zhao SL, 2008, CANCER INVEST, V26, P317, DOI 10.1080/07357900701834686	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53149	10.1371/journal.pone.0053149	http://dx.doi.org/10.1371/journal.pone.0053149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359796	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600010
J	Ye, XF; Wang, HZ; Zhou, JX; Li, HQ; Liu, J; Wang, Z; Chen, AQ; Zhao, Q				Ye, Xiaofeng; Wang, Haozhe; Zhou, Jingxin; Li, Haiqing; Liu, Jun; Wang, Zhe; Chen, Anqing; Zhao, Qiang			The Effect of Heparin-VEGF Multilayer on the Biocompatibility of Decellularized Aortic Valve with Platelet and Endothelial Progenitor Cells	PLOS ONE			English	Article							OUTFLOW TRACT RECONSTRUCTION; CONGENITAL HEART-DISEASE; IN-VITRO; TISSUE; SURFACE; MATRIX; GROWTH; BLOOD; FILMS; RECELLULARIZATION	The application of polyelectrolyte multilayer films is a new, versatile approach to surface modification of decellularized tissue, which has the potential to greatly enhance the functionality of engineered tissue constructs derived from decellularized organs. In the present study, we test the hypothesis that Heparin-vascular endothelial growth factor (VEGF) multilayer film can not only act as an antithrombotic coating reagent, but also induce proliferation of endothelial progenitor cells (EPCs) on the decellularized aortic heart valve. SEM demonstrated the adhesion and geometric deformation of platelets. The quantitative assay of platelet activation was determined by measuring the production of soluble P-selectin. Binding and subsequent release of heparin and VEGF from valve leaflets were assessed qualitatively by laser confocal scanning microscopy and quantitatively by ELISA methods. Human blood derived EPCs were cultured and the adhesion and growth of EPCs on the surface modified valvular scaffolds were assessed. The results showed that Heparin-VEGF multilayer film improved decellularized valve haemocompatibility with respect to a substantial reduction of platelet adhesion. Release of VEGF from the decellularized heart valve leaflets at physiological conditions was sustained over 5 days. In vitro biological tests demonstrated that EPCs achieved better adhesion, proliferation and migration on the coatings with Heparin-VEGF multilayer film. Combined, these results indicate that Heparin-VEGF multilayer film could be used to cover the decellularized porcine aortic valve to decrease platelet adhesion while exhibiting excellent EPCs biocompatibility.	[Ye, Xiaofeng; Wang, Haozhe; Zhou, Jingxin; Li, Haiqing; Liu, Jun; Wang, Zhe; Chen, Anqing; Zhao, Qiang] Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.	zq11607@rjh.com.cn		Zhou, Jingxin/0000-0003-0471-1961	National Natural Science Foundation of China [81000096]; Shanghai Municipal Science and Technology Commission of Natural Science Foundation [11ZR1422500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission of Natural Science Foundation	The research was partially financially supported by the National Natural Science Foundation of China (81000096) and Shanghai Municipal Science and Technology Commission of Natural Science Foundation (11ZR1422500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X; Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161; Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; De Cock LJ, 2010, BIOMACROMOLECULES, V11, P1002, DOI 10.1021/bm9014649; Kasimir MT, 2006, J HEART VALVE DIS, V15, P278; Konertz W, 2011, J HEART VALVE DIS, V20, P341; Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010; Perri G, 2012, EUR J CARDIO-THORAC, V41, P1320, DOI 10.1093/ejcts/ezr221; Richard D, 2010, SMALL, V6, P2405, DOI 10.1002/smll.201000228; Rippel RA, 2012, WORLD J SURG, V36, P1581, DOI 10.1007/s00268-012-1535-y; Ruel M, 2007, CIRCULATION, V116, pI294, DOI 10.1161/CIRCULATIONAHA.106.681429; Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159; Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027; Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106; Tan QG, 2005, J MATER SCI-MATER M, V16, P687, DOI 10.1007/s10856-005-2541-5; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Wilcox HE, 2005, J HEART VALVE DIS, V14, P228; Ye XF, 2012, ACTA BIOMATER, V8, P1057, DOI 10.1016/j.actbio.2011.11.011; Ye XF, 2009, TISSUE ENG PT A, V15, P1, DOI 10.1089/ten.tea.2008.0001; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	27	33	37	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54622	10.1371/journal.pone.0054622	http://dx.doi.org/10.1371/journal.pone.0054622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359625	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600079
J	Araripe, J; do Rego, PS; Queiroz, H; Sampaio, I; Schneider, H				Araripe, Juliana; do Rego, Pericles Sena; Queiroz, Helder; Sampaio, Iracilda; Schneider, Horacio			Dispersal Capacity and Genetic Structure of Arapaima gigas on Different Geographic Scales Using Microsatellite Markers	PLOS ONE			English	Article							SOFTWARE; SCHINZ	Despite the ecological and economic importance of the Arapaima gigas (Cuvier 1817), few data about its dispersal capacity are available. The present study was based on the analysis of microsatellite markers in order to estimate the dispersal capacity of the species on fine, meso, and large geographic scales. For this, 561 specimens obtained from stocks separated by distances of up to 25 km (fine scale), 100 km (meso scale), and 1300-2300 km (large scale) were analyzed. The fine scale analysis indicated a marked genetic similarity between lakes, with low genetic differentiation, and significant differences between only a few pairs of sites. Low to moderate genetic differentiation was observed between pairs of sites on a meso scale (100 km), which could be explained by the distances between sites. By contrast, major genetic differentiation was recorded in the large scale analysis, that is, between stocks separated by distances of over 1300 km, with the analysis indicating that differentiation was not related solely to distance. The genetic structuring analysis indicated the presence of two stocks, one represented by the arapaimas of the Mamiraua Reserve, and the other by those of Santarem and Tucurui. The dispersal of arapaimas over short distances indicates a process of lateral migration within the varzea floodplains, which may be the principal factor determining the considerable homogeneity observed among the varzea lakes. The populations separated by distances of approximately 100 km were characterized by reduced genetic differentiation, which was associated with the geographic distances between sites. Populations separated by distances of over 1300 km were characterized by a high degree of genetic differentiation, which may be related primarily to historical bottlenecks in population size and the sedentary behavior of the species. Evidence was found of asymmetric gene flow, resulting in increasing genetic variability in the population of the Mamiraua Reserve.	[Araripe, Juliana; do Rego, Pericles Sena; Sampaio, Iracilda; Schneider, Horacio] Fed Univ Para, Inst Estudos Costeiros, Braganca, Para, Brazil; [Queiroz, Helder] Inst Desenvolvimento Sustentavel Mamiraua, Tefe, Amazonas, Brazil	Universidade Federal do Para	Araripe, J (corresponding author), Fed Univ Para, Inst Estudos Costeiros, Campus Braganca, Braganca, Para, Brazil.	araripe@ufpa.br	Schneider, Horacio/J-7131-2012; Araripe, Juliana/J-3248-2012; Queiroz, Helder/M-3049-2019; Queiroz, Helder/A-4199-2010; Rêgo, Péricles S/J-2620-2012; Araripe, Juliana/N-9071-2019; SAMPAIO, IRACILDA/J-6514-2012; Araripe, Juliana/U-4665-2018	Schneider, Horacio/0000-0002-5987-6395; Queiroz, Helder/0000-0002-4425-3208; Queiroz, Helder/0000-0002-4425-3208; Rêgo, Péricles S/0000-0002-4537-946X; Araripe, Juliana/0000-0002-8014-3081; SAMPAIO, IRACILDA/0000-0002-2137-4656; Araripe, Juliana/0000-0002-8014-3081	MCT/CNPq/PPG-7 [556893/2005-0, 48/2005 - Phase II SPC T]; PROPESP/UFPA; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FADESP	MCT/CNPq/PPG-7(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPESP/UFPA; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FADESP	This research was supported by grant 556893/2005-0 (MCT/CNPq/PPG-7 edital No. 48/2005 - Phase II SPC & T) and PROPESP/UFPA, CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br); PROPESP/UFPA (www.propesp.ufpa.br); FADESP (www.fadesp.org.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOL CONSERVACAO MAN; Arantes CC, 2010, ECOL FRESHW FISH, V19, P455, DOI 10.1111/j.1600-0633.2010.00431.x; ARANTES CC, 2006, UAKARI, V2, P37; Ayres J.M., 1995, MATAS VARZEA MAMIRAU; Barthem R., 1997, CATFISH CONNECTION E; Barthem RB, 2004, PESCA RECURSOS PESQU, P272; Buil-Aranda C, 2011, LECT NOTES COMPUT SC, V6644, P1, DOI 10.1007/978-3-642-21064-8_1; Castello L, 2008, J FISH BIOL, V72, P1520, DOI 10.1111/j.1095-8649.2007.01778.x; Castello L, 2008, ECOL FRESHW FISH, V17, P38, DOI 10.1111/j.1600-0633.2007.00255.x; Castello L, 2010, J APPL ICHTHYOL, V26, P49, DOI 10.1111/j.1439-0426.2009.01355.x; Castello L, 2009, ENVIRON MANAGE, V43, P197, DOI 10.1007/s00267-008-9220-5; Environmental Systems Research Institute [ESRI], 2008, SOFTW GEOGR INF SYST; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FabrU N.N., 2005, MANEJO PESCA GRANDES; Farias IP, 2003, MOL ECOL NOTES, V3, P128, DOI 10.1046/j.1471-8286.2003.00375.x; Goudet G. J., 2002, FSTAT PROGRAM WINDOW; Goulding M, 1980, FISHES FOREST EXPLOI; Goulding M., 1996, FLOODS FORTUNE ECOLO; Henderson PA, 1999, ESTRATEGIAS MANEJO R, P1; Hrbek T., 2007, Braz. J. Biol., V67, P909, DOI 10.1590/S1519-69842007000500015; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Isaac V.J., 1993, POVOS AGUAS REALIDAD, P188; Martinelli NMC, 1999, FISHERIES MANAG ECOL, V6, P233, DOI 10.1046/j.1365-2400.1999.00135.x; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Pritchard JK, 2000, GENETICS, V155, P945; Queiroz HL, 1999, ESTRATEGIAS MANEJO R, P108; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrook J, 2001, MOL CLONING LAB MANU; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verissimo J., 1895, PESCA AMAZONIA; Viana J.P., 2007, AREAS AQUATICAS PROT, P239; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060	33	36	36	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54470	10.1371/journal.pone.0054470	http://dx.doi.org/10.1371/journal.pone.0054470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372730	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500076
J	Baldanzi, S; McQuaid, CD; Cannicci, S; Porri, F				Baldanzi, Simone; McQuaid, Christopher D.; Cannicci, Stefano; Porri, Francesca			Environmental Domains and Range-Limiting Mechanisms: Testing the Abundant Centre Hypothesis Using Southern African Sandhoppers	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CRAB EMERITA-BRASILIENSIS; LIMPET COLLISELLA-SCABRA; POPULATION-DYNAMICS; CONSERVATION BIOGEOGRAPHY; TALITRUS-SALTATOR; CLIMATE-CHANGE; NEW-ZEALAND; FOOD SOURCE; SAND BEACH	Predicting shifts of species geographical ranges is a fundamental challenge for conservation ecologists given the great complexity of factors involved in setting range limits. Distributional patterns are frequently modelled to "simplify" species responses to the environment, yet the central mechanisms that drive a particular pattern are rarely understood. We evaluated the distributions of two sandhopper species (Crustacea, Amphipoda, Talitridae), Talorchestia capensis and Africorchestia quadrispinosa along the Namibian and South African coasts, encompassing three biogeographic regions influenced by two different oceanographic systems, the Benguela and Agulhas currents. We aimed to test whether the Abundant Centre Hypothesis (ACH) can explain the distributions of these species' abundances, sizes and sex ratios and examined which environmental parameters influence/drive these distributions. Animals were collected during a once-off survey at 29 sites over c. 3500 km of coastline. The ACH was tested using a non-parametric constraint space analysis of the goodness of fit of five hypothetical models. Distance Based Linear Modelling (DistLM) was performed to evaluate which environmental traits influenced the distribution data. Abundance, size and sex ratio showed different patterns of distribution. A ramped model fitted the abundance (Ramped North) and size (Ramped South) distribution for A. quadrispinosa. The Inverse Quadratic model fitted the size distribution of T. capensis. Beach slope, salinity, sand temperature and percentage of detritus found on the shore at the time of collection played important roles in driving the abundance of A. quadrispinosa. T. capensis was mainly affected by salinity and the morphodynamic state of the beach. Our results provided only some support for the ACH predictions. The DistLM confirmed that the physical state of the beach is an important factor for sandy beach organisms. The effect of salinity and temperature suggest metabolic responses to local conditions and a role in small to mesoscale shifts in the range of these populations.	[Baldanzi, Simone; McQuaid, Christopher D.; Porri, Francesca] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Cannicci, Stefano] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy	Rhodes University; University of Florence	Baldanzi, S (corresponding author), Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa.	baldanzi.simone@gmail.com	Porri, Francesca/M-4258-2017; McQuaid, Christopher/AAT-3725-2020; Cannicci, Stefano/L-7136-2015; Cannicci, Stefano/N-8512-2019	Porri, Francesca/0000-0001-8247-4506; McQuaid, Christopher/0000-0002-3473-8308; Cannicci, Stefano/0000-0002-6544-0213; Cannicci, Stefano/0000-0002-6544-0213; Baldanzi, Simone/0000-0002-7153-4734	National Research Foundation - NRF; EU IRSES [247514]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF)	National Research Foundation - NRF; EU IRSES; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF)	Funding came from the National Research Foundation - NRF http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to two anonymous reviewers, which contributed with highly constructive criticisms. S. B. thank Pamela Cramb, Linda Johnson, Lukholo Macala, Jennifer Booth, Adam Ludford, Rachel Tintswalo Ndhlovu, Madison Hall, Dr Charles von der Meden, Dr Marco Fusi, Dr Riccardo Simoni, Simone Babbini, Dr Irene Ortolani, Leandro Bergamino and Eleonora Puccinelli for field assistance. Thanks to Prof. Charles Griffiths and Dr Jim Lowry for the precious taxonomic support. Particular thanks to Dr Marco Fusi for help on data analysis. The author thanks Prof. Glyn Armstrong from the Department of Geography at Rhodes University, for the logistic support and help on sedimentology analysis. This paper was written under the framework of the project "CREC" (EU IRSES #247514) and is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF).	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adin R, 2003, ESTUAR COAST SHELF S, V56, P91, DOI 10.1016/S0272-7714(02)00124-5; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; [Anonymous], 1988, CRUSTACEANA, V55; Booth DT, 2006, CORAL REEFS, V25, P629, DOI 10.1007/s00338-006-0135-4; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cardoso RS, 2003, J COASTAL RES, P392; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Cardoso RS, 2002, MAR BIOL, V141, P167, DOI 10.1007/s00227-002-0784-y; Chelazzi L, 2005, VIE MILIEU, V55, P127; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crawley KR, 2009, MAR ECOL PROG SER, V376, P33, DOI 10.3354/meps07810; Defeo O, 2004, DIVERS DISTRIB, V10, P89, DOI 10.1111/j.1366-9516.2004.00070.x; Defeo O, 2002, MAR ECOL PROG SER, V239, P169, DOI 10.3354/meps239169; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo O, 2011, MAR ECOL PROG SER, V433, P29, DOI 10.3354/meps09206; Duarte C, 2010, HYDROBIOLOGIA, V651, P291, DOI 10.1007/s10750-010-0309-5; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; ENQUIST BJ, 1995, EVOL ECOL, V9, P586, DOI 10.1007/BF01237657; Fenberg PB, 2011, J BIOGEOGR, V38, P2286, DOI 10.1111/j.1365-2699.2011.02572.x; Folk R.L., 1957, J SEDIMENT RES, V27, P3, DOI [10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D, 10.1306/74d70646-2b21-11d7-8648000102c1865]; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gilman S, 2005, J BIOGEOGR, V32, P1583, DOI 10.1111/j.1365-2699.2005.01274.x; Gilman SE, 2006, ECOGRAPHY, V29, P709, DOI 10.1111/j.0906-7590.2006.04572.x; Gilman SE, 2006, OECOLOGIA, V148, P270, DOI 10.1007/s00442-006-0372-9; Goltsman M, 2005, J ZOOL, V267, P405, DOI 10.1017/S0952836905007557; Gomez J, 2012, ESTUAR COAST SHELF S, V98, P84, DOI 10.1016/j.ecss.2011.12.008; GRIFFITHS C L, 1976, P106; Harris L, 2011, ESTUAR COAST SHELF S, V92, P78, DOI 10.1016/j.ecss.2010.12.013; Johnston M, 2005, COMP BIOCHEM PHYS B, V140, P251, DOI 10.1016/j.cbpc.2004.10.007; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; Lima M, 2000, MAR ECOL PROG SER, V207, P97, DOI 10.3354/meps207097; Lincoln RJ, 1979, BRIT AMPHIOPODA GAMM; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; MARSDEN ID, 1991, J EXP MAR BIOL ECOL, V152, P75, DOI 10.1016/0022-0981(91)90136-K; MARSDEN ID, 1991, J EXP MAR BIOL ECOL, V152, P61, DOI 10.1016/0022-0981(91)90135-J; MCARDLE SB, 1991, MAR ECOL PROG SER, V76, P91, DOI 10.3354/meps076091; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; Meiri S, 2009, P ROY SOC B-BIOL SCI, V276, P1469, DOI 10.1098/rspb.2008.1318; Morritt D, 1998, J CRUSTACEAN BIOL, V18, P25, DOI 10.2307/1549517; Morritt D, 1988, FUNC ECOL, V12, P351; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pavesi L, 2009, HYDROBIOLOGIA, V635, P171, DOI 10.1007/s10750-009-9909-3; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Porri F, 2011, MAR ECOL PROG SER, V426, P253, DOI 10.3354/meps08951; Poulin R, 2002, ANIM BEHAV, V63, P269, DOI 10.1006/anbe.2001.1938; R Development Core Team, 2007, R LANG ENV STAT COMP; Rivadeneira MM, 2010, J BIOGEOGR, V37, P486, DOI 10.1111/j.1365-2699.2009.02224.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Soares AG, 2003, THESIS U PORT ELIZAB; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tam JC, 2011, J BIOGEOGR, V38, P1536, DOI 10.1111/j.1365-2699.2011.02498.x; Tolley KA, 2008, DIVERS DISTRIB, V14, P400, DOI 10.1111/j.1472-4642.2007.00428.x; Tsubokura T, 1997, J CRUSTACEAN BIOL, V17, P674, DOI 10.2307/1549370; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; Tuya F, 2008, MAR ECOL PROG SER, V372, P225, DOI 10.3354/meps07718; Virgos E, 2011, J BIOGEOGR, V38, P1546, DOI 10.1111/j.1365-2699.2011.02512.x; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886; Ward DF, 2005, SOCIOBIOL, V45; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; WILLIAMS JA, 1995, J CRUSTACEAN BIOL, V15, P466, DOI 10.2307/1548768; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	76	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54598	10.1371/journal.pone.0054598	http://dx.doi.org/10.1371/journal.pone.0054598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372740	Green Published, gold			2022-12-25	WOS:000314021500093
J	Cizkova, J; Hribova, E; Humplikova, L; Christelova, P; Suchankova, P; Dolezel, J				Cizkova, Jana; Hribova, Eva; Humplikova, Lenka; Christelova, Pavla; Suchankova, Pavla; Dolezel, Jaroslav			Molecular Analysis and Genomic Organization of Major DNA Satellites in Banana (Musa spp.)	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; RIBOSOMAL-RNA GENES; REPETITIVE DNA; CHROMOSOMAL LOCALIZATION; CENTROMERIC REGIONS; SEQUENCE-ANALYSIS; ACUMINATA GENOME; L. GENOME; EVOLUTION; REPEATS	Satellite DNA sequences consist of tandemly arranged repetitive units up to thousands nucleotides long in head-to-tail orientation. The evolutionary processes by which satellites arise and evolve include unequal crossing over, gene conversion, transposition and extra chromosomal circular DNA formation. Large blocks of satellite DNA are often observed in heterochromatic regions of chromosomes and are a typical component of centromeric and telomeric regions. Satellite-rich loci may show specific banding patterns and facilitate chromosome identification and analysis of structural chromosome changes. Unlike many other genomes, nuclear genomes of banana (Musa spp.) are poor in satellite DNA and the information on this class of DNA remains limited. The banana cultivars are seed sterile clones originating mostly from natural intra-specific crosses within M. acuminata (A genome) and inter-specific crosses between M. acuminata and M. balbisiana (B genome). Previous studies revealed the closely related nature of the A and B genomes, including similarities in repetitive DNA. In this study we focused on two main banana DNA satellites, which were previously identified in silico. Their genomic organization and molecular diversity was analyzed in a set of nineteen Musa accessions, including representatives of A, B and S (M. schizocarpa) genomes and their inter-specific hybrids. The two DNA satellites showed a high level of sequence conservation within, and a high homology between Musa species. FISH with probes for the satellite DNA sequences, rRNA genes and a single-copy BAC clone 2G17 resulted in characteristic chromosome banding patterns in M. acuminata and M. balbisiana which may aid in determining genomic constitution in interspecific hybrids. In addition to improving the knowledge on Musa satellite DNA, our study increases the number of cytogenetic markers and the number of individual chromosomes, which can be identified in Musa.	[Cizkova, Jana; Hribova, Eva; Humplikova, Lenka; Christelova, Pavla; Suchankova, Pavla; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Dolezel, J (corresponding author), Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic.	dolezel@ueb.cas.cz	Cizkova, Jana/F-7673-2014; hribova, eva/F-7291-2014; Dolezel, Jaroslav/B-7716-2008	Dolezel, Jaroslav/0000-0002-6263-0492; Cizkova, Jana/0000-0001-7787-1849; Hribova, Eva/0000-0002-6868-4344	Academy of Sciences of the Czech Republic [KJB500380901]; Bioversity International [LoA CfL 2011/51]; Ministry of Education, Youth and Sports of the Czech Republic [LG12021]; European Regional Development Fund (Operational Programme Research and Development for Innovations) [ED0007/01/01]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Bioversity International; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (Operational Programme Research and Development for Innovations)	This work was supported by the Academy of Sciences of the Czech Republic (award KJB500380901), by the Bioversity International (LoA CfL 2011/51), Ministry of Education, Youth and Sports of the Czech Republic (award LG12021) and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bao WD, 2006, MOL GENET GENOMICS, V275, P421, DOI 10.1007/s00438-006-0103-2; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; Dechyeva D, 2003, CHROMOSOME RES, V11, P3, DOI 10.1023/A:1022005514470; DODDS KS, 1948, HEREDITY, V2, P101, DOI 10.1038/hdy.1948.6; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezelova M, 1998, BIOL PLANTARUM, V41, P497, DOI 10.1023/A:1001880030275; Dover G, 2002, TRENDS GENET, V18, P587, DOI 10.1016/S0168-9525(02)02789-0; DOVER GA, 1982, SCIENCE, V218, P1069, DOI 10.1126/science.7146895; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; GALASSO I, 1995, THEOR APPL GENET, V91, P928, DOI 10.1007/BF00223902; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Hribova E, 2008, BIOL PLANTARUM, V52, P445, DOI 10.1007/s10535-008-0089-1; Hribova E, 2007, CYTOGENET GENOME RES, V119, P268, DOI 10.1159/000112073; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; INGHAM LD, 1993, MOL GEN GENET, V238, P350, DOI 10.1007/BF00291993; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King K, 1995, J MOL EVOL, V41, P996; Kopecky D, 2008, CYTOGENET GENOME RES, V120, P370, DOI 10.1159/000121086; Kopecky D, 2010, CYTOGENET GENOME RES, V129, P162, DOI 10.1159/000313379; Kubis S, 1998, ANN BOT-LONDON, V82, P45, DOI 10.1006/anbo.1998.0779; Kubis SE, 1998, PLANT MOL BIOL, V36, P821, DOI 10.1023/A:1005973932556; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumekawa N, 2001, MOL GENET GENOMICS, V265, P480, DOI 10.1007/s004380000436; Lysak MA, 1999, THEOR APPL GENET, V98, P1344, DOI 10.1007/s001220051201; Macas J, 2000, MOL GEN GENET, V263, P741, DOI 10.1007/s004380000245; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2006, CHROMOSOMA, V115, P437, DOI 10.1007/s00412-006-0070-8; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Macas J, 2010, BIOINFORMATICS, V26, P2101, DOI 10.1093/bioinformatics/btq343; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Navratilova A, 2003, ANN BOT-LONDON, V91, P921, DOI 10.1093/aob/mcg099; Navratilova A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-90; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Osuji JO, 1997, ANN BOT-LONDON, V80, P787, DOI 10.1006/anbo.1997.0516; Otto F, 1990, Methods Cell Biol, V33, P105; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Schmidt T, 1998, TRENDS PLANT SCI, V3, P195, DOI 10.1016/S1360-1385(98)01223-0; SCHMIDT T, 1995, CHROMOSOME RES, V3, P335, DOI 10.1007/BF00710014; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Sharma S, 2005, CYTOGENET GENOME RES, V109, P15, DOI 10.1159/000082377; Shepherd K, 1999, CYTOGENETICS GENUS M; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tek AL, 2004, CHROMOSOMA, V113, P77, DOI 10.1007/s00412-004-0297-1; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; Torres GA, 2011, G3-GENES GENOM GENET, V1, P85, DOI 10.1534/g3.111.000125; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; Valarik M, 2002, CHROMOSOME RES, V10, P89, DOI 10.1023/A:1014945730035; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Willard HF, 1991, CURR OPIN GENET DEV, V1, P509, DOI 10.1016/S0959-437X(05)80200-X; WILSON GB, 1946, GENETICS, V31, P475; Zatloukalova P, 2011, CHROMOSOME RES, V19, P729, DOI 10.1007/s10577-011-9235-2; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	74	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54808	10.1371/journal.pone.0054808	http://dx.doi.org/10.1371/journal.pone.0054808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372772	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500130
J	Alvarez-Arguelles, ME; Melon, S; Junquera, ML; Boga, JA; Villa, L; Perez-Castro, S; de Ona, M				Elena Alvarez-Argueelles, Marta; Melon, Santiago; Luisa Junquera, Maria; Antonio Boga, Jose; Villa, Laura; Perez-Castro, Sonia; de Ona, Maria			Human Papillomavirus Infection in a Male Population Attending a Sexually Transmitted Infection Service	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; MALE ANOGENITAL SITES; HPV DETECTION; PREVALENCE; MEN; RISK; EPIDEMIOLOGY; WOMEN; DNA; DETERMINANTS	Objective: Human Papillomavirus (HPV) infection in men may produce cancer and other major disorders. Men play an important role in the transmission of the virus and act as a reservoir. The aim of this study was to determine the HPV-genotypes and their prevalence in a group of men attending a Sexually Transmitted Infection service. Patients and Samples: Between July 2002 and June 2011, 1392 balanopreputial, 435 urethral, 123 anal, and 67 condyloma lesions from 1551 men with a mean age of 35.8 +/- 11.3 years old (range: 17-87) were collected for HPV-DNA testing. Methods: A fragment of the L1-gene and a fragment of the E6/E7-genes were amplified by PCR. Positive samples were typed by hybridization. Results: The HPV genome was detected in 36.9% (486/1318) balanopreputial and in 24.9% (101/405) urethral (p<0.0001) swabs from 38.1% (538) of 1469 men. Co-infections were present in 5.4% (80/1469) of cases. HPV was found in 43.9% (373/850) of men younger than 35 vs. 31.7% (187/589) of men aged >35. HPV was found in 59.4% (104) of 165 men with lesions (macroscopic or positive peniscopy), and in 22.8% (61/267) without clinical alterations. HPV was also detected in 71.4% (40/56) men with condylomata and in 58.7% (64/109) of men with positive peniscopy. Conclusions: HPV prevalence in men was high and decreased with age. HPV was found more frequently in balanopreputial than in urethral swabs. There was a low rate of co-infections. Low-risk HPV vaccine genotypes were the most recurrent especially in younger. Although HPV has been associated with clinical alterations, it was also found in men without any clinical presentation. Inclusion of men in the national HPV vaccination program may reduce their burden of HPV-related disease and reduce transmission of the virus to non-vaccinated women.	[Elena Alvarez-Argueelles, Marta; Melon, Santiago; Antonio Boga, Jose; Villa, Laura; de Ona, Maria] Hosp Univ Cent Asturias, Microbiol Serv, Oviedo, Spain; [Luisa Junquera, Maria] Hosp Monte Naranco, Unidad ITS, Oviedo, Spain; [Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Microbiol Serv, Vigo, Spain	Central University Hospital Asturias; Complexo Hospitalario Universitario de Vigo	Alvarez-Arguelles, ME (corresponding author), Hosp Univ Cent Asturias, Microbiol Serv, Oviedo, Spain.	martaealvarez@gmail.com	Boga, Jose Antonio/ABA-2719-2021; Melón, Santiago/AAY-1466-2021; Villa, Laura/AAF-3395-2021; Melón García, Santiago/AHE-7360-2022	Boga, Jose Antonio/0000-0002-5500-9972; Melón, Santiago/0000-0001-5770-7902; Villa, Laura/0000-0002-4228-7041; Melón García, Santiago/0000-0001-5770-7902; PEREZ CASTRO, SONIA/0000-0003-1734-1904				Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; Barzon L, 2010, J MED VIROL, V82, P1424, DOI 10.1002/jmv.21733; Benevolo M, 2008, J MED VIROL, V80, P1275, DOI 10.1002/jmv.21189; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Burchell A, 2006, VACCINE S3, P54; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castellsague X, 1997, J INFECT DIS, V176, P353, DOI 10.1086/514052; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Costa FAM, 2009, J MED VIROL, V81, P2007, DOI 10.1002/jmv.21624; Rocha MGD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040988; de Ona M, 2010, J MED VIROL, V82, P597, DOI 10.1002/jmv.21697; Deza J, 2007, 19 C AN AS ESP PAT C; DICKENS P, 1991, J PATHOL, V165, P243, DOI 10.1002/path.1711650308; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; Flores R, 2008, J VIROL METHODS, V149, P136, DOI 10.1016/j.jviromet.2007.12.010; Foresta C, 2010, FERTIL STERIL, V94, P1723, DOI 10.1016/j.fertnstert.2009.11.012; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Georgieva S, 2009, J BUON, V14, P391; Georgousakis M, 2012, LANCET INFECT DIS, V12, P627, DOI 10.1016/S1473-3099(12)70031-2; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2008, J INFECT DIS, V198, P827, DOI 10.1086/591095; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Grulich AE, 2010, SEX HEALTH, V7, P244, DOI 10.1071/SH10020; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Lajous M, 2005, CANCER EPIDEM BIOMAR, V14, P1710, DOI 10.1158/1055-9965.EPI-04-0926; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; MANOS MM, 1989, CANCER CEL, V7, P209; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moscicki AB, 1988, J PEDIAT, V132, P277; Nielson CM, 2007, CANCER EPIDEM BIOMAR, V16, P1107, DOI 10.1158/1055-9965.EPI-06-0997; Nielson CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Schiffman M, 2012, LANCET ONCOL, V13, P10, DOI 10.1016/S1470-2045(11)70324-2; Shukla S, 2009, INDIAN J MED RES, V130, P222; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2010, INT J CANCER, V126, P572, DOI 10.1002/ijc.24770; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Vaccarella S, 2006, INT J CANCER, V119, P1934, DOI 10.1002/ijc.21992; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; Wong AK, 2010, MODERN PATHOL, V23, P144, DOI 10.1038/modpathol.2009.143	47	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54375	10.1371/journal.pone.0054375	http://dx.doi.org/10.1371/journal.pone.0054375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372715	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500065
J	Grodzki, ACG; Giulivi, C; Lein, PJ				Grodzki, Ana Cristina G.; Giulivi, Cecilia; Lein, Pamela J.			Oxygen Tension Modulates Differentiation and Primary Macrophage Functions in the Human Monocytic THP-1 Cell Line	PLOS ONE			English	Article							RESPONSIVE TRANSCRIPTION FACTORS; HYPOXIA-INDUCIBLE FACTOR-1; NF-KAPPA-B; IN-VITRO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ALVEOLAR; RECEPTOR; GLUTATHIONE; SYNCHRONIZATION	The human THP-1 cell line is widely used as an in vitro model system for studying macrophage differentiation and function. Conventional culture conditions for these cells consist of ambient oxygen pressure (similar to 20% v/v) and medium supplemented with the thiol 2-mercaptoethanol (2-ME) and serum. In consideration of the redox activities of O-2 and 2-ME, and the extensive experimental evidence supporting a role for reactive oxygen species (ROS) in the differentiation and function of macrophages, we addressed the question of whether culturing THP-1 cells under a more physiologically relevant oxygen tension (5% O-2) in the absence of 2-ME and serum would alter THP-1 cell physiology. Comparisons of cultures maintained in 18% O-2 versus 5% O-2 indicated that reducing oxygen tension had no effect on the proliferation of undifferentiated THP-1 cells. However, decreasing the oxygen tension to 5% O-2 significantly increased the rate of phorbol ester-induced differentiation of THP-1 cells into macrophage-like cells as well as the metabolic activity of both undifferentiated and PMA-differentiated THP-1 cells. Removal of both 2-ME and serum from the medium decreased the proliferation of undifferentiated THP-1 cells but increased metabolic activity and the rate of differentiation under either oxygen tension. In differentiated THP-1 cells, lowering the oxygen tension to 5% O-2 decreased phagocytic activity, the constitutive release of beta-hexosaminidase and LPS-induced NF-kappa B activation but enhanced LPS-stimulated release of cytokines. Collectively, these data demonstrate that oxygen tension influences THP-1 cell differentiation and primary macrophage functions, and suggest that culturing these cells under tightly regulated oxygen tension in the absence of exogenous reducing agent and serum is likely to provide a physiologically relevant baseline from which to study the role of the local redox environment in regulating THP-1 cell physiology.	[Grodzki, Ana Cristina G.; Giulivi, Cecilia; Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis	Lein, PJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	pjlein@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [R01 ES017592, T32 HL007013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the National Institutes of Health (grant R01 ES017592 to PJL) and a postdoctoral fellowship to ACGG (T32 HL007013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; Bunbury A, 2009, FASEB J, V23, P164, DOI 10.1096/fj.08-109439; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; Cooper S, 2009, CELL BIOL INT, V33, P71, DOI 10.1016/j.cellbi.2008.09.009; COWAN DB, 1992, J MOL CELL CARDIOL, V24, P423, DOI 10.1016/0022-2828(92)93196-Q; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goth SR, 2006, J IMMUNOL METHODS, V308, P179, DOI 10.1016/j.jim.2005.10.012; Haddad JJ, 2002, RESP RES, V3, DOI 10.1186/rr190; Harper Jane V., 2004, V296, P157; Hutter D, 2000, J CELL PHYSIOL, V183, P45, DOI 10.1002/(SICI)1097-4652(200004)183:1<45::AID-JCP6>3.3.CO;2-G; Johansson A, 1997, AM J RESP CELL MOL, V16, P582, DOI 10.1165/ajrcmb.16.5.9160840; Karagenc L, 2004, REPROD BIOMED ONLINE, V9, P409, DOI 10.1016/S1472-6483(10)61276-X; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Krieger JA, 1996, INT J IMMUNOPHARMACO, V18, P545, DOI 10.1016/S0192-0561(96)00057-4; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Pasztoi M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2697; Pfau JC, 2004, AM J PHYSIOL-LUNG C, V286, pL354, DOI 10.1152/ajplung.00380.2002; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sasaki H, 2009, FREE RADICAL BIO MED, V47, P189, DOI 10.1016/j.freeradbiomed.2009.04.025; SCHNYDER J, 1978, J EXP MED, V148, P435, DOI 10.1084/jem.148.2.435; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; VANOTTEREN GM, 1995, AM J RESP CELL MOL, V13, P399, DOI 10.1165/ajrcmb.13.4.7546769; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yan HM, 2010, TOXICOL SCI, V117, P515, DOI 10.1093/toxsci/kfq208	48	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54926	10.1371/journal.pone.0054926	http://dx.doi.org/10.1371/journal.pone.0054926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355903	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500144
J	Nakashima, H; Ogawa, Y; Shono, S; Kinoshita, M; Nakashima, M; Sato, A; Ikarashi, M; Seki, S				Nakashima, Hiroyuki; Ogawa, Yoshiko; Shono, Satoshi; Kinoshita, Manabu; Nakashima, Masahiro; Sato, Atsushi; Ikarashi, Masami; Seki, Shuhji			Activation of CD11b(+) Kupffer Cells/Macrophages as a Common Cause for Exacerbation of TNF/Fas-Ligand-Dependent Hepatitis in Hypercholesterolemic Mice	PLOS ONE			English	Article							LIVER INNATE IMMUNITY; AG+ T-CELLS; ALPHA-GALACTOSYLCERAMIDE; BACTERIAL-DNA; MEDIATED FUNCTION; CPG MOTIFS; ATHEROSCLEROSIS; INJURY; MACROPHAGES; MECHANISMS	We have reported that the mouse hepatic injury induced by either alpha-galactosylceramide (alpha-GalCer) or bacterial DNA motifs (CpG-ODN) is mediated by the TNF/NKT cell/Fas-ligand (FasL) pathway. In addition, F4/80(+) Kupffer cells can be subclassified into CD68(+) subset with a phagocytosing capacity and CD11b(+) subset with a TNF-producing capacity. CD11b(+) subset increase if mice are fed high-fat and cholesterol diet (HFCD). The present study examined how a HFCD affects the function of NKT cells and F4/80(+) CD11b(+) subset and these hepatitis models. After the C57BL/6 mice received a HFCD, high-cholesterol diet (HCD), high-fat diet (HFD) and control diet (CD) for four weeks, the HFCD mice increased surface CD1d and intracellular TLR-9 expression by the CD11b(+) population compared to CD mice. Hepatic injury induced either by alpha-GalCer or CpG-ODN was more severe in HCD and HFCD mice compared to CD mice, which was in proportion to the serum TNF levels. In addition, liver cholesterol levels but not serum cholesterol levels nor liver triglyceride levels were involved in the aggravation of hepatitis. The FasL expression of NKT cells induced by both reagents was upregulated in HFCD mice. Furthermore, the liver mononuclear cells and purified F4/80(+) CD11b(+) subset from HFCD mice stimulated with either reagent in vitro produced a larger amount of TNF than did those from CD mice. Intracellular TNF production in F4/80(+) CD11b(+) cells was confirmed. The increased number of F4/80(+) CD11b(+) Kupffer cells/macrophages by HFCD and their enhanced TNF production thus play a pivotal role in TNF/NKT cell/FasL dependent hepatic injury.	[Nakashima, Hiroyuki; Ogawa, Yoshiko; Shono, Satoshi; Kinoshita, Manabu; Nakashima, Masahiro; Sato, Atsushi; Ikarashi, Masami; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan	Seki, S (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan.	btraums@ndmc.ac.jp						Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Fuji N, 2000, CLIN CANCER RES, V6, P3380; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Habu Y, 2004, IMMUNOLOGY, V113, P35, DOI 10.1111/j.1365-2567.2004.01932.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hong SM, 1999, IMMUNOL REV, V169, P31, DOI 10.1111/j.1600-065X.1999.tb01304.x; Inatsu A, 2009, HEPATOLOGY, V49, P2044, DOI 10.1002/hep.22888; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Motoki K, 1996, ONCOL RES, V8, P155; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakagawa R, 2004, J IMMUNOL, V172, P6550, DOI 10.4049/jimmunol.172.11.6550; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Schramm C, 2008, Z GASTROENTEROL, V46, P1369, DOI 10.1055/s-2008-1027411; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; Takayama E, 2003, IMMUNOLOGY, V108, P211, DOI 10.1046/j.1365-2567.2003.01575.x; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Yamaguchi Y, 1996, ONCOL RES, V8, P399	37	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e49339	10.1371/journal.pone.0049339	http://dx.doi.org/10.1371/journal.pone.0049339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372642	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500002
J	Wrench, AP; Gardner, CL; Gonzalez, CF; Lorca, GL				Wrench, Algevis P.; Gardner, Christopher L.; Gonzalez, Claudio F.; Lorca, Graciela L.			Identification of a Small Molecule That Modifies MglA/SspA Interaction and Impairs Intramacrophage Survival of Francisella tularensis	PLOS ONE			English	Article							STRINGENT STARVATION PROTEIN; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTORS; NOVICIDA; GENE; EXPRESSION; TULAREMIA; POLYMERASE; DISCOVERY	The transcription factors MglA and SspA of Francisella tularensis form a heterodimer complex and interact with the RNA polymerase to regulate the expression of the Francisella pathogenicity island (FPI) genes. These genes are essential for this pathogen's virulence and survival within host cells. In this study, we used a small molecule screening to identify quinacrine as a thermal stabilizing compound for F. tularensis SCHU S4 MglA and SspA. A bacterial two-hybrid system was used to analyze the in vivo effect of quinacrine on the heterodimer complex. The results show that quinacrine affects the interaction between MglA and SspA, indicated by decreased beta-galactosidase activity. Further in vitro analyses, using size exclusion chromatography, indicated that quinacrine does not disrupt the heterodimer formation, however, changes in the alpha helix content were confirmed by circular dichroism. Structure-guided site-directed mutagenesis experiments indicated that quinacrine makes contact with amino acid residues Y63 in MglA, and K97 in SspA, both located in the "cleft" of the interacting surfaces. In F. tularensis subsp. novicida, quinacrine decreased the transcription of the FPI genes, iglA, iglD, pdpD and pdpA. As a consequence, the intramacrophage survival capabilities of the bacteria were affected. These results support use of the MglA/SspA interacting surface, and quinacrine's chemical scaffold, for the design of high affinity molecules that will function as therapeutics for the treatment of Tularemia.	[Wrench, Algevis P.; Gardner, Christopher L.; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu		Gardner, Christopher/0000-0001-6416-8476	Institute of Food and Agricultural Sciences, University of Florida; University of Florida Open Access Publishing Fund	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); University of Florida Open Access Publishing Fund	This work was supported by a grant from the Institute of Food and Agricultural Sciences, University of Florida. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger JL, 1998, J BACTERIOL, V180, P793, DOI 10.1128/JB.180.4.793-800.1998; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Comer JE, 2006, J TOXICOL ENV HEAL A, V69, P1083, DOI 10.1080/15287390500360281; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DeReuse H, 1997, RES MICROBIOL, V148, P289, DOI 10.1016/S0923-2508(97)81585-9; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Hansen AM, 2005, J BIOL CHEM, V280, P17380, DOI 10.1074/jbc.M501444200; ISHIHAMA A, 1979, J MOL BIOL, V129, P517, DOI 10.1016/0022-2836(79)90466-2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; McRae S, 2010, J BIOL CHEM, V285, P5171, DOI 10.1074/jbc.M109.039511; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MILLER J H, 1972, P466; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Nishimura A, 2010, P NATL ACAD SCI US; Orzaz M, 2009, BIOORG MED CHEM LETT, V19, P1592, DOI 10.1016/j.bmcl.2009.02.020; Oyston PCF, 2009, EXPERT REV VACCINES, V8, P1575, DOI [10.1586/erv.09.114, 10.1586/ERV.09.114]; Pagliai FA, 2010, J BIOL CHEM, V285, P16921, DOI 10.1074/jbc.M110.111138; Pande SG, 2011, MOL MICROBIOL, V81, P1623, DOI 10.1111/j.1365-2958.2011.07796.x; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; REEH S, 1976, MOL GEN GENET, V149, P279, DOI 10.1007/BF00268529; Sambrook J., 2002, MOL CLONING LAB MANU; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Tran HNA, 2010, BIOORG MED CHEM LETT, V20, P1866, DOI 10.1016/j.bmcl.2010.01.149; TYERYAR FJ, 1969, J BACTERIOL, V100, P1112, DOI 10.1128/JB.100.2.1112-1113.1969; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whipple FW, 1998, NUCLEIC ACIDS RES, V26, P3700, DOI 10.1093/nar/26.16.3700; WILLIAMS MD, 1991, GENE, V109, P21, DOI 10.1016/0378-1119(91)90584-X; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54498	10.1371/journal.pone.0054498	http://dx.doi.org/10.1371/journal.pone.0054498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372736	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500080
J	Both, L; van Dolleweerd, C; Wright, E; Banyard, AC; Bulmer-Thomas, B; Selden, D; Altmann, F; Fooks, AR; Ma, JKC				Both, Leonard; van Dolleweerd, Craig; Wright, Edward; Banyard, Ashley C.; Bulmer-Thomas, Bianca; Selden, David; Altmann, Friedrich; Fooks, Anthony R.; Ma, Julian K. -C.			Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans	FASEB JOURNAL			English	Article						plant biotechnology; molecular pharming; PEP; tobacco	VIRUS-NEUTRALIZING EPITOPE; POSTEXPOSURE PROPHYLAXIS; GLYCOSYLATION; LYSSAVIRUSES; PATHOGENICITY; GLYCOPROTEIN; COCKTAIL; IDENTIFICATION; IMMUNOTHERAPY; COMBINATION	Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP). The purpose here was to establish a plant-based production system for a chimeric mouse-human version of mAb 62-71-3, to characterize the recombinant antibody and investigate at a molecular level its interaction with rabies virus glycoprotein. Chimeric 62-71-3 was successfully expressed in Nicotiana benthamiana. Glycosylation was analyzed by mass spectroscopy; functionality was confirmed by antigen ELISA, as well as rabies and pseudotype virus neutralization. Epitope characterization was performed using pseudotype virus expressing mutagenized rabies glycoproteins. Purified mAb demonstrated potent viral neutralization at 500 IU/mg. A critical role for antigenic site I of the glycoprotein, as well as for two specific amino acid residues (K226 and G229) within site I, was identified with regard to mAb 62-71-3 neutralization. Pseudotype viruses expressing glycoprotein from lyssaviruses known not to be neutralized by this antibody were the controls. The results provide the molecular rationale for developing 62-71-3 mAb for rabies PEP; they also establish the basis for developing an inexpensive plant-based antibody product to benefit low-income families in developing countries.	[Both, Leonard; van Dolleweerd, Craig; Ma, Julian K. -C.] Univ London, Div Clin Sci, Hotung Mol Immunol Unit, London SW17 0RE, England; [Both, Leonard; Wright, Edward; Banyard, Ashley C.; Selden, David; Fooks, Anthony R.] Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Wright, Edward] Univ Westminster, Sch Life Sci, London W1R 8AL, England; [Wright, Edward; Bulmer-Thomas, Bianca] UCL, Wohl Vir Ctr, Div Infect & Immun, London, England; [Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria	University of London; Veterinary Laboratories Agency; University of Westminster; University of London; University College London; University of Natural Resources & Life Sciences, Vienna	Ma, JKC (corresponding author), Univ London, Div Clin Sci, Hotung Mol Immunol Unit, London SW17 0RE, England.	jma@sgul.ac.uk	Banyard, Ashley/C-7998-2011; Fooks, Anthony R/F-5418-2010	Banyard, Ashley/0000-0002-1286-9825; van Dolleweerd, Craig/0000-0002-1380-6930; Wright, Edward/0000-0001-7041-5138; Ma, Julian/0000-0003-0767-0042; Altmann, Friedrich/0000-0002-0112-7877	EU; Dr. Hadwen Trust for Humane Research; Hotung Foundation; St. George's, University of London (London, UK); AHVLA; COST projects [FAO94]	EU(European Commission); Dr. Hadwen Trust for Humane Research; Hotung Foundation; St. George's, University of London (London, UK); AHVLA; COST projects	The authors thank Marie Paule Kieny (World Health Organization, Geneva, Switzerland) and Charles E. Rupprecht (U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA) for providing the 62-71-3 variable domain sequences and Polymun Scientific Immunbiologische Forschung (Klosterneuberg, Austria) for providing the 4E10 constant domain sequences. The authors also thank Thomas Muller [Friedrich Loeffler Institut(FLI), Wusterhausen, Germany] for the E559 hybridoma, Robin Weiss (University College London, London, UK) for help with the PNA, and Derek Healy [Animal Health and Veterinary Laboratories Agency (AHVLA), Weybridge, UK] for help with the FAVN. The authors are grateful to the EU-funded Pharma-Planta, Future-Pharma, and COST (FAO94) projects and the Dr. Hadwen Trust for Humane Research, as well as the Hotung Foundation. This work was supported by St. George's, University of London (London, UK), and AHVLA.	Arai YT, 2003, EMERG INFECT DIS, V9, P333, DOI 10.3201/eid0903.020252; Badrane H, 2001, J VIROL, V75, P3268, DOI 10.1128/JVI.75.7.3268-3276.2001; Bakker ABH, 2008, VACCINE, V26, P5922, DOI 10.1016/j.vaccine.2008.08.050; Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; Champion JM, 2000, J IMMUNOL METHODS, V235, P81, DOI 10.1016/S0022-1759(99)00223-9; CONSTANTINE DG, 1967, RABIES TRANSMISSION; DIETZSCHOLD B, 1990, J VIROL, V64, P3804, DOI 10.1128/JVI.64.8.3804-3809.1990; DIETZSCHOLD B, 1983, P NATL ACAD SCI-BIOL, V80, P70, DOI 10.1073/pnas.80.1.70; DIETZSCHOLD B, 1982, J VIROL, V44, P595, DOI 10.1128/JVI.44.2.595-602.1982; Dodet B, 2009, VACCINE, V27, P5027, DOI [10.1016/j.vaccine.2009.06.030, 10.1016/j.vaccine.2009.02.012]; FISHBEIN DB, 1993, NEW ENGL J MED, V329, P1632, DOI 10.1056/NEJM199311253292208; Fooks A R, 2005, Euro Surveill, V10, P1; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hanlon CA, 2005, VIRUS RES, V111, P44, DOI 10.1016/j.virusres.2005.03.009; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Horton DL, 2010, J VIROL, V84, P11841, DOI 10.1128/JVI.01153-10; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Ko K, 2005, VIRUS RES, V111, P93, DOI 10.1016/j.virusres.2005.03.016; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Kuzmin IV, 2003, VIRUS RES, V97, P65, DOI 10.1016/S0168-1702(03)00217-X; Lafay F, 1996, J GEN VIROL, V77, P339, DOI 10.1099/0022-1317-77-2-339; LAFON M, 1983, J GEN VIROL, V64, P843, DOI 10.1099/0022-1317-64-4-843; Luo TR, 1997, VIRUS RES, V51, P35, DOI 10.1016/S0168-1702(97)00080-4; Ma JKC, 2005, VACCINE, V23, P1814, DOI 10.1016/j.vaccine.2004.11.011; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Mansfield KL, 2004, J GEN VIROL, V85, P3279, DOI 10.1099/vir.0.80362-0; Marissen WE, 2005, J VIROL, V79, P4672, DOI 10.1128/JVI.79.8.4672-4678.2005; McCormick AA, 2008, P NATL ACAD SCI USA, V105, P10131, DOI 10.1073/pnas.0803636105; Muller T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000542; Muhamuda K, 2007, HUM VACCINES, V3, P192, DOI 10.4161/hv.3.5.4386; PREHAUD C, 1988, J VIROL, V62, P1; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Rupprecht CE, 2004, NEW ENGL J MED, V351, P2626, DOI 10.1056/NEJMcp042140; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Rupprecht CE, 2009, VACCINE, V27, P7141, DOI 10.1016/j.vaccine.2009.09.029; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; SATPATHY DM, 2005, J INDIAN MED ASSOC, V103, P241; SEIF I, 1985, J VIROL, V53, P926, DOI 10.1128/JVI.53.3.926-934.1985; Shantavasinkul P, 2010, CLIN INFECT DIS, V50, P77, DOI 10.1086/649873; Sloan SE, 2007, VACCINE, V25, P2800, DOI 10.1016/j.vaccine.2006.12.031; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Sudarshan M K, 2006, J Commun Dis, V38, P32; Tacket CO, 2000, J INFECT DIS, V182, P302, DOI 10.1086/315653; Tekoah Y, 2004, ARCH BIOCHEM BIOPHYS, V426, P266, DOI 10.1016/j.abb.2004.02.034; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Warrell M, 2010, INT J ANTIMICROB AG, V36, pS47, DOI 10.1016/j.ijantimicag.2010.06.021; Warrell MJ, 2003, VACCINE, V21, P706, DOI 10.1016/S0264-410X(02)00585-6; Wertheim HFL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000044; WHO, 2002, WHO CONS RAB MON ANT; Winkler W G, 1968, Wildl Dis, V4, P37; World Health Organization, 2012, RAB FACT SHEET 99; Wright E, 2008, J GEN VIROL, V89, P2204, DOI 10.1099/vir.0.2008/000349-0; Zeitlin L, 1998, NAT BIOTECHNOL, V16, P1361, DOI 10.1038/4344	63	32	35	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2055	2065		10.1096/fj.12-219964	http://dx.doi.org/10.1096/fj.12-219964			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23371065	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000318226100025
J	Schlumm, F; Mauceri, D; Freitag, HE; Bading, H				Schlumm, Friederike; Mauceri, Daniela; Freitag, H. Eckehard; Bading, Hilmar			Nuclear Calcium Signaling Regulates Nuclear Export of a Subset of Class IIa Histone Deacetylases following Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NMDA RECEPTORS; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; MEDIATED ACTIVATION; NEURONAL SURVIVAL; DENDRITIC GROWTH; KINASE-II; HDAC4; PHOSPHORYLATION	In neurons, dynamic changes in the subcellular localization of histone deacetylases (HDACs) are thought to contribute to signal-regulated gene expression. Here we show that in mouse hippocampal neurons, synaptic activity-dependent nucleo-cytoplasmic shuttling is a common feature of all members of class IIa HDACs, which distinguishes them from other classes of HDACs. Nuclear calcium, a key regulator in neuronal gene expression, is required for the nuclear export of a subset of class IIa HDACs. We found that inhibition of nuclear calcium signaling using CaMBP4 or increasing the nuclear calcium buffering capacity by means of expression of a nuclear targeted version of parvalbumin (PV.NLS-mC) led to a build-up of HDAC4 and HDAC5 in the cell nucleus, which in the case of PV. NLS-mC can be reversed by nuclear calcium transients triggered by bursts of action potential firing. A similar nuclear accumulation of HDAC4 and HDAC5 was observed in vivo in the mouse hippocampus following stereotaxic delivery of recombinant adeno-associated viruses expressing either CaMBP4 or PV. NLS-mC. The modulation of HDAC4 activity either by RNA interference-mediated reduction of HDAC4 protein levels or by expression of a constitutively nuclear localized mutant of HDAC4 leads to changes in the mRNA levels of several nuclear calcium-regulated genes with known functions in acquired neuroprotection (atf3, serpinb2), memory consolidation (homer1, arc), and the development of chronic pain (ptgs2, c1qc). These results identify nuclear calcium as a regulator of nuclear export of HDAC4 and HDAC5. The reduction of nuclear localized HDACs represents a novel transcription-promoting pathway stimulated by nuclear calcium.	[Schlumm, Friederike; Mauceri, Daniela; Freitag, H. Eckehard; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, INF 364, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633	Deutsche Forschungsgemeinschaft; ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 636]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, an ERC Advanced Grant (to H.B.), and the Sonderforschungsbereich 636 of the Deutsche Forschungsgemeinschaft.	Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Baltan S, 2011, TRANSL STROKE RES, V2, P411, DOI 10.1007/s12975-011-0087-z; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen RH, 1996, ONCOGENE, V12, P1493; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Glozak MA, 2009, J BIOL CHEM, V284, P11446, DOI 10.1074/jbc.M809394200; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guan YJ, 2012, AM J PHYSIOL-CELL PH, V303, pC33, DOI 10.1152/ajpcell.00348.2011; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	83	43	45	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8074	8084		10.1074/jbc.M112.432773	http://dx.doi.org/10.1074/jbc.M112.432773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364788	Green Published, hybrid			2022-12-25	WOS:000316564500008
J	Hosseini, S; Naderi-Manesh, H; Mountassif, D; Cerruti, M; Vali, H; Faghihi, S				Hosseini, Samaneh; Naderi-Manesh, Hossein; Mountassif, Driss; Cerruti, Marta; Vali, Hojatollah; Faghihi, Shahab			C-terminal Amidation of an Osteocalcin-derived Peptide Promotes Hydroxyapatite Crystallization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; MATRIX PROTEINS; HELICAL STRUCTURE; IN-VITRO; BINDING; NUCLEATION; PHOSPHORYLATION; MINERALIZATION; ADSORPTION; EXPRESSION	Genesis of natural biocomposite-based materials, such as bone, cartilage, and teeth, involves interactions between organic and inorganic systems. Natural biopolymers, such as peptide motif sequences, can be used as a template to direct the nucleation and crystallization of hydroxyapatite (HA). In this study, a natural motif sequence consisting of 13 amino acids present in the first helix of osteocalcin was selected based on its calcium binding ability and used as substrate for nucleation of HA crystals. The acidic (acidic osteocalcin-derived peptide (OSC)) and amidic (amidic osteocalcin-derived peptide (OSN)) forms of this sequence were synthesized to investigate the effects of different C termini on the process of biomineralization. Electron microscopy analyses show the formation of plate-like HA crystals with random size and shape in the presence of OSN. In contrast, spherical amorphous calcium phosphate is formed in the presence of OSC. Circular dichroism experiments indicate conformational changes of amidic peptide to an open and regular structure as a consequence of interaction with calcium and phosphate. There is no conformational change detectable in OSC. It is concluded that HA crystal formation, which only occurred in OSN, is attributable to C-terminal amidation of a natural peptide derived from osteocalcin. It is also proposed that natural peptides with the ability to promote biomineralization have the potential to be utilized in hard tissue regeneration.	[Hosseini, Samaneh; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 14115175, Iran; [Hosseini, Samaneh; Faghihi, Shahab] Natl Inst Genet Engn & Biotechnol, Tissue Engn & Biomat Div, Tehran 14965161, Iran; [Mountassif, Driss; Vali, Hojatollah] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Cerruti, Marta] McGill Univ, Dept Min & Mat Engn, Montreal, PQ H3A 0C7, Canada; [Vali, Hojatollah] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 0C7, Canada	Tarbiat Modares University; McGill University; McGill University; McGill University	Naderi-Manesh, H (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 14115175, Iran.	naderman@modares.ac.ir; sfaghihi@nigeb.ac.ir	Hosseini, Samaneh/I-1232-2019; Vali, Hojatollah/F-3511-2012	Vali, Hojatollah/0000-0003-3464-9943; Hosseini, Samaneh/0000-0002-5701-6666; Naderi-Manesh, Hossein/0000-0002-4227-171X	Tarbiat Modares University; Canada Research Chair Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada	Tarbiat Modares University; Canada Research Chair Foundation(Canada Research Chairs); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Tarbiat Modares University and Canada Research Chair Foundation (to M. C.) and the Natural Sciences and Engineering Research Council (NSERC) of Canada (to H. V.).	Aarden EM, 1996, HISTOCHEM CELL BIOL, V106, P495, DOI 10.1007/s004180050069; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Addison WN, 2010, BIOMATERIALS, V31, P9422, DOI 10.1016/j.biomaterials.2010.08.064; Amblard Muriel, 2005, V298, P3; ATKINSON RA, 1995, EUR J BIOCHEM, V232, P515, DOI 10.1111/j.1432-1033.1995.515zz.x; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Chung WJ, 2011, LANGMUIR, V27, P7620, DOI 10.1021/la104757g; Delak K, 2009, BIOCHEMISTRY-US, V48, P3669, DOI 10.1021/bi900113v; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FUJISAWA R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P56; GARNERO P, 1994, J BONE MINER RES, V9, P255; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x; Gungormus M, 2010, BIOMATERIALS, V31, P7266, DOI 10.1016/j.biomaterials.2010.06.010; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; In Y, 2005, FEBS J, V272, P5079, DOI 10.1111/j.1742-4658.2005.04919.x; In Y, 2001, J PEPT RES, V58, P399, DOI 10.1034/j.1399-3011.2001.00891.x; In Y, 2001, ACTA CRYSTALLOGR B, V57, P72, DOI 10.1107/S0108768100013975; Juban M M, 1997, Methods Mol Biol, V78, P73; Kulp JL, 2005, LANGMUIR, V21, P11907, DOI 10.1021/la050961x; Kulp JL, 2007, LANGMUIR, V23, P3857, DOI 10.1021/la062442f; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leonor IB, 2007, J MATER CHEM, V17, P4057, DOI 10.1039/b707304f; LINDE A, 1995, INT J DEV BIOL, V39, P213; Novak JF, 1997, J BONE MINER RES, V12, P1035, DOI 10.1359/jbmr.1997.12.7.1035; PAGE AE, 1993, INT J BIOCHEM, V25, P545, DOI 10.1016/0020-711X(93)90662-X; POSER JW, 1979, J BIOL CHEM, V254, P431; Potetinova Z, 2006, BIOCHEMISTRY-US, V45, P11113, DOI 10.1021/bi060500q; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322; Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008; Shiba K, 2010, CHEM SOC REV, V39, P117, DOI 10.1039/b719081f; Srivastava AK, 2002, BONE, V31, P62, DOI 10.1016/S8756-3282(02)00793-7; Strandberg E, 2007, PURE APPL CHEM, V79, P717, DOI 10.1351/pac200779040717; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275	53	21	22	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7885	7893		10.1074/jbc.M112.422048	http://dx.doi.org/10.1074/jbc.M112.422048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362258	Green Published, hybrid			2022-12-25	WOS:000316455300042
J	Kimura, T; Tsutsumi, K; Taoka, M; Saito, T; Masuda-Suzukake, M; Ishiguro, K; Plattner, F; Uchida, T; Isobe, T; Hasegawa, M; Hisanaga, SI				Kimura, Taeko; Tsutsumi, Koji; Taoka, Masato; Saito, Taro; Masuda-Suzukake, Masami; Ishiguro, Koichi; Plattner, Florian; Uchida, Takafumi; Isobe, Toshiaki; Hasegawa, Masato; Hisanaga, Shin-Ichi			Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROLYL ISOMERASE; MICROTUBULE-BINDING; WILD-TYPE; CDK5; P35; FTDP-17; MUTATIONS; ACTIVATOR; CLEAVAGE	Neurodegenerative diseases associated with the pathological aggregation of microtubule-associated protein Tau are classified as tauopathies. Alzheimer disease, the most common tauopathy, is characterized by neurofibrillary tangles that are mainly composed of abnormally phosphorylated Tau. Similar hyperphosphorylated Tau lesions are found in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) that is induced by mutations within the tau gene. To further understand the etiology of tauopathies, it will be important to elucidate the mechanism underlying Tau hyper-phosphorylation. Tau phosphorylation occurs mainly at proline-directed Ser/Thr sites, which are targeted by protein kinases such as GSK3 beta and Cdk5. We reported previously that dephosphorylation of Tau at Cdk5-mediated sites was enhanced byPin1, a peptidyl-prolylisomerase that stimulates dephosphorylation at proline-directed sites by protein phosphatase 2A. Pin1 deficiency is suggested to cause Tau hyperphosphorylation in Alzheimer disease. Up to the present, Pin1 binding was only shown for two Tau phosphorylation sites (Thr-212 and Thr-231) despite the presence of many more hyperphosphorylated sites. Here, we analyzed the interaction of Pin1 with Tau phosphorylated by Cdk5-p25 using a GST pulldown assay and Biacore approach. We found that Pin1 binds and stimulates dephosphorylation of Tau at all Cdk5-mediated sites (Ser-202, Thr-205, Ser-235, and Ser-404). Furthermore, FTDP-17 mutant Tau (P301L or R406W) showed slightly weaker Pin1 binding than non-mutated Tau, suggesting that FTDP-17 mutations induce hyperphosphorylation by reducing the interaction between Pin1 and Tau. Together, these results indicate that Pin1 is generally involved in the regulation of Tau hyperphosphorylation and hence the etiology of tauopathies.	[Kimura, Taeko; Tsutsumi, Koji; Saito, Taro; Hisanaga, Shin-Ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Biol Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Masuda-Suzukake, Masami; Hasegawa, Masato] Tokyo Metropolitan Univ, Setagaya Ku, Tokyo 1568506, Japan; [Ishiguro, Koichi] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; [Plattner, Florian] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Tokyo Metropolitan University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Texas System; University of Texas Southwestern Medical Center Dallas; Tohoku University	Hisanaga, SI (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp	Isobe, Toshiaki/Q-9279-2017	Uchida, Takafumi/0000-0003-3665-4906; Taoka, Masato/0000-0001-5554-4951; Plattner, Florian/0000-0002-3150-1866	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. H.).	Allen B, 2002, J NEUROSCI, V22, P9340; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Daum S, 2006, BIOCHEMISTRY-US, V45, P12125, DOI 10.1021/bi0608820; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Imahori K, 1997, J BIOCHEM, V121, P179; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lu PJ, 1999, NATURE, V399, P784; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Nykanen NP, 2012, J BIOL CHEM, V287, P6743, DOI 10.1074/jbc.M111.309385; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Smet C, 2005, J MED CHEM, V48, P4815, DOI 10.1021/jm0500119; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Yotsumoto K, 2009, J BIOL CHEM, V284, P16840, DOI 10.1074/jbc.M109.003277; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	66	42	43	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7968	7977		10.1074/jbc.M112.433326	http://dx.doi.org/10.1074/jbc.M112.433326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362255	Green Published, hybrid			2022-12-25	WOS:000316455300049
J	Bjerg, A; Ekerljung, L; Eriksson, J; Olafsdottir, IS; Middelveld, R; Franklin, KA; Forsberg, B; Larsson, K; Lotvall, J; Toren, K; Dahlen, SE; Lundback, B; Janson, C				Bjerg, Anders; Ekerljung, Linda; Eriksson, Jonas; Olafsdottir, Inga Sif; Middelveld, Roelinde; Franklin, Karl A.; Forsberg, Bertil; Larsson, Kjell; Lotvall, Jan; Toren, Kjell; Dahlen, Sven-Erik; Lundback, Bo; Janson, Christer			Higher Risk of Wheeze in Female than Male Smokers. Results from the Swedish GA(2)LEN Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NORD-TRONDELAG HEALTH; LUNG-FUNCTION; BRONCHIAL HYPERRESPONSIVENESS; METHACHOLINE REACTIVITY; RESPIRATORY SYMPTOMS; GENDER-DIFFERENCES; CIGARETTE-SMOKING; WOMEN; COPD	Background: Women who smoke have higher risk of lung function impairment, COPD and lung cancer than smoking men. An influence of sex hormones has been demonstrated, but the mechanisms are unclear and the associations often subject to confounding. This was a study of wheeze in relation to smoking and sex with adjustment for important confounders. Methods: In 2008 the Global Allergy and Asthma European Network (GA(2)LEN) questionnaire was mailed to 45.000 Swedes (age 16-75 years), and 26.851 (60%) participated. "Any wheeze'': any wheeze during the last 12 months. "Asthmatic wheeze'': wheeze with breathlessness apart from colds. Results: Any wheeze and asthmatic wheeze was reported by 17.3% and 7.1% of women, vs. 15.8% and 6.1% of men (both p<0.001). Although smoking prevalence was similar in both sexes, men had greater cumulative exposure, 16.2 pack-years vs. 12.8 in women (p<0.001). Most other exposures and characteristics associated with wheeze were significantly overrepresented in men. Adjusted for these potential confounders and pack-years, current smoking was a stronger risk factor for any wheeze in women aged <53 years, adjusted odds ratio (aOR) 1.85 (1.56-2.19) vs. 1.60 (1.30-1.96) in men. Cumulative smoke exposure and current smoking each interacted significantly with female sex, aOR 1.02 per pack-year (p<0.01) and aOR 1.28 (p = 0.04) respectively. Female compared to male current smokers also had greater risk of asthmatic wheeze, aOR 1.53 vs. 1.03, interaction aOR 1.52 (p = 0.02). These interactions were not seen in age >= 53 years. Discussion: In addition to the increased risk of COPD and lung cancer female, compared to male, smokers are at greater risk of significant wheezing symptoms in younger age. This became clearer after adjustment for important confounders including cumulative smoke exposure. Estrogen has previously been shown to increase the bioactivation of several compounds in tobacco smoke, which may enhance smoke-induced airway inflammation in fertile women.	[Bjerg, Anders; Ekerljung, Linda; Eriksson, Jonas; Lotvall, Jan; Lundback, Bo] Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden; [Bjerg, Anders] Sunderby Cent Hosp Norrbotten, OLIN Studies, Dept Med, Lulea, Sweden; [Olafsdottir, Inga Sif] Univ Gothenburg, Sahlgrenska Sch Publ Hlth, Gothenburg, Sweden; [Middelveld, Roelinde; Dahlen, Sven-Erik] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Middelveld, Roelinde; Larsson, Kjell; Toren, Kjell; Dahlen, Sven-Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Franklin, Karl A.] Umea Univ, Dept Surg, Umea, Sweden; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Umea University; Umea University; Sahlgrenska University Hospital; Uppsala University	Bjerg, A (corresponding author), Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden.	anders.bjerg@gu.se	Bjerg, Anders/GRR-3443-2022	Franklin, Karl/0000-0002-5306-1697; Lotvall, Jan/0000-0001-9195-9249	EU [FOOD-CT-2004-506378]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	EU(European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	This study was carried out as part of the GA2LEN survey and was financially supported by the EU Sixth Framework programme for research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by VBG Group Centre for Asthma and Allergy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Benowitz NL, 2006, CLIN PHARMACOL THER, V79, P480, DOI 10.1016/j.clpt.2006.01.008; Bjerg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016082; BJORNSSON E, 1994, EUR RESPIR J, V7, P2146, DOI 10.1183/09031936.94.07122146; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; de Marco R, 1998, EUR RESPIR J, V11, P599; de Meer G, 2005, ALLERGY, V60, P1499, DOI 10.1111/j.1398-9995.2005.00930.x; Fokkens W, 2007, RHINOLOGY, V45, P97; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Greaves Lorraine J, 2007, Proc Am Thorac Soc, V4, P675, DOI 10.1513/pats.200706-079SD; Holmen TL, 2002, RESP MED, V96, P796, DOI 10.1053/rmed.2002.1350; Langhammer A, 2000, J EPIDEMIOL COMMUN H, V54, P917, DOI 10.1136/jech.54.12.917; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; LUNDBACK B, 1993, ALLERGY, V48, P117, DOI 10.1111/j.1398-9995.1993.tb00696.x; McCormack VA, 2010, INT J CANCER, V127, P2402, DOI 10.1002/ijc.25252; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; PAOLETTI P, 1995, AM J RESP CRIT CARE, V151, P1770, DOI 10.1164/ajrccm.151.6.7767519; Prescott E, 1997, EUR RESPIR J, V10, P822; Rodstrom K, 2003, MENOPAUSE, V10, P538, DOI 10.1097/01.GME.0000094395.59028.0F; Ronmark EP, 2009, RESP MED, V103, P1807, DOI 10.1016/j.rmed.2009.07.014; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Spivack SD, 2003, CLIN CANCER RES, V9, P6002; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; Wilson AS, 1996, TOXICOLOGY, V114, P233, DOI 10.1016/S0300-483X(96)03515-9; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zorrilla-Torras B, 2005, EUR J PUBLIC HEALTH, V15, P43, DOI 10.1093/eurpub/cki110	30	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54137	10.1371/journal.pone.0054137	http://dx.doi.org/10.1371/journal.pone.0054137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357876	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600034
J	Mi, Y; Zhang, X; Zhang, F; Qi, JL; Gao, HX; Huang, DY; Li, L; Zhang, HL; Du, XN				Mi, Yao; Zhang, Xuan; Zhang, Fan; Qi, Jinlong; Gao, Haixia; Huang, Dongyang; Li, Li; Zhang, Hailin; Du, Xiaona			The Role of Potassium Channel Activation in Celecoxib-Induced Analgesic Action	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SENSORY NEURONS; NEUROPATHIC PAIN; K+ CHANNELS; INHIBITION; CURRENTS; PROTEIN; CYCLOOXYGENASE; IDENTIFICATION; NOCICEPTION	Background and Purpose: Celecoxib (CXB) is a widely prescribed COX-2 inhibitor used clinically to treat pain and inflammation. Recently, COX-2 independent mechanisms have been described to be the targets of CXB. For instance, ion channels such as the voltage-gated sodium channel, L-type calcium channel, Kv2.1, Kv1.5, Kv4.3 and HERG potassium channel were all reported to be inhibited by CXB. Our recent study revealed that CXB is a potent activator of Kv7/M channels. M currents expressed in dorsal root ganglia play an important role in nociception. Our study was aimed at establishing the role of COX-2 independent M current activation in the analgesic action of CXB. Methods and Results: We compared the effects of CXB and its two structural analogues, unmethylated CXB (UMC) and 2,5-dimethyl-CXB (DMC), on Kv7/M currents and pain behavior in animal models. UMC is a more potent inhibitor of COX-2 than CXB while DMC has no COX-2 inhibiting activity. We found that CXB, UMC and DMC concentration-dependently activated Kv7.2/7.3 channels expressed in HEK293 cells and the M-type current in dorsal root ganglia neurons, negatively shifted I-V curve of Kv7.2/7.3 channels, with a potency and efficiency inverse to their COX-2 inhibitory potential. Furthermore, CXB, UMC and DMC greatly reduced inflammatory pain behavior induced by bradykinin, mechanical pain behavior induced by stimulation with von Frey filaments and thermal pain behavior in the Hargreaves test. CXB and DMC also significantly attenuated hyperalgesia in chronic constriction injury neuropathic pain. Conclusion: CXB, DMC and UMC are openers of Kv7/M K+ channels with effects independent of COX-2 inhibition. The analgesic effects of CXBs on pain behaviors, especially those of DMC, suggest that activation of Kv7/M K+ channels may play an important role in the analgesic action of CXB. This study strengthens the notion that Kv7/M K+ channels are a potential target for pain treatment.	[Mi, Yao; Zhang, Xuan; Zhang, Fan; Gao, Haixia; Huang, Dongyang; Li, Li; Zhang, Hailin; Du, Xiaona] Minist Educ, Key Lab Neural & Vasc Biol, Dept Pharmacol, Shijiazhuang, Peoples R China; [Qi, Jinlong] Hebei Med Univ, Dept New Drug Dev, Shijiazhuang, Peoples R China	Hebei Medical University	Du, XN (corresponding author), Minist Educ, Key Lab Neural & Vasc Biol, Dept Pharmacol, Shijiazhuang, Peoples R China.	du_xiaona@yahoo.com	张, 凡/GRX-6695-2022	张, 凡/0000-0003-0458-6742	National Natural Science Foundation of China [30500112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30500112) (X.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2002, J BIOL CHEM, V277, P27613, DOI 10.1074/jbc.M201119200; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; CASSELL JF, 1987, BRIT J PHARMACOL, V91, P259, DOI 10.1111/j.1476-5381.1987.tb10279.x; Chuang HC, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-38; Du XN, 2011, BRIT J PHARMACOL, V164, P1722, DOI 10.1111/j.1476-5381.2011.01483.x; Franco L, 1999, PROSTAG OTH LIPID M, V58, P9, DOI 10.1016/S0090-6980(99)00020-9; Frolov RV, 2008, NEUROSCIENCE, V154, P1525, DOI 10.1016/j.neuroscience.2008.05.004; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026344; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Ke M, 2008, BRAIN RES, V1209, P57, DOI 10.1016/j.brainres.2008.02.096; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Lynch JJ, 2004, PAIN, V110, P56, DOI 10.1016/j.pain.2004.03.010; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2003, EXP NEUROL, V183, P581, DOI 10.1016/S0014-4886(03)00182-1; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Rodrigues-Filho R, 2004, BRAIN RES, V1018, P159, DOI 10.1016/j.brainres.2004.05.058; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; White WB, 2007, AM J CARDIOL, V99, P91, DOI 10.1016/j.amjcard.2006.07.069; Zhang Y, 2007, PHARMACOL RES, V56, P267, DOI 10.1016/j.phrs.2007.07.004	37	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54797	10.1371/journal.pone.0054797	http://dx.doi.org/10.1371/journal.pone.0054797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358696	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600113
J	Ramakrishna, S; Kim, YH; Kim, H				Ramakrishna, Suresh; Kim, Young-Hoon; Kim, Hyongbum			Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TARGETED GENE KNOCKOUT; HOMOLOGOUS RECOMBINATION; PATHWAY; DISRUPTION; DROSOPHILA; MUTATIONS; CLEAVAGE; ENZYMES	Background: Zinc finger nucleases (ZFNs) are powerful tools for gene therapy and genetic engineering. The characterization of ZFN protein stability and the development of simple methods to improve ZFN function would facilitate the application of this promising technology. However, the factors that affect ZFN protein stability and function are not yet clear. Here, we determined the stability and half-life of two ZFN proteins and examined the effect of MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-Hl), a proteasome inhibitor, on ZFN-mediated gene modifications. Methodology/Principal Findings: ZFN proteins were expressed in 293T cells after transfection of ZFN-encoding plasmids. We studied two ZFN pairs: Z-224, which targets the CCR5 gene, and K-230, which targets a region 230 kbp upstream of CCR5. Western blotting after treatment with cycloheximide showed that the half-life of these ZFN proteins was around two hours. An immunoprecipitation assay revealed that the ZFN interacts with ubiquitin molecules and undergoes polyubiquitination in vivo. Western blotting showed that the addition of MG132, a proteasomal inhibitor, increased ZFN protein levels. Finally, a surrogate reporter assay and a T7E1 assay revealed that MG132 treatment enhanced ZFN-directed gene editing. Conclusions: To our knowledge, this is the first study to investigate ZFN protein stability and to show that a small molecule can increase ZFN activity. Our protein stability study should lay the foundation for further improvement of ZFN technology; as a first step, the use of the small molecule MG132 can enhance the efficiency of ZFN-mediated gene editing.	[Ramakrishna, Suresh; Kim, Young-Hoon; Kim, Hyongbum] Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Med, Seoul 133791, South Korea	Hanyang University	Kim, H (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Med, Seoul 133791, South Korea.	hkim1@hanyang.ac.kr	Kim, Hyongbum Henry/D-5804-2019; Ramakrishna, Suresh/AAX-4096-2021	Kim, Hyongbum Henry/0000-0002-4693-738X; 	Ministry of Education, Science and Technology of Korea [2012-0006105, 2012-0003376, 2012-0006735, 2012-0009337, 2012K001482]	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Ministry of Education, Science and Technology of Korea (2012-0006105, 2012-0003376, 2012-0006735, 2012-0009337, and 2012K001482). No additional funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Ellis B.L., 2012, GENE THER; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Pan HZ, 2011, PROTEIN CELL, V2, P950, DOI 10.1007/s13238-011-1132-0; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	38	16	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54282	10.1371/journal.pone.0054282	http://dx.doi.org/10.1371/journal.pone.0054282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365657	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600045
J	Wilke, C; Synofzik, M; Lindner, A				Wilke, Carlo; Synofzik, Matthis; Lindner, Axel			Sensorimotor Recalibration Depends on Attribution of Sensory Prediction Errors to Internal Causes	PLOS ONE			English	Article							MOTOR ADAPTATION; PERCEPTION; SCHIZOPHRENIA; CONSEQUENCES; AGENCY; ABNORMALITIES; INFORMATION; AWARENESS; CORRELATE; DYNAMICS	Sensorimotor learning critically depends on error signals. Learning usually tries to minimise these error signals to guarantee optimal performance. Errors can, however, have both internal causes, resulting from one's sensorimotor system, and external causes, resulting from external disturbances. Does learning take into account the perceived cause of error information? Here, we investigated the recalibration of internal predictions about the sensory consequences of one's actions. Since these predictions underlie the distinction of self- and externally produced sensory events, we assumed them to be recalibrated only by prediction errors attributed to internal causes. When subjects were confronted with experimentally induced visual prediction errors about their pointing movements in virtual reality, they recalibrated the predicted visual consequences of their movements. Recalibration was not proportional to the externally generated prediction error, but correlated with the error component which subjects attributed to internal causes. We also revealed adaptation in subjects' motor performance which reflected their recalibrated sensory predictions. Thus, causal attribution of error information is essential for sensorimotor learning.	[Wilke, Carlo; Lindner, Axel] Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lindner, A (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	a.lindner@medizin.uni-tuebingen.de	Wilke, Carlo/AAJ-8207-2020	Wilke, Carlo/0000-0002-7250-8597; Lindner, Axel/0000-0002-8201-788X; Synofzik, Matthis/0000-0002-2280-7273	German Research Council (Werner Reichardt Centre for Integrative Neuroscience); Bernstein Center for Computational Neuroscience Tubingen [BMBF FKZ 01GQ1002]; Volkswagen Stiftung [VW II/85158]	German Research Council (Werner Reichardt Centre for Integrative Neuroscience); Bernstein Center for Computational Neuroscience Tubingen; Volkswagen Stiftung(Volkswagen)	This work was supported by grants from the German Research Council (Werner Reichardt Centre for Integrative Neuroscience), the Bernstein Center for Computational Neuroscience Tubingen (BMBF FKZ 01GQ1002) and the Volkswagen Stiftung (VW II/85158 to MS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bland AR, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00080; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Cressman EK, 2011, PROG BRAIN RES, V191, P91, DOI 10.1016/B978-0-444-53752-2.00011-4; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Farrer C, 2003, CONSCIOUS COGN, V12, P609, DOI 10.1016/S1053-8100(03)00047-3; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; HAITH A, 2008, UNIFYING SENSORY MOT; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lai EJ, 2003, EXP BRAIN RES, V153, P76, DOI 10.1007/s00221-003-1584-4; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nakanishi J, 2004, NEURAL NETWORKS, V17, P1453, DOI 10.1016/j.neunet.2004.05.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Preston C, 2010, CONSCIOUS COGN, V19, P986, DOI 10.1016/j.concog.2010.04.005; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reuschel J, 2011, EXP BRAIN RES, V209, P619, DOI 10.1007/s00221-011-2596-0; Reuschel J, 2010, EXP BRAIN RES, V201, P853, DOI 10.1007/s00221-009-2099-4; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Synofzik M, 2009, CONSCIOUS COGN, V18, P1065, DOI 10.1016/j.concog.2009.07.007; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Torres-Oviedo G, 2012, J NEUROPHYSIOL, V107, P346, DOI 10.1152/jn.00570.2011; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wilke C, 2012, CONSCIOUS COGN, V21, P18, DOI 10.1016/j.concog.2011.06.004; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	66	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54925	10.1371/journal.pone.0054925	http://dx.doi.org/10.1371/journal.pone.0054925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359818	gold, Green Published			2022-12-25	WOS:000314023600136
J	Bowman, H; Filetti, M; Janssen, D; Su, L; Alsufyani, A; Wyble, B				Bowman, Howard; Filetti, Marco; Janssen, Dirk; Su, Li; Alsufyani, Abdulmajeed; Wyble, Brad			Subliminal Salience Search Illustrated: EEG Identity and Deception Detection on the Fringe of Awareness	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; EVENT-RELATED POTENTIALS; COMPLEX TRIAL PROTOCOL; TERM CONCEPTUAL MEMORY; ATTENTIONAL BLINK; CONCEALED INFORMATION; TEMPORAL ATTENTION; WORKING-MEMORY; TESTS; P300	We propose a novel deception detection system based on Rapid Serial Visual Presentation (RSVP). One motivation for the new method is to present stimuli on the fringe of awareness, such that it is more difficult for deceivers to confound the deception test using countermeasures. The proposed system is able to detect identity deception (by using the first names of participants) with a 100% hit rate (at an alpha level of 0.05). To achieve this, we extended the classic Event-Related Potential (ERP) techniques (such as peak-to-peak) by applying Randomisation, a form of Monte Carlo resampling, which we used to detect deception at an individual level. In order to make the deployment of the system simple and rapid, we utilised data from three electrodes only: Fz, Cz and Pz. We then combined data from the three electrodes using Fisher's method so that each participant was assigned a single p-value, which represents the combined probability that a specific participant was being deceptive. We also present subliminal salience search as a general method to determine what participants find salient by detecting breakthrough into conscious awareness using EEG.	[Bowman, Howard; Filetti, Marco; Alsufyani, Abdulmajeed] Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England; [Janssen, Dirk] NHTV Breda Univ Appl Sci, Breda, Netherlands; [Su, Li] Univ Cambridge, Cambridge, England; [Wyble, Brad] Syracuse Univ, Coll Arts & Sci, Dept Psychol, Syracuse, NY USA	University of Kent; Breda University of Applied Sciences; University of Cambridge; Syracuse University	Bowman, H (corresponding author), Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England.	H.Bowman@kent.ac.uk	Alsufyani, abdulmajeed/AGG-9038-2022	Alsufyani, abdulmajeed/0000-0001-6110-3642; Su, Li/0000-0002-6347-3986	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	One of the PhD students involved in this research was supported financially by the University of Kent (www.kent.ac.uk). Initial ideas that led to the approach presented here were developed under United Kingdom (UK) Engineering and Physical Sciences Research Council funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2010, IEEE ENG MED BIO, P2686, DOI 10.1109/IEMBS.2010.5626548; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Barnard PJ, 2005, VIS COGN, V12, P181, DOI 10.1080/13506280444000139; Barnard PJ, 2004, PSYCHOL SCI, V15, P179, DOI 10.1111/j.0956-7976.2004.01503006.x; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Battye G, 2003, CONNECTIONIST MODELL; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; BOTELLA J, 1992, PERCEPT PSYCHOPHYS, V52, P547, DOI 10.3758/BF03206716; Bowman H., 2011, HUMAN ATTENTION DIGI, P114, DOI DOI 10.1017/CB09780511974519.005; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Chennu S., 2011, 33 ANN C COGN SCI SO, V33, P2598; Chennu S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000576; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Craston P, 2009, J COGNITIVE NEUROSCI, V21, P550, DOI 10.1162/jocn.2009.21036; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; ELAAD E, 1992, J APPL PSYCHOL, V77, P757, DOI 10.1037/0021-9010.77.5.757; Farwell LA, 2001, J FORENSIC SCI, V46, P135; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Labkovsky E, 2012, APPL PSYCHOPHYS BIOF, V37, P1, DOI 10.1007/s10484-011-9171-0; Lan T, 2010, ESANN EUR S ART NEUR, P351; LAWRENCE DH, 1971, PERCEPT PSYCHOPHYS, V10, P85, DOI 10.3758/BF03214320; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Lykken D.T., 1998, TREMOR BLOOD USES AB; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Miller AR, 2002, J PSYCHOPHYSIOL, V16, P1, DOI 10.1027//0269-8803.16.1.1; Nieuwenhuis S, 2005, J EXP PSYCHOL GEN, V134, P291, DOI 10.1037/0096-3445.134.3.291; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; Potter MC, 2010, J EXP PSYCHOL HUMAN, V36, P1486, DOI 10.1037/a0018730; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; POTTER MC, 1993, MEM COGNITION, V21, P156, DOI 10.3758/BF03202727; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rosenfeld JP, 2007, BIOL PSYCHOL, V74, P396, DOI 10.1016/j.biopsycho.2006.10.002; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 2006, INT J PSYCHOPHYSIOL, V60, P251, DOI 10.1016/j.ijpsycho.2005.06.002; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; Shih SI, 2002, PSYCHOL REV, V109, P260, DOI 10.1037//0033-295X.109.2.260; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wyble B, 2006, ELECTROPHYSIOLOGICAL; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	57	24	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54258	10.1371/journal.pone.0054258	http://dx.doi.org/10.1371/journal.pone.0054258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372697	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500049
J	Heynen, SR; Meneau, I; Caprara, C; Samardzija, M; Imsand, C; Levine, EM; Grimm, C				Heynen, Severin Reinhard; Meneau, Isabelle; Caprara, Christian; Samardzija, Marijana; Imsand, Cornelia; Levine, Edward M.; Grimm, Christian			CDC42 Is Required for Tissue Lamination and Cell Survival in the Mouse Retina	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; OPTIC-NERVE; PHOTORECEPTOR DEGENERATION; NEUROTROPHIC FACTOR; MAMMALIAN RETINA; TRANSGENIC MICE; BETA-CATENIN; LIGHT DAMAGE; RHO-GTPASES; N-CADHERIN	The small GTPase CDC42 has pleiotropic functions during development and in the adult. These functions include intra-as well as intercellular tasks such as organization of the cytoskeleton and, at least in epithelial cells, formation of adherens junctions. To investigate CDC42 in the neuronal retina, we generated retina-specific Cdc42-knockdown mice (Cdc42-KD) and analyzed the ensuing consequences for the developing and postnatal retina. Lack of CDC42 affected organization of the developing retina as early as E17.5, prevented correct tissue lamination, and resulted in progressive retinal degeneration and severely reduced retinal function of the postnatal retina. Despite the disorganization of the retina, formation of the primary vascular plexus was not strongly affected. However, both deeper vascular plexi developed abnormally with no clear layering of the vessels. Retinas of Cdc42-KD mice showed increased expression of pro-survival, but also of pro-apoptotic and pro-inflammatory genes and exhibited prolonged Muller glia hypertrophy. Thus, functional CDC42 is important for correct tissue organization already during retinal development. Its absence leads to severe destabilization of the postnatal retina with strong degeneration and loss of retinal function.	[Heynen, Severin Reinhard; Meneau, Isabelle; Caprara, Christian; Samardzija, Marijana; Imsand, Cornelia; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, CH-8006 Zurich, Switzerland; [Heynen, Severin Reinhard; Caprara, Christian; Grimm, Christian] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland; [Levine, Edward M.] Univ Utah, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Grimm, Christian] Univ Zurich, Ctr Neurosci, CH-8006 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Utah System of Higher Education; University of Utah; University of Zurich	Grimm, C (corresponding author), Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, CH-8006 Zurich, Switzerland.	cgrimm@opht.uzh.ch	Levine, Edward/N-3878-2015; Samardzija, Marijana/B-9245-2008	Levine, Edward/0000-0003-1725-2805; Samardzija, Marijana/0000-0003-0991-4653; Grimm, Christian/0000-0001-9318-4352	University of Zurich; Swiss National Science Foundation (SNF) [3100A0-117760]; NATIONAL EYE INSTITUTE [P30EY014800, R01EY013760] Funding Source: NIH RePORTER	University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a cooperative ZIHP project (University of Zurich) and the Swiss National Science Foundation (SNF #3100A0-117760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Burgi S, 2009, MOL VIS, V15, P1631; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Caprara C, 2011, INVEST OPHTH VIS SCI, V52, P2109, DOI 10.1167/iovs.10-6222; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen TJ, 2006, J NEUROBIOL, V66, P103, DOI 10.1002/neu.20204; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Heynen SR, 2011, MOL VIS, V17, P2934; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Lange C, 2010, J NEUROCHEM, V113, P1210, DOI 10.1111/j.1471-4159.2010.06686.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mitchell DC, 2007, MOL VIS, V13, P1144; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Randlett O, 2011, DEV NEUROBIOL, V71, P567, DOI 10.1002/dneu.20841; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Santos-Bredariol AS, 2002, J NEUROCYTOL, V31, P149, DOI 10.1023/A:1023997506760; Schnack C, 2008, NEUROSCIENCE, V154, P1450, DOI 10.1016/j.neuroscience.2008.02.049; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Stone J, 1995, NEUROSCIENCE, V5, P4738; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vazquez-Chona FR, 2009, INVEST OPHTH VIS SCI, V50, P3996, DOI 10.1167/iovs.08-3189; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yokota Y, 2010, DEVELOPMENT, V137, P4101, DOI 10.1242/dev.048637; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhu XW, 2000, INT J DEV NEUROSCI, V18, P433, DOI 10.1016/S0736-5748(00)00010-1	59	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53806	10.1371/journal.pone.0053806	http://dx.doi.org/10.1371/journal.pone.0053806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372671	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000314021500025
J	Mariani, F; Sena, P; Pedroni, M; Benatti, P; Manni, P; Di Gregorio, C; Manenti, A; Palumbo, C; de Leon, MP; Roncucci, L				Mariani, Francesco; Sena, Paola; Pedroni, Monica; Benatti, Piero; Manni, Paola; Di Gregorio, Carmela; Manenti, Antonio; Palumbo, Carla; de Leon, Maurizio Ponz; Roncucci, Luca			Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ABERRANT CRYPT FOCI; LINEAGE DIFFERENTIATION; POSITIVE SELECTION; MUCOSAL IMMUNITY; GENE-EXPRESSION; CANCER PATIENTS; LYTIC FUNCTION; HUMAN COLON; LYMPHOCYTES	We purposed to evaluate the role of Th inducing POZ-Kruppel Factor (ThPOK), a transcriptional regulator of T cell fate, in tumour-induced immune system plasticity in colorectal carcinogenesis. The amounts of CD4+, CD8+ and CD56+ and ThPOK+ cells infiltrate in normal colorectal mucosa (NM), in dysplastic aberrant crypt foci (microadenomas, MA), the earliest detectable lesions in colorectal carcinogenesis, and in colorectal carcinomas (CRC), were measured, and the colocalization of ThPOK with the above-mentioned markers of immune cells was evaluated using confocal microscopy. Interestingly, ThPOK showed a prominent increase since MA. A strong colocalization of ThPOK with CD4 both in NM and in MA was observed, weaker in carcinomas. Surprisingly, there was a peak in the colocalization levels of ThPOK with CD8 in MA, which was evident, although to a lesser extent, in carcinomas, too. In conclusion, according to the data of the present study, ThPOK may be considered a central regulator of the earliest events in the immune system during colorectal cancer development, decreasing the immune response against cancer cells.	[Mariani, Francesco; Pedroni, Monica; Benatti, Piero; de Leon, Maurizio Ponz; Roncucci, Luca] Univ Modena & Reggio Emilia, Dept Internal Med, Modena, Italy; [Sena, Paola; Palumbo, Carla] Univ Modena & Reggio Emilia, Dept Morphol Sci, Modena, Italy; [Manni, Paola; Di Gregorio, Carmela] Univ Modena & Reggio Emilia, Dept Serv Diagnost Lab & Med Legale, Modena, Italy; [Manenti, Antonio] Univ Modena & Reggio Emilia, Dept Surg, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Roncucci, L (corresponding author), Univ Modena & Reggio Emilia, Dept Internal Med, Modena, Italy.	luca.roncucci@unimore.it	Benatti, Piero/C-1052-2015; Roncucci, Luca/L-1392-2016; de Leon, Maurizio Ponz/A-9356-2015; Pedroni, Monica/C-9384-2015; Sena, Paola/G-9394-2016; Palumbo, Carla/E-5802-2012; Palumbo, Carla/V-5905-2019	Benatti, Piero/0000-0002-6826-1480; Roncucci, Luca/0000-0002-0410-1760; de Leon, Maurizio Ponz/0000-0003-4465-1043; Pedroni, Monica/0000-0001-5374-5362; Sena, Paola/0000-0003-4724-8786; Palumbo, Carla/0000-0003-0587-0112; Palumbo, Carla/0000-0003-0587-0112; Mariani, Francesco/0000-0002-0650-3253	Fondazione Umberto Veronesi	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was supported by the Fondazione Umberto Veronesi (which supported the grant for Dott. Francesco Mariani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Betts G, 2011, GUT; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; DiGregori C, 1997, HISTOPATHOLOGY, V30, P328, DOI 10.1046/j.1365-2559.1997.d01-626.x; Disis ML, 2009, LANCET, V373, P673, DOI 10.1016/S0140-6736(09)60404-9; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Frey AB, 2006, J LEUKOCYTE BIOL, V79, P652, DOI 10.1189/jlb.1105628; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Gulubova M, 2009, APMIS, V117, P870, DOI 10.1111/j.1600-0463.2009.02547.x; Guven H, 2003, LEUKEMIA, V17, P1973, DOI 10.1038/sj.leu.2403083; Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Ma C, 2011, SCAND J IMMUNOL, V74, P47, DOI 10.1111/j.1365-3083.2011.02539.x; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Mulder WMC, 1997, GUT, V40, P113, DOI 10.1136/gut.40.1.113; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Parmiani G, 2005, NEW ENGL J MED, V353, P2640, DOI 10.1056/NEJMp058236; Radoja S, 2000, MOL MED, V6, P465, DOI 10.1007/BF03401788; RONCUCCI L, 1991, CANCER EPIDEM BIOMAR, V1, P57; Sena P, 2010, CANCER EPIDEM BIOMAR, V19, P351, DOI 10.1158/1055-9965.EPI-09-0438; Setoguchi R, 2009, J IMMUNOL, V183, P4467, DOI 10.4049/jimmunol.0901428; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Wang L, 2010, EUR J IMMUNOL, V40, P2385, DOI 10.1002/eji.201040534; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; WATT AG, 1978, CANCER, V41, P279, DOI 10.1002/1097-0142(197801)41:1<279::AID-CNCR2820410139>3.0.CO;2-B	50	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54488	10.1371/journal.pone.0054488	http://dx.doi.org/10.1371/journal.pone.0054488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349906	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900070
J	Cook, I; Wang, T; Almo, SC; Kim, J; Falany, CN; Leyh, TS				Cook, Ian; Wang, Ting; Almo, Steven C.; Kim, Jungwook; Falany, Charles N.; Leyh, Thomas S.			Testing the Sulfotransferase Molecular Pore Hypothesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATION; LIGAND; MODEL; ENZYMOLOGY; BIOLOGY	Human cytosolic sulfotransferases (SULTs) regulate the activities of hundreds of signaling metabolites via transfer of the sulfuryl moiety (-SO3) from activated sulfate (3'-phosphoadenosine 5'-phosphosulfate) to the hydroxyls and primary amines of xeno- and endobiotics. How SULTs select substrates from the scores of competing ligands present in a cytosolic milieu is an important issue in the field. Selectivity appears to be sterically controlled by a molecular pore that opens and closes in response to nucleotide binding. This point of view is fostered by structures showing nucleotide-dependent pore closure and the fact that nucleotide binding induces an isomerization that restricts access to the acceptor-binding pocket. Molecular dynamics models underscore the importance of pore isomerization in selectivity and predict that specific molecular linkages stabilize the closed pore in response to nucleotide binding. To test the pore model, these linkages were disrupted in SULT2A1 via mutagenesis, and the effects on selectivity were determined. The mutations uncoupled nucleotide binding from selectivity and produced enzymes that no longer discriminated between large and small substrates. The mutations did not affect the affinity or turnover of small substrates but resulted in a 183-fold gain in catalytic efficiently toward large substrates. Models predict that an 11-residue "flap" covering the acceptor-binding pocket can open and admit large substrates when nucleotide is bound; a mutant structure demonstrated that this is so. In summary, the model was shown to be a robust, accurate predictor of SULT structure and selectivity whose general features will likely apply to other members of the SULT family.	[Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Almo, Steven C.; Kim, Jungwook] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Falany, Charles N.] Univ Alabama Birmingham, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Wang, Ting/J-7577-2015; Kim, Jungwook/AAP-1322-2020	Kim, Jungwook/0000-0001-5213-9299	National Institutes of Health [GM54469, GM48623, GM38953]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R01GM038953, R29GM038953, R01GM048623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54469, GM48623, and GM38953.	Aidoo-Gyamfi K, 2009, ANTI-CANCER AGENT ME, V9, P599, DOI 10.2174/187152009788679985; Anderson JAM, 2001, J BIOL CHEM, V276, P9755, DOI 10.1074/jbc.M010048200; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W. W, 1970, ENZYMES, V2, P1; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Dong D, 2012, EXPERT OPIN DRUG MET, V8, P635, DOI 10.1517/17425255.2012.677027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Falany JL, 1996, ENDOCRINOLOGY, V137, P1395, DOI 10.1210/en.137.4.1395; Falany JL, 2002, BREAST CANCER RES TR, V74, P167, DOI 10.1023/A:1016147004188; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Li L, 2007, J CYST FIBROS, V6, P23, DOI 10.1016/j.jcf.2006.05.001; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; STEVENTON GB, 1989, NEUROLOGY, V39, P883, DOI 10.1212/WNL.39.7.883; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	31	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8619	8626		10.1074/jbc.M112.445015	http://dx.doi.org/10.1074/jbc.M112.445015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362278	hybrid, Green Published			2022-12-25	WOS:000316564500062
J	Zhang, J; Xu, ES; Chen, XB				Zhang, Jin; Xu, Enshun; Chen, Xinbin			TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC TARGET GENES; BREAST-CANCER CELLS; KINASE C-ABL; DNA-DAMAGE; UBIQUITIN LIGASE; P73 EXPRESSION; FEEDBACK LOOP; MUTANT P53; DELTA-NP73; ACETYLATION	Histone deacetylases (HDACs) play important roles in fundamental cellular processes, and HDAC inhibitors are emerging as promising cancer therapeutics. p73, a member of the p53 family, plays a critical role in tumor suppression and neural development. Interestingly, p73 produces two classes of proteins with opposing functions: the full-length TAp73 and the N-terminally truncated Delta Np73. In the current study, we sought to characterize the potential regulation of p73 by HDACs and found that histone deacetylase 1 (HDAC1) is a key regulator of TAp73 protein stability. Specifically, we showed that HDAC1 inhibition by HDAC inhibitors or by siRNA shortened the half-life of TAp73 protein and subsequently decreased TAp73 expression under normal and DNA damage-induced conditions. Mechanistically, we found that HDAC1 knockdown resulted in hyperacetylation and inactivation of heat shock protein 90, which disrupted the interaction between heat shock protein 90 and TAp73 and thus promoted the proteasomal degradation of TAp73. Functionally, we found that down-regulation of TAp73 was required for the enhanced cell migration mediated by HDAC1 knockdown. Together, we uncover a novel regulation of TAp73 protein stability by HDAC1-heat shock protein 90 chaperone complex, and our data suggest that TAp73 is a critical downstream mediator of HDAC1-regulated cell migration.	[Zhang, Jin; Xu, Enshun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA081237, CA076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA081237, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA081237 and CA076069.	Agami R, 1999, NATURE, V399, P809; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Fuino L, 2003, MOL CANCER THER, V2, P971; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jones EV, 2007, BIOCHEM J, V405, P617, DOI 10.1042/BJ20061778; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kikuchi H, 2006, ONCOGENE, V25, P7608, DOI 10.1038/sj.onc.1209748; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marabese M, 2003, NUCLEIC ACIDS RES, V31, P6624, DOI 10.1093/nar/gkg869; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; Ozaki T, 2009, BIOCHEM BIOPH RES CO, V386, P207, DOI 10.1016/j.bbrc.2009.06.035; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Slade N, 2004, CELL DEATH DIFFER, V11, P357, DOI 10.1038/sj.cdd.4401335; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Wallace DM, 2009, J NEUROSCI RES, V87, P887, DOI 10.1002/jnr.21910; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhang J, 2007, MOL CELL BIOL, V27, P3868, DOI 10.1128/MCB.02112-06; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	67	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7727	7737		10.1074/jbc.M112.429522	http://dx.doi.org/10.1074/jbc.M112.429522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362263	Green Published, hybrid			2022-12-25	WOS:000316455300029
J	Ishii, T; Funato, Y; Miki, H				Ishii, Tasuku; Funato, Yosuke; Miki, Hiroaki			Thioredoxin-related Protein 32 (TRP32) Specifically Reduces Oxidized Phosphatase of Regenerating Liver (PRL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CATALYTIC DOMAIN; METASTASIS; EXPRESSION; OXIDATION; TRP14; PLAYS; CELLS; PTEN	PRL family constitutes a unique class of phosphatases associated with metastasis. The phosphatase activity of PRL has been reported to be important for promoting metastasis, and it is inactivated by reversible oxidation of its catalytic cysteine. Here, we show that TRP32 specifically reduces PRL. Reduction of oxidized PRL in cells is inhibited by 2,4-dinitro-1-chlorobenzene, an inhibitor of TRX reductase. In vitro assays for the reduction of PRL show that only TRP32 can potently reduce oxidized PRL, whereas other TRX-related proteins linked to TRX reductase show little or no reducing activity. Indeed, TRP32 knockdown significantly prolongs the H2O2-induced oxidation of PRL. Binding analyses reveal that the unique C-terminal domain of TRP32 is required and sufficient for its direct interaction with PRL. These results suggest that TRP32 maintains the reduced state of PRL and thus regulates the biological function of PRL.	[Ishii, Tasuku; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan	Osaka University	Miki, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp			Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS); Exciting Leading-Edge Research Projects from Osaka University; JSPS; Ministry of Education, Culture, Sports, Science and Technology-Japan	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exciting Leading-Edge Research Projects from Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (JSPS) (to H. M.), Exciting Leading-Edge Research Projects from Osaka University (to H. M.), and grants-in-aid for scientific research from the JSPS and Ministry of Education, Culture, Sports, Science and Technology-Japan (to H. M. and Y. F.).	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Anagnostopoulos Athanasios K., 2005, Cancer Genomics & Proteomics, V2, P271; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Cheng JZ, 2001, J BIOL CHEM, V276, P41213, DOI 10.1074/jbc.M106838200; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Goroncy AK, 2010, PROTEINS, V78, P2176, DOI 10.1002/prot.22719; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2003, CANCER RES, V63, P2716	28	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7263	7270		10.1074/jbc.M112.418004	http://dx.doi.org/10.1074/jbc.M112.418004			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362275	hybrid, Green Published			2022-12-25	WOS:000316002400046
J	Furuhashi, T; Saito, C; Torii, K; Nishida, E; Yamazaki, S; Morita, A				Furuhashi, Takuya; Saito, Chiyo; Torii, Kan; Nishida, Emi; Yamazaki, Sayuri; Morita, Akimichi			Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis	PLOS ONE			English	Article							UVB INDUCES APOPTOSIS; INDUCED IMMUNOSUPPRESSION; CONTACT HYPERSENSITIVITY; SUPPRESSIVE FUNCTION; RECEPTOR EXPRESSION; DENDRITIC CELLS; ULTRAVIOLET; PHOTOTHERAPY; KERATINOCYTES; PATHOGENESIS	Background: Photo(chemo)therapy is widely used to treat psoriasis, the pathogenesis of which might be caused by an imbalance of Th17 cells/regulatory T cells (Treg). In the present study, we evaluated the effects of photo(chemo)therapy on the Th17/Treg balance and Treg function. Methods: Peripheral blood was obtained from psoriasis patients treated with bath-psoralen ultraviolet A (UVA, n = 50) or narrowband ultraviolet B (UVB, n = 18), and age-matched healthy volunteers (n = 20). CD3(+)CD4(+)IL-17A(+) or CD4(+)CD25(+)Foxp3(+)cells were analyzed to estimate Th17 or Treg number by fluorescence-activated cell sorting. Moreover, CD4(+) CD25(-) T cells from patients treated with PUVA(n = 14) were incubated in CFSE and activated with or without CD4(+)CD25(+)T cells, and the suppressive function of CD4(+) CD25(+)T cells were analyzed. Results: Photo(chemo)therapy significantly reduced Th17 levels from 5.66 +/- 3.15% to 2.96 +/- 2.89% in patients with increased Th17 (Th17/CD4>3.01% [mean+SD of controls]). In contrast, photo(chemo)therapy significantly increased Treg levels from 2.77 +/- 0.75 to 3.40 +/- 1.88% in patients with less than 4.07% Treg level, defined as the mean of controls. Furthermore, while Treg suppressed the CD4(+)CD25(-) T cell proliferation to a greater extent in controls (Treg Functional Ratio 94.4 +/- 4.28%) than in patients (70.3 +/- 25.1%), PUVA significantly increased Treg Functional Ratio to 88.1 +/- 6.47%. Th17 levels in severe patients (>30 PASI) were significantly higher as compared to controls. Th17 levels that were left after treatment in the patients not achieving PASI 50 (3.78 +/- 4.18%) were significantly higher than those in the patients achieving PASI 75 (1.83 +/- 1.87%). Treg levels in patients achieving PASI 90 (4.89 +/- 1.70%) were significantly higher than those in the patients not achieving PASI 90 (3.90 +/- 1.66%). Treg levels prior to treatment with Th17 high decreased group (5.16 +/- 2.20%) was significantly higher than that with Th17 high increased group (3.33 +/- 1.39%). Conclusion: These findings indicate that Treg is dysfunctional in psoriasis patients, and photochemotherapy restores those dysfunctional Treg. Photo(chemo)therapy resolved the Th17/Treg imbalance in patients with psoriasis.	[Furuhashi, Takuya; Saito, Chiyo; Torii, Kan; Nishida, Emi; Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan	Nagoya City University	Furuhashi, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan.	tmail@med.nagoya-cu.ac.jp		Nishida, Emi/0000-0001-6563-1274; Torii, Kan/0000-0003-1964-0529	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23390088] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2012, TRENDS IMMUNOL, V33, P505, DOI 10.1016/j.it.2012.05.004; Aufiero BM, 2006, J PHOTOCH PHOTOBIO B, V82, P132, DOI 10.1016/j.jphotobiol.2005.08.011; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Brazzelli V, 2008, INT J IMMUNOPATH PH, V21, P481, DOI 10.1177/039463200802100232; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Furuhashi T, 2011, EXP DERMATOL, V20, P768, DOI 10.1111/j.1600-0625.2011.01316.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Krutmann J, 1999, J INVEST DERM SYMP P, V4, P70, DOI 10.1038/sj.jidsp.5640185; Krutmann J., 2007, FITZPATRICKS DERMATO, V7th ed, P2243; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Meyer T, 2007, BRIT J DERMATOL, V157, P1, DOI 10.1111/j.1365-2133.2007.08264.x; Ozawa M, 1999, J EXP MED, V189, P711, DOI 10.1084/jem.189.4.711; Racz E, 2011, J INVEST DERMATOL, V131, P1547, DOI 10.1038/jid.2011.53; Saito C, 2009, J DERMATOL SCI, V53, P231, DOI 10.1016/j.jdermsci.2008.09.011; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Schwarz A, 2007, J IMMUNOL, V178, P877, DOI 10.4049/jimmunol.178.2.877; Schwarz A, 2011, J ALLERGY CLIN IMMUN, V128, P826, DOI 10.1016/j.jaci.2011.06.005; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shintani Y, 2008, PHOTODERMATOL PHOTO, V24, P32, DOI 10.1111/j.1600-0781.2008.00333.x; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Sweeney CM, 2011, ARCH DERMATOL RES, V303, P691, DOI 10.1007/s00403-011-1169-1; Tan ZY, 2009, INT J BIOCHEM CELL B, V41, P733, DOI 10.1016/j.biocel.2008.04.027; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Zhang L, 2010, CLIN IMMUNOL, V135, P108, DOI 10.1016/j.clim.2009.11.008	38	77	83	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54895	10.1371/journal.pone.0054895	http://dx.doi.org/10.1371/journal.pone.0054895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365685	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600132
J	Garza-Ramos, G; Mujica-Jimenez, C; Munoz-Clares, RA				Garza-Ramos, Georgina; Mujica-Jimenez, Carlos; Munoz-Clares, Rosario A.			Potassium and Ionic Strength Effects on the Conformational and Thermal Stability of Two Aldehyde Dehydrogenases Reveal Structural and Functional Roles of K+-Binding Sites	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MONOVALENT CATIONS; AMYLOID FIBRILS; PORCINE KIDNEY; BETAINE; PURIFICATION; ENZYME; ASSOCIATION; CLONING	Many aldehyde dehydrogenases (ALDHs) have potential potassium-binding sites of as yet unknown structural or functional roles. To explore possible K+-specific effects, we performed comparative structural studies on the tetrameric betaine aldehyde dehydrogenase from Pseudomonas aeruginosa (PaBADH) and on the dimeric BADH from spinach (SoBADH), whose activities are K+-dependent and K+-independent, respectively, although both enzymes contain potassium-binding sites. Size exclusion chromatography, dynamic light scattering, far- and near-UV circular dichroism, and extrinsic fluorescence results indicated that in the absence of K+ ions and at very low ionic strength, PaBADH remained tetrameric but its tertiary structure was significantly altered, accounting for its inactivation, whereas SoBADH formed tetramers that maintained the native tertiary structure. The recovery of PaBADH native tertiary-structure was hyperbolically dependent on KCl concentration, indicating potassium-specific structuring effects probably arising from binding to a central-cavity site present in PaBADH but not in SoBADH. K+ ions stabilized the native structure of both enzymes against thermal denaturation more than did tetraethylammonium (TEA(+)) ions. This indicated specific effects of potassium on both enzymes, particularly on PaBADH whose apparent T-m values showed hyperbolical dependence on potassium concentration, similar to that observed with the tertiary structure changes. Interestingly, we also found that thermal denaturation of both enzymes performed in low ionic-strength buffers led to formation of heat-resistant, inactive soluble aggregates that retain 80% secondary structure, have increased beta-sheet content and bind thioflavin T. These structured aggregates underwent further thermal-induced aggregation and precipitation when the concentrations of KCl or TEACl were raised. Given that PaBADH and SoBADH belong to different ALDH families and differ not only in amino acid composition but also in association state and surface electrostatic potential, the formation of this kind of beta-sheet pre-fibrillar aggregates, not described before for any ALDH enzyme, appear to be a property of the ALDH fold.	[Garza-Ramos, Georgina] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Mujica-Jimenez, Carlos; Munoz-Clares, Rosario A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munoz-Clares, RA (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico.	clares@unam.mx		Garza Ramos, Georgina/0000-0003-3496-9525; Munoz-Clares, Rosario A./0000-0002-0115-3565	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [59654]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors acknowledge the financial support of Consejo Nacional de Ciencia y Tecnologia (CONACYT grant 59654) to R.A.M.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTS GF, 1979, BIOCHEM J, V183, P633, DOI 10.1042/bj1830633; BLACK S, 1951, ARCH BIOCHEM BIOPHYS, V34, P86, DOI 10.1016/S0003-9861(51)80013-4; Boch J, 1997, ARCH MICROBIOL, V168, P282, DOI 10.1007/s002030050500; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; DEPREZ E, 1994, FEBS LETT, V347, P207, DOI 10.1016/0014-5793(94)00545-1; Diaz-Sanchez AG, 2012, PLANT PHYSIOL, V158, P1570, DOI 10.1104/pp.112.194514; DRAGOLOVICH J, 1994, J EXP ZOOL, V270, P417, DOI 10.1002/jez.1402700502; FALKENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1034, P253, DOI 10.1016/0304-4165(90)90046-Y; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Segura L, 2005, BIOCHIMIE, V87, P1056, DOI 10.1016/j.biochi.2005.06.007; Gonzalez-Segura L, 2013, CHEM-BIOL INTERACT, V202, P41, DOI 10.1016/j.cbi.2012.12.007; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guzman-Partida AM, 1998, COMP BIOCHEM PHYS B, V119, P485, DOI 10.1016/S0305-0491(98)00009-1; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; JACOBSON MK, 1974, BIOCHIM BIOPHYS ACTA, V350, P277, DOI 10.1016/0005-2744(74)90502-6; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Pujar NS, 1998, J CHROMATOGR A, V796, P229, DOI 10.1016/S0021-9673(97)01003-0; Rahuel-Clermont S, 2005, J BIOL CHEM, V280, P18590, DOI 10.1074/jbc.M414110200; Sedlak E, 2008, ARCH BIOCHEM BIOPHYS, V474, P128, DOI 10.1016/j.abb.2008.02.037; SORGER GJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P1, DOI 10.1016/S0926-6593(66)80139-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STEINMAN CR, 1968, J BIOL CHEM, V243, P730; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Valenzuela-Soto EM, 2006, ENZYMOL MOL BIOL CAR, V12, P104; Valenzuela-Soto EM, 2003, CHEM-BIOL INTERACT, V143, P139, DOI 10.1016/S0009-2797(02)00198-9; Velasco-Garcia R, 2006, ARCH MICROBIOL, V185, P14, DOI 10.1007/s00203-005-0054-8; Velasco-Garcia R, 1999, J BACTERIOL, V181, P1292; VONTIGER.RG, 1968, J BIOL CHEM, V243, P2691; VONTIGERSTROM RG, 1968, J BIOL CHEM, V243, P6495; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Wei BX, 2000, BIOCHEMISTRY-US, V39, P5295, DOI 10.1021/bi000028n; WERETILNYK EA, 1989, ARCH BIOCHEM BIOPHYS, V271, P56, DOI 10.1016/0003-9861(89)90255-5; Yamanaka Y, 2002, BIOCHEM BIOPH RES CO, V298, P632, DOI 10.1016/S0006-291X(02)02523-8; Zaldivar-Machorro VJ, 2011, BIOCHIMIE, V93, P286, DOI 10.1016/j.biochi.2010.09.022	41	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54899	10.1371/journal.pone.0054899	http://dx.doi.org/10.1371/journal.pone.0054899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365686	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600133
J	Hoek-van den Hil, EF; Keijer, J; Bunschoten, A; Vervoort, JJM; Stankova, B; Bekkenkamp, M; Herreman, L; Venema, D; Hollman, PCH; Tvrzicka, E; Rietjens, IMCM; van Schothorst, EM				Hoek-van den Hil, Elise F.; Keijer, Jaap; Bunschoten, Annelies; Vervoort, Jacques J. M.; Stankova, Barbora; Bekkenkamp, Melissa; Herreman, Laure; Venema, Dini; Hollman, Peter C. H.; Tvrzicka, Eva; Rietjens, Ivonne M. C. M.; van Schothorst, Evert M.			Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice	PLOS ONE			English	Article							FATTY-ACID; LIVER; METABOLISM; DISEASE; DIETARY; FLAVONOIDS; RISK; CAR; RAT; ACTIVATION	Elevated circulating lipid levels are known risk factors for cardiovascular diseases (CVD). In order to examine the effects of quercetin on lipid metabolism, mice received a mild-high-fat diet without (control) or with supplementation of 0.33% (w/w) quercetin for 12 weeks. Gas chromatography and H-1 nuclear magnetic resonance were used to quantitatively measure serum lipid profiles. Whole genome microarray analysis of liver tissue was used to identify possible mechanisms underlying altered circulating lipid levels. Body weight, energy intake and hepatic lipid accumulation did not differ significantly between the quercetin and the control group. In serum of quercetin-fed mice, triglycerides (TG) were decreased with 14% (p<0.001) and total poly unsaturated fatty acids (PUFA) were increased with 13% (p<0.01). Palmitic acid, oleic acid, and linoleic acid were all decreased by 9-15% (p<0.05) in quercetin-fed mice. Both palmitic acid and oleic acid can be oxidized by omega (omega)-oxidation. Gene expression profiling showed that quercetin increased hepatic lipid metabolism, especially omega-oxidation. At the gene level, this was reflected by the up-regulation of cytochrome P450 (Cyp) 4a10, Cyp4a14, Cyp4a31 and Acyl-CoA thioesterase 3 (Acot3). Two relevant regulators, cytochrome P450 oxidoreductase (Por, rate limiting for cytochrome P450s) and the transcription factor constitutive androstane receptor (Car; official symbol Nr1i3) were also upregulated in the quercetin-fed mice. We conclude that quercetin intake increased hepatic lipid omega-oxidation and lowered corresponding circulating lipid levels, which may contribute to potential beneficial effects on CVD.	[Hoek-van den Hil, Elise F.; Rietjens, Ivonne M. C. M.; van Schothorst, Evert M.] Wageningen Univ, Div Toxicol, NL-6700 AP Wageningen, Netherlands; [Hoek-van den Hil, Elise F.; Venema, Dini; Hollman, Peter C. H.] RIKILT Inst Food Safety, Wageningen, Netherlands; [Stankova, Barbora; Tvrzicka, Eva] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic; [Vervoort, Jacques J. M.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Charles University Prague; Wageningen University & Research	van Schothorst, EM (corresponding author), Wageningen Univ, Div Toxicol, NL-6700 AP Wageningen, Netherlands.	evert.vanschothorst@wur.nl	Hollman, Peter C.H./I-7446-2013; Tvrzicka, Eva/Q-6300-2016; Keijer, Jaap/J-8089-2013; Stankova, Barbora/L-7933-2016	Hollman, Peter C.H./0000-0002-7510-6809; Tvrzicka, Eva/0000-0003-0794-8454; Keijer, Jaap/0000-0002-9720-7491; Rietjens, Ivonne/0000-0003-1894-3544; van Schothorst, Evert/0000-0002-3036-5903; Hoek - van den Hil, Elise/0000-0002-2646-9136; Stankova, Barbora/0000-0002-6184-4878	graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG); RIKILT-instutute of food safety	graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG); RIKILT-instutute of food safety	The research is funded by the graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG), and RIKILT-instutute of food safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Baskin-Bey ES, 2007, WORLD J GASTROENTERO, V13, P5635, DOI 10.3748/wjg.v13.i42.5635; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; CARLSON LA, 1985, CLIN CHIM ACTA, V149, P89, DOI 10.1016/0009-8981(85)90277-3; de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Fiorini RN, 2004, CLIN TRANSPLANT, V18, P700, DOI 10.1111/j.1399-0012.2004.00282.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harchaoui KEL, 2009, CURR CARDIOL REV, V5, P216, DOI 10.2174/157340309788970315; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hoch U, 2000, ARCH BIOCHEM BIOPHYS, V373, P63, DOI 10.1006/abbi.1999.1504; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoek-van den Hil EF, 2012, ANAL BIOANAL CHEM, V402, P1389, DOI 10.1007/s00216-011-5563-5; Hollman PCH, 2010, J NUTR, V140, P600, DOI 10.3945/jn.109.116632; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hunt MC, 2005, J LIPID RES, V46, P2029, DOI 10.1194/jlr.E500003-JLR200; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Jung CH, 2012, PHYTOTHER RES; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Lavoie JM, 2006, CELL MOL LIFE SCI, V63, P1393, DOI 10.1007/s00018-006-6600-y; Li LH, 2009, PHARM RES-DORDR, V26, P872, DOI 10.1007/s11095-008-9788-8; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Mutch DM, 2007, J PROTEOME RES, V6, P3976, DOI 10.1021/pr0700448; Mutch DM, 2006, AM J PHYSIOL-GASTR L, V291, pG63, DOI 10.1152/ajpgi.00565.2005; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; Tukiainen T, 2008, BIOCHEM BIOPH RES CO, V375, P356, DOI 10.1016/j.bbrc.2008.08.007; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136; VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Yao RQ, 2010, J AGR FOOD CHEM, V58, P2168, DOI 10.1021/jf903711q; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	43	58	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e51588	10.1371/journal.pone.0051588	http://dx.doi.org/10.1371/journal.pone.0051588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359794	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600003
J	Piyathilake, CJ; Badiga, S; Alvarez, RD; Partridge, EE; Johanning, GL				Piyathilake, Chandrika J.; Badiga, Suguna; Alvarez, Ronald D.; Partridge, Edward E.; Johanning, Gary L.			A Lower Degree of PBMC L1 Methylation Is Associated with Excess Body Weight and Higher HOMA-IR in the Presence of Lower Concentrations of Plasma Folate	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; LINE-1 METHYLATION; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; LOWER RISK; HYPOMETHYLATION; ELEMENTS; OBESITY; CANCER; LEVEL	Background: Identification of associations between global DNA methylation and excess body weight (EBW) and related diseases and their modifying factors are an unmet research need that may lead to decreasing DNA methylation-associated disease risks in humans. The purpose of the current study was to evaluate the following; 1) Association between the degree of peripheral blood mononuclear cell (PBMC) L1 methylation and folate, and indicators of EBW, 2) Association between the degree of PBMC L1 methylation and folate, and insulin resistance (IR) as indicated by a higher homeostasis model assessment (HOMA-IR). Methods: The study population consisted of 470 child-bearing age women diagnosed with abnormal pap. The degree of PBMC L1 methylation was assessed by pyrosequencing. Logistic regression models specified indicators of EBW (body mass index-BMI, body fat-BF and waist circumference-WC) or HOMA-IR as dependent variables and the degree of PBMC L1 methylation and circulating concentrations of folate as the independent predictor of primary interest. Results: Women with a lower degree of PBMC L1 methylation and lower plasma folate concentrations were significantly more likely to have higher BMI, % BF or WC (OR = 2.49, 95% CI: 1.41-4.47, P = 0.002; OR = 2.49, 95% CI: 1.40-4.51, P = 0.002 and OR = 1.98, 95% = 1.14-3.48 P = 0.0145, respectively) and higher HOMA-IR (OR = 1.78, 95% CI: 1.02-3.13, P = 0.041). Conclusion: Our results demonstrated that a lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR, especially in the presence of lower concentrations of plasma folate.	[Piyathilake, Chandrika J.; Badiga, Suguna] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Alvarez, Ronald D.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Partridge, Edward E.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Johanning, Gary L.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Smithville, TX USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	piyathic@uab.edu			National Cancer Institute; Fulbright Senior Scholar Research Grant;  [R01 CA105448]; NATIONAL CANCER INSTITUTE [R01CA105448] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fulbright Senior Scholar Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by R01 CA105448 funded by the National Cancer Institute and a Fulbright Senior Scholar Research Grant awarded to Piyathilake CJ administered via the Korean-American Educational Commission (2012, Chungbuk National University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2010, EPIGENETICS-US, V5; Bajos N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2573; Beeson W L, 2010, Int J Body Compos Res, V8, P45; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Cash HL, 2011, EPIGENETICS-US, V6, P1257, DOI 10.4161/epi.6.10.17728; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Chowdhury S, 2011, BIRTH DEFECTS RES A, V91, P69, DOI 10.1002/bdra.20761; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gallo MF, 2003, COCHRANE DB SYST REV; Green NS, 2002, J NUTR, V132, p2356S, DOI 10.1093/jn/132.8.2356S; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Holt VL, 2002, OBSTET GYNECOL, V99, P820, DOI 10.1016/S0029-7844(02)01939-7; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kim SJ, 2012, DIABETES METAB J, V36, P108, DOI 10.4093/dmj.2012.36.2.108; Kimmons Joel E, 2006, MedGenMed, V8, P59; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kulie T, 2011, J AM BOARD FAM MED, V24, P75, DOI 10.3122/jabfm.2011.01.100076; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lash MM, 2009, FERTIL STERIL, V91, P1712, DOI 10.1016/j.fertnstert.2008.02.141; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mojtabai R, 2004, EUR J EPIDEMIOL, V19, P1029, DOI 10.1007/s10654-004-2253-z; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Pearce MS, 2012, INT J EPIDEMIOL, V41, P210, DOI 10.1093/ije/dys020; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Piyathilake CJ, 2009, CANCER PREV RES, V2, P658, DOI 10.1158/1940-6207.CAPR-08-0175; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Takanabe-Mori R, 2010, BIOCHEM BIOPH RES CO, V398, P576, DOI 10.1016/j.bbrc.2010.06.123; THAYER RE, 1993, GENE, V133, P273, DOI 10.1016/0378-1119(93)90651-I; Tinker SC, 2012, BIRTH DEFECTS RES A, V94, P749, DOI 10.1002/bdra.23024; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Warholm L, 2012, EUR J CONTRACEP REPR, V17, P245, DOI 10.3109/13625187.2012.692411; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048	58	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54544	10.1371/journal.pone.0054544	http://dx.doi.org/10.1371/journal.pone.0054544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358786	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600066
J	Quiroz-Martinez, B; Salgado-Maldonado, G				Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo			Patterns of Distribution of the Helminth Parasites of Freshwater Fishes of Mexico	PLOS ONE			English	Article							RIVER-BASIN; N. SP; DISTANCE DECAY; OSTEICHTHYES; NEMATODA; CICHLIDAE; BIOGEOGRAPHY; SIMILARITY; TELEOSTEI; RICHNESS	In order to draw patterns in helminth parasite composition and species richness in Mexican freshwater fishes we analyse a presence-absence matrix representing every species of adult helminth parasites of freshwater fishes from 23 Mexican hydrological basins. We examine the distributional patterns of the helminth parasites with regard to the main hydrological basins of the country, and in doing so we identify areas of high diversity and point out the biotic similarities and differences among drainage basins. Our dataset allows us to evaluate the relationships among drainage basins in terms of helminth diversity. This paper shows that the helminth fauna of freshwater fishes of Mexico can characterise hydrological basins the same way as fish families do, and that the basins of south-eastern Mexico are home to a rich, predominantly Neotropical, helminth fauna whereas the basins of the Mexican Highland Plateau and the Nearctic area of Mexico harbour a less diverse Nearctic fauna, following the same pattern of distribution of their fish host families. The composition of the helminth fauna of each particular basin depends on the structure of the fish community rather than on the limnological characteristics and geographical position of the basin itself. This work shows distance decay of similarity and a clear linkage between host and parasite distributions.	[Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo] Univ Nacl Autonoma Mexico, Inst Biol, Lab Helmintol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Salgado-Maldonado, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Lab Helmintol, Mexico City 04510, DF, Mexico.	gsalgado@ibiologia.unam.mx	Quiroz-Martinez, Benjamin/AAG-2856-2019; Salgado-Maldonado, Guillermo/AAB-4960-2021	Quiroz-Martinez, Benjamin/0000-0001-9791-7031; Salgado-Maldonado, Guillermo/0000-0002-0772-0938	Universidad Nacional Autonoma de Mexico (UNAM); Direccion General de Asuntos del Personal Academico [PAPIIT IN220810]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [174861]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Universidad Nacional Autonoma de Mexico (UNAM), Direccion General de Asuntos del Personal Academico, projects PAPIIT IN220810, and by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) through a postdoctoral fellowship grant (no. 174861) to B.Q.M., Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Aguilar R, 2003, J BIOGEOGR, V30, P1861, DOI 10.1111/j.1365-2699.2003.00931.x; Aguilar-Aguilar R, 2005, REGIONALIZACION BIOG; Aguilar-Aguilar R, 2008, BIOL J LINN SOC, V94, P435, DOI 10.1111/j.1095-8312.2008.00994.x; BARBOUR CD, 1973, COPEIA, P533; Caspeta-Mandujano JM, 2010, HELMINTHOLOGIA, V47, P33, DOI 10.2478/s11687-010-0006-y; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; De Cserna Z., 1995, ENVIRON ENG GEOSCI, V1, P29, DOI DOI 10.2113/GSEEGEOSCI.I.1.29; de Leon GPP, 2002, COMP PARASITOL, V69, P10, DOI 10.1654/1525-2647(2002)069[0010:AEPOIF]2.0.CO;2; Dogiel VA, 1961, PARASITOLOGY FISHES, P1; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3, DOI [DOI 10.1007/BF02908211, 10.1007/BF02908211]; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Flores Crespo J., 2003, Tecnica Pecuaria en Mexico, V41, P175; Gopar-Merino L, 2005, J PARASITOL, V91, P909, DOI 10.1645/GE-411R.1; Hudson P.F., 2005, RIVERS N AM, P1030, DOI [10.1016/B978-012088253-3/50026-2, DOI 10.1016/B978-012088253-3/50026-2]; Jimenez-Garcia MI, 2001, J PARASITOL, V87, P907, DOI 10.1645/0022-3395(2001)087[0907:MIIANC]2.0.CO;2; Lopez-Jimenez S, 2001, GACETA SIGOLFO SISTE, V2001, P8; Luque JL, 2007, PARASITOLOGY, V134, P865, DOI 10.1017/S0031182007002272; Caspeta-Mandujano JM, 2009, J PARASITOL, V95, P392, DOI 10.1645/GE-1502.1; Mendez O, 2010, ZOOTAXA, P44; Mendoza-Franco EF, 2008, J PARASITOL, V94, P28, DOI 10.1645/GE-1241.1; Mendoza-Palmero CA, 2009, J PARASITOL, V95, P315, DOI 10.1645/GE-1761.1; Miller R.R., 1986, P487; MILLER R R, 1986, Anales de la Escuela Nacional de Ciencias Biologicas Mexico, V30, P121; Mittermeier R. A., 1999, BIODIVERSIDAD AMENAZ; Moravec F, 2007, FOLIA PARASIT, V54, P215, DOI 10.14411/fp.2007.029; Morrone Juan J., 2001, M&T Manuales y Tesis SEA, V3, P1; Morrone Juan J., 2002, Acta Zool. Mex, P83; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NORRIS S. M., 2005, FRESHWATER FISHES ME; Palmer MW, 2005, J VEG SCI, V16, P161, DOI 10.1111/j.1654-1103.2005.tb02351.x; Perez-Ponce de Leon G, 2005, J BIOGEOGR, V32, P645, DOI 10.1111/j.1365-2699.2005.01218.x; De Leon GPP, 2009, ZOOTAXA, P1; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Poulin R, 2011, PHILOS T R SOC B, V366, P2379, DOI 10.1098/rstb.2011.0048; Razo-Mendivil U, 2008, J PARASITOL, V94, P1371, DOI 10.1645/GE-1546.1; Rodriguez-Olarte D, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P243; Salgado-Maldonado G, 2005, PARASITOL RES, V96, P69, DOI 10.1007/s00436-005-1315-9; Salgado-Maldonado G, 2004, COMP PARASITOL, V71, P190, DOI 10.1654/4088; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P196; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P204; Salgado-Maldonado G, PARASITOLOG IN PRESS; Salgado-Maldonado G, 2008, ZOOTAXA, P29; Salgado-Maldonado G, 2003, BIOL INVASIONS, V5, P261, DOI 10.1023/A:1026189331093; Salgado-Maldonado G, 2006, ZOOTAXA, P1; Salgado-Maldonado G, 2012, J PARASITOL, V98, P404, DOI 10.1645/GE-2907.1; Salgado-Maldonado G, 2011, J PARASITOL, V97, P707, DOI 10.1645/GE-2662.1; Salgado-Maldonado G, 2011, PARASITOL RES, V108, P31, DOI 10.1007/s00436-010-2035-3; Salgado-Maldonado G, 2010, SYST PARASITOL, V75, P231, DOI 10.1007/s11230-009-9218-2; Salgado-Maldonado G, 2009, SYST PARASITOL, V73, P193, DOI 10.1007/s11230-009-9189-3; SALGADOMALDONAD.G, 2005, BIODIVERSIDAD ESTADO, P145; Schaefer S, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P259; Sedlock R.L., 1993, GEOLOGICAL SOC AM SP, V278, P1, DOI DOI 10.1130/SPE278-P1; Vidal-Martinez V.M., 2000, P227; WOOTTEN R, 1973, J ZOOL, V171, P323, DOI 10.1111/j.1469-7998.1973.tb05342.x	56	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54787	10.1371/journal.pone.0054787	http://dx.doi.org/10.1371/journal.pone.0054787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359347	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600109
J	Yilmazer, A; de Lazaro, I; Bussy, C; Kostarelos, K				Yilmazer, Acelya; de Lazaro, Irene; Bussy, Cyrill; Kostarelos, Kostas			In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors	PLOS ONE			English	Article							HYDRODYNAMICS-BASED TRANSFECTION; STEM-CELLS; CARDIAC FIBROBLASTS; EXPRESSION; MOUSE; GENERATION; HEPATOCYTES; LIVER	The ability to induce the reprogramming of somatic mammalian cells to a pluripotent state by the forced expression of specific transcription factors has helped redefine the rules of cell fate and plasticity, as well as open possibilities for disease modeling, drug screening and regenerative medicine. Here, we hypothesized that the non-viral forced expression of the four originally discovered defined factors (OKSM) in adult mice could result in in vivo reprogramming of cells in the transfected tissue in situ. We show that a single hydrodynamic tail-vein (HTV) injection of two plasmids encoding for Oct3/4, Sox2, Klf4 and c-Myc respectively, are highly expressed in the liver tissue of Balb/C adult mice. Hallmark pluripotency markers were upregulated within 24-48 h after injection, followed by down-regulation of all major hepatocellular markers. Generation of transcriptionally reprogrammed cells in vivo was further confirmed by positive staining of liver tissue sections for all major pluripotency markers in Balb/C mice and the Nanog-GFP reporter transgenic strain (TNG-A) with concomitant upregulation of GFP expression in situ. No signs of physiological or anatomical abnormalities or teratoma formation were observed in the liver examined up to 120 days. These findings indicate that virus-free expression of OKSM factors in vivo can transcriptionally reprogram cells in situ rapidly, efficiently and transiently, absent of host tissue damage or teratoma formation.	[Yilmazer, Acelya; de Lazaro, Irene; Bussy, Cyrill; Kostarelos, Kostas] UCL, UCL Sch Life & Med Sci, UCL Sch Pharm, Nanomed Lab, London, England	University of London; University College London	Kostarelos, K (corresponding author), UCL, UCL Sch Life & Med Sci, UCL Sch Pharm, Nanomed Lab, Brunswick Sq, London, England.	k.kostarelos@ucl.ac.uk	Bussy, Cyrill/C-7190-2008; Yilmazer, Acelya/L-4562-2013; de Lázaro, Irene/AAH-7605-2019; Kostarelos, Kostas/AAP-6879-2021	Bussy, Cyrill/0000-0001-8870-443X; Yilmazer, Acelya/0000-0003-2712-7450; de Lázaro, Irene/0000-0002-2775-0173; Kostarelos, Kostas/0000-0002-2224-6672	Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom); European Commission FP-7 Program NANONEUROHOP [PIEF-GA-2010-276051]; European Commission FP-7 Program ANTICARB [HEALTH-2008-20157]; Ministry of Education (Turkey); British Council; CAIXA Foundation (Spain)	Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom); European Commission FP-7 Program NANONEUROHOP; European Commission FP-7 Program ANTICARB; Ministry of Education (Turkey)(Ministry of National Education - Turkey); British Council(The British Council in India); CAIXA Foundation (Spain)	This work was partially supported by the Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom) and the European Commission FP-7 Programs NANONEUROHOP (PIEF-GA-2010-276051) and ANTICARB (HEALTH-2008-20157). AY was supported by a full-time PhD scholarship from the Ministry of Education (Turkey) and IL acknowledges partial support from the British Council and the CAIXA Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dolgin E, 2011, NATURE, V470, P13, DOI 10.1038/470013a; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; tenHagen TLM, 1996, J IMMUNOL METHODS, V193, P81, DOI 10.1016/0022-1759(96)00045-2; Vivien C, 2012, J BIOL CHEM, V287, P7427, DOI 10.1074/jbc.M111.324368; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54754	10.1371/journal.pone.0054754	http://dx.doi.org/10.1371/journal.pone.0054754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355895	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500120
J	Ahmad, A; Ali, S; Ahmed, A; Ali, AS; Raz, A; Sakr, WA; Rahman, KMW				Ahmad, Aamir; Ali, Shadan; Ahmed, Alia; Ali, Azfur S.; Raz, Avraham; Sakr, Wael A.; Rahman, K. M. Wahidur			3, 3 '- diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; M1 TRANSCRIPTION FACTOR; PROSTATE-CANCER; PANCREATIC-CANCER; DOWN-REGULATION; TRASTUZUMAB RESISTANCE; MIR-200 FAMILY; MICRORNA EXPRESSION; GROWTH-INHIBITION; APOPTOSIS	Herceptin failure is a major clinical problem in breast cancer. A subset of breast cancer patients with high HER-2/neu levels eventually experience metastatic disease progression when treated with Herceptin as a single agent. Mechanistic details of development of this aggressive disease are not clear. Therefore, there is a dire need to better understand the mechanisms by which drug resistance develops and to design new combined treatments that benefit patients with aggressive breast cancer and have minimal toxicity. We hypothesized that 3, 3'-diindolylmethane (DIM), a non-toxic agent can be combined with Herceptin to treat breast cancers with high levels of HER-2/neu. Here, we evaluated the effects of Herceptin alone and in combination with DIM on cell viability, apoptosis and clonogenic assays in SKBR3 (HER-2/neu-expressing) and MDA-MB-468 (HER-2/neu negative) breast cancer cells. We found that DIM could enhance the effectiveness of Herceptin by significantly reducing cell viability, which was associated with apoptosis-induction and significant inhibition of colony formation, compared with single agent treatment. These results were consistent with the down-regulation of Akt and NF-kB p65. Mechanistic investigations revealed a significant upregulation of miR-200 and reduction of FoxM1 expression in DIM and Herceptin-treated breast cancer cells. We, therefore, transfected cells with pre-miR-200 or silenced FoxM1 in these cells for understanding the molecular mechanism involved. These results provide experimental evidence, for the first time, that DIM plus Herceptin therapy could be translated to the clinic as a therapeutic modality to improve treatment outcome of patients with breast cancer, particularly for the patients whose tumors express high levels of HER-2/neu.	[Ahmad, Aamir; Ahmed, Alia; Ali, Azfur S.; Raz, Avraham; Sakr, Wael A.; Rahman, K. M. Wahidur] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Ali, Shadan; Raz, Avraham] Wayne State Univ, Sch Med, Div Hematol Oncol, Karmanos Canc Inst, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Rahman, KMW (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	kmrahman@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; Shah, Alia/0000-0001-6441-3902	Department of Pathology, Wayne State University, Detroit, Michigan; National Institutes of Health-National Cancer Institute grant [R01CA51714]; Department of Defense grant [W81XWH-05-1-0505]; NATIONAL CANCER INSTITUTE [R01CA140314, P30CA022453, R01CA051714] Funding Source: NIH RePORTER	Department of Pathology, Wayne State University, Detroit, Michigan; National Institutes of Health-National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Department of Pathology, Wayne State University, Detroit, Michigan, National Institutes of Health-National Cancer Institute grant R01CA51714 (AR) and Department of Defense grant W81XWH-05-1-0505 (KMWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, INT J CANCER, V129, P1781, DOI 10.1002/ijc.25839; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bedard PL, 2009, CURR CANCER DRUG TAR, V9, P148, DOI 10.2174/156800909787581024; BLOCK G, 1991, AM J CLIN NUTR, V53, pS356, DOI 10.1093/ajcn/53.1.356S; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hahn T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-471; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Khalili P, 2005, ONCOGENE, V24, P6657, DOI 10.1038/sj.onc.1208790; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Li YW, 2005, FRONT BIOSCI-LANDMRK, V10, P236, DOI 10.2741/1523; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; McGuire KP, 2006, J SURG RES, V132, P208, DOI 10.1016/j.jss.2006.02.008; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2012, CURR MED CHEM, V19, P1065, DOI 10.2174/092986712799320691; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Radisky DC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2885; Rahman KMW, 2006, MOL CANCER THER, V5, P2747, DOI 10.1158/1535-7163.MCT-06-0221; Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918; Rahman KMW, 2009, CANCER RES, V69, P4468, DOI 10.1158/0008-5472.CAN-08-4423; Rahman KM, 2007, MOL CANCER THER, V6, P1; Rahman KMW, 2005, CANCER RES, V65, P364; Rahman KMW, 2000, ONCOGENE, V19, P5764, DOI 10.1038/sj.onc.1203959; Rahman KMW, 2003, NUTR CANCER, V45, P101, DOI 10.1207/S15327914NC4501_12; Rahman KW, 2004, NUTR CANCER, V48, P84, DOI 10.1207/s15327914nc4801_12; Sato J, 2011, J HEPATO-BIL-PAN SCI, V18, P700, DOI 10.1007/s00534-011-0376-7; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Wang TTY, 2012, MOL CARCINOGEN, V51, P244, DOI 10.1002/mc.20774; Wang ZW, 2008, MOL CANCER THER, V7, P341, DOI 10.1158/1535-7163.MCT-07-0476; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wilken JA, 2010, ANN NY ACAD SCI, V1210, P53, DOI 10.1111/j.1749-6632.2010.05782.x	55	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54657	10.1371/journal.pone.0054657	http://dx.doi.org/10.1371/journal.pone.0054657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23372748	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100088
J	Chou, KM; Lee, CC; Chen, CH; Sun, CY				Chou, Kuei-Mei; Lee, Chin-Chan; Chen, Chih-Huang; Sun, Chiao-Yin			Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; TUBULAR MARKERS; RENAL-FUNCTION; NEPHROPATHY; KIDNEY; BIOMARKER; PATHOGENESIS; PROGRESSION; RISK	Objectives: Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to determine the role of albuminuria, and that of serum and urine levels of NGAL and L-FABP as predictors of a decline in the glomerular filtration rate (GFR) in patients with type 2 diabetes. Methods: A longitudinal cohort study with one hundred forty type 2 diabetic patients was conducted. Serum and urine levels of NGAL and L-FABP, and the urine albumin excretion rate were determined. The correlation between the kidney injury biomarkers and rate of GFR decline was analyzed. Results: The eGFR of study subjects decreased significantly as the study progressed (86.4 +/- 31.1 vs. 74.4 +/- 27.3 ml/min/ 1.73 m(2), P<0.001), and the urine albumin excretion rate increased significantly (264.9 +/- 1060.3 vs. 557.7 +/- 2092.5 mg/day, P = 0.009). The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR (P<0.05). The results of regression analysis for the correlations between the rate of eGFR change and the baseline levels of NGAL and L-FABP, and the urine albumin excretion rate showed that only the urine albumin excretion rate was significantly correlated with the rate of eGFR change (standardized coefficients: -0.378; t: -4.298; P<0.001). Conclusions: Tubular markers, such as NGAL and L-FABP, may not be predictive factors associated with GFR decline in type 2 diabetic patients.	[Chou, Kuei-Mei; Chen, Chih-Huang] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Keelung, Taiwan; [Lee, Chin-Chan; Sun, Chiao-Yin] Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Sun, CY (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan.	fish3970@gmail.com			Chang Gung Memorial Hospital research grant	Chang Gung Memorial Hospital research grant(Chang Gung Memorial Hospital)	This study was supported by the Chang Gung Memorial Hospital research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Adler S, 2004, KIDNEY INT, V66, P2095, DOI 10.1111/j.1523-1755.2004.00988.x; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Bataille A, 2011, TRANSPLANTATION, V92, P1024, DOI 10.1097/TP.0b013e318230c079; Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Zeeuw D, 2006, KIDNEY INT, V69, P1675, DOI 10.1038/sj.ki.5000326; Deferrari G, 1998, NEPHROL DIAL TRANSPL, V13, P11; Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; FIORETTO P, 1992, AM J KIDNEY DIS, V20, P549, DOI 10.1016/S0272-6386(12)70217-2; Fu WJ, 2012, ENDOCRINE, V41, P82, DOI 10.1007/s12020-011-9509-7; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gray SP, 2011, NAT REV NEPHROL, V7, P71, DOI 10.1038/nrneph.2010.176; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo A, 2006, MOL CELL BIOCHEM, V284, P175, DOI 10.1007/s11010-005-9047-9; Kim SS, 2012, DIABETES RES CLIN PR, V97, P251, DOI 10.1016/j.diabres.2012.02.019; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; McMahon BA, 2010, KIDNEY INT, V77, P657, DOI 10.1038/ki.2010.5; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Nielsen SE, 2011, KIDNEY INT, V79, P1113, DOI 10.1038/ki.2010.554; Nielsen SE, 2011, NEPHRON CLIN PRACT, V118, pC130, DOI 10.1159/000320615; Nielsen SE, 2010, DIABETES CARE, V33, P1320, DOI 10.2337/dc09-2242; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Yamazaki Masatoshi, 1991, Journal of Diabetic Complications, V5, P138, DOI 10.1016/0891-6632(91)90047-S; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003	38	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54863	10.1371/journal.pone.0054863	http://dx.doi.org/10.1371/journal.pone.0054863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349979	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100102
J	Cobine, PA; Cruz, LF; Navarrete, F; Duncan, D; Tygart, M; De La Fuente, L				Cobine, Paul A.; Cruz, Luisa F.; Navarrete, Fernando; Duncan, Daniel; Tygart, Melissa; De La Fuente, Leonardo			Xylella fastidiosa Differentially Accumulates Mineral Elements in Biofilm and Planktonic Cells	PLOS ONE			English	Article							COPPER RESISTANCE; PIERCES-DISEASE; BACTERIAL PATHOGEN; VIRULENCE FACTORS; OXIDATIVE STRESS; ZINC UPTAKE; AGGREGATION; GENES; HOST; IDENTIFICATION	Xylella fastidiosa is a bacterial plant pathogen that infects numerous plant hosts. Disease develops when the bacterium colonizes the xylem vessels and forms a biofilm. Inductively coupled plasma optical emission spectroscopy was used to examine the mineral element content of this pathogen in biofilm and planktonic states. Significant accumulations of copper (30-fold), manganese (6-fold), zinc (5-fold), calcium (2-fold) and potassium (2-fold) in the biofilm compared to planktonic cells were observed. Other mineral elements such as sodium, magnesium and iron did not significantly differ between biofilm and planktonic cells. The distribution of mineral elements in the planktonic cells loosely mirrors the media composition; however the unique mineral element distribution in biofilm suggests specific mechanisms of accumulation from the media. A cell-to-surface attachment assay shows that addition of 50 to 100 mu M Cu to standard X. fastidiosa media increases biofilm, while higher concentrations (> 200 mu M) slow cell growth and prevent biofilm formation. Moreover cell-to-surface attachment was blocked by specific chelation of copper. Growth of X. fastidiosa in microfluidic chambers under flow conditions showed that addition of 50 mu M Cu to the media accelerated attachment and aggregation, while 400 mu M prevented this process. Supplementation of standard media with Mn showed increased biofilm formation and cell-to-cell attachment. In contrast, while the biofilm accumulated Zn, supplementation to the media with this element caused inhibited growth of planktonic cells and impaired biofilm formation. Collectively these data suggest roles for these minerals in attachment and biofilm formation and therefore the virulence of this pathogen.	[Cobine, Paul A.; Duncan, Daniel; Tygart, Melissa] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Cruz, Luisa F.; Navarrete, Fernando; Duncan, Daniel; De La Fuente, Leonardo] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul A/G-3107-2011; Cruz, Luisa/AAA-5729-2020; De La Fuente, Leonardo/A-2012-2013; Cobine, Paul/AAH-6619-2020	Cobine, Paul A/0000-0001-6012-0985; De La Fuente, Leonardo/0000-0002-0027-4840; Cobine, Paul/0000-0001-6012-0985; Navarrete, Fernando/0000-0003-1971-441X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2010-65108-20633]; Department of Entomology and Plant Pathology; National Science Foundation NSF-DMS [112-2343]; Division Of Mathematical Sciences [1122434] Funding Source: National Science Foundation	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Department of Entomology and Plant Pathology; National Science Foundation NSF-DMS(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65108-20633 from the USDA National Institute of Food and Agriculture. The authors also acknowledge funds provided by the Department of Entomology and Plant Pathology, and from the National Science Foundation NSF-DMS 112-2343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2004, CURR MICROBIOL, V48, P368, DOI 10.1007/s00284-003-4219-x; Andersen PC, 2007, FEMS MICROBIOL LETT, V274, P210, DOI 10.1111/j.1574-6968.2007.00827.x; Arirachakaran P, 2007, CARIES RES, V41, P503, DOI 10.1159/000110883; Behlau F, 2011, APPL ENVIRON MICROB, V77, P4089, DOI 10.1128/AEM.03043-10; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Choat B, 2009, PHYSIOL PLANTARUM, V136, P384, DOI 10.1111/j.1399-3054.2009.01231.x; COOKSEY DA, 1990, APPL ENVIRON MICROB, V56, P431, DOI 10.1128/AEM.56.2.431-435.1990; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Fedatto LM, 2006, MICROBIOL RES, V161, P263, DOI 10.1016/j.micres.2005.10.001; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Leary SC, 2009, BBA-MOL CELL RES, V1793, P146, DOI 10.1016/j.bbamcr.2008.05.002; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Mackie KA, 2012, ENVIRON POLLUT, V167, P16, DOI 10.1016/j.envpol.2012.03.023; Muranaka LS, 2012, J BACTERIOL, V194, P4561, DOI 10.1128/JB.00436-12; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Ordax M, 2010, RES MICROBIOL, V161, P549, DOI 10.1016/j.resmic.2010.05.003; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rodrigues CM, 2008, APPL MICROBIOL BIOT, V77, P1145, DOI 10.1007/s00253-007-1232-1; Rogers EE, 2012, MOL PLANT MICROBE IN, V25, P747, DOI 10.1094/MPMI-11-10-0270; Rose RK, 2000, BBA-GEN SUBJECTS, V1475, P76, DOI 10.1016/S0304-4165(00)00048-9; Ryan RP, 2007, FEMS MICROBIOL LETT, V268, P40, DOI 10.1111/j.1574-6968.2006.00592.x; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Silva MS, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-58; Srinandan CS, 2010, BIOFOULING, V26, P449, DOI 10.1080/08927011003739760; Tang DJ, 2005, MOL PLANT MICROBE IN, V18, P652, DOI 10.1094/MPMI-18-0652; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; White PJ, 2012, NEW PHYTOL, V196, P101, DOI 10.1111/j.1469-8137.2012.04228.x; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu HJ, 2006, MOL MICROBIOL, V60, P401, DOI 10.1111/j.1365-2958.2006.05079.x; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x	46	57	57	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54936	10.1371/journal.pone.0054936	http://dx.doi.org/10.1371/journal.pone.0054936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349991	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100112
J	Reynolds, MR; Lane, AN; Robertson, B; Kemp, S; Liu, Y; Hill, BG; Dean, DC; Clem, BF				Reynolds, M. R.; Lane, A. N.; Robertson, B.; Kemp, S.; Liu, Y.; Hill, B. G.; Dean, D. C.; Clem, B. F.			Control of glutamine metabolism by the tumor suppressor Rb	ONCOGENE			English	Article						retinoblastoma protein; metabolism; glutamine; cancer; tumor suppressor	ENERGY-METABOLISM; CELL-PROLIFERATION; GROWTH-FACTOR; G(1) CONTROL; FACTOR-I; INHIBITION; PROTEIN; CANCER; GLYCOLYSIS; APOPTOSIS	Retinoblastoma (Rb) protein is a tumor suppressor that is dysregulated in a majority of human cancers. Rb functions to inhibit cell cycle progression in part by directly disabling the E2F family of cell cycle-promoting transcription factors. Because the de novo synthesis of multiple glutamine-derived anabolic precursors is required for cell cycle progression, we hypothesized that Rb also may directly regulate proteins involved in glutamine metabolism. We examined glutamine metabolism in mouse embryonic fibroblasts (MEFs) isolated from mice that have triple knock-outs (TKO) of all three Rb family members (Rb-1, Rbl1 and Rbl2) and found that loss of global Rb function caused a marked increase in C-13-glutamine uptake and incorporation into glutamate and tricarboxylic acid cycle (TCA) intermediates in part via upregulated expression of the glutamine transporter ASCT2 and the activity of glutaminase 1 (GLS1). The Rb-controlled transcription factor E2F-3 altered glutamine uptake by direct regulation of ASCT2 mRNA and protein expression, and E2F-3 was observed to associate with the ASCT2 promoter. We next examined the functional consequences of the observed increase in glutamine uptake and utilization and found that glutamine exposure potently increased oxygen consumption, whereas glutamine deprivation selectively decreased ATP concentration in the Rb TKO MEFs but not the wildtype (WT) MEFs. In addition, TKO MEFs exhibited elevated production of glutathione from exogenous glutamine and had increased expression of gamma-glutamylcysteine ligase relative to WT MEFs. Importantly, this metabolic shift towards glutamine utilization was required for the proliferation of Rb TKO MEFs but not for the proliferation of the WT MEFs. Last, addition of the TCA cycle intermediate alpha-ketoglutarate to the Rb TKO MEFs reversed the inhibitory effects of glutamine deprivation on ATP, GSH levels and viability. Taken together, these studies demonstrate that the Rb/E2F cascade directly regulates a major energetic and anabolic pathway that is required for neoplastic growth.	[Reynolds, M. R.; Lane, A. N.; Robertson, B.; Kemp, S.; Hill, B. G.; Clem, B. F.] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Reynolds, M. R.; Hill, B. G.; Dean, D. C.; Clem, B. F.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Reynolds, M. R.; Robertson, B.; Kemp, S.; Liu, Y.; Dean, D. C.; Clem, B. F.] Univ Louisville, Mol Targets Grp, Louisville, KY 40202 USA; [Lane, A. N.] Univ Louisville, James Graham Brown Canc Ctr, Struct Biol Program, Louisville, KY 40202 USA; [Liu, Y.; Dean, D. C.] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Hill, B. G.] Univ Louisville, Inst Mol Cardiol, Diabetes & Obes Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville	Clem, BF (corresponding author), Univ Louisville, Dept Med, 505 S Hancock St,CTRB,Rm 422, Louisville, KY 40202 USA.	bfclem01@louisville.edu	Hill, Bradford/I-4154-2013	Hill, Bradford/0000-0001-5332-8286	Brown Foundation; NCCRR [1P20 RR18733]; Center of Biomedical Research Excellence in Molecular Targets grant from the National Center for Research Resources [3P20RR018733-09-BFC];  [RR024489]; NATIONAL CANCER INSTITUTE [R01CA166327] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489, P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	Brown Foundation; NCCRR; Center of Biomedical Research Excellence in Molecular Targets grant from the National Center for Research Resources; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge Jason Chesney, Sucheta Telang and John Eaton for their insightful discussions, and thank Tyler Jacks for the kind gift of the TKO MEFs. NMR experiments were carried out at the James Graham Brown Cancer Center NMR facility, supported in part by the Brown Foundation and NCCRR grant 1P20 RR18733. This work was supported by a Center of Biomedical Research Excellence in Molecular Targets (3P20RR018733-09-BFC) grant from the National Center for Research Resources and by RR024489 (BGH).	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Ciavarra G, 2010, J CELL BIOL, V191, P291, DOI 10.1083/jcb.201005067; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Clem BF, 2011, ONCOGENE, V30, P3370, DOI 10.1038/onc.2011.51; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dang CV, 1997, J BIOENERG BIOMEMBR, V29, P345, DOI 10.1023/A:1022446730452; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McClellan KA, 2009, MOL CELL BIOL, V29, P4701, DOI 10.1128/MCB.01767-08; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Takahashi C, 2012, CANCER SCI, V103, P1182, DOI 10.1111/j.1349-7006.2012.02284.x; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Warburg O, 1924, BIOCHEM Z, V152, P319; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	43	134	138	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					556	566		10.1038/onc.2012.635	http://dx.doi.org/10.1038/onc.2012.635			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23353822	Green Accepted			2022-12-25	WOS:000331125100004
J	Clemente, P; Peralta, S; Cruz-Bermudez, A; Echevarria, L; Fontanesi, F; Barrientos, A; Fernandez-Moreno, MA; Garesse, R				Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fontanesi, Flavia; Barrientos, Antoni; Fernandez-Moreno, Miguel A.; Garesse, Rafael			hCOA3 Stabilizes Cytochrome c Oxidase 1 (COX1) and Promotes Cytochrome c Oxidase Assembly in Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; PROTEIN; DEFECTS; SUBUNIT; TRANSLATION; COMPLEX; EXPRESSION; C12ORF62; MSS51P; LRPPRC	Cytochrome c oxidase (COX) or complex IV of the mitochondrial respiratory chain plays a fundamental role in energy production of aerobic cells. In humans, COX deficiency is the most frequent cause of mitochondrial encephalomyopathies. Human COX is composed of 13 subunits of dual genetic origin, whose assembly requires an increasing number of nuclear-encoded accessory proteins known as assembly factors. Here, we have identified and characterized human CCDC56, an 11.7-kDa mitochondrial transmembrane protein, as a new factor essential for COX biogenesis. CCDC56 shares sequence similarity with the yeast COX assembly factor Coa3 and was termed hCOA3. hCOA3-silenced cells display a severe COX functional alteration owing to a decreased stability of newly synthesized COX1 and an impairment in the holoenzyme assembly process. We show that hCOA3 physically interacts with both the mitochondrial translation machinery and COX structural subunits. We conclude that hCOA3 stabilizes COX1 co-translationally and promotes its assembly with COX partner subunits. Finally, our results identify hCOA3 as a new candidate when screening for genes responsible for mitochondrial diseases associated with COX deficiency.	[Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Univ Autonoma Madrid, Dept Bioquim, Inst Invest Biomed Alberto Sols, UAM Consejo Super Invest Cient, Madrid 28029, Spain; [Clemente, Paula; Peralta, Susana; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Clemente, Paula; Cruz-Bermudez, Alberto; Echevarria, Lucia; Fernandez-Moreno, Miguel A.; Garesse, Rafael] Hosp 12 Octubre I 12, Inst Invest Sanitaria, Madrid 28029, Spain; [Fontanesi, Flavia; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem, Miami, FL 33136 USA; [Fernandez-Moreno, Miguel A.; Garesse, Rafael] Comunidad Madrid, MITOLAB Consortium BMD 2402 P2010, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; University of Miami; University of Miami	Garesse, R (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Lab B19, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	rafael.garesse@uam.es	Fernandez-Moreno, Miguel Angel/K-4425-2017; Garesse, Rafael/F-3836-2012; Bermúdez, Alberto Cruz/AAE-1341-2021; Clemente, Paula/AAA-5768-2021	Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Bermúdez, Alberto Cruz/0000-0001-5136-7011; Echevarria, Lucia/0000-0001-9307-6992; Garesse, Rafael/0000-0002-0338-2281; Clemente, Paula/0000-0002-6885-3750; Fontanesi, Flavia/0000-0003-0509-3835	Instituto de Salud Carlos III [PI 10/0703]; Comunidad Autonoma de Madrid [S2010/BMD-2402]; Muscular Dystrophy Association [158547]; National Institutes of Health [GM071775A]; Ministerio de Ciencia e Innovacion grant (Spain); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion grant (Spain); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Instituto de Salud Carlos III Grant PI 10/0703 (to R. G.), Comunidad Autonoma de Madrid Grant S2010/BMD-2402 (to R. G.), Muscular Dystrophy Association Grants 158547 (to F. F). and 158547 (to A. B.), and National Institutes of Health Grant GM071775A (to A. B.).; Supported by Ministerio de Ciencia e Innovacion grant (Spain).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Peralta S, 2012, J BIOL CHEM, V287, P24174, DOI 10.1074/jbc.M112.343764; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201	45	36	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8321	8331		10.1074/jbc.M112.422220	http://dx.doi.org/10.1074/jbc.M112.422220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362268	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000316564500032
J	Crona, M; Avesson, L; Sahlin, M; Lundin, D; Hinas, A; Klose, R; Soderbom, F; Sjoberg, BM				Crona, Mikael; Avesson, Lotta; Sahlin, Margareta; Lundin, Daniel; Hinas, Andrea; Klose, Ralph; Soderbom, Fredrik; Sjoberg, Britt-Marie			A Rare Combination of Ribonucleotide Reductases in the Social Amoeba Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ALLOSTERIC REGULATION; PSEUDOMONAS-AERUGINOSA; DIPHOSPHATE REDUCTASE; GENE-EXPRESSION; DNA; REVEALS; SUBUNIT; GENOME; GROWTH	Ribonucleotide reductases (RNRs) catalyze the only pathway for de novo synthesis of deoxyribonucleotides needed for DNA replication and repair. The vast majority of eukaryotes encodes only a class I RNR, but interestingly some eukaryotes, including the social amoeba Dictyostelium discoideum, encode both a class I and a class II RNR. The amino acid sequence of the D. discoideum class I RNR is similar to other eukaryotic RNRs, whereas that of its class IIRNRis most similar to the monomeric class II RNRs found in Lactobacillus spp. and a few other bacteria. Here we report the first study of RNRs in a eukaryotic organism that encodes class I and class II RNRs. Both classes of RNR genes were expressed in D. discoideum cells, although the class I transcripts were more abundant and strongly enriched during mid-development compared with the class II transcript. The quaternary structure, allosteric regulation, and properties of the diiron-oxo/radical cofactor of D. discoideum class I RNR are similar to those of the mammalian RNRs. Inhibition of D. discoideum class I RNR by hydroxyurea resulted in a 90% reduction in spore formation and decreased the germination viability of the surviving spores by 75%. Class II RNR could not compensate for class I inhibition during development, and an excess of vitamin B-12 coenzyme, which is essential for class II activity, did not improve spore formation. We suggest that class I is the principal RNR during D. discoideum development and growth and is important for spore formation, possibly by providing dNTPs for mitochondrial replication.	[Crona, Mikael; Sahlin, Margareta; Klose, Ralph; Sjoberg, Britt-Marie] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden; [Sahlin, Margareta; Lundin, Daniel; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Avesson, Lotta; Hinas, Andrea; Soderbom, Fredrik] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala Biomed Ctr, SE-75124 Uppsala, Sweden	Stockholm University; Stockholm University; Swedish University of Agricultural Sciences	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@dbb.su.se		Sjoberg, Britt-Marie/0000-0001-5953-3360; Avesson, Lotta/0000-0002-5526-6768; Lundin, Daniel/0000-0002-8779-6464; Crona, Mikael/0000-0002-6420-6097	Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Community [EC005120]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Community(European Commission)	This work was supported by the Swedish Research Council (to B.M.S. and F.S.), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (the Swedish Research Council Formas) (to F.S.), and the European Community (Function of Small RNAs across Kingdoms (FOSRAK) Grant EC005120) (to F.S.).	ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Birgander PL, 2005, J BIOL CHEM, V280, P14997, DOI 10.1074/jbc.M500565200; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Chida J, 2004, J CELL SCI, V117, P3141, DOI 10.1242/jcs.01140; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; DURSTON AJ, 1978, EXP CELL RES, V115, P454, DOI 10.1016/0014-4827(78)90308-7; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; LARSSON A, 1966, J BIOL CHEM, V241, P2533; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; MATSUYAMA SI, 1995, DEV BIOL, V172, P182, DOI 10.1006/dbio.1995.0014; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; SANDONA D, 1995, J BIOL CHEM, V270, P5587, DOI 10.1074/jbc.270.10.5587; Sauge-Merle S, 1999, EUR J BIOCHEM, V266, P62, DOI 10.1046/j.1432-1327.1999.00814.x; SHAULSKY G, 1995, P NATL ACAD SCI USA, V92, P5660, DOI 10.1073/pnas.92.12.5660; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Srinivasan S, 2000, TRENDS CELL BIOL, V10, P215, DOI 10.1016/S0962-8924(00)01758-X; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; Thelander L, 1978, Methods Enzymol, V51, P227; Torrents E, 2006, J BIOL CHEM, V281, P5604, DOI 10.1074/jbc.M512962200; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Tsang A, 1996, BBA-GENE STRUCT EXPR, V1309, P100, DOI 10.1016/S0167-4781(96)00109-1; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288; ZADAHAMES IM, 1978, DEV BIOL, V63, P307, DOI 10.1016/0012-1606(78)90136-7; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; ZIMMERMAN W, 1993, DEV BIOL, V160, P178, DOI 10.1006/dbio.1993.1296	58	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8198	8208		10.1074/jbc.M112.442434	http://dx.doi.org/10.1074/jbc.M112.442434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23372162	hybrid, Green Published			2022-12-25	WOS:000316564500020
J	Gao, N; Huang, J; He, WQ; Zhu, MS; Kamm, KE; Stull, JT				Gao, Ning; Huang, Jian; He, Weiqi; Zhu, Minsheng; Kamm, Kristine E.; Stull, James T.			Signaling through Myosin Light Chain Kinase in Smooth Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; OKADAIC ACID; CALYCULIN-A; RHO-KINASE; PHOSPHORYLATION; CONTRACTION; ACTIVATION; CALCIUM; BINDING	Ca2+/calmodulin-dependent myosin light chain kinase (MLCK) phosphorylates smooth muscle myosin regulatory light chain (RLC) to initiate contraction. We used a tamoxifen-activated, smooth muscle-specific inactivation of MLCK expression in adult mice to determine whether MLCK was differentially limiting in distinct smooth muscles. A 50% decrease in MLCK in urinary bladder smooth muscle had no effect on RLC phosphorylation or on contractile responses, whereas an 80% decrease resulted in only a 20% decrease in RLC phosphorylation and contractile responses to the muscarinic agonist carbachol. Phosphorylation of the myosin light chain phosphatase regulatory subunit MYPT1 at Thr-696 and Thr-853 and the inhibitor protein CPI-17 were also stimulated with carbachol. These results are consistent with the previous findings that activation of a small fraction of MLCK by limiting amounts of free Ca2+/calmodulin combined with myosin light chain phosphatase inhibition is sufficient for robust RLC phosphorylation and contractile responses in bladder smooth muscle. In contrast, a 50% decrease in MLCK in aortic smooth muscle resulted in 40% inhibition of RLC phosphorylation and aorta contractile responses, whereas a 90% decrease profoundly inhibited both responses. Thus, MLCK content is limiting for contraction in aortic smooth muscle. Phosphorylation of CPI-17 and MYPT1 at Thr-696 and Thr-853 were also stimulated with phenylephrine but significantly less than in bladder tissue. These results indicate differential contributions of MLCK to signaling. Limiting MLCK activity combined with modest Ca2+ sensitization responses provide insights into how haploinsufficiency of MLCK may result in contractile dysfunction in vivo, leading to dissections of human thoracic aorta.	[Gao, Ning; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [He, Weiqi; Zhu, Minsheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [He, Weiqi; Zhu, Minsheng] Nanjing Univ, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing University; Nanjing University	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu	He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420	National Institutes of Health [HL26043, HL110869]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; National Basic Research Program of China (973) [2009CB942602, 2007CB947100]; National Natural Science of China Grant [30570911]; China Postdoctoral Science Foundation [20110491391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, P01HL110869, R37HL026043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science of China Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL26043 and HL110869, the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.), National Basic Research Program of China (973) Grants 2009CB942602 and 2007CB947100 (to M. S. Z), National Natural Science of China Grant 30570911 (to M. S. Z.), and China Postdoctoral Science Foundation Grant 20110491391 (to W. Q. H.).	[Anonymous], 2014, CELL SIGNAL BIOL; Arens WHJM, 2000, AM J PHYSIOL-REG I, V278, pR1305, DOI 10.1152/ajpregu.2000.278.5.R1305; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Emmert DA, 2004, AM J PHYSIOL-CELL PH, V286, pC8, DOI 10.1152/ajpcell.00428.2002; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Geguchadze R, 2004, FEBS LETT, V557, P121, DOI 10.1016/S0014-5793(03)01456-X; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKEBE M, 1985, J BIOL CHEM, V260, P27; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kitazawa T, 2010, BIOCHEM BIOPH RES CO, V401, P75, DOI 10.1016/j.bbrc.2010.09.011; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; PATO MD, 1983, J BIOL CHEM, V258, P7047; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; TAKAI A, 1995, BIOCHEM J, V306, P657, DOI 10.1042/bj3060657; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Wang HB, 2012, J NEUROSCI RES, V90, P1547, DOI 10.1002/jnr.23036; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Yamawaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1040, DOI 10.1006/bbrc.2001.5290; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	61	45	51	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7596	7605		10.1074/jbc.M112.427112	http://dx.doi.org/10.1074/jbc.M112.427112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362260	hybrid, Green Published			2022-12-25	WOS:000316455300017
J	Patwardhan, CA; Fauq, A; Peterson, LB; Miller, C; Blagg, BSJ; Chadli, A				Patwardhan, Chaitanya A.; Fauq, Abdul; Peterson, Laura B.; Miller, Charles; Blagg, Brian S. J.; Chadli, Ahmed			Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 COCHAPERONE P23; HEAT-SHOCK; MOLECULAR CHAPERONE; ANDROGEN RECEPTOR; CRYSTAL-STRUCTURE; BREAST-CANCER; CELASTROL; TRITERPENE; COMPLEX; ACTIVATION	Pharmacological inhibition of Hsp90 is an exciting option for cancer therapy. The clinical efficacy of Hsp90 inhibitors is, however, less than expected. Binding of the co-chaperone p23 to Hsp90 and induced overexpression of anti-apoptotic proteins Hsp70 and Hsp27 are thought to contribute to this outcome. Herein, we report that the natural product gedunin may provide a new alternative to inactivate the Hsp90 machine. We show that gedunin directly binds to p23 and inactivates it, without overexpression of Hsp27 and relatively modest induction of Hsp70. Using molecular docking and mutational analysis, we mapped the gedunin-binding site on p23. Functional analysis shows that gedunin inhibits the p23 chaperoning activity, blocks its cellular interaction with Hsp90, and interferes with p23-mediated gene regulation. Cell treatment with gedunin leads to cancer cell death by apoptosis through inactivation of p23 and activation of caspase 7, which cleaves p23 at the C terminus. These results provide important insight into the molecular mechanism of action of this promising lead compound.	[Patwardhan, Chaitanya A.; Chadli, Ahmed] Georgia Regents Univ, Canc Res Ctr, Mol Chaperones Program, Augusta, GA 30912 USA; [Fauq, Abdul] Mayo Clin, Coll Med, Organ Chem Lab, Jacksonville, FL 32224 USA; [Peterson, Laura B.; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Miller, Charles] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA 70112 USA	University System of Georgia; Augusta University; Mayo Clinic; University of Kansas; Tulane University	Chadli, A (corresponding author), Georgia Regents Univ, Canc Res Ctr, Mol Chaperones Program, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA.	achadli@georgiahealth.edu	blagg, brian s j/X-7770-2018; Miller, Charles A/I-3978-2019	blagg, brian s j/0000-0002-6200-3480; Miller, Charles A/0000-0003-0644-7455	National Institutes of Health [R01 GM102443-01]; American Heart Association [0930019N]; NATIONAL CANCER INSTITUTE [U01CA109265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM102443-01 (to A. C.). This work was also supported by Scientist Development Grant 0930019N from the American Heart Association (to A. C.).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Brandt GEL, 2008, J MED CHEM, V51, P6495, DOI 10.1021/jm8007486; Burlison JA, 2008, J ORG CHEM, V73, P2130, DOI 10.1021/jo702191a; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kamath SG, 2009, INT J GYNECOL CANCER, V19, P1564, DOI 10.1111/IGC.0b013e3181a83135; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Knoblauch R, 1999, MOL CELL BIOL, V19, P3748; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Oxelmark E, 2003, J BIOL CHEM, V278, P36547, DOI 10.1074/jbc.M305960200; Oxelmark E, 2006, MOL CELL BIOL, V26, P5205, DOI 10.1128/MCB.00009-06; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Poksay KS, 2012, J MOL NEUROSCI, V46, P303, DOI 10.1007/s12031-011-9574-7; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rao J, 2001, J BIOL CHEM, V276, P5814, DOI 10.1074/jbc.M007385200; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Simpson NE, 2012, MOL ENDOCRINOL, V26, P194, DOI 10.1210/me.2011-1068; Simpson NE, 2010, CANCER RES, V70, P8446, DOI 10.1158/0008-5472.CAN-10-1590; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woo SH, 2009, J BIOL CHEM, V284, P30871, DOI 10.1074/jbc.M109.052720; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zelin E, 2012, MOL CELL, V48, P459, DOI 10.1016/j.molcel.2012.08.026; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	61	85	88	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7313	7325		10.1074/jbc.M112.427328	http://dx.doi.org/10.1074/jbc.M112.427328			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23355466	Green Published, hybrid			2022-12-25	WOS:000316002400051
J	Saleem, H; Tovey, SC; Rahman, T; Riley, AM; Potter, BVL; Taylor, CW				Saleem, Huma; Tovey, Stephen C.; Rahman, Taufiq; Riley, Andrew M.; Potter, Barry V. L.; Taylor, Colin W.			Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Analogues of IP3	PLOS ONE			English	Article							LIGAND-BINDING; TRISPHOSPHATE RECEPTOR; TYPE-1; PHOSPHATES; ACTIVATION; INSP(3); PROTEIN; DOMAIN; MOBILIZATION; INVOLVEMENT	Most animal cells express mixtures of the three subtypes of inositol 1,4,5-trisphosphate receptor (IP3R) encoded by vertebrate genomes. Activation of each subtype by different agonists has not hitherto been examined in cells expressing defined homogenous populations of IP3R. Here we measure Ca2+ release evoked by synthetic analogues of IP3 using a Ca2+ indicator within the lumen of the endoplasmic reticulum of permeabilized DT40 cells stably expressing single subtypes of mammalian IP3R. Phosphorylation of (1,4,5)IP3 to (1,3,4,5)IP4 reduced potency by similar to 100-fold. Relative to (1,4,5)IP3, the potencies of IP3 analogues modified at the 1-position (malachite green (1,4,5)IP3), 2-position (2-deoxy(1,4,5)IP3) or 3-position (3-deoxy(1,4,5)IP3, (1,3,4,5)IP4) were similar for each IP3R subtype. The potency of an analogue, (1,4,6)IP3, in which the orientations of the 2- and 3-hydroxyl groups were inverted, was also reduced similarly for all three IP3R subtypes. Most analogues of IP3 interact similarly with the three IP3R subtypes, but the decrease in potency accompanying removal of the 1-phosphate from (1,4,5) IP3 was least for IP(3)R3. Addition of a large chromophore (malachite green) to the 1-phosphate of (1,4,5)IP3 only modestly reduced potency suggesting that similar analogues could be used to measure (1,4,5)IP3 binding optically. These data provide the first structure-activity analyses of key IP3 analogues using homogenous populations of each mammalian IP3R subtype. They demonstrate broadly similar structure-activity relationships for all mammalian IP3R subtypes and establish the potential utility of (1,4,5)IP3 analogues with chromophores attached to the 1-position.	[Saleem, Huma; Tovey, Stephen C.; Rahman, Taufiq; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riley, Andrew M.; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Cambridge; University of Bath	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	rahman, taufiq/E-9806-2013; Potter, Barry/AAX-4781-2020; Riley, Andrew M/F-3526-2013; rahman, taufiq/GON-8210-2022; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; Riley, Andrew M/0000-0001-9003-3540; rahman, taufiq/0000-0003-3830-5160; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust [085295, 082837]; Biotechnology and Biological Sciences Research Council [BB/H009736/1]; Jameel Family Trust; BBSRC [BB/H009736/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Jameel Family Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust to CWT [085295], and BVLP and AMR [082837], and from Biotechnology and Biological Sciences Research Council to CWT [BB/H009736/1]. HS is supported by a research studentship from the Jameel Family Trust. TR was a research fellow of Pembroke College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Bird GSJ, 1996, J BIOL CHEM, V271, P6766, DOI 10.1074/jbc.271.12.6766; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BURGESS GM, 1985, BIOCHEM J, V232, P237, DOI 10.1042/bj2320237; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELISLE S, 1994, AM J PHYSIOL, V266, pC429, DOI 10.1152/ajpcell.1994.266.2.C429; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/s004410050345; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; HAGIWARA T, 1994, B CHEM SOC JPN, V67, P390, DOI 10.1246/bcsj.67.390; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Inoue T, 1999, BIOORG MED CHEM LETT, V9, P1697, DOI 10.1016/S0960-894X(99)00256-5; Inoue T, 2001, CHEM BIOL, V8, P9, DOI 10.1016/S1074-5521(00)00051-X; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; KOZIKOWSKI AP, 1993, J AM CHEM SOC, V115, P4429, DOI 10.1021/ja00064a002; LAMPE D, 1992, J CHEM SOC PERK T 1, P2899, DOI 10.1039/p19920002899; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Loomis-Husselbee JW, 1998, BIOCHEM J, V331, P947, DOI 10.1042/bj3310947; LU PJ, 1994, BIOCHEMISTRY-US, V33, P11586, DOI 10.1021/bi00204a021; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Marchant JS, 1997, BIOCHEM J, V321, P573, DOI 10.1042/bj3210573; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Merlino A, 2012, MEDCHEMCOMM, V3, P90, DOI 10.1039/c1md00223f; Mills SJ, 1996, J ORG CHEM, V61, P8980, DOI 10.1021/jo961280x; Nakanishi W, 2002, BIOORG MED CHEM LETT, V12, P911, DOI 10.1016/S0960-894X(02)00044-6; Nerou EP, 2001, BIOCHEM J, V355, P59, DOI 10.1042/bj3550059; Pantazaka E, 2011, J BIOL CHEM, V286, P23378, DOI 10.1074/jbc.M111.236372; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poinas A, 2005, CHEMBIOCHEM, V6, P1449, DOI 10.1002/cbic.200400443; POTTER BVL, 1995, ANGEW CHEM INT EDIT, V34, P1933, DOI 10.1002/anie.199519331; Rahman T. U., 2009, NATURE, V458, P655; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Riley AM, 1997, ANGEW CHEM INT EDIT, V36, P1472, DOI 10.1002/anie.199714721; Rossi AM, 2010, BRIT J PHARMACOL, V161, P1070, DOI 10.1111/j.1476-5381.2010.00947.x; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sureshan KM, 2012, J MED CHEM, V55, P1706, DOI 10.1021/jm201571p; Sureshan KM, 2009, CHEM COMMUN, P1204, DOI 10.1039/b819328b; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wilcox RA, 1997, FEBS LETT, V402, P241, DOI 10.1016/S0014-5793(96)01540-2; Wilcox RA, 1998, TRENDS PHARMACOL SCI, V19, P467, DOI 10.1016/S0165-6147(98)01260-7; YAMAMOTOHINO M, 1995, NEUROREPORT, V6, P273, DOI 10.1097/00001756-199501000-00012; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129	57	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54877	10.1371/journal.pone.0054877	http://dx.doi.org/10.1371/journal.pone.0054877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372785	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400038
J	Angell, RL; Butlin, RK; Altringham, JD				Angell, Ruth L.; Butlin, Roger K.; Altringham, John D.			Sexual Segregation and Flexible Mating Patterns in Temperate Bats	PLOS ONE			English	Article							LONG-EARED BAT; PLECOTUS-AURITUS; SWARMING SITES; BECHSTEINS BAT; POPULATION-STRUCTURE; MYOTIS-BECHSTEINII; GENETIC-STRUCTURE; NATTERERS BATS; PHILOPATRY; BEHAVIOR	Social structure evolves from a trade-off between the costs and benefits of group-living, which are in turn dependent upon the distribution of key resources such as food and shelter. Males and females, or juveniles and adults, may have different priorities when selecting habitat due to differences in physiological or behavioural imperatives, leading to complex patterns in group composition. We studied social structure and mating behaviour in the insectivorous bat Myotis daubentonii along an altitudinal gradient, combining field studies with molecular genetics. With increasing altitude the proportion of males in summer roosts increased and only males were present in the highest roosts. With increasing altitude environmental temperature decreased, nightly variation in temperature increased, and bat foraging activity decreased, supporting the hypothesis that the harsher, high elevation sites cannot support breeding females. We found that offspring in female-dominated lowland roosts had a very high probability of being fathered by bats caught during autumn swarming at hibernation sites, in contrast to those in intermediate roosts, which had a high probability of being fathered by males sharing the nursery roost with the females. Whilst females normally appear to exclude males from nursery colonies, for those in marginal habitats, one explanation for the presence of males is that the thermoregulatory benefits to the females may outweigh disadvantages, such as competition for food, and give some males an opportunity to increase their breeding success. We suggest that the environment, and its effects on resource distribution, thus determine social structure, which in turn determines the mating pattern that has evolved.	[Angell, Ruth L.; Altringham, John D.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Butlin, Roger K.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; University of Sheffield	Altringham, JD (corresponding author), Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.	j.d.altringham@leeds.ac.uk	Butlin, Roger K/F-7709-2013	Butlin, Roger K/0000-0003-4736-0954	Natural Environment Research Council (NERC) PhD Studentship; NERC; Natural Environment Research Council [NBAF010001, NE/J006300/1] Funding Source: researchfish; NERC [NE/J006300/1, NBAF010001] Funding Source: UKRI	Natural Environment Research Council (NERC) PhD Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RLA was supported by a Natural Environment Research Council (NERC) PhD Studentship (www.nerc.ac.uk). Molecular work was carried out at the NERC Biomolecular Analysis Facility (NBAF) at the University of Sheffield with additional funding from NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Altringham John D., 2005, P280; Angell RL, 2008, THESIS U LEEDS; Anthony E.L.P., 1988, P47; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2004, ETHOLOGY, V110, P987, DOI 10.1111/j.1439-0310.2004.01040.x; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P203, DOI 10.1007/s00265-002-0499-6; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Petri B, 1997, MOL ECOL, V6, P235, DOI 10.1046/j.1365-294X.1997.00176.x; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; RICHARDSON PW, 1994, J ZOOL, V233, P307, DOI 10.1111/j.1469-7998.1994.tb08590.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559	28	37	40	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54194	10.1371/journal.pone.0054194	http://dx.doi.org/10.1371/journal.pone.0054194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365652	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600037
J	Kaasinen, E; Aavikko, M; Vahteristo, P; Patama, T; Li, YL; Saarinen, S; Kilpivaara, O; Pitkanen, E; Knekt, P; Laaksonen, M; Artama, M; Lehtonen, R; Aaltonen, LA; Pukkala, E				Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Patama, Toni; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Knekt, Paul; Laaksonen, Maarit; Artama, Miia; Lehtonen, Rainer; Aaltonen, Lauri A.; Pukkala, Eero			Nationwide Registry-Based Analysis of Cancer Clustering Detects Strong Familial Occurrence of Kaposi Sarcoma	PLOS ONE			English	Article							CARCINOID-TUMORS; PREDISPOSITION; POPULATION; FINLAND; RISK; GENE; HERPESVIRUS; DEFICIENCY; MUTATIONS; DISCOVERY	Many cancer predisposition syndromes are rare or have incomplete penetrance, and traditional epidemiological tools are not well suited for their detection. Here we have used an approach that employs the entire population based data in the Finnish Cancer Registry (FCR) for analyzing familial aggregation of all types of cancer, in order to find evidence for previously unrecognized cancer susceptibility conditions. We performed a systematic clustering of 878,593 patients in FCR based on family name at birth, municipality of birth, and tumor type, diagnosed between years 1952 and 2011. We also estimated the familial occurrence of the tumor types using cluster score that reflects the proportion of patients belonging to the most significant clusters compared to all patients in Finland. The clustering effort identified 25,910 birth name-municipality based clusters representing 183 different tumor types characterized by topography and morphology. We produced information about familial occurrence of hundreds of tumor types, and many of the tumor types with high cluster score represented known cancer syndromes. Unexpectedly, Kaposi sarcoma (KS) also produced a very high score (cluster score 1.91, p-value<0.0001). We verified from population records that many of the KS patients forming the clusters were indeed close relatives, and identified one family with five affected individuals in two generations and several families with two first degree relatives. Our approach is unique in enabling systematic examination of a national epidemiological database to derive evidence of aberrant familial aggregation of all tumor types, both common and rare. It allowed effortless identification of families displaying features of both known as well as potentially novel cancer predisposition conditions, including striking familial aggregation of KS. Further work with high-throughput methods should elucidate the molecular basis of the potentially novel predisposition conditions found in this study.	[Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Fac Med, Genome Scale Biol Res Program, Helsinki, Finland; [Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Fac Med, Dept Med Genet, Helsinki, Finland; [Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Patama, Toni; Artama, Miia; Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; [Knekt, Paul; Laaksonen, Maarit] Natl Inst Hlth & Welf, Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Finnish Cancer Registry; Finland National Institute for Health & Welfare; Tampere University	Aaltonen, LA (corresponding author), Univ Helsinki, Fac Med, Genome Scale Biol Res Program, Helsinki, Finland.	lauri.aaltonen@helsinki.fi	Laaksonen, Maarit A/O-3467-2016; Aaltonen, Lauri/A-5375-2010; Pitkanen, Esa/H-2435-2018	Laaksonen, Maarit A/0000-0002-3676-0787; Aaltonen, Lauri/0000-0001-6839-4286; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Pitkanen, Esa/0000-0002-9818-6370; Kaasinen, Eevi/0000-0002-1333-8049	Academy of Finland Center of Excellence in Cancer Genetics Research [250345]; Postdoctoral Researcher's grants [21290, 137680]; European Research Council [268648 - NGG]; Cancer Society of Finland; Ida Montini Foundation; Paulo Foundation; Orion Pharmos Foundation; Sigrid Juselius Foundation	Academy of Finland Center of Excellence in Cancer Genetics Research(Academy of Finland); Postdoctoral Researcher's grants; European Research Council(European Research Council (ERC)European Commission); Cancer Society of Finland; Ida Montini Foundation; Paulo Foundation; Orion Pharmos Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Center of Excellence in Cancer Genetics Research (No 250345) and Postdoctoral Researcher's grants (No 21290 and 137680), European Research Council (No 268648 - NGG), Cancer Society of Finland, Ida Montini Foundation, Paulo Foundation, Orion Pharmos Foundation, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenthal DT, 2008, NEUROLOGY, V71, P1015, DOI 10.1212/01.wnl.0000326597.60605.27; Brown EE, 2006, CANCER EPIDEM BIOMAR, V15, P926, DOI 10.1158/1055-9965.EPI-05-0791; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Camcioglu Y, 2004, J PEDIATR-US, V144, P519, DOI 10.1016/j.jpeds.2003.11.012; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cottoni F, 1996, ACTA DERM-VENEREOL, V76, P59; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DIGIOVANNA JJ, 1981, AM J MED, V71, P779, DOI 10.1016/0002-9343(81)90364-8; Dorak MT, 2005, J MED VIROL, V76, P302, DOI 10.1002/jmv.20361; Dukers NHTM, 2003, AIDS, V17, P1717, DOI 10.1097/00002030-200308150-00001; Farge D, 1993, Eur J Med, V2, P339; Fata F, 2002, J CLIN ONCOL, V20, P1415, DOI 10.1200/JCO.2002.20.5.1415; Gazouli M, 2004, ANTICANCER RES, V24, P1311; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldin LR, 2009, BRIT J HAEMATOL, V146, P91, DOI 10.1111/j.1365-2141.2009.07721.x; Guerini Franca Rosa, 2006, Cancer Genomics & Proteomics, V3, P191; Guttman-Yassky E, 2005, ARCH DERMATOL, V141, P1429, DOI 10.1001/archderm.141.11.1429; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Hale L R, 1998, Australas J Dermatol, V39, P241, DOI 10.1111/j.1440-0960.1998.tb01481.x; Hemminki K, 2010, BRIT J CANCER, V102, P1786, DOI 10.1038/sj.bjc.6605708; Hemminki K, 2001, INT J CANCER, V94, P444, DOI 10.1002/ijc.1473; Hiripi E, 2009, ANN ONCOL, V20, P950, DOI 10.1093/annonc/mdn706; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; KALOTERAKIS A, 1995, TISSUE ANTIGENS, V45, P117, DOI 10.1111/j.1399-0039.1995.tb02427.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Mancuso R, 2011, J GEN VIROL, V92, P744, DOI 10.1099/vir.0.027847-0; Matikainen MP, 2000, INT J CANCER, V88, P307, DOI 10.1002/1097-0215(20001015)88:2&lt;307::AID-IJC25&gt;3.0.CO;2-7; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pukkala E, 2010, SMALL AREA BASED MAP; Pukkala E, 2011, METHODS MOL BIOL, V675, P127, DOI 10.1007/978-1-59745-423-0_5; SAFAI B, 1985, ANN INTERN MED, V103, P744, DOI 10.7326/0003-4819-103-5-744; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Weissmann-Brenner A, 2004, CLIN ONCOL-UK, V16, P125, DOI 10.1016/S0936-6555(03)00249-8	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55209	10.1371/journal.pone.0055209	http://dx.doi.org/10.1371/journal.pone.0055209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365693	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600159
J	Kwon, WS; Park, YJ; Kim, YH; You, YA; Kim, IC; Pang, MG				Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Kim, In Cheul; Pang, Myung-Geol			Vasopressin Effectively Suppresses Male Fertility	PLOS ONE			English	Article							SPERM CAPACITATION; MOUSE SPERM; TYROSINE PHOSPHORYLATION; SPERMATOZOA; PROTEIN; IDENTIFICATION; OXYTOCIN; CALCIUM; FLUORESCENCE; EXPRESSION	Arginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility. However, very little is known about the involvement of VP in controlling mammalian reproductive process. The goal of this study was to confirm that effect of VP receptor (AVPR2) on sperm function in capacitation condition. Deamino [Cys 1, D-ArgS] vasopressin (dDAVP), an AVPR2 agonist that operates only on AVPR2, was used. Also, Mouse spermatozoa were incubated with various concentrations of dDAVP (10(-11)-10(-5) M) and sperm motility, capacitation status, Protein Kinase A activity (PKA), tyrosine phosphorylation, fertilization, and embryo development were assessed using computer-assisted sperm analysis, Combined Hoechst 33258/chlortetracycline fluorescence, Western blotting, and in vitro fertilization, respectively. AVPR2 was placed on the acrosome region and mid-piece in cauda epididymal spermatozoa, but the caput epididymal spermatozoa was mid-piece only. The high dDAVP treatment (10(-8) and 10(-5) M) significantly decreased sperm motility, intracellular pH and PKA substrates (approximately 55 and 22 kDa) and increased Ca2+ concentration. The highest concentration treatment significantly decreased PKA substrate (approximately 23 kDa) and tyrosine phosphorylation (approximately 30 kDa). VP detrimentally affected capacitation, acrosome reaction, and embryo development. Treatment with the lowest concentration (10(-11) M) was not significantly different. Our data have shown that VP stimulates ion transport across sperm membrane through interactions with AVPR2. VP has a detrimental effect in sperm function, fertilization, and embryonic development, suggesting its critical role in the acquisition of fertilizing ability of mouse spermatozoa. These research findings will enable further study to determine molecular mechanism associated with fertility in capacitation and fertilization. It is also an important pivotal precondition to the progress of diagnostic test to identify infertility and to apply male contraception.	[Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Sch Bioresource & Biosci, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Sch Bioresource & Biosci, BET Res Inst, Anseong, Gyeonggi Do, South Korea; [Kim, In Cheul] Rural Dev Adm, Natl Inst Anim Sci, Cheonan, Chungcheongnam, South Korea	Chung Ang University; Chung Ang University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Pang, MG (corresponding author), Chung Ang Univ, Sch Bioresource & Biosci, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Pang, Myung-Geol/AAV-2014-2021; Kwon, Woo-Sung/J-6731-2019	Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; You, Younag-Ah/0000-0001-6714-7144	Cooperative Research Program for Agriculture Science & Technology Development [PJ907170]; Rural Development Administration, Republic of Korea	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ907170), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Assinder SJ, 2000, BIOL REPROD, V63, P448, DOI 10.1095/biolreprod63.2.448; Baker SS, 2004, J ANDROL, V25, P744; Baldi E, 1996, FRONT BIOSCI, V1, P189; BROTHERTON J, 1990, ANDROLOGIA, V22, P305; Fernandes S, 2002, ENDOCRINOLOGY, V143, P2759, DOI 10.1210/en.143.7.2759; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; FRASER LR, 1992, J REPROD FERTIL, V96, P363, DOI 10.1530/jrf.0.0960363; Greenhalgh JR, 2009, J ANDROL, V30, P548, DOI 10.2164/jandrol.108.006049; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagedorn TA, 2007, BIOL REPROD, V77, P416, DOI 10.1095/biolreprod.106.056762; Harris CC, 1998, J ENDOCRINOL, V156, P35, DOI 10.1677/joe.0.1560035; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; KASSON BG, 1985, J BIOL CHEM, V260, P5302; KIHLSTROM JE, 1974, J ENDOCRINOL, V60, P445, DOI 10.1677/joe.0.0600445; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Maxwell WMC, 1999, THERIOGENOLOGY, V52, P1353, DOI 10.1016/S0093-691X(99)00222-8; MEIDAN R, 1985, ENDOCRINOLOGY, V116, P416, DOI 10.1210/endo-116-1-416; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Nicholson HD, 1999, J REPROD FERTIL, V117, P299, DOI 10.1530/jrf.0.1170299; Oh SA, 2008, THESIS CHUNG ANG U S; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; PICKERING BT, 1989, ANN NY ACAD SCI, V564, P198, DOI 10.1111/j.1749-6632.1989.tb25898.x; Pinto FM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-71; PURI S, 1985, ARCH ANDROLOGY, V14, P263, DOI 10.3109/01485018508988309; QUINN P, 1982, J REPROD FERTIL, V66, P161; RATNASOORIYA WD, 1993, MED SCI RES, V21, P13; Romero F, 2007, FERTIL STERIL, V87, P1345, DOI 10.1016/j.fertnstert.2006.11.054; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; SLIWA L, 1994, ARCH ANDROLOGY, V33, P145; Tabuchi T, 2008, J REPROD DEVELOP, V54, P502, DOI 10.1262/jrd.20021; Tian Y, 2000, ENDOCRINOLOGY, V141, P307, DOI 10.1210/en.141.1.307; Tulsiani DR, 2007, IOC REPROD FERTIL S, V63, P237; Varisli O, 2009, J ANDROL, V30, P75, DOI 10.2164/jandrol.107.004333; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Xia JS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-119; ZANEVELD LJD, 1991, HUM REPROD, V6, P1265, DOI 10.1093/oxfordjournals.humrep.a137524	45	40	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54192	10.1371/journal.pone.0054192	http://dx.doi.org/10.1371/journal.pone.0054192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365651	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600036
J	Maksimov, M; Vaht, M; Harro, J; Bachmann, T				Maksimov, Margus; Vaht, Mariliis; Harro, Jaanus; Bachmann, Talis			Can Common Functional Gene Variants Affect Visual Discrimination in Metacontrast Masking?	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; POLYMORPHISM; BRAIN; AMYGDALA; STIMULUS; IMPACTS	Mechanisms of visual perception should be robustly fast and provide veridical information about environmental objects in order to facilitate survival and successful coping. Because species-specific brain mechanisms for fast vision must have evolved under heavy pressure for efficiency, it has been held that different human individuals see the physical world in the same way and produce psychophysical functions of visual discrimination that are qualitatively the same. For many years, this assumption has been implicitly accepted in vision research studying extremely fast, basic visual processes, including studies of visual masking. However, in recent studies of metacontrast masking surprisingly robust individual differences in the qualitative aspects of subjects' performance have been found. As the basic species-specific visual functions very likely are based on universal brain mechanisms of vision, these differences probably are the outcome of variability in ontogenetic development (i.e., formation of idiosyncrasic skills of perception). Such developmental differences can be brought about by variants of genes that are differentially expressed in the course of CNS development. The objective of this study was to assess whether visual discrimination in metacontrast masking is related to three widely studied genetic polymorphisms implicated in brain function and used here as independent variables. The findings suggest no main effects of BDNF Val66Met, NRG1/rs6994992, or 5-HTTLPR polymorphisms on metacontrast performance, but several notable interactions of genetic variables with gender, stage of the sequence of experimental trials, perceptual strategies, and target/mask shape congruence were found. Thus, basic behavioral functions of fast vision may be influenced by common genetic variability. Also, when left uncontrolled, genetic factors may seriously confound variables in vision research using masking, obscure clear theoretical interpretation, lead to unexplicable inter-regional differences and create problems of replicability of formerly successful experiments.	[Maksimov, Margus; Vaht, Mariliis; Harro, Jaanus; Bachmann, Talis] Univ Tartu, EE-50090 Tartu, Estonia	University of Tartu	Bachmann, T (corresponding author), Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia.	talis.bachmann@ut.ee	Harro, Jaanus/W-4939-2017; Vaht, Mariliis/AAI-7521-2020	Harro, Jaanus/0000-0002-4484-2096; Vaht, Mariliis/0000-0002-5733-7056; Bachmann, Talis/0000-0001-9595-1594	Estonian Ministry of Science and Education [SF0180027s12]	Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia)	Our research was supported by Estonian Ministry of Science and Education through a targeted financing project SF0180027s12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2012, CONSCIOUS COGN, V21, P1222, DOI 10.1016/j.concog.2012.04.006; Albrecht T, 2010, CONSCIOUS COGN, V19, P656, DOI 10.1016/j.concog.2009.12.002; [Anonymous], VISUAL MASKING; Aru J, 2009, NEUROSCI LETT, V450, P351, DOI 10.1016/j.neulet.2008.11.063; Bachmann T, 1994, PSYCHOPHYSIOLOGY OF; Bachmann T, 2010, CONSCIOUS COGN, V19, P667, DOI 10.1016/j.concog.2010.01.012; Barnes A, 2012, NEUROIMAGE, V59, P2057, DOI 10.1016/j.neuroimage.2011.10.007; Beste C, 2011, NEUROPHARMACOLOGY, V60, P467, DOI 10.1016/j.neuropharm.2010.10.028; Everaerd D, 2012, NEUROPSYCHOPHARMACOL, V37, P1848, DOI 10.1038/npp.2012.32; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; HUNTLEY GW, 1992, DEV BRAIN RES, V70, P53, DOI 10.1016/0165-3806(92)90103-4; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; Koch C, 2004, THE QUEST FOR CONSCI; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Maksimov M, 2011, SCAND J PSYCHOL, V52, P524, DOI 10.1111/j.1467-9450.2011.00904.x; McIntosh AM, 2008, MOL PSYCHIATR, V13, P1054, DOI 10.1038/sj.mp.4002103; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Sprooten E, 2009, MOL PSYCHIATR, V14, P237, DOI 10.1038/mp.2008.136; Stottenberg SF, 2010, NEUROPHARMACOLOGY, V58, P423, DOI 10.1016/j.neuropharm.2009.09.010; Wei SM, 2012, J NEUROSCI, V32, P7074, DOI 10.1523/JNEUROSCI.5375-11.2012	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55287	10.1371/journal.pone.0055287	http://dx.doi.org/10.1371/journal.pone.0055287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359627	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600163
J	Mountzios, G; Kostopoulos, I; Kotoula, V; Sfakianaki, I; Fountzilas, E; Markou, K; Karasmanis, I; Leva, S; Angouridakis, N; Vlachtsis, K; Nikolaou, A; Konstantinidis, I; Fountzilas, G				Mountzios, Giannis; Kostopoulos, Ioannis; Kotoula, Vassiliki; Sfakianaki, Ioanna; Fountzilas, Elena; Markou, Konstantinos; Karasmanis, Ilias; Leva, Sofia; Angouridakis, Nikolaos; Vlachtsis, Konstantinos; Nikolaou, Angelos; Konstantinidis, Ioannis; Fountzilas, George			Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; LUNG-CANCER; BREAST-CANCER; NECK-CANCER; HEAD; CARCINOMA; ASSOCIATION; PROGNOSIS; PROMOTER; TISSUES	Introduction: Prognosis of patients with operable laryngeal cancer is highly variable and therefore potent prognostic biomarkers are warranted. The insulin-like growth factor receptor (IGFR) signaling pathway plays a critical role in laryngeal carcinogenesis and progression. Patients and Methods: We identified all patients with localized TNM stage I-III laryngeal cancer managed with potentially curative surgery between 1985 and 2008. Immunohistochemical (IHC) expression of IGF1R-alpha, IGF1R-beta and IGF2R was evaluated using the immunoreactive score (IRS) and mRNA levels of important effectors of the IGFR pathway were assessed, including IGF1R, IGF-binding protein 3 (IGFBP3), suppressor of cytokine signaling 2 (SOCS2) and members of the MAP-kinase (MAP2K1, MAPK9) and phosphatidyl-inositol-3 kinase (PIK3CA, PIK3R1) families. Cox-regression models were applied to assess the predictive value of biomarkers on disease-free survival (DFS) and overall survival (OS). Results: Among 289 eligible patients, 95.2% were current or ex smokers, 75.4% were alcohol abusers, 15.6% had node-positive disease and 32.2% had received post-operative irradiation. After a median follow-up of 74.5 months, median DFS was 94.5 months and median OS was 106.3 months. Using the median IRS as the pre-defined cut-off, patients whose tumors had increased IGF1R-alpha cytoplasm or membrane expression experienced marginally shorter DFS and significantly shorter OS compared to those whose tumors had low IGF1R-alpha expression (91.1 vs 106.2 months, p = 0.0538 and 100.3 vs 118.6 months, p = 0.0157, respectively). Increased mRNA levels of MAPK9 were associated with prolonged DFS (p = 0.0655) and OS (p = 0.0344). In multivariate analysis, IGF1R-alpha overexpression was associated with a 46.6% increase in the probability for relapse (p = 0.0374). Independent predictors for poor OS included node-positive disease (HR = 2.569, p < 0.0001), subglottic/transglottic localization (HR = 1.756, p = 0.0438) and IGF1R-alpha protein overexpression (HR = 1.475, p = 0.0504). Conclusion: IGF1R-alpha protein overexpression may serve as an independent predictor of relapse and survival in operable laryngeal cancer. Prospective evaluation of the IGF1R-alpha prognostic utility is warranted.	[Mountzios, Giannis] 251 AF Gen Hosp, Dept Med Oncol, Athens, Greece; [Kostopoulos, Ioannis; Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Hellenic Fdn Canc Res, Sch Med, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Sfakianaki, Ioanna; Fountzilas, Elena; Leva, Sofia; Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Med, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Markou, Konstantinos; Angouridakis, Nikolaos; Vlachtsis, Konstantinos] Aristotle Univ Thessaloniki, AHEPA Hosp, Dept Otorhinolaryngol 1, Sch Med, GR-54006 Thessaloniki, Greece; [Karasmanis, Ilias; Nikolaou, Angelos] G Papanikolaou Gen Hosp, ENT Dept, Thessaloniki, Greece; [Konstantinidis, Ioannis] Papageorgiou Hosp, ENT Dept, Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital; George Papanikolaou General Hospital of Thessaloniki; Papageorgiou Hospital	Mountzios, G (corresponding author), 251 AF Gen Hosp, Dept Med Oncol, Athens, Greece.	gmountzios@gmail.com	Vlachtsis, Konstantinos/AAD-1262-2021; Mountzios, Giannis/ABE-1197-2020; Fountzilas, George/ABF-2139-2020	Markou, Konstantinos/0000-0001-9891-5185; Fountzilas, George/0000-0001-8045-2186	Hellenic Cooperative Oncology Group [HE R_5G]	Hellenic Cooperative Oncology Group	This work was in part funded by the Hellenic Cooperative Oncology Group (HE R_5G research grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenschein G, 2011, J THORAC ONCOL, V6, pS1799, DOI 10.1097/01.JTO.0000407563.14653.0c; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; Chui X, 1996, BRIT J CANCER, V73, P1233, DOI 10.1038/bjc.1996.236; Chung CH, 2011, HEAD NECK-J SCI SPEC, V33, P1804, DOI 10.1002/hed.21478; Ciampolillo A, 2007, CURR PHARM DESIGN, V13, P729, DOI 10.2174/138161207780249209; Doyle SL, 2012, AM J GASTROENTEROL, V107, P196, DOI 10.1038/ajg.2011.417; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Fountzilas E, 2012, ANN ONCOL, V23, P2146, DOI 10.1093/annonc/mdr576; Friedrich RE, 2010, ANTICANCER RES, V30, P1641; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Jameson MJ, 2011, MOL CANCER THER, V10, P2124, DOI 10.1158/1535-7163.MCT-11-0294; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; KREBS DL, 2003, SCI STKE, pPE6; Lefebvre JL, 2012, CURR OPIN ONCOL, V24, P218, DOI 10.1097/CCO.0b013e3283523c95; LeRoith D, 2005, J CLIN INVEST, V115, P233, DOI 10.1172/JCI200524228; Li S, 2011, HEAD NECK-J SCI SPEC, V33, P368, DOI 10.1002/hed.21457; Liu SG, 2010, EUR J CANCER, V46, P1744, DOI 10.1016/j.ejca.2010.03.038; Malaguarnera R, 2011, J CLIN ENDOCR METAB, V96, P766, DOI 10.1210/jc.2010-1255; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Niu JG, 2011, HEAD NECK-J SCI SPEC, V33, P650, DOI 10.1002/hed.21514; Oh SH, 2012, CANCER SCI, V103, P1259, DOI 10.1111/j.1349-7006.2012.02301.x; Papadimitrakopoulou VA, 2006, CANCER LETT, V239, P136, DOI 10.1016/j.canlet.2005.08.009; Penteroudakis G, 2012, ORAL ONCOL, DOI 10,1016/j.oraloncology.2012.02.002; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Sun JM, 2011, ORAL ONCOL, V47, P714, DOI 10.1016/j.oraloncology.2011.06.007; Thomas L, 2012, CANCER TREAT REV, V38, P203, DOI 10.1016/j.ctrv.2011.05.010; Victory K, 2011, J DENT RES, V90, P347, DOI 10.1177/0022034510388037	33	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54048	10.1371/journal.pone.0054048	http://dx.doi.org/10.1371/journal.pone.0054048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365645	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600026
J	Pistohl, T; Schmidt, TSB; Ball, T; Schulze-Bonhage, A; Aertsen, A; Mehring, C				Pistohl, Tobias; Schmidt, Thomas Sebastian Benedikt; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten			Grasp Detection from Human ECoG during Natural Reach-to-Grasp Movements	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; HAND MOVEMENT; EEG; CORTEX; TRAJECTORIES; DIRECTION; ARM	Various movement parameters of grasping movements, like velocity or type of the grasp, have been successfully decoded from neural activity. However, the question of movement event detection from brain activity, that is, decoding the time at which an event occurred (e. g. movement onset), has been addressed less often. Yet, this may be a topic of key importance, as a brain-machine interface (BMI) that controls a grasping prosthesis could be realized by detecting the time of grasp, together with an optional decoding of which type of grasp to apply. We, therefore, studied the detection of time of grasps from human ECoG recordings during a sequence of natural and continuous reach-to-grasp movements. Using signals recorded from the motor cortex, a detector based on regularized linear discriminant analysis was able to retrieve the time-point of grasp with high reliability and only few false detections. Best performance was achieved using a combination of signal components from time and frequency domains. Sensitivity, measured by the amount of correct detections, and specificity, represented by the amount of false detections, depended strongly on the imposed restrictions on temporal precision of detection and on the delay between event detection and the time the event occurred. Including neural data from after the event into the decoding analysis, slightly increased accuracy, however, reasonable performance could also be obtained when grasping events were detected 125 ms in advance. In summary, our results provide a good basis for using detection of grasping movements from ECoG to control a grasping prosthesis.	[Pistohl, Tobias; Schmidt, Thomas Sebastian Benedikt; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Pistohl, Tobias; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Pistohl, Tobias] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Freiburg; University of Freiburg; Imperial College London; Imperial College London; Newcastle University - UK	Pistohl, T (corresponding author), Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	tobias.pistohl@ncl.ac.uk	Schmidt, Thomas/F-3022-2014; Schulze-Bonhage, Andreas/AAJ-3107-2020; Mehring, Carsten/R-8986-2019	Schmidt, Thomas/0000-0001-8587-4177; Mehring, Carsten/0000-0001-8125-5205	German Federal Ministry of Education and Research: BMBF [01GQ0420]; GoBio grant [0313891]	German Federal Ministry of Education and Research: BMBF(Federal Ministry of Education & Research (BMBF)); GoBio grant	This work was funded by the German Federal Ministry of Education and Research: BMBF grant 01GQ0420 to BCCN Freiburg and GoBio grant 0313891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bashashati Ali, 2007, Comput Intell Neurosci, P84386, DOI 10.1155/2007/84386; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Masic N, 1993, Artif Intell Med, V5, P503, DOI 10.1016/0933-3657(93)90040-A; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Parks T. W., 1987, DIGITAL FILTER DESIG; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; RUMEAU C, 1994, AM J NEURORADIOL, V15, P567; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Solis-Escalante T, 2008, J NEUROSCI METH, V175, P148, DOI 10.1016/j.jneumeth.2008.07.019; STEINMETZ H, 1989, ELECTROEN CLIN NEURO, V72, P499, DOI 10.1016/0013-4694(89)90227-7; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	21	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54658	10.1371/journal.pone.0054658	http://dx.doi.org/10.1371/journal.pone.0054658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359537	gold, Green Published			2022-12-25	WOS:000314023600087
J	Schuchman, EH; Ge, Y; Lai, A; Borisov, Y; Faillace, M; Eliyahu, E; He, XX; Iatridis, J; Vlassara, H; Striker, G; Simonaro, CM				Schuchman, Edward H.; Ge, Yi; Lai, Alon; Borisov, Yury; Faillace, Meghan; Eliyahu, Efrat; He, Xingxuan; Iatridis, James; Vlassara, Helen; Striker, Gary; Simonaro, Calogera M.			Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses	PLOS ONE			English	Article							JOINT DISEASE; BONE; PROLIFERATION; INVOLVEMENT; INHIBITOR; MECHANISM; SODIUM; INJURY; VI	Background: Pentosan polysulfate (PPS) is an FDA-approved, oral medication with anti-inflammatory and pro-chondrogenic properties. We have previously shown that animal models of the mucopolysaccharidoses (MPS) exhibit significant inflammatory disease, contributing to cartilage degeneration. Enzyme replacement therapy (ERT) only partly reduced inflammation, and anti-TNF-alpha antibody therapy significantly enhanced clinical and pathological outcomes. Here we describe the use of PPS for the treatment of MPS type VI rats. Methodology/Principal Findings: Treatment began during prenatal development and at 1 and 6 months of age. All animals were treated until they were 9 months old. Significant reductions in the serum and tissue levels of several inflammatory markers (e.g., TNF-alpha, MIP-1alpha and RANTES/CCL5) were observed, as was reduced expression of inflammatory markers in cultured articular chondrocytes. ADAMTS-5/aggrecanase-2 levels also were reduced in chondrocytes, consistent with an elevation of serum tissue inhibitor of metalloproteinase 1. Marked improvements in motility and grooming behavior occurred, along with a reduction in eye and nasal secretions and a lessening of the tracheal deformities. MicroCT and radiographic analyses further revealed that the treated MPS skulls were longer and thinner, and that the teeth malocclusions, misalignments and mineral densities were improved. MicroCT analysis of the femurs and vertebrae revealed improvements in trabecular bone mineral densities, number and spacing in a subset of treated MPS animals. Biomechanical assessments of PPS-treated spines showed partially restored torsional behaviors, suggesting increased spinal stability. No improvements were observed in cortical bone or femur length. The positive changes in the PPS-treated MPS VI rats occurred despite glycosaminoglycan accumulation in their tissues. Conclusions: Based on these findings we conclude that PPS could be a simple and effective therapy for MPS that might provide significant clinical benefits alone and in combination with other therapies.	[Schuchman, Edward H.; Ge, Yi; Lai, Alon; Borisov, Yury; Faillace, Meghan; Eliyahu, Efrat; He, Xingxuan; Iatridis, James; Vlassara, Helen; Striker, Gary; Simonaro, Calogera M.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Simonaro, CM (corresponding author), Mt Sinai Sch Med, New York, NY USA.	Calogera.simonaro@mssm.edu		Iatridis, James/0000-0002-2186-0590; Lai, Alon/0000-0002-0163-4588	National Institutes of Health [DK087185, AR056639, AR051146]; Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051146, R01AR056639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK096182, R01DK087185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants DK087185, AR056639 and AR051146, and a grant from the Mucopolysaccharidosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger JT, 2011, INT UROGYNECOL J, V22, P395, DOI 10.1007/s00192-010-1252-8; Barbir A, 2011, SPINE, V36, P607, DOI 10.1097/BRS.0b013e3181d9b58b; Beck M, 2010, J PEDIATR REHAB MED, V3, P39, DOI 10.3233/PRM-2010-0100; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; Fotopoulos VC, 2012, KNEE SURG SPORT TR A, V20, P1159, DOI 10.1007/s00167-011-1676-9; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Ghosh P, 2001, BEST PRACT RES CL RH, V15, P693, DOI 10.1053/berh.2001.0188; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Ho STB, 2009, GROWTH FACTORS, V27, P321, DOI 10.1080/08977190903137595; Honda H, 2012, NEUROPATHOLOGY, V32, P124, DOI 10.1111/j.1440-1789.2011.01245.x; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; Kumagai Kenji, 2010, BMC Clin Pharmacol, V10, P7, DOI 10.1186/1472-6904-10-7; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; Kwan C, 2012, AUST VET J, V90, P315, DOI 10.1111/j.1751-0813.2012.00959.x; Lupia E, 2012, LAB INVEST, V92, P236, DOI 10.1038/labinvest.2011.154; McIlwraith CW, 2012, AM J VET RES, V73, P628, DOI 10.2460/ajvr.73.5.628; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Miyata N, 2010, CLIN EXP HYPERTENS, V32, P511, DOI 10.3109/10641963.2010.496511; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Oussoren E, 2011, BBA-MOL BASIS DIS, V1812, P1542, DOI 10.1016/j.bbadis.2011.07.013; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Smit TH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-38; Takizawa M, 2008, FEBS LETT, V582, P2945, DOI 10.1016/j.febslet.2008.07.036; Tommasini SM, 2009, J BONE MINER RES, V24, P606, DOI [10.1359/jbmr.081224, 10.1359/JBMR.081224]; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; White KK, 2011, RHEUMATOLOGY, V50, pV26, DOI 10.1093/rheumatology/ker393; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Zhao JG, 2011, MED HYPOTHESES, V76, P610, DOI 10.1016/j.mehy.2011.01.016	39	72	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54459	10.1371/journal.pone.0054459	http://dx.doi.org/10.1371/journal.pone.0054459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365668	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600056
J	Vegran, F; Rebucci, M; Chevrier, S; Cadouot, M; Boidot, R; Lizard-Nacol, S				Vegran, Frederique; Rebucci, Magali; Chevrier, Sandy; Cadouot, Muriel; Boidot, Romain; Lizard-Nacol, Sarab			Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma	PLOS ONE			English	Article							GENE ALTERATIONS; PROGNOSTIC-SIGNIFICANCE; CANCER PATIENTS; TP53 MUTATIONS; POOR SURVIVAL; EXPRESSION; ASSOCIATION; PROLIFERATION; INFORMATION; INVASION	The presence of a TP53 gene mutation can influence tumour response to some treatments, especially in breast cancer. In this study, we analysed p53 mRNA expression, LOH at 17p13 and TP53 mutations from exons 2 to 11 in 206 patients with breast carcinoma and correlated the results with disease-free and overall survival. The observed mutations were classified according to their type and location in the three protein domains (transactivation domain, DNA binding domain, oligomerization domain) and correlated with disease-free and overall survival. In our population, neither p53 mRNA expression nor LOH correlated with outcome. Concerning TP53 mutations, 27% of tumours were mutated (53/197) and the presence of a mutation in the TP53 gene was associated with worse overall survival (p=0.0026) but not with disease-free survival (p=0.0697), with median survival of 80 months and 78 months, respectively. When alterations were segregated into mutation categories and locations, and related to survival, tumours harbouring mutations other than missense mutations in the DNA binding domain of P53 had the same survival profiles as wild-type tumours. Concerning missense mutations in the DNA binding domain, median disease-free and overall survival was 23 months and 35 months, respectively (p=0.0021 and p < 0.0001, respectively), compared with 78 and 80 months in mutated tumours overall. This work shows that disease-free and overall survival in patients with a frameshift mutation of TP53 or missense mutation in the oligomerization domain are the same as those in wild-type TP53 patients.	[Vegran, Frederique; Rebucci, Magali; Chevrier, Sandy; Cadouot, Muriel; Boidot, Romain; Lizard-Nacol, Sarab] Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc	Boidot, R (corresponding author), Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France.	rboidot@cgfl.fr	VEGRAN, Frédérique/H-4792-2017; VEGRAN, Frederique/O-9986-2018	VEGRAN, Frederique/0000-0002-4377-1441	l'Association pour la Recherche contre le Cancer; Conseil Regional de Bourgogne; La Ligue contre le Cancer de Cote d'Or; La Ligue contre le Cancer de l'Yonne	l'Association pour la Recherche contre le Cancer; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); La Ligue contre le Cancer de Cote d'Or; La Ligue contre le Cancer de l'Yonne	FV was financially supported by l'Association pour la Recherche contre le Cancer. RB was financially supported by the Conseil Regional de Bourgogne, and by grants from La Ligue contre le Cancer de Cote d'Or and La Ligue contre le Cancer de l'Yonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN TI, 1993, BRIT J CANCER, V68, P540, DOI 10.1038/bjc.1993.383; Aramayo R, 2011, NUCLEIC ACIDS RES, V39, P8960, DOI 10.1093/nar/gkr386; Arnal M, 2000, BREAST CANCER RES TR, V61, P13, DOI 10.1023/A:1006449931921; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Berns EMJJ, 1998, BRIT J CANCER, V77, P1130, DOI 10.1038/bjc.1998.187; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Doyon G, 2009, J BIOL CHEM, V284, P25220, DOI 10.1074/jbc.M109.022632; ELLEDGE RM, 1993, BREAST CANCER RES TR, V26, P225, DOI 10.1007/BF00665800; Falette N, 1998, CANCER RES, V58, P1451; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Iacopetta B, 1998, CLIN CANCER RES, V4, P1597; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Kovach JS, 1996, P NATL ACAD SCI USA, V93, P1093, DOI 10.1073/pnas.93.3.1093; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levrero M, 2000, J CELL SCI, V113, P1661; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; MERLO GR, 1992, AM J PATHOL, V140, P215; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Oshima T, 2008, ONCOL REP, V19, P953; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Powell B, 2000, CLIN CANCER RES, V6, P443; Sarkar C, 2003, CANCER GENET CYTOGEN, V144, P156, DOI 10.1016/S0165-4608(02)00937-8; SHIAO YH, 1995, CANCER RES, V55, P1485; Soong R, 1997, INT J CANCER, V74, P642, DOI 10.1002/(SICI)1097-0215(19971219)74:6<642::AID-IJC15>3.0.CO;2-7; THORLACIUS S, 1995, EUR J CANCER, V31A, P1856, DOI 10.1016/0959-8049(95)00399-4; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Vegran F, 2007, ONCOGENE, V26, P290, DOI 10.1038/sj.onc.1209784; Velculescu VE, 1996, CLIN CHEM, V42, P858; Wegran F, 2006, CLIN CANCER RES, V12, P5794, DOI 10.1158/1078-0432.CCR-06-0725; Yang X, 2003, CELL DEATH DIFFER, V10, P400, DOI 10.1038/cj.cdd.4401182	38	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55103	10.1371/journal.pone.0055103	http://dx.doi.org/10.1371/journal.pone.0055103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359294	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600152
J	Ye, JN; Chen, XS; Su, L; Liu, YL; Cai, QY; Zhan, XL; Xu, Y; Zhao, SF; Yao, ZX				Ye, Jian-Ning; Chen, Xing-Shu; Su, Le; Liu, Yun-Lai; Cai, Qi-Yan; Zhan, Xiao-Li; Xu, Yan; Zhao, Shi-Fu; Yao, Zhong-Xiang			Progesterone Alleviates Neural Behavioral Deficits and Demyelination with Reduced Degeneration of Oligodendroglial Cells in Cuprizone-Induced Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; MODEL; REMYELINATION; RAT; NEUROPROTECTION; DIFFERENTIATION; PROGENITORS; INCREASES	Demyelination occurs widely in neurodegenerative diseases. Progesterone has neuroprotective effects, is known to reduce the clinical scores and the inflammatory response. Progesterone also promotes remyelination in experimental autoimmune encephalomyelitis and cuprizone-induced demyelinating brain. However, it still remains unclear whether progesterone can alleviate neural behavioral deficits and demyelination with degeneration of oligodendroglial cells in cuprizone-induced mice. In this study, mice were fed with 0.2% cuprizone to induce demyelination, and treated with progesterone to test its potential protective effect on neural behavioral deficits, demyelination and degeneration of oligodendroglial cells. Our results showed noticeable alleviation of neural behavioral deficits following progesterone treatment as assessed by changes in average body weight, and activity during the open field and Rota-rod tests when compared with the vehicle treated cuprizone group. Progesterone treatment alleviated demyelination as shown by Luxol fast blue staining, MBP immunohistochemical staining, and electron microscopy. There was an obvious decrease in TUNEL and Caspase-3-positive apoptotic cells, and an increase in the number of oligodendroglial cells staining positive for PDGFR alpha, Olig2, Sox10 and CC-1 antibody in the brains of cuprizone-induced mice after progesterone administration. These results indicate that progesterone can alleviate neural behavioral deficits and demyelination against oligodendroglial cell degeneration in cuprizone-induced mice.	[Ye, Jian-Ning; Zhao, Shi-Fu] Third Mil Med Univ, Dept Neurol, Xin Qiao Hosp, Chongqing, Peoples R China; [Chen, Xing-Shu; Liu, Yun-Lai; Cai, Qi-Yan; Zhan, Xiao-Li; Yao, Zhong-Xiang] Third Mil Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China; [Xu, Yan; Yao, Zhong-Xiang] Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Zhao, SF (corresponding author), Third Mil Med Univ, Dept Neurol, Xin Qiao Hosp, Chongqing, Peoples R China.	shifuzhao@yahoo.com; yaozhx@yahoo.com		Yao, Zhong-xiang/0000-0002-3335-1961	National Natural Science Foundation of China [31100771]; Open Foundation of Key Laboratory; Ministry of Education [2011JSDC01]; Natural Science Foundation Project of ChongQing Science and Technology Commission [2011jjA10029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of Key Laboratory; Ministry of Education; Natural Science Foundation Project of ChongQing Science and Technology Commission(Natural Science Foundation of Chongqing)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31100771), Open Foundation of Key Laboratory, and Ministry of Education (Grant No. 2011JSDC01), and Natural Science Foundation Project of ChongQing Science and Technology Commission (Grant No. 2011jjA10029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Copray JCVM, 2005, NEUROPATH APPL NEURO, V31, P600, DOI 10.1111/j.1365-2990.2005.00656.x; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay L, 2008, NEUROIMMUNOMODULAT, V15, P76, DOI 10.1159/000135627; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; HERVEY E, 1967, J ENDOCRINOL, V37, P361, DOI 10.1677/joe.0.0370361; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; JungTestas I, 1996, CELL MOL NEUROBIOL, V16, P439, DOI 10.1007/BF02088110; Kipp M, 2011, INFLAMM RES, V60, P723, DOI 10.1007/s00011-011-0339-0; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koenig HL, 2000, REV REPROD, V5, P189; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Makinodan M, 2009, PROG NEURO-PSYCHOPH, V33, P978, DOI 10.1016/j.pnpbp.2009.05.006; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Paxinos G., 2001, MOUSE BRAIN STEREOTO; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Vukusic S, 2009, J NEUROL SCI, V286, P114, DOI 10.1016/j.jns.2009.08.056; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079	31	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54590	10.1371/journal.pone.0054590	http://dx.doi.org/10.1371/journal.pone.0054590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359803	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600077
J	Dandoy, P; Meunier, CF; Leroux, G; Voisin, V; Giordano, L; Caron, N; Michiels, C; Su, BL				Dandoy, Philippe; Meunier, Christophe F.; Leroux, Gregory; Voisin, Virginie; Giordano, Laetitia; Caron, Nathalie; Michiels, Carine; Su, Bao-Lian			A Hybrid Assembly by Encapsulation of Human Cells within Mineralised Beads for Cell Therapy	PLOS ONE			English	Article							BIOARTIFICIAL ORGANS; ANIMAL-CELLS; SILICA; MICROENCAPSULATION; CAPSULES; ALGINATE	Background: The design of new technologies for treatment of human disorders such as protein deficiencies is a complex and difficult task. Particularly, the construction of artificial organs, based on the immunoisolation of protein-secreting cells, requires the use of suitable materials which have to be biocompatible with the immunoisolated cells and avoid any inappropriate host response. Methodology/Principal Findings: This work investigates the in vivo behavior of mechanically resistant hybrid beads which can be considered as a model for artificial organ for cell therapy. This hybrid system was designed and fabricated via the encapsulation of living cells (HepG2) within alginate-silica composites. Two types of beads (alginate-silica hybrid (AS) or alginate/silica hybrid subsequently covered by an external layer of pure alginate (ASA)), with or without HepG2 cells, were implanted into several female Wistar rats. After four weeks, the potential inflammatory local response that might be due to the presence of materials was studied by histochemistry. The results showed that the performance of ASA beads was quite promising compared to AS beads, where less abnormal rat behaviour and less inflammatory cells in histological sections were observed in the case of ASA beads. Conclusions/Significance: The current study highlights that alginate-silica composite materials coated with an extra-alginate shell offer much promise in the development of robust implantation devices and artificial organs.	[Dandoy, Philippe; Meunier, Christophe F.; Leroux, Gregory; Su, Bao-Lian] Univ Namur FUNDP, Lab Inorgan Mat Chem CMI, Namur, Belgium; [Voisin, Virginie; Giordano, Laetitia; Caron, Nathalie] Univ Namur FUNDP, Lab Mol Physiol URPhyM NARILIS, Namur, Belgium; [Michiels, Carine] Univ Namur FUNDP, Lab Biochem & Cellular Biol URBC NARILIS, Namur, Belgium	University of Namur; University of Namur; University of Namur	Meunier, CF (corresponding author), Univ Namur FUNDP, Lab Inorgan Mat Chem CMI, Namur, Belgium.	christophe.meunier@fundp.ac.be		Su, Bao-Lian/0000-0001-8474-0652	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles); University of Namur (Rue de Bruxelles, 61 - B5000 Namur)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles)(Fonds de la Recherche Scientifique - FNRS); University of Namur (Rue de Bruxelles, 61 - B5000 Namur)	The funders are the Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles; http://www1.frs-fnrs.be/) and The University of Namur (Rue de Bruxelles, 61 - B5000 Namur; http://www.fundp.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Bartkowiak A, 1999, ANN NY ACAD SCI, V875, P135, DOI 10.1111/j.1749-6632.1999.tb08499.x; Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g; Boninsegna S, 2003, J SOL-GEL SCI TECHN, V26, P1151, DOI 10.1023/A:1020731429533; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Carturan G, 2004, J MATER CHEM, V14, P2087, DOI 10.1039/b401450b; CARTURAN G, 1989, J MOL CATAL, V57, pL13, DOI 10.1016/0304-5102(89)80121-X; Carturan G, 1997, P SOC PHOTO-OPT INS, V3136, P366, DOI 10.1117/12.279168; Coradin T, 2003, J SOL-GEL SCI TECHN, V26, P1165, DOI 10.1023/A:1020787514512; Dandoy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020983; Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9; Desimone MF, 2003, BIOTECHNOL LETT, V25, P671, DOI 10.1023/A:1023481304479; DeVos P, 1997, DIABETOLOGIA, V40, P262; Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Meunier CF, 2010, LANGMUIR, V26, P6568, DOI 10.1021/la9039286; Meunier CF, 2010, J COLLOID INTERF SCI, V342, P211, DOI 10.1016/j.jcis.2009.10.050; Morris PJ, 1996, TRENDS BIOTECHNOL, V14, P163, DOI 10.1016/0167-7799(96)10020-2; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033; Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)00073-7; Perullini M, 2008, CHEM MATER, V20, P3015, DOI 10.1021/cm703075b; Perullini M, 2007, J BIOTECHNOL, V127, P542, DOI 10.1016/j.jbiotec.2006.07.024; Pope EJA, 1997, J SOL-GEL SCI TECHN, V8, P635, DOI 10.1007/BF02436914; Pressi G, 2003, J SOL-GEL SCI TECHN, V26, P1189, DOI 10.1023/A:1020704118146; Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043; Sakai S, 2002, BIOTECHNOL PROGR, V18, P401, DOI 10.1021/bp010147+; Sakai S, 2001, BIOMATERIALS, V22, P2827, DOI 10.1016/S0142-9612(01)00016-3	30	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54683	10.1371/journal.pone.0054683	http://dx.doi.org/10.1371/journal.pone.0054683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372752	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500105
J	Fernandez-Duque, E; Huck, M				Fernandez-Duque, Eduardo; Huck, Maren			Till Death (Or an Intruder) Do Us Part: Intrasexual-Competition in a Monogamous Primate	PLOS ONE			English	Article							OPERATIONAL SEX-RATIO; MONKEYS AOTUS-AZARAI; INFANT DEVELOPMENT; CANINE SIZE; SELECTION; FEMALE; DIMORPHISM; INTENSITY; EVOLUTION; AGGRESSION	Polygynous animals are often highly dimorphic, and show large sex-differences in the degree of intra-sexual competition and aggression, which is associated with biased operational sex ratios (OSR). For socially monogamous, sexually monomorphic species, this relationship is less clear. Among mammals, pair-living has sometimes been assumed to imply equal OSR and low frequency, low intensity intra-sexual competition; even when high rates of intra-sexual competition and selection, in both sexes, have been theoretically predicted and described for various taxa. Owl monkeys are one of a few socially monogamous primates. Using long-term demographic and morphological data from 18 groups, we show that male and female owl monkeys experience intense intra-sexual competition and aggression from solitary floaters. Pair-mates are regularly replaced by intruding floaters (27 female and 23 male replacements in 149 group-years), with negative effects on the reproductive success of both partners. Individuals with only one partner during their life produced 25% more offspring per decade of tenure than those with two or more partners. The termination of the pair-bond is initiated by the floater, and sometimes has fatal consequences for the expelled adult. The existence of floaters and the sporadic, but intense aggression between them and residents suggest that it can be misleading to assume an equal OSR in socially monogamous species based solely on group composition. Instead, we suggest that sexual selection models must assume not equal, but flexible, context-specific, OSR in monogamous species.	[Fernandez-Duque, Eduardo; Huck, Maren] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Fernandez-Duque, Eduardo] Consejo Nacl Invest Cient & Tecn, Ctr Ecol Aplicada Litoral, RA-1033 Buenos Aires, DF, Argentina	University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez-Duque, E (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	eduardof@sas.upenn.edu			Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society; National Science Foundation [BCS-0621020]; University of Pennsylvania Research Foundation; Zoological Society of San Diego; German Science Foundation [HU 1746-2/1]	Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; Zoological Society of San Diego; German Science Foundation(German Research Foundation (DFG))	EFD acknowledges financial support from the Wenner-Gren Foundation, the L.S.B. Leakey Foundation, the National Geographic Society, the National Science Foundation (BCS-0621020), the University of Pennsylvania Research Foundation and the Zoological Society of San Diego, and MH from the German Science Foundation (HU 1746-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Crawley MJ., 2007, R BOOK; de Jong K, 2009, ANIM BEHAV, V78, P1229, DOI 10.1016/j.anbehav.2009.08.006; DIXSON AF, 1981, J ZOOL, V194, P25, DOI 10.1111/j.1469-7998.1981.tb04576.x; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fernandez-Duque E, 2003, INT J PRIMATOL, V24, P1113, DOI 10.1023/A:1026284430453; Fernandez-Duque E, 2009, BEHAVIOUR, V146, P583, DOI 10.1163/156853908X397925; Fernandez-Duque E., 2011, PRIMATES PERSPECTIVE, P139; Fernandez-Duque E, 2011, AM J PHYS ANTHROPOL, V146, P38, DOI 10.1002/ajpa.21541; Fitze PS, 2008, ECOL LETT, V11, P432, DOI 10.1111/j.1461-0248.2008.01158.x; Garcia-Navas V, 2011, BEHAV ECOL, V22, P932, DOI 10.1093/beheco/arr067; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Grant JWA, 2002, CAN J ZOOL, V80, P2242, DOI 10.1139/Z02-217; HESKE EJ, 1990, J MAMMAL, V71, P510, DOI 10.2307/1381789; Huck, 2013, BUILDING BABIES PRIM, P361, DOI DOI 10.1007/978-1-4614-4060-4_16; Huck M, 2012, BEHAV ECOL SOCIOBIOL, V66, P505, DOI 10.1007/s00265-011-1297-9; Huck M, 2011, INT J PRIMATOL, V32, P1133, DOI 10.1007/s10764-011-9530-y; Knell RJ, 2009, J ZOOL, V278, P83, DOI 10.1111/j.1469-7998.2009.00566.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Lawrence J. M., 2007, THESIS COLUMBIA U; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; MITANI JC, 1984, BEHAV ECOL SOCIOBIOL, V15, P225, DOI 10.1007/BF00292979; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Mulder MB, 2009, HUM NATURE-INT BIOS, V20, P130, DOI 10.1007/s12110-009-9060-x; PALOMBIT R, 1994, BEHAVIOUR, V128, P65, DOI 10.1163/156853994X00055; Juarez CP, 2011, INT J PRIMATOL, V32, P69, DOI 10.1007/s10764-010-9437-z; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodman PS, 2007, AM J PHYS ANTHROPOL, P201; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rotundo M, 2005, INT J PRIMATOL, V26, P1459, DOI 10.1007/s10764-005-5329-z; Sandell MI, 2007, BEHAV ECOL SOCIOBIOL, V62, P255, DOI 10.1007/s00265-007-0460-9; Setchell JM, 2003, ADV STUD BEHAV, V33, P87, DOI 10.1016/S0065-3454(03)33003-7; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Thoren S, 2006, AM J PHYS ANTHROPOL, V130, P50, DOI 10.1002/ajpa.20321; van de Pol M, 2006, BEHAV ECOL, V17, P982, DOI 10.1093/beheco/arl036; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; Wright P., 1981, ECOLOGY BEHAVIOUR NE, P211; Wright P.C., 1984, Monographs in Primatology, V4, P59; Zuur Alain F., 2009, P1	46	51	52	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53724	10.1371/journal.pone.0053724	http://dx.doi.org/10.1371/journal.pone.0053724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372665	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500020
J	Jean, JC; George, E; Kaestner, KH; Brown, LAS; Spira, A; Joyce-Brady, M				Jean, Jyh-Chang; George, Elizabeth; Kaestner, Klaus H.; Brown, Lou Ann Scism; Spira, Avrum; Joyce-Brady, Martin			Transcription Factor Klf4, Induced in the Lung by Oxygen at Birth, Regulates Perinatal Fibroblast and Myofibroblast Differentiation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; GAMMA-GLUTAMYL-TRANSFERASE; NF-KAPPA-B; GENE-EXPRESSION; RAT LUNG; ANTIOXIDANT ENZYMES; MOUSE LUNG; STRESS; MORPHOGENESIS; PROGRESSION	The fluid-filled lung exists in relative hypoxia in utero (similar to 25 mm Hg), but at birth fills with ambient air where the partial pressure of oxygen is >150 mm Hg. The impact of this change was studied in mouse lung with microarrays to analyze gene expression one day before, and 2, 6, 12 and 24 hours after birth into room air or 10% O-2. The expression levels of >150 genes, representing transcriptional regulation, structure, apoptosis and antioxidants were altered 2 hrs after birth in room air but blunted or absent with birth in 10% O-2. Kruppel-like factor 4 (Klf4), a regulator of cell growth arrest and differentiation, was the most significantly altered lung gene at birth. Its protein product was expressed in fibroblasts and airway epithelial cells. Klf4 mRNA was induced in lung fibroblasts exposed to hyperoxia and constitutive expression of Klf4 mRNA in Klf4-null fibroblasts induced mRNAs for p21(cip1/Waf1), smooth muscle actin, type 1 collagen, fibronectin and tenascin C. In Klf4 perinatal null lung, p21(cip1/Waf1) mRNA expression was deficient prior to birth and associated with ongoing cell proliferation after birth; connective tissue gene expression was deficient around birth and smooth muscle actin protein expression was absent from myofibroblasts at tips of developing alveoli; p53, p21(cip1/Waf1) and caspase-3 protein expression were widespread at birth suggesting excess apoptosis compared to normal lung. We propose that the changing oxygen environment at birth acts as a physiologic signal to induce lung Klf4 mRNA expression, which then regulates proliferation and apoptosis in fibroblasts and airway epithelial cells, and connective tissue gene expression and myofibroblast differentiation at the tips of developing alveoli.	[Jean, Jyh-Chang; George, Elizabeth; Spira, Avrum; Joyce-Brady, Martin] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [George, Elizabeth; Spira, Avrum] Boston Univ, Coll Engn, Bioinformat Program, Boston, MA 02215 USA; [Spira, Avrum] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA; [Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Brown, Lou Ann Scism] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Boston University; Boston University; Boston University; University of Pennsylvania; Emory University	Joyce-Brady, M (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	mjbrady@bu.edu		Spira, Avrum/0000-0003-1467-0489; Joyce-Brady, Martin/0000-0002-1898-6002; Jean, Jyh-Chang/0000-0002-6569-5910	National Institutes of Health [PO1-HL47049]; National Institutes of Health (USA) [5RO1 AA012197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was funded by National Institutes of Health PO1-HL47049 (MJB). Dr. Lou Ann Brown acknowledges her grant 5RO1 AA012197 from the National Institutes of Health (USA). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1985, EXP LUNG RES, V8, P261, DOI 10.3109/01902148509087808; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bonner AE, 2004, ONCOGENE, V23, P1166, DOI 10.1038/sj.onc.1207234; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Bretz F, 2005, METHOD INFORM MED, V44, P431; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; CHEN YW, 1993, PEDIATR RES, V34, P27, DOI 10.1203/00006450-199307000-00008; CLERCH LB, 1992, AM J PHYSIOL, V263, pL466, DOI 10.1152/ajplung.1992.263.4.L466; Das KC, 2001, AM J RESP CELL MOL, V25, P226, DOI 10.1165/ajrcmb.25.2.4314; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, P530; Foronjy R, 2001, RESPIR RES, V2, P348, DOI 10.1186/rr85; Frank L, 1996, BIOL NEONATE, V70, P116; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Haddad JJE, 2001, CYTOKINE, V13, P138, DOI 10.1006/cyto.2000.0789; Haddad JJE, 2000, BIOCHEM BIOPH RES CO, V271, P257, DOI 10.1006/bbrc.2000.2607; Haddad JJE, 2000, AM J PHYSIOL-LUNG C, V278, pL492, DOI 10.1152/ajplung.2000.278.3.L492; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jean JC, 1999, GENOMICS, V57, P201, DOI 10.1006/geno.1999.5761; Jean JC, 2002, AM J PHYSIOL-LUNG C, V283, pL766, DOI 10.1152/ajplung.00250.2000; Jean JC, 2002, AM J PHYSIOL-LUNG C, V282, pL75, DOI 10.1152/ajplung.2002.282.1.L75; Jean JC, 2008, J CELL BIOCHEM, V103, P1886, DOI 10.1002/jcb.21584; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; JoyceBrady M, 1996, J CLIN INVEST, V97, P1774, DOI 10.1172/JCI118605; Kaminski N, 2002, AM J RESP CELL MOL, V27, P125, DOI 10.1165/ajrcmb.27.2.f247; Katz JP, 2002, DEVELOPMENT, V129, P2619; KAUFFMAN SL, 1974, ANAT RECORD, V180, P63, DOI 10.1002/ar.1091800108; Klings ES, 2009, AM J PATHOL, V175, P2309, DOI 10.2353/ajpath.2009.081017; Land SC, 2005, ANTIOXID REDOX SIGN, V7, P92, DOI 10.1089/ars.2005.7.92; Landesberg LJ, 2001, AM J PHYSIOL-LUNG C, V281, pL1138, DOI 10.1152/ajplung.2001.281.5.L1138; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; Millien G, 2008, GENE EXPR PATTERNS, V8, P124, DOI 10.1016/j.modgep.2007.09.003; Millien G, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-35; NARDELL EA, 1982, J APPL PHYSIOL, V53, P140, DOI 10.1152/jappl.1982.53.1.140; Oakes S, 1997, AM J PHYSIOL, V272, P739; Oakes SM, 1997, AM J PHYSIOL-LUNG C, V272, pL739, DOI 10.1152/ajplung.1997.272.4.L739; OHARE KH, 1970, J MORPHOL, V132, P69, DOI 10.1002/jmor.1051320105; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schittny JC, 1998, AM J RESP CELL MOL, V18, P786, DOI 10.1165/ajrcmb.18.6.3031; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Toledano MB, 2009, MOL CELL, V34, P637, DOI 10.1016/j.molcel.2009.06.005; Wagner TE, 2003, J HISTOCHEM CYTOCHEM, V51, P1307, DOI 10.1177/002215540305101008; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	54	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54806	10.1371/journal.pone.0054806	http://dx.doi.org/10.1371/journal.pone.0054806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372771	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500129
J	Luzon-Toro, B; Fernandez, RM; Torroglosa, A; de Agustin, JC; Mendez-Vidal, C; Segura, DI; Antinolo, G; Borrego, S				Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Carlos de Agustin, Juan; Mendez-Vidal, Cristina; Isabel Segura, Dolores; Antinolo, Guillermo; Borrego, Salud			Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients	PLOS ONE			English	Article							CREST-DERIVED CELLS; RECEPTOR TYROSINE KINASE; DISEASE; RET; MIGRATION; LOCUS; PROLIFERATION; EXPRESSION; REPELLENT; SEMA3A	Hirschsprung disease (HSCR, OMIM 142623) is a developmental disorder characterized by the absence of ganglion cells along variable lengths of the distal gastrointestinal tract, which results in tonic contraction of the aganglionic colon segment and functional intestinal obstruction. The RET proto-oncogene is the major gene associated to HSCR with differential contributions of its rare and common, coding and noncoding mutations to the multifactorial nature of this pathology. In addition, many other genes have been described to be associated with this pathology, including the semaphorins class III genes SEMA3A (7p12.1) and SEMA3D (7q21.11) through SNP array analyses and by next-generation sequencing technologies. Semaphorins are guidance cues for developing neurons implicated in the axonal projections and in the determination of the migratory pathway for neural-crest derived neural precursors during enteric nervous system development. In addition, it has been described that increased SEMA3A expression may be a risk factor for HSCR through the upregulation of the gene in the aganglionic smooth muscle layer of the colon in HSCR patients. Here we present the results of a comprehensive analysis of SEMA3A and SEMA3D in a series of 200 Spanish HSCR patients by the mutational screening of its coding sequence, which has led to find a number of potentially deleterious variants. RET mutations have been also detected in some of those patients carrying SEMAs variants. We have evaluated the A131T-SEMA3A, S598G-SEMA3A and E198K-SEMA3D mutations using colon tissue sections of these patients by immunohistochemistry. All mutants presented increased protein expression in smooth muscle layer of ganglionic segments. Moreover, A131T-SEMA3A also maintained higher protein levels in the aganglionic muscle layers. These findings strongly suggest that these mutants have a pathogenic effect on the disease. Furthermore, because of their coexistence with RET mutations, our data substantiate the additive genetic model proposed for this rare disorder and further support the association of SEMAs genes with HSCR.	[Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Mendez-Vidal, Cristina; Antinolo, Guillermo; Borrego, Salud] Univ Seville, Consejo Super Invest Cient, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain; [Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Mendez-Vidal, Cristina; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis, Seville, Spain; [Carlos de Agustin, Juan] Univ Hosp Virgen del Rocio, Dept Pediat Surg, Seville, Spain; [Isabel Segura, Dolores] Univ Hosp Virgen del Rocio, Dept Pathol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Borrego, S (corresponding author), Univ Seville, Consejo Super Invest Cient, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, MALFORMACIONES/H-7372-2016; IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; LUZON, BERTA/D-4884-2014; De Agustin, Juan/AAT-1824-2021; IBIS, GENETICA/P-3384-2015; Torroglosa, Ana/AAU-9812-2020; Méndez-Vidal, Cristina/F-1366-2015	De Agustin, Juan/0000-0002-2413-2871; Méndez-Vidal, Cristina/0000-0002-1282-1688; Torroglosa, Ana/0000-0003-1911-7906; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII), Spain [PI1001290]; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia [CTS-7447]	Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III); Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia	This study was funded by the Instituto de Salud Carlos III (ISCIII), Spain (PI1001290) and Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia (CTS-7447). The CIBER de Enfermedades Raras is an initiative of the ISCIII, Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2007, DEV BIOL, V305, P287, DOI 10.1016/j.ydbio.2007.02.020; Anderson RB, 2006, CELL TISSUE RES, V323, P11, DOI 10.1007/s00441-005-0047-6; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2003, J Med Genet, V40, pe18, DOI 10.1136/jmg.40.3.e18; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Brooks AS, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038125; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2002, METABOLIC MOL BASES; Charoy C, 2012, NEURON, V75, P1051, DOI 10.1016/j.neuron.2012.08.021; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Gershon MD, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P499; Goshima Y, 2012, EXPERT OPIN THER TAR, V16, P933, DOI 10.1517/14728222.2012.710201; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Maden CH, 2012, DEV BIOL, V369, P277, DOI 10.1016/j.ydbio.2012.06.026; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023475; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Shepherd IT, 1999, DEV BIOL, V212, P42, DOI 10.1006/dbio.1999.9294; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Wang LL, 2012, BIRTH DEFECTS RES A, V94, P91, DOI 10.1002/bdra.22866; Wang LL, 2011, BIRTH DEFECTS RES A, V91, P842, DOI 10.1002/bdra.20837; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029	42	22	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54800	10.1371/journal.pone.0054800	http://dx.doi.org/10.1371/journal.pone.0054800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372769	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500128
J	Olea, PP; Mateo-Tomas, P				Olea, Pedro P.; Mateo-Tomas, Patricia			Assessing Species Habitat Using Google Street View: A Case Study of Cliff-Nesting Vultures	PLOS ONE			English	Article							BIODIVERSITY	The assessment of a species' habitat is a crucial issue in ecology and conservation. While the collection of habitat data has been boosted by the availability of remote sensing technologies, certain habitat types have yet to be collected through costly, on-ground surveys, limiting study over large areas. Cliffs are ecosystems that provide habitat for a rich biodiversity, especially raptors. Because of their principally vertical structure, however, cliffs are not easy to study by remote sensing technologies, posing a challenge for many researches and managers working with cliff-related biodiversity. We explore the feasibility of Google Street View, a freely available on-line tool, to remotely identify and assess the nesting habitat of two cliff-nesting vultures (the griffon vulture and the globally endangered Egyptian vulture) in northwestern Spain. Two main usefulness of Google Street View to ecologists and conservation biologists were evaluated: i) remotely identifying a species' potential habitat and ii) extracting fine-scale habitat information. Google Street View imagery covered 49% (1,907 km) of the roads of our study area (7,000 km(2)). The potential visibility covered by on-ground surveys was significantly greater (mean: 97.4%) than that of Google Street View (48.1%). However, incorporating Google Street View to the vulture's habitat survey would save, on average, 36% in time and 49.5% in funds with respect to the on-ground survey only. The ability of Google Street View to identify cliffs (overall accuracy = 100%) outperformed the classification maps derived from digital elevation models (DEMs) (62-95%). Nonetheless, high-performance DEM maps may be useful to compensate Google Street View coverage limitations. Through Google Street View we could examine 66% of the vultures' nesting-cliffs existing in the study area (n = 148): 64% from griffon vultures and 65% from Egyptian vultures. It also allowed us the extraction of fine-scale features of cliffs. This World Wide Web-based methodology may be a useful, complementary tool to remotely map and assess the potential habitat of cliff-dependent biodiversity over large geographic areas, saving survey-related costs.	[Olea, Pedro P.; Mateo-Tomas, Patricia] Univ Castilla La Mancha, Consejo Super Invest Cient, Inst Invest Recursos Cineget, E-13071 Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Olea, PP (corresponding author), Univ Castilla La Mancha, Consejo Super Invest Cient, Inst Invest Recursos Cineget, E-13071 Ciudad Real, Spain.	olea.pedro1@gmail.com	Olea, Pedro P/M-1502-2014; Mateo-Tomás, Patricia/L-8471-2014	Olea, Pedro P/0000-0001-5387-9598; Mateo-Tomás, Patricia/0000-0001-6762-9514	Junta de Comunidades de Castilla-La Mancha; Fondo Social Europeo	Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Fondo Social Europeo(European Social Fund (ESF)European Commission)	PMT was supported by a postdoctoral grant funded by Junta de Comunidades de Castilla-La Mancha and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, ASSESSING ACCURACY R; Arroyo B., 1990, CENSO NACL BUITRE LE; Benham Phred M., 2011, Endangered Species Research, V13, P145, DOI 10.3354/esr00323; BirdLife International, 2008, NEOPHR PERCN IUCN 20; BirdLife International, 2008, GYPS FULV IUCN 2011; Butler D, 2006, NATURE, V439, P776, DOI 10.1038/439776a; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Camp RJ, 1998, CONSERV BIOL, V12, P1302, DOI 10.1046/j.1523-1739.1998.97363.x; Cao SX, 2010, LANDSCAPE URBAN PLAN, V94, P228, DOI 10.1016/j.landurbplan.2009.10.007; Ceballos O., 1988, MUNIBE, V40, P3; Del Moral J. C., 2009, BUITRE LEONADO ESPAN; Del Moral J. C., 2009, ALIMOCHE COMUN ESPAN; DELMORAL J, 2002, ALIMOCHE COMUN ESPAN; Devaux A, 2010, P INT C MULT, P903; Donazar J.A., 1993, BUITRES IBERICOS BIO; Franklin J, 2009, MAPPING SPECIES DIST; Gamer M, 2012, IRR VARIOUS COEFFICI; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Jubete F, 1997, ATLAS AVES NIDIFICAN; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Krajick K, 1999, SCIENCE, V283, P1623, DOI 10.1126/science.283.5408.1623; Krebs CJ, 2001, ECOLOGY EXPT ANAL DI; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Lengyel S, 2008, BIODIVERS CONSERV, V17, P3327, DOI 10.1007/s10531-008-9395-3; Marti R., 2001, BUITRE LEONADO PENIN; Mateo-Tomas P, 2011, IBIS, V153, P832, DOI 10.1111/j.1474-919X.2011.01154.x; Mateo-Tomas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012374; Mateo-Tomas P, 2010, ORYX, V44, P434, DOI 10.1017/S0030605310000505; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; Mawdsley JR, 2008, J INSECT CONSERV, V12, P689, DOI 10.1007/s10841-007-9113-6; McMillan MA, 2002, CONSERV BIOL, V16, P389, DOI 10.1046/j.1523-1739.2002.00377.x; Olea PP, 2011, DIVERS DISTRIB, V17, P714, DOI 10.1111/j.1472-4642.2011.00777.x; Olea Pedro P., 1999, Ardeola, V46, P81; Ozuag E, 2011, MACH LEARN SIGN PROC, P1; Pearce JM, 2007, RESOUR CONSERV RECY, V51, P435, DOI 10.1016/j.resconrec.2006.10.010; R Development Core Team, 2012, R LANG ENV STAT COMP; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; SEO, 1981, ARDEOLA, V26, p165 312; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Stock GM, 2012, EARTH SURF PROC LAND, V37, P546, DOI 10.1002/esp.3192; Svensson L., 2010, COLLINS BIRD GUIDE, V2nd ed.; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2	46	33	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54582	10.1371/journal.pone.0054582	http://dx.doi.org/10.1371/journal.pone.0054582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355880	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500089
J	Sonah, H; Bastien, M; Iquira, E; Tardivel, A; Legare, G; Boyle, B; Normandeau, E; Laroche, J; Larose, S; Jean, M; Belzile, F				Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Legare, Gaetan; Boyle, Brian; Normandeau, Eric; Laroche, Jerome; Larose, Stephane; Jean, Martine; Belzile, Francois			An Improved Genotyping by Sequencing (GBS) Approach Offering Increased Versatility and Efficiency of SNP Discovery and Genotyping	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME	Highly parallel SNP genotyping platforms have been developed for some important crop species, but these platforms typically carry a high cost per sample for first-time or small-scale users. In contrast, recently developed genotyping by sequencing (GBS) approaches offer a highly cost effective alternative for simultaneous SNP discovery and genotyping. In the present investigation, we have explored the use of GBS in soybean. In addition to developing a novel analysis pipeline to call SNPs and indels from the resulting sequence reads, we have devised a modified library preparation protocol to alter the degree of complexity reduction. We used a set of eight diverse soybean genotypes to conduct a pilot scale test of the protocol and pipeline. Using ApeKI for GBS library preparation and sequencing on an Illumina GAIIx machine, we obtained 5.5 M reads and these were processed using our pipeline. A total of 10,120 high quality SNPs were obtained and the distribution of these SNPs mirrored closely the distribution of gene-rich regions in the soybean genome. A total of 39.5% of the SNPs were present in genic regions and 52.5% of these were located in the coding sequence. Validation of over 400 genotypes at a set of randomly selected SNPs using Sanger sequencing showed a 98% success rate. We then explored the use of selective primers to achieve a greater complexity reduction during GBS library preparation. The number of SNP calls could be increased by almost 40% and their depth of coverage was more than doubled, thus opening the door to an increase in the throughput and a significant decrease in the per sample cost. The approach to obtain high quality SNPs developed here will be helpful for marker assisted genomics as well as assessment of available genetic resources for effective utilisation in a wide number of species.	[Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Jean, Martine; Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; [Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Legare, Gaetan; Boyle, Brian; Normandeau, Eric; Laroche, Jerome; Larose, Stephane; Jean, Martine; Belzile, Francois] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Normandeau, Eric] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Belzile, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	francois.belzile@fsaa.ulaval.ca		Sonah, Humira/0000-0003-4796-6120; Belzile, Francois/0000-0001-6893-4529	Natural Sciences and Engineering Research Council of Canada; Semences Prograin Inc. [RDCPJ 382089-09]; Agriculture and AgriFood Canada; Canadian Field Crop Research Alliance [DIAP 5987]; Canadian International Development Agency (CGIAR-Canada Linkage Fund)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Semences Prograin Inc.; Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); Canadian Field Crop Research Alliance; Canadian International Development Agency (CGIAR-Canada Linkage Fund)(CGIAR)	Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada and Semences Prograin Inc. (Grant no. RDCPJ 382089-09), Agriculture and AgriFood Canada and the Canadian Field Crop Research Alliance (Grant no. DIAP 5987) and the Canadian International Development Agency (CGIAR-Canada Linkage Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Haun WJ, 2011, PLANT PHYSIOL, V155, P645, DOI 10.1104/pp.110.166736; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Semagn K, 2006, AFR J BIOTECHNOL, V5, P2540; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sonah H, 2011, BIOTECHNOL ADV, V29, P199, DOI 10.1016/j.biotechadv.2010.11.002; Varala K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024811; Zhu YL, 2003, GENETICS, V163, P1123	20	301	322	1	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54603	10.1371/journal.pone.0054603	http://dx.doi.org/10.1371/journal.pone.0054603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372741	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500095
J	Swartz, MD; Peterson, CB; Lupo, PJ; Wu, XF; Forman, MR; Spitz, MR; Hernandez, LM; Vannucci, M; Shete, S				Swartz, Michael D.; Peterson, Christine B.; Lupo, Philip J.; Wu, Xifeng; Forman, Michele R.; Spitz, Margaret R.; Hernandez, Ladia M.; Vannucci, Marina; Shete, Sanjay			Investigating Multiple Candidate Genes and Nutrients in the Folate Metabolism Pathway to Detect Genetic and Nutritional Risk Factors for Lung Cancer	PLOS ONE			English	Article							ONE-CARBON METABOLISM; DNA-REPAIR CAPACITY; VARIABLE SELECTION; BREAST-CANCER; B-VITAMINS; STOCHASTIC SEARCH; MODEL SELECTION; DIETARY-INTAKE; BETAINE INTAKE; POLYMORPHISMS	Purpose: Folate metabolism, with its importance to DNA repair, provides a promising region for genetic investigation of lung cancer risk. This project investigates genes (MTHFR, MTR, MTRR, CBS, SHMT1, TYMS), folate metabolism related nutrients (B vitamins, methionine, choline, and betaine) and their gene-nutrient interactions. Methods: We analyzed 115 tag single nucleotide polymorphisms (SNPs) and 15 nutrients from 1239 and 1692 non-Hispanic white, histologically-confirmed lung cancer cases and controls, respectively, using stochastic search variable selection (a Bayesian model averaging approach). Analyses were stratified by current, former, and never smoking status. Results: Rs6893114 in MTRR (odds ratio [OR] = 2.10; 95% credible interval [CI]: 1.20-3.48) and alcohol (drinkers vs. nondrinkers, OR = 0.48; 95% CI: 0.26-0.84) were associated with lung cancer risk in current smokers. Rs13170530 in MTRR (OR = 1.70; 95% CI: 1.10-2.87) and two SNP*nutrient interactions [betaine*rs2658161 (OR = 0.42; 95% CI: 0.19-0.88) and betaine*rs16948305 (OR = 0.54; 95% CI: 0.30-0.91)] were associated with lung cancer risk in former smokers. SNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers. Conclusions: This study identified possible nutrient and genetic factors related to folate metabolism associated with lung cancer risk, which could potentially lead to nutritional interventions tailored by smoking status to reduce lung cancer risk.	[Swartz, Michael D.] Univ Texas Sch Publ Hlth, Div Biostat, Houston, TX USA; [Peterson, Christine B.; Vannucci, Marina] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Lupo, Philip J.] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Swartz, Michael D.; Wu, Xifeng; Forman, Michele R.; Spitz, Margaret R.; Hernandez, Ladia M.; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Rice University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Swartz, MD (corresponding author), Univ Texas Sch Publ Hlth, Div Biostat, Houston, TX USA.	Michael.D.Swartz@uth.tmc.edu	Lupo, Philip/R-8314-2019; Vannucci, Marina/I-8439-2014; Swartz, Michael/AEX-2820-2022	Lupo, Philip/0000-0003-0978-5863; Vannucci, Marina/0000-0002-7360-5321; Peterson, Christine/0000-0003-3316-0468; Swartz, Michael/0000-0003-3953-8775	National Cancer Institute (NCI) [K07-CA 123109, R03 CA141998]; NCI [R01 CA55679]; NATIONAL CANCER INSTITUTE [P30CA016672, K07CA123109, T32CA096520, R03CA141998] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors would like to acknowledge the funding sources National Cancer Institute (NCI) award K07-CA 123109, and R03 CA141998 (MDS PI), NCI award R01 CA55679 (Lung Cancer Study, MRS PI). The funders had no role in study design, data collection and analysis, decision to publis or preaparation of this manuscript.	Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; American Cancer Society, 2010, CANC FACTS FIG 2010; Bagnardi V, 2011, ANN ONCOL; Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bassett JK, 2012, EUR J CLIN NUTR, V66, P182, DOI 10.1038/ejcn.2011.157; Benedetti A, 2006, CANCER CAUSE CONTROL, V17, P469, DOI 10.1007/s10552-005-0496-y; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965; Block G, 1994, DIETSYS VERSION 3 0, P10; Boccia S, 2009, CANCER LETT, V273, P55, DOI 10.1016/j.canlet.2008.07.026; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cho E, 2010, BRIT J CANCER, V102, P489, DOI 10.1038/sj.bjc.6605510; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; FORMAN MR, 1993, AM J CLIN NUTR, V58, P519, DOI 10.1093/ajcn/58.4.519; Fridley BL, 2009, GENET EPIDEMIOL, V33, P27, DOI 10.1002/gepi.20353; Gelman A., 2004, BAYESIAN DATA ANAL, VXXV; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kruschke JK, 2011, DOING BAYESIAN DATA, pxvii; Kwon S, 2007, BMC P, V1, pSX; Lee JE, 2010, CANCER EPIDEM BIOMAR, V19, P884, DOI 10.1158/1055-9965.EPI-09-1295; Liu HL, 2008, LUNG CANCER, V61, P21, DOI 10.1016/j.lungcan.2007.12.001; Mahabir S, 2008, CARCINOGENESIS, V29, P949, DOI 10.1093/carcin/bgn043; Mahabir S, 2007, CANCER EPIDEM BIOMAR, V16, P2756, DOI 10.1158/1055-9965.EPI-07-0324; Mahabir S, 2007, INT J CANCER, V120, P1108, DOI 10.1002/ijc.22451; Mao RF, 2008, J HUM GENET, V53, P340, DOI 10.1007/s10038-008-0262-6; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; NIEHS SNPS, 2010, NIEHS ENV GEN PROJ; Parle-McDermott A, 2006, MOL GENET METAB, V88, P290, DOI 10.1016/j.ymgme.2006.02.011; Piskac-Collier AL, 2011, GENE CHROMOSOME CANC, V50, P1, DOI 10.1002/gcc.20826; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohrmann S, 2006, AM J EPIDEMIOL, V164, P1103, DOI 10.1093/aje/kwj326; Sakoda LC, 2011, CANCER CAUSE CONTROL, V22, P449, DOI 10.1007/s10552-010-9716-1; Schumacher Fredrick R, 2007, BMC Proc, V1 Suppl 1, pS112; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shen M, 2005, LUNG CANC; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Shi QL, 2005, CARCINOGENESIS, V26, P649, DOI 10.1093/carcin/bgh351; Spiegelhalter DJ, 2007, WINBUGS 1 4 2; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Srivastava S, 2009, BMC P S7, V3, pS21; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Swartz MD, 2006, BIOMETRICS, V62, P495, DOI 10.1111/j.1541-0420.2005.00451.x; Swartz MD, 2004, THESIS RICE U HOUSTO; Swartz Michael D, 2007, BMC Proc, V1 Suppl 1, pS113; Swartz MD, 2007, GENET EPIDEMIOL, V31, pS96, DOI 10.1002/gepi.20285; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; Wang L, 2007, LUNG CANCER, V57, P143, DOI 10.1016/j.lungcan.2007.03.002; Wei QY, 2003, CANCER EPIDEM BIOMAR, V12, P963; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 1998, NUTR EPIDEMIOLOGY, pxiv; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Zeisel SH, 2003, J NUTR, V133, P1302; Zijno A, 2003, CARCINOGENESIS, V24, P1097, DOI 10.1093/carcin/bgg064	70	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53475	10.1371/journal.pone.0053475	http://dx.doi.org/10.1371/journal.pone.0053475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372658	Green Published, gold			2022-12-25	WOS:000314021500014
J	Zhao, GY; Cai, CK; Yang, TT; Qiu, XC; Liao, B; Li, W; Ji, ZW; Zhao, J; Zhao, HE; Guo, MJ; Ma, Q; Xiao, C; Fan, QY; Ma, BA				Zhao, Guangyi; Cai, Chengkui; Yang, Tongtao; Qiu, Xiuchun; Liao, Bo; Li, Wei; Ji, Zhenwei; Zhao, Jian; Zhao, Haien; Guo, Mingjun; Ma, Qiong; Xiao, Chun; Fan, Qingyu; Ma, Baoan			MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; PROSTATE-CANCER CELLS; MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; GASTRIC-CANCER; BREAST-CANCER; LUNG-CANCER; SMALL RNAS; CYCLIN D1; EXPRESSION	Background: MicroRNAs are short regulatory RNAs that negatively modulate protein expression at a post-transcriptional and/or translational level and are deeply involved in the pathogenesis of several types of cancers. Specifically, microRNA-221 (miR-221) is overexpressed in many human cancers, wherein accumulating evidence indicates that it functions as an oncogene. However, the function of miR-221 in human osteosarcoma has not been totally elucidated. In the present study, the effects of miR-221 on osteosarcoma and the possible mechanism by which miR-221 affected the survival, apoptosis, and cisplatin resistance of osteosarcoma were investigated. Methodology/Principal Findings: Real-time quantitative PCR analysis revealed miR-221 was significantly upregulated in osteosarcoma cell lines than in osteoblasts. Both human osteosarcoma cell lines SOSP-9607 and MG63 were transfected with miR-221 mimic or inhibitor to regulate miR-221 expression. The effects of miR-221 were then assessed by cell viability, cell cycle analysis, apoptosis assay, and cisplatin resistance assay. In both cells, upregulation of miR-221 induced cell survival and cisplatin resistance and reduced cell apoptosis. In addition, knockdown of miR-221 inhibited cell growth and cisplatin resistance and induced cell apoptosis. Potential target genes of miR-221 were predicted using bioinformatics. Moreover, luciferase reporter assay and western blot confirmed that PTEN was a direct target of miR-221. Furthermore, introduction of PTEN cDNA lacking 39-UTR or PI3K inhibitor LY294002 abrogated miR-221-induced cisplatin resistance. Finally, both miR-221 and PTEN expression levels in osteosarcoma samples were examined by using real-time quantitative PCR and immunohistochemistry. High miR-221 expression level and inverse correlation between miR-221 and PTEN levels were revealed in osteosarcoma tissues. Conclusions/Significance: These results for the first time demonstrate that upregulation of miR-221 induces the malignant phenotype of human osteosarcoma whereas knockdown of miR-221 reverses this phenotype, suggesting that miR-221 could be a potential target for osteosarcoma treatment.	[Zhao, Guangyi; Cai, Chengkui; Yang, Tongtao; Qiu, Xiuchun; Liao, Bo; Li, Wei; Ji, Zhenwei; Zhao, Jian; Zhao, Haien; Guo, Mingjun; Ma, Qiong; Xiao, Chun; Fan, Qingyu; Ma, Baoan] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Fan, QY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China.	bonetm@fmmu.edu.cn; gukemba@fmmu.edu.cn			National Natural Science Foundation of China [81072194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO. 81072194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2004, J BIOL CHEM, V279, P38710, DOI 10.1074/jbc.M403329200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cenni V, 2004, INT J ONCOL, V25, P1599; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dai HZ, 2012, CARCINOGENESIS, V33, P30, DOI 10.1093/carcin/bgr232; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; delPeso L, 1997, SCIENCE, V278, P687; Diaz-Montero CM, 2006, EUR J CANCER, V42, P1491, DOI 10.1016/j.ejca.2006.03.007; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Huang J, 2012, AUTOPHAGY, V8, P275, DOI 10.4161/auto.8.2.18940; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; Jin ML, 2001, LUNG CANCER-J IASLC, V34, P207, DOI 10.1016/S0169-5002(01)00225-2; Joaquin M, 2003, J BIOL CHEM, V278, P44255, DOI 10.1074/jbc.M308953200; Kim VN, 2005, MOL CELLS, V19, P1; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lai VK, 2012, CELL CYCLE, V11, P767, DOI 10.4161/cc.11.4.19211; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Miwa S, 2011, INT J ONCOL, V39, P465, DOI 10.3892/ijo.2011.1051; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Sun Y, 2007, MOL CANCER THER, V6, P2477, DOI 10.1158/1535-7163.MCT-07-0186; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Wang Guowen, 2010, Mol Biol (Mosk), V44, P1010; Wu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014648; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamada KM, 2001, J CELL SCI, V114, P2375; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang YW, 2001, ONCOGENE, V20, P4138, DOI 10.1038/sj.onc.1204563; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3	62	188	203	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53906	10.1371/journal.pone.0053906	http://dx.doi.org/10.1371/journal.pone.0053906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372675	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500030
J	Li, T; Lu, YY; Zhao, XD; Guo, HQ; Liu, CH; Li, H; Zhou, L; Han, YN; Wu, KC; Nie, YZ; Shi, YQ; Fan, DM				Li, T.; Lu, Y. Y.; Zhao, X. D.; Guo, H. Q.; Liu, C. H.; Li, H.; Zhou, L.; Han, Y. N.; Wu, K. C.; Nie, Y. Z.; Shi, Y. Q.; Fan, D. M.			MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1	ONCOGENE			English	Article						CDX1; miR-296-5p; gastric cancer; proliferation; apoptosis	MESSENGER-RNA EXPRESSION; HELICOBACTER-PYLORI; EPITHELIAL-CELLS; GENE-EXPRESSION; DOWN-REGULATION; KINASE PATHWAY; CDX1; CARCINOMA; MIR-296; TARGET	Caudal-related homeobox 1 (CDX1), an intestinal-specific transcription factor, has been reported to have vital roles in gastric intestinal metaplasia (IM). Although IM is a high-risk factor for gastric cancer (GC), the specific role of CDX1 in GC is largely unknown. In this study, we investigated the expression of CDX1 and its functional roles in GC, and its upstream regulatory mechanisms at the microRNA (miRNA) level were further explored. We found that CDX1 is lost in GC when compared with adjacent IM tissues. Gain-of-function studies showed that CDX1 significantly inhibited GC cell growth by inducing cell cycle arrest and apoptosis. Interestingly, we identified and verified an onco-mir, miR-296-5p, as a direct upstream regulator of CDX1. miR-296-5p overexpression significantly promoted GC cell growth and attenuated the CDX1-induced anti-growth effects by recurring cell cycle distribution and apoptotic status, whereas knockdown of miR-296-5p decreased GC cell growth. Furthermore, we found that the extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation and the subsequent downstream changes in protein levels related to cell cycle and apoptosis partly account for the miR-296-5p-CDX1-induced GC growth promotion. In addition, the detection of miR-296-5p and expression of CDX1 in primary GC tissues and adjacent IM tissues revealed that miR-296-5p is inversely correlated with CDX1, further supporting our in vitro results. Our results showed an anti-growth effect of CDX1 and identified its miRNA regulatory mechanism in GC. The identification of this novel miR-296-5p-CDX1-ERK1/2 axis sheds new light on the understanding of the process from IM to GC and may provide therapeutic targets for the treatment of GC.	Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; Fourth Mil Med Univ, Xijing Hosp, Dept Gastroenterol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Shi, YQ (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, West Changle Rd, Xian 710032, Shaan Xi, Peoples R China.	shiyquan@fmmu.edu.cn; daimingfan@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020		National 973 Project of China [2010CB732405, 2010CB529300, 2010CB529302, 2010CB529305, 2010CB529306]; National Natural Science Foundation of China [81030044, 81270445, 81172062]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge Z CHEN, GB TANG, JH DOU and G REN from the State Key Laboratory of Cancer Biology for the assistance in tissue sample collection. This work was supported by the National 973 Project of China (no. 2010CB732405, 05; 2010CB529300, 02, 05, 06) and the National Natural Science Foundation of China (no. 81030044, 81270445, 81172062).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boussioutas A, 2003, CANCER RES, V63, P2569; Camilo V, 2012, CARCINOGENESIS, V33, P1985, DOI 10.1093/carcin/bgs233; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Domon-Dell C, 2003, ONCOGENE, V22, P7913, DOI 10.1038/sj.onc.1206756; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Ito K, 2011, GASTROENTEROLOGY, V140, P1536, DOI 10.1053/j.gastro.2011.01.043; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Johnstone CN, 2002, J BIOL CHEM, V277, P34531, DOI 10.1074/jbc.M204865200; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kazumori H, 2009, GUT, V58, P620, DOI 10.1136/gut.2008.152975; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lynch J, 2003, ONCOGENE, V22, P6395, DOI 10.1038/sj.onc.1206770; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Lynch JP, 2008, NEOPLASIA, V10, P8, DOI 10.1593/neo.07703; Mallo GV, 1997, INT J CANCER, V74, P35, DOI 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pucci B, 2009, J CELL BIOCHEM, V108, P1166, DOI 10.1002/jcb.22345; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Soubeyran P, 2001, ONCOGENE, V20, P4180, DOI 10.1038/sj.onc.1204551; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaira V, 2012, ONCOGENE, V31, P27, DOI 10.1038/onc.2011.209; Wong NACS, 2005, P NATL ACAD SCI USA, V102, P7565, DOI 10.1073/pnas.0502031102; Wong NACS, 2004, P NATL ACAD SCI USA, V101, P574, DOI 10.1073/pnas.0307190101; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	48	82	86	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					783	793		10.1038/onc.2012.637	http://dx.doi.org/10.1038/onc.2012.637			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23353818				2022-12-25	WOS:000331129200012
J	Yang, HB; Li, GY; Wu, JJ; Wang, LD; Uhler, M; Simeone, DM				Yang, Huibin; Li, Gangyong; Wu, Jing-Jiang; Wang, Lidong; Uhler, Michael; Simeone, Diane M.			Protein Kinase A Modulates Transforming Growth Factor-beta Signaling through a Direct Interaction with Smad4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CANCER STEM-CELLS; TGF-BETA; E-CADHERIN; REGULATORY SUBUNIT; MOLECULAR-BASIS; BINDING-SITES; PROLINE-RICH; CAMP; ACTIVATION	Transforming growth factor beta (TGF beta) signaling normally functions to regulate embryonic development and cellular homeostasis. It is increasingly recognized that TGF beta signaling is regulated by cross-talk with other signaling pathways. We previously reported that TGF beta activates protein kinase A (PKA) independent of cAMP through an interaction of an activated Smad3-Smad4 complex and the regulatory subunit of the PKA holoenzyme (PKA-R). Here we define the interaction domains of Smad4 and PKA-R and the functional consequences of this interaction. Using a series of Smad4 and PKA-R truncation mutants, we identified amino acids 290-300 of the Smad4 linker region as critical for the specific interaction of Smad4 and PKA-R. Co-immunoprecipitation assays showed that the B cAMP binding domain of PKA-R was sufficient for interaction with Smad4. Targeting of B domain regions conserved among all PKA-R isoforms and exposed on the molecular surface demonstrated that amino acids 281-285 and 320-329 were required for complex formation with Smad4. Interactions of these specific regions of Smad4 and PKA-R were necessary for TGF beta-mediated increases in PKA activity, CREB (cAMP-response element-binding protein) phosphorylation, induction of p21, and growth inhibition. Moreover, this Smad4-PKA interaction was required for TGF beta-induced epithelial mesenchymal transition, invasion of pancreatic tumor cells, and regulation of tumor growth in vivo.	[Yang, Huibin; Li, Gangyong; Wu, Jing-Jiang; Wang, Lidong; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Uhler, Michael] Univ Michigan, Dept Biochem, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Translat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Med Ctr, TC 2210B,Box 5343,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	simeone@umich.edu			National Institutes of Health [DK-061507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-061507 (to D. M. S.).	Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Attisano L., 2001, GENOME BIOL, V2, p3010.3011, DOI [DOI 10.1186/GB-2001-2-8-REVIEWS3010, 10.1186/gb-2001-2-8-reviews3010]; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Makkar P, 2009, J MOL GRAPH MODEL, V27, P803, DOI 10.1016/j.jmgm.2008.12.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Peng FF, 2008, AM J PHYSIOL-RENAL, V295, pF153, DOI 10.1152/ajprenal.00419.2007; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; ROBINSONSTEINER AM, 1983, J BIOL CHEM, V258, P1032; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; SHABB JB, 1995, PROTEIN SCI, V4, P2100, DOI 10.1002/pro.5560041015; Sharma K, 1997, J BIOL CHEM, V272, P14617, DOI 10.1074/jbc.272.23.14617; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; Takano S, 2007, J BIOCHEM, V141, P345, DOI 10.1093/jb/mvm039; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang LW, 1998, J BIOL CHEM, V273, P8522, DOI 10.1074/jbc.273.14.8522; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	58	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8737	8749		10.1074/jbc.M113.455675	http://dx.doi.org/10.1074/jbc.M113.455675			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362281	hybrid, Green Published			2022-12-25	WOS:000316564500073
J	van den Akker, T; Beltman, J; Leyten, J; Mwagomba, B; Meguid, T; Stekelenburg, J; van Roosmalen, J				van den Akker, Thomas; Beltman, Jogchum; Leyten, Joey; Mwagomba, Beatrice; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos			The WHO Maternal Near Miss Approach: Consequences at Malawian District Level	PLOS ONE			English	Article							NETHERLANDS; CARE	Introduction: WHO proposes a set of organ-failure based criteria for maternal near miss. Our objective was to evaluate what implementation of these criteria would mean for the analysis of a cohort of 386 women in Thyolo District, Malawi, who sustained severe acute maternal morbidity according to disease-based criteria. Methods and Findings: A WHO Maternal Near Miss (MNM) Tool, created to compare disease-, intervention- and organfailure based criteria for maternal near miss, was completed for each woman, based on a review of all available medical records. Using disease-based criteria developed for the local setting, 341 (88%) of the 386 women fulfilled the WHO disease-based criteria provided by the WHO MNM Tool, 179 (46%) fulfilled the intervention-based criteria, and only 85 (22%) the suggested organ-failure based criteria. Conclusions: In this low-resource setting, application of these organ-failure based criteria that require relatively sophisticated laboratory and clinical monitoring underestimates the occurrence of maternal near miss. Therefore, these criteria and the suggested WHO approach may not be suited to compare maternal near miss across all settings.	[van den Akker, Thomas; Beltman, Jogchum; Mwagomba, Beatrice] Thyolo Dist Hlth Off, Minist Hlth, Thyolo, Malawi; [van den Akker, Thomas; van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Med Humanities, Amsterdam, Netherlands; [van den Akker, Thomas; Beltman, Jogchum; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos] Dutch Soc Obstet & Gynecol, Utrecht, Netherlands; [van den Akker, Thomas; Beltman, Jogchum; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos] Netherlands Soc Trop Med & Int Hlth, Utrecht, Netherlands; [Beltman, Jogchum; Leyten, Joey; van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Meguid, Tarek] Univ Pittsburgh, Sch Law, Pittsburgh, PA 15260 USA; [Meguid, Tarek] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Meguid, Tarek] Bottom Hosp, Dept Obstet & Gynecol, Lilongwe, Malawi; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical Center Leeuwarden	van den Akker, T (corresponding author), Thyolo Dist Hlth Off, Minist Hlth, Thyolo, Malawi.	thomas_vd_akker@hotmail.com	Stekelenburg, Jelle/B-3129-2017	Stekelenburg, Jelle/0000-0002-2732-6620	Thyolo District Health Office	Thyolo District Health Office	The study was self-funded by the Thyolo District Health Office. There were no external funders that had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker W, 2011, TROP MED INT HEALTH, V16, P1243, DOI 10.1111/j.1365-3156.2011.02832.x; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Cavagnero E, 2008, LANCET, V371, P1284, DOI 10.1016/S0140-6736(08)60563-2; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *NAT STAT OFF, 2005, MAL DEM HLTH SURV 20; Oladapo Olufemi T, 2005, Reprod Health, V2, P9, DOI 10.1186/1742-4755-2-9; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Republic of Malawi Ministry of Health National Health Sciences Research Committee, 2001, SUMM GUID WRIT RES P; Republic of Malawi National Research Committee of Malawi, 2002, PROC GUID COND RES M; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; van den Akker T, 2011, OBSTET GYNECOL, V118, P266, DOI 10.1097/AOG.0b013e3182254d03; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van den Akker T, 2009, INT J GYNECOL OBSTET, V107, P289, DOI 10.1016/j.ijgo.2009.09.005; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x	21	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54805	10.1371/journal.pone.0054805	http://dx.doi.org/10.1371/journal.pone.0054805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372770	Green Published, gold			2022-12-25	WOS:000315210400031
J	de la Puerta, ML; Trinidad, AG; Rodriguez, MD; de Pereda, JM; Crespo, MS; Bayon, Y; Alonso, A				Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Maria de Pereda, Jose; Sanchez Crespo, Mariano; Bayon, Yolanda; Alonso, Andres			The Autoimmunity Risk Variant LYP-W620 Cooperates with CSK in the Regulation of TCR Signaling	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; T-CELL; KINASE P50(CSK); PTP-PEST; DOMAIN; PHOSPHORYLATION; ACTIVATION; PREDICTION; SEQUENCE; PEP	The protein tyrosine phosphatase LYP, a key regulator of TCR signaling, presents a single nucleotide polymorphism, C1858T, associated with several autoimmune diseases such as type I diabetes, rheumatoid arthritis, and lupus. This polymorphism changes an R by a W in the P1 Pro rich motif of LYP, which binds to CSK SH3 domain, another negative regulator of TCR signaling. Based on the analysis of the mouse homologue, Pep, it was proposed that LYP and CSK bind constitutively to inhibit LCK and subsequently TCR signaling. The detailed study of LYP/CSK interaction, here presented, showed that LYP/CSK interaction was inducible upon TCR stimulation, and involved LYP P1 and P2 motifs, and CSK SH3 and SH2 domains. Abrogating LYP/CSK interaction did not preclude the regulation of TCR signaling by these proteins.	[Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Sanchez Crespo, Mariano; Bayon, Yolanda; Alonso, Andres] Univ Valladolid, IBGM, CSIC, Valladolid, Spain; [Maria de Pereda, Jose] Univ Salamanca, Ctr Invest Canc, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Alonso, A (corresponding author), Univ Valladolid, IBGM, CSIC, Valladolid, Spain.	andres@ibgm.uva.es	de Pereda, Jose M/F-1733-2010; de Pereda, Jose M/AAE-5226-2022; Alonso, Andrés/L-7523-2014; BAyón, Yolanda/L-7635-2014	de Pereda, Jose M/0000-0002-8912-6739; de Pereda, Jose M/0000-0002-8912-6739; Alonso, Andrés/0000-0001-8674-9378; BAyón, Yolanda/0000-0003-3089-5485; Sanchez Crespo, Mariano/0000-0002-6149-154X	Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-09724]; Fundacion Mutua Madrilena; Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III; Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain; European Social Fund through FEDER-FSE	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain(German Research Foundation (DFG)); European Social Fund through FEDER-FSE	This work was supported by a grant (SAF2009-09724) from Ministerio de Ciencia e Innovacion (MICINN, http://www.idi.mineco.gob.es/portal/site/MICINN), by Fundacion Mutua Madrilena (http://www.fundacionmutua.es), and by Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III (http://www.recava.com). Y. Bayon has been under contract within the Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain, co-funded by the European Social Fund through FEDER-FSE (http://www.educacion.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Encinar JA, 2009, BIOINFORMATICS, V25, P2418, DOI 10.1093/bioinformatics/btp424; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gregoire C, 2007, EUR J IMMUNOL, V37, P3259, DOI 10.1002/eji.200737563; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Kingston Robert E, 2003, Curr Protoc Mol Biol, VChapter 9, DOI 10.1002/0471142727.mb0901s63; Lefvert AK, 2008, J NEUROIMMUNOL, V197, P110, DOI 10.1016/j.jneuroim.2008.04.004; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; de la Puerta ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004431; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wang B, 2001, MOL CELL BIOL, V21, P1077, DOI 10.1128/MCB.21.4.1077-1088.2001; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54569	10.1371/journal.pone.0054569	http://dx.doi.org/10.1371/journal.pone.0054569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359562	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600072
J	Neumann, M; Coskun, E; Fransecky, L; Mochmann, LH; Bartram, I; Sartangi, NF; Heesch, S; Gokbuget, N; Schwartz, S; Brandts, C; Schlee, C; Haas, R; Duhrsen, U; Griesshammer, M; Dohner, H; Ehninger, G; Burmeister, T; Blau, O; Thiel, E; Hoelzer, D; Hofmann, WK; Baldus, CD				Neumann, Martin; Coskun, Ebru; Fransecky, Lars; Mochmann, Liliana H.; Bartram, Isabelle; Sartangi, Nasrin Farhadi; Heesch, Sandra; Goekbuget, Nicola; Schwartz, Stefan; Brandts, Christian; Schlee, Cornelia; Haas, Rainer; Duehrsen, Ulrich; Griesshammer, Martin; Doehner, Hartmut; Ehninger, Gerhard; Burmeister, Thomas; Blau, Olga; Thiel, Eckhard; Hoelzer, Dieter; Hofmann, Wolf-Karsten; Baldus, Claudia D.			FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; C-KIT; PROGNOSTIC IMPLICATIONS; NORMAL CYTOGENETICS; GROUP-B; ACTIVATION; NOTCH1; CANCER	Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) has been identified as high-risk subgroup of acute T-lymphoblastic leukemia (T-ALL) with a high rate of FLT3-mutations in adults. To unravel the underlying pathomechanisms and the clinical course we assessed molecular alterations and clinical characteristics in a large cohort of ETP-ALL (n = 68) in comparison to non-ETP T-ALL adult patients. Interestingly, we found a high rate of FLT3-mutations in ETP-ALL samples (n = 24, 35%). Furthermore, FLT3 mutated ETP-ALL was characterized by a specific immunophenotype (CD2+/CD5-/CD13+/CD33-), a distinct gene expression pattern (aberrant expression of IGFBP7, WT1, GATA3) and mutational status (absence of NOTCH1 mutations and a low frequency, 21%, of clonal TCR rearrangements). The observed low GATA3 expression and high WT1 expression in combination with lack of NOTCH1 mutations and a low rate of TCR rearrangements point to a leukemic transformation at the pluripotent prothymocyte stage in FLT3 mutated ETP-ALL. The clinical outcome in ETP-ALL patients was poor, but encouraging in those patients with allogeneic stem cell transplantation (3-year OS: 74%). To further explore the efficacy of targeted therapies, we demonstrate that T-ALL cell lines transfected with FLT3 expression constructs were particularly sensitive to tyrosine kinase inhibitors. In conclusion, FLT3 mutated ETP-ALL defines a molecular distinct stem cell like leukemic subtype. These data warrant clinical studies with the implementation of FLT3 inhibitors in addition to early allogeneic stem cell transplantation for this high risk subgroup.	[Neumann, Martin; Coskun, Ebru; Fransecky, Lars; Mochmann, Liliana H.; Bartram, Isabelle; Sartangi, Nasrin Farhadi; Heesch, Sandra; Schwartz, Stefan; Schlee, Cornelia; Burmeister, Thomas; Blau, Olga; Thiel, Eckhard; Baldus, Claudia D.] Univ Hosp Berlin, Dept Hematol & Oncol, Charite, Berlin, Germany; [Goekbuget, Nicola; Brandts, Christian; Hoelzer, Dieter] Goethe Univ Hosp, Dept Med Hematol & Oncol 2, Frankfurt, Germany; [Haas, Rainer] Univ Dusseldorf, Dept Hematol & Oncol, D-40225 Dusseldorf, Germany; [Duehrsen, Ulrich] Univ Essen Gesamthsch, Dept Hematol & Oncol, Essen, Germany; [Griesshammer, Martin] Klinikum Minden, Dept Hematol & Oncol, Minden, Germany; [Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Ehninger, Gerhard] Univ Dresden, Dept Hematol & Oncol, Dresden, Germany; [Hofmann, Wolf-Karsten] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Heinrich Heine University Dusseldorf; University of Duisburg Essen; Ruhr University Bochum; Ulm University; Technische Universitat Dresden; Ruprecht Karls University Heidelberg	Baldus, CD (corresponding author), Univ Hosp Berlin, Dept Hematol & Oncol, Charite, Campus Benjamin Franklin, Berlin, Germany.	claudia.baldus@charite.de	Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536; Blau, Olga/0000-0002-4304-5079; Brandts, Christian H./0000-0003-1732-2535; Burmeister, Thomas/0000-0003-4843-2876; Schwartz, Stefan/0000-0001-8833-5793; Coskun, Ebru/0000-0001-5045-2003; Bartram, Isabelle/0000-0003-1035-8084	Berliner Krebsgesellschaft; Deutsche Krebshilfe	Berliner Krebsgesellschaft; Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by research funding from Berliner Krebsgesellschaft and Deutsche Krebshilfe to C.D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Asnafi V, 2009, BLOOD, V113, P3918, DOI 10.1182/blood-2008-10-184069; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Blom B, 1999, BLOOD, V93, P3033; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; Bruggemann M, 2006, BLOOD, V107, P1116, DOI 10.1182/blood-2005-07-2708; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; Cascavilla N, 1998, HAEMATOLOGICA, V83, P392; Chillon MC, 2012, LEUKEMIA, V26, P2360, DOI 10.1038/leu.2012.161; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gokbuget Nicola, 2006, Hematology Am Soc Hematol Educ Program, P133; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; GUNJI Y, 1993, BLOOD, V82, P3283; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Heesch S, 2010, LEUKEMIA, V24, P1429, DOI 10.1038/leu.2010.130; Heesch S, 2010, HAEMATOL-HEMATOL J, V95, P942, DOI 10.3324/haematol.2009.016386; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Hoehn D, 2012, AM J CLIN PATHOL, V137, P213, DOI 10.1309/AJCPR3N3JMSYLPFG; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; IKEDA H, 1991, BLOOD, V78, P2962; Inukai T, 2012, BRIT J HAEMATOL, V156, P358, DOI 10.1111/j.1365-2141.2011.08955.x; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Neumann M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.49; Paganin M, 2010, BLOOD REV; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Paietta E, 2010, BEST PRACT RES CL HA, V23, P359, DOI 10.1016/j.beha.2010.08.001; Paschka P, 2008, J CLIN ONCOL, V26, P4595, DOI 10.1200/JCO.2007.15.2058; Pemmaraju N, 2011, CANCER-AM CANCER SOC, V117, P3293, DOI 10.1002/cncr.25908; Pratz KW, 2010, BLOOD, V115, P1425, DOI 10.1182/blood-2009-09-242859; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; REUSSBORST MA, 1994, LEUKEMIA, V8, P258; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Sanz M, 2009, CURR OPIN ONCOL, V21, P594, DOI 10.1097/CCO.0b013e32833118fd; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Vlierberghe P, 2005, BLOOD, V106, P4414, DOI 10.1182/blood-2005-06-2267; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	52	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53190	10.1371/journal.pone.0053190	http://dx.doi.org/10.1371/journal.pone.0053190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359050	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600011
J	Nishikimi, T; Okamoto, H; Nakamura, M; Ogawa, N; Horii, K; Nagata, K; Nakagawa, Y; Kinoshita, H; Yamada, C; Nakao, K; Minami, T; Kuwabara, Y; Kuwahara, K; Masuda, I; Kangawa, K; Minamino, N; Nakao, K				Nishikimi, Toshio; Okamoto, Hiroyuki; Nakamura, Masahiro; Ogawa, Naoko; Horii, Kazukiyo; Nagata, Kiyoshi; Nakagawa, Yasuaki; Kinoshita, Hideyuki; Yamada, Chinatsu; Nakao, Kazuhiro; Minami, Takeya; Kuwabara, Yoshihiro; Kuwahara, Koichiro; Masuda, Izuru; Kangawa, Kenji; Minamino, Naoto; Nakao, Kazuwa			Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MOLECULAR-FORMS; NT-PROBNP; PRECURSOR	Background: Recent studies have shown that in addition to brain (or B-type) natriuretic peptide (BNP) and the N-terminal proBNP fragment, levels of intact proBNP are also increased in heart failure. Moreover, present BNP immunoassays also measure proBNP, as the anti-BNP antibody cross-reacts with proBNP. It is important to know the exact levels of proBNP in heart failure, because elevation of the low-activity proBNP may be associated with the development of heart failure. Methodology/Principal Findings: We therefore established a two-step immunochemiluminescent assay for total BNP (BNP+proBNP) and proBNP using monoclonal antibodies and glycosylated proBNP as a standard. The assay enables measurement of plasma total BNP and proBNP within only 7 h, without prior extraction of the plasma. The detection limit was 0.4 pmol/L for a 50-mu l plasma sample. Within-run CVs ranged from 5.2%-8.0% in proBNP assay and from 7.0%-8.4% in total BNP assay, and between-run CVs ranged from 5.3-7.4% in proBNP assay and from 2.9%-9.5% in total BNP assay, respectively. The dilution curves for plasma samples showed good linearity (correlation coefficients = 0.998-1.00), and analytical recovery was 90-101%. The mean total BNP and proBNP in plasma from 116 healthy subjects were 1.4 +/- 1.2 pM and 1.0 +/- 0.7 pM, respectively, and were 80 +/- 129 pM and 42 +/- 70 pM in 32 heart failure patients. Plasma proBNP levels significantly correlate with age in normal subjects. Conclusions/Significance: Our immunochemiluminescent assay is sufficiently rapid and precise for routine determination of total BNP and proBNP in human plasma.	[Nishikimi, Toshio; Nakagawa, Yasuaki; Kinoshita, Hideyuki; Yamada, Chinatsu; Nakao, Kazuhiro; Minami, Takeya; Kuwabara, Yoshihiro; Kuwahara, Koichiro; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Okamoto, Hiroyuki; Nakamura, Masahiro; Ogawa, Naoko; Horii, Kazukiyo; Nagata, Kiyoshi] Shionogi & Co Ltd, Div Diagnost, Osaka 553, Japan; [Masuda, Izuru] Takeda Hosp, Medial Examinat Ctr, Kyoto, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovascular Ctr, Res Inst, Dept Biochem, Osaka, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovascular Ctr, Res Inst, Dept Mol Pharmacol, Osaka, Japan	Kyoto University; Shionogi & Company Limited	Nishikimi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	nishikim@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Kuwabara, Yoshihiro/0000-0003-4161-2970	Ministry of Education, Culture, Sports, Science and Technology of Japan [20590837, 23591041]; Japan Science and Technology Agency [232Z01 302F]; Suzuken Memorial Foundation; Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan; Grants-in-Aid for Scientific Research [24659386, 24591095, 21229013] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Suzuken Memorial Foundation; Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Scientific Research Grants-in-Aid 20590837 and 23591041 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Nishikimi); a grant (AS 232Z01 302F) from the Japan Science and Technology Agency (to T. Nishikimi); a grant from the Suzuken Memorial Foundation (to T. Nishikimi); and the Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan (to N. Minamino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Hammerer-Lercher A, 2008, CLIN CHEM, V54, P858, DOI 10.1373/clinchem.2007.090266; Heublein DM, 2007, HYPERTENSION, V49, P1114, DOI 10.1161/HYPERTENSIONAHA.106.081083; ISHIKAWA E, 1983, J IMMUNOASSAY, V4, P209, DOI 10.1080/15321818308057011; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Liang FQ, 2007, J AM COLL CARDIOL, V49, P1071, DOI 10.1016/j.jacc.2006.10.063; Maisel AS, 2011, INT HEART J, V52, P253, DOI 10.1536/ihj.52.253; Menon Santosh G, 2009, Clin Cardiol, V32, pE36, DOI 10.1002/clc.20480; Minamino N, 2006, HDB BIOL ACTIVE PEPT, P1217, DOI 10.1016/B978-012369442-3/50168-9; Nishikimi T, 2010, HEART, V96, P432, DOI 10.1136/hrt.2009.178392; Nishikimi T, 2007, HYPERTENSION, V50, pE163, DOI 10.1161/HYPERTENSIONAHA.107.098350; Nishikimi T, 2012, HEART, V98, P152, DOI 10.1136/heartjnl-2011-300102; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Seferian KR, 2008, CLIN CHEM, V54, P866, DOI 10.1373/clinchem.2007.100040; Seferian KR, 2007, CLIN CHEM, V53, P866, DOI 10.1373/clinchem.2006.076141; Semenov AG, 2011, CLIN CHIM ACTA, V412, P850, DOI 10.1016/j.cca.2011.03.006; Tsuji T, 2004, U.S. Patent, P16, Patent No. [6677124, 6, 677, 124 B2]; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051	19	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53233	10.1371/journal.pone.0053233	http://dx.doi.org/10.1371/journal.pone.0053233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365636	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600013
J	Strnad, P; von Figura, G; Gruss, R; Jareis, KM; Stiehl, A; Kulaksiz, H				Strnad, Pavel; von Figura, Guido; Gruss, Regina; Jareis, Katja-Marlen; Stiehl, Adolf; Kulaksiz, Hasan			Oblique Bile Duct Predisposes to the Recurrence of Bile Duct Stones	PLOS ONE			English	Article							RISK-FACTORS; GALLSTONE DISEASE; MANAGEMENT; CHOLEDOCHOLITHIASIS; SPHINCTEROTOMY	Background and Study Aims: Bile stones represent a highly prevalent condition and abnormalities of the biliary tree predispose to stone recurrence due to development of biliary stasis. In our study, we assessed the importance of an altered bile duct course for stone formation. Patients and Methods: 1,307 patients with choledocholithiasis in the absence of any associated hepatobiliary disease who underwent endoscopic retrograde cholangiopancreatography (ERCP) between 2002 and 2009 were analysed. The angle enclosed between the horizontal portion of the common bile duct (CBD) and the horizontal plane was measured (angle alpha). Oblique common bile duct (OCBD) was defined as a CBD with angle alpha<45 degrees. Results: 103 patients (7.9%) were found to harbour OCBD and these were compared to 104 randomly selected control subjects. Compared to controls, OCBD patients were (i) significantly older (72613 vs. 67613, p < 0.00001); (ii) more frequently underwent a cholecystectomy (p = 0.02) and biliary surgery (p = 0.003) prior to the diagnosis and (iii) more often developed chronic pancreatitis (p = 0.04) as well as biliary fistulae (p = 0.03). Prior to and after ERCP, OCBD subjects displayed significantly elevated cholestatic parameters and angle a negatively correlated with common bile duct diameter (r = -0.29, p = 0.003). OCBD subjects more often required multiple back-to-back ERCP sessions to remove bile stones (p = 0.005) as well as more ERCPs later on due to recurrent stone formation (p < 0.05). Conclusion: OCBD defines a novel variant of the biliary tree, which is associated with chronic cholestasis, hampers an efficient stone removal and predisposes to recurrence of bile duct stones.	[Strnad, Pavel; von Figura, Guido; Gruss, Regina; Jareis, Katja-Marlen; Kulaksiz, Hasan] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany; [Strnad, Pavel] Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany; [Strnad, Pavel] Univ Hosp Aachen, IZKF, Aachen, Germany; [Stiehl, Adolf] Univ Med Ctr Heidelberg, Dept Internal Med 1, Div Gastroenterol, Heidelberg, Germany; [Kulaksiz, Hasan] Hosp Waldshut Tiengen, Dept Internal Med 2, Waldshut Tiengen, Germany	Ulm University; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg	Strnad, P (corresponding author), Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany.	pstrnad@ukaachen.de; Hasan.Kulaksiz@spital-waldshut.de			Emmy Noether program of the German Research Foundation [STR 1095/2-1]	Emmy Noether program of the German Research Foundation(German Research Foundation (DFG))	This work was supported by the Emmy Noether program of the German Research Foundation STR 1095/2-1 (P. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2003, GUT, V52, P116, DOI 10.1136/gut.52.1.116; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Chathadi Krishnavel V, 2003, Semin Gastrointest Dis, V14, P199; Cheon YK, 2006, EUR J GASTROEN HEPAT, V18, P461, DOI 10.1097/00042737-200605000-00001; Costamagna G, 2002, ENDOSCOPY, V34, P273, DOI 10.1055/s-2002-23632; Frossard JL, 2010, GASTROINTEST ENDOSC, V72, P808, DOI 10.1016/j.gie.2010.06.033; Geenen DJ, 1998, ENDOSCOPY, V30, P18, DOI 10.1055/s-2007-993722; Kim DI, 2001, GASTROINTEST ENDOSC, V54, P42, DOI 10.1067/mge.2001.115335; Lammert F, 2008, J HEPATOL, V48, pS124, DOI 10.1016/j.jhep.2008.01.012; Li ZF, 2007, HEPATOB PANCREAT DIS, V6, P67; MADDEN JL, 1973, SURG CLIN N AM, V53, P1095; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; RIZO RJ, 1995, RADIOGRAPHICS, V15, P49, DOI 10.1148/radiographics.15.1.7899613; SIEG A, 1986, DEUT MED WOCHENSCHR, V111, P1760, DOI 10.1055/s-2008-1068706; Tazuma S, 2006, BEST PRACT RES CL GA, V20, P1075, DOI 10.1016/j.bpg.2006.05.009; Williams EJ, 2008, GUT, V57, P1004, DOI 10.1136/gut.2007.121657	16	15	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54601	10.1371/journal.pone.0054601	http://dx.doi.org/10.1371/journal.pone.0054601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365676	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600078
J	Thomson, DW; Bracken, CP; Szubert, JM; Goodall, GJ				Thomson, Daniel W.; Bracken, Cameron P.; Szubert, Jan M.; Goodall, Gregory J.			On Measuring miRNAs after Transient Transfection of Mimics or Antisense Inhibitors	PLOS ONE			English	Article							ENDONUCLEOLYTIC CLEAVAGE; RNA; MICRORNAS; DEGRADOME; DELIVERY; SITES	The ability to alter microRNA (miRNA) abundance is crucial for studying miRNA function. To achieve this there is widespread use of both exogenous double-stranded miRNA mimics for transient over-expression, and single stranded antisense RNAs (antimiRs) for miRNA inhibition. The success of these manipulations is often assessed using qPCR, but this does not accurately report the level of functional miRNA. Here, we draw attention to this discrepancy, which is overlooked in many published reports. We measured the functionality of exogenous miRNA by comparing the total level of transfected miRNA in whole cell extracts to the level of miRNA bound to Argonaute following transfection and show that the supraphysiological levels of transfected miRNA frequently seen using qPCR do not represent the functional levels, because the majority of transfected RNA that is detected is vesicular and not accessible for loading into Argonaute as functionally active miRNAs. In the case of microRNA inhibition by transient transfection with antisense inhibitors, there is also the potential for discrepancy, because following cell lysis the abundant inhibitor levels from cellular vesicles can directly interfere with the PCR reaction used to measure miRNA level.	[Thomson, Daniel W.; Bracken, Cameron P.; Szubert, Jan M.; Goodall, Gregory J.] S Australia Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Thomson, Daniel W.; Bracken, Cameron P.; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), S Australia Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	greg.goodall@health.sa.gov.au		Bracken, Cameron/0000-0001-7722-625X; Thomson, Daniel/0000-0001-8890-4263; Goodall, Gregory/0000-0003-1294-0692	PhD scholarship from Adelaide University; National Breast Cancer Foundation Australia; National Health and Medical Research Council; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	PhD scholarship from Adelaide University; National Breast Cancer Foundation Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by a PhD scholarship from Adelaide University (to DWT), a fellowship from the National Breast Cancer Foundation Australia (to CPB) and by grants from the National Health and Medical Research Council (to GJG and CPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bracken CP, 2011, NUCLEIC ACIDS RES, V39, P5658, DOI 10.1093/nar/gkr110; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005	12	86	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55214	10.1371/journal.pone.0055214	http://dx.doi.org/10.1371/journal.pone.0055214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358900	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600160
J	Ye, JR; Xin, RL; Yu, SQ; Bai, LS; Wang, WS; Wu, TC; Su, XL; Lu, HY; Pang, XH; Yan, H; Feng, X; He, X; Zeng, Y				Ye, Jingrong; Xin, Ruolei; Yu, Shuangqing; Bai, Lishi; Wang, Weishi; Wu, Tingchen; Su, Xueli; Lu, Hongyan; Pang, Xinghuo; Yan, Hong; Feng, Xia; He, Xiong; Zeng, Yi			Phylogenetic and Temporal Dynamics of Human Immunodeficiency Virus Type 1 CRF01_AE in China	PLOS ONE			English	Article							HIV-1; SUBTYPES; GUANGXI	To explore the epidemic history of HIV-1 CRF01_AE in China, 408 fragments of gag gene sequences of CRF01_AE sampled in 2002-2010 were determined from different geographical regions and risk populations in China. Phylogenetic analysis indicates that the CRF01_AE sequences can be grouped into four clusters, suggesting that at least four genetically independent CRF01_AE descendants are circulating in China, of which two were closely related to the isolates from Thailand and Vietnam. Cluster 1 has the most extensive distribution in China. In North China, cluster 1 and cluster 4 were mainly transmitted through homosexuality. The real substance of the recent HIV-1 epidemic in men who have sex with men(MSM) of North China is a rapid spread of CRF01_AE, or rather two distinctive natives CRF01_AE. The time of the most recent common ancestor (tMRCA) of four CRF01_AE clusters ranged from the years 1990.9 to 2003.8 in different regions of China. This is the first phylogenetic and temporal dynamics study of HIV-1 CRF01_AE in China.	[Ye, Jingrong; Xin, Ruolei; Bai, Lishi; Wu, Tingchen; Su, Xueli; Lu, Hongyan; Pang, Xinghuo; He, Xiong] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Ye, Jingrong; Yan, Hong; Zeng, Yi] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Ye, Jingrong; Yu, Shuangqing; Feng, Xia; Zeng, Yi] China Ctr Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Weishi] Univ Toronto, Program Pharmacol & Toxicol, Toronto, ON, Canada	Beijing University of Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Toronto	Feng, X (corresponding author), China Ctr Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	fengxia621@126.com; hexiong200@sina.com; basketball197602@hotmail.com			China megaprojects in infectious diseases [2012ZX10001-005, 2012ZX10001-002]; College of Life Science and Bio-engineering, Beijing University of Technology; National Institute for Viral Disease Control and Prevention of China	China megaprojects in infectious diseases; College of Life Science and Bio-engineering, Beijing University of Technology; National Institute for Viral Disease Control and Prevention of China	This study was supported by China megaprojects in infectious diseases (2012ZX10001-005 and 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the entire laboratory members of Beijing Center for Disease Prevention and Control, College of Life Science and Bio-engineering, Beijing University of Technology and the National Institute for Viral Disease Control and Prevention of China for their support in carrying out this project.	Bontell I, 2012, INFECT GENET EVOL, V12, P448, DOI 10.1016/j.meegid.2011.04.034; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Cheng Chun-Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P720; CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025286, 10.1371/journal.pone.0018954]; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; MURPHY E, 1993, AIDS RES HUM RETROV, V9, P997, DOI 10.1089/aid.1993.9.997; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; The Ministry of Health of China, 2012, CHIN J AIDS STD, V18, P1; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; Ye JR, 2012, AIDS RES HUM RETROV, V28, P119, DOI [10.1089/aid.2011.0012, 10.1089/AID.2011.0012]; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364	17	23	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54238	10.1371/journal.pone.0054238	http://dx.doi.org/10.1371/journal.pone.0054238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365653	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600040
J	Hill, MS; Hill, AL; Lopez, J; Peterson, KJ; Pomponi, S; Diaz, MC; Thacker, RW; Adamska, M; Boury-Esnault, N; Cardenas, P; Chaves-Fonnegra, A; Danka, E; De Laine, BO; Formica, D; Hajdu, E; Lobo-Hajdu, G; Klontz, S; Morrow, CC; Patel, J; Picton, B; Pisani, D; Pohlmann, D; Redmond, NE; Reed, J; Richey, S; Riesgo, A; Rubin, E; Russell, Z; Rutzler, K; Sperling, EA; di Stefano, M; Tarver, JE; Collins, AG				Hill, Malcolm S.; Hill, April L.; Lopez, Jose; Peterson, Kevin J.; Pomponi, Shirley; Diaz, Maria C.; Thacker, Robert W.; Adamska, Maja; Boury-Esnault, Nicole; Cardenas, Paco; Chaves-Fonnegra, Andia; Danka, Elizabeth; De laine, Bre-Onna; Formica, Dawn; Hajdu, Eduardo; Lobo-Hajdu, Gisele; Klontz, Sarah; Morrow, Christine C.; Patel, Jignasa; Picton, Bernard; Pisani, Davide; Pohlmann, Deborah; Redmond, Niamh E.; Reed, John; Richey, Stacy; Riesgo, Ana; Rubin, Ewelina; Russell, Zach; Ruetzler, Klaus; Sperling, Erik A.; di Stefano, Michael; Tarver, James E.; Collins, Allen G.			Reconstruction of Family-Level Phylogenetic Relationships within Demospongiae (Porifera) Using Nuclear Encoded Housekeeping Genes	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; SPONGES PORIFERA; MARINE SPONGES; CALCAREOUS SPONGES; SEQUENCE ALIGNMENT; MOLECULAR CLOCKS; PHYLUM PORIFERA; FRESH-WATER; EVOLUTION; SYSTEMATICS	Background: Demosponges are challenging for phylogenetic systematics because of their plastic and relatively simple morphologies and many deep divergences between major clades. To improve understanding of the phylogenetic relationships within Demospongiae, we sequenced and analyzed seven nuclear housekeeping genes involved in a variety of cellular functions from a diverse group of sponges. Methodology/Principal Findings: We generated data from each of the four sponge classes (i.e., Calcarea, Demospongiae, Hexactinellida, and Homoscleromorpha), but focused on family-level relationships within demosponges. With data for 21 newly sampled families, our Maximum Likelihood and Bayesian-based approaches recovered previously phylogenetically defined taxa: Keratosa(p), Myxospongiae(p), Spongillida(p), Haploscleromorpha(p) (the marine haplosclerids) and Democlavia(p). We found conflicting results concerning the relationships of Keratosa(p) and Myxospongiae(p) to the remaining demosponges, but our results strongly supported a clade of Haploscleromorpha(p)+Spongillida(p)+Democlavia(p). In contrast to hypotheses based on mitochondrial genome and ribosomal data, nuclear housekeeping gene data suggested that freshwater sponges (Spongillida(p)) are sister to Haploscleromorpha(p) rather than part of Democlavia(p). Within Keratosa(p), we found equivocal results as to the monophyly of Dictyoceratida. Within Myxospongiae(p), Chondrosida and Verongida were monophyletic. A well-supported clade within Democlavia(p), Tetractinellida(p), composed of all sampled members of Astrophorina and Spirophorina (including the only lithistid in our analysis), was consistently revealed as the sister group to all other members of Democlavia(p). Within Tetractinellida(p), we did not recover monophyletic Astrophorina or Spirophorina. Our results also reaffirmed the monophyly of order Poecilosclerida (excluding Desmacellidae and Raspailiidae), and polyphyly of Hadromerida and Halichondrida. Conclusions/Significance: These results, using an independent nuclear gene set, confirmed many hypotheses based on ribosomal and/or mitochondrial genes, and they also identified clades with low statistical support or clades that conflicted with traditional morphological classification. Our results will serve as a basis for future exploration of these outstanding questions using more taxon- and gene-rich datasets.	[Hill, Malcolm S.; Hill, April L.; Danka, Elizabeth; De laine, Bre-Onna; Pohlmann, Deborah; Richey, Stacy; Russell, Zach; di Stefano, Michael] Univ Richmond, Gottwald Sci Ctr, Richmond, VA 23173 USA; [Lopez, Jose; Chaves-Fonnegra, Andia; Formica, Dawn; Patel, Jignasa; Rubin, Ewelina] Nova SE Univ, Oceanog Ctr, Dania, FL USA; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Pomponi, Shirley; Reed, John] Florida Atlantic Univ, Oceanog Inst, Harbor Branch, Ft Pierce, FL USA; [Diaz, Maria C.] Museo Marino de Margarita, Boca Del Rio, Nueva Esparta, Venezuela; [Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Adamska, Maja] Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Boury-Esnault, Nicole] Univ Aix Marseille, CNRS, IMBE, UMR7263,Stn Marine Endoume, Marseille, France; [Cardenas, Paco] Uppsala Univ, Evolutionary Biol Ctr, Dept Systemat Biol, Uppsala, Sweden; [Hajdu, Eduardo] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Lobo-Hajdu, Gisele] Univ Estado Rio de Janeiro, IBRAG, Dept Genet, BR-20550011 Rio De Janeiro, Brazil; [Klontz, Sarah; Redmond, Niamh E.; Ruetzler, Klaus; Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Morrow, Christine C.] Queens Univ Belfast, Sch Biol Sci, MBC, Belfast, Antrim, North Ireland; [Picton, Bernard] Natl Museums No Ireland, Holywood, North Ireland; [Pisani, Davide; Tarver, James E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Pisani, Davide] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Riesgo, Ana] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sperling, Erik A.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Natl Systemat Lab NOAAs Fisheries Serv, Washington, DC 20560 USA	University of Richmond; Nova Southeastern University; Dartmouth College; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Alabama System; University of Alabama Birmingham; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Uppsala University; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Smithsonian Institution; Smithsonian National Museum of Natural History; Queens University Belfast; University of Bristol; University of Bristol; Harvard University; Harvard University; Smithsonian Institution; Smithsonian National Museum of Natural History	Collins, AG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	collinsa@si.edu	Lobo-Hajdu, Gisele/A-6709-2008; Peterson, Kevin J/A-2188-2009; Hill, Malcolm/B-6204-2015; Riesgo, Ana/E-3341-2014; Lopez, Jose V/F-8809-2011; Pisani, Davide/ABD-5225-2021; Adamska, Maja/M-4128-2014; Picton, Bernard/K-2482-2019; Adamska, Maja/L-3306-2015; Hajdu, Eduardo/C-3863-2009; Collins, Allen/A-7944-2008	Lobo-Hajdu, Gisele/0000-0001-7792-9609; Riesgo, Ana/0000-0002-7993-1523; Lopez, Jose V/0000-0002-1637-4125; Pisani, Davide/0000-0003-0949-6682; Adamska, Maja/0000-0002-4223-8450; Hajdu, Eduardo/0000-0002-8760-9403; Morrow, Christine/0000-0001-5686-8747; Collins, Allen/0000-0002-3664-9691; Chaves Fonnegra, Andia/0000-0002-6781-0089; Picton, Bernard/0000-0002-1500-2215; Danka, Elizabeth/0000-0001-5705-9466	National Science Foundation's Assembling the Tree of Life Program; DEB award [0829763, 0829783, 0829791, 0829986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; Direct For Biological Sciences [0829986, 0829763] Funding Source: National Science Foundation; Division Of Environmental Biology [0829791] Funding Source: National Science Foundation	National Science Foundation's Assembling the Tree of Life Program; DEB award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation's Assembling the Tree of Life Program (http://www.nsf.gov/funding/pgm_summ.jsp?pims_ id = 5129; DEB awards 0829763, 0829783, 0829791, and 0829986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez B, 2000, ZOOL SCR, V29, P169, DOI 10.1046/j.1463-6409.2000.00029.x; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2000, HYDROBIOLOGIA, V420, P15, DOI 10.1023/A:1003996517083; Brain C, 2012, S AFR J SCI, V108, P658; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018318; CHOMBARD C, 1998, THESIS MUSEUM NATL H; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Cummins CA, 2011, SYST BIOL, V60, P833, DOI 10.1093/sysbio/syr064; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Paula TS, 2012, MOL PHYLOGENET EVOL, V62, P529, DOI 10.1016/j.ympev.2011.11.001; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Drummond A. J., 2006, GENEIOUS V1 2 1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1571, DOI 10.1017/S0025315407058201; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1563, DOI 10.1017/S0025315407058195; Erpenbeck D, 2012, MOL PHYLOGENET EVOL, V63, P809, DOI 10.1016/j.ympev.2012.02.024; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Ferrario F, 2010, ORG DIVERS EVOL, V10, P275, DOI 10.1007/s13127-010-0027-x; Fortunato S, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-14; Gazave E, 2010, MOL PHYLOGENET EVOL, V57, P35, DOI 10.1016/j.ympev.2010.05.028; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HAJDU E, 1994, SPONGES IN TIME AND SPACE, P123; Hajdu E, 1999, MEM QUEENSLAND MUS, V44, P225; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI; Hooper JNA, 2002, SYSTEMA PORIFERA GUI, P169; Itskovich Valeria, 2007, V28, P383; Kelly-Borges Michelle, 1994, Molecular Marine Biology and Biotechnology, V3, P87; Kober KM, 2007, J MAR BIOL ASSOC UK, V87, P1585, DOI 10.1017/S0025315407058237; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; LAFAY B, 1992, BIOSYSTEMS, V28, P139, DOI 10.1016/0303-2647(92)90016-R; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Ma J, 2007, ACTA PALAEONTOLOGICA, V46, P480; Maldonado M., 2002, SYSTEMA PORIFERA GUI, P141, DOI DOI 10.1007/978-1-4615-0747-5_15; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; McCormack GP, 2002, J ZOOL SYST EVOL RES, V40, P237, DOI 10.1046/j.1439-0469.2002.00204.x; Milsom C., 2010, FOSSILS GLANCE; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Negandhi K, 2010, SYMBIOSIS, V51, P117, DOI 10.1007/s13199-010-0059-1; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pisani D, 2002, SYST BIOL, V51, P151, DOI 10.1080/106351502753475925; Pisera A., 2002, SYSTEMA PORIFERA GUI, P299, DOI DOI 10.1007/978-1-4615-0747-5_33; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Raleigh J, 2007, J MAR BIOL ASSOC UK, V87, P1577, DOI 10.1017/S0025315407058341; Rao JV, 2009, ENVIRON MONIT ASSESS, V156, P451, DOI 10.1007/s10661-008-0497-x; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; Reed John K., 1997, P1387; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rutzler K, 1990, 3 INT C BIOL SPONG, P344; Rutzler Klaus, 2000, Zoosystema, V22, P337; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Vacelet Jean, 2000, Zoosystema, V22, P313; Van Soest R.W.M., 2002, SYSTEMA PORIFERA GUI, P831; van Soest RWM, 2012, WORLD PORIFERA DATAB; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; West Lani, 1993, Molecular Marine Biology and Biotechnology, V2, P71; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	89	37	38	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50437	10.1371/journal.pone.0050437	http://dx.doi.org/10.1371/journal.pone.0050437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372644	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500004
J	Lakshmi, PS; Verma, D; Yang, XD; Lloyd, B; Daniell, H				Lakshmi, Priya Saikumar; Verma, Dheeraj; Yang, Xiangdong; Lloyd, Bethany; Daniell, Henry			Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro	PLOS ONE			English	Article							TOXIN-B-SUBUNIT; HEAT-LABILE ENTEROTOXIN; MYCOBACTERIUM-TUBERCULOSIS; ORAL DELIVERY; ESCHERICHIA-COLI; CHOLERA-TOXIN; FUSION PROTEIN; THERAPEUTIC PROTEINS; TOBACCO CHLOROPLASTS; POLYPROTEIN VACCINE	Tuberculosis (TB) caused by Mycobacterium tuberculosis is one of the leading fatal infectious diseases. The development of TB vaccines has been recognized as a major public health priority by the World Health Organization. In this study, three candidate antigens, ESAT-6 (6kDa early secretory antigenic target) and Mtb72F (a fusion polyprotein from two TB antigens, Mtb32 and Mtb39) fused with cholera toxin B-subunit (CTB) and LipY (a cell wall protein) were expressed in tobacco and/or lettuce chloroplasts to facilitate bioencapsulation/oral delivery. Site-specific transgene integration into the chloroplast genome was confirmed by Southern blot analysis. In transplastomic leaves, CTB fusion proteins existed in soluble monomeric or multimeric forms of expected sizes and their expression levels varied depending upon the developmental stage and time of leaf harvest, with the highest-level of accumulation in mature leaves harvested at 6PM. The CTB-ESAT6 and CTB-Mtb72F expression levels reached up to 7.5% and 1.2% of total soluble protein respectively in mature tobacco leaves. Transplastomic CTB-ESAT6 lettuce plants accumulated up to 0.75% of total leaf protein. Western blot analysis of lyophilized lettuce leaves stored at room temperature for up to six months showed that the CTB-ESAT6 fusion protein was stable and preserved proper folding, disulfide bonds and assembly into pentamers for prolonged periods. Also, antigen concentration per gram of leaf tissue was increased 22 fold after lyophilization. Hemolysis assay with purified CTB-ESAT6 protein showed partial hemolysis of red blood cells and confirmed functionality of the ESAT-6 antigen. GM1-binding assay demonstrated that the CTB-ESAT6 fusion protein formed pentamers to bind with the GM1-ganglioside receptor. The expression of functional Mycobacterium tuberculosis antigens in transplastomic plants should facilitate development of a cost-effective and orally deliverable TB booster vaccine with potential for long-term storage at room temperature. To our knowledge, this is the first report of expression of TB vaccine antigens in chloroplasts.	[Lakshmi, Priya Saikumar; Verma, Dheeraj; Yang, Xiangdong; Lloyd, Bethany; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019	Daniell, Henry/0000-0003-4485-1176; Saikumar lakshmi, Priya/0000-0001-9446-5770	National Institutes of Health [NIH R01 GM 63879, NIH R01 HL 107904]; Bill and Melinda Gates Foundation [OPP 1031406]; JDRF [17-2011-286]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JDRF(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health NIH R01 GM 63879, NIH R01 HL 107904, Bill and Melinda Gates Foundation Global Health grant OPP 1031406 and JDRF grant 17-2011-286 to Dr. Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; [Anonymous], 2011, GLOB TUB CONTR; Arlen PA, 2008, INFECT IMMUN, V76, P3640, DOI 10.1128/IAI.00050-08; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Boyhan D, 2011, PLANT BIOTECHNOL J, V9, P585, DOI 10.1111/j.1467-7652.2010.00582.x; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; BREWER TF, 1995, CLIN INFECT DIS, V20, P126, DOI 10.1093/clinids/20.1.126; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Cheng L, 2010, PLANT CELL REP, V29, P371, DOI 10.1007/s00299-010-0828-6; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Coler RN, 2009, VACCINE, V27, P223, DOI 10.1016/j.vaccine.2008.10.056; Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Davoodi-Semiromi A, 2010, PLANT BIOTECHNOL J, V8, P223, DOI 10.1111/j.1467-7652.2009.00479.x; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Derrick SC, 2004, VACCINE, V23, P780, DOI 10.1016/j.vaccine.2004.07.036; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dorokhov YL, 2007, TUBERCULOSIS, V87, P218, DOI 10.1016/j.tube.2006.10.001; Soria-Guerra RE, 2009, PLANTA, V229, P1293, DOI 10.1007/s00425-009-0918-2; Gisby MF, 2011, PLANT BIOTECHNOL J, V9, P618, DOI 10.1111/j.1467-7652.2011.00619.x; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Kumar M, 2010, TUBERCULOSIS, V90, P60, DOI 10.1016/j.tube.2009.10.003; Kupferschmidt K, 2011, SCIENCE, V334, P1488, DOI 10.1126/science.334.6062.1488; Kwon KC, 2012, ADV DRUG DELIV REV; Kwon KC, 2013, PLANT BIOTECHNOL J, V11, P77, DOI 10.1111/pbi.12008; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Ozeki Y, 2011, VACCINE, V29, P6881, DOI 10.1016/j.vaccine.2011.07.051; Penney CA, 2011, PLANT CELL REP, V30, P789, DOI 10.1007/s00299-010-0995-5; Pniewski T, 2011, J APPL GENET, V52, P125, DOI 10.1007/s13353-010-0001-5; Rigano MM, 2004, PLANT CELL REP, V22, P502, DOI 10.1007/s00299-003-0718-2; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; Rubio-Infante N, 2012, PLANT MOL BIOL, V78, P337, DOI 10.1007/s11103-011-9870-1; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Scotti N, 2012, BIOTECHNOL ADV, V30, P387, DOI 10.1016/j.biotechadv.2011.07.019; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Streatfield Stephen J, 2003, Expert Rev Vaccines, V2, P763, DOI 10.1586/14760584.2.6.763; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Triccas James A, 2010, Bioeng Bugs, V1, P110, DOI 10.4161/bbug.1.2.10483; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; TSUJI T, 1995, MICROBIOL IMMUNOL, V39, P817, DOI 10.1111/j.1348-0421.1995.tb03262.x; Tyagi AK, 2011, TUBERCULOSIS, V91, P469, DOI 10.1016/j.tube.2011.01.003; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Webster DE, 2006, VACCINE, V24, P3538, DOI 10.1016/j.vaccine.2006.02.002; Wilkins MR, 1999, METH MOL B, V112, P531; Xing Z, 2006, TUBERCULOSIS, V86, P211, DOI 10.1016/j.tube.2006.01.017; Yacono MD, 2012, PLANT BIOTECHNOL J, V10, P1136, DOI 10.1111/pbi.12001; Zelada AM, 2006, TUBERCULOSIS, V86, P263, DOI 10.1016/j.tube.2006.01.003	75	88	96	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54708	10.1371/journal.pone.0054708	http://dx.doi.org/10.1371/journal.pone.0054708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355891	Green Published, gold			2022-12-25	WOS:000314021500113
J	Verdugo, RA; Zeller, T; Rotival, M; Wild, PS; Munzel, T; Lackner, KJ; Weidmann, H; Ninio, E; Tregouet, DA; Cambien, F; Blankenberg, S; Tiret, L				Verdugo, Ricardo A.; Zeller, Tanja; Rotival, Maxime; Wild, Philipp S.; Muenzel, Thomas; Lackner, Karl J.; Weidmann, Henri; Ninio, Ewa; Tregouet, David-Alexandre; Cambien, Francois; Blankenberg, Stefan; Tiret, Laurence			Graphical Modeling of Gene Expression in Monocytes Suggests Molecular Mechanisms Explaining Increased Atherosclerosis in Smokers	PLOS ONE			English	Article							ENDOTHELIAL TRANSCRIPTIONAL PROFILES; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; 52 COUNTRIES; SMOKING; RISK; CORONARY; CELLS; LOCI	Smoking is a risk factor for atherosclerosis with reported widespread effects on gene expression in circulating blood cells. We hypothesized that a molecular signature mediating the relation between smoking and atherosclerosis may be found in the transcriptome of circulating monocytes. Genome-wide expression profiles and counts of atherosclerotic plaques in carotid arteries were collected in 248 smokers and 688 non-smokers from the general population. Patterns of co-expressed genes were identified by Independent Component Analysis (ICA) and network structure of the pattern-specific gene modules was inferred by the PC-algorithm. A likelihood-based causality test was implemented to select patterns that fit models containing a path "smoking -> gene expression -> plaques". Robustness of the causal inference was assessed by bootstrapping. At a FDR <= 0.10, 3,368 genes were associated to smoking or plaques, of which 93% were associated to smoking only. SASH1 showed the strongest association to smoking and PPARG the strongest association to plaques. Twenty-nine gene patterns were identified by ICA. Modules containing SASH1 and PPARG did not show evidence for the "smoking -> gene expression -> plaques" causality model. Conversely, three modules had good support for causal effects and exhibited a network topology consistent with gene expression mediating the relation between smoking and plaques. The network with the strongest support for causal effects was connected to plaques through SLC39A8, a gene with known association to HDL-cholesterol and cellular uptake of cadmium from tobacco, while smoking was directly connected to GAS6, a gene reported to have anti-inflammatory effects in atherosclerosis and to be up-regulated in the placenta of women smoking during pregnancy. Our analysis of the transcriptome of monocytes recovered genes relevant for association to smoking and atherosclerosis, and connected genes that before, were only studied in separate contexts. Inspection of correlation structure revealed candidates that would be missed by expression-phenotype association analysis alone.	[Verdugo, Ricardo A.; Rotival, Maxime; Weidmann, Henri; Ninio, Ewa; Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence] Univ Paris 06, INSERM, UMR S 937, Paris, France; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Muenzel, Thomas] Univ Med Ctr Mainz, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Thrombosis & Haemostasis, Mainz, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Verdugo, Ricardo A.] Univ Chile, Sch Med, Human Genet Program, Santiago, Chile; [Rotival, Maxime] Imperial Coll London, Hammersmith Hosp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Universidad de Chile; Imperial College London	Tiret, L (corresponding author), Univ Paris 06, INSERM, UMR S 937, Paris, France.	laurence.tiret@upmc.fr	Trégouët, David-Alexandre/P-9210-2019; Munzel, Thomas/A-2912-2014; Tregouet, David-Alexandre/E-3961-2016; Wild, Philipp S./M-2106-2019; Verdugo, Ricardo A/A-3970-2013; Cambien, Francois/AAP-9751-2020	Trégouët, David-Alexandre/0000-0001-9084-7800; Munzel, Thomas/0000-0001-5503-4150; Wild, Philipp/0000-0003-4413-9752; Verdugo, Ricardo/0000-0001-5668-5449; Zeller, Tanja/0000-0003-3379-2641; Rotival, Maxime/0000-0003-2519-8044	government of Rheinland-Pfalz [AZ 961-386261/733]; research programs "Wissen schafft Zukunft"; "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Gutenberg Health Study; National Genome Network "NGFNplus" [A3 01GS0833]; Federal Ministry of Education and Research, Germany [BMBF 01KU0908A]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; Fondation pour la Recherche Medicale; Region Ile-de-France	government of Rheinland-Pfalz; research programs "Wissen schafft Zukunft"; "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Gutenberg Health Study; National Genome Network "NGFNplus"; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France)	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation, contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. Specifically, the research reported in this article was supported by the National Genome Network "NGFNplus" by the Federal Ministry of Education and Research, Germany (contract number project A3 01GS0833) and by a joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A) and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01) for the project CARDomics. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale and the Region Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2002, CAUSE CORRELATION BI; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Burridge KA, 2010, AM J PHYSIOL-HEART C, V299, pH837, DOI 10.1152/ajpheart.00002.2010; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Carey V, 2010, RBGL INTERFACE BOOST; Charlesworth JC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-29; Chickering D. M., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P87; Clauser S, 2012, THROMB HAEMOSTASIS, V107, P140, DOI 10.1160/TH11-05-0368; Conway DE, 2009, CARDIOVASC RES, V81, P669, DOI 10.1093/cvr/cvn360; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gastaldelli A, 2010, CURR PHARM DESIGN, V16, P2526, DOI 10.2174/138161210792062858; Hardin J. W., 2007, GEN LINEAR MODELS EX, DOI DOI 10.1016/j.marpol.2012.12.026; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Lunceford JK, 2011, PHARM STAT, V10, P302, DOI 10.1002/pst.466; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marchini JL, 2010, FASTICA FASTICA ALGO; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; MCGILL HC, 1990, ADV EXP MED BIOL, V273, P9; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Murphy K.P., 1998, INFERENCE LEARNING H; Napolitano JR, 2012, AM J PHYSL LUNG CELL; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Neter J., 1996, APPL LINEAR STAT MOD; Norata GD, 2011, CURR OPIN LIPIDOL, V22, P410, DOI 10.1097/MOL.0b013e32834adac3; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 2010, SOCIOL METHODOL, V40, P75, DOI 10.1111/j.1467-9531.2010.01228.x; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Sales G, 2011, BIOINFORMATICS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spirtes P, 2001, CAUSATION PREDICTION; Spirtes P, 2010, J MACH LEARN RES, V11, P1643; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tjwa M, 2009, CURR OPIN LIPIDOL, V20, P386, DOI 10.1097/MOL.0b013e328330982e; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120; Yang Q, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S12; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang J, 2008, AM J PHYSIOL-HEART C, V295, pH1556, DOI 10.1152/ajpheart.00540.2008; Zhou YP, 2011, BIOL REPROD, V84, P1242, DOI 10.1095/biolreprod.110.087494	64	28	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50888	10.1371/journal.pone.0050888	http://dx.doi.org/10.1371/journal.pone.0050888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372645	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500005
J	Weng, S; Sprague, JE; Oh, J; Riek, AE; Chin, K; Garcia, M; Bernal-Mizrachi, C				Weng, Sherry; Sprague, Jennifer E.; Oh, Jisu; Riek, Amy E.; Chin, Kathleen; Garcia, Miguel; Bernal-Mizrachi, Carlos			Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MACROPHAGE DIFFERENTIATION; INSULIN-RESISTANCE; NATIONAL-HEALTH; RISK; 25-HYDROXYVITAMIN-D; HYPERTENSION; ACTIVATION; CALCIUM; CELLS	Multiple epidemiological studies link vitamin D deficiency to increased cardiovascular disease (CVD), but causality and possible mechanisms underlying these associations are not established. To clarify the role of vitamin D-deficiency in CVD in vivo, we generated mouse models of diet-induced vitamin D deficiency in two backgrounds (LDL receptor-and ApoE-null mice) that resemble humans with diet-induced hypertension and atherosclerosis. Mice were fed vitamin D-deficient or sufficient chow for 6 weeks and then switched to high fat (HF) vitamin D-deficient or -sufficient diet for 8-10 weeks. Mice with diet-induced vitamin D deficiency showed increased systolic and diastolic blood pressure, high plasma renin, and decreased urinary sodium excretion. Hypertension was reversed and renin was suppressed by returning chow-fed vitamin D-deficient mice to vitamin D-sufficient chow diet for 6 weeks. On a HF diet, vitamin D-deficient mice had similar to 2-fold greater atherosclerosis in the aortic arch and similar to 2-8-fold greater atherosclerosis in the thoracic and abdominal aorta compared to vitamin D-sufficient mice. In the aortic root, HF-fed vitamin D-deficient mice had increased macrophage infiltration with increased fat accumulation and endoplasmic reticulum (ER) stress activation, but a lower prevalence of the M1 macrophage phenotype within atherosclerotic plaques. Similarly, peritoneal macrophages from vitamin D-deficient mice displayed an M2-predominant phenotype with increased foam cell formation and ER stress. Treatment of vitamin D-deficient mice with the ER stress reliever PBA during HF feeding suppressed atherosclerosis, decreased peritoneal macrophage foam cell formation, and downregulated ER stress proteins without changing blood pressure. Thus, we suggest that vitamin D deficiency activates both the renin angiotensin system and macrophage ER stress to contribute to the development of hypertension and accelerated atherosclerosis, highlighting vitamin D replacement as a potential therapy to reduce blood pressure and atherosclerosis.	[Weng, Sherry] Washington Univ, Dept Anesthesiol, St Louis, MO USA; [Sprague, Jennifer E.] Washington Univ, Div Pediat Endocrinol & Diabet, St Louis, MO USA; [Oh, Jisu; Riek, Amy E.; Chin, Kathleen; Garcia, Miguel; Bernal-Mizrachi, Carlos] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bernal-Mizrachi, C (corresponding author), Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA.	cbernal@dom.wustl.edu		Bernal-Mizrachi, Carlos/0000-0002-8991-7522	National Institutes of Health (NIH) [R01HL094818-0, P30DK079333, P60 DK 20569, P30 DK56341]; Children's Discovery Institute [CH-II-2012-209]; NIH under Ruth L. Kirschstein National Research Service Award from the NICHD [2 T32 HD043010]; NIH from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000448, KL2TR000450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, P30DK056341, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NIH under Ruth L. Kirschstein National Research Service Award from the NICHD; NIH from the National Center for Advancing Translational Sciences (NCATS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) R01HL094818-0, P30DK079333, P60 DK 20569, P30 DK56341 and the Children's Discovery Institute CH-II-2012-209. JES is supported by the NIH under Ruth L. Kirschstein National Research Service Award 2 T32 HD043010 from the NICHD. AER is supported by NIH UL1TR000448/Sub-Award KL2TR000450 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Borges ACR, 1999, BRIT J PHARMACOL, V127, P772, DOI 10.1038/sj.bjp.0702581; Bories G, 2012, DIABETES VASC DIS RE, V9, P189, DOI 10.1177/1479164111430242; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; CHOBANIAN AV, 1989, HYPERTENSION, V14, P203, DOI 10.1161/01.HYP.14.2.203; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2008, FASEB J, V22; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Navarro H, 2007, FRONT BIOSCI-LANDMRK, V12, P4439, DOI 10.2741/2400; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6; Kreisberg RA, 2002, J CLIN ENDOCR METAB, V87, P423, DOI 10.1210/jc.87.2.423; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Ma YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035835; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagao T, 2007, ARTERIOSCL THROM VAS, V27, P1596, DOI 10.1161/ATVBAHA.107.145086; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Schrier RW, 2010, NAT REV NEPHROL, V6, P61, DOI 10.1038/nrneph.2009.228; Stienstra R, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Weiss D, 2001, CIRCULATION, V103, P448; Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	70	94	100	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54625	10.1371/journal.pone.0054625	http://dx.doi.org/10.1371/journal.pone.0054625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349943	Green Published, gold			2022-12-25	WOS:000314019100086
J	Dorenkamp, M; Morguet, AJ; Sticherling, C; Behrens, S; Zabel, M				Dorenkamp, Marc; Morguet, Andreas J.; Sticherling, Christian; Behrens, Steffen; Zabel, Markus			Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; PROGRAMMED VENTRICULAR STIMULATION; MONOPHASIC ACTION-POTENTIALS; T-WAVE ALTERNANS; ELECTRICAL RESTITUTION; CYCLE LENGTH; CARDIAC RESTITUTION; IN-VIVO; FIBRILLATION; HEART	Background: An action potential duration (APD) restitution curve with a steep slope >= 1 has been associated with increased susceptibility for malignant ventricular arrhythmias. We aimed to evaluate the "restitution hypothesis" and tested ventricular APD restitution slope as well as effective refractory period (ERP)/APD ratio for long-term prognostic value in patients with ischemic (ICM) or dilated cardiomyopathy (DCM). Methodology/Principal Findings: Monophasic action potentials were recorded in patients with ICM (n = 32) and DCM (n = 42) undergoing routine programmed ventricular stimulation (PVS). Left ventricular ejection fraction was 32 +/- 7% and 28 +/- 9%, respectively. APD and ERP were measured at baseline stimulation (S-1) and upon introduction of one to three extrastimuli (S-2-S-4). ERP/APD ratios and the APD restitution curve were calculated and the maximum restitution slope was determined. After a mean follow-up of 6.1 +/- 3.0 years, the combined end-point of mortality and and/or implantable cardioverter-defibrillator shock was not predicted by restitution slope or ERP/APD ratios. Comparing S-2 vs. S-3 vs. S-4 extrastimuli for restitution slope (1.5 +/- 0.6 vs. 1.4 +/- 0.4 vs. 1.3 +/- 0.5; p = NS), additional extrastimuli did not lead to a steepening restitution slope. ERP/APD ratio decreased with additional extrastimuli (0.98 +/- 0.09 [S-1] vs. 0.97 +/- 0.10 [S-2] vs. 0.93 +/- 0.11 [S-3]; p = 0.03 S-1 vs. S-3). Positive PVS was strongly predictive of outcome (p = 0.006). Conclusions/Significance: Neither ventricular APD restitution slope nor ERP/APD ratios predict outcome in patients with ICM or DCM.	[Dorenkamp, Marc] Charite, Dept Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Morguet, Andreas J.] Charite, Dept Cardiol & Pulmonol, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Sticherling, Christian] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Behrens, Steffen] Vivantes Humboldt Klinikum, Dept Cardiol, Berlin, Germany; [Zabel, Markus] Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dorenkamp, M (corresponding author), Charite, Dept Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	marc.dorenkamp@charite.de	Sticherling, Christian/AAY-4435-2021	Sticherling, Christian/0000-0001-8428-7050				Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Bode F, 2002, J AM COLL CARDIOL, V40, P731, DOI 10.1016/S0735-1097(02)02008-9; Bode F, 2001, J AM COLL CARDIOL, V37, P920, DOI 10.1016/S0735-1097(00)01189-X; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; FRANZ MR, 1995, PACE, V18, P1666, DOI 10.1111/j.1540-8159.1995.tb06988.x; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Grimm W, 1998, J AM COLL CARDIOL, V32, P739, DOI 10.1016/S0735-1097(98)00306-4; HAWS CW, 1990, CIRCULATION, V81, P281, DOI 10.1161/01.CIR.81.1.281; HUMMEL JD, 1994, CIRCULATION, V90, P2827, DOI 10.1161/01.CIR.90.6.2827; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Koller ML, 2005, CIRCULATION, V112, P1542, DOI 10.1161/CIRCULATIONAHA.104.502831; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; KURZ RW, 1994, EUR HEART J, V15, P547, DOI 10.1093/oxfordjournals.eurheartj.a060541; KURZ RW, 1993, EUR HEART J, V14, P1410, DOI 10.1093/eurheartj/14.10.1410; Lee SD, 1997, J AM COLL CARDIOL, V29, P100, DOI 10.1016/S0735-1097(96)00423-8; MADIT Executive Committee Multicenter Automatic Defibrillator, 1991, PACE, V14, P920; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Selvaraj RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1262, DOI 10.1152/ajpheart.00913.2006; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Xie FG, 2004, J CLIN INVEST, V113, P686, DOI 10.1172/JCI200417341; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zrenner B, 2000, PACE, V23, P54, DOI 10.1111/j.1540-8159.2000.tb00650.x	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54768	10.1371/journal.pone.0054768	http://dx.doi.org/10.1371/journal.pone.0054768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349967	Green Published, gold, Green Submitted			2022-12-25	WOS:000313872800077
J	Talaveron, R; Matarredona, ER; de la Cruz, RR; Pastor, AM				Talaveron, Rocio; Matarredona, Esperanza R.; de la Cruz, Rosa R.; Pastor, Angel M.			Neural Progenitor Cell Implants Modulate Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor Expression in Rat Axotomized Neurons	PLOS ONE			English	Article							ABDUCENS INTERNUCLEAR NEURONS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STEM-CELLS; MESSENGER-RNA; ADULT CAT; EXTRAOCULAR MOTONEURONS; CORTICOSPINAL NEURONS; SYNAPTIC COMPOSITION; SUBVENTRICULAR ZONE	Axotomy of central neurons leads to functional and structural alterations which largely revert when neural progenitor cells (NPCs) are implanted in the lesion site. The new microenvironment created by NPCs in the host tissue might modulate in the damaged neurons the expression of a high variety of molecules with relevant roles in the repair mechanisms, including neurotrophic factors. In the present work, we aimed to analyze changes in neurotrophic factor expression in axotomized neurons induced by NPC implants. For this purpose, we performed immunofluorescence followed by confocal microscopy analysis for the detection of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and nerve growth factor (NGF) on brainstem sections from rats with axotomy of abducens internuclear neurons that received NPC implants (implanted group) or vehicle injections (axotomized group) in the lesion site. Control abducens internuclear neurons were strongly immunoreactive to VEGF and BDNF but showed a weak staining for NT-3 and NGF. Comparisons between groups revealed that lesioned neurons from animals that received NPC implants showed a significant increase in VEGF content with respect to animals receiving vehicle injections. However, the immunoreactivity for BDNF, which was increased in the axotomized group as compared to control, was not modified in the implanted group. The modifications induced by NPC implants on VEGF and BDNF content were specific for the population of axotomized abducens internuclear neurons since the neighboring abducens motoneurons were not affected. Similar levels of NT-3 and NGF immunolabeling were obtained in injured neurons from axotomized and implanted animals. Among all the analyzed neurotrophic factors, only VEGF was expressed by the implanted cells in the lesion site. Our results point to a role of NPC implants in the modulation of neurotrophic factor expression by lesioned central neurons, which might contribute to the restorative effects of these implants.	[Talaveron, Rocio; Matarredona, Esperanza R.; de la Cruz, Rosa R.; Pastor, Angel M.] Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain	University of Sevilla	Pastor, AM (corresponding author), Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain.	ampastor@us.es	Matarredona, Esperanza R./E-6859-2010; Pastor, Angel M. M/A-6385-2010; Talaveron, Rocio/AAG-8792-2021	Pastor, Angel M. M/0000-0002-6213-7454; Matarredona, Esperanza R./0000-0002-2226-4686; Talaveron, Rocio/0000-0002-5068-9171; Rodriguez de la Cruz, Rosa Maria/0000-0001-5301-5108	Spain MEC-FEDER [BFU2009-07121]; Junta de Andalucia-FEDER [CVI-6053]	Spain MEC-FEDER; Junta de Andalucia-FEDER(Junta de Andalucia)	The study was funded by grants in Spain BFU2009-07121 and BFU2012-33975 from MEC-FEDER and CVI-6053 from Junta de Andalucia-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Benitez-Temino B, 2004, J COMP NEUROL, V473, P538, DOI 10.1002/cne.20095; Benitez-Temino B, 2003, NEUROSCIENCE, V118, P611, DOI 10.1016/S0306-4522(03)00003-4; Benitez-Temino B, 2002, J COMP NEUROL, V444, P324, DOI 10.1002/cne.10147; Buttner-Ennever JA, 2006, NEUROANATOMY OCULOMO; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Conner JM, 1997, J NEUROSCI, V17, P2295; de Carrizosa MADL, 2010, J NEUROSCI, V30, P8308, DOI 10.1523/JNEUROSCI.0719-10.2010; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; de la Cruz RR, 2000, J COMP NEUROL, V427, P391, DOI 10.1002/1096-9861(20001120)427:3<391::AID-CNE6>3.0.CO;2-E; de la Cruz RR, 1998, J COMP NEUROL, V390, P377, DOI 10.1002/(SICI)1096-9861(19980119)390:3<377::AID-CNE6>3.0.CO;2-Z; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Duprey-Diaz MV, 2003, BRAIN RES, V982, P54, DOI 10.1016/S0006-8993(03)02948-2; Fagerlund M, 2012, CELL TRANSPLANT, V21, P739, DOI 10.3727/096368911X612459; Giehl KM, 2001, REV NEUROSCIENCE, V12, P79; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Gulino R, 2004, BRAIN RES, V1013, P174, DOI 10.1016/j.brainres.2004.03.055; Imitola J, 2004, PHILOS T R SOC B, V359, P823, DOI 10.1098/rstb.2004.1474; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Lambrechts D, 2006, BBA-MOL BASIS DIS, V1762, P1109, DOI 10.1016/j.bbadis.2006.04.005; Lee PG, 2001, MOL BRAIN RES, V87, P31, DOI 10.1016/S0169-328X(00)00277-1; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; McCloskey DP, 2008, BRAIN RES BULL, V76, P36, DOI 10.1016/j.brainresbull.2007.11.018; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; Morado-Diaz CJ, 2011, ABSTR SOC NEUROSCI; Morcuende S, 2011, J COMP NEUROL, V519, P2335, DOI 10.1002/cne.22630; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Pastor AM, 2000, J COMP NEUROL, V427, P370, DOI 10.1002/1096-9861(20001120)427:3<370::AID-CNE5>3.0.CO;2-M; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pluchino S, 2010, ARCH ITAL BIOL, V148, P173; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; TITMUS MJ, 1990, PROG NEUROBIOL, V35, P1, DOI 10.1016/0301-0082(90)90039-J; Tonchev AB, 2007, NEUROSCIENCE, V144, P1425, DOI 10.1016/j.neuroscience.2006.10.052; Tonra JR, 1998, J NEUROSCI, V18, P4374; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Venero JL, 2000, EXP NEUROL, V161, P38, DOI 10.1006/exnr.1999.7243; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; ZHOU XF, 1994, BRAIN RES, V643, P162, DOI 10.1016/0006-8993(94)90022-1	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54519	10.1371/journal.pone.0054519	http://dx.doi.org/10.1371/journal.pone.0054519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349916	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800059
J	Blevin, P; Carravieri, A; Jaeger, A; Chastel, O; Bustamante, P; Cherel, Y				Blevin, Pierre; Carravieri, Alice; Jaeger, Audrey; Chastel, Olivier; Bustamante, Paco; Cherel, Yves			Wide Range of Mercury Contamination in Chicks of Southern Ocean Seabirds	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; GULLS LARUS-ARGENTATUS; TERNS STERNA-HIRUNDO; HEAVY-METAL CONCENTRATIONS; SKUAS CATHARACTA-SKUA; KERGUELEN-ISLANDS; COMMON TERNS; INDIAN-OCEAN; TROPHIC POSITION; FEEDING ECOLOGY	Using top predators as sentinels of the marine environment, Hg contamination was investigated within the large subantarctic seabird community of Kerguelen Islands, a remote area from the poorly known Southern Indian Ocean. Chicks of 21 sympatric seabirds presented a wide range of Hg concentrations, with the highest contaminated species containing similar to 102 times more feather Hg than the less contaminated species. Hence, Kerguelen seabirds encompass the whole range of chick feather Hg values that were previously collected worldwide in poorly industrialized localities. Using stable isotopes, the effects of foraging habitats (reflected by delta C-13) and trophic positions (reflected by delta N-15) on Hg concentrations were investigated. Species-related Hg variations were highly and positively linked to feather delta N-15 values, thus highlighting the occurrence of efficient Hg biomagnification processes within subantarctic marine trophic webs. By contrast, Hg contamination overall correlated poorly with feeding habitats, because of the pooling of species foraging within different isotopic gradients corresponding to distinct seabird habitats (benthic, pelagic, neritic and oceanic). However, when focusing on oceanic seabirds, Hg concentration was related to feather delta C-13 values, with species feeding in colder waters (lower delta C-13 values) south of Kerguelen Islands being less prone to be contaminated than species feeding in northern warmer waters (higher delta C-13 values). Within the context of continuous increase in global Hg emissions, Kerguelen Islands that are located far away from anthropogenic sources can be considered as an ideal study site to monitor the temporal trend of global Hg contamination. The present work helps selecting some seabird species as sentinels of environmental pollution according to their high Hg concentrations and their contrasted foraging ecology.	[Blevin, Pierre; Carravieri, Alice; Jaeger, Audrey; Chastel, Olivier; Cherel, Yves] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Bustamante, Paco] Univ La Rochelle, CNRS, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite	Cherel, Y (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	cherel@cebc.cnrs.fr	Bustamante, Paco/G-5833-2011	Bustamante, Paco/0000-0003-3877-9390; Jaeger, Audrey/0000-0002-5649-0315	Agence Nationale de la Recherche (program POLARTOP); Institut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes et Antarctiques Francaises (TAAF)	Agence Nationale de la Recherche (program POLARTOP)(French National Research Agency (ANR)); Institut Polaire Francais Paul Emile Victor (IPEV); Terres Australes et Antarctiques Francaises (TAAF)	Financial support was provided by the Agence Nationale de la Recherche (program POLARTOP, O. Chastel), the Institut Polaire Francais Paul Emile Victor (IPEV, program no. 109, H. Weimerskirch), and the Terres Australes et Antarctiques Francaises (TAAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2008, ECOTOXICOLOGY, V17, P789, DOI 10.1007/s10646-008-0237-6; Akaike H., 1973, P 2 INT S INF THEOR, V1, P267; Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bargagli R, 1998, MAR ECOL PROG SER, V169, P65, DOI 10.3354/meps169065; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Bearhop S, 2000, MAR ECOL PROG SER, V195, P261, DOI 10.3354/meps195261; Becker Peter H., 2000, Ornitologia Neotropical, V11, P165; BECKER PH, 1994, ARCH ENVIRON CON TOX, V27, P162; Becker PH, 2002, MAR ECOL PROG SER, V243, P261, DOI 10.3354/meps243261; Bocher P, 2003, POLAR BIOL, V26, P759, DOI 10.1007/s00300-003-0552-6; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Bond AL, 2009, SCI TOTAL ENVIRON, V407, P4340, DOI 10.1016/j.scitotenv.2009.04.018; Bond AL, 2009, ARCH ENVIRON CON TOX, V56, P286, DOI 10.1007/s00244-008-9185-7; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; BURGER J, 1995, ENVIRON TOXICOL CHEM, V14, P1233, DOI 10.1002/etc.5620140716; BURGER J, 1992, ARCH ENVIRON CON TOX, V23, P105; Burger J, 1996, AUK, V113, P399, DOI 10.2307/4088906; BURGER J, 1993, ENVIRON MONIT ASSESS, V24, P181, DOI 10.1007/BF00547986; BURGER J, 1994, ARCH ENVIRON CON TOX, V26, P351; Burger J, 1995, ENVIRON MONIT ASSESS, V38, P37, DOI 10.1007/BF00547125; Burger J, 1997, ENVIRON MONIT ASSESS, V48, P285, DOI 10.1023/A:1005760321417; Burger J, 2001, ENVIRON MONIT ASSESS, V71, P71, DOI 10.1023/A:1011695829296; Burger J, 1999, ENVIRON TOXICOL CHEM, V18, P673, DOI 10.1002/etc.5620180413; Burger J, 2000, ARCH ENVIRON CON TOX, V38, P254, DOI 10.1007/s002449910033; Burger J, 2000, ENVIRON RES, V82, P207, DOI 10.1006/enrs.1999.4015; Burger J, 2000, SCI TOTAL ENVIRON, V257, P37, DOI 10.1016/S0048-9697(00)00496-4; Burger J, 1997, ENVIRON RES, V75, P160, DOI 10.1006/enrs.1997.3778; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Burger J, 2009, ENVIRON MONIT ASSESS, V152, P179, DOI 10.1007/s10661-008-0306-6; Burger Joanna, 1994, Reviews in Environmental Toxicology, V5, P203; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Bustamante P, 2003, SCI TOTAL ENVIRON, V313, P25, DOI 10.1016/S0048-9697(03)00265-1; Catry T, 2008, MAR BIOL, V155, P637, DOI 10.1007/s00227-008-1060-6; Cherel Y, 2000, MAR ECOL PROG SER, V207, P183, DOI 10.3354/meps207183; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2002, MAR ECOL PROG SER, V228, P283, DOI 10.3354/meps228283; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Connan M, 2008, MAR ECOL PROG SER, V373, P123, DOI 10.3354/meps07723; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Delord Karine, 2010, Endangered Species Research, V13, P1, DOI 10.3354/esr00309; Ebinghaus R, 2002, ENVIRON SCI TECHNOL, V36, P1238, DOI 10.1021/es015710z; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FURNESS RW, 1995, HELGOLANDER MEERESUN, V49, P605, DOI 10.1007/BF02368386; FURNESS RW, 1986, MAR POLLUT BULL, V17, P27, DOI 10.1016/0025-326X(86)90801-5; GOCHFELD M, 1980, ENVIRON POLLUT A, V22, P197, DOI 10.1016/0143-1471(80)90014-8; GOCHFELD M, 1980, MAR POLLUT BULL, V11, P362, DOI 10.1016/0025-326X(80)90284-2; Gochfeld M, 1999, ENVIRON MONIT ASSESS, V59, P343, DOI 10.1023/A:1006134125236; Goutner V, 2000, ARCH ENVIRON CON TOX, V39, P200, DOI 10.1007/s002440010097; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; Hindell MA, 1999, POLAR BIOL, V22, P102, DOI 10.1007/s003000050396; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kahle S, 1999, CHEMOSPHERE, V39, P2451, DOI 10.1016/S0045-6535(99)00154-X; Kim EY, 1996, ARCH ENVIRON CON TOX, V30, P259; Kojadinovic J, 2007, SCI TOTAL ENVIRON, V384, P194, DOI 10.1016/j.scitotenv.2007.05.018; Lancelot R., 2005, SELECTION MODELES AV; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lescroel A, 2005, MAR ECOL PROG SER, V302, P245, DOI 10.3354/meps302245; LEWIS SA, 1991, ARCH ENVIRON CON TOX, V21, P316, DOI 10.1007/BF01055352; LOCK JW, 1992, ENVIRON POLLUT, V75, P289, DOI 10.1016/0269-7491(92)90129-X; MONTEIRO LR, 1995, ARCH ENVIRON CON TOX, V28, P304, DOI 10.1007/BF00213106; Monteiro LR, 1996, MAR ECOL PROG SER, V141, P21, DOI 10.3354/meps141021; MONTEIRO LR, 1995, WATER AIR SOIL POLL, V80, P851, DOI 10.1007/BF01189736; Monteiro LR, 1999, MAR ENVIRON RES, V47, P137, DOI 10.1016/S0141-1136(98)00110-X; Monticelli D, 2008, WATERBIRDS, V31, P231, DOI 10.1675/1524-4695(2008)31[231:DAFEOR]2.0.CO;2; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Moreno R, 2011, MAR ECOL PROG SER, V442, P229, DOI 10.3354/meps09420; Mougeot F, 1998, J ZOOL, V244, P429, DOI 10.1017/S0952836998003136; MUIRHEAD SJ, 1988, MAR POLLUT BULL, V19, P278, DOI 10.1016/0025-326X(88)90599-1; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Nisbet ICT, 2002, MAR ECOL PROG SER, V242, P267, DOI 10.3354/meps242267; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1997, DEEP-SEA RES PT II, V44, P963, DOI 10.1016/S0967-0645(97)00004-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Development Core Team, 2008, LANG ENV STAT COMP; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Sanpera C, 2007, CONDOR, V109, P268, DOI 10.1650/0010-5422(2007)109[268:MASIIF]2.0.CO;2; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Selin NE, 2009, ANNU REV ENV RESOUR, V34, P43, DOI 10.1146/annurev.environ.051308.084314; Stahl J.-C., 1986, Oiseau et la Revue Francaise d'Ornithologie, V56, P287; Stewart FM, 1997, MAR ECOL PROG SER, V151, P237, DOI 10.3354/meps151237; Stewart FM, 1999, MAR ECOL PROG SER, V178, P295, DOI 10.3354/meps178295; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Tavares PC, 2007, ARDEOLA, V54, P275; Tavares PC, 2005, B ENVIRON CONTAM TOX, V74, P177, DOI 10.1007/s00128-004-0565-z; THOMPSON DR, 1993, POLAR BIOL, V13, P239; THOMPSON DR, 1989, MAR POLLUT BULL, V20, P577, DOI 10.1016/0025-326X(89)90361-5; THOMPSON DR, 1993, J APPL ECOL, V30, P316, DOI 10.2307/2404633; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Watanabe YY, 2011, J EXP BIOL, V214, P412, DOI 10.1242/jeb.050161; WEIMERSKIRCH H, 1989, EMU, V89, P15, DOI 10.1071/MU9890015; WENZEL C, 1995, ARCH ENVIRON CON TOX, V29, P198	100	86	86	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54508	10.1371/journal.pone.0054508	http://dx.doi.org/10.1371/journal.pone.0054508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349912	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900074
J	Streets, AM; Sourigues, Y; Kopito, RR; Melki, R; Quake, SR				Streets, Aaron M.; Sourigues, Yannick; Kopito, Ron R.; Melki, Ronald; Quake, Stephen R.			Simultaneous Measurement of Amyloid Fibril Formation by Dynamic Light Scattering and Fluorescence Reveals Complex Aggregation Kinetics	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; MUTANT HUNTINGTIN; THIOFLAVIN-T; MECHANISM; NUCLEATION; PROTEINS; PROTOFIBRILS; INCLUSIONS; BINDING; FUSION	An apparatus that combines dynamic light scattering and Thioflavin T fluorescence detection is used to simultaneously probe fibril formation in polyglutamine peptides, the aggregating subunit associated with Huntington's disease, in vitro. Huntington's disease is a neurodegenerative disorder in a class of human pathologies that includes Alzheimer's and Parkinson's disease. These pathologies are all related by the propensity of their associated protein or polypeptide to form insoluble, beta-sheet rich, amyloid fibrils. Despite the wide range of amino acid sequence in the aggregation prone polypeptides associated with these diseases, the resulting amyloids display strikingly similar physical structure, an observation which suggests a physical basis for amyloid fibril formation. Thioflavin T fluorescence reports beta-sheet fibril content while dynamic light scattering measures particle size distributions. The combined techniques allow elucidation of complex aggregation kinetics and are used to reveal multiple stages of amyloid fibril formation.	[Streets, Aaron M.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sourigues, Yannick; Melki, Ronald] Ctr Natl Rech Sci, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	quake@stanford.edu			Stanford DARE Fellowship; Agence Nationale de la Recherche [ANR-08-NEUR-001-01, ANR-09-MNPS-013-01]; CNRS; NINDS; Human Frontier Science Program; Huntington's Disease Society of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	Stanford DARE Fellowship; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program(Human Frontier Science Program); Huntington's Disease Society of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AMS was supported by the Stanford DARE Fellowship. YS and RM were supported by the Agence Nationale de la Recherche (ANR-08-NEUR-001-01 and ANR-09-MNPS-013-01) and the CNRS. This work was also supported by grants from the NINDS, the Human Frontier Science Program, and the Huntington's Disease Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Jayaraman M, 2011, METHODS, V53, P246, DOI 10.1016/j.ymeth.2011.01.001; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Pecora R, 2000, DYNAMIC LIGHT SCATTE; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; RICKA J, 1993, APPL OPTICS, V32, P2860, DOI 10.1364/AO.32.002860; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Streets AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178102; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	33	57	57	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54541	10.1371/journal.pone.0054541	http://dx.doi.org/10.1371/journal.pone.0054541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349924	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900076
J	Downs, CA; Kumar, A; Kreiner, LH; Johnson, NM; Helms, MN				Downs, Charles A.; Kumar, Amrita; Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.			H2O2 Regulates Lung Epithelial Sodium Channel (ENaC) via Ubiquitin-like Protein Nedd8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; REDOX REGULATION; ALPHA-SUBUNIT; TRANSPORT; CELLS; SGK1; PHOSPHORYLATION; ARCHITECTURE; DEGRADATION; INHIBITION	Redundancies in both the ubiquitin and epithelial sodium transport pathways allude to their importance of proteolytic degradation and ion transport in maintaining normal cell function. The classical pathway implicated in ubiquitination of the epithelial sodium channel (ENaC) involves Nedd4-2 regulation of sodium channel subunit expression and has been studied extensively studied. However, less attention has been given to the role of the ubiquitin-like protein Nedd8. Here we show that Nedd8 plays an important role in the ubiquitination of ENaC in alveolar epithelial cells. We report that the Nedd8 pathway is redox-sensitive and that under oxidizing conditions Nedd8 conjugation to Cullin-1 is attenuated, resulting in greater surface expression of alpha-ENaC. This observation was confirmed in our electrophysiology studies in which we inhibited Nedd8-activating enzyme using MLN4924 (a specific Nedd8-activating enzyme inhibitor) and observed a marked increase in ENaC activity (measured as the product of the number of channels (N) and the open probability (Po) of a channel). These results suggest that ubiquitination of lung ENaC is redox-sensitive and may have significant implications for our understanding of the role of ENaC in pulmonary conditions where oxidative stress occurs, such as pulmonary edema and acute lung injury.	[Downs, Charles A.] Emory Univ, Sch Med, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Sch Med, Dept Pediat, Ctr Dev Lung Biol, Atlanta, GA 30322 USA; [Downs, Charles A.; Kumar, Amrita; Kreiner, Lisa H.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Helms, MN (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr Dev Lung Biol, 2015 Uppergate Dr NE,316-K, Atlanta, GA 30322 USA.	mhelms@emory.edu						Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Gao DM, 2010, PROTEIN CELL, V1, P881, DOI 10.1007/s13238-010-0123-x; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; Hummler E, 1996, KIDNEY BLOOD PRESS R, V19, P160, DOI 10.1159/000174065; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kumar A., 2011, FASEB J, V22, P328; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Lazrak A, 2012, AM J RESP CELL MOL, V46, P342, DOI 10.1165/rcmb.2011-0309OC; Lazrak A, 2011, AM J PHYSIOL-LUNG C, V301, pL557, DOI 10.1152/ajplung.00094.2011; Li T, 2009, AM J PHYSIOL-LUNG C, V296, pL527, DOI 10.1152/ajplung.90506.2008; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Rafii B, 1998, AM J PHYSIOL-LUNG C, V275, pL764, DOI 10.1152/ajplung.1998.275.4.L764; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, CURR OPIN NEPHROL HY, V6, P447, DOI 10.1097/00041552-199709000-00007; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; Xu H, 2007, AM J PHYSIOL-LUNG C, V293, pL1454, DOI 10.1152/ajplung.00248.2007; Yu L, 2008, AM J PHYSIOL-RENAL, V295, pF1519, DOI 10.1152/ajprenal.00605.2007; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	43	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8136	8145		10.1074/jbc.M112.389536	http://dx.doi.org/10.1074/jbc.M112.389536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362276	Green Published, hybrid			2022-12-25	WOS:000316564500014
J	Eapen, A; Kulkarni, R; Ravindran, S; Ramachandran, A; Sundivakkam, P; Tiruppathi, C; George, A				Eapen, Asha; Kulkarni, Roma; Ravindran, Sriram; Ramachandran, Amsaveni; Sundivakkam, Premanand; Tiruppathi, Chinnaswammy; George, Anne			Dentin Phosphophoryn Activates Smad Protein Signaling through Ca2+-Calmodulin-dependent Protein Kinase II in Undifferentiated Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOPROTEIN; EXPRESSION; INHIBITOR; GENE; DPP; DIFFERENTIATION; SIALOPROTEIN; GROWTH; KN-62; BMP	Dentin phosphophoryn (DPP) is a major noncollagenous protein in the dentin matrix. In this study, we demonstrate that pluripotent stem cells such as C3H10T1/2 and human bone marrow cells can be committed to the osteogenic lineage by DPP. Treatment with DPP can stimulate the release of intracellular Ca2+. This calcium flux triggered the activation of Ca2+-calmodulin-dependent protein kinase II (CaMKII). Activated CaMKII induced the phosphorylation of Smad1 and promoted nuclear translocation of p-Smad1. Inhibition of store Ca2+ depletion by 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester) or down-regulation of CaMKII by KN-62, a selective cell-permeable pharmacological inhibitor or a dominant negative plasmid of CaMKII, blocked DPP-mediated Smad1 phosphorylation. Activation of Smad1 resulted in the expression of osteogenic markers such as Runx2, Osterix, DMP1, Bone sialoprotein, Osteocalcin, NFATc1, and Schnurri-2, which have been implicated in osteoblast differentiation. These findings suggest that DPP is capable of triggering commitment of pluripotent stem cells to the osteogenic lineage.	[Eapen, Asha; Kulkarni, Roma; Ravindran, Sriram; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Sundivakkam, Premanand; Tiruppathi, Chinnaswammy] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 19633]; Brodie Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 19633. This work was also supported by The Brodie Endowment Fund.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931; Eapen A, 2012, CELL ADHES MIGR, V6, P307, DOI 10.4161/cam.20627; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; George A, 2005, CELLS TISSUES ORGANS, V181, P232, DOI 10.1159/000091384; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; LINDE A, 1980, J BIOL CHEM, V255, P5931; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Moustakas A, 2001, J CELL SCI, V114, P4359; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Praskova M, 2002, ARCH DERMATOL RES, V294, P198, DOI 10.1007/s00403-002-0312-4; RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; SCHWEITZER ES, 1995, J CELL SCI, V108, P2619; Sfeir C., 2000, CHEM BIOL MINERALIZE, P181; Souchelnytskyi S, 2002, TRENDS CELL BIOL, V12, P304, DOI 10.1016/S0962-8924(02)02300-0; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200	36	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8585	8595		10.1074/jbc.M112.413997	http://dx.doi.org/10.1074/jbc.M112.413997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23362283	hybrid, Green Published			2022-12-25	WOS:000316564500059
J	Saha, S; Dey, SK; Biswas, A; Das, P; Das, MR; Jana, SS				Saha, Shekhar; Dey, Sumit K.; Biswas, Arunima; Das, Provas; Das, Mahua R.; Jana, Siddhartha S.			The Effect of Including the C2 Insert of Nonmuscle Myosin II-C on Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; LIGHT-CHAIN; ARP2/3 COMPLEX; GROWTH CONES; PHOSPHORYLATION; DRIVES; FILOPODIA; ISOFORMS; KINASE; DIFFERENTIATION	The functional role of the C2 insert of nonmuscle myosin II-C (NM II-C) is poorly understood. Here, we report for the first time that the expression of the C2 insert-containing isoform, NM II-C1C2, is inducible in Neuro-2a cells during differentiation both at mRNA and protein levels. Immunoblot and RTPCR analysis reveal that expression of NM II-C1C2 peaks between days 3 and 6 of differentiation. Localization of NM II-C1C2 in Neuro-2a cells suggests that the C2 insert-containing isoform is localized in the cytosol and along the neurites, specifically at the adherence point to substratum. Inhibition of endogenous NM II-C1C2 using siRNA decreases the neurite length by 43% compared with control cells treated with nonspecific siRNA. Time lapse image analysis reveals that neurites of C2-siRNA-treated cells have a net negative change in neurite length per minute, leading to a reduction of overall neurite length. During neuritogenesis, NM II-C1C2 can interact and colocalize with beta 1-integrin in neurites. Altogether, these studies indicate thatNMII-C1C2 may be involved in stabilizing neurites by maintaining their structure at adhesion sites.	[Saha, Shekhar; Dey, Sumit K.; Das, Provas; Das, Mahua R.; Jana, Siddhartha S.] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 32, India; [Biswas, Arunima] Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata 32, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Jana, SS (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 32, India.	bcssj@iacs.res.in	saha, shekhar/P-8302-2017; BISWAS, ARUNIMA/AAY-8896-2021; Das, Provas/AAW-5814-2020	saha, shekhar/0000-0002-2797-3000; BISWAS, ARUNIMA/0000-0001-5099-6756; Dey, Sumit Kumar/0000-0001-5584-9704	Indian Association for the Cultivation of Science; Department of Biotechnology, Government of India	Indian Association for the Cultivation of Science(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Indian Association for the Cultivation of Science and the Department of Biotechnology, Government of India.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; Jing F, 2012, J CEREBR BLOOD F MET, V32, P248, DOI 10.1038/jcbfm.2011.133; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Rosado LAR, 2011, J CELL SCI, V124, P483, DOI 10.1242/jcs.074211; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Seidman KJN, 1996, J NEUROCHEM, V66, P1011; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Vervoort VS, 2002, SCIENCE, V296, P2401; Vicente-Manzanares M, 2010, BIOCHEM BIOPH RES CO, V402, P537, DOI 10.1016/j.bbrc.2010.10.071; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wright JW, 2002, NEUROSCI BIOBEHAV R, V26, P529, DOI 10.1016/S0149-7634(02)00019-2; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	56	8	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7815	7828		10.1074/jbc.M112.417196	http://dx.doi.org/10.1074/jbc.M112.417196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355468	hybrid, Green Published			2022-12-25	WOS:000316455300036
J	Goggs, R; Savage, JS; Mellor, H; Poole, AW				Goggs, Robert; Savage, Joshua S.; Mellor, Harry; Poole, Alastair W.			The Small GTPase Rif Is Dispensable for Platelet Filopodia Generation in Mice	PLOS ONE			English	Article							INTEGRIN ALPHA(IIB)BETA(3); RHO GTPASES; CDC42; ACTIVATION; MDIA1; INSIGHTS; COLLAGEN; KINASE; CELLS	Background: Formation of filopodia and other shape change events are vital for platelet hemostatic function. The mechanisms regulating filopodia formation by platelets are incompletely understood however. In particular the small GTPase responsible for initiating filopodia formation by platelets remains elusive. The canonical pathway involving Cdc42 is not essential for filopodia formation in mouse platelets. The small GTPase Rif (RhoF) provides an alternative route to filopodia generation in other cell types and is expressed in both human and mouse platelets. Hypothesis/Objective: We hypothesized that Rif might be responsible for generating filopodia by platelets and generated a novel knockout mouse model to investigate the functional role of Rif in platelets. Methodology/Principal Findings: Constitutive RhoF(-/-) mice are viable and have normal platelet, leukocyte and erythrocyte counts and indices. RhoF(-/-) platelets form filopodia and spread normally on various agonist surfaces in static conditions and under arterial shear. In addition, RhoF(-/-) platelets have normal actin dynamics, are able to activate and aggregate normally and secrete from alpha and dense granules in response to collagen related peptide and thrombin stimulation. Conclusions: The small GTPase Rif does not appear to be critical for platelet function in mice. Functional overlap between Rif and other small GTPases may be responsible for the non-essential role of Rif in platelets.	[Goggs, Robert; Savage, Joshua S.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Mellor, Harry] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol; University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Savage, Joshua/A-8738-2008	Savage, Joshua/0000-0003-0599-0245; Poole, Alastair/0000-0002-0868-297X; Goggs, Robert/0000-0001-7446-6987; Mellor, Harry/0000-0003-3894-0623	Wellcome Trust [WT090093MA]; British Heart Foundation [RG/05/083, RG/10/006/28299]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was funded by grant WT090093MA from the Wellcome Trust (www.wellcome.ac.uk/) awarded to RG, HM and AWP. JSS was supported by grant RG/05/083 awarded to AWP by the British Heart Foundation (www.bhf.org.uk/). Work in Prof. Alastair Poole's laboratory is also supported by a programme grant from the British Heart Foundation (Ref: RG/10/006/28299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022117; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; Eliautou S, 2009, THROMB HAEMOSTASIS, V102, P792, DOI 10.1160/TH09-06-0379; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hartwig JH, 2007, PLATELETS, 2ND EDITION, P75, DOI 10.1016/B978-012369367-9/50766-7; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jones ML, 2010, J THROMB HAEMOST, V8, P567, DOI 10.1111/j.1538-7836.2009.03719.x; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Pula G, 2008, PLATELETS, V19, P199, DOI 10.1080/09537100701777303; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; ROWLEY JW, 2011, BLOOD; Thomas SG, 2011, J THROMB HAEMOST, V9, P1648, DOI 10.1111/j.1538-7836.2011.04357.x; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958	31	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54663	10.1371/journal.pone.0054663	http://dx.doi.org/10.1371/journal.pone.0054663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359340	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600089
J	Pavoine, S; Blondel, J; Dufour, AB; Gasc, A; Bonsall, MB				Pavoine, Sandrine; Blondel, Jacques; Dufour, Anne B.; Gasc, Amandine; Bonsall, Michael B.			A New Technique for Analysing Interacting Factors Affecting Biodiversity Patterns: Crossed-DPCoA	PLOS ONE			English	Article							QUADRATIC ENTROPY; TAXONOMIC DISTINCTNESS; SPECIES-DIVERSITY; TRAIT DIVERSITY; COMMUNITIES; EVOLUTIONARY; RICHNESS; INDEXES	We developed an approach for analysing the effects of two crossed factors A and B on the functional, taxonomic or phylogenetic composition of communities. The methodology, known as crossed-DPCoA, defines a space where species, communities and the levels of the two factors are organised as a set of points. In this space, the Euclidean distance between two species-specific points is a measure of the (functional, taxonomic or phylogenetic) dissimilarity. The communities are positioned at the centroid of their constitutive species; and the levels of two factors at the centroid of the communities associated with them. We develop two versions for crossed-DPCoA, the first one moves the levels of factor B to the centre of the space and analyses the axes of highest variance in the coordinates of the levels of factor A. It is related to previous ordination approaches such as partial canonical correspondence analysis and partial non-symmetrical correspondence analysis. The second version projects all points on the orthogonal complement of the space generated by the principal axes of factor B. This second version should be preferred when there is an a priori suspicion that factor A and B are associated. We apply the two versions of crossed-DPCoA to analyse the phylogenetic composition of Central European and Mediterranean bird communities. Applying crossed-DPCoA on bird communities supports the hypothesis that allopatric speciation processes during the Quaternary occurred in open and patchily distributed landscapes, while the lack of geographic barriers to dispersal among forest habitats may explain the homogeneity of forest bird communities over the whole western Palaearctic. Generalizing several ordination analyses commonly used in ecology, crossed-DPCoA provides an approach for analysing the effects of crossed factors on functional, taxonomic and phylogenetic diversity, environmental and geographic structure of species niches, and more broadly the role of genetics on population structures.	[Pavoine, Sandrine; Gasc, Amandine] UPMC, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7204,CNRS, Paris, France; [Pavoine, Sandrine; Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Blondel, Jacques] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Dufour, Anne B.] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Gasc, Amandine] Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 7205, Paris, France; [Bonsall, Michael B.] Univ Oxford, St Peters Coll, Oxford, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Pavoine, S (corresponding author), UPMC, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7204,CNRS, Paris, France.	pavoine@mnhn.fr	Dufour, Anne-Béatrice/I-9475-2016	Dufour, Anne-Béatrice/0000-0002-9339-4293; Bonsall, Michael/0000-0003-0250-0423	national French MERT grant at the University of Lyon; European Commission (EIF-FP6, project OxPhyloDiv); Royal Society	national French MERT grant at the University of Lyon; European Commission (EIF-FP6, project OxPhyloDiv)(European Commission); Royal Society(Royal Society of London)	SP was first funded by a national French MERT grant (2002-2005) at the University of Lyon. SP and MBB would like to thank the European Commission (EIF-FP6, project OxPhyloDiv) and the Royal Society for supporting this collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; BLONDEL J, 1988, ECOLOGY, V69, P1899, DOI 10.2307/1941167; Blondel J, 1996, J EVOLUTION BIOL, V9, P871, DOI 10.1046/j.1420-9101.1996.9060871.x; Blondel J, 2000, VIE MILIEU, V50, P205; BLONDEL J, 1988, OECOLOGIA, V75, P83, DOI 10.1007/BF00378818; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J., 1995, BIOGEOGRAPHIE APPROC; Blondel J, 2008, J BIOGEOGR, V35, P509, DOI 10.1111/j.1365-2699.2007.01819.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Champely S, 2002, ENVIRON ECOL STAT, V9, P167, DOI 10.1023/A:1015170104476; Chessel D, 1987, REV STAT APPL, V35, P55; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; COX DR, 2000, THEORY DESIGN EXPT; Davis KE, 2008, THESIS U GLASGOW GLA; de Vienne DM, 2011, SYST BIOL, V60, P826, DOI 10.1093/sysbio/syr066; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Gusewell S, 2012, ECOL INDIC, V20, P134, DOI 10.1016/j.ecolind.2012.02.011; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Izsak J, 1995, ENVIRON ECOL STAT, V2, P213, DOI 10.1007/BF00456668; Lauro C, 1999, APPL STOCH MODEL D A, V15, P1; Lauro N, 1984, DATA ANAL INFORMATIC, P433; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; LIU ZJ, 1995, J STAT PLAN INFER, V43, P1, DOI 10.1016/0378-3758(94)00005-G; LYONS NI, 1981, AM NAT, V118, P438, DOI 10.1086/283836; Mayfield MM, 2009, AM NAT, V174, pE1, DOI 10.1086/599293; NAYAK TK, 1986, SANKHYA SER B, V48, P315; Nayak TK, 1983, THESIS U PITTSBURGH, P1; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; Pavoine S, 2005, ENVIRON ECOL STAT, V12, P125, DOI 10.1007/s10651-005-1037-2; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2007, ECOLOGY, V88, P512, DOI 10.1890/05-1806; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Pavoine S, 2009, ECOL LETT, V12, P898, DOI [10.1111/j.1461-0248.2009.01348.x, 10.1111/j.1461-0248.2009.01344.x]; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Pavoine S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-156; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; POLLOCK DD, 1995, MOL BIOL EVOL, V12, P713; Pontier J, 1987, P 3 S DAT AN INS OUT, P49; Rao CR, 2010, SANKHYA SER A, V72, P70, DOI 10.1007/s13171-010-0016-3; Rao C. R., 1986, ENCY STAT SCI, V7, P614; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Rao CR, 1984, INEQUALITIES STAT PR, V5, P68, DOI DOI 10.1214/LNMS/1215465631; Ricotta C, 2005, ECOL MODEL, V183, P365, DOI 10.1016/j.ecolmodel.2004.08.020; SABATIER R, 1989, MULTIWAY DATA ANAL, P341; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Ter Braak CJF, 1987, UNIMODAL MODELS RELA, P83; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; YOCCOZ N, 1988, CR ACAD SCI III-VIE, V307, P189	62	13	13	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54530	10.1371/journal.pone.0054530	http://dx.doi.org/10.1371/journal.pone.0054530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359802	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600065
J	Pinchuk, IV; Morris, KT; Nofchissey, RA; Earley, RB; Wu, JY; Ma, TY; Beswick, EJ				Pinchuk, Irina V.; Morris, Katherine T.; Nofchissey, Robert A.; Earley, Rachel B.; Wu, Jeng-Yih; Ma, Thomas Y.; Beswick, Ellen J.			Stromal Cells Induce Th17 during Helicobacter pylori Infection and in the Gastric Tumor Microenvironment	PLOS ONE			English	Article							T-CELLS; UP-REGULATION; TGF-BETA; EXPRESSION; FIBROBLASTS; CANCER; IL-17; MYOFIBROBLASTS; GROWTH; DIFFERENTIATION	Gastric cancer is associated with chronic inflammation and Helicobacter pylori infection. Th17 cells are CD4(+) T cells associated with infections and inflammation; but their role and mechanism of induction during carcinogenesis is not understood. Gastric myofibroblasts/fibroblasts (GMF) are abundant class II MHC expressing cells that act as novel antigen presenting cells. Here we have demonstrated the accumulation of Th17 in H. pylori-infected human tissues and in the gastric tumor microenvironment. GMF isolated from human gastric cancer and H. pylori infected tissues co-cultured with CD4(+) T cells induced substantially higher levels of Th17 than GMF from normal tissues in an IL-6, TGF-beta, and IL-21 dependent manner. Th17 required interaction with class II MHC on GMF for activation and proliferation. These studies suggest that Th17 are induced during both H. pylori infection and gastric cancer in the inflammatory milieu of gastric stroma and may be an important link between inflammation and carcinogenesis.	[Pinchuk, Irina V.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Morris, Katherine T.] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Earley, Rachel B.; Beswick, Ellen J.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Wu, Jeng-Yih] Kaohsiung Med Univ, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Ma, Thomas Y.] Univ New Mexico, Dept Internal Med, Div Gastroenterol & Hepatol, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico; Kaohsiung Medical University; University of New Mexico	Beswick, EJ (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	ebeswick@salud.unm.edu	Pinchuk, Irina V/A-7227-2008	Pinchuk, Irina V/0000-0003-1505-5779	American Cancer Society [RSG-10-159-01-LIB]; National Institutes of Health [8UL1TR000041, 1U54RR02614]; The University of New Mexico Clinical and Translational Science Center; American Gastroenterological Association Research Scholar Award; The University of Texas Medical Branch Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071, UL1TR000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of New Mexico Clinical and Translational Science Center; American Gastroenterological Association Research Scholar Award; The University of Texas Medical Branch Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the American Cancer Society RSG-10-159-01-LIB, National Institutes of Health 8UL1TR000041, The University of New Mexico Clinical and Translational Science Center, American Gastroenterological Association Research Scholar Award, and National Institutes of Health 1U54RR02614 The University of Texas Medical Branch Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboyega PA, 2002, ARCH PATHOL LAB MED, V126, P829; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10; Caruso R, 2007, WORLD J GASTROENTERO, V13, P5547, DOI 10.3748/wjg.v13.i42.5547; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Ferraccioli G, 2011, DISCOV MED, V11, P413; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hendrix A, 2011, CLIN RES HEPATOL GAS, V35, P714, DOI 10.1016/j.clinre.2011.05.003; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Iida T, 2011, ONCOL REP, V25, P1271, DOI 10.3892/or.2011.1201; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Liu T, 2012, INCREASED CIRCULATIN; Lossius A, 2011, J NEUROIMMUNOL, V240, P87, DOI 10.1016/j.jneuroim.2011.09.011; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Mojibian M, 2009, DIABETES, V58, P1789, DOI 10.2337/db08-1579; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Pinchuk IV, 2008, GASTROENTEROLOGY, V135, P1228, DOI 10.1053/j.gastro.2008.07.016; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; Rolig AS, 2011, P NATL ACAD SCI USA, V108, P19749, DOI 10.1073/pnas.1104598108; Schirmer C, 2010, BLOOD, V116, P1715, DOI 10.1182/blood-2010-01-263509; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Scotti C, 2010, HELICOBACTER, V15, P76, DOI 10.1111/j.1523-5378.2009.00733.x; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Suzuki Hidekazu, 2002, Keio J Med, V51 Suppl 2, P40; Tartour E, 1999, INTERLEUKIN 17 T CEL; Torpy Janet M, 2010, JAMA, V303, P1771, DOI 10.1001/jama.303.17.1771; Vogel JD, 2004, GASTROENTEROLOGY, V126, P63, DOI 10.1053/j.gastro.2003.10.046; Vykhovanets EV, 2011, INT J CLIN EXP PATHO, V4, P552; Wang L, 2010, IL 17 ENHANCES TUMOR; Wilke CM, 2011, TH17 CELLS CANC HELP; Yamada Y, 2012, PREVALENCE CLIN RELE; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015; Zhu X, 2008, IL 17 EXPRESSION BRE; Zhuang YA, 2011, IMMUNOBIOLOGY, V216, P200, DOI 10.1016/j.imbio.2010.05.005	45	38	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53798	10.1371/journal.pone.0053798	http://dx.doi.org/10.1371/journal.pone.0053798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365642	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600022
J	Wiria, AE; Wammes, LJ; Hamid, F; Dekkers, OM; Prasetyani, MA; May, L; Kaisar, MMM; Verweij, JJ; Tamsma, JT; Partono, F; Sartono, E; Supali, T; Yazdanbakhsh, M; Smit, JWA				Wiria, Aprilianto Eddy; Wammes, Linda J.; Hamid, Firdaus; Dekkers, Olaf M.; Prasetyani, Margaretta A.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Tamsma, Jouke T.; Partono, Felix; Sartono, Erliyani; Supali, Taniawati; Yazdanbakhsh, Maria; Smit, Johannes W. A.			Relationship between Carotid Intima Media Thickness and Helminth Infections on Flores Island, Indonesia	PLOS ONE			English	Article							REGULATORY T-CELLS; CARDIOVASCULAR RISK-FACTORS; SCHISTOSOMA-JAPONICUM; NUTRITIONAL-STATUS; BLOOD-PRESSURE; CHILDREN; ATHEROSCLEROSIS; POPULATION; ASSOCIATION; ADOLESCENTS	Objective: To examine the association between helminth infections and atherosclerosis. Background: Chronic helminth infection, which can lead to poor nutritional status and anti-inflammatory response, might protect against the development of atherosclerosis. Methods: A cross-sectional study was performed in Flores, Indonesia, an area highly endemic for soil-transmitted helminths (STH). Stool samples from 675 participants aged 18-80 years were collected and screened for Trichuris trichiura by microscopy and for Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, and Strongyloides stercoralis by qPCR. We collected data on body mass index (BMI), waist to hip ratio (WHR), blood pressure, fasting blood glucose (FBG), lipid, high sensitive C-reactive protein (hs-CRP), total immunoglobulin-E (TIgE) and Escherichia coli lipopolysaccharide stimulated cytokines (tumor necrosis factor and interleukin-10). In a subset of 301 elderly adults (>= 40 years of age) carotid intima media thickness (cIMT) was measured. Results: Participants with any STH infection had lower BMI (kg/m2) (mean difference -0.66, 95%CI [-1.26, -0.06]), WHR (-0.01, [-0.02, -0.00]), total cholesterol (mmol/L) (-0.22, [-0.43, -0.01]) and LDL-cholesterol (mmol/L) (-0.20, [-0.39, -0.00]) than uninfected participants. After additional adjustment for BMI the association between helminth infection and total cholesterol (mean difference -0.17, 95%CI [-0.37, 0.03]) as well as LDL-cholesterol (-.15, [-0.33, 0.04]) was less pronounced. BMI, WHR, and total cholesterol were negatively associated with number species of helminth co-infections. Participants with high TIgE, an indicator of exposure to helminths, had lower FBG, TC, and HDL. The association between TIgE and TC and HDL remained significant after adjustment with BMI. No clear association was found between STH infection or TIgE and mean cIMT. Conclusions: This cross-sectional study presents evidence that helminth infections were negatively associated with risk factors for cardiovascular disease, an association at least partially mediated by an effect on BMI. The significance of this finding needs to be determined.	[Wiria, Aprilianto Eddy; Prasetyani, Margaretta A.; Kaisar, Maria M. M.; Partono, Felix; Supali, Taniawati] Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Wiria, Aprilianto Eddy; Wammes, Linda J.; Hamid, Firdaus; Prasetyani, Margaretta A.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Hamid, Firdaus] Hasanuddin Univ, Dept Microbiol, Fac Med, Makassar, Indonesia; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Dekkers, Olaf M.; Tamsma, Jouke T.; Smit, Johannes W. A.] Leiden Univ, Med Ctr, Dept Endocrinol & Gen Internal Med, Leiden, Netherlands; [Smit, Johannes W. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands	University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universitas Hasanuddin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Wiria, AE (corresponding author), Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.	a.e.wiria@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Wiria, Aprilianto Eddy/AAZ-2419-2021; Smit, J.W.A./H-8091-2014; Hamid, Firdaus/M-6862-2017	Yazdanbakhsh, Maria/0000-0002-7666-1441; Wiria, Aprilianto Eddy/0000-0002-6482-424X; Smit, J.W.A./0000-0003-1052-9314; Hamid, Firdaus/0000-0003-1788-0836; Dekkers, Olaf/0000-0002-1333-7580; Verweij, Jaco J./0000-0001-8553-931X; Kaisar, Maria M. M./0000-0002-7515-7673	Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436]; Prof. Dr. P.C. Flu Foundation	Royal Netherlands Academy of Arts and Science (KNAW); European Commission(European CommissionEuropean Commission Joint Research Centre); Prof. Dr. P.C. Flu Foundation	This study was funded by The Royal Netherlands Academy of Arts and Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts INCO-CT-2006-031714 and INCO-CT-2006-032436, and the Prof. Dr. P.C. Flu Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzi F, 2010, OBES REV, V11, P127, DOI 10.1111/j.1467-789X.2009.00605.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cooper PJ, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-33; Coutinho HM, 2006, AM J TROP MED HYG, V75, P720, DOI 10.4269/ajtmh.2006.75.720; Coutinho HM, 2006, J NUTR, V136, P183, DOI 10.1093/jn/136.1.183; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GUPTA MC, 1977, LANCET, V2, P108; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; Kallio K, 2010, CIRC-CARDIOVASC QUAL, V3, P196, DOI 10.1161/CIRCOUTCOMES.109.857771; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Lakka TA, 1999, HYPERTENSION, V34, P51, DOI 10.1161/01.HYP.34.1.51; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Meurs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024393; Moya MD, 2012, ATHEROSCLEROSIS, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032; Mwatha JK, 1998, J IMMUNOL, V160, P1992; Pasha SM, 2011, J HYPERTENS, V29, P2194, DOI 10.1097/HJH.0b013e32834bbba8; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ricci ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001383; SALONEN JT, 1993, CIRCULATION, V87, P56; Soliman EZ, 2010, J STROKE CEREBROVASC, V19, P58, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.008; Stanley RG, 2009, ATHEROSCLEROSIS, V207, P131, DOI 10.1016/j.atherosclerosis.2009.04.037; Touboul PJ, 2009, CEREBROVASC DIS, V27, P361, DOI 10.1159/000202013; Van Bortel LM, 1998, J HUM HYPERTENS, V12, P583, DOI 10.1038/sj.jhh.1000669; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Wammes LJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001655; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676; WIEDERMANN U, 1991, ZBL BAKT-INT J MED M, V275, P279; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Wiria AE, 2012, SEMIN IMMUNOPATHOL, V34, P889, DOI 10.1007/s00281-012-0358-0; World Heatlh Organization, 2010, PREVENTION OF CARDIO; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	37	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54855	10.1371/journal.pone.0054855	http://dx.doi.org/10.1371/journal.pone.0054855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365679	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600124
J	Buckingham, G; Goodale, MA				Buckingham, Gavin; Goodale, Melvyn A.			Size Matters: A Single Representation Underlies Our Perceptions of Heaviness in the Size-Weight Illusion	PLOS ONE			English	Article							OBJECTS	In the size-weight illusion (SWI), a small object feels heavier than an equally-weighted larger object. It is thought that this illusion is a consequence of the way that we internally represent objects' properties - lifters expect one object to outweigh the other, and the subsequent illusion reflects a contrast with their expectations. Similar internal representations are also thought to guide the application of fingertip forces when we grip and lift objects. To determine the nature of the representations underpinning how we lift objects and perceive their weights, we examined weight judgments in addition to the dynamics and magnitudes of the fingertip forces when individuals lifted small and large exemplars of metal and polystyrene cubes, all of which had been adjusted to have exactly the same mass. Prior to starting the experiment, subjects expected the density of the metal cubes to be higher than that of the polystyrene cubes. Their illusions, however, did not reflect their conscious expectations of heaviness; instead subjects experienced a SWI of the same magnitude regardless of the cubes' material. Nevertheless, they did report that the polystyrene cubes felt heavier than the metal ones (i. e. they experienced a material-weight illusion). Subjects persisted in lifting the large metal cube with more force than the small metal cube, but lifted the large polystyrene cube with roughly the same amount of force that they used to lift the small polystyrene cube. These findings suggest that our perceptual and sensorimotor representations are not only functionally independent from one another, but that the perceptual system represents a more single, simple size-weight relationship which appears to drive the SWI itself.	[Buckingham, Gavin; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario)	Buckingham, G (corresponding author), Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada.	gavin.buckingham.hwu@gmail.com	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Buckingham, Gavin/0000-0002-6950-5504	Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	G. Buckingham was funded with a Banting Postdoctoral Fellowship awarded from the Natural Sciences and Engineering Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugh LA, 2012, J NEUROPHYSIOL; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2011, ATTEN PERCEPT PSYCHO, V73, P36, DOI 10.3758/s13414-010-0007-4; Buckingham G, 2011, J VISION, V11, DOI 10.1167/11.1.4; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; DAVIS CM, 1976, PERCEPT PSYCHOPHYS, V20, P33, DOI 10.3758/BF03198701; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; Ernst MO, 2009, CURR BIOL, V19, pR23, DOI 10.1016/j.cub.2008.10.039; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; HARSHFIELD SP, 1970, PSYCHON SCI, V20, P365, DOI 10.3758/BF03335692; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	22	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54709	10.1371/journal.pone.0054709	http://dx.doi.org/10.1371/journal.pone.0054709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372759	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500114
J	Cal, AJ; Liu, DC; Mauleon, R; Hsing, YIC; Serraj, R				Cal, Andrew J.; Liu, Dongcheng; Mauleon, Ramil; Hsing, Yue-Ie Caroline; Serraj, Rachid			Transcriptome Profiling of Leaf Elongation Zone under Drought in Contrasting Rice Cultivars	PLOS ONE			English	Article							GENE-EXPRESSION; WATER DEFICITS; FLOWERING TIME; MAIZE; XYLOGLUCAN; PEROXIDASE; ARABIDOPSIS; INCREASE; ENZYMES; GROWTH	Inhibition of leaf elongation and expansion is one of the earliest responses of rice to water deficit. Despite this sensitivity, a great deal of genetic variation exists in the extant of leaf elongation rate (LER) reduction in response to declining soil moisture. We analyzed global gene expression in the leaf elongation zone under drought in two rice cultivars with disparate LER sensitivities to water stress. We found little overlap in gene regulation between the two varieties under moderate drought; however, the transcriptional response to severe drought was more conserved. In response to moderate drought, we found several genes related to secondary cell wall deposition that were down regulated in Moroberekan, an LER tolerant variety, but up-regulated in LER sensitive variety IR64.	[Cal, Andrew J.; Liu, Dongcheng; Mauleon, Ramil; Serraj, Rachid] Int Rice Res Inst, Los Banos, Philippines; [Hsing, Yue-Ie Caroline] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	CGIAR; International Rice Research Institute (IRRI); Academia Sinica - Taiwan	Cal, AJ (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	andrew.j.cal@gmail.com	Mauleon, Ramil/AAW-1697-2020	Mauleon, Ramil/0000-0001-8512-144X	Academia Sinica; Bill and Melinda Gates Foundation	Academia Sinica(Academia Sinica - Taiwan); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would like to thank Bill Hardy for careful reading of the manuscript and G. Dimayuga, E. Mico, E. Arcillas, R. Torres, the drought physiology team at IRRI for technical support. Affymetrix GeneChip assays were performed by the Affymetrix Gene Expression Service Laboratory http://ipmb.sinica.edu.tw/affy/, supported by Academia Sinica.; This work was funded by the Bill and Melinda Gates Foundation project "Stress-Tolerant Rice for Africa and South Asia." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Bacon MA, 1998, PLANT PHYSIOL, V118, P1507, DOI 10.1104/pp.118.4.1507; Bacon MA, 1997, J EXP BOT, V48, P2075, DOI 10.1093/jxb/48.12.2075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; CUTLER JM, 1980, CROP SCI, V20, P314, DOI 10.2135/cropsci1980.0011183X002000030006x; de Souza IRP, 1998, PHYSIOL PLANTARUM, V104, P556, DOI 10.1034/j.1399-3054.1998.1040406.x; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Hazen Samuel P., 2005, Functional & Integrative Genomics, V5, P104, DOI 10.1007/s10142-004-0126-x; He H, 2009, ACTA PHYSIOL PLANT, V31, P749, DOI 10.1007/s11738-009-0287-2; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Parent B, 2010, PLANT CELL ENVIRON, V33, P1256, DOI 10.1111/j.1365-3040.2010.02145.x; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; Price NJ, 2003, J BIOL CHEM, V278, P41389, DOI 10.1074/jbc.M304519200; Puckridge D, 1980, FIELD CROPS RES, V3, P303; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; SINCLAIR TR, 1986, AUST J PLANT PHYSIOL, V13, P329, DOI 10.1071/PP9860329; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; TANGUILIG VC, 1987, PLANT SOIL, V103, P155, DOI 10.1007/BF02370385; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Volkenburgh E, 1980, PLANTA, V148, P273; Wonprasaid S, 1996, FIELD CROP RES, V47, P267, DOI 10.1016/0378-4290(96)00013-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	33	18	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54537	10.1371/journal.pone.0054537	http://dx.doi.org/10.1371/journal.pone.0054537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372737	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500084
J	de Voux, A; Chan, MC; Folefoc, AT; Madziva, MT; Flanagan, CA				de Voux, Alex; Chan, Mei-Chi; Folefoc, Asongna T.; Madziva, Michael T.; Flanagan, Colleen A.			Constitutively Active CCR5 Chemokine Receptors Differ in Mediating HIV Envelope-dependent Fusion	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; IMMUNODEFICIENCY-VIRUS TYPE-1; BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL INSTABILITY; DRY MOTIF; BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE HELIX-2; INDUCED ACTIVATION; SMALL-MOLECULE	The CCR5 chemokine receptor is a rhodopsin-like G protein-coupled receptor that mediates the effects of pro-inflammatory beta-chemokines. CCR5 is also the major co-receptor for entry of human immunodeficiency virus (HIV) into human cells. G protein-coupled receptors exist in ensembles of active and inactive conformations. Active receptor conformations can be stabilized by mutations. Although binding of the HIV envelope protein to CCR5 stimulates cellular signaling, the CCR5 conformation that induces fusion of the viral membrane with cellular membranes is not known. We mutated conserved amino acids to generate constitutively active CCR5 receptors, which are stabilized in active conformations, and tested the ability of constitutively active CCR5 receptors to mediate HIV envelope-directed membrane fusion. Mutation of the Asp(3.49(125)) and Arg(6.32(225)) residues of CCR5 did not cause constitutive activity, but Lys or Pro substitutions for Thr(2.56(82)), in the TxP motif, caused high basal inositol phosphate signaling. Signaling did not increase in response to MIP-1 beta, suggesting that the Thr(2.56(82)) mutants were fully stabilized in active conformations. The Thr(2.56(82)) Lys mutation severely decreased cell surface CCR5 expression. Combining the Thr(2.56(82)) Lys mutation with an Arg(6.32(225)) Gln mutation partially reversed the decrease in expression. Mutants with Thr(2.56(82)) Lys substitutions were poor mediators of HIV envelope-directed membrane fusion, but mutants with the Thr(2.65(82)) Pro substitution exhibited full co-receptor function. Our results suggest that the Thr(2.65(82)) Lys and Thr(2.65(82)) Pro mutations stabilize distinct constitutively active CCR5 conformations. Lys in position 2.65(82) stabilizes activated receptor conformations that appear to be constitutively internalized and do not induce envelope-dependent membrane fusion, whereas Pro stabilizes activated conformations that are not constitutively internalized and fully mediate envelope-directed membrane fusion.	[de Voux, Alex; Chan, Mei-Chi; Folefoc, Asongna T.] Univ Cape Town, Fac Hlth Sci, Med Res Council Receptor Biol Res Unit, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Madziva, Michael T.; Flanagan, Colleen A.] Univ Witwatersrand, Sch Physiol, Med Res Council Receptor Biol Res Unit, Johannesburg, South Africa	University of Cape Town; University of Witwatersrand	Flanagan, CA (corresponding author), Univ Witwatersrand, Sch Physiol, Med Res Council Receptor Biol Res Unit, Johannesburg, South Africa.	Colleen.Flanagan@wits.ac.za	Flanagan, Colleen/ABG-2109-2020	Flanagan, Colleen A./0000-0003-2803-8986	South African Medical Research Council; National Research Foundation; Polio research Foundation; Mandela Rhodes Foundation	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Polio research Foundation; Mandela Rhodes Foundation	This work was supported by grants from the South African Medical Research Council, the National Research Foundation and the Polio research Foundation. Alex de Voux was supported by scholarships from the Mandela Rhodes Foundation and the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beinborn M, 2004, MOL PHARMACOL, V65, P753, DOI 10.1124/mol.65.3.753; Buontempo PJ, 2009, VIROLOGY, V395, P268, DOI 10.1016/j.virol.2009.09.029; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Flanagan CA, 1998, ENDOCRINOLOGY, V139, P4115, DOI 10.1210/en.139.10.4115; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Folefoc AT, 2010, JAIDS-J ACQ IMM DEF, V54, P352, DOI 10.1097/QAI.0b013e3181e0c7b2; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Fromme BJ, 2008, AIDS RES HUM RETROV, V24, P1527, DOI 10.1089/aid.2008.0105; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jenkinson S, 2003, RECEPTOR CHANNEL, V9, P117, DOI 10.1080/10606820308248; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Millar R, 1995, METH NEUROSCI, P145; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2007, CELL SIGNAL, V19, P1446, DOI 10.1016/j.cellsig.2007.01.022; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	64	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54532	10.1371/journal.pone.0054532	http://dx.doi.org/10.1371/journal.pone.0054532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355876	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500083
J	Hewitt, KM; Mannino, FL; Gonzalez, A; Chase, JH; Caporaso, JG; Knight, R; Kelley, ST				Hewitt, Krissi M.; Mannino, Frank L.; Gonzalez, Antonio; Chase, John H.; Caporaso, J. Gregory; Knight, Rob; Kelley, Scott T.			Bacterial Diversity in Two Neonatal Intensive Care Units (NICUs)	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; NOSOCOMIAL INFECTION-RATES; ENVIRONMENTAL CONTAMINATION; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK; ACQUISITION; PATTERNS; SURFACES; STATES	Infants in Neonatal Intensive Care Units (NICUs) are particularly susceptible to opportunistic infection. Infected infants have high mortality rates, and survivors often suffer life-long neurological disorders. The causes of many NICU infections go undiagnosed, and there is debate as to the importance of inanimate hospital environments (IHEs) in the spread of infections. We used culture-independent next-generation sequencing to survey bacterial diversity in two San Diego NICUs and to track the sources of microbes in these environments. Thirty IHE samples were collected from two Level-Three NICU facilities. We extracted DNA from these samples and amplified the bacterial small subunit (16S) ribosomal RNA gene sequence using 'universal' barcoded primers. The purified PCR products were pooled into a single reaction for pyrosequencing, and the data were analyzed using QIIME. On average, we detected 93+/-39 (mean +/- standard deviation) bacterial genera per sample in NICU IHEs. Many of the bacterial genera included known opportunistic pathogens, and many were skin-associated (e. g., Propionibacterium). In one NICU, we also detected fecal coliform bacteria (Enterobacteriales) in a high proportion of the surface samples. Comparison of these NICU-derived sequences to previously published high-throughput 16S rRNA amplicon studies of other indoor environments (offices, restrooms and healthcare facilities), as well as human-and soil-associated environments, found the majority of the NICU samples to be similar to typical building surface and air samples, with the notable exception of the IHEs which were dominated by Enterobacteriaceae. Our findings provide evidence that NICU IHEs harbor a high diversity of human-associated bacteria and demonstrate the potential utility of molecular methods for identifying and tracking bacterial diversity in NICUs.	[Hewitt, Krissi M.; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mannino, Frank L.] Univ San Diego, Med Ctr, San Diego, CA 92110 USA; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Chase, John H.; Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Comp Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	California State University System; San Diego State University; University of San Diego; University of Colorado System; University of Colorado Boulder; Northern Arizona University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Kelley, ST (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skelley@sciences.sdsu.edu	Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Knight, Rob/0000-0002-0975-9019	Alfred P. Sloan foundation; Howard Hughes Medical Institute	Alfred P. Sloan foundation(Alfred P. Sloan Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Part of the study was funded by the Alfred P. Sloan foundation, the Howard Hughes Medical Institute, and the rest through an independent fund owned by the P. I. Scott Kelley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gonzalez A, 2012, BIOINFORMATICS, V28, P436, DOI 10.1093/bioinformatics/btr685; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hota B, 2009, J HOSP INFECT, V71, P123, DOI 10.1016/j.jhin.2008.10.030; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; JARVIS WR, 1991, AM J MED, V91, pS185, DOI 10.1016/0002-9343(91)90367-7; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maragakis LL, 2004, JAMA-J AM MED ASSOC, V292, P3006, DOI 10.1001/jama.292.24.3006; Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905; Mayfield JL, 2000, CLIN INFECT DIS, V31, P995, DOI 10.1086/318149; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Urrea M, 2003, AM J INFECT CONTROL, V31, P505, DOI 10.1016/S0196-6553(03)00077-4; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	35	91	92	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54703	10.1371/journal.pone.0054703	http://dx.doi.org/10.1371/journal.pone.0054703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372757	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500111
J	Ogiwara, K; Fujimori, C; Rajapakse, S; Takahashi, T				Ogiwara, Katsueki; Fujimori, Chika; Rajapakse, Sanath; Takahashi, Takayuki			Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MESSENGER RIBONUCLEIC-ACIDS; ACTIVE RECOMBINANT FSH; OOCYTE MATURATION; GONADOTROPIN RECEPTORS; GRANULOSA-CELLS; MOLECULAR CHARACTERIZATION; MATRIX METALLOPROTEINASES; ZEBRAFISH GONADOTROPINS; EXPRESSION PATTERNS	The molecular properties and roles of luteinizing hormone (Lh) and its receptor (Lhcgrbb) have not been studied for the medaka (Oryzias latipes), which is an excellent animal model for ovulation studies. Here, we characterized the medaka Lh/Lhcgrbb system, with attention to its involvement in the ovulatory process of this teleost fish. In the medaka ovary, follicle-stimulating hormone receptor mRNA was expressed in small and medium-sized follicles, while lhcgrbb mRNA was expressed in the follicle layers of all growing follicles. Experiments using HEK 293T cells expressing medaka Lhcgrbb in vitro revealed that gonadotropin from pregnant mare's serum and medaka recombinant Lh (rLh) bound to the fish Lhcgrbb. The fish gonadotropin subunits Gtha, Fshb, and Lhb were essentially expressed at fairly constant levels in the pituitary of the fish during a 24-h spawning cycle. Using medaka rLh, we developed a follicle culture system that allowed us to follow the whole process of oocyte maturation and ovulation in vitro. This follicle culture method enabled us to determine that the Lh surge for the preovulatory follicle occurred in vivo between 19 and 15 h before ovulation. The present study also showed that oocyte maturation and ovulation were delayed several hours in vitro compared with in vivo. Treatment of large follicles with medaka rLh in vitro significantly increased the expression of Mmp15, which was previously demonstrated to be crucial for ovulation in the fish. These findings demonstrate that Lh/Lhcgrbb is critically involved in the induction of oocyte maturation and ovulation.	[Ogiwara, Katsueki; Fujimori, Chika; Takahashi, Takayuki] Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 060, Japan; [Rajapakse, Sanath] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka	Hokkaido University; University of Peradeniya	Takahashi, T (corresponding author), Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 060, Japan.	ttakaha@sci.hokudai.ac.jp		Fujimori, Chika/0000-0003-0574-6277	Ministry of Education, Culture, Sports, Science and Technology of Japan [21370024, 24247010]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research (nos. 21370024 and 24247010 to TT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bogerd J, 2005, GEN COMP ENDOCR, V142, P34, DOI 10.1016/j.ygcen.2004.12.008; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Chaffin CL, 1999, BIOL REPROD, V61, P14, DOI 10.1095/biolreprod61.1.14; Chaffin CL, 1999, HUM REPROD, V14, P642, DOI 10.1093/humrep/14.3.642; Chaffin CL, 2000, MOL HUM REPROD, V6, P11, DOI 10.1093/molehr/6.1.11; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Crespo D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-34; Egami N., 1959, Journal of the Faculty of Science Tokyo University Zoology, V8, P539; Espey LL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P425; Fujimori C, 2012, MOL CELL ENDOCRINOL, V362, P76, DOI 10.1016/j.mce.2012.05.013; Fujimori C, 2011, MOL CELL ENDOCRINOL, V332, P67, DOI 10.1016/j.mce.2010.09.015; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; Gazourian L, 1997, GEN COMP ENDOCR, V108, P327, DOI 10.1006/gcen.1997.6981; Goetz FW, 1997, FISH PHYSIOL BIOCHEM, V17, P33, DOI 10.1023/A:1007765902327; GOETZ FW, 1993, BIOL REPROD, V48, P846, DOI 10.1095/biolreprod48.4.846; GOETZ FW, 1982, GEN COMP ENDOCR, V48, P154, DOI 10.1016/0016-6480(82)90012-0; Gordon WL, 1985, LUTEINIZING HORMONE, P173; Hagglund AC, 1999, ENDOCRINOLOGY, V140, P4351, DOI 10.1210/en.140.9.4351; Hazzard TM, 1999, MOL HUM REPROD, V5, P1115, DOI 10.1093/molehr/5.12.1115; Horiguchi M, 2008, ZOOL SCI, V25, P937, DOI 10.2108/zsj.25.937; Huang H, 2009, GEN COMP ENDOCR, V162, P192, DOI 10.1016/j.ygcen.2009.02.012; Ishikawa Y, 1997, NATURE, V386, P234, DOI 10.1038/386234a0; IWAMATSU T, 1978, J EXP ZOOL, V206, P355, DOI 10.1002/jez.1402060307; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; IWAMATSU T, 1988, ZOOL SCI, V5, P353; KAGAWA H, 1981, B JPN SOC SCI FISH, V47, P1119; Karigo T, 2012, ENDOCRINOLOGY, V153, P3394, DOI 10.1210/en.2011-2022; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kato Y, 2010, CELL TISSUE RES, V340, P595, DOI 10.1007/s00441-010-0969-5; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; KOBAYASHI M, 1986, B JPN SOC SCI FISH, V52, P1153; KOOS RD, 1995, BIOL REPROD, V52, P1426, DOI 10.1095/biolreprod52.6.1426; Kusakabe R, 1999, INT J DEV BIOL, V43, P541; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li S, 1993, Chin J Biotechnol, V9, P247; Lister AL, 2008, GEN COMP ENDOCR, V159, P46, DOI 10.1016/j.ygcen.2008.07.017; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Matsui H, 2000, EUR J BIOCHEM, V267, P4658, DOI 10.1046/j.1432-1327.2000.01513.x; MIWA S, 1994, BIOL REPROD, V50, P629, DOI 10.1095/biolreprod50.3.629; Moyle W.R., 1996, REPROD ENDOCRINOLOGY, P683; Nagahama Y, 1997, STEROIDS, V62, P190, DOI 10.1016/S0039-128X(96)00180-8; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nagahama Yoshitaka, 1994, P393; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Ogiwara K, 2007, P NATL ACAD SCI USA, V104, P7021, DOI 10.1073/pnas.0610447104; Ogiwara K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093880; Ogiwara K, 2010, ZOOL SCI, V27, P762, DOI 10.2108/zsj.27.762; OZATO K, 1994, DEV GROWTH DIFFER, V36, P437; PATINO R, 1990, BIOL REPROD, V43, P818, DOI 10.1095/biolreprod43.5.818; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PINTER J, 1995, BIOL REPROD, V52, P667, DOI 10.1095/biolreprod52.3.667; Pinter J, 1999, GEN COMP ENDOCR, V115, P200, DOI 10.1006/gcen.1999.7312; Raldua D, 2006, AM J PHYSIOL-REG I, V290, pR456, DOI 10.1152/ajpregu.00528.2005; Robinson EJ, 1943, BIOL BULL-US, V84, P115, DOI 10.2307/1538054; Rocha A, 2007, MOL CELL ENDOCRINOL, V272, P63, DOI 10.1016/j.mce.2007.04.007; Sambroni E, 2007, J ENDOCRINOL, V195, P213, DOI 10.1677/JOE-06-0122; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Sorbera LA, 2001, BIOL REPROD, V64, P382, DOI 10.1095/biolreprod64.1.382; THEOFAN G, 1981, COMP BIOCHEM PHYS A, V69, P557, DOI 10.1016/0300-9629(81)93019-X; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Ulloa-Aguirre A, 2011, REV ENDOCR METAB DIS, V12, P259, DOI 10.1007/s11154-011-9176-2; Vischer HF, 2003, BIOL REPROD, V68, P1324, DOI 10.1095/biolreprod.102.009985; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Wallis M., 1985, BIOCH POLYPEPTIDE HO, P147; Wong TT, 2004, ENDOCRINOLOGY, V145, P5210, DOI 10.1210/en.2004-0558; Wu FR, 2009, COMP BIOCHEM PHYS A, V153, P44, DOI 10.1016/j.cbpa.2008.12.013; Wu YS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095646; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	76	56	57	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54482	10.1371/journal.pone.0054482	http://dx.doi.org/10.1371/journal.pone.0054482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372734	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500078
J	Theocharatos, S; Wilkinson, DJ; Darling, S; Wilm, B; Kenny, SE; Edgar, D				Theocharatos, Sokratis; Wilkinson, David J.; Darling, Sarah; Wilm, Bettina; Kenny, Simon E.; Edgar, David			Regulation of Progenitor Cell Proliferation and Neuronal Differentiation in Enteric Nervous System Neurospheres	PLOS ONE			English	Article							CREST STEM-CELLS; HIRSCHSPRUNG DISEASE; FATE DETERMINATION; GLIAL-CELLS; NEUROGENESIS; GUT; GLIOGENESIS; TRANSPLANTATION; MAINTENANCE; MECHANISM	Enteric nervous system (ENS) progenitor cells isolated from mouse and human bowel can be cultured in vitro as neurospheres which are aggregates of the proliferating progenitor cells, together with neurons and glial cells derived from them. To investigate the factors regulating progenitor cell proliferation and differentiation, we first characterised cell proliferation in mouse ENS neurospheres by pulse chase experiments using thymidine analogs. We demonstrate rapid and continuous cell proliferation near the neurosphere periphery, after which postmitotic cells move away from the periphery to become distributed throughout the neurosphere. While many proliferating cells expressed glial markers, expression of the neuronal markers beta-tubulin III (Tuj1) and nitric oxide synthase was detected in increasing numbers of post-mitotic cells after a delay of several days. Treatment of both mouse and human neurospheres with the gamma-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) reduced expression of the transcription factors Hes1 and Hes5, demonstrating inhibition of Notch signaling. DAPT treatment also inhibited progenitor cell proliferation and increased the numbers of differentiating neurons expressing Tuj1 and nitric oxide synthase. To confirm that the cellular effects of DAPT treatment were due to inhibition of Notch signaling, siRNA knockdown of RBPj kappa, a key component of the canonical Notch signaling pathway, was demonstrated both to reduce proliferation and to increase neuronal differentiation in neurosphere cells. These observations indicate that Notch signaling promotes progenitor cell proliferation and inhibits neuronal differentiation in ENS neurospheres.	[Theocharatos, Sokratis; Wilkinson, David J.; Darling, Sarah; Wilm, Bettina; Edgar, David] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Kenny, Simon E.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Edgar, D (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	dhedgar@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Kenny, Simon/0000-0002-5917-8554; Wilkinson, David/0000-0001-5165-8230	Children's Research Fund, Liverpool; Royal College of Surgeons of England; British Association of Paediatric Surgeons; Action Medical Research Clinical Research Training Fellowship; UK Medical Research Council [G0802548]; Medical Research Council [G0802548] Funding Source: researchfish; Action Medical Research [1795] Funding Source: researchfish; MRC [G0802548] Funding Source: UKRI	Children's Research Fund, Liverpool; Royal College of Surgeons of England; British Association of Paediatric Surgeons; Action Medical Research Clinical Research Training Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ST was supported by a grant to SEK and DE from the Children's Research Fund, Liverpool. DJW was supported by a Research Fellowship from the Royal College of Surgeons of England and British Association of Paediatric Surgeons, and an Action Medical Research Clinical Research Training Fellowship. The work was funded by the Project Grant G0802548 from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Becker L, 2012, AM J PHYSIOL-GASTR L, V302, pG958, DOI 10.1152/ajpgi.00511.2011; Binder E, 2010, GUT, V59, pA141, DOI 10.1136/gut.2009.209049g; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Jarvi K, 2010, ANN SURG, V252, P977, DOI 10.1097/SLA.0b013e3182018542; Jia HM, 2012, INT J COLORECTAL DIS, V27, P37, DOI 10.1007/s00384-011-1295-4; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mosher JT, 2007, DEV BIOL, V303, P1, DOI 10.1016/j.ydbio.2006.10.026; Ngan ESW, 2011, J CLIN INVEST, V121, P3467, DOI 10.1172/JCI43737; Okamura Y, 2008, DEVELOPMENT, V135, P3555, DOI 10.1242/dev.022319; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sander GR, 2003, J HISTOCHEM CYTOCHEM, V51, P969, DOI 10.1177/002215540305100712; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theocharatos S, 2008, EARLY HUM DEV, V84, P801, DOI 10.1016/j.earlhumdev.2008.09.007; Tsarovina K, 2008, MOL CELL NEUROSCI, V37, P20, DOI 10.1016/j.mcn.2007.08.010; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wilkinson DJ, 2012, SEMIN PEDIATR SURG, V21, P364, DOI 10.1053/j.sempedsurg.2012.07.010; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	33	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54809	10.1371/journal.pone.0054809	http://dx.doi.org/10.1371/journal.pone.0054809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372773	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500131
J	Gallo, A; Russo, GL; Tosti, E				Gallo, Alessandra; Russo, Gian Luigi; Tosti, Elisabetta			T-Type Ca2+Current Activity during Oocyte Growth and Maturation in the Ascidian Styela plicata	PLOS ONE			English	Article							EARLY DEVELOPMENTAL-STAGES; CALCIUM-CHANNELS; MEIOSIS REINITIATION; MEIOTIC MATURATION; CA2+ CHANNELS; ION CURRENTS; CELL-CYCLE; RUDITAPES-PHILIPPINARUM; FERTILIZATION CURRENT; SIGNALING PATHWAYS	Voltage-dependent calcium currents play a fundamental role during oocyte maturation, mostly L-type calcium currents, whereas T-type calcium currents are involved in sperm physiology and cell growth. In this paper, using an electrophysiological and pharmacological approach, we demonstrated, for the first time in oocytes, that T-type calcium currents are present with functional consequences on the plasma membrane of growing immature oocytes of the ascidian Styela plicata. We classified three subtypes of immature oocytes at the germinal vesicle stage on the basis of their size, morphology and accessory cellular structures. These stages were clearly associated with an increased activity of T-type calcium currents and hyperpolarization of the plasma membrane. We also observed that T-type calcium currents oscillate in the post-fertilization embryonic stages, with minimal amplitude of the currents in the zygote and maximal at 8-cell stage. In addition, chemical inhibition of T-type calcium currents, obtained by applying specific antagonists, induced a significant reduction in the rate of cleavage and absence of larval formation. We suggest that calcium entry via T-type calcium channels may act as a potential pacemaker in regulating cytosolic calcium involved in fertilization and early developmental events.	[Gallo, Alessandra; Russo, Gian Luigi; Tosti, Elisabetta] Stn Zool Anton Dohrn, Anim Physiol & Evolut Lab, Naples, Italy; [Russo, Gian Luigi] CNR, Inst Food Sci, Avellino, Italy	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Tosti, E (corresponding author), Stn Zool Anton Dohrn, Anim Physiol & Evolut Lab, Naples, Italy.	tosti@szn.it	Gallo, Alessandra/AAA-3132-2022; RUSSO, GIAN LUIGI/GQB-0962-2022	Gallo, Alessandra/0000-0002-2558-4722; RUSSO, GIAN LUIGI/0000-0001-9321-1613	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	Institutional funds from Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOULT C, 1994, J MEMBRANE BIOL, V137, P127; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bezzaouia A, 2012, ZYGOTE IN PRESS; Boni R, 2002, BIOL REPROD, V66, P836, DOI 10.1095/biolreprod66.3.836; Boni R, 2007, THERIOGENOLOGY, V68, pS156, DOI 10.1016/j.theriogenology.2007.05.048; BOSMA MM, 1990, J MEMBRANE BIOL, V114, P231, DOI 10.1007/BF01869217; BROWNLEE C, 1990, PROC R SOC SER B-BIO, V239, P321, DOI 10.1098/rspb.1990.0019; Cantiello HF, 1997, J EXP ZOOL, V279, P425, DOI 10.1002/(SICI)1097-010X(19971201)279:5<425::AID-JEZ4>3.0.CO;2-Q; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Cui XS, 2007, REPROD FERT DEVELOP, V19, P25, DOI 10.1071/RD06128; Cuomo A, 2006, MOL REPROD DEV, V73, P501, DOI 10.1002/mrd.20404; Cuomo A, 2005, J EXP ZOOL PART A, V303A, P193, DOI 10.1002/jez.a.152; Dale, 1997, IN VITRO FERTILIZATI; DALE B, 1991, EXP CELL RES, V192, P302, DOI 10.1016/0014-4827(91)90190-6; DALE B, 1983, FERTILIZATION ANIMAL; Dale B., 2011, OOCYTE MATURATION FE, P104; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Day ML, 1998, PFLUG ARCH EUR J PHY, V436, P834, DOI 10.1007/s004240050712; DUBE F, 1992, BIOCHEM BIOPH RES CO, V189, P79, DOI 10.1016/0006-291X(92)91528-X; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; GUERRIER P, 1993, DEV BIOL, V159, P474, DOI 10.1006/dbio.1993.1257; HAGIWARA S, 1979, ANNU REV BIOPHYS BIO, V8, P385, DOI 10.1146/annurev.bb.08.060179.002125; HIRANO T, 1984, J PHYSIOL-LONDON, V347, P327, DOI 10.1113/jphysiol.1984.sp015068; HOMA ST, 1995, MOL REPROD DEV, V40, P122, DOI 10.1002/mrd.1080400116; Hotsuliak Ia M, 2002, Fiziol Zh, V48, P98; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Jaffe L.F., 1980, Annals of the New York Academy of Sciences, V339, P86, DOI 10.1111/j.1749-6632.1980.tb15971.x; Jagannathan S, 2002, REPRODUCTION, V123, P203, DOI 10.1530/rep.0.1230203; JEFFERY WR, 1978, DEV BIOL, V67, P152, DOI 10.1016/0012-1606(78)90306-8; Kumano G, 2007, DEV DYNAM, V236, P1732, DOI 10.1002/dvdy.21108; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lambert CC, 2005, DEV GROWTH DIFFER, V47, P265; Lambert CC, 2011, MOL REPROD DEV, V78, P726, DOI 10.1002/mrd.21349; Leclerc C, 2000, BIOL CELL, V92, P285, DOI 10.1016/S0248-4900(00)01069-8; Lee JH, 2011, J ASSIST REPROD GEN, V28, P23, DOI 10.1007/s10815-010-9480-x; Lee JH, 2004, MOL REPROD DEV, V69, P174, DOI 10.1002/mrd.20162; Lemaire P, 2011, DEVELOPMENT, V138, P2143, DOI 10.1242/dev.048975; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; McGivern JG, 2006, CNS NEUROL DISORD-DR, V5, P587, DOI 10.2174/187152706779025535; Menezo Y.R., 2011, OOCYTE MATURATION FE, P64; Moody WJ, 1998, CURR TOP DEV BIOL, V39, P159, DOI 10.1016/S0070-2153(08)60455-X; Moreau M, 1996, ZYGOTE, V4, P151, DOI 10.1017/S0967199400003038; Murnane JM, 1993, ZYGOTE, V1, P50, DOI 10.1017/S0967199400001295; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Russo GL, 1998, SEMIN CELL DEV BIOL, V9, P559, DOI 10.1006/scdb.1998.0250; SAKAIRI K, 1991, DEV GROWTH DIFFER, V33, P155; Satoh N., 1994, DEV BIOL ASCIDIAN; Silvestre F, 2009, MOL REPROD DEV, V76, P1084, DOI 10.1002/mrd.21073; SIMONCINI L, 1988, SCIENCE, V242, P1572, DOI 10.1126/science.2849207; *STAT AN SYST I, 1988, US GUID STAT REL 6 0; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Tomkowiak M, 1997, J CELL BIOCHEM, V64, P152, DOI 10.1002/(SICI)1097-4644(199701)64:1<152::AID-JCB17>3.0.CO;2-N; Tosti E, 2004, HUM REPROD UPDATE, V10, P53, DOI 10.1093/humupd/dmh006; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Tosti E, 2000, AM J PHYSIOL-CELL PH, V279, pC1795, DOI 10.1152/ajpcell.2000.279.6.C1795; Tosti E., 2011, OOCYTE MATURATION FE; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Tosti E, 2011, MOL REPROD DEV, V78, P854, DOI 10.1002/mrd.21316; Tosti E, 2010, MOL REPROD DEV, V77, P856, DOI 10.1002/mrd.21215; Ullrich N, 1997, AM J PHYSIOL-CELL PH, V273, pC1290, DOI 10.1152/ajpcell.1997.273.4.C1290; Yamashita M, 2000, Prog Cell Cycle Res, V4, P115; YAMASHITA N, 1982, J PHYSIOL-LONDON, V329, P263, DOI 10.1113/jphysiol.1982.sp014302; Yanagimachi R., 1994, PHYSL REPROD; YAZAKI I, 1995, DEVELOPMENT, V121, P1827	72	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54604	10.1371/journal.pone.0054604	http://dx.doi.org/10.1371/journal.pone.0054604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349937	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100083
J	Spurny, R; Billen, B; Howard, RJ; Brams, M; Debaveye, S; Price, KL; Weston, DA; Strelkov, SV; Tytgat, J; Bertrand, S; Bertrand, D; Lummis, SCR; Ulens, C				Spurny, Radovan; Billen, Bert; Howard, Rebecca J.; Brams, Marijke; Debaveye, Sarah; Price, Kerry L.; Weston, David A.; Strelkov, Sergei V.; Tytgat, Jan; Bertrand, Sonia; Bertrand, Daniel; Lummis, Sarah C. R.; Ulens, Chris			Multisite Binding of a General Anesthetic to the Prokaryotic Pentameric Erwinia chrysanthemi Ligand-gated Ion Channel (ELIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; ACID TYPE-A; VOLATILE ANESTHETICS; GLYCINE RECEPTORS; MECHANISMS; GABA(A); ALCOHOL; MODULATION; SUBUNIT	Pentameric ligand-gated ion channels (pLGICs), such as nicotinic acetylcholine, glycine, gamma-aminobutyric acid GABA(A/C) receptors, and the Gloeobacter violaceus ligand-gated ion channel (GLIC), are receptors that contain multiple allosteric binding sites for a variety of therapeutics, including general anesthetics. Here, we report the x-ray crystal structure of the Erwinia chrysanthemi ligand-gated ion channel (ELIC) in complex with a derivative of chloroform, which reveals important features of anesthetic recognition, involving multiple binding at three different sites. One site is located in the channel pore and equates with a noncompetitive inhibitor site found in many pLGICs. A second transmembrane site is novel and is located in the lower part of the transmembrane domain, at an interface formed between adjacent subunits. A third site is also novel and is located in the extracellular domain in a hydrophobic pocket between the beta 7-beta 10 strands. Together, these results extend our understanding of pLGIC modulation and reveal several specific binding interactions that may contribute to modulator recognition, further substantiating a multisite model of allosteric modulation in this family of ion channels.	[Spurny, Radovan; Billen, Bert; Brams, Marijke; Debaveye, Sarah; Ulens, Chris] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Louvain, Belgium; [Howard, Rebecca J.] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Price, Kerry L.; Weston, David A.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB 1QW, England; [Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, B-3000 Louvain, Belgium; [Tytgat, Jan] Katholieke Univ Leuven, Toxicol Lab, B-3000 Louvain, Belgium; [Bertrand, Sonia; Bertrand, Daniel] HiQScreen Sarl, CH-1211 Geneva 12, Switzerland	KU Leuven; University of Texas System; University of Texas Austin; University of Cambridge; KU Leuven; KU Leuven	Ulens, C (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Herestr 49,PB 601, B-3000 Louvain, Belgium.	chris.ulens@med.kuleuven.be	Strelkov, Sergei V/G-7425-2014	Strelkov, Sergei V/0000-0001-7189-4652; Price, Kerry/0000-0002-5563-4567; Tytgat, Jan/0000-0003-1778-6022; Howard, Rebecca/0000-0003-2049-3378	KU Leuven [OT/08/048]; FWO-Vlaanderen [G.0739.09, G.0743.10, G.0939.11]; European Union [HEALTH-F2-2007-202088]; Wellcome Trust; Medical Research Council (MRC)	KU Leuven(KU Leuven); FWO-Vlaanderen(FWO); European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants KU Leuven OT/08/048 and FWO-Vlaanderen G.0739.09, G.0743.10, and G.0939.11 (to C. U.), the European Union Seventh Framework Programme under grant agreement HEALTH-F2-2007-202088 (to C. U., D. B., and S. C. R. L.), and the Wellcome Trust (to S. C. R. L. and K. L. P.).; Recipient of a Medical Research Council (MRC) studentship.	Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Beckstead MJ, 2000, MOL PHARMACOL, V57, P1199; Beckstead MJ, 2002, J NEUROCHEM, V82, P1343, DOI 10.1046/j.1471-4159.2002.01086.x; Beckstead MJ, 2001, J BIOL CHEM, V276, P24959, DOI 10.1074/jbc.M011627200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Daniels S, 1998, TOXICOL LETT, V101, P71, DOI 10.1016/S0378-4274(98)00167-2; FORMAN SA, 1995, MOL PHARMACOL, V48, P574; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Gumilar F, 2003, NEUROPHARMACOLOGY, V45, P964, DOI 10.1016/S0028-3908(03)00247-8; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; HARRISON NL, 1993, MOL PHARMACOL, V44, P628; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jenkins A, 2008, ANESTH ANALG, V107, P486, DOI 10.1213/ane.0b013e31817b70c1; Kash TL, 2003, BRAIN RES, V960, P36, DOI 10.1016/S0006-8993(02)03748-4; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; LENA C, 1993, TRENDS NEUROSCI, V16, P181, DOI 10.1016/0166-2236(93)90150-K; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Nakahiro M, 1996, NEUROSCI LETT, V205, P127, DOI 10.1016/0304-3940(96)12397-1; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Pascual JM, 1998, J GEN PHYSIOL, V112, P611, DOI 10.1085/jgp.112.5.611; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; Sear JW, 2009, BRIT J ANAESTH, V103, P50, DOI 10.1093/bja/aep092; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; WACHTEL RE, 1995, J PHARMACOL EXP THER, V274, P1355; Wallner M, 2008, BRIT J PHARMACOL, V154, P288, DOI 10.1038/bjp.2008.32; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Yu Y, 2003, P NATL ACAD SCI USA, V100, P3907, DOI 10.1073/pnas.0730718100; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	49	80	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8355	8364		10.1074/jbc.M112.424507	http://dx.doi.org/10.1074/jbc.M112.424507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364792	Green Published, hybrid			2022-12-25	WOS:000316564500035
J	Rass, E; Chandramouly, G; Zha, S; Alt, FW; Xie, AY				Rass, Emilie; Chandramouly, Gurushankar; Zha, Shan; Alt, Frederick W.; Xie, Anyong			Ataxia Telangiectasia Mutated (ATM) Is Dispensable for Endonuclease I-Scel-induced Homologous Recombination in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; GENOMIC INSTABILITY; IONIZING-RADIATION; HISTONE H2AX; FUNCTIONAL SYNERGY; KINASE-ACTIVITY; REPAIR PATHWAY; MDC1; PHOSPHORYLATION	Ataxia telangiectasia mutated (ATM) is activated upon DNA double strand breaks (DSBs) and phosphorylates numerous DSB response proteins, including histone H2AX on serine 139 (Ser-139) to form gamma-H2AX. Through interaction with MDC1, gamma-H2AX promotes DSB repair by homologous recombination (HR). H2AX Ser-139 can also be phosphorylated by DNA-dependent protein kinase catalytic subunit and ataxia telangiectasia- and Rad3-related kinase. Thus, we tested whether ATM functions in HR, particularly that controlled by gamma-H2AX, by comparing HR occurring at the euchromatic ROSA26 locus between mouse embryonic stem cells lacking either ATM, H2AX, or both. We show here that loss of ATM does not impair HR, including H2AX-dependent HR, but confers sensitivity to inhibition of poly(ADP-ribose) polymerases. Loss of ATM or H2AX has independent contributions to cellular sensitivity to ionizing radiation. The ATM-independent HR function of H2AX requires both Ser-139 phosphorylation and gamma-H2AX/MDC1 interaction. Our data suggest that ATM is dispensable for HR, including that controlled by H2AX, in the context of euchromatin, excluding the implication of such an HR function in genomic instability, hypersensitivity to DNA damage, and poly(ADP-ribose) polymerase inhibition associated with ATM deficiency.	[Rass, Emilie; Chandramouly, Gurushankar; Xie, Anyong] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Rass, Emilie; Chandramouly, Gurushankar; Xie, Anyong] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zha, Shan; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Immune Dis Inst, Boston, MA 02115 USA; [Zha, Shan; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Xie, AY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, 330 Brookline Ave, Boston, MA 02215 USA.	axie@bidmc.harvard.edu		Zha, Shan/0000-0002-6568-1818	National Institutes of Health [R01GM073894]; NATIONAL CANCER INSTITUTE [R01CA158073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073894.	Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choi S, 2010, CELL CYCLE, V9, P4052, DOI 10.4161/cc.9.20.13471; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Daniel JA, 2012, J CELL BIOL, V198, P295, DOI 10.1083/jcb.201204035; Dar I, 2011, J BIOL CHEM, V286, P15361, DOI 10.1074/jbc.M110.204172; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu CG, 2008, FEBS LETT, V582, P2703, DOI 10.1016/j.febslet.2008.06.051; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Menissier-de Murcia J, 2001, MOL CELL BIOL, V21, P1828; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Serrano MA, 2013, ONCOGENE, V32, P2452, DOI 10.1038/onc.2012.257; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2010, CELL CYCLE, V9, P3602, DOI 10.4161/cc.9.17.12884; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yamamoto K, 2012, J CELL BIOL, V198, P305, DOI 10.1083/jcb.201204098; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	54	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7086	7095		10.1074/jbc.M112.445825	http://dx.doi.org/10.1074/jbc.M112.445825			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23355489	Green Published, hybrid			2022-12-25	WOS:000316002400030
J	Castilho, A; Neumann, L; Gattinger, P; Strasser, R; Vorauer-Uhl, K; Sterovsky, T; Altmann, F; Steinkellner, H				Castilho, Alexandra; Neumann, Laura; Gattinger, Pia; Strasser, Richard; Vorauer-Uhl, Karola; Sterovsky, Thomas; Altmann, Friedrich; Steinkellner, Herta			Generation of Biologically Active Multi-Sialylated Recombinant Human EPOFc in Plants	PLOS ONE			English	Article							HAMSTER OVARY CELLS; N-GLYCAN STRUCTURES; FC FUSION PROTEIN; HUMAN-ERYTHROPOIETIN; CHO-CELLS; NICOTIANA-BENTHAMIANA; MASS-SPECTROMETRY; TOBACCO PLANTS; SUGAR CHAINS; GLYCOSYLATION	Hyperglycosylated proteins are more stable, show increased serum half-life and less sensitivity to proteolysis compared to non-sialylated forms. This applies particularly to recombinant human erythropoietin (rhEPO). Recent progress in N-glycoengineering of non-mammalian expression hosts resulted in in vivo protein sialylation at great homogeneity. However the synthesis of multi-sialylated N-glycans is so far restricted to mammalian cells. Here we used a plant based expression system to accomplish multi-antennary protein sialylation. A human erythropoietin fusion protein (EPOFc) was transiently expressed in Nicotiana benthamiana Delta XTFT, a glycosylation mutant that lacks plant specific N-glycan residues. cDNA of the hormone was co-delivered into plants with the necessary genes for (i) branching (ii) beta 1,4-galactosylation as well as for the (iii) synthesis, transport and transfer of sialic acid. This resulted in the production of recombinant EPOFc carrying bi-tri-and tetra-sialylated complex N-glycans. The formation of this highly complex oligosaccharide structure required the coordinated expression of 11 human proteins acting in different subcellular compartments at different stages of the glycosylation pathway. In vitro receptor binding assays demonstrate the generation of biologically active molecules. We demonstrate the in planta synthesis of one of the most complex mammalian glycoforms pointing to an outstanding high degree of tolerance to changes in the glycosylation pathway in plants.	[Castilho, Alexandra; Gattinger, Pia; Strasser, Richard; Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Neumann, Laura; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria; [Vorauer-Uhl, Karola] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Sterovsky, Thomas] Polymun Sci GmbH, Klosterneuburg, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	herta.steinkellner@boku.ac.at	Steinkellner, Herta/N-4267-2016; Strasser, Richard/AAD-2916-2020; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Gattinger, Pia/0000-0001-6724-8543; Vorauer-Uhl, Karola/0000-0003-4217-8846; Altmann, Friedrich/0000-0002-0112-7877; Strasser, Richard/0000-0001-8764-6530	Laura Bassi Centres of Expertise [822757]; Wiener Wissenschafts- und Technologie fonds (WWTF) [L575-B13]; Wiener Forschungs- und Technologie fonds [L575-B13]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Laura Bassi Centres of Expertise; Wiener Wissenschafts- und Technologie fonds (WWTF); Wiener Forschungs- und Technologie fonds; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Laura Bassi Centres of Expertise (Grant Number 822757) and the Wiener Wissenschafts-, Forschungs- und Technologie fonds (WWTF) (Grant Number L575-B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2000, J IMMUNOL METHODS, V237, P95, DOI 10.1016/S0022-1759(00)00135-6; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Bork K, 2007, FEBS LETT, V581, P4195, DOI 10.1016/j.febslet.2007.07.060; Bragonzi A, 2000, BBA-GEN SUBJECTS, V1474, P273, DOI 10.1016/S0304-4165(00)00023-4; Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Conley AJ, 2009, PLANT BIOTECHNOL J, V7, P183, DOI 10.1111/j.1467-7652.2008.00389.x; Davies HM, 2010, PLANT BIOTECHNOL J, V8, P845, DOI 10.1111/j.1467-7652.2010.00550.x; Dirnberger D, 2001, EUR J BIOCHEM, V268, P4570, DOI 10.1046/j.1432-1327.2001.02384.x; DUBE S, 1988, J BIOL CHEM, V263, P17516; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; HOKKE CH, 1995, EUR J BIOCHEM, V228, P981, DOI 10.1111/j.1432-1033.1995.tb20350.x; Im SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024574; Kittur FS, 2012, PLANT CELL REP, V31, P1233, DOI 10.1007/s00299-012-1244-x; KOMATSU N, 1991, CANCER RES, V51, P341; Lombardi R, 2012, TRANSGENIC RES, V21, P1005, DOI 10.1007/s11248-012-9587-1; Loos A, 2012, ARCH BIOCH BIOPHYS; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; MATSUMOTO S, 1995, PLANT MOL BIOL, V27, P1163, DOI 10.1007/BF00020889; MORGAN WTJ, 1969, BRIT MED BULL, V25, P30, DOI 10.1093/oxfordjournals.bmb.a070666; Nagels B, 2012, J BIOTECHNOL, V160, P242, DOI 10.1016/j.jbiotec.2012.03.003; Pabst M, 2012, BIOL CHEM, V393, P719, DOI 10.1515/hsz-2012-0148; Parsons J, 2012, PLANT BIOTECHNOL J, V10, P851, DOI 10.1111/j.1467-7652.2012.00704.x; Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z; RECNY MA, 1987, J BIOL CHEM, V262, P17156; SASAKI H, 1988, BIOCHEMISTRY-US, V27, P8618, DOI 10.1021/bi00423a017; Schriebl K, 2006, PROTEIN EXPRES PURIF, V49, P265, DOI 10.1016/j.pep.2006.05.018; Shahrokh Z, 2011, MOL PHARMACEUT, V8, P286, DOI 10.1021/mp100353a; Skibeli V, 2001, BLOOD, V98, P3626, DOI 10.1182/blood.V98.13.3626; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; Taschwer M, 2012, J BIOTECHNOL, V157, P295, DOI 10.1016/j.jbiotec.2011.11.014; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Wang MD, 2002, BIOTECHNOL BIOENG, V77, P194, DOI 10.1002/bit.10144; Wang Z, 2011, BIOTECHNOL BIOENG, V108, P1634, DOI 10.1002/bit.23091; WASLEY LC, 1991, BLOOD, V77, P2624; Way JC, 2005, PROTEIN ENG DES SEL, V18, P111, DOI 10.1093/protein/gzi021; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Yuen CT, 2003, BRIT J HAEMATOL, V121, P511, DOI 10.1046/j.1365-2141.2003.04307.x	50	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54836	10.1371/journal.pone.0054836	http://dx.doi.org/10.1371/journal.pone.0054836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372778	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400033
J	Cheung, MK; Lam, WY; Fung, WYW; Law, PTW; Au, CH; Nong, WY; Kam, KM; Kwan, HS; Tsui, SKW				Cheung, Man Kit; Lam, Wai Yip; Fung, Wendy Yin Wan; Law, Patrick Tik Wan; Au, Chun Hang; Nong, Wenyan; Kam, Kai Man; Kwan, Hoi Shan; Tsui, Stephen Kwok Wing			Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA Pyrosequencing	PLOS ONE			English	Article							CYSTIC-FIBROSIS; GUT MICROBIOME; DIVERSITY; INFECTION; DISEASE; HEALTH; STREPTOCOCCI; COMMUNITIES; PATHOGENS; BIOFILMS	Background: Tuberculosis (TB) remains a global threat in the 21st century. Traditional studies of the disease are focused on the single pathogen Mycobacterium tuberculosis. Recent studies have revealed associations of some diseases with an imbalance in the microbial community. Characterization of the TB microbiota could allow a better understanding of the disease. Methodology/Principal Findings: Here, the sputum microbiota in TB infection was examined by using 16S rRNA pyrosequencing. A total of 829,873 high-quality sequencing reads were generated from 22 TB and 14 control sputum samples. Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria were the five major bacterial phyla recovered, which together composed over 98% of the microbial community. Proteobacteria and Bacteroidetes were more represented in the TB samples and Firmicutes was more predominant in the controls. Sixteen major bacterial genera were recovered. Streptococcus, Neisseria and Prevotella were the most predominant genera, which were dominated by several operational taxonomic units grouped at a 97% similarity level. Actinomyces, Fusobacterium, Leptotrichia, Prevotella, Streptococcus, and Veillonella were found in all TB samples, possibly representing the core genera in TB sputum microbiota. The less represented genera Mogibacterium, Moryella and Oribacterium were enriched statistically in the TB samples, while a genus belonging to the unclassified Lactobacillales was enriched in the controls. The diversity of microbiota was similar in the TB and control samples. Conclusions/Significance: The composition and diversity of sputum microbiota in TB infection was characterized for the first time by using high-throughput pyrosequencing. It lays the framework for examination of potential roles played by the diverse microbiota in TB pathogenesis and progression, and could ultimately facilitate advances in TB treatment.	[Cheung, Man Kit; Au, Chun Hang; Nong, Wenyan; Kwan, Hoi Shan] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Wai Yip; Fung, Wendy Yin Wan; Tsui, Stephen Kwok Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Law, Patrick Tik Wan] Chinese Univ Hong Kong, Core Facil Genome Sequencing Lab, Hong Kong, Hong Kong, Peoples R China; [Kam, Kai Man] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China; [Tsui, Stephen Kwok Wing] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Kwan, HS (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	hoishankwan@cuhk.edu.hk; kwtsui@cuhk.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015; KAM, Kai Man/K-4546-2012; Nong, Wenyan/E-3260-2010; Kwan, Hoi Shan/GOV-6863-2022; Cheung, Man Kit/M-6972-2019; Cheung, Man Kit/E-5696-2012	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; KAM, Kai Man/0000-0003-0579-0307; Nong, Wenyan/0000-0002-3277-716X; Cheung, Man Kit/0000-0002-2764-2113; Cheung, Man Kit/0000-0002-2764-2113; Kwan, Hoi Shan/0000-0002-7943-2513	Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government [09080442]	Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government (Ref. No. 09080442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Brigham KS, 2009, CURR OPIN PEDIATR, V21, P437, DOI 10.1097/MOP.0b013e32832c9668; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlier JP, 2007, INT J SYST EVOL MICR, V57, P725, DOI 10.1099/ijs.0.64705-0; Carlier JP, 2004, INT J SYST EVOL MICR, V54, P1611, DOI 10.1099/ijs.0.63060-0; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Geng JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034769; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Han XY, 2006, J CLIN MICROBIOL, V44, P160, DOI 10.1128/JCM.44.1.160-165.2006; Haraldsson G, 2005, ANAEROBE, V11, P285, DOI 10.1016/j.anaerobe.2005.02.004; HILL GB, 1987, J CLIN MICROBIOL, V25, P1540, DOI 10.1128/JCM.25.8.1540-1545.1987; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; JACOBS JA, 1994, CLIN ORTHOP RELAT R, P183; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Murdoch DA, 1999, ANAEROBE, V5, P555, DOI 10.1006/anae.1999.0197; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rabunal Ramon, 2009, J Med Case Rep, V3, P37, DOI 10.1186/1752-1947-3-37; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Shankar EM, 2007, J MED MICROBIOL, V56, P1709, DOI 10.1099/jmm.0.47497-0; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stop TB Partnership, 2011, THE GLOBAL PLAN TO S; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; You M, J PERIODONTAL RES IN; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109; Zhou FX, 2012, WORLD J GASTROENTERO, V18, P2344, DOI 10.3748/wjg.v18.i19.2344; Zhou YH, 2010, ACTA BIOCH BIOPH SIN, V42, P754, DOI 10.1093/abbs/gmq081	47	64	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54574	10.1371/journal.pone.0054574	http://dx.doi.org/10.1371/journal.pone.0054574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365674	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600075
J	Cui, YY; Yamada, S				Cui, Yuanyuan; Yamada, Soichiro			N-Cadherin Dependent Collective Cell Invasion of Prostate Cancer Cells Is Regulated by the N-Terminus of alpha-Catenin	PLOS ONE			English	Article							BETA-CATENIN; TUMOR-METASTASIS; PROGNOSTIC VALUE; OVARIAN-CANCER; ACTIN-BINDING; GAMMA-CATENIN; EXPRESSION; SURVIVAL; ADHESION; COMPLEX	Cancer cell invasion is the critical first step of metastasis, yet, little is known about how cancer cells invade and initiate metastasis in a complex extracellular matrix. Using a cell line from bone metastasis of prostate cancer (PC3), we analyzed how prostate cancer cells migrate in a physiologically relevant 3D Matrigel. We found that PC3 cells migrated more efficiently as multi-cellular clusters than isolated single cells, suggesting that the presence of cell-cell adhesion improves 3D cell migration. Perturbation of N-cadherin function by transfection of either the N-cadherin cytoplasmic domain or shRNA specific to N-cadherin abolished collective cell migration. Interestingly, PC3 cells do not express alpha-catenin, an actin binding protein in the cadherin complex. When the full-length alpha-catenin was re-introduced, the phenotype of PC3 cells reverted back to a more epithelial phenotype with a decreased cell migration rate in 3D Matrigel. Interestingly, we found that the N-terminal half of alpha-catenin was sufficient to suppress invasive phenotype. Taken together, these data suggest that the formation of N-cadherin junctions promotes 3D cell migration of prostate cancer cells, and this is partly due to an aberrant regulation of the N-cadherin complex in the absence of alpha-catenin.	[Cui, Yuanyuan; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019; Cui, Yuanyuan/G-1899-2015; Cui, Yuanyuan/G-1787-2017	Yamada, Soichiro/0000-0001-6413-0814; Cui, Yuanyuan/0000-0002-1455-5643	Beckman Young Investigator Award; Hellman Family New Faculty Award; NIH EUREKA [GM094798]; University of California Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798] Funding Source: NIH RePORTER	Beckman Young Investigator Award; Hellman Family New Faculty Award; NIH EUREKA; University of California Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Beckman Young Investigator Award, a Hellman Family New Faculty Award, a NIH EUREKA GM094798, and the funds from the University of California Cancer Research Coordinating Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 1999, BRIT J CANCER, V80, P477, DOI 10.1038/sj.bjc.6690381; Aaltomaa S, 2005, ANTICANCER RES, V25, P4707; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Carmona FJ, 2012, J PATHOL; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Chung S, 2012, ONCOGENE; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gao P., 2012, ONCOGENE; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ishida E, 2004, PATHOL INT, V54, P918, DOI 10.1111/j.1440-1827.2004.01773.x; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; Jaggi M, 2006, PROSTATE, V66, P193, DOI 10.1002/pros.20334; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li G, 2001, CANCER RES, V61, P3819; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; MORTON RA, 1993, CANCER RES, V53, P3585; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Richmond PJM, 1997, CANCER RES, V57, P3189; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Shih W, 2012, J CELL SCI; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tamura D, 2008, INT J ONCOL, V33, P17; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tomita K, 2000, CANCER RES, V60, P3650; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wong AST, 1999, INT J CANCER, V81, P180; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	40	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55069	10.1371/journal.pone.0055069	http://dx.doi.org/10.1371/journal.pone.0055069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359820	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600148
J	Davis, MF; Peterson, AE; Julian, KG; Greene, WH; Price, LB; Nelson, K; Whitener, CJ; Silbergeld, EK				Davis, Meghan F.; Peterson, Amy E.; Julian, Kathleen G.; Greene, Wallace H.; Price, Lance B.; Nelson, Kenrad; Whitener, Cynthia J.; Silbergeld, Ellen K.			Household Risk Factors for Colonization with Multidrug-Resistant Staphylococcus aureus Isolates	PLOS ONE			English	Article							SINGLE-DISK METHOD; METHICILLIN-RESISTANT; COMPANION ANIMALS; UNITED-STATES; ANTIBIOTIC SUSCEPTIBILITY; NASAL COLONIZATION; MRSA STRAINS; COMMUNITY; TRANSMISSION; PREVALENCE	Antimicrobial resistance, particularly in pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), limits treatment options and increases healthcare costs. To understand patient risk factors, including household and animal contact, potentially associated with colonization with multidrug-resistant MRSA isolates, we performed a prospective study of case patients colonized with MRSA on admission to a rural tertiary care hospital. Patients were interviewed and antimicrobial resistance patterns were tested among isolates from admitted patients colonized with MRSA in 2009-10. Prevalence of resistance was compared by case-patient risk factors and length-of-stay outcome among 88 MRSA case patients. Results were compared to NHANES 2003-04. Overall prevalence of multidrug resistance (non-susceptibility to >= four antimicrobial classes) in MRSA nasal isolates was high (73%) and was associated with a 1.5-day increase in subsequent length of stay (p = 0.008). History of hospitalization within the past six months, but not antimicrobial use in the same time period, was associated with resistance patterns. Within a subset of working-age case patients without recent history of hospitalization, animal contact was potentially associated with multidrug resistance. History of hospitalization, older age, and small household size were associated with multidrug resistance in NHANES data. In conclusion, recent hospitalization of case patients was predictive of antimicrobial resistance in MRSA isolates, but novel risk factors associated with the household may be emerging in CA-MRSA case patients. Understanding drivers of antimicrobial resistance in MRSA isolates is important to hospital infection control efforts, relevant to patient outcomes and to indicators of the economic burden of antimicrobial resistance.	[Davis, Meghan F.; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Peterson, Amy E.; Nelson, Kenrad] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Julian, Kathleen G.; Greene, Wallace H.; Whitener, Cynthia J.] Penn State Hershey Med Ctr, Hershey, PA USA; [Price, Lance B.] Translat Genom Res Inst TGen N, Div Pathogen Genom, Phoenix, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Translational Genomics Research Institute	Davis, MF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	mdavis@jhsph.edu	Davis, Meghan F./C-1494-2013	Davis, Meghan F./0000-0002-3475-4578	Johns Hopkins Center for a Livable Future; Heinz Foundation; Sommer Scholarship	Johns Hopkins Center for a Livable Future; Heinz Foundation; Sommer Scholarship	Research was supported by grants from the Johns Hopkins Center for a Livable Future (http://www.jhsph.edu/clf/) and the Heinz Foundation (http://www.heinzfamily.org/aboutus/philanthropies_02.html). AEP and MFD were supported by Johns Hopkins Center for a Livable Future Predoctoral Fellowships. Additionally, MFD was supported by a Sommer Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; *AM SOC MICR, 1995, REP ASM TASK FORC AN; Appelbaum PC, 2007, INT J ANTIMICROB AG, V30, P398, DOI 10.1016/j.ijantimicag.2007.07.011; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BARRY AL, 1970, AM J CLIN PATHOL, V53, P149; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bordon J, 2010, DIAGN MICR INFEC DIS, V67, P395, DOI 10.1016/j.diagmicrobio.2010.03.006; Bramble M, 2011, VECTOR-BORNE ZOONOT, V11, P617, DOI 10.1089/vbz.2010.0025; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2003, NAT HLTH NUTR EX SUR; Clinical Laboratory Standards Institute, 2010, 2009 S AUR CLSI BREA; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003; Freitas EAF, 2010, INFECT CONT HOSP EP, V31, P469, DOI 10.1086/651672; Garcia Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI DOI 10.1016/S1473-3099(11)70126-8; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Kosowska-Shick K, 2008, ANTIMICROB AGENTS CH, V52, P4510, DOI 10.1128/AAC.01073-08; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lucet JC, 2009, ARCH INTERN MED, V169, P1372, DOI 10.1001/archinternmed.2009.217; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Miller R, 2010, EPIDEMIOL INFECT, V138, P655, DOI 10.1017/S0950268809991294; Milstone AM, 2010, EMERG INFECT DIS, V16, P647, DOI 10.3201/eid1604.090107; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Morris DO, 2006, VET DERMATOL, V17, P332, DOI 10.1111/j.1365-3164.2006.00536.x; Peterson AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038354; Popovich K, 2007, J CLIN MICROBIOL, V45, P2293, DOI 10.1128/JCM.00044-07; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Smith Tara C., 2010, Reviews on Environmental Health, V25, P121; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Winston LG, 2009, ANTIMICROBIAL RESIST	44	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54733	10.1371/journal.pone.0054733	http://dx.doi.org/10.1371/journal.pone.0054733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359808	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600099
J	Jacobson, AL; Kennedy, GG				Jacobson, Alana L.; Kennedy, George G.			Specific Insect-Virus Interactions Are Responsible for Variation in Competency of Different Thrips tabaci Isolines to Transmit Different Tomato Spotted Wilt Virus Isolates	PLOS ONE			English	Article							FRANKLINIELLA-FUSCA; TOBACCO THRIPS; ONION THRIPS; THYSANOPTERA; POPULATIONS; TOSPOVIRUS; VECTOR; HOST; EPIDEMIOLOGY; TEMPERATURE	Local adaptation between sympatric host and parasite populations driven by vector genetics appears to be a factor that influences dynamics of disease epidemics and evolution of insect-vectored viruses. Although T. tabaci is the primary vector of Tomato spotted wilt virus (TSWV) in some areas of the world, it is not an important vector of this economically important plant virus in many areas where it occurs. Previous studies suggest that genetic variation of thrips populations, virus isolates, or both are important factors underlying the localized importance of this species as a vector of TSWV. This study was undertaken to quantify variation in transmissibility of TSWV isolates by T. tabaci, in the ability of T. tabaci to transmit isolates of TSWV, and to examine the possibility that genetic interactions and local adaptation contribute to the localized nature of this species as a vector of TSWV. Isofemale lines of Thrips tabaci from multiple locations were tested for their ability to transmit multiple TSWV isolates collected at the same and different locations as the thrips. Results revealed that the probability of an isofemale line transmitting TSWV varied among virus isolates, and the probability of an isolate being transmitted varied among isofemale lines. These results indicate that the interaction of T. tabaci and TSWV isolate genetic determinants underlie successful transmission of TSWV by T. tabaci. Further analysis revealed sympatric vector-virus pairing resulted in higher transmission than allopatric pairing, which suggests that local adaptation is occurring between T. tabaci and TSWV isolates.	[Jacobson, Alana L.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Kennedy, GG (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	george_kennedy@ncsu.edu			North Carolina Tobacco Commission	North Carolina Tobacco Commission	The sources of funding for this work were provided by the North Carolina Tobacco Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatzivassiliou EK, 2008, PLANT DIS, V92, P1012, DOI 10.1094/PDIS-92-7-1012; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Chatzivassiliou EK, 1998, RECENT PROGR TOSPOVI, P59; CULBREATH AK, 1991, PLANT DIS, V75, P483, DOI 10.1094/PD-75-0483; Eckel CS, 1996, ENTOMOL EXP APPL, V78, P19, DOI 10.1007/BF00304453; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Groves RL, 2001, PHYTOPATHOLOGY, V91, P891, DOI 10.1094/PHYTO.2001.91.9.891; Groves RL, 2003, J ECON ENTOMOL, V96, P1, DOI 10.1603/0022-0493-96.1.1; Groves RL, 2002, PLANT DIS, V86, P573, DOI 10.1094/PDIS.2002.86.6.573; Jenser G., 2006, Acta Phytopathologica et Entomologica Hungarica, V41, P297, DOI 10.1556/APhyt.41.2006.3-4.12; Jenser G, 2003, J APPL ENTOMOL, V127, P7, DOI 10.1046/j.1439-0418.2003.00704.x; KENDALL DM, 1990, SOUTHWEST ENTOMOL, V15, P80; King A. M. Q., 2012, VIRUS TAXONOMY, P737; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; LEMMETTY A, 1993, AGR SCI FINLAND, V2, P189, DOI 10.23986/afsci.72648; Morsello SC, 2008, ENVIRON ENTOMOL, V37, P79, DOI 10.1603/0046-225X(2008)37[79:TAPASP]2.0.CO;2; Morsello SC, 2009, ENTOMOL EXP APPL, V130, P138, DOI 10.1111/j.1570-7458.2008.00801.x; Moudy, 2007, AM J TROP MED HYG, V77, P1176; Nagata T, 2004, PLANT PATHOL, V53, P136, DOI 10.1111/j.0032-0862.2004.00984.x; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; PALIWAL YC, 1974, CAN J BOT, V52, P1177, DOI 10.1139/b74-151; PALIWAL YC, 1976, CAN J BOT, V54, P402, DOI 10.1139/b76-038; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Peters D, 1995, ACTA HORTIC, P29; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Sakimura K, 1932, J ECON ENTOMOL, V25, P884, DOI 10.1093/jee/25.4.884; SHERWOOD JL, 2000, ENCY PLANT PATHOLOGY, P1034; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Tedeschi R, 2001, PHYTOPARASITICA, V29, P37, DOI 10.1007/BF02981812; TRJAPITZIN SV, 1995, NATO ADV SCI INST SE, V276, P237; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wilson CR, 1998, PLANT PATHOL, V47, P171, DOI 10.1046/j.1365-3059.1998.00227.x; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	40	24	26	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54567	10.1371/journal.pone.0054567	http://dx.doi.org/10.1371/journal.pone.0054567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358707	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600071
J	Sun, YBY; Qu, XL; Zhang, XM; Caruana, G; Bertram, JF; Li, JH				Sun, Yu Bo Yang; Qu, Xinli; Zhang, Xueming; Caruana, Georgina; Bertram, John F.; Li, Jinhua			Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ADVANCED DIABETIC-NEPHROPATHY; NONDIABETIC RENAL-DISEASE; GLYCATION END-PRODUCTS; NF-KAPPA-B; RELAXING FACTOR; FILTRATION BARRIER; GENE-EXPRESSION; MICE LACKING; POLYMORPHISM	The role of podocytes in the development and progression of glomerular disease has been extensively investigated in the past decade. However, the importance of glomerular endothelial cells in the pathogenesis of proteinuria and glomerulosclerosis has been largely ignored. Recent studies have demonstrated that endothelial nitric oxide synthatase (eNOS) deficiency exacerbates renal injury in anti-GBM and remnant kidney models and accelerates diabetic kidney damage. Increasing evidence also demonstrates the importance of the glomerular endothelium in preventing proteinuria. We hypothesize that endothelial dysfunction can initiate and promote the development and progression of glomerulopathy. Administration of adriamycin (ADR) to C57BL/6 mice, normally an ADR resistant strain, with an eNOS deficiency induced overt proteinuria, severe glomerulosclerosis, interstitial fibrosis and inflammation. We also examined glomerular endothelial cell and podocyte injury in ADR-induced nephropathy in Balb/c mice, an ADR susceptible strain, by immunostaining, TUNEL and Western blotting. Interestingly, down-regulation of eNOS and the appearance of apoptotic glomerular endothelial cells occurred as early as 24 hours after ADR injection, whilst synaptopodin, a functional podocyte marker, was reduced 7 days after ADR injection and coincided with a significant increase in the number of apoptotic podocytes. Furthermore, conditioned media from mouse microvascular endothelial cells over-expressing GFP-eNOS protected podocytes from TNF-alpha-induced loss of synaptopodin. In conclusion, our study demonstrated that endothelial dysfunction and damage precedes podocyte injury in ADR-induced nephropathy. Glomerular endothelial cells may protect podocytes from inflammatory insult. Understanding the role of glomerular endothelial dysfunction in the development of kidney disease will facilitate in the design of novel strategies to treat kidney disease.	[Sun, Yu Bo Yang; Qu, Xinli; Zhang, Xueming; Caruana, Georgina; Bertram, John F.; Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Zhang, Xueming] Inner Mongolia Univ Sci & Technol, Baotou Med Coll, Baotou, Peoples R China	Monash University; Baotou Medical College; Inner Mongolia University of Science & Technology	Li, JH (corresponding author), Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic, Australia.	jinhua.li@monash.edu	Li, Jinhua/I-2741-2014; Bertram, John F/I-2588-2014	Bertram, John F/0000-0001-5863-6464; Sun, Yu Bo Yang/0000-0003-0863-2769; Li, Jinhua/0000-0003-4039-5759	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia; NHMRC Career Development Award	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Monash University Accelerating Programme and the National Health and Medical Research Council (NHMRC) of Australia. JL is the recipient of a NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVASTHI PS, 1980, J CLIN INVEST, V65, P121, DOI 10.1172/JCI109641; Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Davila-Esqueda ME, 2005, RENAL FAILURE, V27, P115, DOI 10.1081/JDI-200042728; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; FORSTERMANN U, 1989, EUR HEART J, V10, P36, DOI 10.1093/eurheartj/10.suppl_F.36; FORSTERMANN U, 1993, EUR HEART J, V14, P10; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Guzik TJ, 2007, CIRC RES, V101, P227, DOI 10.1161/CIRCRESAHA.107.158295; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Lafayette RA, 1998, KIDNEY INT, V54, P1240, DOI 10.1046/j.1523-1755.1998.00097.x; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Morita T, 1999, CLIN NEPHROL, V52, P203; MUNDEL P, 1995, HISTOCHEM CELL BIOL, V103, P75, DOI 10.1007/BF01464478; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sharma M, 2005, KIDNEY INT, V68, P2735, DOI 10.1111/j.1523-1755.2005.00744.x; Sharma M, 2009, AM J PHYSIOL-RENAL, V296, pF1386, DOI 10.1152/ajprenal.90369.2008; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shin YS, 2004, DIABETES RES CLIN PR, V65, P257, DOI 10.1016/j.diabres.2004.01.010; SHULTZ PJ, 1990, AM J PHYSIOL, V258, pF162, DOI 10.1152/ajprenal.1990.258.1.F162; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Slater SC, 2012, INT J BIOCHEM CELL B, V44, P1482, DOI 10.1016/j.biocel.2012.05.020; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Stehouwer CDA, 2004, NEPHROL DIAL TRANSPL, V19, P778, DOI 10.1093/ndt/gfh015; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Ueda S, 2010, J NEPHROL, V23, P377; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yao J, 1998, KIDNEY INT, V53, P598, DOI 10.1046/j.1523-1755.1998.00793.x; Zanchi A, 2000, KIDNEY INT, V57, P405, DOI 10.1046/j.1523-1755.2000.00860.x; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	51	73	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55027	10.1371/journal.pone.0055027	http://dx.doi.org/10.1371/journal.pone.0055027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359116	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600144
J	Weber, BS; Miyata, ST; Iwashkiw, JA; Mortensen, BL; Skaar, EP; Pukatzki, S; Feldman, MF				Weber, Brent S.; Miyata, Sarah T.; Iwashkiw, Jeremy A.; Mortensen, Brittany L.; Skaar, Eric P.; Pukatzki, Stefan; Feldman, Mario F.			Genomic and Functional Analysis of the Type VI Secretion System in Acinetobacter	PLOS ONE			English	Article							IRON ACQUISITION FUNCTIONS; PROTEIN SECRETION; BAUMANNII PATHOGENESIS; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; BURKHOLDERIA-CENOCEPACIA; INTESTINAL INFLAMMATION; GALLERIA-MELLONELLA; ESCHERICHIA-COLI	The genus Acinetobacter is comprised of a diverse group of species, several of which have raised interest due to potential applications in bioremediation and agricultural purposes. In this work, we show that many species within the genus Acinetobacter possess the genetic requirements to assemble a functional type VI secretion system (T6SS). This secretion system is widespread among Gram negative bacteria, and can be used for toxicity against other bacteria and eukaryotic cells. The most studied species within this genus is A. baumannii, an emerging nosocomial pathogen that has become a significant threat to healthcare systems worldwide. The ability of A. baumannii to develop multidrug resistance has severely reduced treatment options, and strains resistant to most clinically useful antibiotics are frequently being isolated. Despite the widespread dissemination of A. baumannii, little is known about the virulence factors this bacterium utilizes to cause infection. We determined that the T6SS is conserved and syntenic among A. baumannii strains, although expression and secretion of the hallmark protein Hcp varies between strains, and is dependent on TssM, a known structural protein required for T6SS function. Unlike other bacteria, A. baumannii ATCC 17978 does not appear to use its T6SS to kill Escherichia coli or other Acinetobacter species. Deletion of tssM does not affect virulence in several infection models, including mice, and did not alter biofilm formation. These results suggest that the T6SS fulfils an important but as-yet-unidentified role in the various lifestyles of the Acinetobacter spp.	[Weber, Brent S.; Iwashkiw, Jeremy A.; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada; [Miyata, Sarah T.; Pukatzki, Stefan] Univ Alberta, Heritage Med Res Ctr, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Mortensen, Brittany L.; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	University of Alberta; University of Alberta; Vanderbilt University	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976	University of Alberta; Alberta Glycomics Center; Alberta Innovates-Health Solutions; Canadian Institute for Health Research Operating Grant [MOP-84473]; Alberta Heritage Foundation for Medical Research Endowment Fund; Childhood Infections Research Program [1T32AI095202-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095202] Funding Source: NIH RePORTER	University of Alberta(University of Alberta); Alberta Glycomics Center; Alberta Innovates-Health Solutions; Canadian Institute for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research Endowment Fund; Childhood Infections Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the Feldman lab is supported by the University of Alberta and the Alberta Glycomics Center. MFF is a Alberta Heritage Foundation for Medical Research scholar and Canadian Institutes of Health Research new investigator. STM is the recipient of an Alberta Innovates-Health Solutions Graduate Studentship Award. Work in SUP's laboratory is supported by the Canadian Institute for Health Research Operating Grant MOP-84473 and Alberta Innovates-Health Solutions (funded by the Alberta Heritage Foundation for Medical Research Endowment Fund). EPS is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases. BLM was supported by the Childhood Infections Research Program training program (1T32AI095202-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Carr EL, 2003, INT J SYST EVOL MICR, V53, P953, DOI 10.1099/ijs.0.02486-0; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hood MI, 2012, INFECT IMMUN; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Houang ETS, 2001, J CLIN MICROBIOL, V39, P228, DOI 10.1128/JCM.39.1.228-234.2001; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; JUNI E, 1972, J BACTERIOL, V112, P917, DOI 10.1128/JB.112.2.917-931.1972; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mara K, 2012, RES MICROBIOL, V163, P161, DOI 10.1016/j.resmic.2011.12.002; March C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010033; Margetts MB, 2000, PROTEIN EXPRES PURIF, V18, P262, DOI 10.1006/prep.2000.1193; McConnell MJ, 2012, FEMS MICROBIOL REV; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rokhbakhsh-Zamin F, 2011, J MICROBIOL BIOTECHN, V21, P556, DOI 10.4014/jmb.1012.12006; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Rupper A, 2001, BBA-GEN SUBJECTS, V1525, P205, DOI 10.1016/S0304-4165(01)00106-4; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sahl JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-291; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006; Vidal R, 1996, MICROBIOS, V86, P49; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	75	76	80	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55142	10.1371/journal.pone.0055142	http://dx.doi.org/10.1371/journal.pone.0055142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365692	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600157
J	Curtis, VF; Wang, H; Yang, PY; McLendon, RE; Li, XH; Zhou, QY; Wang, XF				Curtis, Valerie F.; Wang, Hui; Yang, Pengyuan; McLendon, Roger E.; Li, Xiaohan; Zhou, Qun-Yong; Wang, Xiao-Fan			A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; TEMOZOLOMIDE; PROKINETICINS; MACROPHAGES; RESISTANCE; RECEPTORS; SURVIVAL; BV8; MICROENVIRONMENT; REFRACTORINESS	Infiltration of myeloid cells in the tumor microenvironment is often associated with enhanced angiogenesis and tumor progression, resulting in poor prognosis in many types of cancer. The polypeptide chemokine PK2 (Bv8, PROK2) has been shown to regulate myeloid cell mobilization from the bone marrow, leading to activation of the angiogenic process, as well as accumulation of macrophages and neutrophils in the tumor site. Neutralizing antibodies against PK2 were shown to display potent anti-tumor efficacy, illustrating the potential of PK2-antagonists as therapeutic agents for the treatment of cancer. In this study we demonstrate the anti-tumor activity of a small molecule PK2 antagonist, PKRA7, in the context of glioblastoma and pancreatic cancer xenograft tumor models. For the highly vascularized glioblastoma, PKRA7 was associated with decreased blood vessel density and increased necrotic areas in the tumor mass. Consistent with the anti-angiogenic activity of PKRA7 in vivo, this compound effectively reduced PK2-induced microvascular endothelial cell branching in vitro. For the poorly vascularized pancreatic cancer, the primary anti-tumor effect of PKRA7 appears to be mediated by the blockage of myeloid cell migration/infiltration. At the molecular level, PKRA7 inhibits PK2-induced expression of certain pro-migratory chemokines and chemokine receptors in macrophages. Combining PKRA7 treatment with standard chemotherapeutic agents resulted in enhanced effects in xenograft models for both types of tumor. Taken together, our results indicate that the anti-tumor activity of PKRA7 can be mediated by two distinct mechanisms that are relevant to the pathological features of the specific type of cancer. This small molecule PK2 antagonist holds the promise to be further developed as an effective agent for combinational cancer therapy.	[Curtis, Valerie F.; Wang, Hui; Yang, Pengyuan; Wang, Xiao-Fan] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Li, Xiaohan; Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	Duke University; Duke University; University of California System; University of California Irvine	Wang, XF (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA.	xiao.fan.wang@duke.edu			National Cancer Institute [CA151541]; National Institutes of Health [MH67753]; NATIONAL CANCER INSTITUTE [R01CA151541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067753] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This was supported by CA151541 to XFW from the National Cancer Institute (www.cancer.gov) and by MH67753 to QYZ from National Institutes of Health (www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cheng CL, 2005, MOL CANCER THER, V4, P1364, DOI 10.1158/1535-7163.MCT-05-0128; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Cummings TJ, 2001, ARCH PATHOL LAB MED, V125, P637; Damaraju VL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-121; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P141, DOI 10.1007/s002329900093; Dempke WCM, 2009, EUR J CANCER, V45, P1117, DOI 10.1016/j.ejca.2008.11.038; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Franchi S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-60; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Kim SY, 1996, J MEMBRANE BIOL, V152, P117, DOI 10.1007/s002329900091; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Martucci C, 2006, BRIT J PHARMACOL, V147, P225, DOI 10.1038/sj.bjp.0706467; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Patel VJ, 2000, CLIN CANCER RES, V6, P4154; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rich JN, 2005, CLIN CANCER RES, V11, P8145, DOI 10.1158/1078-0432.CCR-05-0319; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Shojaei F, 2008, DRUG RESIST UPDATE, V11, P219, DOI 10.1016/j.drup.2008.09.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi Yutaka, 2011, Front Biosci (Elite Ed), V3, P541, DOI 10.2741/e268; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Urayama K, 2009, CARDIOVASC RES, V81, P28, DOI 10.1093/cvr/cvn251; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wen HT, 2007, EUR J IMMUNOL, V37, P2487, DOI 10.1002/eji.200737370; Wong BM, 2001, J LEUKOCYTE BIOL, V69, P959; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhou QY, 2006, MOL INTERV, V6, P330, DOI 10.1124/mi.6.6.6	51	40	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54916	10.1371/journal.pone.0054916	http://dx.doi.org/10.1371/journal.pone.0054916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372791	gold, Green Published			2022-12-25	WOS:000314021500143
J	Kang, BN; Ha, SG; Bahaie, NS; Hosseinkhani, MR; Ge, XN; Blumenthal, MN; Rao, SP; Sriramarao, P				Kang, Bit Na; Ha, Sung Gil; Bahaie, Nooshin S.; Hosseinkhani, M. Reza; Ge, Xiao Na; Blumenthal, Malcolm N.; Rao, Savita P.; Sriramarao, P.			Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; 5-HT2A RECEPTOR ANTAGONIST; INDUCED DOPAMINE RELEASE; CELL-MIGRATION; THROMBOXANE A(2); BONE-MARROW; RHO GTPASES; ACTIVATION; 5-HYDROXYTRYPTAMINE; ADHESION	Association of the neurotransmitter serotonin (5-HT) with the pathogenesis of allergic asthma is well recognized and its role as a chemoattractant for eosinophils (Eos) in vitro and in vivo has been previously demonstrated. Here we have examined the regulation of 5-HT-induced human and murine Eos trafficking and migration at a cellular and molecular level. Eos from allergic donors and bone marrow-derived murine Eos (BM-Eos) were found to predominantly express the 5-HT2A receptor. Exposure to 5-HT or 2,5-dimethoxy-4-iodoamphetamine (DOI), a 5-HT2A/C selective agonist, induced rolling of human Eos and AML14.3D10 human Eos-like cells on vascular cell adhesion molecule (VCAM)-1 under conditions of flow in vitro coupled with distinct cytoskeletal and cell shape changes as well as phosphorylation of MAPK. Blockade of 5-HT2A or of ROCK MAPK, PI3K, PKC and calmodulin, but not G(alpha i)-proteins, with specific inhibitors inhibited DOI-induced rolling, actin polymerization and changes in morphology of VCAM-1-adherent AML14.3D10 cells. More extensive studies with murine BM-Eos demonstrated the role of 5-HT in promoting rolling in vivo within inflamed post-capillary venules of the mouse cremaster microcirculation and confirmed that down-stream signaling of 5-HT2A activation involves ROCK, MAPK, PI3K, PKC and calmodulin similar to AML14.3D10 cells. DOI-induced migration of BM-Eos is also dependent on these signaling molecules and requires Ca2+. Further, activation of 5-HT2A with DOI led to an increase in intracellular Ca2+ levels in murine BM-Eos. Overall, these data demonstrate that 5-HT (or DOI)/5-HT2A interaction regulates Eos trafficking and migration by promoting actin polymerization associated with changes in cell shape/morphology that favor cellular trafficking and recruitment via activation of specific intracellular signaling molecules (ROCK, MAPK, PI3K and the PKC-calmodulin pathway).	[Kang, Bit Na; Ha, Sung Gil; Bahaie, Nooshin S.; Hosseinkhani, M. Reza; Ge, Xiao Na; Rao, Savita P.; Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, Lab Allerg Dis & Inflammat, St Paul, MN 55108 USA; [Blumenthal, Malcolm N.; Sriramarao, P.] Univ Minnesota, Dept Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sriramarao, P (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Lab Allerg Dis & Inflammat, St Paul, MN 55108 USA.	psrao@umn.edu		Rao, Srirama/0000-0001-9082-1029	National Institutes of Health [HL079304, AI35796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035796, R01AI035796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants HL079304 and AI35796 to P. Sriramarao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bahaie NS, 2012, J IMMUNOL, V188, P1479, DOI 10.4049/jimmunol.1102253; Bahaie NS, 2011, J BIOL CHEM, V286, P38231, DOI 10.1074/jbc.M111.279554; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Boehme SA, 1999, J IMMUNOL, V163, P1611; Boehme SA, 2004, J IMMUNOL, V173, P3599, DOI 10.4049/jimmunol.173.6.3599; BOOIJNOORD H, 1969, SCAND J RESPIR DIS, V50, P301; Broide D, 2008, CELLULAR ADHESION IN, V1, P149; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; Delaney C, 2011, AM J PHYSIOL-LUNG C, V301, pL937, DOI 10.1152/ajplung.00198.2011; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Freire-Garabal M, 2003, BRIT J PHARMACOL, V139, P457, DOI 10.1038/sj.bjp.0705188; Gandullia E, 1966, Minerva Pediatr, V18, P2230; HELLSTRAND K, 1990, CELL IMMUNOL, V127, P199, DOI 10.1016/0008-8749(90)90125-B; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; ICHIKAWA J, 1995, BRAIN RES, V698, P204, DOI 10.1016/0006-8993(95)00865-N; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; IKEN K, 1995, CELL IMMUNOL, V163, P1, DOI 10.1006/cimm.1995.1092; Kang BN, 2012, AM J PHYSIOL-LUNG C, V302, pL1179, DOI 10.1152/ajplung.00005.2012; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; Kitson SL, 2007, CURR PHARM DESIGN, V13, P2621, DOI 10.2174/138161207781663000; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Kuroki T, 2003, BRAIN RES, V972, P216, DOI 10.1016/S0006-8993(03)02516-2; Kurrasch-Orbaugh DM, 2003, J NEUROCHEM, V86, P980, DOI 10.1046/j.1471-4159.2003.01921.x; Kushnir-Sukhov NM, 2006, J IMMUNOL, V177, P6422, DOI 10.4049/jimmunol.177.9.6422; Lechin F, 1998, J CLIN PHARMACOL, V38, P918, DOI 10.1002/j.1552-4604.1998.tb04387.x; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lima C, 2007, CLIN EXP ALLERGY, V37, P723, DOI 10.1111/j.1365-2222.2007.02700.x; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; MAREK GJ, 1994, EUR J PHARMACOL, V259, P137, DOI 10.1016/0014-2999(94)90502-9; Marek GJ, 1996, J PHARMACOL EXP THER, V278, P1373; Matsusaka S, 2005, BIOCHEM BIOPH RES CO, V337, P916, DOI 10.1016/j.bbrc.2005.09.129; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Menard G, 2007, CLIN EXP IMMUNOL, V150, P340, DOI 10.1111/j.1365-2249.2007.03492.x; Miike S, 2000, J LEUKOCYTE BIOL, V67, P117, DOI 10.1002/jlb.67.1.117; Mikulski Z, 2010, AM J PHYSIOL-LUNG C, V299, pL272, DOI 10.1152/ajplung.00032.2010; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Pakala R, 1997, CIRCULATION, V96, P2280; Pakala R, 1998, J LAB CLIN MED, V131, P527, DOI 10.1016/S0022-2143(98)90061-0; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Sabroe I, 1999, J IMMUNOL, V162, P2946; Sasaki T, 1966, Arerugi, V15, P831; Sikora L, 2003, AM J PHYSIOL-LUNG C, V285, pL654, DOI 10.1152/ajplung.00448.2002; SORENSEN SM, 1993, J PHARMACOL EXP THER, V266, P684; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; VONDRA V, 1975, Casopis Lekaru Ceskych, V114, P401; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Zuberi RI, 2009, J IMMUNOL, V183, P3971, DOI 10.4049/jimmunol.0901604	68	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54840	10.1371/journal.pone.0054840	http://dx.doi.org/10.1371/journal.pone.0054840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372779	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500135
J	Marquez, JC; Kolasa, J				Marquez, Juan C.; Kolasa, Jurek			Local and Regional Processes in Community Assembly	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; NULL MODEL ANALYSIS; ECOLOGICAL COMMUNITIES; SPECIES-DIVERSITY; METACOMMUNITY STRUCTURE; DISPERSAL LIMITATION; NEUTRAL THEORY; ROCK POOLS; RULES; DYNAMICS	Controversy on whether local (deterministic) or regional (stochastic) factors control the structure of communities persists after decades of research. The main reason for why it has not been resolved may lie in the nature of evidence which largely comes from realized natural communities. In such communities assembly history leaves a mark that may support either set of factors. To avoid the confounding effects of assembly history we controlled for these effects experimentally. We created a null community by mixing 17 rock pool communities. We then divided the null community into replicates and distributed among treatments representing a gradient of factors from local to regional. We hypothesized that if deterministic factors dominate the assembly of communities, community structures should show a corresponding gradient from being very similar and convergent to dissimilar and divergent. In contrast, if local processes are predominantly stochastic in nature, such a gradient of community configurations should emerge even in the homogeneous setting. Our results appear to partially support both hypotheses and thus suggest that both deterministic and stochastic processes contribute to the assembly of communities. Furthermore, we found that to satisfactorily explain patterns observed in natural communities environmental heterogeneity and regional processes must also be considered. In conclusion, although deterministic mechanisms seem to be important in the assembly of communities, in natural systems their signal may be diluted and masked whenever other factors exert meaningful influence. Such factors increase the number of possible paths to the point that the number of paths equals the number of communities in a metacommunity.	[Marquez, Juan C.; Kolasa, Jurek] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Marquez, JC (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	juancmarquezh@gmail.com		Kolasa, Jurek/0000-0003-0910-8950	Natural Science and Engineering Research Council of Canada [NSERC 5-31314-6100]; Colfuturo grant for graduate studies	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Colfuturo grant for graduate studies	This study was funded by the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number NSERC 5-31314-6100 to Jurek Kolasa and the Colfuturo grant for graduate studies (http://www.colfuturo.org/) to Juan Marquez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Beisner Beatrix E., 2005, P321; Belyea L.R., 2004, ASSEMBLY RULES RESTO, P115; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; Brown JH, 2002, AM NAT, V160, P815, DOI 10.1086/343882; Buenau KE, 2007, ECOLOGY, V88, P3022, DOI 10.1890/06-1850.1; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2005, MECOMMUNITIES SPATIA; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fox BJ, 1987, EVOL ECOL, V1, P201, DOI 10.1007/BF02067551; FOX BJ, 1995, OIKOS, V73, P125, DOI 10.2307/3545735; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 1997, OIKOS, V80, P311, DOI 10.2307/3546599; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Hu XS, 2007, AM NAT, V170, P844, DOI 10.1086/522935; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jenkins DG, 2006, ECOLOGY, V87, P1523, DOI 10.1890/0012-9658(2006)87[1523:ISOQEI]2.0.CO;2; Jenkins DG, 2011, PHILOS T R SOC B, V366, P2331, DOI 10.1098/rstb.2011.0064; Jenkins DG, 1998, ECOL MONOGR, V68, P421, DOI 10.1890/0012-9615(1998)068[0421:DSCDIS]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Jocque M, 2010, FRESHWATER BIOL, V55, P1587, DOI 10.1111/j.1365-2427.2010.02402.x; Kolasa J, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P212; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Mouquet N, 2003, OIKOS, V103, P618, DOI 10.1034/j.1600-0706.2003.12772.x; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; RAUP DM, 1979, J PALEONTOL, V53, P1213; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Romanuk TN, 2001, ECOSCIENCE, V8, P259, DOI 10.1080/11956860.2001.11682652; Shurin JB, 2000, ECOLOGY, V81, P3062, DOI 10.2307/177401; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Therriault Thomas W., 2002, Aquatic Ecology, V36, P529, DOI 10.1023/A:1021178629707; Therriault TW, 2001, ISR J ZOOL, V47, P477, DOI 10.1560/BWWA-DTXB-LBJK-5GV5; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Ulrich W, 2004, OIKOS, V107, P603, DOI 10.1111/j.0030-1299.2004.12981.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Verdy A, 2010, J THEOR BIOL, V262, P116, DOI 10.1016/j.jtbi.2009.09.011; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056	57	21	22	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54580	10.1371/journal.pone.0054580	http://dx.doi.org/10.1371/journal.pone.0054580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355879	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500088
J	Huang, SD; Yuan, Y; Tang, H; Liu, XH; Fu, CG; Cheng, HZ; Bi, JW; Yu, YW; Gong, DJ; Zhang, W; Chen, J; Xu, ZY				Huang, Sheng-Dong; Yuan, Yang; Tang, Hao; Liu, Xiao-Hong; Fu, Chuan-Gang; Cheng, He-Zhong; Bi, Jian-Wei; Yu, Yong-Wei; Gong, De-Jun; Zhang, Wei; Chen, Jie; Xu, Zhi-Yun			Tumor Cells Positive and Negative for the Common Cancer Stem Cell Markers Are Capable of Initiating Tumor Growth and Generating Both Progenies	PLOS ONE			English	Article							MELANOMA-CELLS; GLIOMA-CELLS; IDENTIFICATION; LEUKEMIA; CD133(+); HETEROGENEITY; POPULATIONS; PERSISTENCE	The cancer stem cell (CSC) model depicts that tumors are hierarchically organized and maintained by CSCs lying at the apex. CSCs have been "identified" in a variety of tumors through the tumor-forming assay, in which tumor cells distinguished by a certain cell surface marker (known as a CSC marker) were separately transplanted into immunodeficient mice. In such assays, tumor cells positive but not negative for the CSC marker (hereby defined as CSC+ and CSC- cells, respectively) have the ability of tumor-forming and generating both progenies. However, here we show that CSC+ and CSC- cells exhibit similar proliferation in the native states. Using a cell tracing method, we demonstrate that CSC- cells exhibit similar tumorigenesis and proliferation as CSC+ cells when they were co-transplanted into immunodeficient mice. Through serial single-cell derived subline construction, we further demonstrated that CSC+ and CSC- cells from CSC marker expressing tumors could invariably generate both progenies, and their characteristics are maintained among different generations irrespective of the origins (CSC+-derived or CSC--derived). These findings demonstrate that tumorigenic cells cannot be distinguished by common CSC markers alone and we propose that cautions should be taken when using these markers independently to identify cancer stem cells due to the phenotypic plasticity of tumor cells.	[Huang, Sheng-Dong; Yuan, Yang; Tang, Hao; Liu, Xiao-Hong; Cheng, He-Zhong; Gong, De-Jun; Xu, Zhi-Yun] Second Mil Med Univ, Inst Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China; [Fu, Chuan-Gang; Zhang, Wei] Second Mil Med Univ, Dept Colorectal Surg, Changhai Hosp, Shanghai, Peoples R China; [Bi, Jian-Wei] Second Mil Med Univ, Dept Gen Surg, Changhai Hosp, Shanghai, Peoples R China; [Yu, Yong-Wei] Second Mil Med Univ, Dept Pathol, Changhai Hosp, Shanghai, Peoples R China; [Chen, Jie] Second Mil Med Univ, Dept Hematol, Changhai Hosp, Shanghai, Peoples R China; [Xu, Zhi-Yun] Second Mil Med Univ, Dept Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Huang, SD (corresponding author), Second Mil Med Univ, Inst Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China.	huangsd@smmu.edu.cn; zhiyunxu@smmu.edu.cn			National Natural Science Foundation of China [30471718, 30801094, 30872552]; Shanghai Municipal Natural Science Foundation [10140902300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (grants 30471718, 30801094, and 30872552) and the Shanghai Municipal Natural Science Foundation (grant 10140902300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Becker MW, 2011, BLOOD REV, V25, P75, DOI 10.1016/j.blre.2010.11.001; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Guzman Monica L, 2004, Cancer Control, V11, P97; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	48	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54579	10.1371/journal.pone.0054579	http://dx.doi.org/10.1371/journal.pone.0054579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349932	gold, Green Submitted, Green Published			2022-12-25	WOS:000313943000045
J	Picard-Jean, F; Bougie, I; Shuto, S; Bisaillon, M				Picard-Jean, Frederic; Bougie, Isabelle; Shuto, Satoshi; Bisaillon, Martin			The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme	PLOS ONE			English	Article							POLYMERASE-II; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GUANYLYLTRANSFERASE; MECHANISM; RIBAVIRIN; CELLS; CAP; DEHYDROGENASE	Mizoribine monophosphate (MZP) is a specific inhibitor of the cellular inosine-5'-monophosphate dehydrogenase (IMPDH), the enzyme catalyzing the rate-limiting step of de novo guanine nucleotide biosynthesis. MZP is a highly potent antagonistic inhibitor of IMPDH that blocks the proliferation of T and B lymphocytes that use the de novo pathway of guanine nucleotide synthesis almost exclusively. In the present study, we investigated the ability of MZP to directly inhibit the human RNA capping enzyme (HCE), a protein harboring both RNA 5'-triphosphatase and RNA guanylyltransferase activities. HCE is involved in the synthesis of the cap structure found at the 5' end of eukaryotic mRNAs, which is critical for the splicing of the cap-proximal intron, the transport of mRNAs from the nucleus to the cytoplasm, and for both the stability and translation of mRNAs. Our biochemical studies provide the first insight that MZP can inhibit the formation of the RNA cap structure catalyzed by HCE. In the presence of MZP, the RNA 5'-triphosphatase activity appears to be relatively unaffected while the RNA guanylyltransferase activity is inhibited, indicating that the RNA guanylyltransferase activity is the main target of MZP inhibition. Kinetic studies reveal that MZP is a non-competitive inhibitor that likely targets an allosteric site on HCE. Mizoribine also impairs mRNA capping in living cells, which could account for the global mechanism of action of this therapeutic agent. Together, our study clearly demonstrates that mizoribine monophosphate inhibits the human RNA guanylyltransferase in vitro and impair mRNA capping in cellulo.	[Picard-Jean, Frederic; Bougie, Isabelle; Bisaillon, Martin] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Quebec City, PQ, Canada; [Shuto, Satoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	University of Sherbrooke; Hokkaido University	Bisaillon, M (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Quebec City, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Shuto, Satoshi/AAH-4998-2020	Shuto, Satoshi/0000-0001-7850-8064	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; Ishida K, 2009, BIOL PHARM BULL, V32, P741, DOI 10.1248/bpb.32.741; Issur M, 2011, WIRES RNA, V2, P184, DOI 10.1002/wrna.43; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kim HJ, 2004, MOL CELL BIOL, V24, P6184, DOI 10.1128/MCB.24.14.6184-6193.2004; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KOYAMA H, 1983, BIOCHEM PHARMACOL, V32, P3547, DOI 10.1016/0006-2952(83)90301-5; Li GD, 1998, ENDOCRINOLOGY, V139, P3752, DOI 10.1210/en.139.9.3752; Liu D, 2005, TRANSPL INT, V18, P401, DOI 10.1111/j.1432-2277.2004.00042.x; Mao XD, 1996, MOL CELL BIOL, V16, P475; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; MIZUMOTO K, 1987, PROG NUCLEIC ACID RE, V34, P1, DOI 10.1016/S0079-6603(08)60491-2; MIZUNO K, 1974, J ANTIBIOT, V27, P775, DOI 10.7164/antibiotics.27.775; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Saijo M, 2005, ANTIVIR RES, V66, P159, DOI 10.1016/j.antiviral.2005.01.003; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seo KW, 2005, TRANSPL P, V37, P155, DOI 10.1016/j.transproceed.2005.01.020; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; Tsuzuki K, 2002, PEDIATR INT, V44, P224, DOI 10.1046/j.1328-8067.2001.01531.x; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Weber G, 1976, Adv Enzyme Regul, V14, P3, DOI 10.1016/0065-2571(76)90005-4; Wen YX, 1998, P NATL ACAD SCI USA, V95, P12226, DOI 10.1073/pnas.95.21.12226; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yan YF, 2005, RNA, V11, P1238, DOI 10.1261/rna.2930805; Yokota S, 2002, PEDIATR INT, V44, P196, DOI 10.1046/j.1328-8067.2002.01536.x; Yoshioka K, 2000, KIDNEY INT, V58, P317, DOI 10.1046/j.1523-1755.2000.00168.x; Zhong Binbin, 2005, Mod Rheumatol, V15, P264, DOI 10.1007/s10165-005-0406-x	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54621	10.1371/journal.pone.0054621	http://dx.doi.org/10.1371/journal.pone.0054621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349942	Green Published, Green Submitted, gold			2022-12-25	WOS:000313738900082
J	Beloglazova, N; Flick, R; Tchigvintsev, A; Brown, G; Popovic, A; Nocek, B; Yakunin, AF				Beloglazova, Natalia; Flick, Robert; Tchigvintsev, Anatoli; Brown, Greg; Popovic, Ana; Nocek, Boguslaw; Yakunin, Alexander F.			Nuclease Activity of the Human SAMHD1 Protein Implicated in the Aicardi-Goutieres Syndrome and HIV-1 Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 1.2 PROTEIN; HD-DOMAIN; TRIPHOSPHATE TRIPHOSPHOHYDROLASE; DEOXYGUANOSINE TRIPHOSPHATE; TREX1; ACID; REPLICATION; MUTATIONS; INFECTION; FAMILY	The human HD domain protein SAMHD1 is implicated in the Aicardi-Goutieres autoimmune syndrome and in the restriction of HIV-1 replication in myeloid cells. Recently, this protein has been shown to possess dNTP triphosphatase activity, which is proposed to inhibit HIV-1 replication and the autoimmune response by hydrolyzing cellular dNTPs. Here, we show that the purified full-length human SAMHD1 protein also possesses metal-dependent 3' -> 5' exonuclease activity against single-stranded DNAs and RNAs in vitro. In double-stranded substrates, this protein preferentially cleaved 3'-overhangs and RNA in blunt-ended DNA/RNA duplexes. Full-length SAMHD1 also exhibited strong DNA and RNA binding to substrates with complex secondary structures. Both nuclease and dNTP triphosphatase activities of SAMHD1 are associated with its HD domain, but the SAM domain is required for maximal activity and nucleic acid binding. The nuclease activity of SAMHD1 could represent an additional mechanism contributing to HIV-1 restriction and suppression of the autoimmune response through direct cleavage of viral and endogenous nucleic acids. In addition, we demonstrated the presence of dGTP triphosphohydrolase and nuclease activities in several microbial HD domain proteins, suggesting that these proteins might contribute to anti-viral defense in prokaryotes.	[Beloglazova, Natalia; Flick, Robert; Tchigvintsev, Anatoli; Brown, Greg; Popovic, Ana; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5S 3E5, Canada; [Nocek, Boguslaw] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5S 3E5, Canada.	a.iakounine@utoronto.ca	Popovic, Ana/AAF-8508-2021; Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; Ontario Research Fund Grant [ORF-GL2-01-004]; Natural Sciences and Engineering Research Council (NSERC)	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fund Grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Government of Canada through Genome Canada and Ontario Genomics Institute Grant 2009-OGI-ABC-1405, Ontario Research Fund Grant ORF-GL2-01-004, and a Natural Sciences and Engineering Research Council (NSERC) Discovery team grant (to A.F.Y.).	Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; MYERS JA, 1987, J BIOL CHEM, V262, P5288; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Oussenko IA, 2002, J BACTERIOL, V184, P6250, DOI 10.1128/JB.184.22.6250-6259.2002; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schultz J, 1997, PROTEIN SCI, V6, P249; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; WURGLER SM, 1993, J BIOL CHEM, V268, P20046; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	39	163	170	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8101	8110		10.1074/jbc.M112.431148	http://dx.doi.org/10.1074/jbc.M112.431148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23364794	Green Published, hybrid			2022-12-25	WOS:000316564500011
J	Nelson, JW; Subrahmanyan, RM; Summers, SA; Xiao, XS; Alkayed, NJ				Nelson, Jonathan W.; Subrahmanyan, Rishi M.; Summers, Sol A.; Xiao, Xiangshu; Alkayed, Nabil J.			Soluble Epoxide Hydrolase Dimerization Is Required for Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TARGET; GENETIC-VARIATION; COMPLEMENTATION; POLYMORPHISMS; PHOSPHATASE; PROTEINS; ENZYME; STROKE; CELLS; EPHX2	Soluble epoxide hydrolase (sEH) plays a key role in the metabolic conversion of the protective eicosanoid 14,15-epoxyeicosatrienoic acid to 14,15-dihydroxyeicosatrienoic acid. Accordingly, inhibition of sEH hydrolase activity has been shown to be beneficial in multiple models of cardiovascular diseases, thus identifying sEH as a valuable therapeutic target. Recently, a common human polymorphism (R287Q) was identified that reduces sEH hydrolase activity and is localized to the dimerization interface of the protein, suggesting a relationship between sEH dimerization and activity. To directly test the hypothesis that dimerization is essential for the proper function of sEH, we generated mutations within the sEH protein that would either disrupt or stabilize dimerization. We quantified the dimerization state of each mutant using a split firefly luciferase protein fragment-assisted complementation system. The hydrolase activity of each mutant was determined using a fluorescence-based substrate conversion assay. We found that mutations that disrupted dimerization also eliminated hydrolase enzymatic activity. In contrast, a mutation that stabilized dimerization restored hydrolase activity. Finally, we investigated the kinetics of sEH dimerization and found that the human R287Q polymorphism was metastable and capable of swapping dimer partners faster than the WT enzyme. These results indicate that dimerization is required for sEH hydrolase activity. Disrupting sEH dimerization may therefore serve as a novel therapeutic strategy for reducing sEH hydrolase activity.	[Nelson, Jonathan W.; Subrahmanyan, Rishi M.; Summers, Sol A.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Nelson, Jonathan W.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Xiao, Xiangshu] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Alkayed, NJ (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, 3181 SW Sam Jackson Pk Rd,UHN 2, Portland, OR 97239 USA.	alkayedn@ohsu.edu		Nelson, Jonathan/0000-0003-1456-9399	National Institutes of Health [R01 NS44313]; American Heart Association [11PRE5710008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044313, P30NS061800, R01NS070837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS44313 (to N.J.A.). This work was also supported by American Heart Association Predoctoral Fellowship 11PRE5710008 (to J.W.N.).	Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Burdon KP, 2008, DIABETES VASC DIS RE, V5, P128, DOI 10.3132/dvdr.2008.021; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Iliff JJ, 2009, FUTUR NEUROL, V4, P179, DOI 10.2217/14796708.4.2.179; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jester BW, 2010, J AM CHEM SOC, V132, P11727, DOI 10.1021/ja104491h; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Lee CR, 2011, HYPERTENSION, V57, P116, DOI 10.1161/HYPERTENSIONAHA.110.161695; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Zhang L, 2008, PHARMACOGENET GENOM, V18, P45, DOI 10.1097/FPC.0b013e3282f313e8; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	20	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7697	7703		10.1074/jbc.M112.429258	http://dx.doi.org/10.1074/jbc.M112.429258			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362272	Green Published, hybrid			2022-12-25	WOS:000316455300026
J	Schofield, AV; Gamell, C; Suryadinata, R; Sarcevic, B; Bernard, O				Schofield, Alice V.; Gamell, Cristina; Suryadinata, Randy; Sarcevic, Boris; Bernard, Ora			Tubulin Polymerization Promoting Protein 1 (Tppp1) Phosphorylation by Rho-associated Coiled-coil Kinase (Rock) and Cyclin-dependent Kinase 1 (Cdk1) Inhibits Microtubule Dynamics to Increase Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; IDENTIFICATION; TPPP/P25; PROGRESSION; SUBSTRATE; ASSEMBLIES; ACTIVATION; TRANSITION; EXPRESSION; MITOSIS	Tubulin polymerization promoting protein 1 (Tppp1) regulates microtubule (MT) dynamics via promoting MT polymerization and inhibiting histone deacetylase 6 (Hdac6) activity to increase MT acetylation. Our results reveal that as a consequence, Tppp1 inhibits cell proliferation by delaying the G(1)/S-phase and the mitosis to G(1)-phase transitions. We show that phosphorylation of Tppp1 by Rho-associated coiled-coil kinase (Rock) prevents its Hdac6 inhibitory activity to enable cells to enter S-phase. Whereas, our analysis of the role of Tppp1 during mitosis revealed that inhibition of its MT polymerizing and Hdac6 regulatory activities were necessary for cells to re-enter the G(1)-phase. During this investigation, we also discovered that Tppp1 is a novel Cyclin B/Cdk1 (cyclin-dependent kinase) substrate and that Cdk phosphorylation of Tppp1 inhibits its MT polymerizing activity. Overall, our results show that dual Rock and Cdk phosphorylation of Tppp1 inhibits its regulation of the cell cycle to increase cell proliferation.	[Schofield, Alice V.; Gamell, Cristina; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Cytoskeleton & Canc Unit, Fitzroy, Vic 3065, Australia; [Suryadinata, Randy; Sarcevic, Boris] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Cell Cycle & Canc Unit, Fitzroy, Vic 3065, Australia; [Schofield, Alice V.; Sarcevic, Boris; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Bernard, O (corresponding author), 9 Princes St, Fitzroy, Vic 3065, Australia.	obernard@svi.edu.au	Suryadinata, Randy/C-2819-2013	Sarcevic, Boris/0000-0002-8063-1050; Gamell, Cristina/0000-0003-0720-2652	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Cancer Council of Victoria; Victorian Government's Operational Infrastructure Support Program; Australian Postgraduate Award; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government's Operational Infrastructure Support Program; Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Cancer Council of Victoria, and the Victorian Government's Operational Infrastructure Support Program.; Recipient of an Australian Postgraduate Award.; Supported by a Fellowship from the NHMRC.	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charrasse S, 2000, EXP CELL RES, V254, P249, DOI 10.1006/excr.1999.4740; Chen J, 2008, INVEST OPHTH VIS SCI, V49, P175, DOI 10.1167/iovs.07-0488; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Harvey SAK, 2004, INVEST OPHTH VIS SCI, V45, P2168, DOI 10.1167/iovs.03-1218; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Li AQ, 2011, NAT CELL BIOL, V13, P402, DOI 10.1038/ncb2218; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; MASSON D, 1995, J CELL BIOL, V131, P1015, DOI 10.1083/jcb.131.4.1015; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Schofield AV, 2012, J BIOL CHEM, V287, P43620, DOI 10.1074/jbc.M112.394965; Skorobogatko YV, 2011, AMINO ACIDS, V40, P765, DOI 10.1007/s00726-010-0645-9; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	35	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7907	7917		10.1074/jbc.M112.441048	http://dx.doi.org/10.1074/jbc.M112.441048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23355470	Green Published, hybrid			2022-12-25	WOS:000316455300044
J	Pilli, E; Modi, A; Serpico, C; Achilli, A; Lancioni, H; Lippi, B; Bertoldi, F; Gelichi, S; Lari, M; Caramelli, D				Pilli, Elena; Modi, Alessandra; Serpico, Ciro; Achilli, Alessandro; Lancioni, Hovirag; Lippi, Barbara; Bertoldi, Francesca; Gelichi, Sauro; Lari, Martina; Caramelli, David			Monitoring DNA Contamination in Handled vs. Directly Excavated Ancient Human Skeletal Remains	PLOS ONE			English	Article							SEQUENCES; GENETICS; TEETH	Bones, teeth and hair are often the only physical evidence of human or animal presence at an archaeological site; they are also the most widely used sources of samples for ancient DNA (aDNA) analysis. Unfortunately, the DNA extracted from ancient samples, already scarce and highly degraded, is widely susceptible to exogenous contaminations that can affect the reliability of aDNA studies. We evaluated the molecular effects of sample handling on five human skeletons freshly excavated from a cemetery dated between the 11 to the 14th century. We collected specimens from several skeletal areas (teeth, ribs, femurs and ulnas) from each individual burial. We then divided the samples into two different sets: one labeled as "virgin samples'' (i.e. samples that were taken by archaeologists under contamination-controlled conditions and then immediately sent to the laboratory for genetic analyses), and the second called "lab samples''(i.e. samples that were handled without any particular precautions and subject to normal washing, handling and measuring procedures in the osteological lab). Our results show that genetic profiles from "lab samples'' are incomplete or ambiguous in the different skeletal areas while a different outcome is observed in the "virgin samples'' set. Generally, all specimens from different skeletal areas in the exception of teeth present incongruent results between "lab'' and "virgin'' samples. Therefore teeth are less prone to contamination than the other skeletal areas we analyzed and may be considered a material of choice for classical aDNA studies. In addition, we showed that bones can also be a good candidate for human aDNA analysis if they come directly from the excavation site and are accompanied by a clear taphonomic history.	[Pilli, Elena; Modi, Alessandra; Serpico, Ciro; Lippi, Barbara; Lari, Martina; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy; [Achilli, Alessandro; Lancioni, Hovirag] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Bertoldi, Francesca; Gelichi, Sauro] Univ Ca Foscari Venezia, Dipartimento Studi Umanistici, Venice, Italy	University of Florence; University of Perugia; Universita Ca Foscari Venezia	Lari, M (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy.	martina.lari@unifi.it	Achilli, Alessandro/I-9236-2012; Lari, Martina/A-4085-2009; Lancioni, Hovirag/F-9067-2014	Achilli, Alessandro/0000-0001-6871-3451; Lancioni, Hovirag/0000-0001-5514-1853; Caramelli, David/0000-0001-6468-1675; Pilli, Elena/0000-0002-3150-5082	MIUR [2008TE2B8S_002]; Progetti di ricerca fondamentale o di base Sardinia Region [CRP2_439]; FIRB [RBFR08U07M]	MIUR(Ministry of Education, Universities and Research (MIUR)); Progetti di ricerca fondamentale o di base Sardinia Region; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by MIUR grant #2008TE2B8S_002 and Progetti di ricerca fondamentale o di base Sardinia Region grant #CRP2_439 assigned to DC, and by FIRB grant #RBFR08U07M "Futuro in Ricerca'' assigned to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bouwman AS, 2006, AM J PHYS ANTHROPOL, V131, P428, DOI 10.1002/ajpa.20411; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2007, FORENSIC SCI INT, V173, P36, DOI 10.1016/j.forsciint.2007.01.020; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Cooper A, 2000, SCIENCE, V289, P1139; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Gilbert MTP, 2006, INT J OSTEOARCHAEOL, V16, P156, DOI 10.1002/oa.832; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Linderholm A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002316; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; RICHARDS M, 1993, WORLD ARCHAEOL, V25, P18, DOI 10.1080/00438243.1993.9980225; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Serre D, 2004, MOL BIOL EVOL, V21, P1463, DOI 10.1093/molbev/msh139; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wandeler P, 2003, MOL ECOL, V12, P1087, DOI 10.1046/j.1365-294X.2003.01807.x	28	35	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52524	10.1371/journal.pone.0052524	http://dx.doi.org/10.1371/journal.pone.0052524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372650	gold, Green Published			2022-12-25	WOS:000315210400003
J	Habart, D; Cheli, Y; Nugent, DJ; Ruggeri, ZM; Kunicki, TJ				Habart, David; Cheli, Yann; Nugent, Diane J.; Ruggeri, Zaverio M.; Kunicki, Thomas J.			Conditional Knockout of Integrin alpha 2 beta 1 in Murine Megakaryocytes Leads to Reduced Mean Platelet Volume	PLOS ONE			English	Article							PROPLATELET FORMATION; GLYCOPROTEIN-VI; COLLAGEN; ADHESION; MOUSE; EXPRESSION; GENERATION; MODEL; GPVI	We have engineered a transgenic mouse on a C57BL/6 background that bears a floxed Itga2 gene. The crossing of this mouse strain to transgenic mice expressing Cre recombinase driven by the megakaryocyte (MK)-specific Pf4 promoter permits the conditional knockout of Itga2 in the MK/platelet lineage. Mice lacking MK alpha 2 beta 1 develop normally, are fertile, and like their systemic alpha 2 beta 1 knockout counterparts, exhibit defective adhesion to and aggregation induced by soluble type I collagen and a delayed onset to low dose fibrillar collagen-induced aggregation, results consistent with blockade or loss of platelet alpha 2 beta 1. At the same time, we observed a significant reduction in mean platelet volume, which is consistent with the reported role of alpha 2 beta 1 in MK maturation and proplatelet formation in vivo. This transgenic mouse strain bearing a floxed Itga2 gene will prove valuable to distinguish in vivo the temporal and spatial contributions of alpha 2 integrin in selected cell types.	[Habart, David; Cheli, Yann; Ruggeri, Zaverio M.; Kunicki, Thomas J.] Scripps Res Inst, Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA; [Nugent, Diane J.; Kunicki, Thomas J.] CHOC Childrens Hosp, Orange, CA USA	Scripps Research Institute	Kunicki, TJ (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tkunicki@choc.org	Cheli, Yann/O-5783-2016; Habart, David/B-4291-2009	Cheli, Yann/0000-0001-9839-4332; 	NHLBI [R01 HL086904]; Roon Research Foundation; Ministry of Health, Czech Republic for development of research organization IKEM, Prague [00023001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086904, R01HL042846] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Roon Research Foundation; Ministry of Health, Czech Republic for development of research organization IKEM, Prague; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI (www.nhlbi.nih.gov) R01 HL086904 awarded to TJK, institutional support 00023001 from the Ministry of Health, Czech Republic for development of research organization IKEM, Prague awarded to DH, and a grant from the Roon Research Foundation awarded to ZMR. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; COLLER BS, 1989, BLOOD, V74, P182; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Kunicki TJ, 2012, ARTERIOSCL THROM VAS, V32, P147, DOI 10.1161/ATVBAHA.111.239392; KUNICKI TJ, 1988, J BIOL CHEM, V263, P4516; Kunicki TJ, 2011, HAEMATOLOGICA, V97, P692; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lundberg S, 2006, INFLAMM BOWEL DIS, V12, P172, DOI 10.1097/01.MIB.0000217765.96604.83; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Pallotta I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008359; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; TOPP KS, 1990, BLOOD, V76, P912; Trifiro E, 2009, BLOOD, V114, P1893, DOI 10.1182/blood-2009-03-209510; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Zou ZY, 2009, BLOOD, V113, P6428, DOI 10.1182/blood-2008-08-175356	32	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55094	10.1371/journal.pone.0055094	http://dx.doi.org/10.1371/journal.pone.0055094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359821	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600151
J	Basith, S; Manavalan, B; Gosu, V; Choi, S				Basith, Shaherin; Manavalan, Balachandran; Gosu, Vijayakumar; Choi, Sangdun			Evolutionary, Structural and Functional Interplay of the I kappa B Family Members	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NORMAL-MODE CALCULATIONS; DNA-BINDING; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; NUCLEAR-PROTEIN; ANKYRIN REPEAT; NETWORK MODEL; C-REL	A primary level of control for nuclear factor kappa B (NF-kappa B) is effected through its interactions with the inhibitor protein, inhibitor of kappa B (I kappa B). Several lines of evidence confirm the existence of multiple forms of I kappa B that appear to regulate NF-kappa B by distinct mechanisms. Therefore, we performed a comprehensive bioinformatics analysis to understand the evolutionary history and intrinsic functional diversity of IkB family members. Phylogenetic relationships were constructed to trace the evolution of the IkB family genes. Our phylogenetic analysis revealed 10 I kappa B subfamily members that clustered into 5 major clades. Since the ankyrin (ANK) domain appears to be more ancient than the Rel homology domain (RHD), our phylogenetic analysis suggests that some undefined ancestral set of ANK repeats acquired an RHD before any duplication and was later duplicated and then diverged into the different I kappa B subfamilies. Functional analysis identified several functionally divergent sites in the ANK repeat domains (ARDs) and revealed that this region has undergone strong purifying selection, suggesting its functional importance in I kappa B genes. Structural analysis showed that the major variations in the number of ANK repeats and high conformational changes in the finger loop ARD region contribute to the differing binding partner specificities, thereby leading to distinct I kappa B functions. In summary, our study has provided useful information about the phylogeny and structural and functional divergence of the I kappa B family. Additionally, we identified a number of amino acid sites that contribute to the predicted functional divergence of these proteins.	[Basith, Shaherin; Gosu, Vijayakumar; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Manavalan, Balachandran] Korea Inst Adv Study, Sch Computat Sci, Ctr In Silico Prot Sci, Seoul, South Korea	Ajou University; Korea Institute for Advanced Study (KIAS)	Choi, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Manavalan, Balachandran/Q-8279-2019	Manavalan, Balachandran/0000-0003-0697-9419; Gosu, Vijayakumar/0000-0001-6038-4104	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012016803]; Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources [KSC-2012-C3-28]; Priority Research Centers Program [NRF 2012-0006687]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources; Priority Research Centers Program	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012016803). This work was also partly supported by the Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources (KSC-2012-C3-28) and the Priority Research Centers Program (NRF 2012-0006687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Basith S, 2011, EXPERT OPIN THER PAT, V21, P927, DOI 10.1517/13543776.2011.569494; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Finn R. D., 2008, NUCLEIC ACIDS RES, V38, pD211; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HARRISON RW, 1984, BIOPOLYMERS, V23, P2943, DOI 10.1002/bip.360231216; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huguet C, 1997, ONCOGENE, V15, P2965, DOI 10.1038/sj.onc.1201471; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Huxford T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000075; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Manavalan B, 2012, ENCY SIGNALING MOL, P892; Manavalan B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00041; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Manavalan B, 2011, J MOL RECOGNIT, V24, P597, DOI 10.1002/jmr.1085; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; McDowall J, 2011, METHODS MOL BIOL, V694, P37, DOI 10.1007/978-1-60761-977-2_3; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Wu ZH, 2009, BIOCHEM BIOPH RES CO, V387, P348, DOI 10.1016/j.bbrc.2009.07.023; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000	83	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54178	10.1371/journal.pone.0054178	http://dx.doi.org/10.1371/journal.pone.0054178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372681	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500035
J	Gong, H; Zhang, X; Cheng, BA; Sun, Y; Li, CZ; Li, T; Zheng, L; Huang, K				Gong, Hao; Zhang, Xin; Cheng, Biao; Sun, Yue; Li, Chuanzhou; Li, Ting; Zheng, Ling; Huang, Kun			Bisphenol A Accelerates Toxic Amyloid Formation of Human Islet Amyloid Polypeptide: A Possible Link between Bisphenol A Exposure and Type 2 Diabetes	PLOS ONE			English	Article							MEMBRANE DISRUPTION; MISFOLDING DISEASES; HUMAN HEALTH; PEPTIDE; PROTEIN; IAPP; BPA; AGGREGATION; MECHANISM; INSULIN	Bisphenol A (BPA) is a chemical compound widely used in manufacturing plastic products. Recent epidemiological studies suggest BPA exposure is positively associated with the incidence of type 2 diabetes mellitus (T2DM), however the mechanisms underlying this link remain unclear. Human islet amyloid polypeptide (hIAPP) is a hormone synthesized and secreted by the pancreatic beta-cells. Misfolding of hIAPP into toxic oligomers and mature fibrils can disrupt cell membrane and lead to beta-cell death, which is regarded as one of the causative factors of T2DM. To test whether there are any connections between BPA exposure and hIAPP misfolding, we investigated the effects of BPA on hIAPP aggregation using thioflavin-T based fluorescence, transmission electronic microscopy, circular dichroism, dynamic light scattering, size-exclusion chromatography, fluorescence-dye leakage assay in an artificial micelle system and the generation of reactive oxygen species in INS-1 cells. We demonstrated that BPA not only dose-dependently promotes the aggregation of hIAPP and enhances the membrane disruption effects of hIAPP, but also promotes the extent of hIAPP aggregation related oxidative stress. Taken together, our results suggest that BPA exposure increased T2DM risk may involve the exacerbated toxic aggregation of hIAPP.	[Gong, Hao; Zhang, Xin; Cheng, Biao; Li, Ting; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Sun, Yue; Li, Chuanzhou; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Huang, Kun] Wuhan Inst Biotechnol, Ctr Biomed Res, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	lzheng217@hotmail.com; kunhuang2008@hotmail.com		Zheng, Ling/0000-0002-6545-4180; Li, Chuanzhou/0000-0003-0174-4215	National Basic Research Program of China [2009BC918304, 2012CB524901]; Natural Science Foundation of China [81222043, 30970607, 81172971, 81100687, 31271370]; Program for New Century Excellent Talents in University [NECT100623, NECT11-0170]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (2009BC918304 & 2012CB524901 to LZ), the Natural Science Foundation of China (Nos. 81222043, 30970607, 81172971 to KH; and Nos. 81100687 & 31271370 to LZ), the Program for New Century Excellent Talents in University (NECT100623 to LZ & NECT11-0170 to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Benachour N, 2009, TOXICOL APPL PHARM, V241, P322, DOI 10.1016/j.taap.2009.09.005; Bontempo P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-48; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Cheng B, 2012, PROTEINS IN PRESS; Cheng BA, 2012, BIOCHEM BIOPH RES CO, V419, P495, DOI 10.1016/j.bbrc.2012.02.042; Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cui W, 2009, FEBS J, V276, P3365, DOI 10.1111/j.1742-4658.2009.07061.x; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Law E, 2010, DIABETOLOGIA, V53, P1415, DOI 10.1007/s00125-010-1717-9; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Lee S, 2008, J NEUROSCI RES, V86, P2932, DOI 10.1002/jnr.21739; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lubick N, 2010, ENVIRON HEALTH PERSP, V118, pA116, DOI 10.1289/ehp.118-a116a; Manley S, 1997, DIABETES, V46, P1307; Mead MN, 2010, ENVIRON HEALTH PERSP, V118, pA399, DOI 10.1289/ehp.118-a399a; Melzer D, 2009, JAMA-J AM MED ASSOC, V301, P721; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Salamekh S, 2011, J MOL BIOL, V410, P294, DOI 10.1016/j.jmb.2011.05.015; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Zhang X, 2011, FEBS LETT, V585, P71, DOI 10.1016/j.febslet.2010.11.050; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	62	62	63	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54198	10.1371/journal.pone.0054198	http://dx.doi.org/10.1371/journal.pone.0054198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372685	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500039
J	Kebschull, M; Haupt, M; Jepsen, S; Deschner, J; Nickenig, G; Werner, N				Kebschull, Moritz; Haupt, Manuela; Jepsen, Soren; Deschner, James; Nickenig, Georg; Werner, Nikos			Mobilization of Endothelial Progenitors by Recurrent Bacteremias with a Periodontal Pathogen	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS INFECTION; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STEM-CELL NICHE; OSTEOPROTEGERIN EXPRESSION; SYSTEMIC INFLAMMATION; APOLIPOPROTEIN-E; IMMUNE-RESPONSE; ORAL INFECTION; ATHEROSCLEROSIS	Background: Periodontal infections are independent risk factors for atherosclerosis. However, the exact mechanisms underlying this link are yet unclear. Here, we evaluate the in vivo effects of bacteremia with a periodontal pathogen on endothelial progenitors, bone marrow-derived cells capable of endothelial regeneration, and delineate the critical pathways for these effects. Methods: 12-week old C57bl6 wildtype or toll-like receptor (TLR)-2 deficient mice were repeatedly intravenously challenged with 10(9) live P. gingivalis 381 or vehicle. Numbers of Sca1+/flk1+ progenitors, circulating angiogenic cells, CFU-Hill, and late-outgrowth EPC were measured by FACS/culture. Endothelial function was assessed using isolated organ baths, reendothelization was measured in a carotid injury model. RANKL/osteoprotegerin levels were assessed by ELISA/qPCR. Results: In wildtype mice challenged with intravenous P. gingivalis, numbers of Sca1+/flk1+ progenitors, CAC, CFU-Hill, and late-outgrowth EPC were strongly increased in peripheral circulation and spleen, whereas Sca1+/flk1+ progenitor numbers in bone marrow decreased. Circulating EPCs were functional, as indicated by improved endothelial function and improved reendothelization in infected mice. The osteoprotegerin/RANKL ratio was increased after P. gingivalis challenge in the bone marrow niche of wildtype mice and late-outgrowth EPC in vitro. Conversely, in mice deficient in TLR2, no increase in progenitor mobilization or osteoprotegerin/RANKL ratio was detected. Conclusion: Recurrent transient bacteremias, a feature of periodontitis, increase peripheral EPC counts and decrease EPC pools in the bone marrow, thereby possibly reducing overall endothelial regeneration capacity, conceivably explaining proatherogenic properties of periodontal infections. These effects are seemingly mediated by toll-like receptor (TLR)-2.	[Kebschull, Moritz; Jepsen, Soren; Deschner, James] Univ Bonn, Dept Periodontol Operat & Prevent Dent, Bonn, Germany; [Kebschull, Moritz; Haupt, Manuela; Nickenig, Georg; Werner, Nikos] Univ Bonn, Dept Internal Med 2, Bonn, Germany	University of Bonn; University of Bonn	Werner, N (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, Germany.	nikos.werner@ukb.uni-bonn.de	Kebschull, Moritz/F-7207-2010; DESCHNER, JAMES/AAW-3998-2021	Kebschull, Moritz/0000-0003-1863-0679; 	German Research Foundation [DFG KFO208 TP6, DFG KFO208 TP9]	German Research Foundation(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG KFO208 TP6 & TP9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Belibasakis GN, 2010, INFLAMMATION; Benslimane-Ahmim Z, 2011, J THROMB HAEMOST; Borden WB, 2009, REV CARDIOVASC MED, V10, P63; Brehm M, 2009, CLIN RES CARDIOL, V98, P477, DOI 10.1007/s00392-009-0021-5; Brouchet L, 2001, CIRCULATION, V103, P423; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cole JE, 2010, EXPERT REV CARDIOVAS, V8, P1619, DOI 10.1586/ERC.10.149; D'Amelio P, 2009, J Endocrinol Invest, V32, P6; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; de Villeroche VJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2934; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; Goussetis E, 2009, BLOOD CELL MOL DIS, V42, P294, DOI 10.1016/j.bcmd.2009.01.003; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hajishengallis G, 2008, J IMMUNOL, V181, P4141, DOI 10.4049/jimmunol.181.6.4141; Hajishengallis G, 2009, PERIODONTOL 2000, V51, P181, DOI 10.1111/j.1600-0757.2009.00304.x; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Honda T, 2005, ORAL MICROBIOL IMMUN, V20, P82, DOI 10.1111/j.1399-302X.2004.00193.x; Hujoel PP, 2001, J PERIODONTAL RES, V36, P48, DOI 10.1034/j.1600-0765.2001.00011.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ito H, 1999, CANCER RES, V59, P5875; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kinane DF, 2005, J CLIN PERIODONTOL, V32, P708, DOI 10.1111/j.1600-051X.2005.00741.x; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Li XA, 2011, J CLIN PERIODONTOL, V38, P148, DOI 10.1111/j.1600-051X.2010.01651.x; Li X, 2009, J CLIN PERIODONTOL, V36, P933, DOI 10.1111/j.1600-051X.2009.01481.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Lockhart PB, 2012, CIRCULATION; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lu HK, 2008, ORAL MICROBIOL IMMUN, V23, P220, DOI 10.1111/j.1399-302X.2007.00415.x; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; McGonigle JS, 2009, ANGIOGENESIS, V12, P35, DOI 10.1007/s10456-008-9127-z; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Padfield GJ, 2010, AM J PHYSIOL-HEART C, V298, pH2054, DOI 10.1152/ajpheart.00921.2009; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pollreisz A, 2010, J PERIODONTAL RES, V45, P239, DOI 10.1111/j.1600-0765.2009.01225.x; Reddi D, 2008, MICROBES INFECT, V10, P1459, DOI 10.1016/j.micinf.2008.08.007; Rodrigues PH, 2008, FRONT BIOSCI-LANDMRK, V13, P178, DOI 10.2741/2668; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Secchiero P, 2008, BLOOD, V111, P1287, DOI 10.1182/blood-2007-05-092031; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Sommers Marilyn Sawyer, 2003, Crit Care Nurs Clin North Am, V15, P13, DOI 10.1016/S0899-5885(02)00046-1; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2007, BASIC RES CARDIOL, V102, P565, DOI 10.1007/s00395-007-0680-1; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang JF, 2002, FEBS LETT, V521, P180, DOI 10.1016/S0014-5793(02)02872-7; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	70	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54860	10.1371/journal.pone.0054860	http://dx.doi.org/10.1371/journal.pone.0054860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355901	Green Published, gold, Green Submitted			2022-12-25	WOS:000314021500137
J	Parrilla-Bel, J; Young, MT; Moreno-Azanza, M; Canudo, JI				Parrilla-Bel, Jara; Young, Mark T.; Moreno-Azanza, Miguel; Ignacio Canudo, Jose			The First Metriorhynchid Crocodylomorph from the Middle Jurassic of Spain, with Implications for Evolution of the Subclade Rhacheosaurini	PLOS ONE			English	Article							SALT-GLANDS; CRETACEOUS TRANSITION; THALATTOSUCHIA; GEOSAURUS; SKULL; CROCODYLIFORM; MESOEUCROCODYLIA; DAKOSAURUS; SYSTEM; MEXICO	Background: Marine deposits from the Callovian of Europe have yielded numerous species of metriorhynchid crocodylomorphs. While common in English and French Formations, metriorhynchids are poorly known from the Iberian Peninsula. Twenty years ago an incomplete, but beautifully preserved, skull was discovered from the Middle Callovian of Spain. It is currently the oldest and best preserved metriorhynchid specimen from the Iberian Peninsula. Until now it has never been properly described and its taxonomic affinities remained obscure. Methodology/Principal Findings: Here we present a comprehensive description for this specimen and in doing so we refer it to a new genus and species: Maledictosuchus riclaensis. This species is diagnosed by numerous autapomorphies, including: heterodont dentition; tightly interlocking occlusion; lachrymal anterior process excludes the jugal from the preorbital fenestra; orbits longer than supratemporal fenestrae; palatine has two non-midline and one midline anterior processes. Our phylogenetic analysis finds Maledictosuchus riclaensis to be the basal-most known member of Rhacheosaurini (the subclade of increasingly mesopelagic piscivores that includes Cricosaurus and Rhacheosaurus). Conclusions/Significance: Our description of Maledictosuchus riclaensis shows that the craniodental morphologies that underpinned the success of Rhacheosaurini in the Late Jurassic and Early Cretaceous, as a result of increasing marine specialization to adaptations for feeding on fast small-bodied prey (i.e. divided and retracted external nares; reorientation of the lateral processes of the frontal; elongate, tubular rostrum; procumbent and non-carinated dentition; high overall tooth count; and dorsolaterally inclined paroccipital processes), first appeared during the Middle Jurassic. Rhacheosaurins were curiously rare in the Middle Jurassic, as only one specimen of Maledictosuchus riclaensis is known (with no representatives discovered from the well-sampled Oxford Clay Formation of England). As such, the feeding/marine adaptations of Rhacheosaurini did not confer an immediate selective advantage upon the group, and it took until the Late Jurassic for this subclade to dominate in Western Europe.	[Parrilla-Bel, Jara; Moreno-Azanza, Miguel; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus, IUCA Inst Univ Invest Ciencias Ambientales Aragon, E-50009 Zaragoza, Spain; [Young, Mark T.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	University of Zaragoza; University of Edinburgh	Parrilla-Bel, J (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus, IUCA Inst Univ Invest Ciencias Ambientales Aragon, E-50009 Zaragoza, Spain.	jarapb@unizar.es	Parrilla-Bel, Jara/K-7671-2017; Young, Mark T/P-3469-2014; Moreno-Azanza, Miguel/G-9165-2017	Parrilla-Bel, Jara/0000-0002-2426-7450; Young, Mark T/0000-0002-7263-6505; Moreno-Azanza, Miguel/0000-0002-7210-1033; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Spanish Ministerio de Economia y Competitividad [CGL2010-16447]; European Regional Development Fund; Government of Aragon ("Grupos Consolidados"); Government of Aragon ("Direccion General de Patrimonio Cultural"); Government of Aragon [B105/10]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados")(Gobierno de Aragon); Government of Aragon ("Direccion General de Patrimonio Cultural"); Government of Aragon(Gobierno de Aragon)	This paper forms part of the project CGL2010-16447, subsidized by the Spanish Ministerio de Economia y Competitividad, the European Regional Development Fund, and the Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"). JP-B is supported by a predoctoral research grant (B105/10) from the Government of Aragon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C. W., 1913, DESCRIPTIVE CATALO 2; [Anonymous], 2008, GEOTEMAS; [Anonymous], 2005, NATURALEZA ARAGONESA, V14, P95; Antunes MT, 1967, MEMORIAS SERVICOS GE, V13, P1; Aurell M., 2002, GEOLOGY SPAIN, P223; Bardet Nathalie, 1994, Historical Biology, V7, P313; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Buchy MC, 2008, NEUES JAHRB GEOL P-A, V249, P1, DOI 10.1127/0077-7749/2008/0249-0001; Buchy MC, 2006, CR PALEVOL, V5, P785, DOI 10.1016/j.crpv.2006.03.003; Buchy MC, ORYCTOS IN PRESS; BUFFETAUT E, 1987, SHORT HIST VERTEBRAT; Canudo JI, 2006, NEUES JAHRB GEOL P-A, V239, P77; Canudo JI, 1998, ARAGONIA, V1, P13; Canudo JI, 1997, CUADERNOS PALEONTOLO, V1, P14; Cariou E., 1988, P 2 INT S JUR STRAT, P395; Cau A, 2011, GONDWANA RES, V19, P550, DOI 10.1016/j.gr.2010.07.007; De Andrade MB, 2010, J VERTEBR PALEONTOL, V30, P1451, DOI 10.1080/02724634.2010.501442; de la Fuente MS., 2007, ASOCIACI N PALEONTOL, V11, P137; Fernandez M, 2000, LETHAIA, V33, P269; Fernandez M, 2008, NATURWISSENSCHAFTEN, V95, P79, DOI 10.1007/s00114-007-0296-1; Fernandez MS, 2011, J VERTEBR PALEONTOL, V31, P369, DOI 10.1080/02724634.2011.550361; Fernandez MS, 2009, J VERTEBR PALEONTOL, V29, P702, DOI 10.1671/039.029.0323; Ferreira OV., 1959, AN FAC CIEN PORTO, V41, P121; Fitzinger LI, 1843, SYSTEMA REPTILIUM, P20; Fraas E., 1902, PALAEONTOGRAPHICA, V49, P1; Fraas E, 1901, JAHRESHEFTE VEREINS, V57, P409; Frey E, 2002, CAN J EARTH SCI, V39, P1467, DOI 10.1139/E02-060; Gamez Vintaned JA, 2006, TESOROS FOSILES ARAG; Gandola R, 2006, J VERTEBR PALEONTOL, V26, P1009, DOI 10.1671/0272-4634(2006)26[1009:SGITFC]2.0.CO;2; Gasparini Z., 2008, REV GEOL CHILE, V35, P335; Gasparini Z. B, 1977, NEUES JB GEOLOGIE PA, V153, p341 ; Genera i Monells M, 2010, ORIGENES EVOLUCION E; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomez JJ, 2006, PALAEOGEOGR PALAEOCL, V236, P190, DOI 10.1016/j.palaeo.2005.11.008; Gomez J.J., 2004, GEOLOGIA ESPANA, P500; Grange DR, 1996, PALAEONTOLOGY, V39, P497; Hay O.P., 1930, 2 BIBLIO CATALOGUE F, V2; Hua S, 2000, GEOBIOS-LYON, V33, P467, DOI 10.1016/S0016-6995(00)80080-7; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Karl Hans-Volker, 2006, Studia Geologica Salmanticensia, V42, P49; Langston W. Jr., 1973, P263; Lendinez A, 1995, SERIE MAGNA EPILA HO; Lepage Yves, 2008, Bulletin de la Societe Geologique de Normandie et des Amis du Museum du Havre, V95, P5; Linan E, 2002, NATURALEZA ARAGONESA, V9, P16; Linan Eladio, 2010, P17; Linan Guijarro E, 2006, AQUARIA AGUA TERRITO, P18; Martinez R. D., 1995, NATURALIA PATAGONICA, V3, P93; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; Melendez G, 2000, CURSOS C, V128, P197; Melendez G, 2001, ENSENANZA CIENCIAS T, V9, P160; Melendez G, 1988, 3 C JUR ESP GUIA EXC, P265; Meyer CEH von, 1832, PALAOLOGICA GESCH ER; Meyer H.von., 1831, NOVA ACTA ACAD LEOPO, V15, P173; Ochev VG, 1981, PRIRODA, V5, P103; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Page KN, 2004, RIV ITAL PALEONTOL S, V110, P191, DOI 10.13130/2039-4942/6285; Parrilla-Bel J, 2011, VIAJANDO MUNDOS PRET, P241; Pereda Suberbiola X., 2012, BERNISSART DINOSAURS, P379; Perez Urresti I, 2005, CUADERNOS PALEONTOLO, V3, P50; Perez Urresti I, 2003, CUADERNOS PALEONTOLO, V2, P8; PHANSALKAR VG, 1994, CURR SCI INDIA, V67, P460; Pierce SE, 2009, J ANAT, V215, P555, DOI 10.1111/j.1469-7580.2009.01137.x; Pierce SE, 2009, PALAEONTOLOGY, V52, P1057, DOI 10.1111/j.1475-4983.2009.00904.x; Pol Diego, 2007, P116; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Quesada Juan M., 1998, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V94, P101; Ramajo J, 2006, THESIS U ZARAGOZA ZA; Rieppel O., 1979, BURGERGEMEINDE BERN, V7, P277; Royo-Torres R, 2009, PALAEONTOLOGY, V52, P1009, DOI 10.1111/j.1475-4983.2009.00898.x; Ruiz-Omenaca J. I., 2007, 23 JORN SOC ESP PAL, P204; Ruiz-Omenaca JI, 2010, COMM 5 C JUR ESP, P193; Sender Palomar LM, 2010, NATURALEZA ARAGONESA, V25, P4; SEQUEIROS L, 1984, Estudios Geologicos (Madrid), V40, P411; Steel R., 1973, HDB PALAOHERPETOL 16; Vignaud P, 1995, THESIS U POITIERS PO; von Sommerring ST, 1816, DENKSCHRIFTEN KONIGL, V6, P37; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Young MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044985; Young MT, 2012, ANAT REC, V295, P1147, DOI 10.1002/ar.22491; Young MT, 2011, ZOOL J LINN SOC-LOND, V163, P1199, DOI 10.1111/j.1096-3642.2011.00734.x; Young MT, 2011, BIOL LETTERS, V7, P913, DOI 10.1098/rsbl.2011.0357; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Young MT, 2009, ZOOL J LINN SOC-LOND, V157, P551, DOI 10.1111/j.1096-3642.2009.00536.x; Young MT, J SYST PALA IN PRESS	85	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54275	10.1371/journal.pone.0054275	http://dx.doi.org/10.1371/journal.pone.0054275			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372699	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500051
J	Gonzalez-Quintela, A; Alonso, M; Campos, J; Vizcaino, L; Loidi, L; Gude, F				Gonzalez-Quintela, Arturo; Alonso, Manuela; Campos, Joaquin; Vizcaino, Luis; Loidi, Lourdes; Gude, Francisco			Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GAMMA-GLUTAMYL-TRANSFERASE; ALCOHOL-CONSUMPTION; PLASMA-LEVELS; HIGH-DENSITY; THE-159C/T POLYMORPHISM; BACTERIAL-ENDOTOXIN; INCREASING PROTEIN; PROMOTER REGION; POTENTIAL ROLE	Background and Aim: Assessment of serum concentration of lipopolysaccharide (LPS)-binding protein (LBP) has been suggested as a useful biomarker to indicate activation of innate immune responses to microbial products. We investigated LBP concentrations and associations with demographics, lifestyle factors, and common metabolic abnormalities in adults. We also examined if LBP concentrations were associated with common polymorphisms in genes coding for LBP (rs2232618), CD14 (rs2569190), and TLR4 (rs4986790), the molecules responsible for the innate immune response to LPS, or serum levels of soluble CD14 (sCD14) and proinflammatory cytokines. Methods: Serum LBP was measured with a commercial immunoassay in a random sample of the adult population (n = 420, 45% males, age 18-92 years) from a single municipality. Results: Serum LBP concentrations increased with age (P<0.001) and were higher in individuals who were overweight or obese than in normal-weight individuals (P<0.001). Similarly, LBP concentrations were higher in individuals with metabolic syndrome than in individuals without it (P<0.001). Among metabolic syndrome components, LBP concentrations were independently associated with abdominal obesity (P=0.002) and low concentrations of HDL-cholesterol (P<0.001). Serum LBP concentrations tended to be independently associated with smoking (P=0.05), but not with alcohol consumption. Likewise, there was not significant association between LBP concentrations and gene polymorphisms. Concentrations of LBP significantly correlated with serum levels of proinflammatory cytokines (IL-6 and IL-8), sCD14, and with liver enzymes. Conclusions: Serum LBP concentrations increased with age. Overweight, obesity, and having metabolic syndrome (particularly, low HDL cholesterol levels) were associated with higher LBP concentrations. These findings are consistent with microbial exposure playing a role in these inflammatory, metabolic abnormalities.	[Gonzalez-Quintela, Arturo; Alonso, Manuela; Campos, Joaquin] Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain; [Vizcaino, Luis] Complejo Hosp Univ, Dept Biochem, Santiago De Compostela, Spain; [Loidi, Lourdes] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain; [Gude, Francisco] Complejo Hosp Univ, Dept Clin Epidemiol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Gonzalez-Quintela, A (corresponding author), Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain.	arturo.gonzalez.quintela@usc.es	Alonso, Manuela/F-7682-2016; Campos-Franco, Joaquin/S-5489-2019	Campos-Franco, Joaquin/0000-0003-1629-5424; Gonzalez-Quintela, Arturo/0000-0002-6909-1807	Xunta de Galicia, Spain [PGIDIT06PXIB918313, 10CSA918028PR]	Xunta de Galicia, Spain(Xunta de Galicia)	This study was supported by the Xunta de Galicia (www.xunta.es), Spain (project no. PGIDIT06PXIB918313 and 10CSA918028PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Barnes RL, 2007, NICOTINE TOB RES, V9, P995, DOI 10.1080/14622200701488392; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; BAZIL V, 1991, J IMMUNOL, V147, P1567; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Campos J, 2006, ALCOHOL CLIN EXP RES, V30, P7, DOI 10.1111/j.1530-0277.2006.00007.x; Campos J, 2005, ALCOHOL CLIN EXP RES, V29, P1206, DOI 10.1097/01.ALC.0000171977.25531.7A; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J, 2000, INTENS CARE MED, V26, pS51, DOI 10.1007/s001340051119; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gonzalez-Quintela A, 2007, CYTOKINE, V38, P54, DOI 10.1016/j.cyto.2007.05.006; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Gude F, 2009, CLIN CHIM ACTA, V407, P67, DOI 10.1016/j.cca.2009.06.034; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hubacek JA, 1997, BIOCHEM BIOPH RES CO, V236, P427, DOI 10.1006/bbrc.1997.6970; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Kirschning CJ, 1997, GENOMICS, V46, P416, DOI 10.1006/geno.1997.5030; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Lequier LL, 2000, CHEST, V117, P1706, DOI 10.1378/chest.117.6.1706; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Levels JHM, 2005, INFECT IMMUN, V73, P2321, DOI 10.1128/IAI.73.4.2321-2326.2005; Levels JHM, 2001, INFECT IMMUN, V69, P2821, DOI 10.1128/IAI.69.5.2821-2828.2001; MA TY, 1992, EXP GERONTOL, V27, P321, DOI 10.1016/0531-5565(92)90059-9; Morange PE, 2004, EUR J HUM GENET, V12, P1041, DOI 10.1038/sj.ejhg.5201277; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Novitsky TJ, 1998, ANN NY ACAD SCI, V851, P416, DOI 10.1111/j.1749-6632.1998.tb09018.x; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Ruiz AG, 2007, OBES SURG, V17, P1374; SAWEIRS WM, 1985, AGE AGEING, V14, P312, DOI 10.1093/ageing/14.5.312; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Schroder NWJ, 2005, J ENDOTOXIN RES, V11, P237, DOI 10.1179/096805105X37420; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Schumann RR, 2000, CHEM IMMUNOL, V74, P42; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; TOBIAS PS, 1993, IMMUNOBIOLOGY, V187, P227, DOI 10.1016/S0171-2985(11)80341-4; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vainas T, 2006, J VASC SURG, V44, P326, DOI 10.1016/j.jvs.2006.04.035; Vercelli D, 2010, CURR OPIN ALLERGY CL, V10, P145, DOI 10.1097/ACI.0b013e32833653d7; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Zeng L, 2012, ANN SURG, V255, P147, DOI 10.1097/SLA.0b013e3182389515	68	127	131	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54600	10.1371/journal.pone.0054600	http://dx.doi.org/10.1371/journal.pone.0054600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349936	Green Published, gold			2022-12-25	WOS:000314019100082
J	Lagergren, K; Lindam, A; Lagergren, J				Lagergren, Katarina; Lindam, Anna; Lagergren, Jesper			Dietary Proportions of Carbohydrates, Fat, and Protein and Risk of Oesophageal Cancer by Histological Type	PLOS ONE			English	Article							GASTRIC CARDIA; BARRETTS-ESOPHAGUS; ADENOCARCINOMA; REPRODUCIBILITY; VALIDITY; PATTERNS; SUBTYPES; HUMANS; REFLUX	Background: Dietary habits influence the risk of cancer of the oesophagus and oesophago-gastric junction, but the role of proportions of the main dietary macronutrients carbohydrates, fats and proteins is uncertain. Methods: Data was derived from a nationwide Swedish population-based case-control study conducted in 1995-1997, in which case ascertainment was rapid, and all cases were uniformly classified. Information on the subjects' history of dietary intake was collected in personal interviews. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression, with adjustment for potentially confounding factors. Results: Included were 189 oesophageal adenocarcinomas, 262 oesophago-gastric adenocarcinomas, 167 oesophageal squamous cell carcinomas, and 820 control subjects. Regarding oesophageal or oesophago-gastric junctional adenocarcinoma, a high dietary proportion of carbohydrates decreased the risk (OR 0.50, CI 0.34-0.73), and a high portion of fat increased the risk (OR 1.96, CI 1.34-2.87), while a high proportion of protein did not influence the risk (OR 1.08, 95% CI 0.75-1.56). Regarding oesophageal squamous cell carcinoma, the single macronutrients did not influence the risk statistically significantly. Conclusions: A diet with a low proportion of carbohydrates and a high proportion of fat might increase the risk of oesophageal adenocarcinoma.	[Lagergren, Katarina; Lindam, Anna; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	jesper.lagergren@ki.se		Lindam, Anna/0000-0002-6230-0354; Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council [80749601]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council (ID 80749601; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berretta Massimiliano, 2012, Front Biosci (Elite Ed), V4, P351; Bravi F, 2011, ANN ONCOL; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, INT J CANCER, V85, P340; Lagergren J, 2011, INT J CANC; Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; Levitan EB, 2007, AM J CLIN NUTR, V85, P548, DOI 10.1093/ajcn/85.2.548; Murphy SJ, 2010, J NUTR, V140, P1757, DOI 10.3945/jn.110.124362; O'Doherty MG, 2011, INT J CANCER, V129, P1493, DOI 10.1002/ijc.26108; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P95; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Silvera SAN, 2008, INT J CANCER, V123, P852, DOI 10.1002/ijc.23544; Silvera SAN, 2011, ANN EPIDEMIOL, V21, P543, DOI 10.1016/j.annepidem.2010.11.019; Terry P, 2001, EUR J CANCER PREV, V10, P365, DOI 10.1097/00008469-200108000-00010; Weiderpass Vainio E, 2012, GUT; Wolk A, 1997, NUTR CANCER, V29, P234, DOI 10.1080/01635589709514630; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057	21	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54913	10.1371/journal.pone.0054913	http://dx.doi.org/10.1371/journal.pone.0054913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349988	gold, Green Published, Green Submitted			2022-12-25	WOS:000314019100110
J	Zhang, H; Berel, D; Wang, YP; Li, P; Bhowmick, NA; Figlin, RA; Kim, HL				Zhang, Hao; Berel, Dror; Wang, Yanping; Li, Ping; Bhowmick, Neil A.; Figlin, Robert A.; Kim, Hyung L.			A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models	PLOS ONE			English	Article							COMPETITIVE MAMMALIAN TARGET; HYPOXIA-INDUCIBLE FACTORS; RAPAMYCIN MTOR; INTERFERON-ALPHA; KINASE INHIBITOR; CANCER; THERAPY; TUMORS; TRIAL; EVEROLIMUS	Rapamycin analogs, temsirolimus and everolimus, are approved for the treatment of advance renal cell carcinoma (RCC). Currently approved agents inhibit mechanistic target of rapamycin (mTOR) complex 1 (mTORC1). However, the mTOR kinase exists in two distinct multiprotein complexes, mTORC1 and mTORC2, and both complexes may be critical regulators of cell metabolism, growth and proliferation. Furthermore, it has been proposed that drug resistance develops due to compensatory activation of mTORC2 signaling during treatment with temsirolimus or everolimus. We evaluated Ku0063794, which is a small molecule that inhibits both mTOR complexes. Ku0063794 was compared to temsirolimus in preclinical models for renal cell carcinoma. Ku0063794 was effective in inhibiting the phosphorylation of signaling proteins downstream of both mTORC1 and mTORC2, including p70 S6K, 4E-BP1 and Akt. Ku0063794 was more effective than temsirolimus in decreasing the viability and growth of RCC cell lines, Caki-1 and 786-O, in vitro by inducing cell cycle arrest and autophagy, but not apoptosis. However, in a xenograft model there was no difference in the inhibition of tumor growth by Ku0063794 or temsirolimus. A potential explanation is that temsirolimus has additional effects on the tumor microenvironment. Consistent with this possibility, temsirolimus, but not Ku0063794, decreased tumor angiogenesis in vivo, and decreased the viability of HUVEC (Human Umbilical Vein Endothelial Cells) cells in vitro at pharmacologically relevant concentrations. Furthermore, expression levels of VEGF and PDGF were lower in Caki-1 and 786-O cells treated with temsirolimus than cells treated with Ku0063794.	[Zhang, Hao; Wang, Yanping; Li, Ping; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA; [Berel, Dror] Cedars Sinai Med Ctr, Biostat Core, Los Angeles, CA 90048 USA; [Bhowmick, Neil A.; Figlin, Robert A.] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [Berel, Dror; Kim, Hyung L.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kim, HL (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA.	kimhl@cshs.org	Zhang, Hao/L-3197-2015; Bhowmick, Neil/AAA-7302-2019; Kim, Hyung/F-5129-2017	Bhowmick, Neil/0000-0001-8747-5989; Kim, Hyung/0000-0003-2085-6140	Winnick Family Foundation; AUA foundation/NCI/NIDDK; NIH/NCI [K23CA120075]; Kure It Cancer Research Foundation; Lauhlere Family Fund; NATIONAL CANCER INSTITUTE [R01CA133072, K23CA120075] Funding Source: NIH RePORTER	Winnick Family Foundation; AUA foundation/NCI/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kure It Cancer Research Foundation; Lauhlere Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Winnick Family Foundation, AUA foundation/NCI/NIDDK, and NIH/NCI grant K23CA120075 (http://grants.nih.gov/grants/oer.htm), Kure It Cancer Research Foundation, and Lauhlere Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Creighton CJ, 2007, ONCOGENE, V26, P4648, DOI 10.1038/sj.onc.1210245; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Furge KA, 2010, LANCET ONCOL, V11, P571, DOI 10.1016/S1470-2045(09)70380-8; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Glenn ST, 2007, BIOTECHNIQUES, V43, P639, DOI 10.2144/000112562; Glenn ST, 2010, J BIOMOL SCREEN, V15, P80, DOI 10.1177/1087057109355059; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, J CLIN ONCOL, V25, P3958, DOI 10.1200/JCO.2006.10.5916; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2011, BRIT J CANCER, V104, P643, DOI 10.1038/bjc.2011.15; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54918	10.1371/journal.pone.0054918	http://dx.doi.org/10.1371/journal.pone.0054918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349989	Green Submitted, gold, Green Published			2022-12-25	WOS:000314019100111
J	Barreto, RE; Miyai, CA; Sanches, FHC; Giaquinto, PC; Delicio, HC; Volpato, GL				Barreto, Rodrigo Egydio; Miyai, Caio Akira; Carretero Sanches, Fabio Henrique; Giaquinto, Percilia Cardoso; Delicio, Helton Carlos; Volpato, Gilson Luiz			Blood Cues Induce Antipredator Behavior in Nile Tilapia Conspecifics	PLOS ONE			English	Article							CHEMICAL ALARM CUES; PREDATION RISK; PHYSIOLOGICAL-RESPONSES; FATHEAD MINNOWS; SKIN EXTRACT; SIGNALS; CELLS; INFORMATION; ODORS	In this study, we show that the fish Nile tilapia displays an antipredator response to chemical cues present in the blood of conspecifics. This is the first report of alarm response induced by blood-borne chemical cues in fish. There is a body of evidence showing that chemical cues from epidermal 'club' cells elicit an alarm reaction in fish. However, the chemical cues of these 'club' cells are restricted to certain species of fish. Thus, as a parsimonious explanation, we assume that an alarm response to blood cues is a generalized response among animals because it occurs in mammals, birds and protostomian animals. Moreover, our results suggest that researchers must use caution when studying chemically induced alarm reactions because it is difficult to separate club cell cues from traces of blood.	[Barreto, Rodrigo Egydio; Miyai, Caio Akira; Carretero Sanches, Fabio Henrique; Giaquinto, Percilia Cardoso; Delicio, Helton Carlos; Volpato, Gilson Luiz] UNESP Univ Estadual Paulista, Dept Fisiol, Inst Biociencias, BR-18618970 Sao Paulo, Brazil	Universidade Estadual Paulista	Barreto, RE (corresponding author), UNESP Univ Estadual Paulista, Dept Fisiol, Inst Biociencias, Campus Botucatu Rubiao Jr, BR-18618970 Sao Paulo, Brazil.	rebarreto@yahoo.com	Delicio, Helton/B-5443-2014; Giaquinto, Percilia/A-8395-2018; Volpato, Gilson/B-2304-2008; Barreto, Rodrigo E/A-3440-2013; Miyai, Caio A/J-7498-2013; Sanches, Fabio H C/K-3526-2013	Giaquinto, Percilia/0000-0003-4591-4415; Barreto, Rodrigo E/0000-0002-4611-0059; Miyai, Caio A/0000-0002-6116-3159; Sanches, Fabio H C/0000-0002-1105-4894	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil [2010/11319-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study received financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil (2010/11319-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa A, 2012, PHYSIOL BEHAV, V105, P784, DOI 10.1016/j.physbeh.2011.10.007; Barbosa A, 2010, ACTA ETHOL, V13, P119, DOI 10.1007/s10211-010-0081-6; Barreto RE, 2012, AQUAT BIOL, V15, P205, DOI 10.3354/ab00429; Barreto RE, 2010, MAR FRESHW BEHAV PHY, V43, P75, DOI 10.1080/10236241003654139; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Carreau-Green ND, 2008, J FISH BIOL, V73, P2390, DOI 10.1111/j.1095-8649.2008.02092.x; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Foam PE, 2005, BEHAVIOUR, V142, P129, DOI 10.1163/1568539053627631; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Giaquinto PC, 2001, BEHAVIOUR, V138, P1205, DOI 10.1163/15685390152822175; Barcellos LJG, 2011, PHYSIOL BEHAV, V103, P372, DOI 10.1016/j.physbeh.2011.03.009; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HAZLETT BA, 1994, J CHEM ECOL, V20, P1525, DOI 10.1007/BF02059878; Henley WF, 2001, AM MALACOL BULL, V16, P131; HIDALGO J, 1987, HISTOCHEMISTRY, V88, P65, DOI 10.1007/BF00490170; HORNBUCKLE PA, 1974, BEHAV BIOL, V12, P573, DOI 10.1016/S0091-6773(74)92531-0; Ide LM, 2003, J FISH BIOL, V63, P332, DOI 10.1046/j.1095-8649.2003.00152.x; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; JONES RB, 1979, BEHAV NEURAL BIOL, V27, P319, DOI 10.1016/S0163-1047(79)92384-7; Jordao LC, 2000, BEHAVIOUR, V137, P681, DOI 10.1163/156853900502286; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kristensen EA, 2004, J FISH BIOL, V64, P643, DOI 10.1111/j.1095-8649.2004.00328.x; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Morishita VR, 2011, MAR ECOL PROG SER, V435, P173, DOI 10.3354/meps09253; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; PFEIFFER W, 1963, EXPERIENTIA, V19, P113, DOI 10.1007/BF02171582; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; Shabani S, 2008, J EXP BIOL, V211, P2600, DOI 10.1242/jeb.016667; Smee DL, 2006, J CHEM ECOL, V32, P605, DOI 10.1007/s10886-005-9021-8; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; Smith R. Jan F., 1999, P475; SMITH RJF, 1979, CAN J ZOOL, V57, P1278, DOI 10.1139/z79-164; STEVENS DA, 1973, BEHAV BIOL, V8, P75, DOI 10.1016/S0091-6773(73)80008-2; Stickney R.R., 1994, PRINCIPLES AQUACULTU; Terlouw EMC, 1998, APPL ANIM BEHAV SCI, V57, P9, DOI 10.1016/S0168-1591(97)00122-6; von Frisch K, 1941, Z VERGL PHYSIOL, V29, P46; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Zimmer RK, 2000, BIOL BULL, V198, P168, DOI 10.2307/1542522	43	24	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54642	10.1371/journal.pone.0054642	http://dx.doi.org/10.1371/journal.pone.0054642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349945	Green Published, Green Submitted, gold			2022-12-25	WOS:000313872800068
J	Rubin, CT; Seeherman, H; Qin, YX; Gross, TS				Rubin, Clinton T.; Seeherman, Howard; Qin, Yi-Xian; Gross, Ted S.			The mechanical consequences of load bearing in the equine third metacarpal across speed and gait: the nonuniform distributions of normal strain, shear strain, and strain energy density	FASEB JOURNAL			English	Article						stress history; locomotion; skeleton; cannon bone; bone remodeling; bone adaptation; vertebrate morphology	BONE-MINERAL LOSS; LONG BONES; LOCOMOTION; STRESS; ADAPTATION; RACEHORSES; SIMILARITY; FORELIMB; STIMULUS; TISSUE	Distributions of normal strain, shear strain, and strain energy density (SED) were determined across the midshaft of the third metacarpal (MCIII, or cannon bone) of 3 adult thoroughbred horses as a function of speed and gait. A complete characterization of the mechanical demands of the bone made through the stride and from mild through the extremes of locomotion was possible by using three 3-element rosette strain gauges bonded at the diaphyseal midshaft of the MCIII and evaluating the strain output with beam theory and finite element analysis. Mean +/- SD values of normal strain, shear strain, and SED increased with speed and peaked during a canter (-3560 +/- 380 microstrain, 1760 +/- 470 microstrain, and 119 +/- 23 kPa, respectively). While the location of these peaks was similar across animals and gaits, the resulting strain distributions across the cortex were consistently nonuniform, establishing between a 73-fold (slow trot) to a 330-fold (canter) disparity between the sites of maximum and minimum SED for each gait cycle. Using strain power density as an estimate of strain history across the bone revealed a 154-fold disparity between peak and minimum at the walk but fell to similar to 32-fold at the canter. The nonuniform, minimally varying, strain environment suggests either that bone homeostasis is mediated by magnitude-independent mechanical signals or that the duration of stimuli necessary to establish and maintain tissue integrity is relatively brief, and thus the vast majority of strain information is disregarded.	[Rubin, Clinton T.; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA; [Seeherman, Howard] Pfizer Res, Tissue Repair Grp, Cambridge, MA USA; [Gross, Ted S.] Univ Washington, Orthopaed Sci Labs, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pfizer; University of Washington; University of Washington Seattle	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA.	clinton.rubin@stonybrook.edu			U.S. National Institutes of Health [AR-49438, EB914351]; U.S. Army; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061821, R01AR052379] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army(United States Department of DefenseUnited States Army); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was kindly supported by U.S. National Institutes of Health grants AR-49438 and EB914351 and by the U.S. Army. The authors are grateful to the veterinary staff at Tufts University in general and to Linda Kinney in particular, as well as to Ken McLeod for his tremendous help with data collection. This work was performed at the Equine Sports Medicine Center at the Cummings School of Veterinary Medicine (Tufts University, North Grafton, MA, USA). The authors declare no conflicts of interest.	Adams DJ, 1997, J BIOMECH, V30, P671, DOI 10.1016/S0021-9290(97)00004-3; BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507; BIEWENER AA, 1986, CALCIFIED TISSUE INT, V39, P390, DOI 10.1007/BF02555177; BIEWENER AA, 1983, J BIOMECH, V16, P565, DOI 10.1016/0021-9290(83)90107-0; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; COWIN SC, 1987, J BIOMECH, V20, P1111, DOI 10.1016/0021-9290(87)90028-5; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; FROST HM, 1992, BONE MINER, V19, P257, DOI 10.1016/0169-6009(92)90875-E; Frost HM, 1986, INTERMEDIARY ORG SKE; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; GROSS TS, 1992, J BIOMECH, V25, P1081, DOI 10.1016/0021-9290(92)90044-2; JONES HH, 1977, J BONE JOINT SURG AM, V59, P204, DOI 10.2106/00004623-197759020-00012; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; LANYON LE, 1970, ACTA ORTHOP SCAND, V41, P238, DOI 10.3109/17453677008991511; LANYON LE, 1987, J BIOMECH, V20, P1083, DOI 10.1016/0021-9290(87)90026-1; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; Moreno CA, 2008, J EXP BIOL, V211, P1148, DOI 10.1242/jeb.012419; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; NUNAMAKER DM, 1991, AM J VET RES, V52, P97; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; Qin YX, 1996, J ORTHOPAED RES, V14, P862, DOI 10.1002/jor.1100140604; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; RYBICKI EF, 1977, J BIOMECH, V10, P701, DOI 10.1016/0021-9290(77)90085-9; Skedros JG, 1996, ANAT RECORD, V246, P47; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1; Weinbaum S, 2001, BIORHEOLOGY, V38, P119; Wolff J, 1892, GESETZ TRANSFORMATIO	36	20	20	1	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2013	27	5					1887	1894		10.1096/fj.12-216804	http://dx.doi.org/10.1096/fj.12-216804			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23355269	Green Published			2022-12-25	WOS:000318226100009
J	Yu, WQ; Sun, XF; Robson, SC; Hill, WG				Yu, Weiqun; Sun, Xiaofeng; Robson, Simon C.; Hill, Warren G.			Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway	FASEB JOURNAL			English	Article						detrusor; uridine nucleotides; urinary tract; micturition; myography	PURINERGIC RECEPTOR EXPRESSION; AGE-RELATED-CHANGES; URINARY-BLADDER; UROTHELIAL CELLS; HUMAN DETRUSOR; ATP RELEASE; PURINOCEPTOR EXPRESSION; QUANTITATIVE-ANALYSIS; P2X(3) RECEPTOR; RELAXATION	Bladder dysfunction characterized by abnormal bladder smooth muscle (BSM) contractions is pivotal to the disease process in overactive bladder, urge incontinence, and spinal cord injury. Purinergic signaling comprises one key pathway in modulating BSM contractility, but molecular mechanisms remain unclear. Here we demonstrate, using myography, that activation of P2Y(6) by either UDP or a specific agonist (MRS 2693) induced a sustained increase in BSM tone (up to 2 mN) in a concentration-dependent manner. Notably, activation of P2Y(6) enhanced ATP-mediated BSM contractile force by up to 45%, indicating synergistic interactions between P2X and P2Y signaling. P2Y(6)-activated responses were abolished by phospholipase C (PLC) and inositol trisphosphate (IP3) receptor antagonists U73122 and xestospongin C, demonstrating involvement of the PLC/ IP3 signal pathway. Mice null for Entpd1, an ectonucleotidase on BSM, demonstrated increased force generation on P2Y(6) activation (150%). Thus, in vivo perturbations to purinergic signaling resulted in altered P2Y(6) activity and bladder contractility. We conclude that UDP, acting on P2Y(6), regulates BSM tone and in doing so selectively maximizes P2X(1)-mediated contraction forces. This novel neurotransmitter pathway may play an important role in urinary voiding disorders characterized by abnormal bladder motility.	[Yu, Weiqun; Hill, Warren G.] Beth Israel Deaconess Med Ctr, Lab Voiding Dysfunct, Boston, MA 02215 USA; [Yu, Weiqun] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Sun, Xiaofeng; Robson, Simon C.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Hill, Warren G.] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hill, WG (corresponding author), Beth Israel Deaconess Med Ctr, RN349,330 Brookline Ave, Boston, MA 02215 USA.	whill@bidmc.harvard.edu	Hill, Warren/AAM-1917-2020; Robson, Simon C./AAA-8537-2021	Hill, Warren/0000-0002-2772-7264; 	U.S. National Institute of Diabetes and Digestive and Kidney Diseases [DK083299]; U.S. National Heart, Lung, and Blood Institute [P01-HL076540, R01-HL094400]; NATIONAL CANCER INSTITUTE [R21CA164970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL094400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083299] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Bernard Robaye (Universite Libre de Bruxelles, Brussels, Belgium) for providing bladders from P2Y<INF>6</INF>-knockout mice. The project described was supported by the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (grant DK083299 to W.G.H.) and the U.S. National Heart, Lung, and Blood Institute (grants P01-HL076540 and R01-HL094400 to S.C.R.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the U.S. National Institutes of Health.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Bayliss M, 1999, J UROLOGY, V162, P1833, DOI 10.1016/S0022-5347(05)68247-X; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Birder LA, 2004, AM J PHYSIOL-RENAL, V287, pF1084, DOI 10.1152/ajprenal.00118.2004; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; BOLAND B, 1993, BRIT J PHARMACOL, V108, P749, DOI 10.1111/j.1476-5381.1993.tb12872.x; BOLEGO C, 1995, BRIT J PHARMACOL, V114, P1557, DOI 10.1111/j.1476-5381.1995.tb14939.x; Brady CM, 2004, EUR UROL, V46, P247, DOI 10.1016/j.eururo.2003.12.017; BURNSTOCK G, 1972, BRIT J PHARMACOL, V46, P234, DOI 10.1111/j.1476-5381.1972.tb06868.x; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Calvert RC, 2001, J UROLOGY, V166, P1530, DOI 10.1016/S0022-5347(05)65825-9; Chua WCN, 2007, EXP GERONTOL, V42, P686, DOI 10.1016/j.exger.2007.02.003; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; FINKBEINER AE, 1980, UROLOGY, V16, P650, DOI 10.1016/0090-4295(80)90582-8; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Fry CH, 2012, AM J PHYSIOL-RENAL, V302, pF1447, DOI 10.1152/ajprenal.00436.2011; Heppner TJ, 2009, J PHYSIOL-LONDON, V587, P5275, DOI 10.1113/jphysiol.2009.178806; Jacobson KA, 2009, PURINERG SIGNAL, V5, P75, DOI 10.1007/s11302-008-9106-2; Kageyama A, 2008, NEUROSCI LETT, V436, P81, DOI 10.1016/j.neulet.2008.02.065; Kim JC, 2008, BJU INT, V101, P371, DOI 10.1111/j.1464-410X.2007.07251.x; King BF, 2004, BRIT J PHARMACOL, V142, P519, DOI 10.1038/sj.bjp.0705790; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kumar V, 2010, EUR UROL, V57, P1087, DOI 10.1016/j.eururo.2009.11.042; Moore KH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0002.2001; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; O'Reilly BA, 2001, BJU INT, V87, P617, DOI 10.1046/j.1464-410x.2001.02179.x; O'Reilly BA, 2001, J UROLOGY, V165, P1730, DOI 10.1016/S0022-5347(05)66403-8; Pinna C, 2006, LIFE SCI, V79, P1301, DOI 10.1016/j.lfs.2006.03.035; Ray FR, 2003, CELL TISSUE RES, V314, P351, DOI 10.1007/s00441-003-0788-z; Rayment SJ, 2007, BRIT J PHARMACOL, V150, P604, DOI 10.1038/sj.bjp.0707120; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; SIBLEY GNA, 1984, J PHYSIOL-LONDON, V354, P431, DOI 10.1113/jphysiol.1984.sp015386; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Smith CP, 2008, NEUROCHEM INT, V52, P1068, DOI 10.1016/j.neuint.2007.11.006; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Sugaya K, 2009, BIOMED RES-TOKYO, V30, P287, DOI 10.2220/biomedres.30.287; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Sun Y, 2004, J UROLOGY, V171, P448, DOI 10.1097/01.ju.0000099660.46774.3c; Sun Y, 2002, BJU INT, V90, P381, DOI 10.1046/j.1464-410X.2002.02912.x; Sun Y, 2010, CURR BLADDER DYSFUNC, V5, P219, DOI 10.1007/s11884-010-0063-6; Tempest HV, 2004, BJU INT, V93, P1344, DOI 10.1111/j.1464-410X.2004.04858.x; Tong YC, 1997, NEUROSCI LETT, V225, P181, DOI 10.1016/S0304-3940(97)00212-7; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Yoshida M, 2004, UROLOGY, V63, P17, DOI 10.1016/j.urology.2003.11.003; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3; Yu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018704	50	25	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1895	1903		10.1096/fj.12-219006	http://dx.doi.org/10.1096/fj.12-219006			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23362118	Green Published			2022-12-25	WOS:000318226100010
J	Das, F; Ghosh-Choudhury, N; Bera, A; Dey, N; Abboud, HE; Kasinath, BS; Choudhury, GG				Das, Falguni; Ghosh-Choudhury, Nandini; Bera, Amit; Dey, Nirmalya; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			Transforming Growth Factor beta Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SMOOTH-MUSCLE-CELLS; RICTOR-MTOR COMPLEX; HIGH GLUCOSE; DIABETIC-NEPHROPATHY; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET; FIBRONECTIN EXPRESSION; MESENCHYMAL TRANSITION	In many renal diseases, transforming growth factor beta (TGF beta)-stimulated canonical Smad 3 and noncanonical mechanistic target of rapamycin (mTOR) promote increased protein synthesis and mesangial cell hypertrophy. The cellular underpinnings involving these signaling molecules to regulate mesangial cell hypertrophy are not fully understood. Deptor has recently been identified as an mTOR interacting protein and functions as an endogenous inhibitor of the kinase activity for both TORC1 and TORC2. Prolonged incubation of mesangial cells with TGF beta reduced the levels of deptor concomitant with an increase in TORC1 and TORC2 activity. Sustained TGF beta activation was required to inhibit association of deptor with mTOR, whereas rapid activation had no effect. Using the mTOR inhibitor PP242, we found that TGF beta-induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression. PP242-induced reversal of deptor suppression by TGF beta was associated with a significant inhibition of TGF beta-stimulated protein synthesis and hypertrophy. Interestingly, expression of siRNA against Smad 3 or Smad 7, which blocks TGF beta receptor-specific Smad 3 signaling, prevented TGF beta-induced suppression of deptor abundance and TORC1/2 activities. Furthermore, overexpression of Smad 3 decreased deptor expression similar to TGF beta stimulation concomitant with increased TORC1 and TORC2 activities. Finally, knockdown of deptor reversed Smad 7-mediated inhibition of protein synthesis and mesangial cell hypertrophy induced by TGF beta. These data reveal the requirement of both early and late activation of mTOR for TGF beta-induced protein synthesis. Our results support that TGF beta-stimulated Smad 3 acts as a key node to instill a feedback loop between deptor down-regulation and TORC1/2 activation in driving mesangial cell hypertrophy.	[Ghosh-Choudhury, Nandini; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Bera, Amit; Dey, Nirmalya; Abboud, Hanna E.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health [RO1 DK50190, RO1 AR 52425, RO1 DK 78971, RO1 DK 077295, RC2A 036613]; Veterans Affairs Merit Review grants; Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio; Juvenile Diabetes Research Foundation; Veterans Affairs Research Service; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation [1-2008-185]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Service(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK50190 and Veterans Affairs Merit Review grants (to G. G. C.).; Supported by National Institutes of Health Grant RO1 AR 52425, Veterans Affairs Merit Review grants, and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio.; Supported by National Institutes of Health Grant RO1 DK 78971 and Veterans Affairs Merit Review and Juvenile Diabetes Research Foundation grants.; Supported by National Institutes of Health Grants RO1 DK 077295 and RC2A 036613 and the Veterans Affairs Research Service.; Recipient of Veterans Affairs Senior Research Career Scientist Award and supported by Juvenile Diabetes Research Foundation Grant 1-2008-185.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Chen S, 2004, KIDNEY INT, V65, P1191, DOI 10.1111/j.1523-1755.2004.00492.x; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Das F, 2007, FEBS LETT, V581, P5259, DOI 10.1016/j.febslet.2007.10.014; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim HW, 2004, KIDNEY INT, V66, P1859, DOI 10.1111/j.1523-1755.2004.00959.x; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mavrakis M, 2007, AUTOPHAGY, V3, P151, DOI 10.4161/auto.3632; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7756	7768		10.1074/jbc.M113.455782	http://dx.doi.org/10.1074/jbc.M113.455782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23362262	Green Published, hybrid			2022-12-25	WOS:000316455300031
J	Dong, NZ; Fang, CD; Jiang, YZ; Zhou, TT; Liu, M; Zhou, JP; Shen, JZ; Fukuda, K; Qin, J; Wu, QY				Dong, Ningzheng; Fang, Chaodong; Jiang, Yizhi; Zhou, Tiantian; Liu, Meng; Zhou, Jianping; Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu			Corin Mutation R539C from Hypertensive Patients Impairs Zymogen Activation and Generates an Inactive Alternative Ectodomain Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; SALT-SENSITIVE HYPERTENSION; ANCHORED SERINE PROTEASES; IRON-DEFICIENCY ANEMIA; PLASMA SOLUBLE CORIN; CARDIAC-HYPERTROPHY; RECEPTOR GENE; ASSOCIATION; BLOOD; CELL	Corin is a cardiac transmembrane serine protease that regulates blood pressure by activating natriuretic peptides. Corin variants have been associated with African Americans with hypertension and heart disease. Here, we report a new mutation in exon 12 of the CORIN gene identified in a family of patients with hypertension. The mutation resulted in R539C substitution in the Fz2 (Frizzled-2) domain of the corin propeptide region. We expressed and characterized the corin R539C mutant in HEK293 cells. As determined by Western blot analysis, the R539C mutation did not alter corin expression in transfected cells but impaired corin zymogen activation. In a proatrial natriuretic peptide processing assay, the corin mutant had reduced activity and exhibited a dominant-negative effect on wild-type corin. In addition, the R539C mutation altered corin ectodomain shedding, producing an alternative similar to 75-kDa fragment that was biologically inactive. Using protease inhibitors and the catalytically inactive corin mutant S985A, we showed that the similar to 75-kDa fragment was generated by corin autocleavage. We constructed a series of mutants by replacing single or double Arg residues in the corin propeptide and identified Arg-530 in the Fz2 domain as the alternative autocleavage site. Our results show that the corin mutation R539C identified in hypertensive patients impairs corin zymogen activation and causes an alternative autocleavage that reduces corin activity. These data support that human CORIN gene mutations causing impaired corin activity may be an underlying mechanism in hypertension.	[Dong, Ningzheng; Fang, Chaodong; Jiang, Yizhi; Zhou, Tiantian; Liu, Meng; Wu, Qingyu] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Dong, Ningzheng; Jiang, Yizhi] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Thrombosis & Hemostasis Key Lab,Minist Hlth, Suzhou 215123, Peoples R China; [Zhou, Jianping] First Hosp Yancheng, Dept Gerontol, Yancheng 224001, Peoples R China; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Nephrol, Cleveland, OH 44195 USA; [Shen, Jianzhong; Fukuda, Koichi; Qin, Jun; Wu, Qingyu] Cleveland Clin, Dept Hypertens, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org	Shen, Jianzhong/AAH-8184-2019	Qin, Jun/0000-0002-2647-9270; Wu, Qingyu/0000-0003-0561-9315	National Institutes of Health [HL089298]; National Natural Science Foundation of China [31070716, 81170247, 31161130356]; Natural Science Foundation of the Jiangsu Higher Education Institutions [10KJB320017]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Proteases and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Proteases and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL089298. This work was also supported by National Natural Science Foundation of China Grants 31070716, 81170247, and 31161130356; Natural Science Foundation of the Jiangsu Higher Education Institutions Grant 10KJB320017; the Priority Academic Program Development of Jiangsu Higher Education Institutions; and the Danish-Chinese Center for Proteases and Cancer.	Ambrosius WT, 1999, HYPERTENSION, V34, P631, DOI 10.1161/01.HYP.34.4.631; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Buckley CL, 2011, REGUL PEPTIDES, V172, P44, DOI 10.1016/j.regpep.2011.08.006; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Cui YJ, 2009, KIDNEY INT, V76, P1137, DOI 10.1038/ki.2009.357; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dong NZ, 2012, CLIN CHIM ACTA, V413, P378, DOI 10.1016/j.cca.2011.10.032; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Mullins LJ, 2006, PHYSIOL REV, V86, P709, DOI 10.1152/physrev.00016.2005; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tran KL, 2004, AM J PHYSIOL-HEART C, V287, pH1625, DOI 10.1152/ajpheart.00298.2004; Wang W, 2012, HYPERTENSION, V60, P1352, DOI 10.1161/HYPERTENSIONAHA.112.201244; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Zhou YQ, 2009, NEPHROL DIAL TRANSPL, V24, P1071, DOI 10.1093/ndt/gfn727	49	50	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7867	7874		10.1074/jbc.M112.411512	http://dx.doi.org/10.1074/jbc.M112.411512			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23372161	hybrid, Green Published			2022-12-25	WOS:000316455300040
J	Jung, HY; Wang, X; Jun, S; Park, JI				Jung, Hae-Yun; Wang, Xin; Jun, Sohee; Park, Jae-Il			Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE HTERT; REGULATES TELOMERASE; UBIQUITIN LIGASE; APOPTOTIC RESPONSE; PROTEIN-KINASES; DYRK FAMILY; DNA; END; PHOSPHORYLATION; CHROMOSOMES	Telomerase maintains the telomere, a specialized chromosomal end structure that is essential for genomic stability and cell immortalization. Telomerase is not active in most somatic cells, but its reactivation is one of the hallmarks of cancer. In this study, we found that dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (Dyrk2) negatively regulates telomerase activity. Dyrk2 phosphorylates TERT protein, a catalytic subunit of telomerase. Phosphorylated TERT is then associated with the EDD-DDB1-VprBP E3 ligase complex for subsequent ubiquitin-mediated TERT protein degradation. During the cell cycle, Dyrk2 interacts with TERT at the G2/M phase and induces degradation. In contrast, depletion of endogenous Dyrk2 disrupts the cell cycle-dependent regulation of TERT and elicits the constitutive activation of telomerase. Similarly, a Dyrk2 nonsense mutation identified in breast cancer compromises ubiquitination-mediated TERT protein degradation. Our findings suggest the novel molecular mechanism of kinase-associated telomerase regulation.	[Jung, Hae-Yun; Wang, Xin; Jun, Sohee; Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Park, JI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jaeil@mdanderson.org	park, jaeil/AAS-5894-2021	PARK, JAE-IL/0000-0002-0737-2654; Jung, Hae-Yun/0000-0001-9467-2219	University Cancer Foundation [IRG-08-061-01]; Center for Stem Cell and Developmental Biology Transformative Pilot Grant; Institutional Research Grant; New Faculty Award (M.D. Anderson Cancer Center Support Grant); Metastasis Research Center Grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	University Cancer Foundation; Center for Stem Cell and Developmental Biology Transformative Pilot Grant; Institutional Research Grant; New Faculty Award (M.D. Anderson Cancer Center Support Grant); Metastasis Research Center Grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University Cancer Foundation (IRG-08-061-01), a Center for Stem Cell and Developmental Biology Transformative Pilot Grant (M.D. Anderson), an Institutional Research Grant (M.D. Anderson), a New Faculty Award (M.D. Anderson Cancer Center Support Grant), and a Metastasis Research Center Grant (M.D. Anderson).; We thank Pierre McCrea, Lei Li, and Junjie Chen for helpful comments on the manuscript and Junjie Chen and Sub-bareddy Maddika for providing reagents. The DNA Analysis Core Facility was supported by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant, CA016672.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Blackburn EH, 2000, NAT STRUCT BIOL, V7, P847, DOI 10.1038/79594; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonifaci N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014078; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oh W, 2010, ONCOGENE, V29, P4101, DOI 10.1038/onc.2010.160; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; RHYU MS, 1995, J NATL CANCER I, V87, P884, DOI 10.1093/jnci/87.12.884; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452	57	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7252	7262		10.1074/jbc.M112.416792	http://dx.doi.org/10.1074/jbc.M112.416792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23362280	hybrid, Green Published			2022-12-25	WOS:000316002400045
J	Schwingel, M; Bastmeyer, M				Schwingel, Melanie; Bastmeyer, Martin			Force Mapping during the Formation and Maturation of Cell Adhesion Sites with Multiple Optical Tweezers	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; F-ACTIN FLOW; FLUORESCENT SPECKLE MICROSCOPY; NEURONAL GROWTH CONES; FOCAL ADHESIONS; EXTRACELLULAR-MATRIX; RETROGRADE FLOW; MIGRATING CELLS; IN-VIVO; MECHANICAL-PROPERTIES	Focal contacts act as mechanosensors allowing cells to respond to their biomechanical environment. Force transmission through newly formed contact sites is a highly dynamic process requiring a stable link between the intracellular cytoskeleton and the extracellular environment. To simultaneously investigate cellular traction forces in several individual maturing adhesion sites within the same cell, we established a custom-built multiple trap optical tweezers setup. Beads functionalized with fibronectin or RGD-peptides were placed onto the apical surface of a cell and trapped with a maximum force of 160 pN. Cells form adhesion contacts around the beads as demonstrated by vinculin accumulation and start to apply traction forces after 30 seconds. Force transmission was found to strongly depend on bead size, surface density of integrin ligands and bead location on the cell surface. Highest traction forces were measured for beads positioned on the leading edge. For mouse embryonic fibroblasts, traction forces acting on single beads are in the range of 80 pN after 5 minutes. If two beads were positioned parallel to the leading edge and with a center-to-center distance less than 10 mm, traction forces acting on single beads were reduced by 40%. This indicates a spatial and temporal coordination of force development in closely related adhesion sites. We also used our setup to compare traction forces, retrograde transport velocities, and migration velocities between two cell lines (mouse melanoma and fibroblasts) and primary chick fibroblasts. We find that maximal force development differs considerably between the three cell types with the primary cells being the strongest. In addition, we observe a linear relation between force and retrograde transport velocity: a high retrograde transport velocity is associated with strong cellular traction forces. In contrast, migration velocity is inversely related to traction forces and retrograde transport velocity.	[Schwingel, Melanie; Bastmeyer, Martin] KIT, Inst Zool, Karlsruhe, Germany; [Schwingel, Melanie; Bastmeyer, Martin] KIT, DFG Ctr Funct Nanostruct CFN, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology	Bastmeyer, M (corresponding author), KIT, Inst Zool, Karlsruhe, Germany.	bastmeyer@kit.edu	Bastmeyer, Martin/H-9342-2013	Bastmeyer, Martin/0000-0003-3471-8400	DFG Research Center for Functional Nanostructures, Karlsruhe, Germany	DFG Research Center for Functional Nanostructures, Karlsruhe, Germany(German Research Foundation (DFG))	This work was supported by the DFG Research Center for Functional Nanostructures, Karlsruhe, Germany (http://www.cfn.kit.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; ASHKIN A, 1989, P NATL ACAD SCI USA, V86, P7914, DOI 10.1073/pnas.86.20.7914; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bordeleau F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3626864; Brenner MD, 2011, BIOPOLYMERS, V95, P332, DOI 10.1002/bip.21587; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Brownell WE, 2010, BIOPHYS J, V99, P845, DOI 10.1016/j.bpj.2010.05.025; Caspi A, 2001, BIOPHYS J, V81, P1990, DOI 10.1016/S0006-3495(01)75849-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coussen F, 2002, J CELL SCI, V115, P2581; Cramer, 1997, FRONT BIOSCI, V2, pd260, DOI DOI 10.2741/A189; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Diez G, 2011, BIOCHEM BIOPH RES CO, V406, P85, DOI 10.1016/j.bbrc.2011.01.115; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916; Fukui Y, 1999, J CELL SCI, V112, P877; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GRINNELL F, 1986, EXP CELL RES, V162, P449, DOI 10.1016/0014-4827(86)90349-6; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, METHOD ENZYMOL, V361, P162; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hochmuth FM, 1996, BIOPHYS J, V70, P358, DOI DOI 10.1016/S0006-3495(96)79577-2); Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Icard-Arcizet D, 2008, BIOPHYS J, V94, P2906, DOI 10.1529/biophysj.107.118265; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; Lagunas A, 2011, NANOMEDICINE, V8, P432; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Laurent VM, 2002, J BIOMECH ENG-T ASME, V124, P408, DOI 10.1115/1.1485285; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Malmstrom J, 2010, NANO LETT, V10, P686, DOI 10.1021/nl903875r; Marg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011530; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mejean CO, 2009, OPT EXPRESS, V17, P6209, DOI 10.1364/OE.17.006209; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; ROHDE H, 1980, H-S Z PHYSIOL CHEM, V361, P1651, DOI 10.1515/bchm2.1980.361.2.1651; Rohrbach A, 2004, REV SCI INSTRUM, V75, P2197, DOI 10.1063/1.1753097; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sato S, 1996, OPT QUANT ELECTRON, V28, P1, DOI 10.1007/BF00578546; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Singer W, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011916; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; SVITKINA TM, 1986, J CELL SCI, V82, P235; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; VISSCHER K, 1991, CYTOMETRY, V12, P486, DOI 10.1002/cyto.990120604; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]	109	26	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54850	10.1371/journal.pone.0054850	http://dx.doi.org/10.1371/journal.pone.0054850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372781	Green Published, gold			2022-12-25	WOS:000315210400034
J	Chama, L; Berens, DG; Downs, CT; Farwig, N				Chama, Lackson; Berens, Dana G.; Downs, Colleen T.; Farwig, Nina			Habitat Characteristics of Forest Fragments Determine Specialisation of Plant-Frugivore Networks in a Mosaic Forest Landscape	PLOS ONE			English	Article							SEED-DISPERSAL; SCALE; CONSERVATION; BIODIVERSITY; POLLINATION; CONSEQUENCES; PATTERNS; ECOLOGY	Plant-frugivore networks play a key role in the regeneration of sub-tropical forest ecosystems. However, information about the impact of habitat characteristics on plant-frugivore networks in fragmented forests is scarce. We investigated the importance of fruit abundance, fruiting plant species richness and canopy cover within habitat fragments for the structure and robustness of plant-frugivore networks in a mosaic forest landscape of South Africa. In total, 53 avian species were involved in fruit removal of 31 fleshy-fruiting plant species. Species specialisation was always higher for plants than for frugivores. Both species and network-level specialisation increased with increasing fruit abundance and decreased with increasing fruiting plant species richness and canopy cover within fragments. Interaction diversity was unaffected by fruit abundance and canopy cover, but increased slightly with increasing fruiting plant species richness. These findings suggest that especially the availability of resources is an important determinant of the structure of plant-frugivore networks in a fragmented forest landscape.	[Chama, Lackson; Berens, Dana G.; Farwig, Nina] Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany; [Downs, Colleen T.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	Philipps University Marburg; University of Kwazulu Natal	Berens, DG (corresponding author), Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany.	dana.berens@staff.uni-marburg.de	Downs, Colleen T./A-7770-2010	Downs, Colleen T./0000-0001-8334-1510; Chama, Lackson/0000-0002-0094-9238	Robert Bosch Stiftung	Robert Bosch Stiftung	The study was funded by the Robert Bosch Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzures-Dadda A, 2007, ANIM CONSERV, V10, P69, DOI 10.1111/j.1469-1795.2006.00074.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Boon R., 2010, POOLEYS TREES E S AF; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; Dormann C.F., 2008, R NEWS, V8, P8, DOI DOI 10.1159/000265935; Estrada E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016103; FAO, 2009, FAOSTAT ONL STAT SER; Farwig N, 2006, OECOLOGIA, V147, P238, DOI 10.1007/s00442-005-0288-9; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garcia D, 2007, CONSERV BIOL, V21, P400, DOI 10.1111/j.1523-1739.2006.00593.x; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Herrera Carlos M., 2002, P185; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kankam BO, 2011, AFRICAN J ECOLOGY, V50, P21; Khamcha D, 2012, J TROP ECOL, V28, P1, DOI 10.1017/S026646741100054X; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Menke S, 2012, OIKOS, V121, P1553, DOI 10.1111/j.1600-0706.2011.20210.x; Mucina L., 2006, VEGETATION S AFRICA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; Mello MAR, 2011, OECOLOGIA, V167, P131, DOI 10.1007/s00442-011-1984-2; Saracco JF, 2004, OECOLOGIA, V139, P235, DOI 10.1007/s00442-004-1493-7; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Stouffer DB, 2012, SCIENCE, V335, P1489, DOI 10.1126/science.1216556; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; von Maltitz G, 2003, 2003017 ENVPC; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	52	17	17	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54956	10.1371/journal.pone.0054956	http://dx.doi.org/10.1371/journal.pone.0054956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365688	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600138
J	Hu, JP; Liu, M; Tang, DY; Chang, S				Hu, Jianping; Liu, Ming; Tang, Dianyong; Chang, Shan			Substrate Recognition and Motion Mode Analyses of PFV Integrase in Complex with Viral DNA via Coarse-Grained Models	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 INTEGRASE; BINDING MODES; IN-VITRO; DYNAMICS; INHIBITORS; IDENTIFICATION; PROTEINS; RESIDUES; PREDICTION	HIV-1 integrase (IN) is an important target in the development of drugs against the AIDS virus. Drug design based on the structure of IN was markedly hampered due to the lack of three-dimensional structure information of HIV-1 IN-viral DNA complex. The prototype foamy virus (PFV) IN has a highly functional and structural homology with HIV-1 IN. Recently, the X-ray crystal complex structure of PFV IN with its cognate viral DNA has been obtained. In this study, both Gaussian network model (GNM) and anisotropy network model (ANM) have been applied to comparatively investigate the motion modes of PFV DNA-free and DNA-bound IN. The results show that the motion mode of PFV IN has only a slight change after binding with DNA. The motion of this enzyme is in favor of association with DNA, and the binding ability is determined by its intrinsic structural topology. Molecular docking experiments were performed to gain the binding modes of a series of diketo acid (DKA) inhibitors with PFV IN obtained from ANM, from which the dependability of PFV IN-DNA used in the drug screen for strand transfer (ST) inhibitors was confirmed. It is also found that the functional groups of keto-enol, bis-diketo, tetrazole and azido play a key role in aiding the recognition of viral DNA, and thus finally increase the inhibition capability for the corresponding DKA inhibitor. Our study provides some theoretical information and helps to design anti-AIDS drug based on the structure of IN.	[Hu, Jianping; Tang, Dianyong] Leshan Normal Univ, Dept Chem & Life Sci, Leshan, Peoples R China; [Liu, Ming] Beijing Inst Biotechnol, Beijing, Peoples R China; [Chang, Shan] S China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China	Leshan Normal University; South China Agricultural University	Chang, S (corresponding author), S China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China.	schang1982@yahoo.cn		tang, Dianyong/0000-0001-9389-870X; Chang, Shan/0000-0001-7169-9398	National Natural Science Foundation of China [11147175, 11247018, 31200990]; key Project of Chinese Ministry of Education [211159]; Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration [201003]; key project of Leshan Science and Technology Administration [2011SZD109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Project of Chinese Ministry of Education(Ministry of Education, China); Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration; key project of Leshan Science and Technology Administration	This work was supported by the National Natural Science Foundation of China (11147175, 11247018, 31200990), the key Project of Chinese Ministry of Education (211159), the Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration (201003), and the key project of Leshan Science and Technology Administration (2011SZD109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GOLD 3 1 1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Chow SA, 1997, METHODS, V12, P306, DOI 10.1006/meth.1997.0484; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Erman B, 2006, BIOPHYS J, V91, P3589, DOI 10.1529/biophysj.106.090803; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Gordon CP, 2007, MED CHEM, V3, P199, DOI 10.2174/157340607780059558; Haliloglu T, 2005, BIOPHYS J, V88, P1552, DOI 10.1529/biophysj.104.051342; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hu JP, 2008, BIOPHYS CHEM, V132, P69, DOI 10.1016/j.bpc.2007.09.008; Hu JP, 2013, J BIOMOL STRUCT DYN, V31, P734, DOI 10.1080/07391102.2012.709458; Hu JP, 2010, CHINESE J CHEM, V28, P33, DOI 10.1002/cjoc.201090032; Huang M, 2011, J MOL GRAPH MODEL, V29, P956, DOI 10.1016/j.jmgm.2011.04.002; Kong R, 2006, BBA-PROTEINS PROTEOM, V1764, P766, DOI 10.1016/j.bbapap.2005.12.017; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Marchand C, 2003, MOL PHARMACOL, V64, P600, DOI 10.1124/mol.64.3.600; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Pais GCG, 2002, J MED CHEM, V45, P3184, DOI 10.1021/jm020037p; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Zhang XC, 2003, BIOORG MED CHEM LETT, V13, P1215, DOI 10.1016/S0960-894X(03)00059-3; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zhuang LC, 2003, J MED CHEM, V46, P453, DOI 10.1021/jm025553u	36	8	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54929	10.1371/journal.pone.0054929	http://dx.doi.org/10.1371/journal.pone.0054929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365687	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600137
J	Busman-Sahay, K; Drake, L; Sitaram, A; Marks, M; Drake, JR				Busman-Sahay, Kathleen; Drake, Lisa; Sitaram, Anand; Marks, Michael; Drake, James R.			Cis and Trans Regulatory Mechanisms Control AP2-Mediated B Cell Receptor Endocytosis via Select Tyrosine-Based Motifs	PLOS ONE			English	Article							CLATHRIN-COATED VESICLES; ANTIGEN RECEPTOR; IG-ALPHA; STRUCTURAL EXPLANATION; STRUCTURE PREDICTION; T-CELLS; INTERNALIZATION; BETA; KINASE; REQUIREMENTS	Following antigen recognition, B cell receptor (BCR)-mediated endocytosis is the first step of antigen processing and presentation to CD4+ T cells, a crucial component of the initiation and control of the humoral immune response. Despite this, the molecular mechanism of BCR internalization is poorly understood. Recently, studies of activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) have shown that mutations within the BCR subunit CD79b leads to increased BCR surface expression, suggesting that CD79b may control BCR internalization. Adaptor protein 2 (AP2) is the major mediator of receptor endocytosis via clathrin-coated pits. The BCR contains five putative AP2-binding Yxxempty set motifs, including four that are present within two immunoreceptor tyrosine-based activation motifs (ITAMs). Using a combination of in vitro and in situ approaches, we establish that the sole mediator of AP2-dependent BCR internalization is the membrane proximal ITAM Yxxempty set motif in CD79b, which is a major target of mutation in ABC DLBCL. In addition, we establish that BCR internalization can be regulated at a minimum of two different levels: regulation of Yxxempty set AP2 binding in cis by downstream ITAM-embedded DCSM and QTAT regulatory elements and regulation in trans by the partner cytoplasmic domain of the CD79 heterodimer. Beyond establishing the basic rules governing BCR internalization, these results illustrate an underappreciated role for ITAM residues in controlling clathrin-dependent endocytosis and highlight the complex mechanisms that control the activity of AP2 binding motifs in this receptor system.	[Busman-Sahay, Kathleen; Drake, Lisa; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Sitaram, Anand; Marks, Michael] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sitaram, Anand; Marks, Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Albany Medical College; University of Pennsylvania; University of Pennsylvania	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	DrakeJ@mail.amc.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262	National Institutes of Health (NIH) [AI-065773]; NATIONAL EYE INSTITUTE [R01EY015625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI-065773 to J.R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Caballero A, 2006, EUR J IMMUNOL, V36, P3131, DOI 10.1002/eji.200636447; Cassard S, 1998, J IMMUNOL, V160, P1767; Cassard S, 1996, J BIOL CHEM, V271, P23786, DOI 10.1074/jbc.271.39.23786; CHESNUT RW, 1982, J IMMUNOL, V129, P2382; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; DAmbrosio D, 1996, EUR J IMMUNOL, V26, P1960, DOI 10.1002/eji.1830260842; Davis RE, NATURE, V463, P88; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Gondre-Lewis TA, 2001, J IMMUNOL, V166, P6657, DOI 10.4049/jimmunol.166.11.6657; GREY HM, 1982, J IMMUNOL, V129, P2389; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Jang C, 2010, IMMUNOL LETT, V134, P75, DOI 10.1016/j.imlet.2010.09.001; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim JH, 2007, INT IMMUNOL, V19, P1403, DOI 10.1093/intimm/dxm110; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Li C, 2002, INT IMMUNOL, V14, P1179, DOI 10.1093/intimm/dxf083; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; Putnam MA, 2003, J IMMUNOL, V170, P905, DOI 10.4049/jimmunol.170.2.905; SALAMERO J, 1995, EUR J IMMUNOL, V25, P2757, DOI 10.1002/eji.1830251007; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; Siemasko K, 1999, J IMMUNOL, V162, P6518; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54938	10.1371/journal.pone.0054938	http://dx.doi.org/10.1371/journal.pone.0054938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372794	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500147
J	Mayeur, C; Gratadoux, JJ; Bridonneau, C; Chegdani, F; Larroque, B; Kapel, N; Corcos, O; Thomas, M; Joly, F				Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Larroque, Beatrice; Kapel, Nathalie; Corcos, Olivier; Thomas, Muriel; Joly, Francisca			Faecal D/L Lactate Ratio Is a Metabolic Signature of Microbiota Imbalance in Patients with Short Bowel Syndrome	PLOS ONE			English	Article							BUTYRATE-PRODUCING BACTERIA; HUMAN GUT MICROBIOTA; D-LACTIC ACIDEMIA; LARGE-INTESTINE; ADULT PATIENTS; HUMAN FECES; PARENTERAL-NUTRITION; ACIDOSIS; COLON; ABSORPTION	Our objective was to understand the functional link between the composition of faecal microbiota and the clinical characteristics of adults with short bowel syndrome (SBS). Sixteen patients suffering from type II SBS were included in the study. They displayed a total oral intake of 2661 +/- 1005 Kcal/day with superior sugar absorption (83 +/- 12%) than protein (42 +/- 13%) or fat (39 +/- 26%). These patients displayed a marked dysbiosis in faecal microbiota, with a predominance of Lactobacillus/Leuconostoc group, while Clostridium and Bacteroides were under-represented. Each patient exhibited a diverse lactic acid bacteria composition (L. delbrueckii subsp. bulgaricus, L. crispatus, L. gasseri, L. johnsonii, L. reuteri, L. mucosae), displaying specific D and L-lactate production profiles in vitro. Of 16 patients, 9/16 (56%) accumulated lactates in their faecal samples, from 2 to 110 mM of D-lactate and from 2 to 80 mM of L-lactate. The presence of lactates in faeces (56% patients) was used to define the Lactate-accumulator group (LA), while absence of faecal lactates (44% patients) defines the Non lactate-accumulator group (NLA). The LA group had a lower plasma HCO3(-) concentration (17.1 +/- 2.8 mM) than the NLA group (22.8 +/- 4.6 mM), indicating that LA and NLA groups are clinically relevant sub-types. Two patients, belonging to the LA group and who particularly accumulated faecal D-lactate, were at risk of D-encephalopathic reactions. Furthermore, all patients of the NLA group and those accumulating preferentially L isoform in the LA group had never developed D-acidosis. The D/L faecal lactate ratio seems to be the most relevant index for a higher D-encephalopathy risk, rather than D-and L-lactate faecal concentrations per se. Testing criteria that take into account HCO3(-) value, total faecal lactate and the faecal D/L lactate ratio may become useful tools for identifying SBS patients at risk for D-encephalopathy.	[Kapel, Nathalie; Corcos, Olivier; Joly, Francisca] Hop Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy, France; [Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Thomas, Muriel] INRA, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France; [Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Thomas, Muriel] AgroParisTech, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France; [Larroque, Beatrice] Hop Beaujon, Epidemiol & Clin Res Unit, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Thomas, M (corresponding author), INRA, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France.	muriel.thomas@jouy.inra.fr; francisca.joly@bjn.aphp.fr	thomas, muriel/HDO-3887-2022; Chegdani, Fatima/AAW-9322-2021; Thomas, Muriel/D-9164-2015	Chegdani, Fatima/0000-0002-2473-0302; Corcos, Olivier/0000-0002-9034-7053; Thomas, Muriel/0000-0002-7608-3274	APHP (Assistance Publique - Hopitaux de Paris) grant; Ferring-SAS France laboratory grant	APHP (Assistance Publique - Hopitaux de Paris) grant; Ferring-SAS France laboratory grant	This work was supported by APHP (Assistance Publique - Hopitaux de Paris) and by Ferring-SAS France laboratory grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekara S, 2007, AM J PHYSIOL-ENDOC M, V293, pE558, DOI 10.1152/ajpendo.00063.2007; Achour L, 2007, EUR J CLIN NUTR, V61, P233, DOI 10.1038/sj.ejcn.1602496; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Belenguer A, 2011, FEMS MICROBIOL ECOL, V77, P107, DOI 10.1111/j.1574-6941.2011.01086.x; Bongaerts G, 2000, J PEDIATR GASTR NUTR, V30, P288, DOI 10.1097/00005176-200003000-00014; BONGAERTS G, 1995, CLIN CHEM, V41, P107; Bongaerts GPA, 1997, MICROB PATHOGENESIS, V22, P285, DOI 10.1006/mpat.1996.0122; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; BRIET F, 1995, GASTROENTEROLOGY, V109, P1446, DOI 10.1016/0016-5085(95)90629-0; BUSTOS D, 1994, DIGEST DIS SCI, V39, P2315, DOI 10.1007/BF02087644; CUMMINGS JH, 1973, LANCET, V1, P344; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DEVRESE M, 1990, CLIN NUTR, V9, P23, DOI 10.1016/0261-5614(90)90069-5; DiBaise JK, 2006, CLIN GASTROENTEROL H, V4, P11, DOI 10.1016/j.cgh.2005.10.020; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Ewaschuk JB, 2002, J CHROMATOGR B, V781, P39, DOI 10.1016/S1570-0232(02)00500-7; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gerard P, 2008, J MOL MICROB BIOTECH, V14, P115, DOI 10.1159/000106090; HINO T, 1993, APPL ENVIRON MICROB, V59, P255, DOI 10.1128/AEM.59.1.255-259.1993; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; HOVE H, 1995, DIGEST DIS SCI, V40, P1372, DOI 10.1007/BF02065554; HOVE H, 1993, GUT, V34, P625, DOI 10.1136/gut.34.5.625; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; James PD, 2010, CAN MED ASSOC J, V182, P276, DOI 10.1503/cmaj.090009; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; Joly F, 2009, GASTROENTEROLOGY, V136, P824, DOI 10.1053/j.gastro.2008.10.084; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kapel N, 1999, CLIN CHEM LAB MED, V37, P29, DOI 10.1515/CCLM.1999.004; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Messing B, 2006, GASTROENTEROLOGY, V130, pS43, DOI 10.1053/j.gastro.2005.09.064; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MESSING B, 1995, GASTROENTEROLOGY, V108, P1005, DOI 10.1016/0016-5085(95)90196-5; Messing B, 2006, J CLIN GASTROENTEROL, V40, pS75, DOI 10.1097/01.mcg.0000212677.06549.80; MILLER DS, 1959, BRIT J NUTR, V13, P501, DOI 10.1079/BJN19590064; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Nielsen C, 2011, SCAND J CLIN LAB INV, V71, P507, DOI 10.3109/00365513.2011.590900; NORDGAARD I, 1994, LANCET, V343, P373, DOI 10.1016/S0140-6736(94)91220-3; Nordgaard I, 1996, AM J CLIN NUTR, V64, P222, DOI 10.1093/ajcn/64.2.222; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Uribarri J, 1998, MEDICINE, V77, P73, DOI 10.1097/00005792-199803000-00001; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	57	59	65	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54335	10.1371/journal.pone.0054335	http://dx.doi.org/10.1371/journal.pone.0054335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372709	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500060
J	Nausch, H; Huckauf, J; Koslowski, R; Meyer, U; Broer, I; Mikschofsky, H				Nausch, Henrik; Huckauf, Jana; Koslowski, Roswitha; Meyer, Udo; Broer, Inge; Mikschofsky, Heike			Recombinant Production of Human Interleukin 6 in Escherichia coli	PLOS ONE			English	Article							PROTEIN-PRODUCTION; GLUCOSE-UTILIZATION; EXPRESSION; SOLUBILITY; FUSION; GROWTH; OVEREXPRESSION; PURIFICATION; AGGREGATION; STRATEGIES	In this study, we compared basic expression approaches for the efficient expression of bioactive recombinant human interleukin-6 (IL6), as an example for a difficult-to-express protein. We tested these approaches in a laboratory scale in order to pioneer the commercial production of this protein in Escherichia coli (E. coli). Among the various strategies, which were tested under Research and Development (R&D) conditions, aggregation-prone IL6 was solubilized most effectively by co-expressing cytoplasmic chaperones. Expression of a Glutathion-S-Transferase (GST) fusion protein was not efficient to increase IL6 solubility. Alteration of the cultivation temperature significantly increased the solubility in both cases, whereas reduced concentrations of IPTG to induce expression of the T7lac-promotor only had a positive effect on chaperone-assisted expression. The biological activity was comparable to that of commercial IL6. Targeting the expressed protein to an oxidizing environment was not effective in the generation of soluble IL6. Taken together, the presence of chaperones and a lowered cultivation temperature seem effective to isolate large quantities of soluble IL6. This approach led to in vivo soluble, functional protein fractions and reduces purification and refolding requirements caused by downstream purification procedures. The final yield of soluble recombinant protein averaged approximately 2.6 mg IL6/liter of cell culture. These findings might be beneficial for the development of the large-scale production of IL6 under the conditions of current good manufacturing practice (cGMP).	[Nausch, Henrik; Huckauf, Jana; Broer, Inge; Mikschofsky, Heike] Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, D-18055 Rostock, Germany; [Koslowski, Roswitha; Meyer, Udo] Bioserv GmbH, Rostock, Germany	University of Rostock	Broer, I (corresponding author), Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, D-18055 Rostock, Germany.	inge.broer@uni-rostock.de		Nausch, Henrik/0000-0001-5393-3267	University of Rostock	University of Rostock	The first author appreciates the grant from the doctorate program of the University of Rostock. No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRAKENHOFF JPJ, 1987, J IMMUNOL, V139, P4116; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Cong YH, 2012, BIOCONJUGATE CHEM, V23, P248, DOI 10.1021/bc200530x; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; Ejima D, 1999, BIOTECHNOL BIOENG, V62, P301, DOI 10.1002/(SICI)1097-0290(19990205)62:3<301::AID-BIT6>3.3.CO;2-N; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Jeong KJ, 2001, PROTEIN EXPRES PURIF, V23, P311, DOI 10.1006/prep.2001.1508; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; Kim TW, 2005, BIOTECHNOL PROGR, V21, P524, DOI 10.1021/bp049645j; Lauber T, 2001, PROTEIN EXPRES PURIF, V22, P108, DOI 10.1006/prep.2001.1415; Lee EG, 2009, ENZYME MICROB TECH, V44, P254, DOI 10.1016/j.enzmictec.2008.12.014; Li YY, 2002, PROTEIN EXPRES PURIF, V25, P437, DOI 10.1016/S1046-5928(02)00028-1; Lobel L, 2002, PROTEIN EXPRES PURIF, V25, P124, DOI 10.1006/prep.2002.1618; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; MAY LT, 1991, J BIOL CHEM, V266, P9950; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Negrete A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-75; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Niiranen L, 2007, PROTEIN EXPRES PURIF, V52, P210, DOI 10.1016/j.pep.2006.09.005; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Phue JN, 2004, J BIOTECHNOL, V109, P21, DOI 10.1016/j.jbiotec.2003.10.038; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; Schlapschy M, 2006, PROTEIN ENG DES SEL, V19, P385, DOI 10.1093/protein/gzl018; Seo JH, 2003, BIOTECHNOL APPL BIOC, V37, P103; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shiloach J, 1996, BIOTECHNOL BIOENG, V49, P421, DOI 10.1002/(SICI)1097-0290(19960220)49:4<421::AID-BIT9>3.0.CO;2-R; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Spiridonova VA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P424, DOI 10.1134/S0006297907040098; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; TONOUCHI N, 1988, J BIOCHEM-TOKYO, V104, P30, DOI 10.1093/oxfordjournals.jbchem.a122416; Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60; Venturi M, 2002, J MOL BIOL, V315, P1, DOI 10.1006/jmbi.2001.5221; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Waegeman H, 2012, BIOTECHNOL LETT, V34, P329, DOI 10.1007/s10529-011-0774-6; Waegeman H, 2011, J IND MICROBIOL BIOT, V38, P1891, DOI 10.1007/s10295-011-1034-4; Wu HP, 2009, INFLAMM RES, V58, P385, DOI 10.1007/s00011-009-0003-0; Xu YL, 2008, WORLD J MICROB BIOT, V24, P2827, DOI 10.1007/s11274-008-9813-4	51	26	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54933	10.1371/journal.pone.0054933	http://dx.doi.org/10.1371/journal.pone.0054933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372793	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500146
J	Noto, JM; Khizanishvili, T; Chaturvedi, R; Piazuelo, MB; Romero-Gallo, J; Delgado, AG; Khurana, SS; Sierra, JC; Krishna, US; Suarez, G; Powell, AE; Goldenring, JR; Coffey, RJ; Yang, VW; Correa, P; Mills, JC; Wilson, KT; Peek, RM				Noto, Jennifer M.; Khizanishvili, Tinatin; Chaturvedi, Rupesh; Piazuelo, M. Blanca; Romero-Gallo, Judith; Delgado, Alberto G.; Khurana, Shradha S.; Sierra, Johanna C.; Krishna, Uma S.; Suarez, Giovanni; Powell, Anne E.; Goldenring, James R.; Coffey, Robert J.; Yang, Vincent W.; Correa, Pelayo; Mills, Jason C.; Wilson, Keith T.; Peek, Richard M., Jr.			Helicobacter Pylori Promotes the Expression of Kruppel-Like Factor 5, a Mediator of Carcinogenesis, In Vitro and In Vivo	PLOS ONE			English	Article							BINDING-PROTEIN; SELF-RENEWAL; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; BETA-CATENIN; STEM; KLF5; LRIG1; PROLIFERATION; ACTIVATION	Helicobacter pylori is the strongest known risk factor for the development of gastric adenocarcinoma. H. pylori expresses a repertoire of virulence factors that increase gastric cancer risk, including the cag pathogenicity island and the vacuolating cytotoxin (VacA). One host element that promotes carcinogenesis within the gastrointestinal tract is Kruppel-like factor 5 (KLF5), a transcription factor that mediates key cellular functions. To define the role of KLF5 within the context of H. pylori-induced inflammation and injury, human gastric epithelial cells were co-cultured with the wild-type cag(+) H. pylori strain 60190. KLF5 expression was significantly upregulated following co-culture with H. pylori, but increased expression was independent of the cag island or VacA. To translate these findings into an in vivo model, C57BL/6 mice were challenged with the wild-type rodent-adapted cag(+) H. pylori strain PMSS1 or a PMSS1 cagE(-) isogenic mutant. Similar to findings in vitro, KLF5 staining was significantly enhanced in gastric epithelium of H. pylori-infected compared to uninfected mice and this was independent of the cag island. Flow cytometry revealed that the majority of KLF5(+) cells also stained positively for the stem cell marker, Lrig1, and KLF5(+)/Lrig1(+) cells were significantly increased in H. pylori-infected versus uninfected tissue. To extend these results into the natural niche of this pathogen, levels of KLF5 expression were assessed in human gastric biopsies isolated from patients with or without premalignant lesions. Levels of KLF5 expression increased in parallel with advancing stages of neoplastic progression, being significantly elevated in gastritis, intestinal metaplasia, and dysplasia compared to normal gastric tissue. These results indicate that H. pylori induces expression of KLF5 in gastric epithelial cells in vitro and in vivo, and that the degree of KLF5 expression parallels the severity of premalignant lesions in human gastric carcinogenesis.	[Noto, Jennifer M.; Khizanishvili, Tinatin; Chaturvedi, Rupesh; Piazuelo, M. Blanca; Romero-Gallo, Judith; Delgado, Alberto G.; Sierra, Johanna C.; Krishna, Uma S.; Suarez, Giovanni; Coffey, Robert J.; Correa, Pelayo; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Med, St Louis, MO USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Dev Biol, St Louis, MO USA; [Powell, Anne E.; Goldenring, James R.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Goldenring, James R.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Yang, Vincent W.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Immunol, Nashville, TN USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Noto, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA.	jennifer.noto@vanderbilt.edu	Mills, Jason/AAA-6688-2021	Mills, Jason/0000-0002-0402-4662; Wilson, Keith/0000-0003-4421-1830; Zemper, Anne/0000-0001-8238-1406	National Institutes of Health (NIH) [F32CA153539, R01CA077955, R01DK058587, P30DK058404, P01CA116087, R01DK053620, P01CA028842]; Vanderbilt University Digestive Disease Research Cente [P30DK058404]; Office of Medical Research, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA119925, R01CA046413, P01CA116087, P01CA028842, F32CA153539, T32CA113275, R01CA077955] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094989, P30DK058404, R01DK058587, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Cente; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health (NIH) grants: F32CA153539 (JMN); R01CA077955 (RMP), R01DK058587 (RMP), P30DK058404 (RMP), P01CA116087 (RMP and KTW), R01DK053620 (KTW), P01CA028842 (KTW and PC), the flow cytometry core of the Vanderbilt University Digestive Disease Research Center grant (P30DK058404), and a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (KTW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kojima S, 1997, J BIOCHEM, V121, P389; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Nagy TA, 2011, GASTROENTEROLOGY, V141, P553, DOI 10.1053/j.gastro.2011.05.004; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038338; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235	49	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54344	10.1371/journal.pone.0054344	http://dx.doi.org/10.1371/journal.pone.0054344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372710	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500061
J	Takahashi, RH; Capetillo-Zarate, E; Lin, MT; Milner, TA; Gouras, GK				Takahashi, Reisuke H.; Capetillo-Zarate, Estibaliz; Lin, Michael T.; Milner, Teresa A.; Gouras, Gunnar K.			Accumulation of Intraneuronal beta-Amyloid 42 Peptides Is Associated with Early Changes in Microtubule-Associated Protein 2 in Neurites and Synapses	PLOS ONE			English	Article							INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PRECURSOR-PROTEIN; PLAQUE-FORMATION; MOUSE MODEL; SELECTIVE VULNERABILITY; A-BETA-42 ACCUMULATION; COGNITIVE DEFICITS; SYNAPTIC PATHOLOGY	Pathologic aggregation of beta-amyloid (A beta) peptide and the axonal microtubule-associated protein tau protein are hallmarks of Alzheimer's disease (AD). Evidence supports that A beta peptide accumulation precedes microtubule-related pathology, although the link between A beta and tau remains unclear. We previously provided evidence for early co-localization of A beta 42 peptides and hyperphosphorylated tau within postsynaptic terminals of CA1 dendrites in the hippocampus of AD transgenic mice. Here, we explore the relation between A beta peptide accumulation and the dendritic, microtubule-associated protein 2 (MAP2) in the well-characterized amyloid precursor protein Swedish mutant transgenic mouse (Tg2576). We provide evidence that localized intraneuronal accumulation of A beta 42 peptides is spatially associated with reductions of MAP2 in dendrites and postsynaptic compartments of Tg2576 mice at early ages. Our data support that reduction in MAP2 begins at sites of A beta 42 monomer and low molecular weight oligomer (M/LMW) peptide accumulation. Cumulative evidence suggests that accumulation of M/LMW A beta 42 peptides occurs early, before high molecular weight oligomerization and plaque formation. Since synaptic alteration is the best pathologic correlate of cognitive dysfunction in AD, the spatial association of M/LMW A beta peptide accumulation with pathology of MAP2 within neuronal processes and synaptic compartments early in the disease process reinforces the importance of intraneuronal A beta accumulation in AD pathogenesis.	[Takahashi, Reisuke H.] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan; [Takahashi, Reisuke H.; Capetillo-Zarate, Estibaliz; Lin, Michael T.; Milner, Teresa A.; Gouras, Gunnar K.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Milner, Teresa A.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; [Gouras, Gunnar K.] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Tokyo Medical University; Cornell University; Rockefeller University; Lund University	Takahashi, RH (corresponding author), Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan.	takaharh@tokyo-med.ac.jp; gunnar.gouras@med.lu.se	Gouras, Gunnar/B-3021-2010; Capetillo-Zarate, Estibaliz/Z-5772-2019	Gouras, Gunnar/0000-0002-5500-6325; Capetillo-Zarate, Estibaliz/0000-0002-8416-0495	National Institutes of Health [HL18974, DA08259, NS045677, AG028174]; MultiPark; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG028174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MultiPark; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health grants HL18974, DA08259 (TAM), NS045677 and AG028174, and MultiPark (GKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Capetillo-Zarate E, 2011, AM J PATHOL, V179, P2551, DOI 10.1016/j.ajpath.2011.07.045; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Funato H, 1999, AM J PATHOL, V155, P23, DOI 10.1016/S0002-9440(10)65094-8; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Milner TA, 1998, J COMP NEUROL, V395, P310; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Peters A., 1991, FINE STRUCTURE NERVO; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Shie FS, 2003, NEUROREPORT, V14, P123, DOI 10.1097/00001756-200301200-00023; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Upadhaya AR, 2012, J CELL MOL MED, V16, P287, DOI 10.1111/j.1582-4934.2011.01306.x; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	60	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51965	10.1371/journal.pone.0051965	http://dx.doi.org/10.1371/journal.pone.0051965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372648	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500008
J	Chang, SLY; Liu, YC; Chen, SY; Huang, TH; Liu, PT; Liu, FC				Chang, Sunny Li-Yun; Liu, Ya-Chi; Chen, Shih-Yun; Huang, Ting-Hao; Liu, Pei-Tsen; Liu, Fu-Chin			Identification of Two Evolutionarily Conserved 5 ' cis-Elements Involved in Regulating Spatiotemporal Expression of Nolz-1 during Mouse Embryogenesis	PLOS ONE			English	Article							GENE; FAMILY; DROSOPHILA; MORPHOGENESIS; DOMAINS; SIGNALS; REGION; ELBOW	Proper development of vertebrate embryos depends not only on the crucial funtions of key evolutionarily conserved transcriptional regulators, but also on the precisely spatiotemporal expression of these transcriptional regulators. The mouse Nolz-1/Znf503/Zfp503 gene is a mammalian member of the conserved zinc-finger containing NET family. The expression pattern of Nolz-1 in mouse embryos is highly correlated with that of its homologues in different species. To study the spatiotemporal regulation of Nolz-1, we first identified two evolutionarily conserved cis-elements, UREA and UREB, in 5' upstream regions of mouse Nolz-1 locus. We then generated UREA-LacZ and UREB-LacZ transgenic reporter mice to characterize the putative enhancer activity of UREA and UREB. The results indicated that both UREA and UREB contained tissue-specific enhancer activity for directing LacZ expression in selective tissue organs during mouse embryogensis. UREA directed LacZ expression preferentially in selective regions of developing central nervous system, including the forebrain, hindbrain and spinal cord, whereas UREB directed LacZ expression mainly in other developing tissue organs such as the Nolz-1 expressing branchial arches and its derivatives, the apical ectodermal ridge of limb buds and the urogenital tissues. Both UREA and UREB directed strong LacZ expression in the lateral plate mesoderm where endogenous Nolz-1 was also expressed. Despite that the LacZ expression pattern did not full recapitulated the endogenous Nolz-1 expression and some mismatched expression patterns were observed, co-expression of LacZ and Nolz-1 did occur in many cells of selective tissue organs, such as in the ventrolateral cortex and ventral spinal cord of UREA-LacZ embryos, and the urogenital tubes of UREB-LacZ embryos. Taken together, our study suggests that UREA and UREB may function as evolutionarily conserved cis-regulatory elements that coordinate with other cis-elements to regulate spatiotemporal expression of Nolz-1 in different tissue organs during mouse embryogenesis.	[Chang, Sunny Li-Yun; Liu, Ya-Chi; Liu, Pei-Tsen] China Med Univ, Inst Mol Syst Biomed, Taichung, Taiwan; [Chen, Shih-Yun; Huang, Ting-Hao; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University	Chang, SLY (corresponding author), China Med Univ, Inst Mol Syst Biomed, Taichung, Taiwan.	liyunchang@mail.cmu.edu.tw; fuchin@ym.edu.tw			National Science Council [NSC99-2311-B-010-005-MY3, NSC97-2320-B-039-038, NSC-98-2320-B-039-034-MY3]; China Medical University [CMU97-224]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Ministry of Education	This work was supported by grants from National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp = 7), Grant numbers: NSC99-2311-B-010-005-MY3 (F.-C. L.), NSC97-2320-B-039-038 (S.L.-Y.C) and NSC-98-2320-B-039-034-MY3 (S.L.-Y.C.) and also supported by China Medical University (http://english.cmu.edu.tw/), Grant number CMU97-224 (S.L.-Y.C.) and Ministry of Education (http://english.moe.gov.tw/mp.asp?mp = 1), Talent Researchers Recruitment Program for University and College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-44; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chang SLY, 2011, GENE EXPR PATTERNS, V11, P525, DOI 10.1016/j.gep.2011.09.003; CHEAH PY, 1994, MOL CELL BIOL, V14, P1487, DOI 10.1128/MCB.14.2.1487; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Ji SJ, 2009, DEVELOPMENT, V136, P231, DOI 10.1242/dev.028043; Lee AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020088; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; McGlinn E, 2008, DEV DYNAM, V237, P1172, DOI 10.1002/dvdy.21508; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Runko AP, 2003, DEV BIOL, V262, P254, DOI 10.1016/S0012-1606(03)00388-9; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Stenman J, 2003, J NEUROSCI, V23, P167; Tseng ASK, 2002, GENETICS, V162, P229; Weihe U, 2004, DEVELOPMENT, V131, P767, DOI 10.1242/dev.00979; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Zaki PA, 2003, CURR OPIN GENET DEV, V13, P423, DOI 10.1016/S0959-437X(03)00084-4; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao XJ, 2002, DEVELOPMENT, V129, P1497	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54485	10.1371/journal.pone.0054485	http://dx.doi.org/10.1371/journal.pone.0054485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349903	Green Submitted, Green Published, gold			2022-12-25	WOS:000314019100074
J	Mankovich, AR; Lee, CY; Heinrich, V				Mankovich, Alexander R.; Lee, Cheng-Yuk; Heinrich, Volkmar			Differential Effects of Serum Heat Treatment on Chemotaxis and Phagocytosis by Human Neutrophils	PLOS ONE			English	Article							BINDING LECTIN SITE; MAC-1 CD11B/CD18; LABILE OPSONINS; CROSS-LINKING; COMPLEMENT; ADHESION; DOMAIN; AGGREGATION; SPECIFICITY; INFECTIONS	Neutrophils, in cooperation with serum, are vital gatekeepers of a host's microbiome and frontline defenders against invading microbes. Yet because human neutrophils are not amenable to many biological techniques, the mechanisms governing their immunological functions remain poorly understood. We here combine state-of-the-art single-cell experiments with flow cytometry to examine how temperature-dependent heat treatment of serum affects human neutrophil interactions with "target" particles of the fungal model zymosan. Assessing separately both the chemotactic as well as the phagocytic neutrophil responses to zymosan, we find that serum heat treatment modulates these responses in a differential manner. Whereas serum treatment at 52 degrees C impairs almost all chemotactic activity and reduces cell-target adhesion, neutrophils still readily engulf target particles that are maneuvered into contact with the cell surface under the same conditions. Higher serum-treatment temperatures gradually suppress phagocytosis even after enforced cell-target contact. Using fluorescent staining, we correlate the observed cell behavior with the amounts of C3b and IgG deposited on the zymosan surface in sera treated at the respective temperatures. This comparison not only affirms the critical role of complement in chemotactic and adhesive neutrophil interactions with fungal surfaces, but also unmasks an important participation of IgGs in the phagocytosis of yeast-like fungal particles. In summary, this study presents new insight into fundamental immune mechanisms, including the chemotactic recruitment of immune cells, the adhesive capacity of cell-surface receptors, the role of IgGs in fungal recognition, and the opsonin-dependent phagocytosis morphology of human neutrophils. Moreover, we show how, by fine-tuning the heat treatment of serum, one can selectively study chemotaxis or phagocytosis under otherwise identical conditions. These results not only refine our understanding of a widely used laboratory method, they also establish a basis for new applications of this method.	[Mankovich, Alexander R.; Lee, Cheng-Yuk; Heinrich, Volkmar] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Heinrich, V (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	vheinrich@ucdavis.edu		Heinrich, Volkmar/0000-0002-4932-5012	National Institutes of Health, USA [R01 A1072391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072391] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, USA, grant R01 A1072391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; BOULANGER P., 1960, CANADIAN JOUR COMP MED AND VET SCI, V24, P262; Casals J, 1941, J EXP MED, V74, P409, DOI 10.1084/jem.74.5.409; Chiani P, 2009, VACCINE, V27, P513, DOI 10.1016/j.vaccine.2008.11.030; DAHL MV, 1979, J IMMUNOL METHODS, V29, P301, DOI 10.1016/0022-1759(79)90001-2; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Ecker EE, 1943, J IMMUNOL, V47, P181; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; FERRANTE A, 1979, SABOURAUDIA, V17, P293; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hamburger HJ, 1927, HDB BIOL ARBEITSME 4, P953; HED J, 1982, IMMUNOLOGY, V45, P727; Heinrich V, 2005, LANGMUIR, V21, P1962, DOI 10.1021/la047801q; Heinrich V, 2011, J CELL SCI, V124, P3041, DOI 10.1242/jcs.086413; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Herant M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001068; JUNGKIND DL, 1986, J CLIN MICROBIOL, V23, P381, DOI 10.1128/JCM.23.2.381-382.1986; Kocher M, 1997, J IMMUNOL, V159, P3940; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Pillemer L, 1941, J BIOL CHEM, V137, P139; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; PUTNAM FW, 1987, PLASMA PROTEINS STRU; Rivas-Fuentes S, 2010, CELL IMMUNOL, V263, P114, DOI 10.1016/j.cellimm.2010.03.006; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Rudnicki MA, 1987, TERATOCARCINOMAS EMB, P19; SCRIBNER DJ, 1976, J IMMUNOL, V116, P892; SIMON SI, 1995, J IMMUNOL, V155, P1502; SMITH MR, 1969, P NATL ACAD SCI USA, V63, P1151, DOI 10.1073/pnas.63.4.1151; SOLTIS RD, 1979, IMMUNOLOGY, V36, P37; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; VANEPPS DE, 1976, INFECT IMMUN, V13, P741, DOI 10.1128/IAI.13.3.741-749.1976; VERHOEF J, 1977, IMMUNOLOGY, V33, P191; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang G R, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P325; Weatherby D, 2004, BLOOD CHEM CBC ANAL; Weiss S A, 1995, Methods Mol Biol, V39, P65; Xia Y, 1999, J IMMUNOL, V162, P7285; Zhelev DV, 2004, BIOPHYS J, V87, P688, DOI 10.1529/biophysj.103.036699; Zhelev DV, 1996, CELL MOTIL CYTOSKEL, V35, P331	49	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54735	10.1371/journal.pone.0054735	http://dx.doi.org/10.1371/journal.pone.0054735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349959	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100093
J	Sonstegard, TS; Cole, JB; VanRaden, PM; Van Tassell, CP; Null, DJ; Schroeder, SG; Bickhart, D; McClure, MC				Sonstegard, Tad S.; Cole, John B.; VanRaden, Paul M.; Van Tassell, Curtis P.; Null, Daniel J.; Schroeder, Steven G.; Bickhart, Derek; McClure, Matthew C.			Identification of a Nonsense Mutation in CWC15 Associated with Decreased Reproductive Efficiency in Jersey Cattle	PLOS ONE			English	Article							CALVES; GENE; NUCLEOTIDE; EXPRESSION; HAPLOTYPES; FERTILITY; DISCOVERY; ALIGNMENT; COMPLEX; MARKERS	With the recent advent of genomic tools for cattle, several recessive conditions affecting fertility have been identified and selected against, such as deficiency of uridine monophosphate synthase, complex vertebral malformation, and brachyspina. The current report refines the location of a recessive haplotype affecting fertility in Jersey cattle using crossover haplotypes, discovers the causative mutation using whole genome sequencing, and examines the gene's role in embryo loss. In an attempt to identify unknown recessive lethal alleles in the current dairy population, a search using deep Mendelian sampling of 5,288 Jersey cattle was conducted for high-frequency haplotypes that have a deficit of homozygotes at the population level. This search led to the discovery of a putative recessive lethal in Jersey cattle on Bos taurus autosome 15. The haplotype, denoted JH1, was associated with reduced fertility, and further investigation identified one highly-influential Jersey bull as the putative source ancestor. By combining SNP analysis of whole-genome sequences aligned to the JH1 interval and subsequent SNP validation a nonsense mutation in CWC15 was identified as the likely causative mutation underlying the fertility phenotype. No homozygous recessive individuals were found in 749 genotyped animals, whereas all known carriers and carrier haplotypes possessed one copy of the mutant allele. This newly identified lethal has been responsible for a substantial number of spontaneous abortions in Jersey dairy cattle throughout the past half-century. With the mutation identified, selection against the deleterious allele in breeding schemes will aid in reducing the incidence of this defect in the population. These results also show that carrier status can be imputed with high accuracy. Whole-genome resequencing proved to be a powerful strategy to rapidly identify a previously mapped deleterious mutation in a known carrier of a recessive lethal allele.	[Cole, John B.; VanRaden, Paul M.; Null, Daniel J.] ARS, Anim Improvement Programs Labs, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Cole, JB (corresponding author), ARS, Anim Improvement Programs Labs, USDA, Beltsville, MD USA.	john.cole@ars.usda.gov	Van Tassell, Curtis P./O-4247-2019; Cole, John B./J-8571-2014; Kushnir, Irina/D-8583-2016	Van Tassell, Curtis P./0000-0002-8416-2087; Cole, John B./0000-0003-1242-4401; Kushnir, Irina/0000-0002-8575-3970; Bickhart, Derek/0000-0003-2223-9285; Schroeder, Steven/0000-0001-9103-5150	American Jersey Cattle Association; Bovine Functional Genomics Laboratories [1265-31000-096-00, 1265-31000-098-00]	American Jersey Cattle Association; Bovine Functional Genomics Laboratories	The American Jersey Cattle Association provided funding for genome sequencing. The contribution by scientists in the Animal Improvement Programs and Bovine Functional Genomics Laboratories are supported by appropriated projects 1265-31000-096-00 and 1265-31000-098-00, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2006, J VET DIAGN INVEST, V18, P418, DOI 10.1177/104063870601800421; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; [Anonymous], 2011, INTERBULL B; Center for Bioinformatics and Computatonal Biology, 2010, BOS TAURUS ASSEMBLY; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Cingolani P, 2012, ISO 2; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Duan Jia-Zhong, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P637; ELDRIDGE FE, 1951, J HERED, V42, P241, DOI 10.1093/oxfordjournals.jhered.a106217; ELHAMIDI M, 1989, J VET MED A, V36, P731, DOI 10.1111/j.1439-0442.1989.tb00786.x; Georges M, 2010, International Patent Publ. No, Patent No. [W0201.0/012690., 2010012690, W02010/012690 Al, 02010012690]; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HAFNER A, 1993, J VET MED B, V40, P413, DOI 10.1111/j.1439-0450.1993.tb00158.x; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Harpestad GW, 1987, J HERED, V75, P337; LEIPOLD HW, 1973, VET MED SM ANIM CLIN, V68, P645; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIEN S, 1993, ANIM GENET, V24, P373, DOI 10.1111/j.1365-2052.1993.tb00343.x; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Michelizzi VN, 2011, INT J BIOL SCI, V7, P18, DOI 10.7150/ijbs.7.18; Page BT, 2004, J ANIM SCI, V82, P3474; Seichter D, 2011, ANIM GENET, V42, P544, DOI 10.1111/j.1365-2052.2010.02167.x; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VanRaden PM, 2004, J DAIRY SCI, V87, P2285, DOI 10.3168/jds.S0022-0302(04)70049-1; Wetterstrand KA, 2012, DNA SEQUENCING COSTS; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707	37	75	77	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54872	10.1371/journal.pone.0054872	http://dx.doi.org/10.1371/journal.pone.0054872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349982	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100105
J	Sun, T; Tian, H; Wang, CQ; Yin, P; Zhu, YQ; Chen, XH; Tang, ZD				Sun, Ting; Tian, Hua; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde			A Survey of Congenital Heart Disease and Other Organic Malformations Associated with Different Types of Orofacial Clefts in Eastern China	PLOS ONE			English	Article							BIRTH-DEFECTS; ORAL CLEFTS; PALATE; LIP; ANOMALIES	Background: A high incidence of orofacial clefts is reported in China, but no data has shown the relation between cleft types and the incidence of other defects so far. The aim of this study is to assess the incidence of congenital heart diseases and other organic defects associated with different types of orofacial clefts. Methodology and Principal Findings: All children with orofacial clefts, which were sought out from the Health Information System of Shanghai Ninth People's Hospital between 1st Jan 2009 and 30th Dec 2011, were enrolled in this study. All subjects underwent a thorough examination and grouped by the cleft phenotype. The numbers and types of other organic defects were recorded and analyzed statistically using SPSS 17.0. Of 2180 cases reported as having orofacial clefts, 657 (30.1%) had other congenital abnormalities, which were significantly more common in cleft palate (47.9% (329/687)) than that in cleft lip (10.6% (80/755)) or cleft lip and palate (33.6% (248/738)) (P<0.01). In subgroups, unilateral cleft lip and palate had a statistically higher incidence of associated abnormalities than bilateral cleft lip and palate (P<0.01). The most common malformation was congenital heart disease, which counted 45.1% (296/657) of all malformations. Disorders of the central nervous system (14.3%(94/657)) and Skeletal anomalies (13.1%(86/657)) were also frequently associated. Additionally, the most common defect in heart was atrial septal defect, which was 39.7% (118/296) of all congenital heart diseases. Conclusions and Significance: As the high incidence of heart defects and other organic abnormalities in the children with cleft palate in Eastern China, special attention should be paid to them and echocardiography should be a proposed examination in the evaluation of children with cleft palate before any surgical correction being executed.	[Sun, Ting; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Tian, Hua] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, T (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	beibeisun2008@163.com; changqianwang@hotmail.com			Specialized Research Fund for the Doctoral Program of Higher Education of China [20110073120105]; Research Project of Shanghai Municipal Health Bureau [2011169]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Project of Shanghai Municipal Health Bureau	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (20110073120105) Research Project of Shanghai Municipal Health Bureau (2011169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunhan H, 2012, BRIT J ORAL MAX SURG, V50, P541, DOI 10.1016/j.bjoms.2011.08.001; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; Barbosa MM, 2003, PEDIATR CARDIOL, V24, P369, DOI 10.1007/s00246-002-0335-9; Beriaghi S, 2009, J CLIN PEDIATR DENT, V33, P207, DOI 10.17796/jcpd.33.3.c244761467507721; Dai L, 2010, BIRTH DEFECTS RES A, V88, P41, DOI 10.1002/bdra.20607; Genisca AE, 2009, AM J MED GENET A, V149A, P1149, DOI 10.1002/ajmg.a.32854; Han J, 2006, TOXICOL LETT, V166, P248, DOI 10.1016/j.toxlet.2006.07.308; Liang Chi-Di, 1999, Acta Paediatrica Taiwanica, V40, P414; Luijsterburg AJM, 2011, CLEFT PALATE-CRAN J, V48, P173, DOI 10.1597/08-150; Rittler M, 2008, CLEFT PALATE-CRAN J, V45, P525, DOI 10.1597/06-250.1; Sarkozi Andrea, 2005, BMC Oral Health, V5, P4, DOI 10.1186/1472-6831-5-4; Shafi T, 2003, BRIT J PLAST SURG, V56, P106, DOI 10.1016/S0007-1226(03)00044-4; SHPRINTZEN RJ, 1985, AM J MED GENET, V20, P585, DOI 10.1002/ajmg.1320200404; Slator Rona, 2009, J Fam Health Care, V19, P101; Vallino-Napoli LD, 2006, CLEFT PALATE-CRAN J, V43, P571, DOI 10.1597/05-123; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yi N. N., 1999, Annals Academy of Medicine Singapore, V28, P655	17	42	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54726	10.1371/journal.pone.0054726	http://dx.doi.org/10.1371/journal.pone.0054726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349958	Green Submitted, gold, Green Published			2022-12-25	WOS:000313943000048
J	Lin, YT; Wu, YH; Tseng, CK; Lin, CK; Chen, WC; Hsu, YC; Lee, JC				Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Hsu, Yao-Chin; Lee, Jin-Ching			Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; (-)-EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; RNA REPLICATION; CELL-CULTURE; INFECTION; EXPRESSION; CYCLOOXYGENASE-2; CATECHINS; SYSTEM	Chronic hepatitis C virus (HCV) infection is the leading risk factor for hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Green tea, in addition to being consumed as a healthy beverage, contains phenolic catechins that have been used as medicinal substances. In the present study, we illustrated that the epicatechin isomers (+)-epicatechin and (-)-epicatechin concentration-dependently inhibited HCV replication at nontoxic concentrations by using in vitro cell-based HCV replicon and JFH-1 infectious systems. In addition to significantly suppressing virus-induced cyclooxygenase-2 (COX-2) expression, our results revealed that the anti-HCV activity of the epicatechin isomers occurred through the down-regulation of COX-2. Furthermore, both the epicatechin isomers additively inhibited HCV replication in combination with either interferon-alpha or viral enzyme inhibitors [2'-C-methylcytidine (NM-107) or telaprevir]. They also had prominent anti-inflammatory effects by inhibiting the gene expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and inducible nitrite oxide synthase as well as the COX-2 in viral protein-expressing hepatoma Huh-7 cells. Collectively, (+)-epicatechin and (-)-epicatechin may serve as therapeutic supplements for treating HCV-related diseases.	[Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Hsu, Yao-Chin] ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University	Hsu, YC (corresponding author), ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan.	cmh7100@mail.chimei.org.tw; jclee@kmu.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	 [NSC 101-2113-M-037-010];  [NSC 101-2311-B-037-002-MY3];  [KMUER014];  [97CM-KMU-13]	; ; ; 	NSC 101-2113-M-037-010, NSC 101-2311-B-037-002-MY3 (http://web1.nsc.gov.tw/), KMUER014, 97CM-KMU-13 (http://www2.kmu.edu.tw/index.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chang LK, 2003, BIOCHEM BIOPH RES CO, V301, P1062, DOI 10.1016/S0006-291X(03)00067-6; Chen C, 2012, ARCH VIROL; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h; Dong-rui Ma, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P914; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gee J, 2008, UROL ONCOL-SEMIN ORI, V26, P641, DOI 10.1016/j.urolonc.2007.05.015; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u; Hou DX, 2007, ARCH BIOCHEM BIOPHYS, V460, P67, DOI 10.1016/j.abb.2007.01.009; Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021; Isaacs CE, 2011, ANTIMICROB AGENTS CH, V55, P5646, DOI 10.1128/AAC.05531-11; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Jiang YF, 2011, CELL BIOL INT, V35, P1225, DOI 10.1042/CBI20110102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Laurie SA, 2005, CANCER CHEMOTH PHARM, V55, P33, DOI 10.1007/s00280-004-0859-1; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2003, ANAL BIOCHEM, V316, P162, DOI 10.1016/S0003-2697(03)00053-8; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li Jianxiang, 2001, Zhonghua Yufang Yixue Zazhi, V35, P404; Li Shenwei, 2010, Antiviral Chemistry & Chemotherapy, V20, P239, DOI 10.3851/IMP1597; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Matthews Carolyn M, 2010, Proc (Bayl Univ Med Cent), V23, P142; Morinaga S, 2007, J GASTROEN HEPATOL, V22, P1249, DOI 10.1111/j.1440-1746.2006.04367.x; Nunez O, 2004, GUT, V53, P1665, DOI 10.1136/gut.2003.038364; Okamoto Mika, 2009, Antivir Chem Chemother, V20, P47, DOI 10.3851/IMP1372; Pan KL, 2009, ANTIMICROB AGENTS CH, V53, P4825, DOI 10.1128/AAC.00601-09; Park CM, 2010, FOOD CHEM TOXICOL, V48, P1255, DOI 10.1016/j.fct.2010.02.019; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Roh C, 2011, TALANTA, V85, P2639, DOI 10.1016/j.talanta.2011.08.035; Sakaki M, 2010, HEPATOL RES, V40, P1219, DOI 10.1111/j.1872-034X.2010.00727.x; Salloum S, 2012, TRANSL RES, V159, P421, DOI 10.1016/j.trsl.2011.12.007; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schaefer Martin, 2008, Curr Drug Abuse Rev, V1, P177; Shanafelt TD, 2012, CANCER; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tseng CK, 2011, ANAL BIOCHEM, V418, P50, DOI 10.1016/j.ab.2011.06.042; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Wohlfarth C, 2009, ACTA PHARMACOL SIN, V30, P25, DOI 10.1038/aps.2008.5; Wu KM, 2010, REGUL TOXICOL PHARM, V56, P1, DOI 10.1016/j.yrtph.2009.09.012; Zuo GY, 2007, ANTIVIR RES, V76, P86, DOI 10.1016/j.antiviral.2007.06.001	55	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54466	10.1371/journal.pone.0054466	http://dx.doi.org/10.1371/journal.pone.0054466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365670	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600058
J	de Carvalho, AL; Nelson, BW; Bianchini, MC; Plagnol, D; Kuplich, TM; Daly, DC				de Carvalho, Anelena L.; Nelson, Bruce W.; Bianchini, Milton C.; Plagnol, Daniela; Kuplich, Tatiana M.; Daly, Douglas C.			Bamboo-Dominated Forests of the Southwest Amazon: Detection, Spatial Extent, Life Cycle Length and Flowering Waves	PLOS ONE			English	Article							TROPICAL FOREST; LONG	We map the extent, infer the life-cycle length and describe spatial and temporal patterns of flowering of sarmentose bamboos (Guadua spp) in upland forests of the southwest Amazon. We first examine the spectra and the spectral separation of forests with different bamboo life stages. False-color composites from orbital sensors going back to 1975 are capable of distinguishing life stages. These woody bamboos flower produce massive quantities of seeds and then die. Life stage is synchronized, forming a single cohort within each population. Bamboo dominates at least 161,500 km(2) of forest, coincident with an area of recent or ongoing tectonic uplift, rapid mechanical erosion and poorly drained soils rich in exchangeable cations. Each bamboo population is confined to a single spatially continuous patch or to a core patch with small outliers. Using spatial congruence between pairs of mature-stage maps from different years, we estimate an average life cycle of 27-28 y. It is now possible to predict exactly where and approximately when new bamboo mortality events will occur. We also map 74 bamboo populations that flowered between 2001 and 2008 over the entire domain of bamboo-dominated forest. Population size averaged 330 km(2). Flowering events of these populations are temporally and/or spatially separated, restricting or preventing gene exchange. Nonetheless, adjacent populations flower closer in time than expected by chance, forming flowering waves. This may be a consequence of allochronic divergence from fewer ancestral populations and suggests a long history of widespread bamboo in the southwest Amazon.	[de Carvalho, Anelena L.] Natl Inst Amazon Res, Grad Program Forest Sci, Cruzeiro Do Sul, Brazil; [Bianchini, Milton C.] Natl Inst Amazon Res, Grad Program Ecol, Inst Criminalist Amazonas IC, Dept Policia Tecn Cient DPTC Policia Civil Estado, Manaus, Amazonas, Brazil; [Nelson, Bruce W.; Plagnol, Daniela] Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil; [Kuplich, Tatiana M.] So Reg INPE CRS, Natl Inst Space Res, Santa Maria, RS, Brazil; [Daly, Douglas C.] New York Bot Garden, Bronx, NY 10458 USA	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Instituto Nacional de Pesquisas Espaciais (INPE); New York Botanical Garden	Nelson, BW (corresponding author), Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil.	bnelsonbr@gmail.com	Kuplich, Tatiana/C-6429-2013; Kuplich, Tatiana M/U-1112-2018; Nelson, Bruce/G-4562-2013; Gomes de Carvalho, Andre Luiz/M-9503-2017; Fernandes, Daniel/D-7168-2013	Kuplich, Tatiana M/0000-0003-0657-4024; Nelson, Bruce/0000-0002-0488-6895; Gomes de Carvalho, Andre Luiz/0000-0002-2528-6274; Fernandes, Daniel/0000-0001-6155-6246	Brazilian National Research Council (CNPq) [52.3102/96]; National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	CLASlite image-processing software was developed by the Carnegie Institution of Washington, with support from The Gordon and Betty Moore Foundation and The John D. and Catherine T. MacArthur Foundation. Petrobras provided a low-level helicopter flight over senescing Guadua sarcocarpa. Brazil's National Institute for Space Research (INPE) provided the aircraft and 150 km low-level flight over juvenile bamboo populations. Funding for this research was provided by the Brazilian National Research Council (CNPq) via grant 52.3102/96, by CNPq via the GEOMA environmental modelling network and by the National Institute for Amazon Research (INPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D, 1962, EVOLUTIONARY RELATIO; [Anonymous], J ED, DOI [DOI 10.1080/01619569509538834, DOI 10.1080/10106048809354132]; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Balee W., 1989, Advances in Economic Botany, V7, P1; Barlow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033373; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Deering DW, 1999, REMOTE SENS ENVIRON, V67, P205, DOI 10.1016/S0034-4257(98)00087-X; Espirito-Santo FB, 2003, DETECCAO DINAMICA FL, P649; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; GADGIL M, 1984, BIOTROPICA, V16, P161, DOI 10.2307/2388050; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Hill RA, 1999, INT J REMOTE SENS, V20, P1039, DOI 10.1080/014311699213082; IBGE EMBRAPA, 2001, MAP SOL BRAS; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; Kratter AW, 1997, BIOTROPICA, V29, P100, DOI 10.1111/j.1744-7429.1997.tb00011.x; LONDONO X, 1991, SYST BOT, V16, P630, DOI 10.2307/2418866; Mascarenhas Artur Fernando Silva, 2004, Acta Amaz., V34, P61, DOI 10.1590/S0044-59672004000100008; Nelson B., 1994, REMOTE SENSING REV, V10, P105, DOI [10.1080/02757259409532239, DOI 10.1080/02757259409532239]; NELSON BW, 2006, AN SEM NAC BAMB FAC, P49; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Regard V, 2009, GEOMORPHOLOGY, V107, P107, DOI 10.1016/j.geomorph.2008.12.003; Santos H.G., 2018, BRAZILIAN SOIL CLASS, V5th edition, DOI [10.1016/j.eja.2021.126308, DOI 10.1016/J.EJA.2021.126308]; SANTOS U D M, 1988, Acta Amazonica, V18, P145; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Silveira M., 1999, Ecotropica, V5, P213; SINGH A, 1987, INT J REMOTE SENS, V8, P971, DOI 10.1080/01431168708954741; Smith M, 2011, J TROP ECOL, V27, P59, DOI 10.1017/S026646741000057X; Toivonen T, 2006, REMOTE SENS ENVIRON, V100, P550, DOI 10.1016/j.rse.2005.11.006; Williams KS, 1995, ANNU REV ENTOMOL, V40, P36	35	84	92	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54852	10.1371/journal.pone.0054852	http://dx.doi.org/10.1371/journal.pone.0054852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359438	gold, Green Published, Green Submitted			2022-12-25	WOS:000314023600123
J	Cao, Y; Zhou, XX; Huang, XY; Li, QL; Gao, LL; Jiang, LJ; Huang, M; Zhou, JF				Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng			Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis	PLOS ONE			English	Article							CELLS; TARGETS; ESCAPE	Background: T cell immunoglobulin mucin-3 (Tim-3) has been identified as a negative regulator of anti-tumor immunity. Recent studies highlight the important role of Tim-3 in the CD8(+) T cell exhaustion that takes place in both human and animal cancer models. However, the nature of Tim-3 expression in the tumor cell and the mechanism by which it inhibits anti-tumor immunity are unclear. This present study aims to determine Tim-3 is expressed in cervical cancer cells and to evaluate the role of Tim-3 in cervical cancer progression. Methodology: A total of 85 cervical tissue specimens including 43 human cervical cancer, 22 cervical intraepithelial neoplasia (CIN) and 20 chronic cervicitis were involved. Tim-3 expression in tumor cells was detected and was found to correlate with clinicopathological parameters. Meanwhile, expression of Tim-3 was assessed by RT-PCR, Western Blot and confocal microscopy in cervical cancer cell lines, HeLa and SiHa. The migration and invasion potential of Hela cells was evaluated after inhibiting Tim-3 expression by ADV-antisense Tim-3. Conclusions: We found that Tim-3 was expressed at a higher level in the clinical cervical cancer cells compared to the CIN and chronic cervicitis controls. We supported this finding by confirming the presence of Tim-3 mRNA and protein in the cervical cell lines. Tim-3 expression in tumor cells correlated with clinicopathological parameters. Patients with high expression of Tim-3 had a significant metastatic potential, advanced cancer grades and shorter overall survival than those with lower expression. Multivariate analysis showed that Tim-3 expression was an independent factor for predicting the prognosis of cervical cancer. Significantly, down-regulating the expression of Tim-3 protein inhibited migration and invasion of Hela cells. Our study suggests that the expression of Tim-3 in tumor cells may be an independent prognostic factor for patients with cervical cancer. Moreover, Tim-3 expression may promote metastatic potential in cervical cancers.	[Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Huang, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China.	huangmei@medmail.com.cn	Cao, Yang/HGD-6463-2022	Yu, Shiqiang/0000-0003-3519-0943	National Science Foundation of China [81001049]; National Science Fund for Distinguished Young Scholars of China [81025011]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This article was supported by National Science Foundation of China (No. 81001049) and National Science Fund for Distinguished Young Scholars of China (No. 81025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2012, NAT REV CANCER, V12, P453; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Ibrahim R, 2006, CANCER-AM CANCER SOC, V106, P1065, DOI 10.1002/cncr.21697; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; No JH, 2011, MOL CARCINOGEN, V50, P244, DOI 10.1002/mc.20657; Norde WJ, 2012, BLOOD, V120, P728, DOI 10.1182/blood-2012-02-412510; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Zhou JF, 2005, CLIN CANCER RES, V11, P8431, DOI 10.1158/1078-0432.CCR-05-1085; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425	19	106	126	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53834	10.1371/journal.pone.0053834	http://dx.doi.org/10.1371/journal.pone.0053834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335978	Green Published, Green Submitted, gold			2022-12-25	WOS:000314707700036
J	Wang, Y; Wang, H; Zhang, W; Shao, C; Xu, P; Shi, CH; Shi, JG; Li, YM; Fu, Q; Xue, W; Lei, YH; Gao, JY; Wang, JY; Gao, XP; Li, JQ; Yuan, JL; Zhang, YT				Wang, Yong; Wang, He; Zhang, Wei; Shao, Chen; Xu, Peng; Shi, Chang Hong; Shi, Jian Guo; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping; Li, Jin Qing; Yuan, Jian Lin; Zhang, Yun Tao			Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-kappa B/IKK Pathway-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; MAMMARY TUMORIGENESIS; B ACTIVATION; GROWTH; CYTOTOXICITY; REPLICATION; INHIBITION; EXPOSURE; BETA; NBS1	Bladder cancer is the most common malignant urological disease in China. Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years. Previous research has demonstrated that the isoflavone, genistein, can sensitize multiple cancer cell lines to HCPT treatment, such as prostate and cervical cancer. In this study, we investigated whether genistein could sensitize bladder cancer cell lines and bladder epithelial cell BDEC cells to HCPT treatment, and investigated the possible underlying molecular mechanisms. Genistein could significantly and dose-dependently sensitize multiple bladder cancer cell lines and BDEC cells to HCPT-induced apoptosis both in vitro and in vivo. Genistein and HCPT synergistically inhibited bladder cell growth and proliferation, and induced G2/M phase cell cycle arrest and apoptosis in TCCSUP bladder cancer cell and BDEC cell. Pretreatment with genistein sensitized BDEC and bladder cancer cell lines to HCPT-induced DNA damage by the synergistic activation of ataxia telangiectasia mutated (ATM) kinase. Genistein significantly attenuated the ability of HCPT to induce activation of the antiapoptotic NF-kappa B pathway both in vitro and in vivo in a bladder cancer xenograft model, and thus counteracted the antiapoptotic effect of the NF-kappa B pathway. This study indicates that genistein could act as a promising non-toxic agent to improve efficacy of HCPT bladder cancer chemotherapy.	[Wang, Yong; Wang, He; Zhang, Wei; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Shao, Chen; Yuan, Jian Lin; Zhang, Yun Tao] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Dept Med, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Training Dept, Xian 710032, Shaanxi, Peoples R China; [Shi, Chang Hong] Fourth Mil Med Univ, Dept Expt Anim, Xian 710032, Shaanxi, Peoples R China; [Shi, Jian Guo] Fourth Mil Med Univ, Dept Canc Res Inst, Xian 710032, Shaanxi, Peoples R China; [Li, Jin Qing] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhang, YT (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China.	lijinqing@yahoo.cn; jianliny@fmmu.edu.cn; jiangru@fmmu.edu.cn	Wang, Chuan-Yue/C-9369-2015; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; zhang, wei/0000-0001-8511-7360; Xu, Zhi-Qing David/0000-0002-0387-7559	National Natural Science Foundation of China [30901498, 30100185, 81250036, 30973000, 30872583, 81072116]; Natural Science Foundation of Shaan'xi Province, China [2009JQ4003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaan'xi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901498, No. 30100185, No. 81250036, No. 30973000, No. 30872583, No. 81072116) and the Natural Science Foundation of Shaan'xi Province, China (2009JQ4003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Cheon J, 2002, INT J UROL, V9, P445, DOI 10.1046/j.1442-2042.2002.00500.x; Choi EJ, 2004, LIFE SCI, V75, P499, DOI 10.1016/j.lfs.2004.01.010; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Dheekollu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001257; Fu SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038465; Hilakivi-Clarke L, 1999, ONCOL REP, V6, P1089; Hilakivi-Clarke L, 1999, BRIT J CANCER, V80, P1682, DOI 10.1038/sj.bjc.6690584; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kakehi Y, 2010, JPN J CLIN ONCOL, V40, pi57, DOI 10.1093/jjco/hyq128; Kawakami K, 2011, BIOSCI BIOTECH BIOCH, V75, P650, DOI 10.1271/bbb.100738; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kontos S, 2011, UROL INT, V87, P151, DOI 10.1159/000324262; Kumi-Diaka J, 2010, J MED FOOD, V13, P842, DOI 10.1089/jmf.2009.0199; Lavin MF, 2005, ADV EXP MED BIOL, V570, P457, DOI 10.1007/1-4020-3764-3_16; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Manoharan N, 2010, ASIAN PAC J CANCER P, V11, P73; Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026903; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Papazisis KT, 2006, CANCER LETT, V233, P255, DOI 10.1016/j.canlet.2005.03.022; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040955; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Wang Yong, 2003, Ai Zheng, V22, P1272; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yee DS, 2011, UROLOGY, V78, P544, DOI 10.1016/j.urology.2011.02.042; [张思维 ZHANG Si-wei], 2009, [中华泌尿外科杂志, Chinese Journal of Urology], V30, P673; Zhou JR, 1998, CANCER RES, V58, P5231; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	33	172	181	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e50175	10.1371/journal.pone.0050175	http://dx.doi.org/10.1371/journal.pone.0050175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23741354	Green Published, Green Submitted, gold			2022-12-25	WOS:000314023600001
J	Wang, HLS; Yu, RJ; Wu, YT; Lee, WY; Lin, MF; Chen, CY; Shen, EY				Wang, Hsiao-Lan Sharon; Yu, Rongjun; Wu, Yu-Tzu; Lee, Wen-Yuan; Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao			The Changes of Cerebral Morphology Related to Aging in Taiwanese Population	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHITE-MATTER; PHYSICAL-ACTIVITY; CHILDREN-A; BRAIN; MR; VOLUME; ADULT; MECHANISMS; PATTERNS	A cross-sectional study with the 3-dimensional (3D) MRI reconstruction technique was conducted to investigate cerebral complexity changes related to age differences in native Taiwanese population. In our sample of 85 participants aged between 25 and 81, age was associated with gradual ventricular expansion. A nonlinear quadratic relationship between white matter volume and age was found overall in the brain. Widespread age-related reduction in white matter was detected from late adulthood onwards. However, no significant age-related changes in the cortex and whole brain volume were determined throughout adulthood. These findings provided information in describing brain structural complexity, which might in the future serve as an objective diagnostic index or as a predictive parameter for neurological diseases. Our method then may be used for cross-cultural longitudinal studies to evaluate the effect of disease, environment and aging on the brain.	[Wang, Hsiao-Lan Sharon] Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan; [Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wu, Yu-Tzu] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Lee, Wen-Yuan; Shen, Ein-Yiao] China Med Univ Hosp, Taipei Branch, Taipei, Taiwan; [Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Taiwan Normal University; South China Normal University; South China Normal University; University of Cambridge; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Shen, EY (corresponding author), China Med Univ Hosp, Taipei Branch, Taipei, Taiwan.	acupmoxi123@gmail.com	Chen, Chia-Yuan/N-7780-2014; Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Chen, Chun-Hong/0000-0002-5166-9017; Wang, Hui-Min/0000-0002-4692-4917; Ho, Mei-Ling/0000-0001-8064-8488; Wu, Yu-Tzu/0000-0002-0874-4448	National Science Council in Taiwan, NSC [99-2320-B-039-018-MY2]	National Science Council in Taiwan, NSC	This study was supported the National Science Council in Taiwan, NSC 99-2320-B-039-018-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Boss B J, 1991, SCI Nurs, V8, P42; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Free SL, 1996, CEREB CORTEX, V6, P830, DOI 10.1093/cercor/6.6.830; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hobbs F, 2000, CENSUS 2000 SPECIAL; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Maillet D, 2011, BRAIN RES, V1420, P68, DOI 10.1016/j.brainres.2011.08.071; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Shen EY, 2010, CHILD NERV SYST, V26, P1619, DOI 10.1007/s00381-010-1280-1; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang X, 1985, Popul Res, V2, P24; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Xu J, 2000, AM J NEURORADIOL, V21, P112	35	81	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55241	10.1371/journal.pone.0055241	http://dx.doi.org/10.1371/journal.pone.0055241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23762223	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600161
J	Lin, YC; Chen, JC; Morni, WZW; Putra, DF; Huang, CL; Li, CC; Hsieh, JF				Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang			Vaccination Enhances Early Immune Responses in White Shrimp Litopenaeus vannamei after Secondary Exposure to Vibrio alginolyticus	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; PROPHENOLOXIDASE-ACTIVATING SYSTEM; HOT-WATER EXTRACT; PENAEUS-MONODON; GRACILARIA-TENUISTIPITATA; RESISTANCE; HEMOCYTES; INNATE; CLASSIFICATION; CRUSTACEANS	Background: Recent work suggested that the presence of specific memory or some form of adaptive immunity occurs in insects and shrimp. Hypervariable pattern recognition molecules, known as Down syndrome cell adhesion molecules, are able to mount specific recognition, and immune priming in invertebrates. In the present study, we attempted to understand the immune response pattern of white shrimp Litopenaeus vannamei which received primary (PE) and secondary exposure (SE) to Vibrio alginolyticus. Methodology: Immune parameters and proliferation of haematopoietic tissues (HPTs) of shrimp which had received PE and SE to V. alginolyticus were measured. In the PE trial, the immune parameters and proliferation of HPTs of shrimp that received heat-killed V. alginolyticus (HVa) and formalin-inactivated V. alginolyticus (FVa) were measured. Mortality, immune parameters and proliferation of HPTs of 7-day-HVa-PE shrimp (shrimp that received primary exposure to HVa after 7 days) and 7-day-FVa-PE shrimp (shrimp that received primary exposure to FVa after 7 days) following SE to live V. alginolyticus (LVa) were measured. Phagocytic activity and clearance efficiency were examined for the 7 similar to 35-day-HVa-PE and FVa-PE shrimp. Results: HVa-receiving shrimp showed an earlier increase in the immune response on day 1, whereas FVa-receiving shrimp showed a late increase in the immune response on day 5. The 7-day-FVa-PE shrimp showed enhancement of immunity when encountering SE to LVa, whereas 7-day-HVa-PE shrimp showed a minor enhancement in immunity. 7-day-FVa-PE shrimp showed higher proliferation and an HPT mitotic index. Both phagocytic activity and clearance maintained higher for both HVa-PE and FVa-PE shrimp after 28 days. Conclusions: HVa-and FVa-receiving shrimp showed the bacteria agglutinated prior to being phagocytised. FVa functions as a vaccine, whereas HVa functions as an inducer and can be used as an immune adjuvant. A combined mixture of FVa and HVa can serve as a "vaccine component" to modulate the immunity of shrimp.	[Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan	National Taiwan Ocean University	Chen, JC (corresponding author), Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan.	jcchen@mail.ntou.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	National Science Council [NSC98-2313-B-019-002-MY3, NSC101-2313-B-019-002]; Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	National Science Council(Ministry of Science and Technology, Taiwan); Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	This paper was supported by grants from the National Science Council (NSC98-2313-B-019-002-MY3 and NSC101-2313-B-019-002), and the Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AO, 1999, AQUACULTURE, V178, P1, DOI 10.1016/S0044-8486(99)00131-3; Arala-Chaves M, 2000, AQUACULTURE, V191, P247, DOI 10.1016/S0044-8486(00)00430-0; BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W; BIAGINI G, 1995, NEUROSCI LETT, V190, P212, DOI 10.1016/0304-3940(95)11529-6; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; CHAN SM, 1988, BIOL BULL, V175, P185, DOI 10.2307/1541558; Chang CC, 2008, FISH SHELLFISH IMMUN, V25, P672, DOI 10.1016/j.fsi.2008.09.004; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P1, DOI 10.1016/j.fsi.2004.03.002; Chou PH, 2011, FISH SHELLFISH IMMUN, V30, P1109, DOI 10.1016/j.fsi.2011.02.009; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Eliss A. E., 1990, TECHNIQUES FISH IMMU, P101, DOI DOI 10.1016/S0145-305X(01)00038-6; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Hossain M. M. M., 2009, Journal of Biological Sciences, V9, P392, DOI 10.3923/jbs.2009.392.401; Hou WY, 2005, FISH SHELLFISH IMMUN, V19, P127, DOI 10.1016/j.fsi.2004.11.009; Humason G.L., 1979, ANIMAL TISSUE TECHNI, P661, DOI DOI 10.5962/BHL.TITLE.5890; ITAMI T, 1991, Journal of Aquatic Animal Health, V3, P151, DOI 10.1577/1548-8667(1991)003&lt;0151:SOLGTP&gt;2.3.CO;2; Itami T, 1989, J AQUAT ANIM HEALTH, V1, P234; Itami T, 1992, FISHERIES, V40, P139; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; Li CC, 2010, FISH SHELLFISH IMMUN, V28, P121, DOI 10.1016/j.fsi.2009.10.003; Li CC, 2008, FISH SHELLFISH IMMUN, V25, P853, DOI 10.1016/j.fsi.2008.09.014; Lightner DV, 1998, AQUACULTURE, V164, P201, DOI 10.1016/S0044-8486(98)00187-2; Liu CH, 2004, DIS AQUAT ORGAN, V61, P169, DOI 10.3354/dao061169; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Namikoshi A, 2004, AQUACULTURE, V229, P25, DOI 10.1016/S0044-8486(03)00363-6; Pereira J. J., 2009, Tamilnadu Journal of Veterinary and Animal Sciences, V5, P246; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pope EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020960; Powell A, 2011, J INVERTEBR PATHOL, V107, P95, DOI 10.1016/j.jip.2011.02.006; Rodriguez J, 2000, AQUACULTURE, V191, P109, DOI 10.1016/S0044-8486(00)00421-X; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Rowley AF, 2007, J IMMUNOL, V179, P7209, DOI 10.4049/jimmunol.179.11.7209; Sirirustananun N, 2011, FISH SHELLFISH IMMUN, V31, P848, DOI 10.1016/j.fsi.2011.07.025; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; Smith VJ, 2003, FISH SHELLFISH IMMUN, V15, P71, DOI 10.1016/S1050-4648(02)00140-7; SODERHALL K, 1979, CAN J MICROBIOL, V25, P406, DOI 10.1139/m79-062; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Tayag CM, 2010, FISH SHELLFISH IMMUN, V28, P764, DOI 10.1016/j.fsi.2010.01.023; Teunissen OSP, 1998, AQUACULTURE, V164, P359, DOI 10.1016/S0044-8486(98)00200-2; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yeh ST, 2008, AQUACULTURE, V276, P22, DOI 10.1016/j.aquaculture.2008.01.034; Yeh ST, 2009, FISH SHELLFISH IMMUN, V26, P724, DOI 10.1016/j.fsi.2009.02.025; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003	60	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69722	10.1371/journal.pone.0069722	http://dx.doi.org/10.1371/journal.pone.0069722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23365670	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100079
J	Luo, JL; Li, WF; Qiu, J; Wei, DT; Liu, YJ; Zhang, QL				Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin			Neural Basis of Scientific Innovation Induced by Heuristic Prototype	PLOS ONE			English	Article							DIVERGENT THINKING; CREATIVE-THINKING; INSIGHT; EEG; MEMORY; RECOGNITION; PERFORMANCE; LOCUS; FMRI	A number of major inventions in history have been based on bionic imitation. Heuristics, by applying biological systems to the creation of artificial devices and machines, might be one of the most critical processes in scientific innovation. In particular, prototype heuristics propositions that innovation may engage automatic activation of a prototype such as a biological system to form novel associations between a prototype's function and problem-solving. We speculated that the cortical dissociation between the automatic activation and forming novel associations in innovation is critical point to heuristic creativity. In the present study, novel and old scientific innovations (NSI and OSI) were selected as experimental materials in using learning-testing paradigm to explore the neural basis of scientific innovation induced by heuristic prototype. College students were required to resolve NSI problems (to which they did not know the answers) and OSI problems (to which they knew the answers). From two fMRI experiments, our results showed that the subjects could resolve NSI when provided with heuristic prototypes. In Experiment 1, it was found that the lingual gyrus (LG; BA18) might be related to prototype heuristics in college students resolving NSI after learning a relative prototype. In Experiment 2, the LG (BA18) and precuneus (BA31) were significantly activated for NSI compared to OSI when college students learned all prototypes one day before the test. In addition, the mean beta-values of these brain regions of NSI were all correlated with the behavior accuracy of NSI. As our hypothesis indicated, the findings suggested that the LG might be involved in forming novel associations using heuristic information, while the precuneus might be involved in the automatic activation of heuristic prototype during scientific innovation.	[Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin] Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Junlong] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China	Southwest University - China; Shanghai Normal University	Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; qlzhang.swu@gmail.com	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [31170983, 30970892, 31200768, 31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [NSKD11007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31170983; 30970892; 31200768; 31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Program for Talents in Colleges and Universities in Chongqing, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (NSKD11007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; BLAGROVE M, 1994, PERS INDIV DIFFER, V16, P981, DOI 10.1016/0191-8869(94)90242-9; Blagrove M, 2000, PERS INDIV DIFFER, V28, P41, DOI 10.1016/S0191-8869(99)00078-1; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; Dickinson MH, 1999, P NATL ACAD SCI USA, V96, P14208, DOI 10.1073/pnas.96.25.14208; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; DOMINO G, 1970, J CONSULT CLIN PSYCH, V35, P48, DOI 10.1037/h0029624; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; Fink A, 2007, METHODS, V42, P68, DOI 10.1016/j.ymeth.2006.12.001; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Jausovec N, 2000, INT J PSYCHOPHYSIOL, V36, P73, DOI 10.1016/S0167-8760(99)00113-0; Jausovec N, 2000, BRAIN TOPOGR, V12, P229, DOI 10.1023/A:1023446024923; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Molle M, 1999, PSYCHOPHYSIOLOGY, V36, P95, DOI 10.1017/S0048577299961619; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Razoumnikova OM, 2000, COGNITIVE BRAIN RES, V10, P11, DOI 10.1016/S0926-6410(00)00017-3; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Vogel S, 2000, CATS PAWS CATAPULTS	34	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e49231	10.1371/journal.pone.0049231	http://dx.doi.org/10.1371/journal.pone.0049231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	24098501	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400001
J	Yao, XL; Fu, BJ; Lu, YH; Sun, FX; Wang, S; Liu, M				Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min			Comparison of Four Spatial Interpolation Methods for Estimating Soil Moisture in a Complex Terrain Catchment	PLOS ONE			English	Article							SEMIARID LOESS PLATEAU; LINEAR-REGRESSION; VARIABILITY; WATER; PREDICTION; SURFACE; MODEL; SCALE; SCATTEROMETER; INFORMATION	Many spatial interpolation methods perform well for gentle terrains when producing spatially continuous surfaces based on ground point data. However, few interpolation methods perform satisfactorily for complex terrains. Our objective in the present study was to analyze the suitability of several popular interpolation methods for complex terrains and propose an optimal method. A data set of 153 soil water profiles (1 m) from the semiarid hilly gully Loess Plateau of China was used, generated under a wide range of land use types, vegetation types and topographic positions. Four spatial interpolation methods, including ordinary kriging, inverse distance weighting, linear regression and regression kriging were used for modeling, randomly partitioning the data set into 2/3 for model fit and 1/3 for independent testing. The performance of each method was assessed quantitatively in terms of mean-absolute-percentage-error, root-mean-square-error, and goodness-of-prediction statistic. The results showed that the prediction accuracy differed significantly between each method in complex terrain. The ordinary kriging and inverse distance weighted methods performed poorly due to the poor spatial autocorrelation of soil moisture at small catchment scale with complex terrain, where the environmental impact factors were discontinuous in space. The linear regression model was much more suitable to the complex terrain than the former two distance-based methods, but the predicted soil moisture changed too sharply near the boundary of the land use types and junction of the sunny (southern) and shady (northern) slopes, which was inconsistent with reality because soil moisture should change gradually in short distance due to its mobility in soil. The most optimal interpolation method in this study for the complex terrain was the hybrid regression kriging, which produced a detailed, reasonable prediction map with better accuracy and prediction effectiveness.	[Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009; Wang, Shuai/B-2334-2017	Wang, Shuai/0000-0003-1595-9858; Feng, Haiyang/0000-0002-2169-2347; Shen, Wen-Hui/0000-0001-7988-6382	National Natural Science Foundation of China [40930528]; State Forestry Administration [201004058]; CAS/SAFEA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (No. 40930528), State Forestry Administration (No. 201004058) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergel C, 2008, HYDROL EARTH SYST SC, V12, P1323, DOI 10.5194/hess-12-1323-2008; Bai Tian-lu, 2009, Shengtaixue Zazhi, V28, P2508; Baskan O, 2009, CLAY MINER, V44, P181, DOI 10.1180/claymin.2009.044.2.181; Bi HX, 2008, J AM WATER RESOUR AS, V44, P1121, DOI 10.1111/j.1752-1688.2008.00236.x; Bi HX, 2009, INT J SEDIMENT RES, V24, P63, DOI 10.1016/S1001-6279(09)60016-0; Carre F, 2002, GEODERMA, V110, P241, DOI 10.1016/S0016-7061(02)00233-1; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Gilbert B, 1997, LANDSCAPE URBAN PLAN, V37, P235, DOI 10.1016/S0169-2046(97)80007-2; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Lesch SM, 2008, GEODERMA, V148, P130, DOI 10.1016/j.geoderma.2008.09.014; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Lin GF, 2004, J HYDROL, V288, P288, DOI 10.1016/j.jhydrol.2003.10.008; Liu W, 2010, AGR WATER MANAGE, V97, P1133, DOI 10.1016/j.agwat.2010.01.001; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Minet J, 2011, HYDROL EARTH SYST SC, V15, P1323, DOI 10.5194/hess-15-1323-2011; Moran MS, 2004, CAN J REMOTE SENS, V30, P805, DOI 10.5589/m04-043; Perry MA, 2008, HYDROL EARTH SYST SC, V12, P39, DOI 10.5194/hess-12-39-2008; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; Sigua GC, 2008, J SOIL SEDIMENT, V8, P193, DOI 10.1007/s11368-008-0003-7; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Sun W, 2012, J PLANT NUTR SOIL SC, V175, P212, DOI 10.1002/jpln.201100005; Tabari H, 2011, METEOROL ATMOS PHYS, V110, P135, DOI 10.1007/s00703-010-0110-z; Tischler M, 2007, ENVIRON MODELL SOFTW, V22, P891, DOI 10.1016/j.envsoft.2006.05.022; Toth E, 2008, CEREAL RES COMMUN, V36, P307; Tramblay Y, 2010, J HYDROL, V387, P176, DOI 10.1016/j.jhydrol.2010.04.006; Vanita Pandey, 2010, International Journal of Geosciences, V1, P87; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Wang M, 2012, PLOS ONE, V7; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 2009, J GEOGR SCI, V19, P707, DOI 10.1007/s11442-009-0707-7; Wu J, 2006, GEODERMA, V134, P187, DOI 10.1016/j.geoderma.2005.11.002; Yao XL, 2012, J SOIL SEDIMENT, V12, P694, DOI 10.1007/s11368-012-0481-5; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zeng C, 2011, ACTA AGR SCAND B-S P, V61, P1, DOI 10.1080/09064710903352589; Zhang CL, 2008, INT FED INFO PROC, V258, P719; Zhang CL, 2009, INT FED INFO PROC, V293, P285; Zhao PP, 2010, ACTA AGR SCAND B-S P, V60, P117, DOI 10.1080/09064710802676377; Zhu Q, 2010, PEDOSPHERE, V20, P594, DOI 10.1016/S1002-0160(10)60049-5; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433; Zribi M, 2003, REMOTE SENS ENVIRON, V86, P30, DOI 10.1016/S0034-4257(03)00065-8	48	126	136	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54660	10.1371/journal.pone.0054660	http://dx.doi.org/10.1371/journal.pone.0054660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23483879	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500101
J	Luo, JF; Wang, Y; Tang, SS; Liang, JW; Lin, WT; Luo, LX				Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin			Isolation and Identification of Algicidal Compound from Streptomyces and Algicidal Mechanism to Microcystis aeruginosa	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; TOXIC DINOFLAGELLATE; BIOLOGICAL-ACTIVITY; RED-TIDE; CYANOBACTERIA; BACTERIUM; SAPONIN; METABOLITES; BLOOMS; FUNGUS	The biological control of cyanobacterial harmful algal blooms (cyanoHABs) is important to promote human health, environmental protection, and economic growth. Active algicidal compounds and algicidal mechanisms should be identified and investigated to control cyanoHABs. In this study, the algicidal actinobacterium Streptomyces sp. L74 was isolated from the soil of a nearby pond which located in the center lake of Guanghzou Higher Education Mega Center. Results showed that the algicidal activities of cyanoHABs are mainly achieved via an indirect attack by producing algicidal compounds. All active algicidal compounds are hydrophilic substances that are heat and pH stable. In the present study, an active compound (B3) was isolated and purified by high-performance liquid chromatography and identified as a type of triterpenoid saponin (2-hydroxy-12-oleanene-3, 28-O-D- glucopyranosyl) with a molecular formula of C42H70O13 as determined by infrared spectrometry, electrospray ionization mass spectrometry, and nuclear magnetic resonance. Active algicidal compounds from Streptomyces sp. L74 were shown to disrupt the antioxidant systems of Microcystis aeruginosa cells.	[Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Lin, WT (corresponding author), S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	weitie@21cn.com; btlxluo@scut.edu.cn	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [21076090, 21276099]; Specialized Research Found for the Doctoral Program of Higher Education of China [20120172120045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Found for the Doctoral Program of Higher Education of China	This work was supported by the National Natural Science Foundation of China (21076090 and 21276099) and the Specialized Research Found for the Doctoral Program of Higher Education of China (20120172120045)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H E, 1983, METHOD ENZYMATIC ANA, P273, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Aliyu AB, 2011, J MED PLANTS RES, V5, P6709, DOI 10.5897/JMPR10.708; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Arabski M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/286216; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; CIVELLO PM, 1995, J AGR FOOD CHEM, V43, P2596, DOI 10.1021/jf00058a008; DAFT MJ, 1975, FRESHWATER BIOL, V5, P577, DOI 10.1111/j.1365-2427.1975.tb00157.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gause GF, 2004, HDB MICROBIOLOGICAL, P704; Hasegawa H, 1996, PLANTA MED, V62, P453, DOI 10.1055/s-2006-957938; Isaka M, 2011, J NAT PROD, V74, P300, DOI 10.1021/np100873t; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakamura N, 2003, J BIOSCI BIOENG, V95, P179, DOI 10.1263/jbb.95.179; Noike M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042090; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Podolak Irma, 2007, Acta Pol Pharm, V64, P39; REDHEAD K, 1978, APPL ENVIRON MICROB, V35, P962, DOI 10.1128/AEM.35.5.962-969.1978; SAFFERMAN RS, 1963, SCIENCE, V140, P679, DOI 10.1126/science.140.3567.679; SAFFERMAN RS, 1962, APPL MICROBIOL, V10, P289, DOI 10.1128/AEM.10.4.289-292.1962; Sakata T, 2011, FISHERIES SCI, V77, P397, DOI 10.1007/s12562-011-0345-8; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; SHIGEMATSU N, 1992, J ANTIBIOT, V45, P704, DOI 10.7164/antibiotics.45.704; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Volk RB, 2005, J APPL PHYCOL, V17, P339, DOI 10.1007/s10811-005-7292-7; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yang JD, 2009, INT J MOL SCI, V10, P4157, DOI 10.3390/ijms10094157; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	44	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76444	10.1371/journal.pone.0076444	http://dx.doi.org/10.1371/journal.pone.0076444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098501	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600052
J	Lee, YA; Kim, YH; Kim, BJ; Kim, BG; Kim, KJ; Auh, JH; Schmidt, JA; Ryu, BY				Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Auh, Joong-Hyuck; Schmidt, Jonathan A.; Ryu, Buom-Yong			Cryopreservation in Trehalose Preserves Functional Capacity of Murine Spermatogonial Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; MOUSE TESTES; GERM-CELLS; PHOSPHATIDYLSERINE EXPRESSION; HEMATOPOIETIC-CELLS; TESTICULAR TISSUE; CANCER-TREATMENT; A SPERMATOGONIA; SELF-RENEWAL; ANNEXIN-V	Development of techniques to isolate, culture, and transplant human spermatogonial stem cells (SSCs) has the future potential to treat male infertility. To maximize the efficiency of these techniques, methods for SSC cryopreservation need to be developed to bank SSCs for extended periods of time. Although, it has been demonstrated that SSCs can reinitiate spermatogenesis after freezing, optimal cryopreservation protocols that maximize SSC proliferative capacity post-thaw have not been identified. The objective of this study was to develop an efficient cryopreservation technique for preservation of SSCs. To identify efficient cryopreservation methods for long-term preservation of SSCs, isolated testis cells enriched for SSCs were placed in medium containing dimethyl sulfoxide (DMSO) or DMSO and trehalose (50 mM, 100 mM, or 200 mM), and frozen in liquid nitrogen for 1 week, 1 month, or 3 months. Freezing in 50 mM trehalose resulted in significantly higher cell viability compared to DMSO at all thawing times and a higher proliferation rate compared to DMSO for the 1 week freezing period. Freezing in 200 mM trehalose did not result in increased cell viability; however, proliferation activity was significantly higher and percentage of apoptotic cells was significantly lower compared to DMSO after freezing for 1 and 3 months. To confirm the functionality of SSCs frozen in 200 mM trehalose, SSC transplantation was performed. Donor SSCs formed spermatogenic colonies and sperm capable of generating normal progeny. Collectively, these results indicate that freezing in DMSO with 200 mM trehalose serves as an efficient method for the cryopreservation of SSCs.	[Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Auh, Joong-Hyuck] Chung Ang Univ, Dept Food Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Schmidt, Jonathan A.] Spokane Community Coll, Dept Sci, Spokane, WA USA	Chung Ang University; Chung Ang University	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea.	byryu@cau.ac.kr	Auh, Joong Hyuck/ABG-9137-2021	Auh, Joong Hyuck/0000-0001-9425-2599; Park, Chankyu/0000-0003-4855-2210; Lee, Yong-An/0000-0001-7253-2397	Next-Generation BioGreen 21 Program [PJ0080482012]; Rural Development Administration, a National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0006786]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, a National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the Next-Generation BioGreen 21 Program (No.PJ0080482012) and Rural Development Administration, a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (2012-0006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Araki Y, 2010, BIOL REPROD, V83, P951, DOI 10.1095/biolreprod.109.082800; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 1992, ANN NY ACAD SCI, V364, P140; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2001, CRYOBIOLOGY, V43, P320; Ewing L L, 1980, Int Rev Physiol, V22, P41; FOSSA SD, 1989, BRIT J UROL, V64, P524, DOI 10.1111/j.1464-410X.1989.tb05292.x; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Izadyar F, 2002, J ANDROL, V23, P537; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2003, HUM REPROD, V18, P2660, DOI 10.1093/humrep/deg483; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kim BG, 2010, BIOL REPROD, V82, P1162, DOI 10.1095/biolreprod.109.079558; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAZUR P, 1988, ANN NY ACAD SCI, V541, P514, DOI 10.1111/j.1749-6632.1988.tb22288.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2004, ARCH HISTOL CYTOL, V67, P297, DOI 10.1679/aohc.67.297; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077	54	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54889	10.1371/journal.pone.0054889	http://dx.doi.org/10.1371/journal.pone.0054889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23675467	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100108
J	Yu, CC; Huang, SP; Lee, YC; Huang, CY; Liu, CC; Hour, TC; Huang, CN; You, BJ; Chang, TY; Huang, CH; Bao, BY				Yu, Chia-Cheng; Huang, Shu-Pin; Lee, Yung-Chin; Huang, Chao-Yuan; Liu, Chia-Chu; Hour, Tzyh-Chyuan; Huang, Chun-Nung; You, Bang-Jau; Chang, Ta-Yuan; Huang, Chun-Hsiung; Bao, Bo-Ying			Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer	PLOS ONE			English	Article							CAG REPEAT LENGTH; RECEPTOR GENE; ENDOCRINE-THERAPY; ANTIGEN NADIR; SURVIVAL; POLYMORPHISMS; TESTOSTERONE; LEVEL; RISK; TIME	Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate cancer treated with ADT was genotyped for 18 polymorphisms across 12 key genes involved in androgen and estrogen metabolism. We found that after adjusting for known risk factors in multivariate Cox regression models, AKR1C3 rs12529 and AR-CAG repeat length remained significantly associated with prostate cancer-specific mortality (PCSM) after ADT (P <= 0.041). Furthermore, individuals carrying two unfavorable genotypes at these loci presented a 13.7-fold increased risk of PCSM compared with individuals carrying zero (P<0.001). Our results identify two candidate molecular markers in key genes of androgen and estrogen pathways associated with PCSM after ADT, establishing the role of pharmacogenomics in this therapy.	[Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan; [Yu, Chia-Cheng] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Yu, Chia-Cheng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Dept Urol, Fac Med, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; CHOW, LU-PING/0000-0002-4420-211X; LIN, CHUNG-WU/0000-0001-5042-0503; HUANG, CHAO-YUAN/0000-0002-9322-6062; YANG, JYH-CHIN/0000-0003-4219-0685; Wu, Ming-Shiang/0000-0002-1940-6428; Yu, Cheng-Ping/0000-0002-0693-5056; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council (NSC), Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]; Kaohsiung Medical University Hospital [KMUH100-0R42]; Kaohsiung Veterans General Hospital [VGHKS97-048, VGHKS101-112]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital	This work was supported by the National Science Council (NSC), Taiwan (grant numbers: NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), China Medical University (grant number: CMU98-N1-21 and CMU98-C-12), Kaohsiung Medical University Hospital (grant number: KMUH100-0R42), and Kaohsiung Veterans General Hospital (grant number: VGHKS97-048 and VGHKS101-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2006, AM J CLIN ONCOL-CANC, V29, P14, DOI 10.1097/01.coc.0000195085.34162.88; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; GELLER J, 1984, J UROLOGY, V132, P693, DOI 10.1016/S0022-5347(17)49829-6; Gregory CW, 2001, CANCER RES, V61, P4315; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Imamoto T, 2001, ENDOCR J, V48, P573, DOI 10.1507/endocrj.48.573; Klotz L, 2005, PROSTATE CANCER P D, V8, P179, DOI 10.1038/sj.pcan.4500792; Kwak C, 2002, J UROLOGY, V168, P995, DOI 10.1016/S0022-5347(05)64559-4; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lindstrom S, 2006, PROSTATE, V66, P1729, DOI 10.1002/pros.20489; Misra D, 2011, BJU INT, V108, P1086, DOI 10.1111/j.1464-410X.2010.10037.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Sircar K, 2007, PROSTATE CANCER P D, V10, P360, DOI 10.1038/sj.pcan.4500967; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki H, 2002, PROSTATE, V51, P219, DOI 10.1002/pros.10080; Takeda H, 1996, CANCER, V77, P934, DOI 10.1002/(SICI)1097-0142(19960301)77:5<934::AID-CNCR20>3.3.CO;2-Q; Taplin ME, 1999, CANCER RES, V59, P2511; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	42	149	150	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54627	10.1371/journal.pone.0054627	http://dx.doi.org/10.1371/journal.pone.0054627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23460808	Green Submitted, gold, Green Published			2022-12-25	WOS:000314023600080
J	Yang, YL; Ji, C; Bi, ZG; Lu, CC; Wang, R; Gu, B; Cheng, L				Yang, Yan-li; Ji, Chao; Bi, Zhi-gang; Lu, Chun-cheng; Wang, Rong; Gu, Bing; Cheng, Lei			Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE ACTIVITY; AMPK ACTIVATION; DOWN-REGULATION; AKT INHIBITOR; IN-VITRO; CERAMIDE; GROWTH; HSP90; CONTRIBUTES	Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly improved, and the search for potential alternative therapies is encouraging. Here we demonstrate that deguelin administration causes a significant HNSCC cell death. Deguelin induces both cell apoptosis and autophagy by modulating multiple signaling pathways in cultured HNSCC cells. Deguelin inhibits Akt signaling, and down-regulates survivin and cyclin-dependent kinase 4 (Cdk4) expressions, by disrupting their association with heat shock protein-90 (Hsp-90). Deguelin induces ceramide production through de novo synthase pathway to promote HNSCC cell death. Importantly, increased ceramide level activates AMP-activated protein kinase (AMPK), which then directly phosphorylates Ulk1 and eventually leads to cell autophagy. We found that a low dose of deguelin sensitized HNSCC cells to 5-FU. Finally, using a nude mice Hep-2 xenograft model, we also showed a significant anti-tumor ability of deguelin in vivo. Together, we suggest that deguelin may represent a novel and effective chemo-agent against HNSCC.	[Yang, Yan-li; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Bi, Zhi-gang] Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Lu, Chun-cheng] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Rong] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Gu, Bing] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	eltonbibenqhospital@yahoo.com.cn; jspent@126.com	Cheng, Lei/AAT-2690-2021; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022	Cheng, Lei/0000-0001-6541-7702; Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation [810701297, 81101188, 30671894, 30972822, 30801016]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province [XK200719, XK200731, RC2007065, RC2011071]; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China [2010NJMUZ19]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China	This research was supported by grants from the National Natural Science Foundation (810701297, 81101188, 30671894, 30972822 and 30801016), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project of Jiangsu Province (XK200719, XK200731, RC2007065 and RC2011071), and the Science & Technology Development Foundation of Nanjing Medical University (2010NJMUZ19), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bozec A, 2009, EXPERT OPIN EMERG DR, V14, P299, DOI 10.1517/14728210902997947; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GERHAUSER C, 1995, NAT MED, V1, P260, DOI 10.1038/nm0395-260; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jang K.Y., 2012, CANC LETT; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Ji C, 2012, BIOCH BIOPHYS RES CO; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Ji C, 2010, INT J MOL MED, V26, P257, DOI 10.3892/ijmm_00000460; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Lippert BM, 2007, INT J CANCER, V121, P1169, DOI 10.1002/ijc.22941; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simmonds MA, 2003, CA-CANCER J CLIN, V53, P4, DOI 10.3322/canjclin.53.1.4; Sommer K, 2001, INT J ONCOL, V18, P1145; STELL PM, 1989, EUR J SURG ONCOL, V15, P407; STELL PM, 1991, HEAD NECK-J SCI SPEC, V13, P277, DOI 10.1002/hed.2880130403; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tripathi A, 2003, J CANCER RES CLIN, V129, P642, DOI 10.1007/s00432-003-0485-z; Udeani GO, 1997, CANCER RES, V57, P3424; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Yao C, 2012, CELL BIOCH BIOPHYS; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	66	286	295	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54736	10.1371/journal.pone.0054736	http://dx.doi.org/10.1371/journal.pone.0054736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23383172	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500119
